Citrus Sinensis ID: 043185
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 724 | 2.2.26 [Sep-21-2011] | |||||||
| O65238 | 872 | G-type lectin S-receptor- | yes | no | 0.965 | 0.801 | 0.563 | 0.0 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.912 | 0.805 | 0.381 | 1e-121 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.885 | 0.774 | 0.346 | 2e-84 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.859 | 0.750 | 0.344 | 8e-84 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.875 | 0.727 | 0.318 | 2e-81 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.837 | 0.760 | 0.334 | 8e-81 | |
| P17801 | 817 | Putative receptor protein | N/A | no | 0.928 | 0.822 | 0.321 | 4e-78 | |
| O64780 | 814 | G-type lectin S-receptor- | no | no | 0.841 | 0.748 | 0.303 | 3e-71 | |
| O64771 | 809 | G-type lectin S-receptor- | no | no | 0.850 | 0.761 | 0.298 | 2e-69 | |
| Q39202 | 832 | G-type lectin S-receptor- | no | no | 0.839 | 0.730 | 0.307 | 1e-68 |
| >sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 820 bits (2117), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/726 (56%), Positives = 530/726 (73%), Gaps = 27/726 (3%)
Query: 11 FLFIAPASSISFSEFIHPNFTASHVKFIDYG-GSFLTSHNGTFKAAIVNTRSQQNS--FY 67
F+F++ ASSI EF++PNFTAS+++F+D G+FL S N FKA + + +S FY
Sbjct: 18 FVFVSCASSI---EFVYPNFTASNLRFVDSSKGAFLLSRNSIFKAGLFSPGGDDSSTGFY 74
Query: 68 LCIIHVLSNTIIWSANRDTPISGSGKMNLTPKGI-IISDENGNLK-WSTPPLKSSVSALR 125
++HV S + IWS+NRD+P+S SG MNLTP+GI +I D + WSTP L S V +LR
Sbjct: 75 FSVVHVDSGSTIWSSNRDSPVSSSGTMNLTPQGISVIEDGKSQIPVWSTPVLASPVKSLR 134
Query: 126 LTEMGNLVLLDGFNGSLWESFHHPRDTIVIGQHLPAGASLSSAVSDYNLSTGDYSLTVGA 185
LT+ GNL+LLD N SLWESF P D+IV+GQ L G LS +VS + STGDY VG
Sbjct: 135 LTDAGNLLLLDHLNVSLWESFDFPTDSIVLGQRLKLGMFLSGSVSRSDFSTGDYKFLVGE 194
Query: 186 SDAELQWQGQMYWKLSMDTKAYVDSRYIVDYMAINRTGVYLFGNNGSAVVIRVVLPPS-N 244
SD +QW+GQ YWKL M +A VDS + V+Y+ + +G+ L NG+ VV+RV LPPS +
Sbjct: 195 SDGLMQWRGQNYWKLRMHIRANVDSNFPVEYLTVTTSGLALMARNGTVVVVRVALPPSSD 254
Query: 245 FRIAKLDASGQFTVLRLSGSDLEQEYMGPDDGCQIPFICGRMGMCADDATSGSPSCSCPA 304
FR+AK+D+SG+F V R SG +L E+ GP D CQIPF+CG++G+C D S + SCSCP
Sbjct: 255 FRVAKMDSSGKFIVSRFSGKNLVTEFSGPMDSCQIPFVCGKLGLCNLDNASENQSCSCPD 314
Query: 305 GFHLASQNTSGCVPSDASHSLPVACNSTRKESLLNASVVSYLRLGYGMDYFANHFFQPST 364
+ + CVP S SLPV+C A +SYL LG G+ YF+ HF P
Sbjct: 315 EMRMDA-GKGVCVPVSQSLSLPVSCE---------ARNISYLELGLGVSYFSTHFTDPVE 364
Query: 365 YDVNLSFCQELCSDDCSCLGIFFKNSSGSCYMLGNVLGSI--MSSNTVDSDLVGYIKVLV 422
+ + L C ++CS +CSCLG+F++N+S SCY++ + GS+ + ++ + DL+GY+K+ +
Sbjct: 365 HGLPLLACHDICSKNCSCLGVFYENTSRSCYLVKDSFGSLSLVKNSPENHDLIGYVKLSI 424
Query: 423 GPTQADLNPNNSSSNQNQDFPLVALVLLPFTGFFLFSALGFLWWRRWKLHKST---DSKS 479
T A P +++ FP++ALVLLP +GFFL ALG LWWRR + + + + +
Sbjct: 425 RKTNA--QPPGNNNRGGSSFPVIALVLLPCSGFFLLIALGLLWWRRCAVMRYSSIREKQV 482
Query: 480 GNPNTLSSGDLEAFYIPGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGILNDKTIVAV 539
P + SGDL +F+IPGLPQ+F++EELE AT+NFK IGSGGFG+VYKG L D+T++AV
Sbjct: 483 TRPGSFESGDLGSFHIPGLPQKFEFEELEQATENFKMQIGSGGFGSVYKGTLPDETLIAV 542
Query: 540 KKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILF- 598
KKITN G+ G+++FCTEIAIIGNI H NLVKL+GFCA+GRQ LLVYEYMNHGSL++ LF
Sbjct: 543 KKITNHGLHGRQEFCTEIAIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFS 602
Query: 599 GNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSK 658
GNGPVLEWQERFDIALGTARGLAYLHSGC+QKIIHCD+KPENILLH HFQ KISDFGLSK
Sbjct: 603 GNGPVLEWQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSK 662
Query: 659 LLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSH 718
LL E+SSLFTTMRGTRGYLAPEW+TN+AISEK DVYS+GMVLLELVSGR+NCS RS+S+
Sbjct: 663 LLNQEESSLFTTMRGTRGYLAPEWITNAAISEKADVYSYGMVLLELVSGRKNCSFRSRSN 722
Query: 719 SMDSNS 724
S+ ++
Sbjct: 723 SVTEDN 728
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 436 bits (1121), Expect = e-121, Method: Compositional matrix adjust.
Identities = 269/705 (38%), Positives = 390/705 (55%), Gaps = 44/705 (6%)
Query: 26 IHPNFTASHVKFIDYGGSFLTSHNGTFKAAIVNTRSQQNSFYLCIIHVLSNTIIWSANRD 85
I P F S + +I+ G FL S+N F V T+ F L IIH S +IWSANR
Sbjct: 29 ITPGFGGSQMNYINNDGIFLESNNSAFGFGFVTTQDSVTLFTLSIIHKSSTKLIWSANRA 88
Query: 86 TPISGSGKMNLTPKGIIISDENGNLKWSTPPLKSSVSALRLTEMGNLVLLDGFNGSLWES 145
+P+S S K G ++ + G W + S + L + GNLV++ S+WES
Sbjct: 89 SPVSNSDKFVFDDNGNVVME--GTEVWRLDNSGKNASRIELRDSGNLVVVSVDGTSIWES 146
Query: 146 FHHPRDTIVIGQHLPAGASLSSAVSDYNLSTGDYSLTVGASDAELQWQG---QMYWKLSM 202
F HP DT++ Q G L+S+ S N++ Y+L + + D L Q+YW ++
Sbjct: 147 FDHPTDTLITNQAFKEGMKLTSSPSSSNMT---YALEIKSGDMVLSVNSLTPQVYWSMAN 203
Query: 203 DTKAYVDSRYIVDYMAINRTGVYLFGNNGSAVVIRVVLPPSNFR----IAKLDASG--QF 256
+ ++ V + + F + ++ + V + IA L +G F
Sbjct: 204 ARERIINKDGGVVTSSSLLGNSWRFFDQKQVLLWQFVFSDNKDDNTTWIAVLGNNGVISF 263
Query: 257 TVLRLSGSDLEQEYMGPDDGCQIPFICGRMGMCADDATSGSPSCSCPAGFHLASQNTSGC 316
+ L S + P D C P CG +C SGS C C +G A
Sbjct: 264 SNLGSGASAADSSTKIPSDLCGTPEPCGPYYVC-----SGSKVCGCVSGLSRAR------ 312
Query: 317 VPSDASHSLPVACNSTRKESLLNASVVSYLRLGYGMDYFANHFFQPSTYDVNLSFCQELC 376
SD + C T+ + L +VS G G+DYFA + P + +L C+E C
Sbjct: 313 --SDCKTGITSPCKKTKDNATLPLQLVS---AGDGVDYFALGYAPPFSKKTDLDSCKEFC 367
Query: 377 SDDCSCLGIFFKNSSGSCYMLGNVLGSIMSSNTVDSDLVGYIKVLVGPTQADLNPNNSSS 436
++CSCLG+FF+NSSG+C++ + +GS +S S V YIK+ ++
Sbjct: 368 HNNCSCLGLFFQNSSGNCFLF-DYIGSFKTSGNGGSGFVSYIKI----ASTGSGGGDNGE 422
Query: 437 NQNQDFPLVALVLLPFTGFFLFSALGFLWWRRWKLHKSTDSKSGNPNTLSSGDLEAFYIP 496
+ + FP V ++++ + L + +++HK P S D +
Sbjct: 423 DDGKHFPYVVIIVVVTV-----FIIAVLIFVAFRIHKRKKMILEAPQESSEEDNFLENLS 477
Query: 497 GLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTE 556
G+P RF Y++L+ AT+NF +G GGFG+VY+G L D + +AVKK+ +G QGKK+F E
Sbjct: 478 GMPIRFAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKLEGIG-QGKKEFRAE 536
Query: 557 IAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILF--GNGPV-LEWQERFDIA 613
++IIG+IHH++LV+L+GFCA+G RLL YE+++ GSL+R +F +G V L+W RF+IA
Sbjct: 537 VSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIA 596
Query: 614 LGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRG 673
LGTA+GLAYLH C+ +I+HCDIKPENILL +F AK+SDFGL+KL+T EQS +FTTMRG
Sbjct: 597 LGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTTMRG 656
Query: 674 TRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSH 718
TRGYLAPEW+TN AISEK+DVYS+GMVLLEL+ GR+N P S
Sbjct: 657 TRGYLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPSETSE 701
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 314 bits (804), Expect = 2e-84, Method: Compositional matrix adjust.
Identities = 251/724 (34%), Positives = 351/724 (48%), Gaps = 83/724 (11%)
Query: 25 FIHPNFTASHVK--FIDYGGSFLTSHNGTFKAAIVNTRSQQNSFYLCIIHVLSNTIIWSA 82
FIH + + F G + S +GT++ S N + LS TI+W A
Sbjct: 16 FIHGSSAVDTISGDFTLSGDQTIVSSDGTYEMGFFKPGSSSNFYIGMWYKQLSQTILWVA 75
Query: 83 NRDTPIS--GSGKMNLTPKGIIISDENGNLK-WSTP-PLKSSVSALR--LTEMGNLVLLD 136
NRD +S S ++ +I+ D N WST SSVSAL L + GNLVL
Sbjct: 76 NRDKAVSDKNSSVFKISNGNLILLDGNYQTPVWSTGLNSTSSVSALEAVLQDDGNLVLRT 135
Query: 137 GFNG----SLWESFHHPRDT------IVIGQHLPAGASLSSAVSDYNLSTGDYSLTVGAS 186
G + LW+SF HP DT I + + L+S S + S G +SL + S
Sbjct: 136 GGSSLSANVLWQSFDHPGDTWLPGVKIRLDKRTGKSQRLTSWKSLEDPSPGLFSLELDES 195
Query: 187 DA-ELQWQG-QMYWKLSMDTKAYVDSRYIVDYMAINRTG-VY---LFGNNGSAVVIRVVL 240
A ++ W G YW + + I D + R +Y F N + +
Sbjct: 196 TAYKILWNGSNEYWS----SGPWNPQSRIFDSVPEMRLNYIYNFSFFSNTTDSYFTYSIY 251
Query: 241 PPSNFRIAKLDASGQFTVLR-LSGSDLEQEYMG-PDDGCQIPFICGRMGMCADDATSGSP 298
N +D SGQ L G+ + P CQ+ CG G+C+D + P
Sbjct: 252 NQLNVSRFVMDVSGQIKQFTWLEGNKAWNLFWSQPRQQCQVYRYCGSFGICSDKS---EP 308
Query: 299 SCSCPAGFHLASQN-------TSGCVPSDASHSLPVACNSTRKESLLNASVVSYLRLGYG 351
C CP GF SQ ++GCV + C+ + + RL
Sbjct: 309 FCRCPQGFRPMSQKDWDLKDYSAGCV-----RKTELQCS--------RGDINQFFRLP-N 354
Query: 352 MDYFANHFFQPSTYDVNLSFCQELCSDDCSCLGIFFKNSSGSCYMLGNVLGSIMSSNTVD 411
M N T +LS C C DCSC + S C + + ++ +
Sbjct: 355 MKLADNSEVLTRT---SLSICASACQGDCSCKAYAYDEGSSKCLVWSKDVLNLQQLEDEN 411
Query: 412 SD-LVGYIKVLVGPTQADLNPNNSSSNQNQDFPLVALVLLPFTGFFLFSALGFLWWRRWK 470
S+ + Y+++ PN +S ++ + L+ +L G + L + R++
Sbjct: 412 SEGNIFYLRLAASDV-----PNVGASGKSNNKGLIFGAVLGSLGVIVLVLLVVILILRYR 466
Query: 471 LHKSTDSKSGNPNTLSSGDLEAFYIPGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGI 530
K + G+ TLS+ F Y EL+ AT NF + +G GGFG+V+KG
Sbjct: 467 RRKRMRGEKGD-GTLSA--------------FSYRELQNATKNFSDKLGGGGFGSVFKGA 511
Query: 531 LNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590
L D + +AVK++ + QG+K F TE+ IG I HVNLV+L+GFC++G ++LLVY+YM +
Sbjct: 512 LPDSSDIAVKRLEGIS-QGEKQFRTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPN 570
Query: 591 GSLDRILFGNGP----VLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYH 646
GSLD LF N VL W+ RF IALGTARGLAYLH C IIHCDIKPENILL
Sbjct: 571 GSLDSHLFLNQVEEKIVLGWKLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQ 630
Query: 647 FQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS 706
F K++DFGL+KL+ + S + TTMRGTRGYLAPEW++ AI+ K DVYS+GM+L ELVS
Sbjct: 631 FCPKVADFGLAKLVGRDFSRVLTTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVS 690
Query: 707 GRRN 710
GRRN
Sbjct: 691 GRRN 694
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 312 bits (799), Expect = 8e-84, Method: Compositional matrix adjust.
Identities = 235/683 (34%), Positives = 343/683 (50%), Gaps = 61/683 (8%)
Query: 47 SHNGTFKAAIVNTRSQQNSFYLCIIHVLSNTIIWSANRDTPISGSGKMNLTPKG-IIISD 105
S N TF + V + S NSF L + + IWSA + G + L G + +++
Sbjct: 44 SPNSTFSVSFVPSPSP-NSF-LAAVSFAGSVPIWSAG---TVDSRGSLRLHTSGSLRLTN 98
Query: 106 ENGNLKWSTPPLKSSVSALRLTEMGNLVLLDGFNGSLWESFHHPRDTIVIGQHLPAGASL 165
+G W + + V++ + + G +LL+ + +W SF +P DTIV Q+ AG L
Sbjct: 99 GSGTTVWDSKTDRLGVTSGSIEDTGEFILLNNRSVPVWSSFDNPTDTIVQSQNFTAGKIL 158
Query: 166 SSAVSDYNLSTGDYSLTVGASDAELQWQ-GQMYWKLSMDTKAYVDSRYIVDYMAINRTGV 224
S + + L + + L+W +YW + + S +++ GV
Sbjct: 159 RSGLYSFQLER--------SGNLTLRWNTSAIYW--NHGLNSSFSSNLSSPRLSLQTNGV 208
Query: 225 Y-LFGNN---GSAVVIRVVLPPSN-FRIAKLDASGQFTVLRLSG--SDLEQEYMGPDDGC 277
+F +N G+ +V SN FR KLD G + + S + D C
Sbjct: 209 VSIFESNLLGGAEIVYSGDYGDSNTFRFLKLDDDGNLRIYSSASRNSGPVNAHWSAVDQC 268
Query: 278 QIPFICGRMGMCADDATSGSPSCSCPA---GFHLASQNTSGCVPSDASHSLPVACNSTRK 334
+ CG G+C+ + T+ P CSCP+ F + GC L +T
Sbjct: 269 LVYGYCGNFGICSYNDTN--PICSCPSRNFDFVDVNDRRKGC---KRKVELSDCSGNTTM 323
Query: 335 ESLLNASVVSYLRLGYGMDYFANHFFQPSTYDVNLSFCQELCSDDCSCLG-IFFKNSSGS 393
L++ + +Y D + FF S S C+ C CL + + SG+
Sbjct: 324 LDLVHTRLFTYED-----DPNSESFFAGS------SPCRANCLSSVLCLASVSMSDGSGN 372
Query: 394 CYMLGNVLGSIMSSNTVDS-DLVGYIKVLVGPTQAD-LNPNNSSSNQNQDFPLVALVLLP 451
C+ GS + S Y+KV GP A+ L + N L + +
Sbjct: 373 CWQ--KHPGSFFTGYQWPSVPSTSYVKV-CGPVVANTLERATKGDDNNSKVHLWIVAVAV 429
Query: 452 FTGFFLFSALGF-LWWRRWKLHKSTDSKSGNPNTLSSGDLEAFYIPGLPQRFDYEELEVA 510
G A+ LWW K+ TLSS Y G P +F Y+EL+
Sbjct: 430 IAGLLGLVAVEIGLWW-------CCCRKNPRFGTLSSHYTLLEYASGAPVQFTYKELQRC 482
Query: 511 TDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVK 570
T +FK +G+GGFG VY+G+L ++T+VAVK++ + QG+K F E+A I + HH+NLV+
Sbjct: 483 TKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEGIE-QGEKQFRMEVATISSTHHLNLVR 541
Query: 571 LKGFCAQGRQRLLVYEYMNHGSLDRILF--GNGPVLEWQERFDIALGTARGLAYLHSGCE 628
L GFC+QGR RLLVYE+M +GSLD LF + L W+ RF+IALGTA+G+ YLH C
Sbjct: 542 LIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYRFNIALGTAKGITYLHEECR 601
Query: 629 QKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL-FTTMRGTRGYLAPEWLTNSA 687
I+HCDIKPENIL+ +F AK+SDFGL+KLL P+ + +++RGTRGYLAPEWL N
Sbjct: 602 DCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLP 661
Query: 688 ISEKTDVYSFGMVLLELVSGRRN 710
I+ K+DVYS+GMVLLELVSG+RN
Sbjct: 662 ITSKSDVYSYGMVLLELVSGKRN 684
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 304 bits (778), Expect = 2e-81, Method: Compositional matrix adjust.
Identities = 228/715 (31%), Positives = 346/715 (48%), Gaps = 81/715 (11%)
Query: 47 SHNGTFKAAIVNTRSQQNSFYLCIIHVLS----NTIIWSANRDTPISGSGKMNLTPKG-I 101
S NGTF AI TR + +L I TI+WS NR++P++ + L G +
Sbjct: 47 SANGTF--AIGFTRFKPTDRFLLSIWFAQLPGDPTIVWSPNRNSPVTKEAVLELEATGNL 104
Query: 102 IISDENGNLKWSTPPLKSSVSALRLTEMGNLVLLDG---FNGSLWESFHHPRDTIVIGQH 158
++SD+N + W++ V + ++E GN +LL ++W+SF P DT++ Q
Sbjct: 105 VLSDQN-TVVWTSNTSNHGVESAVMSESGNFLLLGTEVTAGPTIWQSFSQPSDTLLPNQP 163
Query: 159 LPAGASLSSAVSDYNLSTGDYSLTVGASDAELQ-----------------WQGQMYWKLS 201
L L+S S G YSL + L W G ++
Sbjct: 164 LTVSLELTSNPSPSR--HGHYSLKMLQQHTSLSLGLTYNINLDPHANYSYWSGPDISNVT 221
Query: 202 MDTKAYVDS--RYIVDYMAINRTGVYLFGN--------NGSA--------VVIRVVLPPS 243
D A +D + + Y + VY++ N N S+ V+ R+VL +
Sbjct: 222 GDVTAVLDDTGSFKIVYGESSIGAVYVYKNPVDDNRNYNNSSNLGLTKNPVLRRLVLENN 281
Query: 244 -NFRIAKLDASGQFTVLRLSGSDLEQEYMGPDDGCQIPFICGRMGMCADDATSGSPSCSC 302
N R+ + D S E+ + C I ICG G+C D T + C C
Sbjct: 282 GNLRLYRWDNDMN------GSSQWVPEWAAVSNPCDIAGICGN-GVCNLDRTKKNADCLC 334
Query: 303 -PAGFHLASQNTSGCVPSDASHSLPVACNSTRKESLLNASVVSYLRLGYGMDYFANHFFQ 361
P L Q + ++S N R S + + Y YF+
Sbjct: 335 LPGSVKLPDQENAKLCSDNSSLVQECESNINRNGSF---KISTVQETNY---YFSERSVI 388
Query: 362 PSTYDV-NLSFCQELCSDDCSCLGIFFKNSSGSCYMLGNVLGSIMSSNTVDSDLVGYIKV 420
+ D+ N+ C E+C DC C+ + Y +L S+ D ++K
Sbjct: 389 ENISDISNVRKCGEMCLSDCKCVASVYGLDDEKPYCW--ILKSLNFGGFRDPGSTLFVKT 446
Query: 421 LVGPTQADLNPNNSSSNQNQDFPLVALVLLPFT--GFFLFSALGFLWWRRWKLHKSTDSK 478
+ + NN S ++ ++++P L + LG L L+ + D K
Sbjct: 447 RANESYPSNSNNNDSKSRKSHGLRQKVLVIPIVVGMLVLVALLGML------LYYNLDRK 500
Query: 479 SGNPNTLSSGDLEAFYIPGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGILNDKTIVA 538
TL + + P F Y +L+ T+NF L+GSGGFG VYKG + +T+VA
Sbjct: 501 ----RTLKRAAKNSLILCDSPVSFTYRDLQNCTNNFSQLLGSGGFGTVYKGTVAGETLVA 556
Query: 539 VKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILF 598
VK++ G+++F TE+ IG++HH+NLV+L G+C++ RLLVYEYM +GSLD+ +F
Sbjct: 557 VKRLDRALSHGEREFITEVNTIGSMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIF 616
Query: 599 GN---GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFG 655
+ +L+W+ RF+IA+ TA+G+AY H C +IIHCDIKPENILL +F K+SDFG
Sbjct: 617 SSEQTANLLDWRTRFEIAVATAQGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFG 676
Query: 656 LSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRN 710
L+K++ E S + T +RGTRGYLAPEW++N I+ K DVYS+GM+LLE+V GRRN
Sbjct: 677 LAKMMGREHSHVVTMIRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRN 731
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 302 bits (773), Expect = 8e-81, Method: Compositional matrix adjust.
Identities = 236/706 (33%), Positives = 346/706 (49%), Gaps = 100/706 (14%)
Query: 36 KFIDYGGSFLTSHNGTFKAAIVNTRSQQNSFYLCIIH--VLSNTIIWSANRDTPISG--S 91
K I G + S F+ +T + +++YL I + + + T +W ANR P+S S
Sbjct: 24 KVIIKGNQTILSFKAIFRLGFFSTTNGSSNWYLGISYASMPTPTHVWVANRIRPVSDPDS 83
Query: 92 GKMNLTPKG-IIISDENGNLKWSTPPLKSSVSALRLTEMGNLVLLDGFNGSLWESFHHPR 150
+ LT G +I+S+ + W T K + R +E GNL+L++ +W+SF +P
Sbjct: 84 STLELTSTGYLIVSNLRDGVVWQTDN-KQPGTDFRFSETGNLILINDDGSPVWQSFDNPT 142
Query: 151 DTIVIGQHLPAGASLSSAVSDYNLSTGDYSLTVGASDAELQ--WQGQM-YWKLSMDT-KA 206
DT + G ++ +++S S ++ S G YSL + S E Q ++G YW T +A
Sbjct: 143 DTWLPGMNVTGLTAMTSWRSLFDPSPGFYSLRLSPSFNEFQLVYKGTTPYWSTGNWTGEA 202
Query: 207 YVDSRYIVDYMAINRTGVYLFGNNGSAVV-IRVVLPP----SNFRIAK--LDASGQFTVL 259
+V V M I + F N + ++PP S R+ + + A+GQ L
Sbjct: 203 FVG----VPEMTIPYIYRFHFVNPYTPTASFWYIVPPLDSVSEPRLTRFMVGANGQ---L 255
Query: 260 RLSGSDLEQE-----YMGPDDGCQIPFICGRMGMCADDATSGSPSCSCPAGFHLASQNTS 314
+ D + + ++ P+D C++ +CG++G C+ + C+C GF +N +
Sbjct: 256 KQYTWDPQTQSWNMFWLQPEDPCRVYNLCGQLGFCSSELLK---PCACIRGFR--PRNDA 310
Query: 315 GCVPSDASHSLPVACNSTRKESLLNASVVSYL-RLGYGMDYFANHFFQPSTYDVNLSFCQ 373
D S C +S + + L Y D + S V+ S C
Sbjct: 311 AWRSDDYSD----GCRRENGDSGEKSDTFEAVGDLRYDGD------VKMSRLQVSKSSCA 360
Query: 374 ELCSDDCSCLGIFFKNSSGSCYML-------GNVLGSIMSSNTVDSDLVGYIKVLVGPTQ 426
+ C + SC+G + K S C +L N G+I S + +VG I VL
Sbjct: 361 KTCLGNSSCVGFYHKEKSNLCKILLESPNNLKNSKGNISKSIIILCSVVGSISVL----- 415
Query: 427 ADLNPNNSSSNQNQDFPLVALVLLPFTGFFLFSALGFLWWRRWKLHKSTDSKSGNPNTLS 486
GF L L L +S
Sbjct: 416 ---------------------------GFTLLVPLILL------------KRSRKRKKTR 436
Query: 487 SGDLEAFYIPGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNV 545
D + F + L + F ++EL+ AT+ F + +G GGFGAV+KG L T VAVK++
Sbjct: 437 KQDEDGFAVLNL-KVFSFKELQSATNGFSDKVGHGGFGAVFKGTLPGSSTFVAVKRLERP 495
Query: 546 GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGP-VL 604
G G+ +F E+ IGNI HVNLV+L+GFC++ RLLVY+YM GSL L P +L
Sbjct: 496 G-SGESEFRAEVCTIGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSYLSRTSPKLL 554
Query: 605 EWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664
W+ RF IALGTA+G+AYLH GC IIHCDIKPENILL + AK+SDFGL+KLL +
Sbjct: 555 SWETRFRIALGTAKGIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFGLAKLLGRDF 614
Query: 665 SSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRN 710
S + TMRGT GY+APEW++ I+ K DVYSFGM LLEL+ GRRN
Sbjct: 615 SRVLATMRGTWGYVAPEWISGLPITTKADVYSFGMTLLELIGGRRN 660
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P17801|KPRO_MAIZE Putative receptor protein kinase ZmPK1 OS=Zea mays GN=PK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 293 bits (749), Expect = 4e-78, Method: Compositional matrix adjust.
Identities = 246/766 (32%), Positives = 368/766 (48%), Gaps = 94/766 (12%)
Query: 1 MEPLLFVATIF-LFIAPASSISFSEFIHPNFTASHVKFIDYGGSFLTSHNGTFKAAIVNT 59
+ LL A I FIA + S I P S + Y S L S +GTF +
Sbjct: 5 LAALLSTACILSFFIALFPRAASSRDILP--LGSSLVVESYESSTLQSSDGTFSSGFYEV 62
Query: 60 RSQQNSFYLCIIHVLS-----NTIIWSANRDTPI-SGSGKMNLTPKG-IIISDENGNLKW 112
+ +F + + TI+WSAN D P+ + + L G ++++D +G W
Sbjct: 63 YTHAFTFSVWYSKTEAAAANNKTIVWSANPDRPVHARRSALTLQKDGNMVLTDYDGAAVW 122
Query: 113 STPPLK-SSVSALRLTEMGNLVLLDGFNGSLWESFHHPRDTIVIGQHLPAGASLSSAVSD 171
+ V RL + GNLV+ D ++W+SF P DT + Q + A L
Sbjct: 123 RADGNNFTGVQRARLLDTGNLVIEDSGGNTVWQSFDSPTDTFLPTQLITAATRLVPTTQ- 181
Query: 172 YNLSTGDY-----SLTVGASDAELQWQGQMYWKLSMDTKAYVDSRYIVDYM---AINRTG 223
+ S G+Y L+V + + +YW D Y D R + + +G
Sbjct: 182 -SRSPGNYIFRFSDLSVLSLIYHVPQVSDIYWP-DPDQNLYQDGRNQYNSTRLGMLTDSG 239
Query: 224 VYLFGN--NGSAVVIRVVLPPSNFRIAKLDASGQFTVLRLSGSD--LEQEYMGPDDGCQI 279
V + +G A+V V P R+ LD G + ++ SD + C I
Sbjct: 240 VLASSDFADGQALVASDVGPGVKRRLT-LDPDGNLRLYSMNDSDGSWSVSMVAMTQPCNI 298
Query: 280 PFICGRMGMCADDATSGSPSCSCPAGFHLASQN----TSGCVPSDASHSLPVACNSTRKE 335
+CG G+C S +P+CSCP G+ A++N T GC+ + C+ K
Sbjct: 299 HGLCGPNGICH---YSPTPTCSCPPGY--ATRNPGNWTEGCMAI-----VNTTCDRYDKR 348
Query: 336 SLLNASVVSYLRLGYGMDYFANHFFQPSTYDVNLSFCQELCSDDCSCLGIFFKNSSGSCY 395
S+ ++RL D++ + Q V+L C+++C DC+C G ++ +GSCY
Sbjct: 349 SM------RFVRLP-NTDFWGSD--QQHLLSVSLRTCRDICISDCTCKGFQYQEGTGSCY 399
Query: 396 MLGNVLGSIMSSNTVDSDLVGYIKVLVG-----------------PTQADLNPNNSSSNQ 438
L S + T D + Y+K+ G P + D + N S +
Sbjct: 400 PKA-YLFSGRTYPTSDVRTI-YLKLPTGVSVSNALIPRSDVFDSVPRRLDCDRMNKSIRE 457
Query: 439 NQDFPLVALVLLPFTGFFLF------------SALGFLWWRRWKLHKSTDSKSGNPNTLS 486
FP V + +F F S + F W+ K + P+ L
Sbjct: 458 --PFPDVHKTGGGESKWFYFYGFIAAFFVVEVSFISFAWFFVLK-------RELRPSELW 508
Query: 487 SGDLEAFYIPGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVG 546
+ + + +R+ Y EL AT FK +G G G VYKG+L D VAVKK+ NV
Sbjct: 509 ASEKGYKAMTSNFRRYSYRELVKATRKFKVELGRGESGTVYKGVLEDDRHVAVKKLENVR 568
Query: 547 VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGP--VL 604
QGK+ F E+++IG I+H+NLV++ GFC++G RLLV EY+ +GSL ILF G +L
Sbjct: 569 -QGKEVFQAELSVIGRINHMNLVRIWGFCSEGSHRLLVSEYVENGSLANILFSEGGNILL 627
Query: 605 EWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664
+W+ RF+IALG A+GLAYLH C + +IHCD+KPENILL F+ KI+DFGL KLL
Sbjct: 628 DWEGRFNIALGVAKGLAYLHHECLEWVIHCDVKPENILLDQAFEPKITDFGLVKLLNRGG 687
Query: 665 SSL-FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
S+ + +RGT GY+APEW+++ I+ K DVYS+G+VLLEL++G R
Sbjct: 688 STQNVSHVRGTLGYIAPEWVSSLPITAKVDVYSYGVVLLELLTGTR 733
|
Probable receptor. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64780|Y1614_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61400 OS=Arabidopsis thaliana GN=At1g61400 PE=2 SV=4 | Back alignment and function description |
|---|
Score = 270 bits (690), Expect = 3e-71, Method: Compositional matrix adjust.
Identities = 217/715 (30%), Positives = 332/715 (46%), Gaps = 106/715 (14%)
Query: 42 GSFLTSHNGTFKAAIVNTRSQQNSFY-LCIIHVLSNTIIWSANRDTPISGSGKMNLTPKG 100
G L+S NG ++ + + QN + + ++ ++W ANR+ P++ S
Sbjct: 45 GQTLSSSNGVYELGFFSFNNSQNQYVGISFKGIIPRVVVWVANREKPVTDSAA------N 98
Query: 101 IIISDENGNLK---------WST-PPLKSSVSALRLTEMGNLVLLDGFNG-SLWESFHH- 148
++IS NG+L+ WS+ L S+ S + L + GNLV+++ +G +LWESF H
Sbjct: 99 LVISS-NGSLQLFNGKHGVVWSSGKALASNGSRVELLDSGNLVVIEKVSGRTLWESFEHL 157
Query: 149 -----PRDTIVIGQHLPAGASLSSAVSDYNLSTGDYSLTVGA---SDAELQWQGQMYWKL 200
P TI+ H L+S S + S GD+ + + S L Y++
Sbjct: 158 GDTLLPHSTIMYNVHTGEKRGLTSWKSYTDPSPGDFVVLITPQVPSQGFLMRGSTPYFRS 217
Query: 201 SMDTKA------YVDSRYIVDY---MAINRTGVY-LFGNNGSAVVIRVVLPPSNFRIAKL 250
K +D Y + +N +G Y F + IR L
Sbjct: 218 GPWAKTKFTGLPQMDESYTSPFSLTQDVNGSGYYSYFDRDNKRSRIR------------L 265
Query: 251 DASGQFTVLRLSGSDLEQEYMGPDDGCQIPFICGRMGMCADDATSGSPSCSCPAGFHLAS 310
G LR +G D + Y GP + C I +CG G C S P C C GF S
Sbjct: 266 TPDGSMKALRYNGMDWDTTYEGPANSCDIYGVCGPFGFCV---ISVPPKCKCFKGFIPKS 322
Query: 311 QN-------TSGCVPSDASHSLPVACNSTRKESLLNASVVSYLRLGYGMDYFANHFFQPS 363
TSGCV H NST K++ + +V + P
Sbjct: 323 IEEWKTGNWTSGCVRRSELH---CQGNSTGKDANVFHTV--------------PNIKPPD 365
Query: 364 TYD----VNLSFCQELCSDDCSCLGIFFKNSSGSCYMLGNVLGSIMSSNTVDSDLVGYIK 419
Y+ V+ CQ+ C ++CSCL Y+ G +G +M S DL+ ++
Sbjct: 366 FYEYADSVDAEECQQNCLNNCSCLAF--------AYIPG--IGCLMWSK----DLMDTVQ 411
Query: 420 VLVGPTQADLNPNNSSSNQNQDFPLVALVLLPFTGFFLFSALGFLWWRRWKLHKSTDSKS 479
G + S + N+ + + + T F + F +WRR + S+
Sbjct: 412 FAAGGELLSIRLARSELDVNKRKKTIIAITVSLTLFVILGFTAFGFWRRRVEQNALISED 471
Query: 480 GNPNTLSSGDLEAFYIPGLPQRFDYEELEVATDNFK--NLIGSGGFGAVYKGILNDKTIV 537
N L + D +PGL + F+ ++ AT+NF N +G GGFG+VYKG L D +
Sbjct: 472 AWRNDLQTQD-----VPGL-EYFEMNTIQTATNNFSLSNKLGHGGFGSVYKGKLQDGREI 525
Query: 538 AVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRIL 597
AVK++++ QGK++F EI +I + H NLV++ G C +G ++LL+YE+M + SLD +
Sbjct: 526 AVKRLSSSSEQGKQEFMNEIVLISKLQHRNLVRVLGCCVEGTEKLLIYEFMKNKSLDTFV 585
Query: 598 FGNGPVLE--WQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFG 655
F + LE W +RFDI G ARGL YLH +IIH D+K NILL KISDFG
Sbjct: 586 FDSKKRLEIDWPKRFDIIQGIARGLLYLHRDSRLRIIHRDLKVSNILLDEKMNPKISDFG 645
Query: 656 LSKLL-TPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
L+++ E + GT GY++PE+ SEK+D+YSFG++LLE++SG +
Sbjct: 646 LARMFHGTEYQDKTRRVVGTLGYMSPEYAWAGVFSEKSDIYSFGVLLLEIISGEK 700
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64771|Y1148_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61480 OS=Arabidopsis thaliana GN=At1g61480 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 264 bits (675), Expect = 2e-69, Method: Compositional matrix adjust.
Identities = 213/714 (29%), Positives = 340/714 (47%), Gaps = 98/714 (13%)
Query: 42 GSFLTSHNGTFKAAIVNTRSQQNSFY-LCIIHVLSNTIIWSANRDTPISGSG-KMNLTPK 99
G L+S NG ++ + + QN + + ++ ++W ANR+ P++ S + ++
Sbjct: 35 GKTLSSSNGVYELGFFSFNNSQNQYVGIWFKGIIPRVVVWVANREKPVTDSAANLTISSN 94
Query: 100 G-IIISDENGNLKWST-PPLKSSVSALRLTEMGNLVLLDGFNG-SLWESFHHPRDTIV-- 154
G +++ +EN ++ WS S+ S LT+ GNLV++D +G +LWESF H DT++
Sbjct: 95 GSLLLFNENHSVVWSIGETFASNGSRAELTDNGNLVVIDNNSGRTLWESFEHFGDTMLPF 154
Query: 155 --IGQHLPAGAS--LSSAVSDYNLSTGDYSLTVGA---SDAELQWQGQMYWKLSMDTKAY 207
+ +L G L+S S + S GD+++ + S A + YW+ + +
Sbjct: 155 SNLMYNLATGEKRVLTSWKSHTDPSPGDFTVQITPQVPSQACTMRGSKTYWR----SGPW 210
Query: 208 VDSRYI-VDYMAINRTGVYLF--GNNGSAVVIRVVLPPSNFRIA--KLDASGQFTVLRLS 262
+R+ + M T + NGS NF+++ + + G + + +
Sbjct: 211 AKTRFTGIPVMDDTYTSPFSLQQDTNGSGSFTYF---ERNFKLSYIMITSEGSLKIFQHN 267
Query: 263 GSDLEQEYMGPDDGCQIPFICGRMGMCADDATSGSPSCSCPAGFHLASQN-------TSG 315
G D E + P++ C I CG G+C S P C C GF S T G
Sbjct: 268 GMDWELNFEAPENSCDIYGFCGPFGICV---MSVPPKCKCFKGFVPKSIEEWKRGNWTDG 324
Query: 316 CVPSDASHSLPVACNSTRKESLLNASVVSYLRLGYGMDYFAN----HFFQPSTYDVNLSF 371
CV H C +N G + AN F++ +++ V+
Sbjct: 325 CVRHTELH-----CQGNTNGKTVN-----------GFYHVANIKPPDFYEFASF-VDAEG 367
Query: 372 CQELCSDDCSCLGIFFKNSSGSCYMLGNVL---------GSIMSSNTVDSDLVGYIKVLV 422
C ++C +CSCL + N G C M L G I+S S+L G
Sbjct: 368 CYQICLHNCSCLAFAYINGIG-CLMWNQDLMDAVQFSAGGEILSIRLASSELGG------ 420
Query: 423 GPTQADLNPNNSSSNQNQDFPLVALVLLPFTGFFLFSALGFLWWRRWKLHKSTDSKSGNP 482
N+ + ++V L F+A FL R+K+ + +K
Sbjct: 421 --------------NKRNKIIVASIVSLSLFVILAFAAFCFL---RYKVKHTVSAKISKI 463
Query: 483 NTLSS--GDLEAFYIPGLPQRFDYEELEVATDNFK--NLIGSGGFGAVYKGILNDKTIVA 538
+ + DLE + GL + F+ ++ ATDNF N +G GGFG+VYKG L D +A
Sbjct: 464 ASKEAWNNDLEPQDVSGL-KFFEMNTIQTATDNFSLSNKLGQGGFGSVYKGKLQDGKEIA 522
Query: 539 VKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILF 598
VK++++ QGK++F EI +I + H NLV++ G C +G +RLLVYE++ + SLD LF
Sbjct: 523 VKRLSSSSGQGKEEFMNEIVLISKLQHKNLVRILGCCIEGEERLLVYEFLLNKSLDTFLF 582
Query: 599 GNGPVLE--WQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGL 656
+ LE W +RF+I G ARGL YLH ++IH D+K NILL KISDFGL
Sbjct: 583 DSRKRLEIDWPKRFNIIEGIARGLHYLHRDSCLRVIHRDLKVSNILLDEKMNPKISDFGL 642
Query: 657 SKLLT-PEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
+++ E + GT GY+APE+ SEK+D+YSFG++LLE+++G +
Sbjct: 643 ARMYQGTEYQDNTRRVAGTLGYMAPEYAWTGMFSEKSDIYSFGVILLEIITGEK 696
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 261 bits (667), Expect = 1e-68, Method: Compositional matrix adjust.
Identities = 210/684 (30%), Positives = 324/684 (47%), Gaps = 76/684 (11%)
Query: 72 HVLSNTIIWSANRDTPISG----SGKMNLTPKG-IIISDENGNLKWSTPPLKSSVSALRL 126
+ TI+W A +G K+ LT G ++I+D G W SVS R
Sbjct: 78 KISDKTIVWHAQAVNTTTGLVPNGSKVTLTADGGLVIADPRGQELWRALS-GGSVSRGRF 136
Query: 127 TEMGNLVLL-DGFNGS---LWESFHHPRDTIVIGQHLPAGASLSSAVSDYNLSTGDYSLT 182
T+ GN VL DG S LW SF +P DT++ Q++ G +LSS ++ + G +SL
Sbjct: 137 TDDGNFVLFRDGSEDSDEVLWSSFENPTDTLLPNQNIEVGRNLSSRRTETSFKKGRFSLR 196
Query: 183 VGASDAELQWQGQMYWKLSMDTKAYVD---SRYIVDYMAINRTGVYLFGNNGSAVVIRVV 239
+ D LQ L+ +T + D Y + N G+ L N + V
Sbjct: 197 L-EDDGNLQLHS-----LNAETASESDIYSQYYESNTNDPNNPGIQLVFNQSGEIY---V 247
Query: 240 LPPSNFRIAKLDASGQFTVLR--------LSGSDLEQEYMGPDDGCQIPFICGRMGMCAD 291
L +N R D F++ L + + +E GC + +C R MC+
Sbjct: 248 LQRNNSRFVVKDRDPDFSIAAPFYISTGFLLSTIIPKEARRIVGGCLLG-LC-RDNMCSP 305
Query: 292 DATSGS----------------PSCSCPAGFHLA--SQNTSGCVPSDASHSLPVACNSTR 333
D G+ P C CP F L S C+P + C
Sbjct: 306 DDALGNMACGYNNICSLGNNKRPKCECPERFVLKDPSNEYGDCLPDFEMQT----CRPEN 361
Query: 334 KESLLNASVVSYLRLGYGMDYFANHFFQPSTYDVNLSFCQELCSDDCSCLGIFF-KNSSG 392
+ + + ++ ++ L F ++ S + + C+ C DC C + F N
Sbjct: 362 QTANSDVNLYEFITLEKTNWPFGDY---ESYANYDEERCKASCLSDCLCAAVIFGTNRDL 418
Query: 393 SCYMLGNVLGSIMSSNTVDSDLVGYIKVLVGPTQADLNPNNSSSNQNQDFPLVAL-VLLP 451
C+ L S DSD +IKV + AD+ P + + D+ ++A VLL
Sbjct: 419 KCWKKKFPLSHGERSPRGDSDT--FIKVR-NRSIADV-PVTGNRAKKLDWLIIACSVLLG 474
Query: 452 FTGFFLF-SALGFLWWRRWK-LHKSTDSKSGNPNTLSSGDLEAFYIPGLPQRFDYEELEV 509
+ F +F ++ + ++ K + K+ G ++ + + F Y EL
Sbjct: 475 TSAFVIFDTSCSYRKTKKSKNMMKNQARDIGRTTATTTANELNLRV------FTYGELAE 528
Query: 510 ATDNFKNLIGSGGFGAVYKGILN----DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHH 565
AT +F +G G FG VYKG L + VAVKK+ + + +K+F E+ +IG IHH
Sbjct: 529 ATRDFTEELGRGAFGIVYKGYLEVAGGSEVTVAVKKLDRLDLDNEKEFKNEVKVIGQIHH 588
Query: 566 VNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHS 625
NLV+L GFC +G+ +++VYE++ G+L LF P W++R +IA+ ARG+ YLH
Sbjct: 589 KNLVRLIGFCNEGQSQMIVYEFLPQGTLANFLFRR-PRPSWEDRKNIAVAIARGILYLHE 647
Query: 626 GCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTN 685
C ++IIHCDIKP+NILL ++ +ISDFGL+KLL Q+ T +RGT+GY+APEW N
Sbjct: 648 ECSEQIIHCDIKPQNILLDEYYTPRISDFGLAKLLLMNQTYTLTNIRGTKGYVAPEWFRN 707
Query: 686 SAISEKTDVYSFGMVLLELVSGRR 709
S I+ K DVYS+G++LLE+V ++
Sbjct: 708 SPITSKVDVYSYGVMLLEIVCCKK 731
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 724 | ||||||
| 225459499 | 1049 | PREDICTED: G-type lectin S-receptor-like | 0.990 | 0.683 | 0.689 | 0.0 | |
| 255545436 | 793 | s-receptor kinase, putative [Ricinus com | 0.889 | 0.812 | 0.723 | 0.0 | |
| 147784458 | 1114 | hypothetical protein VITISV_029567 [Viti | 0.921 | 0.598 | 0.663 | 0.0 | |
| 357461595 | 879 | Receptor-like protein kinase like protei | 0.980 | 0.807 | 0.636 | 0.0 | |
| 297805088 | 872 | hypothetical protein ARALYDRAFT_493603 [ | 0.958 | 0.795 | 0.579 | 0.0 | |
| 351725125 | 771 | receptor-like protein kinase like protei | 0.852 | 0.800 | 0.661 | 0.0 | |
| 79525859 | 872 | S-locus lectin protein kinase-like prote | 0.965 | 0.801 | 0.563 | 0.0 | |
| 10178100 | 836 | S-receptor kinase [Arabidopsis thaliana] | 0.919 | 0.796 | 0.542 | 0.0 | |
| 3047096 | 821 | similar to eukaryotic protein kinase dom | 0.906 | 0.799 | 0.542 | 0.0 | |
| 224145590 | 845 | predicted protein [Populus trichocarpa] | 0.928 | 0.795 | 0.536 | 0.0 |
| >gi|225459499|ref|XP_002284416.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1031 bits (2667), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 495/718 (68%), Positives = 589/718 (82%), Gaps = 1/718 (0%)
Query: 4 LLFVATIFLFIAPASSISFSEFIHPNFTASHVKFIDYGGSFLTSHNGTFKAAIVNTRSQQ 63
L+F++TI L + +S SE I+PNFTAS+ F++Y G+FL S N TFK A+ N +QQ
Sbjct: 184 LVFLSTILLSFSLVCGLSSSELIYPNFTASNFNFVEYNGAFLFSRNETFKVAMFNPGAQQ 243
Query: 64 NSFYLCIIHVLSNTIIWSANRDTPISGSGKMNLTPKGIIISDENGNLKWSTPPLKSSVSA 123
+FYLCIIHV S IIWSANRD P+S GKMNLT GI ++D+ G++KW TPPLKSSVSA
Sbjct: 244 KNFYLCIIHVASGAIIWSANRDAPVSNYGKMNLTINGITVTDQGGSVKWGTPPLKSSVSA 303
Query: 124 LRLTEMGNLVLLDGFNGSLWESFHHPRDTIVIGQHLPAGASLSSAVSDYNLSTGDYSLTV 183
L L E GNL+LLD FNGSLW+SF +P DTIVIGQ LP G SLS A+SD +LST DY V
Sbjct: 304 LLLAETGNLILLDQFNGSLWQSFDYPTDTIVIGQRLPVGTSLSGALSDNDLSTSDYRFVV 363
Query: 184 GASDAELQWQGQMYWKLSMDTKAYVDSRYIVDYMAINRTGVYLFGNNGSAVVIRVVLPPS 243
S+A +QW G YWKLSMDT AY +S Y+V+YMA+N+TG++LFG NGS VVI++ L PS
Sbjct: 364 STSNAIMQWHGLTYWKLSMDTSAYKNSNYLVEYMAMNQTGLFLFGRNGSVVVIQMDLSPS 423
Query: 244 NFRIAKLDASGQFTVLRLSGSDLEQEYMGPDDGCQIPFICGRMGMCADDATSGSPSCSCP 303
+FRIAKLDASGQF + LSG+ L+QEY+GP D C+IPFICGR+G+C DD S SP CSCP
Sbjct: 424 DFRIAKLDASGQFIISTLSGTVLKQEYVGPKDACRIPFICGRLGLCTDDTASNSPVCSCP 483
Query: 304 AGFHLASQNTSGCVPSDASHSLPVACNSTRKESLLNASVVSYLRLGYGMDYFANHFFQPS 363
+GF ++ + CVPSD+S+SLP CN T S N SVVSYL L YG++YFAN+F++P
Sbjct: 484 SGFRADPKSVTNCVPSDSSYSLPSPCNLTNSVSQSNLSVVSYLMLAYGVEYFANNFWEPV 543
Query: 364 TYDVNLSFCQELCSDDCSCLGIFFKNSSGSCYMLGNVLGSIMSSNTVDSDLVGYIKVLVG 423
Y VNLS C+ LCS DCSCLGIF +NSSGSCY++ NVLGS++SS+T ++ +G IKVLVG
Sbjct: 544 QYGVNLSVCENLCSGDCSCLGIFHENSSGSCYLVENVLGSLISSSTNENVQLGCIKVLVG 603
Query: 424 PTQADLNPNNSSSNQNQDFPLVALVLLPFTGFFLFSALGFLWWRRWKLHKSTDSKSGNPN 483
+ +++ NNSSSNQ+Q+FP+ ALVLLP TGFFLF ALGFLWWRRW K+ D K G+ +
Sbjct: 604 -SSPNMDGNNSSSNQSQEFPIAALVLLPSTGFFLFVALGFLWWRRWGFSKNRDLKLGHSS 662
Query: 484 TLSSGDLEAFYIPGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKIT 543
+ SS DL+AF IPGLP RF+YEE+E ATDNFK IGSGGFGAVYKGI+ DKT+VAVKKIT
Sbjct: 663 SPSSEDLDAFSIPGLPIRFEYEEIEAATDNFKTQIGSGGFGAVYKGIMPDKTLVAVKKIT 722
Query: 544 NVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPV 603
N+GVQGKK+FCTEIA+IGNIHHVNLVKLKGFCA+GRQRLLVYEYMN SLDR LF NGPV
Sbjct: 723 NLGVQGKKEFCTEIAVIGNIHHVNLVKLKGFCAKGRQRLLVYEYMNRSSLDRTLFSNGPV 782
Query: 604 LEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE 663
LEWQER DIALGTARGLAYLHSGCE KIIHCD+KPENILLH +FQAKISDFGLSKLL+PE
Sbjct: 783 LEWQERVDIALGTARGLAYLHSGCEHKIIHCDVKPENILLHDNFQAKISDFGLSKLLSPE 842
Query: 664 QSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSMD 721
+S+LFTTMRGTRGYLAPEWLT+SAIS+KTDVYSFGMVLLELVSGR+NCS R+QSHS+D
Sbjct: 843 ESTLFTTMRGTRGYLAPEWLTSSAISDKTDVYSFGMVLLELVSGRKNCSLRTQSHSID 900
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545436|ref|XP_002513778.1| s-receptor kinase, putative [Ricinus communis] gi|223546864|gb|EEF48361.1| s-receptor kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 966 bits (2498), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 471/651 (72%), Positives = 540/651 (82%), Gaps = 7/651 (1%)
Query: 71 IHVLSNTIIWSANRDTPISGSGKMNLTPKGIIISDENGNLKWSTPPLKSSVSALRLTEMG 130
+HV S+TIIWSAN D PIS SGKM+LT +GI I+D++GN KWSTP L+SSV AL LTEMG
Sbjct: 1 MHVASSTIIWSANSDAPISSSGKMDLTAQGIHITDQDGNPKWSTPALRSSVYALLLTEMG 60
Query: 131 NLVLLDGFNGSLWESFHHPRDTIVIGQHLPAGASLSSAVSDYNLSTGDYSLTVGASDAEL 190
NLVLLD NGSLWESFH+PRDT+VIGQHLP G LSSAVS NLSTG Y L + SDA L
Sbjct: 61 NLVLLDQLNGSLWESFHYPRDTLVIGQHLPKGKLLSSAVSSNNLSTGHYRLAISDSDAIL 120
Query: 191 QWQGQMYWKLSMDTKAYVDSRYIVDYMAINRTGVYLFGNNGSAVVIRVVLPPSNFRIAKL 250
QWQGQ YWKLSMD AY +S YIVD+MAINRTG++LFG NGSA+VI++ L PSNFR+A+L
Sbjct: 121 QWQGQTYWKLSMDAGAYTNSNYIVDFMAINRTGLFLFGLNGSAIVIQMSLSPSNFRVAQL 180
Query: 251 DASGQFTVLRLSGSDLEQEYMGPDDGCQIPFICGRMGMCADDATSGSPSCSCPAGFHLAS 310
ASGQFT+ SGS+ +QE++GP DGCQIP CG++G+C D TS P+CSCP GF S
Sbjct: 181 GASGQFTISSFSGSNKQQEFVGPMDGCQIPLACGKIGLCID-TTSSRPTCSCPLGFRGGS 239
Query: 311 QNTSGCVPSDASHSLPVACNSTRKESLLNASVVSYLRLGYGMDYFANHFFQPSTYDVNLS 370
QN+SGCVPSD SLP AC STR S LN+S VSY+RLGYGMDYFA F +P+ Y VN S
Sbjct: 240 QNSSGCVPSDGP-SLPHACVSTRNGSQLNSSAVSYMRLGYGMDYFAIDFSEPTRYGVNFS 298
Query: 371 FCQELCSDDCSCLGIFFKNSSGSCYMLGNVLGSIMSSNTVDSDLVGYIKVLVGPTQADLN 430
CQ+LC+ DC+CLGIF++NSSGSCY L LGSI+SS ++DL+GYIKV+ T
Sbjct: 299 VCQDLCTMDCACLGIFYENSSGSCYALEKDLGSIISSTKNENDLLGYIKVINRST----- 353
Query: 431 PNNSSSNQNQDFPLVALVLLPFTGFFLFSALGFLWWRRWKLHKSTDSKSGNPNTLSSGDL 490
P+ S NQNQ FP+VALVLLPFTGF L AL FLWWRR ++ K + K G ++ SSGDL
Sbjct: 354 PDGSDDNQNQQFPVVALVLLPFTGFLLVVALYFLWWRRRRISKDREMKLGCGSSRSSGDL 413
Query: 491 EAFYIPGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGK 550
AFYIPGLPQRFDY+ELEVAT NFK IGSGGFG+VYKG L DK++VAVKKI+N+GVQGK
Sbjct: 414 NAFYIPGLPQRFDYDELEVATGNFKTQIGSGGFGSVYKGTLLDKSVVAVKKISNLGVQGK 473
Query: 551 KDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERF 610
KDFCTEIA+IG+IHH+NLVKL+GFC QGRQRLLVYEYMN GSLDR LFG+GPVLEWQERF
Sbjct: 474 KDFCTEIAVIGSIHHINLVKLRGFCVQGRQRLLVYEYMNRGSLDRTLFGSGPVLEWQERF 533
Query: 611 DIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670
+IALGTARGLAYLH+GCE KIIHCD+KPENILLH HFQAKISDFGLSKLL+PEQSSLFTT
Sbjct: 534 EIALGTARGLAYLHAGCEHKIIHCDVKPENILLHDHFQAKISDFGLSKLLSPEQSSLFTT 593
Query: 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSMD 721
MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGR+NC RSQS S++
Sbjct: 594 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRKNCWTRSQSASVE 644
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147784458|emb|CAN72729.1| hypothetical protein VITISV_029567 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 939 bits (2427), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 458/690 (66%), Positives = 545/690 (78%), Gaps = 23/690 (3%)
Query: 27 HPNFTASHVKFIDYGGSFLTSHNGTFKAAIVNTRSQQNSFYLCIIHVLSNTIIWSANRDT 86
+PNFTAS+ F++Y G+FL S N TFK A+ N +QQ +FYLCIIHV S +IWSANRD
Sbjct: 174 YPNFTASNFNFVEYNGAFLFSRNETFKVAMFNPGAQQKNFYLCIIHVASGAVIWSANRDA 233
Query: 87 PISGSGKMNLTPKGIIISDENGNLKWSTPPLKSSVSALRLTEMGNLVLLDGFNGSLWESF 146
P+S GKMNLT GI ++D+ G++KW TPPLKSSVSAL L E GNL+LLD FNGSLW+SF
Sbjct: 234 PVSNYGKMNLTINGITVTDQGGSVKWGTPPLKSSVSALLLAETGNLILLDQFNGSLWQSF 293
Query: 147 HHPRDTIVIGQHLPAGASLSSAVSDYNLSTGDYSLTVGASDAELQWQGQMYWKLSMDTKA 206
+P DTIVIGQ L G SLS A+SD +LST DY V S+A +QW G YWKLSMDT A
Sbjct: 294 DYPTDTIVIGQRLSVGTSLSGALSDNDLSTSDYRFVVSTSNAIMQWHGLTYWKLSMDTSA 353
Query: 207 YVDSRYIVDYMAINRTGVYLFGNNGSAVVIRVVLPPSNFRIAKLDASGQFTVLRLSGSDL 266
Y +S Y+V+YMA+N+TG++LFG NGS VVI++ L PS+FRIAKLDASGQF + LSG+ L
Sbjct: 354 YKNSNYLVEYMAMNQTGLFLFGRNGSVVVIQMDLSPSDFRIAKLDASGQFIISTLSGTVL 413
Query: 267 EQEYMGPDDGCQIPFICGRMGMCADDATSGSPSCSCPAGFHLASQNTSGCVPSDASHSLP 326
+QEY+GP D C+IPFICGR+G+C DD S SP CSCP+GF ++ + CVPSD+S+SLP
Sbjct: 414 KQEYVGPKDACRIPFICGRLGLCTDDTASNSPVCSCPSGFRADPKSVTNCVPSDSSYSLP 473
Query: 327 VACNSTRKESLLNASVVSYLRLGYGMDYFANHFFQPSTYDVNLSFCQELCSDDCSCLGIF 386
CN T S N SVVSYL L YG++YFAN+F++P Y VNLS C+ LCS DCSCLGIF
Sbjct: 474 SPCNLTNSVSQSNLSVVSYLMLAYGVEYFANNFWEPVQYGVNLSVCENLCSGDCSCLGIF 533
Query: 387 FKNSSGSCYMLGNVLGSIMSSNTVDSDLVGYIKVLVGPTQADLNPNNSSSNQNQDFPLVA 446
+NSSGSCY++ VLGS++SS+T ++ +G IKVLVG + +++ NNSSSNQ+Q+FP+ A
Sbjct: 534 HENSSGSCYLVEXVLGSLISSSTNENVQLGXIKVLVG-SSPNMDGNNSSSNQSQEFPIAA 592
Query: 447 LVLLPFTGFFLFSALGFLWWRRWKLHKSTDSKSGNPNTLSSGDLEAFYIPGLPQRFDYEE 506
LVLLP TGFFLF ALGFLWWRRW K+ D K G+ ++ SS DL+AF IPGLP RF+YEE
Sbjct: 593 LVLLPSTGFFLFVALGFLWWRRWGFSKNRDLKLGHSSSPSSXDLDAFSIPGLPIRFEYEE 652
Query: 507 LEVATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHV 566
+E ATDNFK IGSGGFGAVYKGI+ DKT+VAVKKITN+GVQGKK+FCTEIA+IGNIHH
Sbjct: 653 IEAATDNFKTQIGSGGFGAVYKGIMPDKTLVAVKKITNLGVQGKKEFCTEIAVIGNIHH- 711
Query: 567 NLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSG 626
MN SLDR LF NGPVLEWQER DIALGTARGLAYLHSG
Sbjct: 712 ---------------------MNRXSLDRTLFSNGPVLEWQERVDIALGTARGLAYLHSG 750
Query: 627 CEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNS 686
CE KIIHCD+KPENILLH +FQAKISDFGLSKLL+PE+S LFTTMRGTRGYLAPEWLT+S
Sbjct: 751 CEHKIIHCDVKPENILLHDNFQAKISDFGLSKLLSPEESXLFTTMRGTRGYLAPEWLTSS 810
Query: 687 AISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716
AIS+KTDVYSFGMVLLELVSGR+NCS R+Q
Sbjct: 811 AISDKTDVYSFGMVLLELVSGRKNCSLRTQ 840
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357461595|ref|XP_003601079.1| Receptor-like protein kinase like protein [Medicago truncatula] gi|355490127|gb|AES71330.1| Receptor-like protein kinase like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 879 bits (2270), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 468/735 (63%), Positives = 555/735 (75%), Gaps = 25/735 (3%)
Query: 6 FVATIFL-FIAPASSISFSEFIHPNFTASHVKFIDYGGSFLTSHNGTFKAAIVNTRSQQN 64
F +TIFL F S+ +FS+ I PNFTAS+++FI G+FL S N TFKAAI N +QQ
Sbjct: 7 FSSTIFLLFTTSISAYTFSDHISPNFTASYLQFIANTGTFLLSRNKTFKAAIFNPGNQQT 66
Query: 65 SFYLCIIHVLSNTIIWSANRDTPISGSGKMNLTPKGIIISDENGNLKWSTPPLKSSVSAL 124
SFYLCIIH SNT+IWSAN PIS S + LT +GI I D+NGN KWSTPPLKS V L
Sbjct: 67 SFYLCIIHAASNTVIWSANH-APISDSDTVKLTVEGITIFDKNGNSKWSTPPLKSQVQKL 125
Query: 125 RLTEMGNLVLLDGFNGSLWESFHHPRDTIVIGQHLPAGASLSSAVSDYNLSTGDYSLTVG 184
LTEMGNLVLLD NGSLWESF HP DTIVIGQ L GASLSSA S+ NLSTG+Y LT+
Sbjct: 126 SLTEMGNLVLLDQSNGSLWESFQHPTDTIVIGQRLSVGASLSSASSNSNLSTGNYKLTIT 185
Query: 185 ASDAELQWQGQMYWKLSMDTKAYVDSRYIVDYMAINRTGVYLFGNNGSAVVIRVVLPPSN 244
+SDA LQW GQ YWK+SMD+KAY +S V+YMA+N TG YLFG+N V +V L +N
Sbjct: 186 SSDAILQWHGQTYWKISMDSKAYKNSNDDVEYMAVNTTGFYLFGHNEQVHVYQVGLSVAN 245
Query: 245 FRIAKLDASGQFTVLRLSGSDLEQEYMGPDDGCQIPFICGRMGMCADDATSGSPSCSCPA 304
FR+AKL + GQFT+ SG++L+QE++GPDDGCQIP CGR+G+C D++ S S S + +
Sbjct: 246 FRVAKLASDGQFTISSFSGTNLKQEFVGPDDGCQIPLACGRIGLCNDNSLSSSSSSTSSS 305
Query: 305 --------GFHLASQNTSGCVPSDASHSLPVACNS--TRKESLLNASVVSYLRLGYGMDY 354
FH+AS N GCVP+D S +LP+AC+S S N+SVVS+L +GYG+ Y
Sbjct: 306 SPVCSCPSNFHVASGNLHGCVPNDVSRTLPLACSSLTNNNHSQSNSSVVSFLNIGYGVKY 365
Query: 355 FANHFFQPSTYDVNLSFCQELCSDDCSCLGIFFKNSSGSCYMLGNVLGSIMSSNTVDSDL 414
F N + P + V+LS CQ CS +CSCLGI ++NSSGSCYM+ N LGSI SN + D+
Sbjct: 366 FGNIYSDPIMFGVSLSDCQGHCSSNCSCLGILYRNSSGSCYMIENELGSI--SNGGEGDM 423
Query: 415 VGYIKVLVGPTQADLNPNNSSSNQNQDFPLVALVLLPFTGF-FLFSALGFLWWRRWKLHK 473
+G IKV +G + +N ++Q FP++A VLLP G FL + + FL WR++ K
Sbjct: 424 LGLIKVNIGH-----DIDNEQNSQKDGFPVIAAVLLPIVGIIFLLALVFFLMWRKFTKSK 478
Query: 474 STDSKSGNPNTLS---SGDLE--AFYIPGLPQRFDYEELEVATDNFKNLIGSGGFGAVYK 528
+ K G ++S SGDL+ AFYIPGLP RFDYEELEVATDNFK LIGSG FG VYK
Sbjct: 479 KQEVKLGKQISISQHSSGDLDQDAFYIPGLPTRFDYEELEVATDNFKTLIGSGAFGVVYK 538
Query: 529 GILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588
G+L DKTIVAVKKI N+G+QG+KDF EIA+IGNIHHVNLV+LKGFCAQ R+LVYEYM
Sbjct: 539 GVLPDKTIVAVKKIINIGIQGRKDFFAEIAVIGNIHHVNLVRLKGFCAQRGHRMLVYEYM 598
Query: 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQ 648
N GSLDR LFG PVLEWQER D+ALGTARGLAYLHSGCEQKIIHCDIKPENILLH FQ
Sbjct: 599 NRGSLDRNLFGGHPVLEWQERCDVALGTARGLAYLHSGCEQKIIHCDIKPENILLHDQFQ 658
Query: 649 AKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGR 708
AKISDFGLSKLL+PEQS LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGR
Sbjct: 659 AKISDFGLSKLLSPEQSGLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGR 718
Query: 709 RNCSPRSQSHSMDSN 723
+NCS +S+SHS+D +
Sbjct: 719 KNCSFKSRSHSIDDD 733
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297805088|ref|XP_002870428.1| hypothetical protein ARALYDRAFT_493603 [Arabidopsis lyrata subsp. lyrata] gi|297316264|gb|EFH46687.1| hypothetical protein ARALYDRAFT_493603 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 829 bits (2142), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 419/723 (57%), Positives = 532/723 (73%), Gaps = 29/723 (4%)
Query: 11 FLFIAPASSISFSEFIHPNFTASHVKFIDYG-GSFLTSHNGTFKAAIVNT---RSQQNSF 66
F++++ ASS +EF++PNFTAS+++FID G+FL S N FKA + + S F
Sbjct: 18 FVYVSCASS---TEFVYPNFTASNLRFIDSSKGAFLFSRNSNFKAGLFSPGGDDSSSTGF 74
Query: 67 YLCIIHVLSNTIIWSANRDTPISGSGKMNLTPKGI-IISDENGNLK-WSTPPLKSSVSAL 124
Y ++HV S + IWS+NRD+P+S SGKMNLTP+GI +I D L WSTP L S V +L
Sbjct: 75 YFSVVHVDSGSTIWSSNRDSPVSSSGKMNLTPQGISVIEDGKSQLPVWSTPVLPSPVHSL 134
Query: 125 RLTEMGNLVLLDGFNGSLWESFHHPRDTIVIGQHLPAGASLSSAVSDYNLSTGDYSLTVG 184
RLT+ GNL+LLD N SLWESF P D+IV+GQ L G LS +VS + STGDY VG
Sbjct: 135 RLTDAGNLLLLDHLNVSLWESFDFPTDSIVLGQRLKLGMFLSGSVSRSDFSTGDYKFLVG 194
Query: 185 ASDAELQWQGQMYWKLSMDTKAYVDSRYIVDYMAINRTGVYLFGNNGSAVVIRVVLPPS- 243
SD +QW+GQ YWKL M T+A VDS + V+Y+ + +G+ L G NG+ VV+RV LPPS
Sbjct: 195 ESDCLMQWKGQNYWKLRMHTRANVDSNFPVEYLTVTTSGLALMGRNGTVVVVRVALPPSS 254
Query: 244 NFRIAKLDASGQFTVLRLSGSDLEQEYMGPDDGCQIPFICGRMGMCADDATSGSPSCSCP 303
+FR+AK+D+SG+F V R SG +L E+ GP D CQIPF+CG++G+C D S + SCSCP
Sbjct: 255 DFRVAKMDSSGKFIVSRFSGKNLVPEFSGPMDSCQIPFVCGKLGLCHLDNASENQSCSCP 314
Query: 304 AGFHLASQNTSGCVPSDASHSLPVACNSTRKESLLNASVVSYLRLGYGMDYFANHFFQPS 363
L + CVP + S SLPV+C A +SYL LG G+ YF+ F P
Sbjct: 315 DEMRLDA-GKGVCVPVNQSLSLPVSCE---------ARNISYLELGLGVSYFSTQFTDPV 364
Query: 364 TYDVNLSFCQELCSDDCSCLGIFFKNSSGSCYMLGNVLGSI-MSSNTVDS-DLVGYIKVL 421
+D+ L C +LCS +CSCLG+F++N+S SCY++ + GS+ + N+ D+ DL+GY+K+
Sbjct: 365 EHDLPLLACHDLCSKNCSCLGVFYENTSRSCYLVKDSFGSLSLVKNSPDNHDLIGYVKLS 424
Query: 422 VGPTQADLNPNNSSSNQNQDFPLVALVLLPFTGFFLFSALGFLWWRRWKLHKST---DSK 478
+ A + NN N+ FPL+ALVLLP +GFFL ALG LWWRR + + + + +
Sbjct: 425 IRKQIAQPSVNN---NRGSSFPLIALVLLPCSGFFLLIALGLLWWRRCAVMRYSSIREKQ 481
Query: 479 SGNPNTLSSGDLEAFYIPGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGILNDKTIVA 538
P + SGDL +F+IPGLPQ+F+YEELE AT+NFK IGSGGFG+VYKG L D+T++A
Sbjct: 482 VTRPGSFGSGDLGSFHIPGLPQKFEYEELEQATENFKLQIGSGGFGSVYKGTLPDETLIA 541
Query: 539 VKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILF 598
VKKITN G+ G+++FCTEIAIIGNI H NLVKL+GFCA+GRQ LLVYEYMNHGSL++ LF
Sbjct: 542 VKKITNHGLHGRQEFCTEIAIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLF 601
Query: 599 -GNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLS 657
GNGPVLEWQERFDIALGTARGLAYLHSGC+QKIIHCD+KPENILLH HFQ KISDFGLS
Sbjct: 602 SGNGPVLEWQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLS 661
Query: 658 KLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717
KLL E+SSLFTTMRGTRGYLAPEW+TN+AISEK DVYS+GMVLLELVSGR+NCS RS+S
Sbjct: 662 KLLNQEESSLFTTMRGTRGYLAPEWITNAAISEKADVYSYGMVLLELVSGRKNCSFRSRS 721
Query: 718 HSM 720
+S+
Sbjct: 722 NSV 724
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351725125|ref|NP_001238617.1| receptor-like protein kinase like protein [Glycine max] gi|223452339|gb|ACM89497.1| receptor-like protein kinase like protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 823 bits (2125), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 418/632 (66%), Positives = 486/632 (76%), Gaps = 15/632 (2%)
Query: 94 MNLTPKGIIISDENGNLKWSTPPLKSSVSALRLTEMGNLVLLDGFNGSLWESFHHPRDTI 153
M L+ KGI I DE+GN KWSTP LKS V+ L+LTEMGNLVLLD NGSLWESF +P DTI
Sbjct: 1 MLLSFKGITILDEHGNTKWSTPSLKSQVNRLQLTEMGNLVLLDKSNGSLWESFQNPTDTI 60
Query: 154 VIGQHLPAGASLSSAVSDYNLSTGDYSLTVGASDAELQWQGQMYWKLSMDTKAYVDSRYI 213
VIGQ LP GASLSSA S+ +LS G+Y LT+ +SDA LQW GQ YWKLS DT+ Y +S +
Sbjct: 61 VIGQRLPVGASLSSAASNSDLSKGNYKLTITSSDAVLQWYGQTYWKLSTDTRVYKNSNDM 120
Query: 214 VDYMAINRTGVYLFGNNGSAVVIRVVLPPSNFRIAKLDASGQFTVLRLSGSD-LEQEYMG 272
++YMAIN TG YLFG+ G+ V ++ LP +NFRIAKL SGQF V SG++ L+QE++G
Sbjct: 121 LEYMAINNTGFYLFGDGGT--VFQLGLPLANFRIAKLGTSGQFIVNSFSGTNNLKQEFVG 178
Query: 273 PDDGCQIPFICGRMGMCADDATSGSPSCSCPAGFHLASQNTSGCVPSDASHSLPVACNST 332
P+DGCQ P CGR G+C ++ S SP CSCP FH+ S GC PS+ S+SLP+AC
Sbjct: 179 PEDGCQTPLACGRAGLCTENTVSSSPVCSCPPNFHVGSGTFGGCEPSNGSYSLPLACK-- 236
Query: 333 RKESLLNASVVSYLRLGYGMDYFANHFFQPSTYDVNLSFCQELCSDDCSCLGIFFKNSSG 392
N+S S+L +GY ++YF N + P Y VNLS CQ LCS +CSCLGIF+K++SG
Sbjct: 237 ------NSSAFSFLNIGY-VEYFGNFYSDPVLYKVNLSACQSLCSSNCSCLGIFYKSTSG 289
Query: 393 SCYMLGNVLGSIMSSNTVDS-DLVGYIKVL-VGPTQADLNPNNSSSN-QNQDFPLVALVL 449
SCYM+ N LGSI SSN D D++G+IK + V T + + N+ N QN +FP+ VL
Sbjct: 290 SCYMIENELGSIQSSNGGDERDILGFIKAITVASTTSSNDGNDDKENSQNGEFPVAVAVL 349
Query: 450 LPFTGFFLFSALGFLWWRRWKLHKSTDSKSGNPNTLSSGDLEAFYIPGLPQRFDYEELEV 509
LP GF + AL FL WRR L N+ SSGDL+AFYIPGLP RFDYEELE
Sbjct: 350 LPIIGFIILMALIFLVWRRLTLMSKMQEVKLGKNSPSSGDLDAFYIPGLPARFDYEELEE 409
Query: 510 ATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLV 569
AT+NFK LIGSGGFG VYKG+L DK++VAVKKI N+G+QGKKDFCTEIA+IGNIHHVNLV
Sbjct: 410 ATENFKTLIGSGGFGTVYKGVLPDKSVVAVKKIGNIGIQGKKDFCTEIAVIGNIHHVNLV 469
Query: 570 KLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQ 629
KLKGFCAQGR RLLVYEYMN GSLDR LFG PVLEWQERFD+ALGTARGLAYLHSGC Q
Sbjct: 470 KLKGFCAQGRHRLLVYEYMNRGSLDRNLFGGEPVLEWQERFDVALGTARGLAYLHSGCVQ 529
Query: 630 KIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAIS 689
KIIHCDIKPENILL FQAKISDFGLSKLL+ EQS LFTTMRGTRGYLAPEWLTNSAI+
Sbjct: 530 KIIHCDIKPENILLQDQFQAKISDFGLSKLLSAEQSGLFTTMRGTRGYLAPEWLTNSAIT 589
Query: 690 EKTDVYSFGMVLLELVSGRRNCSPRSQSHSMD 721
EKTDVYSFGMVLLELVSGR+NC RS+SHSMD
Sbjct: 590 EKTDVYSFGMVLLELVSGRKNCYYRSRSHSMD 621
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|79525859|ref|NP_198387.2| S-locus lectin protein kinase-like protein [Arabidopsis thaliana] gi|313471768|sp|O65238.2|Y5537_ARATH RecName: Full=G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370; Flags: Precursor gi|332006576|gb|AED93959.1| S-locus lectin protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 820 bits (2117), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/726 (56%), Positives = 530/726 (73%), Gaps = 27/726 (3%)
Query: 11 FLFIAPASSISFSEFIHPNFTASHVKFIDYG-GSFLTSHNGTFKAAIVNTRSQQNS--FY 67
F+F++ ASSI EF++PNFTAS+++F+D G+FL S N FKA + + +S FY
Sbjct: 18 FVFVSCASSI---EFVYPNFTASNLRFVDSSKGAFLLSRNSIFKAGLFSPGGDDSSTGFY 74
Query: 68 LCIIHVLSNTIIWSANRDTPISGSGKMNLTPKGI-IISDENGNLK-WSTPPLKSSVSALR 125
++HV S + IWS+NRD+P+S SG MNLTP+GI +I D + WSTP L S V +LR
Sbjct: 75 FSVVHVDSGSTIWSSNRDSPVSSSGTMNLTPQGISVIEDGKSQIPVWSTPVLASPVKSLR 134
Query: 126 LTEMGNLVLLDGFNGSLWESFHHPRDTIVIGQHLPAGASLSSAVSDYNLSTGDYSLTVGA 185
LT+ GNL+LLD N SLWESF P D+IV+GQ L G LS +VS + STGDY VG
Sbjct: 135 LTDAGNLLLLDHLNVSLWESFDFPTDSIVLGQRLKLGMFLSGSVSRSDFSTGDYKFLVGE 194
Query: 186 SDAELQWQGQMYWKLSMDTKAYVDSRYIVDYMAINRTGVYLFGNNGSAVVIRVVLPPS-N 244
SD +QW+GQ YWKL M +A VDS + V+Y+ + +G+ L NG+ VV+RV LPPS +
Sbjct: 195 SDGLMQWRGQNYWKLRMHIRANVDSNFPVEYLTVTTSGLALMARNGTVVVVRVALPPSSD 254
Query: 245 FRIAKLDASGQFTVLRLSGSDLEQEYMGPDDGCQIPFICGRMGMCADDATSGSPSCSCPA 304
FR+AK+D+SG+F V R SG +L E+ GP D CQIPF+CG++G+C D S + SCSCP
Sbjct: 255 FRVAKMDSSGKFIVSRFSGKNLVTEFSGPMDSCQIPFVCGKLGLCNLDNASENQSCSCPD 314
Query: 305 GFHLASQNTSGCVPSDASHSLPVACNSTRKESLLNASVVSYLRLGYGMDYFANHFFQPST 364
+ + CVP S SLPV+C A +SYL LG G+ YF+ HF P
Sbjct: 315 EMRMDA-GKGVCVPVSQSLSLPVSCE---------ARNISYLELGLGVSYFSTHFTDPVE 364
Query: 365 YDVNLSFCQELCSDDCSCLGIFFKNSSGSCYMLGNVLGSI--MSSNTVDSDLVGYIKVLV 422
+ + L C ++CS +CSCLG+F++N+S SCY++ + GS+ + ++ + DL+GY+K+ +
Sbjct: 365 HGLPLLACHDICSKNCSCLGVFYENTSRSCYLVKDSFGSLSLVKNSPENHDLIGYVKLSI 424
Query: 423 GPTQADLNPNNSSSNQNQDFPLVALVLLPFTGFFLFSALGFLWWRRWKLHKST---DSKS 479
T A P +++ FP++ALVLLP +GFFL ALG LWWRR + + + + +
Sbjct: 425 RKTNA--QPPGNNNRGGSSFPVIALVLLPCSGFFLLIALGLLWWRRCAVMRYSSIREKQV 482
Query: 480 GNPNTLSSGDLEAFYIPGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGILNDKTIVAV 539
P + SGDL +F+IPGLPQ+F++EELE AT+NFK IGSGGFG+VYKG L D+T++AV
Sbjct: 483 TRPGSFESGDLGSFHIPGLPQKFEFEELEQATENFKMQIGSGGFGSVYKGTLPDETLIAV 542
Query: 540 KKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILF- 598
KKITN G+ G+++FCTEIAIIGNI H NLVKL+GFCA+GRQ LLVYEYMNHGSL++ LF
Sbjct: 543 KKITNHGLHGRQEFCTEIAIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFS 602
Query: 599 GNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSK 658
GNGPVLEWQERFDIALGTARGLAYLHSGC+QKIIHCD+KPENILLH HFQ KISDFGLSK
Sbjct: 603 GNGPVLEWQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSK 662
Query: 659 LLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSH 718
LL E+SSLFTTMRGTRGYLAPEW+TN+AISEK DVYS+GMVLLELVSGR+NCS RS+S+
Sbjct: 663 LLNQEESSLFTTMRGTRGYLAPEWITNAAISEKADVYSYGMVLLELVSGRKNCSFRSRSN 722
Query: 719 SMDSNS 724
S+ ++
Sbjct: 723 SVTEDN 728
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|10178100|dbj|BAB11487.1| S-receptor kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 768 bits (1983), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 392/723 (54%), Positives = 511/723 (70%), Gaps = 57/723 (7%)
Query: 11 FLFIAPASSISFSEFIHPNFTASHVKFIDYG-GSFLTSHNGTFKAAIVNTRSQQNS--FY 67
F+F++ ASSI EF++PNFTAS+++F+D G+FL S N FKA + + +S FY
Sbjct: 18 FVFVSCASSI---EFVYPNFTASNLRFVDSSKGAFLLSRNSIFKAGLFSPGGDDSSTGFY 74
Query: 68 LCIIHVLSNTIIWSANRDTPISGSGKMNLTPKGI-IISDENGNLK-WSTPPLKSSVSALR 125
++HV S + IWS+NRD+P+S SG MNLTP+GI +I D + WSTP L S V +LR
Sbjct: 75 FSVVHVDSGSTIWSSNRDSPVSSSGTMNLTPQGISVIEDGKSQIPVWSTPVLASPVKSLR 134
Query: 126 LTEMGNLVLLDGFNGSLWESFHHPRDTIVIGQHLPAGASLSSAVSDYNLSTGDYSLTVGA 185
LT+ GNL+LLD N SLWESF P D+IV+GQ L G LS +VS + STGDY VG
Sbjct: 135 LTDAGNLLLLDHLNVSLWESFDFPTDSIVLGQRLKLGMFLSGSVSRSDFSTGDYKFLVGE 194
Query: 186 SDAELQWQGQMYWKLSMDTKAYVDSRYIVDYMAINRTGVYLFGNNGSAVVIRVVLPPS-N 244
SD +QW+GQ YWKL M +A VDS + V+Y+ + +G+ L NG+ VV+RV LPPS +
Sbjct: 195 SDGLMQWRGQNYWKLRMHIRANVDSNFPVEYLTVTTSGLALMARNGTVVVVRVALPPSSD 254
Query: 245 FRIAKLDASGQFTVLRLSGSDLEQEYMGPDDGCQIPFICGRMGMCADDATSGSPSCSCPA 304
FR+AK+D+SG+F V R SG +L E+ GP D CQIPF+CG++G+C D S + SCSCP
Sbjct: 255 FRVAKMDSSGKFIVSRFSGKNLVTEFSGPMDSCQIPFVCGKLGLCNLDNASENQSCSCPD 314
Query: 305 GFHLASQNTSGCVPSDASHSLPVACNSTRKESLLNASVVSYLRLGYGMDYFANHFFQPST 364
+ DA+ + +SYL LG G+ YF+ HF P
Sbjct: 315 EMRM-----------DAARN------------------ISYLELGLGVSYFSTHFTDPVE 345
Query: 365 YDVNLSFCQELCSDDCSCLGIFFKNSSGSCYMLGNVLGSI--MSSNTVDSDLVGYIKVLV 422
+ + L C ++CS +CSCLG+F++N+S SCY++ + GS+ + ++ + DL+GY+K+ +
Sbjct: 346 HGLPLLACHDICSKNCSCLGVFYENTSRSCYLVKDSFGSLSLVKNSPENHDLIGYVKLSI 405
Query: 423 GPTQADLNPNNSSSNQNQDFPLVALVLLPFTGFFLFSALGFLWWRRWKLHKSTDSKSGNP 482
T A NN+ + FP++ALVLLP S + + R ++ + P
Sbjct: 406 RKTNAQPPGNNNRGGSS--FPVIALVLLPC------SVMRYSSIREKQVTR--------P 449
Query: 483 NTLSSGDLEAFYIPGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKI 542
+ SGDL +F+IPGLPQ+F++EELE AT+NFK IGSGGFG+VYKG L D+T++AVKKI
Sbjct: 450 GSFESGDLGSFHIPGLPQKFEFEELEQATENFKMQIGSGGFGSVYKGTLPDETLIAVKKI 509
Query: 543 TNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILF-GNG 601
TN G+ G+++FCTEIAIIGNI H NLVKL+GFCA+GRQ LLVYEYMNHGSL++ LF GNG
Sbjct: 510 TNHGLHGRQEFCTEIAIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFSGNG 569
Query: 602 PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT 661
PVLEWQERFDIALGTARGLAYLHSGC+QKIIHCD+KPENILLH HFQ KISDFGLSKLL
Sbjct: 570 PVLEWQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLN 629
Query: 662 PEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSMD 721
E+SSLFTTMRGTRGYLAPEW+TN+AISEK DVYS+GMVLLELVSGR+NCS RS+S+S+
Sbjct: 630 QEESSLFTTMRGTRGYLAPEWITNAAISEKADVYSYGMVLLELVSGRKNCSFRSRSNSVT 689
Query: 722 SNS 724
++
Sbjct: 690 EDN 692
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|3047096|gb|AAC13608.1| similar to eukaryotic protein kinase domains (Pfam: pkinase.hmm, score: 189.74) [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 760 bits (1962), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/710 (54%), Positives = 502/710 (70%), Gaps = 54/710 (7%)
Query: 24 EFIHPNFTASHVKFIDYG-GSFLTSHNGTFKAAIVNTRSQQNS--FYLCIIHVLSNTIIW 80
+F++PNFTAS+++F+D G+FL S N FKA + + +S FY ++HV S + IW
Sbjct: 13 KFVYPNFTASNLRFVDSSKGAFLLSRNSIFKAGLFSPGGDDSSTGFYFSVVHVDSGSTIW 72
Query: 81 SANRDTPISGSGKMNLTPKGI-IISDENGNLK-WSTPPLKSSVSALRLTEMGNLVLLDGF 138
S+NRD+P+S SG MNLTP+GI +I D + WSTP L S V +LRLT+ GNL+LLD
Sbjct: 73 SSNRDSPVSSSGTMNLTPQGISVIEDGKSQIPVWSTPVLASPVKSLRLTDAGNLLLLDHL 132
Query: 139 NGSLWESFHHPRDTIVIGQHLPAGASLSSAVSDYNLSTGDYSLTVGASDAELQWQGQMYW 198
N SLWESF P D+IV+GQ L G LS +VS + STGDY VG SD +QW+GQ YW
Sbjct: 133 NVSLWESFDFPTDSIVLGQRLKLGMFLSGSVSRSDFSTGDYKFLVGESDGLMQWRGQNYW 192
Query: 199 KLSMDTKAYVDSRYIVDYMAINRTGVYLFGNNGSAVVIRVVLPPS-NFRIAKLDASGQFT 257
KL M +A VDS + V+Y+ + +G+ L NG+ VV+RV LPPS +FR+AK+D+SG+F
Sbjct: 193 KLRMHIRANVDSNFPVEYLTVTTSGLALMARNGTVVVVRVALPPSSDFRVAKMDSSGKFI 252
Query: 258 VLRLSGSDLEQEYMGPDDGCQIPFICGRMGMCADDATSGSPSCSCPAGFHLASQNTSGCV 317
V R SG +L E+ GP D CQIPF+CG++G+C D S + SCSCP +
Sbjct: 253 VSRFSGKNLVTEFSGPMDSCQIPFVCGKLGLCNLDNASENQSCSCPDEMRM--------- 303
Query: 318 PSDASHSLPVACNSTRKESLLNASVVSYLRLGYGMDYFANHFFQPSTYDVNLSFCQELCS 377
DA+ + +SYL LG G+ YF+ HF P + + L C ++CS
Sbjct: 304 --DAARN------------------ISYLELGLGVSYFSTHFTDPVEHGLPLLACHDICS 343
Query: 378 DDCSCLGIFFKNSSGSCYMLGNVLGSI--MSSNTVDSDLVGYIKVLVGPTQADLNPNNSS 435
+CSCLG+F++N+S SCY++ + GS+ + ++ + DL+GY+K+ + T A NN+
Sbjct: 344 KNCSCLGVFYENTSRSCYLVKDSFGSLSLVKNSPENHDLIGYVKLSIRKTNAQPPGNNNR 403
Query: 436 SNQNQDFPLVALVLLPFTGFFLFSALGFLWWRRWKLHKSTDSKSGNPNTLSSGDLEAFYI 495
+ FP++ALVLLP S + + R ++ + P + SGDL +F+I
Sbjct: 404 GGSS--FPVIALVLLPC------SVMRYSSIREKQVTR--------PGSFESGDLGSFHI 447
Query: 496 PGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCT 555
PGLPQ+F++EELE AT+NFK IGSGGFG+VYKG L D+T++AVKKITN G+ G+++FCT
Sbjct: 448 PGLPQKFEFEELEQATENFKMQIGSGGFGSVYKGTLPDETLIAVKKITNHGLHGRQEFCT 507
Query: 556 EIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILF-GNGPVLEWQERFDIAL 614
EIAIIGNI H NLVKL+GFCA+GRQ LLVYEYMNHGSL++ LF GNGPVLEWQERFDIAL
Sbjct: 508 EIAIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFSGNGPVLEWQERFDIAL 567
Query: 615 GTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGT 674
GTARGLAYLHSGC+QKIIHCD+KPENILLH HFQ KISDFGLSKLL E+SSLFTTMRGT
Sbjct: 568 GTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEESSLFTTMRGT 627
Query: 675 RGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSMDSNS 724
RGYLAPEW+TN+AISEK DVYS+GMVLLELVSGR+NCS RS+S+S+ ++
Sbjct: 628 RGYLAPEWITNAAISEKADVYSYGMVLLELVSGRKNCSFRSRSNSVTEDN 677
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224145590|ref|XP_002325698.1| predicted protein [Populus trichocarpa] gi|222862573|gb|EEF00080.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 724 bits (1870), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/721 (53%), Positives = 491/721 (68%), Gaps = 49/721 (6%)
Query: 11 FLFIAPASSISFSEFIHPNFTASHVKFIDYGGSFLTSHNGTFKAAIVNTRSQQNSFYLCI 70
+L I+ S++ + I FTASH FID G FL S NG F A+I N+ + +Y CI
Sbjct: 17 YLCISGPSTV---QTIKQPFTASHFFFIDQSGVFLISSNGNFTASISNSE-ENPPYYFCI 72
Query: 71 IHVLSNTIIWSANRDTPISGSGKMNLTPKGIIISD----ENGNLKWSTPPLK--SSVSAL 124
HV SN IIW ANR+ PIS S K+ LT G+ I+ ++ WST L S VSA+
Sbjct: 73 THVKSNAIIWIANRNHPISDSDKLYLTTNGLAINSTYNSSTTSVVWSTEGLSPSSQVSAM 132
Query: 125 RLTEMGNLVLLDGFNGSLWESFHHPRDTIVIGQHLPAGASLSSAVSDYNLSTGDYSLTVG 184
L + GNLVLL+ N SLWESF P DTIV+GQ L G S+ ++ ++S GDY L V
Sbjct: 133 ELRDSGNLVLLNRNNVSLWESFDQPTDTIVMGQSLAVGTSVDCYNAENDMSVGDYRLVVT 192
Query: 185 ASDAELQWQGQMYWKLSMDTKAYVDSRYIVDYMAINRTGVYLFGNNGSAVVIRVVLPPSN 244
DA LQW G YWKLSM+ K DS+ V ++A+N TG++L G++ S VVI++ L P++
Sbjct: 193 GGDAVLQWNGMSYWKLSMEPKGSQDSKVPVSFLALNDTGLFLLGSDRSTVVIKLTLGPAD 252
Query: 245 FRIAKLDASGQFTVLRLSGSDLEQEYMGPDDGCQIPFICGRMGMCADDATSGSPSCSCPA 304
FR+AKL G+ +V + + QE++ P D CQIP C +MG+C+ S CSCP
Sbjct: 253 FRVAKLGFDGKLSVRKFVDQNWVQEFVSPADECQIPLSCNKMGLCS------SGRCSCPP 306
Query: 305 GFHLASQNTSGCVPSDASHSLPVACNSTRKESLLNASVVSYLRLGYGMDYFANHFFQPST 364
FH P++ LN+SV Y+ LG +DYFAN F P+
Sbjct: 307 NFH----------------GDPLS-------KKLNSSVF-YVNLGSELDYFANGFMAPAK 342
Query: 365 YDVNLSFCQELCSDDCSCLGIFFKNSSGSCYMLGNVLGSIMSSNTVDSDLVGYIKVLVGP 424
D+NL CQ+LC+ +CSCLGIF+ NSSGSCY+L N LGSIM +++ +S +GY+K +V
Sbjct: 343 RDINLLACQDLCTRNCSCLGIFYGNSSGSCYLLENPLGSIMEASSSNSKRLGYVKTIVVS 402
Query: 425 TQADLNPNNSSSNQNQDFPLVALVLLPFTGFFLF--SALGFLWWRRWKLHKSTDSKSGNP 482
++A+ N++ FP+V LVLLP +G L LGF+ WRR +L+++ K G
Sbjct: 403 SRAN------KVNESAKFPIVGLVLLPSSGILLIIIVVLGFICWRRNRLYRTAKLKLGRG 456
Query: 483 NTLSSGDLEAFYIPGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKI 542
++ SS +LE IPGLP RF+YE+L AT++F IGSGGFG VYKG L DK++VAVKKI
Sbjct: 457 DSSSS-ELEIISIPGLPVRFNYEDLVAATESFSTQIGSGGFGTVYKGTLPDKSVVAVKKI 515
Query: 543 TNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGP 602
TNVGVQGKK+FCTEIAIIG+ HVNLVKLKGFCAQGRQR LVYEYMN GSLDR LFGNGP
Sbjct: 516 TNVGVQGKKEFCTEIAIIGSTRHVNLVKLKGFCAQGRQRFLVYEYMNRGSLDRTLFGNGP 575
Query: 603 VLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP 662
VL+WQERF+IALGTARGLAYLHS CE+KIIHCD+KPENILLH + Q KISDFGLSKLLTP
Sbjct: 576 VLKWQERFEIALGTARGLAYLHSYCERKIIHCDVKPENILLHDNLQVKISDFGLSKLLTP 635
Query: 663 EQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSMDS 722
EQSSLFTTMRGTRGYLAPEWL IS+K DVYS+GMVLLE+V GR+N + + QS S+++
Sbjct: 636 EQSSLFTTMRGTRGYLAPEWLAGVTISDKADVYSYGMVLLEIVRGRKNSAAQPQSRSIEN 695
Query: 723 N 723
+
Sbjct: 696 D 696
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 724 | ||||||
| TAIR|locus:2182603 | 872 | AT5G35370 [Arabidopsis thalian | 0.973 | 0.808 | 0.564 | 3.5e-217 | |
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.574 | 0.506 | 0.451 | 5.5e-93 | |
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.294 | 0.257 | 0.582 | 9.1e-88 | |
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.700 | 0.611 | 0.360 | 1.8e-72 | |
| TAIR|locus:2197744 | 807 | AT1G61420 [Arabidopsis thalian | 0.459 | 0.412 | 0.347 | 1.3e-69 | |
| TAIR|locus:2197709 | 809 | AT1G61480 [Arabidopsis thalian | 0.461 | 0.412 | 0.351 | 4.7e-69 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.872 | 0.761 | 0.318 | 9.2e-68 | |
| TAIR|locus:2197714 | 792 | AT1G61440 [Arabidopsis thalian | 0.343 | 0.314 | 0.422 | 9.9e-67 | |
| TAIR|locus:2197724 | 806 | AT1G61430 [Arabidopsis thalian | 0.444 | 0.399 | 0.351 | 1.5e-64 | |
| TAIR|locus:2197664 | 804 | AT1G61490 [Arabidopsis thalian | 0.343 | 0.309 | 0.411 | 2e-64 |
| TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2098 (743.6 bits), Expect = 3.5e-217, P = 3.5e-217
Identities = 414/734 (56%), Positives = 531/734 (72%)
Query: 4 LLFVATIFLFIAPASSISFSEFIHPNFTASHVKFIDYG-GSFLTSHNGTFKAAIVNTRSQ 62
LL + +F+F++ ASSI EF++PNFTAS+++F+D G+FL S N FKA + +
Sbjct: 11 LLSLNLLFVFVSCASSI---EFVYPNFTASNLRFVDSSKGAFLLSRNSIFKAGLFSPGGD 67
Query: 63 QNS--FYLCIIHVLSNTIIWSANRDTPISGSGKMNLTPKGI-IISDENGNLK-WSTPPLK 118
+S FY ++HV S + IWS+NRD+P+S SG MNLTP+GI +I D + WSTP L
Sbjct: 68 DSSTGFYFSVVHVDSGSTIWSSNRDSPVSSSGTMNLTPQGISVIEDGKSQIPVWSTPVLA 127
Query: 119 SSVSALRLTEMGNLVLLDGFNGSLWESFHHPRDTIVIGQHLPAGASLSSAVSDYNLSTGD 178
S V +LRLT+ GNL+LLD N SLWESF P D+IV+GQ L G LS +VS + STGD
Sbjct: 128 SPVKSLRLTDAGNLLLLDHLNVSLWESFDFPTDSIVLGQRLKLGMFLSGSVSRSDFSTGD 187
Query: 179 YSLTVGASDAELQWQGQMYWKLSMDTKAYVDSRYIVDYMAINRTGVYLFGNNGSAVVIRV 238
Y VG SD +QW+GQ YWKL M +A VDS + V+Y+ + +G+ L NG+ VV+RV
Sbjct: 188 YKFLVGESDGLMQWRGQNYWKLRMHIRANVDSNFPVEYLTVTTSGLALMARNGTVVVVRV 247
Query: 239 VLPPSN-FRIAKLDASGQFTVLRLSGSDLEQEYMGPDDGCQIPFICGRMGMCADDATSGS 297
LPPS+ FR+AK+D+SG+F V R SG +L E+ GP D CQIPF+CG++G+C D S +
Sbjct: 248 ALPPSSDFRVAKMDSSGKFIVSRFSGKNLVTEFSGPMDSCQIPFVCGKLGLCNLDNASEN 307
Query: 298 PSCSCPAGFHLASQNTSGCVPSDASHSLPVACNSTRKESLLNASVVSYLRLGYGMDYFAN 357
SCSCP + + CVP S SLPV+C + +SYL LG G+ YF+
Sbjct: 308 QSCSCPDEMRMDA-GKGVCVPVSQSLSLPVSCEARN---------ISYLELGLGVSYFST 357
Query: 358 HFFQPSTYDVNLSFCQELCSDDCSCLGIFFKNSSGSCYMLGNVLGSI-MSSNTVDS-DLV 415
HF P + + L C ++CS +CSCLG+F++N+S SCY++ + GS+ + N+ ++ DL+
Sbjct: 358 HFTDPVEHGLPLLACHDICSKNCSCLGVFYENTSRSCYLVKDSFGSLSLVKNSPENHDLI 417
Query: 416 GYIKVLVGPTQADLXXXXXXXXXXXDFPLVALVLLPFTGFFLFSALGFLWWRRWKL--HK 473
GY+K+ + T A FP++ALVLLP +GFFL ALG LWWRR + +
Sbjct: 418 GYVKLSIRKTNAQ--PPGNNNRGGSSFPVIALVLLPCSGFFLLIALGLLWWRRCAVMRYS 475
Query: 474 STDSKS-GNPNTLSSGDLEAFYIPGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGILN 532
S K P + SGDL +F+IPGLPQ+F++EELE AT+NFK IGSGGFG+VYKG L
Sbjct: 476 SIREKQVTRPGSFESGDLGSFHIPGLPQKFEFEELEQATENFKMQIGSGGFGSVYKGTLP 535
Query: 533 DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGS 592
D+T++AVKKITN G+ G+++FCTEIAIIGNI H NLVKL+GFCA+GRQ LLVYEYMNHGS
Sbjct: 536 DETLIAVKKITNHGLHGRQEFCTEIAIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGS 595
Query: 593 LDRILF-GNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKI 651
L++ LF GNGPVLEWQERFDIALGTARGLAYLHSGC+QKIIHCD+KPENILLH HFQ KI
Sbjct: 596 LEKTLFSGNGPVLEWQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKI 655
Query: 652 SDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNC 711
SDFGLSKLL E+SSLFTTMRGTRGYLAPEW+TN+AISEK DVYS+GMVLLELVSGR+NC
Sbjct: 656 SDFGLSKLLNQEESSLFTTMRGTRGYLAPEWITNAAISEKADVYSYGMVLLELVSGRKNC 715
Query: 712 SPRSQSHSM--DSN 723
S RS+S+S+ D+N
Sbjct: 716 SFRSRSNSVTEDNN 729
|
|
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 926 (331.0 bits), Expect = 5.5e-93, P = 5.5e-93
Identities = 202/447 (45%), Positives = 281/447 (62%)
Query: 287 GMCADDATSGSPSCSC----PAG-FHLAS-QNTSGCVP------SDASHSLPVACNSTRK 334
G A D+++ PS C P G +++ S GCV SD + C T+
Sbjct: 269 GASAADSSTKIPSDLCGTPEPCGPYYVCSGSKVCGCVSGLSRARSDCKTGITSPCKKTKD 328
Query: 335 ESLLNASVVSYLRLGYGMDYFANHFFQPSTYDVNLSFCQELCSDDCSCLGIFFKNSSGSC 394
+ L +VS G G+DYFA + P + +L C+E C ++CSCLG+FF+NSSG+C
Sbjct: 329 NATLPLQLVS---AGDGVDYFALGYAPPFSKKTDLDSCKEFCHNNCSCLGLFFQNSSGNC 385
Query: 395 YMLGNVLGSIMSSNTVDSDLVGYIKVL-VGPTQADLXXXXXXXXXXXDFPLVALVLLPFT 453
++ + +GS +S S V YIK+ G D FP V ++++
Sbjct: 386 FLF-DYIGSFKTSGNGGSGFVSYIKIASTGSGGGD-----NGEDDGKHFPYVVIIVV--V 437
Query: 454 GFFLFSALGFLWWRRWKLHKSTDSKSGNPNTLSSGDLEAFYIPGLPQRFDYEELEVATDN 513
F+ + L F+ +R +HK P S D + G+P RF Y++L+ AT+N
Sbjct: 438 TVFIIAVLIFVAFR---IHKRKKMILEAPQESSEEDNFLENLSGMPIRFAYKDLQSATNN 494
Query: 514 FKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKG 573
F +G GGFG+VY+G L D + +AVKK+ +G QGKK+F E++IIG+IHH++LV+L+G
Sbjct: 495 FSVKLGQGGFGSVYEGTLPDGSRLAVKKLEGIG-QGKKEFRAEVSIIGSIHHLHLVRLRG 553
Query: 574 FCAQGRQRLLVYEYMNHGSLDRILFG--NGPVL-EWQERFDIALGTARGLAYLHSGCEQK 630
FCA+G RLL YE+++ GSL+R +F +G VL +W RF+IALGTA+GLAYLH C+ +
Sbjct: 554 FCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKGLAYLHEDCDAR 613
Query: 631 IIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISE 690
I+HCDIKPENILL +F AK+SDFGL+KL+T EQS +FTTMRGTRGYLAPEW+TN AISE
Sbjct: 614 IVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTTMRGTRGYLAPEWITNYAISE 673
Query: 691 KTDVYSFGMVLLELVSGRRNCSPRSQS 717
K+DVYS+GMVLLEL+ GR+N P S
Sbjct: 674 KSDVYSYGMVLLELIGGRKNYDPSETS 700
|
|
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 641 (230.7 bits), Expect = 9.1e-88, Sum P(2) = 9.1e-88
Identities = 127/218 (58%), Positives = 159/218 (72%)
Query: 497 GLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTE 556
G F Y EL+ AT NF + +G GGFG+V+KG L D + +AVK++ + QG+K F TE
Sbjct: 478 GTLSAFSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGIS-QGEKQFRTE 536
Query: 557 IAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGP----VLEWQERFDI 612
+ IG I HVNLV+L+GFC++G ++LLVY+YM +GSLD LF N VL W+ RF I
Sbjct: 537 VVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQI 596
Query: 613 ALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMR 672
ALGTARGLAYLH C IIHCDIKPENILL F K++DFGL+KL+ + S + TTMR
Sbjct: 597 ALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLTTMR 656
Query: 673 GTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRN 710
GTRGYLAPEW++ AI+ K DVYS+GM+L ELVSGRRN
Sbjct: 657 GTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRN 694
|
|
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 706 (253.6 bits), Expect = 1.8e-72, Sum P(2) = 1.8e-72
Identities = 201/557 (36%), Positives = 282/557 (50%)
Query: 174 LSTGDYSLTVGAS-DAELQWQ-GQMYWKLSMDTKAYVDSRYIVDYMAINRTGVY-LFGNN 230
L +G YS + S + L+W +YW +++ S +++ GV +F +N
Sbjct: 158 LRSGLYSFQLERSGNLTLRWNTSAIYWNHGLNSS--FSSNLSSPRLSLQTNGVVSIFESN 215
Query: 231 ---GSAVVIRVVLPPSN-FRIAKLDASGQFTVLRLSGSDLEQEYMGPDDG-CQIPFICGR 285
G+ +V SN FR KLD G LR+ S GP + C
Sbjct: 216 LLGGAEIVYSGDYGDSNTFRFLKLDDDGN---LRIYSSASRNS--GPVNAHWSAVDQCLV 270
Query: 286 MGMCAD----DATSGSPSCSCPAGFHLASQNTSGCVPSDASHSLPVACNSTRKESLLNAS 341
G C + +P CSCP S+N +D C RK L + S
Sbjct: 271 YGYCGNFGICSYNDTNPICSCP------SRNFDFVDVNDRRKG----CK--RKVELSDCS 318
Query: 342 V-VSYLRLGYGMDYFANHFFQPSTYDVNLSFCQELCSDDCSCLG-IFFKNSSGSCYMLGN 399
+ L L + + ++ S C+ C CL + + SG+C+
Sbjct: 319 GNTTMLDLVHTRLFTYEDDPNSESFFAGSSPCRANCLSSVLCLASVSMSDGSGNCWQKHP 378
Query: 400 VLGSIMSSNTVDS-DLVGYIKVLVGPTQAD-LXXXXXXXXXXXDFPLVALVLLPFTGFFL 457
GS + S Y+KV GP A+ L L + + G
Sbjct: 379 --GSFFTGYQWPSVPSTSYVKVC-GPVVANTLERATKGDDNNSKVHLWIVAVAVIAGLLG 435
Query: 458 FSALGF-LWWRRWKLHKSTDSKSGNPNTLSSGDLEAFYIPGLPQRFDYEELEVATDNFKN 516
A+ LWW + K+ TLSS Y G P +F Y+EL+ T +FK
Sbjct: 436 LVAVEIGLWWCCCR-------KNPRFGTLSSHYTLLEYASGAPVQFTYKELQRCTKSFKE 488
Query: 517 LIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCA 576
+G+GGFG VY+G+L ++T+VAVK++ + QG+K F E+A I + HH+NLV+L GFC+
Sbjct: 489 KLGAGGFGTVYRGVLTNRTVVAVKQLEGIE-QGEKQFRMEVATISSTHHLNLVRLIGFCS 547
Query: 577 QGRQRLLVYEYMNHGSLDRILF--GNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHC 634
QGR RLLVYE+M +GSLD LF + L W+ RF+IALGTA+G+ YLH C I+HC
Sbjct: 548 QGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYRFNIALGTAKGITYLHEECRDCIVHC 607
Query: 635 DIKPENILLHYHFQAKISDFGLSKLLTPEQSSL-FTTMRGTRGYLAPEWLTNSAISEKTD 693
DIKPENIL+ +F AK+SDFGL+KLL P+ + +++RGTRGYLAPEWL N I+ K+D
Sbjct: 608 DIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLPITSKSD 667
Query: 694 VYSFGMVLLELVSGRRN 710
VYS+GMVLLELVSG+RN
Sbjct: 668 VYSYGMVLLELVSGKRN 684
|
|
| TAIR|locus:2197744 AT1G61420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 520 (188.1 bits), Expect = 1.3e-69, Sum P(2) = 1.3e-69
Identities = 124/357 (34%), Positives = 198/357 (55%)
Query: 359 FFQPSTYDVNLSFCQELCSDDCSCLGIFFKNSSGSCYMLG-NVLGSIMSSNTVDSDLVGY 417
F++ +++ VN+ CQ+ C +CSCL + + G C M +++ ++ S +L+
Sbjct: 356 FYEFASF-VNVEECQKSCLHNCSCLAFAYIDGIG-CLMWNQDLMDAVQFSE--GGELLS- 410
Query: 418 IKVLVGPTQADLXXXXXXXXXXXDFPLVALVLLPFTGFFLFSALGFLWWRRWKLHKSTDS 477
I++ +++L +V+L L+ F + F +WR +++ + D
Sbjct: 411 IRL----ARSELGGNKRKKAITAS--IVSLSLVVIIAF-----VAFCFWR-YRVKHNADI 458
Query: 478 KSGNPNTLSSGDLEAFYIPGLPQRFDYEELEVATDNFK--NLIGSGGFGAVYKGILNDKT 535
+ DL+ +PGL FD ++ AT+NF N +G GGFG VYKG L D
Sbjct: 459 TTDASQVSWRNDLKPQDVPGL-DFFDMHTIQTATNNFSISNKLGQGGFGPVYKGKLQDGK 517
Query: 536 IVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDR 595
+AVK++++ QGK++F EI +I + H NLV++ G C +G ++LL+YE+M + SLD
Sbjct: 518 EIAVKRLSSSSGQGKEEFMNEIVLISKLQHKNLVRILGCCIEGEEKLLIYEFMLNNSLDT 577
Query: 596 ILFGNGPVLE--WQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISD 653
LF + LE W +R DI G ARG+ YLH K+IH D+K NILL KISD
Sbjct: 578 FLFDSRKRLEIDWPKRLDIIQGIARGIHYLHRDSHLKVIHRDLKVSNILLDEKMNPKISD 637
Query: 654 FGLSKLLT-PEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
FGL+++ E + GT GY+APE+ SEK+D+YSFG+++LE++SG +
Sbjct: 638 FGLARMYQGTEYQDNTRRVVGTLGYMAPEYAWTGMFSEKSDIYSFGVLMLEIISGEK 694
|
|
| TAIR|locus:2197709 AT1G61480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 502 (181.8 bits), Expect = 4.7e-69, Sum P(2) = 4.7e-69
Identities = 126/358 (35%), Positives = 191/358 (53%)
Query: 359 FFQPSTYDVNLSFCQELCSDDCSCLGIFFKNSSGSCYMLGNVLGSIMSSNTVDSDLVGYI 418
F++ +++ V+ C ++C +CSCL + N G C M L + V G I
Sbjct: 356 FYEFASF-VDAEGCYQICLHNCSCLAFAYINGIG-CLMWNQDL-----MDAVQFSAGGEI 408
Query: 419 KVLVGPTQADLXXXXXXXXXXXDFPLVALVLLPFTGFFLFSALGFLWWRRWKLHKSTDSK 478
+ L + ++V L F+A FL R+K+ + +K
Sbjct: 409 LSI------RLASSELGGNKRNKIIVASIVSLSLFVILAFAAFCFL---RYKVKHTVSAK 459
Query: 479 SGNPNTLSS--GDLEAFYIPGLPQRFDYEELEVATDNFK--NLIGSGGFGAVYKGILNDK 534
+ + DLE + GL + F+ ++ ATDNF N +G GGFG+VYKG L D
Sbjct: 460 ISKIASKEAWNNDLEPQDVSGL-KFFEMNTIQTATDNFSLSNKLGQGGFGSVYKGKLQDG 518
Query: 535 TIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLD 594
+AVK++++ QGK++F EI +I + H NLV++ G C +G +RLLVYE++ + SLD
Sbjct: 519 KEIAVKRLSSSSGQGKEEFMNEIVLISKLQHKNLVRILGCCIEGEERLLVYEFLLNKSLD 578
Query: 595 RILFGNGPVLE--WQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKIS 652
LF + LE W +RF+I G ARGL YLH ++IH D+K NILL KIS
Sbjct: 579 TFLFDSRKRLEIDWPKRFNIIEGIARGLHYLHRDSCLRVIHRDLKVSNILLDEKMNPKIS 638
Query: 653 DFGLSKLLT-PEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
DFGL+++ E + GT GY+APE+ SEK+D+YSFG++LLE+++G +
Sbjct: 639 DFGLARMYQGTEYQDNTRRVAGTLGYMAPEYAWTGMFSEKSDIYSFGVILLEIITGEK 696
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 688 (247.2 bits), Expect = 9.2e-68, P = 9.2e-68
Identities = 228/715 (31%), Positives = 340/715 (47%)
Query: 45 LTSHNGTFKAAI---VNTRSQQNSFYLCIIHVLSNTIIWSANRDTPIS-GSGKMNLTPKG 100
+ S++ TF+ VN+ + + I V T++W AN ++PI+ SG ++++ +G
Sbjct: 37 VVSNHSTFRFGFFSPVNSTGRYAGIWFNNIPV--QTVVWVANSNSPINDSSGMVSISKEG 94
Query: 101 -IIISDENGNLKWSTP---PLKSSVSALRLTEMGNLVLLDGFN-GS--LWESFHHPRD-- 151
+++ D G + WST P+ ++ RL GNLVLL N G LWESF HP++
Sbjct: 95 NLVVMDGRGQVHWSTNVLVPVAANTFYARLLNTGNLVLLGTTNTGDEILWESFEHPQNIY 154
Query: 152 --TIVIGQHLPAGASLS--SAVSDYNLSTGDYSL-TVGASDAELQ-WQGQMY-WKLSMDT 204
T+ + G SL S S ++ S G YS + EL W+ + W+
Sbjct: 155 LPTMSLATDTKTGRSLKLRSWKSPFDPSPGRYSAGLIPLPFPELVVWKDDLLMWRSGPWN 214
Query: 205 KAYVDSRYIVDYMAINRTGVYLFGNNGSAVVIRVVLPPSNFRIAKLDASGQFTVLRLSGS 264
Y +DY IN + L +N +V + + LD+ G +V + +
Sbjct: 215 GQYFIGLPNMDYR-INLFELTLSSDNRGSVSMSYAGNTLLYHFL-LDSEG--SVFQRDWN 270
Query: 265 DLEQEYMG----PDDGCQIPFICGRMGMCADDATSGSPSCSCPAGFH---LASQN----T 313
QE+ P C CG+ C + S +P C C GF A N T
Sbjct: 271 VAIQEWKTWLKVPSTKCDTYATCGQFASCRFNPGS-TPPCMCIRGFKPQSYAEWNNGNWT 329
Query: 314 SGCVPSDASHSLPVACNSTRKESLLNASVVSYLRLGYGMDYFANHFFQPSTYDVNLSFCQ 373
GCV P+ C S R + + ++R+ H P N C
Sbjct: 330 QGCV-----RKAPLQCES-RDNNDGSRKSDGFVRV---QKMKVPH--NPQRSGANEQDCP 378
Query: 374 ELCSDDCSCLGIFFKNSSGSCYMLGNVLGSIMSSNTVDSDLVGYIKVLVGPTQADLXXXX 433
E C +CSC F G GN++ S T +V YI++ AD
Sbjct: 379 ESCLKNCSCTAYSFDRGIGCLLWSGNLMDMQEFSGT---GVVFYIRL------ADSEFKK 429
Query: 434 XXXXXXXDFPLVALVLLPFTGFFLFSALGFLWWRRWKL--H--KSTDSKSGNPN--TLSS 487
++ + LL G FLF+ G + WK+ H K+ +++ N LSS
Sbjct: 430 RTNRSI----VITVTLL--VGAFLFA--GTVVLALWKIAKHREKNRNTRLLNERMEALSS 481
Query: 488 GDLEA-----FYIPGLPQRFDYEELEVATDNFK--NLIGSGGFGAVYKGILNDKTIVAVK 540
D+ A + + LP F+++ L VAT+NF N +G GGFGAVYKG L + +AVK
Sbjct: 482 NDVGAILVNQYKLKELPL-FEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAVK 540
Query: 541 KITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFG- 599
+++ QG ++F E+ +I + H NLV+L GFC +G +R+LVYE+M LD LF
Sbjct: 541 RLSRTSGQGVEEFVNEVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDP 600
Query: 600 -NGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSK 658
+L+W+ RF+I G RGL YLH KIIH D+K NILL + KISDFGL++
Sbjct: 601 VKQRLLDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLAR 660
Query: 659 LLTPEQSSLFTT-MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCS 712
+ + + T + GT GY+APE+ SEK+DV+S G++LLE+VSGRRN S
Sbjct: 661 IFQGNEDEVSTVRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSS 715
|
|
| TAIR|locus:2197714 AT1G61440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 499 (180.7 bits), Expect = 9.9e-67, Sum P(2) = 9.9e-67
Identities = 114/270 (42%), Positives = 160/270 (59%)
Query: 445 VALVLLPFTGFFLFSALGFLWWRRWKLHKSTDSKSGNPNTLSSGDLEAFYIPGLPQRFDY 504
V+L L GF F GF W R K H + N L S D +PGL + F+
Sbjct: 425 VSLTLFVILGFATF---GF-WRNRVKHHDAWR------NDLQSQD-----VPGL-EFFEM 468
Query: 505 EELEVATDNFK--NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGN 562
++ AT NF N +G GGFG+VYKG L D +AVK++++ QGK++F EI +I
Sbjct: 469 NTIQTATSNFSLSNKLGHGGFGSVYKGKLQDGREIAVKRLSSSSEQGKQEFMNEIVLISK 528
Query: 563 IHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLE--WQERFDIALGTARGL 620
+ H NLV++ G C +G+++LL+YE+M + SLD +FG+ LE W +RFDI G RGL
Sbjct: 529 LQHRNLVRVLGCCVEGKEKLLIYEFMKNKSLDTFVFGSRKRLELDWPKRFDIIQGIVRGL 588
Query: 621 AYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT-MRGTRGYLA 679
YLH ++IH D+K NILL KISDFGL++L Q T + GT GY++
Sbjct: 589 LYLHRDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARLFQGSQYQDKTRRVVGTLGYMS 648
Query: 680 PEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
PE+ SEK+D+YSFG++LLE++SG +
Sbjct: 649 PEYAWTGVFSEKSDIYSFGVLLLEIISGEK 678
|
|
| TAIR|locus:2197724 AT1G61430 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 484 (175.4 bits), Expect = 1.5e-64, Sum P(2) = 1.5e-64
Identities = 123/350 (35%), Positives = 184/350 (52%)
Query: 368 NLSFCQELCSDDCSCLGIFFKNSSGSCYMLGNVLGSIMSSNTVDSDLVGYIKVLVGPTQA 427
N C + C +CSCL + G C M L + +L + + + ++
Sbjct: 363 NAEECHQNCLHNCSCLAFSYIPGIG-CLMWSKDLMDTRQFSAA-GEL---LSIRLARSEL 417
Query: 428 DLXXXXXXXXXXXDFPLVALVLLPFTGFFLFSALGFLWWRRWKLHKSTDSKSGNPNTLSS 487
D+ V+L L GF +A GF WR H + S N L S
Sbjct: 418 DVNKRKMTIVAST----VSLTLFVIFGF---AAFGF--WRCRVEHNAHISNDAWRNFLQS 468
Query: 488 GDLEAFYIPGLPQRFDYEELEVATDNFK--NLIGSGGFGAVYK---GILNDKTIVAVKKI 542
D +PGL + F+ ++ AT+NF N +G GGFG+VYK G L D +AVK++
Sbjct: 469 QD-----VPGL-EFFEMNAIQTATNNFSLSNKLGPGGFGSVYKARNGKLQDGREIAVKRL 522
Query: 543 TNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGP 602
++ QGK++F EI +I + H NLV++ G C +G ++LL+Y ++ + SLD +F
Sbjct: 523 SSSSGQGKQEFMNEIVLISKLQHRNLVRVLGCCVEGTEKLLIYGFLKNKSLDTFVFDARK 582
Query: 603 VLE--WQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLL 660
LE W +RF+I G ARGL YLH ++IH D+K NILL KISDFGL+++
Sbjct: 583 KLELDWPKRFEIIEGIARGLLYLHRDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMF 642
Query: 661 TPEQSSLFTT-MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
Q T + GT GY++PE+ SEK+D+YSFG++LLE++SG++
Sbjct: 643 QGTQYQEKTRRVVGTLGYMSPEYAWTGVFSEKSDIYSFGVLLLEIISGKK 692
|
|
| TAIR|locus:2197664 AT1G61490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 493 (178.6 bits), Expect = 2.0e-64, Sum P(2) = 2.0e-64
Identities = 107/260 (41%), Positives = 156/260 (60%)
Query: 455 FFLFSALGFLWWRRWKLHKSTDSKSGNPNTLSSGDLEAFYIPGLPQRFDYEELEVATDNF 514
F + ++ F +WR HK+ K N L S + +PGL + F+ ++ AT+NF
Sbjct: 437 FVILTSAAFGFWRYRVKHKAYTLKDAWRNDLKSKE-----VPGL-EFFEMNTIQTATNNF 490
Query: 515 K--NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLK 572
N +G GGFG+VYKG L D +AVK++++ QGK++F EI +I + H NLV++
Sbjct: 491 SLSNKLGQGGFGSVYKGKLQDGKEIAVKQLSSSSGQGKEEFMNEIVLISKLQHRNLVRVL 550
Query: 573 GFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLE--WQERFDIALGTARGLAYLHSGCEQK 630
G C +G ++LL+YE+M + SLD +F LE W +RFDI G ARGL YLH K
Sbjct: 551 GCCIEGEEKLLIYEFMLNKSLDTFVFDARKKLEVDWPKRFDIVQGIARGLLYLHRDSRLK 610
Query: 631 IIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT-MRGTRGYLAPEWLTNSAIS 689
+IH D+K NILL KISDFGL+++ Q T + GT GY++PE+ S
Sbjct: 611 VIHRDLKVSNILLDEKMNPKISDFGLARMYEGTQCQDKTRRVVGTLGYMSPEYAWTGVFS 670
Query: 690 EKTDVYSFGMVLLELVSGRR 709
EK+D+YSFG++LLE++ G +
Sbjct: 671 EKSDIYSFGVLLLEIIIGEK 690
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O65238 | Y5537_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5633 | 0.9654 | 0.8016 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 724 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-56 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-55 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-52 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-51 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-49 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-49 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-42 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-40 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-37 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-33 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-31 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-30 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-29 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-29 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-29 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-28 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-27 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-25 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-25 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-24 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 9e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-23 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-23 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-23 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-23 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-23 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-23 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-22 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-22 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-22 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-22 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-21 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-21 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-21 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-21 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-21 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-20 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-20 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-20 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-19 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-19 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-19 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-18 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-18 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-18 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-17 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-17 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 1e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-17 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-17 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 7e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-16 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-16 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-15 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 1e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-15 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-15 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 9e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-14 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-14 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-13 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 9e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-07 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 4e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 6e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 9e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.002 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.002 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.002 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.003 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 193 bits (493), Expect = 1e-56
Identities = 83/195 (42%), Positives = 102/195 (52%), Gaps = 9/195 (4%)
Query: 518 IGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKD--FCTEIAIIGNIHHVNLVKLKGF 574
+GSG FG VYK IVAVK + + KKD EI I+ + H N+V+L
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 575 CAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHC 634
LV EY G L L GP L E IAL RGL YLHS IIH
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGGP-LSEDEAKKIALQILRGLEYLHS---NGIIHR 122
Query: 635 DIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL-TNSAISEKTD 693
D+KPENILL + KI+DFGL+K L SS TT GT Y+APE L + K D
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSSS-LTTFVGTPWYMAPEVLLGGNGYGPKVD 181
Query: 694 VYSFGMVLLELVSGR 708
V+S G++L EL++G+
Sbjct: 182 VWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 187 bits (478), Expect = 3e-55
Identities = 79/191 (41%), Positives = 99/191 (51%), Gaps = 8/191 (4%)
Query: 518 IGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKD-FCTEIAIIGNIHHVNLVKLKGFC 575
+G GGFG VY VA+K I + EI I+ ++H N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 576 AQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCD 635
LV EY GSL +L N L E I L GL YLHS IIH D
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRD 117
Query: 636 IKPENILLHY-HFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPE-WLTNSAISEKTD 693
+KPENILL + + K++DFGLSKLLT SL T+ GT Y+APE L SEK+D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLT-SDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 694 VYSFGMVLLEL 704
++S G++L EL
Sbjct: 177 IWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 1e-52
Identities = 66/197 (33%), Positives = 96/197 (48%), Gaps = 8/197 (4%)
Query: 514 FKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGK-KDFCTEIAIIGNIHHVNLVKL 571
+G G FG VY +VA+K I ++ + EI I+ + H N+V+L
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRL 62
Query: 572 KGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKI 631
+ LV EY G L +L G + E + RF L YLHS + I
Sbjct: 63 YDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARF-YLRQILSALEYLHS---KGI 118
Query: 632 IHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEK 691
+H D+KPENILL K++DFGL++ L P TT GT Y+APE L +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDP--GEKLTTFVGTPEYMAPEVLLGKGYGKA 176
Query: 692 TDVYSFGMVLLELVSGR 708
D++S G++L EL++G+
Sbjct: 177 VDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 6e-51
Identities = 71/202 (35%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 514 FKNLIGSGGFGAVYKGILNDK-----TIVAVKKI-TNVGVQGKKDFCTEIAIIGNIHHVN 567
+G G FG VYKG L K VAVK + + Q ++F E I+ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 568 LVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGC 627
+VKL G C + +V EYM G L L N P L + AL ARG+ YL S
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES-- 120
Query: 628 EQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRG---YLAPEWLT 684
+ IH D+ N L+ + KISDFGLS+ L + RG + ++APE L
Sbjct: 121 -KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY---YRKRGGKLPIRWMAPESLK 176
Query: 685 NSAISEKTDVYSFGMVLLELVS 706
+ K+DV+SFG++L E+ +
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 3e-49
Identities = 70/203 (34%), Positives = 101/203 (49%), Gaps = 16/203 (7%)
Query: 514 FKNLIGSGGFGAVYKGILNDK-----TIVAVKKI-TNVGVQGKKDFCTEIAIIGNIHHVN 567
+G G FG VYKG L K VAVK + + Q ++F E I+ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 568 LVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGP-VLEWQERFDIALGTARGLAYLHSG 626
+VKL G C + ++V EYM G L L N P L + AL ARG+ YL S
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES- 121
Query: 627 CEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRG---YLAPEWL 683
+ IH D+ N L+ + KISDFGLS+ L + ++G + ++APE L
Sbjct: 122 --KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY---YKVKGGKLPIRWMAPESL 176
Query: 684 TNSAISEKTDVYSFGMVLLELVS 706
+ K+DV+SFG++L E+ +
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 171 bits (437), Expect = 8e-49
Identities = 66/203 (32%), Positives = 104/203 (51%), Gaps = 14/203 (6%)
Query: 514 FKNLIGSGGFGAVYKGILND-----KTIVAVKKIT-NVGVQGKKDFCTEIAIIGNIHHVN 567
+G G FG VYKG L +T VAVK + + +++F E +I+ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 568 LVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGC 627
+V+L G C QG +V EYM G L L +G L ++ +AL A+G+ YL S
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES-- 120
Query: 628 EQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRG---YLAPEWLT 684
+ +H D+ N L+ + KISDFGLS+ + + G + ++APE L
Sbjct: 121 -KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY--RKRGGGKLPIKWMAPESLK 177
Query: 685 NSAISEKTDVYSFGMVLLELVSG 707
+ + K+DV+SFG++L E+ +
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 2e-42
Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 516 NLIGSGGFGAVYKGILNDK----TIVAVKKITNVGV-QGKKDFCTEIAIIGNIHHVNLVK 570
+G G FG VYKG L K T VAVK + + +KDF E ++ + H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 571 LKGFCAQGRQRLLVYEYMNHGSLDRIL--------FGNGPVLEWQERFDIALGTARGLAY 622
L G C + LV EYM G L L L ++ A+ A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 623 LHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRG-----Y 677
L S +K +H D+ N L+ KISDFGLS+ + + + T G +
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY----YRKKTGGKLPIRW 173
Query: 678 LAPEWLTNSAISEKTDVYSFGMVLLELVS 706
+APE L + + K+DV+SFG++L E+ +
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 146 bits (372), Expect = 7e-40
Identities = 71/210 (33%), Positives = 100/210 (47%), Gaps = 11/210 (5%)
Query: 514 FKNL--IGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVK 570
F+ L IG GGFG VYK VA+K I + K+ EI I+ H N+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 571 LKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQK 630
G + + +V E+ + GSL +L L + + +GL YLHS
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS---NG 118
Query: 631 IIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISE 690
IIH DIK NILL + K+ DFGLS L+ ++ TM GT ++APE +
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR--NTMVGTPYWMAPEVINGKPYDY 176
Query: 691 KTDVYSFGMVLLELVSGRRNCSPRSQSHSM 720
K D++S G+ +EL G+ P S+ M
Sbjct: 177 KADIWSLGITAIELAEGK---PPYSELPPM 203
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 61/203 (30%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 516 NLIGSGGFGAVYKGILND-KTIVAVKKI--TNVGVQGKKDFCTEIAIIGNIHHVNLVKLK 572
L+G G FG+VY + D ++AVK + + + + EI I+ ++ H N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 573 GFC--AQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTA---RGLAYLHSGC 627
G + + EY++ GSL +L G + E I T GLAYLHS
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE----PVIRKYTRQILEGLAYLHS-- 119
Query: 628 EQKIIHCDIKPENILLHYHFQAKISDFGLSKLL-TPEQSSLFTTMRGTRGYLAPEWLTNS 686
I+H DIK NIL+ K++DFG +K L E ++RGT ++APE +
Sbjct: 120 -NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 687 AISEKTDVYSFGMVLLELVSGRR 709
D++S G ++E+ +G+
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 76/229 (33%), Positives = 106/229 (46%), Gaps = 30/229 (13%)
Query: 514 FKNLIGSGGFGAVYKG---ILNDKT--IVAVKKI-TNVGVQGKKDFCTEIAIIGNIHHVN 567
F +G G FG V L D T VAVK + + Q + DF EI I+ + H N
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 568 LVKLKGFC--AQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHS 625
+VK KG C GR L+ EY+ GSL L + + + + +G+ YL S
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 626 GCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT----------PEQSSLFTTMRGTR 675
Q+ IH D+ NIL+ KISDFGL+K+L P +S +F
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF------- 177
Query: 676 GYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQSHSMDSN 723
+ APE L S S +DV+SFG+ L EL + G + SP ++ M
Sbjct: 178 -WYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI 225
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 69/202 (34%), Positives = 98/202 (48%), Gaps = 10/202 (4%)
Query: 514 FKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKG 573
IG G FG V G + VAVK + + + F E +++ + H NLV+L G
Sbjct: 10 LGATIGKGEFGDVMLGDYRGQK-VAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLG 67
Query: 574 FCAQGRQRLLVYEYMNHGSLDRILFGNG-PVLEWQERFDIALGTARGLAYLHSGCEQKII 632
QG +V EYM GSL L G V+ ++ AL G+ YL E+ +
Sbjct: 68 VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFV 124
Query: 633 HCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKT 692
H D+ N+L+ AK+SDFGL+K + Q S ++ T APE L S K+
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTKS 180
Query: 693 DVYSFGMVLLELVSGRRNCSPR 714
DV+SFG++L E+ S R PR
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPR 202
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 4e-32
Identities = 69/201 (34%), Positives = 107/201 (53%), Gaps = 14/201 (6%)
Query: 514 FKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGK--KDFCTEIAIIGNIHHVNLVK 570
+LIG G FG VYKG+ L VA+K+I+ ++ + K EI ++ N+ H N+VK
Sbjct: 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 571 LKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTA---RGLAYLHSGC 627
G ++ EY +GSL +I+ GP E +A+ +GLAYLH
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL----VAVYVYQVLQGLAYLH--- 116
Query: 628 EQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSA 687
EQ +IH DIK NIL K++DFG++ L + S ++ GT ++APE + S
Sbjct: 117 EQGVIHRDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPEVIEMSG 175
Query: 688 ISEKTDVYSFGMVLLELVSGR 708
S +D++S G ++EL++G
Sbjct: 176 ASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 67/210 (31%), Positives = 107/210 (50%), Gaps = 28/210 (13%)
Query: 515 KNLIGSGGFGAVYKG-ILNDKTIVAVKKI--TNVGVQGKKDFCTEIAIIGNIHHVNLVKL 571
IG G FG VY +D + +K+I +N+ + ++D E+ I+ ++H N++K
Sbjct: 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64
Query: 572 KGFCAQGRQRLL-VYEYMNHGSLDRIL----FGNGP-----VLEW--QERFDIALGTARG 619
+ + +L V EY + G L + + P +L+W Q + L
Sbjct: 65 YE-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ----LCLA---- 115
Query: 620 LAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLA 679
L YLHS +KI+H DIKP+NI L + K+ DFG+SK+L+ L T+ GT YL+
Sbjct: 116 LKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS-STVDLAKTVVGTPYYLS 171
Query: 680 PEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
PE N + K+D++S G VL EL + +
Sbjct: 172 PELCQNKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 125 bits (313), Expect = 6e-31
Identities = 75/212 (35%), Positives = 103/212 (48%), Gaps = 20/212 (9%)
Query: 513 NFKNLIGSGGFGAVYKGILNDKTIVAVKKI---TNVGVQGKKDFCTEIAIIGNI-HHVNL 568
+G G FG VY D+ +VA+K + + + F EI I+ ++ H N+
Sbjct: 3 RILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 569 VKLKGFCAQGRQRLLVYEYMNHGSLDRIL--FGNGPVLEWQERFDIALGTARGLAYLHSG 626
VKL F LV EY++ GSL+ +L G L E I L YLH
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH-- 118
Query: 627 CEQKIIHCDIKPENILLHYH-FQAKISDFGLSKLLTPEQSS-----LFTTMRGTRGYLAP 680
+ IIH DIKPENILL K+ DFGL+KLL S+ L +T GT GY+AP
Sbjct: 119 -SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 681 EWLT---NSAISEKTDVYSFGMVLLELVSGRR 709
E L + S +D++S G+ L EL++G
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLP 209
|
Length = 384 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 67/208 (32%), Positives = 110/208 (52%), Gaps = 12/208 (5%)
Query: 506 ELEVATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHH 565
E++ + +G+G FG V++G+ N+ T VAVK + G KDF E I+ + H
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRH 60
Query: 566 VNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLH 624
L++L C +V E M +GSL L G G L+ + D+A A G+AYL
Sbjct: 61 PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE 120
Query: 625 SGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPE 681
+ Q IH D+ N+L+ + K++DFGL++++ + ++ G + + APE
Sbjct: 121 A---QNYIHRDLAARNVLVGENNICKVADFGLARVI---KEDIYEAREGAKFPIKWTAPE 174
Query: 682 WLTNSAISEKTDVYSFGMVLLELVS-GR 708
+ S K+DV+SFG++L E+V+ GR
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 68/197 (34%), Positives = 101/197 (51%), Gaps = 14/197 (7%)
Query: 518 IGSGGFGAVYKGILNDKT--IVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKG- 573
+G G G VYK + T I A+KKI G + +K E+ + + +VK G
Sbjct: 9 LGQGSSGVVYKVR-HKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 574 FCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERF--DIALGTARGLAYLHSGCEQKI 631
F +G + V EYM+ GSL +L V + E IA +GL YLH+ ++ I
Sbjct: 68 FYKEGEISI-VLEYMDGGSLADLL---KKVGKIPEPVLAYIARQILKGLDYLHT--KRHI 121
Query: 632 IHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEK 691
IH DIKP N+L++ + KI+DFG+SK+L T GT Y++PE + + S
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTL-DQCNTFVGTVTYMSPERIQGESYSYA 180
Query: 692 TDVYSFGMVLLELVSGR 708
D++S G+ LLE G+
Sbjct: 181 ADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 7e-30
Identities = 69/201 (34%), Positives = 103/201 (51%), Gaps = 10/201 (4%)
Query: 511 TDNFKNL--IGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVN 567
+ +KNL IG G G VYK VA+KK+ + Q K+ EI I+ + H N
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPN 76
Query: 568 LVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVL-EWQERFDIALGTARGLAYLHSG 626
+V G + +V EYM+ GSL I+ N + E Q + + +GL YLHS
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-VCREVLQGLEYLHS- 134
Query: 627 CEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNS 686
Q +IH DIK +NILL K++DFG + LT E+S ++ GT ++APE +
Sbjct: 135 --QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR-NSVVGTPYWMAPEVIKRK 191
Query: 687 AISEKTDVYSFGMVLLELVSG 707
K D++S G++ +E+ G
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 81/231 (35%), Positives = 119/231 (51%), Gaps = 41/231 (17%)
Query: 514 FKNLIGSGGFGAVYK---GILNDKT--IVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNL 568
F +G G FG+V L D T +VAVKK+ + + +DF EI I+ ++ H N+
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 569 VKLKGFC-AQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERFD------IALGTARGL 620
VK KG C + GR+ L LV EY+ +GSL L + +ER D A +G+
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH------RERLDHRKLLLYASQICKGM 121
Query: 621 AYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLL----------TPEQSSLFTT 670
YL S ++ +H D+ NIL+ + KI DFGL+K+L P +S +F
Sbjct: 122 EYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF-- 176
Query: 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQSHSM 720
+ APE LT S S +DV+SFG+VL EL + ++CSP ++ M
Sbjct: 177 ------WYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRM 221
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 67/206 (32%), Positives = 109/206 (52%), Gaps = 19/206 (9%)
Query: 516 NLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGK--KDFCTEIAIIGNIHHVNLVKLK 572
N IG G FG VY + L+ ++AVK+I K K+ E+ ++ + H NLVK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 573 GFCAQGRQRLLVY-EYMNHGSLDRILFGNGPVLEWQ--ERFDIALGTARGLAYLHSGCEQ 629
G R+++ ++ EY + G+L+ +L +G +L+ + + L GLAYLHS
Sbjct: 66 GVEVH-REKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTLQL--LEGLAYLHS---H 118
Query: 630 KIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT---TMRGTRGYLAPEWLTNS 686
I+H DIKP NI L ++ K+ DFG + L +++ ++ GT Y+APE +T
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 687 AISEK---TDVYSFGMVLLELVSGRR 709
D++S G V+LE+ +G+R
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 7e-29
Identities = 69/198 (34%), Positives = 103/198 (52%), Gaps = 16/198 (8%)
Query: 518 IGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ 577
+G+G FG V+ G N T VAVK + G + F E I+ + H LV+L C++
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKP-GTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 578 GRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDI 636
+V EYM+ GSL D + G G L + D+A A G+AYL S + IH D+
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDL 129
Query: 637 KPENILLHYHFQAKISDFGLSKLL-----TPEQSSLFTTMRGTRGYLAPEWLTNSAISEK 691
NIL+ + KI+DFGL++L+ T + + F + APE + K
Sbjct: 130 AARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK-----WTAPEAANYGRFTIK 184
Query: 692 TDVYSFGMVLLELVS-GR 708
+DV+SFG++L E+V+ GR
Sbjct: 185 SDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 69/221 (31%), Positives = 105/221 (47%), Gaps = 38/221 (17%)
Query: 514 FKNLIGSGGFGAVYKGIL------NDKTIVAVKKITNVGV-QGKKDFCTEIAIIGNIHHV 566
K +G G FG V+ G NDK +VAVK + +KDF E ++ N H
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 567 NLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGP-------------VLEWQERFDIA 613
N+VK G C +G ++V+EYM HG L++ L +GP L + IA
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 614 LGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT--- 670
+ A G+ YL S Q +H D+ N L+ Y KI DFG+S+ ++TT
Sbjct: 129 VQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVVKIGDFGMSR-------DVYTTDYY 178
Query: 671 -MRGTR----GYLAPEWLTNSAISEKTDVYSFGMVLLELVS 706
+ G ++ PE + + ++DV+SFG+VL E+ +
Sbjct: 179 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 73/203 (35%), Positives = 94/203 (46%), Gaps = 23/203 (11%)
Query: 518 IGSGGFGAVYKGIL-NDKTIVAVKKIT---NVGVQGKKDFCTEIAIIGNIHHVNLVKLKG 573
+G G G+V K L N I A+K IT N +Q K E+ I + +VK G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQ--KQILRELEINKSCKSPYIVKYYG 66
Query: 574 FCAQGRQRLL--VYEYMNHGSLDRILFGNGPVLEWQERFD------IALGTARGLAYLHS 625
+ EY GSLD I V + R IA +GL+YLHS
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDSIY---KKVKKRGGRIGEKVLGKIAESVLKGLSYLHS 123
Query: 626 GCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTN 685
+KIIH DIKP NILL Q K+ DFG+S L + FT GT Y+APE +
Sbjct: 124 ---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GTSFYMAPERIQG 177
Query: 686 SAISEKTDVYSFGMVLLELVSGR 708
S +DV+S G+ LLE+ R
Sbjct: 178 KPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 69/200 (34%), Positives = 108/200 (54%), Gaps = 15/200 (7%)
Query: 516 NLIGSGGFGAVYKGILN---DKTI-VAVKKITNVGVQGKK--DFCTEIAIIGNIHHVNLV 569
+IG G FG V +G L K I VA+K + G K+ DF TE +I+G H N++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 570 KLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQ 629
+L+G + R +++ EYM +GSLD+ L N + + G A G+ YL E
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL---SEM 125
Query: 630 KIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRG---TRGYLAPEWLTNS 686
+H D+ NIL++ + K+SDFGLS+ L + + +TT G R + APE +
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE-DSEATYTTKGGKIPIR-WTAPEAIAYR 183
Query: 687 AISEKTDVYSFGMVLLELVS 706
+ +DV+SFG+V+ E++S
Sbjct: 184 KFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 55/202 (27%), Positives = 103/202 (50%), Gaps = 16/202 (7%)
Query: 518 IGSGGFGAVYKGIL-----NDKTIVAVKKI-TNVGVQGKKDFCTEIAIIGNIHHVNLVKL 571
+GSG FG VYKG+ K VA+K + + K+ E ++ ++ H ++V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 572 KGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKI 631
G C Q L+ + M G L + + + Q + + A+G++YL E+++
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRL 130
Query: 632 IHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTNSAI 688
+H D+ N+L+ KI+DFGL+KLL ++ G + ++A E + +
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAE--GGKVPIKWMALESILHRIY 188
Query: 689 SEKTDVYSFGMVLLELVS-GRR 709
+ K+DV+S+G+ + EL++ G +
Sbjct: 189 THKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 71/206 (34%), Positives = 98/206 (47%), Gaps = 31/206 (15%)
Query: 518 IGSGGFGAVYK-GILNDKTIVAVKKITNVGVQGKKDFC----------TEIAIIGNIHHV 566
+G G FG V + + A+K + KK TE I+ I+H
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVL-------KKKKIIKRKEVEHTLTERNILSRINHP 53
Query: 567 NLVKLKGFCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERF---DIALGTARGLAY 622
+VKL + Q ++L LV EY G L L G E + RF +I L L Y
Sbjct: 54 FIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLA----LEY 108
Query: 623 LHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEW 682
LHS II+ D+KPENILL K++DFGL+K L+ E S T GT YLAPE
Sbjct: 109 LHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT-NTFCGTPEYLAPEV 164
Query: 683 LTNSAISEKTDVYSFGMVLLELVSGR 708
L + D +S G++L E+++G+
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 67/205 (32%), Positives = 100/205 (48%), Gaps = 10/205 (4%)
Query: 517 LIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFC 575
+G G +G+VYK I +VA+K + ++ EI+I+ +VK G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 576 AQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCD 635
+ +V EY GS+ I+ L +E I T +GL YLHS K IH D
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRD 124
Query: 636 IKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVY 695
IK NILL+ QAK++DFG+S LT + T+ GT ++APE + + K D++
Sbjct: 125 IKAGNILLNEEGQAKLADFGVSGQLTDTMAKR-NTVIGTPFWMAPEVIQEIGYNNKADIW 183
Query: 696 SFGMVLLELVSGRRNCSPRSQSHSM 720
S G+ +E+ G+ P S H M
Sbjct: 184 SLGITAIEMAEGK---PPYSDIHPM 205
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 71/195 (36%), Positives = 104/195 (53%), Gaps = 11/195 (5%)
Query: 518 IGSGGFGAVYKGILNDKT--IVAVKKI-TNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGF 574
+G+G G V K +L+ T I+AVK I + +K E+ I+ + +V G
Sbjct: 9 LGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 575 CAQGRQRLLVYEYMNHGSLDRIL-FGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIH 633
+ EYM+ GSLD+IL G + E IA+ +GL YLH + KIIH
Sbjct: 68 FYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK-IAVAVLKGLTYLHE--KHKIIH 124
Query: 634 CDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTD 693
D+KP NIL++ Q K+ DFG+S L +SL T GT Y+APE + + S K+D
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSGQLV---NSLAKTFVGTSSYMAPERIQGNDYSVKSD 181
Query: 694 VYSFGMVLLELVSGR 708
++S G+ L+EL +GR
Sbjct: 182 IWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 3e-26
Identities = 67/204 (32%), Positives = 105/204 (51%), Gaps = 11/204 (5%)
Query: 518 IGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ 577
IGSG FG V+ G +K VA+K I G ++DF E ++ + H LV+L G C +
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIRE-GAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 578 GRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIK 637
LV+E+M HG L L + + L G+AYL S +IH D+
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLA 127
Query: 638 PENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTNSAISEKTDV 694
N L+ + K+SDFG+++ + +Q +T+ GT+ + +PE + S S K+DV
Sbjct: 128 ARNCLVGENQVVKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184
Query: 695 YSFGMVLLELVS-GRRNCSPRSQS 717
+SFG+++ E+ S G+ RS S
Sbjct: 185 WSFGVLMWEVFSEGKTPYENRSNS 208
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 63/193 (32%), Positives = 95/193 (49%), Gaps = 10/193 (5%)
Query: 518 IGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ 577
+GSG FG V+ G K VA+K I G + DF E ++ + H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 578 GRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIK 637
R +V EYM +G L L L + D+ + YL S IH D+
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLA 127
Query: 638 PENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTNSAISEKTDV 694
N L+ K+SDFGL++ + +Q +T+ +GT+ + PE S S K+DV
Sbjct: 128 ARNCLVGEDNVVKVSDFGLARYVLDDQ---YTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184
Query: 695 YSFGMVLLELVSG 707
+SFG+++ E+ S
Sbjct: 185 WSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 8e-26
Identities = 61/192 (31%), Positives = 102/192 (53%), Gaps = 9/192 (4%)
Query: 518 IGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ 577
+GSG FG V++G+ ++ VA+K + + + ++DF E+ + + H +L+ L C+
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 578 GRQRLLVYEYMNHGSLDRILFG-NGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDI 636
G ++ E M GSL L G VL D+A A G+AYL EQ IH D+
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDL 130
Query: 637 KPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGY--LAPEWLTNSAISEKTDV 694
NIL+ K++DFGL++L+ + ++ + Y APE ++ S K+DV
Sbjct: 131 AARNILVGEDLVCKVADFGLARLI---KEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDV 187
Query: 695 YSFGMVLLELVS 706
+SFG++L E+ +
Sbjct: 188 WSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 67/197 (34%), Positives = 97/197 (49%), Gaps = 13/197 (6%)
Query: 517 LIGSGGFGAVYKGILNDKTIVAVK--KITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGF 574
IG G FG VYKG+L T VAVK + T K+ F E I+ H N+VKL G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDL-KRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 575 CAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHC 634
C Q + +V E + GSL L L ++ ++L A G+ YL S IH
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHR 117
Query: 635 DIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR----GYLAPEWLTNSAISE 690
D+ N L+ + KISDFG+S+ E+ ++T G + + APE L +
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 691 KTDVYSFGMVLLELVSG 707
++DV+S+G++L E S
Sbjct: 175 ESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 62/203 (30%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 515 KNLIGSGGFGAVYKGILN----DKTIVAVKKI-TNVGVQGKKDFCTEIAIIGNIHHVNLV 569
+ +IG+G FG V++GIL + VA+K + + ++DF +E +I+G H N++
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 570 KLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQ 629
+L+G + + +++ EYM +G+LD+ L + + + G A G+ YL +
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---SDM 126
Query: 630 KIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRG--YLAPEWLTNSA 687
+H D+ NIL++ + + K+SDFGLS++L + +TT G + APE +
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 688 ISEKTDVYSFGMVLLELVS-GRR 709
+ +DV+SFG+V+ E++S G R
Sbjct: 187 FTSASDVWSFGIVMWEVMSFGER 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 62/203 (30%), Positives = 96/203 (47%), Gaps = 15/203 (7%)
Query: 514 FKNL--IGSGGFGAVYKGI-LNDKTIVAVKKIT----NVGVQGKKDFCTEIAIIGNIHHV 566
++ L IG G +G VYK IVA+KKI + G+ K EI ++ ++H
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIP--KTALREIKLLKELNHP 58
Query: 567 NLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSG 626
N++KL LV+E+M+ L +++ L +GLA+ HS
Sbjct: 59 NIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS- 116
Query: 627 CEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNS 686
I+H D+KPEN+L++ K++DFGL++ +T TR Y APE L
Sbjct: 117 --HGILHRDLKPENLLINTEGVLKLADFGLARSFGS-PVRPYTHYVVTRWYRAPELLLGD 173
Query: 687 AI-SEKTDVYSFGMVLLELVSGR 708
S D++S G + EL+S R
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 65/204 (31%), Positives = 97/204 (47%), Gaps = 24/204 (11%)
Query: 518 IGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKD-----FCTEIAIIGNIHHVNLVKL 571
IG G +G VYK +VA+KKI ++ +K+ EI ++ + H N+V+L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR---MENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 572 KGF---CAQGRQRLLVYEYMNH---GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHS 625
K +G +V+EYM+H G LD E Q + GL YLHS
Sbjct: 64 KEIVTSKGKG-SIYMVFEYMDHDLTGLLDS---PEVKFTESQIKC-YMKQLLEGLQYLHS 118
Query: 626 GCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTN 685
I+H DIK NIL++ K++DFGL++ T S+ +T T Y PE L
Sbjct: 119 ---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLG 175
Query: 686 SAI-SEKTDVYSFGMVLLELVSGR 708
+ + D++S G +L EL G+
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 19/216 (8%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKIT--NVGVQGKKDFCTEIAI 559
DYE LE IG G FG V K +D I+ K+I N+ + K+ +E+ I
Sbjct: 1 DYEVLET--------IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNI 52
Query: 560 IGNIHHVNLVKL--KGFCAQGRQRLLVYEYMNHGSLDRIL---FGNGPVLEWQERFDIAL 614
+ + H N+V+ + + +V EY G L +++ +E + + I
Sbjct: 53 LRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILT 112
Query: 615 GTARGLAYLHSGC--EQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMR 672
L H+ ++H D+KP NI L + K+ DFGL+K+L SS T
Sbjct: 113 QLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG-HDSSFAKTYV 171
Query: 673 GTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGR 708
GT Y++PE L + + EK+D++S G ++ EL +
Sbjct: 172 GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 27/204 (13%)
Query: 518 IGSGGFGAVYKGI-LNDKTIVAVKKI----TNVGVQGKKDFCT---EIAIIGNIHHVNLV 569
+G G +G VYK IVA+KKI G+ T EI+++ + H N+V
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIP-----STALREISLLKELKHPNIV 61
Query: 570 KLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQ 629
KL R+ LV+EY + L + L L I RGLAY HS
Sbjct: 62 KLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS---H 117
Query: 630 KIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNS--- 686
+I+H D+KP+NIL++ K++DFGL++ + +T T Y APE L S
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-YTHEVVTLWYRAPEILLGSKHY 176
Query: 687 --AISEKTDVYSFGMVLLELVSGR 708
A+ D++S G + E+++G+
Sbjct: 177 STAV----DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 67/205 (32%), Positives = 105/205 (51%), Gaps = 16/205 (7%)
Query: 513 NFK--NLIGSGGFGAVYK-GILNDKTIVAVKKITNVGVQGKK---DFCTEIAIIGNIHHV 566
+FK +G G +G+VYK L+D A+K+ ++G +K D EI I+ +++H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKE-VDLGSMSQKEREDAVNEIRILASVNHP 59
Query: 567 NLVKLKGFCAQGRQRLLVYEYMNHGSLDRIL---FGNGPVLEWQERFDIALGTARGLAYL 623
N++ K G + +V EY G L + + ++ QE + I + RGL L
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 624 HSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL 683
H EQKI+H D+K NILL + KI D G+SK+L ++ T GT Y+APE
Sbjct: 120 H---EQKILHRDLKSANILLVANDLVKIGDLGISKVLK---KNMAKTQIGTPHYMAPEVW 173
Query: 684 TNSAISEKTDVYSFGMVLLELVSGR 708
S K+D++S G +L E+ +
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 30/220 (13%)
Query: 514 FKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV--QGKKDF-CTEIAIIGNI-HHVNL 568
F +IG G F V A+K + + + K + E ++ + H +
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI 64
Query: 569 VKLKGFCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGC 627
+KL + Q + L V EY +G L + + G + E RF A L YLHS
Sbjct: 65 IKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF-YAAEILLALEYLHS-- 120
Query: 628 EQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL-------------------F 668
+ IIH D+KPENILL KI+DFG +K+L P S F
Sbjct: 121 -KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179
Query: 669 TTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGR 708
+ GT Y++PE L + +D+++ G ++ ++++G+
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 65/202 (32%), Positives = 96/202 (47%), Gaps = 24/202 (11%)
Query: 518 IGSGGFGAVYKGIL---NDKTI-VAVKKIT-NVGVQGKKDFCTEIAIIGNIHHVNLVKLK 572
+G G FG+V KG+ + K + VAVK + GKK+F E +++ + H +V+L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 573 GFCAQGRQRLLVYEYMNHGSLDRILFGNGPV-----LEWQERFDIALGTARGLAYLHSGC 627
G C +G +LV E G L + L + E A A G+AYL
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLE--- 112
Query: 628 EQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLT 684
+ +H D+ N+LL QAKISDFG+S+ L S + R + APE +
Sbjct: 113 SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAG-SDYYRATTAGRWPLKWYAPECIN 171
Query: 685 NSAISEKTDVYSFGMVLLELVS 706
S K+DV+S+G+ L E S
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 60/200 (30%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 518 IGSGGFGAVYK-GILNDKTIVAVKKITNVGVQGKKDFCT--EIAIIGNIHHVNLVKLKGF 574
IG G G V+K VA+KK+ ++G EI + H +VKL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 575 CAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHC 634
G +LV EYM + + P+ E Q + +G+AY+H I+H
Sbjct: 68 FPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVK-SYMRMLLKGVAYMH---ANGIMHR 123
Query: 635 DIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNS-AISEKTD 693
D+KP N+L+ KI+DFGL++L + E+ L++ TR Y APE L + D
Sbjct: 124 DLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVD 183
Query: 694 VYSFGMVLLELVSGRRNCSP 713
+++ G + EL+ N SP
Sbjct: 184 LWAVGCIFAELL----NGSP 199
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 64/201 (31%), Positives = 93/201 (46%), Gaps = 12/201 (5%)
Query: 514 FKNLIGSGGFGAVYKGILND-KTIVAVKKITNVGVQGK---KDFCTEIAIIGNIHHVNLV 569
+IG G FG V D K + A+K + K ++ E I+ ++H LV
Sbjct: 4 LLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLV 63
Query: 570 KLKGFCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCE 628
L + Q + + LV + + G L L E Q +F I L YLHS
Sbjct: 64 NLW-YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC-EIVLALEYLHS--- 118
Query: 629 QKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAI 688
+ IIH DIKP+NILL I+DF ++ +TP+ + T+ GT GY+APE L
Sbjct: 119 KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT--TSTSGTPGYMAPEVLCRQGY 176
Query: 689 SEKTDVYSFGMVLLELVSGRR 709
S D +S G+ E + G+R
Sbjct: 177 SVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 4e-23
Identities = 65/216 (30%), Positives = 105/216 (48%), Gaps = 27/216 (12%)
Query: 514 FKNLIGSGGFGAVYKG------ILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVN 567
K +G G FG V+ DK +VAVK + + + +KDF E ++ N+ H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 568 LVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGP----VLEWQER-----------FDI 612
+VK G C G ++V+EYM HG L++ L +GP +++ Q R I
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 613 ALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT--T 670
A A G+ YL S Q +H D+ N L+ + KI DFG+S+ + T
Sbjct: 129 ASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS 706
M R ++ PE + + ++DV+SFG++L E+ +
Sbjct: 186 MLPIR-WMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 5e-23
Identities = 72/219 (32%), Positives = 109/219 (49%), Gaps = 20/219 (9%)
Query: 517 LIGSGGFGAVYKGILNDKT--IVAVKKI----TNVG--VQGKKDFC----TEIAIIGNIH 564
LIG G +G VY LN T ++AVK++ T G +KD +EI + ++
Sbjct: 8 LIGKGTYGRVYLA-LNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 565 HVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLH 624
H+N+V+ GF + EY+ GS+ L G E RF GLAYLH
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRF-FTEQVLEGLAYLH 125
Query: 625 SGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF-TTMRGTRGYLAPEWL 683
S + I+H D+K +N+L+ KISDFG+SK + +M+G+ ++APE +
Sbjct: 126 S---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182
Query: 684 TNS--AISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSM 720
+ S K D++S G V+LE+ +GRR S +M
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM 221
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 5e-23
Identities = 64/212 (30%), Positives = 110/212 (51%), Gaps = 13/212 (6%)
Query: 507 LEVATDNFKNLIGSGGFGAVYKGIL---NDKTIVAVKKITNVGVQGK--KDFCTEIAIIG 561
++ + + +IG+G FG V G L + I K G K +DF +E +I+G
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMG 60
Query: 562 NIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLA 621
H N++ L+G + + ++V EYM +GSLD L + + + G A G+
Sbjct: 61 QFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMK 120
Query: 622 YLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR---GYL 678
YL + +H D+ NIL++ + K+SDFGLS++L + + +TT RG + +
Sbjct: 121 YL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT-RGGKIPIRWT 176
Query: 679 APEWLTNSAISEKTDVYSFGMVLLELVS-GRR 709
APE + + +DV+S+G+V+ E++S G R
Sbjct: 177 APEAIAYRKFTSASDVWSYGIVMWEVMSYGER 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 6e-23
Identities = 78/224 (34%), Positives = 109/224 (48%), Gaps = 23/224 (10%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGK-KDFCTEIAII 560
D EEL + IG G FG V+KGI N + +VA+K I + + +D EI ++
Sbjct: 1 DPEELFTKLER----IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVL 56
Query: 561 GNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGS-LDRILFGNGPVLEWQERFDIAL---GT 616
+ K G +G + ++ EY+ GS LD L GP E+Q IA
Sbjct: 57 SQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALD--LLRAGPFDEFQ----IATMLKEI 110
Query: 617 ARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRG 676
+GL YLHS +K IH DIK N+LL K++DFG++ LT Q T GT
Sbjct: 111 LKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR-NTFVGTPF 166
Query: 677 YLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSM 720
++APE + SA K D++S G+ +EL G P S H M
Sbjct: 167 WMAPEVIQQSAYDSKADIWSLGITAIELAKGE---PPNSDMHPM 207
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 7e-23
Identities = 71/224 (31%), Positives = 101/224 (45%), Gaps = 23/224 (10%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEIAIIG 561
DYE ++ IGSG +G VYK + +VA+K I + EI+++
Sbjct: 4 DYELIQR--------IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLK 55
Query: 562 NIHHVNLVKLKGFCAQGRQRL-LVYEYMNHGSLDRIL-FGNGPVLEWQERFDIALGTARG 619
H N+V G R +L +V EY GSL I GP+ E Q + + T +G
Sbjct: 56 ECRHPNIVAYFG-SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAY-VCRETLKG 113
Query: 620 LAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLA 679
LAYLH E IH DIK NILL K++DFG+S LT + + GT ++A
Sbjct: 114 LAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLT-ATIAKRKSFIGTPYWMA 169
Query: 680 PEWLTNSAIS---EKTDVYSFGMVLLELVSGRRNCSPRSQSHSM 720
PE K D+++ G+ +EL + P H M
Sbjct: 170 PEVAAVERKGGYDGKCDIWALGITAIELAELQ---PPMFDLHPM 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 8e-23
Identities = 70/211 (33%), Positives = 93/211 (44%), Gaps = 21/211 (9%)
Query: 517 LIGSGGFGAVYKGILNDK-TIVAVKKI------TNVGVQGKKDFCTEIAIIGNIHHVNLV 569
IG G FG VYK I +VA+K I + +D EI + +
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI-----EDIQQEIQFLSQCRSPYIT 62
Query: 570 KLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQ 629
K G +G + ++ EY GS L G + E F I GL YLH E+
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSC-LDLLKPGKLDETYIAF-ILREVLLGLEYLH---EE 117
Query: 630 KIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAIS 689
IH DIK NILL K++DFG+S LT S T + GT ++APE + S
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYD 176
Query: 690 EKTDVYSFGMVLLELVSGRRNCSPRSQSHSM 720
EK D++S G+ +EL G P S H M
Sbjct: 177 EKADIWSLGITAIELAKGE---PPLSDLHPM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 70/221 (31%), Positives = 96/221 (43%), Gaps = 40/221 (18%)
Query: 504 YEELEVATDNFKNLIGSGGFGAVYKGILNDKT--IVAVKKI------TNVGVQGKKDFCT 555
YE L V +G G +G V K N T IVA+KK +V KK
Sbjct: 3 YEVLGV--------VGEGAYGVVLK-CRNKATGEIVAIKKFKESEDDEDV----KKTALR 49
Query: 556 EIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHG---SLDRILFGNGP----VLEWQE 608
E+ ++ + H N+V LK + + LV+EY+ L+ G P WQ
Sbjct: 50 EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ- 108
Query: 609 RFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668
+ +AY HS IIH DIKPENIL+ K+ DFG ++ L +S
Sbjct: 109 -------LLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158
Query: 669 TTMRGTRGYLAPEWLTNSAISEK-TDVYSFGMVLLELVSGR 708
T TR Y APE L K DV++ G ++ EL+ G
Sbjct: 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-22
Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 505 EELEVATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGK--KDFCTEIAIIGN 562
E+LE +D +G+G G+V K V KK+ ++G + K E+ I+
Sbjct: 5 EDLETISD-----LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHE 59
Query: 563 IHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFD----IALGTAR 618
+V G + E+M+ GSLDRI GP+ + IA+
Sbjct: 60 CRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPI-----PVEILGKIAVAVVE 114
Query: 619 GLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYL 678
GL YL++ +I+H DIKP NIL++ Q K+ DFG+S L +S+ T GT Y+
Sbjct: 115 GLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI---NSIADTFVGTSTYM 169
Query: 679 APEWLTNSAISEKTDVYSFGMVLLELVSGR 708
+PE + + K+DV+S G+ ++EL G+
Sbjct: 170 SPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-22
Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 38/217 (17%)
Query: 518 IGSGGFGAVY----KGIL--NDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKL 571
+G G FG V+ +L DK +VAVK + ++DF E ++ + H ++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 572 KGFCAQGRQRLLVYEYMNHGSLDRILFGNGP--------------VLEWQERFDIALGTA 617
G C +GR L+V+EYM HG L+R L +GP L + IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 618 RGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT---MRGT 674
G+ YL S +H D+ N L+ KI DFG+S+ +++T G
Sbjct: 133 SGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGDFGMSR-------DIYSTDYYRVGG 182
Query: 675 RGYLAPEWLTNSAI-----SEKTDVYSFGMVLLELVS 706
R L W+ +I + ++D++SFG+VL E+ +
Sbjct: 183 RTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 3e-22
Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 24/213 (11%)
Query: 514 FKNLIGSGGFGAVYKGIL------NDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVN 567
K +G G FG V+ DK +VAVK + + +KDF E ++ N+ H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 568 LVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGP------------VLEWQERFDIALG 615
+VK G C +G ++V+EYM HG L++ L +GP L + IA
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 616 TARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLL--TPEQSSLFTTMRG 673
A G+ YL S Q +H D+ N L+ + KI DFG+S+ + T TM
Sbjct: 129 IAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185
Query: 674 TRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS 706
R ++ PE + + ++DV+S G+VL E+ +
Sbjct: 186 IR-WMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 4e-22
Identities = 66/225 (29%), Positives = 106/225 (47%), Gaps = 46/225 (20%)
Query: 518 IGSGGFGAVYK----GILNDK--TIVAVKKITN-VGVQGKKDFCTEIAIIGNIHHVNLVK 570
IG G FG V++ G+L + T+VAVK + + DF E A++ H N+VK
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 571 LKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPV---------------------LEWQER 609
L G CA G+ L++EYM +G L+ L P L E+
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 610 FDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669
IA A G+AYL E+K +H D+ N L+ + KI+DFGLS+ ++++
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR-------NIYS 182
Query: 670 T--MRGTRGYLAP-EWLTNSAI-----SEKTDVYSFGMVLLELVS 706
+ + P W+ +I + ++DV+++G+VL E+ S
Sbjct: 183 ADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 4e-22
Identities = 65/228 (28%), Positives = 108/228 (47%), Gaps = 34/228 (14%)
Query: 506 ELEVATDNFKNLIGSGGFGAVYKGILNDK------TIVAVKKIT-NVGVQGKKDFCTEIA 558
E+ ++ F +G G FG VYKG L T VA+K + N + +++F E
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60
Query: 559 IIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPV--------------- 603
++ ++ H N+V L G C + + +++EY+ HG L L N P
Sbjct: 61 LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120
Query: 604 LEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE 663
L+ + IA+ A G+ YL S +H D+ N L+ KISDFGLS+ +
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVKISDFGLSRDI--- 174
Query: 664 QSSLFTTMRGTRGYLAPEWLTNSAI-----SEKTDVYSFGMVLLELVS 706
S+ + ++ + L W+ AI + ++D++SFG+VL E+ S
Sbjct: 175 YSADYYRVQS-KSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 5e-22
Identities = 58/198 (29%), Positives = 102/198 (51%), Gaps = 8/198 (4%)
Query: 515 KNLIGSGGFGAVYKGILN-DKTIVAVKKI--TNVGVQGKKDFCTEIAIIGNIHHVNLVKL 571
N IG G FG V+K + DK + A+K+I + + + +++ E ++ + +++
Sbjct: 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRY 64
Query: 572 KGFCAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQK 630
+ +V EY +G L + G L + + + GLA+LHS +K
Sbjct: 65 YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KK 121
Query: 631 IIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISE 690
I+H DIK N+ L + KI D G++KLL+ ++ T+ GT YL+PE + +E
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD-NTNFANTIVGTPYYLSPELCEDKPYNE 180
Query: 691 KTDVYSFGMVLLELVSGR 708
K+DV++ G+VL E +G+
Sbjct: 181 KSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 5e-22
Identities = 76/249 (30%), Positives = 120/249 (48%), Gaps = 46/249 (18%)
Query: 477 SKSGNPNTLSSGDLEAFYIPGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGILNDKT- 535
S S + ++ SS A ELE N IGSG G VYK +++ T
Sbjct: 51 SSSSSSSSSSSASGSA-----PSAAKSLSELERV-----NRIGSGAGGTVYK-VIHRPTG 99
Query: 536 -IVAVKKI-TNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSL 593
+ A+K I N ++ C EI I+ +++H N+VK + ++ E+M+ GSL
Sbjct: 100 RLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL 159
Query: 594 D--RILFGNGPVLEWQERF--DIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQA 649
+ I E+F D+A G+AYLH + I+H DIKP N+L++
Sbjct: 160 EGTHI---------ADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNV 207
Query: 650 KISDFGLSKLLT----PEQSSLFTTMRGTRGYLAPEWLTNSAISEKT------DVYSFGM 699
KI+DFG+S++L P SS+ GT Y++PE + N+ ++ D++S G+
Sbjct: 208 KIADFGVSRILAQTMDPCNSSV-----GTIAYMSPERI-NTDLNHGAYDGYAGDIWSLGV 261
Query: 700 VLLELVSGR 708
+LE GR
Sbjct: 262 SILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 5e-22
Identities = 63/203 (31%), Positives = 103/203 (50%), Gaps = 21/203 (10%)
Query: 517 LIGSGGFGAVYKGILNDK-TIVAVK--KITNVGVQGK---KDFCTEIAIIGNIHHVNLVK 570
L+GSG FG+VY+G+ D AVK + + G G+ K EIA++ + H N+V+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 571 LKGFCAQGRQRLLVY-EYMNHGSLDRILFGNGPVLEWQERFDIALGTAR---GLAYLHSG 626
G + L ++ E + GSL ++L G E I L T + GL YLH
Sbjct: 67 YLG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPV----IRLYTRQILLGLEYLHD- 120
Query: 627 CEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNS 686
+ +H DIK NIL+ + K++DFG++K + E S + +G+ ++APE +
Sbjct: 121 --RNTVHRDIKGANILVDTNGVVKLADFGMAKQVV-EFSFA-KSFKGSPYWMAPEVIAQQ 176
Query: 687 -AISEKTDVYSFGMVLLELVSGR 708
D++S G +LE+ +G+
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 6e-22
Identities = 59/192 (30%), Positives = 100/192 (52%), Gaps = 10/192 (5%)
Query: 518 IGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ 577
+G+G FG V G + VA+K I G + +F E ++ + H LV+L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 578 GRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIK 637
R +V EYM++G L L +G + + ++ G+AYL S ++ IH D+
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLA 127
Query: 638 PENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTNSAISEKTDV 694
N L+ K+SDFGLS+ + ++ +T+ G++ + PE L S S K+DV
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLLYSKFSSKSDV 184
Query: 695 YSFGMVLLELVS 706
++FG+++ E+ S
Sbjct: 185 WAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 7e-22
Identities = 64/214 (29%), Positives = 114/214 (53%), Gaps = 15/214 (7%)
Query: 507 LEVATDNFKNLIGSGGFGAVYKGILN----DKTIVAVKKITNVGV--QGKKDFCTEIAII 560
++V+ + +IG+G FG V +G L + VA+K + G + ++DF +E +I+
Sbjct: 1 IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIM 59
Query: 561 GNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGL 620
G H N++ L+G + R +++ E+M +G+LD L N + + G A G+
Sbjct: 60 GQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGM 119
Query: 621 AYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS-LFTTMRGTR---G 676
YL E +H D+ NIL++ + K+SDFGLS+ L + S +T+ G +
Sbjct: 120 KYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR 176
Query: 677 YLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRR 709
+ APE + + +DV+S+G+V+ E++S G R
Sbjct: 177 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 8e-22
Identities = 56/210 (26%), Positives = 101/210 (48%), Gaps = 28/210 (13%)
Query: 518 IGSGGFGAVYKGILND------KTIVAVKKIT-NVGVQGKKDFCTEIAIIGNIHHVNLVK 570
+G G FG VY+G+ +T VA+K + N ++ + +F E +++ + ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 571 LKGFCAQGRQRLLVYEYMNHGSL---------DRILFGNGPVLEWQERFDIALGTARGLA 621
L G + G+ L+V E M G L + Q+ +A A G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 622 YLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYL--- 678
YL +K +H D+ N ++ KI DFG+++ + ++ + +G +G L
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY--ETDYYR--KGGKGLLPVR 186
Query: 679 --APEWLTNSAISEKTDVYSFGMVLLELVS 706
APE L + + K+DV+SFG+VL E+ +
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 22/217 (10%)
Query: 506 ELEVATDNFKNLIGSGGFGAVYKGILND-KTIVAVKKITNVGVQGKKDFCTEIAIIGNIH 564
E+E K+ +G G +G VY+G+ VAVK + ++ ++F E A++ I
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 60
Query: 565 HVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNG-----PVLEWQERFDIALGTARG 619
H NLV+L G C + ++ E+M +G+L L V+ +A +
Sbjct: 61 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY----MATQISSA 116
Query: 620 LAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR---G 676
+ YL + IH D+ N L+ + K++DFGLS+L+T + +T G +
Sbjct: 117 MEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIK 170
Query: 677 YLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSP 713
+ APE L + S K+DV++FG++L E+ + SP
Sbjct: 171 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT--YGMSP 205
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 66/196 (33%), Positives = 102/196 (52%), Gaps = 12/196 (6%)
Query: 518 IGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ 577
+G+G FG V+ G N T VAVK + G + F E I+ + H LV+L ++
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 578 GRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDI 636
+V EYM+ GSL D + G G L+ D+A A G+AY+ IH D+
Sbjct: 73 -EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDL 128
Query: 637 KPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTNSAISEKTD 693
+ NIL+ KI+DFGL++L+ + + +T +G + + APE + K+D
Sbjct: 129 RSANILVGDGLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 694 VYSFGMVLLELVSGRR 709
V+SFG++L ELV+ R
Sbjct: 186 VWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 4e-21
Identities = 69/205 (33%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 518 IGSGGFGAVY---KGILNDKTIVAVKKITNVGVQGK---KDFCTEIAIIGNIHHVNLVKL 571
I G +G V+ K D I A+K I + K TE I+ +VKL
Sbjct: 1 ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 572 KGFCA-QGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQ 629
+ + QG++ L LV EY+ G L +L G + E R IA L YLHS
Sbjct: 59 --YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIA-EIVLALEYLHS---N 112
Query: 630 KIIHCDIKPENILLHYHFQAKISDFGLSKL-LTPEQSSLFTTMR------GTRGYLAPEW 682
IIH D+KP+NIL+ + K++DFGLSK+ L Q +L + GT Y+APE
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 683 LTNSAISEKTDVYSFGMVLLELVSG 707
+ S+ D +S G +L E + G
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 5e-21
Identities = 65/208 (31%), Positives = 105/208 (50%), Gaps = 15/208 (7%)
Query: 508 EVATDNFK--NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHH 565
EV + K +G+G FG V+ G N T VA+K + G + F E ++ + H
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQ-GSMSPEAFLAEANLMKQLQH 60
Query: 566 VNLVKLKGFCAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERFDIALGTARGLAYLH 624
LV+L Q ++ EYM +GSL D + G L + D+A A G+A++
Sbjct: 61 PRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE 119
Query: 625 SGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPE 681
+ IH D++ NIL+ KI+DFGL++L+ + +T G + + APE
Sbjct: 120 ---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPE 173
Query: 682 WLTNSAISEKTDVYSFGMVLLELVS-GR 708
+ + K+DV+SFG++L E+V+ GR
Sbjct: 174 AINYGTFTIKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 5e-21
Identities = 67/195 (34%), Positives = 100/195 (51%), Gaps = 12/195 (6%)
Query: 517 LIGSGGFGAVYKGILNDKTIVAVKKIT-NVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFC 575
L+G G FG V+KG L DKT VAVK ++ + K F +E I+ H N+VKL G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 576 AQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCD 635
Q + +V E + G L L+ ++ AL A G+AYL S + IH D
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLES---KNCIHRD 118
Query: 636 IKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR----GYLAPEWLTNSAISEK 691
+ N L+ + KISDFG+S+ E ++++ G + + APE L S +
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR---QEDDGIYSS-SGLKQIPIKWTAPEALNYGRYSSE 174
Query: 692 TDVYSFGMVLLELVS 706
+DV+S+G++L E S
Sbjct: 175 SDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 6e-21
Identities = 66/200 (33%), Positives = 105/200 (52%), Gaps = 19/200 (9%)
Query: 514 FKNLIGSGGFGAVYKGI-LNDKTIVAVKKIT-NVGVQGKKDFCTEIAIIGNIHHVNLVKL 571
++ ++G G G VYK L + I+AVK I ++ V+ +K +E+ I+ ++
Sbjct: 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 572 KG-FCAQGRQRLLVYEYMNHGSLDRILFGNGP--VLEWQERFDIALGTARGLAYLHSGCE 628
G F + R + E+M+ GSLD ++ P VL IA+ +GL YL S
Sbjct: 65 YGAFFVENRISICT-EFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYLWS--- 113
Query: 629 QKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAI 688
KI+H D+KP N+L++ Q K+ DFG+S L +S+ T GT Y+APE ++
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTYVGTNAYMAPERISGEQY 170
Query: 689 SEKTDVYSFGMVLLELVSGR 708
+DV+S G+ +EL GR
Sbjct: 171 GIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 8e-21
Identities = 73/206 (35%), Positives = 105/206 (50%), Gaps = 13/206 (6%)
Query: 518 IGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGK-KDFCTEIAIIGNIHHVNLVKLKGFC 575
IG G FG V+KGI N + +VA+K I + + +D EI ++ + K G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 576 AQGRQRLLVYEYMNHGS-LDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHC 634
+ + ++ EY+ GS LD L GP+ E Q I +GL YLHS +K IH
Sbjct: 72 LKDTKLWIIMEYLGGGSALD--LLEPGPLDETQIA-TILREILKGLDYLHS---EKKIHR 125
Query: 635 DIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDV 694
DIK N+LL H + K++DFG++ LT Q T GT ++APE + SA K D+
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR-NTFVGTPFWMAPEVIKQSAYDSKADI 184
Query: 695 YSFGMVLLELVSGRRNCSPRSQSHSM 720
+S G+ +EL G P S+ H M
Sbjct: 185 WSLGITAIELAKGE---PPHSELHPM 207
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 8e-21
Identities = 67/196 (34%), Positives = 97/196 (49%), Gaps = 17/196 (8%)
Query: 518 IGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFC-TEIAIIGNIHHVNLVKLKGFC 575
IG G G VY I + VA+K++ N+ Q KK+ EI ++ H N+V
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 576 AQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTAR----GLAYLHSGCEQKI 631
G + +V EY+ GSL + V E R L +LHS ++
Sbjct: 86 LVGDELWVVMEYLAGGSLTDV------VTETCMDEGQIAAVCRECLQALEFLHS---NQV 136
Query: 632 IHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEK 691
IH DIK +NILL K++DFG +TPEQS +TM GT ++APE +T A K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKAYGPK 195
Query: 692 TDVYSFGMVLLELVSG 707
D++S G++ +E+V G
Sbjct: 196 VDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 65/195 (33%), Positives = 91/195 (46%), Gaps = 12/195 (6%)
Query: 518 IGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKD-FCTEIAIIGNIHHVNLVKLKGFC 575
IG G FG V+ G L D T VAVK K F E I+ H N+V+L G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 576 AQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCD 635
Q + +V E + G L GP L+ +E + A G+ YL S IH D
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRD 119
Query: 636 IKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR----GYLAPEWLTNSAISEK 691
+ N L+ KISDFG+S+ E+ ++ + G + + APE L S +
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 692 TDVYSFGMVLLELVS 706
+DV+SFG++L E S
Sbjct: 177 SDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 1e-20
Identities = 69/201 (34%), Positives = 102/201 (50%), Gaps = 18/201 (8%)
Query: 518 IGSGGFGAVYKG-ILNDKTIVAVKKIT-NVGVQGKKDFCTEIAIIGNIHHVNLVKLKG-F 574
IG G FGAV +G K VAVK I +V Q F E A++ +HH NLV+L G
Sbjct: 14 IGEGEFGAVLQGEYTGQK--VAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 575 CAQGRQRLLVYEYMNHGSLDRILFGNGPVL-EWQERFDIALGTARGLAYLHSGCEQKIIH 633
G +V E M+ G+L L G L + +L A G+ YL S +K++H
Sbjct: 69 LHNGLY--IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVH 123
Query: 634 CDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTD 693
D+ NIL+ AK+SDFGL+++ + + + + APE L + S K+D
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKLPVK-WTAPEALKHKKFSSKSD 179
Query: 694 VYSFGMVLLELVSGRRNCSPR 714
V+S+G++L E+ S R P+
Sbjct: 180 VWSYGVLLWEVFSYGRAPYPK 200
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 77/221 (34%), Positives = 107/221 (48%), Gaps = 17/221 (7%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGK-KDFCTEIAII 560
D EEL + IG G FG VYKGI N K +VA+K I + + +D EI ++
Sbjct: 1 DPEELFTKLER----IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVL 56
Query: 561 GNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGS-LDRILFGNGPVLEWQERFDIALGTARG 619
+ + G +G + ++ EY+ GS LD L GP LE I +G
Sbjct: 57 SQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALD--LLKPGP-LEETYIATILREILKG 113
Query: 620 LAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLA 679
L YLHS ++ IH DIK N+LL K++DFG++ LT Q T GT ++A
Sbjct: 114 LDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR-NTFVGTPFWMA 169
Query: 680 PEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSM 720
PE + SA K D++S G+ +EL G P S H M
Sbjct: 170 PEVIKQSAYDFKADIWSLGITAIELAKGE---PPNSDLHPM 207
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 71/233 (30%), Positives = 104/233 (44%), Gaps = 37/233 (15%)
Query: 508 EVATDNFK--NLIGSGGFGAVYKGIL------NDKTIVAVKKITNVGV-QGKKDFCTEIA 558
EV D+ +G G FG VY+G+ + VAVK + Q + DF E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 559 IIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGP------VLEWQERFDI 612
I+ +H N+V+L G + R ++ E M G L L N P L ++
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 613 ALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQ---AKISDFGLSKLLTPEQSSLFT 669
A A+G YL E IH DI N LL AKI+DFG+++ + ++S +
Sbjct: 122 ARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIY--RASYYR 176
Query: 670 TMRGTRGYLAPEWLTNSAISE-----KTDVYSFGMVLLELVS-------GRRN 710
+G R L +W+ A + KTDV+SFG++L E+ S GR N
Sbjct: 177 --KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN 227
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 69/210 (32%), Positives = 108/210 (51%), Gaps = 25/210 (11%)
Query: 517 LIGSGGFGAVYKGILNDKT--IVAVKK--ITNVGVQGKKD-------FCTEIAIIGNIHH 565
LIGSG FG+VY G +N + ++AVK+ + +V K EIA++ + H
Sbjct: 7 LIGSGSFGSVYLG-MNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65
Query: 566 VNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHS 625
N+V+ G + EY+ GS+ +L G E R + +GL YLH+
Sbjct: 66 ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNYLHN 124
Query: 626 GCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRG-------YL 678
+ IIH DIK NIL+ KISDFG+SK L E +SL T G R ++
Sbjct: 125 ---RGIIHRDIKGANILVDNKGGIKISDFGISKKL--EANSLSTKTNGARPSLQGSVFWM 179
Query: 679 APEWLTNSAISEKTDVYSFGMVLLELVSGR 708
APE + ++ + K D++S G +++E+++G+
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 70/223 (31%), Positives = 98/223 (43%), Gaps = 37/223 (16%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKI------TNVGVQGKKDFCT 555
DYE +EV IG G VY I L + VA+K+I T+V +
Sbjct: 2 DYELIEV--------IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV-----DELRK 48
Query: 556 EIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRIL---FGNGPVLEWQERFDI 612
E+ + +H N+VK G + LV Y++ GSL I+ + G + I
Sbjct: 49 EVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRG----GLDEAII 104
Query: 613 AL---GTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSK-LLTPEQSSLF 668
A +GL YLHS IH DIK NILL KI+DFG+S L +
Sbjct: 105 ATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRK 161
Query: 669 --TTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGR 708
T GT ++APE + K D++SFG+ +EL +G
Sbjct: 162 VRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 518 IGSGGFGAVYKGILNDKTIVAVKKITNVGVQGK-KDFCTEIAIIGNIHHVNLVKL-KGFC 575
+G G FG VYK + + A KI + + + +DF EI I+ H N+V L + +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 576 AQGRQRLLVYEYMNHGSLDRILFGNGPVL-EWQERFDIALGTARGLAYLHSGCEQKIIHC 634
+ + +L+ E+ + G+LD I+ L E Q R+ + L +LHS K+IH
Sbjct: 73 YENKLWILI-EFCDGGALDSIMLELERGLTEPQIRY-VCRQMLEALNFLHS---HKVIHR 127
Query: 635 DIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL-----TNSAIS 689
D+K NILL K++DFG+S T GT ++APE + ++
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR-DTFIGTPYWMAPEVVACETFKDNPYD 186
Query: 690 EKTDVYSFGMVLLELVSGRRNCSPRSQSHSM 720
K D++S G+ L+EL P + + M
Sbjct: 187 YKADIWSLGITLIELAQME---PPHHELNPM 214
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 3e-20
Identities = 58/204 (28%), Positives = 106/204 (51%), Gaps = 15/204 (7%)
Query: 516 NLIGSGGFGAVYKGILNDKTIVAVKKI---TNVGVQGKKDF---CTEIAIIGNIHHVNLV 569
++G G +G VY G+ N ++AVK++ T+ + +K++ E+ ++ ++ HVN+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 570 KLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQ 629
+ G C + E++ GS+ IL GP+ E G+AYLH+ C
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFC-KYTKQILDGVAYLHNNC-- 122
Query: 630 KIIHCDIKPENILLHYHFQAKISDFGLSKLL-----TPEQSSLFTTMRGTRGYLAPEWLT 684
++H DIK N++L + K+ DFG ++ L S++ +M GT ++APE +
Sbjct: 123 -VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181
Query: 685 NSAISEKTDVYSFGMVLLELVSGR 708
S K+D++S G + E+ +G+
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 4e-20
Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 13/212 (6%)
Query: 506 ELEVATDNFKNLIGSGGFGAVYKGILN----DKTIVAVKKI-TNVGVQGKKDFCTEIAII 560
EL+ + + ++G+G FG + +G L + VA+ + + ++ F E +
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 561 GNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGL 620
G H N+V+L+G +G ++V EYM++G+LD L + L + + G A G+
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGM 120
Query: 621 AYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYL-- 678
YL E +H + +L++ KIS F +L + +++TTM G L
Sbjct: 121 KYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWA 175
Query: 679 APEWLTNSAISEKTDVYSFGMVLLELVS-GRR 709
APE + S +DV+SFG+V+ E++S G R
Sbjct: 176 APEAIQYHHFSSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 5e-20
Identities = 65/195 (33%), Positives = 95/195 (48%), Gaps = 11/195 (5%)
Query: 518 IGSGGFGAVYKGILNDKT--IVAVKKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLKG 573
IG G +G V+K N +T IVA+KK KK EI ++ + H NLV L
Sbjct: 9 IGEGSYGVVFK-CRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 574 FCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIH 633
+ R+ LV+EY +H L+ + V E + I T + + + H IH
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK-KIIWQTLQAVNFCHK---HNCIH 123
Query: 634 CDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT-NSAISEKT 692
D+KPENIL+ Q K+ DFG +++LT +T TR Y APE L ++
Sbjct: 124 RDVKPENILITKQGQIKLCDFGFARILTG-PGDDYTDYVATRWYRAPELLVGDTQYGPPV 182
Query: 693 DVYSFGMVLLELVSG 707
DV++ G V EL++G
Sbjct: 183 DVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 9e-20
Identities = 70/197 (35%), Positives = 99/197 (50%), Gaps = 22/197 (11%)
Query: 518 IGSGGFGAVYKGILNDKT--IVAVKKITNVGVQGK---KDFCTEIAIIGNIHHVNLVKLK 572
IG G FGAVY + +T +VA+KK++ G Q +D E+ + + H N ++ K
Sbjct: 23 IGHGSFGAVYFA-RDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 573 GFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKII 632
G + LV EY GS IL + L+ E I G +GLAYLHS I
Sbjct: 82 GCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER---I 137
Query: 633 HCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISE-- 690
H DIK NILL K++DFG + L++P S + GT ++APE + A+ E
Sbjct: 138 HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVIL--AMDEGQ 190
Query: 691 ---KTDVYSFGMVLLEL 704
K DV+S G+ +EL
Sbjct: 191 YDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 1e-19
Identities = 64/196 (32%), Positives = 102/196 (52%), Gaps = 12/196 (6%)
Query: 518 IGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ 577
+G G FG V+ G N T VA+K + G + F E I+ + H LV L ++
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 578 GRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDI 636
+V E+M GSL D + G+G L+ + D+A A G+AY+ IH D+
Sbjct: 73 -EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDL 128
Query: 637 KPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTNSAISEKTD 693
+ NIL+ + KI+DFGL++L+ + + +T +G + + APE + K+D
Sbjct: 129 RAANILVGDNLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 694 VYSFGMVLLELVSGRR 709
V+SFG++L ELV+ R
Sbjct: 186 VWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 69/199 (34%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 518 IGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ 577
IG G FG V G VAVK I N + F E +++ + H NLV+L G +
Sbjct: 14 IGKGEFGDVMLGDYRGNK-VAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 578 GRQRL-LVYEYMNHGSLDRILFGNG-PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCD 635
+ L +V EYM GSL L G VL +L + YL + +H D
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRD 127
Query: 636 IKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVY 695
+ N+L+ AK+SDFGL+K E SS T + + APE L S K+DV+
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVW 183
Query: 696 SFGMVLLELVSGRRNCSPR 714
SFG++L E+ S R PR
Sbjct: 184 SFGILLWEIYSFGRVPYPR 202
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-19
Identities = 61/196 (31%), Positives = 100/196 (51%), Gaps = 12/196 (6%)
Query: 518 IGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ 577
+G G FG V+ G N T VA+K + G + F E ++ + H LV+L ++
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 578 GRQRLLVYEYMNHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDI 636
+V EYM+ GSL L G G L + D+A A G+AY+ +H D+
Sbjct: 73 -EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 128
Query: 637 KPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTNSAISEKTD 693
+ NIL+ + K++DFGL++L+ + + +T +G + + APE + K+D
Sbjct: 129 RAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 694 VYSFGMVLLELVSGRR 709
V+SFG++L EL + R
Sbjct: 186 VWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 2e-19
Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 32/215 (14%)
Query: 513 NFKNLIGSGGFGAV---YKGILNDKTIVAVKKITNV---GVQGKKDFCTEIAIIGNIHHV 566
IGSG +G V K VA+KKI+NV + K+ EI ++ ++ H
Sbjct: 3 ELLKPIGSGAYGVVCSAVDKRTGRK--VAIKKISNVFDDLIDAKRIL-REIKLLRHLRHE 59
Query: 567 NLVKLKG-FCAQGRQRL----LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLA 621
N++ L + +V E M L +++ P+ + ++ RGL
Sbjct: 60 NIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY-FLYQILRGLK 117
Query: 622 YLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRG---TRGYL 678
YLHS +IH D+KP NIL++ + KI DFGL++ + P++ + TR Y
Sbjct: 118 YLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK-GFLTEYVVTRWYR 173
Query: 679 APEWLTNS-----AISEKTDVYSFGMVLLELVSGR 708
APE L +S AI D++S G + EL++ +
Sbjct: 174 APELLLSSSRYTKAI----DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (221), Expect = 2e-19
Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 45/213 (21%)
Query: 518 IGSGGFGAVYKGILNDK-TIVAVKKITNVGVQGKKDF-----CT---EIAIIGNI-HHVN 567
+G G FG+VY + +VA+KK+ KK F C E+ + + H N
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 568 LVKLKGFCAQGRQRLLVYEYMNHGSL-------DRILFGNGPVLEWQERFDIALGTARGL 620
+VKLK + + V+EYM G+L F + I +GL
Sbjct: 60 IVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVI------RSIIYQILQGL 112
Query: 621 AYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAP 680
A++H H D+KPEN+L+ KI+DFGL++ + +T TR Y AP
Sbjct: 113 AHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREI--RSRPPYTDYVSTRWYRAP 167
Query: 681 EWLT-----NSAISEKTDVYSFGMVLLELVSGR 708
E L +S + D+++ G ++ EL + R
Sbjct: 168 EILLRSTSYSSPV----DIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 59/205 (28%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 508 EVATDNFKNL--IGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHH 565
E+ ++ K + +G+G FG V+ G N+ T VAVK + G + F E ++ + H
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQH 60
Query: 566 VNLVKLKGFCAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERFDIALGTARGLAYLH 624
LV+L + ++ EYM GSL D + G + + D + A G+AY+
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 120
Query: 625 SGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPE 681
+ IH D++ N+L+ KI+DFGL++++ + +T G + + APE
Sbjct: 121 ---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPE 174
Query: 682 WLTNSAISEKTDVYSFGMVLLELVS 706
+ + + K+DV+SFG++L E+V+
Sbjct: 175 AINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 30/208 (14%)
Query: 512 DNFKNLIGSGGFGAVYKGILNDKT---IVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNL 568
DNF IG G G V I DK+ VAVKK+ Q ++ E+ I+ + H N+
Sbjct: 22 DNFVK-IGEGSTGIVC--IATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 569 VKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFD------IALGTARGLAY 622
V++ G + +V E++ G+L I+ R + + L + L++
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDIVT--------HTRMNEEQIATVCLAVLKALSF 130
Query: 623 LHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT---PEQSSLFTTMRGTRGYLA 679
LH+ Q +IH DIK ++ILL + K+SDFG ++ P + SL GT ++A
Sbjct: 131 LHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV----GTPYWMA 183
Query: 680 PEWLTNSAISEKTDVYSFGMVLLELVSG 707
PE ++ + D++S G++++E+V G
Sbjct: 184 PEVISRLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 4e-19
Identities = 45/123 (36%), Positives = 73/123 (59%), Gaps = 6/123 (4%)
Query: 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY 645
E+M+ GSLD++L G + E I++ RGL YL + KI+H D+KP NIL++
Sbjct: 79 EHMDGGSLDQVLKKAGRIPE-NILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNS 135
Query: 646 HFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELV 705
+ K+ DFG+S L S+ + GTR Y++PE L + + ++D++S G+ L+E+
Sbjct: 136 RGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMA 192
Query: 706 SGR 708
GR
Sbjct: 193 IGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 5e-19
Identities = 64/206 (31%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 515 KNLIGSGGFGAVYKG--ILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLK 572
+N+I G GA YKG I N V VK+I +V +EIA +G + H N+VKL
Sbjct: 695 ENVISRGKKGASYKGKSIKNGMQFV-VKEINDVNSIPS----SEIADMGKLQHPNIVKLI 749
Query: 573 GFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKII 632
G C + L++EY+ +L +L L W+ R IA+G A+ L +LH C ++
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVV 805
Query: 633 HCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKT 692
++ PE I++ + + +L P T + Y+APE I+EK+
Sbjct: 806 VGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISSAYVAPETRETKDITEKS 859
Query: 693 DVYSFGMVLLELVSGRRNCSPRSQSH 718
D+Y FG++L+EL++G+ H
Sbjct: 860 DIYGFGLILIELLTGKSPADAEFGVH 885
|
Length = 968 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 5e-19
Identities = 62/197 (31%), Positives = 97/197 (49%), Gaps = 13/197 (6%)
Query: 517 LIGSGGFGAVYKGILNDKT--IVAVKKITNVGVQG--KKDFCTEIAIIGNIHHVNLVKLK 572
L+G G +G V K + +T IVA+KK KK EI ++ + H NLV L
Sbjct: 8 LVGEGSYGMVMK-CKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 573 GFCAQGRQRLLVYEYMNHGSLDRI-LFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKI 631
+ ++ LV+E+++H LD + + NG L+ RG+ + HS I
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCHS---HNI 121
Query: 632 IHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT-NSAISE 690
IH DIKPENIL+ K+ DFG ++ L +T TR Y APE L ++
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV-YTDYVATRWYRAPELLVGDTKYGR 180
Query: 691 KTDVYSFGMVLLELVSG 707
D+++ G ++ E+++G
Sbjct: 181 AVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 8e-19
Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 20/201 (9%)
Query: 517 LIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKK--DFCTEIAIIGNIHHV---NLVK 570
LIG G +GAVY+G +VA+K I N+ D E+A++ + N+ K
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALK-IINLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 571 LKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIAL---GTARGLAYLHSGC 627
G +G + ++ EY GS+ R L GP+ E++ I++ L Y+H
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPI---AEKY-ISVIIREVLVALKYIHK-- 119
Query: 628 EQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTN-S 686
+IH DIK NIL+ K+ DFG++ LL + SS +T GT ++APE +T
Sbjct: 120 -VGVIHRDIKAANILVTNTGNVKLCDFGVAALLN-QNSSKRSTFVGTPYWMAPEVITEGK 177
Query: 687 AISEKTDVYSFGMVLLELVSG 707
K D++S G+ + E+ +G
Sbjct: 178 YYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 1e-18
Identities = 79/234 (33%), Positives = 114/234 (48%), Gaps = 28/234 (11%)
Query: 482 PNTLSSGDLEAFYIPGLPQRFDYEELEVATDNFKNL--IGSGGFGAVY-KGILNDKTIVA 538
P+T +G L+ I L + D E+L F +L IG G FGAVY + +VA
Sbjct: 1 PSTSRAGSLKDPEIAELFFKEDPEKL------FTDLREIGHGSFGAVYFARDVRTNEVVA 54
Query: 539 VKKITNVGVQGK---KDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDR 595
+KK++ G Q +D E+ + I H N ++ KG + LV EY + D
Sbjct: 55 IKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDL 114
Query: 596 ILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFG 655
+ P+ E E I G +GLAYLHS +IH DIK NILL Q K++DFG
Sbjct: 115 LEVHKKPLQE-VEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFG 170
Query: 656 LSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISE-----KTDVYSFGMVLLEL 704
+ + +P S + GT ++APE + A+ E K DV+S G+ +EL
Sbjct: 171 SASIASPANSFV-----GTPYWMAPEVIL--AMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 59/212 (27%), Positives = 88/212 (41%), Gaps = 32/212 (15%)
Query: 514 FKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKD---FCT--EIAIIGNIHHVN 567
+G G + VYK IVA+KKI + KD F EI ++ + H N
Sbjct: 4 KGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPN 63
Query: 568 LVKLKGFCAQGRQRLLVYEYMNHGSLD------RILFGNGPVLEWQERFDIALGTARGLA 621
++ L LV+E+M L+ I+ + + L T RGL
Sbjct: 64 IIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSY------MLMTLRGLE 116
Query: 622 YLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPE 681
YLHS I+H D+KP N+L+ K++DFGL++ + T TR Y APE
Sbjct: 117 YLHS---NWILHRDLKPNNLLIASDGVLKLADFGLAR-SFGSPNRKMTHQVVTRWYRAPE 172
Query: 682 WL-----TNSAISEKTDVYSFGMVLLELVSGR 708
L + D++S G + EL+
Sbjct: 173 LLFGARHYGVGV----DMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 2e-18
Identities = 61/194 (31%), Positives = 100/194 (51%), Gaps = 13/194 (6%)
Query: 518 IGSGGFGAVYKGILNDKTI---VAVKKITNVGVQGKKDFC-TEIAIIGNIHHVNLVKLKG 573
IG G G V+ D VA+K+I N+ Q KK+ EI ++ + + N+V
Sbjct: 27 IGQGASGTVFTA--IDVATGQEVAIKQI-NLQKQPKKELIINEILVMKELKNPNIVNFLD 83
Query: 574 FCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIH 633
G + +V EY+ GSL ++ ++ + + + L +LH+ ++IH
Sbjct: 84 SFLVGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALEFLHA---NQVIH 138
Query: 634 CDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTD 693
DIK +N+LL K++DFG +TPEQS +TM GT ++APE +T A K D
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 694 VYSFGMVLLELVSG 707
++S G++ +E+V G
Sbjct: 198 IWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 58/210 (27%), Positives = 110/210 (52%), Gaps = 10/210 (4%)
Query: 508 EVATDNFKNL--IGSGGFGAVYKGILNDKTIVAVKKITNVGVQG--KKDFCTEIAIIGNI 563
E+ D+F+ + +G+G G V+K ++ +K+ ++ ++ + E+ ++
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 564 HHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYL 623
+ +V G + + E+M+ GSLD++L G + E Q +++ +GL YL
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-QILGKVSIAVIKGLTYL 119
Query: 624 HSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL 683
+ KI+H D+KP NIL++ + K+ DFG+S L ++ F GTR Y++PE L
Sbjct: 120 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERL 174
Query: 684 TNSAISEKTDVYSFGMVLLELVSGRRNCSP 713
+ S ++D++S G+ L+E+ GR P
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 10/196 (5%)
Query: 514 FKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKG 573
F +GSG FG V+ G + VA+K I N G ++DF E ++ + H LV+L G
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 574 FCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIH 633
C Q + +V E+M +G L L L + G+ YL IH
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIH 123
Query: 634 CDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTNSAISE 690
D+ N L+ K+SDFG+++ + ++ +T+ G + + PE S S
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDE---YTSSSGAKFPVKWSPPEVFNFSKYSS 180
Query: 691 KTDVYSFGMVLLELVS 706
K+DV+SFG+++ E+ +
Sbjct: 181 KSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 70/197 (35%), Positives = 97/197 (49%), Gaps = 22/197 (11%)
Query: 518 IGSGGFGAVYKGILNDKT--IVAVKKITNVGVQGK---KDFCTEIAIIGNIHHVNLVKLK 572
IG G FGAVY N T +VAVKK++ G Q +D E+ + + H N ++ K
Sbjct: 29 IGHGSFGAVYFAT-NSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 573 GFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKII 632
G + LV EY + D + P+ E E I G +GLAYLHS +I
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQE-VEIAAITHGALQGLAYLHSHN---MI 143
Query: 633 HCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISE-- 690
H DIK NILL Q K++DFG + +P S + GT ++APE + A+ E
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVIL--AMDEGQ 196
Query: 691 ---KTDVYSFGMVLLEL 704
K DV+S G+ +EL
Sbjct: 197 YDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 35/218 (16%)
Query: 517 LIGSGGFGAVYKGIL------NDKTIVAVKKI-TNVGVQGKKDFCTEIAIIGNI-HHVNL 568
+G G FG V K N+ + VAVK + + + D +E+ ++ I H N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 569 VKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFD---------------IA 613
+ L G C Q +V EY HG+L L P E+ D A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 614 LGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRG 673
ARG+ +L S +K IH D+ N+L+ KI+DFGL++ + + +
Sbjct: 139 YQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLAR----DIHHIDYYRKT 191
Query: 674 TRGYL-----APEWLTNSAISEKTDVYSFGMVLLELVS 706
T G L APE L + + ++DV+SFG++L E+ +
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 58/197 (29%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 517 LIGSGGFGAVYKGIL-----NDKTIVAVKKITN-VGVQGKKDFCTEIAIIGNIHHVNLVK 570
L+GSG FG V+KGI + K VA+K I + G Q ++ + +G++ H +V+
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 571 LKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQK 630
L G C G LV + GSL + + L+ Q + + A+G+ YL E +
Sbjct: 74 LLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHR 129
Query: 631 IIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR-GYLAPEWLTNSAIS 689
++H ++ NILL +I+DFG++ LL P+ F + T ++A E + +
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYT 189
Query: 690 EKTDVYSFGMVLLELVS 706
++DV+S+G+ + E++S
Sbjct: 190 HQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 68/227 (29%), Positives = 113/227 (49%), Gaps = 40/227 (17%)
Query: 508 EVATDNFKNL--IGSGGFGAVYKGILND------KTIVAVKKIT-NVGVQGKKDFCTEIA 558
EV+ + L +G G FG VY+G D +T VAVK + + ++ + +F E +
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 559 IIG--NIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLE---------WQ 607
++ HHV V+L G ++G+ L+V E M HG L L P E Q
Sbjct: 62 VMKGFTCHHV--VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 119
Query: 608 ERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667
E +A A G+AYL++ +K +H D+ N ++ + F KI DFG+++ +
Sbjct: 120 EMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR-------DI 169
Query: 668 FTT---MRGTRG-----YLAPEWLTNSAISEKTDVYSFGMVLLELVS 706
+ T +G +G ++APE L + + +D++SFG+VL E+ S
Sbjct: 170 YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 68/218 (31%), Positives = 106/218 (48%), Gaps = 36/218 (16%)
Query: 504 YEELEVATDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKD-----FCTEI 557
YEEL IG G +G VYK LN VA+KK+ V ++ EI
Sbjct: 1 YEEL--------AEIGEGAYGTVYKARDLNTGRFVALKKVR---VPLSEEGIPLSTLREI 49
Query: 558 AI---IGNIHHVNLVKLKGFCAQGR-----QRLLVYEYMN---HGSLDRILFGNGPVLEW 606
A+ + + H N+V+L C R + LV+E+++ L + P L
Sbjct: 50 ALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKC---PKPGLPP 106
Query: 607 QERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666
+ D+ RG+ +LHS I+H D+KP+NIL+ Q KI+DFGL+++ + + +
Sbjct: 107 ETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYS-FEMA 162
Query: 667 LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLEL 704
L T++ T Y APE L S+ + D++S G + EL
Sbjct: 163 L-TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 6e-18
Identities = 65/204 (31%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 517 LIGSGGFGAVYKGILND-KTIVAVKKI-TNVGVQGKKDFCTEI-AIIGNIHHVNLVKLKG 573
IG G FG V K + TI+AVK+I + V + +K ++ ++ + +VK G
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 574 FCAQGRQRLLVYEYMNHGSLD---RILFGNGPVLEWQERF--DIALGTARGLAYLHSGCE 628
+ + E M+ SLD + ++ E IA+ T + L YL E
Sbjct: 71 ALFREGDCWICMELMDI-SLDKFYKYVYEVLKS-VIPEEILGKIAVATVKALNYLKE--E 126
Query: 629 QKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMR-GTRGYLAPEWLTNSA 687
KIIH D+KP NILL + K+ DFG+S L S+ T G R Y+APE + SA
Sbjct: 127 LKIIHRDVKPSNILLDRNGNIKLCDFGISGQL---VDSIAKTRDAGCRPYMAPERIDPSA 183
Query: 688 ISE---KTDVYSFGMVLLELVSGR 708
++DV+S G+ L E+ +G+
Sbjct: 184 RDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 6e-18
Identities = 65/214 (30%), Positives = 99/214 (46%), Gaps = 29/214 (13%)
Query: 516 NLIGSGGFGAVYKGILND-------KTIVAVKKITN-VGVQGKKDFCTEIAIIGNIHHVN 567
N +GSG FG VY+G D VAVK + Q KK+F E ++ N +H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 568 LVKLKGFCAQGRQRLLVYEYMNHGSLDRILFG------NGPVLEWQERFDIALGTARGLA 621
+VKL G C + ++ E M G L L P+L +E DI L A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 622 YLHSGCEQKIIHCDIKPENILLHYHFQA-----KISDFGLSKLLTPEQSSLFTTMRGTR- 675
YL + IH D+ N L+ KI DFGL++ + S + G
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI---YKSDYYRKEGEGL 174
Query: 676 ---GYLAPEWLTNSAISEKTDVYSFGMVLLELVS 706
++APE L + + ++DV+SFG+++ E+++
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 6e-18
Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 518 IGSGGFGAVYKGI-LNDKTIVAVKKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLKGF 574
IGSG +G V I VA+KKI + K E+ I+ + H N++ ++
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 575 C----AQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTA-RGLAYLHSGCEQ 629
A + +V + M L I+ + P+ E E L RGL Y+HS
Sbjct: 73 LRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTE--EHIRYFLYQLLRGLKYIHSAN-- 127
Query: 630 KIIHCDIKPENILLHYHFQAKISDFGLSKLL--TPEQSSLFTTMR-GTRGYLAPE-WLTN 685
+IH D+KP N+L++ + +I DFG+++ L +P + F T TR Y APE L+
Sbjct: 128 -VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSL 186
Query: 686 SAISEKTDVYSFGMVLLELVSGRRNCSP 713
+ D++S G + E++ GRR P
Sbjct: 187 PEYTTAIDMWSVGCIFAEML-GRRQLFP 213
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 1e-17
Identities = 63/192 (32%), Positives = 100/192 (52%), Gaps = 9/192 (4%)
Query: 518 IGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFC-TEIAIIGNIHHVNLVKLKGFC 575
IG G G VY I + VA+K++ N+ Q KK+ EI ++ + N+V
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 576 AQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCD 635
G + +V EY+ GSL ++ ++ + + + L +LHS ++IH D
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALDFLHS---NQVIHRD 140
Query: 636 IKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVY 695
IK +NILL K++DFG +TPEQS +TM GT ++APE +T A K D++
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 696 SFGMVLLELVSG 707
S G++ +E+V G
Sbjct: 200 SLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 34/228 (14%)
Query: 506 ELEVATDNFKNLIGSGGFGAVYKGIL-----NDKTIVAVKKITNVG-VQGKKDFCTEIAI 559
EL ++ F +G FG +YKG L + +VA+K + ++ Q +F E ++
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60
Query: 560 IGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGP----------------V 603
+ +HH N+V L G Q + +++EY+N G L L P
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 604 LEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE 663
L+ + IA+ A G+ YL S +H D+ NIL+ KISD GLS+ +
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177
Query: 664 -----QSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS 706
Q +R ++ PE + S +D++SFG+VL E+ S
Sbjct: 178 DYYRVQPKSLLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 64/214 (29%), Positives = 105/214 (49%), Gaps = 27/214 (12%)
Query: 514 FKNLIGSGGFGAVYKGILN---DKTIVAVKKITNVGVQGK-KDFCTEIAIIGNI-HHVNL 568
F+++IG G FG V + ++ K A+K + + +DF E+ ++ + HH N+
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 569 VKLKGFCAQGRQRLLVYEYMNHGSL------DRIL---------FGNGPVLEWQERFDIA 613
+ L G C + EY +G+L R+L G L Q+ A
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 614 LGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTM-R 672
A G+ YL E++ IH D+ N+L+ + +KI+DFGLS+ E+ + TM R
Sbjct: 126 SDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGR 179
Query: 673 GTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS 706
++A E L S + K+DV+SFG++L E+VS
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-17
Identities = 58/210 (27%), Positives = 109/210 (51%), Gaps = 10/210 (4%)
Query: 508 EVATDNFKNL--IGSGGFGAVYKGILNDKTIVAVKKITNVGVQG--KKDFCTEIAIIGNI 563
E+ D+F+ + +G+G G V K ++ +K+ ++ ++ + E+ ++
Sbjct: 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 564 HHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYL 623
+ +V G + + E+M+ GSLD++L + E + +++ RGLAYL
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE-EILGKVSIAVLRGLAYL 119
Query: 624 HSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL 683
+ +I+H D+KP NIL++ + K+ DFG+S L ++ F GTR Y++PE L
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERL 174
Query: 684 TNSAISEKTDVYSFGMVLLELVSGRRNCSP 713
+ S ++D++S G+ L+EL GR P
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 1e-17
Identities = 36/115 (31%), Positives = 51/115 (44%), Gaps = 4/115 (3%)
Query: 38 IDYGGSFLTSHNGTFKAAIVNTRSQQNSFYLCIIHV-LSNTIIWSANRDTPISGSGKMNL 96
G L S F+ Q Y I++ S T++W ANRD P S + L
Sbjct: 3 PLSSGQTLVSSGSLFELGFFKLIMQSR-DYNLILYKGSSRTVVWVANRDNPSGSSCTLTL 61
Query: 97 TPKG-IIISDENGNLKWSTP-PLKSSVSALRLTEMGNLVLLDGFNGSLWESFHHP 149
G ++I D +G + WS+ + L L + GNLVL D LW+SF +P
Sbjct: 62 QSDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 63/197 (31%), Positives = 97/197 (49%), Gaps = 22/197 (11%)
Query: 518 IGSGGFGAVY--KGILNDKTIVAVKKITNVGVQGK---KDFCTEIAIIGNIHHVNLVKLK 572
IG G FGAVY + + N + +VA+KK++ G Q +D E+ + + H N ++ +
Sbjct: 23 IGHGSFGAVYFARDVRNSE-VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 573 GFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKII 632
G + LV EY + D + P+ E E + G +GLAYLHS +I
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE-VEIAAVTHGALQGLAYLHS---HNMI 137
Query: 633 HCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISE-- 690
H D+K NILL K+ DFG + ++ P + GT ++APE + A+ E
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVIL--AMDEGQ 190
Query: 691 ---KTDVYSFGMVLLEL 704
K DV+S G+ +EL
Sbjct: 191 YDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 62/216 (28%), Positives = 107/216 (49%), Gaps = 17/216 (7%)
Query: 501 RFDYEELEVATDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEIAI 559
++YE E + + ++G G +G VY L+ + +A+K+I + + EIA+
Sbjct: 2 EYEYEYDE---NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIAL 58
Query: 560 IGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGN-GPVLEWQERFDIALGTAR 618
+ H N+V+ G ++ + E + GSL +L GP+ + ++ I T +
Sbjct: 59 HSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQT--IIFYTKQ 116
Query: 619 ---GLAYLHSGCEQKIIHCDIKPENILLH-YHFQAKISDFGLSKLLTPEQSSLFTTMRGT 674
GL YLH + +I+H DIK +N+L++ Y KISDFG SK L + T GT
Sbjct: 117 ILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-GINPCTETFTGT 172
Query: 675 RGYLAPEWLTNS--AISEKTDVYSFGMVLLELVSGR 708
Y+APE + D++S G ++E+ +G+
Sbjct: 173 LQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 67/224 (29%), Positives = 108/224 (48%), Gaps = 27/224 (12%)
Query: 504 YEELEVATDNFKNLIGSGGFGAVYKGILNDKTI---VAVKKITNVGVQGK-KDFCTEIAI 559
Y LE F+++IG G FG V K + + A+K++ + +DF E+ +
Sbjct: 1 YPVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 60
Query: 560 IGNI-HHVNLVKLKGFCAQGRQRLLVYEYMNHGSL------DRIL---------FGNGPV 603
+ + HH N++ L G C L EY HG+L R+L
Sbjct: 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120
Query: 604 LEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE 663
L Q+ A ARG+ YL +++ IH D+ NIL+ ++ AKI+DFGLS+ +
Sbjct: 121 LSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQ 174
Query: 664 QSSLFTTM-RGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS 706
+ + TM R ++A E L S + +DV+S+G++L E+VS
Sbjct: 175 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 72/214 (33%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 518 IGSGGFGAVYKGIL------NDKT--IVAVKKI-TNVGVQGKKDFCTEIAIIGNIHHVNL 568
+G G FG V L ND T +VAVK + G Q + EI I+ ++H N+
Sbjct: 12 LGEGHFGKV---SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 569 VKLKGFCAQGRQR--LLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSG 626
VK KG C++ + L+ EY+ GSL L + L F A G+AYLHS
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLF--AQQICEGMAYLHS- 125
Query: 627 CEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRG---YLAPEWL 683
Q IH D+ N+LL KI DFGL+K + PE + + A E L
Sbjct: 126 --QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAVECL 182
Query: 684 TNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717
+ S +DV+SFG+ L EL++ +C QS
Sbjct: 183 KENKFSYASDVWSFGVTLYELLT---HCDS-KQS 212
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 24/214 (11%)
Query: 518 IGSGGFGAVY------KGILNDKT--IVAVKKIT-NVGVQGKKDFCTEIAIIGNIHHVNL 568
+G G FG V +G D T VAVK + G D EI I+ N++H N+
Sbjct: 12 LGEGHFGKVELCRYDPEG---DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 569 VKLKGFCAQ--GRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSG 626
VK KG C + G L+ E++ GSL L N + +++ A+ +G+ YL S
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS- 127
Query: 627 CEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRG----YLAPEW 682
++ +H D+ N+L+ Q KI DFGL+K + ++ + T++ + APE
Sbjct: 128 --RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE--YYTVKDDLDSPVFWYAPEC 183
Query: 683 LTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715
L S +DV+SFG+ L EL++ SP +
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLTYCDSESSPMT 217
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-17
Identities = 64/201 (31%), Positives = 102/201 (50%), Gaps = 23/201 (11%)
Query: 518 IGSGGFGAVY--KGILNDKTIVAVKKI--TNVGVQGKKDFCTEIAIIGNIHHVNLVKLKG 573
IG G FG +Y K + + V +K+I T + V+ K+ E+ ++ + H N+V
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 574 FCAQGRQRLLVYEYMNHGSLDR-------ILFGNGPVLEWQERFDIALGTARGLAYLHSG 626
+ + +V EY + G L + +LF +L W I+LG L ++H
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW--FVQISLG----LKHIH-- 118
Query: 627 CEQKIIHCDIKPENILLHYHFQ-AKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTN 685
++KI+H DIK +NI L + AK+ DFG+++ L + L T GT YL+PE N
Sbjct: 119 -DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPYYLSPEICQN 176
Query: 686 SAISEKTDVYSFGMVLLELVS 706
+ KTD++S G VL EL +
Sbjct: 177 RPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 48/205 (23%), Positives = 90/205 (43%), Gaps = 18/205 (8%)
Query: 517 LIGSGGFGAVYKGIL------NDKTIVAVKKITNVGVQG-KKDFCTEIAIIGNIHHVNLV 569
+G G FG V+ +T+V VK + + + +F E+ + + H N+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 570 KLKGFCAQGRQRLLVYEYMNHGSLDRILFGN--------GPVLEWQERFDIALGTARGLA 621
+L G C + ++ EY + G L + L P L +++ + A G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 622 YLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPE 681
+L + + +H D+ N L+ + K+S LSK + + +LAPE
Sbjct: 132 HLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 682 WLTNSAISEKTDVYSFGMVLLELVS 706
+ S K+DV+SFG+++ E+ +
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 42/224 (18%)
Query: 518 IGSGGFGAVYKGI------LNDKTIVAVKKITNVGVQGK-KDFCTEIAIIGNIHHVNLVK 570
+G G FG V K T VAVK + + +D +E ++ ++H +++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 571 LKGFCAQGRQRLLVYEYMNHGSLDRIL-----FGNGPVLEWQER---------------- 609
L G C+Q LL+ EY +GSL L G + R
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 610 --FDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667
A +RG+ YL E K++H D+ N+L+ + KISDFGLS+ + E S +
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 668 FTTMRGTRG-----YLAPEWLTNSAISEKTDVYSFGMVLLELVS 706
+ ++G ++A E L + + ++DV+SFG++L E+V+
Sbjct: 185 ----KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 62/199 (31%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 517 LIGSGGFGAVYKGI---LNDKTI-VAVKKITNVGVQG-KKDFCTEIAIIGNIHHVNLVKL 571
+G G FG V +G K I VAVK + + + DF E AI+ ++ H NL++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 572 KGFCAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQK 630
G ++V E GSL DR+ D A+ A G+ YL S ++
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KR 117
Query: 631 IIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTNSA 687
IH D+ NILL + KI DFGL + L P+ + + + APE L
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRAL-PQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 688 ISEKTDVYSFGMVLLELVS 706
S +DV+ FG+ L E+ +
Sbjct: 177 FSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 59/212 (27%), Positives = 105/212 (49%), Gaps = 12/212 (5%)
Query: 506 ELEVATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHH 565
E+ + + +G+G FG V+ N T VAVK + G + F E ++ + H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQH 60
Query: 566 VNLVKLKGFCAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERFDIALGTARGLAYLH 624
LVKL + ++ E+M GSL D + G + D + A G+A++
Sbjct: 61 DKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 119
Query: 625 SGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPE 681
++ IH D++ NIL+ KI+DFGL++++ + + +T G + + APE
Sbjct: 120 ---QRNYIHRDLRAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPE 173
Query: 682 WLTNSAISEKTDVYSFGMVLLELVSGRRNCSP 713
+ + + K+DV+SFG++L+E+V+ R P
Sbjct: 174 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYP 205
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 7e-17
Identities = 66/219 (30%), Positives = 105/219 (47%), Gaps = 22/219 (10%)
Query: 516 NLIGSGGFGAVYKGILND----KTIVAVK---KITNVGVQGKKDFCTEIAIIGNIHHVNL 568
+IG G FG VY G L D K AVK +IT++ + + F E I+ + H N+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL--EEVEQFLKEGIIMKDFSHPNV 58
Query: 569 VKLKGFC-AQGRQRLLVYEYMNHGSLDRILFG--NGPVLEWQERFDIALGTARGLAYLHS 625
+ L G C L+V YM HG L + + P + ++ L A+G+ YL S
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTV--KDLIGFGLQVAKGMEYLAS 116
Query: 626 GCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEW 682
+K +H D+ N +L F K++DFGL++ + ++ G + ++A E
Sbjct: 117 ---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173
Query: 683 LTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSMD 721
L + K+DV+SFG++L EL++ R P S D
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVDSFD 210
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 7e-17
Identities = 33/84 (39%), Positives = 46/84 (54%), Gaps = 3/84 (3%)
Query: 77 TIIWSANRDTPI-SGSGKMNLTPKG-IIISDENGNLKWST-PPLKSSVSALRLTEMGNLV 133
T++W ANR P+ S + L G +++ D NG + WS+ K S L + GNLV
Sbjct: 3 TVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGNLV 62
Query: 134 LLDGFNGSLWESFHHPRDTIVIGQ 157
L D LW+SF HP DT++ GQ
Sbjct: 63 LYDNSGKVLWQSFDHPTDTLLPGQ 86
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 66/206 (32%), Positives = 96/206 (46%), Gaps = 25/206 (12%)
Query: 516 NLIGSGGFGAVYKGILNDKT---IVAVKKITNVGVQGKKD-----FCTEIAIIGNIHHVN 567
N IG G +G VY+ D T IVA+KK V + ++D EI ++ N+ H N
Sbjct: 13 NRIGEGTYGIVYRA--RDTTSGEIVALKK---VRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 568 LVKLKGFCAQGRQR---LLVYEYMNHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYL 623
+V+LK G+ LV EY L +L P E Q + + L RGL YL
Sbjct: 68 IVELKE-VVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKC-LMLQLLRGLQYL 124
Query: 624 HSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL 683
H IIH D+K N+LL KI+DFGL++ + + T Y APE L
Sbjct: 125 HENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPELL 180
Query: 684 TNSAI-SEKTDVYSFGMVLLELVSGR 708
+ D+++ G +L EL++ +
Sbjct: 181 LGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 59/227 (25%), Positives = 102/227 (44%), Gaps = 31/227 (13%)
Query: 517 LIGSGGFGAVYKGILN--DKTI--VAVK--KITNVGVQGKKDFCTEIAIIGNIHHVNLVK 570
++G G FG+V +G L+ D + VAVK K+ ++F +E A + + H N++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 571 LKGFCAQGRQR------LLVYEYMNHGSLDRILF----GNGPV-LEWQERFDIALGTARG 619
L G C + +++ +M HG L L G P L Q + A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 620 LAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR---- 675
+ YL + + IH D+ N +L ++DFGLSK + R R
Sbjct: 126 MEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSG-----DYYRQGRIAKM 177
Query: 676 --GYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSM 720
++A E L + + K+DV++FG+ + E+ + + P ++H +
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI 224
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 38/215 (17%)
Query: 518 IGSGGFGAVY----KGILNDK--TIVAVKKIT-NVGVQGKKDFCTEIAIIG--NIHHVNL 568
+G G FG VY KG++ D+ T VA+K + ++ + +F E +++ N HHV
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV-- 71
Query: 569 VKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLE---------WQERFDIALGTARG 619
V+L G +QG+ L++ E M G L L P +E ++ +A A G
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 620 LAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT---MRGTRG 676
+AYL++ K +H D+ N ++ F KI DFG+++ ++ T +G +G
Sbjct: 132 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR-------DIYETDYYRKGGKG 181
Query: 677 -----YLAPEWLTNSAISEKTDVYSFGMVLLELVS 706
+++PE L + + +DV+SFG+VL E+ +
Sbjct: 182 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 518 IGSGGFGAVYKGILN-DKTI--VAVK--KITNVGVQGKKDFCTEIAIIGNIHHVNLVKLK 572
+G G FG+V +G LN D +I VAVK KI +DF +E + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 573 GFCAQGRQR------LLVYEYMNHGSLDRILF----GNGPV-LEWQERFDIALGTARGLA 621
G C Q + +++ +M HG L L G+ P L Q A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 622 YLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR---GYL 678
YL S + IH D+ N +L+ + ++DFGLSK + + R + ++
Sbjct: 127 YLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIY--NGDYYRQGRIAKMPVKWI 181
Query: 679 APEWLTNSAISEKTDVYSFGMVLLELVS 706
A E L + + K+DV+SFG+ + E+ +
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 65/221 (29%), Positives = 100/221 (45%), Gaps = 26/221 (11%)
Query: 517 LIGSGGFGAVYKGILNDK-TIVAVKKITNVGVQGKKDFCTEIAIIGNI-HHVNLVK---- 570
+IG G +G VYK +VA+K I ++ +++ E I+ +H N+
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 571 --LKGFCAQGRQRLLVYEYMNHGS----LDRILFGNGPVLEWQERFDIALGTARGLAYLH 624
K Q LV E GS + + + E + I T RGLAYLH
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY-ILRETLRGLAYLH 130
Query: 625 SGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT 684
E K+IH DIK +NILL + + K+ DFG+S L T + GT ++APE +
Sbjct: 131 ---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWMAPEVIA 186
Query: 685 -----NSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSM 720
+++ ++DV+S G+ +EL G+ P H M
Sbjct: 187 CDEQPDASYDARSDVWSLGITAIELADGK---PPLCDMHPM 224
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 80.2 bits (197), Expect = 2e-16
Identities = 60/192 (31%), Positives = 100/192 (52%), Gaps = 9/192 (4%)
Query: 518 IGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFC-TEIAIIGNIHHVNLVKLKGFC 575
IG G G VY + + VA++++ N+ Q KK+ EI ++ + N+V
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 576 AQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCD 635
G + +V EY+ GSL ++ ++ + + + L +LHS ++IH D
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHS---NQVIHRD 141
Query: 636 IKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVY 695
IK +NILL K++DFG +TPEQS +TM GT ++APE +T A K D++
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 696 SFGMVLLELVSG 707
S G++ +E++ G
Sbjct: 201 SLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 27/212 (12%)
Query: 516 NLIGSGGFGAVYKGILND---KTIVAVKKITNVGVQGK-KDFCTEIAIIGNI-HHVNLVK 570
++IG G FG V K + + A+K++ + +DF E+ ++ + HH N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 571 LKGFCAQGRQRLLVYEYMNHGSL------DRIL---------FGNGPVLEWQERFDIALG 615
L G C L EY HG+L R+L L Q+ A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 616 TARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTM-RGT 674
ARG+ YL +++ IH D+ NIL+ ++ AKI+DFGLS+ ++ + TM R
Sbjct: 121 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 174
Query: 675 RGYLAPEWLTNSAISEKTDVYSFGMVLLELVS 706
++A E L S + +DV+S+G++L E+VS
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 66/200 (33%), Positives = 96/200 (48%), Gaps = 20/200 (10%)
Query: 518 IGSGGFGAVYKGILNDKTIV-AVKKITNVGV----QGKKDFCTEIAIIGNIHHVNLVKL- 571
+G GGFG V + K A+K + + Q + F E I+ +H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS-EKEILEECNHPFIVKLY 59
Query: 572 KGFCAQGRQRLLVY---EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCE 628
+ F + + +Y EY G L IL G E+ RF IA YLH+
Sbjct: 60 RTF----KDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIA-CVVLAFEYLHN--- 111
Query: 629 QKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAI 688
+ II+ D+KPEN+LL + K+ DFG +K L Q + T GT Y+APE + N
Sbjct: 112 RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFCGTPEYVAPEIILNKGY 169
Query: 689 SEKTDVYSFGMVLLELVSGR 708
D +S G++L EL++GR
Sbjct: 170 DFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 69/235 (29%), Positives = 97/235 (41%), Gaps = 48/235 (20%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKD-F----CTE 556
DYE L +G G FG VYK + +VA+KKI + +KD F E
Sbjct: 9 DYEILGK--------LGEGTFGEVYKARQIKTGRVVALKKIL---MHNEKDGFPITALRE 57
Query: 557 IAIIGNIHHVNLVKLKGFC-----AQGRQRLLVY---EYMNHGSLDRILFGNGPVLEWQE 608
I I+ + H N+V L R+R VY YM+H L +L L +
Sbjct: 58 IKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQ 116
Query: 609 RFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL- 667
L G+ YLH E I+H DIK NIL+ KI+DFGL++ +
Sbjct: 117 IKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPK 173
Query: 668 ---------FTTMRGTRGYLAPEWLT-----NSAISEKTDVYSFGMVLLELVSGR 708
+T + TR Y PE L +A+ D++ G V E+ + R
Sbjct: 174 GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 52/199 (26%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 517 LIGSGGFGAVY--KGILNDKTIVAVKKITNVGVQGKKDFC--TEIAIIGNIHHVNLVKLK 572
++G G FG V+ + D+ +V +K+I + + E ++ + H N+++
Sbjct: 7 VVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 573 GFCAQGRQRLLVYEYMNHGSLDRILFGNG-PVLEWQERFDIALGTARGLAYLHSGCEQKI 631
+ + ++V EY G+L + +L+ + L ++H+ + I
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLI 122
Query: 632 IHCDIKPENILLHYH-FQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISE 690
+H D+K +NILL H KI DFG+SK+L+ + + T+ GT Y++PE ++
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA--YTVVGTPCYISPELCEGKPYNQ 180
Query: 691 KTDVYSFGMVLLELVSGRR 709
K+D+++ G VL EL S +R
Sbjct: 181 KSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 57/201 (28%), Positives = 101/201 (50%), Gaps = 19/201 (9%)
Query: 517 LIGSGGFGAVYKGIL-----NDKTIVAVKKIT-NVGVQGKKDFCTEIAIIGNIHHVNLVK 570
++GSG FG VYKGI K VA+K + G + +F E I+ ++ H +LV+
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 571 LKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQK 630
L G C +L V + M HG L + + + Q + + A+G+ YL E++
Sbjct: 74 LLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERR 129
Query: 631 IIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAI-- 688
++H D+ N+L+ KI+DFGL++LL ++ G + +W+ I
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE----YNADGGKMPIKWMALECIHY 185
Query: 689 ---SEKTDVYSFGMVLLELVS 706
+ ++DV+S+G+ + EL++
Sbjct: 186 RKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 5e-16
Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 42/217 (19%)
Query: 515 KNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCT----EIAIIGNIHHVNLV 569
+ IG G +G V VA+KKI+ + FC EI I+ H N++
Sbjct: 10 LSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE---HQTFCQRTLREIKILRRFKHENII 66
Query: 570 KLKGF-CAQGRQRL----LVYEYM----------NHGSLDRILFGNGPVLEWQERFDIAL 614
+ + +V E M H S D I + +Q
Sbjct: 67 GILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQY-----FLYQ------- 114
Query: 615 GTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE--QSSLFTTMR 672
RGL Y+HS ++H D+KP N+LL+ + KI DFGL+++ PE + T
Sbjct: 115 -ILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV 170
Query: 673 GTRGYLAPE-WLTNSAISEKTDVYSFGMVLLELVSGR 708
TR Y APE L + ++ D++S G +L E++S R
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-16
Identities = 61/196 (31%), Positives = 95/196 (48%), Gaps = 12/196 (6%)
Query: 518 IGSGGFGAVYKGILNDKT---IVAVKKITNVGVQG--KKDFCTEIAIIGNIHHVNLVKLK 572
+GSG FG V KG+ K VAVK + N K + E ++ + + +V++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 573 GFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKII 632
G C + +LV E G L++ L N V E + ++ + G+ YL E +
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTE-KNITELVHQVSMGMKYLE---ETNFV 117
Query: 633 HCDIKPENILLHYHFQAKISDFGLSKLLTPEQS--SLFTTMRGTRGYLAPEWLTNSAISE 690
H D+ N+LL AKISDFGLSK L +++ T + + APE + S
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177
Query: 691 KTDVYSFGMVLLELVS 706
K+DV+SFG+++ E S
Sbjct: 178 KSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 7e-16
Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 517 LIGSGGFGAVYK--GILNDKTIVAVKKIT----NVGVQGKK------DFCTEIAIIG-NI 563
+GSG FG VYK N + ++A+K+I G ++ D +E+ II +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 564 HHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERF------DIALGTA 617
H N+V+ + + +V + + L F + + E ++RF +I +
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPL-GEHFNS--LKEKKQRFTEERIWNIFVQMV 123
Query: 618 RGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGY 677
L YLH E++I+H D+ P NI+L + I+DFGL+K PE S T++ GT Y
Sbjct: 124 LALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE--SKLTSVVGTILY 179
Query: 678 LAPEWLTNSAISEKTDVYSFGMVLLELVS 706
PE + N EK DV++FG +L ++ +
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 8e-16
Identities = 56/205 (27%), Positives = 101/205 (49%), Gaps = 19/205 (9%)
Query: 517 LIGSGGFGAVYKGI-LNDKTIVAVKKIT----NVGVQGK--KDFCTEIAIIGNIHHVNLV 569
+G+G F + Y+ + T++AVK++T Q + + EI ++ ++H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 570 KLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIA--LGTARGLAYLHSGC 627
++ G + L E+M GS+ +L G ++E I RGL+YLH
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA---FKEAVIINYTEQLLRGLSYLH--- 120
Query: 628 EQKIIHCDIKPENILLHYHFQ-AKISDFGLSKLLTPE--QSSLFT-TMRGTRGYLAPEWL 683
E +IIH D+K N+L+ Q +I+DFG + L + + F + GT ++APE L
Sbjct: 121 ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180
Query: 684 TNSAISEKTDVYSFGMVLLELVSGR 708
DV+S G V++E+ + +
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 8e-16
Identities = 60/216 (27%), Positives = 108/216 (50%), Gaps = 22/216 (10%)
Query: 496 PGLPQRFDYEELEVATDNFKNLIGSGGFGAV-YKGILNDKTIVAVKKITNVGVQGKKDFC 554
PG P+ + DNF IG G G V + + +VAVKK+ Q ++
Sbjct: 15 PGDPRTY--------LDNFIK-IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLF 65
Query: 555 TEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIAL 614
E+ I+ + H N+V++ G + +V E++ G+L I+ + ++ + L
Sbjct: 66 NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCL 123
Query: 615 GTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT---PEQSSLFTTM 671
+ L+ LH+ Q +IH DIK ++ILL + + K+SDFG ++ P + SL
Sbjct: 124 AVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV--- 177
Query: 672 RGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSG 707
GT ++APE ++ + D++S G++++E+V G
Sbjct: 178 -GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 64/204 (31%), Positives = 103/204 (50%), Gaps = 28/204 (13%)
Query: 518 IGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKD-----FCTEIAIIGNIH---HVNL 568
IG G +G VYK + VA+K +V VQ +D E+A++ + H N+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALK---SVRVQTNEDGLPLSTVREVALLKRLEAFDHPNI 64
Query: 569 VKLKGFCAQGR-----QRLLVYEYMNH---GSLDRILFGNGPVLEWQERFDIALGTARGL 620
V+L CA R + LV+E+++ LD++ P L + D+ RGL
Sbjct: 65 VRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKV---PPPGLPAETIKDLMRQFLRGL 121
Query: 621 AYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAP 680
+LH+ C I+H D+KPENIL+ Q K++DFGL+++ + + + T + T Y AP
Sbjct: 122 DFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA--LTPVVVTLWYRAP 176
Query: 681 EWLTNSAISEKTDVYSFGMVLLEL 704
E L S + D++S G + E+
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 1e-15
Identities = 35/112 (31%), Positives = 54/112 (48%), Gaps = 5/112 (4%)
Query: 40 YGGSFLTSHNGTFKAAIVNTRSQQNSFYLCIIHV-LSNTIIWSANRDTPISGSGKMNLTP 98
G L S N F+ Q + Y I++ S T++W ANRD P+S S + L
Sbjct: 5 SSGQTLVSGNSLFELGFFTLIMQ--NDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQS 62
Query: 99 KG-IIISDENGNLKWSTPP-LKSSVSALRLTEMGNLVLLDGFNGSLWESFHH 148
G +++ D +G + WS+ + L L + GNLV+ D LW+SF +
Sbjct: 63 DGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 59/225 (26%), Positives = 101/225 (44%), Gaps = 39/225 (17%)
Query: 514 FKNLIGSGGFGAVY----KGIL-----------NDKTIVAVKKI-TNVGVQGKKDFCTEI 557
K +G G FG V+ +G+ +VAVK + +V + DF EI
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 558 AIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRIL-----------FGNGPVLEW 606
I+ + + N+++L G C ++ EYM +G L++ L N P +
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 607 QERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666
+A+ A G+ YL S +H D+ N L+ H+ KI+DFG+S+ L S
Sbjct: 129 ANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCLVGNHYTIKIADFGMSRNL---YSG 182
Query: 667 LFTTMRGTRGYLAPEWLTNSAI-----SEKTDVYSFGMVLLELVS 706
+ ++G R L W+ +I + +DV++FG+ L E+ +
Sbjct: 183 DYYRIQG-RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 58/196 (29%), Positives = 97/196 (49%), Gaps = 8/196 (4%)
Query: 518 IGSGGFG-AVYKGILNDKTIVAVKKI--TNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGF 574
+G G FG A D ++V K++ T + + ++D EI I+ + H N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 575 CAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIH 633
L+ EY N G+L D+I+ G + E + ++Y+H + I+H
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILH 124
Query: 634 CDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTD 693
DIK NI L K+ DFG+SK+L E S+ T+ GT Y++PE + K+D
Sbjct: 125 RDIKTLNIFLTKAGLIKLGDFGISKILGSE-YSMAETVVGTPYYMSPELCQGVKYNFKSD 183
Query: 694 VYSFGMVLLELVSGRR 709
+++ G VL EL++ +R
Sbjct: 184 IWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 67/205 (32%), Positives = 102/205 (49%), Gaps = 24/205 (11%)
Query: 518 IGSGGFGAVYKGI---LNDKTIVAVKKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLK 572
IG G +G V N+K VA+KKI N K EI ++ ++ H N++ +K
Sbjct: 13 IGRGAYGIVCSAKNSETNEK--VAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIK 70
Query: 573 GFC-AQGRQRL----LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGC 627
R+ +VYE M+ L +I+ + + + ++ + RGL Y+HS
Sbjct: 71 DIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFL-YQLLRGLKYIHSA- 127
Query: 628 EQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSA 687
++H D+KP N+LL+ + KI DFGL++ T E+ T TR Y APE L N
Sbjct: 128 --NVLHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFMTEYVVTRWYRAPELLLNC- 183
Query: 688 ISEKT---DVYSFGMVLLELVSGRR 709
SE T DV+S G + EL+ GR+
Sbjct: 184 -SEYTTAIDVWSVGCIFAELL-GRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 18/207 (8%)
Query: 515 KNLIGSGGFGAVYKGILNDKTI-----VAVKKITNVGVQGKKD-FCTEIAIIGNIHHVNL 568
+L+ G FG ++ GIL D+ V VK + + + + E ++ + H N+
Sbjct: 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNI 70
Query: 569 VKLKGFCAQGRQRLLV-YEYMNHGSLDRIL-------FGNGPVLEWQERFDIALGTARGL 620
+ + C + + V Y YMN G+L L N L Q+ +A+ A G+
Sbjct: 71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130
Query: 621 AYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP-EQSSLFTTMRGTRGYLA 679
+YLH + +IH DI N ++ Q KI+D LS+ L P + L ++A
Sbjct: 131 SYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMA 187
Query: 680 PEWLTNSAISEKTDVYSFGMVLLELVS 706
E L N S +DV+SFG++L EL++
Sbjct: 188 LESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 27/207 (13%)
Query: 518 IGSGGFGAVYKGI-LNDKTIVAVKKI-TNVGVQGKKDFCTEIAI-IGNIHHVNLVKLKGF 574
+G G +G V K + TI+AVK+I V Q +K ++ I + ++ V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 575 CAQGRQRLLVYEYMNHGSLDRI--------LFGNGPVLEWQERFDIALGTARGLAYLHSG 626
+ + E M+ SLD+ L +L IA+ + L YLHS
Sbjct: 69 LFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILG-----KIAVSIVKALEYLHS- 121
Query: 627 CEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMR-GTRGYLAPEW--- 682
+ +IH D+KP N+L++ + Q K+ DFG+S L S+ T+ G + Y+APE
Sbjct: 122 -KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV---DSVAKTIDAGCKPYMAPERINP 177
Query: 683 -LTNSAISEKTDVYSFGMVLLELVSGR 708
L K+DV+S G+ ++EL +GR
Sbjct: 178 ELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 54/203 (26%), Positives = 102/203 (50%), Gaps = 13/203 (6%)
Query: 511 TDNFK--NLIGSGGFGAVYKGI-LNDKTIVAVKKIT---NVGVQGKKDFCTEIAIIGNIH 564
NFK IG G F VYK I L D +VA+KK+ + + ++D EI ++ +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 565 HVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRIL--FGN-GPVLEWQERFDIALGTARGLA 621
H N++K + + +V E + G L R++ F ++ + + + L
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 622 YLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPE 681
++HS ++I+H DIKP N+ + K+ D GL + + + ++ + + GT Y++PE
Sbjct: 121 HMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176
Query: 682 WLTNSAISEKTDVYSFGMVLLEL 704
+ + + K+D++S G +L E+
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 63/218 (28%), Positives = 109/218 (50%), Gaps = 26/218 (11%)
Query: 496 PGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGILNDKTI---VAVKKITNVGVQGKKD 552
PG P+ + D+F IG G G V I +K VAVKK+ Q ++
Sbjct: 17 PGDPREY--------LDSFIK-IGEGSTGIVC--IATEKHTGKQVAVKKMDLRKQQRREL 65
Query: 553 FCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDI 612
E+ I+ + HH N+V + G + +V E++ G+L I+ + ++ +
Sbjct: 66 LFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATV 123
Query: 613 ALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT---PEQSSLFT 669
L R L+YLH+ Q +IH DIK ++ILL + K+SDFG ++ P++ SL
Sbjct: 124 CLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV- 179
Query: 670 TMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSG 707
GT ++APE ++ + D++S G++++E++ G
Sbjct: 180 ---GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 6e-15
Identities = 68/196 (34%), Positives = 88/196 (44%), Gaps = 12/196 (6%)
Query: 518 IGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIA----IIGNIHHVNLVKLK 572
IG G FG V D AVK + + KK+ +A ++ N+ H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 573 GFCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKI 631
+ Q +L V +Y+N G L L E + RF A A L YLHS I
Sbjct: 63 -YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLHS---LNI 117
Query: 632 IHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEK 691
I+ D+KPENILL ++DFGL K E S +T GT YLAPE L
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRT 176
Query: 692 TDVYSFGMVLLELVSG 707
D + G VL E++ G
Sbjct: 177 VDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 6e-15
Identities = 63/200 (31%), Positives = 97/200 (48%), Gaps = 16/200 (8%)
Query: 517 LIGSGGFGAVYKGI-LNDKTIVAVKKIT--NVGVQGKKDFCT---EIAIIGNIHHVNLVK 570
L+G G FG VY ++ +AVK++ + KK+ EI ++ N+ H +V+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 571 LKGFCAQGRQRLLVY-EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQ 629
G C + + L ++ EYM GS+ L G + E R G+ YLHS
Sbjct: 69 YYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYLHS---N 123
Query: 630 KIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMR---GTRGYLAPEWLTNS 686
I+H DIK NIL K+ DFG SK L SS T M+ GT +++PE ++
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG-TGMKSVTGTPYWMSPEVISGE 182
Query: 687 AISEKTDVYSFGMVLLELVS 706
K DV+S G ++E+++
Sbjct: 183 GYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 7e-15
Identities = 65/210 (30%), Positives = 97/210 (46%), Gaps = 34/210 (16%)
Query: 513 NFKNLIGSGGFGAV----YKG--------ILNDKTIVAVKKITNVGVQGKKDFCTEIAII 560
F +G+G FG V +KG IL+ IV +K++ +V E I+
Sbjct: 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHV--------LNEKRIL 55
Query: 561 GNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERF---DIALGTA 617
+I H LV L G LV EY+ G L L +G E RF + L
Sbjct: 56 QSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLA-- 113
Query: 618 RGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGY 677
L YLHS I++ D+KPEN+LL KI+DFG +K + T+ GT Y
Sbjct: 114 --LEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY----TLCGTPEY 164
Query: 678 LAPEWLTNSAISEKTDVYSFGMVLLELVSG 707
LAPE + + + D ++ G+++ E+++G
Sbjct: 165 LAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 8e-15
Identities = 55/191 (28%), Positives = 90/191 (47%), Gaps = 27/191 (14%)
Query: 537 VAVKKITNVGVQG---KKDFCTEIAIIGNIHHVNLVKL--KGFCAQGRQRLLVYEYMNHG 591
VA+K + + + F E A+ ++H N+V L G G V+EY+
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLL-FAVFEYVPGR 64
Query: 592 SLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILL-------H 644
+L +L +G L E + L LA H+ Q I+H D+KP+NI++ H
Sbjct: 65 TLREVLAADGA-LPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTGVRPH 120
Query: 645 YHFQAKISDFGLSKLLT------PEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFG 698
AK+ DFG+ LL + T + GT Y APE L ++ +D+Y++G
Sbjct: 121 ----AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 699 MVLLELVSGRR 709
++ LE ++G+R
Sbjct: 177 LIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 9e-15
Identities = 57/196 (29%), Positives = 95/196 (48%), Gaps = 12/196 (6%)
Query: 518 IGSGGFGAVYKGI--LNDKTI-VAVKKITNVGVQGKKD-FCTEIAIIGNIHHVNLVKLKG 573
+GSG FG V KG+ + K I VA+K + N + +D E I+ + + +V++ G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 574 FCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIH 633
C + +LV E + G L++ L G + ++ + G+ YL + +H
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVH 118
Query: 634 CDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTNSAISE 690
D+ N+LL AKISDFGLSK L + S + + + APE + S
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGAD-DSYYKARSAGKWPLKWYAPECINFRKFSS 177
Query: 691 KTDVYSFGMVLLELVS 706
++DV+S+G+ + E S
Sbjct: 178 RSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 58/196 (29%), Positives = 96/196 (48%), Gaps = 16/196 (8%)
Query: 518 IGSGGFGAVYKGILNDKTIVAVKKITNVGVQGK-KDFCTEIAIIGNIHHVNLVKLKG-FC 575
+G G FG VYK + +A K+ + + +D+ EI I+ +H +VKL G F
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 576 AQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCD 635
G+ +++ E+ G++D I+ L + I L YLHS KIIH D
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRD 135
Query: 636 IKPENILLHYHFQAKISDFGLS--KLLTPEQSSLFTTMRGTRGYLAP-----EWLTNSAI 688
+K N+LL K++DFG+S + T ++ F GT ++AP E + ++
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI---GTPYWMAPEVVMCETMKDTPY 192
Query: 689 SEKTDVYSFGMVLLEL 704
K D++S G+ L+E+
Sbjct: 193 DYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 68/198 (34%), Positives = 97/198 (48%), Gaps = 14/198 (7%)
Query: 517 LIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQGKKDFCTEIA----IIGNIHHVNLVKL 571
+IG G FG V +D + AVK + + KK+ +A ++ N+ H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 572 KGFCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQK 630
+ Q ++L V +Y+N G L L LE + RF A A + YLHS
Sbjct: 62 H-YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLHS---LN 116
Query: 631 IIHCDIKPENILLHYHFQAKISDFGLSKL-LTPEQSSLFTTMRGTRGYLAPEWLTNSAIS 689
II+ D+KPENILL ++DFGL K + PE+++ +T GT YLAPE L
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT--STFCGTPEYLAPEVLRKEPYD 174
Query: 690 EKTDVYSFGMVLLELVSG 707
D + G VL E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 49/174 (28%), Positives = 92/174 (52%), Gaps = 12/174 (6%)
Query: 537 VAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRI 596
VAVK + Q ++ E+ I+ + H N+V++ G + ++ E++ G+L I
Sbjct: 49 VAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDI 108
Query: 597 LFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGL 656
+ + L ++ + + L YLHS Q +IH DIK ++ILL + K+SDFG
Sbjct: 109 V--SQTRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGF 163
Query: 657 SKLLT---PEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSG 707
++ P++ SL GT ++APE ++ + + D++S G++++E+V G
Sbjct: 164 CAQISKDVPKRKSLV----GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 61/197 (30%), Positives = 98/197 (49%), Gaps = 18/197 (9%)
Query: 518 IGSGGFGAVYKGILNDKTIVAVKKITNVGVQGK-KDFCTEIAIIGNIHHVNLVKL-KGFC 575
+G G FG VYK + ++A K+ + + + +D+ EI I+ + H N+VKL F
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 576 AQGRQRLLVYEYMNHGSLDRILFG-NGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHC 634
+ +L+ E+ G++D ++ P+ E Q R + T L YLH E KIIH
Sbjct: 73 YENNLWILI-EFCAGGAVDAVMLELERPLTEPQIRV-VCKQTLEALNYLH---ENKIIHR 127
Query: 635 DIKPENILLHYHFQAKISDFGLS--KLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISE-- 690
D+K NIL K++DFG+S T ++ F GT ++APE + +
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI---GTPYWMAPEVVMCETSKDRP 184
Query: 691 ---KTDVYSFGMVLLEL 704
K DV+S G+ L+E+
Sbjct: 185 YDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 23/207 (11%)
Query: 518 IGSGGFGAV----YKGILNDKTIVAVKKITNVGVQGKKDFCT----EIAII----GNIHH 565
+G G +G V +++ VA+KKITNV KK E+ ++ G+ +
Sbjct: 8 LGQGAYGIVCSARNAET-SEEETVAIKKITNVF--SKKILAKRALRELKLLRHFRGHKNI 64
Query: 566 VNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHS 625
L + L +YE + L +I+ P+ + + I GL Y+HS
Sbjct: 65 TCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFI-YQILCGLKYIHS 123
Query: 626 GCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP---EQSSLFTTMRGTRGYLAPE- 681
++H D+KP N+L++ + KI DFGL++ + E + T TR Y APE
Sbjct: 124 A---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEI 180
Query: 682 WLTNSAISEKTDVYSFGMVLLELVSGR 708
L+ + ++ DV+S G +L EL+ +
Sbjct: 181 MLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 57/206 (27%), Positives = 103/206 (50%), Gaps = 23/206 (11%)
Query: 518 IGSGGFGAVYKG--ILNDKTIVAVKKITNVGVQGKKD-----FCTEIAIIGNIH---HVN 567
IG G +G V+K + N VA+K+ V VQ ++ E+A++ ++ H N
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKR---VRVQTGEEGMPLSTIREVAVLRHLETFEHPN 65
Query: 568 LVKLKGFCAQGR-----QRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAY 622
+V+L C R + LV+E+++ + P + + D+ RGL +
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 623 LHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEW 682
LHS +++H D+KP+NIL+ Q K++DFGL+++ + + T++ T Y APE
Sbjct: 126 LHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEV 180
Query: 683 LTNSAISEKTDVYSFGMVLLELVSGR 708
L S+ + D++S G + E+ +
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 26/210 (12%)
Query: 513 NFKNL--IGSGGFGAVYKGILNDKT--IVAVKKITNVGVQGKKDFCT-EIAIIGNIHHVN 567
NFK L +G G + VYKG N T IVA+K+I +G EI+++ + H N
Sbjct: 1 NFKQLEKLGEGTYATVYKG-RNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHEN 59
Query: 568 LVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTAR--------G 619
+V+L + +LV+EYM+ L + + +G R + T + G
Sbjct: 60 IVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHG------VRGALDPNTVKSFTYQLLKG 112
Query: 620 LAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLA 679
+A+ H E +++H D+KP+N+L++ + K++DFGL++ ++ F+ T Y A
Sbjct: 113 IAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT-FSNEVVTLWYRA 168
Query: 680 PEWLTNSAI-SEKTDVYSFGMVLLELVSGR 708
P+ L S S D++S G ++ E+++GR
Sbjct: 169 PDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 59/224 (26%), Positives = 91/224 (40%), Gaps = 38/224 (16%)
Query: 516 NLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKD--------------FCT--EIA 558
+G G +G V K IVA+KK+ + + D F T E+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKII--EISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 559 IIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTAR 618
I+ I H N++ L +G LV + M L +++ + E Q + I L
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKC-ILLQILN 130
Query: 619 GLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGL-------------SKLLTPEQS 665
GL LH +H D+ P NI ++ KI+DFGL SK T ++
Sbjct: 131 GLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187
Query: 666 SLFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGR 708
T+ T Y APE L + D++S G + EL++G+
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 3e-14
Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 47/217 (21%)
Query: 518 IGSGGFGAVYKGILNDKT--IVAVKKITNVGVQGKKD---------FCTEIAIIGNIHHV 566
+G G +G V+K I + +T +VA+KKI + + D F E+ H
Sbjct: 15 LGKGAYGIVWKAI-DRRTKEVVALKKIFD-AFRNATDAQRTFREIMFLQELG-----DHP 67
Query: 567 NLVKLKG-FCAQGRQRL-LVYEYMN--------HGSLDRILFGNGPVLEWQERFDIALGT 616
N+VKL A+ + + LV+EYM L+ + +R+ I
Sbjct: 68 NIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDV----------HKRY-IMYQL 116
Query: 617 ARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT----PEQSSLFTTMR 672
+ L Y+HSG +IH D+KP NILL+ + K++DFGL++ L+ ++ + T
Sbjct: 117 LKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173
Query: 673 GTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGR 708
TR Y APE L S ++ D++S G +L E++ G+
Sbjct: 174 ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 54/209 (25%), Positives = 100/209 (47%), Gaps = 35/209 (16%)
Query: 517 LIGSGGFGAVYKGIL-----NDKTIVAVKKITN-VGVQGKKDFCTEIAIIGNIHHVNLVK 570
++GSG FG VYKG+ K VA+K++ + K+ E ++ ++ + ++ +
Sbjct: 14 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 73
Query: 571 LKGFCAQGRQRLLVYEYMNHGSL--------DRILFGNGPVLEWQERFDIALGTARGLAY 622
L G C +L + + M G L D I G+ +L W + A+G+ Y
Sbjct: 74 LLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNI--GSQYLLNW------CVQIAKGMNY 124
Query: 623 LHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEW 682
L E++++H D+ N+L+ KI+DFGL+KLL ++ G + +W
Sbjct: 125 LE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE----YHAEGGKVPIKW 177
Query: 683 LTNSAISEKT-----DVYSFGMVLLELVS 706
+ +I + DV+S+G+ + EL++
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 23/214 (10%)
Query: 518 IGSGGFGAVYKGILNDKT--IVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFC 575
+G G +G+VYK +L+ T +A+K+I + K F I + +H + F
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESK--FNQIIMELDILHKAVSPYIVDFY 65
Query: 576 AQGRQRLLVY---EYMNHGSLDRILFGN---GPVLEWQERFDIALGTARGLAYLHSGCEQ 629
VY EYM+ GSLD++ G + E R I +GL +L E
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRR-ITYAVVKGLKFLKE--EH 122
Query: 630 KIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT----- 684
IIH D+KP N+L++ + Q K+ DFG+S L +SL T G + Y+APE +
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV---ASLAKTNIGCQSYMAPERIKSGGPN 179
Query: 685 -NSAISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717
N + ++DV+S G+ +LE+ GR P + +
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA 213
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 4e-14
Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 26/202 (12%)
Query: 518 IGSGGFGAVYKGIL----NDKTIVAVKKITNVGVQGKK--DFCTEIAIIGNIHHVNLVKL 571
IG G FG K IL D +K+I + K+ + E+A++ N+ H N+V+
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 572 KGFCAQGRQRLLVYEYMNHGSLDR-------ILFGNGPVLEWQERFDIALGTARGLAYLH 624
+ + +V +Y G L + +LF +L+W + +AL ++H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL------KHVH 118
Query: 625 SGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT 684
++KI+H DIK +NI L K+ DFG++++L L T GT YL+PE
Sbjct: 119 ---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLN-STVELARTCIGTPYYLSPEICE 174
Query: 685 NSAISEKTDVYSFGMVLLELVS 706
N + K+D+++ G VL E+ +
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 42/212 (19%)
Query: 518 IGSGGFGAVYKGI-LNDKTIVAVKKI----TNVGVQGKKDFCTEIAIIGNIHHVNLVKLK 572
IG G +G VYK IVA+KKI + GV EI+++ ++H N+V+L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTA--IREISLLKELNHPNIVRLL 64
Query: 573 GFCAQGRQRLLVYEYMNHG---SLDRI-LFGNGPVL----EWQERFDIALGTARGLAYLH 624
+ LV+E+++ +D L G P L +Q +G+AY H
Sbjct: 65 DVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQ--------LLQGIAYCH 116
Query: 625 SGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLL-------TPEQSSLFTTMRGTRGY 677
S +++H D+KP+N+L+ K++DFGL++ T E +L+ Y
Sbjct: 117 S---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLW--------Y 165
Query: 678 LAPEWLTNSA-ISEKTDVYSFGMVLLELVSGR 708
APE L S S D++S G + E+V+ R
Sbjct: 166 RAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 5e-14
Identities = 37/92 (40%), Positives = 53/92 (57%), Gaps = 4/92 (4%)
Query: 618 RGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGY 677
RGL YLHS I+H DIKP N+L++ + KI DFGL+++ P++S T T+ Y
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
Query: 678 LAPEWLTNSA-ISEKTDVYSFGMVLLELVSGR 708
APE L S + D++S G + EL+ R
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 35/209 (16%)
Query: 517 LIGSGGFGAVYKGIL-----NDKTIVAVKKI-TNVGVQGKKDFCTEIAIIGNIHHVNLVK 570
++GSG FG VYKGI N K VA+K + N + K+ E ++ + + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 571 LKGFCAQGRQRLLVYEYMNHGSL--------DRILFGNGPVLEWQERFDIALGTARGLAY 622
L G C +L V + M +G L DRI G+ +L W + A+G++Y
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRI--GSQDLLNW------CVQIAKGMSY 124
Query: 623 LHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEW 682
L E +++H D+ N+L+ KI+DFGL++LL ++ T G + +W
Sbjct: 125 LE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE----TEYHADGGKVPIKW 177
Query: 683 LTNSAI-----SEKTDVYSFGMVLLELVS 706
+ +I + ++DV+S+G+ + EL++
Sbjct: 178 MALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 67/215 (31%), Positives = 98/215 (45%), Gaps = 34/215 (15%)
Query: 516 NLIGSGGFGAVYKGILNDK-TIVAVKKITNVGVQGKKD-----FCTEIAIIGNIHHVNLV 569
IG G +G VYK D +VA+KK V + +K+ EI I+ ++H N+V
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKK---VRLDNEKEGFPITAIREIKILRQLNHRNIV 69
Query: 570 KLK----------GFCAQGRQRLLVYEYMNH---GSLDRIL--FGNGPVLEWQERFDIAL 614
LK F LV+EYM+H G L+ L F + + ++
Sbjct: 70 NLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL---- 125
Query: 615 GTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGT 674
GL Y H ++ +H DIK NILL+ Q K++DFGL++L E+S +T T
Sbjct: 126 --LEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVIT 180
Query: 675 RGYLAPEWLT-NSAISEKTDVYSFGMVLLELVSGR 708
Y PE L DV+S G +L EL + +
Sbjct: 181 LWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 6e-14
Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 21/207 (10%)
Query: 511 TDNFKNL--IGSGGFGAV--YKGILNDKTIVAVKKITN---VGVQGKKDFCTEIAIIGNI 563
T+ + +L +G G FG V + L + VA+KKI V K+ + E+ ++ ++
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQN-VAIKKIMKPFSTPVLAKRTY-RELKLLKHL 66
Query: 564 HHVNLVKLKG-FCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAY 622
H N++ L F + V E + L R+L + P LE Q RGL Y
Sbjct: 67 RHENIISLSDIFISPLEDIYFVTELLG-TDLHRLL-TSRP-LEKQFIQYFLYQILRGLKY 123
Query: 623 LHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPE- 681
+HS ++H D+KP NIL++ + KI DFGL+++ Q T TR Y APE
Sbjct: 124 VHSA---GVVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRYYRAPEI 176
Query: 682 WLTNSAISEKTDVYSFGMVLLELVSGR 708
LT + D++S G + E++ G+
Sbjct: 177 MLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 6e-14
Identities = 68/224 (30%), Positives = 107/224 (47%), Gaps = 45/224 (20%)
Query: 504 YEELEVATDNFKNLIGSGGFGAVYKG---ILNDKTIVAVKKI----TNVGVQGKKDFCTE 556
YE++E IG G +G VYK + N+ +A+KKI + GV E
Sbjct: 4 YEKVEK--------IGEGTYGVVYKARDRVTNE--TIALKKIRLEQEDEGVPSTA--IRE 51
Query: 557 IAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRIL---------FGNGPVLEWQ 607
I+++ + H N+V+L+ ++ LV+EY LD L F P L
Sbjct: 52 ISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKT 106
Query: 608 ERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQA-KISDFGLSKLL-TPEQS 665
+ I RG+AY HS +++H D+KP+N+L+ A K++DFGL++ P ++
Sbjct: 107 YLYQI----LRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159
Query: 666 SLFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGR 708
FT T Y APE L S S D++S G + E+V+ +
Sbjct: 160 --FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 9e-14
Identities = 56/198 (28%), Positives = 100/198 (50%), Gaps = 16/198 (8%)
Query: 518 IGSGGFGAVYKG--ILNDKTIVAVKKITNVGVQGKKDFCT---EIAIIGNIHHVNLVKLK 572
+G G + VYKG L D +VA+K+I +G CT E++++ ++ H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAP--CTAIREVSLLKDLKHANIVTLH 70
Query: 573 GFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKII 632
+ LV+EY++ L + L G + RGL Y H +K++
Sbjct: 71 DIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVL 126
Query: 633 HCDIKPENILLHYHFQAKISDFGLSKLLT-PEQSSLFTTMRGTRGYLAPEWLTNSA-ISE 690
H D+KP+N+L++ + K++DFGL++ + P ++ ++ T Y P+ L S S
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKT--YSNEVVTLWYRPPDILLGSTDYST 184
Query: 691 KTDVYSFGMVLLELVSGR 708
+ D++ G + E+ +GR
Sbjct: 185 QIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 9e-14
Identities = 57/197 (28%), Positives = 102/197 (51%), Gaps = 14/197 (7%)
Query: 518 IGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCT---EIAIIGNIHHVNLVKLKG 573
+G G + V+KG + +VA+K+I +G CT E++++ N+ H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAP--CTAIREVSLLKNLKHANIVTLHD 70
Query: 574 FCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIH 633
R LV+EY++ L + L G ++ RGL+Y H ++KI+H
Sbjct: 71 IIHTERCLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILH 126
Query: 634 CDIKPENILLHYHFQAKISDFGLSKLLT-PEQSSLFTTMRGTRGYLAPEWLTNSA-ISEK 691
D+KP+N+L++ + K++DFGL++ + P ++ ++ T Y P+ L S S
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSTEYSTP 184
Query: 692 TDVYSFGMVLLELVSGR 708
D++ G +L E+ +GR
Sbjct: 185 IDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 66/197 (33%), Positives = 89/197 (45%), Gaps = 12/197 (6%)
Query: 517 LIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKD----FCTEIAIIGNIHHVNLVKL 571
+IG G FG V ++ AVK + + KK+ ++ N+ H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 572 KGFCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQK 630
F Q +L V +Y+N G L L LE + RF A A L YLHS
Sbjct: 62 H-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLHS---LN 116
Query: 631 IIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISE 690
I++ D+KPENILL ++DFGL K E + +T GT YLAPE L
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR 175
Query: 691 KTDVYSFGMVLLELVSG 707
D + G VL E++ G
Sbjct: 176 TVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 54/197 (27%), Positives = 102/197 (51%), Gaps = 14/197 (7%)
Query: 518 IGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCT---EIAIIGNIHHVNLVKLKG 573
+G G + V+KG + +VA+K+I +G CT E++++ ++ H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAP--CTAIREVSLLKDLKHANIVTLHD 71
Query: 574 FCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIH 633
+ LV+EY++ L + + G ++ RGLAY H +K++H
Sbjct: 72 IVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLH 127
Query: 634 CDIKPENILLHYHFQAKISDFGLSKLLT-PEQSSLFTTMRGTRGYLAPEWLTNSA-ISEK 691
D+KP+N+L++ + K++DFGL++ + P ++ ++ T Y P+ L S+ S +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSSEYSTQ 185
Query: 692 TDVYSFGMVLLELVSGR 708
D++ G + E+ SGR
Sbjct: 186 IDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 56/214 (26%), Positives = 89/214 (41%), Gaps = 48/214 (22%)
Query: 518 IGSGGFGAVYKG------------ILNDKTIVAVKKITNVG-------VQGKKDFCTEIA 558
I G FG+VY +L ++A ++TNV +QG+ +
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPY----- 58
Query: 559 IIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPV-LEWQERFDIALGTA 617
+ KL LV EY+N G ++ G + +W +++
Sbjct: 59 ---------VAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY--IAEVV 107
Query: 618 RGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSK--LLTPEQSSLFTTMRGTR 675
G+ LH ++ IIH DIKPEN+L+ K++DFGLS+ L + GT
Sbjct: 108 LGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV-------GTP 157
Query: 676 GYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
YLAPE + + +D +S G V+ E + G
Sbjct: 158 DYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 58/199 (29%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 515 KNLIGSGGFGAVYKGIL----NDKTIVAVKKITNVGVQGKKD-FCTEIAIIGNIHHVNLV 569
IG G FG VY+G+ N+K VAVK N ++ F E I+ H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 570 KLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQ 629
KL G + +V E G L L N L+ + + LAYL S +
Sbjct: 71 KLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---K 126
Query: 630 KIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR--GYLAPEWLTNSA 687
+ +H DI N+L+ K+ DFGLS+ L E S + +G ++APE +
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL--EDESYYKASKGKLPIKWMAPESINFRR 184
Query: 688 ISEKTDVYSFGMVLLELVS 706
+ +DV+ FG+ + E++
Sbjct: 185 FTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 31/216 (14%)
Query: 518 IGSGGFGAVYK----GILNDK----TIVAVKKITNVGVQGK-KDFCTEIAIIGNI-HHVN 567
+G G FG V GI DK VAVK + + + D +E+ ++ I H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 568 LVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIA-------------- 613
++ L G C Q ++ EY + G+L L P + +DIA
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRP-PGMEYSYDIARVPDEQMTFKDLVS 141
Query: 614 --LGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSK-LLTPEQSSLFTT 670
ARG+ YL S QK IH D+ N+L+ + KI+DFGL++ + + T
Sbjct: 142 CTYQVARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198
Query: 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS 706
R ++APE L + + ++DV+SFG+++ E+ +
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 65/205 (31%), Positives = 94/205 (45%), Gaps = 27/205 (13%)
Query: 517 LIGSGGFGAVY------------KGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIH 564
L+G G FG V IL + I+A ++ + TE ++ N
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHT--------LTESRVLKNTR 53
Query: 565 HVNLVKLKGFCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYL 623
H L LK + Q + RL V EY+N G L L E + RF L YL
Sbjct: 54 HPFLTSLK-YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYL 111
Query: 624 HSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL 683
HSG KI++ D+K EN++L KI+DFGL K + +++ T GT YLAPE L
Sbjct: 112 HSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM-KTFCGTPEYLAPEVL 167
Query: 684 TNSAISEKTDVYSFGMVLLELVSGR 708
++ D + G+V+ E++ GR
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 59/198 (29%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 518 IGSGGFGAVYK-GILNDKTIVAVKKITNVGV---QGKKDFCTEIAIIGNIHHVNLVKLKG 573
+G GGFG V + + A KK+ + +G++ E I+ + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 574 FCAQGRQRL-LVYEYMNHGSLDRILFGNG-PVL-EWQERFDIALGTARGLAYLHSGCEQK 630
+ + + L LV MN G L ++ G P E + F A GL +LH +++
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA-QIICGLEHLH---QRR 115
Query: 631 IIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISE 690
I++ D+KPEN+LL H +ISD GL+ L + GT GY+APE L
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVEL-KGGKKI-KGRAGTPGYMAPEVLQGEVYDF 173
Query: 691 KTDVYSFGMVLLELVSGR 708
D ++ G L E+++GR
Sbjct: 174 SVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 58/227 (25%), Positives = 101/227 (44%), Gaps = 40/227 (17%)
Query: 513 NFKNLIGSGGFGAVY------------KGILNDK-----TIVAVKKI-TNVGVQGKKDFC 554
NF +G G FG V+ K + +VAVK + + ++DF
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 555 TEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRIL----------FGNGPVL 604
E+ I+ + N+ +L G C ++ EYM +G L++ L N L
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 605 EWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664
+ +A A G+ YL S +H D+ N L+ ++ KI+DFG+S+ L
Sbjct: 128 SFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNL---Y 181
Query: 665 SSLFTTMRGTRGYLAPEWLTNSAI-----SEKTDVYSFGMVLLELVS 706
SS + ++G R L W+ ++ + K+DV++FG+ L E+++
Sbjct: 182 SSDYYRVQG-RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 61/194 (31%), Positives = 95/194 (48%), Gaps = 15/194 (7%)
Query: 518 IGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFC---TEIAIIGNIHHVNLVKLKG 573
+GSG +G VYK L+ + AVK I ++ DF EI ++ H N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQEIFMVKECKHCNIVAYFG 73
Query: 574 FCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIH 633
+ + EY GSL I GP+ E Q + + T +GLAYLHS + +H
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY-VCRETLQGLAYLHSKGK---MH 129
Query: 634 CDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT---NSAISE 690
DIK NILL + K++DFG++ +T + + GT ++APE N ++
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKITATIAKR-KSFIGTPYWMAPEVAAVEKNGGYNQ 188
Query: 691 KTDVYSFGMVLLEL 704
D+++ G+ +EL
Sbjct: 189 LCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 12/197 (6%)
Query: 518 IGSGGFGAVYK-GILNDKTIVAVKKITNVGVQ---GKKDFCTEIAIIGNIHHVNLVKLKG 573
+G GGFG V + N + A KK+ ++ G+K E I+ ++ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 574 FCAQGRQRL-LVYEYMNHGSLDRILFGNGPV-LEWQERFDIALGTARGLAYLHSGCEQKI 631
+ + + L LV MN G L ++ G LE + + G+ +LHS I
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDI 116
Query: 632 IHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEK 691
++ D+KPEN+LL ++SD GL+ L + ++ T GT GY+APE L S
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVEL-KDGKTI-TQRAGTNGYMAPEILKEEPYSYP 174
Query: 692 TDVYSFGMVLLELVSGR 708
D ++ G + E+V+GR
Sbjct: 175 VDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 51/198 (25%), Positives = 102/198 (51%), Gaps = 15/198 (7%)
Query: 518 IGSGGFGAVYKGI-LNDKTIVAVKKITN---VGVQGKKDFCTEIAIIGNIHHVNLVKLKG 573
IG G F VY+ L D VA+KK+ + + + D EI ++ ++H N++K
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 574 FCAQGRQRLLVYEYMNHGSLDRIL--FGNGPVLEWQE---RFDIALGTARGLAYLHSGCE 628
+ + +V E + G L R++ F L ++ ++ + L +A L ++HS
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA--LEHMHS--- 124
Query: 629 QKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAI 688
++++H DIKP N+ + K+ D GL + + + ++ + + GT Y++PE + +
Sbjct: 125 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGY 183
Query: 689 SEKTDVYSFGMVLLELVS 706
+ K+D++S G +L E+ +
Sbjct: 184 NFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 73/234 (31%), Positives = 107/234 (45%), Gaps = 38/234 (16%)
Query: 499 PQRFDYEELEVATDNFK--NLIGSGGFGAVYKGILN--DKTIVAVKKITNVGVQGKKDFC 554
E L TD ++ IG G +G VYK + N D ++ AVK + + D
Sbjct: 9 SSMLGLESLGDPTDTWEIIETIGKGTYGKVYK-VTNKKDGSLAAVKILDPI-----SDVD 62
Query: 555 TEIAIIGNI-----HHVNLVKLKGFCAQ-----GRQRLLVYEYMNHGSLDRILFGNGPVL 604
EI NI +H N+VK G + G Q LV E N GS+ ++ G +L
Sbjct: 63 EEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKG---LL 119
Query: 605 EWQERFD------IALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSK 658
+R D I G GL +LH+ +IIH D+K NILL K+ DFG+S
Sbjct: 120 ICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176
Query: 659 LLTPEQSSLFTTMRGTRGYLAPEWLT-----NSAISEKTDVYSFGMVLLELVSG 707
LT + T++ GT ++APE + + + + DV+S G+ +EL G
Sbjct: 177 QLTSTRLRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 63/209 (30%), Positives = 105/209 (50%), Gaps = 24/209 (11%)
Query: 513 NFKNL--IGSGGFGAVYKGILNDKT--IVAVKKI----TNVGVQGKKDFCTEIAIIGNIH 564
NF+ + IG G +G VYK N T +VA+KKI GV EI+++ ++
Sbjct: 1 NFQKVEKIGEGTYGVVYKA-RNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELN 57
Query: 565 HVNLVKLKGFCAQGRQRLLVYEYMNHGSLDR---ILFGNGPVLEWQERFDIALGTARGLA 621
H N+VKL + LV+E+++ L + +G L + + L +GLA
Sbjct: 58 HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQL--LQGLA 114
Query: 622 YLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLL-TPEQSSLFTTMRGTRGYLAP 680
+ HS +++H D+KP+N+L++ K++DFGL++ P ++ +T T Y AP
Sbjct: 115 FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAP 169
Query: 681 EWLTNSAI-SEKTDVYSFGMVLLELVSGR 708
E L S D++S G + E+V+ R
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-13
Identities = 64/205 (31%), Positives = 92/205 (44%), Gaps = 27/205 (13%)
Query: 517 LIGSGGFGAVY------------KGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIH 564
L+G G FG V IL + I+A ++ + TE ++ N
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT--------VTESRVLQNTR 53
Query: 565 HVNLVKLKGFCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYL 623
H L LK + Q RL V EY N G L L E + RF A L YL
Sbjct: 54 HPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALEYL 111
Query: 624 HSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL 683
HS + +++ DIK EN++L KI+DFGL K + +++ T GT YLAPE L
Sbjct: 112 HS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM-KTFCGTPEYLAPEVL 167
Query: 684 TNSAISEKTDVYSFGMVLLELVSGR 708
++ D + G+V+ E++ GR
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 29/215 (13%)
Query: 518 IGSGGFGAVYK----GILNDK----TIVAVKKITNVGV-QGKKDFCTEIAIIGNI-HHVN 567
+G G FG V GI DK VAVK + + + D +E+ ++ I H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 568 LVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGP---------------VLEWQERFDI 612
++ L G C Q ++ EY + G+L L P L +++
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 613 ALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSK-LLTPEQSSLFTTM 671
A ARG+ YL S QK IH D+ N+L+ KI+DFGL++ + + T
Sbjct: 140 AYQVARGMEYLAS---QKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 672 RGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS 706
R ++APE L + + ++DV+SFG++L E+ +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 8e-13
Identities = 70/254 (27%), Positives = 120/254 (47%), Gaps = 34/254 (13%)
Query: 468 RWKLHKSTDSKSGNPNTLSSGDLEAFYIPGLPQRFDYEE-LEVATDN--FKNLIGSGGFG 524
RWK+ +S +GN E YI P + Y+ E +N F +G+G FG
Sbjct: 4 RWKVIESI---NGN---------EYVYID--PTQLPYDLKWEFPRNNLSFGKTLGAGAFG 49
Query: 525 AVYKG-----ILNDKTI-VAVKKITNVGVQGKKD-FCTEIAIIGNI-HHVNLVKLKGFCA 576
V + +D + VAVK + +++ +E+ I+ ++ +H N+V L G C
Sbjct: 50 KVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT 109
Query: 577 QGRQRLLVYEYMNHGSLDRILFGNGPV-LEWQERFDIALGTARGLAYLHSGCEQKIIHCD 635
G L++ EY +G L L L ++ + A+G+A+L S + IH D
Sbjct: 110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRD 166
Query: 636 IKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTNSAISEKT 692
+ N+LL + KI DFGL++ + S + R ++APE + N + ++
Sbjct: 167 LAARNVLLTHGKIVKICDFGLARDIM--NDSNYVVKGNARLPVKWMAPESIFNCVYTFES 224
Query: 693 DVYSFGMVLLELVS 706
DV+S+G++L E+ S
Sbjct: 225 DVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 9e-13
Identities = 63/196 (32%), Positives = 94/196 (47%), Gaps = 13/196 (6%)
Query: 518 IGSGGFGAVYKGILNDKT-IVAVKKITNVGVQGKKDFCTEIA---IIGNIHHVNLVKLKG 573
IG G FG V + D I A+K I + + + +A ++ ++ +V LK
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59
Query: 574 FCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERFDIA-LGTARGLAYLHSGCEQKI 631
F Q ++L LV ++N G L L G + RF A L A L LH + +
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCA--LENLH---KFNV 114
Query: 632 IHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEK 691
I+ D+KPENILL Y + DFGL K L + T GT YLAPE L ++
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGHGYTKA 173
Query: 692 TDVYSFGMVLLELVSG 707
D ++ G++L E+++G
Sbjct: 174 VDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 1e-12
Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 20/217 (9%)
Query: 517 LIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNI-HHVNLVKLKGFC 575
L+G+G +G VYKG +A K+ +V +++ EI ++ HH N+ G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 576 AQGR------QRLLVYEYMNHGSL-DRILFGNGPVLEWQERFDIALGTARGLAYLHSGCE 628
+ Q LV E+ GS+ D I G L+ + I RGL++LH +
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---Q 129
Query: 629 QKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT---- 684
K+IH DIK +N+LL + + K+ DFG+S L T GT ++APE +
Sbjct: 130 HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD-RTVGRRNTFIGTPYWMAPEVIACDEN 188
Query: 685 -NSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSM 720
++ K+D++S G+ +E+ G P H M
Sbjct: 189 PDATYDFKSDLWSLGITAIEMAEG---APPLCDMHPM 222
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 67/208 (32%), Positives = 92/208 (44%), Gaps = 33/208 (15%)
Query: 517 LIGSGGFGAV-----------YK-GILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIH 564
L+G G FG V Y IL + I+A ++ + TE ++ N
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHT--------LTESRVLQNTR 53
Query: 565 HVNLVKLKGFCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYL 623
H L LK + Q RL V EY N G L L E + RF A L YL
Sbjct: 54 HPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALGYL 111
Query: 624 HSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMR---GTRGYLAP 680
HS +++ D+K EN++L KI+DFGL K E S TM+ GT YLAP
Sbjct: 112 HS---CDVVYRDLKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYLAP 164
Query: 681 EWLTNSAISEKTDVYSFGMVLLELVSGR 708
E L ++ D + G+V+ E++ GR
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 2e-12
Identities = 59/223 (26%), Positives = 85/223 (38%), Gaps = 53/223 (23%)
Query: 518 IGSGGFGAVYKGIL---NDKTIVAVKKITNVGVQGKKDF-------CTEIAIIGNIHHVN 567
IG G +G VYK D A+KK K+ + C EIA++ + H N
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKF----KGDKEQYTGISQSACREIALLRELKHEN 63
Query: 568 LVKLKGFCAQGRQRL--LVYEYMNHGSLDRILFGNGPV-----------LEWQERFDIAL 614
+V L + + L+++Y H I F L WQ
Sbjct: 64 VVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ------- 116
Query: 615 GTARGLAYLHSGCEQKIIHCDIKPENILL----HYHFQAKISDFGLSKLLTPEQSSLFTT 670
G+ YLHS ++H D+KP NIL+ KI D GL++L L
Sbjct: 117 -ILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172
Query: 671 MRG--TRGYLAPEWLT-----NSAISEKTDVYSFGMVLLELVS 706
T Y APE L AI D+++ G + EL++
Sbjct: 173 DPVVVTIWYRAPELLLGARHYTKAI----DIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 35/216 (16%)
Query: 512 DNFK--NLIGSGGFGAVYKGILNDKT---IVAVKKITNVGVQGKKDF----CTEIAIIGN 562
D ++ N I G +G VY+ DK IVA+KK+ + K+ F EI I+
Sbjct: 5 DEYEKLNRIEEGTYGVVYRA--RDKKTGEIVALKKLKME--KEKEGFPITSLREINILLK 60
Query: 563 IHHVNLVKLK----GFCAQGRQRLLVYEYMNH---GSLDRILFGNGPVLEWQERFDIALG 615
+ H N+V +K G + + +V EY+ H ++ + P L+ E + L
Sbjct: 61 LQHPNIVTVKEVVVG--SNLDKIYMVMEYVEHDLKSLMETM---KQPFLQ-SEVKCLMLQ 114
Query: 616 TARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL--FTTMRG 673
G+A+LH + I+H D+K N+LL+ KI DFGL++ S L +T +
Sbjct: 115 LLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREY---GSPLKPYTQLVV 168
Query: 674 TRGYLAPEWLTNSAI-SEKTDVYSFGMVLLELVSGR 708
T Y APE L + S D++S G + EL++ +
Sbjct: 169 TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 20/217 (9%)
Query: 517 LIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNI-HHVNLVKLKGF- 574
++G+G +G VYKG +A K+ +V +++ EI ++ HH N+ G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 575 -----CAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERFDIALGTARGLAYLHSGCE 628
Q LV E+ GS+ D + G L+ I RGLA+LH+
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA--- 139
Query: 629 QKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT---- 684
K+IH DIK +N+LL + + K+ DFG+S L T GT ++APE +
Sbjct: 140 HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD-RTVGRRNTFIGTPYWMAPEVIACDEN 198
Query: 685 -NSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSM 720
++ ++D++S G+ +E+ G P H M
Sbjct: 199 PDATYDYRSDIWSLGITAIEMAEG---APPLCDMHPM 232
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 56/196 (28%), Positives = 98/196 (50%), Gaps = 9/196 (4%)
Query: 517 LIGSGGFGAVYKGILND-KTIVAVKKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLKG 573
++G G +G V K + K IVA+KK + + K+ E+ ++ + N+V+LK
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 574 FCAQGRQRLLVYEYMNHGSLDRIL-FGNGPVLEWQERFDIALGTARGLAYLHSGCEQKII 632
+ + LV+EY+ L+ + NG E + L A +H + I+
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKA-----IHWCHKNDIV 122
Query: 633 HCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKT 692
H DIKPEN+L+ ++ K+ DFG ++ L+ ++ +T TR Y +PE L + +
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAV 182
Query: 693 DVYSFGMVLLELVSGR 708
D++S G +L EL G+
Sbjct: 183 DMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 28/206 (13%)
Query: 517 LIGSGGFGAV----YKGILNDKTIVAVKKITNVGVQGKKDFCTE-----IAIIGNIHHVN 567
++G G FG V KG + +KK +V +Q CT +A+ G H
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKK--DVILQDDDVECTMTEKRVLALAGK--HPF 57
Query: 568 LVKLKGFCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERF---DIALGTARGLAYL 623
L +L C Q + RL V EY+N G L + +G E + RF +I LG L +L
Sbjct: 58 LTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLG----LQFL 112
Query: 624 HSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKL-LTPEQSSLFTTMRGTRGYLAPEW 682
H E+ II+ D+K +N+LL KI+DFG+ K + ++ +T GT Y+APE
Sbjct: 113 H---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT--STFCGTPDYIAPEI 167
Query: 683 LTNSAISEKTDVYSFGMVLLELVSGR 708
L+ D ++ G++L E+++G+
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 61/214 (28%), Positives = 93/214 (43%), Gaps = 33/214 (15%)
Query: 518 IGSGGFGAVYKGILND-KTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCA 576
+G G G V+ + +D VAVKKI Q K EI II + H N+VK+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 577 QGRQRL--------------LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAY 622
L +V EYM L +L GP+ E R RGL Y
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVL-EQGPLSEEHARL-FMYQLLRGLKY 129
Query: 623 LHSGCEQKIIHCDIKPENILLHYH-FQAKISDFGLSKLLTPEQS--SLFTTMRGTRGYLA 679
+HS ++H D+KP N+ ++ KI DFGL++++ P S + T+ Y +
Sbjct: 130 IHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRS 186
Query: 680 PEWLT-----NSAISEKTDVYSFGMVLLELVSGR 708
P L AI D+++ G + E+++G+
Sbjct: 187 PRLLLSPNNYTKAI----DMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 65/205 (31%), Positives = 93/205 (45%), Gaps = 26/205 (12%)
Query: 517 LIGSGGFGAVY------------KGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIH 564
L+G G FG V IL + IVA ++ + TE ++ N
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT--------LTENRVLQNSR 53
Query: 565 HVNLVKLKGFCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYL 623
H L LK + Q RL V EY N G L L E + RF A L YL
Sbjct: 54 HPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYL 111
Query: 624 HSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL 683
HS E+ +++ D+K EN++L KI+DFGL K + +++ T GT YLAPE L
Sbjct: 112 HS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM-KTFCGTPEYLAPEVL 168
Query: 684 TNSAISEKTDVYSFGMVLLELVSGR 708
++ D + G+V+ E++ GR
Sbjct: 169 EDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-12
Identities = 71/204 (34%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 518 IGSGGFGAVYKGILND-KTIVAVKKITNVGVQGKKDFCTEIA-IIG--NIHHVN------ 567
IG G FG VY+ D + I A+K ++ + KK E+A IG NI
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKK----EVAHTIGERNILVRTLLDESP 56
Query: 568 -LVKLKGFCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHS 625
+V LK F Q L LV +YM+ G L L G E + +F IA L +LH
Sbjct: 57 FIVGLK-FSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLH- 113
Query: 626 GCEQKIIHCDIKPENILLHYHFQAKISDFGLSKL-LTPEQSSLFTTMRGTRGYLAPEWLT 684
+ I++ D+KPENILL + DFGLSK LT +++ T GT YLAPE L
Sbjct: 114 --KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT--NTFCGTTEYLAPEVLL 169
Query: 685 NSA-ISEKTDVYSFGMVLLELVSG 707
+ ++ D +S G+++ E+ G
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 6e-12
Identities = 60/228 (26%), Positives = 99/228 (43%), Gaps = 48/228 (21%)
Query: 517 LIGSGGFGAVYKGILNDKTI---VAVKKITNVGVQG---KKDFCTEIAIIGNIHHVNLVK 570
LIG GG G VY D VA+KKI + KK F E I ++ H +V
Sbjct: 9 LIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 571 LKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERF---DIALGTA---------- 617
+ C+ G Y+ +L +L WQ+ ++A T+
Sbjct: 67 VYSICSDGDPVYYTMPYIEGYTLKSLLKSV-----WQKESLSKELAEKTSVGAFLSIFHK 121
Query: 618 --RGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSK-----------LLTPEQ 664
+ Y+HS + ++H D+KP+NILL + I D+G + + E+
Sbjct: 122 ICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 665 SSLFTTMR------GTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS 706
+ +++M GT Y+APE L SE TD+Y+ G++L ++++
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 51/199 (25%), Positives = 103/199 (51%), Gaps = 17/199 (8%)
Query: 518 IGSGGFGAVYKGI-LNDKTIVAVKKIT---NVGVQGKKDFCTEIAIIGNIHHVNLVK-LK 572
IG G F VY+ L D+ VA+KK+ + + ++D EI ++ ++H N++K L
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 573 GFCAQGRQRLLVYEYMNHGSLDRIL--FGNGPVLEWQE---RFDIALGTARGLAYLHSGC 627
F + V E + G L +++ F L + ++ + L +A + ++HS
Sbjct: 70 SFIEDNELNI-VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA--VEHMHS-- 124
Query: 628 EQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSA 687
++++H DIKP N+ + K+ D GL + + + ++ + + GT Y++PE + +
Sbjct: 125 -RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENG 182
Query: 688 ISEKTDVYSFGMVLLELVS 706
+ K+D++S G +L E+ +
Sbjct: 183 YNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 59/194 (30%), Positives = 97/194 (50%), Gaps = 15/194 (7%)
Query: 518 IGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCT---EIAIIGNIHHVNLVKLKG 573
IGSG +G VYK +N + A+K I ++ +DF EI ++ + H N+V G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKHSNIVAYFG 73
Query: 574 FCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIH 633
+ + + E+ GSL I GP+ E Q + ++ T +GL YLHS + +H
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAY-VSRETLQGLYYLHS---KGKMH 129
Query: 634 CDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT---NSAISE 690
DIK NILL + K++DFG+S +T + + GT ++APE ++
Sbjct: 130 RDIKGANILLTDNGHVKLADFGVSAQITATIAKR-KSFIGTPYWMAPEVAAVERKGGYNQ 188
Query: 691 KTDVYSFGMVLLEL 704
D+++ G+ +EL
Sbjct: 189 LCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 54/224 (24%), Positives = 94/224 (41%), Gaps = 26/224 (11%)
Query: 506 ELEVATDNFKNLIGSGGFGAVYKGIL------NDKTIVAVKKITN-VGVQGKKDFCTEIA 558
E+ ++T F +G FG VYKG L VA+K + + +++F E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 559 IIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGP---------------V 603
+ + H N+V L G + + +++ Y +H L L P
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 604 LEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGL-SKLLTP 662
LE + I A G+ +L S ++H D+ N+L+ KISD GL ++
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 663 EQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS 706
+ L +++PE + S +D++S+G+VL E+ S
Sbjct: 178 DYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 65/228 (28%), Positives = 102/228 (44%), Gaps = 22/228 (9%)
Query: 495 IPGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKG-ILNDKTIVAVKKITNVGV-QGKKD 552
I G D +LE + IGSG G VYK ++AVK++ G + K
Sbjct: 5 IDGQKYPADLNDLENLGE-----IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKR 59
Query: 553 FCTEIAIIGNIHHV-NLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFG-NGPVLEWQERF 610
++ ++ H +VK G+ + E M+ LD++L GP+ E
Sbjct: 60 ILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKRIQGPIPE-DILG 117
Query: 611 DIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670
+ + + L YL + +IH D+KP NILL K+ DFG+S L ++ T
Sbjct: 118 KMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TR 173
Query: 671 MRGTRGYLAPEWLT----NSAISEKTDVYSFGMVLLELVSGR---RNC 711
G Y+APE + N + DV+S G+ L+EL +G+ +NC
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC 221
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 43/151 (28%), Positives = 72/151 (47%), Gaps = 6/151 (3%)
Query: 556 EIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALG 615
E ++ N++H +++++K G +V + + L L L + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQ 165
Query: 616 TARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR 675
GL YLH+ Q+IIH D+K ENI ++ Q I D G ++ P + F + GT
Sbjct: 166 ILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQF--PVVAPAFLGLAGTV 220
Query: 676 GYLAPEWLTNSAISEKTDVYSFGMVLLELVS 706
APE L + K D++S G+VL E+++
Sbjct: 221 ETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 59/211 (27%), Positives = 108/211 (51%), Gaps = 34/211 (16%)
Query: 516 NLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGF 574
N+IG+G FG VY+ I ++ VA+KK+ +Q + E+ I+ N++H+N++ LK +
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKV----LQDPQYKNRELLIMKNLNHINIIFLKDY 127
Query: 575 ----CAQGRQRLL------------VYEYMNHGSLDRILFGNGPVLEWQERFDIALGTAR 618
C + ++ + V++YM H + + P+ + + L R
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHAL---PLF-LVKLYSYQL--CR 181
Query: 619 GLAYLHSGCEQKIIHCDIKPENILLHYHFQA-KISDFGLSKLLTPEQSSLFTTMRGTRGY 677
LAY+HS + I H D+KP+N+L+ + K+ DFG +K L Q S+ + +R Y
Sbjct: 182 ALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV--SYICSRFY 236
Query: 678 LAPEWLTNSA-ISEKTDVYSFGMVLLELVSG 707
APE + + + D++S G ++ E++ G
Sbjct: 237 RAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 62/219 (28%), Positives = 106/219 (48%), Gaps = 21/219 (9%)
Query: 517 LIGSGGFGAVYKGI-LNDKTIVAVKKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLKG 573
+IG G +G V I + VA+KKI +V V EI ++ + H ++V++K
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 574 FCAQGRQR-----LLVYEYMNHGSLDRILFGNGPVL-EWQERFDIALGTARGLAYLHSGC 627
+R +V+E M L +++ N + E + F L R L Y+H+
Sbjct: 67 IMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQL--LRALKYIHTA- 122
Query: 628 EQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS--LFTTMRGTRGYLAPEWLTN 685
+ H D+KP+NIL + + KI DFGL+++ + + +T TR Y APE L
Sbjct: 123 --NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCG 179
Query: 686 SAISEKT---DVYSFGMVLLELVSGRRNCSPRSQSHSMD 721
S S+ T D++S G + E+++G+ ++ H +D
Sbjct: 180 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 218
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 515 KNLIGSGGFGAVYKGILNDKT----IVAVKKITNVG-VQGKKDFC---TEIAIIGNIHHV 566
++G GG+G V++ I A+K + V+ +KD E I+ + H
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 567 NLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERF---DIALGTARGLAYL 623
+V L G + L+ EY++ G L L G +E F +I+L L +L
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA----LEHL 116
Query: 624 HSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL 683
H Q II+ D+KPENILL K++DFGL K + + ++ T GT Y+APE L
Sbjct: 117 HQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGTVTHTFCGTIEYMAPEIL 172
Query: 684 TNSAISEKTDVYSFGMVLLELVSG 707
S + D +S G ++ ++++G
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 65/197 (32%), Positives = 88/197 (44%), Gaps = 12/197 (6%)
Query: 517 LIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKD----FCTEIAIIGNIHHVNLVKL 571
+IG G FG V D AVK + V +K+ ++ N+ H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 572 KGFCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQK 630
+ Q ++L V +++N G L L E + RF A A L YLHS
Sbjct: 62 H-YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLHS---IN 116
Query: 631 IIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISE 690
I++ D+KPENILL ++DFGL K QS TT GT YLAPE +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 691 KTDVYSFGMVLLELVSG 707
D + G VL E++ G
Sbjct: 176 TVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 60/198 (30%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 517 LIGSGGFGAVY---KGILNDK-TIVAVK--KITNVGVQGKKDFCTEIAIIGNIHHVNLVK 570
++G G FG V+ K D + A+K K + V+ + E I+ ++H +VK
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 571 LK-GFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQ 629
L F +G+ L++ +++ G L L E +F +A A L +LHS
Sbjct: 63 LHYAFQTEGKLYLIL-DFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDHLHS---L 117
Query: 630 KIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAIS 689
II+ D+KPENILL K++DFGLSK + + + GT Y+APE + +
Sbjct: 118 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY-SFCGTVEYMAPEVVNRRGHT 176
Query: 690 EKTDVYSFGMVLLELVSG 707
+ D +SFG+++ E+++G
Sbjct: 177 QSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 44/133 (33%), Positives = 65/133 (48%), Gaps = 9/133 (6%)
Query: 583 LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENIL 642
L+ +Y+N G L L+ E + R IA L +LH + II+ DIK ENIL
Sbjct: 82 LILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLH---QLGIIYRDIKLENIL 137
Query: 643 LHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT--NSAISEKTDVYSFGMV 700
L ++DFGLSK E+ + GT Y+APE + + + D +S G++
Sbjct: 138 LDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVL 197
Query: 701 LLELVSGRRNCSP 713
EL++G SP
Sbjct: 198 TFELLTG---ASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 26/202 (12%)
Query: 518 IGSGGFGAVYKGILNDKTIVA------VKKIT------NVGVQGKKDFCTEIAIIGNIHH 565
+G G FG VY ++ DK VA +K+I N VQ + E ++ + H
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ----EAQLLSKLDH 61
Query: 566 VNLVKLKGFCAQGRQRLLVYEYMNHGSLD---RILFGNGPVLEWQERFDIALGTARGLAY 622
+VK + ++ EY LD L G L + + + G+ Y
Sbjct: 62 PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121
Query: 623 LHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEW 682
+H +++I+H D+K +NI L + KI DFG+S+LL L TT GT Y++PE
Sbjct: 122 MH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM-GSCDLATTFTGTPYYMSPEA 176
Query: 683 LTNSAISEKTDVYSFGMVLLEL 704
L + K+D++S G +L E+
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 29/215 (13%)
Query: 518 IGSGGFGAVYK----GILNDK----TIVAVKKI-TNVGVQGKKDFCTEIAIIGNI-HHVN 567
+G G FG V G+ +K T VAVK + ++ + D +E+ ++ I H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 568 LVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGP---------------VLEWQERFDI 612
++ L G C Q ++ EY + G+L L P L +++
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 613 ALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSK-LLTPEQSSLFTTM 671
A ARG+ YL S +K IH D+ N+L+ KI+DFGL++ + + T
Sbjct: 146 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 672 RGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS 706
R ++APE L + + ++DV+SFG++L E+ +
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 56/226 (24%), Positives = 101/226 (44%), Gaps = 40/226 (17%)
Query: 514 FKNLIGSGGFGAVY----KGIL-------------NDKTIVAVKKI-TNVGVQGKKDFCT 555
FK +G G FG V+ +G+ N +VAVK + + + DF
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 556 EIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRIL----------FGNGPVLE 605
EI I+ + N+++L C ++ EYM +G L++ L + +
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 606 WQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS 665
+ +A A G+ YL S +H D+ N L+ ++ KI+DFG+S+ L S
Sbjct: 129 YSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNL---YS 182
Query: 666 SLFTTMRGTRGYLAPEWLTNSAI-----SEKTDVYSFGMVLLELVS 706
+ ++G R L W++ +I + +DV++FG+ L E+++
Sbjct: 183 GDYYRIQG-RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 55/195 (28%), Positives = 96/195 (49%), Gaps = 10/195 (5%)
Query: 518 IGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKK-DFCTEIAIIGNIHHVNLVKLKGFC 575
+G G + VYKGI + +VA+K I+ +G E +++ + H N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 576 AQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCD 635
V+EYM H L + + + L RGLAY+H Q I+H D
Sbjct: 73 HTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRD 128
Query: 636 IKPENILLHYHFQAKISDFGLSKLLT-PEQSSLFTTMRGTRGYLAPEWLTNSA-ISEKTD 693
+KP+N+L+ Y + K++DFGL++ + P Q+ +++ T Y P+ L + S D
Sbjct: 129 LKPQNLLISYLGELKLADFGLARAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALD 186
Query: 694 VYSFGMVLLELVSGR 708
++ G + +E++ G+
Sbjct: 187 IWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 38/214 (17%)
Query: 518 IGSGGFGAVYKGIL----NDKTIVAVKKITNV-GVQGKK-----DFCTEIAIIGNIHHVN 567
+G G F +YKG+L + + ++++ V V G F +++ + H +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 568 LVKLKGFC-AQGRQRLLVYEYMNHGSLDRIL--FGNGPVLEWQERFDIALGTARGLAYLH 624
LVKL G C +V EY+ G LD L N L W + D+A A L YL
Sbjct: 63 LVKLYGVCVRDENI--MVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 625 SGCEQKIIHCDIKPENILL-------HYHFQAKISDFGLSK-LLTPEQSSLFTTMRGTRG 676
++K++H ++ +NIL+ Y K+SD G+ +L+ E+ R R
Sbjct: 119 ---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREE-------RVERI 168
Query: 677 -YLAPEWLTN--SAISEKTDVYSFGMVLLELVSG 707
++APE + N ++++ D +SFG LLE+ S
Sbjct: 169 PWIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 32/205 (15%)
Query: 517 LIGSGGFGAVYKG------------ILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIH 564
+G+G FG V+ ++ ++ +K+ +V +K E++
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHV--HNEKRVLKEVS------ 59
Query: 565 HVNLVKLKGFCAQGRQRLL--VYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAY 622
H +++L F + QR L + EY+ G L L +G F A L Y
Sbjct: 60 HPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCALEY 116
Query: 623 LHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEW 682
LHS ++I++ D+KPENILL K++DFG +K L T+ GT YLAPE
Sbjct: 117 LHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT----WTLCGTPEYLAPEV 169
Query: 683 LTNSAISEKTDVYSFGMVLLELVSG 707
+ + ++ D ++ G+++ E++ G
Sbjct: 170 IQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 4e-11
Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 32/223 (14%)
Query: 497 GLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGILND-KTIVAVKKIT---NVGVQGKKD 552
+P R Y+ L + +GSG +G V VA+KK++ + K+
Sbjct: 12 EVPDR--YQNL--------SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRT 61
Query: 553 FCTEIAIIGNIHHVNLVKL-KGFCAQG-----RQRLLVYEYMNHGSLDRILFGNGPVLEW 606
+ E+ ++ ++ H N++ L F + LV M L+ I+ + +
Sbjct: 62 Y-RELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMG-ADLNNIV-KCQKLSDD 118
Query: 607 QERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666
+F + RGL Y+HS IIH D+KP NI ++ + KI DFGL++
Sbjct: 119 HIQF-LVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHT----DD 170
Query: 667 LFTTMRGTRGYLAPEWLTNSAISEKT-DVYSFGMVLLELVSGR 708
T TR Y APE + N +T D++S G ++ EL++G+
Sbjct: 171 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 517 LIGSGGFGAVYK-GILNDKTIVAVKKITNVGVQGKKD---FCTEIAIIGNIHHVNLVKLK 572
++G GGFG V + + A KK+ ++ +K E I+ ++ +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL- 65
Query: 573 GFCAQGRQRL-LVYEYMNHGSLDRILF--GNGPVLEWQERFDIALGTARGLAYLHSGCEQ 629
+ + + L LV MN G L ++ G E + F A GL LH ++
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF-YAAEICCGLEDLH---QE 121
Query: 630 KIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAIS 689
+I++ D+KPENILL H +ISD GL+ + PE ++ + GT GY+APE + N +
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRV-GTVGYMAPEVVKNERYT 179
Query: 690 EKTDVYSFGMVLLELVSGRRNCSPRSQ 716
D ++ G +L E+++G+ SP Q
Sbjct: 180 FSPDWWALGCLLYEMIAGQ---SPFQQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 6e-11
Identities = 57/237 (24%), Positives = 97/237 (40%), Gaps = 54/237 (22%)
Query: 514 FKNLIGSGGFGAVY--------------------KGILNDKTIVAVKKI-TNVGVQGKKD 552
FK +G G FG V+ KG +VAVK + + + D
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKG---RPLLVAVKILRPDANKNARND 65
Query: 553 FCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILF-------------- 598
F E+ I+ + N+++L G C ++ EYM +G L++ L
Sbjct: 66 FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDA 125
Query: 599 ----GNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDF 654
P + + +AL A G+ YL S +H D+ N L+ + KI+DF
Sbjct: 126 VPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADF 182
Query: 655 GLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAI-----SEKTDVYSFGMVLLELVS 706
G+S+ L + + ++G R L W+ I + +DV++FG+ L E++
Sbjct: 183 GMSRNL---YAGDYYRIQG-RAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 7e-11
Identities = 57/199 (28%), Positives = 89/199 (44%), Gaps = 13/199 (6%)
Query: 518 IGSGGFGAVYKGILNDK-TIVAVKKITNVGVQGKKDF---CTEIAIIGNIHHVNLVKLKG 573
+G GGFG V + + A KK+ ++ +K + E I+ +H +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 574 FCAQGRQRL-LVYEYMNHGSLDRILFG---NGPVLEWQERFDIALGTARGLAYLHSGCEQ 629
+ Q + L LV MN G L ++ P GL +LH ++
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QR 116
Query: 630 KIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAIS 689
+II+ D+KPEN+LL +ISD GL+ L QS GT G++APE L
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKT-KGYAGTPGFMAPELLQGEEYD 175
Query: 690 EKTDVYSFGMVLLELVSGR 708
D ++ G+ L E+++ R
Sbjct: 176 FSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 72/226 (31%), Positives = 100/226 (44%), Gaps = 39/226 (17%)
Query: 518 IGSGGFGAVYKGILNDK--TIVAVKKITNVGVQGKKDFCTEIAIIGNI-----HHVNLVK 570
IG G +G V+K +LN K + AVK + + D EI NI H N+VK
Sbjct: 26 IGKGTYGKVFK-VLNKKNGSKAAVKILDPI-----HDIDEEIEAEYNILKALSDHPNVVK 79
Query: 571 LKGF-----CAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFD------IALGTARG 619
G G Q LV E N GS+ ++ G L+ ER + I G
Sbjct: 80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKG---FLKRGERMEEPIIAYILHEALMG 136
Query: 620 LAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLA 679
L +LH K IH D+K NILL K+ DFG+S LT + T++ GT ++A
Sbjct: 137 LQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMA 192
Query: 680 PEWLT-----NSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSM 720
PE + +S + DV+S G+ +EL G P + H M
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIELGDGD---PPLADLHPM 235
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 57/198 (28%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 517 LIGSGGFGAVYK-GILNDKTIVAVKKITNVGVQGKKD---FCTEIAIIGNIHHVNLVKLK 572
++G GGFG V + + A K++ ++ +K E I+ ++ +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL- 65
Query: 573 GFCAQGRQRL-LVYEYMNHGSLDRILFGNG-PVLEWQERFDIALGTARGLAYLHSGCEQK 630
+ + + L LV MN G L ++ G P E + A GL LH +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---REN 122
Query: 631 IIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISE 690
++ D+KPENILL + +ISD GL+ + PE S+ + GT GY+APE L N +
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESIRGRV-GTVGYMAPEVLNNQRYTL 180
Query: 691 KTDVYSFGMVLLELVSGR 708
D + G ++ E++ G+
Sbjct: 181 SPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 7e-11
Identities = 55/183 (30%), Positives = 74/183 (40%), Gaps = 19/183 (10%)
Query: 532 NDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHG 591
+ V VK +T G K EI I+ I H ++ L R + V M
Sbjct: 117 EQRKKVIVKAVT-----GGKTPGREIDILKTISHRAIINL---IHAYRWKSTVCMVMPKY 168
Query: 592 SLDRILF----GNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHF 647
D LF +GP L ++ I LAYLH + IIH D+K ENI L
Sbjct: 169 KCD--LFTYVDRSGP-LPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPE 222
Query: 648 QAKISDFGLS-KLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS 706
A + DFG + KL + GT +PE L KTD++S G+VL E+
Sbjct: 223 NAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSV 282
Query: 707 GRR 709
Sbjct: 283 KNV 285
|
Length = 392 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 8e-11
Identities = 65/202 (32%), Positives = 98/202 (48%), Gaps = 20/202 (9%)
Query: 517 LIGSGGFGAVYKGILNDKT----IVAVKKITNVGVQGKKDFCTEI---AIIGNIHHVNLV 569
++G G FG V L I A+KK +V ++ CT + + H L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKK--DVVLEDDDVECTMVERRVLALAWEHPFLT 59
Query: 570 KLKGFCA-QGRQRLL-VYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGC 627
L FC Q ++ L V EY+N G L + +G E + RF A GL +LH
Sbjct: 60 HL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARF-YAAEIICGLQFLHK-- 114
Query: 628 EQKIIHCDIKPENILLHYHFQAKISDFGLSKL-LTPEQSSLFTTMRGTRGYLAPEWLTNS 686
+ II+ D+K +N+LL KI+DFG+ K + E + +T GT Y+APE L
Sbjct: 115 -KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA--STFCGTPDYIAPEILKGQ 171
Query: 687 AISEKTDVYSFGMVLLELVSGR 708
+E D +SFG++L E++ G+
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 62/223 (27%), Positives = 106/223 (47%), Gaps = 41/223 (18%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGILNDKT--IVAVKKI----TNVGVQGKKDFCTE 556
DY ++E IG G +G VYKG N KT IVA+KKI GV E
Sbjct: 1 DYTKIEK--------IGEGTYGVVYKGR-NKKTGQIVAMKKIRLESEEEGVPSTA--IRE 49
Query: 557 IAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN---HGSLDRILFGNGPVLEWQERFDIA 613
I+++ + H N+V L+ Q + L++E+++ LD + G ++ +
Sbjct: 50 ISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSL--PKGQYMDAELVKSYL 107
Query: 614 LGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLS-------KLLTPEQSS 666
+G+ + HS ++++H D+KP+N+L+ K++DFGL+ ++ T E +
Sbjct: 108 YQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVT 164
Query: 667 LFTTMRGTRGYLAPEWLTNSA-ISEKTDVYSFGMVLLELVSGR 708
L+ Y APE L S S D++S G + E+ + +
Sbjct: 165 LW--------YRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 9e-11
Identities = 65/208 (31%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 513 NFKNLIGSGGFGAVY----KGILNDKTIVAVKKITNVGVQGKKDFCTEI-----AIIGNI 563
NF ++G G FG V KG I +KK +V +Q CT + A+ G
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKK--DVIIQDDDVECTMVEKRVLALPGKP 60
Query: 564 HHVNLVKLKGFCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAY 622
L +L C Q RL V EY+N G L + G E F A A GL +
Sbjct: 61 PF--LTQLHS-CFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVF-YAAEIAIGLFF 116
Query: 623 LHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSK--LLTPEQSSLFTTMRGTRGYLAP 680
LHS + II+ D+K +N++L KI+DFG+ K + + + F GT Y+AP
Sbjct: 117 LHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC---GTPDYIAP 170
Query: 681 EWLTNSAISEKTDVYSFGMVLLELVSGR 708
E + + D ++FG++L E+++G+
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 9e-11
Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 504 YEELEVATDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKIT----NVGVQGKKDFCTEIA 558
YE+LE IG G +G V+K IVA+K++ + GV EI
Sbjct: 2 YEKLEK--------IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA--LREIC 51
Query: 559 IIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTAR 618
++ + H N+V+L ++ LV+EY + L + ++ + +
Sbjct: 52 LLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLK 110
Query: 619 GLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLL-TPEQSSLFTTMRGTRGY 677
GLA+ HS ++H D+KP+N+L++ + + K++DFGL++ P + ++ T Y
Sbjct: 111 GLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC--YSAEVVTLWY 165
Query: 678 LAPEWLTNSAI-SEKTDVYSFGMVLLELVSGRR 709
P+ L + + S D++S G + EL + R
Sbjct: 166 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 55/182 (30%), Positives = 79/182 (43%), Gaps = 22/182 (12%)
Query: 518 IGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDF----CTEIAIIGNIHHVNLVKLK 572
IG G FG V+K K IVA+KK+ + K+ F EI I+ + H N+V L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKV--LMENEKEGFPITALREIKILQLLKHENVVNLI 77
Query: 573 GFC-----AQGRQR---LLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLH 624
C R + LV+E+ H L +L E + GL Y+H
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH 136
Query: 625 SGCEQKIIHCDIKPENILLHYHFQAKISDFGLSK---LLTPEQSSLFTTMRGTRGYLAPE 681
KI+H D+K NIL+ K++DFGL++ L + + +T T Y PE
Sbjct: 137 R---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193
Query: 682 WL 683
L
Sbjct: 194 LL 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 40/220 (18%)
Query: 504 YEELEVATDNFKNLIGSGGFGAVYKGI--LNDKTIVAVKKITNVGVQGKKDFCT---EIA 558
Y++L+ +G G + VYKG L + +VA+K+I +G T E +
Sbjct: 7 YKKLDK--------LGEGSYATVYKGRSKLTGQ-LVALKEIRLEHEEGAP--FTAIREAS 55
Query: 559 IIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRIL--FGNGPVLEWQERFDIALGT 616
++ ++ H N+V L + LV+EY+ L + + G G + F L
Sbjct: 56 LLKDLKHANIVTLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQL-- 112
Query: 617 ARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGL-------SKLLTPEQSSLFT 669
RGLAY H ++++H D+KP+N+L+ + K++DFGL SK + E +L+
Sbjct: 113 LRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLW- 168
Query: 670 TMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGR 708
Y P+ L S S D++ G + E+ +GR
Sbjct: 169 -------YRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (157), Expect = 1e-10
Identities = 66/246 (26%), Positives = 115/246 (46%), Gaps = 41/246 (16%)
Query: 498 LPQRFDYEELEVATDNFKNLIGSGGFGAVYKGILNDKT--IVAVKKITNVGVQG--KKDF 553
+P ++D E + IG+G FG V+ + + +T K I+ G++ K
Sbjct: 1 MPGKYDDGESRLNEYEVIKKIGNGRFGEVFL-VKHKRTQEFFCWKAISYRGLKEREKSQL 59
Query: 554 CTEIAIIGNIHHVNLVK-LKGFCAQGRQRL-LVYEYMNHGSLDR------ILFGNGPVLE 605
E+ ++ + H N+V+ + F + Q+L ++ E+ + G L R +FG +E
Sbjct: 60 VIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGK---IE 116
Query: 606 WQERFDIALGTARGLAYLHSGCE----QKIIHCDIKPENILLHYHFQ------------- 648
DI LAY H+ + ++++H D+KP+NI L +
Sbjct: 117 EHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLN 176
Query: 649 ----AKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAIS--EKTDVYSFGMVLL 702
AKI DFGLSK + E S+ + GT Y +PE L + S +K+D+++ G ++
Sbjct: 177 GRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234
Query: 703 ELVSGR 708
EL SG+
Sbjct: 235 ELCSGK 240
|
Length = 1021 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 25/207 (12%)
Query: 518 IGSGGFGAVYKGILND--------KTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLV 569
+G G F ++KGI + KT V +K + + F +++ + H +LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 570 KLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQ 629
G C G + ++V EY+ GSLD L N ++ + ++A A L +L ++
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DK 119
Query: 630 KIIHCDIKPENILLHYHFQA--------KISDFGLSKLLTPEQSSLFTTMRGTRGYLAPE 681
+ H ++ +N+LL K+SD G+S + P++ + ++ PE
Sbjct: 120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE-----ILLERIPWVPPE 174
Query: 682 WLTNS-AISEKTDVYSFGMVLLELVSG 707
+ N +S D +SFG L E+ SG
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 62/213 (29%), Positives = 94/213 (44%), Gaps = 39/213 (18%)
Query: 518 IGSGGFGAVYKGILN---DKTIVAVKKI-TNVGVQGKKDFCTEIAIIGNIHHVNLVKLKG 573
IG+G FG V G +N V VK++ + VQ + F E ++ H NL++ G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 574 FCAQGRQRLLVYEYMNHGSLDRIL--------FGNGPVLEWQERFDIALGTARGLAYLHS 625
C + LLV E+ G L L P + +IAL GL +LH
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL----GLLHLH- 117
Query: 626 GCEQKIIHCDIKPENILLHYHFQAKISDFGLSKL-------LTPEQSSLFTTMRGTRGYL 678
+ IH D+ N LL KI D+GLS +TP+Q L+ +R ++
Sbjct: 118 --KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQ--LWVPLR----WI 169
Query: 679 APEWL----TNSAISEKT---DVYSFGMVLLEL 704
APE + N + ++T +V+S G+ + EL
Sbjct: 170 APELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 28/212 (13%)
Query: 512 DNFKNL--IGSGGFGAVYKGILNDKTI--VAVKKIT---NVGVQGKKDFCTEIAIIGNIH 564
+ ++NL +GSG +G+V + KT VAVKK++ + K+ + E+ ++ ++
Sbjct: 17 ERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 74
Query: 565 HVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGN--GPVLEWQERFD-----IALGTA 617
H N++ L R E N L L G +++ Q+ D +
Sbjct: 75 HENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 130
Query: 618 RGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGY 677
RGL Y+HS IIH D+KP N+ ++ + KI DFGL++ E T TR Y
Sbjct: 131 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWY 183
Query: 678 LAPEWLTNSAISEKT-DVYSFGMVLLELVSGR 708
APE + N +T D++S G ++ EL++GR
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 44/128 (34%), Positives = 68/128 (53%), Gaps = 8/128 (6%)
Query: 583 LVYEYMNHGSLDRILF--GNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPEN 640
LV MN G L ++ GN E + F A T GL LH ++I++ D+KPEN
Sbjct: 77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITC-GLEDLHR---ERIVYRDLKPEN 132
Query: 641 ILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMV 700
ILL + +ISD GL+ + PE ++ + GT GY+APE + N + D + G +
Sbjct: 133 ILLDDYGHIRISDLGLA-VEIPEGETIRGRV-GTVGYMAPEVVKNERYTFSPDWWGLGCL 190
Query: 701 LLELVSGR 708
+ E++ G+
Sbjct: 191 IYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 21/200 (10%)
Query: 517 LIGSGGFG-AVYKGILNDKTIVAVKKIT-NVGVQGKKDFCTEIAIIGNIHHVNLVKLK-G 573
++G G FG A+ +N A+K+I +D E ++ + H N+V K
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 574 FCAQGRQRLLVYEYMNHGSL-DRI------LFGNGPVLEWQERFDIALGTARGLAYLHSG 626
F A G +V EY + G L +I LF +L+W + + G+ ++H
Sbjct: 67 FEADG-HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIH-- 117
Query: 627 CEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNS 686
E++++H DIK +NI L + + K+ DFG ++LLT + T GT Y+ PE N
Sbjct: 118 -EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT-SPGAYACTYVGTPYYVPPEIWENM 175
Query: 687 AISEKTDVYSFGMVLLELVS 706
+ K+D++S G +L EL +
Sbjct: 176 PYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 517 LIGSGGFGAVYKGIL----NDKTIVAVK--KITNVGVQGKKDFCTEIAIIGNIHHVNLVK 570
++G G FG+V + L VAVK K ++F E A + H N++K
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 571 LKGFCAQGR--QRL----LVYEYMNHGSLDRILF----GNGPV-LEWQERFDIALGTARG 619
L G + R RL ++ +M HG L L G P L Q + A G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 620 LAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLS-KLLTPEQSSLFTTMRGTRGYL 678
+ YL S + IH D+ N +L+ + ++DFGLS K+ + + + +L
Sbjct: 126 MEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 679 APEWLTNSAISEKTDVYSFGMVLLELVS 706
A E L ++ + +DV++FG+ + E+++
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 33/217 (15%)
Query: 518 IGSGGFGAVYK----GILNDK----TIVAVKKITNVGV-QGKKDFCTEIAIIGNI-HHVN 567
+G G FG V + GI + VAVK + + + D +E+ ++ I H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 568 LVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGP---------------VLEWQERFDI 612
++ L G C Q ++ EY G+L L P L +++
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 613 ALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMR 672
A ARG+ YL S ++ IH D+ N+L+ KI+DFGL++ + +
Sbjct: 140 AYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLARGV--HDIDYYKKTS 194
Query: 673 GTR---GYLAPEWLTNSAISEKTDVYSFGMVLLELVS 706
R ++APE L + + ++DV+SFG+++ E+ +
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 31/209 (14%)
Query: 518 IGSGGFGAVYKGILN---DKTIVAVKKI-TNVGVQGKKDFCTEIAIIGNIHHVNLVKLKG 573
IG+G FG V G + K V VK++ + + F E+ ++H N+++ G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 574 FCAQGRQRLLVYEYMNHGSL------DRILFGNGPVLEWQERFDIALGTARGLAYLHSGC 627
C + LLV E+ G L +R + + +R +A A GL +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQR--MACEVASGLLWLH--- 117
Query: 628 EQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE-----QSSLFTTMRGTRGYLAPEW 682
+ IH D+ N L KI D+GL+ PE + +R +LAPE
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR----WLAPEL 173
Query: 683 LTN-------SAISEKTDVYSFGMVLLEL 704
+ ++K++++S G+ + EL
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 5e-10
Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 10/158 (6%)
Query: 556 EIAIIGNIHHVNLVKLKGFCAQ--GRQRLLVY-EYMNHGSLDRILFGNGPVLEWQERFDI 612
EI ++ N+ H +V+ G C + + L ++ EYM GS+ L G + E R
Sbjct: 54 EIQLLKNLQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KY 111
Query: 613 ALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP--EQSSLFTT 670
G++YLHS I+H DIK NIL K+ DFG SK L + +
Sbjct: 112 TRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS 168
Query: 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGR 708
+ GT +++PE ++ K DV+S G ++E+++ +
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 59/195 (30%), Positives = 87/195 (44%), Gaps = 14/195 (7%)
Query: 518 IGSGGFGAVYKGILND-KTIVAVKKITNVGVQGK---KDFCTEIAIIGNIHHVNLVKLKG 573
+G GG+G V+ D IVA+K++ + + TE I+ LVKL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 574 FCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKII 632
+ Q + L L EY+ G +L G + E RF +A + LH E I
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFE-AVDALH---ELGYI 123
Query: 633 HCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKT 692
H D+KPEN L+ K++DFGLSK + ++ G+ Y+APE L
Sbjct: 124 HRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEVLRGKGYDFTV 179
Query: 693 DVYSFGMVLLELVSG 707
D +S G +L E + G
Sbjct: 180 DYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 517 LIGSGGFGAVYKGILNDK-TIVAVKKI--------TNVGVQGKKDFCTEIAIIGNIHHVN 567
L+G G FG VY D +AVK++ T+ V + EI ++ N+ H
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALE---CEIQLLKNLLHER 65
Query: 568 LVKLKGFCAQGRQRLL--VYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHS 625
+V+ G +R L E+M GS+ L G + E R G++YLHS
Sbjct: 66 IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTR-KYTRQILEGVSYLHS 124
Query: 626 GCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP--EQSSLFTTMRGTRGYLAPEWL 683
I+H DIK NIL K+ DFG SK L + ++ GT +++PE +
Sbjct: 125 ---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 684 TNSAISEKTDVYSFGMVLLELVSGR 708
+ K D++S G ++E+++ +
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 511 TDNFKNLIGSGGFGAVY----KGILNDKTIVAVKKITNVGVQGKKDFCT--EIAIIGNIH 564
NF ++G G FG V KG I +KK +V +Q CT E ++
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKK--DVVIQDDDVECTMVEKRVLALQD 58
Query: 565 HVNLVKLKGFCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYL 623
+ C Q RL V EY+N G L + G E Q F A + GL +L
Sbjct: 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVF-YAAEISVGLFFL 117
Query: 624 HSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL 683
H + II+ D+K +N++L KI+DFG+ K + + T GT Y+APE +
Sbjct: 118 H---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT-RTFCGTPDYIAPEII 173
Query: 684 TNSAISEKTDVYSFGMVLLELVSGR 708
+ D +++G++L E+++G+
Sbjct: 174 AYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 517 LIGSGGFGAVYK-GILNDKTIVAVKKITNVGVQGKKD---FCTEIAIIGNIHHVNLVKLK 572
++G GGFG V + + A KK+ ++ +K E I+ ++ +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL- 65
Query: 573 GFCAQGRQRL-LVYEYMNHGSLDRILFGNG-PVLEWQERFDIALGTARGLAYLHSGCEQK 630
+ + + L LV MN G L ++ G P + Q A GL L ++
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RER 122
Query: 631 IIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISE 690
I++ D+KPENILL +ISD GL+ + PE ++ + GT GY+APE + N +
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQI-PEGETVRGRV-GTVGYMAPEVINNEKYTF 180
Query: 691 KTDVYSFGMVLLELVSGR 708
D + G ++ E++ G+
Sbjct: 181 SPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 41/212 (19%)
Query: 517 LIGSGGFGAVYKGI-LNDKTIVAVKKIT---NVGVQGKKDFCTEIAIIGNIHHVNLVKLK 572
+GSG +G+V I VA+KK++ + K+ + E+ ++ ++ H N++ L
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY-RELTLLKHMQHENVIGLL 80
Query: 573 G-FCAQGRQR-----LLVYEYM---------NHGSLDRILFGNGPVLEWQERFDIALGTA 617
F + LV YM + S D++ + L +Q
Sbjct: 81 DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQY-----LVYQ--------ML 127
Query: 618 RGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGY 677
GL Y+HS IIH D+KP N+ ++ + KI DFGL++ E + TR Y
Sbjct: 128 CGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV----TRWY 180
Query: 678 LAPEWLTNSAISEKT-DVYSFGMVLLELVSGR 708
APE + N +T D++S G ++ E+++G+
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 45/142 (31%), Positives = 70/142 (49%), Gaps = 11/142 (7%)
Query: 583 LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENIL 642
+ + MN G L L +G E + RF A GL ++H+ + +++ D+KP NIL
Sbjct: 74 FILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHMHN---RFVVYRDLKPANIL 129
Query: 643 LHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVL 701
L H +ISD GL+ + ++ GT GY+APE L +A D +S G +L
Sbjct: 130 LDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGTAYDSSADWFSLGCML 186
Query: 702 LELVSGRRNCSPRSQSHSMDSN 723
+L+ G SP Q + D +
Sbjct: 187 FKLLRGH---SPFRQHKTKDKH 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 47/145 (32%), Positives = 75/145 (51%), Gaps = 23/145 (15%)
Query: 574 FCA-QGRQRLL-VYEYMNHGSLDRILFGNGPVLEWQERFDIALGT------ARGLAYLHS 625
+C Q ++ L V EY+N G L +F ++ +FD+ T GL +LHS
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDL---MFH----IQSCHKFDLPRATFYAAEIICGLQFLHS 114
Query: 626 GCEQKIIHCDIKPENILLHYHFQAKISDFGLSK--LLTPEQSSLFTTMRGTRGYLAPEWL 683
+ I++ D+K +NILL KI+DFG+ K +L ++ F GT Y+APE L
Sbjct: 115 ---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC---GTPDYIAPEIL 168
Query: 684 TNSAISEKTDVYSFGMVLLELVSGR 708
+ D +SFG++L E++ G+
Sbjct: 169 LGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 62/234 (26%), Positives = 90/234 (38%), Gaps = 54/234 (23%)
Query: 517 LIGSGGFGAVY----KG--------ILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIH 564
L+G G G V+ KG +L+ K ++ K+ V TE I+ +
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRV--------LTEQEILATLD 59
Query: 565 HVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRIL-FGNGPVLEWQE-RFDIALGTARGLAY 622
H L L LV +Y G L R+L G L + RF A L Y
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL-ALEY 118
Query: 623 LHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE-----QSSLFTTMR----- 672
LH I++ D+KPENILLH +SDF LSK E ++ + R
Sbjct: 119 LHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 673 ------------------GTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGR 708
GT Y+APE ++ D ++ G++L E++ G
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 65/235 (27%), Positives = 92/235 (39%), Gaps = 60/235 (25%)
Query: 517 LIGSGGFGAVYKGIL----NDKTIVAVKKITNVGVQGKKD---------FCTEIAIIGNI 563
+IG G FG V+ L + + A+K + K D E I+ +
Sbjct: 8 VIGRGAFGEVW---LVRDKDTGQVYAMKVLR------KSDMIKRNQIAHVRAERDILADA 58
Query: 564 HHVNLVKLKGFCA-QGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLA 621
+VKL + + Q + L LV EYM G L +L E RF IA L
Sbjct: 59 DSPWIVKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVL-ALD 115
Query: 622 YLHS-GCEQKIIHCDIKPENILLHYHFQAKISDFGLSK----------LLTPEQSSLFTT 670
+H G IH DIKP+NIL+ K++DFGL K L + LF
Sbjct: 116 SVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 671 MR------------------GTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSG 707
GT Y+APE L + + D +S G++L E++ G
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-09
Identities = 43/159 (27%), Positives = 76/159 (47%), Gaps = 16/159 (10%)
Query: 556 EIAIIGNIHHVNLVKLK--------GFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQ 607
EI +G ++H N++K++ + + +Y +M + D + + P+L Q
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD---WKDRPLL-KQ 268
Query: 608 ERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667
R I + Y+H +K+IH DIK ENI L+ + + DFG + E+ +
Sbjct: 269 TR-AIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAF 324
Query: 668 FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS 706
GT +PE L E TD++S G++LL+++S
Sbjct: 325 DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 5/90 (5%)
Query: 619 GLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYL 678
G+ +LHS IIH D+KP NI++ KI DFGL++ T S + T TR Y
Sbjct: 130 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 184
Query: 679 APEWLTNSAISEKTDVYSFGMVLLELVSGR 708
APE + E D++S G ++ E++ G
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 45/142 (31%), Positives = 69/142 (48%), Gaps = 11/142 (7%)
Query: 583 LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENIL 642
+ + MN G L L +G E + RF A GL ++H+ + +++ D+KP NIL
Sbjct: 74 FILDLMNGGDLHYHLSQHGVFSEAEMRF-YAAEIILGLEHMHN---RFVVYRDLKPANIL 129
Query: 643 LHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVL 701
L H +ISD GL+ + ++ GT GY+APE L A D +S G +L
Sbjct: 130 LDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCML 186
Query: 702 LELVSGRRNCSPRSQSHSMDSN 723
+L+ G SP Q + D +
Sbjct: 187 FKLLRGH---SPFRQHKTKDKH 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 53/167 (31%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 564 HHVNLVKLKGFCAQGRQRLL-VYEYMNHGSLDRILFGNGPVLEWQERF---DIALGTARG 619
+H LV L C Q RL V EY+N G L + + E RF +I+L
Sbjct: 54 NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA---- 108
Query: 620 LAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSK--LLTPEQSSLFTTMRGTRGY 677
L YLH E+ II+ D+K +N+LL K++D+G+ K L + +S F GT Y
Sbjct: 109 LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNY 162
Query: 678 LAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSMDSNS 724
+APE L D ++ G+++ E+++GR S + D N+
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 209
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 44/213 (20%)
Query: 515 KNLIGSGGFGAV----YKG--------ILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGN 562
+G+G FG V +KG L + I+ +K++ +V E +I+
Sbjct: 23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHV--------AQEKSILME 74
Query: 563 IHHVNLVK-LKGFCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERF--DIA----L 614
+ H +V + F Q R+ + E++ G L L G RF D+A
Sbjct: 75 LSHPFIVNMMCSF--QDENRVYFLLEFVVGGELFTHLRKAG-------RFPNDVAKFYHA 125
Query: 615 GTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGT 674
YLHS + II+ D+KPEN+LL K++DFG +K + T+ GT
Sbjct: 126 ELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT----FTLCGT 178
Query: 675 RGYLAPEWLTNSAISEKTDVYSFGMVLLELVSG 707
YLAPE + + + D ++ G++L E ++G
Sbjct: 179 PEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 60/210 (28%), Positives = 93/210 (44%), Gaps = 21/210 (10%)
Query: 513 NFKNLIGSGGFGAVYKGILNDKT---IVAVKKITN--VGVQGKKDFCTEIAIIGNIHHVN 567
+ K+L+G G FG V ++ +K I A+K + + Q F E I +I +
Sbjct: 4 DVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSP 61
Query: 568 LVKLKGFCAQGRQRL-LVYEYMNHGSLDRILFG-NGPVLEWQERFDIA-LGTARGLAYLH 624
+ + Q + L LV EY G L +L E +F +A L A +H
Sbjct: 62 WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLA-----IH 116
Query: 625 SGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT 684
S + +H DIKPEN+L+ K++DFG + LT + GT Y+APE LT
Sbjct: 117 SVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176
Query: 685 ------NSAISEKTDVYSFGMVLLELVSGR 708
+ D +S G++ E++ GR
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 70/257 (27%), Positives = 104/257 (40%), Gaps = 50/257 (19%)
Query: 470 KLHKSTDSKSGNPNTLSSGDLEAFYIPGLPQRFDYEELEVATDNFKNLIGSGGFG----A 525
+LHK DS S P + YE+ NF +G+G FG A
Sbjct: 8 QLHKKKDSDSTKE-------------PKRKNKMKYEDF-----NFIRTLGTGSFGRVILA 49
Query: 526 VYKGILNDKTIVAVKKITNVGVQGKKDF---CTEIAIIGNIHHVNLVKLKGFCAQGRQRL 582
YK D VA+K+ + +K +E I+ I+H V L G
Sbjct: 50 TYKN--EDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107
Query: 583 LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARG------LAYLHSGCEQKIIHCDI 636
LV E++ G L N +RF +G YL S I++ D+
Sbjct: 108 LVLEFVIGGEFFTFLRRN-------KRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDL 157
Query: 637 KPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYS 696
KPEN+LL K++DFG +K++ T+ GT Y+APE L N + D ++
Sbjct: 158 KPENLLLDKDGFIKMTDFGFAKVVDTRT----YTLCGTPEYIAPEILLNVGHGKAADWWT 213
Query: 697 FGMVLLELVSGRRNCSP 713
G+ + E++ G C P
Sbjct: 214 LGIFIYEILVG---CPP 227
|
Length = 340 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 7e-09
Identities = 32/104 (30%), Positives = 57/104 (54%), Gaps = 10/104 (9%)
Query: 603 VLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP 662
V+EW + A L YLH E+ I+H D+K +N+ L K+ D G++++L
Sbjct: 104 VVEW------FVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLE- 153
Query: 663 EQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS 706
Q + +T+ GT Y++PE +N + K+DV++ G + E+ +
Sbjct: 154 NQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 45/136 (33%), Positives = 70/136 (51%), Gaps = 8/136 (5%)
Query: 575 CAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIH 633
C Q RL LV EY+N G L + + E RF A L +LH E+ II+
Sbjct: 64 CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLH---ERGIIY 119
Query: 634 CDIKPENILLHYHFQAKISDFGLSKL-LTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKT 692
D+K +N+LL K++D+G+ K L P ++ +T GT Y+APE L
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT--STFCGTPNYIAPEILRGEEYGFSV 177
Query: 693 DVYSFGMVLLELVSGR 708
D ++ G+++ E+++GR
Sbjct: 178 DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 8e-09
Identities = 65/214 (30%), Positives = 91/214 (42%), Gaps = 37/214 (17%)
Query: 513 NFKNLIGSGGFGAV----YKGILNDKTIVAVKK---ITNVGVQG----KKDFCTEIAIIG 561
++G G FG V YK I A+KK I V+ K+ F T
Sbjct: 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFET----AN 57
Query: 562 NIHHVNLVKLKGFCAQGRQRL-LVYEYMNHGSL----DRILFGNGPVLEWQERFDIALGT 616
+ H LV L C Q + V EY G L +F E + F A
Sbjct: 58 SERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFS-----EPRAVF-YAACV 110
Query: 617 ARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ---SSLFTTMRG 673
GL YLH E KI++ D+K +N+LL KI+DFGL K E +T G
Sbjct: 111 VLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK----EGMGFGDRTSTFCG 163
Query: 674 TRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSG 707
T +LAPE LT ++ + D + G+++ E++ G
Sbjct: 164 TPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 513 NFKNLIGSGGFGAVY----KGILNDKTIVAVKKITNVGVQGKKDFCTEI-----AIIGNI 563
NF ++G G FG V KG I +KK +V +Q CT + A+ G
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKK--DVVIQDDDVECTMVEKRVLALSGKP 60
Query: 564 HHVNLVKLKGFCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAY 622
L +L C Q RL V EY+N G L + G E F A A GL +
Sbjct: 61 PF--LTQLHS-CFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVF-YAAEIAIGLFF 116
Query: 623 LHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSK--LLTPEQSSLFTTMRGTRGYLAP 680
LHS + II+ D+K +N++L KI+DFG+ K + + F GT Y+AP
Sbjct: 117 LHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC---GTPDYIAP 170
Query: 681 EWLTNSAISEKTDVYSFGMVLLELVSGR 708
E + + D ++FG++L E+++G+
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 63/208 (30%), Positives = 90/208 (43%), Gaps = 36/208 (17%)
Query: 518 IGSGGFGAVYKGILNDKTI-VAVKKITNV---GVQGKKDFCTEIAIIGNIHHVNLVKLKG 573
IGSG G V I VAVKK++ K+ + E+ ++ ++H N++ L
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISLLN 87
Query: 574 -FCAQG-----RQRLLVYEYMN-------HGSLDRILFGNGPVLEWQERFDIALGTAR-G 619
F Q + LV E M+ H LD ER L G
Sbjct: 88 VFTPQKSLEEFQDVYLVMELMDANLCQVIHMELD------------HERMSYLLYQMLCG 135
Query: 620 LAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLA 679
+ +LHS IIH D+KP NI++ KI DFGL++ T + + T TR Y A
Sbjct: 136 IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRA 190
Query: 680 PEWLTNSAISEKTDVYSFGMVLLELVSG 707
PE + E D++S G ++ ELV G
Sbjct: 191 PEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 26/206 (12%)
Query: 514 FKNL--IGSGGFG---AVYKGILNDKTIVAVKKITNV---GVQGKKDFCTEIAIIGNIHH 565
++NL IGSG G A Y +L+ VA+KK++ K+ + E+ ++ ++H
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAY-RELVLMKCVNH 75
Query: 566 VNLVKLKG-FCAQG-----RQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARG 619
N++ L F Q + LV E M+ I L+ + + G
Sbjct: 76 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQMLCG 131
Query: 620 LAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLA 679
+ +LHS IIH D+KP NI++ KI DFGL++ T S + T TR Y A
Sbjct: 132 IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRA 186
Query: 680 PEWLTNSAISEKTDVYSFGMVLLELV 705
PE + E D++S G ++ E+V
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 34/89 (38%), Positives = 51/89 (57%), Gaps = 4/89 (4%)
Query: 622 YLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS-SLFTTMRGTRGYLAP 680
++HS + +IH DIK NILL + K+ DFG SK+ S + T GT Y+AP
Sbjct: 158 HVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAP 214
Query: 681 EWLTNSAISEKTDVYSFGMVLLELVSGRR 709
E S+K D++S G++L EL++ +R
Sbjct: 215 EIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 34/92 (36%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 618 RGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGY 677
RGL Y+HS IIH D+KP N+ ++ + +I DFGL++ E T TR Y
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVATRWY 181
Query: 678 LAPEWLTNSAISEKT-DVYSFGMVLLELVSGR 708
APE + N +T D++S G ++ EL+ G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 47/160 (29%), Positives = 82/160 (51%), Gaps = 26/160 (16%)
Query: 558 AIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILF---GNGPVLEWQERFDIAL 614
+++ + H++L + G C +G + ++V E++ HG LD L G PV W + +A
Sbjct: 68 SLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPV-AW--KITVAQ 124
Query: 615 GTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQA-------KISDFGLS-KLLTPEQSS 666
A L+YL ++ ++H ++ +NILL A K+SD G+S L+ E+
Sbjct: 125 QLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREE-- 179
Query: 667 LFTTMRGTR-GYLAPEWLTN-SAISEKTDVYSFGMVLLEL 704
R R ++APE + +++S D +SFG LLE+
Sbjct: 180 -----RVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 20/203 (9%)
Query: 517 LIGSGGFGAVYKGILNDK-TIVAVKKI--------TNVGVQGKKDFCTEIAIIGNIHHVN 567
L+G G FG VY D +AVK++ T+ V + EI ++ N+ H
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALE---CEIQLLKNLRHDR 65
Query: 568 LVKLKGFCAQGRQRLL--VYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHS 625
+V+ G ++ L EYM GS+ L G + E R +G++YLHS
Sbjct: 66 IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQILQGVSYLHS 124
Query: 626 GCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP--EQSSLFTTMRGTRGYLAPEWL 683
I+H DIK NIL K+ DFG SK + + ++ GT +++PE +
Sbjct: 125 ---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 684 TNSAISEKTDVYSFGMVLLELVS 706
+ K DV+S ++E+++
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 5/90 (5%)
Query: 619 GLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYL 678
G+ +LHS IIH D+KP NI++ KI DFGL++ T S + T TR Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 192
Query: 679 APEWLTNSAISEKTDVYSFGMVLLELVSGR 708
APE + E D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 3e-08
Identities = 55/202 (27%), Positives = 99/202 (49%), Gaps = 12/202 (5%)
Query: 512 DNFKNL--IGSGGFGAVYKGI--LNDKTIVAVKKITNVGVQGKK-DFCTEIAIIGNIHHV 566
D+++ L +G G + VYKG +N K +VA+K I +G E +++ + H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGK-LVALKVIRLQEEEGTPFTAIREASLLKGLKHA 63
Query: 567 NLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSG 626
N+V L LV+EY+ H L + + + L + RGL+Y+H
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH-- 120
Query: 627 CEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNS 686
++ I+H D+KP+N+L+ + K++DFGL++ + S ++ T Y P+ L S
Sbjct: 121 -QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP-SHTYSNEVVTLWYRPPDVLLGS 178
Query: 687 A-ISEKTDVYSFGMVLLELVSG 707
S D++ G + +E++ G
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 618 RGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGY 677
+GL Y+H+ IIH D+KP N+ ++ + KI DFGL++ + S T TR Y
Sbjct: 129 KGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR----QTDSEMTGYVVTRWY 181
Query: 678 LAPEWLTN-SAISEKTDVYSFGMVLLELVSGR 708
APE + N ++ D++S G ++ E+++G+
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 60/203 (29%), Positives = 92/203 (45%), Gaps = 24/203 (11%)
Query: 517 LIGSGGFGAVYKGIL-NDKTIVAVKKIT-NVGVQGKKDFCT--EIAIIGNIH-HVNLVKL 571
++G G FG V L + AVK + +V +Q CT E I+ H L +L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 572 KGFCAQGRQRLL-VYEYMNHGSLDRILFGNGPVLEWQERFD------IALGTARGLAYLH 624
C Q RL V E++N G L +F ++ RFD A L +LH
Sbjct: 62 Y-CCFQTPDRLFFVMEFVNGGDL---MFH----IQKSRRFDEARARFYAAEITSALMFLH 113
Query: 625 SGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT 684
++ II+ D+K +N+LL + K++DFG+ K +T GT Y+APE L
Sbjct: 114 ---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTSTFCGTPDYIAPEILQ 169
Query: 685 NSAISEKTDVYSFGMVLLELVSG 707
D ++ G++L E++ G
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 63/225 (28%), Positives = 105/225 (46%), Gaps = 36/225 (16%)
Query: 512 DNFKNLIGSGGFGAVYKGILNDKTI---VAVKKITNVGV----QGKKDFCTEIAIIGNIH 564
+ K LI +G +GAVY ++ K A+KKI + Q ++ F E I+
Sbjct: 4 ETIK-LISNGAYGAVY--LVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFAE 59
Query: 565 HVNLVKLKGFCA-QGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAY 622
+ +V + FC+ + ++ L +V EY+ G +L G + R A T L Y
Sbjct: 60 NPFVVSM--FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFA-ETVLALEY 116
Query: 623 LHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKL-LTPEQSSLF------------- 668
LH+ I+H D+KP+N+L+ K++DFGLSK+ L ++L+
Sbjct: 117 LHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173
Query: 669 TTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSP 713
+ GT Y+APE + + D ++ G++L E + G C P
Sbjct: 174 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG---CVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 43/135 (31%), Positives = 70/135 (51%), Gaps = 21/135 (15%)
Query: 582 LLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTAR------GLAYLHSGCEQKIIHCD 635
V E++N G L +F ++ + RFD+ T GL +LHS + II+ D
Sbjct: 72 FFVMEFLNGGDL---MFH----IQDKGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRD 121
Query: 636 IKPENILLHYHFQAKISDFGLSK--LLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTD 693
+K +N++L KI+DFG+ K + ++S F GT Y+APE L + D
Sbjct: 122 LKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC---GTPDYIAPEILQGLKYTFSVD 178
Query: 694 VYSFGMVLLELVSGR 708
+SFG++L E++ G+
Sbjct: 179 WWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 1e-07
Identities = 54/218 (24%), Positives = 83/218 (38%), Gaps = 40/218 (18%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEI----- 557
+ E+ LI G FG V V K T K I
Sbjct: 12 FLKNCEIVKK--LKLI-DGKFGKVS---------VLKHKPTQ-----KLFVQKIIKAKNF 54
Query: 558 -AIIGNIHHV-----NLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFD 611
AI +H + N +KL + +L+ +Y+ G L +L G + E + +
Sbjct: 55 NAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKK- 113
Query: 612 IALGTARGLAYLHSGCEQKIIHCDIKPENILLH-YHFQAKISDFGLSKLL-TPEQSSLFT 669
I L LH IIH DIK EN+L + + D+GL K++ TP +
Sbjct: 114 IIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------S 164
Query: 670 TMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSG 707
GT Y +PE + D ++ G++ EL++G
Sbjct: 165 CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 1e-07
Identities = 31/91 (34%), Positives = 47/91 (51%), Gaps = 9/91 (9%)
Query: 618 RGLAYLHSGCEQKIIHCDIKPENILLH-YHFQAKISDFGLSKLLTPEQSSLFTTMRGTRG 676
+ L ++H I H DIKPENIL+ K++DFG + + + +T TR
Sbjct: 111 KSLDHMHR---NGIFHRDIKPENILIKDDIL--KLADFGSCRGIYSKPP--YTEYISTRW 163
Query: 677 YLAPE-WLTNSAISEKTDVYSFGMVLLELVS 706
Y APE LT+ K D+++ G V E++S
Sbjct: 164 YRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 26/209 (12%)
Query: 518 IGSGGFGAVYKGILND---KTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKL-KG 573
+G G +G VYK D A+K+I G+ C EIA++ + H N++ L K
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQKV 66
Query: 574 FCAQG-RQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTAR--------GLAYLH 624
F + R+ L+++Y H I F ++ + G + G+ YLH
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN-KKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 625 SGCEQKIIHCDIKPENILLH----YHFQAKISDFGLSKLLTPEQSSL--FTTMRGTRGYL 678
+ ++H D+KP NIL+ + KI+D G ++L L + T Y
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 679 APEWLTNSA-ISEKTDVYSFGMVLLELVS 706
APE L + ++ D+++ G + EL++
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 24/208 (11%)
Query: 518 IGSGGFGAVYKGILND---KTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKL-KG 573
+G G +G VYK D + A+K+I G+ C EIA++ + H N++ L K
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA--CREIALLRELKHPNVIALQKV 66
Query: 574 FCAQG-RQRLLVYEYMNHGSLDRILF-----GNGPVLEWQERFDIAL--GTARGLAYLHS 625
F + R+ L+++Y H I F N ++ +L G+ YLH+
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 626 GCEQKIIHCDIKPENILLH----YHFQAKISDFGLSKLLTPEQSSL--FTTMRGTRGYLA 679
++H D+KP NIL+ + KI+D G ++L L + T Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 680 PEWLTNSA-ISEKTDVYSFGMVLLELVS 706
PE L + ++ D+++ G + EL++
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 29/208 (13%)
Query: 518 IGSGGFGAVYKGILNDK---------TIVAVKKITNVGVQGKKD----FCTEIAIIGNIH 564
+G G +Y GILN K +K I V +D F +++ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 565 HVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLH 624
H ++V L G C + + ++V E++ G LD + VL +F +A A L+YL
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE 122
Query: 625 SGCEQKIIHCDIKPENILL-------HYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGY 677
++ ++H ++ +NILL K+SD G+ + Q + +
Sbjct: 123 ---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERI-----PW 174
Query: 678 LAPEWLTNSA-ISEKTDVYSFGMVLLEL 704
+APE + +S +S D +SFG L E+
Sbjct: 175 IAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 62/250 (24%), Positives = 99/250 (39%), Gaps = 61/250 (24%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGILNDKT---IVAVKKITNVGVQGKKDFC---TE 556
D+E ++V IG G FG V ++ K I A+KK+ + K+ E
Sbjct: 2 DFESIKV--------IGRGAFGEVR--LVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAE 51
Query: 557 IAIIGNIHHVNLVKLKGFCA-QGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERFDIAL 614
I+ + +VKL + + Q L L+ EY+ G + +L E + RF IA
Sbjct: 52 RDILAEADNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA- 108
Query: 615 GTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSK---------------- 658
T + +H IH DIKP+N+LL K+SDFGL
Sbjct: 109 ETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSH 165
Query: 659 -LLTPEQSSLFTTMR--------------------GTRGYLAPEWLTNSAISEKTDVYSF 697
L + + M GT Y+APE + +++ D +S
Sbjct: 166 ALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSL 225
Query: 698 GMVLLELVSG 707
G+++ E++ G
Sbjct: 226 GVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 48/191 (25%), Positives = 84/191 (43%), Gaps = 15/191 (7%)
Query: 526 VYKGILNDKTIV--AVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRL- 582
+YKGI N+K ++ KK EI + I N++K+ GF L
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 583 ---LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPE 639
L+ EY G L +L L ++ + D+A+ +GL L+ + ++
Sbjct: 96 RLSLILEYCTRGYLREVLD-KEKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSV 152
Query: 640 NILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTN--SAISEKTDVYSF 697
+ L+ +++ KI GL K+L+ M Y + + L + S + K D+YS
Sbjct: 153 SFLVTENYKLKIICHGLEKILSSPPFKNVNFM----VYFSYKMLNDIFSEYTIKDDIYSL 208
Query: 698 GMVLLELVSGR 708
G+VL E+ +G+
Sbjct: 209 GVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 43/135 (31%), Positives = 66/135 (48%), Gaps = 6/135 (4%)
Query: 575 CAQGRQRLL-VYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIH 633
C Q + RL V EY+N G L + + E + RF A T L +LH +I+
Sbjct: 64 CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTL-ALMFLH---RHGVIY 119
Query: 634 CDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTD 693
D+K +NILL K++DFG+ K TT GT Y+APE L D
Sbjct: 120 RDLKLDNILLDAEGHCKLADFGMCKEGILN-GVTTTTFCGTPDYIAPEILQELEYGPSVD 178
Query: 694 VYSFGMVLLELVSGR 708
++ G+++ E+++G+
Sbjct: 179 WWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 4e-07
Identities = 19/82 (23%), Positives = 37/82 (45%), Gaps = 6/82 (7%)
Query: 339 NASVVSYLRLGYGMDYFANHFFQPSTYDVNLSFCQELCSDDCSCLGIFFKNSSGSCYMLG 398
+ S +L+L + N + +L C+E C +CSC + N SG C +
Sbjct: 8 DGSTDGFLKLP-DVKLPDNASAITAI---SLEECREACLSNCSCTAYAYNNGSGGCLLWN 63
Query: 399 NVLGSIMSSNTVDSDLVGYIKV 420
+L ++ S ++ L Y+++
Sbjct: 64 GLLNNLRSLSSGGGTL--YLRL 83
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 42/139 (30%), Positives = 72/139 (51%), Gaps = 14/139 (10%)
Query: 575 CAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERF---DIALGTARGLAYLHSGCEQK 630
C Q RL V E+++ G L + + E RF +I+L L +LH E+
Sbjct: 64 CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNFLH---ERG 116
Query: 631 IIHCDIKPENILLHYHFQAKISDFGLSKL-LTPEQSSLFTTMRGTRGYLAPEWLTNSAIS 689
II+ D+K +N+LL K++D+G+ K + P ++ +T GT Y+APE L
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT--STFCGTPNYIAPEILRGEDYG 174
Query: 690 EKTDVYSFGMVLLELVSGR 708
D ++ G+++ E+++GR
Sbjct: 175 FSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 25/217 (11%)
Query: 506 ELEVATDNFK--NLIGSGGFGAV----YKGILNDKTIVAVKKITNVGVQGKKD---FCTE 556
+L + ++F +IG G FG V +K + K + A+K ++ + + D F E
Sbjct: 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHK---SSKQVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 557 IAIIGNIHHVNLVKLKGFCA-QGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERFDIAL 614
I+ + + +V+L A Q + L +V EYM G L L N + E RF A
Sbjct: 94 RDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTA- 149
Query: 615 GTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGT 674
L +HS IH D+KP+N+LL K++DFG + T GT
Sbjct: 150 EVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGT 206
Query: 675 RGYLAPEWLTNSAIS----EKTDVYSFGMVLLELVSG 707
Y++PE L + + D +S G+ L E++ G
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 34/219 (15%)
Query: 512 DNFKNL--IGSGGFGAVYKGI-LNDKTIVAVKK----ITNVGVQGKKDFCTEIAIIGNIH 564
D ++ L IG G +G VYK N +VA+KK + G+ EI+++ +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLLQMLS 58
Query: 565 HVN-LVKLKGFCAQ------GRQRL-LVYEYMN---HGSLDRILFGNGPVLEWQ--ERFD 611
+V+L + G+ L LV+EY++ +D G G L + + F
Sbjct: 59 ESIYIVRL--LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFM 116
Query: 612 IALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQA-KISDFGLSKLLT-PEQSSLFT 669
L +G+A+ H ++H D+KP+N+L+ KI+D GL + + P +S +T
Sbjct: 117 YQL--LKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS--YT 169
Query: 670 TMRGTRGYLAPEWLTNSA-ISEKTDVYSFGMVLLELVSG 707
T Y APE L S S D++S G + E+
Sbjct: 170 HEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 8e-07
Identities = 61/204 (29%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 517 LIGSGGFGAV----YKGILNDKTIVAVKKITNVGVQGKKD---FCTEIAIIGNIHHVNLV 569
+IG G FG V +K + + A+K ++ + + D F E I+ + +V
Sbjct: 50 VIGRGAFGEVQLVRHKS---SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 106
Query: 570 KLKGFCA-QGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGC 627
+L FCA Q + L +V EYM G L L N V E +F A L +HS
Sbjct: 107 QL--FCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTA-EVVLALDAIHS-- 160
Query: 628 EQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSA 687
+IH D+KP+N+LL H K++DFG + T GT Y++PE L +
Sbjct: 161 -MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 688 ----ISEKTDVYSFGMVLLELVSG 707
+ D +S G+ L E++ G
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 620 LAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS-SLFTTMRGTRGYL 678
L +HS +K++H D+K NI L K+ DFG SK + S + ++ GT YL
Sbjct: 182 LDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYL 238
Query: 679 APEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSM 720
APE S+K D++S G++L EL++ R SQ M
Sbjct: 239 APELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIM 280
|
Length = 478 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 31/89 (34%), Positives = 48/89 (53%), Gaps = 4/89 (4%)
Query: 620 LAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLA 679
L +LH + I++ DIK ENILL ++DFGLSK E+ + GT Y+A
Sbjct: 118 LEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMA 174
Query: 680 PEWL-TNSAISEKTDVYSFGMVLLELVSG 707
PE + + D +S G+++ EL++G
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 50/210 (23%), Positives = 87/210 (41%), Gaps = 34/210 (16%)
Query: 518 IGSGGFGAVYKGILNDKTIVA---VKKI-TNVGVQGKKDFCTEIAIIGNIHHVNLVKLKG 573
IG+G FG V + T VA VK++ N + + +F + + H N+++ G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 574 FCAQGRQRLLVYEYMNHGSLDRIL------FGNGPVLEWQERFDIALGTARGLAYLHSGC 627
C + LLV+EY G L L N +L Q +A A G+ ++H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR---MACEIAAGVTHMH--- 116
Query: 628 EQKIIHCDIKPENILLHYHFQAKISDFGL------SKLLTPEQSSLFTTMRGTRGYLAPE 681
+ +H D+ N L K+ D+G+ + E +R +LAPE
Sbjct: 117 KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLR----WLAPE 171
Query: 682 WLTN-------SAISEKTDVYSFGMVLLEL 704
+ + ++ ++V++ G+ L EL
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 42/162 (25%), Positives = 69/162 (42%), Gaps = 21/162 (12%)
Query: 555 TEIAIIGNIHHVNLVKLKGFCAQG--------RQRLLVYEYMNHGSLDRILFGNGPVLEW 606
TE I+ I+H ++++LKG R + +Y Y+ + N + +
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLA----AK---RNIAICDI 184
Query: 607 QERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666
I R + YLH E +IIH DIK ENI +++ + DFG + ++
Sbjct: 185 ---LAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238
Query: 667 LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGR 708
+ GT APE L D++S G+VL E+ +
Sbjct: 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 4/91 (4%)
Query: 617 ARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT-TMRGTR 675
ARG+ +L S +K IH D+ NILL + KI DFGL++ + + + + R
Sbjct: 184 ARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240
Query: 676 GYLAPEWLTNSAISEKTDVYSFGMVLLELVS 706
++APE + + + ++DV+SFG++L E+ S
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 31/91 (34%), Positives = 52/91 (57%), Gaps = 4/91 (4%)
Query: 617 ARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT-TMRGTR 675
ARG+ +L S +K IH D+ NILL + KI DFGL++ + + + R
Sbjct: 183 ARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239
Query: 676 GYLAPEWLTNSAISEKTDVYSFGMVLLELVS 706
++APE + + + ++DV+SFG++L E+ S
Sbjct: 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 60/221 (27%), Positives = 98/221 (44%), Gaps = 43/221 (19%)
Query: 513 NFKNL--IGSGGFGAVY---------------KGILNDKTIVAVKKITNVGVQGKKDFCT 555
NF+ L +G+G +G V+ +L TIV K T + T
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTT-------EHTRT 53
Query: 556 EIAIIGNIHHVNLVKLKGFCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERF---- 610
E ++ +I + + Q +L L+ +Y+N G L F + L +ERF
Sbjct: 54 ERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGEL----FTH---LSQRERFKEQE 106
Query: 611 -DIALG-TARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668
I G L +LH + II+ DIK ENILL + ++DFGLSK ++
Sbjct: 107 VQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERA 163
Query: 669 TTMRGTRGYLAPEWLT--NSAISEKTDVYSFGMVLLELVSG 707
+ GT Y+AP+ + + + D +S G+++ EL++G
Sbjct: 164 YSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 62/215 (28%), Positives = 93/215 (43%), Gaps = 25/215 (11%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGILNDKT---IVAVKKITNVGVQGKKD---FCTE 556
DYE ++V IG G FG V ++ K+ + A+K ++ + + D F E
Sbjct: 44 DYEVVKV--------IGRGAFGEVQ--LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 557 IAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGT 616
I+ + +V+L R +V EYM G L L N V E RF A
Sbjct: 94 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTA-EV 151
Query: 617 ARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRG 676
L +HS IH D+KP+N+LL K++DFG + E T GT
Sbjct: 152 VLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 208
Query: 677 YLAPEWLTNSA----ISEKTDVYSFGMVLLELVSG 707
Y++PE L + + D +S G+ L E++ G
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 29/91 (31%), Positives = 53/91 (58%), Gaps = 4/91 (4%)
Query: 617 ARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT-TMRGTR 675
A+G+++L S + IH D+ NILL + KI DFGL++ + + + + R
Sbjct: 224 AKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 676 GYLAPEWLTNSAISEKTDVYSFGMVLLELVS 706
++APE + N + ++DV+S+G++L E+ S
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 59/238 (24%), Positives = 91/238 (38%), Gaps = 52/238 (21%)
Query: 518 IGSGGFGAVYKGILND-KTIVAVKKITNVGVQGKKDFC---TEIAIIGNIHHVNLVKLKG 573
IG G FG V D + A+K + V + E I+ + +VKL
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY- 67
Query: 574 FCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKII 632
+ Q + L V +Y+ G + +L G E RF IA T + +H + I
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTC-AIESVH---KMGFI 123
Query: 633 HCDIKPENILLHYHFQAKISDFGL-----------------------------------S 657
H DIKP+NIL+ K++DFGL
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRC 183
Query: 658 KLLTPEQSSLFTTMR-------GTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGR 708
+L E+ R GT Y+APE L + ++ D +S G++L E++ G+
Sbjct: 184 RLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 29/77 (37%), Positives = 40/77 (51%), Gaps = 4/77 (5%)
Query: 583 LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENIL 642
LV EY+ G + +L G E I+ A L YLH IIH D+KP+N+L
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS-EVALALDYLH---RHGIIHRDLKPDNML 136
Query: 643 LHYHFQAKISDFGLSKL 659
+ K++DFGLSK+
Sbjct: 137 ISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 30/91 (32%), Positives = 52/91 (57%), Gaps = 4/91 (4%)
Query: 617 ARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT-TMRGTR 675
A+G+ +L S +K IH D+ NILL + KI DFGL++ + + + R
Sbjct: 189 AKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245
Query: 676 GYLAPEWLTNSAISEKTDVYSFGMVLLELVS 706
++APE + + + ++DV+SFG++L E+ S
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 61/244 (25%), Positives = 103/244 (42%), Gaps = 63/244 (25%)
Query: 505 EELEVATDNFK--NLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEIAIIG 561
E+++V+T FK +L+G G FG V + K AVK + NV + +D EI +
Sbjct: 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFME 180
Query: 562 NIHHVN------LVKLKGFCAQ--GRQRLLVYEY--------MNHGS-----LDRILFGN 600
+ + L+K++ + G +++ +Y M HG L +I+F
Sbjct: 181 KVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQT 240
Query: 601 GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILL-----------HYHF-- 647
G L+ Y H+ E ++H D+KPENIL+ +
Sbjct: 241 GVALD----------------YFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282
Query: 648 ---QAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLEL 704
+ +I D G E+ S T + TR Y +PE + TD++S G ++ EL
Sbjct: 283 DPCRVRICDLGGC---CDERHSR-TAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYEL 338
Query: 705 VSGR 708
+G+
Sbjct: 339 YTGK 342
|
Length = 467 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 60/240 (25%), Positives = 94/240 (39%), Gaps = 52/240 (21%)
Query: 512 DNFKNL--IGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLV 569
D+F++L IG G FG V D + KI +K+ I +I LV
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDI----LV 56
Query: 570 KLKG-------FCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLA 621
+ G + Q ++ L L+ E++ G + +L + E +F IA T +
Sbjct: 57 EADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAID 115
Query: 622 YLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLL--------------TPEQSSL 667
+H + IH DIKP+N+LL K+SDFGL L P
Sbjct: 116 AIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172
Query: 668 FTTMR--------------------GTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSG 707
F M GT Y+APE + ++ D +S G+++ E++ G
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 32/128 (25%), Positives = 60/128 (46%), Gaps = 13/128 (10%)
Query: 585 YEYMNHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILL 643
Y R N P L + + + A G+ +L S + +H D+ N+L+
Sbjct: 216 YLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLI 272
Query: 644 HYHFQAKISDFGLSKLLTPE-----QSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFG 698
KI DFGL++ + + + S F ++ ++APE + N+ + +DV+SFG
Sbjct: 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLK----WMAPESIFNNLYTTLSDVWSFG 328
Query: 699 MVLLELVS 706
++L E+ +
Sbjct: 329 ILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 6e-05
Identities = 35/130 (26%), Positives = 51/130 (39%), Gaps = 20/130 (15%)
Query: 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAK 650
SL IL G L +E + + L L LH K NILL +
Sbjct: 1 VSLADILEVRGRPLNEEEIWAVCLQCLGALRELHRQ---------AKSGNILLT--WDGL 49
Query: 651 ISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRN 710
+ G TPEQS R ++APE + + +EK D+YS G+ L E +
Sbjct: 50 LKLDGSVAFKTPEQS------RPDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYE-- 101
Query: 711 CSPRSQSHSM 720
P ++ +
Sbjct: 102 -LPYNEEREL 110
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 9e-05
Identities = 33/128 (25%), Positives = 63/128 (49%), Gaps = 13/128 (10%)
Query: 585 YEYMNHGSLDRILFGNGPV-LEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILL 643
Y+ N + +L +G L + ARG+ +L S + +H D+ N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLL 270
Query: 644 HYHFQAKISDFGLSKLLTPE-----QSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFG 698
KI DFGL++ + + + S F ++ ++APE + ++ + +DV+S+G
Sbjct: 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVK----WMAPESIFDNLYTTLSDVWSYG 326
Query: 699 MVLLELVS 706
++L E+ S
Sbjct: 327 ILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 30/100 (30%), Positives = 54/100 (54%), Gaps = 8/100 (8%)
Query: 617 ARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR- 675
A+G+ +L S + IH D+ N+LL AKI DFGL++ + S + R
Sbjct: 222 AQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDI--MNDSNYVVKGNARL 276
Query: 676 --GYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSP 713
++APE + + + ++DV+S+G++L E+ S ++ P
Sbjct: 277 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYP 316
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 38/159 (23%), Positives = 64/159 (40%), Gaps = 38/159 (23%)
Query: 583 LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENIL 642
L+ E++ G + +L + E + +F IA T + +H + IH DIKP+N+L
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIH---QLGFIHRDIKPDNLL 133
Query: 643 LHYHFQAKISDFGLSKLLTPEQSSLFT--------------------------------- 669
L K+SDFGL L + F
Sbjct: 134 LDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLA 193
Query: 670 -TMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSG 707
+ GT Y+APE + ++ D +S G+++ E++ G
Sbjct: 194 FSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 53/221 (23%), Positives = 82/221 (37%), Gaps = 34/221 (15%)
Query: 519 GSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFC---TEIAIIGNIHHVNLVKLKGFC 575
+ K + T+VAVKKI N+ K+D EI + H N++
Sbjct: 11 EDLMIVHLAKHKPTN-TLVAVKKI-NLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 576 AQGRQRLLVYEYMNHGSLDRIL---FGNG-PVLEWQERFDIAL---GTARGLAYLHS-GC 627
+ +V M +GS + +L F G P L IA L Y+HS G
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELA------IAFILKDVLNALDYIHSKGF 122
Query: 628 EQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRG------YLAPE 681
IH +K +ILL + +S S + + +L+PE
Sbjct: 123 ----IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE 178
Query: 682 WLTNS--AISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSM 720
L + +EK+D+YS G+ EL +G P +
Sbjct: 179 VLQQNLQGYNEKSDIYSVGITACELANG---HVPFKDMPAT 216
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 51/219 (23%), Positives = 89/219 (40%), Gaps = 44/219 (20%)
Query: 517 LIGSGGFGAVYK------GILNDKTIVAVKKITNVGVQGK---------KDFCTEIAIIG 561
LIG GGFG VY+ +N++ + ++ + N + + D I
Sbjct: 19 LIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIH 78
Query: 562 NIHHVNLVKLKGFCAQGRQRLLVYEYM--------NHGSLDRILFGNGPVLEWQERFDIA 613
NI H+ + K G C ++ + Y ++ RI N +++ +I
Sbjct: 79 NIDHLGIPKYYG-CGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIK-----NIM 132
Query: 614 LGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLL---------TPEQ 664
L Y+H E I H DIKPENI++ + + I D+G++ + EQ
Sbjct: 133 KDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQ 189
Query: 665 SSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLE 703
L RGT Y + + ++ + D+ S G +L+
Sbjct: 190 KDL---HRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 47/179 (26%), Positives = 71/179 (39%), Gaps = 51/179 (28%)
Query: 577 QGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCD 635
Q + L V +Y+ G + +L E RF IA T LA + S + IH D
Sbjct: 71 QDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELT---LA-IESVHKMGFIHRD 126
Query: 636 IKPENILLHYHFQAKISDFGL--------------------------------------- 656
IKP+NIL+ K++DFGL
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186
Query: 657 SKLLTPEQSS-------LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGR 708
+L T EQ + L ++ GT Y+APE L ++ D +S G++L E++ G+
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 24/90 (26%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 623 LHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEW 682
+HS + +H DIKP+N+LL + +++DFG + + + + GT Y++PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 683 LTN-----SAISEKTDVYSFGMVLLELVSG 707
L + D +S G+ + E++ G
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 45/172 (26%), Positives = 67/172 (38%), Gaps = 50/172 (29%)
Query: 583 LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENIL 642
V +Y+ G + +L G E RF IA T + S + IH DIKP+NIL
Sbjct: 78 FVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCA----VESVHKMGFIHRDIKPDNIL 133
Query: 643 LHYHFQAKISDFGL---------SKL-----------------------------LTP-- 662
+ K++DFGL SK L P
Sbjct: 134 IDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLE 193
Query: 663 ------EQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGR 708
Q L ++ GT Y+APE L + ++ D +S G++L E++ G+
Sbjct: 194 RRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 27/83 (32%), Positives = 41/83 (49%), Gaps = 4/83 (4%)
Query: 622 YLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT-TMRGTRGYLAP 680
Y+H + IIH DIK EN+L++ + DFG + S+ F + GT AP
Sbjct: 275 YIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAP 331
Query: 681 EWLTNSAISEKTDVYSFGMVLLE 703
E L + D++S G+V+ E
Sbjct: 332 EVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 31/122 (25%), Positives = 43/122 (35%), Gaps = 46/122 (37%)
Query: 632 IHCDIKPENILLHYHFQAKISDFGLS-------------KLLTPEQSSLFTTMR------ 672
IH DIKP+NIL+ K+SDFGLS KLL + + R
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182
Query: 673 ---------------------------GTRGYLAPEWLTNSAISEKTDVYSFGMVLLELV 705
GT Y+APE ++ D +S G ++ E +
Sbjct: 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECL 242
Query: 706 SG 707
G
Sbjct: 243 IG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 23/81 (28%), Positives = 41/81 (50%), Gaps = 5/81 (6%)
Query: 632 IHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT-----NS 686
+H DIKP+NIL+ + +++DFG L + + + GT Y++PE L
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKG 183
Query: 687 AISEKTDVYSFGMVLLELVSG 707
+ D +S G+ + E++ G
Sbjct: 184 KYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.004
Identities = 30/106 (28%), Positives = 52/106 (49%), Gaps = 11/106 (10%)
Query: 499 PQRFDY-EELEVATDNFK--NLIGSGGFGAVYK----GILNDKTI--VAVKKI-TNVGVQ 548
P + Y E+ E DN + +G+G FG V + G+ + + VAVK + +
Sbjct: 24 PTQLPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTD 83
Query: 549 GKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYEYMNHGSL 593
++ +E+ I+ ++ H N+V L G C G L++ EY +G L
Sbjct: 84 EREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDL 129
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 724 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.98 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.98 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.98 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.98 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.98 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.98 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.98 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.98 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.98 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.98 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.98 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.98 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.98 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.98 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.98 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.98 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.96 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.96 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.96 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.96 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.96 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.96 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.96 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.96 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.96 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.96 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.96 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.96 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.96 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.96 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.96 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.96 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.96 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.95 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.95 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.95 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.95 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.95 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.95 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.95 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.95 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.95 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.95 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.95 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.95 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.95 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.95 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.95 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.95 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.95 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.95 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.95 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.95 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.95 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.95 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.94 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.94 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.94 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.94 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.94 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.94 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.93 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.93 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.92 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.92 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.91 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.91 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.9 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.9 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.9 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.9 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.86 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.86 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.83 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.77 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.77 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.72 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.69 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.67 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.67 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.65 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.62 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.58 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.56 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.55 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.55 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.52 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.5 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.49 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.49 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.41 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.4 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.2 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.19 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.15 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.11 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.11 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.1 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.08 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.07 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 98.99 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.92 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.91 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.78 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 98.77 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.74 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.7 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.62 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.59 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.54 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.51 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.49 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.36 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.34 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.22 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.21 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.11 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.09 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.03 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.02 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.96 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.94 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.94 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.85 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.8 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 97.74 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.67 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.64 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.61 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.52 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 97.47 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 97.35 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.31 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.23 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 97.2 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.1 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.08 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.06 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.04 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.95 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.5 | |
| PLN02236 | 344 | choline kinase | 96.43 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.41 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.38 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.71 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.71 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.56 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.48 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.41 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.37 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.32 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.32 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-45 Score=386.86 Aligned_cols=216 Identities=54% Similarity=0.934 Sum_probs=193.9
Q ss_pred CCCCCChHHHHHhhcccc--ccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceecee
Q 043185 498 LPQRFDYEELEVATDNFK--NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFC 575 (724)
Q Consensus 498 ~~~~~~~~~l~~a~~~~~--~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~ 575 (724)
....|+++++..||.+|+ ++||+|+||.||+|.+.++..||||++.....+..++|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 456799999999999997 699999999999999999999999998765433156699999999999999999999999
Q ss_pred ecCC-eEEEEEEecCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEe
Q 043185 576 AQGR-QRLLVYEYMNHGSLDRILFGNGP-VLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISD 653 (724)
Q Consensus 576 ~~~~-~~~lV~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 653 (724)
.+.+ +++||||||++|+|.++|+.... .++|..|++||.++|+||+|||+.+...||||||||+|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9999 59999999999999999988765 899999999999999999999998888999999999999999999999999
Q ss_pred ecCccccCC-CCccceecc-cccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 654 FGLSKLLTP-EQSSLFTTM-RGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 654 FGla~~~~~-~~~~~~~~~-~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
||+|+.... ... .... .||.+|+|||++.....++|+|||||||+|+||++|+++.+...
T Consensus 221 FGLa~~~~~~~~~--~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~ 282 (361)
T KOG1187|consen 221 FGLAKLGPEGDTS--VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR 282 (361)
T ss_pred ccCcccCCccccc--eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC
Confidence 999966543 221 1222 79999999999999999999999999999999999999987644
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=353.07 Aligned_cols=198 Identities=32% Similarity=0.480 Sum_probs=177.3
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
.+.+.||+|+|++||+|++. ++..||||.+.+. .....+-...|+.+|+.++|||||++++++..++..+||||||.
T Consensus 13 ~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~ 92 (429)
T KOG0595|consen 13 ELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCN 92 (429)
T ss_pred eehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCC
Confidence 34466999999999999985 6789999999765 34455667899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCC------CcEEEEeecCccccCCC
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYH------FQAKISDFGLSKLLTPE 663 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~------~~~kl~DFGla~~~~~~ 663 (724)
+|+|.+|++..+ .+++.....++.|||.||++||+ ++||||||||.||||+.. -.+||+|||+|+.+...
T Consensus 93 gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~ 168 (429)
T KOG0595|consen 93 GGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG 168 (429)
T ss_pred CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence 999999998765 68899999999999999999996 999999999999999764 46899999999988754
Q ss_pred CccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 664 QSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 664 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.. ..+.+|++.|||||++..++|+.|+|+||+|+++|||++|++||+....
T Consensus 169 ~~--a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 169 SM--AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred hH--HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 33 4578999999999999999999999999999999999999999996554
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=347.21 Aligned_cols=198 Identities=39% Similarity=0.633 Sum_probs=176.4
Q ss_pred cccccccccEEEEEEEECCccEEEEEEeecCCccc--HHHHHHHHHHHhcCCCCCccceeceeecCC-eEEEEEEecCCC
Q 043185 515 KNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQG--KKDFCTEIAIIGNIHHVNLVKLKGFCAQGR-QRLLVYEYMNHG 591 (724)
Q Consensus 515 ~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-~~~lV~e~~~~g 591 (724)
.+.||+|+||+||+|.+.+...||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. ...||||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 35699999999999999887779999997643222 568999999999999999999999999988 799999999999
Q ss_pred CHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-eEecCCCCCCeEEeCCC-cEEEEeecCccccCCCCccce
Q 043185 592 SLDRILFG-NGPVLEWQERFDIALGTARGLAYLHSGCEQK-IIHCDIKPENILLHYHF-QAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 592 sL~~~l~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-iiH~Dlkp~NILl~~~~-~~kl~DFGla~~~~~~~~~~~ 668 (724)
+|..++.. ....+++..+++++.|||.||.|||+ .+ ||||||||+||||+.++ ++||+|||+++...... ...
T Consensus 126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~ 201 (362)
T KOG0192|consen 126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TSM 201 (362)
T ss_pred cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-ccc
Confidence 99999988 46789999999999999999999997 66 99999999999999997 99999999998765432 223
Q ss_pred eccccccccccccccc--CCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLT--NSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~--~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
+...||..|||||+++ ...|+.|+|||||||+||||+||+.||.....
T Consensus 202 ~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 202 TSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred cCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence 4468999999999999 56999999999999999999999999987764
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=327.37 Aligned_cols=202 Identities=35% Similarity=0.499 Sum_probs=180.6
Q ss_pred CChHHHHHhhccccccccccccEEEEEEEEC-CccEEEEEEeec-CCcccHHHHHHHHHHHhcCCCCCccceeceeecCC
Q 043185 502 FDYEELEVATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITN-VGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR 579 (724)
Q Consensus 502 ~~~~~l~~a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 579 (724)
.+..+|+.- +.||+|..|+|||++++ +++.+|+|.+.. ......+++.+|++++.+.+||+||.++|.|..+.
T Consensus 76 i~~~dle~~-----~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 76 ISLSDLERL-----GVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG 150 (364)
T ss_pred cCHHHhhhh-----hhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence 555666543 67999999999999986 678899999943 33455688999999999999999999999999988
Q ss_pred -eEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCcc
Q 043185 580 -QRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSK 658 (724)
Q Consensus 580 -~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~ 658 (724)
...|+||||++|+|+.++... ..+++...-+|+.++++||.|||+ ..+||||||||+||||+..|++||||||.++
T Consensus 151 ~~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~ 227 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSG 227 (364)
T ss_pred ceEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccH
Confidence 599999999999999999766 458889999999999999999996 4899999999999999999999999999998
Q ss_pred ccCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 659 LLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 659 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
.+... ...+++||..|||||.+.+..|+.++||||||+.++|++.|+-||.+.
T Consensus 228 ~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 228 ILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred Hhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 77654 346788999999999999999999999999999999999999999875
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=330.21 Aligned_cols=202 Identities=29% Similarity=0.382 Sum_probs=178.3
Q ss_pred ccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 514 FKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 514 ~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
+.++||+|+||+||+++.. .++.+|+|.+++.. ..+.+...+|..+|.+++||+||+++-.|++.+.+|||+||+.
T Consensus 29 ~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~ 108 (357)
T KOG0598|consen 29 ILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLN 108 (357)
T ss_pred eeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccC
Confidence 4589999999999999964 67889999997643 2345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
||.|..+|.+++ .+++..+.-++.+|+.||.|||+ .+||||||||+|||||++|+++|+||||++....... ...
T Consensus 109 GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~-~t~ 183 (357)
T KOG0598|consen 109 GGELFYHLQREG-RFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD-ATR 183 (357)
T ss_pred CccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC-ccc
Confidence 999999998765 56777777788899999999997 9999999999999999999999999999986544332 235
Q ss_pred cccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSM 720 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~~~ 720 (724)
+++||+.|||||++.+..|+..+|.||||+++|||++|.+||.+++....+
T Consensus 184 tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~ 234 (357)
T KOG0598|consen 184 TFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMY 234 (357)
T ss_pred cccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHH
Confidence 689999999999999999999999999999999999999999988765444
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=342.94 Aligned_cols=210 Identities=35% Similarity=0.504 Sum_probs=185.4
Q ss_pred HHHHhhccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEE
Q 043185 506 ELEVATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVY 585 (724)
Q Consensus 506 ~l~~a~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 585 (724)
++.+....+.+.||+|.||+||.|.+++...||+|.++.. ....++|.+|+.+|.+|+|+|||+++|+|..+..++|||
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 4444444566889999999999999999888999999865 344578999999999999999999999999988999999
Q ss_pred EecCCCCHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC
Q 043185 586 EYMNHGSLDRILFG-NGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 586 e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (724)
|||+.|+|.++|.. .+..+...+.+.++.|||+||+||++ +++|||||.++||||+++..+||+|||||+....+.
T Consensus 281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 99999999999986 57789999999999999999999997 999999999999999999999999999999666555
Q ss_pred ccceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCC
Q 043185 665 SSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQSHS 719 (724)
Q Consensus 665 ~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~~~~ 719 (724)
........-...|.|||.+....++.|||||||||+||||+| |+.|+...+-.+.
T Consensus 358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev 413 (468)
T KOG0197|consen 358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV 413 (468)
T ss_pred eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH
Confidence 443344445678999999999999999999999999999999 8999877665443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=342.57 Aligned_cols=205 Identities=30% Similarity=0.441 Sum_probs=185.4
Q ss_pred hhccccccccccccEEEEEEEE-CCccEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNV---GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVY 585 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 585 (724)
.+|...+.||+|||+.||+++. ..++.||+|++.+. .....+...+|+++.+.|+|||||+++++|++.++.|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4566678999999999999997 88999999999763 2445567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc
Q 043185 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 665 (724)
|+|++++|..+++ ....+++.++..+..||+.||.|||+ .+|||||||..|++|+++.++||+|||||..+..+.+
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 9999999999998 45679999999999999999999997 8999999999999999999999999999999886655
Q ss_pred cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCCCC
Q 043185 666 SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHS 719 (724)
Q Consensus 666 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~~ 719 (724)
+. .+.+|||-|+|||++....++..+||||+||+||-||.|++||+.+.-.+.
T Consensus 174 rk-~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket 226 (592)
T KOG0575|consen 174 RK-KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET 226 (592)
T ss_pred cc-ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH
Confidence 43 568999999999999999999999999999999999999999988754443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=327.93 Aligned_cols=205 Identities=33% Similarity=0.429 Sum_probs=175.8
Q ss_pred HHhhccccccccccccEEEEEEEE-CCccEEEEEEeecCCcc-------cHHHHHHHHHHHhcCCCCCccceeceeecCC
Q 043185 508 EVATDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQ-------GKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR 579 (724)
Q Consensus 508 ~~a~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~-------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 579 (724)
....+.+.+.||+|+||.|-+|.- ++++.||||++.+.... ...+..+|+++|++|+|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 445566779999999999999995 57889999999753211 2234579999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCC---CcEEEEeecC
Q 043185 580 QRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYH---FQAKISDFGL 656 (724)
Q Consensus 580 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DFGl 656 (724)
+.|||||||+||+|.+.+-.++ .+.+.....+++|++.|+.|||+ ++|+||||||+|||+..+ ..+||+|||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccch
Confidence 9999999999999999987664 56777778899999999999997 999999999999999766 7799999999
Q ss_pred ccccCCCCccceecccccccccccccccCCc--CC-CccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 043185 657 SKLLTPEQSSLFTTMRGTRGYLAPEWLTNSA--IS-EKTDVYSFGMVLLELVSGRRNCSPRSQSH 718 (724)
Q Consensus 657 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~-~~sDv~SlGv~l~elltG~~p~~~~~~~~ 718 (724)
|+..+. ...+.+.+||+.|.|||++.+.. +. .++|+||+||+||-+++|.+||....+..
T Consensus 326 AK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~ 388 (475)
T KOG0615|consen 326 AKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP 388 (475)
T ss_pred hhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc
Confidence 998763 34467889999999999997664 33 48899999999999999999997776655
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=313.14 Aligned_cols=205 Identities=27% Similarity=0.434 Sum_probs=178.2
Q ss_pred hhccccccccccccEEEEEEE-ECCccEEEEEEeec--CCcccHHHHHHHHHHHhcCCCCCccceec-eeecCCe-EEEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKITN--VGVQGKKDFCTEIAIIGNIHHVNLVKLKG-FCAQGRQ-RLLV 584 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~-~~~~~~vAvK~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g-~~~~~~~-~~lV 584 (724)
+.+.+.++||+|.||+|||+. +.++..+|.|++.- .......+...|+.+|++|+|||||+.++ -+.++.. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 334455889999999999999 46888999999862 33455577899999999999999999999 5566555 8899
Q ss_pred EEecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCC-CeEecCCCCCCeEEeCCCcEEEEeecCcccc
Q 043185 585 YEYMNHGSLDRILFG---NGPVLEWQERFDIALGTARGLAYLHSGCEQ-KIIHCDIKPENILLHYHFQAKISDFGLSKLL 660 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 660 (724)
|||+..|+|...+++ .+..+++..+++++.|++.||..+|+...+ -|+||||||.||+|+.+|.+||+||||++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999998863 467899999999999999999999974333 4899999999999999999999999999998
Q ss_pred CCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 661 TPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 661 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.....- ....+|||.||+||.+.+.+|+.|+||||+||++|||+.-++||.++.
T Consensus 179 ~s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n 232 (375)
T KOG0591|consen 179 SSKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN 232 (375)
T ss_pred cchhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc
Confidence 776543 356789999999999999999999999999999999999999999874
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=329.81 Aligned_cols=202 Identities=31% Similarity=0.437 Sum_probs=183.6
Q ss_pred ccccccccEEEEEEEE-CCccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecC--CeEEEEEEecCC
Q 043185 516 NLIGSGGFGAVYKGIL-NDKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG--RQRLLVYEYMNH 590 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV~e~~~~ 590 (724)
++||+|.||.||||+. .+++.||+|+++-.. ........+|+.||++|+||||++|.+...+. ..+|||+|||+.
T Consensus 123 ~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh 202 (560)
T KOG0600|consen 123 EKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH 202 (560)
T ss_pred HHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc
Confidence 6799999999999994 688999999997543 44456678999999999999999999998876 689999999988
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
+|.-++...+..++..++..++.|++.||+|+|+ ++|+|||||.+|||||.+|.+||+|||||+++.......++.
T Consensus 203 -DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~ 278 (560)
T KOG0600|consen 203 -DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTS 278 (560)
T ss_pred -hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccCCCCccccc
Confidence 8888888888889999999999999999999997 999999999999999999999999999999998877666777
Q ss_pred ccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSMD 721 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~~~~ 721 (724)
.+-|+.|.|||++.+. .|+.++|+||.||||.||+.|++.|+++.+-+.++
T Consensus 279 rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~ 330 (560)
T KOG0600|consen 279 RVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLH 330 (560)
T ss_pred ceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHH
Confidence 8889999999999876 79999999999999999999999999998877665
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=351.41 Aligned_cols=213 Identities=31% Similarity=0.524 Sum_probs=183.2
Q ss_pred HHHHhhccccccccccccEEEEEEEEC------CccEEEEEEeecCCcc-cHHHHHHHHHHHhcCCCCCccceeceeecC
Q 043185 506 ELEVATDNFKNLIGSGGFGAVYKGILN------DKTIVAVKKITNVGVQ-GKKDFCTEIAIIGNIHHVNLVKLKGFCAQG 578 (724)
Q Consensus 506 ~l~~a~~~~~~~lG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 578 (724)
++......+.+.||+|+||+||+|... +...||||.++..... ...+|.+|+++++.++|||||+|+|+|.++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 344444455688999999999999953 3467999999876554 778999999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHhcC---------CC----CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC
Q 043185 579 RQRLLVYEYMNHGSLDRILFGN---------GP----VLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY 645 (724)
Q Consensus 579 ~~~~lV~e~~~~gsL~~~l~~~---------~~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~ 645 (724)
+..+||+|||..|+|.+||... +. .++..+.+.||.|||.||+||.+ +.+|||||..+|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhhceecc
Confidence 9999999999999999999742 12 37889999999999999999997 99999999999999999
Q ss_pred CCcEEEEeecCccccCCCCcccee-cccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 043185 646 HFQAKISDFGLSKLLTPEQSSLFT-TMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQSHSMD 721 (724)
Q Consensus 646 ~~~~kl~DFGla~~~~~~~~~~~~-~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~~~~~~ 721 (724)
+..+||+||||++........... ...-..+|||||.|...+||.+||||||||+|||+++ |+.||.+.+..|.|+
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe 716 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE 716 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHH
Confidence 999999999999977654432222 3335679999999999999999999999999999999 999999887766553
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=312.27 Aligned_cols=194 Identities=36% Similarity=0.565 Sum_probs=166.4
Q ss_pred ccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhc--CCCCCccceeceeecCC----eEEEEEEe
Q 043185 514 FKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGN--IHHVNLVKLKGFCAQGR----QRLLVYEY 587 (724)
Q Consensus 514 ~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~g~~~~~~----~~~lV~e~ 587 (724)
+.++||+|.||.||||.+.+ +.||||++. .++.+.|++|-+|... ++|+||+++++.-..+. +++||+||
T Consensus 214 l~eli~~Grfg~V~KaqL~~-~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLDN-RLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred hHHHhhcCccceeehhhccC-ceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 45789999999999999977 679999997 4556778888887664 58999999999877665 88999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcC------CCCCeEecCCCCCCeEEeCCCcEEEEeecCccccC
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSG------CEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 661 (724)
.+.|+|.++|..+ .++|....+|+..+++||+|||++ ++..|+|||||++||||.+|+++.|+|||+|..+.
T Consensus 290 h~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~ 367 (534)
T KOG3653|consen 290 HPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLE 367 (534)
T ss_pred ccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEec
Confidence 9999999999876 799999999999999999999983 45679999999999999999999999999999887
Q ss_pred CCCc-cceecccccccccccccccCCc-CC-----CccchhhHHHHHHHHHhCCCCCCC
Q 043185 662 PEQS-SLFTTMRGTRGYLAPEWLTNSA-IS-----EKTDVYSFGMVLLELVSGRRNCSP 713 (724)
Q Consensus 662 ~~~~-~~~~~~~gt~~y~aPE~l~~~~-~~-----~~sDv~SlGv~l~elltG~~p~~~ 713 (724)
.... ......+||.+|||||++++.. +. .+.||||+|.+||||++.-+-+++
T Consensus 368 p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~ 426 (534)
T KOG3653|consen 368 PGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP 426 (534)
T ss_pred CCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC
Confidence 5543 2234478999999999998863 22 368999999999999998766654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=300.40 Aligned_cols=199 Identities=30% Similarity=0.409 Sum_probs=174.2
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecCCc--ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCC
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV--QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGS 592 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gs 592 (724)
.++|+|+||.|||++.+ +|+.||||++..... .-.+-.++|+++|++++|+|+|.++.+|.....++||+||++..-
T Consensus 8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTv 87 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTV 87 (396)
T ss_pred hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHH
Confidence 46999999999999975 689999999965432 223557899999999999999999999999999999999999855
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceeccc
Q 043185 593 LDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMR 672 (724)
Q Consensus 593 L~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 672 (724)
|.+ |.......+.+...+++.|++.|+.|+|+ +++|||||||+||||+.++.+||||||+|+.+... ....+.++
T Consensus 88 L~e-Le~~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-gd~YTDYV 162 (396)
T KOG0593|consen 88 LHE-LERYPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP-GDNYTDYV 162 (396)
T ss_pred HHH-HHhccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCC-cchhhhhh
Confidence 544 44444567888999999999999999997 89999999999999999999999999999988753 23357788
Q ss_pred ccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCCCCCC
Q 043185 673 GTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHS 719 (724)
Q Consensus 673 gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~~ 719 (724)
.|+.|+|||.+.+ .+|...+||||+||++.||++|.+-|.++++-+.
T Consensus 163 ATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQ 210 (396)
T KOG0593|consen 163 ATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQ 210 (396)
T ss_pred hhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHH
Confidence 9999999999987 6899999999999999999999999999887654
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=292.49 Aligned_cols=202 Identities=29% Similarity=0.394 Sum_probs=179.8
Q ss_pred ccccccccccEEEEEEEE-CCccEEEEEEeecCCc--ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 514 FKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGV--QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 514 ~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
-.+.||+|.||.||+|+. .+++.||||+++.... .-.....+|++.|+.++|+||+.+++++...+...||+|||+.
T Consensus 6 ~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t 85 (318)
T KOG0659|consen 6 KLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT 85 (318)
T ss_pred hhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc
Confidence 347899999999999995 5788999999975422 2235678999999999999999999999999999999999976
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
+|+..++.....++......++.++++|++|||+ +.|+||||||.|+|++++|.+||+|||+|+.+....... +.
T Consensus 86 -dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~-~~ 160 (318)
T KOG0659|consen 86 -DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ-TH 160 (318)
T ss_pred -cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCccc-cc
Confidence 9999999988899999999999999999999997 999999999999999999999999999999987665433 33
Q ss_pred ccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSM 720 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~~~ 720 (724)
.+-|+.|.|||.+.+. .|+..+|+||.||++.||+-|.+-|.++++-+++
T Consensus 161 ~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL 211 (318)
T KOG0659|consen 161 QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQL 211 (318)
T ss_pred ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHH
Confidence 3789999999999876 6999999999999999999999999998876654
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=339.47 Aligned_cols=205 Identities=31% Similarity=0.569 Sum_probs=181.0
Q ss_pred cccccccccccEEEEEEEEC----CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 513 NFKNLIGSGGFGAVYKGILN----DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
.++++||.|.||+|++|+++ ....||||.++... ...+.+|+.|+.||.+.+||||++|.|+.......+||.||
T Consensus 632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEy 711 (996)
T KOG0196|consen 632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEY 711 (996)
T ss_pred EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhh
Confidence 34678999999999999975 23579999998643 34567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
|++|+|+.||+.+...+++.++..++++||.||.||.+ .++|||||.++|||++.+..+|++||||++.+..+....
T Consensus 712 MENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ 788 (996)
T KOG0196|consen 712 MENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 788 (996)
T ss_pred hhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccceeecccCCCcc
Confidence 99999999999988889999999999999999999996 999999999999999999999999999999887765443
Q ss_pred eecccc--cccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCC
Q 043185 668 FTTMRG--TRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQSHSM 720 (724)
Q Consensus 668 ~~~~~g--t~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~~~~~ 720 (724)
.+...| ..+|.|||.|.-.+++.++|||||||+|||.++ |.+||..-+-.+.+
T Consensus 789 ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI 844 (996)
T KOG0196|consen 789 YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI 844 (996)
T ss_pred ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH
Confidence 343333 468999999999999999999999999999998 99999666555444
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=321.36 Aligned_cols=205 Identities=27% Similarity=0.392 Sum_probs=179.5
Q ss_pred ccccccccccccEEEEEEEE-CCccEEEEEEeecC---CcccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNV---GVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
+.|.+.||+|+|++|++|+- ..++.+|||++.+. .....+....|-.+|.+| .||.|++|+-.|+++..+|+|+|
T Consensus 75 F~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe 154 (604)
T KOG0592|consen 75 FKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLE 154 (604)
T ss_pred cchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEE
Confidence 45678999999999999995 57788999999652 123335567888999999 89999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
|+++|+|.++|.+.+ .+++.....++.+|+.||+|||+ ++||||||||+|||||.|+++||.|||.|+.+.+.+..
T Consensus 155 ~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 155 YAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred ecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence 999999999998774 57888888899999999999997 99999999999999999999999999999988643221
Q ss_pred ----------c--eecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC
Q 043185 667 ----------L--FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSM 720 (724)
Q Consensus 667 ----------~--~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~~~ 720 (724)
. ...++||..|++||++.+...++.+|+|+|||+||+|+.|++||.+..+..++
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliF 296 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIF 296 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHH
Confidence 1 13478999999999999999999999999999999999999999988776544
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=296.26 Aligned_cols=196 Identities=28% Similarity=0.371 Sum_probs=175.9
Q ss_pred cccccccccEEEEEEEEC-CccEEEEEEeecCCcc---cHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 515 KNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQ---GKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 515 ~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
.+.||.|+||.|.+++.+ ++..+|+|++++.... ..+...+|.++|+.+.||+++++.+.+.+.+.++|||||.+|
T Consensus 49 ~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~G 128 (355)
T KOG0616|consen 49 LKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPG 128 (355)
T ss_pred eeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCC
Confidence 478999999999999975 6788999999764333 334567899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
|.|..+|++.+ .+++..+.-+|.||+.||+|||+ .+|++|||||+|||||.+|.+||.|||+|+..... .-+
T Consensus 129 GElFS~Lrk~~-rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r----T~T 200 (355)
T KOG0616|consen 129 GELFSYLRKSG-RFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR----TWT 200 (355)
T ss_pred ccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecCc----EEE
Confidence 99999998764 57778888899999999999997 99999999999999999999999999999876543 356
Q ss_pred ccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSH 718 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~ 718 (724)
.+||+.|+|||.+..++|..++|.|||||++|||+.|.+||....+..
T Consensus 201 lCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~ 248 (355)
T KOG0616|consen 201 LCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ 248 (355)
T ss_pred ecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH
Confidence 799999999999999999999999999999999999999998776543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=318.35 Aligned_cols=197 Identities=34% Similarity=0.528 Sum_probs=176.8
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
.+.+.||+|.||.||||+.+ +.+.||+|.+.+.. ..+.+...+|++++++++|||||.++..|+...++++|.||+.
T Consensus 5 hv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~ 84 (808)
T KOG0597|consen 5 HVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAV 84 (808)
T ss_pred hHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhh
Confidence 34578999999999999975 66889999997643 3345678999999999999999999999999999999999998
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
+ +|..+|...+ .+.++.+..|+.++..||.|||+ .+|+|||+||.|||++..+.+|+||||+|+.+.... ...+
T Consensus 85 g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t-~vlt 158 (808)
T KOG0597|consen 85 G-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT-SVLT 158 (808)
T ss_pred h-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccCc-eeee
Confidence 8 9999997664 58889999999999999999997 999999999999999999999999999999876643 3456
Q ss_pred cccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
...||+.|||||++++.+|+..+|+||+||++||+++|++||..++
T Consensus 159 sikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s 204 (808)
T KOG0597|consen 159 SIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS 204 (808)
T ss_pred eccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH
Confidence 7889999999999999999999999999999999999999997654
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=321.05 Aligned_cols=208 Identities=30% Similarity=0.475 Sum_probs=177.1
Q ss_pred HHHHhhccccccccccccEEEEEEEECCccEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEE
Q 043185 506 ELEVATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLL 583 (724)
Q Consensus 506 ~l~~a~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 583 (724)
++......+.+.||+|.||+||+|.+.+ .||||+++.. ..+..+.|+.|+..+++-+|.||+-+.|+|..... .|
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI 464 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI 464 (678)
T ss_pred ccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence 3333333446889999999999999865 3999999643 34566889999999999999999999999998877 99
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCC
Q 043185 584 VYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE 663 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (724)
|..+++|-+|..+|+.....++..+.+.|+.||++||.|||. ++|||||||..||+|.+++.+||+||||+.....-
T Consensus 465 iTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW 541 (678)
T ss_pred eehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeeeeee
Confidence 999999999999998877789999999999999999999997 99999999999999999999999999999754332
Q ss_pred -CccceecccccccccccccccCC---cCCCccchhhHHHHHHHHHhCCCCCCCCCCCCC
Q 043185 664 -QSSLFTTMRGTRGYLAPEWLTNS---AISEKTDVYSFGMVLLELVSGRRNCSPRSQSHS 719 (724)
Q Consensus 664 -~~~~~~~~~gt~~y~aPE~l~~~---~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~~ 719 (724)
.........|...|||||+++.+ +|++++||||||+++|||++|..||.....+.|
T Consensus 542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI 601 (678)
T KOG0193|consen 542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI 601 (678)
T ss_pred ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe
Confidence 11223445688999999999754 799999999999999999999999985554444
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=314.34 Aligned_cols=197 Identities=31% Similarity=0.470 Sum_probs=179.3
Q ss_pred ccccccccEEEEEEEE-CCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCCHH
Q 043185 516 NLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLD 594 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gsL~ 594 (724)
++||+|+.|.||.++. .+++.||||++.......++-+.+|+.+|+..+|+|||+++..+..++.+|.|||||++|+|.
T Consensus 279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLT 358 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLT 358 (550)
T ss_pred hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchh
Confidence 6799999999999995 567889999998765666677899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceeccccc
Q 043185 595 RILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGT 674 (724)
Q Consensus 595 ~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt 674 (724)
+++.+. .+++.+...|..++++||+|||. ++|||||||.+|||++.+|.+||+|||++..+...+.. ...++||
T Consensus 359 DvVt~~--~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K-R~TmVGT 432 (550)
T KOG0578|consen 359 DVVTKT--RMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK-RSTMVGT 432 (550)
T ss_pred hhhhcc--cccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccCc-cccccCC
Confidence 999665 58899999999999999999997 99999999999999999999999999999888766543 4678999
Q ss_pred ccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 043185 675 RGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSH 718 (724)
Q Consensus 675 ~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~ 718 (724)
+.|||||++....|++|+||||||++++||+.|.+||-.+.+-.
T Consensus 433 PYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr 476 (550)
T KOG0578|consen 433 PYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR 476 (550)
T ss_pred CCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH
Confidence 99999999999999999999999999999999999997765443
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=312.23 Aligned_cols=214 Identities=28% Similarity=0.408 Sum_probs=184.4
Q ss_pred hHHHHHhhccccccccccccEEEEEEEECCccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEE
Q 043185 504 YEELEVATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRL 582 (724)
Q Consensus 504 ~~~l~~a~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 582 (724)
.+|+.+....|.++||+|-||+|.++...+...||||+++... ....++|.+|+++|.+++|||||+++|+|..++.++
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 4456666667789999999999999999998999999998643 345589999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccC
Q 043185 583 LVYEYMNHGSLDRILFGNGPV-LEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 583 lV~e~~~~gsL~~~l~~~~~~-l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 661 (724)
+|+|||++|+|..++.++..+ +.-....+|+.||+.||+||.+ .++|||||.++|+|++.++++||+|||+++.+.
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccc
Confidence 999999999999999876333 3566778899999999999997 999999999999999999999999999999765
Q ss_pred CCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh--CCCCCCCCCCCCCC
Q 043185 662 PEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS--GRRNCSPRSQSHSM 720 (724)
Q Consensus 662 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt--G~~p~~~~~~~~~~ 720 (724)
.... +.....+-..+|||||.+...+++.++|||+||++|||+++ ..+||......+++
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv 750 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV 750 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH
Confidence 5443 22233455789999999999999999999999999999876 68899766655443
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=343.15 Aligned_cols=211 Identities=30% Similarity=0.486 Sum_probs=182.0
Q ss_pred HHHhhccccccccccccEEEEEEEECC--c----cEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeceeecCC
Q 043185 507 LEVATDNFKNLIGSGGFGAVYKGILND--K----TIVAVKKITNV-GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR 579 (724)
Q Consensus 507 l~~a~~~~~~~lG~G~fG~Vy~~~~~~--~----~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 579 (724)
+....-.+.+.||+|+||.||.|.+.+ + ..||||.+++. +.++..+|++|..+|++++|||||+++|+|.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 334444566789999999999999753 2 24899999764 4566789999999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEe
Q 043185 580 QRLLVYEYMNHGSLDRILFGN------GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISD 653 (724)
Q Consensus 580 ~~~lV~e~~~~gsL~~~l~~~------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 653 (724)
..+|++|||++|+|..+|++. ...++...++.++.|||+|+.||++ +++|||||.++|+||++...+||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcc
Confidence 999999999999999999987 6678999999999999999999997 9999999999999999999999999
Q ss_pred ecCccccCCCCccceecc-cccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCC
Q 043185 654 FGLSKLLTPEQSSLFTTM-RGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQSHSM 720 (724)
Q Consensus 654 FGla~~~~~~~~~~~~~~-~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~~~~~ 720 (724)
||+|+.+........... .-..+|||||.+++..|+.|+|||||||+|||++| |..||...+..+++
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~ 914 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL 914 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH
Confidence 999996654443222222 23568999999999999999999999999999999 99999888766554
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=310.03 Aligned_cols=204 Identities=27% Similarity=0.413 Sum_probs=180.7
Q ss_pred hhccccccccccccEEEEEEEE-CCccEEEEEEeecCCcccHHHH--HHHHHHHhcCC-CCCccceeceeecCC-eEEEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQGKKDF--CTEIAIIGNIH-HVNLVKLKGFCAQGR-QRLLV 584 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~--~~E~~~l~~l~-H~nIv~l~g~~~~~~-~~~lV 584 (724)
.+|...++||.|.||.||+|+- ..+..||||++++. ....++. ++|+..|++|+ |||||++..++.+.+ .+++|
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~K-f~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKK-FYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhh-hccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 3455568899999999999995 57788999999865 2334443 68999999998 999999999998888 99999
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC
Q 043185 585 YEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (724)
||||+. +|..+++.....+++..+..|+.||++||+|+|. +|+.|||+||+|||+.....+||+|||+||......
T Consensus 89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp 164 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVRSKP 164 (538)
T ss_pred HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccccCC
Confidence 999976 9999999888999999999999999999999996 999999999999999988899999999999886654
Q ss_pred ccceeccccccccccccccc-CCcCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC
Q 043185 665 SSLFTTMRGTRGYLAPEWLT-NSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSM 720 (724)
Q Consensus 665 ~~~~~~~~gt~~y~aPE~l~-~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~~~ 720 (724)
. .+.++.|+.|+|||++. ...|+.+.|+|++|||++|+.+-++-|.+.++-+++
T Consensus 165 P--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi 219 (538)
T KOG0661|consen 165 P--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQI 219 (538)
T ss_pred C--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHH
Confidence 3 57788999999999875 567899999999999999999999999998876654
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=319.00 Aligned_cols=206 Identities=27% Similarity=0.351 Sum_probs=180.5
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
..|.++||+|+||+|+++.++ +++.+|||.+++.. ..+.+....|-+++... +||.+++++.+++..+++|+|||
T Consensus 370 F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvme 449 (694)
T KOG0694|consen 370 FRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVME 449 (694)
T ss_pred eEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEE
Confidence 445689999999999999986 56789999998743 45567788888888777 59999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
|+.||++..+. +...+++..+.-++..|+.||+|||+ ++||+||||.+|||||.+|++||+|||+++..... ..
T Consensus 450 y~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~-g~ 523 (694)
T KOG0694|consen 450 YVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ-GD 523 (694)
T ss_pred ecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccCCC-CC
Confidence 99999943333 33568888888999999999999996 99999999999999999999999999999865322 23
Q ss_pred ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSMDSN 723 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~~~~~~ 723 (724)
...+++||+.|||||++.+..|+..+|.|||||+|||||.|+.||.++++.+.++++
T Consensus 524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI 580 (694)
T KOG0694|consen 524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI 580 (694)
T ss_pred ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 457899999999999999999999999999999999999999999999998887754
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=311.10 Aligned_cols=190 Identities=37% Similarity=0.571 Sum_probs=169.3
Q ss_pred ccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCCHHH
Q 043185 516 NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDR 595 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gsL~~ 595 (724)
+-||.|+.|.||+|++.+. .||||+++... ..+++.|++|+|+||+.+.|+|.....++||||||..|.|..
T Consensus 130 eWlGSGaQGAVF~Grl~ne-tVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~ 201 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRLHNE-TVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE 201 (904)
T ss_pred hhhccCcccceeeeeccCc-eehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence 5699999999999999775 49999986321 257889999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceecccccc
Q 043185 596 ILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR 675 (724)
Q Consensus 596 ~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~ 675 (724)
+|+.. ..+.......+..+||.||.|||. +.|||||||+-||||..+..+||+|||-++..... .....+.||.
T Consensus 202 VLka~-~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaGTV 275 (904)
T KOG4721|consen 202 VLKAG-RPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAGTV 275 (904)
T ss_pred HHhcc-CccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhhhH
Confidence 99766 457778889999999999999997 99999999999999999999999999999877654 2335678999
Q ss_pred cccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCCCC
Q 043185 676 GYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHS 719 (724)
Q Consensus 676 ~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~~ 719 (724)
.|||||+|++.+.++|+|||||||+|||||||..||..-+...|
T Consensus 276 aWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI 319 (904)
T KOG4721|consen 276 AWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI 319 (904)
T ss_pred hhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee
Confidence 99999999999999999999999999999999999966655544
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=302.03 Aligned_cols=198 Identities=32% Similarity=0.509 Sum_probs=170.2
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCC--eEEEEEEecC
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR--QRLLVYEYMN 589 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--~~~lV~e~~~ 589 (724)
...+.||+|+||.||++... ++...|||.+........+.+.+|+.+|.+++|||||+.+|...... .+++.|||++
T Consensus 20 ~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~ 99 (313)
T KOG0198|consen 20 SKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAP 99 (313)
T ss_pred hhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccC
Confidence 34578999999999999975 47889999987653333567899999999999999999999855444 6889999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC-CCcEEEEeecCccccCC--CCcc
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY-HFQAKISDFGLSKLLTP--EQSS 666 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFGla~~~~~--~~~~ 666 (724)
+|+|.+++...+..+++..+.++..||++||+|||+ ++||||||||+||||+. ++.+||+|||+++.... ....
T Consensus 100 ~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~ 176 (313)
T KOG0198|consen 100 GGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSD 176 (313)
T ss_pred CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccccccccc
Confidence 999999998876578999999999999999999997 99999999999999999 79999999999987763 2222
Q ss_pred ceecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSP 713 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~ 713 (724)
......||+.|||||++... ....++|||||||++.||+||++||..
T Consensus 177 ~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 177 SELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred ccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 23457899999999999963 334599999999999999999999976
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=306.31 Aligned_cols=200 Identities=25% Similarity=0.330 Sum_probs=172.8
Q ss_pred cccccccccEEEEEEEE-CCccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 515 KNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 515 ~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
.+.||+|+||.||+++- ++|..+|+|++++.. ..+.+..+.|-.+|...++|.||+|+-.|++.+++||||||++|
T Consensus 146 Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPG 225 (550)
T KOG0605|consen 146 LKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPG 225 (550)
T ss_pred heeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCC
Confidence 37899999999999995 578999999998743 33446678999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCC-------
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE------- 663 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~------- 663 (724)
|++..+|...+ .+++.....++.+++-|+.-||. .++|||||||+|+|||..|++||+||||+.-+...
T Consensus 226 GD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~ 301 (550)
T KOG0605|consen 226 GDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYR 301 (550)
T ss_pred ccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhc
Confidence 99999997764 57778888888899999999996 99999999999999999999999999998533110
Q ss_pred ---------------Cccc------------------------eecccccccccccccccCCcCCCccchhhHHHHHHHH
Q 043185 664 ---------------QSSL------------------------FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLEL 704 (724)
Q Consensus 664 ---------------~~~~------------------------~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~el 704 (724)
.... ....+|||.|||||++.+..|+...|.||||||||||
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEm 381 (550)
T KOG0605|consen 302 LDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEM 381 (550)
T ss_pred chhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHH
Confidence 0000 0114699999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCC
Q 043185 705 VSGRRNCSPRSQSH 718 (724)
Q Consensus 705 ltG~~p~~~~~~~~ 718 (724)
|.|-+||.++.+.+
T Consensus 382 LvGyPPF~s~tp~~ 395 (550)
T KOG0605|consen 382 LVGYPPFCSETPQE 395 (550)
T ss_pred HhCCCCCCCCCHHH
Confidence 99999999887654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=309.36 Aligned_cols=202 Identities=31% Similarity=0.429 Sum_probs=176.0
Q ss_pred HhhccccccccccccEEEEEEEEC-CccEEEEEEeecC----Cc-ccHHHHHHHHHHHhcCC-CCCccceeceeecCCeE
Q 043185 509 VATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV----GV-QGKKDFCTEIAIIGNIH-HVNLVKLKGFCAQGRQR 581 (724)
Q Consensus 509 ~a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~ 581 (724)
...+.+.+.||+|+||+|++|... +++.||+|.+.+. .. ...+.+.+|+.++++++ ||||++++.++......
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 345667789999999999999864 6789999976553 11 23456678999999998 99999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCC-CcEEEEeecCcccc
Q 043185 582 LLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYH-FQAKISDFGLSKLL 660 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFGla~~~ 660 (724)
++||||+.+|+|.+++.. ...+.+.....++.|++.|++|||+ ++|+||||||+|||++.+ +++||+|||++...
T Consensus 96 ~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred EEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 999999999999999988 4567789999999999999999997 999999999999999999 99999999999877
Q ss_pred CCCCccceecccccccccccccccCCc-CC-CccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 661 TPEQSSLFTTMRGTRGYLAPEWLTNSA-IS-EKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 661 ~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~-~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
. .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+...
T Consensus 172 ~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~ 227 (370)
T KOG0583|consen 172 P-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN 227 (370)
T ss_pred C-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence 4 2223346789999999999999987 85 78999999999999999999998743
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=286.03 Aligned_cols=202 Identities=29% Similarity=0.383 Sum_probs=175.6
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecCCc-cc-HHHHHHHHHHHhcCCCCCccceeceeec--CCeEEEEEEecCC
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV-QG-KKDFCTEIAIIGNIHHVNLVKLKGFCAQ--GRQRLLVYEYMNH 590 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~-~~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV~e~~~~ 590 (724)
+.|++|.||.||+|+.+ +.+.||+|+++.... .+ .-.-++|+.+|.+++|||||.+..+..- -+..||||||++.
T Consensus 82 nrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh 161 (419)
T KOG0663|consen 82 NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH 161 (419)
T ss_pred hhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh
Confidence 67999999999999964 678899999975321 11 1235899999999999999999987754 3579999999988
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
+|..++..-...+...+..-+..|++.|++|||. +.|+|||||++|+|+...|.+||+|||+|+.++... ..++.
T Consensus 162 -DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~-k~~T~ 236 (419)
T KOG0663|consen 162 -DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL-KPYTP 236 (419)
T ss_pred -hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCCc-ccCcc
Confidence 8999998777788899999999999999999996 999999999999999999999999999999987653 33566
Q ss_pred ccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSMDS 722 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~~~~~ 722 (724)
.+-|..|.|||.+.+. .|+...|+||+|||+.||+++++-|.+.++-++++.
T Consensus 237 lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~ 289 (419)
T KOG0663|consen 237 LVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDK 289 (419)
T ss_pred eEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHH
Confidence 7789999999999876 699999999999999999999999999988777653
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=291.77 Aligned_cols=201 Identities=28% Similarity=0.355 Sum_probs=174.4
Q ss_pred hccccccccccccEEEEEEEE-CCccEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 511 TDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNV-GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
.|++.+.||.|..++||+|+. +.++.||||++.-. .......+.+|+..|..++||||++.+..|..++.+|+||.||
T Consensus 27 ~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfM 106 (516)
T KOG0582|consen 27 DYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFM 106 (516)
T ss_pred ceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhh
Confidence 455678999999999999995 56789999999632 2334688999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc-
Q 043185 589 NHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS- 666 (724)
Q Consensus 589 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~- 666 (724)
.+|++.++++.. ...+++..+..|.+++++||.|||. ++.||||||+.||||+.+|.+||+|||.+-.+.....+
T Consensus 107 a~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~ 183 (516)
T KOG0582|consen 107 AGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ 183 (516)
T ss_pred cCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence 999999999865 3458888999999999999999996 99999999999999999999999999987766443322
Q ss_pred --ceecccccccccccccccC--CcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 667 --LFTTMRGTRGYLAPEWLTN--SAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 667 --~~~~~~gt~~y~aPE~l~~--~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
.+....||+.|||||++.. ..|+.|+|||||||+..||.+|+.||..-
T Consensus 184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~ 235 (516)
T KOG0582|consen 184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKY 235 (516)
T ss_pred eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccC
Confidence 1245689999999999754 36999999999999999999999999543
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=312.10 Aligned_cols=205 Identities=34% Similarity=0.455 Sum_probs=175.4
Q ss_pred HHhhccccccccccccEEEEEEEECC--c--cE-EEEEEeec---CCcccHHHHHHHHHHHhcCCCCCccceeceeecCC
Q 043185 508 EVATDNFKNLIGSGGFGAVYKGILND--K--TI-VAVKKITN---VGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR 579 (724)
Q Consensus 508 ~~a~~~~~~~lG~G~fG~Vy~~~~~~--~--~~-vAvK~~~~---~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 579 (724)
....-.+.++||+|+||.||+|++.. + .. ||||..+. ......++|++|+++|++++|||||+++|++....
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 33333445899999999999999753 2 23 89999874 33566789999999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccc
Q 043185 580 QRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKL 659 (724)
Q Consensus 580 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 659 (724)
.++||||+|.||+|.++|.+....++..++++++.+.|.||+|||+ +++|||||.++|+|++.++.+||+|||+++.
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccC
Confidence 9999999999999999999887789999999999999999999997 9999999999999999999999999999875
Q ss_pred cCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 043185 660 LTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQ 716 (724)
Q Consensus 660 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~ 716 (724)
-..-.... ....-..+|+|||.+....|++++|||||||++||+.+ |..||.+...
T Consensus 312 ~~~~~~~~-~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~ 368 (474)
T KOG0194|consen 312 GSQYVMKK-FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN 368 (474)
T ss_pred Ccceeecc-ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH
Confidence 43111110 01134679999999999999999999999999999999 8889987653
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=295.57 Aligned_cols=197 Identities=33% Similarity=0.450 Sum_probs=166.4
Q ss_pred cccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCC-----eEEEEEEec
Q 043185 515 KNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR-----QRLLVYEYM 588 (724)
Q Consensus 515 ~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~lV~e~~ 588 (724)
.+++|.|+||.||+|++. .++.||||+..... +.--+|+.+|++++|||||+|+-++.... ...||||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 378999999999999975 56889999985432 23347999999999999999999886432 335899999
Q ss_pred CCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCC-CcEEEEeecCccccCCCC
Q 043185 589 NHGSLDRILFGN---GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYH-FQAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 589 ~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFGla~~~~~~~ 664 (724)
+. +|..++++. +..++...+.-+..||.+||+|||+ .+|+||||||.|+|+|.+ |.+||||||.|+.+...+
T Consensus 105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 87 888888742 4556666677789999999999997 999999999999999987 899999999999887665
Q ss_pred ccceecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCC
Q 043185 665 SSLFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSMD 721 (724)
Q Consensus 665 ~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~~~~ 721 (724)
.. ....-|+.|+|||.+.+. .|+.+.||||.||++.||+-|++-|.+++..+++.
T Consensus 181 pn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~ 236 (364)
T KOG0658|consen 181 PN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLV 236 (364)
T ss_pred Cc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHH
Confidence 43 455678999999999886 79999999999999999999999999988766554
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=275.84 Aligned_cols=200 Identities=30% Similarity=0.424 Sum_probs=177.0
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
++.+.||+|-||.||+|+.+ ++-.||+|++.+.. .+-.+++.+|+++-.+|+||||+++++++.+....||++||.
T Consensus 25 eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya 104 (281)
T KOG0580|consen 25 EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYA 104 (281)
T ss_pred cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEec
Confidence 34688999999999999975 66789999997643 233467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 589 NHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 589 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
+.|.|...|++. ...+++.....++.|+|.||.|+|. +++|||||||+|+|++.++.+||+|||-+..-. ...
T Consensus 105 ~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---~~k 178 (281)
T KOG0580|consen 105 PRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SNK 178 (281)
T ss_pred CCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC---CCC
Confidence 999999999843 4568888889999999999999996 999999999999999999999999999986543 223
Q ss_pred eecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSH 718 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~ 718 (724)
..+.+||..|.+||+.++..++..+|+|++|++.||++.|.+||...+..+
T Consensus 179 R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e 229 (281)
T KOG0580|consen 179 RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE 229 (281)
T ss_pred ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH
Confidence 467889999999999999999999999999999999999999998776544
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=287.86 Aligned_cols=202 Identities=25% Similarity=0.415 Sum_probs=181.3
Q ss_pred hhccccccccccccEEEEEEEE-CCccEEEEEEeecCCcccHH---HHHHHHHHHhcCCCCCccceeceeecCCeEEEEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQGKK---DFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVY 585 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~---~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 585 (724)
-++.|.+.||+|.||+|-++.- ..++.||||.+++....+.. .+.+|++||..|+||||+.++.+|...+...|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 3456668899999999999984 78899999999775444443 4689999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc
Q 043185 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 665 (724)
||..+|.|.+|+.+.+ .+++.+...++.||..|+.|+|. ++++|||||.+|||||.++++||+||||+..+.....
T Consensus 133 EYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf 208 (668)
T KOG0611|consen 133 EYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF 208 (668)
T ss_pred EecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhccccH
Confidence 9999999999997764 68889999999999999999995 9999999999999999999999999999988765543
Q ss_pred cceecccccccccccccccCCcC-CCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 666 SLFTTMRGTRGYLAPEWLTNSAI-SEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 666 ~~~~~~~gt~~y~aPE~l~~~~~-~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
..+++|++.|.+||.+.+.+| .+.+|-|||||+||-|+.|.-||++.+..
T Consensus 209 --LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk 259 (668)
T KOG0611|consen 209 --LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK 259 (668)
T ss_pred --HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH
Confidence 467899999999999999988 68999999999999999999999998754
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=286.26 Aligned_cols=200 Identities=28% Similarity=0.400 Sum_probs=173.3
Q ss_pred ccccccccEEEEEEEE-CCccEEEEEEeecCCc--ccHHHHHHHHHHHhcCCCCC-ccceeceeecCC------eEEEEE
Q 043185 516 NLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGV--QGKKDFCTEIAIIGNIHHVN-LVKLKGFCAQGR------QRLLVY 585 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~n-Iv~l~g~~~~~~------~~~lV~ 585 (724)
++||+|+||+||+|+. .+++.||+|++.-... .......+|+.++++++|+| ||++++++...+ ..+||+
T Consensus 17 eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvf 96 (323)
T KOG0594|consen 17 EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVF 96 (323)
T ss_pred HHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEE
Confidence 5699999999999995 4778999999975432 23355689999999999999 999999998877 788999
Q ss_pred EecCCCCHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCC
Q 043185 586 EYMNHGSLDRILFGNG---PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP 662 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (724)
||++. +|..++.... ..++......++.||+.||+|||+ ++|+||||||.||||+++|.+||+|||+|+...-
T Consensus 97 e~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~i 172 (323)
T KOG0594|consen 97 EFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLARAFSI 172 (323)
T ss_pred Eeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchHHHhcC
Confidence 99976 9999997654 357778889999999999999997 9999999999999999999999999999997653
Q ss_pred CCccceecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC
Q 043185 663 EQSSLFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSM 720 (724)
Q Consensus 663 ~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~~~ 720 (724)
.. ...+..++|..|.|||++.+. .|+...||||+||++.||+++++-|.+.++.+.+
T Consensus 173 p~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql 230 (323)
T KOG0594|consen 173 PM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQL 230 (323)
T ss_pred Cc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHH
Confidence 32 224667899999999999887 7999999999999999999999999988775443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=303.44 Aligned_cols=198 Identities=29% Similarity=0.446 Sum_probs=175.1
Q ss_pred hccccccccccccEEEEEEEE-CCccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
.+.+++.||+|+-|.|.+|++ .+|+.+|||++.+.. ......+.+|+.+|+-+.|||++++++++.+..++|||+|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 345678899999999999997 588999999997642 2223557899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
|+++|.|.+++..+++ +.+.+..+++.||+.|+.|+|. .+|+||||||+|+|||..+++||+|||+|.+-..+ .
T Consensus 93 yv~gGELFdylv~kG~-l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g--k 166 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKGP-LPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG--K 166 (786)
T ss_pred ecCCchhHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCC--c
Confidence 9999999999987764 6668888999999999999997 99999999999999999999999999999865443 3
Q ss_pred ceecccccccccccccccCCcC-CCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAI-SEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~-~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
...+.+|+++|.+||++++.+| ..++||||.|||||.||+|+.||+.+
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd 215 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD 215 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc
Confidence 3567799999999999999988 57899999999999999999999854
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=292.95 Aligned_cols=199 Identities=27% Similarity=0.389 Sum_probs=172.5
Q ss_pred cccccccccccEEEEEEEE-CCccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 513 NFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
...+.||+|+||.||++.. .+++.||+|++.... ......+.+|+.++.+++|+||+++++++.+++..++|+||+
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05631 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIM 82 (285)
T ss_pred eEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEec
Confidence 4457899999999999996 478899999986432 223346789999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 589 NHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 589 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
++|+|..++... ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.++|+|||++........
T Consensus 83 ~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 157 (285)
T cd05631 83 NGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-- 157 (285)
T ss_pred CCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe--
Confidence 999998887643 3468899999999999999999997 8999999999999999999999999999986543221
Q ss_pred eecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 206 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCc
Confidence 2345689999999999999999999999999999999999999987553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=306.61 Aligned_cols=201 Identities=24% Similarity=0.329 Sum_probs=172.5
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
.+.+.||+|+||+||++... +++.+|+|++.+.. ......+.+|+.++.+++|+||+++++.+.+....+|||||+
T Consensus 4 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~ 83 (363)
T cd05628 4 ESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFL 83 (363)
T ss_pred eEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCC
Confidence 34578999999999999865 57889999997532 223356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc---
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS--- 665 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~--- 665 (724)
++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 84 ~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 159 (363)
T cd05628 84 PGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 159 (363)
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence 999999999765 468889999999999999999997 9999999999999999999999999999875432110
Q ss_pred -------------------------------cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 666 -------------------------------SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 666 -------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0012346999999999999999999999999999999999999999776
Q ss_pred CCC
Q 043185 715 SQS 717 (724)
Q Consensus 715 ~~~ 717 (724)
...
T Consensus 240 ~~~ 242 (363)
T cd05628 240 TPQ 242 (363)
T ss_pred CHH
Confidence 543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=298.74 Aligned_cols=195 Identities=28% Similarity=0.332 Sum_probs=169.8
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCC
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHG 591 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~g 591 (724)
+.||+|+||.||+++.. +++.+|+|+++... ......+.+|++++++++||||+++++++..++..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999974 67889999997532 233456788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceecc
Q 043185 592 SLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTM 671 (724)
Q Consensus 592 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 671 (724)
+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~ 155 (323)
T cd05571 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF 155 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccce
Confidence 999988765 467889999999999999999997 899999999999999999999999999987542221 112345
Q ss_pred cccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 672 RGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 672 ~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 199 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC
Confidence 69999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=301.64 Aligned_cols=198 Identities=27% Similarity=0.356 Sum_probs=173.1
Q ss_pred hccccccccccccEEEEEEEECC--ccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILND--KTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVY 585 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 585 (724)
.+.+.+.||+|+||.||+|+... +..||+|++.... ....+.+.+|++++..++||||+++++++.++...++||
T Consensus 31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 110 (340)
T PTZ00426 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL 110 (340)
T ss_pred hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEE
Confidence 45567899999999999998643 3579999986421 233456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc
Q 043185 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 665 (724)
||+++|+|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 111 Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~- 185 (340)
T PTZ00426 111 EFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT- 185 (340)
T ss_pred eCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc-
Confidence 9999999999997653 58889999999999999999997 899999999999999999999999999998664322
Q ss_pred cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 666 SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 666 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 186 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 233 (340)
T PTZ00426 186 ---YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233 (340)
T ss_pred ---ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH
Confidence 345789999999999998899999999999999999999999976654
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=295.60 Aligned_cols=197 Identities=25% Similarity=0.347 Sum_probs=173.0
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
+.+.+.||+|+||.||++... +++.+|+|++.... ....+.+.+|++++++++||||+++++++.++...++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 345688999999999999975 67889999986432 23345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
+++++|.+++...+ .+++.....++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~--- 155 (291)
T cd05612 83 VPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT--- 155 (291)
T ss_pred CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc---
Confidence 99999999987653 57888899999999999999997 899999999999999999999999999998664322
Q ss_pred eecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
....|++.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 156 -~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~ 203 (291)
T cd05612 156 -WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP 203 (291)
T ss_pred -ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 234689999999999999999999999999999999999999977654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=305.87 Aligned_cols=200 Identities=23% Similarity=0.306 Sum_probs=170.6
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
.+.+.||+|+||+||+|+.. +++.+|+|++.... ....+.+.+|+.++.+++|+||+++++++.+....++||||+
T Consensus 4 ~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~ 83 (381)
T cd05626 4 VKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI 83 (381)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecC
Confidence 44578999999999999964 67889999997532 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc---
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS--- 665 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~--- 665 (724)
++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 84 ~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 84 PGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 9999999987653 57788888899999999999997 8999999999999999999999999999764321000
Q ss_pred -------------------------------------------cceecccccccccccccccCCcCCCccchhhHHHHHH
Q 043185 666 -------------------------------------------SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLL 702 (724)
Q Consensus 666 -------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ 702 (724)
.......||+.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~ 239 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHH
Confidence 0012346999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCC
Q 043185 703 ELVSGRRNCSPRSQ 716 (724)
Q Consensus 703 elltG~~p~~~~~~ 716 (724)
||++|+.||.....
T Consensus 240 elltG~~Pf~~~~~ 253 (381)
T cd05626 240 EMLVGQPPFLAPTP 253 (381)
T ss_pred HHHhCCCCCcCCCH
Confidence 99999999976553
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=296.12 Aligned_cols=195 Identities=29% Similarity=0.350 Sum_probs=169.5
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCC
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNV---GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHG 591 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~g 591 (724)
+.||+|+||.||+++.. ++..||+|+++.. .......+.+|++++++++||||+++++++......++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999964 6788999999753 1233456788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceecc
Q 043185 592 SLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTM 671 (724)
Q Consensus 592 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 671 (724)
+|..++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... .....
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~ 155 (323)
T cd05595 81 ELFFHLSRE-RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTF 155 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-ccccc
Confidence 999888655 357889999999999999999997 8999999999999999999999999999875432221 12345
Q ss_pred cccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 672 RGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 672 ~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.|++.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 199 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC
Confidence 68999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=303.38 Aligned_cols=200 Identities=25% Similarity=0.317 Sum_probs=171.5
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV---GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
.+.+.+.||+|+||.||+++.. +++.+|+|.+.+. .....+.+.+|+.+++.++||||+++++++.++...++|||
T Consensus 44 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E 123 (370)
T cd05621 44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVME 123 (370)
T ss_pred HCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEc
Confidence 3455688999999999999975 5778999998642 12234567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
|+++|+|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.........
T Consensus 124 y~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~ 198 (370)
T cd05621 124 YMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198 (370)
T ss_pred CCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence 99999999998654 47788889999999999999997 89999999999999999999999999999876543322
Q ss_pred ceecccccccccccccccCCc----CCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSA----ISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~----~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
......||+.|+|||++.+.. ++.++|+||||+++|||++|+.||....
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~ 251 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 251 (370)
T ss_pred ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence 223557999999999997643 7889999999999999999999997654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=297.66 Aligned_cols=198 Identities=24% Similarity=0.344 Sum_probs=173.7
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
.+.+.+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.+++..++|||
T Consensus 19 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 98 (329)
T PTZ00263 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE 98 (329)
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEc
Confidence 3456689999999999999975 57889999986531 2334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
|+++++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 99 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 172 (329)
T PTZ00263 99 FVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-- 172 (329)
T ss_pred CCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--
Confidence 999999999987653 57788888899999999999997 899999999999999999999999999998664332
Q ss_pred ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
....|++.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 173 --~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 220 (329)
T PTZ00263 173 --FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP 220 (329)
T ss_pred --ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH
Confidence 235689999999999999999999999999999999999999976543
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=295.97 Aligned_cols=196 Identities=29% Similarity=0.354 Sum_probs=170.5
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCC
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNV---GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHG 591 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~g 591 (724)
+.||+|+||.||+++.. +++.+|+|++.+. ......++.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999964 6788999999753 2234467889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceecc
Q 043185 592 SLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTM 671 (724)
Q Consensus 592 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 671 (724)
+|..++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 155 (328)
T cd05593 81 ELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTF 155 (328)
T ss_pred CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccccc
Confidence 999888654 468889999999999999999997 899999999999999999999999999987543222 122345
Q ss_pred cccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 672 RGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 672 ~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~ 200 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH
Confidence 699999999999999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=294.43 Aligned_cols=193 Identities=27% Similarity=0.371 Sum_probs=169.0
Q ss_pred ccccccEEEEEEEEC-CccEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCCH
Q 043185 518 IGSGGFGAVYKGILN-DKTIVAVKKITNV---GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSL 593 (724)
Q Consensus 518 lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gsL 593 (724)
||+|+||.||+++.. +++.||+|++... .......+.+|+.++.+++||||+++++++.+....++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999975 5778999998642 233446788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceecccc
Q 043185 594 DRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRG 673 (724)
Q Consensus 594 ~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~g 673 (724)
.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....... ......|
T Consensus 81 ~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~g 155 (312)
T cd05585 81 FHHLQRE-GRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTFCG 155 (312)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccccccC
Confidence 9998765 357889999999999999999997 8999999999999999999999999999975433222 2234579
Q ss_pred cccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 674 TRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 674 t~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
|+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~ 197 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN 197 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC
Confidence 999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=299.84 Aligned_cols=203 Identities=28% Similarity=0.446 Sum_probs=167.7
Q ss_pred hhccccccccccccEEEEEEEE------CCccEEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeceeecCC-e
Q 043185 510 ATDNFKNLIGSGGFGAVYKGIL------NDKTIVAVKKITNVG-VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGR-Q 580 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~-~ 580 (724)
..+.+.+.||+|+||.||+|.. ..+..||||++.... ....+.+.+|+.++.++ +||||+++++++.... .
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP 86 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence 3455678999999999999974 234579999987532 23346789999999999 8999999999887644 5
Q ss_pred EEEEEEecCCCCHHHHHhcCC-----------------------------------------------------------
Q 043185 581 RLLVYEYMNHGSLDRILFGNG----------------------------------------------------------- 601 (724)
Q Consensus 581 ~~lV~e~~~~gsL~~~l~~~~----------------------------------------------------------- 601 (724)
.++||||+++|+|.+++....
T Consensus 87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (338)
T cd05102 87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL 166 (338)
T ss_pred eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence 789999999999999986431
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc-ceeccccccccc
Q 043185 602 --PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS-LFTTMRGTRGYL 678 (724)
Q Consensus 602 --~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~ 678 (724)
..+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++........ ......++..|+
T Consensus 167 ~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 167 WKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 236778889999999999999997 89999999999999999999999999999865433221 112334567899
Q ss_pred ccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 679 APEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 679 aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
|||++.+..++.++||||||++||||++ |+.||....
T Consensus 244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~ 281 (338)
T cd05102 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 281 (338)
T ss_pred CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999999999997 999997644
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=304.60 Aligned_cols=200 Identities=23% Similarity=0.306 Sum_probs=170.1
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
.+.++||+|+||.||+|+.. +++.+|+|++.... ....+.+.+|++++++++|+||+++++.+.++...++||||+
T Consensus 4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (382)
T cd05625 4 VKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYI 83 (382)
T ss_pred EEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCC
Confidence 34578999999999999964 67889999986532 233457889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC----
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ---- 664 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~---- 664 (724)
++|+|.+++... ..+++.....++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++..+....
T Consensus 84 ~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 84 PGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 999999998765 357788888899999999999997 899999999999999999999999999975332100
Q ss_pred ------------------------------------------ccceecccccccccccccccCCcCCCccchhhHHHHHH
Q 043185 665 ------------------------------------------SSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLL 702 (724)
Q Consensus 665 ------------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ 702 (724)
........||+.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHH
Confidence 00012346899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCC
Q 043185 703 ELVSGRRNCSPRSQ 716 (724)
Q Consensus 703 elltG~~p~~~~~~ 716 (724)
||++|++||.....
T Consensus 240 elltG~~Pf~~~~~ 253 (382)
T cd05625 240 EMLVGQPPFLAQTP 253 (382)
T ss_pred HHHhCCCCCCCCCH
Confidence 99999999976543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=296.06 Aligned_cols=201 Identities=22% Similarity=0.263 Sum_probs=172.9
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV---GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
+.+.+.||+|+||.||+++.. +++.+|+|++.+. .....+.+.+|+.++..++|+||+++++++.++...++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence 445688999999999999975 5788999998642 123345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
+++|+|.+++......+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++..+.......
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (331)
T cd05597 83 YVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ 159 (331)
T ss_pred CCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence 99999999997656678899999999999999999997 999999999999999999999999999987664433222
Q ss_pred eecccccccccccccccC-----CcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTN-----SAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~-----~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||....
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~ 212 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence 233468999999999863 457889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=297.39 Aligned_cols=197 Identities=27% Similarity=0.348 Sum_probs=173.5
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
+.+.+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|++++..++||||+++++++.++...+|||||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 445688999999999999976 57889999997532 23446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
+++++|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.... .
T Consensus 83 ~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~ 154 (333)
T cd05600 83 VPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----Y 154 (333)
T ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc----c
Confidence 9999999999654 357888999999999999999997 8999999999999999999999999999976543 1
Q ss_pred eecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~ 203 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH
Confidence 2345689999999999999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=301.79 Aligned_cols=200 Identities=26% Similarity=0.346 Sum_probs=171.9
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
.+.+.||+|+||.||+++.. +++.||||++.... ......+.+|+.++..++||||+++++++.++...++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (364)
T cd05599 4 ESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYL 83 (364)
T ss_pred eEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCC
Confidence 44588999999999999975 67889999997531 233456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc--
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS-- 666 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-- 666 (724)
++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.++|+|||++..+......
T Consensus 84 ~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (364)
T cd05599 84 PGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159 (364)
T ss_pred CCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence 9999999987653 58889999999999999999997 89999999999999999999999999998754321100
Q ss_pred -----------------------------------ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCC
Q 043185 667 -----------------------------------LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNC 711 (724)
Q Consensus 667 -----------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~ 711 (724)
......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCC
Confidence 011235899999999999999999999999999999999999999
Q ss_pred CCCCC
Q 043185 712 SPRSQ 716 (724)
Q Consensus 712 ~~~~~ 716 (724)
.....
T Consensus 240 ~~~~~ 244 (364)
T cd05599 240 CSDNP 244 (364)
T ss_pred CCCCH
Confidence 76543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=300.50 Aligned_cols=201 Identities=24% Similarity=0.308 Sum_probs=171.6
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
.+.+.+.||+|+||.||+++.. +++.+|+|++.+.. ....+.+.+|+.+++.++||||+++++++.++...++|||
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 123 (370)
T cd05596 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVME 123 (370)
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEc
Confidence 4455688999999999999975 67889999986421 2334557889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
|+++|+|.+++... .++...+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.........
T Consensus 124 y~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~ 198 (370)
T cd05596 124 YMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198 (370)
T ss_pred CCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence 99999999998654 47778888899999999999997 89999999999999999999999999999876543322
Q ss_pred ceecccccccccccccccCC----cCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNS----AISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~----~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 252 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH
Confidence 22345799999999998654 478999999999999999999999977653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=302.80 Aligned_cols=200 Identities=23% Similarity=0.302 Sum_probs=170.4
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
.+.+.||+|+||.||++... +++.||||++.+.. ....+.+.+|++++.+++||||+++++++.+....+|||||+
T Consensus 4 ~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 83 (377)
T cd05629 4 HTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFL 83 (377)
T ss_pred eEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCC
Confidence 45578999999999999864 67889999986432 233466888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc---
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS--- 665 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~--- 665 (724)
++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 84 ~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 159 (377)
T cd05629 84 PGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159 (377)
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 999999998754 457888888999999999999997 8999999999999999999999999999864321100
Q ss_pred ---------c----------------------------------ceecccccccccccccccCCcCCCccchhhHHHHHH
Q 043185 666 ---------S----------------------------------LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLL 702 (724)
Q Consensus 666 ---------~----------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ 702 (724)
. ......||+.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (377)
T cd05629 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF 239 (377)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhh
Confidence 0 001246899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCC
Q 043185 703 ELVSGRRNCSPRSQ 716 (724)
Q Consensus 703 elltG~~p~~~~~~ 716 (724)
||++|+.||.....
T Consensus 240 elltG~~Pf~~~~~ 253 (377)
T cd05629 240 ECLIGWPPFCSENS 253 (377)
T ss_pred hhhcCCCCCCCCCH
Confidence 99999999976654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=306.69 Aligned_cols=202 Identities=27% Similarity=0.462 Sum_probs=176.9
Q ss_pred cccccccccEEEEEEEE-CCc----cEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 515 KNLIGSGGFGAVYKGIL-NDK----TIVAVKKITNV-GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 515 ~~~lG~G~fG~Vy~~~~-~~~----~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
.++||.|+||+||||.+ +.+ -+||+|++... ..+...++++|+.+|.+++|||++||+|+|.... +.||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 37899999999999995 443 36899988653 3455688999999999999999999999998865 88999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc-
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL- 667 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~- 667 (724)
+.|+|.++++.++..+..+..+.+..|||+||.|||. ++++||||.++||||.+-..+||.|||+++.+..+....
T Consensus 780 P~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~ 856 (1177)
T KOG1025|consen 780 PLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYS 856 (1177)
T ss_pred ccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCccccccc
Confidence 9999999999988889999999999999999999995 999999999999999999999999999999887665432
Q ss_pred eecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQSHSM 720 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~~~~~ 720 (724)
.....-.+.|||-|.+....|+.++|||||||++||++| |..|+++....+|-
T Consensus 857 ~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~ 910 (1177)
T KOG1025|consen 857 APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP 910 (1177)
T ss_pred ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh
Confidence 122234668999999999999999999999999999999 99999988766653
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=296.52 Aligned_cols=201 Identities=22% Similarity=0.271 Sum_probs=173.1
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV---GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
+.+.+.||+|+||.||+++.. +++.+|+|.+.+. .......+.+|..++..++|+||+++++++.+++..++||||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey 82 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY 82 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 445688999999999999975 5678999998642 122334578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
+++|+|..++......+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.........
T Consensus 83 ~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 159 (331)
T cd05624 83 YVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ 159 (331)
T ss_pred CCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence 99999999998755678889999999999999999997 999999999999999999999999999998765443322
Q ss_pred eecccccccccccccccC-----CcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTN-----SAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~-----~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.....|++.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 212 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence 234569999999999875 467889999999999999999999997654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=299.76 Aligned_cols=202 Identities=25% Similarity=0.297 Sum_probs=172.3
Q ss_pred hhccccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVY 585 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 585 (724)
..+.+.+.||+|+||.||+++.. +++.+|+|.+.+.. ....+.+.+|+.+++.++||||+++++.+.++...++||
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 34555689999999999999975 67789999986421 223455788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc
Q 043185 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 665 (724)
||+++|+|.+++... .++...+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 123 Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~ 197 (371)
T cd05622 123 EYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 197 (371)
T ss_pred cCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence 999999999998654 47788888899999999999997 9999999999999999999999999999987654333
Q ss_pred cceecccccccccccccccCC----cCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 666 SLFTTMRGTRGYLAPEWLTNS----AISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 666 ~~~~~~~gt~~y~aPE~l~~~----~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.......||+.|+|||++... .++.++|||||||++|||++|+.||...+.
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 252 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH
Confidence 222356799999999999754 378999999999999999999999987653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=279.78 Aligned_cols=189 Identities=30% Similarity=0.472 Sum_probs=157.7
Q ss_pred ccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcC--CCCCccceeceeecCC----eEEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNI--HHVNLVKLKGFCAQGR----QRLLVY 585 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l--~H~nIv~l~g~~~~~~----~~~lV~ 585 (724)
-.+.+.||+|.||+||+|.+.++. ||||++.. .+++.+.+|.++.+.+ +|+||+.+++.-..++ +++||.
T Consensus 213 I~L~e~IGkGRyGEVwrG~wrGe~-VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvT 288 (513)
T KOG2052|consen 213 IVLQEIIGKGRFGEVWRGRWRGED-VAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVT 288 (513)
T ss_pred eEEEEEecCccccceeeccccCCc-eEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEee
Confidence 345689999999999999998754 99999974 3456778888888765 9999999999765543 789999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcC-----CCCCeEecCCCCCCeEEeCCCcEEEEeecCcccc
Q 043185 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSG-----CEQKIIHCDIKPENILLHYHFQAKISDFGLSKLL 660 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 660 (724)
+|.|.|+|.+||.. ..++.+..++++..+|.||++||-+ -+..|.|||||++|||+..++.+.|+|+|||...
T Consensus 289 dYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h 366 (513)
T KOG2052|consen 289 DYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 366 (513)
T ss_pred ecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEe
Confidence 99999999999976 4789999999999999999999962 3466999999999999999999999999999876
Q ss_pred CCCCc---cceecccccccccccccccCCc----C--CCccchhhHHHHHHHHHh
Q 043185 661 TPEQS---SLFTTMRGTRGYLAPEWLTNSA----I--SEKTDVYSFGMVLLELVS 706 (724)
Q Consensus 661 ~~~~~---~~~~~~~gt~~y~aPE~l~~~~----~--~~~sDv~SlGv~l~ellt 706 (724)
..... ......+||.+|||||++.... + -..+||||||+++||++.
T Consensus 367 ~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 367 DSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred cccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 54421 2234567999999999996642 2 136999999999999875
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=292.81 Aligned_cols=195 Identities=28% Similarity=0.403 Sum_probs=168.1
Q ss_pred ccccccccEEEEEEEE----CCccEEEEEEeecCC----cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 516 NLIGSGGFGAVYKGIL----NDKTIVAVKKITNVG----VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
+.||+|+||.||+++. ..++.+|+|.++... ......+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 356789999987521 22335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
+++++|.+++...+ .+.+..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 156 (323)
T cd05584 82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-V 156 (323)
T ss_pred CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-c
Confidence 99999999987653 56778888899999999999997 8999999999999999999999999999875432221 1
Q ss_pred eecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.....|++.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~ 204 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence 234568999999999999899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=295.04 Aligned_cols=201 Identities=22% Similarity=0.279 Sum_probs=172.1
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV---GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
+.+.++||+|+||.||+++.. +++.+|+|.+.+. .......+.+|+.++..++|+||+++++++.+....++||||
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 345688999999999999976 4677999998642 122334578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
+++|+|.+++.+....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++..........
T Consensus 83 ~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~ 159 (332)
T cd05623 83 YVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 159 (332)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence 99999999998755678889999999999999999997 999999999999999999999999999997654333322
Q ss_pred eeccccccccccccccc-----CCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLT-----NSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~-----~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||...+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~ 212 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence 23456999999999986 3468899999999999999999999997654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=302.72 Aligned_cols=201 Identities=23% Similarity=0.299 Sum_probs=170.8
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
+.+.+.||+|+||.||+++.. +++.+|+|++.+.. ....+.+.+|++++.+++|+||+++++.+.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 445688999999999999964 57889999986421 22345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC---
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ--- 664 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~--- 664 (724)
+++|+|.+++... ..+++.....++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++..+....
T Consensus 83 ~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 83 IPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 9999999999765 357888888899999999999997 899999999999999999999999999975331000
Q ss_pred ---------------------------------------ccceecccccccccccccccCCcCCCccchhhHHHHHHHHH
Q 043185 665 ---------------------------------------SSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELV 705 (724)
Q Consensus 665 ---------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ell 705 (724)
........||+.|+|||++.+..++.++|||||||++|||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 00011346899999999999999999999999999999999
Q ss_pred hCCCCCCCCCC
Q 043185 706 SGRRNCSPRSQ 716 (724)
Q Consensus 706 tG~~p~~~~~~ 716 (724)
+|+.||.....
T Consensus 239 ~G~~Pf~~~~~ 249 (376)
T cd05598 239 VGQPPFLADTP 249 (376)
T ss_pred hCCCCCCCCCH
Confidence 99999977654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=286.98 Aligned_cols=205 Identities=26% Similarity=0.415 Sum_probs=173.1
Q ss_pred HhhccccccccccccEEEEEEEEC----CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEE
Q 043185 509 VATDNFKNLIGSGGFGAVYKGILN----DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLL 583 (724)
Q Consensus 509 ~a~~~~~~~lG~G~fG~Vy~~~~~----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 583 (724)
...+.+.+.||+|+||.||+|++. .+..||+|.++... ....+.+.+|+.++.+++||||+++++++..+...++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 345667789999999999999863 35689999987542 2334678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCC
Q 043185 584 VYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE 663 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (724)
||||+++|+|.+++......+++..++.++.|++.||+|||+ .+++||||||+|||++.++.++++|||.+......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 999999999999998766678999999999999999999996 89999999999999999999999999987654322
Q ss_pred CccceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 043185 664 QSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQ 716 (724)
Q Consensus 664 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~ 716 (724)
.........++..|+|||.+.+..++.++||||||+++||+++ |+.||.....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~ 214 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG 214 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 2111112335678999999999999999999999999999875 9999976543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=290.20 Aligned_cols=196 Identities=34% Similarity=0.484 Sum_probs=175.4
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCCH
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNV-GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSL 593 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gsL 593 (724)
+.||+|.||.||||... .++.||+|.+.-. ...+.++..+|+.++.+++++||.+.+|.+..+..++++||||.+|++
T Consensus 19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv 98 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV 98 (467)
T ss_pred hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence 68999999999999964 6788999999643 345568899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceecccc
Q 043185 594 DRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRG 673 (724)
Q Consensus 594 ~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~g 673 (724)
.+.|.... .+.+....-|..++..||.|||+ .+.+|||||+.|||+.++|.+|++|||.+..+....... .+++|
T Consensus 99 ~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~tfvG 173 (467)
T KOG0201|consen 99 LDLLKSGN-ILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-KTFVG 173 (467)
T ss_pred hhhhccCC-CCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhcc-ccccc
Confidence 99996553 44667777788999999999997 899999999999999999999999999998877655443 67899
Q ss_pred cccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 674 TRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 674 t~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
|+.|||||++....|+.|+||||||++.+||++|.+|+...++
T Consensus 174 TPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP 216 (467)
T KOG0201|consen 174 TPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP 216 (467)
T ss_pred cccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc
Confidence 9999999999988999999999999999999999999966554
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=294.18 Aligned_cols=197 Identities=28% Similarity=0.337 Sum_probs=169.8
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCC
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHG 591 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~g 591 (724)
+.||+|+||.||+++.. +++.+|+|.++... .....++.+|++++..++||||+++++++......++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999964 67889999997531 233456788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceecc
Q 043185 592 SLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTM 671 (724)
Q Consensus 592 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 671 (724)
+|..++... ..+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++.+||+|||+++....... .....
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~ 156 (325)
T cd05594 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKTF 156 (325)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccccc
Confidence 999888654 468899999999999999999995 36999999999999999999999999999875432221 12345
Q ss_pred cccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 672 RGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 672 ~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~ 201 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 201 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH
Confidence 699999999999999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=288.70 Aligned_cols=200 Identities=26% Similarity=0.424 Sum_probs=171.1
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
+.+.+.||+|+||.||+|... +++.||+|+++... ......+.+|++++++++||||+++++++..+...++||||++
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD 86 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence 455688999999999999975 67889999986432 2334567899999999999999999999999999999999998
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
+ +|.+++......+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 87 ~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~~~ 161 (288)
T cd07871 87 S-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-TYS 161 (288)
T ss_pred c-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-ccc
Confidence 5 8998887766678889999999999999999997 8999999999999999999999999999976543221 123
Q ss_pred cccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
...+++.|+|||.+.+ ..++.++||||||+++|||++|++||.+...
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~ 209 (288)
T cd07871 162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV 209 (288)
T ss_pred CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 4467899999999865 5689999999999999999999999976553
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=289.76 Aligned_cols=196 Identities=27% Similarity=0.368 Sum_probs=166.8
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEEEEEecCC
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
+.||+|+||.||+|+.. +++.||+|.++... ....+.+..|..++..+ +||||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 56789999987531 23344556677777654 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
|+|..++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~ 155 (316)
T cd05592 81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAST 155 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccc
Confidence 99999887653 57888899999999999999997 899999999999999999999999999997643322 22234
Q ss_pred ccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
..||+.|+|||++.+..++.++||||||+++|||++|+.||.+...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~ 201 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE 201 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH
Confidence 5689999999999999999999999999999999999999976553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=291.01 Aligned_cols=196 Identities=25% Similarity=0.337 Sum_probs=168.8
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecC---CcccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEEEEEecCC
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNV---GVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
++||+|+||.||+|+.. +++.+|+|+++.. .....+.+..|.+++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999975 5678999998753 123345677888988866 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
++|..++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++........ ....
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 155 (321)
T cd05591 81 GDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTT 155 (321)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-cccc
Confidence 9999888655 357888999999999999999997 8999999999999999999999999999875432221 1234
Q ss_pred ccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
..|++.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~ 201 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE 201 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH
Confidence 5689999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=297.33 Aligned_cols=200 Identities=26% Similarity=0.334 Sum_probs=175.4
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
+.+.+.||+|+||.||+++.. +++.||+|+++... ......+.+|++++..++|+||+++++++.++...++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY 82 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence 445688999999999999975 67889999997532 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC---
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ--- 664 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~--- 664 (724)
+++++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 83 MPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 9999999999766 568889999999999999999997 999999999999999999999999999998665432
Q ss_pred -------------------------ccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 665 -------------------------SSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 665 -------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
........||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 111234568999999999999999999999999999999999999997665
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=296.36 Aligned_cols=201 Identities=25% Similarity=0.278 Sum_probs=174.5
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
+.+.+.||+|+||.||+++.. +++.+|+|+++... ....+.+.+|+.+++.++|+||+++++++.+....++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 445688999999999999975 67889999997532 23445688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
+++++|.+++......+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++..+.......
T Consensus 83 ~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 159 (330)
T cd05601 83 QPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN 159 (330)
T ss_pred CCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence 99999999998765678999999999999999999997 899999999999999999999999999998765443322
Q ss_pred eeccccccccccccccc------CCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLT------NSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~------~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.....||+.|+|||++. ...++.++||||||+++|||++|+.||....
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 213 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC
Confidence 23456899999999986 4567899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=280.52 Aligned_cols=202 Identities=30% Similarity=0.449 Sum_probs=173.8
Q ss_pred cccccccccEEEEEEEEC-CccEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeceeec-----CCeEEEEEE
Q 043185 515 KNLIGSGGFGAVYKGILN-DKTIVAVKKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ-----GRQRLLVYE 586 (724)
Q Consensus 515 ~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-----~~~~~lV~e 586 (724)
.+.||+|+||.|..++.. +++.||||++.+. .....++..+|+++|++++|+||+.+.+++.. -+..|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 367999999999999964 6789999999743 23455788999999999999999999998865 347899999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC-c
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ-S 665 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~-~ 665 (724)
+|+ .+|...++.+ ..++......+.+||+.||.|+|+ .+++||||||+|+|++.+..+||+|||+|+...... .
T Consensus 107 lMe-tDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~ 181 (359)
T KOG0660|consen 107 LME-TDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED 181 (359)
T ss_pred HHh-hHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence 994 5888888665 448889999999999999999998 999999999999999999999999999999875431 2
Q ss_pred cceecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCC
Q 043185 666 SLFTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSMD 721 (724)
Q Consensus 666 ~~~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~~~~ 721 (724)
..++..+.|+.|.|||++.. ..|+...||||.||||.||++|++-|.+.+..+.+.
T Consensus 182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~ 238 (359)
T KOG0660|consen 182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQ 238 (359)
T ss_pred cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHH
Confidence 23467789999999998854 589999999999999999999999999988766554
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=284.82 Aligned_cols=200 Identities=26% Similarity=0.386 Sum_probs=172.0
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
+.+.+.||+|+||.||+++.. +++.+|+|++.... ....+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 445688999999999999985 57789999987532 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
+++.+..+.. ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++...........
T Consensus 83 ~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 83 EKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred CCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence 9987765543 33568889999999999999999996 8999999999999999999999999999987654333223
Q ss_pred ecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
....|++.|+|||++.+..++.++|||||||++|||++|++||...+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~ 205 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES 205 (287)
T ss_pred cccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence 34568999999999999899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=291.91 Aligned_cols=200 Identities=24% Similarity=0.324 Sum_probs=170.4
Q ss_pred ccccccccccccEEEEEEEE----CCccEEEEEEeecCC----cccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEE
Q 043185 512 DNFKNLIGSGGFGAVYKGIL----NDKTIVAVKKITNVG----VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRL 582 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~ 582 (724)
+.+.+.||+|+||.||+++. .+++.+|+|++.+.. ....+.+.+|+.++.++ +|+||+++++++..+...+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 34568899999999999985 357889999986421 22345678899999999 5999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCC
Q 043185 583 LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP 662 (724)
Q Consensus 583 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (724)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 82 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 82 LILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 999999999999998755 357889999999999999999996 8999999999999999999999999999986544
Q ss_pred CCccceecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 663 EQSSLFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 663 ~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
..........||+.|+|||++.+. .++.++||||||+++|||++|+.||....
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 211 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEG 211 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCC
Confidence 333323345799999999999875 47899999999999999999999996543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=289.91 Aligned_cols=197 Identities=25% Similarity=0.329 Sum_probs=169.4
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecC---CcccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEEEEEecCC
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNV---GVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
+.||+|+||.||+++.. +++.||+|++.+. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 5788999998742 223446677888888876 699999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
|+|..++... ..+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~~~ 155 (320)
T cd05590 81 GDLMFHIQKS-RRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TTST 155 (320)
T ss_pred chHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-cccc
Confidence 9999888655 358889999999999999999996 9999999999999999999999999999875432221 1234
Q ss_pred ccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
..||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~ 202 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED 202 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH
Confidence 56899999999999999999999999999999999999999776543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=290.07 Aligned_cols=193 Identities=25% Similarity=0.325 Sum_probs=166.6
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEEEEEecCC
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
+.||+|+||.||+++.. +++.+|+|.+++.. ....+.+.+|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 57789999997532 23345677888888776 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
++|..++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~~ 155 (329)
T cd05618 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTST 155 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cccc
Confidence 9998888655 458889999999999999999997 8999999999999999999999999999875432211 1234
Q ss_pred ccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSP 713 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~ 713 (724)
..||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 5689999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=286.90 Aligned_cols=193 Identities=24% Similarity=0.341 Sum_probs=166.5
Q ss_pred ccccccccEEEEEEEECCccEEEEEEeecCCccc---HHHHHHHHHHHhcCCCCCccceeceeec----CCeEEEEEEec
Q 043185 516 NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQG---KKDFCTEIAIIGNIHHVNLVKLKGFCAQ----GRQRLLVYEYM 588 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lV~e~~ 588 (724)
..||+|++|.||+|+++ ++.||||+++...... .+.|.+|+.++.+++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 46999999999999994 5679999997643333 4678899999999999999999999876 34778999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
++|+|.+++... ..+++....+++.+++.||.|||+ ..+++||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---- 177 (283)
T PHA02988 105 TRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---- 177 (283)
T ss_pred CCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc----
Confidence 999999999765 468889999999999999999996 3478899999999999999999999999998654322
Q ss_pred ecccccccccccccccC--CcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTN--SAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~--~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~ 227 (283)
T PHA02988 178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT 227 (283)
T ss_pred ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH
Confidence 23457899999999976 6899999999999999999999999976543
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=276.45 Aligned_cols=202 Identities=26% Similarity=0.334 Sum_probs=173.9
Q ss_pred cccccccccEEEEEEEECC-ccEEEEEEeecCCc---ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 515 KNLIGSGGFGAVYKGILND-KTIVAVKKITNVGV---QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 515 ~~~lG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
.+.||.|.-|+||++.+.+ ....|+|++.+... ....+...|.+||+.++||.++.|++.++.+...+|+||||+|
T Consensus 82 lk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpG 161 (459)
T KOG0610|consen 82 LKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPG 161 (459)
T ss_pred HHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCC
Confidence 4789999999999999875 47899999976433 3445678899999999999999999999999999999999999
Q ss_pred CCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCC-------
Q 043185 591 GSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP------- 662 (724)
Q Consensus 591 gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~------- 662 (724)
|+|..+++.+ +..+++..+.-++.+++-||+|||- .|||.|||||+||||.++|++.|+||.|+.....
T Consensus 162 GdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s 238 (459)
T KOG0610|consen 162 GDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKS 238 (459)
T ss_pred ccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeecc
Confidence 9999988764 6778888888899999999999996 9999999999999999999999999998653210
Q ss_pred --------------------------C-Cc---------------------cceecccccccccccccccCCcCCCccch
Q 043185 663 --------------------------E-QS---------------------SLFTTMRGTRGYLAPEWLTNSAISEKTDV 694 (724)
Q Consensus 663 --------------------------~-~~---------------------~~~~~~~gt~~y~aPE~l~~~~~~~~sDv 694 (724)
. .. .....++||-.|+|||++.+...+.++|.
T Consensus 239 ~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDW 318 (459)
T KOG0610|consen 239 SSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDW 318 (459)
T ss_pred CCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhH
Confidence 0 00 01112568999999999999999999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCCCCCC
Q 043185 695 YSFGMVLLELVSGRRNCSPRSQSHS 719 (724)
Q Consensus 695 ~SlGv~l~elltG~~p~~~~~~~~~ 719 (724)
|+|||+||||+.|..||.+....+.
T Consensus 319 WtfGIflYEmLyG~TPFKG~~~~~T 343 (459)
T KOG0610|consen 319 WTFGIFLYEMLYGTTPFKGSNNKET 343 (459)
T ss_pred HHHHHHHHHHHhCCCCcCCCCchhh
Confidence 9999999999999999988876543
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=289.82 Aligned_cols=199 Identities=25% Similarity=0.326 Sum_probs=169.8
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEEEEEe
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
.+.+.||+|+||.||+|+.. +++.+|+|.+.+.. ....+.+..|..++..+ +|++|+++++++...+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (323)
T cd05616 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEY 82 (323)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcC
Confidence 45678999999999999975 56789999987532 22334567788888777 689999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
+++|+|..++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 83 ~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~-~ 157 (323)
T cd05616 83 VNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV-T 157 (323)
T ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC-c
Confidence 9999999888655 357889999999999999999997 8999999999999999999999999999875432221 1
Q ss_pred eecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~ 206 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 206 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH
Confidence 2345689999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=290.08 Aligned_cols=198 Identities=28% Similarity=0.393 Sum_probs=171.7
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
+...+.||+|+||.||+++.. ++..+|+|.+.... ....+++.+|++++++++||||+++++++..++..++||||++
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 86 (331)
T cd06649 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 86 (331)
T ss_pred ceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCC
Confidence 344578999999999999975 56788999886532 2334678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
+++|.+++... ..+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||++....... ..
T Consensus 87 ~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~ 160 (331)
T cd06649 87 GGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---AN 160 (331)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc---cc
Confidence 99999998765 357889999999999999999996 3469999999999999999999999999987654322 23
Q ss_pred cccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
...|+..|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 161 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 206 (331)
T cd06649 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206 (331)
T ss_pred cCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 4568999999999999999999999999999999999999996543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=282.92 Aligned_cols=194 Identities=29% Similarity=0.429 Sum_probs=168.2
Q ss_pred ccccccEEEEEEEEC-CccEEEEEEeecCCc---ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCCH
Q 043185 518 IGSGGFGAVYKGILN-DKTIVAVKKITNVGV---QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSL 593 (724)
Q Consensus 518 lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gsL 593 (724)
||+|+||+||++... +++.+|+|++..... ...+.+..|++++++++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999965 678899999865322 2235678899999999999999999999999999999999999999
Q ss_pred HHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 594 DRILFG---NGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 594 ~~~l~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
..++.. ....+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.++|+|||++..+...... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence 888753 33568899999999999999999997 89999999999999999999999999999766443221 234
Q ss_pred ccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
..|++.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 201 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 578999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=289.78 Aligned_cols=193 Identities=24% Similarity=0.315 Sum_probs=167.6
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEEEEEecCC
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
++||+|+||.||+++.. +++.||+|++++.. ....+.+.+|..++.++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999975 67889999997532 23345678899999888 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
|+|..++... ..+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 155 (329)
T cd05588 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-TTST 155 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCC-cccc
Confidence 9999888655 468899999999999999999997 8999999999999999999999999999875322211 2234
Q ss_pred ccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSP 713 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~ 713 (724)
..||+.|+|||++.+..++.++|+||||+++|||++|+.||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 5789999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=288.79 Aligned_cols=200 Identities=25% Similarity=0.316 Sum_probs=170.0
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecC---CcccHHHHHHHHHHHhcCCC-CCccceeceeecCCeEEEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV---GVQGKKDFCTEIAIIGNIHH-VNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lV~e 586 (724)
+.+.+.||+|+||.||+|+.. +++.||+|++.+. .....+.+..|.+++..++| ++|+++++++...+..++|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 345688999999999999975 5678999998753 22345667889999999965 568889999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
|+++|+|..++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~- 156 (324)
T cd05587 82 YVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK- 156 (324)
T ss_pred CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC-
Confidence 99999999988655 357888999999999999999997 8999999999999999999999999999875322211
Q ss_pred ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~ 206 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 206 (324)
T ss_pred ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 22345689999999999999999999999999999999999999976653
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=289.20 Aligned_cols=198 Identities=26% Similarity=0.339 Sum_probs=168.1
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHH---hcCCCCCccceeceeecCCeEEEEE
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAII---GNIHHVNLVKLKGFCAQGRQRLLVY 585 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l---~~l~H~nIv~l~g~~~~~~~~~lV~ 585 (724)
.+.+.||+|+||.||++... +++.||||++++.. ....+.+.+|++++ ++++||||+++++++......++||
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 34578999999999999975 67889999997532 22335566666554 5678999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc
Q 043185 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 665 (724)
||+++++|..++.. ..+++..+..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||+++.......
T Consensus 82 E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 82 EYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred cCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 99999999888854 368999999999999999999997 8999999999999999999999999999875432221
Q ss_pred cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 666 SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 666 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~ 206 (324)
T cd05589 157 -RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE 206 (324)
T ss_pred -cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH
Confidence 12345789999999999999999999999999999999999999977653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=288.87 Aligned_cols=200 Identities=24% Similarity=0.321 Sum_probs=170.5
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecC---CcccHHHHHHHHHHHhcCC-CCCccceeceeecCCeEEEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV---GVQGKKDFCTEIAIIGNIH-HVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~e 586 (724)
+++.+.||+|+||.||+++.. +++.||+|++.+. .....+.+..|..++..+. |++|+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 356688999999999999975 6788999998753 1233456778889988885 6788889999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
|+++|+|..++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 y~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~- 156 (323)
T cd05615 82 YVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV- 156 (323)
T ss_pred CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc-
Confidence 99999999988665 358899999999999999999997 8999999999999999999999999999875432221
Q ss_pred ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
......||+.|+|||++.+..++.++|+||||+++|||++|+.||.....
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~ 206 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE 206 (323)
T ss_pred cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 12345689999999999999999999999999999999999999977654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=279.49 Aligned_cols=202 Identities=27% Similarity=0.431 Sum_probs=174.3
Q ss_pred ccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCC
Q 043185 512 DNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHG 591 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~g 591 (724)
+.+.+.||+|+||.||++...++..+|+|.+... ....+++.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~ 84 (256)
T cd05114 6 LTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENG 84 (256)
T ss_pred cEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCC
Confidence 4456789999999999999988888999988643 334567899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceecc
Q 043185 592 SLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTM 671 (724)
Q Consensus 592 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 671 (724)
+|.+++......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.............
T Consensus 85 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 161 (256)
T cd05114 85 CLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGA 161 (256)
T ss_pred cHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCC
Confidence 9999987655568899999999999999999996 8999999999999999999999999999876543322222223
Q ss_pred cccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 043185 672 RGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQS 717 (724)
Q Consensus 672 ~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~~ 717 (724)
.++..|+|||++.+..++.++|+||||+++|||++ |+.||......
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~ 208 (256)
T cd05114 162 KFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY 208 (256)
T ss_pred CCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 45668999999998899999999999999999999 89999766543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=296.92 Aligned_cols=201 Identities=24% Similarity=0.333 Sum_probs=172.1
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
.+.+.||+|+||.||++... +++.+|+|++.... ......+.+|+.++.+++|+||+++++.+.++...+|||||+
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~ 83 (360)
T cd05627 4 ESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFL 83 (360)
T ss_pred eEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence 34578999999999999975 67889999996421 233456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc---
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS--- 665 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~--- 665 (724)
++|+|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 84 ~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~ 159 (360)
T cd05627 84 PGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF 159 (360)
T ss_pred CCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence 999999998755 357888999999999999999997 9999999999999999999999999999875432110
Q ss_pred -------------------------------cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 666 -------------------------------SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 666 -------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCC
Confidence 0011346899999999999999999999999999999999999999766
Q ss_pred CCC
Q 043185 715 SQS 717 (724)
Q Consensus 715 ~~~ 717 (724)
...
T Consensus 240 ~~~ 242 (360)
T cd05627 240 TPQ 242 (360)
T ss_pred CHH
Confidence 543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=289.22 Aligned_cols=195 Identities=30% Similarity=0.386 Sum_probs=165.0
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHH-HHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIA-IIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
++||+|+||.||+++.. +++.+|+|++.+.. .....++.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 67889999986432 122344555554 57889999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
++|...+... ..+.+.....++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (321)
T cd05603 81 GELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTST 155 (321)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccccc
Confidence 9998888654 457778888899999999999997 899999999999999999999999999987542222 12234
Q ss_pred ccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
..|++.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC
Confidence 568999999999999999999999999999999999999997664
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=305.56 Aligned_cols=202 Identities=26% Similarity=0.301 Sum_probs=173.9
Q ss_pred ccccccccccccEEEEEEEEC-C-ccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-D-KTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
+.+.+.||+|++|.||+|... + ++.||+|++..........+.+|+.+++.++|||||++++++..++..+|||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 566789999999999999854 3 56788887755444445667889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc-
Q 043185 590 HGSLDRILFGN---GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS- 665 (724)
Q Consensus 590 ~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~- 665 (724)
+|+|.+++... ...+++.....++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 99999887542 3457888999999999999999997 8999999999999999999999999999987654322
Q ss_pred cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 666 SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 666 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~ 276 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ 276 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 122345699999999999999999999999999999999999999976554
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=285.22 Aligned_cols=198 Identities=24% Similarity=0.354 Sum_probs=168.6
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCCc-ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV-QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
+.+.+.||+|+||.||+|+.. +++.+|+|++..... .....+.+|+.++++++||||+++++++.++...++||||++
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (303)
T cd07869 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH 86 (303)
T ss_pred ceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC
Confidence 455688999999999999975 678899999865322 233567889999999999999999999999999999999996
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
++|.+++......++...+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 87 -~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~ 161 (303)
T cd07869 87 -TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH-TYS 161 (303)
T ss_pred -cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc-cCC
Confidence 57877777665668889999999999999999997 8999999999999999999999999999875433221 123
Q ss_pred cccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
...+++.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4568899999999865 46889999999999999999999999754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=288.56 Aligned_cols=195 Identities=25% Similarity=0.311 Sum_probs=168.3
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEEEEEecCC
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
++||+|+||.||+++.. +++.+|+|++++.. ....+.+.+|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 56789999997532 23345678899999888 699999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
++|..++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (327)
T cd05617 81 GDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TTST 155 (327)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-ceec
Confidence 9999888654 358899999999999999999997 8999999999999999999999999999875322211 1234
Q ss_pred ccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
..||+.|+|||++.+..++.++||||||+++|||++|+.||+...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~ 200 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIIT 200 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccC
Confidence 579999999999999999999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=288.76 Aligned_cols=196 Identities=31% Similarity=0.389 Sum_probs=166.1
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHH-HHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIA-IIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
+.||+|+||+||+++.. +++.||+|++.... ....+++.+|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999975 67889999996431 222344555554 56789999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
|+|..++... ..+.+..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (323)
T cd05575 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTST 155 (323)
T ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccccc
Confidence 9999988765 457888889999999999999997 899999999999999999999999999987543222 12234
Q ss_pred ccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
..||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~ 201 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT 201 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH
Confidence 5689999999999999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=281.04 Aligned_cols=201 Identities=30% Similarity=0.398 Sum_probs=164.5
Q ss_pred ccccccccccccEEEEEEEE-CCccEEEEEEeecCCcc--------------cHHHHHHHHHHHhcCCCCCccceeceee
Q 043185 512 DNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQ--------------GKKDFCTEIAIIGNIHHVNLVKLKGFCA 576 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~--------------~~~~~~~E~~~l~~l~H~nIv~l~g~~~ 576 (724)
|.+.+.||+|.||.|-+|+. .+++.||||++.+.... ..+...+|+.+|++++|||||+|+.+..
T Consensus 99 y~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLD 178 (576)
T KOG0585|consen 99 YELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLD 178 (576)
T ss_pred eehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeec
Confidence 44567899999999999996 47889999999653211 1257889999999999999999999986
Q ss_pred cC--CeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEee
Q 043185 577 QG--RQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDF 654 (724)
Q Consensus 577 ~~--~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DF 654 (724)
+. +.+|||+|||..|.+...= .....++..++.+++.++..||+|||. ++||||||||+|+||+++|++||+||
T Consensus 179 DP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~VKIsDF 254 (576)
T KOG0585|consen 179 DPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGTVKISDF 254 (576)
T ss_pred CcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCcEEeecc
Confidence 54 5889999999988764332 112338899999999999999999997 99999999999999999999999999
Q ss_pred cCccccCCC----CccceecccccccccccccccCCc----CCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 655 GLSKLLTPE----QSSLFTTMRGTRGYLAPEWLTNSA----ISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 655 Gla~~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~----~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
|.+...... .........||+.|+|||.+.++. .+.+.||||+||+||.|+.|+.||-....
T Consensus 255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~ 324 (576)
T KOG0585|consen 255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE 324 (576)
T ss_pred ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence 998766221 122234578999999999997732 35689999999999999999999966543
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.6e-32 Score=285.97 Aligned_cols=195 Identities=27% Similarity=0.360 Sum_probs=166.9
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEEEEEecCC
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 56789999997531 23345567788888764 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
|+|..++... ..+++.....++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (316)
T cd05619 81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTCT 155 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ceee
Confidence 9999998754 357888999999999999999997 8999999999999999999999999999875322211 1234
Q ss_pred ccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
..||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Confidence 568999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-33 Score=292.66 Aligned_cols=204 Identities=27% Similarity=0.441 Sum_probs=180.6
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeceeecCCe-EEEEEEe
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQ-RLLVYEY 587 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~-~~lV~e~ 587 (724)
|...+++|+|+||.++..+++ +...+++|++.-. .....+...+|+.++++++|||||.+.+.+.+++. .+|||+|
T Consensus 6 Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y 85 (426)
T KOG0589|consen 6 YEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEY 85 (426)
T ss_pred hhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEee
Confidence 344578999999999998875 5567999988643 23344567899999999999999999999999888 8999999
Q ss_pred cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 588 MNHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 588 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
++||+|.+.+... +..++++....++.|++.|+.|||+ ++|+|||||+.||+++.++.+||.|||+|+.+..+..
T Consensus 86 ~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~- 161 (426)
T KOG0589|consen 86 CEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS- 161 (426)
T ss_pred cCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCchh-
Confidence 9999999998765 4778899999999999999999996 9999999999999999999999999999999987652
Q ss_pred ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHS 719 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~~ 719 (724)
......||+.||.||.+.+.+|..|+|||||||++|||++-+++|.+.+....
T Consensus 162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L 214 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL 214 (426)
T ss_pred hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH
Confidence 23567899999999999999999999999999999999999999988876543
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=289.51 Aligned_cols=196 Identities=30% Similarity=0.373 Sum_probs=166.3
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecC---CcccHHHHHHHHH-HHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNV---GVQGKKDFCTEIA-IIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
+.||+|+||.||+++.. +++.+|+|++.+. .....+++..|.. +++.++||||+++++.+..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999964 6788999998643 1223345556654 46778999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
++|..++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~ 155 (325)
T cd05604 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTT 155 (325)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCccc
Confidence 9999888654 458889999999999999999997 899999999999999999999999999987542221 12234
Q ss_pred ccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
..|++.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~ 201 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV 201 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH
Confidence 5689999999999999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=288.80 Aligned_cols=209 Identities=29% Similarity=0.443 Sum_probs=183.8
Q ss_pred HHhhccccccccccccEEEEEEEECC---c--cEEEEEEeec-CCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeE
Q 043185 508 EVATDNFKNLIGSGGFGAVYKGILND---K--TIVAVKKITN-VGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQR 581 (724)
Q Consensus 508 ~~a~~~~~~~lG~G~fG~Vy~~~~~~---~--~~vAvK~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 581 (724)
.++.-.+.++||.|-||.||+|.+.+ + -.||||..+. ......+.|+.|..+|++++||||++++|+|.+ ...
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~ 465 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM 465 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence 33334456889999999999999743 2 2488898876 445667889999999999999999999999987 578
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccC
Q 043185 582 LLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 661 (724)
|||||.++.|.|..||..+...++......++.||+.||+|||+ ..+|||||.++|||+....-+||+|||+++.+.
T Consensus 466 WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred eEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 99999999999999999998899999999999999999999998 999999999999999999999999999999988
Q ss_pred CCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCC
Q 043185 662 PEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQSHSM 720 (724)
Q Consensus 662 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~~~~~ 720 (724)
.+.....+...-...|||||.+.-.+++.++|||.|||+||||++ |.+||.+-.-++.+
T Consensus 543 d~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI 602 (974)
T KOG4257|consen 543 DDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI 602 (974)
T ss_pred ccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE
Confidence 776655555556778999999999999999999999999999998 99999887766654
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=286.44 Aligned_cols=196 Identities=26% Similarity=0.327 Sum_probs=167.5
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEEEEEecCC
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
+.||+|+||.||+++.. +++.||+|.++... ....+.+..|.+++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999975 57789999997531 23345567788888754 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
++|..++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (316)
T cd05620 81 GDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAST 155 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cceec
Confidence 9999888664 457888999999999999999997 899999999999999999999999999987432211 12244
Q ss_pred ccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
..||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~ 201 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE 201 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 6789999999999999999999999999999999999999976553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=296.60 Aligned_cols=202 Identities=29% Similarity=0.380 Sum_probs=176.4
Q ss_pred hccccccccccccEEEEEEEE-CCccEEEEEEeecCCcccHHHHHHHHHHHhcCC-C-----CCccceeceeecCCeEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIH-H-----VNLVKLKGFCAQGRQRLL 583 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~nIv~l~g~~~~~~~~~l 583 (724)
+|.+.+.||+|.||.|-|+.. .+++.||||++++. ..-..+-..|+.+|..|+ | -|+|++++++...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 667789999999999999995 56899999999875 334456678999999996 4 389999999999999999
Q ss_pred EEEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCC--CcEEEEeecCcccc
Q 043185 584 VYEYMNHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYH--FQAKISDFGLSKLL 660 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~--~~~kl~DFGla~~~ 660 (724)
|+|.++. +|.++|+.+ ...++......|+.||+.||.+||+ .+|||+||||+||||..- ..+||+|||.+...
T Consensus 266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 9999865 999999876 4568899999999999999999996 999999999999999653 47999999999865
Q ss_pred CCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCC
Q 043185 661 TPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSMD 721 (724)
Q Consensus 661 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~~~~ 721 (724)
.... ....-++.|+|||+|.+.+|+.+.||||||||+.||.+|.+-|.++++.+++.
T Consensus 342 ~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~ 398 (586)
T KOG0667|consen 342 SQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLA 398 (586)
T ss_pred CCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHH
Confidence 4332 25678899999999999999999999999999999999999999998877664
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-32 Score=288.61 Aligned_cols=200 Identities=28% Similarity=0.401 Sum_probs=172.5
Q ss_pred hhccccccccccccEEEEEEEEC-CccEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV-GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
..+.+.+.||+|+||.||++... ++..+|+|.+... .....+++.+|++++.+++|+||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 34556688999999999999976 5677888887653 223346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
+++++|.+++... ..+++.....++.+++.||.|||+ ..+++||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--- 158 (333)
T cd06650 85 MDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 158 (333)
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc---
Confidence 9999999998765 357888889999999999999996 3579999999999999999999999999987653321
Q ss_pred eecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 133468999999999999899999999999999999999999997654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-32 Score=288.43 Aligned_cols=202 Identities=30% Similarity=0.435 Sum_probs=181.3
Q ss_pred hhccccccccccccEEEEEEEECC-ccEEEEEEeecCCcc---cHHHHHHHHHHHhcCC-CCCccceeceeecCCeEEEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILND-KTIVAVKKITNVGVQ---GKKDFCTEIAIIGNIH-HVNLVKLKGFCAQGRQRLLV 584 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV 584 (724)
..|.+.+.||+|.||.||+++.+. ++.+|+|.+.+.... ..+...+|+.+|+++. |||||.+.+.+......++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 456677899999999999999764 889999999765433 3468899999999998 99999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCC----CcEEEEeecCcccc
Q 043185 585 YEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYH----FQAKISDFGLSKLL 660 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~----~~~kl~DFGla~~~ 660 (724)
||++++|.|.+.+.+. .+++.....++.|++.++.|||+ .+++||||||+|+|+... +.+|++|||++...
T Consensus 115 mEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 9999999999998776 38999999999999999999997 999999999999999643 47999999999988
Q ss_pred CCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 043185 661 TPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSH 718 (724)
Q Consensus 661 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~ 718 (724)
.. .......+||+.|+|||++....|+..+||||+||++|.|++|.+||.++.+..
T Consensus 190 ~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~ 245 (382)
T KOG0032|consen 190 KP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE 245 (382)
T ss_pred cC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH
Confidence 76 334577899999999999999999999999999999999999999999887554
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-32 Score=286.26 Aligned_cols=202 Identities=26% Similarity=0.448 Sum_probs=167.7
Q ss_pred hccccccccccccEEEEEEEECC-----------------ccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCcccee
Q 043185 511 TDNFKNLIGSGGFGAVYKGILND-----------------KTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLK 572 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~~-----------------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~ 572 (724)
.+.+.+.||+|+||.||++...+ +..||+|.+.... .....+|.+|++++.+++||||++++
T Consensus 6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 85 (304)
T cd05096 6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLL 85 (304)
T ss_pred hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence 45567899999999999998532 2369999987532 23456799999999999999999999
Q ss_pred ceeecCCeEEEEEEecCCCCHHHHHhcCC------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEec
Q 043185 573 GFCAQGRQRLLVYEYMNHGSLDRILFGNG------------------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHC 634 (724)
Q Consensus 573 g~~~~~~~~~lV~e~~~~gsL~~~l~~~~------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~ 634 (724)
+++.+.+..++||||+++++|.+++.... ..+++.....++.||+.||.|||+ .+|+||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH~ 162 (304)
T cd05096 86 GVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHR 162 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCcccc
Confidence 99999999999999999999999885421 246778899999999999999997 899999
Q ss_pred CCCCCCeEEeCCCcEEEEeecCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh--CCCCC
Q 043185 635 DIKPENILLHYHFQAKISDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS--GRRNC 711 (724)
Q Consensus 635 Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt--G~~p~ 711 (724)
||||+|||++.++.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ +..||
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 242 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence 9999999999999999999999986543322 11123345788999999998899999999999999999997 56677
Q ss_pred CCCC
Q 043185 712 SPRS 715 (724)
Q Consensus 712 ~~~~ 715 (724)
....
T Consensus 243 ~~~~ 246 (304)
T cd05096 243 GELT 246 (304)
T ss_pred CcCC
Confidence 6543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-34 Score=275.48 Aligned_cols=196 Identities=31% Similarity=0.434 Sum_probs=178.2
Q ss_pred ccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCC
Q 043185 514 FKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGS 592 (724)
Q Consensus 514 ~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gs 592 (724)
+.++||+|+||.|||+.++ .|+.+|||++.- ....+++..|+.+|++.+.|++|+++|.+.....+|+|||||..|+
T Consensus 37 i~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS 114 (502)
T KOG0574|consen 37 IVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS 114 (502)
T ss_pred HHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence 3478999999999999975 789999999864 4567889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceeccc
Q 043185 593 LDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMR 672 (724)
Q Consensus 593 L~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 672 (724)
..++++...+.+.+.+...++...++||+|||. ..-||||||+.||||+-+|.+||+|||.|..+.... ....++.
T Consensus 115 iSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AKRNTVI 190 (502)
T KOG0574|consen 115 ISDIMRARRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AKRNTVI 190 (502)
T ss_pred HHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhH-HhhCccc
Confidence 999999888999999999999999999999996 888999999999999999999999999998775432 2235678
Q ss_pred ccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 673 GTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 673 gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
||+.|||||+++.-.|..++||||||++..||..|++||..-+
T Consensus 191 GTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIH 233 (502)
T KOG0574|consen 191 GTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIH 233 (502)
T ss_pred cCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccc
Confidence 9999999999999999999999999999999999999995433
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=287.12 Aligned_cols=196 Identities=30% Similarity=0.392 Sum_probs=164.4
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHH-HHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEI-AIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~-~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
+.||+|+||.||+++.. +++.+|+|++.... .....++..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999975 56789999986432 12223444444 456788999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
++|..++.... .+.+.....++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~~~ 155 (325)
T cd05602 81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTST 155 (325)
T ss_pred CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Cccc
Confidence 99999987653 46677788899999999999997 8999999999999999999999999999875432221 2234
Q ss_pred ccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
..||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 201 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT 201 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH
Confidence 5699999999999999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=292.11 Aligned_cols=202 Identities=27% Similarity=0.469 Sum_probs=169.1
Q ss_pred hhccccccccccccEEEEEEEE------CCccEEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeceeecCCeE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGIL------NDKTIVAVKKITNVG-VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQR 581 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~ 581 (724)
..+.+.+.||+|+||.||+|+. ..+..||||+++... ....+.+.+|+.++..+ +||||+++++++.++...
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 3456678999999999999973 235579999986432 33446788999999999 899999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCC------------------------------------------------------------
Q 043185 582 LLVYEYMNHGSLDRILFGNG------------------------------------------------------------ 601 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~~------------------------------------------------------------ 601 (724)
++||||+++|+|.+++....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 99999999999999886421
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 602 --------------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 602 --------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 246788899999999999999997 899999999999999999999999999998664432211
Q ss_pred -eecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 043185 668 -FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPR 714 (724)
Q Consensus 668 -~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~ 714 (724)
.....++..|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~ 320 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence 112335668999999999999999999999999999998 88898654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=292.64 Aligned_cols=192 Identities=24% Similarity=0.310 Sum_probs=165.9
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
.|.+.+.||+|+||.||++... .++.||+|+.. ...+.+|++++++++||||+++++++..+...++|+|++.
T Consensus 93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 4566789999999999999964 67889999753 2456789999999999999999999999999999999985
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
++|..++... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...........
T Consensus 167 -~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~ 241 (391)
T PHA03212 167 -TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241 (391)
T ss_pred -CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccc
Confidence 6888887654 357889999999999999999997 89999999999999999999999999999754332222234
Q ss_pred cccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSP 713 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~ 713 (724)
...||+.|+|||++.+..++.++||||||+++|||++|+.||-.
T Consensus 242 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred cccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 46799999999999999999999999999999999999988743
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=288.16 Aligned_cols=196 Identities=27% Similarity=0.374 Sum_probs=170.2
Q ss_pred ccccccccEEEEEEEE----CCccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 516 NLIGSGGFGAVYKGIL----NDKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~----~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
+.||+|+||.||+++. .+++.+|+|++.... ......+.+|++++.+++||||+++++++..+...++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 357889999997532 2234567789999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
+++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~~ 156 (318)
T cd05582 82 GGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAY 156 (318)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-cee
Confidence 99999998654 458899999999999999999997 8999999999999999999999999999876543322 223
Q ss_pred cccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~ 203 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR 203 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH
Confidence 45789999999999998899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=292.25 Aligned_cols=204 Identities=27% Similarity=0.441 Sum_probs=169.2
Q ss_pred HhhccccccccccccEEEEEEEEC------CccEEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeceeecCCe
Q 043185 509 VATDNFKNLIGSGGFGAVYKGILN------DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQ 580 (724)
Q Consensus 509 ~a~~~~~~~lG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~ 580 (724)
...+.+.+.||+|+||.||+++.. +...||+|+++... ....+.+.+|+++++++ +|+||+++++++.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 334556789999999999998842 33579999997532 23346688999999999 89999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCC-----------------------------------------------------------
Q 043185 581 RLLVYEYMNHGSLDRILFGNG----------------------------------------------------------- 601 (724)
Q Consensus 581 ~~lV~e~~~~gsL~~~l~~~~----------------------------------------------------------- 601 (724)
.++||||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999885421
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc-eec
Q 043185 602 ----------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL-FTT 670 (724)
Q Consensus 602 ----------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~ 670 (724)
..+++..+.+++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......... ...
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 236778889999999999999997 899999999999999999999999999997654332211 112
Q ss_pred ccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
..++..|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~ 319 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL 319 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccc
Confidence 335678999999999999999999999999999997 999996544
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=275.14 Aligned_cols=203 Identities=31% Similarity=0.478 Sum_probs=175.0
Q ss_pred HhhccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 509 VATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 509 ~a~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
...+.+.+.||+|++|.||+|...+++.||+|.++.. ....+++.+|++++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG-TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCC-cccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 3456677899999999999999877788999998754 234577999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 589 NHGSLDRILFGNG-PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 589 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
++++|.+++.... ..+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||+++.........
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 9999999987643 568999999999999999999996 899999999999999999999999999998765332211
Q ss_pred eecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
......+..|+|||++.+..++.++|+||||++++||++ |+.||....
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 209 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT 209 (261)
T ss_pred cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 122223457999999999999999999999999999999 999996654
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=293.45 Aligned_cols=198 Identities=32% Similarity=0.517 Sum_probs=172.3
Q ss_pred cccccccccEEEEEEEE-CCccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCC------eEEEEEE
Q 043185 515 KNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR------QRLLVYE 586 (724)
Q Consensus 515 ~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~~lV~e 586 (724)
.+.||+|+||.||+|+. ..|+.||||.+.+.. ....+...+|+++|++++|+|||+++++-.+.. ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 47899999999999995 578999999997643 344567889999999999999999999865543 6689999
Q ss_pred ecCCCCHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC--CCc--EEEEeecCcccc
Q 043185 587 YMNHGSLDRILFGN--GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY--HFQ--AKISDFGLSKLL 660 (724)
Q Consensus 587 ~~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~--~~~--~kl~DFGla~~~ 660 (724)
||.+|+|...|... ...+++.+.+.+..++..||.|||+ ++|+||||||.||++-. +|. .||+|||.|+.+
T Consensus 98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 99999999999764 4578999999999999999999996 99999999999999943 343 799999999988
Q ss_pred CCCCccceecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 661 TPEQSSLFTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 661 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
..+. ......||+.|++||+.+. +.|+..+|.|||||++||++||..||.+....
T Consensus 175 ~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 175 DDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred CCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 6654 4677899999999999995 78999999999999999999999999665543
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=279.34 Aligned_cols=200 Identities=27% Similarity=0.384 Sum_probs=172.3
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
+...++||+|+||.||++... +++.||+|++.... ......+.+|+.++++++||||+++++.+..++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 344578999999999999964 67889999986432 12234578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 588 MNHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 588 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
+++++|.+++... ...+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET- 157 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc-
Confidence 9999999888654 3468899999999999999999997 8999999999999999999999999999986543322
Q ss_pred ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||.+...
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~ 206 (285)
T cd05605 158 -IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206 (285)
T ss_pred -cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch
Confidence 1334689999999999998999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=286.95 Aligned_cols=212 Identities=28% Similarity=0.429 Sum_probs=184.0
Q ss_pred CChHHHHHhhccccccccccccEEEEEEEECC-ccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCe
Q 043185 502 FDYEELEVATDNFKNLIGSGGFGAVYKGILND-KTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQ 580 (724)
Q Consensus 502 ~~~~~l~~a~~~~~~~lG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 580 (724)
.+-.|+++.......+||-|-||.||.|.++. .-.||||.++.. .-..++|++|+.+|+.++|||+|+|+|+|..+..
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 34556665555567899999999999999863 456999999764 4557899999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccc
Q 043185 581 RLLVYEYMNHGSLDRILFGNG-PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKL 659 (724)
Q Consensus 581 ~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 659 (724)
.|||.|||.+|+|.+||.+.. ..+..-.++.++.||+.||+||.. +++|||||.++|+|+.++..+||+||||+++
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhh
Confidence 999999999999999998753 456667788999999999999995 9999999999999999999999999999999
Q ss_pred cCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 043185 660 LTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQS 717 (724)
Q Consensus 660 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~~ 717 (724)
+..+.........-.+.|.|||.+....++.|+|||+|||+||||.| |.-||.+-+.+
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS 473 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 473 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH
Confidence 98776543333445678999999999999999999999999999999 89999776544
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=276.00 Aligned_cols=201 Identities=31% Similarity=0.437 Sum_probs=172.7
Q ss_pred ccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCC
Q 043185 512 DNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHG 591 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~g 591 (724)
+.+.+.||+|+||.||++...++..+|+|.+.+. .....++.+|++++++++|+||+++++++.+....++|+||++++
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred cchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 3456889999999999999887778999998643 234467889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceecc
Q 043185 592 SLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTM 671 (724)
Q Consensus 592 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 671 (724)
+|.+++......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.............
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 161 (256)
T cd05059 85 CLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT 161 (256)
T ss_pred CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccccccCCC
Confidence 9999997765578999999999999999999997 8999999999999999999999999999976643322211222
Q ss_pred cccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 043185 672 RGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQ 716 (724)
Q Consensus 672 ~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~ 716 (724)
.++..|+|||.+.+..++.++|+||||+++|||++ |+.||.....
T Consensus 162 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 207 (256)
T cd05059 162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN 207 (256)
T ss_pred CCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH
Confidence 34457999999999999999999999999999999 8999976543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=283.79 Aligned_cols=196 Identities=26% Similarity=0.350 Sum_probs=168.6
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecC---CcccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEEEEEecCC
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNV---GVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
+.||+|+||.||+++.. +++.+|+|++++. .......+..|.+++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 5678999999753 123445677888998887 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
++|..++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (318)
T cd05570 81 GDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTST 155 (318)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cccc
Confidence 9999888655 358899999999999999999996 8999999999999999999999999999875322221 1234
Q ss_pred ccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
..|++.|+|||++.+..++.++|+|||||++|||++|+.||.....
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~ 201 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE 201 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH
Confidence 5689999999999999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-33 Score=267.94 Aligned_cols=203 Identities=26% Similarity=0.389 Sum_probs=172.4
Q ss_pred ccccccccccccEEEEEEEE-CCccEEEEEEeec--CCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 512 DNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITN--VGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
+.+.+.||+|.|+.||+... ..++..|+|.+.. ....+.+++.+|++|-+.|+||||++++....+....+||+|+|
T Consensus 13 y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m 92 (355)
T KOG0033|consen 13 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 92 (355)
T ss_pred hhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecc
Confidence 34457899999999999885 4677788887742 23446788899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC---CCcEEEEeecCccccCCCCc
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY---HFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DFGla~~~~~~~~ 665 (724)
+|++|-.-+-.. ...++..+-..+.||+++|.|+|. ++|||||+||+|+|+.. ..-+||+|||+|..+....
T Consensus 93 ~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~- 167 (355)
T KOG0033|consen 93 TGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE- 167 (355)
T ss_pred cchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeCCcc-
Confidence 999986544332 356677788899999999999997 99999999999999964 3458999999999887332
Q ss_pred cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC
Q 043185 666 SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSM 720 (724)
Q Consensus 666 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~~~ 720 (724)
......|||+|||||+++..+|+..+|||+.||+||-|+.|.+||.++++++++
T Consensus 168 -~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rly 221 (355)
T KOG0033|consen 168 -AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY 221 (355)
T ss_pred -ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHH
Confidence 235678999999999999999999999999999999999999999998776544
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=274.57 Aligned_cols=200 Identities=29% Similarity=0.451 Sum_probs=173.7
Q ss_pred ccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCC
Q 043185 512 DNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHG 591 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~g 591 (724)
+.+.+.||+|+||.||++...++..+|+|.++.. ....+++.+|+.++.+++||||+++++++.+....++||||++++
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05113 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNG 84 (256)
T ss_pred eEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCC
Confidence 4566889999999999999887777999998753 334567999999999999999999999999988999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceecc
Q 043185 592 SLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTM 671 (724)
Q Consensus 592 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 671 (724)
+|.+++......+++..++.++.||+.||+|||+ .+++|+||||+||+++.++.+||+|||+++.............
T Consensus 85 ~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 161 (256)
T cd05113 85 CLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGS 161 (256)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCC
Confidence 9999997765578999999999999999999996 8999999999999999999999999999886644332222223
Q ss_pred cccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 672 RGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 672 ~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
.++..|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 162 ~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~ 206 (256)
T cd05113 162 KFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN 206 (256)
T ss_pred ccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence 45678999999998889999999999999999998 999996554
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-32 Score=278.74 Aligned_cols=205 Identities=24% Similarity=0.365 Sum_probs=182.9
Q ss_pred hccccccccccccEEEEEEEE-CCccEEEEEEeecCCcc--cHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 511 TDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQ--GKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
-|++++.||+|.|..|-++++ -.|..||||++.+.... ....+.+|++-|+.++|||||+|+.+......+|||+|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 466678899999999999985 47888999999775433 345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC-CCcEEEEeecCccccCCCCcc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY-HFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~ 666 (724)
=++|+|.+|+.++...+.+....+++.||.+|+.|+|. .++|||||||+||.+-+ -|-+||.|||++..+.+.+.
T Consensus 99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k- 174 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK- 174 (864)
T ss_pred cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCcch-
Confidence 99999999999888899999999999999999999996 99999999999998754 68899999999988766543
Q ss_pred ceecccccccccccccccCCcCC-CccchhhHHHHHHHHHhCCCCCCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAIS-EKTDVYSFGMVLLELVSGRRNCSPRSQSHSM 720 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~~-~~sDv~SlGv~l~elltG~~p~~~~~~~~~~ 720 (724)
..+.+|+..|-|||.+.+..|+ +++||||||||||.|++|++||+...+++-+
T Consensus 175 -L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL 228 (864)
T KOG4717|consen 175 -LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL 228 (864)
T ss_pred -hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh
Confidence 5678999999999999999885 6899999999999999999999988877654
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=275.00 Aligned_cols=201 Identities=28% Similarity=0.469 Sum_probs=173.6
Q ss_pred hccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 511 TDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
.+.+.++||+|+||.||+|...++..||+|++... ....+.+.+|+.++++++|+||+++++.+...+..++++||+++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05072 7 SIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAK 85 (261)
T ss_pred HeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCC
Confidence 34456889999999999999888888999998653 23457889999999999999999999999999999999999999
Q ss_pred CCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 591 GSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 591 gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
++|.+++... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||+++...........
T Consensus 86 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 162 (261)
T cd05072 86 GSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTARE 162 (261)
T ss_pred CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCceeccC
Confidence 9999998653 4567888999999999999999996 89999999999999999999999999999876543322222
Q ss_pred cccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
...++..|+|||++....++.++||||||+++|||++ |+.||....
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~ 209 (261)
T cd05072 163 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS 209 (261)
T ss_pred CCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC
Confidence 3345678999999998889999999999999999998 999996543
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=262.75 Aligned_cols=197 Identities=25% Similarity=0.374 Sum_probs=171.2
Q ss_pred ccccccccEEEEEEE-ECCccEEEEEEeecCCcccHHHHHHHHHHHhcCC-CCCccceeceeecCCeEEEEEEecCCCCH
Q 043185 516 NLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIH-HVNLVKLKGFCAQGRQRLLVYEYMNHGSL 593 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~e~~~~gsL 593 (724)
++||+|+|+.|--++ +.++..+|||++.+.......+..+|++++.+.+ |+||+.|+.+|.++...|||||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 789999999999887 5688889999999887788889999999999995 99999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCC---CcEEEEeecCccccCC------CC
Q 043185 594 DRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYH---FQAKISDFGLSKLLTP------EQ 664 (724)
Q Consensus 594 ~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DFGla~~~~~------~~ 664 (724)
...+.+. ..+++.++.++..+|+.||.|||. ++|.||||||+|||...- .-+|||||.|..-+.. ..
T Consensus 164 LshI~~~-~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas 239 (463)
T KOG0607|consen 164 LSHIQKR-KHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS 239 (463)
T ss_pred HHHHHHh-hhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence 9988765 568899999999999999999996 999999999999999654 3489999998764321 12
Q ss_pred ccceeccccccccccccccc-----CCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 665 SSLFTTMRGTRGYLAPEWLT-----NSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 665 ~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.....+.+|+..|||||+.. ...|+.+.|.||||||||-||+|-+||.+...
T Consensus 240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg 296 (463)
T KOG0607|consen 240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG 296 (463)
T ss_pred CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence 22344567999999999873 23689999999999999999999999988765
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=277.18 Aligned_cols=199 Identities=39% Similarity=0.607 Sum_probs=167.9
Q ss_pred ccccccccccEEEEEEEEC-----CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 514 FKNLIGSGGFGAVYKGILN-----DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 514 ~~~~lG~G~fG~Vy~~~~~-----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
+.+.||.|.||.||+|.+. .+..|+||.++... ....++|.+|++.+.+++||||++++|++......++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999987 35679999996532 23468899999999999999999999999988889999999
Q ss_pred cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc-
Q 043185 588 MNHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS- 665 (724)
Q Consensus 588 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~- 665 (724)
+++|+|.++|... ...+++..+..|+.||++||.|||+ .+++|++|+++||+++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence 9999999999887 6779999999999999999999997 8899999999999999999999999999987733222
Q ss_pred cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 666 SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 666 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
...........|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~ 210 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD 210 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 11223446789999999999999999999999999999999 788886543
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=319.32 Aligned_cols=199 Identities=31% Similarity=0.559 Sum_probs=166.7
Q ss_pred CCChHHHHHhhccccccccccccEEEEEEEE-CCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCC
Q 043185 501 RFDYEELEVATDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR 579 (724)
Q Consensus 501 ~~~~~~l~~a~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 579 (724)
.++++++..+ ....+.||+|+||.||+|+. .++..||||+++..... ..+|++.+++++|||||+++|+|.+..
T Consensus 682 ~~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~ 756 (968)
T PLN00113 682 SITINDILSS-LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEK 756 (968)
T ss_pred hhhHHHHHhh-CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCC
Confidence 3555555543 33456899999999999997 57888999998654222 235688999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccc
Q 043185 580 QRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKL 659 (724)
Q Consensus 580 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 659 (724)
..++||||+++|+|.++++ .++|..+.+|+.|+++||+|||..+..+|+||||||+||+++.++..++. |+....
T Consensus 757 ~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~ 831 (968)
T PLN00113 757 GAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL 831 (968)
T ss_pred CCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence 9999999999999999995 37899999999999999999997666899999999999999999888876 666543
Q ss_pred cCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 660 LTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 660 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
.... ....++..|+|||++.+..++.++|||||||++|||++|+.||+..
T Consensus 832 ~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~ 881 (968)
T PLN00113 832 LCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE 881 (968)
T ss_pred cccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Confidence 3221 2235789999999999999999999999999999999999999643
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=285.88 Aligned_cols=199 Identities=27% Similarity=0.459 Sum_probs=166.5
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeceeecC-----CeEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG-----RQRLL 583 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~~l 583 (724)
+.+.+.||+|+||.||+|+.. +++.||||++... ......++.+|++++++++||||+++++++... ...++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 456688999999999999965 6788999998643 223345688999999999999999999987543 25799
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCC
Q 043185 584 VYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE 663 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (724)
||||++ ++|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 v~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 82 VFELME-SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEecCC-CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 999996 5888888654 358899999999999999999997 89999999999999999999999999999765322
Q ss_pred Cc--cceecccccccccccccccC--CcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 664 QS--SLFTTMRGTRGYLAPEWLTN--SAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 664 ~~--~~~~~~~gt~~y~aPE~l~~--~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.. .......|++.|+|||++.+ ..++.++||||||+++|||++|++||....
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~ 212 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 21 11234568999999999876 678999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=282.69 Aligned_cols=202 Identities=24% Similarity=0.434 Sum_probs=169.7
Q ss_pred hhccccccccccccEEEEEEEEC-Ccc----EEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKT----IVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLL 583 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 583 (724)
..+...+.||+|+||.||+|+.. ++. .||+|+++... ....+++.+|+.+++.++||||++++|++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 33455678999999999999863 333 38999986532 33456789999999999999999999999765 5679
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCC
Q 043185 584 VYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE 663 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (724)
|+||+++|+|.+++......+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 999999999999998776678899999999999999999997 89999999999999999999999999999876543
Q ss_pred Cccc-eecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 664 QSSL-FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 664 ~~~~-~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
.... ......+..|+|||++.+..++.++||||||+++|||++ |+.||+...
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~ 216 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 216 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 3211 112234678999999999999999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=273.62 Aligned_cols=192 Identities=29% Similarity=0.421 Sum_probs=165.9
Q ss_pred ccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCCH
Q 043185 518 IGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSL 593 (724)
Q Consensus 518 lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gsL 593 (724)
||+|+||.||+++.. +++.+|+|++.... ....+.+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999965 67889999986421 12234556799999999999999999999999999999999999999
Q ss_pred HHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceeccc
Q 043185 594 DRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMR 672 (724)
Q Consensus 594 ~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 672 (724)
..++... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++........ .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eeccC
Confidence 8887543 3458889999999999999999997 9999999999999999999999999999876643322 23456
Q ss_pred ccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 673 GTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 673 gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 899999999999988999999999999999999999999654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=285.64 Aligned_cols=191 Identities=32% Similarity=0.496 Sum_probs=161.5
Q ss_pred cccccccccEEEEEEEEC-CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCC
Q 043185 515 KNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGS 592 (724)
Q Consensus 515 ~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gs 592 (724)
.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|++++++++|+||+++++++.++...++||||+++++
T Consensus 79 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 158 (353)
T PLN00034 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS 158 (353)
T ss_pred hhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCc
Confidence 478999999999999975 67889999986532 2334678999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceeccc
Q 043185 593 LDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMR 672 (724)
Q Consensus 593 L~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 672 (724)
|... ....+..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+..... ......
T Consensus 159 L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~~~ 229 (353)
T PLN00034 159 LEGT-----HIADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PCNSSV 229 (353)
T ss_pred cccc-----ccCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-cccccc
Confidence 8643 235567788899999999999997 8999999999999999999999999999987643321 123456
Q ss_pred ccccccccccccC-----CcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 673 GTRGYLAPEWLTN-----SAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 673 gt~~y~aPE~l~~-----~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
|+..|+|||++.. ...+.++|||||||++|||++|+.||...
T Consensus 230 gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 276 (353)
T PLN00034 230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG 276 (353)
T ss_pred cCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 8999999998853 23456899999999999999999999743
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=278.19 Aligned_cols=199 Identities=28% Similarity=0.410 Sum_probs=164.8
Q ss_pred ccccccccccccEEEEEEEEC--CccEEEEEEeecCC--cccHHHHHHHHHHHhcC---CCCCccceeceee-----cCC
Q 043185 512 DNFKNLIGSGGFGAVYKGILN--DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNI---HHVNLVKLKGFCA-----QGR 579 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~--~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~-----~~~ 579 (724)
|.+.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|+.+++++ +||||+++++++. ...
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 455688999999999999863 46789999986432 22234566777776665 6999999999885 345
Q ss_pred eEEEEEEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCcc
Q 043185 580 QRLLVYEYMNHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSK 658 (724)
Q Consensus 580 ~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~ 658 (724)
..++|+||++ ++|.+++... ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 6899999997 5888888653 3458899999999999999999997 899999999999999999999999999998
Q ss_pred ccCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 659 LLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 659 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
...... ......|++.|+|||.+.+..++.++||||||+++|||++|++||.....
T Consensus 159 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~ 214 (290)
T cd07862 159 IYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 214 (290)
T ss_pred eccCCc--ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH
Confidence 664332 22345689999999999988999999999999999999999999976553
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=272.41 Aligned_cols=201 Identities=28% Similarity=0.440 Sum_probs=172.4
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
.+.+.+.||+|++|.||+|... .++.+|+|++... ....+++.+|++++++++|+||+++++++..+...++||||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 3456688999999999999975 5778999988753 3445778999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce
Q 043185 590 HGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 590 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
+++|.+++... ...+++..++.++.|+++||+|||+ .+++||||||+||++++++.+||+|||++...........
T Consensus 86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~ 162 (263)
T cd05052 86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 162 (263)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceeecc
Confidence 99999998754 3458899999999999999999996 8999999999999999999999999999987654322211
Q ss_pred ecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
.....+..|+|||.+.+..++.++||||||+++|||++ |..||.+..
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 210 (263)
T cd05052 163 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 210 (263)
T ss_pred CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 22234568999999999999999999999999999998 999987644
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=298.75 Aligned_cols=203 Identities=28% Similarity=0.345 Sum_probs=172.0
Q ss_pred hccccccccccccEEEEEEEE-CCccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCC--------
Q 043185 511 TDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR-------- 579 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-------- 579 (724)
.|.+.+.||+|+||.||+++. .+++.||||++.... ......+.+|+.++..++|+||++++..+....
T Consensus 33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~ 112 (496)
T PTZ00283 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL 112 (496)
T ss_pred CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence 566778999999999999985 478899999986532 334567889999999999999999988765332
Q ss_pred eEEEEEEecCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecC
Q 043185 580 QRLLVYEYMNHGSLDRILFGN---GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGL 656 (724)
Q Consensus 580 ~~~lV~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGl 656 (724)
..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEeccc
Confidence 367999999999999998643 3468889999999999999999997 8999999999999999999999999999
Q ss_pred ccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 657 SKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 657 a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
++.+..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~ 250 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM 250 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 986643221 122345799999999999999999999999999999999999999976554
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=280.28 Aligned_cols=201 Identities=25% Similarity=0.427 Sum_probs=170.5
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
++.+.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|++++++++||||+++++++..++..++||||+
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 86 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL 86 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence 3455688999999999999975 66789999987432 233456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
++ +|..++......+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 87 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 161 (309)
T cd07872 87 DK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-TY 161 (309)
T ss_pred CC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-cc
Confidence 85 8888887666678889999999999999999997 8999999999999999999999999999976543222 12
Q ss_pred ecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
....+++.|+|||.+.+ ..++.++||||||+++|||++|++||.....
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 210 (309)
T cd07872 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV 210 (309)
T ss_pred ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 23457899999999865 4689999999999999999999999976554
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=303.71 Aligned_cols=202 Identities=27% Similarity=0.400 Sum_probs=170.8
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCCc---ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV---QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
+.+.++||+|+||.||+|+.. +++.||+|++..... ...+++.+|++++++++||||+++++++.+++..++||||
T Consensus 4 YeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY 83 (932)
T PRK13184 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPY 83 (932)
T ss_pred eEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEc
Confidence 455689999999999999975 578899999865322 2346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCc
Q 043185 588 MNHGSLDRILFGN----------GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLS 657 (724)
Q Consensus 588 ~~~gsL~~~l~~~----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 657 (724)
+++++|.+++... ....++..+++++.||+.||+|||+ .+|+||||||+|||++.++.++|+|||++
T Consensus 84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999988631 1235567788999999999999997 89999999999999999999999999999
Q ss_pred cccCCCCc-----------------cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 658 KLLTPEQS-----------------SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 658 ~~~~~~~~-----------------~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
+....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~ 236 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence 86621110 011124689999999999999999999999999999999999999976543
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=289.03 Aligned_cols=199 Identities=31% Similarity=0.407 Sum_probs=168.8
Q ss_pred ccccccccccEEEEEEEE-CCccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCC-----eEEEEE
Q 043185 514 FKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR-----QRLLVY 585 (724)
Q Consensus 514 ~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~lV~ 585 (724)
..+.||+|+||.||++.. .+++.||+|++.... ....+++.+|+++++.++|+||+++++++.... ..++|+
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 83 (372)
T cd07853 4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT 83 (372)
T ss_pred ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence 457899999999999996 478889999986532 234467889999999999999999999998776 789999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc
Q 043185 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 665 (724)
||+. ++|...+... ..+++..+..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||+++.......
T Consensus 84 e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 84 ELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred eccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 9997 5787777544 468899999999999999999997 8999999999999999999999999999986654333
Q ss_pred cceecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 666 SLFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 666 ~~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
.......+++.|+|||++.+. .++.++||||||+++|||++|+.||.+....
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 211 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI 211 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH
Confidence 333445678999999999874 5799999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=268.18 Aligned_cols=197 Identities=34% Similarity=0.441 Sum_probs=169.8
Q ss_pred ccccccccEEEEEEEECCccEEEEEEeecCCc-ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCCHH
Q 043185 516 NLIGSGGFGAVYKGILNDKTIVAVKKITNVGV-QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLD 594 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gsL~ 594 (724)
++||+|+||.||+|...++..+|+|++..... .....+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46999999999999988888999999875432 23456889999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceeccccc
Q 043185 595 RILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGT 674 (724)
Q Consensus 595 ~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt 674 (724)
+++......+++..+..++.|++.+|.|||+ .+++|+||||+||+++.++.+||+|||++...............++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 9987666678899999999999999999996 8999999999999999999999999999875443322111222345
Q ss_pred ccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 675 RGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 675 ~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~ 199 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT 199 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC
Confidence 67999999998889999999999999999999 999996543
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=276.67 Aligned_cols=204 Identities=32% Similarity=0.565 Sum_probs=172.5
Q ss_pred hhccccccccccccEEEEEEEECC------ccEEEEEEeecCCcc-cHHHHHHHHHHHhcCCCCCccceeceeecCCeEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILND------KTIVAVKKITNVGVQ-GKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRL 582 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~~------~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 582 (724)
.++.+.+.||+|+||.||+|+..+ +..||+|.++..... ..+++.+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 445567889999999999998643 467999999765333 4578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcE
Q 043185 583 LVYEYMNHGSLDRILFGNG-------------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQA 649 (724)
Q Consensus 583 lV~e~~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 649 (724)
+||||+++++|.+++...+ ..+++..+..++.|++.|++|||+ .+++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeE
Confidence 9999999999999997542 346788899999999999999996 899999999999999999999
Q ss_pred EEEeecCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 043185 650 KISDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQ 716 (724)
Q Consensus 650 kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~ 716 (724)
||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~ 230 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN 230 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999976533221 11122345678999999999999999999999999999998 9999865443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=273.06 Aligned_cols=202 Identities=29% Similarity=0.466 Sum_probs=171.9
Q ss_pred hhccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
..+.+.++||+|+||.||+|+..+...||+|+++.. ....+++.+|++++++++|+||+++++.+.+ ...++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 346677899999999999999877777999999753 2345678999999999999999999998754 56799999999
Q ss_pred CCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce
Q 043185 590 HGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 590 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
+++|.+++... ...+++..+..++.|+++||+|||+ .+++|+||||+||+++.++.++|+|||.++..........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence 99999999753 3457899999999999999999996 8999999999999999999999999999986654332222
Q ss_pred ecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQ 716 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~ 716 (724)
....++..|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~ 209 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 209 (262)
T ss_pred cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh
Confidence 23346678999999998899999999999999999999 8889876543
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=287.72 Aligned_cols=201 Identities=27% Similarity=0.415 Sum_probs=167.7
Q ss_pred hccccccccccccEEEEEEEECC------ccEEEEEEeecCC-cccHHHHHHHHHHHhcCC-CCCccceeceeecCCeEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILND------KTIVAVKKITNVG-VQGKKDFCTEIAIIGNIH-HVNLVKLKGFCAQGRQRL 582 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~~------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~ 582 (724)
.+.+.++||+|+||.||+|+... ...||||+++... ....+.+.+|+++++++. ||||+++++++.+....+
T Consensus 38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~ 117 (400)
T cd05105 38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIY 117 (400)
T ss_pred ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceE
Confidence 44556899999999999998531 2469999997532 233467899999999996 999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCC-------------------------------------------------------------
Q 043185 583 LVYEYMNHGSLDRILFGNG------------------------------------------------------------- 601 (724)
Q Consensus 583 lV~e~~~~gsL~~~l~~~~------------------------------------------------------------- 601 (724)
|||||+++|+|.+++....
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (400)
T cd05105 118 IITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEA 197 (400)
T ss_pred EEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhh
Confidence 9999999999998886421
Q ss_pred ----------------------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCC
Q 043185 602 ----------------------------------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHF 647 (724)
Q Consensus 602 ----------------------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 647 (724)
..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~~~ 274 (400)
T cd05105 198 SKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQGK 274 (400)
T ss_pred hhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeCCC
Confidence 236777888999999999999996 8999999999999999999
Q ss_pred cEEEEeecCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 043185 648 QAKISDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPR 714 (724)
Q Consensus 648 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~ 714 (724)
.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 275 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence 999999999986543322 11122346778999999999999999999999999999997 99998654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=295.14 Aligned_cols=209 Identities=24% Similarity=0.289 Sum_probs=174.7
Q ss_pred ccccccccccccEEEEEEEECCc-cEEEEEEeecCCcccHHHHHHHHHHHhcCC-CCCccceecee-ec------CCeEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILNDK-TIVAVKKITNVGVQGKKDFCTEIAIIGNIH-HVNLVKLKGFC-AQ------GRQRL 582 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~~~-~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~-~~------~~~~~ 582 (724)
..+++.|.+|||+.||+|....+ ..+|+|++-.......+..++|+++|++|. |+|||.+++.. .. .-+.+
T Consensus 39 v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evl 118 (738)
T KOG1989|consen 39 VTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVL 118 (738)
T ss_pred EEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEE
Confidence 34568899999999999998765 889999997777788889999999999996 99999999932 21 12678
Q ss_pred EEEEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccC
Q 043185 583 LVYEYMNHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 583 lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 661 (724)
|.||||++|.|.+++... ...+++.++++|+.++++|+++||. ++.+|||||||-+||||+.+++.||||||.|.-..
T Consensus 119 lLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~ 197 (738)
T KOG1989|consen 119 LLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKI 197 (738)
T ss_pred eehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCccccccccc
Confidence 999999999999999743 2349999999999999999999997 46779999999999999999999999999986432
Q ss_pred CCCcc--c------eecccccccccccccc---cCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCC
Q 043185 662 PEQSS--L------FTTMRGTRGYLAPEWL---TNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSMD 721 (724)
Q Consensus 662 ~~~~~--~------~~~~~gt~~y~aPE~l---~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~~~~ 721 (724)
..... . .....-|+.|+|||++ .+.++++|+|||+|||+||-|+-...||+...+..|++
T Consensus 198 ~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIln 268 (738)
T KOG1989|consen 198 LSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILN 268 (738)
T ss_pred CCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEe
Confidence 22110 0 0012368999999988 67799999999999999999999999999887776665
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=276.08 Aligned_cols=203 Identities=30% Similarity=0.504 Sum_probs=170.0
Q ss_pred hhccccccccccccEEEEEEEE-----CCccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGIL-----NDKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLL 583 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~-----~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 583 (724)
....+.+.||+|+||.||+|.. ..+..+|+|.++... .+...++.+|++++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3445668899999999999984 245679999997533 2334678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcC----------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCC
Q 043185 584 VYEYMNHGSLDRILFGN----------------GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHF 647 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~----------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 647 (724)
||||+++++|.+++... ...+++...+.++.|++.||+|||+ ++++||||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 99999999999998532 1246788889999999999999997 8999999999999999999
Q ss_pred cEEEEeecCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 648 QAKISDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 648 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||.+..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~ 231 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS 231 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999999986543321 11223345678999999998889999999999999999998 999996644
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=286.86 Aligned_cols=194 Identities=29% Similarity=0.421 Sum_probs=171.1
Q ss_pred cccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCCHHH
Q 043185 517 LIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDR 595 (724)
Q Consensus 517 ~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gsL~~ 595 (724)
+||+|.||+||.|+.. +...+|||.+.....+..+-+.+|+.+-++++|.|||+.+|.+.+++..-|.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999964 556799999987666666778899999999999999999999999999999999999999999
Q ss_pred HHhcCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC-CCcEEEEeecCccccCCCCccceeccc
Q 043185 596 ILFGNGPVL--EWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY-HFQAKISDFGLSKLLTPEQSSLFTTMR 672 (724)
Q Consensus 596 ~l~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~ 672 (724)
+|...-.++ .+...-.+..||++||.|||+ +.|||||||-+||||+- .|.+||+|||-++.+..-. ....++.
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P~TETFT 737 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-PCTETFT 737 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCC-ccccccc
Confidence 998876566 667778889999999999996 99999999999999964 7889999999998775433 2346778
Q ss_pred ccccccccccccCC--cCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 673 GTRGYLAPEWLTNS--AISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 673 gt~~y~aPE~l~~~--~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
||..|||||++..+ .|..++|||||||++.||.||++||...
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~El 781 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVEL 781 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeec
Confidence 99999999999765 5899999999999999999999999543
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=272.88 Aligned_cols=198 Identities=28% Similarity=0.397 Sum_probs=170.5
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecCCc---ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV---QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
...+.||+|+||.||++... +++.+|+|++..... ...+.+.+|+.++++++|++|+++++.+.+++..++||||+
T Consensus 3 ~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05630 3 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 82 (285)
T ss_pred eeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEec
Confidence 34578999999999999975 678899999865322 22345778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 589 NHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 589 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
++++|.+++... ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++........
T Consensus 83 ~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-- 157 (285)
T cd05630 83 NGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-- 157 (285)
T ss_pred CCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc--
Confidence 999999988653 3458889999999999999999996 9999999999999999999999999999876543221
Q ss_pred eecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.....|+..|+|||++.+..++.++|+||||+++|||++|+.||....
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 123468999999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=266.48 Aligned_cols=199 Identities=30% Similarity=0.466 Sum_probs=174.6
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
.+.+.||+|++|.||+++.. +++.+++|.+... .....+++.+|++++++++||||+++++++.+....++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAE 82 (256)
T ss_pred eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCC
Confidence 45678999999999999975 6788999998643 23455778999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce
Q 043185 590 HGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 590 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
+++|.+++... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++........ .
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~-~ 158 (256)
T cd08529 83 NGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF-A 158 (256)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccch-h
Confidence 99999998764 5678899999999999999999996 89999999999999999999999999998876543221 2
Q ss_pred ecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
....++..|+|||++.+..++.++|+||||++++||++|+.||....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 205 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205 (256)
T ss_pred hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 33468889999999999999999999999999999999999997665
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-32 Score=259.46 Aligned_cols=199 Identities=30% Similarity=0.449 Sum_probs=171.6
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCCc----c----cHHHHHHHHHHHhcC-CCCCccceeceeecCCeE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV----Q----GKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQR 581 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~----~----~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~ 581 (724)
+.-++.||+|..+.|.+..++ +++..|+|++..... + -.+...+|+.+|+++ -||+|+.+.+++..+...
T Consensus 19 y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~ 98 (411)
T KOG0599|consen 19 YEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFV 98 (411)
T ss_pred cChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchh
Confidence 344578999999999988864 677899998854211 1 124467899999998 699999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccC
Q 043185 582 LLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 661 (724)
++|+|.|+.|.|.++|.+. ..++++...+|+.|+.+|++|||. +.||||||||+|||++++.++||+|||++..+.
T Consensus 99 FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 99 FLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceeeccC
Confidence 9999999999999999765 568899999999999999999997 999999999999999999999999999999876
Q ss_pred CCCccceecccccccccccccccC------CcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 662 PEQSSLFTTMRGTRGYLAPEWLTN------SAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 662 ~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
+... ....+||++|+|||.++- ..|+..+|+|++||+||-|+.|.+||.++.+
T Consensus 175 ~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ 233 (411)
T KOG0599|consen 175 PGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ 233 (411)
T ss_pred Cchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH
Confidence 6543 467789999999999853 3578899999999999999999999977643
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=275.49 Aligned_cols=203 Identities=31% Similarity=0.531 Sum_probs=172.0
Q ss_pred hccccccccccccEEEEEEEEC------CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN------DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLV 584 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 584 (724)
.+.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++.+++||||+++++++......++|
T Consensus 6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (288)
T cd05093 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV 85 (288)
T ss_pred HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 3455688999999999999852 3456899998765555567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCC------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEE
Q 043185 585 YEYMNHGSLDRILFGNG------------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKIS 652 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~~------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 652 (724)
+||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+||++++++.++|+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl~ 162 (288)
T cd05093 86 FEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIG 162 (288)
T ss_pred EEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEec
Confidence 99999999999986432 248899999999999999999996 899999999999999999999999
Q ss_pred eecCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 043185 653 DFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQ 716 (724)
Q Consensus 653 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~ 716 (724)
|||+++....... .......++..|+|||++.+..++.++|+||||++++||++ |++||.....
T Consensus 163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~ 228 (288)
T cd05093 163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 228 (288)
T ss_pred cCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999976543221 11122345778999999999999999999999999999998 9999865543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=268.52 Aligned_cols=203 Identities=29% Similarity=0.468 Sum_probs=173.9
Q ss_pred HHhhccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 508 EVATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 508 ~~a~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
....+++.++||+|+||.||+|...+++.+|+|.+... ....+++.+|+.++++++|+||+++++++. ....++++||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG-SMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCC-CCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 34566778899999999999999888889999998754 334578999999999999999999999874 4578999999
Q ss_pred cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 588 MNHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 588 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
+++++|.+++... +..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999988653 4568889999999999999999996 89999999999999999999999999999766533222
Q ss_pred ceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
......++..|+|||++....++.++|+||||++++||++ |+.||....
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 208 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT 208 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 2223345678999999998889999999999999999999 999997554
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=271.82 Aligned_cols=197 Identities=27% Similarity=0.397 Sum_probs=170.4
Q ss_pred ccccccccccEEEEEEEEC-CccEEEEEEeecCCc---ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 514 FKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV---QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 514 ~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
..+.||+|+||+||++... +++.+|+|.+..... .....+.+|++++++++|+||+++.+.+..++..++|+||++
T Consensus 4 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05632 4 QYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEecc
Confidence 4478999999999999974 678899999865322 223457889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce
Q 043185 590 HGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 590 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
+++|.+++... ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++........ .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~ 158 (285)
T cd05632 84 GGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--I 158 (285)
T ss_pred CccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc--c
Confidence 99999888653 3468999999999999999999997 8999999999999999999999999999876543221 2
Q ss_pred ecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
....|+..|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~ 205 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 33468999999999999899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=283.54 Aligned_cols=194 Identities=28% Similarity=0.342 Sum_probs=162.8
Q ss_pred ccccccEEEEEEEEC-CccEEEEEEeecCCc---ccHHHHHHHHHHHhcC---CCCCccceeceeecCCeEEEEEEecCC
Q 043185 518 IGSGGFGAVYKGILN-DKTIVAVKKITNVGV---QGKKDFCTEIAIIGNI---HHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 518 lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
||+|+||.||+|+.. +++.||+|++.+... .....+..|..++.+. +||||+++++.+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999975 678899999864321 2223455666776655 699999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
|+|..++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~~ 155 (330)
T cd05586 81 GELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNT 155 (330)
T ss_pred ChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-CccC
Confidence 9999888654 457889999999999999999997 8999999999999999999999999999875432221 1234
Q ss_pred ccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
..||..|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~ 202 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT 202 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH
Confidence 5799999999998765 589999999999999999999999977653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-32 Score=283.39 Aligned_cols=188 Identities=33% Similarity=0.480 Sum_probs=168.5
Q ss_pred ccccccccEEEEEEEE-CCccEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCC
Q 043185 516 NLIGSGGFGAVYKGIL-NDKTIVAVKKITNV---GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHG 591 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~g 591 (724)
+.||.|+||.||-++. .+.+.||||++.-. ..+.+.+++.|++.|++++|||++.+.|++..+...|||||||- |
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-G 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-G 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-c
Confidence 4699999999999995 46788999999633 34456789999999999999999999999999999999999995 4
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceecc
Q 043185 592 SLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTM 671 (724)
Q Consensus 592 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 671 (724)
+-.+++.-..+++.+.++..|..+.++||+|||+ .+.||||||+.||||++.|.+||+|||.|.+..+. ..+
T Consensus 111 SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-----nsF 182 (948)
T KOG0577|consen 111 SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-----NSF 182 (948)
T ss_pred cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCch-----hcc
Confidence 7788887777789999999999999999999998 89999999999999999999999999999876553 467
Q ss_pred ccccccccccccc---CCcCCCccchhhHHHHHHHHHhCCCCCC
Q 043185 672 RGTRGYLAPEWLT---NSAISEKTDVYSFGMVLLELVSGRRNCS 712 (724)
Q Consensus 672 ~gt~~y~aPE~l~---~~~~~~~sDv~SlGv~l~elltG~~p~~ 712 (724)
+|||.|||||+|. .+.|+-|+|||||||+..||...++|+-
T Consensus 183 vGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF 226 (948)
T KOG0577|consen 183 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 226 (948)
T ss_pred cCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc
Confidence 8999999999984 4689999999999999999999999974
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=301.38 Aligned_cols=198 Identities=25% Similarity=0.294 Sum_probs=177.3
Q ss_pred cccccccccEEEEEEEEC-CccEEEEEEeec---CCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 515 KNLIGSGGFGAVYKGILN-DKTIVAVKKITN---VGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 515 ~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~---~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
.++||+|+||.|..+++. .++.+|+|++.+ ........|.+|-.+|..-+.+-|+.++-.|+++.++|||||||+|
T Consensus 80 lKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pG 159 (1317)
T KOG0612|consen 80 LKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPG 159 (1317)
T ss_pred HHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccC
Confidence 478999999999999985 577899999976 2234446689999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
|+|-.++.+.. .++++.+.-++..|..||.-||+ .|+|||||||+|||||..|++||+|||.+..+..+.......
T Consensus 160 GDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~ 235 (1317)
T KOG0612|consen 160 GDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSV 235 (1317)
T ss_pred chHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEecc
Confidence 99999998776 78888888889999999999997 999999999999999999999999999998888776665667
Q ss_pred cccccccccccccc----C-CcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLT----N-SAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 671 ~~gt~~y~aPE~l~----~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.+|||.|++||++. + +.|++..|.||+||++|||+.|..||..++-
T Consensus 236 aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl 286 (1317)
T KOG0612|consen 236 AVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL 286 (1317)
T ss_pred ccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH
Confidence 78999999999994 3 5789999999999999999999999987653
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=275.62 Aligned_cols=194 Identities=26% Similarity=0.413 Sum_probs=159.9
Q ss_pred ccccccccEEEEEEEEC---CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeec--CCeEEEEEEecCC
Q 043185 516 NLIGSGGFGAVYKGILN---DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ--GRQRLLVYEYMNH 590 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV~e~~~~ 590 (724)
++||+|+||.||+|+.. +++.+|+|.+... .....+.+|+.++++++||||+++++++.. +...++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 57999999999999964 4578999998653 223567899999999999999999998854 4578899999865
Q ss_pred CCHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEE----eCCCcEEEEeecCcc
Q 043185 591 GSLDRILFGN--------GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILL----HYHFQAKISDFGLSK 658 (724)
Q Consensus 591 gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DFGla~ 658 (724)
+|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 777776422 2247888899999999999999997 899999999999999 456789999999998
Q ss_pred ccCCCCc--cceecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 659 LLTPEQS--SLFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 659 ~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
....... .......+|+.|+|||++.+. .++.++|||||||++|||++|++||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 7654321 122345689999999999774 58999999999999999999999997554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=270.16 Aligned_cols=201 Identities=30% Similarity=0.506 Sum_probs=176.0
Q ss_pred ccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCC
Q 043185 512 DNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHG 591 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~g 591 (724)
+.+.++||.|+||.||+|...++..+|+|.+.........++.+|+.+++.++|+||+++++++......++||||++++
T Consensus 8 y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (261)
T cd05148 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKG 87 (261)
T ss_pred HHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccC
Confidence 44568899999999999999888899999998765555678999999999999999999999999999999999999999
Q ss_pred CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 592 SLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 592 sL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
+|.+++... +..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++......... ...
T Consensus 88 ~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~-~~~ 163 (261)
T cd05148 88 SLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL-SSD 163 (261)
T ss_pred CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcccc-ccC
Confidence 999999764 4568899999999999999999996 89999999999999999999999999999766443221 123
Q ss_pred ccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQ 716 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~ 716 (724)
..++..|+|||.+.+..++.++||||||+++++|++ |+.||.....
T Consensus 164 ~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~ 210 (261)
T cd05148 164 KKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN 210 (261)
T ss_pred CCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 345678999999998899999999999999999998 8999976553
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=269.56 Aligned_cols=200 Identities=32% Similarity=0.473 Sum_probs=170.4
Q ss_pred hccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 511 TDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
.+.+.+.||+|+||.||++...++..+|+|.+.... ...+++.+|+.++++++|+||+++++++.+ ...+++|||+++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~ 84 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSK 84 (260)
T ss_pred HhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCC
Confidence 345668899999999999998888889999987542 345679999999999999999999998754 568899999999
Q ss_pred CCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 591 GSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 591 gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
++|.+++... ...+++..+..++.+++.||+|||+ .+++||||||+||++++++.++|+|||++..+.........
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05070 85 GSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQ 161 (260)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCccccccc
Confidence 9999998754 3458899999999999999999997 89999999999999999999999999999866443222112
Q ss_pred cccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
...++..|+|||.+.+..++.++|+||||+++|||++ |+.||....
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~ 208 (260)
T cd05070 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN 208 (260)
T ss_pred CCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 2335668999999988899999999999999999999 899996644
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=268.51 Aligned_cols=201 Identities=31% Similarity=0.523 Sum_probs=171.4
Q ss_pred ccccccccccccEEEEEEEECC----ccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILND----KTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~~----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
+.+.+.||+|+||.||+|+... ...||||+++... .....+|.+|+.++.+++||||+++++++.+....++|||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 85 (266)
T cd05033 6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITE 85 (266)
T ss_pred ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEE
Confidence 4556899999999999999742 3579999886532 3345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
|+++++|.+++......+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.++|+|||+++........
T Consensus 86 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd05033 86 YMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT 162 (266)
T ss_pred cCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccccccc
Confidence 999999999997766678999999999999999999996 99999999999999999999999999999877522211
Q ss_pred -ceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 667 -LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 667 -~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
......++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 163 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~ 213 (266)
T cd05033 163 YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS 213 (266)
T ss_pred eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC
Confidence 1112234678999999999999999999999999999998 999985433
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=268.99 Aligned_cols=192 Identities=26% Similarity=0.413 Sum_probs=163.0
Q ss_pred ccccccccEEEEEEEECCc-------------cEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEE
Q 043185 516 NLIGSGGFGAVYKGILNDK-------------TIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRL 582 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~-------------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 582 (724)
+.||+|+||.||+|+.... ..|++|.+..........+.+|+.++..++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 4689999999999986421 248888876654445567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCc-------EEEEeec
Q 043185 583 LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQ-------AKISDFG 655 (724)
Q Consensus 583 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~-------~kl~DFG 655 (724)
+||||+++++|..++......+++..+.+++.||++||+|||+ .+|+||||||+|||++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 9999999999999987666678999999999999999999996 89999999999999987664 8999999
Q ss_pred CccccCCCCccceeccccccccccccccc-CCcCCCccchhhHHHHHHHHH-hCCCCCCCCC
Q 043185 656 LSKLLTPEQSSLFTTMRGTRGYLAPEWLT-NSAISEKTDVYSFGMVLLELV-SGRRNCSPRS 715 (724)
Q Consensus 656 la~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~sDv~SlGv~l~ell-tG~~p~~~~~ 715 (724)
++...... ....++..|+|||.+. +..++.++||||||+++|||+ .|+.||....
T Consensus 158 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (262)
T cd05077 158 IPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT 214 (262)
T ss_pred CCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 98655322 2335788899999987 467899999999999999998 5888886543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=266.55 Aligned_cols=197 Identities=33% Similarity=0.449 Sum_probs=167.5
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCCH
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSL 593 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gsL 593 (724)
+.||+|+||.||+|+.. +++.+|+|.+.... ......+.+|++++++++||||+++++++......++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999974 67889999876432 33456789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce-eccc
Q 043185 594 DRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF-TTMR 672 (724)
Q Consensus 594 ~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-~~~~ 672 (724)
.+++......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........... ....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 99997766678999999999999999999996 8999999999999999999999999999875443211110 1112
Q ss_pred ccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 673 GTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 673 gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
.+..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~ 201 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS 201 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 3457999999999899999999999999999998 888886543
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=289.99 Aligned_cols=196 Identities=29% Similarity=0.421 Sum_probs=161.0
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecC--------CeE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG--------RQR 581 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--------~~~ 581 (724)
.+.+.+.||+|+||.||+|... .++.||||++... .....+|+.++++++||||+++++++... ...
T Consensus 67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence 4566789999999999999974 6788999988543 12345799999999999999999876432 246
Q ss_pred EEEEEecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCC-cEEEEeecCc
Q 043185 582 LLVYEYMNHGSLDRILFG---NGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHF-QAKISDFGLS 657 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFGla 657 (724)
++||||+++ +|.+++.. ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||++
T Consensus 143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 799999985 67666542 34568899999999999999999997 8999999999999999765 6999999999
Q ss_pred cccCCCCccceecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 658 KLLTPEQSSLFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 658 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
+.+..... .....+|+.|+|||++.+. .++.++|||||||++|||++|++||.+...
T Consensus 219 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 276 (440)
T PTZ00036 219 KNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS 276 (440)
T ss_pred hhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 86644322 2345689999999998764 689999999999999999999999987653
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=273.62 Aligned_cols=202 Identities=30% Similarity=0.532 Sum_probs=169.9
Q ss_pred ccccccccccccEEEEEEEECCc------cEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILNDK------TIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLV 584 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~~~------~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 584 (724)
+.+.+.||+|+||.||+|..... ..||+|.+.... .....++.+|++++.+++||||+++++++......+++
T Consensus 7 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 86 (283)
T cd05048 7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCML 86 (283)
T ss_pred cchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEE
Confidence 34568899999999999986432 469999886432 23346789999999999999999999999998999999
Q ss_pred EEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcE
Q 043185 585 YEYMNHGSLDRILFGNG---------------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQA 649 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 649 (724)
+||+++++|.+++.... ..+++...+.++.|++.||.|||+ .+++|+||||+||+++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 87 FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred EecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCcE
Confidence 99999999999986532 347788899999999999999997 899999999999999999999
Q ss_pred EEEeecCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 043185 650 KISDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQ 716 (724)
Q Consensus 650 kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~ 716 (724)
+|+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||.+...
T Consensus 164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~ 232 (283)
T cd05048 164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN 232 (283)
T ss_pred EECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9999999976533221 11223456788999999998899999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=283.22 Aligned_cols=201 Identities=25% Similarity=0.275 Sum_probs=170.5
Q ss_pred HHHHHhhccccccccccccEEEEEEEEC---CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeE
Q 043185 505 EELEVATDNFKNLIGSGGFGAVYKGILN---DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQR 581 (724)
Q Consensus 505 ~~l~~a~~~~~~~lG~G~fG~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 581 (724)
..+....+.+.+.||+|+||.||++... .+..||+|.+... +...+|++++++++||||+++++++......
T Consensus 87 ~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 87 ASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred chhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 3344455777889999999999999854 3467899987642 3456899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccC
Q 043185 582 LLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 661 (724)
++|||++. ++|..++. ....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.++|+|||++....
T Consensus 162 ~lv~e~~~-~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred EEEehhcC-CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 99999986 57888874 34568999999999999999999997 899999999999999999999999999997665
Q ss_pred CCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 662 PEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 662 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 4322 12234579999999999999999999999999999999999999996654
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=267.50 Aligned_cols=202 Identities=32% Similarity=0.492 Sum_probs=174.7
Q ss_pred hhccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
..+.+.+.||+|+||.||++..++.+.+|||.+... ....+++.+|+.++++++|+||+++++++......++||||++
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 445567899999999999999888888999998754 3445789999999999999999999999999899999999999
Q ss_pred CCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce
Q 043185 590 HGSLDRILFGNG-PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 590 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
+++|.+++.... ..+++..+..++.+++.|+.|||+ .+++|+||||+||+++.++.++|+|||+++..........
T Consensus 85 ~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 161 (261)
T cd05034 85 KGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAR 161 (261)
T ss_pred CCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhhhhh
Confidence 999999997643 568999999999999999999996 8999999999999999999999999999987654322212
Q ss_pred ecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
.....+..|+|||.+.+..+++++|+||||++++||++ |+.||....
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 209 (261)
T cd05034 162 EGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT 209 (261)
T ss_pred hccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 22335678999999999899999999999999999998 999996544
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=270.13 Aligned_cols=199 Identities=27% Similarity=0.445 Sum_probs=166.2
Q ss_pred cccccccccccEEEEEEEEC-Ccc----EEEEEEeecCCc-ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEE
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKT----IVAVKKITNVGV-QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~----~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
.+.+.||+|+||.||+|+.. +++ .+++|.+..... ....++..|+.++++++||||+++++++.. ...++++|
T Consensus 10 ~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e 88 (279)
T cd05111 10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQ 88 (279)
T ss_pred eeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEE
Confidence 34578999999999999963 333 477777754322 234567888889999999999999998754 56789999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc-
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS- 665 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~- 665 (724)
|+++|+|.+++......+++..+..++.||+.||+|||+ .+++||||||+|||+++++.+||+|||+++.......
T Consensus 89 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T cd05111 89 LSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK 165 (279)
T ss_pred eCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcc
Confidence 999999999998766678999999999999999999997 8999999999999999999999999999986643322
Q ss_pred cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 666 SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 666 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 166 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 216 (279)
T cd05111 166 YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR 216 (279)
T ss_pred cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 12233456788999999998899999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=268.76 Aligned_cols=199 Identities=28% Similarity=0.387 Sum_probs=171.3
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCC
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHG 591 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~g 591 (724)
.+.+.||+|+||.||++... ++..+++|.+........+.+.+|+++++.++||||+++++++..+...++|+||++++
T Consensus 8 ~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~ 87 (282)
T cd06643 8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG 87 (282)
T ss_pred HHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCC
Confidence 34577999999999999976 46678888887655555678899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceecc
Q 043185 592 SLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTM 671 (724)
Q Consensus 592 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 671 (724)
+|..++......+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........ .....
T Consensus 88 ~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~ 163 (282)
T cd06643 88 AVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRDSF 163 (282)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc-ccccc
Confidence 9999887655678999999999999999999997 8999999999999999999999999999876533221 12345
Q ss_pred ccccccccccccc-----CCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 672 RGTRGYLAPEWLT-----NSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 672 ~gt~~y~aPE~l~-----~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.++..|+|||++. +..++.++|+|||||++|||++|++||....
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 212 (282)
T cd06643 164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN 212 (282)
T ss_pred cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC
Confidence 6889999999984 4467889999999999999999999997554
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=267.30 Aligned_cols=204 Identities=27% Similarity=0.460 Sum_probs=173.9
Q ss_pred HHhhccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 508 EVATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 508 ~~a~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
....+.+.+.||+|+||.||++...++..+|+|.+... ....+.+.+|++++++++|+||+++.+++.+ ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 34566778899999999999999877778999988653 2345678999999999999999999999887 778999999
Q ss_pred cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 588 MNHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 588 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
+++++|.+++... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 9999999999763 4567888999999999999999996 89999999999999999999999999999766443222
Q ss_pred ceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQ 716 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~ 716 (724)
......++..|+|||++....++.++|+||||++++||++ |+.||...+.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 209 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 209 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH
Confidence 2223345678999999998889999999999999999999 9999976543
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=272.80 Aligned_cols=197 Identities=28% Similarity=0.409 Sum_probs=170.0
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV-GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
.+.+.||+|+||.||++... ++..+|+|.+... .....+++.+|++++.+++||||+++++++.+++..++|+||+++
T Consensus 4 ~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~ 83 (308)
T cd06615 4 EKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 83 (308)
T ss_pred eEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCC
Confidence 45678999999999999975 5677888887643 223345688999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
++|.+++... ..+++..+..++.|+++||.|||+ ..+++|+||||+|||++.++.++|+|||++....... ...
T Consensus 84 ~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~~~ 157 (308)
T cd06615 84 GSLDQVLKKA-GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANS 157 (308)
T ss_pred CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc---ccc
Confidence 9999999765 457889999999999999999996 3589999999999999999999999999987553321 134
Q ss_pred ccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
..++..|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~ 202 (308)
T cd06615 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD 202 (308)
T ss_pred CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc
Confidence 568899999999988889999999999999999999999996544
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=271.44 Aligned_cols=201 Identities=31% Similarity=0.538 Sum_probs=171.5
Q ss_pred ccccccccccccEEEEEEEEC------CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN------DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVY 585 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 585 (724)
+.+.+.||+|+||.||+++.. +...+++|++........+.+.+|++++++++|+||+++++++......++||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (291)
T cd05094 7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVF 86 (291)
T ss_pred eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEE
Confidence 445688999999999999843 34568899987655555678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEE
Q 043185 586 EYMNHGSLDRILFGNG---------------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAK 650 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 650 (724)
||+++++|.+++.... ..+++..++.++.||+.||+|||+ ++++||||||+||+++.++.++
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~~ 163 (291)
T cd05094 87 EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVK 163 (291)
T ss_pred ecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEE
Confidence 9999999999986532 347889999999999999999996 8999999999999999999999
Q ss_pred EEeecCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 651 ISDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 651 l~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
|+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 230 (291)
T cd05094 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 230 (291)
T ss_pred ECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999976543221 11223446788999999999999999999999999999999 999985544
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=265.30 Aligned_cols=195 Identities=28% Similarity=0.484 Sum_probs=164.0
Q ss_pred cccccccEEEEEEEEC---CccEEEEEEeecCCc-ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCC
Q 043185 517 LIGSGGFGAVYKGILN---DKTIVAVKKITNVGV-QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGS 592 (724)
Q Consensus 517 ~lG~G~fG~Vy~~~~~---~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gs 592 (724)
.||+|+||.||+|.+. .+..||+|++..... ...+++.+|+.++++++|+||+++++++.. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999864 345699998875432 234678999999999999999999998854 57899999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc--eec
Q 043185 593 LDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL--FTT 670 (724)
Q Consensus 593 L~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~--~~~ 670 (724)
|.+++......+++..+.+++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++.......... ...
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 999997666678999999999999999999997 899999999999999999999999999998654332211 111
Q ss_pred ccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
..++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 203 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK 203 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC
Confidence 223578999999998889999999999999999996 999996544
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=267.78 Aligned_cols=200 Identities=31% Similarity=0.452 Sum_probs=170.0
Q ss_pred hccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 511 TDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
.+.+.+.||+|++|.||++...++..+|+|++... ....+.+.+|++++++++|+|++++++++.. ...+++|||+++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~ 84 (260)
T cd05069 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGK 84 (260)
T ss_pred HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCC
Confidence 45667889999999999999887777999988653 2345678999999999999999999998754 568899999999
Q ss_pred CCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 591 GSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 591 gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
++|.+++... ...+++..+..++.|++.||.|||+ .+++|+||||+||++++++.++|+|||++............
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05069 85 GSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQ 161 (260)
T ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccC
Confidence 9999999754 3457899999999999999999996 89999999999999999999999999999766443222222
Q ss_pred cccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
...++..|+|||.+.+..++.++|+||||+++|||++ |+.||....
T Consensus 162 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 208 (260)
T cd05069 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV 208 (260)
T ss_pred CCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 3346678999999998899999999999999999999 899996644
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=271.99 Aligned_cols=200 Identities=29% Similarity=0.429 Sum_probs=174.0
Q ss_pred hccccccccccccEEEEEEEE-CCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 511 TDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
++.+.+.||+|++|.||+|+. .+++.+|+|.+........+.+.+|+.+++.++|+||+++++.+..+...++|+||++
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~ 100 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence 344557899999999999996 4678899999976555556788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
+++|.+++... .+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++......... ..
T Consensus 101 ~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~ 174 (296)
T cd06654 101 GGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RS 174 (296)
T ss_pred CCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccccc-cC
Confidence 99999998643 57889999999999999999997 89999999999999999999999999998765433211 23
Q ss_pred cccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
...+++.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~ 221 (296)
T cd06654 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221 (296)
T ss_pred cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Confidence 34688999999999998899999999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=277.60 Aligned_cols=202 Identities=30% Similarity=0.460 Sum_probs=167.4
Q ss_pred hccccccccccccEEEEEEEEC------CccEEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeceeec-CCeE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN------DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQ-GRQR 581 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~-~~~~ 581 (724)
.+.+.+.||+|+||.||+|... .++.||+|+++... ....+.+.+|+.++.++ +|+||++++++|.. +...
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~ 87 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL 87 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence 4566789999999999999742 23679999987532 22345678899999999 89999999998864 4567
Q ss_pred EEEEEecCCCCHHHHHhcCC------------------------------------------------------------
Q 043185 582 LLVYEYMNHGSLDRILFGNG------------------------------------------------------------ 601 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~~------------------------------------------------------------ 601 (724)
++++||+++++|.+++....
T Consensus 88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (337)
T cd05054 88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK 167 (337)
T ss_pred EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence 89999999999999885421
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc-ceeccccccccccc
Q 043185 602 PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS-LFTTMRGTRGYLAP 680 (724)
Q Consensus 602 ~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aP 680 (724)
..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.++|+|||+++.+...... ......++..|+||
T Consensus 168 ~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 168 EPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 257889999999999999999996 89999999999999999999999999999876433221 12234467789999
Q ss_pred ccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 681 EWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 681 E~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
|++.+..++.++|||||||++|||++ |+.||....
T Consensus 245 E~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~ 280 (337)
T cd05054 245 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 280 (337)
T ss_pred HHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=269.71 Aligned_cols=192 Identities=25% Similarity=0.397 Sum_probs=161.4
Q ss_pred cccccccEEEEEEEECC-------------------------ccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccce
Q 043185 517 LIGSGGFGAVYKGILND-------------------------KTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKL 571 (724)
Q Consensus 517 ~lG~G~fG~Vy~~~~~~-------------------------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l 571 (724)
+||+|+||.||+|.+.. ...|++|++.........+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998521 13488888865444445678899999999999999999
Q ss_pred eceeecCCeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCC----
Q 043185 572 KGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHF---- 647 (724)
Q Consensus 572 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---- 647 (724)
++++.++...++||||+++++|..++......+++..+..++.||+.||+|||+ .+|+||||||+|||++.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCcccC
Confidence 999999999999999999999999997766678899999999999999999996 8999999999999998654
Q ss_pred ---cEEEEeecCccccCCCCccceecccccccccccccccC-CcCCCccchhhHHHHHHHHH-hCCCCCCCCCC
Q 043185 648 ---QAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELV-SGRRNCSPRSQ 716 (724)
Q Consensus 648 ---~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~ell-tG~~p~~~~~~ 716 (724)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||.....
T Consensus 159 ~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred ccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 3899999987644322 12346788999998875 56899999999999999995 69999976543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=285.14 Aligned_cols=190 Identities=22% Similarity=0.240 Sum_probs=164.4
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
+.+.+.||+|+||.||++... .++.||||... ...+.+|++++++++|+|||++++++..+...++|||++.
T Consensus 171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~- 243 (461)
T PHA03211 171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR- 243 (461)
T ss_pred eEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-
Confidence 445678999999999999976 46789999643 2346789999999999999999999999999999999995
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc-ccee
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS-SLFT 669 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~ 669 (724)
++|..++......+++..++.|+.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++....... ....
T Consensus 244 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 320 (461)
T PHA03211 244 SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320 (461)
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence 68888887665679999999999999999999997 8999999999999999999999999999986643322 1122
Q ss_pred cccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCC
Q 043185 670 TMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNC 711 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~ 711 (724)
...||..|+|||++.+..++.++|||||||+||||++|..|+
T Consensus 321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 456999999999999999999999999999999999987655
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=269.28 Aligned_cols=202 Identities=26% Similarity=0.448 Sum_probs=168.0
Q ss_pred hccccccccccccEEEEEEEEC------CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN------DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLL 583 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 583 (724)
.+.+.+.||+|+||.||+|... .+..||+|++.... .....++.+|+.++++++||||+++++++.++...++
T Consensus 7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l 86 (277)
T cd05062 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 86 (277)
T ss_pred HceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEE
Confidence 4556788999999999999853 24579999886432 2334578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEee
Q 043185 584 VYEYMNHGSLDRILFGNG---------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDF 654 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DF 654 (724)
||||+++++|.+++.... ..+++..+..++.|++.||.|||+ .+++|+||||+||++++++.++|+||
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l~df 163 (277)
T cd05062 87 IMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDF 163 (277)
T ss_pred EEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEECCC
Confidence 999999999999986532 235778889999999999999997 89999999999999999999999999
Q ss_pred cCccccCCCCcc-ceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 655 GLSKLLTPEQSS-LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 655 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
|+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~ 226 (277)
T cd05062 164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS 226 (277)
T ss_pred CCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 998765432211 1112235678999999999899999999999999999999 788986554
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=268.80 Aligned_cols=200 Identities=28% Similarity=0.377 Sum_probs=172.1
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
+.+.+.||.|+||.||+|+.. ++..+++|.+........+++.+|+.++++++|+||+++++.+..+...++||||+++
T Consensus 14 y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 93 (292)
T cd06644 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPG 93 (292)
T ss_pred hhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCC
Confidence 445578999999999999975 4788999998766555667889999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
++|..++......+++..+..++.|++.+|+|||+ .+++||||||+||+++.++.++|+|||++........ ....
T Consensus 94 ~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~ 169 (292)
T cd06644 94 GAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ-RRDS 169 (292)
T ss_pred CcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecccccc-ccce
Confidence 99998887665678999999999999999999996 8999999999999999999999999999875432211 1233
Q ss_pred cccccccccccccc-----CCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLT-----NSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 671 ~~gt~~y~aPE~l~-----~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
..++..|+|||++. ...++.++|+||||+++|||++|++||....
T Consensus 170 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 219 (292)
T cd06644 170 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 219 (292)
T ss_pred ecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc
Confidence 45788999999984 3457889999999999999999999996543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=280.80 Aligned_cols=207 Identities=27% Similarity=0.444 Sum_probs=170.6
Q ss_pred HHHHhhccccccccccccEEEEEEEEC------CccEEEEEEeecCCc-ccHHHHHHHHHHHhcCC-CCCccceeceeec
Q 043185 506 ELEVATDNFKNLIGSGGFGAVYKGILN------DKTIVAVKKITNVGV-QGKKDFCTEIAIIGNIH-HVNLVKLKGFCAQ 577 (724)
Q Consensus 506 ~l~~a~~~~~~~lG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~ 577 (724)
++......+.+.||+|+||.||+|+.. .+..||+|+++.... ...+.+.+|++++.++. ||||+++++++..
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 444445556689999999999999864 235799999975422 23457889999999997 9999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHhcCC--------------------------------------------------------
Q 043185 578 GRQRLLVYEYMNHGSLDRILFGNG-------------------------------------------------------- 601 (724)
Q Consensus 578 ~~~~~lV~e~~~~gsL~~~l~~~~-------------------------------------------------------- 601 (724)
....++|+||+++|+|.++++...
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 999999999999999999986431
Q ss_pred -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCC
Q 043185 602 -----------------------------------------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPEN 640 (724)
Q Consensus 602 -----------------------------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~N 640 (724)
..+++..+..++.||+.||+|||+ .+++||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcce
Confidence 235677788899999999999996 899999999999
Q ss_pred eEEeCCCcEEEEeecCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 641 ILLHYHFQAKISDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 641 ILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
||++.++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999999986533221 11122346788999999999899999999999999999998 889986543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=279.29 Aligned_cols=197 Identities=28% Similarity=0.351 Sum_probs=165.1
Q ss_pred hhccccccccccccEEEEEEEEC-CccEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeceeecCC------e
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR------Q 580 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~ 580 (724)
..+.+.+.||+|+||.||++... .+..||+|++... ......++.+|+.+++.++||||+++++++.... .
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 100 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD 100 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence 34556789999999999999964 6788999998643 2234567889999999999999999999886443 5
Q ss_pred EEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCcccc
Q 043185 581 RLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLL 660 (724)
Q Consensus 581 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 660 (724)
.++||||+++ +|...+.. .++...+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 101 ~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 101 VYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred eEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 7999999976 55555532 37788888999999999999997 89999999999999999999999999999765
Q ss_pred CCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 661 TPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 661 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
..... .....+|+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 174 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 174 CTNFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred ccCcc--CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 33221 234568999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=263.97 Aligned_cols=200 Identities=32% Similarity=0.509 Sum_probs=172.7
Q ss_pred ccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCC
Q 043185 512 DNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHG 591 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~g 591 (724)
+.+.+.||+|+||.||++...++..+|+|++... .....++.+|++++++++||||+++++++......++|+||++++
T Consensus 6 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (256)
T cd05112 6 LTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHG 84 (256)
T ss_pred eEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCC
Confidence 4556889999999999999877778999988653 334567899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceecc
Q 043185 592 SLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTM 671 (724)
Q Consensus 592 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 671 (724)
+|.+++......+++..+..++.+++.+++|||+ .+++|+||||+||+++.++.++|+|||+++.............
T Consensus 85 ~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 161 (256)
T cd05112 85 CLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGT 161 (256)
T ss_pred cHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCcccccCCC
Confidence 9999997765568899999999999999999996 8999999999999999999999999999876543322211223
Q ss_pred cccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 672 RGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 672 ~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
.++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 162 ~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 206 (256)
T cd05112 162 KFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS 206 (256)
T ss_pred ccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 35678999999998889999999999999999998 999997554
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=267.29 Aligned_cols=191 Identities=31% Similarity=0.454 Sum_probs=166.4
Q ss_pred cccccccccccEEEEEEEE-CCccEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 513 NFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNV-GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
.+.++||+|+||.||+|+. .+++.+|+|++... .....+++.+|++++++++||||+++++.+......++|+||+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 83 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDG 83 (279)
T ss_pred hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence 3457899999999999986 46788999998643 233446788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
++|..+. .+++.....++.|++.||+|||+ .+|+|+||||+|||++.++.++|+|||++....... ...
T Consensus 84 ~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---~~~ 152 (279)
T cd06619 84 GSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---AKT 152 (279)
T ss_pred CChHHhh-----cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---ccC
Confidence 9997553 46778888999999999999997 999999999999999999999999999997654322 234
Q ss_pred ccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
..++..|+|||++.+..++.++|+||||+++|||++|+.||...
T Consensus 153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 196 (279)
T cd06619 153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQI 196 (279)
T ss_pred CCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhh
Confidence 56899999999999999999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=272.14 Aligned_cols=197 Identities=30% Similarity=0.424 Sum_probs=173.6
Q ss_pred cccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 515 KNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 515 ~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
.++||+|+||.||-+... +|+.+|.|++.+.. .+.....++|-.+|.+++.+.||.+--.+...+.++||+..|.|
T Consensus 190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG 269 (591)
T KOG0986|consen 190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG 269 (591)
T ss_pred eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence 368999999999999864 67788998885432 23445578899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 591 GSLDRILFGNG-PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 591 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
|+|.-+|.+.+ +.+++..+.-++.+|+.||++||+ ..||.|||||+|||||+.|+++|+|+|||..+...+.. .
T Consensus 270 GDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~--~ 344 (591)
T KOG0986|consen 270 GDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI--R 344 (591)
T ss_pred CceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCCCcc--c
Confidence 99998887654 568889999999999999999996 99999999999999999999999999999988665442 3
Q ss_pred cccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
..+||.+|||||++.++.|+...|.|||||+||||+.|+.||..+.+
T Consensus 345 ~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke 391 (591)
T KOG0986|consen 345 GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE 391 (591)
T ss_pred cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh
Confidence 45899999999999999999999999999999999999999966543
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=270.53 Aligned_cols=200 Identities=31% Similarity=0.534 Sum_probs=170.3
Q ss_pred cccccccccccEEEEEEEEC------CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEE
Q 043185 513 NFKNLIGSGGFGAVYKGILN------DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
.+.++||+|+||.||++... ++..+|+|.+........+++.+|+++++.++|+||+++++++......++++|
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (280)
T cd05092 8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFE 87 (280)
T ss_pred eeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEe
Confidence 34688999999999999742 345789998876655666789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEE
Q 043185 587 YMNHGSLDRILFGNG--------------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKIS 652 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 652 (724)
|+++++|.+++.... ..+++..++.++.|++.|++|||+ .+++||||||+|||+++++.+||+
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~kL~ 164 (280)
T cd05092 88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIG 164 (280)
T ss_pred cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCEEEC
Confidence 999999999987543 247889999999999999999996 899999999999999999999999
Q ss_pred eecCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 653 DFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 653 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |++||....
T Consensus 165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 229 (280)
T cd05092 165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS 229 (280)
T ss_pred CCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC
Confidence 9999876543221 11122335678999999999999999999999999999998 899986543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-30 Score=263.51 Aligned_cols=200 Identities=28% Similarity=0.346 Sum_probs=170.4
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCCc-----ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV-----QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVY 585 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 585 (724)
+...+.||+|++|.||++... +++.+|+|.+..... ...+.+.+|++++++++||||+++++++.++...++|+
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 344688999999999999964 678899998864321 12356888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc
Q 043185 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 665 (724)
||+++++|.+++... ..+++.....++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||+++.......
T Consensus 84 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 84 EYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 999999999988755 357888889999999999999996 8999999999999999999999999999876543221
Q ss_pred cce--ecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 666 SLF--TTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 666 ~~~--~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
... ....++..|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 211 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE 211 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc
Confidence 111 23457889999999999999999999999999999999999996543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=265.81 Aligned_cols=195 Identities=28% Similarity=0.388 Sum_probs=167.5
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCCHH
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLD 594 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gsL~ 594 (724)
..||+|+||.||+|+.. ++..||+|.+........+.+.+|+.++++++|+||+++++++..++..++|+||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 57999999999999964 66789999987665556678999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC-CCcEEEEeecCccccCCCCccceecc
Q 043185 595 RILFGNGPVL--EWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY-HFQAKISDFGLSKLLTPEQSSLFTTM 671 (724)
Q Consensus 595 ~~l~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~ 671 (724)
+++......+ ++..+..++.||+.||+|||+ .+|+||||||+||+++. ++.++|+|||++........ .....
T Consensus 94 ~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 169 (268)
T cd06624 94 ALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTETF 169 (268)
T ss_pred HHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-ccccC
Confidence 9997654444 778888899999999999997 89999999999999986 67899999999876543222 12234
Q ss_pred cccccccccccccCC--cCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 672 RGTRGYLAPEWLTNS--AISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 672 ~gt~~y~aPE~l~~~--~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
.++..|+|||++.+. .++.++|+||||+++|||++|++||...
T Consensus 170 ~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~ 214 (268)
T cd06624 170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214 (268)
T ss_pred CCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccc
Confidence 578999999998664 3789999999999999999999999643
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=268.82 Aligned_cols=202 Identities=30% Similarity=0.523 Sum_probs=171.0
Q ss_pred hccccccccccccEEEEEEEEC----CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN----DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVY 585 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 585 (724)
.+.+.+.||+|+||.||+|+.. ....+|+|.++... ....+.+.+|+.++.+++||||+++++++..++..++||
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (267)
T cd05066 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVT 84 (267)
T ss_pred HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence 3456789999999999999863 23368999886432 233467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc
Q 043185 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 665 (724)
||+++++|.+++......+++..+..++.|++.||+|||+ .+++||||||+|||++.++.++|+|||++........
T Consensus 85 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd05066 85 EYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 161 (267)
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence 9999999999998766678999999999999999999996 8999999999999999999999999999987654332
Q ss_pred ccee--cccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 666 SLFT--TMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 666 ~~~~--~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
.... ...++..|+|||++.+..++.++|+||||+++||+++ |+.||....
T Consensus 162 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~ 214 (267)
T cd05066 162 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS 214 (267)
T ss_pred eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC
Confidence 2111 1223568999999998899999999999999999887 999996554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=271.83 Aligned_cols=204 Identities=26% Similarity=0.427 Sum_probs=169.4
Q ss_pred hccccccccccccEEEEEEEECC------ccEEEEEEeecCCcc-cHHHHHHHHHHHhcCCCCCccceeceeecCCeEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILND------KTIVAVKKITNVGVQ-GKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLL 583 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~~------~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 583 (724)
.+.+.+.||+|+||.||+|...+ +..||+|+++..... ..+++.+|+.++.+++||||+++++++.+....++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 34456789999999999998642 467999999754322 23568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCc
Q 043185 584 VYEYMNHGSLDRILFGN---------------GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQ 648 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 648 (724)
++||+++++|..++... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCc
Confidence 99999999999998532 1247788889999999999999997 89999999999999999999
Q ss_pred EEEEeecCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 043185 649 AKISDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQS 717 (724)
Q Consensus 649 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~~ 717 (724)
+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||.+....
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 233 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 233 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999886543221 11123345778999999988889999999999999999998 88898765443
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=265.35 Aligned_cols=200 Identities=28% Similarity=0.339 Sum_probs=170.7
Q ss_pred hccccccccccccEEEEEEEE-CCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 511 TDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
.+.+.+.||+|+||.||+|+. .+++.+|+|++..........+.+|+.++.+++||||+++++.+..+...++|+||++
T Consensus 10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~ 89 (267)
T cd06646 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCG 89 (267)
T ss_pred hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCC
Confidence 345568899999999999996 4678899999875544455678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
+++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++........ ...
T Consensus 90 ~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~ 164 (267)
T cd06646 90 GGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KRK 164 (267)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc-ccC
Confidence 99999988654 357889999999999999999997 8999999999999999999999999999986643221 123
Q ss_pred ccccccccccccccc---CCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLT---NSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~---~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
...++..|+|||.+. ...++.++|+||||++++||++|+.||....
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~ 213 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLH 213 (267)
T ss_pred ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence 346888999999984 3457889999999999999999999985443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=272.69 Aligned_cols=194 Identities=27% Similarity=0.430 Sum_probs=159.1
Q ss_pred ccccccccEEEEEEEEC---CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceee--cCCeEEEEEEecCC
Q 043185 516 NLIGSGGFGAVYKGILN---DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCA--QGRQRLLVYEYMNH 590 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~--~~~~~~lV~e~~~~ 590 (724)
.+||+|+||.||+|+.. .+..+|+|++.... ....+.+|++++++++||||+++++++. .+...++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 57999999999999965 34679999987532 2356789999999999999999999885 35578999999875
Q ss_pred CCHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEE----eCCCcEEEEeecCcc
Q 043185 591 GSLDRILFGN--------GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILL----HYHFQAKISDFGLSK 658 (724)
Q Consensus 591 gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DFGla~ 658 (724)
+|.+++... ...+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 676666421 2247888899999999999999997 899999999999999 566789999999998
Q ss_pred ccCCCCc--cceecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 659 LLTPEQS--SLFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 659 ~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
....... .......+|+.|+|||++.+. .++.++||||||+++|||++|++||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 7654322 112345689999999999764 58999999999999999999999997554
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=269.60 Aligned_cols=200 Identities=30% Similarity=0.432 Sum_probs=174.8
Q ss_pred hccccccccccccEEEEEEEE-CCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 511 TDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
.+.+.+.||+|+||.||+++. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++..+...++||||++
T Consensus 20 ~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 99 (297)
T cd06656 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 99 (297)
T ss_pred hceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccC
Confidence 345567899999999999996 4788899999976555556778899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
+++|.+++.+. .+++..+..++.|++.||.|||+ .+++||||||+|||++.++.++|+|||++......... ..
T Consensus 100 ~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-~~ 173 (297)
T cd06656 100 GGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RS 173 (297)
T ss_pred CCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC-cC
Confidence 99999998653 57888999999999999999997 89999999999999999999999999998765443221 22
Q ss_pred cccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
...+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.....
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~ 220 (297)
T cd06656 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (297)
T ss_pred cccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 34678899999999998999999999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=269.55 Aligned_cols=199 Identities=29% Similarity=0.449 Sum_probs=174.7
Q ss_pred ccccccccccccEEEEEEEE-CCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 512 DNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
+.+.+.||.|++|.||+|.. .+++.|++|.+........+.+.+|+.+++.++||||+++++++..+...++|+||+++
T Consensus 21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 100 (296)
T cd06655 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG 100 (296)
T ss_pred EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCC
Confidence 44567899999999999985 57788999999765555567889999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
++|..++... .+++.++..++.+++.||+|||+ .+++|+||||+||+++.++.++|+|||++......... ...
T Consensus 101 ~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~ 174 (296)
T cd06655 101 GSLTDVVTET--CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-RST 174 (296)
T ss_pred CcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccccccc-CCC
Confidence 9999988654 58899999999999999999997 89999999999999999999999999998765443221 233
Q ss_pred ccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
..++..|+|||.+.+..++.++|+||||+++|||++|+.||....+
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~ 220 (296)
T cd06655 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (296)
T ss_pred cCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 4688899999999998899999999999999999999999977543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=267.65 Aligned_cols=202 Identities=28% Similarity=0.396 Sum_probs=170.0
Q ss_pred hccccccccccccEEEEEEEECC----ccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILND----KTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVY 585 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~~----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 585 (724)
.+.+.+.||+|+||.||+|...+ ...||+|+..... ....+.+.+|+.++++++||||+++++++.+ ...++||
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~ 85 (270)
T cd05056 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVM 85 (270)
T ss_pred hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEE
Confidence 34567899999999999998643 2468999886543 3445678999999999999999999998875 4578999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc
Q 043185 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 665 (724)
||+++++|.+++......+++..+..++.+++.||+|||+ .+++|+||||+||+++.++.++|+|||+++.......
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 86 ELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162 (270)
T ss_pred EcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecccccc
Confidence 9999999999998766678999999999999999999996 8999999999999999999999999999986644322
Q ss_pred cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 043185 666 SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQ 716 (724)
Q Consensus 666 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~ 716 (724)
.......++..|+|||.+....++.++||||||++++||++ |+.||.....
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~ 214 (270)
T cd05056 163 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214 (270)
T ss_pred eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 21122334568999999988889999999999999999996 9999976653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=270.25 Aligned_cols=200 Identities=26% Similarity=0.418 Sum_probs=169.7
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
.+.+.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++..+...++|+||+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 86 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 86 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence 3455678999999999999975 56789999986432 233456789999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
+ ++|..++......+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++........ ..
T Consensus 87 ~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~ 161 (301)
T cd07873 87 D-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TY 161 (301)
T ss_pred c-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-cc
Confidence 7 58988887666678899999999999999999997 8999999999999999999999999999976543221 12
Q ss_pred ecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
....+++.|+|||.+.+. .++.++||||||+++|||++|++||...+
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~ 209 (301)
T cd07873 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST 209 (301)
T ss_pred cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 234578899999998654 57889999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=267.64 Aligned_cols=202 Identities=30% Similarity=0.544 Sum_probs=170.4
Q ss_pred ccccccccccccEEEEEEEEC-Cc---cEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DK---TIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~---~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
+...+.||+|+||.||+|+.. ++ ..+|+|+++... ....+++.+|++++.+++|+||+++++++......++|||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (268)
T cd05063 7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITE 86 (268)
T ss_pred ceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEE
Confidence 344688999999999999974 22 368999886542 3345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
|+++++|.+++......+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++.........
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 163 (268)
T cd05063 87 YMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG 163 (268)
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence 999999999997766678999999999999999999996 89999999999999999999999999999766433221
Q ss_pred cee--cccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 043185 667 LFT--TMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQ 716 (724)
Q Consensus 667 ~~~--~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~ 716 (724)
... ....+..|+|||++....++.++||||||+++|||++ |+.||.....
T Consensus 164 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~ 216 (268)
T cd05063 164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN 216 (268)
T ss_pred ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH
Confidence 111 1223457999999998889999999999999999998 9999965543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-30 Score=262.74 Aligned_cols=200 Identities=30% Similarity=0.342 Sum_probs=175.2
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
+.+.+.||.|+||.||++... +++.+++|.+........+.+.+|++++++++||||+++++++..+...+++|||+++
T Consensus 5 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~ 84 (262)
T cd06613 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGG 84 (262)
T ss_pred eEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCC
Confidence 455688999999999999974 5678999999765555667899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
++|.+++......+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 85 ~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~ 160 (262)
T cd06613 85 GSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-KRKS 160 (262)
T ss_pred CcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh-cccc
Confidence 99999987765678899999999999999999996 8999999999999999999999999999876543221 1233
Q ss_pred ccccccccccccccCC---cCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNS---AISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~---~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
..++..|+|||.+.+. .++.++|+||||+++|||++|+.||....
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~ 208 (262)
T cd06613 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH 208 (262)
T ss_pred ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 4678899999999876 88999999999999999999999997654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=297.24 Aligned_cols=212 Identities=26% Similarity=0.397 Sum_probs=171.2
Q ss_pred CChHHHHHhhccccccccccccEEEEEEEEC-CccEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeceeec-
Q 043185 502 FDYEELEVATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ- 577 (724)
Q Consensus 502 ~~~~~l~~a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~- 577 (724)
+...+.....+.+.+.||+|+||.||+++.. .+..+|+|.+... .......+..|+.++.+++|||||++++++..
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 3334444556777889999999999999975 5667889988643 22345678999999999999999999998754
Q ss_pred -CCeEEEEEEecCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHcCC----CCCeEecCCCCCCeEEeCC---
Q 043185 578 -GRQRLLVYEYMNHGSLDRILFGN---GPVLEWQERFDIALGTARGLAYLHSGC----EQKIIHCDIKPENILLHYH--- 646 (724)
Q Consensus 578 -~~~~~lV~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~----~~~iiH~Dlkp~NILl~~~--- 646 (724)
....+|||||+++++|.++|... ...+++..++.|+.||+.||+|||+.. ..+||||||||+||||+.+
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 35789999999999999998642 346899999999999999999999622 1459999999999999643
Q ss_pred --------------CcEEEEeecCccccCCCCccceecccccccccccccccC--CcCCCccchhhHHHHHHHHHhCCCC
Q 043185 647 --------------FQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTN--SAISEKTDVYSFGMVLLELVSGRRN 710 (724)
Q Consensus 647 --------------~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDv~SlGv~l~elltG~~p 710 (724)
..+||+|||++..+..... .....||+.|+|||++.+ ..++.++|||||||+||||++|+.|
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P 242 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242 (1021)
T ss_pred cccccccccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 3489999999986643322 234568999999999854 4589999999999999999999999
Q ss_pred CCCCC
Q 043185 711 CSPRS 715 (724)
Q Consensus 711 ~~~~~ 715 (724)
|....
T Consensus 243 F~~~~ 247 (1021)
T PTZ00266 243 FHKAN 247 (1021)
T ss_pred CCcCC
Confidence 96543
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=267.45 Aligned_cols=200 Identities=28% Similarity=0.375 Sum_probs=173.3
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
+.+.+.||.|+||.||++... ++..+|+|.+........+.+.+|++++++++|+||+++++.+..+...++||||+++
T Consensus 7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (280)
T cd06611 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDG 86 (280)
T ss_pred HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCC
Confidence 344578999999999999975 6788999998765555667899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
++|.+++......+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++........ ....
T Consensus 87 ~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~ 162 (280)
T cd06611 87 GALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-KRDT 162 (280)
T ss_pred CcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccccc-ccce
Confidence 99999997766678999999999999999999997 8999999999999999999999999999875543222 1233
Q ss_pred cccccccccccccc-----CCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLT-----NSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 671 ~~gt~~y~aPE~l~-----~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
..++..|+|||.+. ...++.++|+||||+++|||++|+.||...+
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~ 212 (280)
T cd06611 163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN 212 (280)
T ss_pred eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC
Confidence 46889999999985 3457789999999999999999999997654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=266.34 Aligned_cols=203 Identities=30% Similarity=0.537 Sum_probs=171.0
Q ss_pred hhccccccccccccEEEEEEEECC-c---cEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILND-K---TIVAVKKITNV-GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLV 584 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~~-~---~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 584 (724)
..+.+.+.||+|+||.||+|.... + ..||+|.+... .....++|..|+.++++++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 345677899999999999999752 2 36999998754 233456899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC
Q 043185 585 YEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (724)
+||+++++|.+++......+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 99999999999998766678999999999999999999996 899999999999999999999999999987654322
Q ss_pred cc-ceeccc---ccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 665 SS-LFTTMR---GTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 665 ~~-~~~~~~---gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
.. ...... .+..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~ 216 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 216 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC
Confidence 11 111111 2457999999999999999999999999999987 999996544
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=277.92 Aligned_cols=196 Identities=26% Similarity=0.335 Sum_probs=165.4
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeceeecC------CeE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG------RQR 581 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~ 581 (724)
.+.+.+.||+|+||.||++... .++.||||++... .....+++.+|+.+++.++||||+++++++... ...
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~ 104 (364)
T cd07875 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 104 (364)
T ss_pred ceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeE
Confidence 4556689999999999999964 5778999998653 223446788999999999999999999987543 357
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccC
Q 043185 582 LLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 661 (724)
++||||+++ +|...+.. .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 105 YIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred EEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 999999976 66666643 37788889999999999999997 899999999999999999999999999998654
Q ss_pred CCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 662 PEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 662 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.... .....+|..|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 178 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 178 TSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred CCCc--ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 3321 234568999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=265.29 Aligned_cols=197 Identities=28% Similarity=0.374 Sum_probs=162.0
Q ss_pred ccccccccEEEEEEEECC---ccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCC
Q 043185 516 NLIGSGGFGAVYKGILND---KTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHG 591 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~---~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~g 591 (724)
+.||+|+||.||+|+..+ ...+|+|+++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 359999999999998653 3568999886543 233457889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc-
Q 043185 592 SLDRILFGNG----PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS- 666 (724)
Q Consensus 592 sL~~~l~~~~----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~- 666 (724)
+|.+++.... ...++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999986432 245677888899999999999997 89999999999999999999999999998754332211
Q ss_pred ceecccccccccccccccCC-------cCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNS-------AISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~-------~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
......++..|+|||++.+. .++.++|+||||+++|||++ |+.||....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 214 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLS 214 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Confidence 11233467889999998642 35789999999999999996 999996544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-30 Score=262.49 Aligned_cols=198 Identities=32% Similarity=0.454 Sum_probs=174.6
Q ss_pred ccccccccccccEEEEEEEECC-ccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 512 DNFKNLIGSGGFGAVYKGILND-KTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
+.+.+.||+|+||.||+++..+ ++.+++|.+..... .+++.+|++++++++|+||+++++++.++...++++||+++
T Consensus 5 y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 82 (256)
T cd06612 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82 (256)
T ss_pred chhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence 3455789999999999999864 78899999875422 67899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
++|.+++......+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 83 ~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 158 (256)
T cd06612 83 GSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRNT 158 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-cccc
Confidence 99999997766788999999999999999999996 8999999999999999999999999999886654321 1223
Q ss_pred ccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
..++..|+|||++.+..++.++||||||+++|||++|++||....
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~ 203 (256)
T cd06612 159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIH 203 (256)
T ss_pred ccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 457889999999999999999999999999999999999996544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=266.73 Aligned_cols=197 Identities=27% Similarity=0.378 Sum_probs=159.8
Q ss_pred ccccccccEEEEEEEECC---ccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCC
Q 043185 516 NLIGSGGFGAVYKGILND---KTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHG 591 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~---~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~g 591 (724)
+.||+|+||.||+|...+ ...+++|.+.... ......+.+|+++++.++|+||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 359999999999998543 3468888775432 233457889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc-c
Q 043185 592 SLDRILFGNG----PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS-S 666 (724)
Q Consensus 592 sL~~~l~~~~----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~-~ 666 (724)
+|.+++.... ...++.....++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 9999997643 234577788999999999999997 8999999999999999999999999999875433211 1
Q ss_pred ceecccccccccccccccC-------CcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTN-------SAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~-------~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
......++..|+|||++.. ..++.++||||||+++|||++ |+.||....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS 214 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence 1122345678999998743 356889999999999999999 788886544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=264.88 Aligned_cols=198 Identities=27% Similarity=0.343 Sum_probs=170.2
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
+.+.+.||+|+||.||+|+.. +++.+|+|.++.........+.+|+.+++.++||||+++++.+......++|+||+++
T Consensus 11 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 90 (267)
T cd06645 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGG 90 (267)
T ss_pred HHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Confidence 334578999999999999964 6788999998765444556788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
++|.+++...+ .+++.....++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........ ....
T Consensus 91 ~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 165 (267)
T cd06645 91 GSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-KRKS 165 (267)
T ss_pred CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-cccc
Confidence 99999986553 58899999999999999999997 8999999999999999999999999999876543221 1234
Q ss_pred cccccccccccccc---CCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLT---NSAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 671 ~~gt~~y~aPE~l~---~~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
..|+..|+|||++. ...++.++|+||||+++|||++|+.||...
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~ 212 (267)
T cd06645 166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred ccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccc
Confidence 56899999999984 456889999999999999999999998543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=272.42 Aligned_cols=200 Identities=32% Similarity=0.503 Sum_probs=165.9
Q ss_pred hccccccccccccEEEEEEEEC-Ccc--EEEEEEeecC-CcccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKT--IVAVKKITNV-GVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVY 585 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~--~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 585 (724)
.+.+.+.||+|+||.||+|... ++. .+|+|+++.. .....+++.+|++++.++ +|+||+++++++.+++..++|+
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 87 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 87 (303)
T ss_pred hceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEE
Confidence 3456688999999999999964 333 4677777643 233446788999999999 8999999999999999999999
Q ss_pred EecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEE
Q 043185 586 EYMNHGSLDRILFGNG---------------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAK 650 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 650 (724)
||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+|||++.++.+|
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~k 164 (303)
T cd05088 88 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAK 164 (303)
T ss_pred EeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcEE
Confidence 9999999999986432 357889999999999999999996 8999999999999999999999
Q ss_pred EEeecCccccCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 651 ISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 651 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
|+|||++........ ......+..|+|||++.+..++.++||||||++++||++ |..||....
T Consensus 165 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 228 (303)
T cd05088 165 IADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228 (303)
T ss_pred eCccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC
Confidence 999999864321111 111224567999999988889999999999999999998 999996554
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=264.16 Aligned_cols=196 Identities=31% Similarity=0.440 Sum_probs=169.3
Q ss_pred ccccccccEEEEEEEECC--c--cEEEEEEeecCCc-ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 516 NLIGSGGFGAVYKGILND--K--TIVAVKKITNVGV-QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~--~--~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
+.||+|++|.||+|.... + ..+|+|.+..... ...+++.+|+.++++++||||+++++.+.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999743 2 3589999976555 556789999999999999999999999988 889999999999
Q ss_pred CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc--c
Q 043185 591 GSLDRILFGNG-PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS--L 667 (724)
Q Consensus 591 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~--~ 667 (724)
++|.+++.... ..+++.....++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++.+...... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999997754 568999999999999999999996 89999999999999999999999999999876542211 1
Q ss_pred eecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
.....++..|+|||.+.+..++.++||||||++++||++ |+.||....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 205 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS 205 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence 122456788999999999999999999999999999999 999996544
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-30 Score=266.74 Aligned_cols=198 Identities=34% Similarity=0.495 Sum_probs=167.1
Q ss_pred ccccccccccccEEEEEEEEC-----CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeec--CCeEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-----DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ--GRQRLLV 584 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV 584 (724)
+.+.+.||+|+||.||++.+. ++..||+|++........+++.+|++++++++||||+++++++.. ....++|
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 85 (284)
T cd05081 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLV 85 (284)
T ss_pred ceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEE
Confidence 345578999999999999853 467899999876655566789999999999999999999998753 3468899
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC
Q 043185 585 YEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (724)
+||+++++|.+++......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 86 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 162 (284)
T cd05081 86 MEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162 (284)
T ss_pred EEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence 99999999999997665678999999999999999999996 899999999999999999999999999998764332
Q ss_pred ccc--eecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCC
Q 043185 665 SSL--FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCS 712 (724)
Q Consensus 665 ~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~ 712 (724)
... .....++..|+|||++.+..++.++|+||||++++||++|..|+.
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred cceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 211 111223456999999998899999999999999999999877653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=266.78 Aligned_cols=200 Identities=26% Similarity=0.433 Sum_probs=167.4
Q ss_pred ccccccccccccEEEEEEEEC-Ccc----EEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKT----IVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVY 585 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 585 (724)
..+.+.||+|+||.||+|+.. ++. .||+|+++... ....+++.+|+.++..++|+||+++++++.. ...++++
T Consensus 9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~ 87 (279)
T cd05109 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVT 87 (279)
T ss_pred eeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEE
Confidence 445588999999999999853 333 48999886432 3345678899999999999999999999875 4577999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc
Q 043185 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 665 (724)
||+++|+|.+++......+++..++.++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++.......
T Consensus 88 ~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~ 164 (279)
T cd05109 88 QLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164 (279)
T ss_pred EcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence 9999999999998766678999999999999999999997 8999999999999999999999999999987654322
Q ss_pred cc-eecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 666 SL-FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 666 ~~-~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
.. .....++..|+|||.+.+..++.++||||||+++|||++ |..||+...
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 216 (279)
T cd05109 165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP 216 (279)
T ss_pred eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 11 112234678999999999899999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=279.90 Aligned_cols=194 Identities=28% Similarity=0.434 Sum_probs=171.9
Q ss_pred ccccccccEEEEEEEECCcc-EEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCCHH
Q 043185 516 NLIGSGGFGAVYKGILNDKT-IVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLD 594 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~-~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gsL~ 594 (724)
..||.|+||.|||++.++.. ..|.|.+...+.+..++|+-|++||..++||+||+|++.+..++.++|..|||.||-.+
T Consensus 38 GELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVD 117 (1187)
T KOG0579|consen 38 GELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVD 117 (1187)
T ss_pred hhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHh
Confidence 46999999999999977543 45678888777788899999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceeccccc
Q 043185 595 RILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGT 674 (724)
Q Consensus 595 ~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt 674 (724)
.++.+-+..+.+.++.-+.+|++.||.|||+ +.|||||||+.|||++-+|.++|+|||.+....... .....+.||
T Consensus 118 aimlEL~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~-qkRDsFIGT 193 (1187)
T KOG0579|consen 118 AIMLELGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR-QKRDSFIGT 193 (1187)
T ss_pred HHHHHhccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhHH-hhhccccCC
Confidence 9998888889999999999999999999997 999999999999999999999999999876443221 223567899
Q ss_pred ccccccccc-----cCCcCCCccchhhHHHHHHHHHhCCCCCCC
Q 043185 675 RGYLAPEWL-----TNSAISEKTDVYSFGMVLLELVSGRRNCSP 713 (724)
Q Consensus 675 ~~y~aPE~l-----~~~~~~~~sDv~SlGv~l~elltG~~p~~~ 713 (724)
+.|||||+. .+.+|+.++|||||||+|.||..+.+|-..
T Consensus 194 PYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe 237 (1187)
T KOG0579|consen 194 PYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE 237 (1187)
T ss_pred cccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc
Confidence 999999987 456899999999999999999999998643
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=280.44 Aligned_cols=194 Identities=27% Similarity=0.444 Sum_probs=164.9
Q ss_pred cccccccccccEEEEEEEEC-CccEEEE--EEeec--CCcccHHHHHHHHHHHhcCCCCCccceeceeecCCe--EEEEE
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAV--KKITN--VGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQ--RLLVY 585 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAv--K~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~--~~lV~ 585 (724)
.|.++||+|+|-+||||... +|-.||= +++.+ ......++|..|+++|+.|+||||++++..+.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 35678999999999999864 4444551 12222 224455889999999999999999999999876654 77999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC-CCcEEEEeecCccccCCCC
Q 043185 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY-HFQAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFGla~~~~~~~ 664 (724)
|.|..|+|..|+++.+ ..+.+....+++||++||.|||+ ...+|||||||-+||+|+. .|.+||+|+|||..++...
T Consensus 123 EL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred ecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 9999999999998764 57888999999999999999998 4689999999999999975 5899999999999887655
Q ss_pred ccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCC
Q 043185 665 SSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCS 712 (724)
Q Consensus 665 ~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~ 712 (724)
. ....|||.|||||+.+ ..|++.+||||||++|+||+|+..||.
T Consensus 201 a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs 244 (632)
T KOG0584|consen 201 A---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS 244 (632)
T ss_pred c---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh
Confidence 3 3478999999999998 689999999999999999999999994
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-30 Score=269.37 Aligned_cols=200 Identities=30% Similarity=0.468 Sum_probs=165.5
Q ss_pred ccccccccccccEEEEEEEECC-c--cEEEEEEeecC-CcccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILND-K--TIVAVKKITNV-GVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~~-~--~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
+.+.+.||+|+||.||+|+..+ + ..+++|.++.. .....+++.+|++++.++ +||||+++++++.+....++|+|
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 83 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE 83 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence 3456889999999999999753 3 24788887642 233446789999999999 79999999999999999999999
Q ss_pred ecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEE
Q 043185 587 YMNHGSLDRILFGNG---------------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKI 651 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 651 (724)
|+++++|.+++.+.. ..+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEEE
Confidence 999999999986532 247888999999999999999996 89999999999999999999999
Q ss_pred EeecCccccCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 043185 652 SDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQ 716 (724)
Q Consensus 652 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~ 716 (724)
+|||++........ ......+..|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 161 ~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~ 224 (297)
T cd05089 161 ADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC 224 (297)
T ss_pred CCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999864321111 111223457999999999899999999999999999998 9999966543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=274.79 Aligned_cols=190 Identities=25% Similarity=0.321 Sum_probs=163.0
Q ss_pred hhccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
..+.+.+.||+|+||.||+|+.. .+..||+|..... ....|+.++++++|+||+++++++.+....++|+||+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 34666789999999999999976 4567888875432 2356999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
. ++|..++......+++..+..|+.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 140 ~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~~ 213 (357)
T PHA03209 140 S-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--AF 213 (357)
T ss_pred C-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCc--cc
Confidence 5 58888887766779999999999999999999997 899999999999999999999999999997543222 12
Q ss_pred ecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNC 711 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~ 711 (724)
....||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 3456899999999999999999999999999999999865444
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=264.60 Aligned_cols=198 Identities=35% Similarity=0.532 Sum_probs=171.1
Q ss_pred ccccccccccccEEEEEEEECC-ccEEEEEEeecCCcccHH--HHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 512 DNFKNLIGSGGFGAVYKGILND-KTIVAVKKITNVGVQGKK--DFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~~~~~--~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
|.+.+.||+|+||+||+++... ++.+|+|++......... ...+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 3456899999999999999864 568999999865433322 3456999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
++++|.+++.. ...+++..+..++.|+++||++||+ .+++|+||||+||++++++.++|+|||.+...... ....
T Consensus 81 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-~~~~ 155 (260)
T PF00069_consen 81 PGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-NENF 155 (260)
T ss_dssp TTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTST-TSEB
T ss_pred ccccccccccc-ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc-cccc
Confidence 99999999973 3467999999999999999999997 89999999999999999999999999999764222 2223
Q ss_pred eccccccccccccccc-CCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLT-NSAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~-~~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
....++..|+|||++. +..++.++|+||||+++++|++|+.||...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 4567899999999998 888999999999999999999999999765
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=277.09 Aligned_cols=196 Identities=27% Similarity=0.329 Sum_probs=164.7
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecC------CeE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG------RQR 581 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~ 581 (724)
.+...+.||+|+||.||++... .++.+|||++.... ....+++.+|+.+++.++||||+++++++... ...
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 97 (355)
T cd07874 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDV 97 (355)
T ss_pred ceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccccee
Confidence 4555688999999999999864 57789999987532 23346778999999999999999999987643 357
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccC
Q 043185 582 LLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 661 (724)
++||||+++ +|...+.. .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 98 ~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 98 YLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred EEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 999999976 56665543 47788889999999999999996 899999999999999999999999999998654
Q ss_pred CCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 662 PEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 662 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.... .....+|+.|+|||++.+..++.++||||||+++|||++|+.||.+..
T Consensus 171 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 171 TSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred Cccc--cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 3221 234568999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=265.49 Aligned_cols=201 Identities=26% Similarity=0.449 Sum_probs=166.4
Q ss_pred cccccccccccEEEEEEEECC----ccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCe------
Q 043185 513 NFKNLIGSGGFGAVYKGILND----KTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQ------ 580 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~~----~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~------ 580 (724)
.+.+.||+|+||.||+|+... ...||+|+++... ......+.+|++.++.++||||+++++++.....
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 356789999999999999642 3679999987532 2334678999999999999999999998866554
Q ss_pred EEEEEEecCCCCHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeec
Q 043185 581 RLLVYEYMNHGSLDRILFGN-----GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFG 655 (724)
Q Consensus 581 ~~lV~e~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFG 655 (724)
.++++||+++++|..++... ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCcc
Confidence 78999999999999888532 2357889999999999999999996 899999999999999999999999999
Q ss_pred CccccCCCCcc-ceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 043185 656 LSKLLTPEQSS-LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQ 716 (724)
Q Consensus 656 la~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~ 716 (724)
+++........ .......+..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~ 221 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN 221 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99866443221 1112234678999999998899999999999999999999 8999866543
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=262.99 Aligned_cols=199 Identities=22% Similarity=0.410 Sum_probs=170.7
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
+.+.+.||+|+||.||+|+.. +++.||||++.... .....++.+|++++++++||||+++++++.+.+..++|+||
T Consensus 4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08228 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEe
Confidence 455688999999999999964 67889999876422 23345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC
Q 043185 588 MNHGSLDRILFG---NGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 588 ~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (724)
+++++|.+++.. ....++...+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999999988753 23457888999999999999999996 899999999999999999999999999988765432
Q ss_pred ccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 665 SSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 665 ~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
.. .....++..|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus 161 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred HH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 21 12346888999999999888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-30 Score=262.59 Aligned_cols=197 Identities=34% Similarity=0.540 Sum_probs=172.6
Q ss_pred ccccccccEEEEEEEECC----ccEEEEEEeecCCcc-cHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 516 NLIGSGGFGAVYKGILND----KTIVAVKKITNVGVQ-GKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~----~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
+.||+|+||.||++.... +..+++|.+...... ..+++.+|++++..++|+||+++++++..+...++|+||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999754 778999999765333 367889999999999999999999999999999999999999
Q ss_pred CCHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCC
Q 043185 591 GSLDRILFGN--------GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP 662 (724)
Q Consensus 591 gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (724)
++|.+++... ...+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875 4678999999999999999999996 9999999999999999999999999999987654
Q ss_pred CCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 663 EQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 663 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
... .......++..|+|||.+....++.++||||||++++||++ |+.||....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 212 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS 212 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC
Confidence 321 11233457889999999998889999999999999999999 699997654
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-30 Score=266.81 Aligned_cols=198 Identities=30% Similarity=0.404 Sum_probs=163.3
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcC---CCCCccceeceeec-----CCe
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNI---HHVNLVKLKGFCAQ-----GRQ 580 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~-----~~~ 580 (724)
+.+.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++..+ +||||+++++++.. ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 345678999999999999975 67889999886432 12234566777776655 79999999998764 345
Q ss_pred EEEEEEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccc
Q 043185 581 RLLVYEYMNHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKL 659 (724)
Q Consensus 581 ~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 659 (724)
.++|+||+++ +|..++... ...+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++.
T Consensus 82 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 82 VTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred EEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCcccc
Confidence 7899999985 888887654 3458899999999999999999997 8999999999999999999999999999986
Q ss_pred cCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 660 LTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 660 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
...... .....++..|+|||++.+..++.++|||||||++|||++|++||....
T Consensus 158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~ 211 (288)
T cd07863 158 YSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 211 (288)
T ss_pred ccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCC
Confidence 643321 233467899999999999899999999999999999999999996654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-30 Score=263.02 Aligned_cols=194 Identities=30% Similarity=0.479 Sum_probs=163.6
Q ss_pred cccccccEEEEEEEEC---CccEEEEEEeecCCc--ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCC
Q 043185 517 LIGSGGFGAVYKGILN---DKTIVAVKKITNVGV--QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHG 591 (724)
Q Consensus 517 ~lG~G~fG~Vy~~~~~---~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~g 591 (724)
.||+|+||.||+|.+. ++..+|+|+++.... ...+++.+|+.++++++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 567899999864322 23467899999999999999999999885 45678999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc--ee
Q 043185 592 SLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL--FT 669 (724)
Q Consensus 592 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~--~~ 669 (724)
+|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++......... ..
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 999998654 358899999999999999999996 899999999999999999999999999998765433211 11
Q ss_pred cccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
...++..|+|||.+....++.++|+||||+++|||++ |+.||....
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 203 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK 203 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 2234578999999988889999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-30 Score=262.37 Aligned_cols=190 Identities=28% Similarity=0.465 Sum_probs=162.5
Q ss_pred ccccccccEEEEEEEECCcc-----------EEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEE
Q 043185 516 NLIGSGGFGAVYKGILNDKT-----------IVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLV 584 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~-----------~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 584 (724)
+.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999976433 4777877644322 6788999999999999999999999988 778999
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCC-------cEEEEeecCc
Q 043185 585 YEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHF-------QAKISDFGLS 657 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-------~~kl~DFGla 657 (724)
+||+++++|.+++......+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999998765578999999999999999999996 8999999999999999888 7999999999
Q ss_pred cccCCCCccceecccccccccccccccCC--cCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 658 KLLTPEQSSLFTTMRGTRGYLAPEWLTNS--AISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 658 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
...... ....++..|+|||++.+. .++.++||||||+++|||++ |..||....
T Consensus 156 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~ 211 (259)
T cd05037 156 ITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS 211 (259)
T ss_pred cccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC
Confidence 865431 223466789999999876 78999999999999999999 577775553
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=265.96 Aligned_cols=196 Identities=28% Similarity=0.365 Sum_probs=172.7
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
+.+.+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.++...++||||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 445688999999999999975 67889999986532 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
+++++|.+++... ..++...+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++......
T Consensus 83 ~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 83 VPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 9999999998765 468889999999999999999997 99999999999999999999999999999876543
Q ss_pred eecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.....+++.|+|||.+.+...+.++|+||||+++|||++|+.||....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 202 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 233468899999999988888999999999999999999999997654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=246.63 Aligned_cols=205 Identities=27% Similarity=0.335 Sum_probs=172.5
Q ss_pred hhccccccccccccEEEEEEE-ECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCC-----eEEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR-----QRLL 583 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~l 583 (724)
.+|.+.+.||+|||+.||+++ ..++..+|+|++.....++.+..++|++..++++|||+++++++...+. ..||
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl 100 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL 100 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence 456778899999999999999 5677889999998776778889999999999999999999999875443 5899
Q ss_pred EEEecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCcccc
Q 043185 584 VYEYMNHGSLDRILFG---NGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLL 660 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 660 (724)
+++|...|+|.+.+.. ++..+++.+.+.|+.+|++||++||+ ...+++||||||.|||+.+++.++|.|||.+...
T Consensus 101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a 179 (302)
T KOG2345|consen 101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYAHRDIKPANILLSDSGLPVLMDLGSATQA 179 (302)
T ss_pred EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCcccccCCCcceeEecCCCceEEEeccCcccc
Confidence 9999999999998864 45689999999999999999999997 1234999999999999999999999999998754
Q ss_pred CCCCc--------cceeccccccccccccccc---CCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 661 TPEQS--------SLFTTMRGTRGYLAPEWLT---NSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 661 ~~~~~--------~~~~~~~gt~~y~aPE~l~---~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.-.-. ..-....-|..|+|||.+. +...++++|||||||+||+|+.|..||+..-
T Consensus 180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~ 245 (302)
T KOG2345|consen 180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY 245 (302)
T ss_pred ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh
Confidence 32110 0011234688999999985 4467899999999999999999999996543
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=263.33 Aligned_cols=200 Identities=23% Similarity=0.412 Sum_probs=172.1
Q ss_pred ccccccccccccEEEEEEEE-CCccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 512 DNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
+.+.+.||+|++|.||++.. .++..+|||.+.... .....++.+|+.+++.++|+||+++++++.+++..++++||
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 83 (267)
T ss_pred hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEe
Confidence 34567899999999999996 477889999886432 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC
Q 043185 588 MNHGSLDRILFG---NGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 588 ~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (724)
+++++|.+++.. ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 84 ADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 999999998863 23467899999999999999999996 899999999999999999999999999987664432
Q ss_pred ccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 665 SSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 665 ~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.. .....++..|+|||.+.+..++.++|+||||+++|||++|..||....
T Consensus 161 ~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08229 161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred cc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc
Confidence 21 233468899999999999899999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=265.33 Aligned_cols=199 Identities=28% Similarity=0.448 Sum_probs=169.5
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV-GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
+++.+.||+|+||.||++... .+..+|+|.++.. ......++.+|+.++.+++|+||+++++.+......++|+||++
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD 82 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence 345578999999999999976 6788999988643 22334678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 590 HGSLDRILFGN--GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 590 ~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
+++|..++... ...+++..+..++.|++.||.|||+ ..+++|+||||+||+++.++.++|+|||++..+....
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 157 (286)
T cd06622 83 AGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL--- 157 (286)
T ss_pred CCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc---
Confidence 99999988764 2368999999999999999999996 3689999999999999999999999999987653322
Q ss_pred eecccccccccccccccCC------cCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNS------AISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~------~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.....++..|+|||.+.+. .++.++|+||||+++|||++|+.||....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 211 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET 211 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc
Confidence 1234578899999998654 35889999999999999999999996544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=287.71 Aligned_cols=197 Identities=25% Similarity=0.349 Sum_probs=160.0
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCC------CCccceeceeecC-CeEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHH------VNLVKLKGFCAQG-RQRL 582 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H------~nIv~l~g~~~~~-~~~~ 582 (724)
.+.+.++||+|+||+||+|+.. .++.||||+++.. ....+++..|+.++++++| .+++++++++..+ .+.+
T Consensus 130 ~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~ 208 (467)
T PTZ00284 130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC 208 (467)
T ss_pred cEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence 4556689999999999999964 5778999999653 2233455667777766654 4588888888754 4788
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCC---------------
Q 043185 583 LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHF--------------- 647 (724)
Q Consensus 583 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~--------------- 647 (724)
+|||++ +++|.+++... ..+++..+..|+.||+.||+|||+ +.+||||||||+|||++.++
T Consensus 209 iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 209 IVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred EEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 999987 66888887655 458889999999999999999996 35999999999999998765
Q ss_pred -cEEEEeecCccccCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 648 -QAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 648 -~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||++...
T Consensus 285 ~~vkl~DfG~~~~~~~~----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 285 CRVRICDLGGCCDERHS----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred ceEEECCCCccccCccc----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 4999999987643221 2346799999999999999999999999999999999999999987654
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=274.81 Aligned_cols=201 Identities=29% Similarity=0.421 Sum_probs=177.2
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCcc--cHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQ--GKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
-+.+.+.||+|.|++|.++++. .+..||+|.+.+.... ....+.+|+++|..++|||||+++.+......+|+||||
T Consensus 57 ~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ey 136 (596)
T KOG0586|consen 57 LYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEY 136 (596)
T ss_pred ceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEe
Confidence 3455689999999999999974 6788999999775432 234588999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
+.+|.+.+++.+++...+ .....++.|+.+|++|||+ +.|+|||||++||||+.+.++||+|||++..+.... .
T Consensus 137 a~~ge~~~yl~~~gr~~e-~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~--~ 210 (596)
T KOG0586|consen 137 ASGGELFDYLVKHGRMKE-KEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL--M 210 (596)
T ss_pred ccCchhHHHHHhcccchh-hhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeecccc--c
Confidence 999999999988876555 8888899999999999997 999999999999999999999999999998886433 3
Q ss_pred eecccccccccccccccCCcC-CCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNSAI-SEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~~~-~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
....+|++.|.|||++.+..| .+++|+||+|++||-|++|..||++..-.
T Consensus 211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk 261 (596)
T KOG0586|consen 211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK 261 (596)
T ss_pred ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc
Confidence 456789999999999999876 68999999999999999999999876543
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=269.98 Aligned_cols=203 Identities=27% Similarity=0.426 Sum_probs=167.3
Q ss_pred hhccccccccccccEEEEEEEECC---------------ccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceec
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILND---------------KTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKG 573 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~~---------------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g 573 (724)
..+.+.+.||+|+||.||+++..+ ...||+|++.... .....++.+|++++.+++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 345567889999999999987642 1248999986532 233467899999999999999999999
Q ss_pred eeecCCeEEEEEEecCCCCHHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeE
Q 043185 574 FCAQGRQRLLVYEYMNHGSLDRILFGNG-----------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENIL 642 (724)
Q Consensus 574 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NIL 642 (724)
++......++||||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence 9999999999999999999999985431 236788899999999999999996 89999999999999
Q ss_pred EeCCCcEEEEeecCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh--CCCCCCCCC
Q 043185 643 LHYHFQAKISDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS--GRRNCSPRS 715 (724)
Q Consensus 643 l~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt--G~~p~~~~~ 715 (724)
++.++.+||+|||++........ .......++..|+|||++.+..++.++|+||||++++||++ |..||....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 99999999999999976543221 11122335678999999998889999999999999999998 667776543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-30 Score=265.60 Aligned_cols=201 Identities=30% Similarity=0.446 Sum_probs=167.2
Q ss_pred ccccccccccccEEEEEEEECC------ccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILND------KTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLV 584 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~~------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 584 (724)
+.+.+.||+|++|.||+|...+ +..||+|.+.... .....+|.+|+.++++++|+||+++++++.+....++|
T Consensus 8 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 87 (277)
T cd05036 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFIL 87 (277)
T ss_pred cEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEE
Confidence 3455789999999999999753 4678888876432 23345789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCC---cEEEEeec
Q 043185 585 YEYMNHGSLDRILFGNG------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHF---QAKISDFG 655 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~DFG 655 (724)
|||+++++|.+++.... ..+++..+++++.||+.||+|||+ .+++||||||+||+++.++ .+||+|||
T Consensus 88 ~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~dfg 164 (277)
T cd05036 88 LELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFG 164 (277)
T ss_pred EecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEeccCc
Confidence 99999999999987543 258899999999999999999997 8999999999999998765 59999999
Q ss_pred CccccCCCCcc-ceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 656 LSKLLTPEQSS-LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 656 la~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
+++........ .......+..|+|||++.+..++.++|||||||++|||++ |+.||+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~ 226 (277)
T cd05036 165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226 (277)
T ss_pred cccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99866332211 1112223568999999999899999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=267.61 Aligned_cols=194 Identities=27% Similarity=0.416 Sum_probs=170.1
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCCHH
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLD 594 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gsL~ 594 (724)
..||+|+||.||++... +++.||+|++........+.+.+|+.++..++||||+++++++..+...++|+||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 46999999999999964 67889999987544455677889999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceeccccc
Q 043185 595 RILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGT 674 (724)
Q Consensus 595 ~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt 674 (724)
.++.. ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++........ ......++
T Consensus 107 ~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~ 180 (297)
T cd06659 107 DIVSQ--TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGT 180 (297)
T ss_pred HHHhh--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccceecC
Confidence 88754 357889999999999999999996 8999999999999999999999999999875543322 12335688
Q ss_pred ccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 675 RGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 675 ~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
..|+|||++.+..++.++||||||++++||++|+.||....
T Consensus 181 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 221 (297)
T cd06659 181 PYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS 221 (297)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999899999999999999999999999996554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=264.34 Aligned_cols=200 Identities=29% Similarity=0.399 Sum_probs=173.4
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
+.+.+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++..+...++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 455678999999999999974 67889999987543 233567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
+++|.+++......+++..+..++.||+.||+|||+ .+++|+||||+||+++.++.++|+|||++...........
T Consensus 82 -~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 82 -PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred -CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 999999987766678999999999999999999997 8999999999999999999999999999987654432223
Q ss_pred ecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
....++..|+|||.+.+. .++.++||||||++++||++|++||....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 205 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN 205 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC
Confidence 345688999999998654 46899999999999999999988886554
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=259.38 Aligned_cols=197 Identities=33% Similarity=0.450 Sum_probs=169.3
Q ss_pred ccccccccEEEEEEEECCccEEEEEEeecCCcc-cHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCCHH
Q 043185 516 NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQ-GKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLD 594 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gsL~ 594 (724)
++||+|+||.||++...+++.||+|++...... ..+.+.+|++++++++|+||+++++++.+....++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877888999998764333 4567899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce-ecccc
Q 043185 595 RILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF-TTMRG 673 (724)
Q Consensus 595 ~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-~~~~g 673 (724)
+++......+++..+..++.+++.+|+|||+ ++++||||||+||+++.++.++|+|||++........... .....
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 9997765668889999999999999999996 8999999999999999999999999999976542221111 11223
Q ss_pred cccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 674 TRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 674 t~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
+..|+|||.+.+..++.++|+||||+++|||++ |..||....
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~ 200 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS 200 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC
Confidence 567999999998899999999999999999999 888886544
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=256.49 Aligned_cols=200 Identities=29% Similarity=0.349 Sum_probs=173.1
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecCCc---ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV---QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
+|.++||+|.||+|-+++-+ .++.+|+|++++.-. .+...-+.|-++|+..+||.+..+.-.++..+.+++||||.
T Consensus 171 dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeya 250 (516)
T KOG0690|consen 171 DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYA 250 (516)
T ss_pred hHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEc
Confidence 35689999999999999864 678899999986433 23344577999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
.||.|..+|.+. ..+++....-+-.+|..||.|||+ ++||.||||.+|.|+|.||++||.|||+++.--.. ....
T Consensus 251 nGGeLf~HLsre-r~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~-g~t~ 325 (516)
T KOG0690|consen 251 NGGELFFHLSRE-RVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY-GDTT 325 (516)
T ss_pred cCceEeeehhhh-hcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcccc-ccee
Confidence 999998888665 356666666678899999999997 99999999999999999999999999999754332 2345
Q ss_pred ecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
.+++||+.|+|||++.+..|...+|.|.+||+||||++|+.||...+..
T Consensus 326 kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~ 374 (516)
T KOG0690|consen 326 KTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE 374 (516)
T ss_pred ccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh
Confidence 7889999999999999999999999999999999999999999877644
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=271.58 Aligned_cols=198 Identities=19% Similarity=0.229 Sum_probs=164.6
Q ss_pred cccccccc--ccEEEEEEEE-CCccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 514 FKNLIGSG--GFGAVYKGIL-NDKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 514 ~~~~lG~G--~fG~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
+.++||+| +|++||++.. .+++.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 34789999 7899999986 477889999986532 233456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc-
Q 043185 589 NHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS- 666 (724)
Q Consensus 589 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~- 666 (724)
++++|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.++++||+.+.........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999998654 3458899999999999999999997 89999999999999999999999999865443211110
Q ss_pred -----ceecccccccccccccccC--CcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 667 -----LFTTMRGTRGYLAPEWLTN--SAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 667 -----~~~~~~gt~~y~aPE~l~~--~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 0112246778999999976 46899999999999999999999999654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-30 Score=274.00 Aligned_cols=203 Identities=28% Similarity=0.434 Sum_probs=166.4
Q ss_pred hhccccccccccccEEEEEEEE------CCccEEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeceeecC-Ce
Q 043185 510 ATDNFKNLIGSGGFGAVYKGIL------NDKTIVAVKKITNVG-VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQG-RQ 580 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~-~~ 580 (724)
..+.+.+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +|+||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 4566778999999999999973 346789999997532 23345688999999999 789999999988654 46
Q ss_pred EEEEEEecCCCCHHHHHhcCC-----------------------------------------------------------
Q 043185 581 RLLVYEYMNHGSLDRILFGNG----------------------------------------------------------- 601 (724)
Q Consensus 581 ~~lV~e~~~~gsL~~~l~~~~----------------------------------------------------------- 601 (724)
.++||||+++|+|.+++....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 789999999999999986421
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc-cceecccc
Q 043185 602 -------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS-SLFTTMRG 673 (724)
Q Consensus 602 -------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~g 673 (724)
..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++........ .......+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 235778888999999999999997 8999999999999999999999999999976533221 11122345
Q ss_pred cccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 674 TRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 674 t~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
+..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 286 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 286 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 678999999999899999999999999999997 999986543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=260.80 Aligned_cols=199 Identities=26% Similarity=0.385 Sum_probs=172.4
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV-GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
.+.+.||+|+||.||++... +++.+|+|.++.. .....+++.+|+.++++++|+||+++++.+..+...++++||+++
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDG 82 (255)
T ss_pred eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCC
Confidence 45688999999999999965 6788999988643 233456788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 591 GSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 591 gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
++|.+++... ...++......++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........ ...
T Consensus 83 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~ 158 (255)
T cd08219 83 GDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-YAC 158 (255)
T ss_pred CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-ccc
Confidence 9999988653 4457889999999999999999996 8999999999999999999999999999976643322 123
Q ss_pred cccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
...++..|+|||++.+..++.++|+||||+++|+|++|+.||....
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 204 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204 (255)
T ss_pred cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC
Confidence 3568899999999999899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=263.53 Aligned_cols=197 Identities=31% Similarity=0.423 Sum_probs=165.4
Q ss_pred cccccccccccEEEEEEEE-----CCccEEEEEEeecCCc-ccHHHHHHHHHHHhcCCCCCccceeceeecC--CeEEEE
Q 043185 513 NFKNLIGSGGFGAVYKGIL-----NDKTIVAVKKITNVGV-QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG--RQRLLV 584 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~-----~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV 584 (724)
.+.+.||+|+||+||++.+ .++..||+|.++.... ...+.+.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 4567899999999988764 3567899999875422 3456788999999999999999999987653 468899
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC
Q 043185 585 YEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (724)
|||+++++|.+++... .+++..+..++.|++.||.|||+ .+++||||||+|||++.++.++|+|||+++......
T Consensus 87 ~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 161 (283)
T cd05080 87 MEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161 (283)
T ss_pred ecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence 9999999999998654 48999999999999999999997 899999999999999999999999999998664332
Q ss_pred cc--ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 665 SS--LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 665 ~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
.. ......++..|+|||.+.+..++.++||||||++++||++|+.||...
T Consensus 162 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 162 EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 11 111223566799999999888999999999999999999999998543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-29 Score=260.09 Aligned_cols=201 Identities=24% Similarity=0.432 Sum_probs=173.3
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV---GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
.+.+.+.||+|+||.||+|... +++.+|+|.++.. .....+++.+|++++++++|+||+++++++.+++..++|||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 3556789999999999999986 7888999988632 22335678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCC
Q 043185 587 YMNHGSLDRILFG---NGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE 663 (724)
Q Consensus 587 ~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (724)
|+++++|..++.. ....+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++..+...
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 9999999998864 23457889999999999999999996 89999999999999999999999999998765433
Q ss_pred CccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 664 QSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 664 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
... .....++..|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus 160 ~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08224 160 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred Ccc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC
Confidence 221 123457889999999998899999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=260.69 Aligned_cols=201 Identities=27% Similarity=0.400 Sum_probs=174.7
Q ss_pred ccccccccccccEEEEEEEE-CCccEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 512 DNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
+.+.+.||.|+||.||.++. .+++.+++|++... .....+++.+|++++++++|+||+++++++.+....+++|||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 44568899999999999985 46788999988643 2344567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 589 NHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 589 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
++++|.+++... ...+++..+..++.|++.+|.|||+ .+++|+||+|+||+++.++.+||+|||++........ .
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~ 157 (256)
T cd08221 82 NGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-M 157 (256)
T ss_pred CCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-c
Confidence 999999999765 4568899999999999999999996 8999999999999999999999999999986644332 2
Q ss_pred eecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.....++..|+|||.+.+..++.++|+||||++++||++|+.||.....
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~ 206 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP 206 (256)
T ss_pred ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH
Confidence 2345688999999999988899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=269.42 Aligned_cols=204 Identities=28% Similarity=0.414 Sum_probs=169.6
Q ss_pred HhhccccccccccccEEEEEEEECC--------ccEEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeceeecC
Q 043185 509 VATDNFKNLIGSGGFGAVYKGILND--------KTIVAVKKITNVG-VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQG 578 (724)
Q Consensus 509 ~a~~~~~~~lG~G~fG~Vy~~~~~~--------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~ 578 (724)
...+.+.+.||+|+||.||+++..+ ...+|+|.+.... .....++.+|++++.++ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3456778999999999999998532 2469999987532 33446788999999999 799999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEE
Q 043185 579 RQRLLVYEYMNHGSLDRILFGNG---------------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILL 643 (724)
Q Consensus 579 ~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 643 (724)
...++|+||+++++|.+++.... ..+++..+++++.|++.||+|||+ .+++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEE
Confidence 99999999999999999997532 247889999999999999999996 899999999999999
Q ss_pred eCCCcEEEEeecCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 644 HYHFQAKISDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 644 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
+.++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 9999999999999876543211 11112234568999999999899999999999999999998 888886544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=266.14 Aligned_cols=197 Identities=29% Similarity=0.443 Sum_probs=167.3
Q ss_pred ccccccccccccEEEEEEEEC-----CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecC--CeEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-----DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG--RQRLL 583 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~l 583 (724)
+...+.||+|+||.||++++. ++..||+|.++... ....+++.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 85 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEE
Confidence 344578999999999999852 46789999987542 33346789999999999999999999998775 56889
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCC
Q 043185 584 VYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE 663 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (724)
||||+++++|.+++......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||+++.+...
T Consensus 86 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 86 IMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred EEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 999999999999997665568999999999999999999996 89999999999999999999999999999876543
Q ss_pred Ccc--ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCC
Q 043185 664 QSS--LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNC 711 (724)
Q Consensus 664 ~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~ 711 (724)
... ......++..|+|||++.+..++.++||||||+++|||++++.|.
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 221 112345677899999999888999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-30 Score=264.66 Aligned_cols=200 Identities=28% Similarity=0.442 Sum_probs=164.3
Q ss_pred ccccccccccEEEEEEEECCcc---EEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeceeecC------CeEE
Q 043185 514 FKNLIGSGGFGAVYKGILNDKT---IVAVKKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG------RQRL 582 (724)
Q Consensus 514 ~~~~lG~G~fG~Vy~~~~~~~~---~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~~ 582 (724)
+.+.||+|+||.||+|+..+.. .+|+|.++.. .....+.+.+|++++++++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 4578999999999999976432 5899988643 233456788999999999999999999987432 2568
Q ss_pred EEEEecCCCCHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCc
Q 043185 583 LVYEYMNHGSLDRILFG-----NGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLS 657 (724)
Q Consensus 583 lV~e~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 657 (724)
+++||+++|+|..++.. ....+++.....++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCcc
Confidence 99999999999988742 22457889999999999999999996 89999999999999999999999999999
Q ss_pred cccCCCCcc-ceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 043185 658 KLLTPEQSS-LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQ 716 (724)
Q Consensus 658 ~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~ 716 (724)
+........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 220 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN 220 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 876433221 1122245678999999999999999999999999999999 8999976443
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=265.17 Aligned_cols=210 Identities=25% Similarity=0.328 Sum_probs=177.2
Q ss_pred HHHHhhccccccccccccEEEEEEEECC-ccEEEEEEeecCC---cccHHHHHHHHHHHhcC-CCCCccceeceeecCCe
Q 043185 506 ELEVATDNFKNLIGSGGFGAVYKGILND-KTIVAVKKITNVG---VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQ 580 (724)
Q Consensus 506 ~l~~a~~~~~~~lG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~ 580 (724)
.+..+..+|..+||+|+||+|.++..++ .+.+|||++++.- ....+--..|-++|+.. +-|.++.++.+++.-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 4555667888999999999999999764 5679999997632 22333345677777766 57899999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCcccc
Q 043185 581 RLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLL 660 (724)
Q Consensus 581 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 660 (724)
+|+||||+.+|+|-..+.+-++ +.+..+.-+|.+||-||-+||+ ++||.||||.+||||+.+|++||+|||+++.-
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccccc
Confidence 9999999999999888876654 5556777899999999999997 99999999999999999999999999999753
Q ss_pred CCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC
Q 043185 661 TPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSM 720 (724)
Q Consensus 661 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~~~ 720 (724)
--.. ....+++||+.|+|||.+..++|+..+|.|||||+||||+.|++||+++++.+.+
T Consensus 501 i~~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF 559 (683)
T KOG0696|consen 501 IFDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF 559 (683)
T ss_pred ccCC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 3222 2345789999999999999999999999999999999999999999999887654
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=262.80 Aligned_cols=195 Identities=32% Similarity=0.499 Sum_probs=162.4
Q ss_pred ccccccccEEEEEEEECC-cc--EEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEEEEEecCC
Q 043185 516 NLIGSGGFGAVYKGILND-KT--IVAVKKITNVG-VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~-~~--~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
+.||+|+||.||+|+..+ +. .+++|.++... ....+.+.+|++++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 469999999999999753 33 46888876432 33456788999999999 899999999999999999999999999
Q ss_pred CCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeec
Q 043185 591 GSLDRILFGNG---------------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFG 655 (724)
Q Consensus 591 gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFG 655 (724)
++|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 99999986532 247889999999999999999996 899999999999999999999999999
Q ss_pred CccccCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 656 LSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 656 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
++........ ......+..|+|||++....++.++||||||++++||++ |+.||....
T Consensus 158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 216 (270)
T cd05047 158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 216 (270)
T ss_pred Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC
Confidence 9863221111 111233567999999998899999999999999999997 999996543
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=273.63 Aligned_cols=194 Identities=27% Similarity=0.394 Sum_probs=163.6
Q ss_pred ccccccccccccEEEEEEEE-CCccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecC------CeEE
Q 043185 512 DNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG------RQRL 582 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~~ 582 (724)
+...+.||+|+||.||++.. .+++.||||++.... ....+.+.+|++++++++||||+++++++... ...+
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07878 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVY 96 (343)
T ss_pred hhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEE
Confidence 44457899999999999996 467789999986532 22345677899999999999999999987543 3568
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCC
Q 043185 583 LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP 662 (724)
Q Consensus 583 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (724)
+++|++ +++|..++.. ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 97 LVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170 (343)
T ss_pred EEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence 999987 7789887754 358899999999999999999997 8999999999999999999999999999986543
Q ss_pred CCccceecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 663 EQSSLFTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 663 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
. .....+++.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 171 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 220 (343)
T cd07878 171 E----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND 220 (343)
T ss_pred C----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence 2 234568999999999977 568999999999999999999999997543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=267.98 Aligned_cols=202 Identities=28% Similarity=0.455 Sum_probs=170.1
Q ss_pred hccccccccccccEEEEEEEEC------CccEEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN------DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRL 582 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~ 582 (724)
.+.+.+.||+|+||.||+++.. .+..+|+|+++... ....+.+.+|+++++++ +|+||+++++++...+..+
T Consensus 36 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 115 (302)
T cd05055 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPIL 115 (302)
T ss_pred HeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceE
Confidence 4556789999999999999742 34579999887542 23346789999999999 7999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccC
Q 043185 583 LVYEYMNHGSLDRILFGNG-PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 583 lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 661 (724)
+|+||+++++|.+++.... ..+++.+...++.|++.||+|||+ .+++|+||||+|||++.++.++|+|||+++...
T Consensus 116 lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 192 (302)
T cd05055 116 VITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIM 192 (302)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCccccccc
Confidence 9999999999999987543 348999999999999999999997 899999999999999999999999999998664
Q ss_pred CCCcc-ceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 662 PEQSS-LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 662 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
..... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~ 248 (302)
T cd05055 193 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP 248 (302)
T ss_pred CCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCC
Confidence 33221 1122345678999999999999999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=267.55 Aligned_cols=206 Identities=27% Similarity=0.417 Sum_probs=171.0
Q ss_pred HHHhhccccccccccccEEEEEEEEC--------CccEEEEEEeecC-CcccHHHHHHHHHHHhcC-CCCCccceeceee
Q 043185 507 LEVATDNFKNLIGSGGFGAVYKGILN--------DKTIVAVKKITNV-GVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCA 576 (724)
Q Consensus 507 l~~a~~~~~~~lG~G~fG~Vy~~~~~--------~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~ 576 (724)
+....+.+.+.||+|+||.||+++.. ++..||+|.+... .....+++.+|+.++..+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 33445566789999999999999742 2346899988643 234456789999999999 8999999999999
Q ss_pred cCCeEEEEEEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCe
Q 043185 577 QGRQRLLVYEYMNHGSLDRILFGNG---------------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENI 641 (724)
Q Consensus 577 ~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NI 641 (724)
.....++||||+++++|.+++.... ..+++..+..++.||++||+|||+ .+++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceE
Confidence 9999999999999999999987532 346788899999999999999997 8999999999999
Q ss_pred EEeCCCcEEEEeecCccccCCCCcc-ceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 642 LLHYHFQAKISDFGLSKLLTPEQSS-LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 642 Ll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999876433221 1122345678999999999899999999999999999998 788886544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-30 Score=267.79 Aligned_cols=203 Identities=29% Similarity=0.472 Sum_probs=167.3
Q ss_pred hhccccccccccccEEEEEEEECC------ccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILND------KTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRL 582 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~~------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 582 (724)
..+.+.+.||+|+||.||+|...+ +..||+|.+.... .....++.+|+.+++.++||||+++++++.+....+
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL 85 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 345567899999999999997532 3479999876432 223456889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEe
Q 043185 583 LVYEYMNHGSLDRILFGN---------GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISD 653 (724)
Q Consensus 583 lV~e~~~~gsL~~~l~~~---------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 653 (724)
+||||+++|+|.+++... ....++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEECc
Confidence 999999999999999642 1345677888999999999999996 8999999999999999999999999
Q ss_pred ecCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 654 FGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 654 FGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
||+++....... .......++..|+|||.+.+..++.++|+||||+++|||++ |+.||....
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~ 226 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 226 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999886543221 11122235678999999999899999999999999999999 788986544
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=262.15 Aligned_cols=197 Identities=29% Similarity=0.444 Sum_probs=166.3
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeceeecC------CeEEEE
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQG------RQRLLV 584 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~------~~~~lV 584 (724)
.+.+.||+|+||.||+|... +++.+|+|++... .....++.+|+.++.++ +|+||+++++++... ...++|
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv 87 (272)
T cd06637 9 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV 87 (272)
T ss_pred hHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEE
Confidence 34577999999999999975 5778999998754 34456788999999998 799999999998653 467899
Q ss_pred EEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCC
Q 043185 585 YEYMNHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE 663 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (724)
|||+++++|.+++... ...+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.++|+|||++......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~ 164 (272)
T cd06637 88 MEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 164 (272)
T ss_pred EEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCceecccc
Confidence 9999999999998764 3468899999999999999999997 89999999999999999999999999999765432
Q ss_pred Cccceeccccccccccccccc-----CCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 664 QSSLFTTMRGTRGYLAPEWLT-----NSAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 664 ~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
.. ......|+..|+|||++. +..++.++||||||+++|||++|+.||...
T Consensus 165 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~ 219 (272)
T cd06637 165 VG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219 (272)
T ss_pred cc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 21 123456889999999986 346788999999999999999999999643
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=262.96 Aligned_cols=198 Identities=32% Similarity=0.408 Sum_probs=173.1
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
+.+.+.||.|++|.||+|+.. +++.+|+|.+.... ......+.+|+.++++++|+||+++++++.++...++|+||++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG 82 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence 344578999999999999975 67889999986543 3344678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
+++|.+++... .+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||+++....... ...
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~ 156 (274)
T cd06609 83 GGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-KRN 156 (274)
T ss_pred CCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeeccccc-ccc
Confidence 99999998654 68899999999999999999996 8999999999999999999999999999987754321 123
Q ss_pred cccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
...++..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 157 ~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~ 202 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH 202 (274)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc
Confidence 4567889999999999889999999999999999999999996544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=260.92 Aligned_cols=199 Identities=27% Similarity=0.471 Sum_probs=170.3
Q ss_pred cccccccccccEEEEEEEECCccEEEEEEeecCCc------ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEE
Q 043185 513 NFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGV------QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
...+.||+|+||.||+|...+++.+|+|.++.... ...+.+.+|++++++++|+||+++++++.+....++|+|
T Consensus 3 ~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (265)
T cd06631 3 TKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME 82 (265)
T ss_pred cccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEe
Confidence 34578999999999999988888999998864321 123568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCC---
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE--- 663 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~--- 663 (724)
|+++++|.+++.... .+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 83 FVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 999999999997653 57788888999999999999996 89999999999999999999999999998765321
Q ss_pred --CccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 664 --QSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 664 --~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.........++..|+|||++.+..++.++|+||||++++||++|+.||....
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 212 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212 (265)
T ss_pred ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCC
Confidence 1111223468899999999999899999999999999999999999996544
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-30 Score=264.48 Aligned_cols=191 Identities=28% Similarity=0.455 Sum_probs=162.5
Q ss_pred ccccccccEEEEEEEECC--------ccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 516 NLIGSGGFGAVYKGILND--------KTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
+.||+|+||.||+|.... ...+++|.+........+++.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998642 234888887654444556788999999999999999999999998999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCc--------EEEEeecCccc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQ--------AKISDFGLSKL 659 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~--------~kl~DFGla~~ 659 (724)
+++|+|..++......+++..++.++.||+.||+|||+ .+|+||||||+||+++.++. ++++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999998776678999999999999999999996 99999999999999988765 69999998865
Q ss_pred cCCCCccceecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCC-CCCCCC
Q 043185 660 LTPEQSSLFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGR-RNCSPR 714 (724)
Q Consensus 660 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~-~p~~~~ 714 (724)
.... ....++..|+|||++.+. .++.++||||||+++|||++|. .|+...
T Consensus 158 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~ 209 (258)
T cd05078 158 VLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL 209 (258)
T ss_pred cCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc
Confidence 4332 234578899999999874 5799999999999999999984 665543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=263.43 Aligned_cols=202 Identities=27% Similarity=0.445 Sum_probs=169.9
Q ss_pred hccccccccccccEEEEEEEECC------ccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILND------KTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLL 583 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~~------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 583 (724)
.+.+.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.++..++|+||+++++++......++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~ 86 (277)
T cd05032 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLV 86 (277)
T ss_pred HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEE
Confidence 44556889999999999998642 3579999986432 2334578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEee
Q 043185 584 VYEYMNHGSLDRILFGNG---------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDF 654 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DF 654 (724)
||||+++++|.+++.... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+||
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~df 163 (277)
T cd05032 87 VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDF 163 (277)
T ss_pred EEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEECCc
Confidence 999999999999986432 246788999999999999999996 89999999999999999999999999
Q ss_pred cCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 655 GLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 655 Gla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
|+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 226 (277)
T cd05032 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226 (277)
T ss_pred ccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC
Confidence 99876543321 11223346788999999998889999999999999999998 999996544
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=264.14 Aligned_cols=204 Identities=29% Similarity=0.442 Sum_probs=171.5
Q ss_pred HhhccccccccccccEEEEEEEECC-----ccEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeceeec-CCeE
Q 043185 509 VATDNFKNLIGSGGFGAVYKGILND-----KTIVAVKKITNV-GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ-GRQR 581 (724)
Q Consensus 509 ~a~~~~~~~lG~G~fG~Vy~~~~~~-----~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~ 581 (724)
...+.+.+.||+|+||.||+|...+ +..|++|++... .....+.+.+|+.++++++|+||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 3455667899999999999999765 678999988653 23345678899999999999999999998766 4678
Q ss_pred EEEEEecCCCCHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEee
Q 043185 582 LLVYEYMNHGSLDRILFGNG-------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDF 654 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~~-------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DF 654 (724)
++++||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCC
Confidence 99999999999999986532 458899999999999999999996 89999999999999999999999999
Q ss_pred cCccccCCCCcc-ceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 655 GLSKLLTPEQSS-LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 655 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
|+++.+...... ......++..|+|||++.+..++.++||||||+++||+++ |+.||....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 224 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID 224 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC
Confidence 999866433221 1122345678999999999899999999999999999999 999997543
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=260.28 Aligned_cols=195 Identities=30% Similarity=0.509 Sum_probs=161.6
Q ss_pred ccccccccEEEEEEEEC----CccEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeceee-cCCeEEEEEEecC
Q 043185 516 NLIGSGGFGAVYKGILN----DKTIVAVKKITNV-GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCA-QGRQRLLVYEYMN 589 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~----~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~-~~~~~~lV~e~~~ 589 (724)
+.||+|+||.||+|+.. ....+|+|++... .....+.+.+|+.+++.++||||+++++++. .+...++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999863 2357999988543 2334567889999999999999999999775 4556889999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc---c
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS---S 666 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~---~ 666 (724)
+++|.+++......+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 999999997765567888889999999999999996 8999999999999999999999999999976543221 1
Q ss_pred ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhC-CCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSG-RRNCSP 713 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG-~~p~~~ 713 (724)
......++..|+|||.+.+..++.++||||||+++|||++| .+||..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~ 205 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 205 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 11223456789999999988999999999999999999995 566643
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=266.24 Aligned_cols=194 Identities=28% Similarity=0.437 Sum_probs=170.0
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCCHH
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLD 594 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gsL~ 594 (724)
..||+|+||.||++... ++..||||++........+.+.+|+.++++++|+||+++++.+..++..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 56999999999999974 67789999987654555677899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceeccccc
Q 043185 595 RILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGT 674 (724)
Q Consensus 595 ~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt 674 (724)
+++... .+++.....++.||+.||+|||+ .+++||||||+||+++.++.++|+|||++........ ......++
T Consensus 108 ~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~ 181 (292)
T cd06658 108 DIVTHT--RMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLVGT 181 (292)
T ss_pred HHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCceeecC
Confidence 988543 57889999999999999999997 8999999999999999999999999999876543222 12334688
Q ss_pred ccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 675 RGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 675 ~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
..|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus 182 ~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 222 (292)
T cd06658 182 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP 222 (292)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999998889999999999999999999999997554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=258.54 Aligned_cols=195 Identities=33% Similarity=0.514 Sum_probs=164.4
Q ss_pred ccccccccEEEEEEEECC----ccEEEEEEeecCCc-ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 516 NLIGSGGFGAVYKGILND----KTIVAVKKITNVGV-QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
++||+|+||.||+|++.. ...+|+|.+..... ...+++.+|+.+++++.|+||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999998532 25799999875433 34567899999999999999999999876 4568999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce--
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF-- 668 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-- 668 (724)
++|.+++.... .+++..+..++.|++.||+|||+ .+++|+||||+|||++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 99999997654 68899999999999999999996 8999999999999999999999999999986644332111
Q ss_pred ecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~ 203 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK 203 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC
Confidence 11223567999999999899999999999999999998 999996644
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=259.14 Aligned_cols=195 Identities=33% Similarity=0.467 Sum_probs=166.1
Q ss_pred hccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceee-cCCeEEEEEEecC
Q 043185 511 TDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCA-QGRQRLLVYEYMN 589 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~-~~~~~~lV~e~~~ 589 (724)
.+.+.+.||+|+||.||++... +..+|+|.++.. ...+.+.+|+.++++++|+|++++++++. ++...++|+||++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 4556689999999999999876 456899988643 33567899999999999999999999764 4567899999999
Q ss_pred CCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce
Q 043185 590 HGSLDRILFGNG-PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 590 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
+++|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---- 156 (256)
T cd05082 84 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---- 156 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC----
Confidence 999999987643 357889999999999999999996 899999999999999999999999999987543322
Q ss_pred ecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
.....+..|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~ 204 (256)
T cd05082 157 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence 22334678999999999899999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=260.16 Aligned_cols=198 Identities=26% Similarity=0.356 Sum_probs=166.4
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecCC-----cccHHHHHHHHHHHhcCCCCCccceeceeecC--CeEEEE
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG-----VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG--RQRLLV 584 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV 584 (724)
...+.||+|+||.||++... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...+++
T Consensus 5 ~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (265)
T cd06652 5 RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIF 84 (265)
T ss_pred eEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEE
Confidence 44678999999999999974 57889999885321 12245788899999999999999999988763 467899
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC
Q 043185 585 YEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (724)
+||+++++|.+++... ..+++....+++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 85 MEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 9999999999998765 347888889999999999999997 899999999999999999999999999987654321
Q ss_pred c--cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 665 S--SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 665 ~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
. .......++..|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 1 1122345888999999999888999999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=260.74 Aligned_cols=200 Identities=30% Similarity=0.460 Sum_probs=170.1
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCCcc---------cHHHHHHHHHHHhcCCCCCccceeceeecCCeE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQ---------GKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQR 581 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~---------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 581 (724)
+.+.+.||+|++|.||+|... +++.+|+|.+...... ..+.+.+|+.++++++||||+++++++.+....
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 345678999999999999864 5788999988643221 125678899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccC
Q 043185 582 LLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 661 (724)
++|+||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||+++...
T Consensus 82 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred EEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 9999999999999999765 457888889999999999999996 899999999999999999999999999988765
Q ss_pred CCCc-----cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 662 PEQS-----SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 662 ~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.... .......++..|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 216 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT 216 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc
Confidence 3211 11123457889999999999889999999999999999999999997543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=263.30 Aligned_cols=198 Identities=27% Similarity=0.403 Sum_probs=167.4
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
.+.+.||+|++|.||+|+.. +++.||+|+++... ....+.+.+|+.++.+++||||+++++++.++...++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (285)
T cd07861 3 TKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS 82 (285)
T ss_pred eEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC
Confidence 44578999999999999975 67889999986432 2234678899999999999999999999999999999999997
Q ss_pred CCCHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 590 HGSLDRILFGN--GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 590 ~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
++|.+++... ...+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++........ .
T Consensus 83 -~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~ 157 (285)
T cd07861 83 -MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-V 157 (285)
T ss_pred -CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc-c
Confidence 5888887543 2568899999999999999999996 8999999999999999999999999999876543321 1
Q ss_pred eecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.....+++.|+|||.+.+. .++.++||||||++++||++|++||....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~ 206 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS 206 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 2234568899999988654 57899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=254.85 Aligned_cols=202 Identities=28% Similarity=0.394 Sum_probs=168.0
Q ss_pred ccccccccccccEEEEEEEEC---Cc--cEEEEEEeecCCc--ccHHHHHHHHHHHhcCCCCCccceeceeec-CCeEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN---DK--TIVAVKKITNVGV--QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ-GRQRLL 583 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~---~~--~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~l 583 (724)
++....||+|.||.||||+.. +. ..+|+|+++.... .-.....+|+.+++.++||||+.+..++.. +...+|
T Consensus 26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l 105 (438)
T KOG0666|consen 26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWL 105 (438)
T ss_pred hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEE
Confidence 444578999999999999743 32 3689999975422 223567899999999999999999999877 789999
Q ss_pred EEEecCCCCHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCC----CcEEEEeec
Q 043185 584 VYEYMNHGSLDRILFGN----GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYH----FQAKISDFG 655 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~----~~~kl~DFG 655 (724)
++||.+. +|..+++.+ ...++......|+.||+.|+.|||+ +-|+||||||.||||..+ |.+||+|||
T Consensus 106 ~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 106 LFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred Eehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 9999988 777777532 3467778889999999999999997 899999999999999887 899999999
Q ss_pred CccccCCCCcc--ceecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 656 LSKLLTPEQSS--LFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 656 la~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
+++.+...-.. ....++-|..|.|||.+.+. .||++.|||+.|||+.||++-++-|.+++..
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k 246 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEK 246 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhh
Confidence 99988764332 22345679999999999886 6899999999999999999999999776543
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=266.30 Aligned_cols=201 Identities=29% Similarity=0.451 Sum_probs=168.9
Q ss_pred ccccccccccccEEEEEEEECC------ccEEEEEEeecC-CcccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILND------KTIVAVKKITNV-GVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLL 583 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~~------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l 583 (724)
+.+.+.||+|+||.||++...+ ...+|+|++... ..+...++.+|+.++.++ +|+||+++++++..+...++
T Consensus 14 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 93 (293)
T cd05053 14 LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYV 93 (293)
T ss_pred eEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEE
Confidence 4456789999999999998642 357899988753 223446788999999999 89999999999999999999
Q ss_pred EEEecCCCCHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCc
Q 043185 584 VYEYMNHGSLDRILFGN---------------GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQ 648 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 648 (724)
+|||+++++|..++... ...+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.
T Consensus 94 i~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~~~~~ 170 (293)
T cd05053 94 VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHV 170 (293)
T ss_pred EEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEcCCCe
Confidence 99999999999998632 3467889999999999999999996 89999999999999999999
Q ss_pred EEEEeecCccccCCCCcc-ceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 649 AKISDFGLSKLLTPEQSS-LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 649 ~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
+||+|||+++.+...... ......++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 171 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 239 (293)
T cd05053 171 MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 239 (293)
T ss_pred EEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence 999999999876443221 1122235678999999999899999999999999999998 999986554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-30 Score=236.09 Aligned_cols=193 Identities=32% Similarity=0.444 Sum_probs=164.9
Q ss_pred ccccccccEEEEEEEE-CCccEEEEEEeec-CCcccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEEEEEecCCCC
Q 043185 516 NLIGSGGFGAVYKGIL-NDKTIVAVKKITN-VGVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYEYMNHGS 592 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~-~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~e~~~~gs 592 (724)
+.||+|++|.|-+.++ .+|...|+|++.. ...+.+++.++|+.+..+. ..|.+|.++|....+...++.||.|.- +
T Consensus 52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-S 130 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-S 130 (282)
T ss_pred hhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-h
Confidence 5799999999988886 4788999999974 3456677888999886555 799999999999999999999999964 7
Q ss_pred HHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 593 LDRILF---GNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 593 L~~~l~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
|+.+-. ..+..+++...-+|+..+.+||.|||+ +..+||||+||+||||+.+|++||||||.+..+...-. .+
T Consensus 131 ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA--kt 206 (282)
T KOG0984|consen 131 LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA--KT 206 (282)
T ss_pred HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhH--HH
Confidence 766644 356778889999999999999999998 78999999999999999999999999999987654322 13
Q ss_pred cccccccccccccccC----CcCCCccchhhHHHHHHHHHhCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTN----SAISEKTDVYSFGMVLLELVSGRRNCSP 713 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~----~~~~~~sDv~SlGv~l~elltG~~p~~~ 713 (724)
...|...|||||.+.. ..|+.|+||||||+.+.||.+++.||+.
T Consensus 207 ~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 207 MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 3568899999999854 3689999999999999999999999964
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=263.47 Aligned_cols=195 Identities=34% Similarity=0.453 Sum_probs=168.8
Q ss_pred ccccccccccEEEEEEEEC-CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCC
Q 043185 514 FKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHG 591 (724)
Q Consensus 514 ~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~g 591 (724)
..+.||+|+||.||+|... +++.||+|.+.... ....+++.+|+.++++++||||+++++++..+...++|+||++++
T Consensus 8 ~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06642 8 KLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGG 87 (277)
T ss_pred HHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCC
Confidence 3467999999999999865 56789999886432 334567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceecc
Q 043185 592 SLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTM 671 (724)
Q Consensus 592 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 671 (724)
+|.+++.. ..+++..+..++.|++.|+.|||+ .+++|+||+|+||++++++.++|+|||++..+...... ....
T Consensus 88 ~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-~~~~ 161 (277)
T cd06642 88 SALDLLKP--GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK-RNTF 161 (277)
T ss_pred cHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcchh-hhcc
Confidence 99998854 357889999999999999999996 89999999999999999999999999999766443211 1234
Q ss_pred cccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 672 RGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 672 ~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
.++..|+|||.+.+..++.++|+||||++++||++|+.|+...
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 204 (277)
T cd06642 162 VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204 (277)
T ss_pred cCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCccc
Confidence 5788999999999989999999999999999999999998644
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=258.43 Aligned_cols=196 Identities=33% Similarity=0.513 Sum_probs=170.7
Q ss_pred hccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 511 TDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
.+.+.+.||.|+||.||++... ++.||+|.++.... ..+++.+|+.++++++|+||+++++++..+...++||||+++
T Consensus 7 ~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 7 ELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 3455688999999999999876 56799999976533 567899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 591 GSLDRILFGNG-PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 591 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
++|.+++.... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||.++.......
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~---- 157 (256)
T cd05039 85 GSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---- 157 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc----
Confidence 99999987653 368999999999999999999996 9999999999999999999999999999986633221
Q ss_pred cccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
....+..|+|||.+....++.++|+||||++++||++ |+.||....
T Consensus 158 ~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 204 (256)
T cd05039 158 SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 2234568999999998889999999999999999998 999986553
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=262.44 Aligned_cols=202 Identities=26% Similarity=0.443 Sum_probs=170.2
Q ss_pred hccccccccccccEEEEEEEECC-c----cEEEEEEeecCCc-ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILND-K----TIVAVKKITNVGV-QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLV 584 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~~-~----~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 584 (724)
.+.+.+.||+|+||.||+|.... + ..+|+|.+..... ....++.+|+.++++++|+||+++++++.. ...++|
T Consensus 8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v 86 (279)
T cd05057 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLI 86 (279)
T ss_pred HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEE
Confidence 34556889999999999999642 2 2588998865432 344678899999999999999999999987 788999
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC
Q 043185 585 YEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (724)
+||+++|+|.+++......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 87 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 87 TQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred EecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 99999999999998776678999999999999999999997 999999999999999999999999999998765432
Q ss_pred ccce-ecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 043185 665 SSLF-TTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQ 716 (724)
Q Consensus 665 ~~~~-~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~ 716 (724)
.... ....++..|+|||.+....++.++|+||||++++|+++ |+.||+....
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 217 (279)
T cd05057 164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA 217 (279)
T ss_pred cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH
Confidence 2111 11223568999999988899999999999999999999 9999976543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=264.18 Aligned_cols=197 Identities=25% Similarity=0.388 Sum_probs=166.5
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
+.+.+.||+|+||.||+|+.. +++.+|+|+++... ......+.+|++++++++|+||+++++++.+....++|+||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 345678999999999999975 67889999986432 222356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
++ +|.+++......+++..+..++.||++||.|||+ .+++||||||+||+++.++.+||+|||+++....... ..
T Consensus 82 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 156 (284)
T cd07839 82 DQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-CY 156 (284)
T ss_pred CC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-Cc
Confidence 74 7888776655668999999999999999999997 8999999999999999999999999999986543321 12
Q ss_pred ecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSP 713 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~ 713 (724)
....++..|+|||.+.+. .++.++||||||+++|||++|+.|+..
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~ 202 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 202 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence 334578899999998765 478999999999999999999888643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=264.24 Aligned_cols=200 Identities=29% Similarity=0.377 Sum_probs=170.0
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCCcc-----cHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQ-----GKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVY 585 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 585 (724)
+.+.+.||+|++|.||+|... +++.||+|+++..... ....+..|++++.+++|+||+++++++.+....++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 345678999999999999975 6788999999754322 2345678999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc
Q 043185 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 665 (724)
||+ +++|.+++......+++..+..++.||++||+|||+ .+++|+||||+||+++.++.++|+|||+++.......
T Consensus 82 e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 82 EFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred ccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 999 899999997665478999999999999999999997 8999999999999999999999999999987654322
Q ss_pred cceecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 666 SLFTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 666 ~~~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
. .....++..|+|||.+.+ ..++.++|+||||++++||++|.+||.....
T Consensus 158 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~ 208 (298)
T cd07841 158 K-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD 208 (298)
T ss_pred c-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc
Confidence 1 223356788999999865 4678999999999999999999888866553
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=263.69 Aligned_cols=199 Identities=25% Similarity=0.408 Sum_probs=168.2
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCCc-ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV-QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
+.+.+.||+|++|.||+|+.. +++.||+|.+..... .....+.+|++++++++|+||+++++++.++...++||||++
T Consensus 7 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07844 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD 86 (291)
T ss_pred eeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC
Confidence 445678999999999999975 678899999864322 223457789999999999999999999999999999999998
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
+ +|.+++......+++.....++.|+++||.|||+ .+++||||||+||+++.++.+||+|||+++....... ...
T Consensus 87 ~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~ 161 (291)
T cd07844 87 T-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-TYS 161 (291)
T ss_pred C-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-ccc
Confidence 5 8999887766678899999999999999999996 8999999999999999999999999999875432211 112
Q ss_pred cccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
...++..|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 162 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 162 NEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred ccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 2346788999999875 468999999999999999999999996554
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=266.74 Aligned_cols=203 Identities=27% Similarity=0.429 Sum_probs=168.3
Q ss_pred hhccccccccccccEEEEEEEEC--------CccEEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeceeecCC
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN--------DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGR 579 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~--------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~ 579 (724)
..+.+.+.||+|+||.||+++.. ....+|+|.++... .....++.+|++++.++ +||||+++++++..+.
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 34556789999999999999742 23568999887432 33456788999999999 6999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEe
Q 043185 580 QRLLVYEYMNHGSLDRILFGNG---------------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLH 644 (724)
Q Consensus 580 ~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~ 644 (724)
..++|+||+++|+|.+++.... ..+++..+..++.|++.||.|||+ .+++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEc
Confidence 9999999999999999986532 347888999999999999999996 8999999999999999
Q ss_pred CCCcEEEEeecCccccCCCCcc-ceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 645 YHFQAKISDFGLSKLLTPEQSS-LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 645 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999866432211 1112234567999999999899999999999999999999 889986654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=261.65 Aligned_cols=199 Identities=31% Similarity=0.420 Sum_probs=169.9
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
+.+.+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+.++++++|+||+++++++......++|+||+
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 82 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC 82 (286)
T ss_pred eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence 445678999999999999976 57889999986432 223456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
+++.|..++... ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++........ ..
T Consensus 83 ~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 157 (286)
T cd07847 83 DHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DY 157 (286)
T ss_pred CccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc-cc
Confidence 998888776544 358999999999999999999997 9999999999999999999999999999987654321 12
Q ss_pred ecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
....++..|+|||.+.+ ..++.++|+||||+++|||++|+.||....
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~ 205 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS 205 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 23457889999999876 467899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=256.39 Aligned_cols=200 Identities=23% Similarity=0.387 Sum_probs=170.7
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeec-CCeEEEEEEe
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ-GRQRLLVYEY 587 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~lV~e~ 587 (724)
|.+.+.||+|++|.||+++.. +++.+|+|++.... ....+.+.+|++++++++|+|++++++.+.. +...+++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 456688999999999999965 56789999986432 2345678899999999999999999998764 4467899999
Q ss_pred cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 588 MNHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 588 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
+++++|.+++... ...+++.++..++.+++.|++|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~- 157 (257)
T cd08223 82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD- 157 (257)
T ss_pred cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccCC-
Confidence 9999999998764 4468999999999999999999996 8999999999999999999999999999986643322
Q ss_pred ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
......+++.|+|||++.+..++.++|+||||++++||++|+.||....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 206 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD 206 (257)
T ss_pred ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 2234568899999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=257.27 Aligned_cols=197 Identities=28% Similarity=0.445 Sum_probs=171.1
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecCC-----cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEE
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG-----VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
...+.||+|++|.||+|... +++.|++|.+.... .+..+.+.+|+.++++++|+||+++++++..+...++++|
T Consensus 3 ~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (258)
T cd06632 3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLE 82 (258)
T ss_pred cccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEE
Confidence 44578999999999999976 78889999986532 1244678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
|+++++|.+++.... .+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-- 156 (258)
T cd06632 83 LVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-- 156 (258)
T ss_pred ecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence 999999999987653 57889999999999999999997 899999999999999999999999999987654432
Q ss_pred ceecccccccccccccccCCc-CCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSA-ISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~-~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
......++..|++||.+.... ++.++|+||||+++|||++|+.||....
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 123456889999999997766 8999999999999999999999996543
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=263.29 Aligned_cols=199 Identities=29% Similarity=0.374 Sum_probs=171.4
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
+.+.+.||+|+||+||++... +++.+|+|++.... ....+++.+|++++..++||||+++++++.....+++|+||++
T Consensus 7 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (284)
T cd06620 7 LETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMD 86 (284)
T ss_pred HHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCC
Confidence 444578999999999999965 57789999876432 3345788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
+++|..++... ..+++..+..++.+++.+|.|||+ ..+++||||||+||+++.++.++|+|||++....... ..
T Consensus 87 ~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---~~ 160 (284)
T cd06620 87 CGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---AD 160 (284)
T ss_pred CCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---cC
Confidence 99999988664 358899999999999999999996 3589999999999999999999999999986543221 12
Q ss_pred cccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
...++..|+|||++.+..++.++|+||||+++|||++|+.||.....
T Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred ccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence 34689999999999888999999999999999999999999975443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-30 Score=268.33 Aligned_cols=195 Identities=31% Similarity=0.489 Sum_probs=171.4
Q ss_pred cccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCC
Q 043185 515 KNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHG 591 (724)
Q Consensus 515 ~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~g 591 (724)
.++||.|-||+||-|+++ +|+.||||++.+.. ......+.+|+.||++++||.||.+.-.|+..+..+.|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 478999999999999975 78999999997642 344577899999999999999999999999999999999999776
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCC---CcEEEEeecCccccCCCCccce
Q 043185 592 SLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYH---FQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 592 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DFGla~~~~~~~~~~~ 668 (724)
=|.-+|......+++..-.-++.||+.||.|||. ++|+|+||||+|||+... -.+||||||.|++++....+
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR-- 723 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR-- 723 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhhhh--
Confidence 6666666666778888888889999999999996 999999999999999654 46999999999999876553
Q ss_pred ecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
...+||+.|+|||+++++.|...-|+||.|||+|.-++|.-||..+
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd 769 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED 769 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence 4578999999999999999999999999999999999999999443
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=277.15 Aligned_cols=204 Identities=26% Similarity=0.422 Sum_probs=175.4
Q ss_pred cccccccccEEEEEEEEC--Cc--cEEEEEEeecCCcc-cHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 515 KNLIGSGGFGAVYKGILN--DK--TIVAVKKITNVGVQ-GKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 515 ~~~lG~G~fG~Vy~~~~~--~~--~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
.|+||+|.||.|++|.++ ++ -.||||.++..... ...+|++|+.+|-+|+|+|+++|+|+..+ ....||+|.++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 478999999999999975 33 35899999765433 66899999999999999999999999987 67889999999
Q ss_pred CCCHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc-c
Q 043185 590 HGSLDRILFG-NGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS-L 667 (724)
Q Consensus 590 ~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~ 667 (724)
.|+|.+.|.+ ....+-...+-.++.|||.||.||.+ +++|||||.++|+||...-.+||+||||.+.+...+.. .
T Consensus 194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv 270 (1039)
T KOG0199|consen 194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV 270 (1039)
T ss_pred cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence 9999999987 45567778888999999999999997 99999999999999999999999999999988654432 2
Q ss_pred eecc-cccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCCCC
Q 043185 668 FTTM-RGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQSHSMDS 722 (724)
Q Consensus 668 ~~~~-~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~~~~~~~ 722 (724)
+... .-...|.|||.++...++.++|||+|||++|||+| |..||-+....+|++.
T Consensus 271 m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~ 327 (1039)
T KOG0199|consen 271 MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKN 327 (1039)
T ss_pred ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHh
Confidence 2211 23457999999999999999999999999999999 7999998887776654
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=264.97 Aligned_cols=201 Identities=28% Similarity=0.349 Sum_probs=171.9
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCCcc---cHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQ---GKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
+.+.+.||+|++|.||++... +++.+|+|.+...... ..+.+.+|++++.+++|+||+++++.+.++...++||||
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY 82 (316)
T ss_pred eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence 345578999999999999976 4788999999754322 446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 588 MNHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 588 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
+++++|.+++... ...+++.....++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (316)
T cd05574 83 CPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159 (316)
T ss_pred cCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence 9999999998753 4568889999999999999999996 89999999999999999999999999998754321100
Q ss_pred ----------------------------ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 667 ----------------------------LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 667 ----------------------------~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
......|+..|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 0112357889999999999899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=263.24 Aligned_cols=199 Identities=30% Similarity=0.433 Sum_probs=169.3
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCCc--ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV--QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
+.+.+.||+|+||.||++... +++.+|+|++..... ...+.+.+|++++++++||||+++++++..+...++|+||+
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (286)
T cd07846 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV 82 (286)
T ss_pred eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecC
Confidence 445688999999999999985 578899998864322 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
++++|..+.... ..+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++........ ..
T Consensus 83 ~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~ 157 (286)
T cd07846 83 DHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VY 157 (286)
T ss_pred CccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-cc
Confidence 999988876544 348999999999999999999997 8999999999999999999999999999886544322 22
Q ss_pred ecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
....++..|+|||++.+ ..++.++||||||++++||++|++||....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~ 205 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc
Confidence 33457889999999875 457889999999999999999999996544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=263.72 Aligned_cols=200 Identities=31% Similarity=0.450 Sum_probs=166.8
Q ss_pred cccccccccccEEEEEEEEC------CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEE
Q 043185 513 NFKNLIGSGGFGAVYKGILN------DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVY 585 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 585 (724)
.+.+.||+|+||.||+|+.. ....+++|.+.... ....+++.+|+.+++.++||||+++++.+......++++
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV 82 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence 34578999999999999853 22468888876432 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeE
Q 043185 586 EYMNHGSLDRILFGN-----------------------GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENIL 642 (724)
Q Consensus 586 e~~~~gsL~~~l~~~-----------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NIL 642 (724)
||+++++|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+|||
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~nil 159 (290)
T cd05045 83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVL 159 (290)
T ss_pred EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheEE
Confidence 999999999988642 1247788899999999999999996 89999999999999
Q ss_pred EeCCCcEEEEeecCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 643 LHYHFQAKISDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 643 l~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
+++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||++++||++ |+.||.+..
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999999999976533221 11122345678999999998899999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=261.27 Aligned_cols=197 Identities=23% Similarity=0.337 Sum_probs=158.1
Q ss_pred ccccccccEEEEEEEECCc---cEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCC
Q 043185 516 NLIGSGGFGAVYKGILNDK---TIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHG 591 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~---~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~g 591 (724)
+.||+|+||.||++...++ ..+++|.+.... ....+++.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3599999999999985433 345666665432 234578999999999999999999999999999999999999999
Q ss_pred CHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC-ccc
Q 043185 592 SLDRILFGN---GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ-SSL 667 (724)
Q Consensus 592 sL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~-~~~ 667 (724)
+|.+++... ...........++.||+.||+|||+ .+++||||||+|||++.++.++|+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 999998754 2345666778899999999999996 899999999999999999999999999986432211 111
Q ss_pred eecccccccccccccccC-------CcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTN-------SAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~-------~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 213 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS 213 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Confidence 223457889999999853 245789999999999999997 577886544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=262.34 Aligned_cols=199 Identities=26% Similarity=0.405 Sum_probs=166.1
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
+.+.+.||+|+||.||+|... +++.+|+|++.... ......+.+|+.+++.++|+||+++++++..+...++|+||+.
T Consensus 7 y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07870 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH 86 (291)
T ss_pred eEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc
Confidence 445678999999999999864 67889999986532 2333567899999999999999999999999999999999996
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
++|..++......+.+..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++........ ..
T Consensus 87 -~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~ 161 (291)
T cd07870 87 -TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT-YS 161 (291)
T ss_pred -CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC-CC
Confidence 67777766554567788888999999999999997 89999999999999999999999999998764332211 12
Q ss_pred cccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
...++..|+|||++.+. .++.++||||||+++|||++|+.||+...
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 33578899999998764 57889999999999999999999997543
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-30 Score=247.01 Aligned_cols=206 Identities=26% Similarity=0.409 Sum_probs=173.5
Q ss_pred CCCChHHHHHhhccccccccccccEEEEEEEEC-CccEEEEEEeecCC-cccHHHHHHHHHHHhcCC-CCCccceeceee
Q 043185 500 QRFDYEELEVATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIH-HVNLVKLKGFCA 576 (724)
Q Consensus 500 ~~~~~~~l~~a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~ 576 (724)
..-+..+|+.- ..||.|..|.|+++++. .+..+|||.+.+.. .++.++++..+.++.+-+ .|.||+.+|+|.
T Consensus 87 ~~~dindl~~l-----~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi 161 (391)
T KOG0983|consen 87 YQADINDLENL-----GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI 161 (391)
T ss_pred cccChHHhhhH-----HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe
Confidence 34556666543 56999999999999976 57889999997643 455678888888887775 999999999999
Q ss_pred cCCeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecC
Q 043185 577 QGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGL 656 (724)
Q Consensus 577 ~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGl 656 (724)
.+...++-||.|.. .++.+++.-..++.+..+-++...+..||.||.+ +++|||||+||+|||+|+.|++|+||||+
T Consensus 162 ~n~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGI 238 (391)
T KOG0983|consen 162 TNTDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGI 238 (391)
T ss_pred eCchHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccc
Confidence 99999999999854 6667776655668888888999999999999998 78999999999999999999999999999
Q ss_pred ccccCCCCccceecccccccccccccccC---CcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 657 SKLLTPEQSSLFTTMRGTRGYLAPEWLTN---SAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 657 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
+..+..... .+...|.+.|||||.+.- ..|+.++|||||||.|+||.||+.||.+-.
T Consensus 239 sGrlvdSkA--htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~ 298 (391)
T KOG0983|consen 239 SGRLVDSKA--HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK 298 (391)
T ss_pred cceeecccc--cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC
Confidence 977654332 345679999999999954 468999999999999999999999997743
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=256.34 Aligned_cols=199 Identities=35% Similarity=0.546 Sum_probs=171.7
Q ss_pred ccccccccccEEEEEEEECC-----ccEEEEEEeecCCcc-cHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 514 FKNLIGSGGFGAVYKGILND-----KTIVAVKKITNVGVQ-GKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 514 ~~~~lG~G~fG~Vy~~~~~~-----~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
+.+.||.|+||.||+++..+ +..||+|++...... ..+.+.+|++++.+++|+||+++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 45789999999999999754 377999999754333 567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 588 MNHGSLDRILFGNGPV-LEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~-l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
+++++|.+++...... +++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 9999999999765444 8999999999999999999996 89999999999999999999999999999876544222
Q ss_pred ceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
......++..|+|||.+.+..++.++|+||||++++||++ |++||....
T Consensus 160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~ 209 (258)
T smart00219 160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS 209 (258)
T ss_pred ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 1112336789999999988889999999999999999998 888886543
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=259.51 Aligned_cols=199 Identities=27% Similarity=0.377 Sum_probs=167.2
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecCC-----cccHHHHHHHHHHHhcCCCCCccceeceeec--CCeEEEE
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG-----VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ--GRQRLLV 584 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV 584 (724)
...+.||+|+||.||++... .+..+|+|++.... .+..+.+.+|+.++++++||||+++++++.+ +...+++
T Consensus 5 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~ 84 (266)
T cd06651 5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIF 84 (266)
T ss_pred cccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEE
Confidence 34578999999999999974 57889999886432 1233568889999999999999999998865 3577899
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC
Q 043185 585 YEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (724)
+||+++++|.+++.... .+++.....++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 85 MEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence 99999999999987653 47888899999999999999996 899999999999999999999999999987654321
Q ss_pred c--cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 665 S--SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 665 ~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
. .......++..|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~ 213 (266)
T cd06651 161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE 213 (266)
T ss_pred ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc
Confidence 1 11123457889999999999889999999999999999999999997553
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=258.55 Aligned_cols=198 Identities=29% Similarity=0.375 Sum_probs=174.3
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
+.+.+.||.|+||.||+++.. +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.++...++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 345688999999999999975 57889999997532 23457889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
+++++|..++... ..+++.....++.|+++||.|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-- 155 (258)
T cd05578 82 LLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL-- 155 (258)
T ss_pred CCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc--
Confidence 9999999998765 468889999999999999999996 8999999999999999999999999999886654321
Q ss_pred eecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 203 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203 (258)
T ss_pred ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence 234568889999999998889999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=265.10 Aligned_cols=203 Identities=25% Similarity=0.416 Sum_probs=167.5
Q ss_pred hccccccccccccEEEEEEEEC-----------------CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCcccee
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-----------------DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLK 572 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-----------------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~ 572 (724)
.+.+.+.||+|+||.||++... +...+|+|++.... .....++.+|+.++++++|+||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~ 85 (296)
T cd05095 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLL 85 (296)
T ss_pred hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 3556788999999999998532 23468999987532 33456789999999999999999999
Q ss_pred ceeecCCeEEEEEEecCCCCHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeE
Q 043185 573 GFCAQGRQRLLVYEYMNHGSLDRILFGNG----------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENIL 642 (724)
Q Consensus 573 g~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NIL 642 (724)
+++..+...++||||+++++|.+++.... ..+++.....++.|++.||+|||+ .+++|+||||+|||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Nil 162 (296)
T cd05095 86 AVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCL 162 (296)
T ss_pred EEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheEE
Confidence 99999999999999999999999986532 236678899999999999999997 89999999999999
Q ss_pred EeCCCcEEEEeecCccccCCCCcc-ceecccccccccccccccCCcCCCccchhhHHHHHHHHHh--CCCCCCCCCC
Q 043185 643 LHYHFQAKISDFGLSKLLTPEQSS-LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS--GRRNCSPRSQ 716 (724)
Q Consensus 643 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt--G~~p~~~~~~ 716 (724)
++.++.++|+|||+++.+...... ......++..|+|||...+..++.++|+||||+++|||++ |..||.....
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 999999999999999765432211 1112234678999999888889999999999999999998 7788865543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=262.53 Aligned_cols=201 Identities=30% Similarity=0.435 Sum_probs=173.8
Q ss_pred hccccccccccccEEEEEEEE-CCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 511 TDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
++.+.+.||+|+||.||++.. .++..+|+|.+........+.+.+|+.++++++||||+++++.+...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 99 (293)
T cd06647 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLA 99 (293)
T ss_pred hceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCC
Confidence 445567899999999999985 4677899999865444555778999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
+++|.+++... .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++......... ..
T Consensus 100 ~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~-~~ 173 (293)
T cd06647 100 GGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RS 173 (293)
T ss_pred CCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc-cc
Confidence 99999998654 47788999999999999999996 89999999999999999999999999998765443221 23
Q ss_pred cccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
...+++.|+|||.+.+..++.++|+||||+++||+++|+.||......
T Consensus 174 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~ 221 (293)
T cd06647 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221 (293)
T ss_pred cccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh
Confidence 346888999999998888999999999999999999999999766543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=265.47 Aligned_cols=202 Identities=26% Similarity=0.422 Sum_probs=169.4
Q ss_pred hccccccccccccEEEEEEEECC-----------------ccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCcccee
Q 043185 511 TDNFKNLIGSGGFGAVYKGILND-----------------KTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLK 572 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~~-----------------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~ 572 (724)
.+.+.+.||+|+||.||+++..+ +..||+|++.... ....+++.+|++++++++||||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 85 (296)
T cd05051 6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLL 85 (296)
T ss_pred hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 45566899999999999998642 2458999987532 23456789999999999999999999
Q ss_pred ceeecCCeEEEEEEecCCCCHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeE
Q 043185 573 GFCAQGRQRLLVYEYMNHGSLDRILFGNG----------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENIL 642 (724)
Q Consensus 573 g~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NIL 642 (724)
+++..+...++++||+++++|..++.... ..+++..+..++.|++.||+|||+ .+++||||||+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Nil 162 (296)
T cd05051 86 GVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCL 162 (296)
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhcee
Confidence 99999999999999999999999987543 257899999999999999999997 89999999999999
Q ss_pred EeCCCcEEEEeecCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh--CCCCCCCCC
Q 043185 643 LHYHFQAKISDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS--GRRNCSPRS 715 (724)
Q Consensus 643 l~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt--G~~p~~~~~ 715 (724)
++.++.++|+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ +..||....
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 99999999999999876543321 11223346778999999998889999999999999999998 677775543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=261.24 Aligned_cols=198 Identities=25% Similarity=0.415 Sum_probs=167.7
Q ss_pred ccccccccccEEEEEEEEC------CccEEEEEEeecCCcc-cHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEE
Q 043185 514 FKNLIGSGGFGAVYKGILN------DKTIVAVKKITNVGVQ-GKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 514 ~~~~lG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
..+.||+|+||.||+|+.. +.+.+++|.+...... ..+++.+|++++++++|+||+++++++.+....++|||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 88 (275)
T cd05046 9 EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILE 88 (275)
T ss_pred eeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEE
Confidence 4468999999999999964 3456899988654333 35679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCcc
Q 043185 587 YMNHGSLDRILFGNG--------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSK 658 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~--------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~ 658 (724)
|+++++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++.
T Consensus 89 ~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~~~~~ 165 (275)
T cd05046 89 YTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSK 165 (275)
T ss_pred ecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccccccc
Confidence 999999999987543 158899999999999999999996 899999999999999999999999999987
Q ss_pred ccCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 043185 659 LLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPR 714 (724)
Q Consensus 659 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~ 714 (724)
..............++..|+|||.+.+..++.++||||||++++||++ |..||...
T Consensus 166 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~ 222 (275)
T cd05046 166 DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL 222 (275)
T ss_pred ccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 543322222233346778999999988889999999999999999999 78888543
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=268.38 Aligned_cols=206 Identities=29% Similarity=0.421 Sum_probs=170.5
Q ss_pred HHHhhccccccccccccEEEEEEEEC--------CccEEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeceee
Q 043185 507 LEVATDNFKNLIGSGGFGAVYKGILN--------DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCA 576 (724)
Q Consensus 507 l~~a~~~~~~~lG~G~fG~Vy~~~~~--------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~ 576 (724)
+....+.+.+.||+|+||.||++... ....||+|.++... ....+++.+|++++.++ +||||+++++++.
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 34445677889999999999999742 12368999886432 33456889999999999 8999999999999
Q ss_pred cCCeEEEEEEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCe
Q 043185 577 QGRQRLLVYEYMNHGSLDRILFGNG---------------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENI 641 (724)
Q Consensus 577 ~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NI 641 (724)
++...++++||+++|+|.+++.... ..+.+..++.++.|++.||+|||+ .+++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Ni 165 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNV 165 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceE
Confidence 9999999999999999999986532 347788899999999999999996 8999999999999
Q ss_pred EEeCCCcEEEEeecCccccCCCCcc-ceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 642 LLHYHFQAKISDFGLSKLLTPEQSS-LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 642 Ll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
|++.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999865432211 1122234567999999999999999999999999999998 888886654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=264.39 Aligned_cols=200 Identities=27% Similarity=0.338 Sum_probs=169.2
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
+.+.+.||+|+||.||++... .++.|++|.+.... ....+.+.+|++++..++||||+++++.+..+...++||||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY 82 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence 345578999999999999975 56789999986532 22345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc--
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS-- 665 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~-- 665 (724)
+++++|.+++...+ .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||+++.......
T Consensus 83 ~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 83 VEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 99999999997653 57888889999999999999997 8999999999999999999999999999864211100
Q ss_pred ------------cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 666 ------------SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 666 ------------~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.......++..|+|||.+.+..++.++|+||||+++|||++|+.||.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~ 220 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 220 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 01112357889999999998889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=259.41 Aligned_cols=196 Identities=32% Similarity=0.453 Sum_probs=170.0
Q ss_pred ccccccccccEEEEEEEEC-CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCC
Q 043185 514 FKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHG 591 (724)
Q Consensus 514 ~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~g 591 (724)
..+.||.|+||.||+|+.. ++..||+|.+.... ......+.+|+.++++++|+||+++++++.++...++||||++++
T Consensus 8 ~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06640 8 KLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGG 87 (277)
T ss_pred hhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCC
Confidence 3467999999999999975 57789999887432 344567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceecc
Q 043185 592 SLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTM 671 (724)
Q Consensus 592 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 671 (724)
+|.+++... .+++.....++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++......... ....
T Consensus 88 ~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~ 161 (277)
T cd06640 88 SALDLLRAG--PFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK-RNTF 161 (277)
T ss_pred cHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc-cccc
Confidence 999988643 57888899999999999999996 89999999999999999999999999999766443221 1234
Q ss_pred cccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 672 RGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 672 ~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.++..|+|||++.+..++.++|+||||+++|||++|+.||....
T Consensus 162 ~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06640 162 VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH 205 (277)
T ss_pred cCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 57889999999998889999999999999999999999996544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=255.63 Aligned_cols=199 Identities=32% Similarity=0.493 Sum_probs=172.2
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCCcc--cHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQ--GKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
|...+.||+|+||.||++... +++.+++|.++..... ..+++.+|+.++++++|+||+++++.+...+..++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 345678999999999999965 6788999998754332 5678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc-
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL- 667 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~- 667 (724)
++++|.+++... ..+++..+..++.++++||+|||+ .+++|+||+|+||++++++.+||+|||++..........
T Consensus 82 ~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 82 SGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 999999998765 357888999999999999999996 899999999999999999999999999988765432211
Q ss_pred --eecccccccccccccccCCc---CCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 668 --FTTMRGTRGYLAPEWLTNSA---ISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 668 --~~~~~gt~~y~aPE~l~~~~---~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
.....++..|+|||++.+.. ++.++||||||++++||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 12346788999999998766 889999999999999999999999654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-30 Score=232.05 Aligned_cols=200 Identities=25% Similarity=0.402 Sum_probs=172.5
Q ss_pred ccccccccEEEEEEEE-CCccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCC
Q 043185 516 NLIGSGGFGAVYKGIL-NDKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGS 592 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gs 592 (724)
++||+|.||+||||+. +.++.||+|+++-.. ..-....++|+.+++.++|.|||++++....+..+-+|+||+.. +
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-d 86 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-D 86 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-H
Confidence 6799999999999996 467889999986432 23346788999999999999999999999999999999999965 8
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceeccc
Q 043185 593 LDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMR 672 (724)
Q Consensus 593 L~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 672 (724)
|..+...-...++.+....++.|+++||.|+|+ .++.||||||.|.||+.+|++|++|||+++.++-.. ...+..+
T Consensus 87 lkkyfdslng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipv-rcysaev 162 (292)
T KOG0662|consen 87 LKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-RCYSAEV 162 (292)
T ss_pred HHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCce-Eeeecee
Confidence 888887777788999999999999999999997 899999999999999999999999999999886543 3345567
Q ss_pred ccccccccccccCC-cCCCccchhhHHHHHHHHHh-CCCCCCCCCCCCCC
Q 043185 673 GTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVS-GRRNCSPRSQSHSM 720 (724)
Q Consensus 673 gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~~~~~ 720 (724)
-|..|.+|.++.+. -|+...|+||-||++.|+.. |++-|.+.+..+.+
T Consensus 163 vtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddql 212 (292)
T KOG0662|consen 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 212 (292)
T ss_pred eeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHH
Confidence 79999999999886 58999999999999999998 66667666554443
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=260.73 Aligned_cols=199 Identities=30% Similarity=0.413 Sum_probs=171.4
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
+++.+.||+|++|.||+|... +++.||+|+++.. .....+.+.+|++++++++|+||+++++++..++..++|+||+
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence 456688999999999999976 5778999988643 2334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
+++.+..+.... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++...........
T Consensus 83 ~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 83 ERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence 987776655443 458899999999999999999996 8999999999999999999999999999987655433223
Q ss_pred ecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
....++..|+|||++.+. .++.++|+||||+++|||++|++||...
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 445678899999999888 8899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=257.12 Aligned_cols=199 Identities=26% Similarity=0.373 Sum_probs=167.5
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecC-----CcccHHHHHHHHHHHhcCCCCCccceeceeecC--CeEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV-----GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG--RQRLL 583 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~l 583 (724)
+.+.+.||+|+||.||++... ++..+|+|++... ..+..+.+.+|++++++++|+||+++++++.+. ...++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 445689999999999999964 5788999987532 123345788999999999999999999998654 46789
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCC
Q 043185 584 VYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE 663 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (724)
++||+++++|.+++.... .+++....+++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 84 FVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 999999999999987653 47888899999999999999997 89999999999999999999999999999865321
Q ss_pred C--ccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 664 Q--SSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 664 ~--~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
. ........++..|+|||.+.+..++.++|+||||++++||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 1 11112345889999999999988999999999999999999999999654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=259.50 Aligned_cols=196 Identities=33% Similarity=0.525 Sum_probs=164.6
Q ss_pred ccccccccEEEEEEEECC-------ccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 516 NLIGSGGFGAVYKGILND-------KTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~-------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
+.||+|+||.||+|+..+ +..+|+|.+.... .....++.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998643 2468999876432 24456889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCC-----cEEEEeecC
Q 043185 588 MNHGSLDRILFGN------GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHF-----QAKISDFGL 656 (724)
Q Consensus 588 ~~~gsL~~~l~~~------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-----~~kl~DFGl 656 (724)
+++++|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.+. .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999998642 2347889999999999999999996 8999999999999999887 899999999
Q ss_pred ccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 043185 657 SKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPR 714 (724)
Q Consensus 657 a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~ 714 (724)
++....... .......++..|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~ 217 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL 217 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc
Confidence 876543221 11122345678999999999999999999999999999998 99998654
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-31 Score=252.85 Aligned_cols=193 Identities=31% Similarity=0.432 Sum_probs=162.0
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecCCc-ccHHHHHHHHHHHhc-CCCCCccceeceeecCCeEEEEEEecCCCC
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV-QGKKDFCTEIAIIGN-IHHVNLVKLKGFCAQGRQRLLVYEYMNHGS 592 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~-l~H~nIv~l~g~~~~~~~~~lV~e~~~~gs 592 (724)
..||.|+||+|+|-.++ .++..|||+++.... .++++++.|.+...+ -+.||||+++|.+..+...||-||.|+- +
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-S 148 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-S 148 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-h
Confidence 46999999999999975 788999999986544 566788889887544 4899999999999999999999999954 6
Q ss_pred HHHHHh----cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce
Q 043185 593 LDRILF----GNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 593 L~~~l~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
|+.+-+ .....+++...-.|..-+..||.||.. +..|||||+||+||||+..|.+||||||.+..+...-. .
T Consensus 149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA--k 224 (361)
T KOG1006|consen 149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA--K 224 (361)
T ss_pred HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHHHH--h
Confidence 665533 124567788888888899999999998 68999999999999999999999999999876643321 2
Q ss_pred ecccccccccccccccC--CcCCCccchhhHHHHHHHHHhCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTN--SAISEKTDVYSFGMVLLELVSGRRNCSP 713 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~--~~~~~~sDv~SlGv~l~elltG~~p~~~ 713 (724)
+...|...|||||.+.. ..|+.++||||||++|+|+.||+-|++.
T Consensus 225 T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~ 271 (361)
T KOG1006|consen 225 TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK 271 (361)
T ss_pred hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch
Confidence 45579999999999964 3589999999999999999999999964
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=263.70 Aligned_cols=197 Identities=27% Similarity=0.476 Sum_probs=164.4
Q ss_pred ccccccccccEEEEEEEEC-Ccc----EEEEEEeecCCc-ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 514 FKNLIGSGGFGAVYKGILN-DKT----IVAVKKITNVGV-QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 514 ~~~~lG~G~fG~Vy~~~~~-~~~----~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
..+.||+|+||.||+|... ++. .+|+|.+..... ....++.+|+.++++++||||+++++++... ..++++||
T Consensus 11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~ 89 (303)
T cd05110 11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQL 89 (303)
T ss_pred eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehh
Confidence 3468999999999999863 333 478888765322 2234688999999999999999999998754 46799999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc-
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS- 666 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~- 666 (724)
+++|+|.+++......+++..+..++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||+++........
T Consensus 90 ~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 166 (303)
T cd05110 90 MPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY 166 (303)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccCccccc
Confidence 99999999998766678899999999999999999996 89999999999999999999999999999866433221
Q ss_pred ceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPR 714 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~ 714 (724)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 167 ~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~ 215 (303)
T cd05110 167 NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215 (303)
T ss_pred ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1122335678999999999999999999999999999998 89999654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=257.95 Aligned_cols=194 Identities=27% Similarity=0.427 Sum_probs=170.2
Q ss_pred ccccccccEEEEEEEE-CCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCCHH
Q 043185 516 NLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLD 594 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gsL~ 594 (724)
+.||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++||||+++++++...+..++|+||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~ 104 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT 104 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence 6899999999999996 467889999987554455567889999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceeccccc
Q 043185 595 RILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGT 674 (724)
Q Consensus 595 ~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt 674 (724)
+++.. ..+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++......... .....|+
T Consensus 105 ~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~ 178 (285)
T cd06648 105 DIVTH--TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-RKSLVGT 178 (285)
T ss_pred HHHHh--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-cccccCC
Confidence 99876 358889999999999999999997 89999999999999999999999999988755433221 2234588
Q ss_pred ccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 675 RGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 675 ~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
..|+|||.+.+..++.++||||||++++||++|+.||....
T Consensus 179 ~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~ 219 (285)
T cd06648 179 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP 219 (285)
T ss_pred ccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC
Confidence 99999999998889999999999999999999999996644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=263.29 Aligned_cols=201 Identities=31% Similarity=0.480 Sum_probs=167.5
Q ss_pred ccccccccccccEEEEEEEEC------CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN------DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLV 584 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 584 (724)
+.+.+.||+|+||.||++... ++..+|+|++.... ....+++.+|+.++++++||||+++++++.++...++|
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv 86 (288)
T cd05050 7 IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLL 86 (288)
T ss_pred ceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEE
Confidence 344578999999999999864 45779999986532 23456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEE
Q 043185 585 YEYMNHGSLDRILFGNG---------------------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILL 643 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~~---------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 643 (724)
+||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+||++
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~nil~ 163 (288)
T cd05050 87 FEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLV 163 (288)
T ss_pred EecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhheEe
Confidence 99999999999986421 246778889999999999999996 899999999999999
Q ss_pred eCCCcEEEEeecCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 644 HYHFQAKISDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 644 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
+.++.++|+|||+++....... ........+..|+|||.+.+..++.++||||||+++|||++ |..||.+..
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999876533221 11122234667999999998899999999999999999998 888886543
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-29 Score=258.04 Aligned_cols=194 Identities=29% Similarity=0.431 Sum_probs=167.2
Q ss_pred ccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCCH
Q 043185 518 IGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSL 593 (724)
Q Consensus 518 lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gsL 593 (724)
||+|+||+||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++.+...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999864 67889999986432 22345567899999999999999999999999999999999999999
Q ss_pred HHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceeccc
Q 043185 594 DRILFGNG-PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMR 672 (724)
Q Consensus 594 ~~~l~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 672 (724)
.+++.... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--ccccc
Confidence 99987653 368899999999999999999997 8999999999999999999999999999876543221 23345
Q ss_pred ccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 673 GTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 673 gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
++..|+|||++.+..++.++|+||||+++++|++|+.||.....
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 199 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKE 199 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence 78899999999888899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=259.35 Aligned_cols=200 Identities=33% Similarity=0.494 Sum_probs=170.7
Q ss_pred ccccccccccccEEEEEEEEC-----CccEEEEEEeecCCcc-cHHHHHHHHHHHhcCCCCCccceeceeec--CCeEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-----DKTIVAVKKITNVGVQ-GKKDFCTEIAIIGNIHHVNLVKLKGFCAQ--GRQRLL 583 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-----~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~l 583 (724)
+.+.+.||+|+||.||++++. .+..+|||+++..... ..+++.+|++++++++|+||+++++++.. ....++
T Consensus 6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05038 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRL 85 (284)
T ss_pred chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEE
Confidence 345578999999999999964 3578999999765332 46789999999999999999999999877 557899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCC
Q 043185 584 VYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE 663 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (724)
|+||+++++|.+++......+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 86 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 86 IMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred EEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 999999999999998776679999999999999999999996 89999999999999999999999999999876532
Q ss_pred Ccc--ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 664 QSS--LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 664 ~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
... ......++..|+|||.+.+..++.++|+||||++++||++|+.|+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred CcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 211 111223456799999999889999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=255.89 Aligned_cols=199 Identities=26% Similarity=0.438 Sum_probs=169.3
Q ss_pred cccccccccccEEEEEEEE-CCccEEEEEEeecCCc------ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEE
Q 043185 513 NFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGV------QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVY 585 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 585 (724)
...+.||+|++|.||++.. .+++.+|+|.+..... ...+++.+|+.++++++|+||+++++++.+....++|+
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 82 (268)
T cd06630 3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV 82 (268)
T ss_pred cccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEE
Confidence 3457899999999999985 5678899999864321 12467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCC-cEEEEeecCccccCCCC
Q 043185 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHF-QAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFGla~~~~~~~ 664 (724)
||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++ .++|+|||++.......
T Consensus 83 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 83 EWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred eccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 9999999999987653 57889999999999999999997 8999999999999998776 59999999987665432
Q ss_pred cc---ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 665 SS---LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 665 ~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.. ......++..|+|||.+.+..++.++|+||||++++||++|+.||....
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 11 1123457889999999998889999999999999999999999996443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=253.92 Aligned_cols=200 Identities=25% Similarity=0.385 Sum_probs=172.4
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
+.+.+.||+|+||.||+++.. +++.+|+|++... .....+++.+|+.++++++||||+++++++.+.+..++|+||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 445688999999999999964 6788999998643 2334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 589 NHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 589 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
++++|.+++... ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~- 157 (256)
T cd08218 82 EGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL- 157 (256)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh-
Confidence 999999988654 3357889999999999999999996 89999999999999999999999999999766443211
Q ss_pred eecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.....++..|+|||++.+..++.++|+||||++++||++|+.||....
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~ 205 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN 205 (256)
T ss_pred hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC
Confidence 123457889999999999899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=255.80 Aligned_cols=199 Identities=28% Similarity=0.458 Sum_probs=168.6
Q ss_pred cccccccccccEEEEEEEECC--ccEEEEEEeecCC----------cccHHHHHHHHHHHhc-CCCCCccceeceeecCC
Q 043185 513 NFKNLIGSGGFGAVYKGILND--KTIVAVKKITNVG----------VQGKKDFCTEIAIIGN-IHHVNLVKLKGFCAQGR 579 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~~--~~~vAvK~~~~~~----------~~~~~~~~~E~~~l~~-l~H~nIv~l~g~~~~~~ 579 (724)
.+.+.||+|+||.||++.... ++.+|+|.+.... .....++.+|+.++.+ ++||||+++++++.++.
T Consensus 3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 82 (269)
T cd08528 3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND 82 (269)
T ss_pred hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC
Confidence 345789999999999999764 6789999875321 1233557788888865 79999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecC
Q 043185 580 QRLLVYEYMNHGSLDRILFG---NGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGL 656 (724)
Q Consensus 580 ~~~lV~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGl 656 (724)
..++||||+++++|.+++.. ....+++..++.++.|++.+|.|||+ ..+++|+||+|+||+++.++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 83 RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecccc
Confidence 99999999999999988743 34568889999999999999999995 36899999999999999999999999999
Q ss_pred ccccCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 657 SKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 657 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
+....... ......++..|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus 161 ~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~ 217 (269)
T cd08528 161 AKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN 217 (269)
T ss_pred eeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC
Confidence 98665432 2344568899999999999889999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-29 Score=259.13 Aligned_cols=200 Identities=31% Similarity=0.400 Sum_probs=165.6
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeceee-----cCCeEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCA-----QGRQRLLV 584 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~-----~~~~~~lV 584 (724)
+.+.+.||+|+||.||+++.. +++.+|+|++... .....++.+|+.++.++ +||||+++++++. .+...++|
T Consensus 20 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv 98 (286)
T cd06638 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLV 98 (286)
T ss_pred eeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEE
Confidence 344578999999999999974 5678999987653 23346688899999999 7999999999874 34578999
Q ss_pred EEecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccC
Q 043185 585 YEYMNHGSLDRILFG---NGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 661 (724)
|||+++++|.+++.. ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+++...
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 175 (286)
T cd06638 99 LELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 175 (286)
T ss_pred EeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence 999999999988753 23467888899999999999999997 899999999999999999999999999988664
Q ss_pred CCCccceecccccccccccccccC-----CcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 662 PEQSSLFTTMRGTRGYLAPEWLTN-----SAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 662 ~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
..... .....|+..|+|||++.. ..++.++||||||+++|||++|+.||.....
T Consensus 176 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~ 234 (286)
T cd06638 176 STRLR-RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234 (286)
T ss_pred cCCCc-cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence 33221 233468999999999853 4578899999999999999999999976543
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=258.28 Aligned_cols=198 Identities=25% Similarity=0.335 Sum_probs=168.1
Q ss_pred cccccccccccEEEEEEEE----CCccEEEEEEeecCC----cccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEE
Q 043185 513 NFKNLIGSGGFGAVYKGIL----NDKTIVAVKKITNVG----VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLL 583 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l 583 (724)
.+.+.||.|+||.||+++. .++..+|+|++.... ....+.+.+|+.++.++ +|+||+++++++..+...++
T Consensus 3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (290)
T cd05613 3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL 82 (290)
T ss_pred eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence 4557899999999999986 367889999987532 22346678899999999 69999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCC
Q 043185 584 VYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE 663 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (724)
|+||+++++|.+++... ..+++.....++.|++.||.|||+ .+++||||+|+|||++.++.+||+|||++......
T Consensus 83 v~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 83 ILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 99999999999998765 357888888899999999999996 89999999999999999999999999999876543
Q ss_pred CccceecccccccccccccccCC--cCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 664 QSSLFTTMRGTRGYLAPEWLTNS--AISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 664 ~~~~~~~~~gt~~y~aPE~l~~~--~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
.........|+..|+|||.+... .++.++||||||+++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 211 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD 211 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcC
Confidence 32222345688999999998753 4688999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=255.79 Aligned_cols=202 Identities=30% Similarity=0.393 Sum_probs=173.5
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
+.+.+.||.|+||.||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+..+...++|+|+++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 445688999999999999964 67789999986432 2355788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc-
Q 043185 590 HGSLDRILFGNG--PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS- 666 (724)
Q Consensus 590 ~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~- 666 (724)
+++|.+++.... ..+++.....++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++..+......
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred CCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 999999997642 468889999999999999999996 99999999999999999999999999998776543321
Q ss_pred --ceecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 667 --LFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 667 --~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
......++..|+|||++... .++.++|+||||++++||++|+.||.....
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~ 212 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP 212 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh
Confidence 12234588999999998876 789999999999999999999999976543
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=250.52 Aligned_cols=196 Identities=34% Similarity=0.480 Sum_probs=175.4
Q ss_pred ccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCC
Q 043185 514 FKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGS 592 (724)
Q Consensus 514 ~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gs 592 (724)
..+.||+|++|.||++... +++.+++|++........+++.+|++++++++|+||+++++++..+...++++||+++++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 83 (253)
T cd05122 4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGS 83 (253)
T ss_pred eeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCc
Confidence 4578999999999999986 678899999976544466789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceeccc
Q 043185 593 LDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMR 672 (724)
Q Consensus 593 L~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 672 (724)
|.+++......+++..+..++.|++.+|.|||+ .+++|+||+|+||++++++.++|+|||.+........ .....
T Consensus 84 L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 158 (253)
T cd05122 84 LKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTMV 158 (253)
T ss_pred HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc--cccee
Confidence 999987765678999999999999999999996 9999999999999999999999999999987654432 23456
Q ss_pred ccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 673 GTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 673 gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
++..|+|||.+.+..++.++|+||||+++++|++|+.||...
T Consensus 159 ~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred cCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 889999999999888999999999999999999999999765
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=257.25 Aligned_cols=199 Identities=29% Similarity=0.428 Sum_probs=170.7
Q ss_pred cccccccccccEEEEEEEE-CCccEEEEEEeecC-CcccHHHHHHHHHHHhcCC---CCCccceeceeecCCeEEEEEEe
Q 043185 513 NFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNV-GVQGKKDFCTEIAIIGNIH---HVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
.+.+.||+|+||.||+|.. .+++.+|+|.+... .....+++.+|+.++++++ |||++++++++..+...++||||
T Consensus 4 ~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06917 4 QRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEY 83 (277)
T ss_pred hhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEec
Confidence 3457899999999999996 46788999998643 2344567889999999986 99999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
+++++|.+++... .+++.....++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++..+......
T Consensus 84 ~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~- 157 (277)
T cd06917 84 AEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK- 157 (277)
T ss_pred CCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc-
Confidence 9999999998654 68899999999999999999996 89999999999999999999999999999876543321
Q ss_pred eecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
.....|+..|+|||.+.+ ..++.++|+||||+++|||++|+.||......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~ 208 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF 208 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh
Confidence 233468899999999865 45789999999999999999999999766543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=260.44 Aligned_cols=194 Identities=34% Similarity=0.455 Sum_probs=166.0
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCCc---ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV---QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
+.+.+.||+|+||.||+|+.. +++.||+|++..... ...+++.+|++++++++||||+++++++.++...++|+||
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 96 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY 96 (307)
T ss_pred hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence 445578999999999999975 678899999864322 2335688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
++ |+|.+++......+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 97 ~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---- 168 (307)
T cd06607 97 CL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---- 168 (307)
T ss_pred hC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC----
Confidence 97 57777776555568999999999999999999997 89999999999999999999999999998765432
Q ss_pred eeccccccccccccccc---CCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLT---NSAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~---~~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
....++..|+|||++. ...++.++||||||+++|||++|++||...
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~ 217 (307)
T cd06607 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (307)
T ss_pred -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc
Confidence 2345788999999884 456889999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=257.03 Aligned_cols=191 Identities=28% Similarity=0.386 Sum_probs=158.6
Q ss_pred cccccccEEEEEEEEC-CccEEEEEEeecCCc---ccHHHHHHHHHH---HhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 517 LIGSGGFGAVYKGILN-DKTIVAVKKITNVGV---QGKKDFCTEIAI---IGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 517 ~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~---l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
.||+|+||.||++... +++.+|+|.+.+... .....+.+|..+ +...+||||+.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999974 578899998865321 112334445433 334479999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
+++|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+|||+++++.++|+|||++........ .
T Consensus 81 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~---~ 153 (279)
T cd05633 81 GGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---H 153 (279)
T ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc---c
Confidence 99999988655 358999999999999999999997 8999999999999999999999999999875543221 2
Q ss_pred ccccccccccccccc-CCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLT-NSAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~-~~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
...|+..|+|||.+. +..++.++|+||||++++||++|+.||...
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 199 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence 346899999999986 456899999999999999999999999654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=280.33 Aligned_cols=198 Identities=22% Similarity=0.349 Sum_probs=157.2
Q ss_pred HhhccccccccccccEEEEEEEECC--ccEEEEE------------------EeecCCcccHHHHHHHHHHHhcCCCCCc
Q 043185 509 VATDNFKNLIGSGGFGAVYKGILND--KTIVAVK------------------KITNVGVQGKKDFCTEIAIIGNIHHVNL 568 (724)
Q Consensus 509 ~a~~~~~~~lG~G~fG~Vy~~~~~~--~~~vAvK------------------~~~~~~~~~~~~~~~E~~~l~~l~H~nI 568 (724)
...|.+.+.||+|+||+||++.... +...++| ++.. .......+.+|+.++++++||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCCc
Confidence 3557777899999999999987532 1112212 1111 12234567899999999999999
Q ss_pred cceeceeecCCeEEEEEEecCCCCHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEe
Q 043185 569 VKLKGFCAQGRQRLLVYEYMNHGSLDRILFGN----GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLH 644 (724)
Q Consensus 569 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~ 644 (724)
+++++++...+..++|+|++.+ +|..++... ...........|+.||+.||+|||+ .+||||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEC
Confidence 9999999999999999999864 666666432 1223356677899999999999997 8999999999999999
Q ss_pred CCCcEEEEeecCccccCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCC
Q 043185 645 YHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNC 711 (724)
Q Consensus 645 ~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~ 711 (724)
.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..++
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999999999877544333233457999999999999999999999999999999999987544
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=254.65 Aligned_cols=194 Identities=29% Similarity=0.396 Sum_probs=168.7
Q ss_pred ccccccEEEEEEEEC-CccEEEEEEeecCCc---ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCCH
Q 043185 518 IGSGGFGAVYKGILN-DKTIVAVKKITNVGV---QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSL 593 (724)
Q Consensus 518 lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gsL 593 (724)
||.|+||.||+++.. +++.+++|.+..... ...+.+.+|++++.+++|+||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999986 488899999865433 3456788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc-------c
Q 043185 594 DRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS-------S 666 (724)
Q Consensus 594 ~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~-------~ 666 (724)
.+++.... .+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99997654 68899999999999999999996 8999999999999999999999999999875533211 1
Q ss_pred ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
......++..|+|||.+.+...+.++|+||||++++||++|+.||....
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 205 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET 205 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 1233457889999999988889999999999999999999999997554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=256.21 Aligned_cols=196 Identities=34% Similarity=0.479 Sum_probs=171.8
Q ss_pred ccccccccccEEEEEEEEC-CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCC
Q 043185 514 FKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHG 591 (724)
Q Consensus 514 ~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~g 591 (724)
+.+.||+|++|.||++... +++.+|+|++.... ....+++.+|++++++++||||+++++.+..+...++++||++++
T Consensus 5 ~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (265)
T cd06605 5 YLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGG 84 (265)
T ss_pred HHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCC
Confidence 4578999999999999986 67889999987643 244567899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceecc
Q 043185 592 SLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTM 671 (724)
Q Consensus 592 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 671 (724)
+|.+++......++.....+++.|++.||+|||+ ..+++|+||||+||+++.++.++|+|||.+........ ...
T Consensus 85 ~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~---~~~ 159 (265)
T cd06605 85 SLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA---KTF 159 (265)
T ss_pred cHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh---hcc
Confidence 9999997665678889999999999999999995 37999999999999999999999999999876533221 125
Q ss_pred cccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 672 RGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 672 ~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
.++..|+|||.+.+..++.++||||||+++++|++|+.||...
T Consensus 160 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 160 VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred cCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 6888999999999999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=257.38 Aligned_cols=197 Identities=32% Similarity=0.433 Sum_probs=172.8
Q ss_pred ccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCC
Q 043185 514 FKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGS 592 (724)
Q Consensus 514 ~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gs 592 (724)
+.+.||.|++|.||++... ++..+++|++..... ..+.+.+|++++++++|+||+++++.+......++|+||+++++
T Consensus 23 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 101 (286)
T cd06614 23 NLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGS 101 (286)
T ss_pred HhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCc
Confidence 3467999999999999986 678899999976433 56778999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceeccc
Q 043185 593 LDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMR 672 (724)
Q Consensus 593 L~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 672 (724)
|.+++......+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........ ......
T Consensus 102 L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 177 (286)
T cd06614 102 LTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KRNSVV 177 (286)
T ss_pred HHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-hhcccc
Confidence 999998765578999999999999999999996 9999999999999999999999999998875543321 112345
Q ss_pred ccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 673 GTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 673 gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
++..|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus 178 ~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~ 220 (286)
T cd06614 178 GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP 220 (286)
T ss_pred CCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 7789999999998889999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-29 Score=259.72 Aligned_cols=198 Identities=32% Similarity=0.436 Sum_probs=165.2
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeceeecC-----CeEEEEE
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQG-----RQRLLVY 585 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~-----~~~~lV~ 585 (724)
.+.+.||+|+||.||++... +++.+|+|.+... .....++.+|+.++.++ +||||+++++++... ...++|+
T Consensus 25 ~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ 103 (291)
T cd06639 25 EIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVL 103 (291)
T ss_pred EEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEE
Confidence 34578999999999999974 6788999998653 22346678899999999 899999999998653 3589999
Q ss_pred EecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCC
Q 043185 586 EYMNHGSLDRILFG---NGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP 662 (724)
Q Consensus 586 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (724)
||+++++|.+++.. ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 104 ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~ 180 (291)
T cd06639 104 ELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180 (291)
T ss_pred EECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEeecccchhccc
Confidence 99999999998753 34568899999999999999999996 8999999999999999999999999999886543
Q ss_pred CCccceecccccccccccccccCC-----cCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 663 EQSSLFTTMRGTRGYLAPEWLTNS-----AISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 663 ~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.... .....++..|+|||.+... .++.++|+||||+++|||++|+.||....
T Consensus 181 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~ 237 (291)
T cd06639 181 TRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237 (291)
T ss_pred cccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc
Confidence 2211 1234678899999998643 36889999999999999999999996654
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=257.95 Aligned_cols=199 Identities=30% Similarity=0.391 Sum_probs=170.1
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecC--CeEEEEEEe
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG--RQRLLVYEY 587 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV~e~ 587 (724)
.+.+.||.|++|.||+|+.. +++.+|+|++.... ....+.+.+|++++++++|+|++++++++... ...++|+||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 34578999999999999976 57889999997642 33446788999999999999999999999888 899999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
+++ +|..++......+++..+..++.|+++||+|||+ .+++|+||+|+||++++++.++|+|||++..........
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 82 MDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred ccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 985 8888887665678999999999999999999997 899999999999999999999999999998765543222
Q ss_pred eecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||+...
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~ 206 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST 206 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 233456788999998765 467899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=253.83 Aligned_cols=192 Identities=29% Similarity=0.381 Sum_probs=168.7
Q ss_pred ccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCCH
Q 043185 518 IGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSL 593 (724)
Q Consensus 518 lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gsL 593 (724)
||.|++|.||+++.. +++.+|+|.+.... ....+.+.+|+.++++++||||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999976 47889999986532 23446789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceecccc
Q 043185 594 DRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRG 673 (724)
Q Consensus 594 ~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~g 673 (724)
.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....... ......+
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~ 154 (262)
T cd05572 81 WTILRDR-GLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCG 154 (262)
T ss_pred HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccC
Confidence 9999765 357889999999999999999996 999999999999999999999999999998765432 1223467
Q ss_pred cccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 674 TRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 674 t~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
+..|++||.+.+..++.++|+||||+++|||++|+.||....
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 889999999988889999999999999999999999997665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=251.36 Aligned_cols=199 Identities=26% Similarity=0.414 Sum_probs=171.5
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
+.+.+.||+|++|.||++... +++.+|+|++... .....+.+.+|++++++++||||+++++.+..+...++|+||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 445688999999999999964 6788999998653 2334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCC-CcEEEEeecCccccCCCCcc
Q 043185 589 NHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYH-FQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 589 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFGla~~~~~~~~~ 666 (724)
++++|.+++... ...+++..+..++.+++.+|.|||+ ++++|+||+|+||+++.+ ..+||+|||++........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~- 157 (256)
T cd08220 82 PGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK- 157 (256)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc-
Confidence 999999999764 3458899999999999999999997 899999999999999865 4589999999987654322
Q ss_pred ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.....++..|+|||.+.+..++.++||||||+++++|++|+.||....
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 205 (256)
T cd08220 158 -AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN 205 (256)
T ss_pred -ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc
Confidence 123467889999999998889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=253.53 Aligned_cols=194 Identities=34% Similarity=0.504 Sum_probs=165.1
Q ss_pred hccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 511 TDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
.+.+.+.||+|+||.||++.. .++.+|+|+++.. ...+.+.+|+.++.+++||||+++++++..+ ..++||||+++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~ 82 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK 82 (254)
T ss_pred HceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence 355678999999999999986 4556999998643 2346789999999999999999999998764 57999999999
Q ss_pred CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 591 GSLDRILFGNG-PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 591 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
++|.+++.... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++....... .
T Consensus 83 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----~ 155 (254)
T cd05083 83 GNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----D 155 (254)
T ss_pred CCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC----C
Confidence 99999997653 457889999999999999999996 899999999999999999999999999987543221 2
Q ss_pred cccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
....+..|+|||.+.+..++.++|+||||+++|||++ |+.||....
T Consensus 156 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 202 (254)
T cd05083 156 NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS 202 (254)
T ss_pred CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC
Confidence 2234568999999998899999999999999999998 999996654
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=253.06 Aligned_cols=203 Identities=28% Similarity=0.405 Sum_probs=171.0
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeceeec--CCeEEEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ--GRQRLLVYE 586 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV~e 586 (724)
+.+.+.||.|+||.||++... +++.+|+|++... .....+++.+|+.++++++|+||+++++++.. +...++++|
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 345578999999999999864 6778999988643 23344678899999999999999999997753 456899999
Q ss_pred ecCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeEecCCCCCCeEEeCCCcEEEEeecCccccC
Q 043185 587 YMNHGSLDRILFGN---GPVLEWQERFDIALGTARGLAYLHSGC--EQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 587 ~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 661 (724)
|+++++|.+++... ...+++..+..++.|++.||.|||..+ ..+++|+||||+||+++.++.+||+|||++....
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~ 161 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG 161 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccccc
Confidence 99999999998653 456889999999999999999999322 3899999999999999999999999999998765
Q ss_pred CCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 662 PEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 662 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
..... .....++..|+|||.+.+..++.++|+||||+++++|++|+.||...+
T Consensus 162 ~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 214 (265)
T cd08217 162 HDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214 (265)
T ss_pred CCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC
Confidence 43321 233468899999999999889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=254.66 Aligned_cols=198 Identities=32% Similarity=0.441 Sum_probs=166.9
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecCCc---c-------cHHHHHHHHHHHhcCCCCCccceeceeecCCeE
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV---Q-------GKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQR 581 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~---~-------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 581 (724)
...+.||.|+||.||+|... +++.+|+|+++.... . ..+.+.+|+.++++++|+||+++++++......
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (272)
T cd06629 4 VKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYL 83 (272)
T ss_pred eecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCce
Confidence 34578999999999999864 678899998753211 0 124578899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccC
Q 043185 582 LLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 661 (724)
++|+||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||+++...
T Consensus 84 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 84 SIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred EEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 9999999999999998766 467888999999999999999997 899999999999999999999999999987654
Q ss_pred CCCc-cceecccccccccccccccCCc--CCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 662 PEQS-SLFTTMRGTRGYLAPEWLTNSA--ISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 662 ~~~~-~~~~~~~gt~~y~aPE~l~~~~--~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
.... .......++..|+|||.+.... ++.++|+||||++++|+++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 215 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc
Confidence 3211 1123345788999999987654 789999999999999999999999643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=257.73 Aligned_cols=194 Identities=27% Similarity=0.432 Sum_probs=169.5
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCCHH
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLD 594 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gsL~ 594 (724)
..||+|+||.||++... +++.||+|++........+.+.+|+.++++++|+||+++++.+..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 57999999999999974 67889999986544455667899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceeccccc
Q 043185 595 RILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGT 674 (724)
Q Consensus 595 ~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt 674 (724)
+++... .+++.....++.|++.+|+|||+ .+++|+||+|+||++++++.++|+|||++........ ......++
T Consensus 106 ~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~ 179 (292)
T cd06657 106 DIVTHT--RMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVGT 179 (292)
T ss_pred HHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccccC
Confidence 987543 57888999999999999999997 8999999999999999999999999999876543321 12334688
Q ss_pred ccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 675 RGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 675 ~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
..|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus 180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~ 220 (292)
T cd06657 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 220 (292)
T ss_pred ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999988889999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=257.92 Aligned_cols=199 Identities=28% Similarity=0.342 Sum_probs=168.3
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCCc--ccHHHHHHHHHHHhcCCCCCccceeceeecC--CeEEEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV--QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG--RQRLLVYE 586 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV~e 586 (724)
+.+.+.||.|+||.||+|+.. +++.+|+|+++.... .....+.+|+.++.+++||||+++++++... ...++|+|
T Consensus 7 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e 86 (293)
T cd07843 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVME 86 (293)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEeh
Confidence 344578999999999999976 578899999864322 2234577899999999999999999998877 89999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
|+++ +|.+++......+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 87 ~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 161 (293)
T cd07843 87 YVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK- 161 (293)
T ss_pred hcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc-
Confidence 9975 9988887665678999999999999999999997 8999999999999999999999999999987654321
Q ss_pred ceecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
......++..|+|||.+.+. .++.++|+||||++++||++|++||....
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~ 211 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS 211 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 12334578899999998764 46899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=252.50 Aligned_cols=199 Identities=32% Similarity=0.445 Sum_probs=174.7
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecCCc-ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV-QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
.+.+.||+|++|.||+++.. +++.+++|++..... ...+++.+|+..+.+++|+||+++++++......++|+||+++
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06623 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDG 83 (264)
T ss_pred eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCC
Confidence 44588999999999999976 488899999876433 4467899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
++|.+++... ..+++..+..++.|+++|++|||+ ..+++|+||+|+||+++.++.++|+|||++......... ...
T Consensus 84 ~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-~~~ 159 (264)
T cd06623 84 GSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-CNT 159 (264)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-ccc
Confidence 9999999765 568899999999999999999994 289999999999999999999999999999876543322 123
Q ss_pred ccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
..++..|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 160 FVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred eeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 457889999999999999999999999999999999999997664
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=256.26 Aligned_cols=199 Identities=27% Similarity=0.452 Sum_probs=168.6
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecCCc-ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV-QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
.+.+.||.|++|.||+|+.. ++..||+|+++.... ...+.+.+|+.++++++|+||+++++++.+.+..++|+||+++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (284)
T cd07836 3 KQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK 82 (284)
T ss_pred eEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc
Confidence 45678999999999999975 678899999875432 3346678899999999999999999999999999999999985
Q ss_pred CCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce
Q 043185 591 GSLDRILFGNG--PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 591 gsL~~~l~~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
+|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++........ ..
T Consensus 83 -~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (284)
T cd07836 83 -DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-TF 157 (284)
T ss_pred -cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-cc
Confidence 8888876543 458899999999999999999997 8999999999999999999999999999976543221 12
Q ss_pred ecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
....++..|++||.+.+. .++.++|+||||+++|||++|+.||...+.
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~ 206 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN 206 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 234578899999988664 578999999999999999999999976653
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=256.17 Aligned_cols=196 Identities=30% Similarity=0.436 Sum_probs=161.9
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecCC-cccHHHHHHHHHH-HhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG-VQGKKDFCTEIAI-IGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~-l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
.+.+.||+|+||.||+++.. +++.||+|+++... .....++..|+.+ ++.++||||+++++++..+...++++||++
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~ 83 (283)
T cd06617 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD 83 (283)
T ss_pred eEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc
Confidence 45578999999999999975 68899999987542 2334556667665 566789999999999999999999999997
Q ss_pred CCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 590 HGSLDRILFG---NGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 590 ~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
++|..++.. ....+++..+..++.|++.||+|||+ ..+++||||||+||+++.++.+||+|||++........
T Consensus 84 -~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (283)
T cd06617 84 -TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA- 159 (283)
T ss_pred -ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEeecccccccccccc-
Confidence 588777754 23568899999999999999999996 23899999999999999999999999999986543221
Q ss_pred ceecccccccccccccccC----CcCCCccchhhHHHHHHHHHhCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTN----SAISEKTDVYSFGMVLLELVSGRRNCSP 713 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~----~~~~~~sDv~SlGv~l~elltG~~p~~~ 713 (724)
.....++..|+|||.+.+ ..++.++|+||||+++|||++|+.||..
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 160 -KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred -cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 123457889999999865 4568899999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=253.94 Aligned_cols=191 Identities=27% Similarity=0.379 Sum_probs=159.6
Q ss_pred cccccccEEEEEEEEC-CccEEEEEEeecCCcc---cHHHHHHHHH---HHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 517 LIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQ---GKKDFCTEIA---IIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 517 ~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~---~~~~~~~E~~---~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
+||+|+||.||++... +++.||+|.+.+.... ....+..|.. +++..+||+|+++++++.+....++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 5788999998653221 1222344443 4445679999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
+++|..++... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++..+..... .
T Consensus 81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~---~ 153 (278)
T cd05606 81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---H 153 (278)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC---c
Confidence 99999888654 468999999999999999999997 8999999999999999999999999999876543221 2
Q ss_pred cccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
...|+..|+|||.+.+. .++.++|+||||+++|||++|+.||...
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 34689999999999754 6899999999999999999999999765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=253.71 Aligned_cols=197 Identities=33% Similarity=0.449 Sum_probs=169.7
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
+.+.+.||+|+||.||+|... ++..+|+|.+.... ....+.+.+|+.++.+++||||+++++++..+...++|+||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 344578999999999999864 67889999886432 2334678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
+++|..++... .+++.....++.+++.++.|||+ .+++|+||+|+||+++.++.++|+|||++..+...... ..
T Consensus 86 ~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~-~~ 159 (277)
T cd06641 86 GGSALDLLEPG--PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RN 159 (277)
T ss_pred CCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchhh-hc
Confidence 99999988643 57899999999999999999996 99999999999999999999999999998765433211 12
Q ss_pred cccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
...++..|+|||.+.+..++.++|+||||++++||++|+.||...
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 204 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 345788999999999888999999999999999999999999644
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=257.51 Aligned_cols=201 Identities=30% Similarity=0.386 Sum_probs=167.4
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCC--------
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR-------- 579 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-------- 579 (724)
.+.+.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|++++++++||||+++++++.+..
T Consensus 8 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~ 87 (302)
T cd07864 8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKD 87 (302)
T ss_pred hhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcccc
Confidence 4455688999999999999985 57889999986532 233356788999999999999999999987655
Q ss_pred --eEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCc
Q 043185 580 --QRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLS 657 (724)
Q Consensus 580 --~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 657 (724)
..++|+||+++ ++...+......+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||++
T Consensus 88 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 88 KGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred CCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeCccccc
Confidence 78999999986 7777776655578999999999999999999997 89999999999999999999999999999
Q ss_pred cccCCCCccceecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 658 KLLTPEQSSLFTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 658 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
...............++..|+|||.+.+ ..++.++||||||++++||++|++||....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~ 222 (302)
T cd07864 164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ 222 (302)
T ss_pred ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 8765433222223346788999998865 457899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=255.39 Aligned_cols=199 Identities=28% Similarity=0.434 Sum_probs=165.4
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeceeec------CCeEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQ------GRQRLL 583 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~------~~~~~l 583 (724)
+.+.+.||.|+||.||+|+.. +++.+|+|.+... .....++..|+.++.++ +|+||+++++++.. ....++
T Consensus 18 ~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i 96 (282)
T cd06636 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWL 96 (282)
T ss_pred hhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEE
Confidence 344578999999999999974 6788999988654 23446788899999998 79999999999853 457899
Q ss_pred EEEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCC
Q 043185 584 VYEYMNHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP 662 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (724)
+|||+++++|.+++... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~ 173 (282)
T cd06636 97 VMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 173 (282)
T ss_pred EEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcchhhhhc
Confidence 99999999999998753 3457788888999999999999997 8999999999999999999999999999875532
Q ss_pred CCccceeccccccccccccccc-----CCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 663 EQSSLFTTMRGTRGYLAPEWLT-----NSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 663 ~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
... ......++..|+|||.+. +..++.++|+||||+++|||++|+.||....
T Consensus 174 ~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~ 230 (282)
T cd06636 174 TVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH 230 (282)
T ss_pred ccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC
Confidence 211 123356889999999986 3467889999999999999999999996543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=255.52 Aligned_cols=198 Identities=27% Similarity=0.395 Sum_probs=166.3
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
+..+.||.|++|.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++.++...++||||+.
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (284)
T cd07860 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH 82 (284)
T ss_pred eeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc
Confidence 34578999999999999975 67889999886432 2233578899999999999999999999999999999999996
Q ss_pred CCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce
Q 043185 590 HGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 590 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
++|..++... ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++........ ..
T Consensus 83 -~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~ 157 (284)
T cd07860 83 -QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TY 157 (284)
T ss_pred -cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-cc
Confidence 5888887643 3568899999999999999999996 8999999999999999999999999999876543221 12
Q ss_pred ecccccccccccccccCCc-CCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTNSA-ISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~~~-~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
....++..|+|||.+.+.. ++.++||||||+++|||++|+.||....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 205 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 205 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 2334678999999887654 6889999999999999999999996654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-28 Score=254.38 Aligned_cols=197 Identities=35% Similarity=0.425 Sum_probs=167.9
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecCCc-ccHHHHHHHHHHHhcCCCCCccceeceeecC--CeEEEEEEec
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV-QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG--RQRLLVYEYM 588 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV~e~~ 588 (724)
.+.+.||.|++|.||++... +++.+|+|.+..... ....++.+|++++++++||||+++++++.+. ...++||||+
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 83 (287)
T cd06621 4 VELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYC 83 (287)
T ss_pred EEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEec
Confidence 34578999999999999974 578899998875322 3456789999999999999999999988654 4689999999
Q ss_pred CCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc
Q 043185 589 NHGSLDRILFG---NGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 589 ~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 665 (724)
++++|.+++.. ....++......++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (287)
T cd06621 84 EGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160 (287)
T ss_pred CCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence 99999988653 34457888999999999999999997 8999999999999999999999999999875543221
Q ss_pred cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 666 SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 666 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
....++..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 161 ---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (287)
T cd06621 161 ---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEG 207 (287)
T ss_pred ---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCccc
Confidence 23457889999999999999999999999999999999999997663
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=255.41 Aligned_cols=197 Identities=25% Similarity=0.318 Sum_probs=164.3
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecCC-cccHHHHHHHHHHHhcCC-CCCccceeceeecC--CeEEEEEEe
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIH-HVNLVKLKGFCAQG--RQRLLVYEY 587 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~--~~~~lV~e~ 587 (724)
.+.+.||+|+||.||+++.. +++.+|+|+++... ........+|+.++.++. |+||+++++++.+. +..++|+||
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 34578999999999999964 67889999987532 222334567888998885 99999999999887 889999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
++ ++|.+.+......+++..+..++.|++.||+|||+ .+++||||||+||+++. +.+||+|||+++.......
T Consensus 82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-- 154 (282)
T cd07831 82 MD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-- 154 (282)
T ss_pred CC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCCC--
Confidence 97 48888887655678999999999999999999997 89999999999999999 9999999999986644322
Q ss_pred eecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.....++..|+|||.+.. ..++.++||||||+++|||++|++||...+.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~ 204 (282)
T cd07831 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE 204 (282)
T ss_pred cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH
Confidence 123457889999997654 5678999999999999999999999976543
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=282.30 Aligned_cols=198 Identities=30% Similarity=0.482 Sum_probs=171.3
Q ss_pred cccccccccccEEEEEEEEC--------CccEEEEEEeecC-CcccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEE
Q 043185 513 NFKNLIGSGGFGAVYKGILN--------DKTIVAVKKITNV-GVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRL 582 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~--------~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~ 582 (724)
.+.+.||+|+||.|++|... ....||||.++.. ...+.+.+..|+++|..+ +|+||+.++|+|.+....+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 45579999999999999853 1457999999754 334567899999999999 7999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCC
Q 043185 583 LVYEYMNHGSLDRILFGNG---------------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHF 647 (724)
Q Consensus 583 lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 647 (724)
+|.||++.|+|..+|++.. ..+....++.++.|||.||+||++ .++|||||.++|||+..+.
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLITKNK 455 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEecCCC
Confidence 9999999999999998776 348889999999999999999997 8999999999999999999
Q ss_pred cEEEEeecCccccCCCCccceecccc--cccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCC
Q 043185 648 QAKISDFGLSKLLTPEQSSLFTTMRG--TRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSP 713 (724)
Q Consensus 648 ~~kl~DFGla~~~~~~~~~~~~~~~g--t~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~ 713 (724)
.+||+|||+|+..............+ ...|||||.+....|+.|+|||||||+||||+| |..||.+
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 99999999999765544432222222 446999999999999999999999999999999 8899875
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=259.48 Aligned_cols=202 Identities=26% Similarity=0.382 Sum_probs=166.9
Q ss_pred ccccccccccccEEEEEEEEC---CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecC--CeEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN---DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG--RQRLL 583 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~---~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~l 583 (724)
+.+.+.||+|+||.||+|+.. .++.+|+|.+.... ....+.+.+|+.++.+++||||+++++++.+. ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 445678999999999999974 46889999997632 33346778999999999999999999999988 78999
Q ss_pred EEEecCCCCHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC----CCcEEEEeec
Q 043185 584 VYEYMNHGSLDRILFGN----GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY----HFQAKISDFG 655 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~----~~~~kl~DFG 655 (724)
||||+++ +|.+++... ...++......++.|++.||.|||+ .+|+||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999986 666655422 2367888999999999999999997 89999999999999999 9999999999
Q ss_pred CccccCCCCc--cceecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 656 LSKLLTPEQS--SLFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 656 la~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
++........ .......++..|+|||.+.+. .++.++||||||++++||++|++||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~ 222 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAK 222 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCccc
Confidence 9986643322 111234578899999988764 5789999999999999999999999766543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=258.29 Aligned_cols=200 Identities=30% Similarity=0.358 Sum_probs=166.5
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCCc--ccHHHHHHHHHHHhcCCCCCccceeceeecC--CeEEEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV--QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG--RQRLLVYE 586 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV~e 586 (724)
+.+.+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|+.++++++|+||+++++++... +..++|+|
T Consensus 9 y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (309)
T cd07845 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVME 88 (309)
T ss_pred eeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEe
Confidence 445678999999999999975 578899999864322 2234567899999999999999999998754 56899999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
|+++ +|.+++......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 89 ~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~- 163 (309)
T cd07845 89 YCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK- 163 (309)
T ss_pred cCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCccC-
Confidence 9975 8888887655678999999999999999999997 8999999999999999999999999999987654321
Q ss_pred ceecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
......++..|+|||.+.+ ..++.++||||||+++|||++|++||...+.
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~ 214 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE 214 (309)
T ss_pred CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 1122345788999999876 4678999999999999999999999975543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-28 Score=253.17 Aligned_cols=197 Identities=28% Similarity=0.394 Sum_probs=166.7
Q ss_pred ccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 514 FKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 514 ~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
+.+.||.|++|.||+|... ++..||+|++.... ....+.+.+|++++++++||||+++++++.++...++++||++
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~- 81 (283)
T cd07835 3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD- 81 (283)
T ss_pred hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-
Confidence 4578999999999999974 78889999986432 2233578899999999999999999999999999999999995
Q ss_pred CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 591 GSLDRILFGNG-PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 591 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
++|.+++.... ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 82 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~ 157 (283)
T cd07835 82 LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-TYT 157 (283)
T ss_pred cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-ccC
Confidence 68998886543 468999999999999999999997 8999999999999999999999999999976543221 112
Q ss_pred cccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
...++..|+|||++.+. .++.++|+||||+++|||++|++||...+
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 204 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDS 204 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 33568899999988664 57899999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=250.16 Aligned_cols=191 Identities=27% Similarity=0.328 Sum_probs=161.9
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecCCc---ccHHHHHHHHHHH-hcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV---QGKKDFCTEIAII-GNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l-~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
+.||+|+||.||+|... +++.||+|.+++... .....+..|..++ ...+|+||+++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999974 578899999865322 1223445555544 455899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||+++..... ..
T Consensus 82 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-----~~ 152 (260)
T cd05611 82 GDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-----KK 152 (260)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceecccc-----cc
Confidence 9999998765 357889999999999999999997 89999999999999999999999999998754331 23
Q ss_pred ccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
..++..|+|||.+.+..++.++||||||+++|||++|..||....
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 197 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET 197 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC
Confidence 457889999999998889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-28 Score=257.19 Aligned_cols=192 Identities=33% Similarity=0.457 Sum_probs=164.8
Q ss_pred ccccccccccEEEEEEEEC-CccEEEEEEeecCCc---ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 514 FKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV---QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 514 ~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
..+.||+|+||.||+++.. ++..+|+|++..... ...+++.+|++++++++|+|++++++++.++...++||||++
T Consensus 29 ~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 108 (317)
T cd06635 29 DLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL 108 (317)
T ss_pred hhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC
Confidence 3467999999999999964 678899999864322 234578899999999999999999999999999999999997
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
+ +|.+++......+++..+..++.+++.||.|||+ .+++||||+|+||+++.++.++|+|||++...... .
T Consensus 109 g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-----~ 179 (317)
T cd06635 109 G-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-----N 179 (317)
T ss_pred C-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc-----c
Confidence 5 7877776655678999999999999999999997 89999999999999999999999999998754332 2
Q ss_pred ccccccccccccccc---CCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLT---NSAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~---~~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
...++..|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 227 (317)
T cd06635 180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 227 (317)
T ss_pred cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 345788999999984 456889999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=255.42 Aligned_cols=199 Identities=28% Similarity=0.390 Sum_probs=164.0
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
+.+.+.||+|++|.||+|+.. +++.+|+|++.... ....+.+.+|++++++++|+||+++++++..+...++|+||+
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL 83 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence 445678999999999999975 67889999886432 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC-CCcEEEEeecCccccCCCCcc
Q 043185 589 NHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY-HFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 589 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~ 666 (724)
++ +|..++... ....++.....++.||+.||+|||+ .+++|+||+|+||+++. ++.+||+|||++........
T Consensus 84 ~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~- 158 (294)
T PLN00009 84 DL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR- 158 (294)
T ss_pred cc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc-
Confidence 64 777776543 2335778888999999999999996 89999999999999985 56799999999976543221
Q ss_pred ceecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
......+++.|+|||++.+. .++.++||||||+++|||++|++||....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~ 208 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS 208 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 12334578899999998764 57899999999999999999999997543
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=249.84 Aligned_cols=200 Identities=29% Similarity=0.434 Sum_probs=171.0
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
+.+.+.||+|+||.||++... ++..+|+|.+... .....+.+.+|+.++++++|+||+++++.+......++|+||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 345678999999999999975 5778999998643 1234567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCc-EEEEeecCccccCCCCcc
Q 043185 589 NHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQ-AKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 589 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~-~kl~DFGla~~~~~~~~~ 666 (724)
++++|.+++... ...+++..+..++.|+++||+|||+ .+++|+||||+||++++++. ++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~- 157 (257)
T cd08225 82 DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME- 157 (257)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc-
Confidence 999999998654 3457899999999999999999997 89999999999999998864 69999999987654322
Q ss_pred ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
......|+..|+|||++.+..++.++|+||||++++||++|+.||....
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 206 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206 (257)
T ss_pred cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 1223458889999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=252.12 Aligned_cols=199 Identities=31% Similarity=0.452 Sum_probs=167.2
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeceeecCC------eEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGR------QRL 582 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~------~~~ 582 (724)
.+.+.+.||+|++|.||+|... +++.+++|++.... ...+++.+|+.+++++ +|+||+++++++.... ..+
T Consensus 7 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (275)
T cd06608 7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW 85 (275)
T ss_pred heeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence 3455688999999999999975 56789999887543 3456789999999999 7999999999986544 589
Q ss_pred EEEEecCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccc
Q 043185 583 LVYEYMNHGSLDRILFGN---GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKL 659 (724)
Q Consensus 583 lV~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 659 (724)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++..
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 162 (275)
T cd06608 86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162 (275)
T ss_pred EEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCcccee
Confidence 999999999999988643 3578899999999999999999996 8999999999999999999999999999876
Q ss_pred cCCCCccceecccccccccccccccC-----CcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 660 LTPEQSSLFTTMRGTRGYLAPEWLTN-----SAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 660 ~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
...... ......++..|+|||++.. ..++.++||||||++++||++|+.||...
T Consensus 163 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 221 (275)
T cd06608 163 LDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221 (275)
T ss_pred cccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence 543221 1233468899999998853 34678999999999999999999999654
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-28 Score=249.57 Aligned_cols=184 Identities=24% Similarity=0.344 Sum_probs=156.0
Q ss_pred ccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEEEEEecCCCCHHH
Q 043185 518 IGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDR 595 (724)
Q Consensus 518 lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~e~~~~gsL~~ 595 (724)
||.|+||.||++... ++..+|+|.+........ |+.....+ +||||+++++.+...+..++||||+++++|.+
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~ 98 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD 98 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence 599999999999964 667788888865322211 22222222 79999999999999999999999999999999
Q ss_pred HHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCC-cEEEEeecCccccCCCCccceeccccc
Q 043185 596 ILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHF-QAKISDFGLSKLLTPEQSSLFTTMRGT 674 (724)
Q Consensus 596 ~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFGla~~~~~~~~~~~~~~~gt 674 (724)
++.... .+++..+..++.|+++||.|||+ .+++||||||+||+++.++ .++|+|||++...... ....++
T Consensus 99 ~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-----~~~~~~ 169 (267)
T PHA03390 99 LLKKEG-KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----SCYDGT 169 (267)
T ss_pred HHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-----ccCCCC
Confidence 997654 78999999999999999999997 8999999999999999998 9999999998765432 234588
Q ss_pred ccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 675 RGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 675 ~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
..|+|||++.+..++.++||||||++++||++|+.||....
T Consensus 170 ~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 210 (267)
T PHA03390 170 LDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210 (267)
T ss_pred CcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 99999999999999999999999999999999999997443
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-28 Score=260.52 Aligned_cols=200 Identities=32% Similarity=0.499 Sum_probs=166.1
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecC--CcccHHHHHHHHHHHhcC-CCCCccceeceeecC--CeEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV--GVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQG--RQRLLV 584 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~--~~~~lV 584 (724)
.+.+.+.||+|+||.||+|... +++.+|+|++... .......+.+|+.++.++ +|+||+++++++... ...++|
T Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv 87 (337)
T cd07852 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLV 87 (337)
T ss_pred HHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEE
Confidence 3445678999999999999975 5788999988542 223445677899999999 999999999988653 468999
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC
Q 043185 585 YEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (724)
+||++ ++|..++... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 88 ~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 88 FEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred ecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 99997 4898888654 67888999999999999999997 899999999999999999999999999998664432
Q ss_pred c----cceecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 665 S----SLFTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 665 ~----~~~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
. .......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||.....
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~ 218 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTST 218 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCCh
Confidence 1 12234568899999998865 4678999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=255.81 Aligned_cols=201 Identities=22% Similarity=0.251 Sum_probs=152.1
Q ss_pred hhccccccccccccEEEEEEEECCc----cEEEEEEeecCCcccH-----------HHHHHHHHHHhcCCCCCccceece
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILNDK----TIVAVKKITNVGVQGK-----------KDFCTEIAIIGNIHHVNLVKLKGF 574 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~~~----~~vAvK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~nIv~l~g~ 574 (724)
..+.+.++||+|+||.||+|...+. ..+|+|+......... .....+...+..++|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 4566778999999999999997543 4455554332211110 112233445667789999999997
Q ss_pred eecCC----eEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEE
Q 043185 575 CAQGR----QRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAK 650 (724)
Q Consensus 575 ~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 650 (724)
+.... ..++++|++.. ++.+.+... ...++..+..++.|++.||+|||+ .+|+||||||+|||++.++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCcEE
Confidence 65543 34677777643 566655433 235678888999999999999996 8999999999999999999999
Q ss_pred EEeecCccccCCCCc------cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 651 ISDFGLSKLLTPEQS------SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 651 l~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
|+|||+++.+..... .......||+.|+|||.+.+..++.++||||||++++||++|+.||....
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 999999986643211 11123469999999999999999999999999999999999999997764
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-28 Score=253.97 Aligned_cols=199 Identities=26% Similarity=0.335 Sum_probs=163.6
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcC-CCCCccceeceeecCCe-----EE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQ-----RL 582 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~-----~~ 582 (724)
+...+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++++ +|+||+++++++..... .+
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 345578999999999999975 67889999876432 22346788899999999 57999999999877665 89
Q ss_pred EEEEecCCCCHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC-CCcEEEEeecCc
Q 043185 583 LVYEYMNHGSLDRILFGN----GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY-HFQAKISDFGLS 657 (724)
Q Consensus 583 lV~e~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFGla 657 (724)
+||||+++ +|.+++... ...+++..+..++.||+.||+|||+ .+++||||||+||+++. ++.+||+|||++
T Consensus 83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 99999986 788887543 2457899999999999999999997 89999999999999998 889999999998
Q ss_pred cccCCCCccceecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 658 KLLTPEQSSLFTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 658 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
+.+...... .....+++.|+|||++.+ ..++.++|+||||+++|||++|..||...+
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~ 216 (295)
T cd07837 159 RAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS 216 (295)
T ss_pred eecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 765432211 122346788999998865 457999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-28 Score=261.31 Aligned_cols=196 Identities=27% Similarity=0.356 Sum_probs=165.2
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeceeecC------CeE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG------RQR 581 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~ 581 (724)
.+...+.||+|+||.||+++.. +++.||+|++... .....+++.+|+.++++++|+||+++++++... ...
T Consensus 17 ~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 96 (353)
T cd07850 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDV 96 (353)
T ss_pred ceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcE
Confidence 4555688999999999999964 6788999998642 223345678899999999999999999987643 357
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccC
Q 043185 582 LLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 661 (724)
++|+||+++ +|...+... ++...+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++...
T Consensus 97 ~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 97 YLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred EEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 999999965 787777543 7888899999999999999997 899999999999999999999999999998664
Q ss_pred CCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 662 PEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 662 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+
T Consensus 170 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 170 TSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred CCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 4322 233457889999999999999999999999999999999999997554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=260.78 Aligned_cols=211 Identities=25% Similarity=0.373 Sum_probs=173.3
Q ss_pred ChHHHHHhhcc---c--cccccccccEEEEEEEE-CCccEEEEEEeecCCcc---cHHHHHHHHHHHhcCCCCCccceec
Q 043185 503 DYEELEVATDN---F--KNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQ---GKKDFCTEIAIIGNIHHVNLVKLKG 573 (724)
Q Consensus 503 ~~~~l~~a~~~---~--~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~g 573 (724)
.|-.|.+++.+ | .+.||-|+||+|.++.- +....+|.|.+++...- .....++|-.||+..+.+-||+|+-
T Consensus 617 nYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyy 696 (1034)
T KOG0608|consen 617 NYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYY 696 (1034)
T ss_pred hHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence 45556665543 2 35799999999999984 55667899998765332 2345678999999999999999999
Q ss_pred eeecCCeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEe
Q 043185 574 FCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISD 653 (724)
Q Consensus 574 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 653 (724)
.|.+++.+|+||||++||++-.+|...+ .+++..+.-++.++..|+++.|. .++|||||||+|||||.||++||.|
T Consensus 697 SFQDkdnLYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTD 772 (1034)
T KOG0608|consen 697 SFQDKDNLYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTD 772 (1034)
T ss_pred EeccCCceEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeee
Confidence 9999999999999999999999987664 46667777777899999999995 9999999999999999999999999
Q ss_pred ecCccccC---------C-C-------------------------------CccceecccccccccccccccCCcCCCcc
Q 043185 654 FGLSKLLT---------P-E-------------------------------QSSLFTTMRGTRGYLAPEWLTNSAISEKT 692 (724)
Q Consensus 654 FGla~~~~---------~-~-------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~s 692 (724)
|||+.-+. . + +.......+||+-|+|||++....|+.-.
T Consensus 773 FGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~c 852 (1034)
T KOG0608|consen 773 FGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLC 852 (1034)
T ss_pred ccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccc
Confidence 99986441 0 0 00011224699999999999999999999
Q ss_pred chhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 693 DVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 693 Dv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
|.||.|||||||+.|++||......
T Consensus 853 dwws~gvil~em~~g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 853 DWWSVGVILYEMLVGQPPFLADTPG 877 (1034)
T ss_pred hhhHhhHHHHHHhhCCCCccCCCCC
Confidence 9999999999999999999766554
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=257.55 Aligned_cols=196 Identities=29% Similarity=0.417 Sum_probs=166.3
Q ss_pred ccccccccccccEEEEEEEECCccEEEEEEeec--CCcccHHHHHHHHHHHhcCC-CCCccceeceeecCCeEEEEEEec
Q 043185 512 DNFKNLIGSGGFGAVYKGILNDKTIVAVKKITN--VGVQGKKDFCTEIAIIGNIH-HVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~--~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
|.+.++||+||.+.||++...+.+.+|+|++.. ...+...-|++|+.+|.+|+ |.+||+|++|-..++.+||||||=
T Consensus 363 Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G 442 (677)
T KOG0596|consen 363 YEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG 442 (677)
T ss_pred hhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc
Confidence 334578999999999999999889999998753 33455678999999999995 999999999999999999999985
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
+ .+|..+|.+....+..-.+..+..|++.++.++|. .+|||.||||.|+|+ ..|.+||+|||.|..+..+.....
T Consensus 443 d-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTsI~ 517 (677)
T KOG0596|consen 443 D-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTSIV 517 (677)
T ss_pred c-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHH---hceeecCCCcccEEE-EeeeEEeeeechhcccCcccccee
Confidence 4 49999998775544433777889999999999996 999999999999999 467999999999998877765332
Q ss_pred -ecccccccccccccccCC-----------cCCCccchhhHHHHHHHHHhCCCCCC
Q 043185 669 -TTMRGTRGYLAPEWLTNS-----------AISEKTDVYSFGMVLLELVSGRRNCS 712 (724)
Q Consensus 669 -~~~~gt~~y~aPE~l~~~-----------~~~~~sDv~SlGv~l~elltG~~p~~ 712 (724)
...+||+-||+||.+... ..+.++||||||||||+|+.|++||.
T Consensus 518 kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~ 573 (677)
T KOG0596|consen 518 KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG 573 (677)
T ss_pred eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH
Confidence 345799999999998432 25678999999999999999999994
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=254.88 Aligned_cols=195 Identities=32% Similarity=0.455 Sum_probs=162.3
Q ss_pred cccccccccEEEEEEEEC-CccEEEEEEeecCC-cccHHHHHHHHHHHhcCC-CCCccceeceeecCCeEEEEEEecCCC
Q 043185 515 KNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIH-HVNLVKLKGFCAQGRQRLLVYEYMNHG 591 (724)
Q Consensus 515 ~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~e~~~~g 591 (724)
.+.||+|+||.||+++.. +++.+|+|++.... .....++.+|+.++.++. |+||+++++++..+...+++|||++.
T Consensus 9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~- 87 (288)
T cd06616 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI- 87 (288)
T ss_pred HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-
Confidence 367999999999999975 57889999986532 234567889999999996 99999999999999999999999864
Q ss_pred CHHHHH---hc-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 592 SLDRIL---FG-NGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 592 sL~~~l---~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
++.++. .. ....+++.....++.+++.||+|||+ ..+++||||||+||+++.++.++|+|||+++........
T Consensus 88 ~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~- 164 (288)
T cd06616 88 SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK- 164 (288)
T ss_pred CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc-
Confidence 554432 22 23568889999999999999999996 358999999999999999999999999999765433221
Q ss_pred eecccccccccccccccCC---cCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNS---AISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~---~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
....++..|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 165 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 213 (288)
T cd06616 165 -TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213 (288)
T ss_pred -ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence 234578899999999876 6899999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=245.58 Aligned_cols=199 Identities=31% Similarity=0.459 Sum_probs=173.8
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCCc--ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV--QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
+.+.+.||+|++|.||+++.. +++.+++|.+..... ...+.+.+|++++.+++|+|++++++++.++...++++||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 345688999999999999865 567899999976543 35567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
++++|.+++... ..+++..+..++.|++.+|.|||+ .+++|+||+|+||+++.++.++|+|||++......... .
T Consensus 82 ~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~ 156 (254)
T cd06627 82 ENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-D 156 (254)
T ss_pred CCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-c
Confidence 999999998765 468999999999999999999996 89999999999999999999999999999876543321 2
Q ss_pred ecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
....++..|+|||.+.+..++.++|+||||+++++|++|+.||....
T Consensus 157 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~ 203 (254)
T cd06627 157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN 203 (254)
T ss_pred cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc
Confidence 33467889999999988888999999999999999999999996543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-28 Score=254.68 Aligned_cols=200 Identities=27% Similarity=0.365 Sum_probs=165.2
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCC--------e
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR--------Q 580 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--------~ 580 (724)
+.+.+.||+|+||.||+++.. +++.||||++.... ......+.+|++++++++||||+++++++.... .
T Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 93 (310)
T cd07865 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGS 93 (310)
T ss_pred eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCce
Confidence 555688999999999999975 67889999886432 222345678999999999999999999886654 4
Q ss_pred EEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCcccc
Q 043185 581 RLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLL 660 (724)
Q Consensus 581 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 660 (724)
.++|+||+.+ +|..++......+++.....++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++...
T Consensus 94 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 94 FYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred EEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 5999999975 7888876665578999999999999999999997 89999999999999999999999999999866
Q ss_pred CCCCc---cceecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 661 TPEQS---SLFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 661 ~~~~~---~~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
..... .......++..|+|||.+.+. .++.++|+||||+++|||++|++||....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~ 228 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT 228 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 43221 112234578889999988765 47889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-29 Score=254.47 Aligned_cols=212 Identities=33% Similarity=0.472 Sum_probs=170.6
Q ss_pred hhccccccccccccEEEEEEE-ECCccEEEEEEeec-CCccc------HHHHHHHHHHHhcCCCCCccceeceeecC-Ce
Q 043185 510 ATDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKITN-VGVQG------KKDFCTEIAIIGNIHHVNLVKLKGFCAQG-RQ 580 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~-~~~~~~vAvK~~~~-~~~~~------~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~ 580 (724)
.+|-+..+||+|+|+.|||+. +...+.||||+-.- ....+ .+...+|.+|-+.|+||.||++++++.-+ +.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 344445789999999999998 45678899997532 11111 13467899999999999999999998654 57
Q ss_pred EEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC---CCcEEEEeecCc
Q 043185 581 RLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY---HFQAKISDFGLS 657 (724)
Q Consensus 581 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DFGla 657 (724)
.+-|+||++|.+|+.+|+.+ +.++++++..|+.||..||.||.+ ...+|||-||||.||||-. -|.+||.||||+
T Consensus 543 FCTVLEYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ceeeeeecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 78999999999999999766 568899999999999999999986 4678999999999999954 478999999999
Q ss_pred cccCCCCc------cceeccccccccccccccc----CCcCCCccchhhHHHHHHHHHhCCCCCCCC-CCCCCCCCC
Q 043185 658 KLLTPEQS------SLFTTMRGTRGYLAPEWLT----NSAISEKTDVYSFGMVLLELVSGRRNCSPR-SQSHSMDSN 723 (724)
Q Consensus 658 ~~~~~~~~------~~~~~~~gt~~y~aPE~l~----~~~~~~~sDv~SlGv~l~elltG~~p~~~~-~~~~~~~~~ 723 (724)
+++..+.. ...+...||-.|++||.+. ...++.|+||||+|||+|.++-|++||... ++.+|+.++
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN 697 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN 697 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence 98865432 2334567999999999873 235789999999999999999999999654 444444443
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-29 Score=279.89 Aligned_cols=188 Identities=32% Similarity=0.469 Sum_probs=153.9
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceee-----------------
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCA----------------- 576 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~----------------- 576 (724)
+.||+||||.|||++.+ ||+.+|||++.-.. ...-..+.+|+.++++|+|||||+++..+.
T Consensus 485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~ 564 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE 564 (1351)
T ss_pred HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence 47999999999999976 88999999997542 233356789999999999999999875300
Q ss_pred --------------------------------------------------------------------------------
Q 043185 577 -------------------------------------------------------------------------------- 576 (724)
Q Consensus 577 -------------------------------------------------------------------------------- 576 (724)
T Consensus 565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~ 644 (1351)
T KOG1035|consen 565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD 644 (1351)
T ss_pred hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence
Q ss_pred ---------------cC-------CeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEec
Q 043185 577 ---------------QG-------RQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHC 634 (724)
Q Consensus 577 ---------------~~-------~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~ 634 (724)
+. ..+||-||||+...|.+++..+...-.....++++.+|++||+|+|+ .+||||
T Consensus 645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~---~giIHR 721 (1351)
T KOG1035|consen 645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD---QGIIHR 721 (1351)
T ss_pred chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh---Cceeec
Confidence 00 13578899999988888887664332467889999999999999996 899999
Q ss_pred CCCCCCeEEeCCCcEEEEeecCccccC-----------------CCCccceecccccccccccccccCCc---CCCccch
Q 043185 635 DIKPENILLHYHFQAKISDFGLSKLLT-----------------PEQSSLFTTMRGTRGYLAPEWLTNSA---ISEKTDV 694 (724)
Q Consensus 635 Dlkp~NILl~~~~~~kl~DFGla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~~sDv 694 (724)
||||.||+++++..+||+|||+|.... .......+..+||..|+|||++.+.. |+.|+|+
T Consensus 722 DLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDm 801 (1351)
T KOG1035|consen 722 DLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDM 801 (1351)
T ss_pred cCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhh
Confidence 999999999999999999999998721 01112345678999999999997754 9999999
Q ss_pred hhHHHHHHHHHh
Q 043185 695 YSFGMVLLELVS 706 (724)
Q Consensus 695 ~SlGv~l~ellt 706 (724)
|||||||+||+.
T Consensus 802 YSLGIVlFEM~y 813 (1351)
T KOG1035|consen 802 YSLGIVLFEMLY 813 (1351)
T ss_pred HHHHHHHHHHhc
Confidence 999999999985
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-28 Score=250.67 Aligned_cols=199 Identities=26% Similarity=0.427 Sum_probs=162.9
Q ss_pred ccccccccccEEEEEEEEC----CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCC------eE
Q 043185 514 FKNLIGSGGFGAVYKGILN----DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR------QR 581 (724)
Q Consensus 514 ~~~~lG~G~fG~Vy~~~~~----~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~ 581 (724)
+.+.||+|+||.||+|... .++.||||++.... ....+++.+|++++++++||||+++++++.... ..
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence 4578999999999999863 35789999986532 234567889999999999999999999875432 24
Q ss_pred EEEEEecCCCCHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecC
Q 043185 582 LLVYEYMNHGSLDRILFGN-----GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGL 656 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGl 656 (724)
++++||+++|+|..++... ...+++.....++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcccc
Confidence 7889999999998887432 1246888899999999999999997 8999999999999999999999999999
Q ss_pred ccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 657 SKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 657 a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
++....... .......++..|++||.+....++.++||||||+++|||++ |++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~ 220 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE 220 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC
Confidence 986643321 11122345678999999999899999999999999999999 889986554
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=245.91 Aligned_cols=199 Identities=30% Similarity=0.435 Sum_probs=174.4
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecCCc--ccHHHHHHHHHHHhcCCCCCccceeceeecC--CeEEEEEEe
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV--QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG--RQRLLVYEY 587 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV~e~ 587 (724)
...+.||+|++|.||+|... +++.+++|++..... ...+.+.+|+.++++++|+||+++++.+.+. ...++|+||
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 82 (260)
T cd06606 3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEY 82 (260)
T ss_pred eeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEe
Confidence 34578999999999999986 678899999875432 4467889999999999999999999999988 899999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc-
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS- 666 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~- 666 (724)
+++++|.+++.... .+++..+..++.|++.+|+|||+ .+++|+||+|+||+++.++.++|+|||.+.........
T Consensus 83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 83 VSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE 158 (260)
T ss_pred cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence 99999999987654 78999999999999999999997 89999999999999999999999999999876554320
Q ss_pred ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
......++..|+|||.+.+...+.++||||||+++++|++|+.||....
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1233568889999999998889999999999999999999999997664
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=245.60 Aligned_cols=199 Identities=31% Similarity=0.478 Sum_probs=174.8
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecCCc--ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV--QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
.+.+.||.|+||.||++... ++..+++|++..... ...+++.+|++++++++|+|++++++.+..+...++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~ 82 (258)
T cd08215 3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYAD 82 (258)
T ss_pred eEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecC
Confidence 44578999999999999975 578899999975433 455778999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 590 HGSLDRILFGN---GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 590 ~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
+++|.+++... ...+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 158 (258)
T cd08215 83 GGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD- 158 (258)
T ss_pred CCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCcc-
Confidence 99999998764 3678999999999999999999997 8999999999999999999999999999987654431
Q ss_pred ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
......+++.|+|||.+.+..++.++|+||||+++++|++|+.||....
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 207 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence 2233468889999999998889999999999999999999999997664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-28 Score=253.09 Aligned_cols=196 Identities=28% Similarity=0.429 Sum_probs=164.4
Q ss_pred cccccccccccEEEEEEEECC-ccEEEEEEeecCC-cccHHHHHHHHHHHhcCC-CCCccceeceeecCCeEEEEEEecC
Q 043185 513 NFKNLIGSGGFGAVYKGILND-KTIVAVKKITNVG-VQGKKDFCTEIAIIGNIH-HVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
.+.+.||+|++|.||+|+..+ ++.+|||+++... .....++.+|+.++.+.+ |+||+++++++.++...+++|||++
T Consensus 18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 97 (296)
T cd06618 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS 97 (296)
T ss_pred eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC
Confidence 456889999999999999874 7889999997542 233456777887777775 9999999999999999999999986
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
+ +|..++......+++..+..++.|++.||+|||+ ..+|+||||+|+||+++.++.+||+|||++..+..... ..
T Consensus 98 ~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~--~~ 172 (296)
T cd06618 98 T-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA--KT 172 (296)
T ss_pred c-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc--cc
Confidence 4 7777776655578999999999999999999996 35899999999999999999999999999876543222 12
Q ss_pred cccccccccccccccCCc----CCCccchhhHHHHHHHHHhCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTNSA----ISEKTDVYSFGMVLLELVSGRRNCSP 713 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~~~----~~~~sDv~SlGv~l~elltG~~p~~~ 713 (724)
...++..|+|||.+.+.. ++.++|+||||+++|||++|+.||..
T Consensus 173 ~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred CCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 335778999999997654 78899999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-30 Score=289.72 Aligned_cols=196 Identities=31% Similarity=0.483 Sum_probs=166.0
Q ss_pred cccccccccEEEEEEEE-CCccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCC
Q 043185 515 KNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHG 591 (724)
Q Consensus 515 ~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~g 591 (724)
...||.|.||.||-+.. ++|...|+|.++-.. ....+...+|+.++..++|||+|+.+|+-.+.+..+|.||||++|
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 35799999999999994 578888999886432 233466789999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc---cce
Q 043185 592 SLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS---SLF 668 (724)
Q Consensus 592 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~---~~~ 668 (724)
+|.+++.+.+ ..++.....+..|++.|++|||+ .+||||||||.||+|+.+|.+|++|||.|+.+..... ...
T Consensus 1320 sLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el 1395 (1509)
T KOG4645|consen 1320 SLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGEL 1395 (1509)
T ss_pred cHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHH
Confidence 9999997653 35555556678899999999996 9999999999999999999999999999998765421 223
Q ss_pred ecccccccccccccccCC---cCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTNS---AISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~~---~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
....||+.|||||++.+. ...-++|||||||+.+||+||++||..-
T Consensus 1396 ~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~ 1444 (1509)
T KOG4645|consen 1396 QSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAEL 1444 (1509)
T ss_pred HhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhc
Confidence 456799999999999764 3567899999999999999999999543
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-28 Score=258.44 Aligned_cols=197 Identities=28% Similarity=0.434 Sum_probs=163.3
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecC-----CeEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG-----RQRLLV 584 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~~lV 584 (724)
+.+.+.||+|+||.||+|+.. +++.||+|++.... .....++.+|+.++++++|+||+++++++... ...++|
T Consensus 7 y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 86 (336)
T cd07849 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIV 86 (336)
T ss_pred eEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEE
Confidence 455688999999999999864 67889999986432 23346688899999999999999999987644 357999
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC
Q 043185 585 YEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (724)
+||+++ +|..++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 87 ~e~~~~-~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 87 QELMET-DLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred ehhccc-CHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 999975 78777744 368889999999999999999997 899999999999999999999999999997654322
Q ss_pred c--cceecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 665 S--SLFTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 665 ~--~~~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1 11123467899999998754 56899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=250.58 Aligned_cols=197 Identities=31% Similarity=0.406 Sum_probs=170.0
Q ss_pred ccccccccccEEEEEEEEC-CccEEEEEEeecCCc--ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 514 FKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV--QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 514 ~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
..+.||.|++|.||++... +++.+++|++..... .....+.+|++++++++|+||+++++++..+...++|+||+++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 82 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT 82 (283)
T ss_pred cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC
Confidence 3467999999999999975 678899999865432 2456788999999999999999999999999999999999976
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
+|..++......+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||.+....... .....
T Consensus 83 -~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~ 157 (283)
T cd05118 83 -DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTH 157 (283)
T ss_pred -CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccC
Confidence 8888887655678999999999999999999996 899999999999999999999999999998775543 11223
Q ss_pred ccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
..++..|+|||.+.+. .++.++|+||||+++++|++|+.||...+
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 203 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 4578889999999876 78999999999999999999999996654
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-28 Score=258.09 Aligned_cols=199 Identities=31% Similarity=0.461 Sum_probs=171.0
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCC-----eEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR-----QRLL 583 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~l 583 (724)
+.+.+.||.|++|.||+++.. .++.+|+|++.... ....+.+.+|+.+++.++|+||+++++++.... ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 455688999999999999975 47889999987643 344567899999999999999999999988775 7899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCC
Q 043185 584 VYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE 663 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (724)
||||+++ +|.+++.... .+++..+..++.|++.||+|||+ .+++|+||||+|||++.++.++|+|||++......
T Consensus 82 v~e~~~~-~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 82 VTELMET-DLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred Eecchhh-hHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 9999984 8888886554 78899999999999999999997 89999999999999999999999999999876544
Q ss_pred Cc--cceecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 664 QS--SLFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 664 ~~--~~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.. .......++..|+|||.+.+. .++.++|+||||+++++|++|++||....
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~ 211 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD 211 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence 21 122344578899999999887 88999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=251.49 Aligned_cols=197 Identities=25% Similarity=0.336 Sum_probs=167.3
Q ss_pred cccccccccccEEEEEEEE----CCccEEEEEEeecCC----cccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEE
Q 043185 513 NFKNLIGSGGFGAVYKGIL----NDKTIVAVKKITNVG----VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLL 583 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l 583 (724)
.+.+.||+|++|.||+++. .++..+|||.+++.. ....+.+.+|+.++.++ +||||+++++.+..+...++
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l 82 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL 82 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence 4567899999999999984 256789999986432 22345688999999999 69999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCC
Q 043185 584 VYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE 663 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (724)
||||+++++|.+++... ..+++.....++.|++.+|+|||+ .+++|+||||+||+++.++.++|+|||+++.....
T Consensus 83 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 83 ILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 99999999999998654 357888899999999999999996 89999999999999999999999999998876544
Q ss_pred CccceecccccccccccccccCCc--CCCccchhhHHHHHHHHHhCCCCCCC
Q 043185 664 QSSLFTTMRGTRGYLAPEWLTNSA--ISEKTDVYSFGMVLLELVSGRRNCSP 713 (724)
Q Consensus 664 ~~~~~~~~~gt~~y~aPE~l~~~~--~~~~sDv~SlGv~l~elltG~~p~~~ 713 (724)
.........++..|+|||.+.+.. .+.++|+||||++++||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 332223346889999999987765 78899999999999999999999954
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=245.57 Aligned_cols=199 Identities=32% Similarity=0.452 Sum_probs=172.4
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
+.+.+.||+|++|.||+++.. +++.+|+|++.... .....++.+|++++++++|+||+++++++.+....++|+||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 345678999999999999864 67789999987532 233457789999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc
Q 043185 589 NHGSLDRILFGN---GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 589 ~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 665 (724)
++++|..++... ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~- 157 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM- 157 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC-
Confidence 999999988652 3568889999999999999999996 899999999999999999999999999998765442
Q ss_pred cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 666 SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 666 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.....++..|+|||.+.+..++.++|+||||++++||++|+.||...+.
T Consensus 158 --~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~ 206 (256)
T cd08530 158 --AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM 206 (256)
T ss_pred --cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 2234578899999999999999999999999999999999999976553
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=251.55 Aligned_cols=192 Identities=34% Similarity=0.478 Sum_probs=164.3
Q ss_pred cccccccccEEEEEEEEC-CccEEEEEEeecCCc---ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 515 KNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV---QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 515 ~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
.+.||+|+||.||+|+.. +++.+++|++..... ...+++.+|++++++++|||++++++++.+....++||||+.
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL- 104 (313)
T ss_pred ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence 357999999999999964 678899999864322 233568899999999999999999999999999999999996
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
++|.+++......+++..+..++.||+.+|.|||+ .+++|+||+|+||+++.++.++|+|||++..... ...
T Consensus 105 ~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----~~~ 176 (313)
T cd06633 105 GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----ANS 176 (313)
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----CCC
Confidence 57777776655678999999999999999999997 8999999999999999999999999998864322 134
Q ss_pred cccccccccccccc---CCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLT---NSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 671 ~~gt~~y~aPE~l~---~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
..++..|+|||++. ...++.++||||||+++|||++|++||....
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~ 224 (313)
T cd06633 177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 224 (313)
T ss_pred ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 56889999999984 4568899999999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-28 Score=257.51 Aligned_cols=199 Identities=27% Similarity=0.414 Sum_probs=165.9
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeec----CCeEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ----GRQRLLV 584 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lV 584 (724)
+.+.+.||+|++|.||++... +++.||+|++.... ....+.+.+|+.++.+++||||+++++++.. ....++|
T Consensus 7 y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 86 (334)
T cd07855 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVV 86 (334)
T ss_pred eeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEE
Confidence 445578999999999999964 68889999986532 2345677889999999999999999998753 3468999
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC
Q 043185 585 YEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (724)
+||+. ++|..++... ..+++.....++.||+.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 87 ~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 87 MDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred Eehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 99996 5898888654 348999999999999999999996 899999999999999999999999999997654322
Q ss_pred c---cceecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 665 S---SLFTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 665 ~---~~~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 216 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN 216 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCC
Confidence 1 11123468899999999865 468999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=249.47 Aligned_cols=200 Identities=28% Similarity=0.440 Sum_probs=172.9
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecC---CcccHHHHHHHHHHHhcCC-CCCccceeceeecCCeEEEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV---GVQGKKDFCTEIAIIGNIH-HVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~e 586 (724)
+.+.+.||+|+||.||+++.. +++.+|+|.+... .....+.+.+|++++.+++ |+||+++++++..+...++|||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 445678999999999999975 6888999998652 1233467889999999998 9999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc-
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS- 665 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~- 665 (724)
|+++++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 83 YAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred CCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 999999999997653 68999999999999999999996 8999999999999999999999999999886644321
Q ss_pred ------------------cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 666 ------------------SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 666 ------------------~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.......++..|+|||.+....++.++|+||||++++|+++|+.||....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 11223457889999999998889999999999999999999999997665
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=248.57 Aligned_cols=198 Identities=32% Similarity=0.428 Sum_probs=165.1
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecCCc--ccHHHHHHHHHHHhcC---CCCCccceeceeecCCe-----E
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV--QGKKDFCTEIAIIGNI---HHVNLVKLKGFCAQGRQ-----R 581 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~~~~-----~ 581 (724)
++.+.||+|+||.||+|+.. +++.+|+|+++.... .....+.+|+.++.++ +|+||+++++++..... .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 34578999999999999986 478899999964322 2234566787776655 69999999999988776 8
Q ss_pred EEEEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCcccc
Q 043185 582 LLVYEYMNHGSLDRILFGNG-PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLL 660 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 660 (724)
+++|||+++ +|.+++.... ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++...
T Consensus 82 ~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 82 TLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred EEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcceec
Confidence 999999975 7888886543 368999999999999999999997 89999999999999999999999999999876
Q ss_pred CCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 661 TPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 661 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
..... .....++..|+|||.+.+..++.++|+||||+++|||++|++||.....
T Consensus 158 ~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~ 211 (287)
T cd07838 158 SFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE 211 (287)
T ss_pred cCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh
Confidence 44322 1233578899999999999999999999999999999999999976553
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=248.08 Aligned_cols=197 Identities=28% Similarity=0.414 Sum_probs=166.6
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecCCc-ccHHHHHHHHHHHhcCC-CCCccceeceeecCCeEEEEEEecC
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV-QGKKDFCTEIAIIGNIH-HVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
.+.+.||+|++|.||+|+.. +++.|++|++..... .......+|+..+.+++ |+||+++++++.++...++||||+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 35678999999999999985 467899999865322 22334567999999998 999999999999999999999999
Q ss_pred CCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce
Q 043185 590 HGSLDRILFGNG-PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 590 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
+++|.+++.... ..+++..+..++.|++.+|.|||+ .+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 155 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--Y 155 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--c
Confidence 789988887653 568999999999999999999997 8999999999999999999999999999976643322 2
Q ss_pred ecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
....++..|+|||++.+ ..++.++|+||||++++||++|++||....
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~ 203 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSS 203 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCC
Confidence 33457889999998854 467899999999999999999999996554
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=253.34 Aligned_cols=192 Identities=31% Similarity=0.446 Sum_probs=164.0
Q ss_pred ccccccccccEEEEEEEEC-CccEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 514 FKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV---GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 514 ~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
..+.||+|+||.||+|+.. +++.+|+|.+... .....+++.+|+++++.++|+|++++++++......++|+||+.
T Consensus 19 ~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 98 (308)
T cd06634 19 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 98 (308)
T ss_pred HHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC
Confidence 3467999999999999964 5678999988642 12334578899999999999999999999999999999999997
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
++|.+++......+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++...... .
T Consensus 99 -~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-----~ 169 (308)
T cd06634 99 -GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----N 169 (308)
T ss_pred -CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc-----c
Confidence 58887776555568899999999999999999997 89999999999999999999999999998765432 2
Q ss_pred ccccccccccccccc---CCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLT---NSAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~---~~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
...++..|+|||.+. ...++.++||||||+++|||++|+.||...
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 217 (308)
T cd06634 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (308)
T ss_pred cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc
Confidence 345788999999974 346788999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=248.42 Aligned_cols=197 Identities=32% Similarity=0.415 Sum_probs=169.7
Q ss_pred ccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 514 FKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 514 ~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
+.+.||+|++|.||+|+.. +++.+|+|++.... ....+.+..|+.++++++|+||+++++++.+....++|+||++
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~- 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD- 81 (282)
T ss_pred eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence 3467999999999999976 58889999997642 3334678899999999999999999999999999999999998
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
++|.+++......+++..+..++.+++.||+|||+ .+++||||+|+||+++.++.++|+|||++........ ....
T Consensus 82 ~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~ 157 (282)
T cd07829 82 MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTH 157 (282)
T ss_pred cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccCc
Confidence 58999997765578999999999999999999997 8999999999999999999999999999976644321 1223
Q ss_pred ccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
..++..|+|||.+.+. .++.++||||||++++||++|++||....
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 203 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS 203 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 3457789999998776 78999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=252.55 Aligned_cols=201 Identities=29% Similarity=0.385 Sum_probs=164.4
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCc--ccHHHHHHHHHHHhcCCCCCccceeceeecCC--------
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV--QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR-------- 579 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-------- 579 (724)
.+.+.+.||+|+||.||+|+.. +++.+|+|++..... .....+.+|++++++++|+||+++++++.+..
T Consensus 9 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 88 (311)
T cd07866 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRG 88 (311)
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCc
Confidence 3455688999999999999975 678899999864322 22346788999999999999999999875433
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccc
Q 043185 580 QRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKL 659 (724)
Q Consensus 580 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 659 (724)
..++|+||++. +|...+......+++..+..++.|+++||+|||+ .+++|+||||+||++++++.++|+|||+++.
T Consensus 89 ~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 89 SVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred eEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 46999999975 6777776655679999999999999999999997 8999999999999999999999999999976
Q ss_pred cCCCCcc----------ceecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 660 LTPEQSS----------LFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 660 ~~~~~~~----------~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
....... ......+++.|+|||.+.+. .++.++||||||+++|||++|++||.+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~ 231 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS 231 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC
Confidence 5432211 11233567889999988654 58999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=251.82 Aligned_cols=195 Identities=23% Similarity=0.213 Sum_probs=160.5
Q ss_pred ccccccccEEEEEEEECCccEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCCH
Q 043185 516 NLIGSGGFGAVYKGILNDKTIVAVKKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSL 593 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gsL 593 (724)
+.+|.|+++.||+++. +++.+|+|++... .....+.+.+|++++++++|+||+++++++.+.+..+++|||+++++|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3445555555555555 5778999998753 334557899999999999999999999999999999999999999999
Q ss_pred HHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc------c
Q 043185 594 DRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS------S 666 (724)
Q Consensus 594 ~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~------~ 666 (724)
.+++... ...+++.....++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||.+........ .
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 9998754 3457888889999999999999997 8999999999999999999999999998865532211 1
Q ss_pred ceecccccccccccccccCC--cCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNS--AISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~--~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
......++..|+|||++... .++.++|+||||++++||++|+.||...
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 11234567889999999763 5889999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=253.90 Aligned_cols=197 Identities=23% Similarity=0.278 Sum_probs=161.6
Q ss_pred cccccc--ccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 516 NLIGSG--GFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 516 ~~lG~G--~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
+.||+| +||+||+++.. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..+...++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456766 99999999974 78899999986432 23346788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc---
Q 043185 591 GSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS--- 666 (724)
Q Consensus 591 gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~--- 666 (724)
++|.+++... ...+++..+..++.|++.||+|||+ .+++||||||+|||++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999998764 2458888889999999999999996 89999999999999999999999999865433211110
Q ss_pred c---eecccccccccccccccCC--cCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 667 L---FTTMRGTRGYLAPEWLTNS--AISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 667 ~---~~~~~gt~~y~aPE~l~~~--~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
. .....++..|+|||++.+. .++.++||||||+++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 214 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence 0 0112345679999999764 47899999999999999999999997643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=255.07 Aligned_cols=198 Identities=30% Similarity=0.440 Sum_probs=165.3
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeceeecC-----CeEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG-----RQRLL 583 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~~l 583 (724)
+...+.||+|+||.||+++.. +++.||||++... ......++.+|+.++..++|+||+++++++... ...++
T Consensus 7 y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 86 (337)
T cd07858 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYI 86 (337)
T ss_pred eeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEE
Confidence 445678999999999999964 6788999998653 233345678899999999999999999987654 35799
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCC
Q 043185 584 VYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE 663 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (724)
|+||+. ++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 87 v~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 87 VYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred EEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 999996 6888888654 468899999999999999999997 89999999999999999999999999999866433
Q ss_pred CccceecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 664 QSSLFTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 664 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
. .......++..|+|||.+.. ..++.++|+||||+++|||++|++||..++
T Consensus 162 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 213 (337)
T cd07858 162 G-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD 213 (337)
T ss_pred c-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC
Confidence 2 11233457889999998865 468999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=254.99 Aligned_cols=202 Identities=28% Similarity=0.392 Sum_probs=164.8
Q ss_pred hHHHHHhhcc--ccccccccccEEEEEEEE-CCccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecC
Q 043185 504 YEELEVATDN--FKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG 578 (724)
Q Consensus 504 ~~~l~~a~~~--~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 578 (724)
.+++...+.+ +.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++.+++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 3344444444 357899999999999985 467889999986532 22346678899999999999999999987543
Q ss_pred ------CeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEE
Q 043185 579 ------RQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKIS 652 (724)
Q Consensus 579 ------~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 652 (724)
...+++++++ +++|.+++... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~ 162 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKIL 162 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEEe
Confidence 3467888876 77998887543 58899999999999999999997 899999999999999999999999
Q ss_pred eecCccccCCCCccceecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 653 DFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 653 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
|||+++..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 163 dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 222 (345)
T cd07877 163 DFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 222 (345)
T ss_pred ccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99998765332 133467889999999876 468899999999999999999999996543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=254.61 Aligned_cols=196 Identities=27% Similarity=0.351 Sum_probs=163.8
Q ss_pred cccccccccEEEEEEEEC-CccEEEEEEeecCCccc--------------HHHHHHHHHHHhcCCCCCccceeceeecCC
Q 043185 515 KNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQG--------------KKDFCTEIAIIGNIHHVNLVKLKGFCAQGR 579 (724)
Q Consensus 515 ~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 579 (724)
.+.||.|+||.||+|... +++.||+|+++...... ...+.+|++++.+++|+||+++++++..++
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 467999999999999965 67889999986532221 125778999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccc
Q 043185 580 QRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKL 659 (724)
Q Consensus 580 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 659 (724)
..++||||++ ++|.+++... ..+++.....++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||+++.
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~dfg~~~~ 168 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARR 168 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCccceee
Confidence 9999999997 5898888654 358889999999999999999996 8999999999999999999999999999976
Q ss_pred cCCCC-------------ccceecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 660 LTPEQ-------------SSLFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 660 ~~~~~-------------~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
..... ........++..|+|||.+.+. .++.++|+||||+++|||++|++||....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 169 YGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred cccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 64111 1111223467889999999764 46899999999999999999999997654
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-29 Score=257.13 Aligned_cols=195 Identities=26% Similarity=0.345 Sum_probs=171.9
Q ss_pred ccccccccEEEEEEEECCccE-EEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCC
Q 043185 516 NLIGSGGFGAVYKGILNDKTI-VAVKKITNV---GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHG 591 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~~-vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~g 591 (724)
..||-|+||.|=+++.+.... .|+|.+++. ....++....|-++|...+.|.||+++-.+.++...||.||-|-||
T Consensus 426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG 505 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG 505 (732)
T ss_pred hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence 469999999999999876543 778877653 3344566788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceecc
Q 043185 592 SLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTM 671 (724)
Q Consensus 592 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 671 (724)
.|...|...+ .++.....-++.-+.+|++|||+ ++||.|||||+|.+|+.+|-+||.|||+|+.+..... .-++
T Consensus 506 ElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K--TwTF 579 (732)
T KOG0614|consen 506 ELWTILRDRG-SFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK--TWTF 579 (732)
T ss_pred hhhhhhhhcC-CcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccCCc--eeee
Confidence 9999997765 46666666788889999999997 9999999999999999999999999999998876543 4678
Q ss_pred cccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 672 RGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 672 ~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
+||+.|+|||.+.++..+..+|.||||+++|||++|++||++.++
T Consensus 580 cGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp 624 (732)
T KOG0614|consen 580 CGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP 624 (732)
T ss_pred cCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch
Confidence 999999999999999999999999999999999999999988765
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=253.95 Aligned_cols=192 Identities=28% Similarity=0.408 Sum_probs=160.3
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCC------eEEE
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR------QRLL 583 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~~l 583 (724)
...+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++||||+++++++.... ..++
T Consensus 18 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 97 (342)
T cd07879 18 TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYL 97 (342)
T ss_pred EEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEE
Confidence 34578999999999999964 67889999986432 223456889999999999999999999886543 4689
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCC
Q 043185 584 VYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE 663 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (724)
|+||+.. +|..++. ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 98 v~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~ 170 (342)
T cd07879 98 VMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE 170 (342)
T ss_pred Eeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC
Confidence 9999974 6766552 357889999999999999999997 89999999999999999999999999998754322
Q ss_pred CccceecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 664 QSSLFTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 664 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.+..
T Consensus 171 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 171 ----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred ----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 123457889999999876 468899999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-27 Score=239.94 Aligned_cols=193 Identities=33% Similarity=0.414 Sum_probs=168.8
Q ss_pred ccccccEEEEEEEEC-CccEEEEEEeecCCc---ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCCH
Q 043185 518 IGSGGFGAVYKGILN-DKTIVAVKKITNVGV---QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSL 593 (724)
Q Consensus 518 lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gsL 593 (724)
||+|+||.||++... +++.+|+|.+..... .....+..|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999975 578899999875422 2345788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceecccc
Q 043185 594 DRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRG 673 (724)
Q Consensus 594 ~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~g 673 (724)
.+++.... .+++.....++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ ......+
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (250)
T cd05123 81 FSHLSKEG-RFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTFCG 155 (250)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccCCcC
Confidence 99997653 58899999999999999999996 9999999999999999999999999999876644321 1234567
Q ss_pred cccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 674 TRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 674 t~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
+..|++||.+.+...+.++|+||||+++|||++|+.||....
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 197 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 889999999998888999999999999999999999997655
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-27 Score=252.75 Aligned_cols=194 Identities=26% Similarity=0.366 Sum_probs=163.2
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCC------eEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR------QRL 582 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~~ 582 (724)
+.+.+.||+|+||.||++... ++..||||++.... ....+.+.+|++++++++||||+++++++..+. ..+
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07880 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFY 96 (343)
T ss_pred eEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEE
Confidence 445678999999999999854 67889999985422 223456889999999999999999999887554 458
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCC
Q 043185 583 LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP 662 (724)
Q Consensus 583 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (724)
+|+||+ +++|..++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++.....
T Consensus 97 lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 97 LVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred EEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 999998 6789888754 358899999999999999999996 8999999999999999999999999999976543
Q ss_pred CCccceecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 663 EQSSLFTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 663 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.. ....+++.|+|||.+.+ ..++.++|+||||+++++|++|+.||....
T Consensus 171 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 220 (343)
T cd07880 171 EM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD 220 (343)
T ss_pred Cc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 22 23457889999999876 458899999999999999999999997553
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-27 Score=252.45 Aligned_cols=199 Identities=27% Similarity=0.400 Sum_probs=163.7
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecC-----------
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG----------- 578 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~----------- 578 (724)
++.+.+.||.|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 6 ~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (342)
T cd07854 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL 85 (342)
T ss_pred ceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccc
Confidence 4555688999999999999974 6788999999766556667889999999999999999999876543
Q ss_pred ---CeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC-CCcEEEEee
Q 043185 579 ---RQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY-HFQAKISDF 654 (724)
Q Consensus 579 ---~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DF 654 (724)
...++|+||++ ++|.+++... .+++.....++.||+.||.|||+ .+++||||||+||+++. ++.+||+||
T Consensus 86 ~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 86 TELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred cccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEECCc
Confidence 35789999997 5888887543 57889999999999999999996 89999999999999974 567899999
Q ss_pred cCccccCCCCcc--ceecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 655 GLSKLLTPEQSS--LFTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 655 Gla~~~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
|+++........ ......++..|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 223 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH 223 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999765432111 1122357889999998754 567889999999999999999999997554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-27 Score=249.99 Aligned_cols=199 Identities=27% Similarity=0.374 Sum_probs=162.7
Q ss_pred ccccccccccccEEEEEEEEC-C--ccEEEEEEeecCC--cccHHHHHHHHHHHhcC-CCCCccceeceeecC----CeE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-D--KTIVAVKKITNVG--VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQG----RQR 581 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~--~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~----~~~ 581 (724)
+.+.+.||+|+||.||+++.. . +..+|+|++.... ....+.+.+|++++.++ +||||+++++.+... ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 345678999999999999975 3 6789999986432 22346788899999999 599999999875432 457
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccC
Q 043185 582 LLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 661 (724)
++++||++ ++|..++... ..+++..+..++.||+.||.|||+ .+++||||||+||+++.++.+||+|||+++.+.
T Consensus 82 ~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 82 YLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 88889886 5888888654 468899999999999999999996 899999999999999999999999999998654
Q ss_pred CCCc---cceecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 662 PEQS---SLFTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 662 ~~~~---~~~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.... .......|+..|+|||++.+ ..++.++|+||||+++|+|++|++||....
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 3221 11223468899999998765 568999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-28 Score=233.99 Aligned_cols=191 Identities=24% Similarity=0.317 Sum_probs=163.0
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeceeec----CCeEEEEEEecC
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQ----GRQRLLVYEYMN 589 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~----~~~~~lV~e~~~ 589 (724)
++||-|-.|+|..+..+ .++..|+|++... ....+|+++--.. .|||||.+++++.. ...+++|||.|+
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me 142 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME 142 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc
Confidence 68999999999999875 6778999988543 3456888876555 69999999998753 457889999999
Q ss_pred CCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC---CCcEEEEeecCccccCCCCc
Q 043185 590 HGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY---HFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 590 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DFGla~~~~~~~~ 665 (724)
||.|..-+... ...+++.++..|..||..|+.|||+ ..|.||||||+|+|... +..+||+|||+|+.-...
T Consensus 143 GGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~-- 217 (400)
T KOG0604|consen 143 GGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP-- 217 (400)
T ss_pred chHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccccccccCCC--
Confidence 99999988765 4568999999999999999999997 99999999999999964 567999999999865432
Q ss_pred cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 666 SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 666 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
....+.+-|+.|.|||++..++|+...|+||+||+||-|++|-+||.....
T Consensus 218 ~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg 268 (400)
T KOG0604|consen 218 GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_pred ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC
Confidence 234566789999999999999999999999999999999999999976543
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-27 Score=240.93 Aligned_cols=198 Identities=26% Similarity=0.391 Sum_probs=163.8
Q ss_pred ccccccccccccEEEEEEEECC-ccEEEEEEeecC-----CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILND-KTIVAVKKITNV-----GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVY 585 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~~-~~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 585 (724)
+.+.+.||+|+||.||+++... +..+++|.++.. ......++.+|+.++++++||||+++++++.+....++|+
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 4566889999999999998653 344555555432 1223345678999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCC
Q 043185 586 EYMNHGSLDRILFG---NGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP 662 (724)
Q Consensus 586 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (724)
||+++++|.+++.. ....+++..+..++.|++.||.|||+ .+++|+||+|+||+++. +.++|+|||++.....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 99999999988864 34568999999999999999999996 89999999999999975 5699999999876643
Q ss_pred CCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 663 EQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 663 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 158 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~ 208 (260)
T cd08222 158 SCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ 208 (260)
T ss_pred Ccc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 322 123445788999999998888999999999999999999999999644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.9e-27 Score=236.89 Aligned_cols=180 Identities=21% Similarity=0.173 Sum_probs=154.2
Q ss_pred cccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCCHHHHHhc
Q 043185 521 GGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFG 599 (724)
Q Consensus 521 G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~ 599 (724)
|.+|.||+++.. +++.+|+|++.... .+.+|...+....||||+++++++.+....++||||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999964 67889999987542 334455556666799999999999999999999999999999998865
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceecccccccccc
Q 043185 600 NGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLA 679 (724)
Q Consensus 600 ~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~a 679 (724)
. ..+++.....++.|++.||+|||+ .+++||||||+||+++.++.++++|||.+....... ....++..|+|
T Consensus 79 ~-~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~a 150 (237)
T cd05576 79 F-LNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYCA 150 (237)
T ss_pred h-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccccC
Confidence 4 358899999999999999999996 899999999999999999999999999886554321 23346778999
Q ss_pred cccccCCcCCCccchhhHHHHHHHHHhCCCCCCC
Q 043185 680 PEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSP 713 (724)
Q Consensus 680 PE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~ 713 (724)
||.+.+..++.++|+||+|+++|||++|+.|++.
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 9999888899999999999999999999988753
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=247.62 Aligned_cols=194 Identities=28% Similarity=0.401 Sum_probs=162.4
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeceeec-CCeEEEEEEe
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ-GRQRLLVYEY 587 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~lV~e~ 587 (724)
+.+.+.||.|+||.||++... +++.+|+|++... .....+.+.+|++++.+++||||+++++++.. ....++|+||
T Consensus 12 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~ 91 (328)
T cd07856 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL 91 (328)
T ss_pred eEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeeh
Confidence 344578999999999999865 7788999988542 12334678899999999999999999998865 5678999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
+ +++|..++... .+++.....++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++......
T Consensus 92 ~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~---- 161 (328)
T cd07856 92 L-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ---- 161 (328)
T ss_pred h-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCCC----
Confidence 8 46898887543 46778888899999999999997 89999999999999999999999999998754322
Q ss_pred eecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.....++..|+|||.+.+ ..++.++|+||||+++|||++|+.||....
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~ 210 (328)
T cd07856 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD 210 (328)
T ss_pred cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 123457889999999866 578999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-29 Score=237.22 Aligned_cols=202 Identities=26% Similarity=0.392 Sum_probs=168.4
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEee--cCCcccHHHHHHHHHHHhcCCCCCccceeceeecC--------CeEEEE
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKIT--NVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG--------RQRLLV 584 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~--~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--------~~~~lV 584 (724)
.+||+|.||+||+|+.. +++.||+|++- +....-....++|+.+|..++|+|++.++..|... ...+||
T Consensus 23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV 102 (376)
T KOG0669|consen 23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV 102 (376)
T ss_pred HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence 57999999999999964 56678887763 22223335678999999999999999999988542 357899
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC
Q 043185 585 YEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (724)
+++++. +|.-+|......++..++.+++.++..||.|+|. ..|+|||+||.|+||+.++.+||+|||+++.+....
T Consensus 103 f~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~ 178 (376)
T KOG0669|consen 103 FDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLARAFSTSK 178 (376)
T ss_pred HHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccccceeccc
Confidence 999987 8888887776788999999999999999999996 999999999999999999999999999998664332
Q ss_pred c---cceecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCC
Q 043185 665 S---SLFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSMD 721 (724)
Q Consensus 665 ~---~~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~~~~ 721 (724)
. ...+..+-|..|++||.+.+. .|+++.|+|.-||+|.||.++.+-+++.++...+.
T Consensus 179 n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~ 239 (376)
T KOG0669|consen 179 NVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLH 239 (376)
T ss_pred ccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHH
Confidence 1 223445569999999998765 79999999999999999999999999887765543
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-28 Score=214.28 Aligned_cols=101 Identities=38% Similarity=0.637 Sum_probs=73.5
Q ss_pred CCeEEEecCCCCCCCC---CceEEEccCc-cEEEcCCCCeEEec-CCCCC--ceeEEEEecCCcEEEecCCCccceeccc
Q 043185 75 SNTIIWSANRDTPISG---SGKMNLTPKG-IIISDENGNLKWST-PPLKS--SVSALRLTEMGNLVLLDGFNGSLWESFH 147 (724)
Q Consensus 75 ~~tvVW~Anr~~pv~~---~~~l~~~~~g-~~l~~~~g~~vWst-~~~~~--~~~~~~L~dsGNlVl~~~~~~~lWQSFd 147 (724)
++||||+|||++|+.. ..+|.|+.|| |+|+|.+|+++|+| ++.+. .+..|+|+|+|||||+|..+.+||||||
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~ 80 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSFD 80 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEESTT
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeecC
Confidence 4799999999999943 3799999999 58999999999999 55544 4789999999999999999999999999
Q ss_pred CCCcccccCCccCC----C--ceEEecCCCCCCC
Q 043185 148 HPRDTIVIGQHLPA----G--ASLSSAVSDYNLS 175 (724)
Q Consensus 148 ~PtDtlLpgq~l~~----~--~~L~S~~s~~dps 175 (724)
|||||+||+|+|+. + ..|+||++.+|||
T Consensus 81 ~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 81 YPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp SSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred CCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 99999999999976 2 3599999999996
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=266.34 Aligned_cols=143 Identities=27% Similarity=0.354 Sum_probs=127.1
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCCc---ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV---QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
+.+.++||+|+||.||+|... +++.||||+++.... .....+.+|+.++..++|+||+++++++......+|||||
T Consensus 6 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy 85 (669)
T cd05610 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEY 85 (669)
T ss_pred EEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeC
Confidence 455688999999999999976 678899999975322 2236788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCcc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSK 658 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~ 658 (724)
+++++|.+++... ..+.+...+.|+.||+.||+|||. .+|+||||||+||||+.++.+||+|||+++
T Consensus 86 ~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 86 LIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999998654 357888899999999999999997 899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=254.17 Aligned_cols=198 Identities=23% Similarity=0.313 Sum_probs=148.0
Q ss_pred ccccccccccccEEEEEEEE-----------------CCccEEEEEEeecCCcccHHHH--------------HHHHHHH
Q 043185 512 DNFKNLIGSGGFGAVYKGIL-----------------NDKTIVAVKKITNVGVQGKKDF--------------CTEIAII 560 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~-----------------~~~~~vAvK~~~~~~~~~~~~~--------------~~E~~~l 560 (724)
+.+.++||+|+||.||+|.. ..++.||||++........++| ..|+.++
T Consensus 147 F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l 226 (507)
T PLN03224 147 FQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMC 226 (507)
T ss_pred ceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHH
Confidence 34568999999999999974 2346799999865433222333 3466777
Q ss_pred hcCCCCCc-----cceeceeec--------CCeEEEEEEecCCCCHHHHHhcCC-----------------------CCC
Q 043185 561 GNIHHVNL-----VKLKGFCAQ--------GRQRLLVYEYMNHGSLDRILFGNG-----------------------PVL 604 (724)
Q Consensus 561 ~~l~H~nI-----v~l~g~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~-----------------------~~l 604 (724)
.+++|.++ ++++++|.. ....+|||||+++++|.++++... ..+
T Consensus 227 ~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~ 306 (507)
T PLN03224 227 AKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKR 306 (507)
T ss_pred HHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccC
Confidence 77766554 677777653 356899999999999999886421 123
Q ss_pred CHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceeccccccccccccccc
Q 043185 605 EWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT 684 (724)
Q Consensus 605 ~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~ 684 (724)
++..+..++.|++.+|.|||+ .+|+||||||+|||++.++.+||+|||+++..............+++.|+|||.+.
T Consensus 307 ~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~ 383 (507)
T PLN03224 307 DINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV 383 (507)
T ss_pred CHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence 567788899999999999996 89999999999999999999999999999765433221111223478999999885
Q ss_pred CCcC----------------------CCccchhhHHHHHHHHHhCCC-CCC
Q 043185 685 NSAI----------------------SEKTDVYSFGMVLLELVSGRR-NCS 712 (724)
Q Consensus 685 ~~~~----------------------~~~sDv~SlGv~l~elltG~~-p~~ 712 (724)
.... ..+.|+||+||+++||++|.. |+.
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 4321 124799999999999999874 664
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=255.21 Aligned_cols=199 Identities=29% Similarity=0.432 Sum_probs=170.5
Q ss_pred hccccccccccccEEEEEEEE-CCccEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeceeec-----CCeEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQ-----GRQRLL 583 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~-----~~~~~l 583 (724)
+..|.+.||.|.+|.||+++. ++++.+|+|++... ....++...|.++++.. +|||++.++|++.. ++.+||
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL 98 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL 98 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence 345678999999999999995 57788889988754 44456778899999887 79999999999864 468999
Q ss_pred EEEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCC
Q 043185 584 VYEYMNHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP 662 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (724)
|||||.+|+..+++++. +..+.|.....|++.++.|+.+||. +.++|||+|-.|||++.++.+||+|||++..+..
T Consensus 99 VMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 99 VMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS 175 (953)
T ss_pred EeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence 99999999999998754 5678899999999999999999996 9999999999999999999999999999987765
Q ss_pred CCccceecccccccccccccccCC-----cCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 663 EQSSLFTTMRGTRGYLAPEWLTNS-----AISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 663 ~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
...+ ..+..||+.|||||++... .|+.++|+||||++..||.-|.+|+-..
T Consensus 176 T~gr-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm 231 (953)
T KOG0587|consen 176 TVGR-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM 231 (953)
T ss_pred cccc-ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc
Confidence 4333 3456899999999999543 4778999999999999999999998433
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=229.61 Aligned_cols=197 Identities=35% Similarity=0.519 Sum_probs=172.0
Q ss_pred ccccccccccEEEEEEEECC-ccEEEEEEeecCCcc-cHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCC
Q 043185 514 FKNLIGSGGFGAVYKGILND-KTIVAVKKITNVGVQ-GKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHG 591 (724)
Q Consensus 514 ~~~~lG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~g 591 (724)
+.+.||.|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 82 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG 82 (225)
T ss_pred eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence 45789999999999999875 788999999765444 5678999999999999999999999999989999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceecc
Q 043185 592 SLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTM 671 (724)
Q Consensus 592 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 671 (724)
+|.+++......+++.....++.+++.++.+||. .+++|+||+|+||+++.++.++|+|||.+..............
T Consensus 83 ~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (225)
T smart00221 83 DLFDYLRKKGGKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV 159 (225)
T ss_pred CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence 9999987654337889999999999999999997 7999999999999999999999999999987654421122344
Q ss_pred cccccccccccc-cCCcCCCccchhhHHHHHHHHHhCCCCCCC
Q 043185 672 RGTRGYLAPEWL-TNSAISEKTDVYSFGMVLLELVSGRRNCSP 713 (724)
Q Consensus 672 ~gt~~y~aPE~l-~~~~~~~~sDv~SlGv~l~elltG~~p~~~ 713 (724)
.++..|++||.+ ....++.++|+|+||++++||++|+.||..
T Consensus 160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 577889999999 667788899999999999999999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=248.50 Aligned_cols=194 Identities=28% Similarity=0.400 Sum_probs=163.8
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeceeecCCe------EE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQ------RL 582 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~------~~ 582 (724)
+.+.+.||+|++|.||+|+.. +++.+|+|++... .....+++.+|+.++++++|+||+++++++...+. .+
T Consensus 17 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07851 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVY 96 (343)
T ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEE
Confidence 344578999999999999975 5788999998643 12234567789999999999999999998876554 89
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCC
Q 043185 583 LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP 662 (724)
Q Consensus 583 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (724)
+|+||+ +++|.+++.. ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 97 lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 97 LVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred EEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence 999998 5699888865 358899999999999999999997 8999999999999999999999999999986543
Q ss_pred CCccceecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 663 EQSSLFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 663 ~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
. .....++..|+|||.+.+. .++.++||||||+++|||++|+.||....
T Consensus 171 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~ 220 (343)
T cd07851 171 E----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD 220 (343)
T ss_pred c----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 2334678899999998653 67899999999999999999999996544
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-27 Score=231.11 Aligned_cols=195 Identities=24% Similarity=0.314 Sum_probs=167.1
Q ss_pred ccccccccccEEEEEEEEC-CccEEEEEEeecC---CcccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEEEEEec
Q 043185 514 FKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV---GVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 514 ~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
+..+||+|+|.+|.++++. ..+.+|+|++++. ..+...-.+.|-.+..+. +||.+|-++.+++.+..+++|.||+
T Consensus 254 ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv 333 (593)
T KOG0695|consen 254 LLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYV 333 (593)
T ss_pred eeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEe
Confidence 3478999999999999975 5678999988753 223344566777777666 7999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
++|+|-.++.... .++++.+.-+..+|.-||.|||+ .+||.||||.+|||+|.+|++||.|+|+++.--.+. ...
T Consensus 334 ~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~~g-d~t 408 (593)
T KOG0695|consen 334 NGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG-DTT 408 (593)
T ss_pred cCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCCCC-ccc
Confidence 9999987776664 46667777788899999999997 999999999999999999999999999998543332 234
Q ss_pred ecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSP 713 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~ 713 (724)
++++||+.|+|||.+++..|...+|.|+|||+|+||+.|+.||+-
T Consensus 409 stfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 409 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred ccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 678999999999999999999999999999999999999999953
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-28 Score=237.02 Aligned_cols=200 Identities=28% Similarity=0.404 Sum_probs=169.6
Q ss_pred ccccccccEEEEEEEE-CCccEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeceeecCC-----eEEEEEEe
Q 043185 516 NLIGSGGFGAVYKGIL-NDKTIVAVKKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR-----QRLLVYEY 587 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~lV~e~ 587 (724)
+.||.|+||.||-++. ++++.||.|++.+. +...-+++.+|+++|.-.+|.|++..+++..... +.|.+.|.
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 5699999999999986 47899999999764 2334578889999999999999999999876543 45677887
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
|.. +|..++-.. ..++.+...-+.+||++||.|||+ .+|.||||||.|.|++.+..+||||||+++.-..++...
T Consensus 139 mQS-DLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h 213 (449)
T KOG0664|consen 139 MQS-DLHKIIVSP-QALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN 213 (449)
T ss_pred HHh-hhhheeccC-CCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccchhhhhh
Confidence 754 776666544 467778888899999999999997 999999999999999999999999999999877776666
Q ss_pred eecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSM 720 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~~~ 720 (724)
++..+-|..|.|||.+.+. .|+.+.||||.||++.|++..+.-|+...+-+.+
T Consensus 214 MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL 267 (449)
T KOG0664|consen 214 MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQL 267 (449)
T ss_pred hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHH
Confidence 6777789999999999986 6899999999999999999999999877665443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-27 Score=251.20 Aligned_cols=193 Identities=30% Similarity=0.380 Sum_probs=162.3
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEEEEEecC
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
+.+...+|.|+|+.|-.+... +.+..+||++.+. ..+-.+|+.++... +||||+++.+.+.++.+.++|||.+.
T Consensus 324 y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~ 399 (612)
T KOG0603|consen 324 YEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD 399 (612)
T ss_pred hccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence 445567999999999998864 6677999999754 23345677666555 79999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEE-eCCCcEEEEeecCccccCCCCccce
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILL-HYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl-~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
++-|.+-+..... .. .++..|+.+|+.|+.|||+ +++|||||||+|||+ +..++++|+|||.++..... .
T Consensus 400 g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~ 470 (612)
T KOG0603|consen 400 GGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----C 470 (612)
T ss_pred ccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh----h
Confidence 9988777765532 22 6777899999999999997 999999999999999 58999999999999877655 2
Q ss_pred ecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
...+-|..|.|||++....|++++|+||||++||+||+|+.||......
T Consensus 471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~ 519 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG 519 (612)
T ss_pred cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch
Confidence 3446688999999999999999999999999999999999999554433
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.4e-27 Score=245.38 Aligned_cols=192 Identities=26% Similarity=0.344 Sum_probs=163.5
Q ss_pred cccccccccEEEEEEEECC-ccEEEEEEeecCCc--------ccHHHHHHHHHHHhcCC---CCCccceeceeecCCeEE
Q 043185 515 KNLIGSGGFGAVYKGILND-KTIVAVKKITNVGV--------QGKKDFCTEIAIIGNIH---HVNLVKLKGFCAQGRQRL 582 (724)
Q Consensus 515 ~~~lG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~ 582 (724)
.+.+|+|+||.|+++.++. ...|+||.+.+... ...-..-.|+.||..++ |+||++++++|++++..|
T Consensus 566 lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy 645 (772)
T KOG1152|consen 566 LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY 645 (772)
T ss_pred eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence 3679999999999999864 45688888865321 11112456999999997 999999999999999999
Q ss_pred EEEEec-CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccC
Q 043185 583 LVYEYM-NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 583 lV~e~~-~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 661 (724)
|++|-. ++-+|.+++.-+ +.+++.+...|+.|++.|+++||+ .+|||||||-+||.++.+|-+||+|||.+....
T Consensus 646 l~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfgsaa~~k 721 (772)
T KOG1152|consen 646 LETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTK 721 (772)
T ss_pred EEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeeccchhhhc
Confidence 999976 466888888544 578899999999999999999996 999999999999999999999999999997665
Q ss_pred CCCccceecccccccccccccccCCcC-CCccchhhHHHHHHHHHhCCCCCCC
Q 043185 662 PEQSSLFTTMRGTRGYLAPEWLTNSAI-SEKTDVYSFGMVLLELVSGRRNCSP 713 (724)
Q Consensus 662 ~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDv~SlGv~l~elltG~~p~~~ 713 (724)
... +..++||..|.|||++.+.+| ...-|||++|++||.++-...||..
T Consensus 722 sgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 722 SGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred CCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 443 467889999999999999887 4567999999999999999999864
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.3e-25 Score=223.51 Aligned_cols=186 Identities=36% Similarity=0.540 Sum_probs=165.3
Q ss_pred ccEEEEEEEEC-CccEEEEEEeecCCccc-HHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCCHHHHHhc
Q 043185 522 GFGAVYKGILN-DKTIVAVKKITNVGVQG-KKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFG 599 (724)
Q Consensus 522 ~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~ 599 (724)
+||.||+|+.. +++.+|+|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999986 47889999997654444 68899999999999999999999999999999999999999999999876
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceecccccccccc
Q 043185 600 NGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLA 679 (724)
Q Consensus 600 ~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~a 679 (724)
... +++..+..++.+++.++.|||+ .+++|+||+|+||+++.++.++|+|||.+....... ......++..|++
T Consensus 81 ~~~-~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~ 154 (244)
T smart00220 81 RGR-LSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA 154 (244)
T ss_pred ccC-CCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence 543 8889999999999999999997 899999999999999999999999999998765432 1234567889999
Q ss_pred cccccCCcCCCccchhhHHHHHHHHHhCCCCCCC
Q 043185 680 PEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSP 713 (724)
Q Consensus 680 PE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~ 713 (724)
||.+.+..+++++|+||||+++++|++|..||..
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999988899999999999999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-26 Score=228.90 Aligned_cols=197 Identities=26% Similarity=0.353 Sum_probs=164.2
Q ss_pred ccccccccccEEEEEEEE------CCccEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeceeecC-CeEEEEE
Q 043185 514 FKNLIGSGGFGAVYKGIL------NDKTIVAVKKITNV-GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG-RQRLLVY 585 (724)
Q Consensus 514 ~~~~lG~G~fG~Vy~~~~------~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~lV~ 585 (724)
.+.++-+|.||.||.|.+ ++.+.|-||.++.. +.-....++.|..++..+.|||+..+.+++.++ ..++.+|
T Consensus 288 l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y 367 (563)
T KOG1024|consen 288 LSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLY 367 (563)
T ss_pred chhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEE
Confidence 356789999999999965 34456778877643 233446788999999999999999999998765 5778999
Q ss_pred EecCCCCHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCcc
Q 043185 586 EYMNHGSLDRILFG-------NGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSK 658 (724)
Q Consensus 586 e~~~~gsL~~~l~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~ 658 (724)
.++.-|+|..+|.. ....++..+...++.|++.|++|||+ .++||.||.++|.+||+..++||+|=.+++
T Consensus 368 ~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~LqVkltDsaLSR 444 (563)
T KOG1024|consen 368 PATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQLQVKLTDSALSR 444 (563)
T ss_pred eccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhheeEEeccchhcc
Confidence 99999999999972 13456677888999999999999996 999999999999999999999999999999
Q ss_pred ccCCCCccc-eecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCC
Q 043185 659 LLTPEQSSL-FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSP 713 (724)
Q Consensus 659 ~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~ 713 (724)
.+-+..... .........||+||.+.+..|+.++|||||||+||||+| |+.|+-.
T Consensus 445 DLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae 501 (563)
T KOG1024|consen 445 DLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE 501 (563)
T ss_pred ccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc
Confidence 876554332 223346789999999999999999999999999999999 8888843
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=251.75 Aligned_cols=194 Identities=23% Similarity=0.264 Sum_probs=138.5
Q ss_pred hccccccccccccEEEEEEEEC-C----ccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceece------eecCC
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-D----KTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGF------CAQGR 579 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~------~~~~~ 579 (724)
.+.+.+.||+|+||.||+|+.. + +..||+|++..... .+....| .+.+..+.++..++.. ...+.
T Consensus 133 ~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred CeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence 3455689999999999999975 4 57899999864321 1222222 1222223333322222 24566
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCC-------------------CCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCC
Q 043185 580 QRLLVYEYMNHGSLDRILFGNGPV-------------------LEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPEN 640 (724)
Q Consensus 580 ~~~lV~e~~~~gsL~~~l~~~~~~-------------------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~N 640 (724)
..+||+||+++++|.+++...... .....+..++.||+.||+|||+ .+|+||||||+|
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP~N 285 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQN 285 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCHHH
Confidence 889999999999999988654211 1123355789999999999997 899999999999
Q ss_pred eEEeC-CCcEEEEeecCccccCCCCccceecccccccccccccccCC----------------------cCCCccchhhH
Q 043185 641 ILLHY-HFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNS----------------------AISEKTDVYSF 697 (724)
Q Consensus 641 ILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----------------------~~~~~sDv~Sl 697 (724)
||++. ++.+||+|||+++.+............+++.|+|||.+... .++.++|||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 99986 57999999999986654333333456789999999966322 23456799999
Q ss_pred HHHHHHHHhCCCCC
Q 043185 698 GMVLLELVSGRRNC 711 (724)
Q Consensus 698 Gv~l~elltG~~p~ 711 (724)
||+||||+++..|+
T Consensus 366 GviL~el~~~~~~~ 379 (566)
T PLN03225 366 GLIFLQMAFPNLRS 379 (566)
T ss_pred HHHHHHHHhCcCCC
Confidence 99999999976554
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=210.04 Aligned_cols=186 Identities=24% Similarity=0.456 Sum_probs=158.1
Q ss_pred ccccccccccEEEEEEE-ECCccEEEEEEeecCCcccHHHHHHHHHHHhcCC-CCCccceeceeecCC--eEEEEEEecC
Q 043185 514 FKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIH-HVNLVKLKGFCAQGR--QRLLVYEYMN 589 (724)
Q Consensus 514 ~~~~lG~G~fG~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~--~~~lV~e~~~ 589 (724)
+.+++|+|-+++||.|. ..+.+.++||.+++. ..+.+.+|+.+|+.|. ||||++++++..+.. .+.||+||++
T Consensus 42 ivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~ 118 (338)
T KOG0668|consen 42 IVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVN 118 (338)
T ss_pred HHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhc
Confidence 34689999999999999 467778999999853 4577899999999997 999999999987654 5679999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCC-CcEEEEeecCccccCCCCccce
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYH-FQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFGla~~~~~~~~~~~ 668 (724)
+.+...+. +.++.......+.+++.||.|+|+ .||.|||+||.|++||.. -.++|+|+|+|.++.+... .
T Consensus 119 n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e--Y 189 (338)
T KOG0668|consen 119 NTDFKQLY----PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--Y 189 (338)
T ss_pred cccHHHHh----hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcCCCce--e
Confidence 98876554 356667778899999999999998 999999999999999865 4699999999998876654 2
Q ss_pred ecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNC 711 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~ 711 (724)
...+.++.|.-||.+.+- .|+..-|+|||||+|.+|+..+.||
T Consensus 190 nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepF 233 (338)
T KOG0668|consen 190 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 233 (338)
T ss_pred eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcc
Confidence 334577888999999764 5788999999999999999999888
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.4e-26 Score=228.04 Aligned_cols=205 Identities=26% Similarity=0.352 Sum_probs=169.4
Q ss_pred ChHHHHHhhccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCC-C-C----Cccceecee
Q 043185 503 DYEELEVATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIH-H-V----NLVKLKGFC 575 (724)
Q Consensus 503 ~~~~l~~a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H-~----nIv~l~g~~ 575 (724)
...+....++.+.+++|+|.||.|-++... .+..||||+++.. ..-.+..+-|+++++++. + | -+|.+.+++
T Consensus 82 ~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF 160 (415)
T KOG0671|consen 82 QVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF 160 (415)
T ss_pred EeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence 334445566667789999999999999854 4688999999875 233455677999999993 2 2 377788889
Q ss_pred ecCCeEEEEEEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC---------
Q 043185 576 AQGRQRLLVYEYMNHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY--------- 645 (724)
Q Consensus 576 ~~~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~--------- 645 (724)
.-.++.+||+|.+ |-++.+++.++ -.+++......|+.|++++++|||+ .+++|-||||+|||+..
T Consensus 161 dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~ 236 (415)
T KOG0671|consen 161 DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNP 236 (415)
T ss_pred hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEecc
Confidence 9999999999988 55899999875 4567888999999999999999996 99999999999999942
Q ss_pred -----------CCcEEEEeecCccccCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 646 -----------HFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 646 -----------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
...+||+|||.|+.-.... ...+.|+.|.|||++.+-.++.+.||||+||||.|+.+|..-|+.-
T Consensus 237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 237 KKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred CCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 3358999999998665443 4567899999999999999999999999999999999999988665
Q ss_pred CC
Q 043185 715 SQ 716 (724)
Q Consensus 715 ~~ 716 (724)
+.
T Consensus 313 en 314 (415)
T KOG0671|consen 313 EN 314 (415)
T ss_pred Cc
Confidence 53
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-25 Score=246.33 Aligned_cols=192 Identities=31% Similarity=0.443 Sum_probs=158.6
Q ss_pred cccccccccEE-EEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEEEEEecCCCC
Q 043185 515 KNLIGSGGFGA-VYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYEYMNHGS 592 (724)
Q Consensus 515 ~~~lG~G~fG~-Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~e~~~~gs 592 (724)
.+++|.|+.|+ ||+|.+.+ +.||||++-. +......+|+..|+.- +||||||+++.-.+....||..|.|.. +
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye~-R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-s 588 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYEG-REVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-S 588 (903)
T ss_pred HHHcccCCCCcEEEEEeeCC-ceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-h
Confidence 36899998875 89999965 5799999853 2234567899999888 699999999999999999999999965 9
Q ss_pred HHHHHhcCCCC---CCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC---C--CcEEEEeecCccccCCCC
Q 043185 593 LDRILFGNGPV---LEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY---H--FQAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 593 L~~~l~~~~~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~--~~~kl~DFGla~~~~~~~ 664 (724)
|++++...... ......+.+..|++.||++||+ .+||||||||.||||+. + ..++|+|||+++.+..+.
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 99999774111 1113446788999999999997 99999999999999976 3 468999999999887654
Q ss_pred c--cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhC-CCCCCCC
Q 043185 665 S--SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSG-RRNCSPR 714 (724)
Q Consensus 665 ~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG-~~p~~~~ 714 (724)
. .......||-+|+|||++....-+.++|||||||++|..++| +.||...
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~ 718 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS 718 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch
Confidence 4 234566799999999999998888899999999999999996 9999543
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-24 Score=191.11 Aligned_cols=108 Identities=31% Similarity=0.508 Sum_probs=95.9
Q ss_pred CCCeEEeCCCeEEEEEEecCCCC-ceEEEEEEeccCCeEEEecCCCCCCCCCceEEEccCc-cEEEcCCCCeEEecCCCC
Q 043185 41 GGSFLTSHNGTFKAAIVNTRSQQ-NSFYLCIIHVLSNTIIWSANRDTPISGSGKMNLTPKG-IIISDENGNLKWSTPPLK 118 (724)
Q Consensus 41 ~~~~lvS~~g~F~lGF~~~~~~~-~~~~i~~~~~~~~tvVW~Anr~~pv~~~~~l~~~~~g-~~l~~~~g~~vWst~~~~ 118 (724)
.+++|+|++|.|++|||++.... .+..||+.+.+ .++||.||++.|....+.|.|+.+| ++|.|.+|.++|+|++.+
T Consensus 6 ~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~~~~ 84 (116)
T cd00028 6 SGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNTTR 84 (116)
T ss_pred CCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCC-CeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEecccC
Confidence 47899999999999999988665 77788887766 8999999999996656899999998 588899999999999875
Q ss_pred -CceeEEEEecCCcEEEecCCCccceecccCC
Q 043185 119 -SSVSALRLTEMGNLVLLDGFNGSLWESFHHP 149 (724)
Q Consensus 119 -~~~~~~~L~dsGNlVl~~~~~~~lWQSFd~P 149 (724)
....+|+|+|+|||||++..+.++|||||||
T Consensus 85 ~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~P 116 (116)
T cd00028 85 VNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116 (116)
T ss_pred CCCceEEEEeCCCCEEEECCCCCEEEcCCCCC
Confidence 5667899999999999999999999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-24 Score=212.56 Aligned_cols=191 Identities=28% Similarity=0.374 Sum_probs=157.0
Q ss_pred ccccccccEEEEEEEE-CCccEEEEEEeec--CCcccHHHHHHHHHHHhcCCCCCccceeceeecCC------eEEEEEE
Q 043185 516 NLIGSGGFGAVYKGIL-NDKTIVAVKKITN--VGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR------QRLLVYE 586 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~~lV~e 586 (724)
+.+|.|+- .|--+-. -.+++||+|++.. ......++..+|..++..++|+||++++.++.... ..|+|||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 45677766 4443332 2467899998854 23455677889999999999999999999986543 6689999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
+|.. +|...+.- .++-+....|..|+..|++|||+ .+|+||||||+||++..+..+||.|||+|+.-... -
T Consensus 102 ~m~~-nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--~ 172 (369)
T KOG0665|consen 102 LMDA-NLCQVILM---ELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--F 172 (369)
T ss_pred hhhh-HHHHHHHH---hcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhcccCcc--c
Confidence 9965 77777652 35667788899999999999997 99999999999999999999999999999865544 2
Q ss_pred ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.++..+.|+.|.|||++.+..+.+.+||||+||++.||++|+.-|.+...
T Consensus 173 ~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~ 222 (369)
T KOG0665|consen 173 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDH 222 (369)
T ss_pred ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchH
Confidence 35677889999999999998899999999999999999999999876654
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-24 Score=225.96 Aligned_cols=211 Identities=24% Similarity=0.270 Sum_probs=176.6
Q ss_pred CCChHHHHHhhccccccccccccEEEEEEEE-CCccEEEEEEeecCCcccHHHHHHHHHHHhcCC------CCCccceec
Q 043185 501 RFDYEELEVATDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIH------HVNLVKLKG 573 (724)
Q Consensus 501 ~~~~~~l~~a~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~------H~nIv~l~g 573 (724)
++.+.|+.-..|.+.-..|+|-|++|..|.. ..++.||||++.+. ....+.=+.|+++|.+|+ .-|+++++-
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 3455677777777777899999999999995 35678999999864 233345578999999995 448999999
Q ss_pred eeecCCeEEEEEEecCCCCHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCC-CcEE
Q 043185 574 FCAQGRQRLLVYEYMNHGSLDRILFGN--GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYH-FQAK 650 (724)
Q Consensus 574 ~~~~~~~~~lV~e~~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~k 650 (724)
.|...++++||+|-+. .+|.++|+.. ...+....+..++.|+..||..|.. .+|+|.||||.|||+++. ..+|
T Consensus 502 ~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~iLK 577 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKNILK 577 (752)
T ss_pred HhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcceee
Confidence 9999999999999875 4899999764 3457778888999999999999996 999999999999999875 4589
Q ss_pred EEeecCccccCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCCCC
Q 043185 651 ISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHS 719 (724)
Q Consensus 651 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~~ 719 (724)
|||||.|......+. +.+.-+..|.|||++.+.+|+...|+||.||+||||.||+.-|.++.-.+.
T Consensus 578 LCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~M 643 (752)
T KOG0670|consen 578 LCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQM 643 (752)
T ss_pred eccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHH
Confidence 999999987655432 344567889999999999999999999999999999999999998875544
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-24 Score=206.60 Aligned_cols=193 Identities=20% Similarity=0.359 Sum_probs=156.1
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceece-eecCCeEEEEEEec
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNI-HHVNLVKLKGF-CAQGRQRLLVYEYM 588 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~-~~~~~~~~lV~e~~ 588 (724)
+++.+.||+|.||.+-++.++ .++.+++|-+.+. ....++|.+|..---.| .|.||+.-+.. |+..+..++++||+
T Consensus 26 y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~a 104 (378)
T KOG1345|consen 26 YTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFA 104 (378)
T ss_pred hhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccC
Confidence 556789999999999999986 5667888887654 45678999998776566 69999987764 66677888999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEe--CCCcEEEEeecCccccCCCCcc
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLH--YHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~--~~~~~kl~DFGla~~~~~~~~~ 666 (724)
+.|+|..-+... .+.+....+++.|++.|+.|+|+ +.+||||||.+||||- +..++||||||+.+..+.--
T Consensus 105 P~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV-- 177 (378)
T KOG1345|consen 105 PRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV-- 177 (378)
T ss_pred ccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCcee--
Confidence 999998887543 56777888999999999999997 9999999999999993 34589999999987554321
Q ss_pred ceecccccccccccccccCC-----cCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNS-----AISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~-----~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
....-+..|-+||..... ...+.+|+|.|||+++.+++|+.||+..
T Consensus 178 --~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka 228 (378)
T KOG1345|consen 178 --KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA 228 (378)
T ss_pred --hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh
Confidence 222345678899987533 3467899999999999999999999843
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-22 Score=200.01 Aligned_cols=183 Identities=43% Similarity=0.636 Sum_probs=159.4
Q ss_pred ccccccEEEEEEEECC-ccEEEEEEeecCCcc-cHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCCHHH
Q 043185 518 IGSGGFGAVYKGILND-KTIVAVKKITNVGVQ-GKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDR 595 (724)
Q Consensus 518 lG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gsL~~ 595 (724)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++|+++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999864 788999999764322 35779999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC-CCcEEEEeecCccccCCCCccceeccccc
Q 043185 596 ILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY-HFQAKISDFGLSKLLTPEQSSLFTTMRGT 674 (724)
Q Consensus 596 ~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~gt 674 (724)
++......+++..+..++.+++.++.+||+ .+++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 987654568899999999999999999997 89999999999999999 89999999999986654321 12334578
Q ss_pred ccccccccccCC-cCCCccchhhHHHHHHHH
Q 043185 675 RGYLAPEWLTNS-AISEKTDVYSFGMVLLEL 704 (724)
Q Consensus 675 ~~y~aPE~l~~~-~~~~~sDv~SlGv~l~el 704 (724)
..|++||.+... .++.++|+|+||+++++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 899999999887 888999999999999887
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.7e-23 Score=183.68 Aligned_cols=107 Identities=30% Similarity=0.489 Sum_probs=95.7
Q ss_pred CCCeEEeCCCeEEEEEEecCCCCceEEEEEEeccCCeEEEecCCCCCCCCCceEEEccCcc-EEEcCCCCeEEecCCC-C
Q 043185 41 GGSFLTSHNGTFKAAIVNTRSQQNSFYLCIIHVLSNTIIWSANRDTPISGSGKMNLTPKGI-IISDENGNLKWSTPPL-K 118 (724)
Q Consensus 41 ~~~~lvS~~g~F~lGF~~~~~~~~~~~i~~~~~~~~tvVW~Anr~~pv~~~~~l~~~~~g~-~l~~~~g~~vWst~~~-~ 118 (724)
.+++|+|++|.|++|||.+.....+..||+...+ .++||+|||+.|+.++..|.++.+|+ +|.|.+|.++|+|++. +
T Consensus 6 ~~~~l~s~~~~f~~G~~~~~~q~dgnlV~~~~~~-~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~t~~~ 84 (114)
T smart00108 6 SGQTLVSGNSLFELGFFTLIMQNDYNLILYKSSS-RTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSSNTTGA 84 (114)
T ss_pred CCCEEecCCCcEeeeccccCCCCCEEEEEEECCC-CcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEecccCC
Confidence 4789999999999999998866677888887766 89999999999998778999999995 7889999999999986 5
Q ss_pred CceeEEEEecCCcEEEecCCCccceecccC
Q 043185 119 SSVSALRLTEMGNLVLLDGFNGSLWESFHH 148 (724)
Q Consensus 119 ~~~~~~~L~dsGNlVl~~~~~~~lWQSFd~ 148 (724)
....+|+|+|+|||||+++.+.++||||||
T Consensus 85 ~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~ 114 (114)
T smart00108 85 NGNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114 (114)
T ss_pred CCceEEEEeCCCCEEEECCCCCEEeCCCCC
Confidence 566789999999999999999999999997
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.2e-23 Score=213.15 Aligned_cols=131 Identities=27% Similarity=0.367 Sum_probs=109.8
Q ss_pred hhccccccccccccEEEEEEEE-CCccEEEEEEeecCCcccHHHHHHHHHHHhcCC-----C---CCccceeceeec---
Q 043185 510 ATDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIH-----H---VNLVKLKGFCAQ--- 577 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~nIv~l~g~~~~--- 577 (724)
.+|...++||-|.|++||++.. .+.+.||+|+.+.+ ..-.+..+.|+++|++++ | ..||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 6777789999999999999995 46788999999865 344466789999999883 3 379999999864
Q ss_pred -CCeEEEEEEecCCCCHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEe
Q 043185 578 -GRQRLLVYEYMNHGSLDRILFG-NGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLH 644 (724)
Q Consensus 578 -~~~~~lV~e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~ 644 (724)
+.+.+||+|++ |.+|..+|.. ..+.+....+.+|++||+.||.|||. +.+|||-||||+|||+.
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLLC 222 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeeee
Confidence 45899999999 4466666654 45678899999999999999999998 68999999999999993
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-22 Score=211.73 Aligned_cols=163 Identities=20% Similarity=0.167 Sum_probs=125.7
Q ss_pred hhccccccccccccEEEEEEEEC--CccEEEEEEeecC-----CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN--DKTIVAVKKITNV-----GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRL 582 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~--~~~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 582 (724)
..|.+.+.||+|+||+||+|... +++.+|||++... .....+.|.+|+++|++++|+|++..+.. ....+
T Consensus 18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~ 94 (365)
T PRK09188 18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDG 94 (365)
T ss_pred CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcE
Confidence 44666789999999999999874 5677899987532 11234568999999999999999964332 24579
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCC-CCCCeEEeCCCcEEEEeecCccccC
Q 043185 583 LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDI-KPENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 583 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dl-kp~NILl~~~~~~kl~DFGla~~~~ 661 (724)
|||||+++++|... ... . ...++.+++++|+|||+ .+|+|||| ||+|||++.++.+||+|||+++.+.
T Consensus 95 LVmE~~~G~~L~~~-~~~----~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 95 LVRGWTEGVPLHLA-RPH----G---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred EEEEccCCCCHHHh-Ccc----c---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 99999999999632 111 1 14578899999999997 99999999 9999999999999999999999775
Q ss_pred CCCc-------cceecccccccccccccccCC
Q 043185 662 PEQS-------SLFTTMRGTRGYLAPEWLTNS 686 (724)
Q Consensus 662 ~~~~-------~~~~~~~gt~~y~aPE~l~~~ 686 (724)
.... .......+++.|+|||.+...
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 4321 111345688899999998643
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-22 Score=206.52 Aligned_cols=190 Identities=29% Similarity=0.401 Sum_probs=158.5
Q ss_pred ccccccccccEEEEEEEEC----CccEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEEEEEec
Q 043185 514 FKNLIGSGGFGAVYKGILN----DKTIVAVKKITNVGVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 514 ~~~~lG~G~fG~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
..++||+|.|++||++... ..+.||+|.+... ....+..+|+++|..+ -|.||+++.+++..++...+|+||+
T Consensus 40 ~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~ 117 (418)
T KOG1167|consen 40 VVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYF 117 (418)
T ss_pred hhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEeccc
Confidence 3578999999999999953 4578999999764 3446789999999999 5999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC-CCcEEEEeecCccccCCCC---
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY-HFQAKISDFGLSKLLTPEQ--- 664 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFGla~~~~~~~--- 664 (724)
+.....+++.+ ++...+..++..+..||+++|. ++||||||||+|+|.+. .+.-.|+|||+|.......
T Consensus 118 ~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~ 190 (418)
T KOG1167|consen 118 EHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTE 190 (418)
T ss_pred CccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHHhhhhhh
Confidence 99999888854 5578888899999999999996 99999999999999976 4678999999997221000
Q ss_pred ----------------------------------------ccceecccccccccccccccCC-cCCCccchhhHHHHHHH
Q 043185 665 ----------------------------------------SSLFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLE 703 (724)
Q Consensus 665 ----------------------------------------~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~e 703 (724)
........||++|.|||++... ..++++||||-|||++-
T Consensus 191 ~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Ls 270 (418)
T KOG1167|consen 191 HSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLS 270 (418)
T ss_pred hhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeeh
Confidence 0001124599999999999765 56889999999999999
Q ss_pred HHhCCCCCC
Q 043185 704 LVSGRRNCS 712 (724)
Q Consensus 704 lltG~~p~~ 712 (724)
+++++.||-
T Consensus 271 lls~~~PFf 279 (418)
T KOG1167|consen 271 LLSRRYPFF 279 (418)
T ss_pred hhccccccc
Confidence 999999983
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.3e-23 Score=218.95 Aligned_cols=192 Identities=29% Similarity=0.377 Sum_probs=166.8
Q ss_pred cccccccccEEEEEEEE-CCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCCH
Q 043185 515 KNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSL 593 (724)
Q Consensus 515 ~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gsL 593 (724)
.+.+|.|.||.|||++. ..++..|+|.++-.......-..+|+-+++..+|||||.++|.+......++.|||+.+|+|
T Consensus 20 lqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggsl 99 (829)
T KOG0576|consen 20 LQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSL 99 (829)
T ss_pred eeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcc
Confidence 36799999999999995 46788999999866566667778899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceecccc
Q 043185 594 DRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRG 673 (724)
Q Consensus 594 ~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~g 673 (724)
++.-+..+ .+++.+.....++..+||.|||+ .+-+|||||-.|||+++.|.+|++|||.+..+..-- .....+.|
T Consensus 100 Qdiy~~Tg-plselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati-~KrksfiG 174 (829)
T KOG0576|consen 100 QDIYHVTG-PLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-AKRKSFIG 174 (829)
T ss_pred cceeeecc-cchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhh-hhhhcccC
Confidence 98876554 58888888899999999999997 888999999999999999999999999987665432 22345789
Q ss_pred cccccccccc---cCCcCCCccchhhHHHHHHHHHhCCCCC
Q 043185 674 TRGYLAPEWL---TNSAISEKTDVYSFGMVLLELVSGRRNC 711 (724)
Q Consensus 674 t~~y~aPE~l---~~~~~~~~sDv~SlGv~l~elltG~~p~ 711 (724)
|+.|||||+. +...|..+.|+|++|+...|+---++|.
T Consensus 175 tpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl 215 (829)
T KOG0576|consen 175 TPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL 215 (829)
T ss_pred CccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence 9999999987 4557899999999999999998877775
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.3e-20 Score=196.54 Aligned_cols=202 Identities=24% Similarity=0.261 Sum_probs=164.1
Q ss_pred hccccccccccccEEEEEEEECCc--cEEEEEEeecCCcccHHHHHHHHHHHhcCCC----CCccceecee-ecCCeEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILNDK--TIVAVKKITNVGVQGKKDFCTEIAIIGNIHH----VNLVKLKGFC-AQGRQRLL 583 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~~~--~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H----~nIv~l~g~~-~~~~~~~l 583 (724)
.+.+.+.||+|+||.||++..... ..+|+|............+..|+.++..+.+ +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 466678999999999999997553 4677777765433322367888888888863 5888899888 57778999
Q ss_pred EEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCC-----CcEEEEeecCc
Q 043185 584 VYEYMNHGSLDRILFGNG-PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYH-----FQAKISDFGLS 657 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-----~~~kl~DFGla 657 (724)
||+.+ +.+|.++..... ..++....++|+.|++.+|++||+ .+++||||||.|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99976 779999885543 679999999999999999999996 999999999999999765 46999999999
Q ss_pred c--ccCCCC------ccc-eecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 658 K--LLTPEQ------SSL-FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 658 ~--~~~~~~------~~~-~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
+ .+.... .+. ....+||.+|.+++...+.+.+.+.|+||++.++.|++.|..||.....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 8 321111 111 2346699999999999999999999999999999999999999966554
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.3e-21 Score=229.55 Aligned_cols=148 Identities=19% Similarity=0.162 Sum_probs=114.6
Q ss_pred cCCC-CCccceecee-------ecCCeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEe
Q 043185 562 NIHH-VNLVKLKGFC-------AQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIH 633 (724)
Q Consensus 562 ~l~H-~nIv~l~g~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH 633 (724)
.++| +||+++++.+ .+....++++||+ +++|.++|......+++.+++.++.||++||.|||+ ++|+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHS---QGIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHh---CCeee
Confidence 3455 5888888877 2334567888987 559999997666678999999999999999999997 99999
Q ss_pred cCCCCCCeEEeCC-------------------CcEEEEeecCccccCCCCc---------------cceecccccccccc
Q 043185 634 CDIKPENILLHYH-------------------FQAKISDFGLSKLLTPEQS---------------SLFTTMRGTRGYLA 679 (724)
Q Consensus 634 ~Dlkp~NILl~~~-------------------~~~kl~DFGla~~~~~~~~---------------~~~~~~~gt~~y~a 679 (724)
|||||+||||+.. +.+||+|||+++....... .......||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 9999999999654 4455666666553211000 00012357888999
Q ss_pred cccccCCcCCCccchhhHHHHHHHHHhCCCCCCC
Q 043185 680 PEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSP 713 (724)
Q Consensus 680 PE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~ 713 (724)
||++.+..++.++|||||||+||||++|.+|+..
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 9999999999999999999999999999988754
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.9e-20 Score=184.38 Aligned_cols=200 Identities=21% Similarity=0.291 Sum_probs=171.3
Q ss_pred hccccccccccccEEEEEEE-ECCccEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEEEEEec
Q 043185 511 TDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
.+.+.++||+|+||.++.|+ +-+++.||||.-.. ..+..++..|.+..+.| ..++|...+-+..++.+-.||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 35567899999999999999 45788899997654 23446777888888777 5889999999889999999999988
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCC-----CcEEEEeecCccccCCC
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYH-----FQAKISDFGLSKLLTPE 663 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-----~~~kl~DFGla~~~~~~ 663 (724)
|-+|+++..-.+..++.+....+|.|++.-++|+|+ +.+|.|||||+|+||..- ..+.|+|||+|+.+...
T Consensus 107 -GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred -CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 669999998888899999999999999999999997 999999999999999643 35899999999988654
Q ss_pred Cc------cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 664 QS------SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 664 ~~------~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.. +......||.+||+--...+.+.+.+.|+=|||-+++..|.|..||++...
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 32 222345699999999999999999999999999999999999999987653
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.3e-20 Score=177.36 Aligned_cols=204 Identities=22% Similarity=0.291 Sum_probs=169.9
Q ss_pred HHHhhccccccccccccEEEEEEE-ECCccEEEEEEeecCCcccHHHHHHHHHHHhcCC-CCCccceeceeecCCeEEEE
Q 043185 507 LEVATDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIH-HVNLVKLKGFCAQGRQRLLV 584 (724)
Q Consensus 507 l~~a~~~~~~~lG~G~fG~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV 584 (724)
+....+.+.++||.|+||.+|.|. ..++..||||.-+.. ....++..|..+.+.++ -..|..+..+..+..+-.||
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 344556777899999999999999 468899999987653 23356778999999886 56888888899999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCC---CcEEEEeecCccccC
Q 043185 585 YEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYH---FQAKISDFGLSKLLT 661 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DFGla~~~~ 661 (724)
||.+ +-+|++++.-....++..+.+.++-|++.-++|+|. +++|||||||+|.|+.-+ ..+.++|||+|+.+.
T Consensus 90 MdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9988 669999886666678899999999999999999996 999999999999999654 458999999999875
Q ss_pred CCCcc------ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 662 PEQSS------LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 662 ~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
..... ......||.+|.+--...+.+.+.+.|+=|+|.+|....-|..||++...
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 43321 22345699999988888887888999999999999999999999987653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.1e-19 Score=187.32 Aligned_cols=198 Identities=38% Similarity=0.532 Sum_probs=168.7
Q ss_pred cccccccccccEEEEEEEECCccEEEEEEeecCCcc---cHHHHHHHHHHHhcCCCC-CccceeceeecCCeEEEEEEec
Q 043185 513 NFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQ---GKKDFCTEIAIIGNIHHV-NLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~H~-nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
...+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +|+++.+.+......+++++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 3 RILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred eeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 34578999999999999987 67899988754332 367899999999999988 7999999997777789999999
Q ss_pred CCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCC-cEEEEeecCccccCCCCc
Q 043185 589 NHGSLDRILFGNG--PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHF-QAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 589 ~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFGla~~~~~~~~ 665 (724)
.++++.+++.... ..+.......+..|++.++.|+|+ .+++|||+||+||+++..+ .++++|||+++.+.....
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 9999997776554 268888999999999999999997 8899999999999999988 799999999986554332
Q ss_pred c-----ceecccccccccccccccC---CcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 666 S-----LFTTMRGTRGYLAPEWLTN---SAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 666 ~-----~~~~~~gt~~y~aPE~l~~---~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
. ......|+..|++||.+.+ ..+....|+||+|++++++++|..||....
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 2356679999999999988 578899999999999999999999976654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.9e-19 Score=175.86 Aligned_cols=138 Identities=15% Similarity=0.150 Sum_probs=108.2
Q ss_pred ccccccccEEEEEEEECCccEEEEEEeecCCcc--c-------HHH-----------------HHHHHHHHhcCCCCCcc
Q 043185 516 NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQ--G-------KKD-----------------FCTEIAIIGNIHHVNLV 569 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~H~nIv 569 (724)
+.||+|+||.||+|...+++.||||+++..... . ... ...|++++.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 679999999999999888899999999753211 1 112 23499999999888775
Q ss_pred ceeceeecCCeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCeEecCCCCCCeEEeCCCc
Q 043185 570 KLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYL-HSGCEQKIIHCDIKPENILLHYHFQ 648 (724)
Q Consensus 570 ~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~iiH~Dlkp~NILl~~~~~ 648 (724)
....+... ..+|||||++++++....... ..++......++.|++.+|.|| |+ .+|+||||||+|||++ ++.
T Consensus 83 ~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 83 CPEPILLK--SHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCcEEEec--CCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-CCc
Confidence 54433222 238999999998776543332 4678889999999999999999 55 8999999999999998 578
Q ss_pred EEEEeecCcccc
Q 043185 649 AKISDFGLSKLL 660 (724)
Q Consensus 649 ~kl~DFGla~~~ 660 (724)
++|+|||++...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.8e-19 Score=178.02 Aligned_cols=173 Identities=12% Similarity=0.088 Sum_probs=131.1
Q ss_pred HHHHhhccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHH---------HHHHHHHHhcCCCCCccceeceee
Q 043185 506 ELEVATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKD---------FCTEIAIIGNIHHVNLVKLKGFCA 576 (724)
Q Consensus 506 ~l~~a~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~---------~~~E~~~l~~l~H~nIv~l~g~~~ 576 (724)
++....+...++||.|+||.||+... ++..+|+|.+.+......+. +.+|+..+.+++|++|..+..++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 34445566678999999999999666 45579999997543222222 678999999999999999998865
Q ss_pred cC--------CeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCc
Q 043185 577 QG--------RQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQ 648 (724)
Q Consensus 577 ~~--------~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 648 (724)
.. ...+|||||++|.+|.++.. ++. ....+++.++..+|. .+++|||+||+||++++++
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-
Confidence 33 35789999999999987742 222 245589999999996 9999999999999999998
Q ss_pred EEEEeecCccccCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHH
Q 043185 649 AKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELV 705 (724)
Q Consensus 649 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ell 705 (724)
++|+|||..+....+... ..+.....+..++|+|+||+.+..+.
T Consensus 173 i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999988655322111 01334445678999999999987654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.8e-18 Score=168.11 Aligned_cols=141 Identities=18% Similarity=0.158 Sum_probs=111.2
Q ss_pred ccccccccEEEEEEEECCccEEEEEEeecCCcc---------------------c-----HHHHHHHHHHHhcCCCCCcc
Q 043185 516 NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQ---------------------G-----KKDFCTEIAIIGNIHHVNLV 569 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~H~nIv 569 (724)
..||+|++|.||+|+..+++.||||+++..... . ...+..|.+.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 579999999999999878899999998753211 0 11235789999999999886
Q ss_pred ceeceeecCCeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcE
Q 043185 570 KLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQA 649 (724)
Q Consensus 570 ~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 649 (724)
....+... ..+|||||++++++....... ..++.....+++.|++.++.+||+ ..+|+||||||+|||++ ++.+
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKD-VPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhhhh-ccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-CCCE
Confidence 65554433 248999999988654332222 346778889999999999999995 48999999999999999 8899
Q ss_pred EEEeecCccccCC
Q 043185 650 KISDFGLSKLLTP 662 (724)
Q Consensus 650 kl~DFGla~~~~~ 662 (724)
+|+|||++.....
T Consensus 157 ~liDFG~a~~~~~ 169 (190)
T cd05145 157 YIIDVSQAVELDH 169 (190)
T ss_pred EEEEcccceecCC
Confidence 9999999986643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=8.7e-19 Score=169.60 Aligned_cols=108 Identities=33% Similarity=0.404 Sum_probs=95.7
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
|+|.+++...+..+++..+..|+.|++.||.|||+ .+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc------
Confidence 68999998766779999999999999999999997 33 999999999999999 99988654322
Q ss_pred ccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
..|++.|||||++.+..+++++||||||+++|||++|+.||....
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~ 108 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEER 108 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence 258899999999999999999999999999999999999996543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-18 Score=153.92 Aligned_cols=107 Identities=25% Similarity=0.395 Sum_probs=78.6
Q ss_pred eeecCCcccccccceeEeeEEecccceEEecCCCceEEEEeec-CCCceEEEEEcCCCcEEEEEEeCCCcce--eeeccC
Q 043185 198 WKLSMDTKAYVDSRYIVDYMAINRTGVYLFGNNGSAVVIRVVL-PPSNFRIAKLDASGQFTVLRLSGSDLEQ--EYMGPD 274 (724)
Q Consensus 198 w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~G~l~~~~~~~~~~~~--~~~~p~ 274 (724)
|++++|++..+++.+.+ .......+.|..+..+.++++.. ..+.++|++||.+|++++|.|.+....| .|.+|.
T Consensus 1 wrsG~WnG~~f~g~p~~---~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~ 77 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEM---SSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPK 77 (110)
T ss_pred CCccccCCeEECCcccc---cccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecc
Confidence 56677776655543322 12233445555666665555554 4567899999999999999998765555 556699
Q ss_pred CCCCCCCCCCCCccccCCCCCCCCCCCCCccccccC
Q 043185 275 DGCQIPFICGRMGMCADDATSGSPSCSCPAGFHLAS 310 (724)
Q Consensus 275 ~~C~~~~~CG~~g~C~~~~~~~~~~C~C~~GF~~~~ 310 (724)
|+||+|+.||+||+|+.+ ..|.|+||+||+|++
T Consensus 78 d~Cd~y~~CG~~g~C~~~---~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 78 DQCDVYGFCGPNGICNSN---NSPKCSCLPGFEPKN 110 (110)
T ss_pred cCCCCccccCCccEeCCC---CCCceECCCCcCCCc
Confidence 999999999999999754 478999999999985
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.7e-18 Score=163.20 Aligned_cols=186 Identities=15% Similarity=0.041 Sum_probs=136.5
Q ss_pred cccccccccEEEEEEEECCccEEEEEEeecCCccc----HHHHHHHHHHHhcCC-CCCccceeceeecCCeEEEEEEecC
Q 043185 515 KNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQG----KKDFCTEIAIIGNIH-HVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 515 ~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~----~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
...|++|+||+||.+.- ++..++.+.+.....-. ...+.+|+++|++++ |+++++++++ ...+++|||++
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 36799999999997766 55667777775443211 125789999999995 5889999886 34689999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCC-CCCCeEEeCCCcEEEEeecCccccCCCCcc--
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDI-KPENILLHYHFQAKISDFGLSKLLTPEQSS-- 666 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dl-kp~NILl~~~~~~kl~DFGla~~~~~~~~~-- 666 (724)
+.+|...+.. ....++.|++.+|.++|+ .+|+|||| ||.|||++.++.++|+|||++.........
T Consensus 82 G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 82 GAAMYQRPPR--------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred CccHHhhhhh--------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 9998654311 113467899999999997 99999999 799999999999999999999855432210
Q ss_pred --cee--------cccccccccccccccCC-cCC-CccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 667 --LFT--------TMRGTRGYLAPEWLTNS-AIS-EKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 667 --~~~--------~~~gt~~y~aPE~l~~~-~~~-~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
... -...++.|++|+...-. ..+ ...+.++-|.-+|.++|++.+.-.+.+
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 000 11246677777654322 223 567999999999999999988754443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.5e-17 Score=161.36 Aligned_cols=134 Identities=17% Similarity=0.249 Sum_probs=104.6
Q ss_pred ccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcC-----CCCCccceeceeecCC---eEE-EEEE
Q 043185 516 NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNI-----HHVNLVKLKGFCAQGR---QRL-LVYE 586 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-----~H~nIv~l~g~~~~~~---~~~-lV~e 586 (724)
+.||+|+||.||. ++.....+||++........+++.+|+.++.++ .||||++++|++.++. ..+ +|+|
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred ceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 6899999999996 443333478888654444567899999999999 5799999999998874 333 7899
Q ss_pred e--cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHH-HHHHcCCCCCeEecCCCCCCeEEeCC----CcEEEEe-ecCcc
Q 043185 587 Y--MNHGSLDRILFGNGPVLEWQERFDIALGTARGL-AYLHSGCEQKIIHCDIKPENILLHYH----FQAKISD-FGLSK 658 (724)
Q Consensus 587 ~--~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~iiH~Dlkp~NILl~~~----~~~kl~D-FGla~ 658 (724)
| +++++|.+++.+. .+++. ..++.+++.++ +|||+ .+|+||||||+|||++.. ..++|+| ||...
T Consensus 86 ~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~~ 158 (210)
T PRK10345 86 FDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNIGEST 158 (210)
T ss_pred CCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECCCCcc
Confidence 9 5689999999654 34444 35567778777 99997 999999999999999743 3799999 55433
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.8e-18 Score=167.04 Aligned_cols=194 Identities=23% Similarity=0.361 Sum_probs=152.9
Q ss_pred ccccccccccccEEEEEEEECCccEEEEEEeec--CCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 512 DNFKNLIGSGGFGAVYKGILNDKTIVAVKKITN--VGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
.++..+|.+...|+.|+|++.+.. +++|++.- ......++|.+|.-.|+...||||+.++|.|.....+.+|..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrwqgnd-ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQGND-IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCcccccccccCcc-hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 345567899999999999998766 55566542 233445789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEE--eecCccccCCCCcc
Q 043185 590 HGSLDRILFGNG-PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKIS--DFGLSKLLTPEQSS 666 (724)
Q Consensus 590 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~--DFGla~~~~~~~~~ 666 (724)
.|+|..+|++.. ...+..++.+++.++|+|++|||+- +.-|.---|.++.|+||++.+.+|+ |--++.
T Consensus 271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsf-------- 341 (448)
T KOG0195|consen 271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF-------- 341 (448)
T ss_pred chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeee--------
Confidence 999999998753 3456778899999999999999982 2334445789999999999988875 321111
Q ss_pred ceecccccccccccccccCCcCC---CccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAIS---EKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~~---~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
......-.+.||+||.+..++-+ ..+|+|||++++||+.|..-||...+
T Consensus 342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadls 393 (448)
T KOG0195|consen 342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLS 393 (448)
T ss_pred eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCC
Confidence 01122346899999999877543 47999999999999999999995544
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.4e-17 Score=191.92 Aligned_cols=197 Identities=20% Similarity=0.219 Sum_probs=156.4
Q ss_pred HHHHHhhccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCC---CCCccceeceeecCCeE
Q 043185 505 EELEVATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIH---HVNLVKLKGFCAQGRQR 581 (724)
Q Consensus 505 ~~l~~a~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~ 581 (724)
-++...++.+.+.||+|+||+||+|...+++.||+|.-+.....+.- -=.+++.+|+ -+.|..+...+.-.+.-
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfY---I~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFY---ICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeee---ehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 34455566677899999999999999988999999998765443221 1112333333 23444444555556677
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC-------CCcEEEEee
Q 043185 582 LLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY-------HFQAKISDF 654 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-------~~~~kl~DF 654 (724)
+||+||.+.|+|.+++. ..+..++.....++.|++..++.||. .+|||+||||+|.||.. ...++|+||
T Consensus 770 ~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEec
Confidence 89999999999999997 44678899999999999999999996 99999999999999943 345999999
Q ss_pred cCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCC
Q 043185 655 GLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGR 708 (724)
Q Consensus 655 Gla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~ 708 (724)
|.+-.+..-.. ..+...++|-.+-.+|+..+.+++.++|.|.|+.+++-||.|+
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 99876643322 3567788999999999999999999999999999999999996
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.1e-18 Score=193.85 Aligned_cols=199 Identities=26% Similarity=0.333 Sum_probs=159.0
Q ss_pred cccccccccEEEEEEEEC-CccEEEEEEeec-C-CcccHH----HHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 515 KNLIGSGGFGAVYKGILN-DKTIVAVKKITN-V-GVQGKK----DFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 515 ~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~-~-~~~~~~----~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
..++|.|++|.|+..... .....+.|.... . .....+ .+..|+.+-..++|+|++..+..+.+.....-+|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 468999999988777643 333333333220 0 111222 255678888889999999999888887777767999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc--
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS-- 665 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~-- 665 (724)
+++ +|..++... ..++..++..++.|+..|+.|||+ .+|.|||+|++|+++..++.+||+|||.+..+.....
T Consensus 403 ~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 403 CPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred ccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 999 999988765 357778888899999999999997 9999999999999999999999999999987755433
Q ss_pred -cceecccccccccccccccCCcCCC-ccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 043185 666 -SLFTTMRGTRGYLAPEWLTNSAISE-KTDVYSFGMVLLELVSGRRNCSPRSQSH 718 (724)
Q Consensus 666 -~~~~~~~gt~~y~aPE~l~~~~~~~-~sDv~SlGv~l~elltG~~p~~~~~~~~ 718 (724)
.......|+..|+|||.+.+.+|.+ ..||||.|+++..|++|+.||......+
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~ 532 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSD 532 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccc
Confidence 3445678999999999999999977 5899999999999999999997766554
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.2e-16 Score=157.61 Aligned_cols=135 Identities=21% Similarity=0.310 Sum_probs=113.5
Q ss_pred ccccccccEEEEEEEECCccEEEEEEeecCCcc--------cHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 516 NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQ--------GKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~--------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
+.||+|++|.||+|.. .+..+++|+....... ...++.+|++++.+++|++|.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5699999999999988 4456888876532211 124577899999999999998888888777888999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCcccc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLL 660 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 660 (724)
+++++|.+++.... . .+..++.+++.+|.+||+ .+++|+|++|.|||++ ++.++|+|||++...
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 99999999986532 1 778899999999999997 8999999999999999 789999999998753
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.8e-18 Score=184.92 Aligned_cols=186 Identities=26% Similarity=0.328 Sum_probs=153.4
Q ss_pred cccccccEEEEEEE----ECCccEEEEEEeecCCcc--cHHHHHHHHHHHhcCC-CCCccceeceeecCCeEEEEEEecC
Q 043185 517 LIGSGGFGAVYKGI----LNDKTIVAVKKITNVGVQ--GKKDFCTEIAIIGNIH-HVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 517 ~lG~G~fG~Vy~~~----~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
.+|+|+||.|+++. .+.+..+|.|.+++.... .......|..++..++ ||.+|++.-.+..+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37899999998765 344566888877653221 1225567888999997 9999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
+|.|...+.+.. ..++.........++-+++++|. .+|+|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEV-MFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---- 152 (612)
T ss_pred cchhhhccccCC-chHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhh----
Confidence 999988776553 34445555566788999999996 9999999999999999999999999999986644322
Q ss_pred cccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSP 713 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~ 713 (724)
.+||..|||||++. .....+|.||||++++||++|..||.+
T Consensus 153 -~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 -ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred -cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 27899999999998 567899999999999999999999987
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.3e-16 Score=157.47 Aligned_cols=141 Identities=20% Similarity=0.194 Sum_probs=108.2
Q ss_pred cccccccccccEEEEEEE--ECCccEEEEEEeecCCcc------------------------cHHHHHHHHHHHhcCCCC
Q 043185 513 NFKNLIGSGGFGAVYKGI--LNDKTIVAVKKITNVGVQ------------------------GKKDFCTEIAIIGNIHHV 566 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~--~~~~~~vAvK~~~~~~~~------------------------~~~~~~~E~~~l~~l~H~ 566 (724)
.+.+.||+|++|.||+|. ..+++.||+|+++..... ....+..|++++.++.+.
T Consensus 31 ~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~ 110 (237)
T smart00090 31 AIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEA 110 (237)
T ss_pred HhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence 356789999999999998 568899999998743210 012356899999999753
Q ss_pred C--ccceeceeecCCeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-eEecCCCCCCeEE
Q 043185 567 N--LVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQK-IIHCDIKPENILL 643 (724)
Q Consensus 567 n--Iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-iiH~Dlkp~NILl 643 (724)
. +.+++.. ...+|||||+++.+|....... ..........++.|++.++.+||. .+ ++||||||+||++
T Consensus 111 ~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~NIli 182 (237)
T smart00090 111 GVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYNILV 182 (237)
T ss_pred CCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhhEEE
Confidence 3 3344432 2348999999998886654333 235556677899999999999997 78 9999999999999
Q ss_pred eCCCcEEEEeecCccccCC
Q 043185 644 HYHFQAKISDFGLSKLLTP 662 (724)
Q Consensus 644 ~~~~~~kl~DFGla~~~~~ 662 (724)
+ ++.++|+|||.+.....
T Consensus 183 ~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 183 H-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred E-CCCEEEEEChhhhccCC
Confidence 9 88999999999875543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.67 E-value=5e-16 Score=153.53 Aligned_cols=131 Identities=18% Similarity=0.282 Sum_probs=107.5
Q ss_pred cccccccEEEEEEEECCccEEEEEEeecCCcc--------cHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 517 LIGSGGFGAVYKGILNDKTIVAVKKITNVGVQ--------GKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 517 ~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~--------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
.||+|+||.||+|... +..+++|+....... ..+++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 4899999999999965 466888886532111 1256778999999999988777666666777789999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCcccc
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLL 660 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 660 (724)
++++|.+++..... .++.+++.+|.+||+ .+++|+|++|.||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999988754311 788999999999997 9999999999999999 889999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=9.8e-16 Score=151.33 Aligned_cols=138 Identities=20% Similarity=0.144 Sum_probs=107.8
Q ss_pred ccccccccccccEEEEEEEECCccEEEEEEeecCCcc----------------------cHHHHHHHHHHHhcCCCCC--
Q 043185 512 DNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQ----------------------GKKDFCTEIAIIGNIHHVN-- 567 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~----------------------~~~~~~~E~~~l~~l~H~n-- 567 (724)
+.+.+.||+|+||.||++...+++.||||++...... ....+..|..++.++.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 4456889999999999999888999999987542100 1123567888999888774
Q ss_pred ccceeceeecCCeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCC
Q 043185 568 LVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHF 647 (724)
Q Consensus 568 Iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 647 (724)
++..++ ....++||||+++++|...... .....++.+++.++.++|+ .+++||||||+||++++++
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEcCCC
Confidence 444443 2345899999999998765421 2345688899999999997 8999999999999999999
Q ss_pred cEEEEeecCccccCCC
Q 043185 648 QAKISDFGLSKLLTPE 663 (724)
Q Consensus 648 ~~kl~DFGla~~~~~~ 663 (724)
.++|+|||++......
T Consensus 163 ~~~liDfg~~~~~~~~ 178 (198)
T cd05144 163 KIYIIDWPQMVSTDHP 178 (198)
T ss_pred cEEEEECCccccCCCc
Confidence 9999999999765543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.6e-16 Score=174.68 Aligned_cols=135 Identities=19% Similarity=0.256 Sum_probs=110.4
Q ss_pred ccccccccccEEEEEEEECCccEEEEEEeecC-Cc------ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEE
Q 043185 514 FKNLIGSGGFGAVYKGILNDKTIVAVKKITNV-GV------QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 514 ~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~-~~------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
..+.||+|+||.||+|.+.+...++.++..+. .. ...+++.+|++++.+++|++++....++......++|||
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E 416 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME 416 (535)
T ss_pred ccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence 35789999999999999876553333333221 11 123568899999999999999998888877778899999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccC
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 661 (724)
|+++++|.+++. ....++.+++++|.|||+ .+++||||||+|||+ .++.++|+|||+++...
T Consensus 417 ~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~~~ 478 (535)
T PRK09605 417 YIGGKDLKDVLE---------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD 478 (535)
T ss_pred ecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence 999999998874 356789999999999996 899999999999999 67899999999998654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.3e-15 Score=155.13 Aligned_cols=196 Identities=23% Similarity=0.289 Sum_probs=130.1
Q ss_pred ccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCC----------CCCccceeceee---
Q 043185 514 FKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIH----------HVNLVKLKGFCA--- 576 (724)
Q Consensus 514 ~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~----------H~nIv~l~g~~~--- 576 (724)
..+.||.|+++.||.++.. +++..|||...... ....+++++|.-.+..+. |-.++..++...
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 3578999999999999986 57889999885322 334567777776665543 223333333321
Q ss_pred ------cC---C-----eEEEEEEecCCCCHHHHHh---cCCC---CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCC
Q 043185 577 ------QG---R-----QRLLVYEYMNHGSLDRILF---GNGP---VLEWQERFDIALGTARGLAYLHSGCEQKIIHCDI 636 (724)
Q Consensus 577 ------~~---~-----~~~lV~e~~~~gsL~~~l~---~~~~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dl 636 (724)
.. . ..+++|+-+ .++|..++. .... .+....++.+..|+++.+++||+ .+++|+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEEST-
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEeccc
Confidence 11 1 235677776 458877753 2211 23445667788999999999997 99999999
Q ss_pred CCCCeEEeCCCcEEEEeecCccccCCCCccceecccccccccccccccC--------CcCCCccchhhHHHHHHHHHhCC
Q 043185 637 KPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTN--------SAISEKTDVYSFGMVLLELVSGR 708 (724)
Q Consensus 637 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~sDv~SlGv~l~elltG~ 708 (724)
+|+|++++.+|.++|+||+.....+... .....+..|.+||.... ..++.+.|.|+||+++|.|++|+
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRY----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEE----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCcee----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 9999999999999999998876554321 11234577999997743 25788999999999999999999
Q ss_pred CCCCCCCCC
Q 043185 709 RNCSPRSQS 717 (724)
Q Consensus 709 ~p~~~~~~~ 717 (724)
-||+.....
T Consensus 248 lPf~~~~~~ 256 (288)
T PF14531_consen 248 LPFGLSSPE 256 (288)
T ss_dssp -STCCCGGG
T ss_pred CCCCCCCcc
Confidence 999866543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=6.1e-16 Score=174.72 Aligned_cols=195 Identities=25% Similarity=0.309 Sum_probs=148.6
Q ss_pred ccccccccccccEEEEEEEECCccEEEEEEeecCC-cccHHHHHHHHHH--HhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 512 DNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVG-VQGKKDFCTEIAI--IGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~--l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
..+.+.||.+.|=+|.+++.+.|. |+||++.+.. .-..+.|.++++- ...++|||.+++.-.-..+...|||-+|.
T Consensus 25 ~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv 103 (1431)
T KOG1240|consen 25 CHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV 103 (1431)
T ss_pred eeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence 345678999999999999998887 8999986543 3344555544433 45558999999988877777888998998
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccC--CCCcc
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT--PEQSS 666 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~--~~~~~ 666 (724)
.+ +|.+-|. .++.+...+..-|+.|++.||.-+|. .+|+|+|||.+||||+.=.=+.|+||..-+... .+...
T Consensus 104 kh-nLyDRlS-TRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 104 KH-NLYDRLS-TRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred hh-hhhhhhc-cchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 66 7777763 34567777888899999999999996 999999999999999988889999997654321 11111
Q ss_pred ce----ecccccccccccccccC----------Cc-CCCccchhhHHHHHHHHHh-CCCCCC
Q 043185 667 LF----TTMRGTRGYLAPEWLTN----------SA-ISEKTDVYSFGMVLLELVS-GRRNCS 712 (724)
Q Consensus 667 ~~----~~~~gt~~y~aPE~l~~----------~~-~~~~sDv~SlGv~l~ellt-G~~p~~ 712 (724)
.+ .+.+.-..|+|||.+.. .. .+++.||||+||++.||++ |+++|.
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 11 12233457999998743 12 5789999999999999999 788884
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.56 E-value=3e-14 Score=133.45 Aligned_cols=133 Identities=24% Similarity=0.193 Sum_probs=112.9
Q ss_pred ccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCC--CCccceeceeecCCeEEEEEEecCCCCH
Q 043185 516 NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHH--VNLVKLKGFCAQGRQRLLVYEYMNHGSL 593 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~~~~lV~e~~~~gsL 593 (724)
+.||+|.++.||++...+ ..+++|....... ..++.+|+.++..++| .++++++++....+..++++||++++.+
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 579999999999999866 5689998865432 5678899999999976 5899999988888889999999998777
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccc
Q 043185 594 DRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKL 659 (724)
Q Consensus 594 ~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 659 (724)
..+ +......++.++++++++||.....+++|+|++|+||+++..+.++++|||.+..
T Consensus 81 ~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 81 DEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 543 4566777899999999999975446899999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.9e-14 Score=140.71 Aligned_cols=138 Identities=20% Similarity=0.194 Sum_probs=97.2
Q ss_pred cccccccccEEEEEEEECCccEEEEEEeecCCcc--cHHHH----------------------HHHHHHHhcCCCCC--c
Q 043185 515 KNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQ--GKKDF----------------------CTEIAIIGNIHHVN--L 568 (724)
Q Consensus 515 ~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~--~~~~~----------------------~~E~~~l~~l~H~n--I 568 (724)
.+.||+|+||.||+|...+++.||||++...... ....+ ..|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 3679999999999999888889999998653211 11111 24555555554332 3
Q ss_pred cceeceeecCCeEEEEEEecCCCCHHHH-HhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCC
Q 043185 569 VKLKGFCAQGRQRLLVYEYMNHGSLDRI-LFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHF 647 (724)
Q Consensus 569 v~l~g~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 647 (724)
.+++++ ...++||||++++.+... +.... .. .....++.+++.++.++|. ..+|+|+||||+||+++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-CC
Confidence 444433 245899999999543211 11110 11 5567889999999999995 38999999999999999 89
Q ss_pred cEEEEeecCccccCC
Q 043185 648 QAKISDFGLSKLLTP 662 (724)
Q Consensus 648 ~~kl~DFGla~~~~~ 662 (724)
.++|+|||.+.....
T Consensus 152 ~~~liDfg~a~~~~~ 166 (187)
T cd05119 152 KVYIIDVPQAVEIDH 166 (187)
T ss_pred cEEEEECcccccccC
Confidence 999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.2e-14 Score=157.20 Aligned_cols=157 Identities=28% Similarity=0.472 Sum_probs=131.3
Q ss_pred HhcCCCCCccceeceeecCCeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCC
Q 043185 560 IGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPE 639 (724)
Q Consensus 560 l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~ 639 (724)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+......+++.....++++|++||+|||+. .-..|+.++++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeeccc
Confidence 4578999999999999999999999999999999999998777899999999999999999999972 33399999999
Q ss_pred CeEEeCCCcEEEEeecCccccCCC-CccceecccccccccccccccCCc-------CCCccchhhHHHHHHHHHhCCCCC
Q 043185 640 NILLHYHFQAKISDFGLSKLLTPE-QSSLFTTMRGTRGYLAPEWLTNSA-------ISEKTDVYSFGMVLLELVSGRRNC 711 (724)
Q Consensus 640 NILl~~~~~~kl~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~-------~~~~sDv~SlGv~l~elltG~~p~ 711 (724)
|.+++....+||+|||+....... .........-...|.|||.++... .+.++|+||||++++||++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998776421 111112223456899999997641 467899999999999999999999
Q ss_pred CCCCCCC
Q 043185 712 SPRSQSH 718 (724)
Q Consensus 712 ~~~~~~~ 718 (724)
+.....+
T Consensus 159 ~~~~~~~ 165 (484)
T KOG1023|consen 159 DLRNLVE 165 (484)
T ss_pred ccccccC
Confidence 7754443
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.52 E-value=9.5e-14 Score=140.68 Aligned_cols=136 Identities=16% Similarity=0.165 Sum_probs=105.0
Q ss_pred cccc-ccccEEEEEEEECCccEEEEEEeecCC-------------cccHHHHHHHHHHHhcCCCCCc--cceeceeecCC
Q 043185 516 NLIG-SGGFGAVYKGILNDKTIVAVKKITNVG-------------VQGKKDFCTEIAIIGNIHHVNL--VKLKGFCAQGR 579 (724)
Q Consensus 516 ~~lG-~G~fG~Vy~~~~~~~~~vAvK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~nI--v~l~g~~~~~~ 579 (724)
..|| .|+.|+||++...+ ..++||++.... ......+.+|++++.+++|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~~-~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPG-VNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeCC-ceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 88999999998864 558999885321 1223567889999999998875 67777644322
Q ss_pred ----eEEEEEEecCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEee
Q 043185 580 ----QRLLVYEYMNH-GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDF 654 (724)
Q Consensus 580 ----~~~lV~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DF 654 (724)
..++|+|++++ .+|.+++... .++.. .+.+++.+|.+||+ .+|+||||||.|||++.++.++|+||
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LIDf 186 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLIDF 186 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEEEC
Confidence 23599999997 6898887543 34433 35689999999996 99999999999999999999999999
Q ss_pred cCccccC
Q 043185 655 GLSKLLT 661 (724)
Q Consensus 655 Gla~~~~ 661 (724)
|.+....
T Consensus 187 g~~~~~~ 193 (239)
T PRK01723 187 DRGELRT 193 (239)
T ss_pred CCcccCC
Confidence 9987643
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.50 E-value=5.3e-15 Score=156.88 Aligned_cols=121 Identities=30% Similarity=0.435 Sum_probs=107.0
Q ss_pred eEEEEEEecCCCCHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCc
Q 043185 580 QRLLVYEYMNHGSLDRILFGN--GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLS 657 (724)
Q Consensus 580 ~~~lV~e~~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 657 (724)
++++.|++++..+|.++|.+. ....++...+.++.|++.+++| ++.+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999643 5567788899999999999999 57899999999999999999999999998
Q ss_pred cccCCCC-----ccceecccccccccccccccCCcCCCccchhhHHHHHHHHHh
Q 043185 658 KLLTPEQ-----SSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS 706 (724)
Q Consensus 658 ~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt 706 (724)
....... ....+...||..||+||.|.+..|+.|+||||||++|+|++.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 8765544 223456679999999999999999999999999999999998
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.4e-14 Score=163.86 Aligned_cols=163 Identities=28% Similarity=0.384 Sum_probs=118.2
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCCHH
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLD 594 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gsL~ 594 (724)
++|..|+||.||..+++ ..++.|+|+-++. .+.+- ++.....|.+| |+-.
T Consensus 89 klisngAygavylvrh~~trqrfa~kiNkq~------lilRn--ilt~a~npfvv---------------------gDc~ 139 (1205)
T KOG0606|consen 89 KLISNGAYGAVYLVRHKETRQRFAMKINKQN------LILRN--ILTFAGNPFVV---------------------GDCA 139 (1205)
T ss_pred EeeccCCCCceeeeeccccccchhhcccccc------hhhhc--cccccCCccee---------------------chhh
Confidence 67999999999999986 4566777433221 11111 22222333333 4444
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc---------
Q 043185 595 RILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS--------- 665 (724)
Q Consensus 595 ~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~--------- 665 (724)
..++.-+. +. .+++.+++|||+ .+|+|||+||+|.+|+.-|++|+.|||+.+...+...
T Consensus 140 tllk~~g~-lP--------vdmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~ 207 (1205)
T KOG0606|consen 140 TLLKNIGP-LP--------VDMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIE 207 (1205)
T ss_pred hhcccCCC-Cc--------chhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchH
Confidence 55544332 22 123778999997 9999999999999999999999999999875422110
Q ss_pred -----cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCCCC
Q 043185 666 -----SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHS 719 (724)
Q Consensus 666 -----~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~~ 719 (724)
-.-...+||+.|+|||++..+.|...+|.|++|+|+||.+-|..||.++.+.+.
T Consensus 208 k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel 266 (1205)
T KOG0606|consen 208 KDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL 266 (1205)
T ss_pred HHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH
Confidence 011245799999999999999999999999999999999999999999865543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1e-13 Score=141.17 Aligned_cols=131 Identities=23% Similarity=0.270 Sum_probs=99.6
Q ss_pred CeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEe--CCC--cEEEEee
Q 043185 579 RQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLH--YHF--QAKISDF 654 (724)
Q Consensus 579 ~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~--~~~--~~kl~DF 654 (724)
..+|+||.-.+. +|..++..+ ..+.....-|+.|+++|+.|||. +++.|||+|++||||. +|+ .+.|+||
T Consensus 316 ~tlylvMkrY~~-tLr~yl~~~--~~s~r~~~~~laQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDF 389 (598)
T KOG4158|consen 316 KTLYLVMKRYRQ-TLREYLWTR--HRSYRTGRVILAQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADF 389 (598)
T ss_pred ceEEEehhcchh-hHHHHHhcC--CCchHHHHHHHHHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEccc
Confidence 467888887654 888888765 46667777789999999999996 9999999999999994 333 4789999
Q ss_pred cCccccCCC-----CccceecccccccccccccccCCc------CCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 655 GLSKLLTPE-----QSSLFTTMRGTRGYLAPEWLTNSA------ISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 655 Gla~~~~~~-----~~~~~~~~~gt~~y~aPE~l~~~~------~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
|++---... .........|...-||||+....+ .-.|+|.|+.|.+.||+++...||..+.
T Consensus 390 GCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG 461 (598)
T KOG4158|consen 390 GCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG 461 (598)
T ss_pred ceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc
Confidence 987533221 111122345777889999885432 1358999999999999999999997743
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.2e-14 Score=161.40 Aligned_cols=204 Identities=26% Similarity=0.320 Sum_probs=162.4
Q ss_pred cccccccccccEEEEEEEEC--CccEEEEEEeecCC--cccHHHHHHHHHHHhcCC-CCCccceeceeecCCeEEEEEEe
Q 043185 513 NFKNLIGSGGFGAVYKGILN--DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIH-HVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~--~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
.+.+.||+|+|+.|-..... ....+|+|.+.... ....+....|..+-..+. |+|++.+++...+.+..++++||
T Consensus 23 ~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~ 102 (601)
T KOG0590|consen 23 KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSY 102 (601)
T ss_pred cccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCc
Confidence 34466999999999887753 34456777765442 222334455777777775 99999999999999999999999
Q ss_pred cCCCCHHHHH-hcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCC-cEEEEeecCccccCC--C
Q 043185 588 MNHGSLDRIL-FGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHF-QAKISDFGLSKLLTP--E 663 (724)
Q Consensus 588 ~~~gsL~~~l-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFGla~~~~~--~ 663 (724)
.+++++...+ .......+......++.|+..++.|+|. ..++.|+|+||+|.+++..+ ..+++|||+|..+.. .
T Consensus 103 s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g 180 (601)
T KOG0590|consen 103 SDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNG 180 (601)
T ss_pred ccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccccccCC
Confidence 9999998888 4433245556667789999999999993 38999999999999999999 999999999998776 2
Q ss_pred Cccceecccc-cccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 043185 664 QSSLFTTMRG-TRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRSQSH 718 (724)
Q Consensus 664 ~~~~~~~~~g-t~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~ 718 (724)
.........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++.....+
T Consensus 181 ~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~ 237 (601)
T KOG0590|consen 181 AERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD 237 (601)
T ss_pred cceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc
Confidence 3334445668 9999999999885 45778999999999999999999997766544
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.2e-12 Score=144.07 Aligned_cols=141 Identities=21% Similarity=0.217 Sum_probs=99.2
Q ss_pred ccccccccEEEEEEEECCccEEEEEEeecCCcccH----------------------------------------HHHHH
Q 043185 516 NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGK----------------------------------------KDFCT 555 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~----------------------------------------~~~~~ 555 (724)
+.||.|++|.||+|++.+|+.||||+.++...... -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 57999999999999999999999999864311100 02445
Q ss_pred HHHHHhcC----C-CCCccceeceeecCCeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHH-HHHHHHcCCCC
Q 043185 556 EIAIIGNI----H-HVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTAR-GLAYLHSGCEQ 629 (724)
Q Consensus 556 E~~~l~~l----~-H~nIv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~-~L~yLH~~~~~ 629 (724)
|++.+.++ + ++++.-..-+.......+|||||++|++|.++........ .+.+++..++. .+..+|. .
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~---~ 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLR---D 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHh---C
Confidence 55555544 2 3333222222223456799999999999988764321122 23456666665 4677885 8
Q ss_pred CeEecCCCCCCeEEeCCCcEEEEeecCccccCC
Q 043185 630 KIIHCDIKPENILLHYHFQAKISDFGLSKLLTP 662 (724)
Q Consensus 630 ~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (724)
+++|+|+||.||+++.++.++++|||++..+..
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999987753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.20 E-value=5.2e-11 Score=114.25 Aligned_cols=130 Identities=18% Similarity=0.072 Sum_probs=94.3
Q ss_pred ccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCcc-ceeceeecCCeEEEEEEecCCCCHH
Q 043185 516 NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLV-KLKGFCAQGRQRLLVYEYMNHGSLD 594 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~lV~e~~~~gsL~ 594 (724)
+.|+.|.++.||+++.. +..+++|....... ....+.+|+.++..+.+.+++ +++.+. ....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 46889999999999976 55699998754321 233567899999988655544 444443 23457999999998875
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeEecCCCCCCeEEeCCCcEEEEeecCccc
Q 043185 595 RILFGNGPVLEWQERFDIALGTARGLAYLHSGC--EQKIIHCDIKPENILLHYHFQAKISDFGLSKL 659 (724)
Q Consensus 595 ~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 659 (724)
.. . .....++.+++++|+.||+.. ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 80 ~~-----~----~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TE-----D----FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc-----c----ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 42 0 111235678999999999721 12369999999999999 67899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.3e-11 Score=96.29 Aligned_cols=60 Identities=22% Similarity=0.426 Sum_probs=48.0
Q ss_pred eeEEEeeccccccccccCCCCCcccCCHHHHHHHcccCCCeeEEEeeC--CCCceE-eecccccc
Q 043185 342 VVSYLRLGYGMDYFANHFFQPSTYDVNLSFCQELCSDDCSCLGIFFKN--SSGSCY-MLGNVLGS 403 (724)
Q Consensus 342 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~y~~--~~~~C~-~~~~l~~~ 403 (724)
.+.|++++++ ++|...... ...++++++|++.||+||||+||+|.+ +++.|+ |.++|+|+
T Consensus 4 ~d~F~~l~~~-~~p~~~~~~-~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 4 GDGFLKLPNM-KLPDFDNAI-VDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVDL 66 (66)
T ss_pred CCEEEEECCe-eCCCCccee-eecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeecC
Confidence 4789999865 777765433 224589999999999999999999986 678999 77888763
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.15 E-value=9.1e-11 Score=130.73 Aligned_cols=141 Identities=17% Similarity=0.178 Sum_probs=89.8
Q ss_pred ccccccccEEEEEEEECC-ccEEEEEEeecCCccc----------------------------------H------HHHH
Q 043185 516 NLIGSGGFGAVYKGILND-KTIVAVKKITNVGVQG----------------------------------K------KDFC 554 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~~~----------------------------------~------~~~~ 554 (724)
+.||.|++|.||+|++.+ |+.||||+.++.-... . -+|.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 479999999999999987 9999999997431100 0 1234
Q ss_pred HHHHHHhcCC----CCCccceeceeec-CCeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHH-HHHHHcCCC
Q 043185 555 TEIAIIGNIH----HVNLVKLKGFCAQ-GRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARG-LAYLHSGCE 628 (724)
Q Consensus 555 ~E~~~l~~l~----H~nIv~l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~-L~yLH~~~~ 628 (724)
+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.++..-.....+.. .++...+.. +.-+. .
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~---~la~~~v~~~~~Qif---~ 278 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMK---LLAERGVEVFFTQVF---R 278 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHH---HHHHHHHHHHHHHHH---h
Confidence 4544444442 3333332233322 456789999999999977532111112211 222222221 22223 3
Q ss_pred CCeEecCCCCCCeEEeCCC----cEEEEeecCccccCC
Q 043185 629 QKIIHCDIKPENILLHYHF----QAKISDFGLSKLLTP 662 (724)
Q Consensus 629 ~~iiH~Dlkp~NILl~~~~----~~kl~DFGla~~~~~ 662 (724)
.+++|+|+||.||+++.++ .++++|||++..+..
T Consensus 279 ~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 279 DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 8999999999999999988 999999999987754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.8e-11 Score=129.58 Aligned_cols=205 Identities=24% Similarity=0.223 Sum_probs=162.3
Q ss_pred HHHHHhhccccccccc--cccEEEEEEEE---CCccEEEEEEeecC--CcccHHHHHHHHHHHhcC-CCCCccceeceee
Q 043185 505 EELEVATDNFKNLIGS--GGFGAVYKGIL---NDKTIVAVKKITNV--GVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCA 576 (724)
Q Consensus 505 ~~l~~a~~~~~~~lG~--G~fG~Vy~~~~---~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~ 576 (724)
.+.......+.+.+|. |.+|.||.+.. .+...+|+|+-+.. ......+-.+|+....++ .|+|.++....+.
T Consensus 109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc
Confidence 3444445566788999 99999999987 35677888884332 223334445677777777 4999999888899
Q ss_pred cCCeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHH----HHHHHHcCCCCCeEecCCCCCCeEEeCC-CcEEE
Q 043185 577 QGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTAR----GLAYLHSGCEQKIIHCDIKPENILLHYH-FQAKI 651 (724)
Q Consensus 577 ~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl 651 (724)
..+..++-+|++. .+|..+.......+.......+..+... |+..+|+ ..++|-|+||.||++..+ ...++
T Consensus 189 ~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~ 264 (524)
T KOG0601|consen 189 GSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKL 264 (524)
T ss_pred cCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCC---Ccccccccchhheecccccceeec
Confidence 9999999999885 6888887766666777888888888888 9999997 999999999999999999 88999
Q ss_pred EeecCccccCCCCcc----ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 652 SDFGLSKLLTPEQSS----LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 652 ~DFGla~~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
.|||+...+...... ......|...|++||.+.+ .++..+|+|++|.+.+|...+......+
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCC
Confidence 999999888665421 1122357889999999876 5688999999999999999998776655
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.11 E-value=9e-10 Score=120.76 Aligned_cols=166 Identities=15% Similarity=0.160 Sum_probs=124.1
Q ss_pred ECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCCHHHHHhcCCCCCCHHHHH
Q 043185 531 LNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERF 610 (724)
Q Consensus 531 ~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~ 610 (724)
..++.+|.|...+...........+-++.|+.++||||++++.....+...|||+|-+. .|..++.+.+ .....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v~ 107 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEVC 107 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHHH
Confidence 34677888888876544333456677889999999999999999999999999999863 5666775543 34455
Q ss_pred HHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceecccccccccccccccCCcCCC
Q 043185 611 DIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISE 690 (724)
Q Consensus 611 ~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ 690 (724)
-.+.||+.||.|||+ +.+++|++|.-..|++++.|+.||++|.++........ ......--..|..|+.+.... -
T Consensus 108 ~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~ 182 (690)
T KOG1243|consen 108 LGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--W 182 (690)
T ss_pred HHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--c
Confidence 577899999999997 78999999999999999999999999998754322111 001111122455565543322 3
Q ss_pred ccchhhHHHHHHHHHhC
Q 043185 691 KTDVYSFGMVLLELVSG 707 (724)
Q Consensus 691 ~sDv~SlGv~l~elltG 707 (724)
..|.|.||++++|++.|
T Consensus 183 s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 183 SIDSWGLGCLIEELFNG 199 (690)
T ss_pred chhhhhHHHHHHHHhCc
Confidence 46999999999999999
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.11 E-value=6.3e-10 Score=103.31 Aligned_cols=142 Identities=18% Similarity=0.236 Sum_probs=108.7
Q ss_pred ccccccccEEEEEEEECCccEEEEEEeecCCc-------ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 516 NLIGSGGFGAVYKGILNDKTIVAVKKITNVGV-------QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~-------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
..|-+|+-+.|+++.+.+...+.-+++.+.-. -..++.++|++++.+++--.|....-++.+...-.|+|||+
T Consensus 13 ~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~ 92 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFI 92 (229)
T ss_pred eeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEec
Confidence 56889999999999998766454445443211 12356789999999998777777777777777778999999
Q ss_pred CC-CCHHHHHhcCCCCCCHHHH-HHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCc---EEEEeecCcccc
Q 043185 589 NH-GSLDRILFGNGPVLEWQER-FDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQ---AKISDFGLSKLL 660 (724)
Q Consensus 589 ~~-gsL~~~l~~~~~~l~~~~~-~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DFGla~~~ 660 (724)
++ .++.+++.........+.. ..++..|-+.+.-||. +.|||+||..+||+|..++. +.++|||++..-
T Consensus 93 ~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 93 DGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred cchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 87 4778888765443333333 6788899999999996 99999999999999977654 589999998644
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.1e-09 Score=102.51 Aligned_cols=132 Identities=23% Similarity=0.258 Sum_probs=102.6
Q ss_pred ccccccccEEEEEEEECCccEEEEE-EeecCCc-c------cHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 516 NLIGSGGFGAVYKGILNDKTIVAVK-KITNVGV-Q------GKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~~vAvK-~~~~~~~-~------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
..+++|+-+.+|.+.+.+.. +++| ++++.-. . ..++..+|++++.+++--.|....-+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999876655 4444 3332111 1 124577899999999877777777777788888999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCcccc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLL 660 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 660 (724)
+++..|.+.+... +..++..+-..+.-||. .+|+|+||.++||++..+. +.++||||+..-
T Consensus 81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA--------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc--------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999999888654 24567778888899996 9999999999999998664 999999999744
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.08 E-value=9.5e-10 Score=110.35 Aligned_cols=141 Identities=21% Similarity=0.269 Sum_probs=108.4
Q ss_pred ccccccccEEEEEEEECCccEEEEEEeecCCc-ccHHHHHHHHHHHhcCCC--CCccceeceeecCC---eEEEEEEecC
Q 043185 516 NLIGSGGFGAVYKGILNDKTIVAVKKITNVGV-QGKKDFCTEIAIIGNIHH--VNLVKLKGFCAQGR---QRLLVYEYMN 589 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~---~~~lV~e~~~ 589 (724)
+.|+.|..+.||++...++..+++|....... ....++..|+++++.+++ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999987767799998764322 234678899999999965 45677787776543 5689999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcC-------------------------------------------
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSG------------------------------------------- 626 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------------------- 626 (724)
+.++...+.. ..++...+..++.+++++|..||+.
T Consensus 84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 9888665431 2466677778888888888888852
Q ss_pred ----------CCCCeEecCCCCCCeEEeC--CCcEEEEeecCcc
Q 043185 627 ----------CEQKIIHCDIKPENILLHY--HFQAKISDFGLSK 658 (724)
Q Consensus 627 ----------~~~~iiH~Dlkp~NILl~~--~~~~kl~DFGla~ 658 (724)
....++|+|+++.||+++. ++.+.|+||+.+.
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 1245899999999999998 6678999999775
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.7e-09 Score=104.85 Aligned_cols=136 Identities=16% Similarity=0.150 Sum_probs=97.6
Q ss_pred ccccccccEEEEEEEECC-------ccEEEEEEeecCCc--c-------------------c-HHHH----HHHHHHHhc
Q 043185 516 NLIGSGGFGAVYKGILND-------KTIVAVKKITNVGV--Q-------------------G-KKDF----CTEIAIIGN 562 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~-------~~~vAvK~~~~~~~--~-------------------~-~~~~----~~E~~~l~~ 562 (724)
..||.|--+.||.|.-.+ +..+|||..+.... + . .+.+ .+|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998653 46899998743100 0 0 1122 279999998
Q ss_pred CCC--CCccceeceeecCCeEEEEEEecCCCCHHH-HHhcCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCeEecCCCC
Q 043185 563 IHH--VNLVKLKGFCAQGRQRLLVYEYMNHGSLDR-ILFGNGPVLEWQERFDIALGTARGLAYL-HSGCEQKIIHCDIKP 638 (724)
Q Consensus 563 l~H--~nIv~l~g~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~iiH~Dlkp 638 (724)
+.. -++.+++++ ...+|||||+.+..+.. .+.. ..++......+..+++.+|..| |. .++||+||++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCCH
Confidence 853 466666654 45689999998754422 2221 1344456667889999999999 75 8999999999
Q ss_pred CCeEEeCCCcEEEEeecCccccC
Q 043185 639 ENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 639 ~NILl~~~~~~kl~DFGla~~~~ 661 (724)
.|||++ ++.++|+|||.+....
T Consensus 154 ~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 154 YNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHEEEE-CCcEEEEECCCceeCC
Confidence 999997 5689999999887554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=98.99 E-value=7.2e-10 Score=92.91 Aligned_cols=72 Identities=22% Similarity=0.366 Sum_probs=50.8
Q ss_pred eEEEeeccccccccccCCCCCcccCCHHHHHHHcccCCCeeEEEeeCCCCceEe-ecccccccccccccCCcceeeEEee
Q 043185 343 VSYLRLGYGMDYFANHFFQPSTYDVNLSFCQELCSDDCSCLGIFFKNSSGSCYM-LGNVLGSIMSSNTVDSDLVGYIKVL 421 (724)
Q Consensus 343 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~y~~~~~~C~~-~~~l~~~~~~~~~~~~~~~~~~k~~ 421 (724)
+.|+++++. ++++..+. . .++++++|++.||+||+|.||+|.++++.|+. ...+.+.+.. ... ....|||++
T Consensus 12 ~~f~~~~~~-~~~~~~~~--~-~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~~~~~~~~~-~~~--~~~~yiKv~ 84 (84)
T cd01098 12 DGFLKLPDV-KLPDNASA--I-TAISLEECREACLSNCSCTAYAYNNGSGGCLLWNGLLNNLRSL-SSG--GGTLYLRLA 84 (84)
T ss_pred CEEEEeCCe-eCCCchhh--h-ccCCHHHHHHHHhcCCCcceeeecCCCCeEEEEeceecceEee-cCC--CcEEEEEeC
Confidence 567777744 66655432 2 56899999999999999999999988899995 4555554432 221 234688873
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.8e-09 Score=108.24 Aligned_cols=150 Identities=25% Similarity=0.383 Sum_probs=116.0
Q ss_pred HHhcCCCCCccceeceeecCC-----eEEEEEEecCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 043185 559 IIGNIHHVNLVKLKGFCAQGR-----QRLLVYEYMNHGSLDRILFGN---GPVLEWQERFDIALGTARGLAYLHSGCEQK 630 (724)
Q Consensus 559 ~l~~l~H~nIv~l~g~~~~~~-----~~~lV~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ 630 (724)
-|-.+.|.|||+++.|+.+.. ...++.|||+.|+|..+|++. ...+......++.-||..||.|||+ |...
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCc
Confidence 345567999999999986543 467899999999999999753 4567778888999999999999997 6899
Q ss_pred eEecCCCCCCeEEeCCCcEEEEeecCccccCC----CCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHh
Q 043185 631 IIHCDIKPENILLHYHFQAKISDFGLSKLLTP----EQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS 706 (724)
Q Consensus 631 iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~----~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt 706 (724)
|+|+++..+.|++..++-+||.--. -..... -.........+-++|.+||+=.....+..+|||+||+..+||.-
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 9999999999999999888875311 111100 01111123456789999998877778889999999999999988
Q ss_pred CCCC
Q 043185 707 GRRN 710 (724)
Q Consensus 707 G~~p 710 (724)
+..-
T Consensus 278 lEiq 281 (458)
T KOG1266|consen 278 LEIQ 281 (458)
T ss_pred heec
Confidence 7643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.91 E-value=7.3e-10 Score=120.49 Aligned_cols=199 Identities=25% Similarity=0.300 Sum_probs=148.7
Q ss_pred cccccccccEEEEEEEEC--CccEEEEEEeecCCcccHHH--HHHHHHHHhcC-CCCCccceeceeecCCeEEEEEEecC
Q 043185 515 KNLIGSGGFGAVYKGILN--DKTIVAVKKITNVGVQGKKD--FCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 515 ~~~lG~G~fG~Vy~~~~~--~~~~vAvK~~~~~~~~~~~~--~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
...||.|.|+.|++...+ ++..+++|.+.+.......+ -..|+.+...+ .|.++++....+...+..++-.||++
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE 349 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc
Confidence 467999999999988754 66788999886543332222 24566666666 58899998888888888889999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCC-CcEEEEeecCccccCCCCccce
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYH-FQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFGla~~~~~~~~~~~ 668 (724)
++++...+ .-...++...++++..|++.++-++|+ +.++|+|+||+||++..+ +..++.|||++..+.....
T Consensus 350 ~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~--- 422 (524)
T KOG0601|consen 350 GGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG--- 422 (524)
T ss_pred Ccchhhhh-HHHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccccccceecc---
Confidence 99887665 223356677888999999999999996 999999999999999886 7889999999864322111
Q ss_pred ecccccccc-cccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCC
Q 043185 669 TTMRGTRGY-LAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSM 720 (724)
Q Consensus 669 ~~~~gt~~y-~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~~~ 720 (724)
.....+..| .+++..+...+..++|++|||.-+.|.+++..--....+...+
T Consensus 423 ~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i 475 (524)
T KOG0601|consen 423 VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTI 475 (524)
T ss_pred cccccccccccchhhccccccccccccccccccccccccCcccCcccccceee
Confidence 111233344 3666667778899999999999999999987655554444333
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.78 E-value=4.7e-08 Score=94.51 Aligned_cols=126 Identities=23% Similarity=0.217 Sum_probs=81.7
Q ss_pred EEEEEEECCccEEEEEEeecCCcc--------------------------cHHHHHHHHHHHhcCCCC--Cccceeceee
Q 043185 525 AVYKGILNDKTIVAVKKITNVGVQ--------------------------GKKDFCTEIAIIGNIHHV--NLVKLKGFCA 576 (724)
Q Consensus 525 ~Vy~~~~~~~~~vAvK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~H~--nIv~l~g~~~ 576 (724)
.||.|...++..+|||..+..... ......+|.+.|.++... ++.+++.+-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 489999988899999987531000 012357899999999765 566666442
Q ss_pred cCCeEEEEEEecC--CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH-HHcCCCCCeEecCCCCCCeEEeCCCcEEEEe
Q 043185 577 QGRQRLLVYEYMN--HGSLDRILFGNGPVLEWQERFDIALGTARGLAY-LHSGCEQKIIHCDIKPENILLHYHFQAKISD 653 (724)
Q Consensus 577 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~y-LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 653 (724)
...|||||++ +..+..+.... ++......++.+++..+.. +|. .+|+|+||.+.|||++++ .+.|+|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE--
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEEEe
Confidence 3469999999 65554443222 1123345566777775555 565 899999999999999988 999999
Q ss_pred ecCccccC
Q 043185 654 FGLSKLLT 661 (724)
Q Consensus 654 FGla~~~~ 661 (724)
||.+....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99887554
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=98.77 E-value=9.6e-09 Score=83.98 Aligned_cols=66 Identities=17% Similarity=0.096 Sum_probs=47.2
Q ss_pred eEEEeeccccccccccCCCCCcccCCHHHHHHHccc---CCCeeEEEeeCCCCceE-eeccc-ccccccccccCCcceee
Q 043185 343 VSYLRLGYGMDYFANHFFQPSTYDVNLSFCQELCSD---DCSCLGIFFKNSSGSCY-MLGNV-LGSIMSSNTVDSDLVGY 417 (724)
Q Consensus 343 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~---nCsC~a~~y~~~~~~C~-~~~~l-~~~~~~~~~~~~~~~~~ 417 (724)
..|+++..+ ..| ....+++++|+++|++ ||||.||+|.+.+++|+ |.+++ .+.+.....+.+. |
T Consensus 9 g~fl~~~~~-klp-------d~~~~s~~eC~~~Cl~~~~nCsC~Aya~~~~~~gC~~W~~~l~~d~~~~~~~g~~L---y 77 (80)
T cd00129 9 GTTLIKIAL-KIK-------TTKANTADECANRCEKNGLPFSCKAFVFAKARKQCLWFPFNSMSGVRKEFSHGFDL---Y 77 (80)
T ss_pred CeEEEeecc-cCC-------cccccCHHHHHHHHhcCCCCCCceeeeccCCCCCeEEecCcchhhHHhccCCCcee---E
Confidence 456665433 333 3344799999999999 99999999987667899 78888 7877654433222 6
Q ss_pred EE
Q 043185 418 IK 419 (724)
Q Consensus 418 ~k 419 (724)
+|
T Consensus 78 ~r 79 (80)
T cd00129 78 EN 79 (80)
T ss_pred eE
Confidence 65
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.4e-07 Score=96.79 Aligned_cols=138 Identities=15% Similarity=0.055 Sum_probs=98.1
Q ss_pred ccccccEEEEEEEECCccEEEEEEeecCCcc-----------cHHHHHHHHHHHhcCCCCC--ccceeceeec-----CC
Q 043185 518 IGSGGFGAVYKGILNDKTIVAVKKITNVGVQ-----------GKKDFCTEIAIIGNIHHVN--LVKLKGFCAQ-----GR 579 (724)
Q Consensus 518 lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~n--Iv~l~g~~~~-----~~ 579 (724)
+-.-....|.+..+. |+.+.||+....... ....+.+|.+.+.++...+ .++++++... ..
T Consensus 30 v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 333333446677664 456999987543211 1114778999998885443 3444555543 23
Q ss_pred eEEEEEEecCCC-CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC-------CCcEE
Q 043185 580 QRLLVYEYMNHG-SLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY-------HFQAK 650 (724)
Q Consensus 580 ~~~lV~e~~~~g-sL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-------~~~~k 650 (724)
..+||+|++++. +|.+++... ....+...+..++.+++..+.-||. .+|+|+|++++|||++. +..+.
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~ 185 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLKLS 185 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCceEE
Confidence 568999999986 898887532 2344566777899999999999996 99999999999999985 46899
Q ss_pred EEeecCccc
Q 043185 651 ISDFGLSKL 659 (724)
Q Consensus 651 l~DFGla~~ 659 (724)
++||+.+..
T Consensus 186 LIDl~r~~~ 194 (268)
T PRK15123 186 VIDLHRAQI 194 (268)
T ss_pred EEECCcccc
Confidence 999998854
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.70 E-value=4.1e-09 Score=120.35 Aligned_cols=203 Identities=21% Similarity=0.244 Sum_probs=142.2
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEe---ecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCC
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKI---TNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHG 591 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~---~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~g 591 (724)
+-+-+|.++.++.++-. .+...++|.. ........+....+-.++-..+||.+++..--+.......|+++|..++
T Consensus 810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~ 889 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG 889 (1205)
T ss_pred ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence 35677888888876632 2222222222 1111222233334444444456777776666555667889999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCC---------
Q 043185 592 SLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP--------- 662 (724)
Q Consensus 592 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~--------- 662 (724)
+|...|+..+. .+.+-....+..+..+++|||+ ..+.|+|++|.|+|+..++..++.||+.......
T Consensus 890 ~~~Skl~~~~~-~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg 965 (1205)
T KOG0606|consen 890 DLPSKLHNSGC-LSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSG 965 (1205)
T ss_pred CchhhhhcCCC-cccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccccCcCCccc
Confidence 99998876653 3333333455567889999996 5589999999999999999999999984322110
Q ss_pred ----------------CCc-----cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCCCCCC
Q 043185 663 ----------------EQS-----SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSMD 721 (724)
Q Consensus 663 ----------------~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~~~~ 721 (724)
... .......+|+.|.+||.+.+......+|.|++|++++|.++|.+||.......+++
T Consensus 966 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ 1045 (1205)
T KOG0606|consen 966 PSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFE 1045 (1205)
T ss_pred ccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhh
Confidence 000 11223468999999999999999999999999999999999999998888777665
Q ss_pred C
Q 043185 722 S 722 (724)
Q Consensus 722 ~ 722 (724)
.
T Consensus 1046 n 1046 (1205)
T KOG0606|consen 1046 N 1046 (1205)
T ss_pred c
Confidence 3
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.4e-07 Score=104.76 Aligned_cols=141 Identities=23% Similarity=0.254 Sum_probs=93.9
Q ss_pred ccccccccEEEEEEEECCccEEEEEEeecCCccc----------------------------------------HHHHHH
Q 043185 516 NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQG----------------------------------------KKDFCT 555 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~----------------------------------------~~~~~~ 555 (724)
+-|+.++-|.||+|++.+|+.||||+.++.-.+. +-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5688999999999999999999999976421110 001344
Q ss_pred HHHHHhcC-----CCCCccceeceeecCCeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHH-HHHHHcCCCC
Q 043185 556 EIAIIGNI-----HHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARG-LAYLHSGCEQ 629 (724)
Q Consensus 556 E~~~l~~l-----~H~nIv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~-L~yLH~~~~~ 629 (724)
|+..+.++ +.+++.-..-+..-.+...|+|||++|-.+.++........+.+. ++..++++ +..+- ..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~---ia~~~~~~f~~q~~---~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKE---LAELLVRAFLRQLL---RD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHH---HHHHHHHHHHHHHH---hc
Confidence 55444444 133333322233334677899999999999888533333444333 33333333 12222 37
Q ss_pred CeEecCCCCCCeEEeCCCcEEEEeecCccccCC
Q 043185 630 KIIHCDIKPENILLHYHFQAKISDFGLSKLLTP 662 (724)
Q Consensus 630 ~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (724)
+++|.|.+|.||+++.++.+.+.|||+...+.+
T Consensus 285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 899999999999999999999999999887654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.59 E-value=5.5e-07 Score=96.18 Aligned_cols=166 Identities=20% Similarity=0.301 Sum_probs=126.0
Q ss_pred EEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceee----cCCeEEEEEEecCC-CCHHHHH
Q 043185 524 GAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCA----QGRQRLLVYEYMNH-GSLDRIL 597 (724)
Q Consensus 524 G~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~----~~~~~~lV~e~~~~-gsL~~~l 597 (724)
.+.||+... +|..+++||+.....+.......-++.++++.|+|+|++..++. .+..+++||+|.++ ++|.++.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 567898864 88889999995433333333345678899999999999999886 34578999999985 5777665
Q ss_pred hcC--------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCC
Q 043185 598 FGN--------------GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE 663 (724)
Q Consensus 598 ~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (724)
+.. +....+..++.++.|++.||.++|+ .|+..+-|.+++||++.+.+++|+.-|....+..+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 422 2345678899999999999999997 89999999999999999989999877766554433
Q ss_pred CccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCC
Q 043185 664 QSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRN 710 (724)
Q Consensus 664 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p 710 (724)
.. |-++. ..+-|.=.||.+++.|.+|...
T Consensus 447 ~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 447 PT---------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 21 11221 2456888999999999999544
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=5.6e-07 Score=89.46 Aligned_cols=133 Identities=19% Similarity=0.139 Sum_probs=92.3
Q ss_pred ccccccccccEEEEEEEECCccEEEEEEeecCCc----------------------ccHHHHHHHHHHHhcCCCC--Ccc
Q 043185 514 FKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGV----------------------QGKKDFCTEIAIIGNIHHV--NLV 569 (724)
Q Consensus 514 ~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~----------------------~~~~~~~~E~~~l~~l~H~--nIv 569 (724)
+.+.||.|--+.||.|..+.+.++|||.=+-... .......+|.++|.+|.-. .+.
T Consensus 95 iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP 174 (304)
T COG0478 95 IGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVP 174 (304)
T ss_pred hccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCC
Confidence 4578999999999999999899999995321100 0122356889999999654 777
Q ss_pred ceeceeecCCeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcE
Q 043185 570 KLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQA 649 (724)
Q Consensus 570 ~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 649 (724)
+.+++ +...+||||+++-.|...-- +....-.|+..|+.-+.-+-. .++||+|+++-||++++||.+
T Consensus 175 ~P~~~----nRHaVvMe~ieG~eL~~~r~------~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~dg~~ 241 (304)
T COG0478 175 KPIAW----NRHAVVMEYIEGVELYRLRL------DVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTEDGDI 241 (304)
T ss_pred Ccccc----ccceeeeehcccceeecccC------cccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEecCCCE
Confidence 77665 44579999999977654321 112222233333333333322 899999999999999999999
Q ss_pred EEEeecCccc
Q 043185 650 KISDFGLSKL 659 (724)
Q Consensus 650 kl~DFGla~~ 659 (724)
.++||--+..
T Consensus 242 ~vIDwPQ~v~ 251 (304)
T COG0478 242 VVIDWPQAVP 251 (304)
T ss_pred EEEeCccccc
Confidence 9999976543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.1e-06 Score=87.16 Aligned_cols=107 Identities=19% Similarity=0.219 Sum_probs=85.1
Q ss_pred HHHHHHHHHHHhcCC--CCCccceeceeecCC----eEEEEEEecCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Q 043185 550 KKDFCTEIAIIGNIH--HVNLVKLKGFCAQGR----QRLLVYEYMNHG-SLDRILFGNGPVLEWQERFDIALGTARGLAY 622 (724)
Q Consensus 550 ~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~~----~~~lV~e~~~~g-sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~y 622 (724)
.....+|...+..++ .-...+++++..... ..+||+|++++. +|.+++..... .+......++.+++..++-
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHH
Confidence 356788888888774 445566677665532 458999999984 79988875332 5566778899999999999
Q ss_pred HHcCCCCCeEecCCCCCCeEEeCCC---cEEEEeecCcccc
Q 043185 623 LHSGCEQKIIHCDIKPENILLHYHF---QAKISDFGLSKLL 660 (724)
Q Consensus 623 LH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~DFGla~~~ 660 (724)
||. .+|+|+|+++.|||++.+. .+.++||+.++..
T Consensus 134 lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 996 9999999999999999887 8999999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.49 E-value=2e-06 Score=83.75 Aligned_cols=138 Identities=20% Similarity=0.123 Sum_probs=103.7
Q ss_pred ccccccEEEEEEEECCccEEEEEEeecCC------cccHHHHHHHHHHHhcCCCC--Cccceeceee-cC----CeEEEE
Q 043185 518 IGSGGFGAVYKGILNDKTIVAVKKITNVG------VQGKKDFCTEIAIIGNIHHV--NLVKLKGFCA-QG----RQRLLV 584 (724)
Q Consensus 518 lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~------~~~~~~~~~E~~~l~~l~H~--nIv~l~g~~~-~~----~~~~lV 584 (724)
-|+||-+.|+.-.+.+. .+-+|+-.+.- .-....|.+|...|.++..- .+.++. ++. .. -..+||
T Consensus 26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 46788899999887666 58889876311 23567899999999988533 344544 332 11 245799
Q ss_pred EEecCC-CCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCc--EEEEeecCcccc
Q 043185 585 YEYMNH-GSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQ--AKISDFGLSKLL 660 (724)
Q Consensus 585 ~e~~~~-gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~--~kl~DFGla~~~ 660 (724)
+|-+++ -+|.+++... ....+...+..+..+++..+.-||. .++.|+|+.+.||+++.++. ++++||.-++..
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~~ 180 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR 180 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence 997764 5888887553 2355777788999999999999996 99999999999999987667 999999876543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=5.4e-06 Score=86.56 Aligned_cols=190 Identities=15% Similarity=0.142 Sum_probs=124.8
Q ss_pred cccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceece----e--ecCC-eEEEEEE
Q 043185 515 KNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNI-HHVNLVKLKGF----C--AQGR-QRLLVYE 586 (724)
Q Consensus 515 ~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~----~--~~~~-~~~lV~e 586 (724)
+..||+|+-+.+|-.---.+ .+.|+..........+. +..|.+. .||-+-.-+.+ . -.+. ..-+.|.
T Consensus 16 gr~LgqGgea~ly~l~e~~d--~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVRD--QVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecchhhc--hhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 35699999999985432111 23466654333322222 2333333 56644331111 0 1111 2346666
Q ss_pred ecCCCCH-HHHHh-----cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCcccc
Q 043185 587 YMNHGSL-DRILF-----GNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLL 660 (724)
Q Consensus 587 ~~~~gsL-~~~l~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 660 (724)
.+++..- ..++. ..-+...|...++.+..++.+.+-||+ .+-+-+|+.++|+|+.+++.+.|.|=+.-..-
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceeec
Confidence 6665422 22221 223568899999999999999999997 88899999999999999999999985543322
Q ss_pred CCCCccceeccccccccccccccc-----CCcCCCccchhhHHHHHHHHHhC-CCCCCCC
Q 043185 661 TPEQSSLFTTMRGTRGYLAPEWLT-----NSAISEKTDVYSFGMVLLELVSG-RRNCSPR 714 (724)
Q Consensus 661 ~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDv~SlGv~l~elltG-~~p~~~~ 714 (724)
.........+|...|.+||.-. +..-++..|.|.|||++++++-| +.||.+-
T Consensus 168 --~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 168 --ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred --cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 2223345567899999999764 33457789999999999999986 9999653
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.34 E-value=2e-06 Score=95.25 Aligned_cols=140 Identities=19% Similarity=0.195 Sum_probs=91.2
Q ss_pred ccccccccEEEEEEEECCccEEEEEEeecCCccc-------------------------------------HHHHHHHHH
Q 043185 516 NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQG-------------------------------------KKDFCTEIA 558 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~-------------------------------------~~~~~~E~~ 558 (724)
+.||.-+.|.||+|++++|+.||||+-++.-... +-+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5799999999999999999999999875421110 112555655
Q ss_pred HHhcC----CCCC------ccceeceeecCCeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCC
Q 043185 559 IIGNI----HHVN------LVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCE 628 (724)
Q Consensus 559 ~l~~l----~H~n------Iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ 628 (724)
-..+. .|-+ |.+++- .-.....|+||||+|..+.+.-.-....++... |+..+.++ |++....
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~---i~~~l~~~--~~~qIf~ 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRGISPHD---ILNKLVEA--YLEQIFK 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcCCCHHH---HHHHHHHH--HHHHHHh
Confidence 44433 3555 222222 223477899999999877665432323344443 33333333 2222223
Q ss_pred CCeEecCCCCCCeEEeC----CCcEEEEeecCccccCC
Q 043185 629 QKIIHCDIKPENILLHY----HFQAKISDFGLSKLLTP 662 (724)
Q Consensus 629 ~~iiH~Dlkp~NILl~~----~~~~kl~DFGla~~~~~ 662 (724)
.|++|+|-+|.||+++. ++++.+.|||+...+..
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 68999999999999984 67899999999876644
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.7e-05 Score=79.67 Aligned_cols=138 Identities=16% Similarity=0.156 Sum_probs=84.8
Q ss_pred ccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCC--ccceeceeecCCeEEEEEEecCCCC-
Q 043185 516 NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVN--LVKLKGFCAQGRQRLLVYEYMNHGS- 592 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~~~~~~~~~lV~e~~~~gs- 592 (724)
..||+|..+.||+. . +...++|..... ....+..+|.++++.+..-. +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~--~-~~~~VlR~~~~~--~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH--K-TGKWMLKLYNPG--FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe--c-CCCEEEEeCCCC--CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 46899999999984 2 334677777542 23456788999998886443 4677777777777889999999963
Q ss_pred HHHHH---------------------hcC-CCCCCHHHHH-HHHH----------HHH-HHHHHHHcC-CCCCeEecCCC
Q 043185 593 LDRIL---------------------FGN-GPVLEWQERF-DIAL----------GTA-RGLAYLHSG-CEQKIIHCDIK 637 (724)
Q Consensus 593 L~~~l---------------------~~~-~~~l~~~~~~-~i~~----------~ia-~~L~yLH~~-~~~~iiH~Dlk 637 (724)
+...+ +.- .......... ++.. .+. ....+|... ....++|+|++
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 21111 110 0011111100 0000 011 112223221 13457899999
Q ss_pred CCCeEEeCCCcEEEEeecCccc
Q 043185 638 PENILLHYHFQAKISDFGLSKL 659 (724)
Q Consensus 638 p~NILl~~~~~~kl~DFGla~~ 659 (724)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.4e-05 Score=78.91 Aligned_cols=136 Identities=23% Similarity=0.214 Sum_probs=92.1
Q ss_pred cccccccEEEEEEEECCccEEEEEEeecCCcccH-------------------HH-----HHHHHHHHhcCC--CCCccc
Q 043185 517 LIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGK-------------------KD-----FCTEIAIIGNIH--HVNLVK 570 (724)
Q Consensus 517 ~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~-------------------~~-----~~~E~~~l~~l~--H~nIv~ 570 (724)
.|..|--+.||+|.-.++..+|||+.+....... ++ ..+|...|.++. +-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 4667778889999988889999999864321110 11 235666666663 455555
Q ss_pred eeceeecCCeEEEEEEecCCCCH-HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcE
Q 043185 571 LKGFCAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQA 649 (724)
Q Consensus 571 l~g~~~~~~~~~lV~e~~~~gsL-~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 649 (724)
.+++.. -.|||||+....+ .=.|. ...++......+..++++.+.-|-. ..++||+||+.-|||+. ++.+
T Consensus 135 Pi~~~~----nVLvMEfIg~~g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 135 PIAFRN----NVLVMEFIGDDGLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred ceeecC----CeEEEEeccCCCCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-CCeE
Confidence 555543 3699999965421 11111 1123333566677778888777764 48999999999999999 8899
Q ss_pred EEEeecCccccC
Q 043185 650 KISDFGLSKLLT 661 (724)
Q Consensus 650 kl~DFGla~~~~ 661 (724)
.|+||+-|....
T Consensus 206 ~iID~~QaV~~~ 217 (268)
T COG1718 206 YIIDVSQAVTID 217 (268)
T ss_pred EEEECccccccC
Confidence 999999887654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.11 E-value=5.9e-07 Score=98.16 Aligned_cols=182 Identities=20% Similarity=0.136 Sum_probs=130.7
Q ss_pred ccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCC-ccceeceeecCCeEEEEEEecCCC-CH
Q 043185 516 NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVN-LVKLKGFCAQGRQRLLVYEYMNHG-SL 593 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~e~~~~g-sL 593 (724)
..++++++++++|.+-...+...++.+... ....-++++|.+++||| .++.++-+..+...+++++++..+ +-
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 457899999999987544444445555322 44456889999999999 788888888888899999999876 22
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceecccc
Q 043185 594 DRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRG 673 (724)
Q Consensus 594 ~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~g 673 (724)
..........+...+...+...-++++++||+ ..-+|+| ||+..+ +..+..||+....+.... ......+
T Consensus 323 ~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~~ 392 (829)
T KOG0576|consen 323 ALEMTVSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTAIG 392 (829)
T ss_pred cccCChhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc--ccccCCC
Confidence 11111111122223334455566778999996 3347888 887765 678999999987776543 2345678
Q ss_pred cccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCC
Q 043185 674 TRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCS 712 (724)
Q Consensus 674 t~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~ 712 (724)
++.++|||++....+..+.|+|++|+-..++.-|-+|-.
T Consensus 393 ~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 393 TPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 999999999999999999999999988778877777653
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.09 E-value=3e-05 Score=79.12 Aligned_cols=138 Identities=12% Similarity=0.070 Sum_probs=85.0
Q ss_pred cccccc-EEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCC-CCCccceeceeecCCeEEEEEEecCCCCHHH
Q 043185 518 IGSGGF-GAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIH-HVNLVKLKGFCAQGRQRLLVYEYMNHGSLDR 595 (724)
Q Consensus 518 lG~G~f-G~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~e~~~~gsL~~ 595 (724)
|-.|.. ..||+....+ ..+.+|+..... ..+..+|++++..+. +--+.+++++...++..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~~-~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGKN-PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCCC-CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444444 7899997654 568888876432 345678888888873 4456677777776667899999999987764
Q ss_pred HHh------------------cCCC----CCC--HHHHHHHHH--------------------HHHHHHHHHHc----CC
Q 043185 596 ILF------------------GNGP----VLE--WQERFDIAL--------------------GTARGLAYLHS----GC 627 (724)
Q Consensus 596 ~l~------------------~~~~----~l~--~~~~~~i~~--------------------~ia~~L~yLH~----~~ 627 (724)
... +..+ ... ....+.... .+...+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 310 0000 000 000000000 01112222211 11
Q ss_pred CCCeEecCCCCCCeEEeCCCcEEEEeecCccc
Q 043185 628 EQKIIHCDIKPENILLHYHFQAKISDFGLSKL 659 (724)
Q Consensus 628 ~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 659 (724)
...++|+|+.|.|||++.+..+.|+||+.+..
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 34599999999999999987789999998753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.03 E-value=1.5e-05 Score=70.86 Aligned_cols=82 Identities=22% Similarity=0.395 Sum_probs=57.7
Q ss_pred EEEccCcc-EEEcCC-CCeEEecCCCCC--ceeEEEEecCCcEEEecCCCccceecccCCCcccccCCccCCCceEEecC
Q 043185 94 MNLTPKGI-IISDEN-GNLKWSTPPLKS--SVSALRLTEMGNLVLLDGFNGSLWESFHHPRDTIVIGQHLPAGASLSSAV 169 (724)
Q Consensus 94 l~~~~~g~-~l~~~~-g~~vWst~~~~~--~~~~~~L~dsGNlVl~~~~~~~lWQSFd~PtDtlLpgq~l~~~~~L~S~~ 169 (724)
+.+..+|+ |+.+.. +.++|++++... ....+.|+++|||||++.++..+|+|=. . +
T Consensus 24 ~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~t---~---~-------------- 83 (114)
T smart00108 24 LIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSSNT---T---G-------------- 83 (114)
T ss_pred cCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEecc---c---C--------------
Confidence 34456786 666554 589999997532 3367899999999999998999999821 1 1
Q ss_pred CCCCCCCcceEEEeCCCccccccc--cccceee
Q 043185 170 SDYNLSTGDYSLTVGASDAELQWQ--GQMYWKL 200 (724)
Q Consensus 170 s~~dps~G~~~~~~~~~~~~~~~~--~~~yw~~ 200 (724)
..|.+.+.++.+|..+.++ +...|.+
T Consensus 84 -----~~~~~~~~L~ddGnlvl~~~~~~~~W~S 111 (114)
T smart00108 84 -----ANGNYVLVLLDDGNLVIYDSDGNFLWQS 111 (114)
T ss_pred -----CCCceEEEEeCCCCEEEECCCCCEEeCC
Confidence 2356888888888875443 4467754
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.02 E-value=4.9e-05 Score=76.60 Aligned_cols=141 Identities=18% Similarity=0.141 Sum_probs=84.3
Q ss_pred ccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCC--Cccceeceeec---CCeEEEEEEecCC
Q 043185 516 NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHV--NLVKLKGFCAQ---GRQRLLVYEYMNH 590 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~g~~~~---~~~~~lV~e~~~~ 590 (724)
+.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++..... ....+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 468889999999999988 57999987543 3456778899998888533 35666664432 3357899999999
Q ss_pred CCHHH----------------HHh---cC---CCCCCHHH---------HHHH------------HHHHHH-HHHHHHc-
Q 043185 591 GSLDR----------------ILF---GN---GPVLEWQE---------RFDI------------ALGTAR-GLAYLHS- 625 (724)
Q Consensus 591 gsL~~----------------~l~---~~---~~~l~~~~---------~~~i------------~~~ia~-~L~yLH~- 625 (724)
..+.. .+. .. ........ .... ...+.+ .+..++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 87776 111 11 01111100 0000 111222 2333332
Q ss_pred ---CCCCCeEecCCCCCCeEEe-CCCcEEEEeecCccc
Q 043185 626 ---GCEQKIIHCDIKPENILLH-YHFQAKISDFGLSKL 659 (724)
Q Consensus 626 ---~~~~~iiH~Dlkp~NILl~-~~~~~kl~DFGla~~ 659 (724)
.....++|+|+.|.|||++ .++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2356799999999999999 666678999987653
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.96 E-value=2.6e-06 Score=94.47 Aligned_cols=100 Identities=25% Similarity=0.453 Sum_probs=78.1
Q ss_pred HHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc--------cceeccccccccccccccc
Q 043185 613 ALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS--------SLFTTMRGTRGYLAPEWLT 684 (724)
Q Consensus 613 ~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~--------~~~~~~~gt~~y~aPE~l~ 684 (724)
+.+++.||.|+|. ..++||+.|.|++|.++..+..||+.|+.+........ ....-......|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3455699999998 68999999999999999999999999998765543111 0111123566899999999
Q ss_pred CCcCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 043185 685 NSAISEKTDVYSFGMVLLELVS-GRRNCSPR 714 (724)
Q Consensus 685 ~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~ 714 (724)
....+.++|+||||+++|.+.. |+.-+...
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~ 213 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAAN 213 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhcc
Confidence 9888999999999999999994 55544443
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.94 E-value=3.9e-05 Score=74.53 Aligned_cols=103 Identities=25% Similarity=0.292 Sum_probs=82.5
Q ss_pred HHHHHHHhcCCC-CCccceeceeecCCeEEEEEEecCCCCHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 043185 554 CTEIAIIGNIHH-VNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILF--GNGPVLEWQERFDIALGTARGLAYLHSGCEQK 630 (724)
Q Consensus 554 ~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ 630 (724)
..|.-+++.+++ +++++++|.|-. ++|.||...+++...-. ...-..+|..|.+||.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357888888875 699999999943 68999998775532100 01124689999999999999999999866667
Q ss_pred eEecCCCCCCeEEeCCCcEEEEeecCcccc
Q 043185 631 IIHCDIKPENILLHYHFQAKISDFGLSKLL 660 (724)
Q Consensus 631 iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 660 (724)
+...|++++|+-+++++++|++|.+.+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 889999999999999999999999876544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.94 E-value=7.4e-05 Score=73.15 Aligned_cols=131 Identities=16% Similarity=0.138 Sum_probs=80.6
Q ss_pred cccccccccEEEEEEEECCccEEEEEEeecCCcccHHHH---------HHHHHHHhcCCCC---Cccceeceee-----c
Q 043185 515 KNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDF---------CTEIAIIGNIHHV---NLVKLKGFCA-----Q 577 (724)
Q Consensus 515 ~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~---------~~E~~~l~~l~H~---nIv~l~g~~~-----~ 577 (724)
.+++-......|.+-..++ ....+|..+......++.| .+++..+.+++.. ....++.+.. -
T Consensus 36 ~kv~k~~~r~~ValIei~~-~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~ 114 (229)
T PF06176_consen 36 IKVFKNTKRNYVALIEIDG-KKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRY 114 (229)
T ss_pred EEeecCCCccEEEEEEECC-cEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccc
Confidence 3445555555666665655 4577887765432222222 2344444444322 2222222222 2
Q ss_pred CCeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCc
Q 043185 578 GRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLS 657 (724)
Q Consensus 578 ~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 657 (724)
....+|+|||++|..|.++.. ++. .++..+.+++.-||. .|+.|+|.+|.|++++.+ .++++||+..
T Consensus 115 ~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~-~i~iID~~~k 181 (229)
T PF06176_consen 115 TSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN-GIRIIDTQGK 181 (229)
T ss_pred eeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-cEEEEECccc
Confidence 235569999999988765531 221 244567788999996 999999999999999865 5999999876
Q ss_pred cc
Q 043185 658 KL 659 (724)
Q Consensus 658 ~~ 659 (724)
+.
T Consensus 182 ~~ 183 (229)
T PF06176_consen 182 RM 183 (229)
T ss_pred cc
Confidence 53
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00012 Score=68.49 Aligned_cols=129 Identities=17% Similarity=0.214 Sum_probs=88.0
Q ss_pred cccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCCHH
Q 043185 515 KNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLD 594 (724)
Q Consensus 515 ~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gsL~ 594 (724)
.+.|++|.+|.||++.+.++ .+|+|+-+. ....+.+..|+++|..++-.++.+=+-.+- ..++.|||++|-.|.
T Consensus 27 ~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg---~~~i~me~i~G~~L~ 100 (201)
T COG2112 27 EKELAKGTTSVVYLGEWRGG-EVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYG---EDFIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhcccccEEEEeeccCc-eEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEec---hhhhhhhhhcCcchh
Confidence 36799999999999999876 588887764 344577889999999887666654332222 224569999998887
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCC-CCCeEEeCCCcEEEEeecCcccc
Q 043185 595 RILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIK-PENILLHYHFQAKISDFGLSKLL 660 (724)
Q Consensus 595 ~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk-p~NILl~~~~~~kl~DFGla~~~ 660 (724)
+.-... +-+..+ .+++.---|. ..+|-|+.|. |..++|..+..+.|+||..|+..
T Consensus 101 ~~~~~~----~rk~l~----~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 101 KLEIGG----DRKHLL----RVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhcc----cHHHHH----HHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 665321 223333 3444433344 3788888887 45555555669999999999743
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00026 Score=84.94 Aligned_cols=77 Identities=13% Similarity=0.243 Sum_probs=56.3
Q ss_pred ccccccccEEEEEEEECCc---cEEEEEEeecCC-cccHHHHHHHHHHHhcCC-CCCc--cceeceeecC---CeEEEEE
Q 043185 516 NLIGSGGFGAVYKGILNDK---TIVAVKKITNVG-VQGKKDFCTEIAIIGNIH-HVNL--VKLKGFCAQG---RQRLLVY 585 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~---~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nI--v~l~g~~~~~---~~~~lV~ 585 (724)
+.++.|.+..+|+....++ ..+++|+..... ......+.+|+++++.+. |.++ .+++.+|.+. ...++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 5688899999999887653 356777764322 233457889999999995 6665 7778877664 4678999
Q ss_pred EecCCCC
Q 043185 586 EYMNHGS 592 (724)
Q Consensus 586 e~~~~gs 592 (724)
||+++..
T Consensus 124 E~v~G~~ 130 (822)
T PLN02876 124 EYLEGRI 130 (822)
T ss_pred EecCCcc
Confidence 9998864
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=97.74 E-value=3.9e-05 Score=68.43 Aligned_cols=81 Identities=22% Similarity=0.404 Sum_probs=57.6
Q ss_pred EEcc-Ccc-EEEcCC-CCeEEecCCCC--CceeEEEEecCCcEEEecCCCccceecccCCCcccccCCccCCCceEEecC
Q 043185 95 NLTP-KGI-IISDEN-GNLKWSTPPLK--SSVSALRLTEMGNLVLLDGFNGSLWESFHHPRDTIVIGQHLPAGASLSSAV 169 (724)
Q Consensus 95 ~~~~-~g~-~l~~~~-g~~vWst~~~~--~~~~~~~L~dsGNlVl~~~~~~~lWQSFd~PtDtlLpgq~l~~~~~L~S~~ 169 (724)
.... +|+ |+.+.. ++++|++|+.. .....+.|+++|||||.+.++..+|||=...
T Consensus 25 ~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~~~~-------------------- 84 (116)
T cd00028 25 IMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNTTR-------------------- 84 (116)
T ss_pred CCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEecccC--------------------
Confidence 3444 775 666554 58999999854 3456789999999999999999999975210
Q ss_pred CCCCCCCcceEEEeCCCccccccc--cccceee
Q 043185 170 SDYNLSTGDYSLTVGASDAELQWQ--GQMYWKL 200 (724)
Q Consensus 170 s~~dps~G~~~~~~~~~~~~~~~~--~~~yw~~ 200 (724)
+.+.+.+.++.+|....++ +...|.+
T Consensus 85 -----~~~~~~~~L~ddGnlvl~~~~~~~~W~S 112 (116)
T cd00028 85 -----VNGNYVLVLLDDGNLVLYDSDGNFLWQS 112 (116)
T ss_pred -----CCCceEEEEeCCCCEEEECCCCCEEEcC
Confidence 1356888888888775443 4566754
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00064 Score=71.39 Aligned_cols=75 Identities=11% Similarity=0.053 Sum_probs=55.9
Q ss_pred ccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCC---CCccceeceeecC---CeEEEEEEecC
Q 043185 516 NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHH---VNLVKLKGFCAQG---RQRLLVYEYMN 589 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H---~nIv~l~g~~~~~---~~~~lV~e~~~ 589 (724)
+.||.|..+.||+....+++ +++|..+. ......+.+|.+.|+.+.. ..+.++++++..+ +..+||||+++
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~-~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGN-PMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred eecCCccceeEEEEEcCCCC-EEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 56999999999998876664 66666432 1234578899999988842 4688888877543 56899999999
Q ss_pred CCCH
Q 043185 590 HGSL 593 (724)
Q Consensus 590 ~gsL 593 (724)
+.++
T Consensus 97 G~~~ 100 (297)
T PRK10593 97 GVSV 100 (297)
T ss_pred CEec
Confidence 8754
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00093 Score=65.28 Aligned_cols=130 Identities=20% Similarity=0.238 Sum_probs=89.2
Q ss_pred ccccccccEEEEEEEECCccEEEEEEeecCC----------------cccHHHHHHHHHHHhcCC------CCCccceec
Q 043185 516 NLIGSGGFGAVYKGILNDKTIVAVKKITNVG----------------VQGKKDFCTEIAIIGNIH------HVNLVKLKG 573 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~----------------~~~~~~~~~E~~~l~~l~------H~nIv~l~g 573 (724)
..||+|+.=.||. +++.....||+..... ....+++.+|+.-...+. +.+|.+++|
T Consensus 7 ~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 5799999988884 4555557778776543 122455666766555444 889999999
Q ss_pred eeecCCeEEEEEEecCC------CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCC
Q 043185 574 FCAQGRQRLLVYEYMNH------GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHF 647 (724)
Q Consensus 574 ~~~~~~~~~lV~e~~~~------gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 647 (724)
+...+...-+|+|.+.+ -+|.+++.+. .++. ...+. +-+-..||-. ..|+.+|++|+||++....
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~-~~~~~---L~~f~~~l~~---~~Iv~~dl~~~NIv~~~~~ 155 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE-ELRQA---LDEFKRYLLD---HHIVIRDLNPHNIVVQRRD 155 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH-HHHHH---HHHHHHHHHH---cCCeecCCCcccEEEEecC
Confidence 99999988899987643 3678888554 3443 33333 3344556664 7899999999999996432
Q ss_pred ----cEEEEe-ecC
Q 043185 648 ----QAKISD-FGL 656 (724)
Q Consensus 648 ----~~kl~D-FGl 656 (724)
.+.|+| ||-
T Consensus 156 ~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 156 SGEFRLVLIDGLGE 169 (199)
T ss_pred CCceEEEEEeCCCC
Confidence 477777 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00038 Score=70.54 Aligned_cols=72 Identities=14% Similarity=0.134 Sum_probs=43.9
Q ss_pred ccccccccE-EEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCC---CccceeceeecC---CeEEEEEEec
Q 043185 516 NLIGSGGFG-AVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHV---NLVKLKGFCAQG---RQRLLVYEYM 588 (724)
Q Consensus 516 ~~lG~G~fG-~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~---nIv~l~g~~~~~---~~~~lV~e~~ 588 (724)
+.|+.|+.. .||+. + ..+++|..+. .....++.+|.+++..+... -+.++++..... ...+++||++
T Consensus 3 ~~~~~gG~~n~vy~~---~-~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL---G-DDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc---C-CceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 346666665 58875 1 2366676543 22345788999999887532 344444443332 2358899999
Q ss_pred CCCCH
Q 043185 589 NHGSL 593 (724)
Q Consensus 589 ~~gsL 593 (724)
+|.++
T Consensus 77 ~G~~l 81 (235)
T cd05155 77 EGETA 81 (235)
T ss_pred cCCCC
Confidence 98766
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00099 Score=67.41 Aligned_cols=73 Identities=21% Similarity=0.144 Sum_probs=46.4
Q ss_pred ccccccccEEEEEEEECC--ccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCc-cceeceeecCCeEEEEEEecCCCC
Q 043185 516 NLIGSGGFGAVYKGILND--KTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNL-VKLKGFCAQGRQRLLVYEYMNHGS 592 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~e~~~~gs 592 (724)
+.|..|-...+|+....+ +..+++|..... ....-+..+|+.++..+...++ +++++... ..++|||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~-~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNK-TELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCC-ccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 457778888999998764 567888876532 2111233478888888853333 44444332 248999999876
Q ss_pred H
Q 043185 593 L 593 (724)
Q Consensus 593 L 593 (724)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.00031 Score=57.39 Aligned_cols=34 Identities=24% Similarity=0.655 Sum_probs=30.0
Q ss_pred ccCCHHHHHHHccc-CCCeeEEEeeCCCCceEeec
Q 043185 365 YDVNLSFCQELCSD-DCSCLGIFFKNSSGSCYMLG 398 (724)
Q Consensus 365 ~~~~~~~C~~~Cl~-nCsC~a~~y~~~~~~C~~~~ 398 (724)
...++++|++.|++ +|+|.||.|..+++.|+++.
T Consensus 23 ~~~s~~~C~~~C~~~~~~C~s~~y~~~~~~C~l~~ 57 (78)
T smart00473 23 SVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWS 57 (78)
T ss_pred cCCCHHHHHHHhCCCCCceEEEEEcCCCCEEEEee
Confidence 45799999999999 99999999987778999654
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0026 Score=56.37 Aligned_cols=99 Identities=21% Similarity=0.334 Sum_probs=63.1
Q ss_pred CeEEeCCCeEEEEEEecCCCCceEEEEEEeccCCeEEEec-CCCCCCCCCceEEEccCcc-EEEcCCCCeEEecCCCCCc
Q 043185 43 SFLTSHNGTFKAAIVNTRSQQNSFYLCIIHVLSNTIIWSA-NRDTPISGSGKMNLTPKGI-IISDENGNLKWSTPPLKSS 120 (724)
Q Consensus 43 ~~lvS~~g~F~lGF~~~~~~~~~~~i~~~~~~~~tvVW~A-nr~~pv~~~~~l~~~~~g~-~l~~~~g~~vWst~~~~~~ 120 (724)
+.+.+.+|.+.|-|-..+ .+. +.. ...++||.. +..........+.|.++|+ ||+|.++.++|+|.. ...
T Consensus 12 ~p~~~~s~~~~L~l~~dG----nLv--l~~-~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~-~pt 83 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDG----NLV--LYD-SNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSFD-YPT 83 (114)
T ss_dssp EEEEECETTEEEEEETTS----EEE--EEE-TTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEESTT-SSS
T ss_pred cccccccccccceECCCC----eEE--EEc-CCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeecC-CCc
Confidence 456565588888886443 121 222 335779999 4344443457899999995 899999999999943 234
Q ss_pred eeEEEEec--CCcEEEecCCCccceecccCCC
Q 043185 121 VSALRLTE--MGNLVLLDGFNGSLWESFHHPR 150 (724)
Q Consensus 121 ~~~~~L~d--sGNlVl~~~~~~~lWQSFd~Pt 150 (724)
.+.+..++ .||++ ........|.|=+.|.
T Consensus 84 dt~L~~q~l~~~~~~-~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 84 DTLLPGQKLGDGNVT-GKNDSLTSWSSNTDPS 114 (114)
T ss_dssp -EEEEEET--TSEEE-EESTSSEEEESS----
T ss_pred cEEEeccCcccCCCc-cccceEEeECCCCCCC
Confidence 45566666 88998 6666778899877663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0012 Score=67.71 Aligned_cols=137 Identities=15% Similarity=0.070 Sum_probs=77.0
Q ss_pred ccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCc-cceeceeecCCeEEEEEEecCCCCHHH-
Q 043185 518 IGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNL-VKLKGFCAQGRQRLLVYEYMNHGSLDR- 595 (724)
Q Consensus 518 lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~e~~~~gsL~~- 595 (724)
+..|-...+|+.... +..+++|........-.-+..+|.++++.+....+ .++++... ..+|+||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~~-~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEHP-GISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEeC-CccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 456777889988744 45677887543211111235678888888864433 34444332 368999999866531
Q ss_pred -------------HHh---cC---CCCCCHHHH-HHHH---------HHHHHHHHHHHcC-----CCCCeEecCCCCCCe
Q 043185 596 -------------ILF---GN---GPVLEWQER-FDIA---------LGTARGLAYLHSG-----CEQKIIHCDIKPENI 641 (724)
Q Consensus 596 -------------~l~---~~---~~~l~~~~~-~~i~---------~~ia~~L~yLH~~-----~~~~iiH~Dlkp~NI 641 (724)
.+. .. ...++.... .... ..+...+..+... ....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 111 11 111222111 1111 0111122222211 124589999999999
Q ss_pred EEeCCCcEEEEeecCcccc
Q 043185 642 LLHYHFQAKISDFGLSKLL 660 (724)
Q Consensus 642 Ll~~~~~~kl~DFGla~~~ 660 (724)
++++++ +.|+||+.+..-
T Consensus 159 l~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred EEeCCC-CEEEeccccCcC
Confidence 999877 789999887643
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0015 Score=68.60 Aligned_cols=140 Identities=14% Similarity=0.127 Sum_probs=84.3
Q ss_pred ccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCC--Cccceece------eecCCeEEEEEEe
Q 043185 516 NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHV--NLVKLKGF------CAQGRQRLLVYEY 587 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~g~------~~~~~~~~lV~e~ 587 (724)
+.|..|....+|+....++ .+++|+... ....+...|++++..+++. .+.+++.. ...++..++|++|
T Consensus 20 ~~i~~G~~n~~y~v~~~~~-~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 20 EGISAGIENTNYFVTTDSG-RYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred ecccCccccceEEEEeCCC-cEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 4577777789999877655 478887754 2345566788888877433 24455442 1223456899999
Q ss_pred cCCCCHHH----H-------H---hc---C-C------CCCCHHHHH----------HHHHHHHHHHHHHHc----CCCC
Q 043185 588 MNHGSLDR----I-------L---FG---N-G------PVLEWQERF----------DIALGTARGLAYLHS----GCEQ 629 (724)
Q Consensus 588 ~~~gsL~~----~-------l---~~---~-~------~~l~~~~~~----------~i~~~ia~~L~yLH~----~~~~ 629 (724)
++|..+.. . + +. . . ....|.... .....+..++.++.. ....
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 99876521 0 1 00 0 0 011221110 011123334444442 1235
Q ss_pred CeEecCCCCCCeEEeCCCcEEEEeecCccc
Q 043185 630 KIIHCDIKPENILLHYHFQAKISDFGLSKL 659 (724)
Q Consensus 630 ~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 659 (724)
.++|+|++|.||+++.+..+.|+||+.+..
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 799999999999999987789999987753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.00046 Score=55.84 Aligned_cols=35 Identities=23% Similarity=0.600 Sum_probs=31.4
Q ss_pred cCCHHHHHHHcccCCCeeEEEeeCCCCceEeeccc
Q 043185 366 DVNLSFCQELCSDDCSCLGIFFKNSSGSCYMLGNV 400 (724)
Q Consensus 366 ~~~~~~C~~~Cl~nCsC~a~~y~~~~~~C~~~~~l 400 (724)
..+.++|++.|+.+|+|.||.|....+.|+++...
T Consensus 24 ~~s~~~Cq~~C~~~~~C~afT~~~~~~~C~lk~~~ 58 (73)
T cd01100 24 ASSAEQCQAACTADPGCLAFTYNTKSKKCFLKSSE 58 (73)
T ss_pred cCCHHHHHHHcCCCCCceEEEEECCCCeEEcccCC
Confidence 46899999999999999999999888999977664
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0041 Score=60.39 Aligned_cols=125 Identities=26% Similarity=0.362 Sum_probs=86.6
Q ss_pred hhcccccccccccc-EEEEEEEECCccEEEEEEeec---CCc------------------ccHHHHHHHHHHHhcCC---
Q 043185 510 ATDNFKNLIGSGGF-GAVYKGILNDKTIVAVKKITN---VGV------------------QGKKDFCTEIAIIGNIH--- 564 (724)
Q Consensus 510 a~~~~~~~lG~G~f-G~Vy~~~~~~~~~vAvK~~~~---~~~------------------~~~~~~~~E~~~l~~l~--- 564 (724)
+..+|.+.||.|.- |.|||+++.+. .+|+|.++. ... .....|..|.+..++|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~-~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGR-IYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCe-EEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 45566789999999 99999999765 799999321 000 01124778888877774
Q ss_pred CCCc--cceeceeecC------------------CeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 043185 565 HVNL--VKLKGFCAQG------------------RQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLH 624 (724)
Q Consensus 565 H~nI--v~l~g~~~~~------------------~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH 624 (724)
+.++ |+++|+..-. ...-||-||.+... .+. .+-+.+|.+-|..+|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~----~~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQ----IRDIPQMLRDLKILH 181 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccc----hhHHHHHHHHHHHHH
Confidence 5566 8999986322 12347788776532 122 223456667778888
Q ss_pred cCCCCCeEecCCCCCCeEEeCCCcEEEEeecCc
Q 043185 625 SGCEQKIIHCDIKPENILLHYHFQAKISDFGLS 657 (724)
Q Consensus 625 ~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 657 (724)
. .+|+-+|+++.|.. .-+|+|||.+
T Consensus 182 k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 K---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred H---CCeeeccCcccccc-----CCEEEecccC
Confidence 5 99999999999986 4589999854
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.012 Score=63.86 Aligned_cols=75 Identities=15% Similarity=0.067 Sum_probs=53.2
Q ss_pred ccccccccEEEEEEEECCc-cEEEEEEeecCC-------cccHHHHHHHHHHHhcCC---CCCccceeceeecCCeEEEE
Q 043185 516 NLIGSGGFGAVYKGILNDK-TIVAVKKITNVG-------VQGKKDFCTEIAIIGNIH---HVNLVKLKGFCAQGRQRLLV 584 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~-~~vAvK~~~~~~-------~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lV 584 (724)
+.||.|.+..||++...++ +.++||...... .-..+++..|.+.|..+. -..+.+++.+ +....++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 4689999999999998876 479999854210 123466778888888762 2456667666 33557899
Q ss_pred EEecCCCC
Q 043185 585 YEYMNHGS 592 (724)
Q Consensus 585 ~e~~~~gs 592 (724)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.01 Score=63.04 Aligned_cols=139 Identities=14% Similarity=0.124 Sum_probs=76.5
Q ss_pred ccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCC--Cccceece------eecCCeEEEEEEe
Q 043185 516 NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHV--NLVKLKGF------CAQGRQRLLVYEY 587 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~g~------~~~~~~~~lV~e~ 587 (724)
+.|+.|....+|+....++ .+++|+... ...+....|+.++..|... .+.+.+.. ....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 3466777788999887766 478888752 1223344455555555322 23343321 1234567899999
Q ss_pred cCCCCHH-----------HHHh---cCC----------CCCCH-HHHHH------------HH-HHHHHHHHHHHc----
Q 043185 588 MNHGSLD-----------RILF---GNG----------PVLEW-QERFD------------IA-LGTARGLAYLHS---- 625 (724)
Q Consensus 588 ~~~gsL~-----------~~l~---~~~----------~~l~~-~~~~~------------i~-~~ia~~L~yLH~---- 625 (724)
++|..+. ..+. ... ..+.| ..... .. ..+...++.+..
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 9987431 1111 000 01111 11111 11 111122233321
Q ss_pred CCCCCeEecCCCCCCeEEeCCCcEEEEeecCcc
Q 043185 626 GCEQKIIHCDIKPENILLHYHFQAKISDFGLSK 658 (724)
Q Consensus 626 ~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~ 658 (724)
....++||+|++|.||+++.+...-|+||+.+.
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 134689999999999999976656899999875
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0034 Score=66.17 Aligned_cols=139 Identities=23% Similarity=0.240 Sum_probs=81.4
Q ss_pred cccccccEEEEEEEECC-------ccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCC-ccceeceeecCCeEEEEEEec
Q 043185 517 LIGSGGFGAVYKGILND-------KTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVN-LVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 517 ~lG~G~fG~Vy~~~~~~-------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~e~~ 588 (724)
.|..|-...+|+....+ ++.+++|+.... .....+..+|.+++..+.... ..++++++.. .+|+||+
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~-~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i 79 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQS-VELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI 79 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCC-CcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence 45566667899988765 467888886543 223345567888888774333 3455555532 3689999
Q ss_pred CCCCHHHH--------------H---hcCC-C-------CCC--HHHHHH--------------------------HHHH
Q 043185 589 NHGSLDRI--------------L---FGNG-P-------VLE--WQERFD--------------------------IALG 615 (724)
Q Consensus 589 ~~gsL~~~--------------l---~~~~-~-------~l~--~~~~~~--------------------------i~~~ 615 (724)
+|..+... + +... . ... +..... +...
T Consensus 80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (302)
T cd05156 80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED 159 (302)
T ss_pred CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence 88765321 1 0100 0 000 101100 1112
Q ss_pred HHHHHHHHHc------CCCCCeEecCCCCCCeEEeCC----CcEEEEeecCcccc
Q 043185 616 TARGLAYLHS------GCEQKIIHCDIKPENILLHYH----FQAKISDFGLSKLL 660 (724)
Q Consensus 616 ia~~L~yLH~------~~~~~iiH~Dlkp~NILl~~~----~~~kl~DFGla~~~ 660 (724)
+...+..|.. .....++|+|+.+.|||++.+ +.++++||+.+..-
T Consensus 160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~ 214 (302)
T cd05156 160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN 214 (302)
T ss_pred HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence 2223334431 135679999999999999985 88999999988643
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.01 Score=62.76 Aligned_cols=140 Identities=14% Similarity=0.141 Sum_probs=82.0
Q ss_pred ccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCC--Cccceecee------ecCCeEEEEEEe
Q 043185 516 NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHV--NLVKLKGFC------AQGRQRLLVYEY 587 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~g~~------~~~~~~~lV~e~ 587 (724)
+.++.|....+|+....+++ .++|+.... ....+...|++++..|... .+.+++... ..++..++++||
T Consensus 28 ~~~~~G~~n~~y~v~t~~~~-~vLK~~~~~--~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVGR-YILTLYEKR--VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred cccCCccccceEEEEeCCCc-EEEEEecCC--CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 45677777889998876664 667876442 1234555677777776422 244544421 223567899999
Q ss_pred cCCCCHH-----------HHH---hc--CC---C------CCCHHHHH------------HHHHHHHHHHHHHHc----C
Q 043185 588 MNHGSLD-----------RIL---FG--NG---P------VLEWQERF------------DIALGTARGLAYLHS----G 626 (724)
Q Consensus 588 ~~~gsL~-----------~~l---~~--~~---~------~l~~~~~~------------~i~~~ia~~L~yLH~----~ 626 (724)
++|..+. ..+ +. .+ . ...|.... .....+...++++.. .
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 9885431 111 11 00 0 01111110 011123344555542 2
Q ss_pred CCCCeEecCCCCCCeEEeCCCcEEEEeecCcc
Q 043185 627 CEQKIIHCDIKPENILLHYHFQAKISDFGLSK 658 (724)
Q Consensus 627 ~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~ 658 (724)
...+++|+|+++.||+++.++...|+||+.+.
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 34789999999999999998877899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.019 Score=59.51 Aligned_cols=32 Identities=22% Similarity=0.407 Sum_probs=26.5
Q ss_pred CCeEecCCCCCCeEEeCCCc-EEEEeecCcccc
Q 043185 629 QKIIHCDIKPENILLHYHFQ-AKISDFGLSKLL 660 (724)
Q Consensus 629 ~~iiH~Dlkp~NILl~~~~~-~kl~DFGla~~~ 660 (724)
..++|+|+++.|||++.++. .-|+||+.+..-
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 45899999999999997555 569999988654
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.03 Score=60.17 Aligned_cols=139 Identities=17% Similarity=0.102 Sum_probs=78.2
Q ss_pred cccccccEEEEEEEECC-----ccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCcc-ceeceeecCCeEEEEEEecCC
Q 043185 517 LIGSGGFGAVYKGILND-----KTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLV-KLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 517 ~lG~G~fG~Vy~~~~~~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~lV~e~~~~ 590 (724)
.|-.|-.-.+|+....+ ++.+++|.......... +-.+|..++..+...++. ++++.+..+ .|+||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 34446677899887643 25678887754322222 236788888888544443 555655433 58999987
Q ss_pred CCHHHH-------H----------hcCC----C-CCCHHHHHHHHHH-----------------HHHHHHHH----Hc-C
Q 043185 591 GSLDRI-------L----------FGNG----P-VLEWQERFDIALG-----------------TARGLAYL----HS-G 626 (724)
Q Consensus 591 gsL~~~-------l----------~~~~----~-~l~~~~~~~i~~~-----------------ia~~L~yL----H~-~ 626 (724)
.+|... + +... . ..-+....++..+ +...+..| .. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 665311 0 1111 0 1112222222111 11112222 21 2
Q ss_pred CCCCeEecCCCCCCeEEeC-CCcEEEEeecCcccc
Q 043185 627 CEQKIIHCDIKPENILLHY-HFQAKISDFGLSKLL 660 (724)
Q Consensus 627 ~~~~iiH~Dlkp~NILl~~-~~~~kl~DFGla~~~ 660 (724)
....++|+|+++.|||+++ ++.++++||..+..-
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 2356999999999999986 468999999988643
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.02 Score=59.91 Aligned_cols=139 Identities=17% Similarity=0.191 Sum_probs=93.2
Q ss_pred ccccccccEEEEEEEECCccEEEEEEeecCCc---------cc-------------HH----HHHHHHHHHhcCCCCCcc
Q 043185 516 NLIGSGGFGAVYKGILNDKTIVAVKKITNVGV---------QG-------------KK----DFCTEIAIIGNIHHVNLV 569 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~---------~~-------------~~----~~~~E~~~l~~l~H~nIv 569 (724)
-+|..|--+.||.+.-.+|..+|||+++..-. .+ .+ -...|++-|.+++...|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 46888889999999999999999998753100 00 01 123577778887766655
Q ss_pred ceeceeecCCeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcE
Q 043185 570 KLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQA 649 (724)
Q Consensus 570 ~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 649 (724)
-..-+... ...|||+|+.......-.. ....++...+..+-.+++.-|.-|-. ..++||.||.--|+|+. +|.+
T Consensus 230 ~PePIlLk--~hVLVM~FlGrdgw~aPkL-Kd~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Lyh-dG~l 303 (520)
T KOG2270|consen 230 CPEPILLK--NHVLVMEFLGRDGWAAPKL-KDASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLYH-DGKL 303 (520)
T ss_pred CCCceeee--cceEeeeeccCCCCcCccc-ccccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheEE-CCEE
Confidence 33333222 3469999986432211111 12345556666677777777777765 57899999999999995 6789
Q ss_pred EEEeecCcccc
Q 043185 650 KISDFGLSKLL 660 (724)
Q Consensus 650 kl~DFGla~~~ 660 (724)
.|+|.+-+...
T Consensus 304 yiIDVSQSVE~ 314 (520)
T KOG2270|consen 304 YIIDVSQSVEH 314 (520)
T ss_pred EEEEccccccC
Confidence 99999876644
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.0026 Score=65.19 Aligned_cols=132 Identities=15% Similarity=0.128 Sum_probs=87.0
Q ss_pred cccccccccccEEEEEEEECCccEEEEEEee--cCC---------------cc-----cHHHHHHHHHHHhcCCC--CCc
Q 043185 513 NFKNLIGSGGFGAVYKGILNDKTIVAVKKIT--NVG---------------VQ-----GKKDFCTEIAIIGNIHH--VNL 568 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~--~~~---------------~~-----~~~~~~~E~~~l~~l~H--~nI 568 (724)
.+.+.||-|--+-||.+....|++.++|.=+ ..+ .. +.-...+|...|+.+.. --+
T Consensus 95 svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpV 174 (465)
T KOG2268|consen 95 SVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPV 174 (465)
T ss_pred hhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCC
Confidence 3568899999999999999888887777321 000 00 01124567778887742 234
Q ss_pred cceeceeecCCeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCc
Q 043185 569 VKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQ 648 (724)
Q Consensus 569 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 648 (724)
.+.+++ +..++|||++.+-.|...-+.. +... +...+..-+.-|.. .++||+|..-=||++++++.
T Consensus 175 PkpiD~----~RH~Vvmelv~g~Pl~~v~~v~----d~~~---ly~~lm~~Iv~la~---~GlIHgDFNEFNimv~dd~~ 240 (465)
T KOG2268|consen 175 PKPIDH----NRHCVVMELVDGYPLRQVRHVE----DPPT---LYDDLMGLIVRLAN---HGLIHGDFNEFNIMVKDDDK 240 (465)
T ss_pred CCcccc----cceeeHHHhhcccceeeeeecC----ChHH---HHHHHHHHHHHHHH---cCceecccchheeEEecCCC
Confidence 455544 3457899999888775543222 1222 22233333445553 89999999999999999999
Q ss_pred EEEEeecCcc
Q 043185 649 AKISDFGLSK 658 (724)
Q Consensus 649 ~kl~DFGla~ 658 (724)
++++||--..
T Consensus 241 i~vIDFPQmv 250 (465)
T KOG2268|consen 241 IVVIDFPQMV 250 (465)
T ss_pred EEEeechHhh
Confidence 9999996443
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.039 Score=57.39 Aligned_cols=72 Identities=17% Similarity=0.280 Sum_probs=46.7
Q ss_pred ccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcC---CCCCccceeceeecCCeEEEEEEecCCC
Q 043185 516 NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNI---HHVNLVKLKGFCAQGRQRLLVYEYMNHG 591 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~~~~~~lV~e~~~~g 591 (724)
+.++.|....+|+.. .+++.+.||.-.. .....|..|.+-|+.| .-..+.+++++....+..+||+||++.+
T Consensus 23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred EecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 468888899999987 6667799998762 3335677888777777 3556788999887777789999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.12 Score=54.36 Aligned_cols=129 Identities=19% Similarity=0.351 Sum_probs=74.1
Q ss_pred ccEEEEEEee-cCCcccHHHHHHHHHHHhcCCC--CCccceeceeecCC--eEEEEEEecCCCCH---------------
Q 043185 534 KTIVAVKKIT-NVGVQGKKDFCTEIAIIGNIHH--VNLVKLKGFCAQGR--QRLLVYEYMNHGSL--------------- 593 (724)
Q Consensus 534 ~~~vAvK~~~-~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~--~~~lV~e~~~~gsL--------------- 593 (724)
+++.++.+-. ........+..+|.++|+.+.- .-+.+.+++|.++. ..+.||+|.++..+
T Consensus 48 ~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~~ 127 (321)
T COG3173 48 GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFAL 127 (321)
T ss_pred CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHHH
Confidence 4556666221 1223344566788888887743 34455667777766 67999999988322
Q ss_pred ---HHHHhc--C---------C--------CCCCHHHHHHHH--------HHHHHHHHHHHc-----CCCCCeEecCCCC
Q 043185 594 ---DRILFG--N---------G--------PVLEWQERFDIA--------LGTARGLAYLHS-----GCEQKIIHCDIKP 638 (724)
Q Consensus 594 ---~~~l~~--~---------~--------~~l~~~~~~~i~--------~~ia~~L~yLH~-----~~~~~iiH~Dlkp 638 (724)
.++|.. . + +...|....+.+ -....-..+|+. .....++|+|+++
T Consensus 128 ~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~ 207 (321)
T COG3173 128 DALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRP 207 (321)
T ss_pred HHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCccc
Confidence 122210 0 0 000111111100 012223444443 1124599999999
Q ss_pred CCeEEeCCCcEEEEeecCccccCC
Q 043185 639 ENILLHYHFQAKISDFGLSKLLTP 662 (724)
Q Consensus 639 ~NILl~~~~~~kl~DFGla~~~~~ 662 (724)
.||+++.+..+-|.||+++..-.+
T Consensus 208 gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 208 GNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred CCEEEeCCCeeEEEeccccccCCc
Confidence 999999999999999999875443
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.16 Score=55.17 Aligned_cols=72 Identities=15% Similarity=0.188 Sum_probs=49.0
Q ss_pred ccccccccEEEEEEEECCccEEEEEEeecC----Cc---ccHHHHHHHHHHHhcCC---CCCccceeceeecCCeEEEEE
Q 043185 516 NLIGSGGFGAVYKGILNDKTIVAVKKITNV----GV---QGKKDFCTEIAIIGNIH---HVNLVKLKGFCAQGRQRLLVY 585 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~----~~---~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lV~ 585 (724)
+.||.|....||+....+ ..++||+-... .. ....+-..|++.|+.+. ...+.+++.++.+ ..+++|
T Consensus 38 ~eiggGn~N~VyrV~~~~-~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlvM 114 (418)
T PLN02756 38 KEVGDGNLNFVYIVVSSS-GSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIGM 114 (418)
T ss_pred EEcCCCceeeEEEEEcCC-ccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEEE
Confidence 568999999999988654 45889987521 11 13344445566666553 3578888888773 457889
Q ss_pred EecCC
Q 043185 586 EYMNH 590 (724)
Q Consensus 586 e~~~~ 590 (724)
|++++
T Consensus 115 E~L~~ 119 (418)
T PLN02756 115 RYLEP 119 (418)
T ss_pred eecCC
Confidence 99977
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.48 E-value=0.16 Score=53.63 Aligned_cols=32 Identities=9% Similarity=0.173 Sum_probs=28.7
Q ss_pred CCCeEecCCCCCCeEEeCCCcEEEEeecCccc
Q 043185 628 EQKIIHCDIKPENILLHYHFQAKISDFGLSKL 659 (724)
Q Consensus 628 ~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 659 (724)
..+++|+|+.++|||++.++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 45799999999999999999999999998753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.41 E-value=0.0026 Score=76.75 Aligned_cols=157 Identities=13% Similarity=0.073 Sum_probs=109.4
Q ss_pred HHHHHHHhcCCCCCccceeceee--cCCeEEEEEEecCCCCHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHcCC-
Q 043185 554 CTEIAIIGNIHHVNLVKLKGFCA--QGRQRLLVYEYMNHGSLDRILFGNG---PVLEWQERFDIALGTARGLAYLHSGC- 627 (724)
Q Consensus 554 ~~E~~~l~~l~H~nIv~l~g~~~--~~~~~~lV~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~~L~yLH~~~- 627 (724)
..|...+++..|+++.....-.. +..+.+.+++|+..|.+.+.+.+.. +.+...-+...-.+...+..-+|+..
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 34455556678888876554332 2345678899999999999886542 22222222222222244444444422
Q ss_pred -CCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHh
Q 043185 628 -EQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS 706 (724)
Q Consensus 628 -~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt 706 (724)
..--+|++||+-|.+|..+.++|+.++|+.+...+. ........+++-|+.|+....-.++.++|+|..+..+|+.--
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence 234789999999999999999999999999844332 222344567888999998888888999999999999999988
Q ss_pred CCCCC
Q 043185 707 GRRNC 711 (724)
Q Consensus 707 G~~p~ 711 (724)
|..+|
T Consensus 1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred ccHHH
Confidence 88776
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.14 Score=54.20 Aligned_cols=134 Identities=22% Similarity=0.266 Sum_probs=79.8
Q ss_pred ccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCC------ccceece--eecC--CeEEEEEEecCCC
Q 043185 522 GFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVN------LVKLKGF--CAQG--RQRLLVYEYMNHG 591 (724)
Q Consensus 522 ~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~g~--~~~~--~~~~lV~e~~~~g 591 (724)
.-..||+....+++. ++|..+.. ....+...|...+..+.-.. |..+-|- ..-. ...+-+++|++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 456789999888886 77777653 45566777788887773211 1222221 1122 3677899999998
Q ss_pred CHHH-----HHh--------------c----C---CCCCCHHH-------------HHHHHHHHHHHHHHHHc----CCC
Q 043185 592 SLDR-----ILF--------------G----N---GPVLEWQE-------------RFDIALGTARGLAYLHS----GCE 628 (724)
Q Consensus 592 sL~~-----~l~--------------~----~---~~~l~~~~-------------~~~i~~~ia~~L~yLH~----~~~ 628 (724)
.+.. .+. . + .....|.. ......++...++.+.+ ...
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 7762 110 0 0 01223330 01123334444444443 112
Q ss_pred CC---eEecCCCCCCeEEeCCCc-EEEEeecCcc
Q 043185 629 QK---IIHCDIKPENILLHYHFQ-AKISDFGLSK 658 (724)
Q Consensus 629 ~~---iiH~Dlkp~NILl~~~~~-~kl~DFGla~ 658 (724)
.. +||+|+.|.||+++.+.. +.++||+-+.
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 23 999999999999999885 8999998764
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.32 E-value=0.21 Score=53.21 Aligned_cols=72 Identities=13% Similarity=0.078 Sum_probs=46.0
Q ss_pred cccccccEEEEEEEECCc-cEEEEEEeecC------C-cccHHHHHHHHHHHhcCC--CCC-ccceeceeecCCeEEEEE
Q 043185 517 LIGSGGFGAVYKGILNDK-TIVAVKKITNV------G-VQGKKDFCTEIAIIGNIH--HVN-LVKLKGFCAQGRQRLLVY 585 (724)
Q Consensus 517 ~lG~G~fG~Vy~~~~~~~-~~vAvK~~~~~------~-~~~~~~~~~E~~~l~~l~--H~n-Iv~l~g~~~~~~~~~lV~ 585 (724)
.||.|....||++..+++ +.|+||.-... + .-..++..-|.+.|.... -|. +.+++ +.+.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEccccceehH
Confidence 479999999999998754 57999976421 1 122345556777776552 343 44443 33445566999
Q ss_pred EecCC
Q 043185 586 EYMNH 590 (724)
Q Consensus 586 e~~~~ 590 (724)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99865
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.32 E-value=0.29 Score=51.65 Aligned_cols=30 Identities=27% Similarity=0.286 Sum_probs=26.1
Q ss_pred CCCeEecCCCCCCeEEeCCCcEEEEeecCcc
Q 043185 628 EQKIIHCDIKPENILLHYHFQAKISDFGLSK 658 (724)
Q Consensus 628 ~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~ 658 (724)
..+++|+|+++.||+++. +.+.|+||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 367999999999999987 678999999664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 724 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-52 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-51 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-40 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-39 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-35 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-34 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-34 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-32 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-24 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-22 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-22 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-22 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-22 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-22 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-22 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-22 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-21 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-21 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-21 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-21 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-21 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-21 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-21 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-21 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-21 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-21 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-21 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-21 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-20 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-20 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-20 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-20 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-20 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-20 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-19 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-19 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-19 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-19 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-19 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-19 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-19 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-19 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-18 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-18 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-18 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-18 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-18 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-18 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-18 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-18 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-18 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-18 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 9e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-17 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-17 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-17 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-17 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-17 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-17 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-17 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-17 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-17 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-17 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-16 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-16 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-16 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-15 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-15 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-14 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-14 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-14 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 8e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 8e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-13 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-12 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-12 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-12 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-12 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-12 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-12 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-12 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 9e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 7e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-10 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 9e-09 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 9e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 9e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 9e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 9e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-08 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-07 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-07 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-07 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-07 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-07 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 350 bits (901), Expect = e-116
Identities = 108/220 (49%), Positives = 150/220 (68%), Gaps = 6/220 (2%)
Query: 497 GLPQRFDYEELEVATDNF--KNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQG-KKDF 553
G +RF EL+VA+DNF KN++G GGFG VYKG L D T+VAVK++ QG + F
Sbjct: 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQF 74
Query: 554 CTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFG---NGPVLEWQERF 610
TE+ +I H NL++L+GFC +RLLVY YM +GS+ L + P L+W +R
Sbjct: 75 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134
Query: 611 DIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670
IALG+ARGLAYLH C+ KIIH D+K NILL F+A + DFGL+KL+ + + + T
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 194
Query: 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRN 710
+RGT G++APE+L+ SEKTDV+ +G++LLEL++G+R
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRA 234
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 311 bits (798), Expect = e-100
Identities = 97/244 (39%), Positives = 143/244 (58%), Gaps = 9/244 (3%)
Query: 477 SKSGNPNTLSSGDLEAFYIPGLPQRFDYEELEVATDNF--KNLIGSGGFGAVYKGILNDK 534
S N+++ ++ +P R +LE AT+NF K LIG G FG VYKG+L D
Sbjct: 4 KYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG 63
Query: 535 TIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLD 594
VA+K+ T QG ++F TEI + H +LV L GFC + + +L+Y+YM +G+L
Sbjct: 64 AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123
Query: 595 RILFGNGP---VLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKI 651
R L+G+ + W++R +I +G ARGL YLH+ IIH D+K NILL +F KI
Sbjct: 124 RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKI 180
Query: 652 SDFGLSKLLTPEQSSLFTTM-RGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRN 710
+DFG+SK T + +T+ +GT GY+ PE+ ++EK+DVYSFG+VL E++ R
Sbjct: 181 TDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
Query: 711 CSPR 714
Sbjct: 241 IVQS 244
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 303 bits (779), Expect = 7e-98
Identities = 94/237 (39%), Positives = 126/237 (53%), Gaps = 20/237 (8%)
Query: 499 PQRFDYEELEVATDNFK--------NLIGSGGFGAVYKGILNDKTIVAVKKITNV----G 546
F + EL+ T+NF N +G GGFG VYKG +N+ T VAVKK+ +
Sbjct: 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT-VAVKKLAAMVDITT 70
Query: 547 VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFG--NGPVL 604
+ K+ F EI ++ H NLV+L GF + G LVY YM +GSL L P L
Sbjct: 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130
Query: 605 EWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664
W R IA G A G+ +LH E IH DIK NILL F AKISDFGL++
Sbjct: 131 SWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 665 SSLFTTM-RGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSM 720
++ T+ GT Y+APE L I+ K+D+YSFG+VLLE+++G + +
Sbjct: 188 QTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 2e-68
Identities = 70/228 (30%), Positives = 101/228 (44%), Gaps = 23/228 (10%)
Query: 502 FDYEELEVATDNFK--NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAI 559
E L + + + G FG V+K L ++ VAVK Q + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY-VAVKIFPIQDKQSWQ-NEYEVYS 71
Query: 560 IGNIHHVNLVKLKGFCAQGR----QRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALG 615
+ + H N+++ G +G L+ + GSL L N V+ W E IA
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAET 129
Query: 616 TARGLAYLHS-------GCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668
ARGLAYLH G + I H DIK +N+LL + A I+DFGL+ +S+
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 669 TTMR-GTRGYLAPEWL-----TNSAISEKTDVYSFGMVLLELVSGRRN 710
T + GTR Y+APE L + D+Y+ G+VL EL S
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA 237
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 1e-63
Identities = 71/232 (30%), Positives = 119/232 (51%), Gaps = 9/232 (3%)
Query: 483 NTLSSGDLEAFYIPGLPQRFDYEELEVATD--NFKNLIGSGGFGAVYKGILNDKTIVAVK 540
+ +S D+ D +++++ N K IG+G FG V++ + VAVK
Sbjct: 8 HPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSD-VAVK 66
Query: 541 KITNVGVQGK--KDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILF 598
+ + +F E+AI+ + H N+V G Q +V EY++ GSL R+L
Sbjct: 67 ILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH 126
Query: 599 GNGP--VLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGL 656
+G L+ + R +A A+G+ YLH+ I+H ++K N+L+ + K+ DFGL
Sbjct: 127 KSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185
Query: 657 SKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGR 708
S+L S + GT ++APE L + +EK+DVYSFG++L EL + +
Sbjct: 186 SRLKASTFLSS-KSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ 236
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 3e-62
Identities = 71/210 (33%), Positives = 109/210 (51%), Gaps = 17/210 (8%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGN 562
DY+E+E + ++G G FG V K K VA+K+I + +K F E+ +
Sbjct: 6 DYKEIE-----VEEVVGRGAFGVVCKAKWRAKD-VAIKQIESE--SERKAFIVELRQLSR 57
Query: 563 IHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPV--LEWQERFDIALGTARGL 620
++H N+VKL G C LV EY GSL +L G P+ L ++G+
Sbjct: 58 VNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 621 AYLHSGCEQKIIHCDIKPENILLHYHFQ-AKISDFGLSKLLTPEQSSLFTTMRGTRGYLA 679
AYLHS + +IH D+KP N+LL KI DFG + + + T +G+ ++A
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMA 171
Query: 680 PEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
PE S SEK DV+S+G++L E+++ R+
Sbjct: 172 PEVFEGSNYSEKCDVFSWGIILWEVITRRK 201
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 6e-60
Identities = 63/225 (28%), Positives = 110/225 (48%), Gaps = 27/225 (12%)
Query: 500 QRFDYEELEVATDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGK-------K 551
E+E ++ IG GGFG V+KG + DK++VA+K + +G+ +
Sbjct: 14 PTLADNEIE-----YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ 68
Query: 552 DFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFD 611
+F E+ I+ N++H N+VKL G +V E++ G L L ++W +
Sbjct: 69 EFQREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLR 126
Query: 612 IALGTARGLAYLHSGCEQKIIHCDIKPENILL-----HYHFQAKISDFGLSKLLTPEQSS 666
+ L A G+ Y+ + I+H D++ NI L + AK++DFGLS+ +
Sbjct: 127 LMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVH 181
Query: 667 LFTTMRGTRGYLAPEWLT--NSAISEKTDVYSFGMVLLELVSGRR 709
+ + G ++APE + + +EK D YSF M+L +++G
Sbjct: 182 SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 1e-59
Identities = 64/218 (29%), Positives = 105/218 (48%), Gaps = 23/218 (10%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQ----GKKDFCTEIA 558
D+ EL + +IG GGFG VY+ VAVK + + ++ E
Sbjct: 5 DFAELT-----LEEIIGIGGFGKVYRAFWIG-DEVAVKAARHDPDEDISQTIENVRQEAK 58
Query: 559 IIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTAR 618
+ + H N++ L+G C + LV E+ G L+R+L +G + + A+ AR
Sbjct: 59 LFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIAR 116
Query: 619 GLAYLHSGCEQKIIHCDIKPENILLHYHFQ--------AKISDFGLSKLLTPEQSSLFTT 670
G+ YLH IIH D+K NIL+ + KI+DFGL++ + +
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE---WHRTTKMS 173
Query: 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGR 708
G ++APE + S S+ +DV+S+G++L EL++G
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 2e-58
Identities = 69/241 (28%), Positives = 108/241 (44%), Gaps = 35/241 (14%)
Query: 502 FDYEELEVATDNFK--NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAI 559
E + DN K LIG G +GAVYKG L+++ VAVK + +++F E I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERP-VAVKVFSF---ANRQNFINEKNI 58
Query: 560 --IGNIHHVNLVKLKGFCAQG-----RQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDI 612
+ + H N+ + + + LLV EY +GSL + L + +W +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRL 116
Query: 613 ALGTARGLAYLHS------GCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP---- 662
A RGLAYLH+ + I H D+ N+L+ ISDFGLS LT
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 663 ---EQSSLFTTMRGTRGYLAPEWLTNS-------AISEKTDVYSFGMVLLELVSGRRNCS 712
E+ + + GT Y+APE L + + ++ D+Y+ G++ E+ +
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236
Query: 713 P 713
P
Sbjct: 237 P 237
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 2e-58
Identities = 71/223 (31%), Positives = 108/223 (48%), Gaps = 20/223 (8%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGK--KDFCTEIAII 560
++ IGSG FG VYKG + VAVK + + + F E+ ++
Sbjct: 22 PDGQIT-----VGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVL 74
Query: 561 GNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGL 620
HVN++ G+ Q +V ++ SL L + E ++ DIA TARG+
Sbjct: 75 RKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGM 133
Query: 621 AYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP-EQSSLFTTMRGTRGYLA 679
YLH+ + IIH D+K NI LH KI DFGL+ + S F + G+ ++A
Sbjct: 134 DYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190
Query: 680 PEWLTNSAI---SEKTDVYSFGMVLLELVSGR---RNCSPRSQ 716
PE + S ++DVY+FG+VL EL++G+ N + R Q
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 2e-58
Identities = 60/242 (24%), Positives = 110/242 (45%), Gaps = 26/242 (10%)
Query: 498 LPQR-FDYEELEVATDNFKNLIGSGGFGAVYKGILNDKTI-VAVKKITNVGVQGKKDFCT 555
+P R F +L ++G G FG K + + +K++ + ++ F
Sbjct: 2 MPHRIFRPSDLI-----HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLK 56
Query: 556 EIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALG 615
E+ ++ + H N++K G + ++ + EY+ G+L I+ W +R A
Sbjct: 57 EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD 116
Query: 616 TARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF------- 668
A G+AYLHS IIH D+ N L+ + ++DFGL++L+ E++
Sbjct: 117 IASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173
Query: 669 ------TTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRR---NCSPRSQSHS 719
T+ G ++APE + + EK DV+SFG+VL E++ + PR+
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG 233
Query: 720 MD 721
++
Sbjct: 234 LN 235
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 4e-57
Identities = 53/221 (23%), Positives = 89/221 (40%), Gaps = 26/221 (11%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGK--KDFCTEIAII 560
+E+LE LIG G FG VY G + + VA++ I K F E+
Sbjct: 31 PFEQLE-----IGELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMAY 83
Query: 561 GNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGL 620
H N+V G C ++ +L ++ VL+ + IA +G+
Sbjct: 84 RQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGM 143
Query: 621 AYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT----PEQSSLFTTMRGTRG 676
YLH+ + I+H D+K +N+ + I+DFGL + + G
Sbjct: 144 GYLHA---KGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLC 199
Query: 677 YLAPEWLTNSAI---------SEKTDVYSFGMVLLELVSGR 708
+LAPE + + S+ +DV++ G + EL +
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 9e-57
Identities = 46/214 (21%), Positives = 84/214 (39%), Gaps = 21/214 (9%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGK--KDFCTEIAII 560
D+++L F + G ++KG + VK + + +DF E +
Sbjct: 8 DFKQLN-----FLTKLNENHSGELWKGRWQG-NDIVVKVLKVRDWSTRKSRDFNEECPRL 61
Query: 561 GNIHHVNLVKLKGFCAQGRQRLL--VYEYMNHGSLDRILF-GNGPVLEWQERFDIALGTA 617
H N++ + G C + +M +GSL +L G V++ + AL A
Sbjct: 62 RIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMA 121
Query: 618 RGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGY 677
RG+A+LH+ E I + ++++ A+IS + +
Sbjct: 122 RGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAW 174
Query: 678 LAPEWLTNS---AISEKTDVYSFGMVLLELVSGR 708
+APE L D++SF ++L ELV+
Sbjct: 175 VAPEALQKKPEDTNRRSADMWSFAVLLWELVTRE 208
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 1e-52
Identities = 65/260 (25%), Positives = 106/260 (40%), Gaps = 43/260 (16%)
Query: 468 RWKLHKSTDSKSGNPNTLSSGDLEAFYIPGLPQRFDYEELEVATDNFKNLIGSGGFGAVY 527
R + +S S SG SG +P L QR ++++ IG G +G V+
Sbjct: 12 RDLIEQSQSSGSG------SG------LPLLVQRTIAKQIQ-----MVKQIGKGRYGEVW 54
Query: 528 KGILNDKTIVAVKKITNVGVQGKKDFC--TEIAIIGNIHHVNLVKLKGFCAQGR----QR 581
G + VAVK + + TEI + H N++ +G Q
Sbjct: 55 MGKWRGEK-VAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110
Query: 582 LLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHS-----GCEQKIIHCDI 636
L+ +Y +GSL L L+ + +A + GL +LH+ + I H D+
Sbjct: 111 YLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDL 168
Query: 637 KPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTM---RGTRGYLAPEWLTNSAI----- 688
K +NIL+ + I+D GL+ + + + GT+ Y+ PE L S
Sbjct: 169 KSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQ 228
Query: 689 -SEKTDVYSFGMVLLELVSG 707
D+YSFG++L E+
Sbjct: 229 SYIMADMYSFGLILWEVARR 248
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 6e-52
Identities = 64/232 (27%), Positives = 102/232 (43%), Gaps = 31/232 (13%)
Query: 496 PGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCT 555
P L QR + + IG G FG V++G + VAVK ++ + ++ +
Sbjct: 33 PLLVQRTIARTIV-----LQESIGKGRFGEVWRGKWRGEE-VAVKIFSS---REERSWFR 83
Query: 556 E--IAIIGNIHHVNLVKLKGFCAQGR----QRLLVYEYMNHGSLDRILFGNGPVLEWQER 609
E I + H N++ + Q LV +Y HGSL L N + +
Sbjct: 84 EAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGM 141
Query: 610 FDIALGTARGLAYLHS---GCEQK--IIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664
+AL TA GLA+LH G + K I H D+K +NIL+ + I+D GL+
Sbjct: 142 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 201
Query: 665 SSLFTTM---RGTRGYLAPEWLTNSAI------SEKTDVYSFGMVLLELVSG 707
++ GT+ Y+APE L +S ++ D+Y+ G+V E+
Sbjct: 202 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 7e-52
Identities = 59/228 (25%), Positives = 98/228 (42%), Gaps = 31/228 (13%)
Query: 500 QRFDYEELEVATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFC--TEI 557
QR ++ +G G +G V++G + VAVK ++ + +K + TE+
Sbjct: 3 QRTVARDIT-----LLECVGKGRYGEVWRGSWQGEN-VAVKIFSS---RDEKSWFRETEL 53
Query: 558 AIIGNIHHVNLVKLKGFCAQGR----QRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIA 613
+ H N++ R Q L+ Y GSL L L+ I
Sbjct: 54 YNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIV 111
Query: 614 LGTARGLAYLHS-----GCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668
L A GLA+LH + I H D+K +NIL+ + Q I+D GL+ + + + L
Sbjct: 112 LSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLD 171
Query: 669 TTM---RGTRGYLAPEWLTNSAI------SEKTDVYSFGMVLLELVSG 707
GT+ Y+APE L + ++ D+++FG+VL E+
Sbjct: 172 VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-44
Identities = 62/217 (28%), Positives = 91/217 (41%), Gaps = 14/217 (6%)
Query: 498 LPQRFDYEELEVATDNFK--NLIGSGGFGAVYKGILNDKTI-VAVKKI-TNVGVQGKKDF 553
L + ++ + ++ IG G FG V+ G L VAVK + K F
Sbjct: 100 LHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKF 159
Query: 554 CTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIA 613
E I+ H N+V+L G C Q + +V E + G L G L + +
Sbjct: 160 LQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMV 219
Query: 614 LGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRG 673
A G+ YL S + IH D+ N L+ KISDFG+S+ ++ G
Sbjct: 220 GDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREE---ADGVYAASGG 273
Query: 674 TRGY----LAPEWLTNSAISEKTDVYSFGMVLLELVS 706
R APE L S ++DV+SFG++L E S
Sbjct: 274 LRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 7e-43
Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 11/200 (5%)
Query: 514 FKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKG 573
+GSG FG V G + VAVK I G + +F E + + H LVK G
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 574 FCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIH 633
C++ +V EY+++G L L +G LE + ++ G+A+L S + IH
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIH 127
Query: 634 CDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTNSAISE 690
D+ N L+ K+SDFG+++ + + + GT+ + APE S
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYV---LDDQYVSSVGTKFPVKWSAPEVFHYFKYSS 184
Query: 691 KTDVYSFGMVLLELVS-GRR 709
K+DV++FG+++ E+ S G+
Sbjct: 185 KSDVWAFGILMWEVFSLGKM 204
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-42
Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 16/219 (7%)
Query: 514 FKNLIGSGGFGAVYKGIL-----NDKTIVAVKKI-TNVGVQGKKDFCTEIAIIGNIHHVN 567
+G G FG V N VAVK + G D EI I+ N++H N
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84
Query: 568 LVKLKGFCAQGRQR--LLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHS 625
+VK KG C + L+ E++ GSL L N + +++ A+ +G+ YL S
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 626 GCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEW 682
++ +H D+ N+L+ Q KI DFGL+K + +T + APE
Sbjct: 145 ---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEYYTVKDDRDSPVFWYAPEC 200
Query: 683 LTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQSHSM 720
L S +DV+SFG+ L EL++ + SP + M
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKM 239
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 8e-42
Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 514 FKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKG 573
F IGSG FG V+ G +K VA+K I G ++DF E ++ + H LV+L G
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 574 FCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIH 633
C + LV E+M HG L L + + + L G+AYL +IH
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIH 127
Query: 634 CDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTNSAISE 690
D+ N L+ + K+SDFG+++ + +T+ GT+ + +PE + S S
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPVKWASPEVFSFSRYSS 184
Query: 691 KTDVYSFGMVLLELVS-GRR 709
K+DV+SFG+++ E+ S G+
Sbjct: 185 KSDVWSFGVLMWEVFSEGKI 204
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 8e-42
Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 15/218 (6%)
Query: 514 FKNLIGSGGFGAVYKGIL-----NDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNL 568
+ + +G G FG+V N +VAVK++ + G ++DF EI I+ +H +
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 569 VKLKGFCAQGRQR--LLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSG 626
VK +G ++ LV EY+ G L L + L+ + +G+ YL S
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS- 145
Query: 627 CEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRG---YLAPEWL 683
++ +H D+ NIL+ KI+DFGL+KLL P + + + APE L
Sbjct: 146 --RRCVHRDLAARNILVESEAHVKIADFGLAKLL-PLDKDYYVVREPGQSPIFWYAPESL 202
Query: 684 TNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQSHSM 720
+++ S ++DV+SFG+VL EL + ++CSP ++ M
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM 240
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-41
Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 13/214 (6%)
Query: 502 FDYEELEVATDNFK--NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAI 559
Y E+ + +G+G FG V G + VA+K I G + +F E +
Sbjct: 14 LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKV 72
Query: 560 IGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARG 619
+ N+ H LV+L G C + R ++ EYM +G L L + Q+ ++
Sbjct: 73 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 132
Query: 620 LAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR---G 676
+ YL S ++ +H D+ N L++ K+SDFGLS+ + +T+ G++
Sbjct: 133 MEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPVR 186
Query: 677 YLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRR 709
+ PE L S S K+D+++FG+++ E+ S G+
Sbjct: 187 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 220
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 6e-41
Identities = 70/218 (32%), Positives = 109/218 (50%), Gaps = 15/218 (6%)
Query: 514 FKNLIGSGGFGAVYKGIL-----NDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNL 568
F +G G FG+V N +VAVKK+ + + +DF EI I+ ++ H N+
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 569 VKLKGFCAQGRQR--LLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSG 626
VK KG C +R L+ EY+ +GSL L + ++ + +G+ YL +
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT- 132
Query: 627 CEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRG---YLAPEWL 683
++ IH D+ NIL+ + KI DFGL+K+L P+ F + APE L
Sbjct: 133 --KRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEFFKVKEPGESPIFWYAPESL 189
Query: 684 TNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQSHSM 720
T S S +DV+SFG+VL EL + ++ SP ++ M
Sbjct: 190 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 227
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 8e-41
Identities = 75/260 (28%), Positives = 121/260 (46%), Gaps = 20/260 (7%)
Query: 472 HKSTDSKSGNPNTLSSGDLEAFYIPGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGIL 531
H N G + + + P +F+ L+ F +G G FG+V
Sbjct: 8 HHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLK-----FLQQLGKGNFGSVEMCRY 62
Query: 532 -----NDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQR--LLV 584
N +VAVKK+ + + +DF EI I+ ++ H N+VK KG C +R L+
Sbjct: 63 DPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 122
Query: 585 YEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLH 644
EY+ +GSL L + ++ + +G+ YL + ++ IH D+ NIL+
Sbjct: 123 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVE 179
Query: 645 YHFQAKISDFGLSKLLTPEQSSLFTTMRGTRG---YLAPEWLTNSAISEKTDVYSFGMVL 701
+ KI DFGL+K+L P+ + + APE LT S S +DV+SFG+VL
Sbjct: 180 NENRVKIGDFGLTKVL-PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL 238
Query: 702 LELVS-GRRNCSPRSQSHSM 720
EL + ++ SP ++ M
Sbjct: 239 YELFTYIEKSKSPPAEFMRM 258
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-40
Identities = 61/217 (28%), Positives = 107/217 (49%), Gaps = 12/217 (5%)
Query: 495 IPGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGILNDKTI-VAVKKITNVGVQGKKDF 553
I G+ +D E+E K+ +G G +G VY+G+ ++ VAVK + ++F
Sbjct: 205 IYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEF 263
Query: 554 CTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRIL-FGNGPVLEWQERFDI 612
E A++ I H NLV+L G C + ++ E+M +G+L L N + +
Sbjct: 264 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 323
Query: 613 ALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMR 672
A + + YL + IH ++ N L+ + K++DFGLS+L+ +T
Sbjct: 324 ATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHA 377
Query: 673 GTR---GYLAPEWLTNSAISEKTDVYSFGMVLLELVS 706
G + + APE L + S K+DV++FG++L E+ +
Sbjct: 378 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-40
Identities = 69/226 (30%), Positives = 113/226 (50%), Gaps = 19/226 (8%)
Query: 496 PGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGIL----NDKTIVAVKKI-TNVGVQGK 550
PG R E+E + + + +IGSG G V G L VA+K + + +
Sbjct: 35 PGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR 94
Query: 551 KDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERF 610
+DF +E +I+G H N+++L+G +GR ++V EYM +GSLD L + +
Sbjct: 95 RDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLV 154
Query: 611 DIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670
+ G G+ YL +H D+ N+L+ + K+SDFGLS++L + + +TT
Sbjct: 155 GMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT 211
Query: 671 MRG------TRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRR 709
G T APE + S +DV+SFG+V+ E+++ G R
Sbjct: 212 TGGKIPIRWT----APEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-40
Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 8/211 (3%)
Query: 499 PQRFDYEELEVATDNFK--NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTE 556
Q + E+ ++ + +G G FG V+ G N T VA+K + G + F E
Sbjct: 171 TQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQE 229
Query: 557 IAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGN-GPVLEWQERFDIALG 615
++ + H LV+L ++ +V EYM+ GSL L G G L + D+A
Sbjct: 230 AQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 288
Query: 616 TARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR 675
A G+AY+ +H D++ NIL+ + K++DFGL++L+ + + +
Sbjct: 289 IASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 345
Query: 676 GYLAPEWLTNSAISEKTDVYSFGMVLLELVS 706
+ APE + K+DV+SFG++L EL +
Sbjct: 346 KWTAPEAALYGRFTIKSDVWSFGILLTELTT 376
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 514 FKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKG 573
+G+G FG V+ G N T VAVK + G F E ++ + H LV+L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 574 FCAQGRQRLLVYEYMNHGSLDRIL-FGNGPVLEWQERFDIALGTARGLAYLHSGCEQKII 632
Q ++ EYM +GSL L +G L + D+A A G+A++ + I
Sbjct: 76 VVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYI 131
Query: 633 HCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYL-----APEWLTNSA 687
H D++ NIL+ KI+DFGL++L+ + + +T G + APE +
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAK--FPIKWTAPEAINYGT 186
Query: 688 ISEKTDVYSFGMVLLELVS-GRR 709
+ K+DV+SFG++L E+V+ GR
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRI 209
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-39
Identities = 60/221 (27%), Positives = 108/221 (48%), Gaps = 15/221 (6%)
Query: 496 PGLPQRFDYEELEVATDNFK--NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDF 553
+ ++ + E+ ++ K +G+G FG V+ N T VAVK + G + F
Sbjct: 172 SKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAF 230
Query: 554 CTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGN-GPVLEWQERFDI 612
E ++ + H LVKL + ++ E+M GSL L + G + D
Sbjct: 231 LAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF 289
Query: 613 ALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMR 672
+ A G+A++ + IH D++ NIL+ KI+DFGL++++ + +T
Sbjct: 290 SAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTARE 343
Query: 673 GTRG---YLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRR 709
G + + APE + + + K+DV+SFG++L+E+V+ GR
Sbjct: 344 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI 384
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-39
Identities = 65/227 (28%), Positives = 115/227 (50%), Gaps = 20/227 (8%)
Query: 496 PGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGILND-----KTIVAVKKI-TNVGVQG 549
P E+ + + +IG+G FG VYKG+L + VA+K + +
Sbjct: 30 PNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ 89
Query: 550 KKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQER 609
+ DF E I+G H N+++L+G ++ + +++ EYM +G+LD+ L +
Sbjct: 90 RVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQL 149
Query: 610 FDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669
+ G A G+ YL + +H D+ NIL++ + K+SDFGLS++L + + +T
Sbjct: 150 VGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 206
Query: 670 TMRG------TRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRR 709
T G T APE ++ + +DV+SFG+V+ E+++ G R
Sbjct: 207 TSGGKIPIRWT----APEAISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-39
Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 8/211 (3%)
Query: 499 PQRFDYEELEVATDNFK--NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTE 556
Q + E+ ++ + +G G FG V+ G N T VA+K + G + F E
Sbjct: 254 TQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQE 312
Query: 557 IAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGN-GPVLEWQERFDIALG 615
++ + H LV+L ++ +V EYM+ GSL L G G L + D+A
Sbjct: 313 AQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 371
Query: 616 TARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR 675
A G+AY+ +H D++ NIL+ + K++DFGL++L+ + + +
Sbjct: 372 IASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 428
Query: 676 GYLAPEWLTNSAISEKTDVYSFGMVLLELVS 706
+ APE + K+DV+SFG++L EL +
Sbjct: 429 KWTAPEAALYGRFTIKSDVWSFGILLTELTT 459
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 8e-39
Identities = 62/221 (28%), Positives = 109/221 (49%), Gaps = 18/221 (8%)
Query: 497 GLPQRFDYEELEVATDNFK--NLIGSGGFGAVYKGILNDKTI-VAVKKITNVGVQGKKDF 553
G P Y++ E+ + + +G G +G VY+G+ ++ VAVK + ++F
Sbjct: 1 GSPN---YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEF 56
Query: 554 CTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRIL-FGNGPVLEWQERFDI 612
E A++ I H NLV+L G C + ++ E+M +G+L L N + +
Sbjct: 57 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 116
Query: 613 ALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMR 672
A + + YL + IH D+ N L+ + K++DFGLS+L+T + +T
Sbjct: 117 ATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHA 170
Query: 673 GTR---GYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRR 709
G + + APE L + S K+DV++FG++L E+ + G
Sbjct: 171 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 211
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 1e-38
Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 16/208 (7%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKIT-NVGVQGKKDFCTEIAII 560
D+E++ +G+G G V+K ++A K I + + E+ ++
Sbjct: 34 DFEKISE--------LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 85
Query: 561 GNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGL 620
+ +V G + + E+M+ GSLD++L G + E +++ +GL
Sbjct: 86 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSIAVIKGL 144
Query: 621 AYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAP 680
YL + KI+H D+KP NIL++ + K+ DFG+S L S+ + GTR Y++P
Sbjct: 145 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSP 199
Query: 681 EWLTNSAISEKTDVYSFGMVLLELVSGR 708
E L + S ++D++S G+ L+E+ GR
Sbjct: 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 13/203 (6%)
Query: 515 KNLIGSGGFGAVYKGILN---DKTIVAVKKI-TNVGVQGKKDFCTEIAIIGNIHHVNLVK 570
+G G FG+V +G+ + VA+K + ++ E I+ + + +V+
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 571 LKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQK 630
L G C Q +LV E G L + L G + ++ + G+ YL E+
Sbjct: 75 LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKN 130
Query: 631 IIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTNSA 687
+H D+ N+LL AKISDFGLSK L S +T + + APE +
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKAL-GADDSYYTARSAGKWPLKWYAPECINFRK 189
Query: 688 ISEKTDVYSFGMVLLELVS-GRR 709
S ++DV+S+G+ + E +S G++
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQK 212
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-38
Identities = 51/206 (24%), Positives = 102/206 (49%), Gaps = 16/206 (7%)
Query: 514 FKNLIGSGGFGAVYKGIL-----NDKTIVAVKKI-TNVGVQGKKDFCTEIAIIGNIHHVN 567
++GSG FG VYKG+ K VA+K++ + K+ E ++ ++ + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 568 LVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGC 627
+ +L G C L+ + M G L + + + Q + + A+G+ YL
Sbjct: 79 VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--- 134
Query: 628 EQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLT 684
+++++H D+ N+L+ KI+DFGL+KLL E+ G + ++A E +
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--EYHAEGGKVPIKWMALESIL 192
Query: 685 NSAISEKTDVYSFGMVLLELVS-GRR 709
+ + ++DV+S+G+ + EL++ G +
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-38
Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 19/208 (9%)
Query: 514 FKNLIGSGGFGAVYKGILN----DKTIVAVKKI-TNVGVQGKKDFCTEIAIIGNIHHVNL 568
++G+G FG V G L + VA+K + + ++DF E +I+G H N+
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 569 VKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCE 628
++L+G + + ++V EYM +GSLD L + + + G A G+ YL
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD--- 165
Query: 629 QKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRG------TRGYLAPEW 682
+H D+ NIL++ + K+SDFGL ++L + + +TT G T +PE
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT----SPEA 221
Query: 683 LTNSAISEKTDVYSFGMVLLELVS-GRR 709
+ + +DV+S+G+VL E++S G R
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGER 249
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 513 NFKNLIGSGGFGAVYKGIL----NDKTIVAVKKI-TNVGVQGKKDFCTEIAIIGNIHHVN 567
+F +IG G FG VY G L K AVK + + F TE I+ + H N
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 568 LVKLKGFCAQGR-QRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSG 626
++ L G C + L+V YM HG L + ++ L A+G+ YL S
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS- 146
Query: 627 CEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYL-----APE 681
+K +H D+ N +L F K++DFGL++ + ++ T L A E
Sbjct: 147 --KKFVHRDLAARNCMLDEKFTVKVADFGLARDM--YDKEYYSVHNKTGAKLPVKWMALE 202
Query: 682 WLTNSAISEKTDVYSFGMVLLELVS 706
L + K+DV+SFG++L EL++
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 6e-38
Identities = 58/225 (25%), Positives = 102/225 (45%), Gaps = 35/225 (15%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEIAIIG 561
D++E+E+ IGSGGFG V+K D +K++ + E+ +
Sbjct: 12 DFKEIEL--------IGSGGFGQVFKAKHRIDGKTYVIKRVK----YNNEKAEREVKALA 59
Query: 562 NIHHVNLVKLKGF-------------CAQGRQRLLVY---EYMNHGSL-DRILFGNGPVL 604
+ HVN+V G + + ++ E+ + G+L I G L
Sbjct: 60 KLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 119
Query: 605 EWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664
+ ++ +G+ Y+HS +K+I+ D+KP NI L Q KI DFGL L +
Sbjct: 120 DKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL--KN 174
Query: 665 SSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
T +GT Y++PE +++ ++ D+Y+ G++L EL+
Sbjct: 175 DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 68/238 (28%), Positives = 103/238 (43%), Gaps = 23/238 (9%)
Query: 495 IPGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGILND-----KTIVAVKKI-TNVGVQ 548
PG P F L+ +G G FG V + +VAVK + + G Q
Sbjct: 21 GPGDPTVFHKRYLK-----KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQ 75
Query: 549 GKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQR--LLVYEYMNHGSLDRILFGNGPVLEW 606
+ + EI I+ ++H +++K KG C LV EY+ GSL L + +
Sbjct: 76 HRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGL 133
Query: 607 QERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666
+ A G+AYLH+ Q IH D+ N+LL KI DFGL+K + PE
Sbjct: 134 AQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV-PEGHE 189
Query: 667 LFTTMRGTR---GYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQSHSM 720
+ + APE L +DV+SFG+ L EL++ + SP ++ +
Sbjct: 190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL 247
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-37
Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 513 NFKNLIGSGGFGAVYKGIL----NDKTIVAVKKI-TNVGVQGKKDFCTEIAIIGNIHHVN 567
+F +IG G FG VY G L K AVK + + F TE I+ + H N
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 568 LVKLKGFCAQGR-QRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSG 626
++ L G C + L+V YM HG L + ++ L A+G+ +L S
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS- 210
Query: 627 CEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYL-----APE 681
+K +H D+ N +L F K++DFGL++ + + T L A E
Sbjct: 211 --KKFVHRDLAARNCMLDEKFTVKVADFGLARDM--YDKEFDSVHNKTGAKLPVKWMALE 266
Query: 682 WLTNSAISEKTDVYSFGMVLLELVS 706
L + K+DV+SFG++L EL++
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 16/206 (7%)
Query: 514 FKNLIGSGGFGAVYKGIL-----NDKTIVAVKKI-TNVGVQGKKDFCTEIAIIGNIHHVN 567
++GSG FG V+KG+ + K V +K I G Q + + IG++ H +
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 568 LVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGC 627
+V+L G C LV +Y+ GSL + + L Q + + A+G+ YL
Sbjct: 77 IVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE--- 132
Query: 628 EQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLT 684
E ++H ++ N+LL Q +++DFG++ LL + ++A E +
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLL--PPDDKQLLYSEAKTPIKWMALESIH 190
Query: 685 NSAISEKTDVYSFGMVLLELVS-GRR 709
+ ++DV+S+G+ + EL++ G
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 61/244 (25%), Positives = 93/244 (38%), Gaps = 22/244 (9%)
Query: 472 HKSTDSKSGNPNTLSSGDLEAFYIPGLPQRF---DYEELEVATDNFKNLIGSGGFGAVYK 528
H+ + S Y P P+ F ++ L +G G +G V+K
Sbjct: 24 HQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSR--------LGHGSYGEVFK 75
Query: 529 GI-LNDKTIVAVKKIT--NVGVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLV 584
D + AVK+ G + + E+ + H V+L+ +G L
Sbjct: 76 VRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135
Query: 585 YEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLH 644
E SL + G L + + T LA+LHS Q ++H D+KP NI L
Sbjct: 136 TELCG-PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLG 191
Query: 645 YHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLEL 704
+ K+ DFGL L + G Y+APE L S DV+S G+ +LE+
Sbjct: 192 PRGRCKLGDFGLLVELGTAGAG--EVQEGDPRYMAPELLQGSY-GTAADVFSLGLTILEV 248
Query: 705 VSGR 708
Sbjct: 249 ACNM 252
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 55/237 (23%), Positives = 100/237 (42%), Gaps = 26/237 (10%)
Query: 481 NPNTLSSGDLEAFYIPGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGIL----NDKTI 536
+ ++ +++ IP + +IG G FG VY G ++
Sbjct: 2 DLDSALLAEVKDVLIP-----HERVVTH-----SDRVIGKGHFGVVYHGEYIDQAQNRIQ 51
Query: 537 VAVKKI-TNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR-QRLLVYEYMNHGSLD 594
A+K + +Q + F E ++ ++H N++ L G ++ YM HG L
Sbjct: 52 CAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLL 111
Query: 595 RILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDF 654
+ + ++ L ARG+ YL QK +H D+ N +L F K++DF
Sbjct: 112 QFIRSPQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADF 168
Query: 655 GLSKLLTPEQSSLFTTMRGTRGYL-----APEWLTNSAISEKTDVYSFGMVLLELVS 706
GL++ + ++ + L A E L + K+DV+SFG++L EL++
Sbjct: 169 GLARDI--LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 38/220 (17%)
Query: 514 FKNLIGSGGFGAVYKGILND--------KTIVAVKKITNVGVQGKKDFCTEIAIIGNIHH 565
F +G G F ++KG+ + +T V +K + + F +++ + H
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 566 VNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHS 625
+LV G C G + +LV E++ GSLD L N + + ++A A + +L
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE 131
Query: 626 GCEQKIIHCDIKPENILLHYHFQ--------AKISDFGLSKLLTPEQSSLFTTMRGTRGY 677
+IH ++ +NILL K+SD G+S + P+
Sbjct: 132 ---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-----------IL 177
Query: 678 ------LAPEWLTNSAI-SEKTDVYSFGMVLLELVS-GRR 709
+ PE + N + TD +SFG L E+ S G +
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-37
Identities = 64/202 (31%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 514 FKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKG 573
IG G FG V G VAVK I + F E +++ + H NLV+L G
Sbjct: 197 LLQTIGKGEFGDVMLGDYRGNK-VAVKCI-KNDAT-AQAFLAEASVMTQLRHSNLVQLLG 253
Query: 574 FCAQGRQRL-LVYEYMNHGSLDRILFGNGP-VLEWQERFDIALGTARGLAYLHSGCEQKI 631
+ + L +V EYM GSL L G VL +L + YL
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNF 310
Query: 632 IHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTNSAI 688
+H D+ N+L+ AK+SDFGL+K +T + + APE L
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKF 363
Query: 689 SEKTDVYSFGMVLLELVS-GRR 709
S K+DV+SFG++L E+ S GR
Sbjct: 364 STKSDVWSFGILLWEIYSFGRV 385
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-37
Identities = 66/249 (26%), Positives = 93/249 (37%), Gaps = 36/249 (14%)
Query: 479 SGNPNTLSSGDLEAFYIPGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGILND----- 533
NPN +G I L + + + +G G FG VY+G ++
Sbjct: 7 HHNPNYCFAGK--TSSISDLKE-VPRKNIT-----LIRGLGHGAFGEVYEGQVSGMPNDP 58
Query: 534 -KTIVAVKKI-TNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHG 591
VAVK + Q + DF E II +H N+V+ G Q R ++ E M G
Sbjct: 59 SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGG 118
Query: 592 SLD------RILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY 645
L R L + +A A G YL IH DI N LL
Sbjct: 119 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTC 175
Query: 646 ---HFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYL-----APEWLTNSAISEKTDVYSF 697
AKI DFG+++ + +G L PE + KTD +SF
Sbjct: 176 PGPGRVAKIGDFGMARDIYRAS----YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 231
Query: 698 GMVLLELVS 706
G++L E+ S
Sbjct: 232 GVLLWEIFS 240
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 4e-37
Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 515 KNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKG 573
+ +G G FG V++ AVKK+ + V + E+ + +V L G
Sbjct: 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVE----ELVACAGLSSPRIVPLYG 117
Query: 574 FCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIH 633
+G + E + GSL +++ G + E + + GL YLH+ ++I+H
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALY-YLGQALEGLEYLHT---RRILH 173
Query: 634 CDIKPENILL-HYHFQAKISDFGLSKLLTPEQSSLFT----TMRGTRGYLAPEWLTNSAI 688
D+K +N+LL +A + DFG + L P+ + GT ++APE +
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 233
Query: 689 SEKTDVYSFGMVLLELVSGRRNCSPRSQSHSM 720
K D++S ++L +++G P +Q
Sbjct: 234 DAKVDIWSSCCMMLHMLNGCH---PWTQYFRG 262
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-37
Identities = 54/254 (21%), Positives = 101/254 (39%), Gaps = 34/254 (13%)
Query: 471 LHKSTDSKSGNPNTLSSGDLEAFYIPGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGI 530
+H SG + ++ + G Y L+ IGSGG V++ +
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMSVKG----RIYSILK--------QIGSGGSSKVFQVL 48
Query: 531 LNDKTIVAVKKITNVGVQGK--KDFCTEIAIIGNIHHVNL--VKLKGFCAQGRQRLLVYE 586
K I A+K + + + EIA + + + ++L + + +V E
Sbjct: 49 NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 108
Query: 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYH 646
N L+ L + W+ + + +H I+H D+KP N L+
Sbjct: 109 CGN-IDLNSWLKKKKSIDPWERKS-YWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-D 162
Query: 647 FQAKISDFGLSKLLTPEQSSLF-TTMRGTRGYLAPEWLTNSA-----------ISEKTDV 694
K+ DFG++ + P+ +S+ + GT Y+ PE + + + IS K+DV
Sbjct: 163 GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 222
Query: 695 YSFGMVLLELVSGR 708
+S G +L + G+
Sbjct: 223 WSLGCILYYMTYGK 236
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 9e-37
Identities = 58/215 (26%), Positives = 92/215 (42%), Gaps = 19/215 (8%)
Query: 514 FKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKD---FCTEIAIIGNIHHVNLV 569
F IG G F VYKG+ VA ++ K + F E ++ + H N+V
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCEL-QDRKLTKSERQRFKEEAEMLKGLQHPNIV 88
Query: 570 KLKGFC---AQGRQRLLVY-EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHS 625
+ +G++ +++ E M G+L L + R +GL +LH+
Sbjct: 89 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLR-SWCRQILKGLQFLHT 147
Query: 626 GCEQKIIHCDIKPENILL-HYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT 684
IIH D+K +NI + KI D GL+ L ++S + GT ++APE
Sbjct: 148 -RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMYE 203
Query: 685 NSAISEKTDVYSFGMVLLELVSGRR---NCSPRSQ 716
E DVY+FGM +LE+ + C +Q
Sbjct: 204 EKY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQ 237
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 12/200 (6%)
Query: 517 LIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFC 575
++G G +G VY G L+++ +A+K+I + + EIA+ ++ H N+V+ G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 576 AQGRQRLLVYEYMNHGSLDRIL---FGNGPVLEWQERFDIALGTARGLAYLHSGCEQKII 632
++ + E + GSL +L +G E F GL YLH +I+
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF-YTKQILEGLKYLHD---NQIV 144
Query: 633 HCDIKPENILLHYHF-QAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAI--S 689
H DIK +N+L++ + KISDFG SK L T GT Y+APE +
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT-ETFTGTLQYMAPEIIDKGPRGYG 203
Query: 690 EKTDVYSFGMVLLELVSGRR 709
+ D++S G ++E+ +G+
Sbjct: 204 KAADIWSLGCTIIEMATGKP 223
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 47/214 (21%), Positives = 86/214 (40%), Gaps = 23/214 (10%)
Query: 513 NFKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKD-FCTEIAIIGNIHHVNLVK 570
+++G G V++G + A+K N+ D E ++ ++H N+VK
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 571 LKGF--CAQGRQRLLVYEYMNHGSL-DRIL-FGNGPVLEWQERFDIALGTARGLAYLHSG 626
L R ++L+ E+ GSL + N L E + G+ +L
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE- 130
Query: 627 CEQKIIHCDIKPENILLHYHFQA----KISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEW 682
I+H +IKP NI+ K++DFG ++ L ++ F ++ GT YL P+
Sbjct: 131 --NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--QFVSLYGTEEYLHPDM 186
Query: 683 LTNSAI--------SEKTDVYSFGMVLLELVSGR 708
+ + D++S G+ +G
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-36
Identities = 51/206 (24%), Positives = 102/206 (49%), Gaps = 16/206 (7%)
Query: 514 FKNLIGSGGFGAVYKGIL-----NDKTIVAVKKI-TNVGVQGKKDFCTEIAIIGNIHHVN 567
++GSG FG VYKG+ K VA+K++ + K+ E ++ ++ + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 568 LVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGC 627
+ +L G C L+ + M G L + + + Q + + A+G+ YL
Sbjct: 79 VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--- 134
Query: 628 EQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLT 684
+++++H D+ N+L+ KI+DFGL+KLL E+ G + ++A E +
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--EYHAEGGKVPIKWMALESIL 192
Query: 685 NSAISEKTDVYSFGMVLLELVS-GRR 709
+ + ++DV+S+G+ + EL++ G +
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-36
Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 26/210 (12%)
Query: 513 NFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCT----EIAIIGNI-HHVN 567
K+++G G G + + D VAVK+I + + E+ ++ H N
Sbjct: 27 CPKDVLGHGAEGTIVYRGMFDNRDVAVKRI-------LPECFSFADREVQLLRESDEHPN 79
Query: 568 LVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGC 627
+++ + + + E +L + E + T GLA+LHS
Sbjct: 80 VIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS-- 136
Query: 628 EQKIIHCDIKPENILL-----HYHFQAKISDFGLSKLLTPEQSSL--FTTMRGTRGYLAP 680
I+H D+KP NIL+ H +A ISDFGL K L + S + + GT G++AP
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 681 EWLTNSAI---SEKTDVYSFGMVLLELVSG 707
E L+ + D++S G V ++S
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-36
Identities = 71/349 (20%), Positives = 132/349 (37%), Gaps = 40/349 (11%)
Query: 388 KNSSGSCYMLGNVLGSIMSSNTVDSDLVGYIKVLVGPTQADLNPNNSSSNQNQDFPLVAL 447
K ++ + N + +I SN+ D D G +++ + L S +
Sbjct: 256 KGANPTHLADFNQVQTIQYSNSEDKDRKGMLQLKIAGAPEPLTVTAPSLTIA-----ENM 310
Query: 448 VLLPFTGFFLFS-ALGFLWWRRWKLHKST----------DSKSGNPNTLSSGDLEAFYIP 496
L L + A R K + + + +T+S + + Y
Sbjct: 311 ADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDD-YAE 369
Query: 497 GLPQRFDYE-----ELEVATDNFK--NLIGSGGFGAVYKGIL----NDKTIVAVKKI-TN 544
+ + Y + E+ + + IG G FG V++GI N VA+K
Sbjct: 370 IIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC 429
Query: 545 VGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVL 604
++ F E + H ++VKL G + ++ E G L L L
Sbjct: 430 TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSL 488
Query: 605 EWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664
+ A + LAYL S ++ +H DI N+L+ + K+ DFGLS+ + +
Sbjct: 489 DLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---E 542
Query: 665 SSLFTTMRGTR---GYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRR 709
S + + ++APE + + +DV+ FG+ + E++ G +
Sbjct: 543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 591
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 16/205 (7%)
Query: 514 FKNLIGSGGFGAVYKGILND----KTIVAVKKI-TNVGVQGKKDFCTEIAIIGNIHHVNL 568
++G G FG VY+G+ + K VAVK + + K+ F +E I+ N+ H ++
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 569 VKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCE 628
VKL G + ++ E +G L L N L+ +L + +AYL S
Sbjct: 76 VKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES--- 131
Query: 629 QKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTN 685
+H DI NIL+ K+ DFGLS+ + + + TR +++PE +
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYI---EDEDYYKASVTRLPIKWMSPESINF 188
Query: 686 SAISEKTDVYSFGMVLLELVS-GRR 709
+ +DV+ F + + E++S G++
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 61/232 (26%), Positives = 99/232 (42%), Gaps = 35/232 (15%)
Query: 503 DYEELEVATDN--FKNLIGSGGFGAVYKGILND------KTIVAVKKITNVGVQGKKDFC 554
+ + K +G G FG V+ + K +VAVK + + + +KDF
Sbjct: 6 GIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQ 65
Query: 555 TEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQER----- 609
E ++ N+ H ++VK G C G ++V+EYM HG L++ L +GP
Sbjct: 66 REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 610 ----------FDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKL 659
IA A G+ YL S Q +H D+ N L+ + KI DFG+S+
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRD 182
Query: 660 LTPEQSSLFTTMRGTRGYL-----APEWLTNSAISEKTDVYSFGMVLLELVS 706
+ G L PE + + ++DV+SFG++L E+ +
Sbjct: 183 VYSTD----YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-36
Identities = 66/251 (26%), Positives = 115/251 (45%), Gaps = 41/251 (16%)
Query: 479 SGNPNTLSSGDLEAFYIPGLPQRFDYEELEVATDN--FKNLIGSGGFGAVYKGILND--- 533
S NP S+ D+ Y+P +E EVA + +G G FG VY+G+
Sbjct: 3 SVNPEYFSAADV---YVP--------DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVK 51
Query: 534 ---KTIVAVKKI-TNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589
+T VA+K + ++ + +F E +++ + ++V+L G +QG+ L++ E M
Sbjct: 52 DEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMT 111
Query: 590 HGSLDRILFGNGPVLEWQERF---------DIALGTARGLAYLHSGCEQKIIHCDIKPEN 640
G L L P + +A A G+AYL++ K +H D+ N
Sbjct: 112 RGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARN 168
Query: 641 ILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYL-----APEWLTNSAISEKTDVY 695
++ F KI DFG+++ + +G +G L +PE L + + +DV+
Sbjct: 169 CMVAEDFTVKIGDFGMTRDIYETD----YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVW 224
Query: 696 SFGMVLLELVS 706
SFG+VL E+ +
Sbjct: 225 SFGVVLWEIAT 235
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 4e-36
Identities = 70/258 (27%), Positives = 97/258 (37%), Gaps = 36/258 (13%)
Query: 470 KLHKSTDSKSGNPNTLSSGDLEAFYIPGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKG 529
KL ST NPN +G I L + + + +G G FG VY+G
Sbjct: 39 KLRTSTIMTDYNPNYCFAGK--TSSISDLKE-VPRKNIT-----LIRGLGHGAFGEVYEG 90
Query: 530 ILND------KTIVAVKKI-TNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRL 582
++ VAVK + Q + DF E II +H N+V+ G Q R
Sbjct: 91 QVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150
Query: 583 LVYEYMNHGSLD------RILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDI 636
++ E M G L R L + +A A G YL IH DI
Sbjct: 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDI 207
Query: 637 KPENILLHY---HFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYL-----APEWLTNSAI 688
N LL AKI DFG+++ + +G L PE
Sbjct: 208 AARNCLLTCPGPGRVAKIGDFGMARDIYRAG----YYRKGGCAMLPVKWMPPEAFMEGIF 263
Query: 689 SEKTDVYSFGMVLLELVS 706
+ KTD +SFG++L E+ S
Sbjct: 264 TSKTDTWSFGVLLWEIFS 281
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-36
Identities = 67/218 (30%), Positives = 92/218 (42%), Gaps = 25/218 (11%)
Query: 502 FDYEELEVATDNFK--NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAI 559
F + K IG G FG V G VAVK I + F E ++
Sbjct: 11 FYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNK-VAVKCI-KNDAT-AQAFLAEASV 67
Query: 560 IGNIHHVNLVKLKGFCAQGRQRL-LVYEYMNHGSLDRILFGNGP-VLEWQERFDIALGTA 617
+ + H NLV+L G + + L +V EYM GSL L G VL +L
Sbjct: 68 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 127
Query: 618 RGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGY 677
+ YL +H D+ N+L+ AK+SDFGL+K +T +
Sbjct: 128 EAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGK-- 175
Query: 678 L-----APEWLTNSAISEKTDVYSFGMVLLELVS-GRR 709
L APE L S K+DV+SFG++L E+ S GR
Sbjct: 176 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 213
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-36
Identities = 63/251 (25%), Positives = 102/251 (40%), Gaps = 46/251 (18%)
Query: 481 NPNTLSSGDLEAFYIPGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGILND------K 534
NP S + ++ K +G G FG V+ ++ K
Sbjct: 26 NPQYFSDACV---------HHIKRRDIV-----LKWELGEGAFGKVFLAECHNLLPEQDK 71
Query: 535 TIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLD 594
+VAVK + ++DF E ++ + H ++V+ G C +GR L+V+EYM HG L+
Sbjct: 72 MLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 131
Query: 595 RILFGNGPVLEWQER--------------FDIALGTARGLAYLHSGCEQKIIHCDIKPEN 640
R L +GP + +A A G+ YL +H D+ N
Sbjct: 132 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRN 188
Query: 641 ILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYL-----APEWLTNSAISEKTDVY 695
L+ KI DFG+S+ + G R L PE + + ++DV+
Sbjct: 189 CLVGQGLVVKIGDFGMSRDIYSTD----YYRVGGRTMLPIRWMPPESILYRKFTTESDVW 244
Query: 696 SFGMVLLELVS 706
SFG+VL E+ +
Sbjct: 245 SFGVVLWEIFT 255
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-36
Identities = 51/205 (24%), Positives = 87/205 (42%), Gaps = 16/205 (7%)
Query: 514 FKNLIGSGGFGAVYKGIL----NDKTIVAVKKI-TNVGVQGKKDFCTEIAIIGNIHHVNL 568
IG G FG V++GI N VA+K ++ F E + H ++
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 569 VKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCE 628
VKL G + ++ E G L L L+ A + LAYL S
Sbjct: 79 VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES--- 134
Query: 629 QKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTN 685
++ +H DI N+L+ + K+ DFGLS+ + + S + + ++APE +
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINF 191
Query: 686 SAISEKTDVYSFGMVLLELVS-GRR 709
+ +DV+ FG+ + E++ G +
Sbjct: 192 RRFTSASDVWMFGVCMWEILMHGVK 216
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 9e-36
Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 16/207 (7%)
Query: 514 FKNLIGSGGFGAVYKGILN----DKTIVAVKKI---TNVGVQGKKDFCTEIAIIGNIHHV 566
+G G FG V +G + VAVK + + DF E+ + ++ H
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 567 NLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSG 626
NL++L G +V E GSL L + A+ A G+ YL S
Sbjct: 82 NLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES- 139
Query: 627 CEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWL 683
++ IH D+ N+LL KI DFGL + L P+ + + + APE L
Sbjct: 140 --KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL-PQNDDHYVMQEHRKVPFAWCAPESL 196
Query: 684 TNSAISEKTDVYSFGMVLLELVS-GRR 709
S +D + FG+ L E+ + G+
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 66/238 (27%), Positives = 103/238 (43%), Gaps = 35/238 (14%)
Query: 494 YIPGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGILND---KTIVAVKKI-TNVGVQG 549
+ P Y L+ F+++IG G FG V K + + A+K++
Sbjct: 9 HGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD 68
Query: 550 KKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRIL----------- 597
+DF E+ ++ + HH N++ L G C L EY HG+L L
Sbjct: 69 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA 128
Query: 598 ----FGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISD 653
L Q+ A ARG+ YL ++ IH D+ NIL+ ++ AKI+D
Sbjct: 129 FAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIAD 185
Query: 654 FGLSKLLTPEQSSLFTTMRGTRGYL-----APEWLTNSAISEKTDVYSFGMVLLELVS 706
FGLS+ ++ T G L A E L S + +DV+S+G++L E+VS
Sbjct: 186 FGLSR-------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 142 bits (358), Expect = 1e-35
Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 13/222 (5%)
Query: 496 PGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGIL---NDKTIVAVKKI-TNVGVQGKK 551
P + +G G FG+V +G+ + VA+K + +
Sbjct: 322 PEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE 381
Query: 552 DFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFD 611
+ E I+ + + +V+L G C Q +LV E G L + L G + +
Sbjct: 382 EMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE 440
Query: 612 IALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTM 671
+ + G+ YL E+ +H ++ N+LL AKISDFGLSK L S +T
Sbjct: 441 LLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL-GADDSYYTAR 496
Query: 672 RGTR---GYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRR 709
+ + APE + S ++DV+S+G+ + E +S G++
Sbjct: 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 538
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 67/251 (26%), Positives = 108/251 (43%), Gaps = 26/251 (10%)
Query: 473 KSTDSKSGNPNTLSSGDLEAFYIPGLPQRFDYEELEVATDNFKNL--------IGSGGFG 524
+ D P A IP P FD+ + + +G G FG
Sbjct: 44 SNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFG 103
Query: 525 AVYKGILND-KTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLL 583
V+K +A K I G++ K++ EI+++ + H NL++L +L
Sbjct: 104 QVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL 163
Query: 584 VYEYMNHGSL-DRILFGNGPVLEWQERFDIALGTAR----GLAYLHSGCEQKIIHCDIKP 638
V EY++ G L DRI+ + + E + + G+ ++H I+H D+KP
Sbjct: 164 VMEYVDGGELFDRIIDESYNLTELD-----TILFMKQICEGIRHMHQ---MYILHLDLKP 215
Query: 639 ENILLHYHFQA--KISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYS 696
ENIL KI DFGL++ P + GT +LAPE + +S TD++S
Sbjct: 216 ENILCVNRDAKQIKIIDFGLARRYKPREK--LKVNFGTPEFLAPEVVNYDFVSFPTDMWS 273
Query: 697 FGMVLLELVSG 707
G++ L+SG
Sbjct: 274 VGVIAYMLLSG 284
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 142 bits (358), Expect = 2e-35
Identities = 68/210 (32%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 514 FKNLIGSGGFGAVYKGILNDKT--IVAVKKITNVGVQGKKD-FCTEIAIIGNIHHVNLVK 570
K +G+GGFG V + I + T VA+K+ ++ +C EI I+ ++H N+V
Sbjct: 18 MKERLGTGGFGYVLRWI-HQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 76
Query: 571 L------KGFCAQGRQRLLVYEYMNHGSL-DRIL-FGNGPVLEWQERFDIALGTARGLAY 622
A LL EY G L + F N L+ + + L Y
Sbjct: 77 AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRY 136
Query: 623 LHSGCEQKIIHCDIKPENILLHYHFQA---KISDFGLSKLLTPEQSSLFTTMRGTRGYLA 679
LH E +IIH D+KPENI+L Q KI D G +K L L T GT YLA
Sbjct: 137 LH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--ELCTEFVGTLQYLA 191
Query: 680 PEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
PE L + D +SFG + E ++G R
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 49/209 (23%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 516 NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGK--KDFCTEIAIIGNI--HHVNLVKL 571
IGSGG V++ + K I A+K + + + EIA + + H +++L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 572 KGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKI 631
+ + +V E N L+ L + W+ + + +H + I
Sbjct: 75 YDYEITDQYIYMVMECGN-IDLNSWLKKKKSIDPWERKS-YWKNMLEAVHTIH---QHGI 129
Query: 632 IHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF-TTMRGTRGYLAPEWLTNSA--- 687
+H D+KP N L+ K+ DFG++ + P+ +S+ + GT Y+ PE + + +
Sbjct: 130 VHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188
Query: 688 --------ISEKTDVYSFGMVLLELVSGR 708
IS K+DV+S G +L + G+
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 15/201 (7%)
Query: 518 IGSGGFGAVYKGILNDK---TIVAVK--KITNVGVQGKKDFCTEIAIIGNIHHVNLVKLK 572
+GSG FG V KG K VAVK K K + E ++ + + +V++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 573 GFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKII 632
G C + +LV E G L++ L N ++ + ++ + G+ YL +
Sbjct: 85 GIC-EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEE---SNFV 139
Query: 633 HCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR---GYLAPEWLTNSAIS 689
H D+ N+LL AKISDFGLSK L ++ + + + + APE + S
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADE-NYYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 690 EKTDVYSFGMVLLELVS-GRR 709
K+DV+SFG+++ E S G++
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQK 219
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 51/233 (21%), Positives = 95/233 (40%), Gaps = 40/233 (17%)
Query: 501 RF--DYEELEVATDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQ-GKKDFCTE 556
R+ D+E ++ +G GGFG V++ D A+K+I + ++ E
Sbjct: 2 RYLTDFEPIQC--------LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMRE 53
Query: 557 IAIIGNIHHVNLVKLKGF---------CAQGRQRLLVY---EYMNHGSLDRILFGNGPVL 604
+ + + H +V+ ++ +Y + +L + G +
Sbjct: 54 VKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIE 113
Query: 605 EWQERF--DIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT- 661
E + I L A + +LHS + ++H D+KP NI K+ DFGL +
Sbjct: 114 ERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 170
Query: 662 ----------PEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLEL 704
+ T GT+ Y++PE + ++ S K D++S G++L EL
Sbjct: 171 DEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 64/242 (26%), Positives = 100/242 (41%), Gaps = 52/242 (21%)
Query: 501 RF--DYEELEVATDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEI 557
R+ D+EE+ V +G G FG V K D A+KKI + + +E+
Sbjct: 3 RYASDFEEIAV--------LGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEV 53
Query: 558 AIIGNIHHVNLVKLKG-FCAQGRQRL------------LVYEYMNHGSL-DRILFGNGPV 603
++ +++H +V+ + + + EY +G+L D I N
Sbjct: 54 MLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQ 113
Query: 604 LEWQERFDIALGTAR----GLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKL 659
D R L+Y+HS Q IIH D+KP NI + KI DFGL+K
Sbjct: 114 QR-----DEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKN 165
Query: 660 LT-------------PEQSSLFTTMRGTRGYLAPEWLTNSAI-SEKTDVYSFGMVLLELV 705
+ P S T+ GT Y+A E L + +EK D+YS G++ E++
Sbjct: 166 VHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225
Query: 706 SG 707
Sbjct: 226 YP 227
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 51/215 (23%), Positives = 101/215 (46%), Gaps = 21/215 (9%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGV---QGKKDFCTEIA 558
++ + IG G F VY+ L D VA+KK+ + + + D EI
Sbjct: 33 NFRIEKK--------IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEID 84
Query: 559 IIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRIL--FGNGPVLEWQERF--DIAL 614
++ ++H N++K + + +V E + G L R++ F L ER +
Sbjct: 85 LLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL-IPERTVWKYFV 143
Query: 615 GTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGT 674
L ++HS ++++H DIKP N+ + K+ D GL + + +++ ++ GT
Sbjct: 144 QLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGT 199
Query: 675 RGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
Y++PE + + + K+D++S G +L E+ + +
Sbjct: 200 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 234
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-35
Identities = 57/242 (23%), Positives = 101/242 (41%), Gaps = 27/242 (11%)
Query: 472 HKSTDSKSGNPNTLSSGDLEAFYIPGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGI- 530
H + L +E Y L+ IG G FG
Sbjct: 5 HHHSSGVDLGTENLYFQSME-----------KYVRLQK--------IGEGSFGKAILVKS 45
Query: 531 LNDKTIVAVKKI--TNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588
D +K+I + + + +++ E+A++ N+ H N+V+ + + +V +Y
Sbjct: 46 TEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYC 105
Query: 589 NHGSL-DRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHF 647
G L RI G + + + D + L ++H +KI+H DIK +NI L
Sbjct: 106 EGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDG 162
Query: 648 QAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSG 707
++ DFG++++L L GT YL+PE N + K+D+++ G VL EL +
Sbjct: 163 TVQLGDFGIARVLN-STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTL 221
Query: 708 RR 709
+
Sbjct: 222 KH 223
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 51/225 (22%), Positives = 100/225 (44%), Gaps = 30/225 (13%)
Query: 505 EELEVATDN--FKNLIGSGGFGAVYKGILNDK----TIVAVK--KITNVGVQGKKDFCTE 556
E++ + + ++G G FG+V +G L + VAVK K+ N + ++F +E
Sbjct: 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE 86
Query: 557 IAIIGNIHHVNLVKLKGFCAQGRQR-----LLVYEYMNHGSLDRIL-----FGNGPVLEW 606
A + + H N+++L G C + + +++ +M +G L L +
Sbjct: 87 AACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL 146
Query: 607 QERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666
Q + A G+ YL + + +H D+ N +L ++DFGLSK +
Sbjct: 147 QTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKI--YSGD 201
Query: 667 LFTTMRGTRGYL-----APEWLTNSAISEKTDVYSFGMVLLELVS 706
+ +G + A E L + + K+DV++FG+ + E+ +
Sbjct: 202 YYR--QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-35
Identities = 50/215 (23%), Positives = 88/215 (40%), Gaps = 25/215 (11%)
Query: 513 NFKNLIGSGGFGAVYKGILNDKT--IVAVKKITNVGVQGKKD-FCTEIAIIGNIHHVNLV 569
+++G G V++G + KT + A+K N+ D E ++ ++H N+V
Sbjct: 12 LLSDILGQGATANVFRGR-HKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 570 KLKGF--CAQGRQRLLVYEYMNHGSL-DRIL-FGNGPVLEWQERFDIALGTARGLAYLHS 625
KL R ++L+ E+ GSL + N L E + G+ +L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 626 GCEQKIIHCDIKPENILLHY----HFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPE 681
I+H +IKP NI+ K++DFG ++ L E F ++ GT YL P+
Sbjct: 131 ---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSLYGTEEYLHPD 185
Query: 682 WLTNSAI--------SEKTDVYSFGMVLLELVSGR 708
+ + D++S G+ +G
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-35
Identities = 54/220 (24%), Positives = 89/220 (40%), Gaps = 34/220 (15%)
Query: 514 FKNLIGSGGFGAVYKGILND------KTIVAVKKI-TNVGVQGKKDFCTEIAIIGNIHHV 566
F +G FG VYKG L VA+K + +++F E + + H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 567 NLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPV---------------LEWQERFD 611
N+V L G + + +++ Y +HG L L P LE +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 612 IALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTM 671
+ A G+ YL S ++H D+ N+L++ KISD GL + + + +
Sbjct: 133 LVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREV--YAADYYKL- 186
Query: 672 RGTRGYL-----APEWLTNSAISEKTDVYSFGMVLLELVS 706
L APE + S +D++S+G+VL E+ S
Sbjct: 187 -LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 6e-35
Identities = 56/253 (22%), Positives = 102/253 (40%), Gaps = 34/253 (13%)
Query: 472 HKSTDSKSGNPNTLSSGDLEAFYIPGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGIL 531
S D + + + SS E + G Y L+ IGSGG V++ +
Sbjct: 30 MDSPDLGTDDDDKASSSANECISVKG----RIYSILK--------QIGSGGSSKVFQVLN 77
Query: 532 NDKTIVAVKKI--TNVGVQGKKDFCTEIAIIGNIHHVNL--VKLKGFCAQGRQRLLVYEY 587
K I A+K + Q + EIA + + + ++L + + +V E
Sbjct: 78 EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC 137
Query: 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHF 647
N L+ L + W+ + + +H + I+H D+KP N L+
Sbjct: 138 GN-IDLNSWLKKKKSIDPWERKS-YWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDG- 191
Query: 648 QAKISDFGLSKLLTPEQSSLF-TTMRGTRGYLAPEWLTNSA-----------ISEKTDVY 695
K+ DFG++ + P+ +S+ + G Y+ PE + + + IS K+DV+
Sbjct: 192 MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 251
Query: 696 SFGMVLLELVSGR 708
S G +L + G+
Sbjct: 252 SLGCILYYMTYGK 264
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 9/200 (4%)
Query: 511 TDNFKNL--IGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVN 567
+ IG G G VY + + VA++++ K+ EI ++ + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 568 LVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGC 627
+V G + +V EY+ GSL ++ + E Q + + L +LHS
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAA-VCRECLQALEFLHS-- 134
Query: 628 EQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSA 687
++IH DIK +NILL K++DFG +TPEQS +TM GT ++APE +T A
Sbjct: 135 -NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKA 192
Query: 688 ISEKTDVYSFGMVLLELVSG 707
K D++S G++ +E++ G
Sbjct: 193 YGPKVDIWSLGIMAIEMIEG 212
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 53/226 (23%), Positives = 95/226 (42%), Gaps = 31/226 (13%)
Query: 505 EELEVATDN--FKNLIGSGGFGAVYKGILNDK----TIVAVK--KITNVGVQGKKDFCTE 556
E++ + ++G G FG+V + L + VAVK K + ++F E
Sbjct: 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75
Query: 557 IAIIGNIHHVNLVKLKGFCAQGRQR------LLVYEYMNHGSLDRIL-----FGNGPVLE 605
A + H ++ KL G + R + +++ +M HG L L N L
Sbjct: 76 AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135
Query: 606 WQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS 665
Q + A G+ YL S + IH D+ N +L ++DFGLS+ +
Sbjct: 136 LQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKI--YSG 190
Query: 666 SLFTTMRGTRGYL-----APEWLTNSAISEKTDVYSFGMVLLELVS 706
+ +G L A E L ++ + +DV++FG+ + E+++
Sbjct: 191 DYYR--QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 53/200 (26%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 511 TDNFKNL--IGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVN 567
+ IG G G V + VAVK + Q ++ E+ I+ + H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 568 LVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGC 627
+V++ G + ++ E++ G+L I+ + E Q + + LAYLH+
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIV-SQVRLNEEQIAT-VCEAVLQALAYLHA-- 159
Query: 628 EQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSA 687
Q +IH DIK ++ILL + K+SDFG ++ + ++ GT ++APE ++ S
Sbjct: 160 -QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR-KSLVGTPYWMAPEVISRSL 217
Query: 688 ISEKTDVYSFGMVLLELVSG 707
+ + D++S G++++E+V G
Sbjct: 218 YATEVDIWSLGIMVIEMVDG 237
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-34
Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 29/219 (13%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKIT-NVGVQGKKDFCTEIAII 560
D E + +G G +G V K I+AVK+I V Q +K ++ I
Sbjct: 8 DLEPIME--------LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS 59
Query: 561 -GNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFD------IA 613
+ V G + + E M+ SLD+ V++ + IA
Sbjct: 60 MRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFY---KQVIDKGQTIPEDILGKIA 115
Query: 614 LGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRG 673
+ + L +LHS + +IH D+KP N+L++ Q K+ DFG+S L G
Sbjct: 116 VSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDIDAG 171
Query: 674 TRGYLAPE----WLTNSAISEKTDVYSFGMVLLELVSGR 708
+ Y+APE L S K+D++S G+ ++EL R
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 9e-34
Identities = 51/198 (25%), Positives = 86/198 (43%), Gaps = 13/198 (6%)
Query: 517 LIGSGGFGAVYKGI-LNDKTIVAVK-----KITNVGVQGKKDFCTEIAIIGNIHHVNLVK 570
+G GGF ++ + K + A K + + K EI+I ++ H ++V
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK--MSMEISIHRSLAHQHVVG 105
Query: 571 LKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQK 630
GF +V E SL + + E + R+ G YLH +
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY-YLRQIVLGCQYLHR---NR 161
Query: 631 IIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISE 690
+IH D+K N+ L+ + KI DFGL+ + + + GT Y+APE L+ S
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSKKGHSF 220
Query: 691 KTDVYSFGMVLLELVSGR 708
+ DV+S G ++ L+ G+
Sbjct: 221 EVDVWSIGCIMYTLLVGK 238
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 53/217 (24%), Positives = 96/217 (44%), Gaps = 19/217 (8%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKI--TNVGVQGKKDFCTEIAI 559
DYE L IG+G +G K +D I+ K++ ++ K+ +E+ +
Sbjct: 7 DYEVLYT--------IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNL 58
Query: 560 IGNIHHVNLVKLKG-FCAQGRQRL-LVYEYMNHGSLDRIL---FGNGPVLEWQERFDIAL 614
+ + H N+V+ + L +V EY G L ++ L+ + +
Sbjct: 59 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 615 GTARGLAYLHS--GCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMR 672
L H ++H D+KP N+ L K+ DFGL+++L + +S T
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKTFV 177
Query: 673 GTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
GT Y++PE + + +EK+D++S G +L EL +
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 214
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 63/276 (22%), Positives = 109/276 (39%), Gaps = 45/276 (16%)
Query: 468 RWKLHKSTDSKSGNPNTLSSGDLEAFYIPGLPQRFDYEELEVATDN--FKNLIGSGGFGA 525
++K +S+ S D E FY+ +D + E +N F ++GSG FG
Sbjct: 2 KYKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYD-LKWEFPRENLEFGKVLGSGAFGK 60
Query: 526 VYKGILND------KTIVAVKKI-TNVGVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQ 577
V VAVK + ++ +E+ ++ + H N+V L G C
Sbjct: 61 VMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120
Query: 578 GRQRLLVYEYMNHGSL----------------------DRILFGNGPVLEWQERFDIALG 615
L++EY +G L + VL +++ A
Sbjct: 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQ 180
Query: 616 TARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR 675
A+G+ +L + +H D+ N+L+ + KI DFGL++ + S +
Sbjct: 181 VAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDI--MSDSNYV--VRGN 233
Query: 676 GYL-----APEWLTNSAISEKTDVYSFGMVLLELVS 706
L APE L + K+DV+S+G++L E+ S
Sbjct: 234 ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 51/198 (25%), Positives = 86/198 (43%), Gaps = 13/198 (6%)
Query: 517 LIGSGGFGAVYKGI-LNDKTIVAVK-----KITNVGVQGKKDFCTEIAIIGNIHHVNLVK 570
+G GGF ++ + K + A K + + K EI+I ++ H ++V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK--MSMEISIHRSLAHQHVVG 79
Query: 571 LKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQK 630
GF +V E SL + + E + R+ G YLH +
Sbjct: 80 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY-YLRQIVLGCQYLHR---NR 135
Query: 631 IIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISE 690
+IH D+K N+ L+ + KI DFGL+ + + + GT Y+APE L+ S
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSKKGHSF 194
Query: 691 KTDVYSFGMVLLELVSGR 708
+ DV+S G ++ L+ G+
Sbjct: 195 EVDVWSIGCIMYTLLVGK 212
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-33
Identities = 61/268 (22%), Positives = 109/268 (40%), Gaps = 46/268 (17%)
Query: 470 KLHKSTDSKSGNPNTLSSGDLEAFYIPGLPQ-RFDYEELEVATDNFKNLIGSGGFGAVYK 528
++ S + P + + +P P+ F ++L +G G FG V
Sbjct: 48 RITTRLSSTADTPMLAGVSE---YELPEDPKWEFPRDKLT-----LGKPLGEGCFGQVVM 99
Query: 529 GIL--------NDKTIVAVKKI-TNVGVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQG 578
+ VAVK + + + D +E+ ++ I H N++ L G C Q
Sbjct: 100 AEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159
Query: 579 RQRLLVYEYMNHGSL---------------DRILFGNGPVLEWQERFDIALGTARGLAYL 623
++ EY + G+L I + +++ ARG+ YL
Sbjct: 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 219
Query: 624 HSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYL----- 678
S QK IH D+ N+L+ + KI+DFGL++ + + T G L
Sbjct: 220 AS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNID----YYKKTTNGRLPVKWM 272
Query: 679 APEWLTNSAISEKTDVYSFGMVLLELVS 706
APE L + + ++DV+SFG+++ E+ +
Sbjct: 273 APEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 64/205 (31%), Positives = 101/205 (49%), Gaps = 17/205 (8%)
Query: 512 DNFK--NLIGSGGFGAVYKGI-LNDKTIVAVK-----KITNVGVQGKKDFCTEIAIIGNI 563
++F+ +G G FG VY K I+A+K ++ GV+ + E+ I ++
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ--LRREVEIQSHL 66
Query: 564 HHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYL 623
H N+++L G+ + L+ EY G++ R L E + I A L+Y
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE-LANALSYC 125
Query: 624 HSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL 683
HS +++IH DIKPEN+LL + KI+DFG S SS T + GT YL PE +
Sbjct: 126 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTDLCGTLDYLPPEMI 179
Query: 684 TNSAISEKTDVYSFGMVLLELVSGR 708
EK D++S G++ E + G+
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 61/261 (23%), Positives = 107/261 (40%), Gaps = 46/261 (17%)
Query: 477 SKSGNPNTLSSGDLEAFYIPGLPQ-RFDYEELEVATDNFKNLIGSGGFGAVYKGIL---- 531
S +P + + +P P+ F ++L +G G FG V
Sbjct: 9 HHSQDPMLAGVSE---YELPEDPKWEFPRDKLT-----LGKPLGEGAFGQVVMAEAVGID 60
Query: 532 ----NDKTIVAVKKI-TNVGVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVY 585
+ VAVK + + + D +E+ ++ I H N++ L G C Q ++
Sbjct: 61 KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 120
Query: 586 EYMNHGSL---------------DRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQK 630
EY + G+L I + +++ ARG+ YL S QK
Sbjct: 121 EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QK 177
Query: 631 IIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYL-----APEWLTN 685
IH D+ N+L+ + KI+DFGL++ + + T G L APE L +
Sbjct: 178 CIHRDLAARNVLVTENNVMKIADFGLARDINNID----YYKKTTNGRLPVKWMAPEALFD 233
Query: 686 SAISEKTDVYSFGMVLLELVS 706
+ ++DV+SFG+++ E+ +
Sbjct: 234 RVYTHQSDVWSFGVLMWEIFT 254
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 42/236 (17%), Positives = 79/236 (33%), Gaps = 29/236 (12%)
Query: 498 LPQRFDYEELEVATDNF--KNLIGSGGFGAVYKGI------LNDKTIVAVKKITNVGVQG 549
LP E ++ + +L+G G F VY+ +K +K
Sbjct: 51 LPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWE 110
Query: 550 KKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSL-DRI----LFGNGPVL 604
+ + +K +LV E ++G+L + I +
Sbjct: 111 FYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMP 170
Query: 605 EWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQA-----------KISD 653
+ A+ + +H +IIH DIKP+N +L F + D
Sbjct: 171 QGLVIS-FAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALID 226
Query: 654 FGLSKLLTP-EQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGR 708
G S + + ++FT T G+ E L+N + + D + + ++ G
Sbjct: 227 LGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-33
Identities = 62/229 (27%), Positives = 92/229 (40%), Gaps = 45/229 (19%)
Query: 513 NFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCT----EIAI-IGNIHHVN 567
+ ++G G G V VAVK++ DFC EI + + H N
Sbjct: 18 VSEKILGYGSSGTVVFQGSFQGRPVAVKRM-------LIDFCDIALMEIKLLTESDDHPN 70
Query: 568 LVKLKGFCAQGRQRLLVYEYMNHGSL-DRI-----LFGNGPVLEWQERFDIALGTARGLA 621
+++ R + E N +L D + N + + + A G+A
Sbjct: 71 VIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 622 YLHSGCEQKIIHCDIKPENILL-------------HYHFQAKISDFGLSKLLTPEQSSLF 668
+LHS KIIH D+KP+NIL+ + + ISDFGL K L QSS
Sbjct: 130 HLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 669 TTMR---GTRGYLAPEWLTNSAI-------SEKTDVYSFGMVLLELVSG 707
T + GT G+ APE L S + D++S G V ++S
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 66/230 (28%), Positives = 106/230 (46%), Gaps = 23/230 (10%)
Query: 505 EELEVATDNFKNL--IGSGGFGAVYKGILN-DKTIVAVKKI-TNVGVQGKKDFCTEIAII 560
+ + ++ K+L IG G +G+V K + I+AVK+I + V + +K ++ ++
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74
Query: 561 -GNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRIL-----FGNGPVLEWQERFDIAL 614
+ +V+ G + + E M+ S D+ + + E I L
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGK-ITL 132
Query: 615 GTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGT 674
T + L +L KIIH DIKP NILL K+ DFG+S L S T G
Sbjct: 133 ATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV--DSIAKTRDAGC 188
Query: 675 RGYLAPEWLTNSAI----SEKTDVYSFGMVLLELVSGRRNCSPRSQSHSM 720
R Y+APE + SA ++DV+S G+ L EL +GR P + +S+
Sbjct: 189 RPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR---FPYPKWNSV 235
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 59/230 (25%), Positives = 100/230 (43%), Gaps = 35/230 (15%)
Query: 505 EELEVATDN--FKNLIGSGGFGAVYKGIL------NDKTIVAVKKI-TNVGVQGKKDFCT 555
E+ E +N F +G+G FG V + + VAVK + + K+ +
Sbjct: 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 98
Query: 556 EIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYEYMNHGSL-------------DRILFGNG 601
E+ I+ ++ H N+V L G C G L++ EY +G L D
Sbjct: 99 ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 602 PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT 661
++ + A+G+A+L S + IH D+ N+LL AKI DFGL++ +
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDI- 214
Query: 662 PEQSSLFTTMRGTRGYL-----APEWLTNSAISEKTDVYSFGMVLLELVS 706
S + L APE + + + ++DV+S+G++L E+ S
Sbjct: 215 -MNDSNYI--VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 53/214 (24%), Positives = 85/214 (39%), Gaps = 21/214 (9%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKIT-NVGVQGKKDFCTEIAII 560
D E L +GSG G V+K ++AVK++ + + K ++ ++
Sbjct: 26 DLENLGE--------MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 561 GN-IHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARG 619
+V+ G + E M + GP+ E + + +
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGK-MTVAIVKA 136
Query: 620 LAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLA 679
L YL + +IH D+KP NILL Q K+ DFG+S L G Y+A
Sbjct: 137 LYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV--DDKAKDRSAGCAAYMA 192
Query: 680 PE-----WLTNSAISEKTDVYSFGMVLLELVSGR 708
PE T + DV+S G+ L+EL +G+
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 517 LIGSGGFGAVYKGI-LNDKTIVAVK-----KITNVGVQGKKDFCTEIAIIGNIHHVNLVK 570
L+G G F VY+ ++ VA+K + G+ + E+ I + H ++++
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR--VQNEVKIHCQLKHPSILE 75
Query: 571 LKGFCAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQ 629
L + LV E ++G + + P E + R + G+ YLHS
Sbjct: 76 LYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH-QIITGMLYLHS---H 131
Query: 630 KIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAIS 689
I+H D+ N+LL + KI+DFGL+ L T+ GT Y++PE T SA
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP-HEKHYTLCGTPNYISPEIATRSAHG 190
Query: 690 EKTDVYSFGMVLLELVSGR 708
++DV+S G + L+ GR
Sbjct: 191 LESDVWSLGCMFYTLLIGR 209
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-33
Identities = 65/251 (25%), Positives = 105/251 (41%), Gaps = 50/251 (19%)
Query: 496 PGLPQRFDYEELEVATDN--FKNLIGSGGFGAVYKGILND------KTIVAVKKI-TNVG 546
L LE +N + IG G FG V++ T+VAVK +
Sbjct: 31 MPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS 90
Query: 547 VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSL------------- 593
+ DF E A++ + N+VKL G CA G+ L++EYM +G L
Sbjct: 91 ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVC 150
Query: 594 ----------DRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILL 643
R+ P L E+ IA A G+AYL +K +H D+ N L+
Sbjct: 151 SLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLV 207
Query: 644 HYHFQAKISDFGLSKLLTPEQSSLFTT---MRGTRGYL-----APEWLTNSAISEKTDVY 695
+ KI+DFGLS+ ++++ + PE + + + ++DV+
Sbjct: 208 GENMVVKIADFGLSR-------NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVW 260
Query: 696 SFGMVLLELVS 706
++G+VL E+ S
Sbjct: 261 AYGVVLWEIFS 271
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 60/198 (30%), Positives = 95/198 (47%), Gaps = 15/198 (7%)
Query: 517 LIGSGGFGAVYKGI-LNDKTIVAVK-----KITNVGVQGKKDFCTEIAIIGNIHHVNLVK 570
+G G FG VY +K I+A+K ++ GV+ + EI I ++ H N+++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ--LRREIEIQSHLRHPNILR 78
Query: 571 LKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQK 630
+ + ++ L+ E+ G L + L +G E + + A L Y H +K
Sbjct: 79 MYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE-LADALHYCHE---RK 134
Query: 631 IIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISE 690
+IH DIKPEN+L+ Y + KI+DFG S S TM GT YL PE + E
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVH---APSLRRRTMCGTLDYLPPEMIEGKTHDE 191
Query: 691 KTDVYSFGMVLLELVSGR 708
K D++ G++ E + G
Sbjct: 192 KVDLWCAGVLCYEFLVGM 209
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-32
Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 24/222 (10%)
Query: 500 QRFDYEELEVATDNFKNL------IGSGGFGAVYKGILND-KTIVAVKKITNVGVQGKKD 552
+++ + +EV + + +GSG FG V++ + + K I K
Sbjct: 35 KKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT 94
Query: 553 FCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERFD 611
EI+I+ +HH L+ L + +L+ E+++ G L DRI + + E
Sbjct: 95 VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSE-----A 149
Query: 612 IALGTAR----GLAYLHSGCEQKIIHCDIKPENILLHYHFQA--KISDFGLSKLLTPEQS 665
+ R GL ++H I+H DIKPENI+ + KI DFGL+ L P++
Sbjct: 150 EVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206
Query: 666 SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSG 707
T + APE + + TD+++ G++ L+SG
Sbjct: 207 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 56/223 (25%), Positives = 99/223 (44%), Gaps = 37/223 (16%)
Query: 514 FKNLIGSGGFGAVYKGILND------KTIVAVKKI-TNVGVQGKKDFCTEIAIIGNI-HH 565
F +G+G FG V + VAVK + + + ++ +E+ ++ + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 566 VNLVKLKGFCAQGRQRLLVYEYMNHGSL-----------------DRILFGNGPVLEWQE 608
+N+V L G C G L++ EY +G L I+ + L+ ++
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 609 RFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668
+ A+G+A+L S + IH D+ NILL + KI DFGL++ + +
Sbjct: 147 LLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS---- 199
Query: 669 TTMRGTRGYL-----APEWLTNSAISEKTDVYSFGMVLLELVS 706
+ L APE + N + ++DV+S+G+ L EL S
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 62/257 (24%), Positives = 105/257 (40%), Gaps = 44/257 (17%)
Query: 481 NPNTLSSGDLEAFYIPGLPQRFDYEELEVATDN--FKNLIGSGGFGAVYKGILND----- 533
+P+ L + + LP +D + E D +G G FG V +
Sbjct: 2 DPDELPLDE----HCERLP--YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTA 55
Query: 534 -KTIVAVKKI-TNVGVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQ-GRQRLLVYEYMN 589
VAVK + + +E+ I+ +I HH+N+V L G C + G +++ E+
Sbjct: 56 TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 115
Query: 590 HGSL---------------DRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHC 634
G+L L + + A+G+ +L S +K IH
Sbjct: 116 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHR 172
Query: 635 DIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYL-----APEWLTNSAIS 689
D+ NILL KI DFGL++ + + +R L APE + + +
Sbjct: 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDY----VRKGDARLPLKWMAPETIFDRVYT 228
Query: 690 EKTDVYSFGMVLLELVS 706
++DV+SFG++L E+ S
Sbjct: 229 IQSDVWSFGVLLWEIFS 245
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-32
Identities = 59/228 (25%), Positives = 101/228 (44%), Gaps = 42/228 (18%)
Query: 514 FKNLIGSGGFGAVYKGIL------NDKTIVAVKKI-TNVGVQGKKDFCTEIAIIGNIHHV 566
+G G FG V K T VAVK + N +D +E ++ ++H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 567 NLVKLKGFCAQGRQRLLVYEYMNHGSL-----------------------DRILFGNGPV 603
+++KL G C+Q LL+ EY +GSL + +
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 604 LEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE 663
L + A ++G+ YL K++H D+ NIL+ + KISDFGLS+ + E
Sbjct: 147 LTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 664 QSSLFTTMRGTRGYL-----APEWLTNSAISEKTDVYSFGMVLLELVS 706
+ ++ ++G + A E L + + ++DV+SFG++L E+V+
Sbjct: 204 D----SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 52/219 (23%), Positives = 97/219 (44%), Gaps = 17/219 (7%)
Query: 511 TDNFKNL--IGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVN 567
+ ++ + +G G FG VYK + A K I + +D+ EI I+ H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 568 LVKLKGFCAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERFDIALGTARGLAYLHSG 626
+VKL G + ++ E+ G++ +L + + E Q + + L +LHS
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-VCRQMLEALNFLHS- 135
Query: 627 CEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNS 686
++IIH D+K N+L+ +++DFG+S + GT ++APE +
Sbjct: 136 --KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR-DSFIGTPYWMAPEVVMCE 192
Query: 687 AISE-----KTDVYSFGMVLLELVSGRRNCSPRSQSHSM 720
+ + K D++S G+ L+E+ P + + M
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIE---PPHHELNPM 228
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-32
Identities = 54/251 (21%), Positives = 105/251 (41%), Gaps = 26/251 (10%)
Query: 472 HKSTDSKSGNPNTLSSGDLEAFYIPGLPQRFDYEELEVATDNFKNL------IGSGGFGA 525
+ + + Y+ + +++ + +E+ D+ + +G+G FG
Sbjct: 113 YDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGV 172
Query: 526 VYKGILNDKT---IVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRL 582
V++ ++ A K + K+ EI + + H LV L + +
Sbjct: 173 VHRVT--ERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 230
Query: 583 LVYEYMNHGSL-DRILFGNGPVLEWQERFDIALGT---ARGLAYLHSGCEQKIIHCDIKP 638
++YE+M+ G L +++ + + E + +GL ++H +H D+KP
Sbjct: 231 MIYEFMSGGELFEKVADEHN---KMSED-EAVEYMRQVCKGLCHMHE---NNYVHLDLKP 283
Query: 639 ENILLHYHFQA--KISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYS 696
ENI+ K+ DFGL+ L P+QS GT + APE + TD++S
Sbjct: 284 ENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWS 341
Query: 697 FGMVLLELVSG 707
G++ L+SG
Sbjct: 342 VGVLSYILLSG 352
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 67/217 (30%), Positives = 105/217 (48%), Gaps = 20/217 (9%)
Query: 511 TDNFKNL--IGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVN 567
+ F L +G G +G+VYK I IVA+K++ V ++ EI+I+ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV-PVESD-LQEIIKEISIMQQCDSPH 85
Query: 568 LVKLKGFCAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERFDIAL---GTARGLAYL 623
+VK G + +V EY GS+ D I N + E + IA T +GL YL
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDE----IATILQSTLKGLEYL 141
Query: 624 HSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL 683
H + IH DIK NILL+ AK++DFG++ LT + T+ GT ++APE +
Sbjct: 142 HF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR-NTVIGTPFWMAPEVI 197
Query: 684 TNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSM 720
+ D++S G+ +E+ G+ P + H M
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGK---PPYADIHPM 231
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-32
Identities = 73/223 (32%), Positives = 107/223 (47%), Gaps = 25/223 (11%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKK-DFCTEIAII 560
+ +LE IG G FG V+KGI + +VA+K I + + D EI ++
Sbjct: 23 LFTKLEK--------IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVL 74
Query: 561 GNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIAL---GTA 617
+ K G + + ++ EY+ GS +L GP+ E Q IA
Sbjct: 75 SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQ----IATILREIL 129
Query: 618 RGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGY 677
+GL YLHS +K IH DIK N+LL H + K++DFG++ LT Q T GT +
Sbjct: 130 KGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR-NTFVGTPFW 185
Query: 678 LAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSM 720
+APE + SA K D++S G+ +EL G P S+ H M
Sbjct: 186 MAPEVIKQSAYDSKADIWSLGITAIELARGE---PPHSELHPM 225
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 68/253 (26%), Positives = 110/253 (43%), Gaps = 34/253 (13%)
Query: 478 KSGNPNTLSSGDLEAFYIPGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGI-LNDKTI 536
G +L D+ + P++ + +L IG G FGAVY + + +
Sbjct: 31 AGGRAGSLKDPDVAELFFKDDPEKL-FSDLRE--------IGHGSFGAVYFARDVRNSEV 81
Query: 537 VAVKKITNVGVQGK---KDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSL 593
VA+KK++ G Q +D E+ + + H N ++ +G + LV EY +
Sbjct: 82 VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSAS 141
Query: 594 DRILFGNGPVLEWQERFDIAL---GTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAK 650
D + P+ E + IA G +GLAYLHS +IH D+K NILL K
Sbjct: 142 DLLEVHKKPLQEVE----IAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVK 194
Query: 651 ISDFGLSKLLTPEQSSLFTTMRGTRGYLAPE---WLTNSAISEKTDVYSFGMVLLELVSG 707
+ DFG + ++ P + GT ++APE + K DV+S G+ +EL
Sbjct: 195 LGDFGSASIMAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249
Query: 708 RRNCSPRSQSHSM 720
+ P ++M
Sbjct: 250 K---PPLFNMNAM 259
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 57/253 (22%), Positives = 93/253 (36%), Gaps = 48/253 (18%)
Query: 497 GLPQRF--DYEELEVATDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKIT--NVGVQGKK 551
G+ R+ ++ ELE IGSG FG+V+K + D I A+K+ G ++
Sbjct: 4 GMKSRYTTEFHELE--------KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQ 55
Query: 552 DFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRIL---FGNGPVLEWQ 607
+ E+ + H ++V+ A+ L+ EY N GSL + + +
Sbjct: 56 NALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEA 115
Query: 608 ERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILL-------------------HYHFQ 648
E D+ L RGL Y+HS ++H DIKP NI +
Sbjct: 116 ELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM 172
Query: 649 AKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPE-WLTNSAISEKTDVYSFGMVLLELVSG 707
KI D G ++ Q G +LA E N K D+++ + ++
Sbjct: 173 FKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA 227
Query: 708 RRNCSPRSQSHSM 720
Sbjct: 228 E---PLPRNGDQW 237
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 60/251 (23%), Positives = 98/251 (39%), Gaps = 31/251 (12%)
Query: 479 SGNPNTLSSGDLEAFYIPGLPQRFDYEELEVATDNFK--NLIGSGGFGAVYKGI-LNDKT 535
S + + S E Y G + + ++ +G GGF V L+D
Sbjct: 3 SSHHHHHHSSGRENLYFQG-------HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGH 55
Query: 536 IVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQR----LLVYEYMNHG 591
A+K+I Q +++ E + +H N+++L +C + R L+ + G
Sbjct: 56 FYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRG 115
Query: 592 SLDRIL---FGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQ 648
+L + G L + + LG RGL +H+ + H D+KP NILL Q
Sbjct: 116 TLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQ 172
Query: 649 AKISDFGLSKLLTPEQSS--------LFTTMRGTRGYLAPEWL---TNSAISEKTDVYSF 697
+ D G + R T Y APE ++ I E+TDV+S
Sbjct: 173 PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSL 232
Query: 698 GMVLLELVSGR 708
G VL ++ G
Sbjct: 233 GCVLYAMMFGE 243
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 64/280 (22%), Positives = 114/280 (40%), Gaps = 44/280 (15%)
Query: 458 FSALGFLWWRRWKLHKSTDSKSGNPNTLSSGDLEAFYIPGLPQ-RFDYEELEVATDNFKN 516
F+ +G+ + +++ + +G + + +P P+ + L
Sbjct: 22 FNGMGYYHHHHHHDYDIPTTENLYFQGMLAG-VSEYELPEDPRWELPRDRLV-----LGK 75
Query: 517 LIGSGGFGAVYKGIL--------NDKTIVAVKKI-TNVGVQGKKDFCTEIAIIGNI-HHV 566
+G G FG V N T VAVK + ++ + D +E+ ++ I H
Sbjct: 76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135
Query: 567 NLVKLKGFCAQGRQRLLVYEYMNHGSL---------------DRILFGNGPVLEWQERFD 611
N++ L G C Q ++ EY + G+L L ++
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 612 IALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTM 671
A ARG+ YL S +K IH D+ N+L+ KI+DFGL++ +
Sbjct: 196 CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID----YYK 248
Query: 672 RGTRGYL-----APEWLTNSAISEKTDVYSFGMVLLELVS 706
+ T G L APE L + + ++DV+SFG++L E+ +
Sbjct: 249 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 63/260 (24%), Positives = 100/260 (38%), Gaps = 51/260 (19%)
Query: 472 HKSTDSKSGNPNTL--SSGDLEAFYIPGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKG 529
H S+ G N S + FYI +EL G G F V +
Sbjct: 6 HHSSGVDLGTENLYFQSMENFNNFYI------LTSKEL-----------GRGKFAVVRQC 48
Query: 530 ILNDKT---IVAVKKI--TNVGVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLL 583
I K+ A K + G + + EIA++ ++ L + +L
Sbjct: 49 I--SKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106
Query: 584 VYEYMNHGSL-DRILFGNGPVLEWQERF--DIALGTAR----GLAYLHSGCEQKIIHCDI 636
+ EY G + + E E + + + G+ YLH I+H D+
Sbjct: 107 ILEYAAGGEIFSLC------LPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDL 157
Query: 637 KPENILL---HYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTD 693
KP+NILL + KI DFG+S+ + + GT YLAPE L I+ TD
Sbjct: 158 KPQNILLSSIYPLGDIKIVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATD 215
Query: 694 VYSFGMVLLELVSGRRNCSP 713
+++ G++ L++ SP
Sbjct: 216 MWNIGIIAYMLLTH---TSP 232
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-31
Identities = 68/252 (26%), Positives = 94/252 (37%), Gaps = 45/252 (17%)
Query: 471 LHKSTDSKSGNPNTLSSGDLEAFYIPGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGI 530
+H SG N G Y N ++G G FG V K
Sbjct: 1 MHHHHHHSSGRENLYFQGTFAERY------------------NIVCMLGKGSFGEVLKCK 42
Query: 531 -LNDKTIVAVKKI--TNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587
+ AVK I + + E+ ++ + H N++KL +V E
Sbjct: 43 DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL 102
Query: 588 MNHGSL-DRILFGNGPVLEWQERF------DIALGTARGLAYLHSGCEQKIIHCDIKPEN 640
G L D I+ ++RF I G+ Y+H I+H D+KPEN
Sbjct: 103 YTGGELFDEIIK--------RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPEN 151
Query: 641 ILL---HYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSF 697
ILL KI DFGLS GT Y+APE L + EK DV+S
Sbjct: 152 ILLESKEKDCDIKIIDFGLSTCFQQNTK--MKDRIGTAYYIAPEVLRGT-YDEKCDVWSA 208
Query: 698 GMVLLELVSGRR 709
G++L L+SG
Sbjct: 209 GVILYILLSGTP 220
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 9e-31
Identities = 62/238 (26%), Positives = 105/238 (44%), Gaps = 26/238 (10%)
Query: 500 QRFDYEELEVATDNFKNL--IGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTE 556
D L F+ + +G+G +G VYKG + + A+K + +V +++ E
Sbjct: 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQE 70
Query: 557 IAIIGNI-HHVNLVK-----LKGFCAQGRQRL-LVYEYMNHGSLDRIL--FGNGPVLEWQ 607
I ++ HH N+ +K +L LV E+ GS+ ++ + E
Sbjct: 71 INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW 130
Query: 608 ERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667
+ I RGL++LH K+IH DIK +N+LL + + K+ DFG+S L
Sbjct: 131 IAY-ICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR- 185
Query: 668 FTTMRGTRGYLAPEWLTNSAISE-----KTDVYSFGMVLLELVSGRRNCSPRSQSHSM 720
T GT ++APE + + K+D++S G+ +E+ G P H M
Sbjct: 186 RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA---PPLCDMHPM 240
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 52/202 (25%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 513 NFKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKL 571
+G G FG V++ + + K K + V + EI+I+ H N++ L
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 572 KGFCAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERFDIALGT---ARGLAYLHSGC 627
+ ++++E+++ + +RI E ER +I L +LHS
Sbjct: 67 HESFESMEELVMIFEFISGLDIFERINTSAF---ELNER-EIVSYVHQVCEALQFLHS-- 120
Query: 628 EQKIIHCDIKPENILLHYHFQA--KISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTN 685
I H DI+PENI+ + KI +FG ++ L P + F + Y APE +
Sbjct: 121 -HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQH 177
Query: 686 SAISEKTDVYSFGMVLLELVSG 707
+S TD++S G ++ L+SG
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSG 199
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 34/218 (15%)
Query: 518 IGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCT-----------------EIAII 560
+ G F + D A+KK ++ K+DF E+ II
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 561 GNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTAR-- 618
+I + + +G + ++YEYM + S+ + L+ I + +
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFV-LDKNYTCFIPIQVIKCI 156
Query: 619 ------GLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMR 672
+Y+H+ E+ I H D+KP NIL+ + + K+SDFG S+ R
Sbjct: 157 IKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEY---MVDKKIKGSR 211
Query: 673 GTRGYLAPEWLTNSAI--SEKTDVYSFGMVLLELVSGR 708
GT ++ PE+ +N + K D++S G+ L +
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 59/235 (25%), Positives = 95/235 (40%), Gaps = 43/235 (18%)
Query: 484 TLSSGDLEAFYIPGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKI 542
++ + ++ +I F ++GSG F V+ + A+K I
Sbjct: 1 SMQTTNIRKTFI------------------FMEVLGSGAFSEVFLVKQRLTGKLFALKCI 42
Query: 543 TNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSL-DRILFGNG 601
EIA++ I H N+V L+ LV + ++ G L DRIL
Sbjct: 43 KKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILE--- 99
Query: 602 PVLEWQERF------DIALGTARGLAYLHSGCEQKIIHCDIKPENILL---HYHFQAKIS 652
+ + + + YLH I+H D+KPEN+L + + I+
Sbjct: 100 -----RGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMIT 151
Query: 653 DFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSG 707
DFGLSK+ +T GT GY+APE L S+ D +S G++ L+ G
Sbjct: 152 DFGLSKMEQNGI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 54/218 (24%), Positives = 93/218 (42%), Gaps = 32/218 (14%)
Query: 513 NFKNLIGSGGFGAVYKGILNDKT---IVAVKKI------TNVGVQGKKDFCTEIAIIGNI 563
+ +GSG F V K +K+ A K I + +++ E++I+ +
Sbjct: 15 DIGEELGSGQFAIVKKCR--EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 564 HHVNLVKLKGFCAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERFDIALGT---ARG 619
H N++ L +L+ E ++ G L D + E + G
Sbjct: 73 LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE----SLSEE-EATSFIKQILDG 127
Query: 620 LAYLHSGCEQKIIHCDIKPENILLHYH----FQAKISDFGLSKLLTPEQSSLFTTMRGTR 675
+ YLH+ +KI H D+KPENI+L K+ DFGL+ + F + GT
Sbjct: 128 VNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FKNIFGTP 182
Query: 676 GYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSP 713
++APE + + + D++S G++ L+SG SP
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG---ASP 217
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 65/247 (26%), Positives = 100/247 (40%), Gaps = 36/247 (14%)
Query: 471 LHKSTDSKSGNPNTLSSGDLEAFYIPGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGI 530
+H SG N G ++ +I FK +GSG FG V+
Sbjct: 1 MHHHHHHSSGRENLYFQGTIDDLFI------------------FKRKLGSGAFGDVHLVE 42
Query: 531 -LNDKTIVAVKKITNVGVQGKK-DFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588
+ +K I Q EI ++ ++ H N++K+ +V E
Sbjct: 43 ERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETC 102
Query: 589 NHGSL-DRILFGNGPVLEWQERFDIALGTAR----GLAYLHSGCEQKIIHCDIKPENILL 643
G L +RI+ E + LAY HS Q ++H D+KPENIL
Sbjct: 103 EGGELLERIVSAQARGKALSEG--YVAELMKQMMNALAYFHS---QHVVHKDLKPENILF 157
Query: 644 ---HYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMV 700
H KI DFGL++L ++ T GT Y+APE ++ K D++S G+V
Sbjct: 158 QDTSPHSPIKIIDFGLAELFKSDE--HSTNAAGTALYMAPEVFKRD-VTFKCDIWSAGVV 214
Query: 701 LLELVSG 707
+ L++G
Sbjct: 215 MYFLLTG 221
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-30
Identities = 68/255 (26%), Positives = 104/255 (40%), Gaps = 36/255 (14%)
Query: 480 GNPNTLSSGDLEAFYIPGLPQRFDYEELEVATDN-----------FKNLIGSGGFGAVYK 528
G L++ A + + F + +L V + +GSG G V
Sbjct: 95 GKRRPLNNNSEIALSLSR-NKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKL 153
Query: 529 GI-LNDKTIVAVKKI--------TNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR 579
VA++ I + + TEI I+ ++H ++K+K F
Sbjct: 154 AFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAE 212
Query: 580 QRLLVYEYMNHGSL-DRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKP 638
+V E M G L D+++ GN + E + + YLH IIH D+KP
Sbjct: 213 DYYIVLELMEGGELFDKVV-GNKRLKEATCK-LYFYQMLLAVQYLHE---NGIIHRDLKP 267
Query: 639 ENILL---HYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAI---SEKT 692
EN+LL KI+DFG SK+L L T+ GT YLAPE L + +
Sbjct: 268 ENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAV 325
Query: 693 DVYSFGMVLLELVSG 707
D +S G++L +SG
Sbjct: 326 DCWSLGVILFICLSG 340
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-30
Identities = 63/203 (31%), Positives = 88/203 (43%), Gaps = 15/203 (7%)
Query: 514 FKNLIGSGGFGAVYKGI-LNDKTIVAVKKI--TNVGVQGKKDFCTEIAIIGNIHHVNLVK 570
+GSG +G V A+K I T+V E+A++ + H N++K
Sbjct: 41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMK 100
Query: 571 LKGFCAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQ 629
L F R LV E G L D I+ E + I G+ YLH
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEII-HRMKFNE-VDAAVIIKQVLSGVTYLHK---H 155
Query: 630 KIIHCDIKPENILL---HYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNS 686
I+H D+KPEN+LL KI DFGLS + ++ GT Y+APE L
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK--MKERLGTAYYIAPEVLRKK 213
Query: 687 AISEKTDVYSFGMVLLELVSGRR 709
EK DV+S G++L L++G
Sbjct: 214 -YDEKCDVWSIGVILFILLAGYP 235
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-30
Identities = 63/204 (30%), Positives = 89/204 (43%), Gaps = 16/204 (7%)
Query: 513 NFKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKD---FCTEIAIIGNIHHVNL 568
+ ++G G FG V AVK I+ V+ K D E+ ++ + H N+
Sbjct: 29 KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 569 VKLKGFCAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERFDIALGTARGLAYLHSGC 627
+KL F LV E G L D I+ E + I G+ Y+H
Sbjct: 89 MKLYEFFEDKGYFYLVGEVYTGGELFDEII-SRKRFSE-VDAARIIRQVLSGITYMHK-- 144
Query: 628 EQKIIHCDIKPENILL---HYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT 684
KI+H D+KPEN+LL +I DFGLS + GT Y+APE L
Sbjct: 145 -NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--MKDKIGTAYYIAPEVLH 201
Query: 685 NSAISEKTDVYSFGMVLLELVSGR 708
+ EK DV+S G++L L+SG
Sbjct: 202 GT-YDEKCDVWSTGVILYILLSGC 224
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 38/221 (17%)
Query: 513 NFKNLIGSGGFGAVYKGILNDKT---IVAVKKI------TNVGVQGKKDFCTEIAIIGNI 563
+GSG F V K K A K I ++ +++ E+ I+ I
Sbjct: 8 EMGEELGSGQFAIVRKCR--QKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 564 HHVNLVKLKGFCAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERF--DIALGTAR-- 618
H N++ L +L+ E ++ G L D + +E D A +
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE--------KESLTEDEATQFLKQI 117
Query: 619 --GLAYLHSGCEQKIIHCDIKPENILLHYHFQA----KISDFGLSKLLTPEQSSLFTTMR 672
G+ YLHS ++I H D+KPENI+L K+ DFG++ + F +
Sbjct: 118 LDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE--FKNIF 172
Query: 673 GTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSP 713
GT ++APE + + + D++S G++ L+SG SP
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG---ASP 210
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 58/200 (29%), Positives = 92/200 (46%), Gaps = 14/200 (7%)
Query: 517 LIGSGGFGAVYKG---ILNDKTIVAVKKITNVGVQGKKDFCT----EIAIIGNIHHVNLV 569
+G GG VY ILN VA+K + + K++ E+ + H N+V
Sbjct: 18 KLGGGGMSTVYLAEDTILN--IKVAIK-AIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 570 KLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQ 629
+ + LV EY+ +L + +GP L + G+ + H +
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP-LSVDTAINFTNQILDGIKHAH---DM 130
Query: 630 KIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAIS 689
+I+H DIKP+NIL+ + KI DFG++K L+ + + GT Y +PE A
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 690 EKTDVYSFGMVLLELVSGRR 709
E TD+YS G+VL E++ G
Sbjct: 191 ECTDIYSIGIVLYEMLVGEP 210
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 31/213 (14%)
Query: 513 NFKNLIGSGGFGAVYKGILNDKT---IVAVKKI------TNVGVQGKKDFCTEIAIIGNI 563
+ +GSG F V K +K+ A K I ++ ++D E++I+ I
Sbjct: 14 DTGEELGSGQFAVVKKCR--EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 564 HHVNLVKLKGFCAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERFDIALGTAR---- 618
H N++ L +L+ E + G L D + E + +
Sbjct: 72 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE----SLTEE-EAT-EFLKQILN 125
Query: 619 GLAYLHSGCEQKIIHCDIKPENILLHYHFQA----KISDFGLSKLLTPEQSSLFTTMRGT 674
G+ YLHS +I H D+KPENI+L KI DFGL+ + F + GT
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGT 180
Query: 675 RGYLAPEWLTNSAISEKTDVYSFGMVLLELVSG 707
++APE + + + D++S G++ L+SG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 1e-29
Identities = 22/230 (9%), Positives = 55/230 (23%), Gaps = 46/230 (20%)
Query: 517 LIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGK---KDFCTEIAIIGNIHHVNLVKLK 572
+ G V+ + A+K T + + + + + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 573 GFC--------------------------AQGRQRLLVYEYMN------HGSLDRILFGN 600
LL+ + +LD +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 601 GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLL 660
G + R A L S + ++H P+N+ + + + D
Sbjct: 189 GD-EGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALW-- 242
Query: 661 TPEQSSLFTTMRGTRGYLAPEWLT--NSAISEKTDVYSFGMVLLELVSGR 708
+ + Y E+L + + + + G+ + +
Sbjct: 243 --KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 38/221 (17%)
Query: 513 NFKNLIGSGGFGAVYKGILNDKT---IVAVKKI------TNVGVQGKKDFCTEIAIIGNI 563
+ +GSG F V K +K+ A K I + +++ E++I+ +
Sbjct: 15 DIGEELGSGQFAIVKKCR--EKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 564 HHVNLVKLKGFCAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERF---DIALGT--- 616
H N++ L +L+ E ++ G L D + +E +
Sbjct: 73 LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQ--------KESLSEEEATSFIKQI 124
Query: 617 ARGLAYLHSGCEQKIIHCDIKPENILLHYH----FQAKISDFGLSKLLTPEQSSLFTTMR 672
G+ YLH+ +KI H D+KPENI+L K+ DFGL+ + F +
Sbjct: 125 LDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FKNIF 179
Query: 673 GTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSP 713
GT ++APE + + + D++S G++ L+SG SP
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG---ASP 217
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 52/212 (24%), Positives = 85/212 (40%), Gaps = 24/212 (11%)
Query: 514 FKNLIGSGGFGAVYKGILNDKT--------IVAVKKITNVGVQGKKDFCTEIAIIGNIHH 565
+IG G F V + I ++ IV V K T+ +D E +I + H
Sbjct: 28 LCEVIGKGPFSVVRRCI--NRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 566 VNLVKLKGFCAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERFDIALGTAR----GL 620
++V+L + +V+E+M+ L I+ + E +A R L
Sbjct: 86 PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA--VASHYMRQILEAL 143
Query: 621 AYLHSGCEQKIIHCDIKPENILL---HYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGY 677
Y H IIH D+KP +LL K+ FG++ L + GT +
Sbjct: 144 RYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG-LVAGGRVGTPHF 199
Query: 678 LAPEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
+APE + + DV+ G++L L+SG
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLSGCL 231
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 3e-29
Identities = 50/202 (24%), Positives = 81/202 (40%), Gaps = 23/202 (11%)
Query: 517 LIGSGGFGAVYKG---ILNDKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLK 572
I GG G +Y +N + V +K + + G + + E + + H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRP-VVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 573 GFCAQGRQRL-----LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGC 627
F + +V EY+ SL R PV E L L+YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPV---AEAIAYLLEILPALSYLH--- 199
Query: 628 EQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSA 687
+++ D+KPENI+L Q K+ D G + + GT G+ APE +
Sbjct: 200 SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN--SFG---YLYGTPGFQAPEIVRTGP 253
Query: 688 ISEKTDVYSFGMVLLELVSGRR 709
+ TD+Y+ G L L
Sbjct: 254 -TVATDIYTVGRTLAALTLDLP 274
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-29
Identities = 30/239 (12%), Positives = 62/239 (25%), Gaps = 55/239 (23%)
Query: 517 LIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKD----------------------- 552
++G A + V
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 553 -----FCTEIAIIGNIHHVNLVKLKGFCAQG--RQRLLVYEYM--NHGSLDRILFG---N 600
F ++ + +++++ R +Y M N + +L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 601 GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLL 660
L R + L R LA LH ++H ++P +I+L ++ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254
Query: 661 TPEQSSLFTTMRGTRGYLAPEWLTNSAI-----------SEKTDVYSFGMVLLELVSGR 708
+ +RG+ PE A + D ++ G+V+ +
Sbjct: 255 ---RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 5e-29
Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 22/207 (10%)
Query: 517 LIGSGGFGAVYKG---ILNDKTIVAVKKITNVGVQGKKDFCT----EIAIIGNIHHVNLV 569
++G GG V+ + VAVK + + F E ++H +V
Sbjct: 19 ILGFGGMSEVHLARDLRDHR--DVAVK-VLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 570 KL--KGFCAQGRQRLLVY---EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLH 624
+ G A+ L Y EY++ +L I+ GP + + ++ + L + H
Sbjct: 76 AVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSH 133
Query: 625 SGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT--MRGTRGYLAPEW 682
+ IIH D+KP NI++ K+ DFG+++ + +S+ T + GT YL+PE
Sbjct: 134 ---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 683 LTNSAISEKTDVYSFGMVLLELVSGRR 709
++ ++DVYS G VL E+++G
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 66/232 (28%), Positives = 95/232 (40%), Gaps = 28/232 (12%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKK-DFCTEIAII 560
DYE EV IGSG V K VA+K+I Q + EI +
Sbjct: 16 DYELQEV--------IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAM 67
Query: 561 GNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQER-FD---IAL-- 614
HH N+V + LV + ++ GS+ I+ E + D IA
Sbjct: 68 SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 615 -GTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT----PEQSSLFT 669
GL YLH IH D+K NILL +I+DFG+S L ++ +
Sbjct: 128 REVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 184
Query: 670 TMRGTRGYLAPEWLT-NSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSM 720
T GT ++APE + K D++SFG+ +EL +G +P + M
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA---APYHKYPPM 233
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-28
Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 514 FKNLIGSGGFGAVYKGI-LNDKTIVAVKKI-------------TNVGVQGKKDFCTEIAI 559
+GSG +G V N + A+K I + ++ EI++
Sbjct: 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 560 IGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERFDIALGTAR 618
+ ++ H N++KL + LV E+ G L ++I+ E + +I
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII-NRHKFDE-CDAANIMKQILS 157
Query: 619 GLAYLHSGCEQKIIHCDIKPENILL---HYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR 675
G+ YLH I+H DIKPENILL + KI DFGLS + + GT
Sbjct: 158 GICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK--LRDRLGTA 212
Query: 676 GYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
Y+APE L +EK DV+S G+++ L+ G
Sbjct: 213 YYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYP 245
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 26/208 (12%)
Query: 513 NFKNLIGSGGFGAVYKGI-LNDKTIVAVKKIT--NVGVQGKKDFCTEIAIIGNIHHVNLV 569
+ K +G G F V + + A K I + + + E I + H N+V
Sbjct: 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 570 KLKGFCAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERF------DIALGTARGLAY 622
+L + LV++ + G L + I+ +E + +AY
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVA--------REFYSEADASHCIQQILESIAY 120
Query: 623 LHSGCEQKIIHCDIKPENILL---HYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLA 679
HS I+H ++KPEN+LL K++DFGL+ + ++ + GT GYL+
Sbjct: 121 CHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGFAGTPGYLS 175
Query: 680 PEWLTNSAISEKTDVYSFGMVLLELVSG 707
PE L S+ D+++ G++L L+ G
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 66/244 (27%), Positives = 90/244 (36%), Gaps = 33/244 (13%)
Query: 471 LHKSTDSKSGNPNTLSSGDLEAFYIPGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGI 530
+H SG N G Y ++G G FG V K
Sbjct: 1 MHHHHHHSSGRENLYFQGTFAERYN------------------IVCMLGKGSFGEVLKCK 42
Query: 531 -LNDKTIVAVKKI--TNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587
+ AVK I + + E+ ++ + H N++KL +V E
Sbjct: 43 DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL 102
Query: 588 MNHGSL-DRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY- 645
G L D I+ E I G+ Y+H I+H D+KPENILL
Sbjct: 103 YTGGELFDEII-KRKRFSEHDAA-RIIKQVFSGITYMHK---HNIVHRDLKPENILLESK 157
Query: 646 --HFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLE 703
KI DFGLS GT Y+APE L + EK DV+S G++L
Sbjct: 158 EKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYI 214
Query: 704 LVSG 707
L+SG
Sbjct: 215 LLSG 218
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 53/206 (25%), Positives = 85/206 (41%), Gaps = 25/206 (12%)
Query: 513 NFKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKL 571
+N IG G +G V + + A KKI V+ F EI I+ ++ H N+++L
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 572 KGFCAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERF--DIALGTAR----GLAYLH 624
LV E G L +R++ + F A + +AY H
Sbjct: 72 YETFEDNTDIYLVMELCTGGELFERVVH--------KRVFRESDAARIMKDVLSAVAYCH 123
Query: 625 SGCEQKIIHCDIKPENILL---HYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPE 681
+ H D+KPEN L K+ DFGL+ P + + T GT Y++P+
Sbjct: 124 K---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--MMRTKVGTPYYVSPQ 178
Query: 682 WLTNSAISEKTDVYSFGMVLLELVSG 707
L + D +S G+++ L+ G
Sbjct: 179 VLEGL-YGPECDEWSAGVMMYVLLCG 203
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 64/250 (25%), Positives = 97/250 (38%), Gaps = 47/250 (18%)
Query: 478 KSGNPNTLSSGDLEAFYIPGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGILNDKT-- 535
+ P + S+ Y P E L G G V + I K
Sbjct: 3 DAALPGSHSTHGFYENYEPK-------EIL-----------GRGVSSVVRRCI--HKPTC 42
Query: 536 -IVAVKKI--------TNVGVQGKKD-FCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLV 584
AVK I + VQ ++ E+ I+ + H N+++LK LV
Sbjct: 43 KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 102
Query: 585 YEYMNHGSL-DRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILL 643
++ M G L D + + E + R I + LH I+H D+KPENILL
Sbjct: 103 FDLMKKGELFDYLT-EKVTLSEKETR-KIMRALLEVICALHK---LNIVHRDLKPENILL 157
Query: 644 HYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKT------DVYSF 697
K++DFG S L P + + GT YLAPE + S D++S
Sbjct: 158 DDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 215
Query: 698 GMVLLELVSG 707
G+++ L++G
Sbjct: 216 GVIMYTLLAG 225
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 63/213 (29%), Positives = 93/213 (43%), Gaps = 28/213 (13%)
Query: 513 NFKNLIGSGGFGAVYKGILNDKT---IVAVKKI--------TNVGVQGKKDFCTEIAIIG 561
+GSG G V ++ VA+K I + + TEI I+
Sbjct: 13 IMSKTLGSGACGEVKLAF--ERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 562 NIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERFDIALGTARGL 620
++H ++K+K F +V E M G L D+++ GN + E + +
Sbjct: 71 KLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVV-GNKRLKEATCK-LYFYQMLLAV 127
Query: 621 AYLHSGCEQKIIHCDIKPENILL---HYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGY 677
YLH IIH D+KPEN+LL KI+DFG SK+L L T+ GT Y
Sbjct: 128 QYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLCGTPTY 182
Query: 678 LAPEWLTNSAI---SEKTDVYSFGMVLLELVSG 707
LAPE L + + D +S G++L +SG
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 9e-28
Identities = 66/249 (26%), Positives = 108/249 (43%), Gaps = 37/249 (14%)
Query: 473 KSTDSKSGNPNTLSSGDLEAFYIPGLPQ---RFDYEELEVATDNFKNLIGSGGFGAVYKG 529
+S S + + ++ + ++I G + +E ++ +G G VY+
Sbjct: 21 QSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFE--------VESELGRGATSIVYRC 72
Query: 530 ILND-KTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588
+ A+K + KK TEI ++ + H N++KLK + LV E +
Sbjct: 73 KQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130
Query: 589 NHGSL-DRILFGNGPVLEWQERF------DIALGTARGLAYLHSGCEQKIIHCDIKPENI 641
G L DRI+ + + D +AYLH I+H D+KPEN+
Sbjct: 131 TGGELFDRIVE--------KGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENL 179
Query: 642 LL---HYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFG 698
L KI+DFGLSK++ + L T+ GT GY APE L A + D++S G
Sbjct: 180 LYATPAPDAPLKIADFGLSKIVEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVG 237
Query: 699 MVLLELVSG 707
++ L+ G
Sbjct: 238 IITYILLCG 246
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 1e-27
Identities = 45/237 (18%), Positives = 79/237 (33%), Gaps = 38/237 (16%)
Query: 503 DYEELEVATDNFKNLIGSG--GFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDF---CTE 556
YE L V IG G V V V++I N+ + E
Sbjct: 26 CYELLTV--------IGKGFEDLMTVNLARYKPTGEYVTVRRI-NLEACSNEMVTFLQGE 76
Query: 557 IAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRIL--FGNGPVLEWQERFDIAL 614
+ + +H N+V + + +V +M +GS ++ + E IA
Sbjct: 77 LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA----IAY 132
Query: 615 ---GTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTM 671
G + L Y+H +H +K +IL+ + +S + +
Sbjct: 133 ILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVH 189
Query: 672 R------GTRGYLAPEWLTNSAI--SEKTDVYSFGMVLLELVSGRRNCSPRSQSHSM 720
+L+PE L + K+D+YS G+ EL +G P +
Sbjct: 190 DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH---VPFKDMPAT 243
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-27
Identities = 45/207 (21%), Positives = 85/207 (41%), Gaps = 25/207 (12%)
Query: 514 FKNLIGSGGFGAVYKGI-LNDKTIVAVKKI--TNVGVQGKKDFCTEIAIIGNIHHVNLVK 570
+G G F V + + + A I + + + E I + H N+V+
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 571 LKGFCAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERF------DIALGTARGLAYL 623
L ++ L+++ + G L + I+ +E + + +
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFEDIVA--------REYYSEADASHCIQQILEAVLHC 126
Query: 624 HSGCEQKIIHCDIKPENILL---HYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAP 680
H ++H ++KPEN+LL K++DFGL+ + EQ + GT GYL+P
Sbjct: 127 HQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFGFAGTPGYLSP 182
Query: 681 EWLTNSAISEKTDVYSFGMVLLELVSG 707
E L + D+++ G++L L+ G
Sbjct: 183 EVLRKDPYGKPVDLWACGVILYILLVG 209
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 5e-27
Identities = 59/208 (28%), Positives = 88/208 (42%), Gaps = 29/208 (13%)
Query: 513 NFKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEIAIIG-NIHHVNLVK 570
K IG G + + I AVK I + K+D EI I+ H N++
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKATNMEFAVKIID----KSKRDPTEEIEILLRYGQHPNIIT 80
Query: 571 LKGFCAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERF------DIALGTARGLAYL 623
LK G+ +V E M G L D+IL Q+ F + + + YL
Sbjct: 81 LKDVYDDGKYVYVVTELMKGGELLDKILR--------QKFFSEREASAVLFTITKTVEYL 132
Query: 624 HSGCEQKIIHCDIKPENILLHYHFQA----KISDFGLSKLLTPEQSSLFTTMRGTRGYLA 679
H+ Q ++H D+KP NIL +I DFG +K L E L T T ++A
Sbjct: 133 HA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-GLLMTPCYTANFVA 188
Query: 680 PEWLTNSAISEKTDVYSFGMVLLELVSG 707
PE L D++S G++L +++G
Sbjct: 189 PEVLERQGYDAACDIWSLGVLLYTMLTG 216
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 6e-27
Identities = 51/207 (24%), Positives = 89/207 (42%), Gaps = 26/207 (12%)
Query: 514 FKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGK--KDFCTEIAIIGNIHHVNLVK 570
K +G G F V + + A K I + + + E I + H N+V+
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92
Query: 571 LKGFCAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERF------DIALGTARGLAYL 623
L + LV++ + G L + I+ +E + +AY
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGELFEDIVA--------REFYSEADASHCIQQILESIAYC 144
Query: 624 HSGCEQKIIHCDIKPENILLHYHFQA---KISDFGLSKLLTPEQSSLFTTMRGTRGYLAP 680
HS I+H ++KPEN+LL + K++DFGL+ + ++ + GT GYL+P
Sbjct: 145 HS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGFAGTPGYLSP 199
Query: 681 EWLTNSAISEKTDVYSFGMVLLELVSG 707
E L S+ D+++ G++L L+ G
Sbjct: 200 EVLKKDPYSKPVDIWACGVILYILLVG 226
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 54/200 (27%), Positives = 83/200 (41%), Gaps = 14/200 (7%)
Query: 517 LIGSGGFGAVYKG---ILNDKTIVAVKKITNVGVQGKKDFCT----EIAIIGNIHHVNLV 569
L+G GG G VY+ + IVA+K + + + F T E G + ++V
Sbjct: 41 LVGRGGMGDVYEAEDTVRER--IVALK-LMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 570 KLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQ 629
+ F Q + +N L +L GP L I L H
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP-LAPPRAVAIVRQIGSALDAAH---AA 153
Query: 630 KIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAIS 689
H D+KPENIL+ A + DFG++ T E+ + GT Y+APE + S +
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHAT 213
Query: 690 EKTDVYSFGMVLLELVSGRR 709
+ D+Y+ VL E ++G
Sbjct: 214 YRADIYALTCVLYECLTGSP 233
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 47/218 (21%), Positives = 88/218 (40%), Gaps = 28/218 (12%)
Query: 517 LIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNI-HHVNLVKLKGF 574
++ GGF VY+ + A+K++ + + + E+ + + H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 575 CAQGRQR--------LLVYEYMNHGSLDRIL--FGNGPVLEWQERFDIALGTARGLAYLH 624
+ G++ LL+ E ++ + GP+ I T R + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSC-DTVLKIFYQTCRAVQHMH 153
Query: 625 SGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT-----------TMRG 673
+ IIH D+K EN+LL K+ DFG + ++ ++ T
Sbjct: 154 R-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 674 TRGYLAPE---WLTNSAISEKTDVYSFGMVLLELVSGR 708
T Y PE +N I EK D+++ G +L L +
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 58/259 (22%), Positives = 103/259 (39%), Gaps = 46/259 (17%)
Query: 468 RWKLHKSTDSKSGNPNTLSSGDLEAFYIPGLPQRFDYEELEVATDNFKNLIGSGGFGAVY 527
+S + P+ ++ + Y P + + G G V
Sbjct: 70 ENLYFQSMGPEDELPDWAAAKEFYQKYDPK-------DVI-----------GRGVSSVVR 111
Query: 528 KGILNDKT---IVAVKKI--------TNVGVQGKKDFCTEIAIIGNIH-HVNLVKLKGFC 575
+ + + AVK + + ++ E I+ + H +++ L
Sbjct: 112 RCV--HRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169
Query: 576 AQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHC 634
LV++ M G L D + + E + R I +++LH+ I+H
Sbjct: 170 ESSSFMFLVFDLMRKGELFDYLT-EKVALSEKETR-SIMRSLLEAVSFLHA---NNIVHR 224
Query: 635 DIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAI------ 688
D+KPENILL + Q ++SDFG S L P + + GT GYLAPE L S
Sbjct: 225 DLKPENILLDDNMQIRLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGY 282
Query: 689 SEKTDVYSFGMVLLELVSG 707
++ D+++ G++L L++G
Sbjct: 283 GKEVDLWACGVILFTLLAG 301
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 62/247 (25%), Positives = 90/247 (36%), Gaps = 55/247 (22%)
Query: 514 FKNLIGSGGFGAVYKGI-LNDKTIVAVK-----KITNVGVQGKKDFCTEIAIIGNIHHVN 567
K IG G +G V I + I A+K KI + + + TE+ ++ +HH N
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 568 LVKLKGFCAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERFDIALGTAR-------- 618
+ +L + LV E + G L D++ +
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 619 ------------------------------GLAYLHSGCEQKIIHCDIKPENILLHYHFQ 648
L YLH+ Q I H DIKPEN L +
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKS 206
Query: 649 A--KISDFGLSKLLT---PEQSSLFTTMRGTRGYLAPEWL--TNSAISEKTDVYSFGMVL 701
K+ DFGLSK + TT GT ++APE L TN + K D +S G++L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 702 LELVSGR 708
L+ G
Sbjct: 267 HLLLMGA 273
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 74/230 (32%), Positives = 108/230 (46%), Gaps = 34/230 (14%)
Query: 498 LPQRFDYEELEVATDNFKNL--IGSGGFGAVYKGILND-KTIVAVKKITNVGVQGKKDFC 554
+P FD E +V D+F+ L IG G FG V ND K + A+K + K C
Sbjct: 2 MPPVFDENE-DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYM-------NKQKC 53
Query: 555 ----------TEIAIIGNIHHVNLVKLKGFCAQGRQRL-LVYEYMNHGSLDRILFGNGPV 603
E+ I+ + H LV L + Q + + +V + + G L L N
Sbjct: 54 VERNEVRNVFKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHF 112
Query: 604 LEWQERFDIA-LGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP 662
E + I L A L YL + Q+IIH D+KP+NILL H I+DF ++ +L
Sbjct: 113 KEETVKLFICELVMA--LDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167
Query: 663 EQSSLFTTMRGTRGYLAPEWLTNSAISEKT---DVYSFGMVLLELVSGRR 709
E TTM GT+ Y+APE ++ + + D +S G+ EL+ GRR
Sbjct: 168 ETQI--TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 55/208 (26%), Positives = 85/208 (40%), Gaps = 27/208 (12%)
Query: 512 DNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNI-HHVNLV 569
D +G G F K + AVK I+ + + + EI + H N+V
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIV 69
Query: 570 KLKGFCAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERF------DIALGTARGLAY 622
KL LV E +N G L +RI ++ F I +++
Sbjct: 70 KLHEVFHDQLHTFLVMELLNGGELFERIKK--------KKHFSETEASYIMRKLVSAVSH 121
Query: 623 LHSGCEQKIIHCDIKPENILLHYHFQA---KISDFGLSKLLTPEQSSLFTTMRGTRGYLA 679
+H ++H D+KPEN+L KI DFG ++L P+ T T Y A
Sbjct: 122 MHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLKTPCFTLHYAA 177
Query: 680 PEWLTNSAISEKTDVYSFGMVLLELVSG 707
PE L + E D++S G++L ++SG
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSG 205
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-26
Identities = 26/234 (11%), Positives = 56/234 (23%), Gaps = 46/234 (19%)
Query: 517 LIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKD----------------------- 552
++G A + V
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 553 -----FCTEIAIIGNIHHVNLVKLKGFCAQG--RQRLLVYEYMN------HGSLDRILFG 599
F ++ + +++++ R +Y M L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 600 NGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKL 659
+ L R + L R LA LH ++H ++P +I+L ++ F
Sbjct: 205 HKS-LVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 660 LTPEQSSLFTTMRGTRGYLAPEWLT-----NSAISEKTDVYSFGMVLLELVSGR 708
S A L + ++ D ++ G+ + +
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 68/250 (27%), Positives = 110/250 (44%), Gaps = 39/250 (15%)
Query: 476 DSKSGNPNTLSSGDLEAFYIPGLPQRFDYEELEVATDNFKNLIGSGGFGAVY----KG-- 529
D + P +G L+ P P++ E+ + F ++G G F V
Sbjct: 2 DGTAAEPRP-GAGSLQHAQPPPQPRKKRPEDFK-----FGKILGEGSFSTVVLARELATS 55
Query: 530 ------ILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRL- 582
IL + I+ K+ V E ++ + H VKL F Q ++L
Sbjct: 56 REYAIKILEKRHIIKENKVPYV--------TRERDVMSRLDHPFFVKLY-FTFQDDEKLY 106
Query: 583 LVYEYMNHGSLDRILFGNGPVLEWQERF---DIALGTARGLAYLHSGCEQKIIHCDIKPE 639
Y +G L + + G E RF +I L YLH + IIH D+KPE
Sbjct: 107 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA----LEYLHG---KGIIHRDLKPE 159
Query: 640 NILLHYHFQAKISDFGLSKLLTPEQSSLFT-TMRGTRGYLAPEWLTNSAISEKTDVYSFG 698
NILL+ +I+DFG +K+L+PE + GT Y++PE LT + + +D+++ G
Sbjct: 160 NILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALG 219
Query: 699 MVLLELVSGR 708
++ +LV+G
Sbjct: 220 CIIYQLVAGL 229
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 67/209 (32%), Positives = 94/209 (44%), Gaps = 34/209 (16%)
Query: 517 LIGSGGFGAVYKGI-LNDKTIVAVK-----KITNVGVQGKKDFCTEIAIIGNIHHVNLVK 570
+G G +G V + + VAVK + + KK EI I ++H N+VK
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVK 69
Query: 571 LKGFCAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERFDIALGTAR--------GLA 621
G +G + L EY + G L DRI + + E A+ G+
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPD---------AQRFFHQLMAGVV 119
Query: 622 YLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE-QSSLFTTMRGTRGYLAP 680
YLH I H DIKPEN+LL KISDFGL+ + + L M GT Y+AP
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 681 EWLTNSA-ISEKTDVYSFGMVLLELVSGR 708
E L +E DV+S G+VL +++G
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 67/229 (29%), Positives = 98/229 (42%), Gaps = 44/229 (19%)
Query: 515 KNLIGSGGFGAVYKGI-LNDKTIVAVK-----KITNVGVQGKKDFCT------------- 555
K+ IG G +G V ND T A+K K+ ++
Sbjct: 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77
Query: 556 --------EIAIIGNIHHVNLVKLKG-FCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLE 605
EIAI+ + H N+VKL L +V+E +N G + + P+ E
Sbjct: 78 GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSE 136
Query: 606 WQERF---DIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP 662
Q RF D+ G + YLH QKIIH DIKP N+L+ KI+DFG+S
Sbjct: 137 DQARFYFQDLIKG----IEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 663 EQSSLFTTMRGTRGYLAPEWLTNSAIS---EKTDVYSFGMVLLELVSGR 708
+ L T GT ++APE L+ + + DV++ G+ L V G+
Sbjct: 190 SDALLSNT-VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 58/215 (26%), Positives = 91/215 (42%), Gaps = 39/215 (18%)
Query: 517 LIGSGGFGAVYKGI-LNDKTIVAVK-----KITNVG-VQGKKDFCTEIAII----GNIHH 565
L+G GGFG V+ G L D+ VA+K ++ + E+A++ H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 566 VNLVKLKGFCAQGRQRLLVYEYMNHGS--LDRILFGNGPVLEWQERFDIALGTAR----- 618
+++L + +LV E D I GP+ E G +R
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE-KGPLGE---------GPSRCFFGQ 147
Query: 619 ---GLAYLHSGCEQKIIHCDIKPENILL-HYHFQAKISDFGLSKLLTPEQSSLFTTMRGT 674
+ + HS + ++H DIK ENIL+ AK+ DFG LL +T GT
Sbjct: 148 VVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTDFDGT 201
Query: 675 RGYLAPEWLTNSA-ISEKTDVYSFGMVLLELVSGR 708
R Y PEW++ + V+S G++L ++V G
Sbjct: 202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-25
Identities = 65/258 (25%), Positives = 109/258 (42%), Gaps = 46/258 (17%)
Query: 472 HKSTDSKSGNPNTLSSGDLEAFYIPGL---PQRFDYEELEVATDNFKNLIGSGGFGAVYK 528
+ + NP + ++ G + Y +V IG+G FG V++
Sbjct: 7 NAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKV--------IGNGSFGVVFQ 58
Query: 529 GILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKG-FCAQGRQRL----- 582
L + VA+KK+ +Q K+ E+ I+ + H N+V LK F + G ++
Sbjct: 59 AKLVESDEVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114
Query: 583 LVYEYMN---HGSLDRILFGNGPVLE-------WQERFDIALGTARGLAYLHSGCEQKII 632
LV EY+ + + + +Q R LAY+HS I
Sbjct: 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ--------LLRSLAYIHS---IGIC 163
Query: 633 HCDIKPENILLHYH-FQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAI-SE 690
H DIKP+N+LL K+ DFG +K+L + + +R Y APE + + +
Sbjct: 164 HRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP--NVSYICSRYYRAPELIFGATNYTT 221
Query: 691 KTDVYSFGMVLLELVSGR 708
D++S G V+ EL+ G+
Sbjct: 222 NIDIWSTGCVMAELMQGQ 239
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 68/260 (26%), Positives = 110/260 (42%), Gaps = 50/260 (19%)
Query: 471 LHKSTDSKSGNPNTLSSGDLEAFYIPGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGI 530
S+ + + +++ P PQ Y + +V IG+G FG VY+
Sbjct: 23 FGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKV--------IGNGSFGVVYQAK 74
Query: 531 LND-KTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKG-FCAQGRQRL-----L 583
L D +VA+KK+ +Q K+ E+ I+ + H N+V+L+ F + G ++ L
Sbjct: 75 LCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130
Query: 584 VYEYMN---HGSLDRILFGNGPVLE-------WQERFDIALGTARGLAYLHSGCEQKIIH 633
V +Y+ + + +Q R LAY+HS I H
Sbjct: 131 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ--------LFRSLAYIHS---FGICH 179
Query: 634 CDIKPENILLHYH-FQAKISDFGLSKLLTPEQSSLFTTMRG---TRGYLAPEWLTNSAI- 688
DIKP+N+LL K+ DFG +K L + +R Y APE + +
Sbjct: 180 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-----PNVSYICSRYYRAPELIFGATDY 234
Query: 689 SEKTDVYSFGMVLLELVSGR 708
+ DV+S G VL EL+ G+
Sbjct: 235 TSSIDVWSAGCVLAELLLGQ 254
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-24
Identities = 64/237 (27%), Positives = 104/237 (43%), Gaps = 32/237 (13%)
Query: 489 DLEAFYIPGLPQRFDYEELEVATDNFKNL--IGSGGFGAVYKGILND-KTIVAVKKITNV 545
L++ Y Q E V + F+ +G GGFG V + + A KK+
Sbjct: 161 YLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKK 220
Query: 546 GVQGKKDF-CT--EIAIIGNIHHVNLVKLKGFCAQGRQRL-LVYEYMNHGSL-------D 594
++ +K E I+ ++ +V L + + + L LV MN G L
Sbjct: 221 RIKKRKGEAMALNEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMG 279
Query: 595 RILFGNGPVLEWQERF---DIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKI 651
+ F E + F +I G L LH ++I++ D+KPENILL H +I
Sbjct: 280 QAGFP-----EARAVFYAAEICCG----LEDLHR---ERIVYRDLKPENILLDDHGHIRI 327
Query: 652 SDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGR 708
SD GL+ + Q+ GT GY+APE + N + D ++ G +L E+++G+
Sbjct: 328 SDLGLAVHVPEGQTI--KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 47/218 (21%)
Query: 517 LIGSGGFGAVYKGI-LNDKTIVAVKKI--TNVGVQGKKDFCT----EIAIIGNIHHV--N 567
L+GSGGFG+VY GI ++D VA+K + + G+ T E+ ++ +
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 568 LVKLKGFCAQGRQRLLVYEY-----------MNHGSLD----RILFGNGPVLEWQERFDI 612
+++L + + +L+ E G+L R F WQ
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF-------WQ----- 157
Query: 613 ALGTARGLAYLHSGCEQKIIHCDIKPENILL-HYHFQAKISDFGLSKLLTPEQSSLFTTM 671
+ + H+ ++H DIK ENIL+ + K+ DFG LL + +++T
Sbjct: 158 ---VLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDF 208
Query: 672 RGTRGYLAPEWLTNSA-ISEKTDVYSFGMVLLELVSGR 708
GTR Y PEW+ V+S G++L ++V G
Sbjct: 209 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 49/232 (21%), Positives = 81/232 (34%), Gaps = 40/232 (17%)
Query: 499 PQRFDYEELEVATDNF-------KNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGK 550
++ E K ++G G G V + A+K + +
Sbjct: 11 GLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD-----S 65
Query: 551 KDFCTEIAIIG-NIHHVNLVKLKGFC----AQGRQRLLVYEYMNHGSL-DRILFGNGPVL 604
E+ ++V + R L++ E M G L RI
Sbjct: 66 PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRI------QE 119
Query: 605 EWQERF------DIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQA---KISDFG 655
+ F +I + +LHS I H D+KPEN+L + K++DFG
Sbjct: 120 RGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176
Query: 656 LSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSG 707
+K T T T Y+APE L + D++S G+++ L+ G
Sbjct: 177 FAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 54/216 (25%), Positives = 86/216 (39%), Gaps = 34/216 (15%)
Query: 515 KNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNI-HHVNLVKLK 572
++++G G V I L AVK I + E+ ++ H N+++L
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 573 GFCAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERF------DIALGTARGLAYLHS 625
F + + LV+E M GS+ I + F + A L +LH+
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIHK--------RRHFNELEASVVVQDVASALDFLHN 129
Query: 626 GCEQKIIHCDIKPENILLHYHFQA---KISDFGLSKLLTPEQSS------LFTTMRGTRG 676
+ I H D+KPENIL + Q KI DF L + T G+
Sbjct: 130 ---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186
Query: 677 YLAPEWLTNSAISEKT-----DVYSFGMVLLELVSG 707
Y+APE + + D++S G++L L+SG
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 39/208 (18%), Positives = 70/208 (33%), Gaps = 19/208 (9%)
Query: 513 NFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLK 572
+ K I + T+ + I + +
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124
Query: 573 GFCAQGRQRLLVY---EYMNHGSL-DRILFGNG-PVLEWQERFDIALGTARGLAYLHSGC 627
G ++ +Y + +L D + E I + A + +LHS
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS-- 182
Query: 628 EQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT-----------PEQSSLFTTMRGTRG 676
+ ++H D+KP NI K+ DFGL + + T GT+
Sbjct: 183 -KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 677 YLAPEWLTNSAISEKTDVYSFGMVLLEL 704
Y++PE + + S K D++S G++L EL
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFEL 269
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 17/94 (18%), Positives = 34/94 (36%), Gaps = 12/94 (12%)
Query: 501 RF--DYEELEVATDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKIT-NVGVQGKKDFCTE 556
R+ D+E ++ +G GGFG V++ D A+K+I ++ E
Sbjct: 3 RYLTDFEPIQC--------MGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMRE 54
Query: 557 IAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590
+ + + H +V+ + E
Sbjct: 55 VKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEI 88
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 63/233 (27%), Positives = 101/233 (43%), Gaps = 23/233 (9%)
Query: 490 LEAFYIPGLPQRFDYEELEVATDNFKNL--IGSGGFGAVYKGILND-KTIVAVKKITNVG 546
L++ Y Q E + D F + +G GGFG V+ + + A KK+
Sbjct: 163 LDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKR 222
Query: 547 VQGKKDF-CT--EIAIIGNIHHVNLVKLKGFCAQGRQRL-LVYEYMNHGSL----DRILF 598
++ +K + E I+ +H +V L + + + L LV MN G + +
Sbjct: 223 LKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDE 281
Query: 599 GNGPVLEWQERF---DIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFG 655
N E + F I G L +LH + II+ D+KPEN+LL +ISD G
Sbjct: 282 DNPGFQEPRAIFYTAQIVSG----LEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLG 334
Query: 656 LSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGR 708
L+ L Q+ GT G++APE L D ++ G+ L E+++ R
Sbjct: 335 LAVELKAGQTKT-KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 67/209 (32%), Positives = 94/209 (44%), Gaps = 34/209 (16%)
Query: 517 LIGSGGFGAVYKGI-LNDKTIVAVK-----KITNVGVQGKKDFCTEIAIIGNIHHVNLVK 570
+G G +G V + + VAVK + + KK EI I ++H N+VK
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVK 69
Query: 571 LKGFCAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERFDIALGTAR--------GLA 621
G +G + L EY + G L DRI + + E A+ G+
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPD---------AQRFFHQLMAGVV 119
Query: 622 YLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE-QSSLFTTMRGTRGYLAP 680
YLH I H DIKPEN+LL KISDFGL+ + + L M GT Y+AP
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 681 EWLTNSA-ISEKTDVYSFGMVLLELVSGR 708
E L +E DV+S G+VL +++G
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 53/205 (25%), Positives = 87/205 (42%), Gaps = 22/205 (10%)
Query: 514 FKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNI-HHVNLVKL 571
++G G G V + + A+K + + E+ + ++V++
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRI 120
Query: 572 KGFC---AQGRQRL-LVYEYMNHGSL-DRILF-GNGPVLEWQERFDIALGTARGLAYLHS 625
GR+ L +V E ++ G L RI G+ E +E +I + YLHS
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLHS 179
Query: 626 GCEQKIIHCDIKPENILLHYHFQA---KISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEW 682
I H D+KPEN+L K++DFG +K T S TT T Y+APE
Sbjct: 180 ---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPCYTPYYVAPEV 234
Query: 683 LTNSAISEKTDVYSFGMVLLELVSG 707
L + D++S G+++ L+ G
Sbjct: 235 LGPEKYDKSCDMWSLGVIMYILLCG 259
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 61/211 (28%), Positives = 92/211 (43%), Gaps = 27/211 (12%)
Query: 512 DNFKNL--IGSGGFGAVYKGILNDKT--IVAVKKITNVGVQGKKDF------CT---EIA 558
+ ++ + IG G +G V+K N T IVA+KK + EI
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCR-NRDTGQIVAIKKF-------LESEDDPVIKKIALREIR 54
Query: 559 IIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTAR 618
++ + H NLV L + R+ LV+EY +H ++ L + I T +
Sbjct: 55 MLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQ 113
Query: 619 GLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYL 678
+ + H IH D+KPENIL+ H K+ DFG ++LLT + TR Y
Sbjct: 114 AVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY-YDDEVATRWYR 169
Query: 679 APEWLTNSAI-SEKTDVYSFGMVLLELVSGR 708
+PE L DV++ G V EL+SG
Sbjct: 170 SPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 27/211 (12%)
Query: 512 DNFKNL--IGSGGFGAVYKGILNDKT--IVAVKKITNVGVQGKKDF------CT---EIA 558
+ ++NL +G G +G V K N T IVA+KK + EI
Sbjct: 25 EKYENLGLVGEGSYGMVMKCR-NKDTGRIVAIKKF-------LESDDDKMVKKIAMREIK 76
Query: 559 IIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTAR 618
++ + H NLV L C + ++ LV+E+++H ++ L L++Q
Sbjct: 77 LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIIN 135
Query: 619 GLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYL 678
G+ + HS IIH DIKPENIL+ K+ DFG ++ L ++ TR Y
Sbjct: 136 GIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYDDEVATRWYR 191
Query: 679 APEWLTNSAI-SEKTDVYSFGMVLLELVSGR 708
APE L + DV++ G ++ E+ G
Sbjct: 192 APELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 52/220 (23%), Positives = 84/220 (38%), Gaps = 49/220 (22%)
Query: 517 LIGSGGFGAVYKGI-LNDKTIVAVK-----KITNVGVQGKKDFCTEIAIIGNIHHVNLVK 570
L+G G +G V + + AVK K+ + EI ++ + H N+++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK-KEIQLLRRLRHKNVIQ 70
Query: 571 LKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLE-----WQERFD-IALG-----TAR- 618
L + + + ++ V+E QE D + A
Sbjct: 71 L-------------VDVLYNEEKQKMYM----VMEYCVCGMQEMLDSVPEKRFPVCQAHG 113
Query: 619 -------GLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE-QSSLFTT 670
GL YLHS Q I+H DIKP N+LL KIS G+++ L P T
Sbjct: 114 YFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 671 MRGTRGYLAPEWLTNSAISE--KTDVYSFGMVLLELVSGR 708
+G+ + PE K D++S G+ L + +G
Sbjct: 171 SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 5e-23
Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 512 DNFKNL--IGSGGFGAVYKGILNDKT--IVAVKKI----TNVGVQGKKDFCT---EIAII 560
+ ++ L +G G +G VYK D IVA+K+I + G+ T EI+++
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAK--DSQGRIVALKRIRLDAEDEGIP-----STAIREISLL 73
Query: 561 GNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGL 620
+HH N+V L R LV+E+M L ++L N L+ + RG+
Sbjct: 74 KELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGV 132
Query: 621 AYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAP 680
A+ H +I+H D+KP+N+L++ K++DFGL++ S +T T Y AP
Sbjct: 133 AHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS-YTHEVVTLWYRAP 188
Query: 681 EWLTNSAI-SEKTDVYSFGMVLLELVSGR 708
+ L S S D++S G + E+++G+
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 52/212 (24%), Positives = 80/212 (37%), Gaps = 24/212 (11%)
Query: 513 NFKNLIGSGGFGAVY----KGILNDKTIVAVKKITNVGVQGKKD---FCTEIAIIGNIHH 565
+IG G F V K + A+K + + + + F E ++ N
Sbjct: 64 EILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 566 VNLVKLKGFCAQGRQRL-LVYEYMNHGSLDRILFGNGPVL-EWQERFDIALGTARGLAYL 623
+ +L F Q L LV EY G L +L G + RF +A + +
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA-EIVMAIDSV 178
Query: 624 HSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL 683
H +H DIKP+NILL +++DFG L + + GT YL+PE L
Sbjct: 179 HR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEIL 235
Query: 684 TNSAISEKTDVY-------SFGMVLLELVSGR 708
T Y + G+ E+ G+
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 2e-22
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 24/209 (11%)
Query: 512 DNFKNL--IGSGGFGAVYKGILNDKT--IVAVKKI----TNVGVQGKKDFCT---EIAII 560
+ + L IG G +G VYK + A+KKI + G+ T EI+I+
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQ--NNYGETFALKKIRLEKEDEGIP-----STTIREISIL 54
Query: 561 GNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGL 620
+ H N+VKL ++ +LV+E+++ L ++L LE L G+
Sbjct: 55 KELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 621 AYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAP 680
AY H ++++H D+KP+N+L++ + KI+DFGL++ +T T Y AP
Sbjct: 114 AYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-YTHEIVTLWYRAP 169
Query: 681 EWLTNSAI-SEKTDVYSFGMVLLELVSGR 708
+ L S S D++S G + E+V+G
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 2e-22
Identities = 47/207 (22%), Positives = 96/207 (46%), Gaps = 17/207 (8%)
Query: 512 DNFKNL--IGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKD-F-CT---EIAIIGNI 563
++ L IG G +G V+K IVA+K++ + + + EI ++ +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR---LDDDDEGVPSSALREICLLKEL 58
Query: 564 HHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYL 623
H N+V+L ++ LV+E+ + L + L+ + +GL +
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 624 HSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL 683
HS + ++H D+KP+N+L++ + + K+++FGL++ ++ T Y P+ L
Sbjct: 118 HS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-YSAEVVTLWYRPPDVL 173
Query: 684 TNSAI-SEKTDVYSFGMVLLELVSGRR 709
+ + S D++S G + EL + R
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 25/211 (11%)
Query: 512 DNFKNL--IGSGGFGAVYKGILND-KTIVAVKKIT-NVGVQGKKDFCTEI-----AIIGN 562
++F IG GGFG VY D + A+K + + + +++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 563 IHHVNLVKLKGFCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERF---DIALGTAR 618
+V + + +L + + MN G L L +G E RF +I LG
Sbjct: 249 GDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG--- 304
Query: 619 GLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYL 678
L ++H+ + +++ D+KP NILL H +ISD GL+ + ++ GT GY+
Sbjct: 305 -LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYM 357
Query: 679 APEWLTNSAISEKT-DVYSFGMVLLELVSGR 708
APE L + + D +S G +L +L+ G
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 54/245 (22%), Positives = 98/245 (40%), Gaps = 47/245 (19%)
Query: 497 GLPQRFDYEELEVATDNF--------KNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQ 548
G+ + + ++ + + I SG +GAV G+ ++ VA+K++ N
Sbjct: 1 GMQAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSD 60
Query: 549 GKKD-------FCT----EIAIIGNIHHVNLVKLKG-FCAQGRQRL----LVYEYMNHGS 592
G+ C EI ++ + HH N++ L+ F + LV E M
Sbjct: 61 GRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TD 119
Query: 593 LDRILFGNGPVLE--------WQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLH 644
L +++ V+ + GL LH ++H D+ P NILL
Sbjct: 120 LAQVIHDQRIVISPQHIQYFMYH--------ILLGLHVLHEA---GVVHRDLHPGNILLA 168
Query: 645 YHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAI-SEKTDVYSFGMVLLE 703
+ I DF L++ T + + T R Y APE + ++ D++S G V+ E
Sbjct: 169 DNNDITICDFNLAREDTADANK--THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAE 226
Query: 704 LVSGR 708
+ + +
Sbjct: 227 MFNRK 231
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 57/207 (27%), Positives = 106/207 (51%), Gaps = 20/207 (9%)
Query: 512 DNFKNL--IGSGGFGAVYKGILNDKT--IVAVKKITNVGVQGKKDF-CT---EIAIIGNI 563
+ + L +G G + VYKG + T +VA+K+I ++ ++ CT E++++ ++
Sbjct: 2 ETYIKLDKLGEGTYATVYKGK-SKLTDNLVALKEIR---LEHEEGAPCTAIREVSLLKDL 57
Query: 564 HHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYL 623
H N+V L + LV+EY++ L + L G ++ RGLAY
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 624 HSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT-PEQSSLFTTMRGTRGYLAPEW 682
H QK++H D+KP+N+L++ + K++DFGL++ + P ++ + T Y P+
Sbjct: 117 HR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--YDNEVVTLWYRPPDI 171
Query: 683 LTNSAI-SEKTDVYSFGMVLLELVSGR 708
L S S + D++ G + E+ +GR
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 9e-22
Identities = 57/216 (26%), Positives = 80/216 (37%), Gaps = 45/216 (20%)
Query: 518 IGSGGFGAVYKGI-LNDKTIVAVK-----KITNVGVQGKKDFCT---EIAIIGNIHHVNL 568
+GSG FG V+ + V VK K+ EIAI+ + H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 569 VKLKGFCAQGRQRLLVYEY-----------MNHGSLD----RILFGNGPVLEWQERFDIA 613
+K+ LV E H LD +F Q
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIF-------RQ------ 138
Query: 614 LGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRG 673
+ YL + IIH DIK ENI++ F K+ DFG + L + LF T G
Sbjct: 139 --LVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK--LFYTFCG 191
Query: 674 TRGYLAPEWLTNSA-ISEKTDVYSFGMVLLELVSGR 708
T Y APE L + + +++S G+ L LV
Sbjct: 192 TIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 63/208 (30%), Positives = 94/208 (45%), Gaps = 33/208 (15%)
Query: 517 LIGSGGFGAVYKGI-LNDKTIVAVK-----KITNVGVQGKKDFCTEIAIIGNIHHVNLVK 570
+G G FG V G VAVK KI ++ V GK EI + H +++K
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGK--IKREIQNLKLFRHPHIIK 75
Query: 571 LKGFCAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERFDIALGTAR--------GLA 621
L + +V EY++ G L D I +G V E AR +
Sbjct: 76 LYQVISTPTDFFMVMEYVSGGELFDYIC-KHGRVEE---------MEARRLFQQILSAVD 125
Query: 622 YLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPE 681
Y H ++H D+KPEN+LL H AKI+DFGLS +++ + T G+ Y APE
Sbjct: 126 YCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRTSCGSPNYAAPE 180
Query: 682 WLTNSA-ISEKTDVYSFGMVLLELVSGR 708
++ + D++S G++L L+ G
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 57/204 (27%), Positives = 85/204 (41%), Gaps = 28/204 (13%)
Query: 518 IGSGGFGAVYKGI-LNDKTIVAVKKI--TNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGF 574
IG G F V + VA+K I T + + E+ I+ ++H N+VKL
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 575 CAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERFDIALGTAR--------GLAYLHS 625
+ L+ EY + G + D ++ +G + E AR + Y H
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLV-AHGRMKE---------KEARSKFRQIVSAVQYCHQ 132
Query: 626 GCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTN 685
++I+H D+K EN+LL KI+DFG S T G Y APE
Sbjct: 133 ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--KLDAFCGAPPYAAPELFQG 187
Query: 686 SA-ISEKTDVYSFGMVLLELVSGR 708
+ DV+S G++L LVSG
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGS 211
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 1e-21
Identities = 64/207 (30%), Positives = 97/207 (46%), Gaps = 16/207 (7%)
Query: 512 DNFKNL--IGSGGFGAVYKGI-LNDKTIVAVKKI-TNVGVQGKKDF-CT---EIAIIGNI 563
++ L +G G F VYK N IVA+KKI + K T EI ++ +
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 564 HHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYL 623
H N++ L LV+++M L+ I+ N VL L T +GL YL
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 128
Query: 624 HSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT-PEQSSLFTTMRGTRGYLAPEW 682
H I+H D+KP N+LL + K++DFGL+K P ++ +T TR Y APE
Sbjct: 129 HQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPEL 183
Query: 683 LTNSAI-SEKTDVYSFGMVLLELVSGR 708
L + + D+++ G +L EL+
Sbjct: 184 LFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 61/211 (28%), Positives = 108/211 (51%), Gaps = 19/211 (9%)
Query: 510 ATDNFKNL--IGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDF-CT---EIAIIGN 562
++ FK L +G+G + VYKG+ VA+K++ + ++ T EI+++
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK---LDSEEGTPSTAIREISLMKE 59
Query: 563 IHHVNLVKLKGFCAQGRQRLLVYEYMNH---GSLDRILFGNGPV-LEWQERFDIALGTAR 618
+ H N+V+L + LV+E+M++ +D GN P LE +
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 619 GLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYL 678
GLA+ H KI+H D+KP+N+L++ Q K+ DFGL++ ++ F++ T Y
Sbjct: 120 GLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT-FSSEVVTLWYR 175
Query: 679 APEWLTNSAI-SEKTDVYSFGMVLLELVSGR 708
AP+ L S S D++S G +L E+++G+
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 23/218 (10%)
Query: 505 EELEVATDNF--KNLIGSGGFGAVY----KGILNDKTIVAVKKITNVGVQGKKD---FCT 555
+L + +++ +IG G FG V K + + A+K ++ + + D F
Sbjct: 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWE 118
Query: 556 EIAIIGNIHHVNLVKLKGFCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERFDIAL 614
E I+ + +V+L + Q + L +V EYM G L ++ N V E RF A
Sbjct: 119 ERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAE 176
Query: 615 GTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGT 674
L +HS IH D+KP+N+LL K++DFG + E T GT
Sbjct: 177 VVL-ALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGT 232
Query: 675 RGYLAPEWLTNSAISEK----TDVYSFGMVLLELVSGR 708
Y++PE L + D +S G+ L E++ G
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 4e-21
Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 35/214 (16%)
Query: 513 NFKNLIGSGGFGAVY----KGILNDKTIVAVKKITNVGVQGKKDFC---------TEIAI 559
++G G FG V+ + + + A+K + KK E I
Sbjct: 27 ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-------KKATLKVRDRVRTKMERDI 79
Query: 560 IGNIHHVNLVKLKGFCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERF---DIALG 615
+ ++H +VKL + Q +L L+ +++ G L L E +F ++AL
Sbjct: 80 LVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALA 138
Query: 616 TARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKL-LTPEQSSLFTTMRGT 674
L +LHS II+ D+KPENILL K++DFGLSK + E+ + + GT
Sbjct: 139 ----LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA--YSFCGT 189
Query: 675 RGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGR 708
Y+APE + ++ D +SFG+++ E+++G
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 5e-21
Identities = 61/205 (29%), Positives = 84/205 (40%), Gaps = 29/205 (14%)
Query: 517 LIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFC 575
IGSG FG K +VAVK G ++ EI ++ H N+V+ K
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVK-YIERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 576 AQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERFDIALGTAR--------GLAYLHSG 626
++ EY + G L +RI G E AR G++Y HS
Sbjct: 86 LTPTHLAIIMEYASGGELYERIC-NAGRFSE---------DEARFFFQQLLSGVSYCHS- 134
Query: 627 CEQKIIHCDIKPENILL--HYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT 684
+I H D+K EN LL + KI DFG SK S + GT Y+APE L
Sbjct: 135 --MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS--SVLHSQPKSTVGTPAYIAPEVLL 190
Query: 685 NSA-ISEKTDVYSFGMVLLELVSGR 708
+ DV+S G+ L ++ G
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 5e-21
Identities = 50/208 (24%), Positives = 87/208 (41%), Gaps = 18/208 (8%)
Query: 513 NFKNLIGSGGFGAVYKGILND-KTIVAVKKITNVGVQGKKD---FCTEIAIIGNIHHVNL 568
+IG G FG V L + + A+K + + + + F E ++ N +
Sbjct: 77 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWI 136
Query: 569 VKLKGFCAQGRQRL-LVYEYMNHGSLDRILF-GNGPVLEWQERFDIA-LGTARGLAYLHS 625
L + Q L LV +Y G L +L + E RF +A + A + +H
Sbjct: 137 TTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA--IDSVHQ 193
Query: 626 GCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTN 685
+H DIKP+NIL+ + +++DFG L + + + GT Y++PE L
Sbjct: 194 ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250
Query: 686 SAISEKT-----DVYSFGMVLLELVSGR 708
+ D +S G+ + E++ G
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 5e-21
Identities = 53/211 (25%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 511 TDNFKNL--IGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCT----EIAIIGNI 563
++NL IGSG G V + VA+KK++ + E+ ++ +
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCV 81
Query: 564 HHVNLVKLKG-FCAQGRQRL-----LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTA 617
+H N++ L F Q +V E M+ +L +++ + + + +
Sbjct: 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI--QMELDHERMSY-LLYQML 137
Query: 618 RGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGY 677
G+ +LHS IIH D+KP NI++ KI DFGL++ + T TR Y
Sbjct: 138 CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYY 192
Query: 678 LAPEWLTNSAISEKTDVYSFGMVLLELVSGR 708
APE + E D++S G ++ E++ G
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 6e-21
Identities = 52/212 (24%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 511 TDNFKNL--IGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCT----EIAIIGNI 563
+ + +GSG +G+V I VA+KK++ + F E+ ++ ++
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHM 80
Query: 564 HHVNLVKLKG-FCAQGRQRL-----LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTA 617
H N++ L F R LV +M L +I+ E + ++ +
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM--GLKFSEEKIQY-LVYQML 136
Query: 618 RGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGY 677
+GL Y+HS ++H D+KP N+ ++ + KI DFGL++ E T TR Y
Sbjct: 137 KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWY 189
Query: 678 LAPEWLTNSAI-SEKTDVYSFGMVLLELVSGR 708
APE + + ++ D++S G ++ E+++G+
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 7e-21
Identities = 64/208 (30%), Positives = 92/208 (44%), Gaps = 24/208 (11%)
Query: 513 NFKNLIGSGGFGAVY----KGILNDKTIVAVKKITNVGVQGKKDF-CT--EIAIIGNIHH 565
+ L+G G FG V K A+K + + K + T E ++ N H
Sbjct: 151 EYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 566 VNLVKLKGFCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERF---DIALGTARGLA 621
L LK + Q RL V EY N G L L E + RF +I L
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA----LD 262
Query: 622 YLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKL-LTPEQSSLFTTMRGTRGYLAP 680
YLHS E+ +++ D+K EN++L KI+DFGL K + + T GT YLAP
Sbjct: 263 YLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM--KTFCGTPEYLAP 318
Query: 681 EWLTNSAISEKTDVYSFGMVLLELVSGR 708
E L ++ D + G+V+ E++ GR
Sbjct: 319 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 8e-21
Identities = 56/208 (26%), Positives = 88/208 (42%), Gaps = 34/208 (16%)
Query: 517 LIGSGGFGAVYKGI-LNDKTIVAVK-----KITNVGVQGKKDFCTEIAIIGNIHHVNLVK 570
+G G FG V + VA+K + + + + EI+ + + H +++K
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE--REISYLKLLRHPHIIK 73
Query: 571 LKGFCAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERFDIALGTAR--------GLA 621
L ++V EY G L D I+ + E R +
Sbjct: 74 LYDVITTPTDIVMVIEYAG-GELFDYIV-EKKRMTE---------DEGRRFFQQIICAIE 122
Query: 622 YLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPE 681
Y H KI+H D+KPEN+LL + KI+DFGLS ++T T G+ Y APE
Sbjct: 123 YCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--FLKTSCGSPNYAAPE 177
Query: 682 WLTNSA-ISEKTDVYSFGMVLLELVSGR 708
+ + DV+S G+VL ++ GR
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 9e-21
Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 27/218 (12%)
Query: 510 ATDNFKNL--IGSGGFGAVYKGI-LNDKTIVAVKKI-TNVGVQGKKDF-CT---EIAI-- 559
AT ++ + IG G +G VYK + VA+K + G G + E+A+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 560 -IGNIHHVNLVKLKGFCAQGRQRL-----LVYEYMNH---GSLDRILFGNGPVLEWQERF 610
+ H N+V+L CA R LV+E+++ LD+ P L +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA---PPPGLPAETIK 123
Query: 611 DIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670
D+ RGL +LH+ I+H D+KPENIL+ K++DFGL+++ + + + T
Sbjct: 124 DLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LTP 178
Query: 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGR 708
+ T Y APE L S + D++S G + E+ +
Sbjct: 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 2e-20
Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 33/208 (15%)
Query: 517 LIGSGGFGAVYKGI-LNDKTIVAVK-----KITNVGVQGKKDFCTEIAIIGNIHHVNLVK 570
+G G FG V G VAVK KI ++ V GK EI + H +++K
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR--REIQNLKLFRHPHIIK 80
Query: 571 LKGFCAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERFDIALGTAR--------GLA 621
L + +V EY++ G L D I NG + E +R G+
Sbjct: 81 LYQVISTPSDIFMVMEYVSGGELFDYIC-KNGRLDE---------KESRRLFQQILSGVD 130
Query: 622 YLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPE 681
Y H ++H D+KPEN+LL H AKI+DFGLS +++ + T G+ Y APE
Sbjct: 131 YCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRTSCGSPNYAAPE 185
Query: 682 WLTNSA-ISEKTDVYSFGMVLLELVSGR 708
++ + D++S G++L L+ G
Sbjct: 186 VISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 64/215 (29%), Positives = 93/215 (43%), Gaps = 39/215 (18%)
Query: 513 NFKNLIGSGGFGAV----YKGILNDKTIVAVKKITNVGVQGKKDFC----------TEIA 558
++ L+G G FG V K A+K + +K+ TE
Sbjct: 8 DYLKLLGKGTFGKVILVREKA---TGRYYAMKIL-------RKEVIIAKDEVAHTVTESR 57
Query: 559 IIGNIHHVNLVKLKGFCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERF---DIAL 614
++ N H L LK + Q RL V EY N G L L E + RF +I
Sbjct: 58 VLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVS 116
Query: 615 GTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKL-LTPEQSSLFTTMRG 673
L YLHS + +++ DIK EN++L KI+DFGL K ++ + T G
Sbjct: 117 A----LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCG 167
Query: 674 TRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGR 708
T YLAPE L ++ D + G+V+ E++ GR
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 56/230 (24%), Positives = 100/230 (43%), Gaps = 27/230 (11%)
Query: 496 PGLPQRFDYEELEVAT--DNFKNL--IGSGGFGAVYKGILNDKT--IVAVKKITNVGVQG 549
P AT D ++ + +G G +G VYK I + T VA+K+I ++
Sbjct: 16 TQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAI-DTVTNETVAIKRIR---LEH 71
Query: 550 KKD-F-CT---EIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVL 604
+++ T E++++ + H N+++LK + L++EY + L + + N V
Sbjct: 72 EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVS 130
Query: 605 EWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQA-----KISDFGLSKL 659
+ G+ + HS ++ +H D+KP+N+LL + KI DFGL++
Sbjct: 131 MRVIK-SFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186
Query: 660 LTPEQSSLFTTMRGTRGYLAPEWLTNSAI-SEKTDVYSFGMVLLELVSGR 708
FT T Y PE L S S D++S + E++
Sbjct: 187 FGIPIRQ-FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 51/222 (22%), Positives = 86/222 (38%), Gaps = 34/222 (15%)
Query: 504 YEELEVATDNFKNLIGSGGFGAVYKGILND-KTIVAVKKITNVGVQGKKDFCT----EIA 558
++ + G G FG V G VA+KK+ F +
Sbjct: 25 FQVERM--------AGQGTFGTVQLGKEKSTGMSVAIKKVIQ-----DPRFRNRELQIMQ 71
Query: 559 IIGNIHHVNLVKLK-GFCAQGRQRL------LVYEYMNHGSLDRILFGNGPVLEWQERFD 611
+ +HH N+V+L+ F G + +V EY+ +L R
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPIL 130
Query: 612 IALGT---ARGLAYLHSGCEQKIIHCDIKPENILLHYH-FQAKISDFGLSKLLTPEQSSL 667
I + R + LH + H DIKP N+L++ K+ DFG +K L+P + +
Sbjct: 131 IKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN- 188
Query: 668 FTTMRGTRGYLAPEWLTNSAI-SEKTDVYSFGMVLLELVSGR 708
+R Y APE + + + D++S G + E++ G
Sbjct: 189 -VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 511 TDNFKNL--IGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCT----EIAIIGNI 563
+ NL IG G +G V +K VA+KKI+ + +C EI I+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE---HQTYCQRTLREIKILLRF 82
Query: 564 HHVNLVKLKG-FCAQGRQRL----LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTAR 618
H N++ + A +++ +V + M L ++L + + R
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQ-HLSNDHICY-FLYQILR 139
Query: 619 GLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ--SSLFTTMRGTRG 676
GL Y+HS ++H D+KP N+LL+ KI DFGL+++ P+ + T TR
Sbjct: 140 GLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 677 YLAPEWLTNSAI-SEKTDVYSFGMVLLELVSGR 708
Y APE + NS ++ D++S G +L E++S R
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 39/219 (17%)
Query: 512 DNFKNL--IGSGGFGAVY---KGILND-KTIVAVKKITNVGVQGKKDFC----------- 554
+ F+ L +G GG+G V+ K + I A+K + KK
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVL-------KKAMIVRNAKDTAHTK 69
Query: 555 TEIAIIGNIHHVNLVKLKGFCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERF--- 610
E I+ + H +V L + Q +L L+ EY++ G L L G +E F
Sbjct: 70 AERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA 128
Query: 611 DIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKL-LTPEQSSLFT 669
+I++ L +LH + II+ D+KPENI+L++ K++DFGL K + +
Sbjct: 129 EISMA----LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT--H 179
Query: 670 TMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGR 708
T GT Y+APE L S + D +S G ++ ++++G
Sbjct: 180 TFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 6e-20
Identities = 54/222 (24%), Positives = 98/222 (44%), Gaps = 33/222 (14%)
Query: 512 DNFKNL---IGSGGFGAVYKGILNDKT---IVAVKKITNVGVQGKKDFCTEIAIIGNIHH 565
D F+ +G G +G VYK D A+K+I G+ C EIA++ + H
Sbjct: 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA--CREIALLRELKH 77
Query: 566 VNLVKLKG-FCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTA------ 617
N++ L+ F + +++ L+++Y H L I+ + ++ + G
Sbjct: 78 PNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136
Query: 618 --RGLAYLHSGCEQKIIHCDIKPENILLHYHFQA----KISDFGLSKLLT-PEQSSLFTT 670
G+ YLH+ ++H D+KP NIL+ KI+D G ++L P +
Sbjct: 137 ILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP--LAD 191
Query: 671 MRG---TRGYLAPEWLTNSAI-SEKTDVYSFGMVLLELVSGR 708
+ T Y APE L + ++ D+++ G + EL++
Sbjct: 192 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-20
Identities = 63/270 (23%), Positives = 106/270 (39%), Gaps = 46/270 (17%)
Query: 470 KLHKSTDSKSGNPNTLSSGDLEAFYIPGLPQRFDYEELEVAT-------DNFKNL--IGS 520
H + S +S D L + + + +NF+ L +G+
Sbjct: 5 HHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGT 64
Query: 521 GGFGAVY----KGILNDKTIVAVKKITNVGVQGKKDFC-----------TEIAIIGNI-H 564
G +G V+ + + A+K + KK TE ++ +I
Sbjct: 65 GAYGKVFLVRKISGHDTGKLYAMKVL-------KKATIVQKAKTTEHTRTERQVLEHIRQ 117
Query: 565 HVNLVKLKGFCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERF---DIALGTARGL 620
LV L + Q +L L+ +Y+N G L L E + + +I L L
Sbjct: 118 SPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA----L 172
Query: 621 AYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAP 680
+LH II+ DIK ENILL + ++DFGLSK +++ GT Y+AP
Sbjct: 173 EHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 229
Query: 681 EWLTNSAISEKTDV--YSFGMVLLELVSGR 708
+ + V +S G+++ EL++G
Sbjct: 230 DIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 7e-20
Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 24/211 (11%)
Query: 511 TDNFKNL--IGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCT----EIAIIGNI 563
++NL IGSG G V VA+KK++ + E+ ++ +
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCV 118
Query: 564 HHVNLVKLKG-FCAQGRQRL-----LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTA 617
+H N++ L F Q LV E M+ +L +++ + + + +
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVI--QMELDHERMSY-LLYQML 174
Query: 618 RGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGY 677
G+ +LHS IIH D+KP NI++ KI DFGL++ + T TR Y
Sbjct: 175 CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYY 229
Query: 678 LAPEWLTNSAISEKTDVYSFGMVLLELVSGR 708
APE + E D++S G ++ E+V +
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 7e-20
Identities = 54/228 (23%), Positives = 102/228 (44%), Gaps = 35/228 (15%)
Query: 499 PQRFDYEELEVA---TDNFKNL--IGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKD 552
+ +DYE V D+++ + +G G + V++ I + + V VK + V KK
Sbjct: 20 REYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKK 76
Query: 553 FCTEIAIIGNI-HHVNLVKLKG-FCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQER 609
EI I+ N+ N++ L + LV+E++N+ ++ L
Sbjct: 77 IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTL---TD 129
Query: 610 FDIA------LGTARGLAYLHSGCEQKIIHCDIKPENILL-HYHFQAKISDFGLSKLLTP 662
+DI L + L Y HS I+H D+KP N+++ H H + ++ D+GL++ P
Sbjct: 130 YDIRFYMYEIL---KALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183
Query: 663 EQSSLFTTMRGTRGYLAPEWLTNSAI-SEKTDVYSFGMVLLELVSGRR 709
Q + +R + PE L + + D++S G +L ++ +
Sbjct: 184 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 56/217 (25%), Positives = 106/217 (48%), Gaps = 31/217 (14%)
Query: 512 DNFKNL--IGSGGFGAVYKGILNDKT--IVAVKKITNVGVQGKKD-F-CT---EIAI--- 559
++ + IG G +G V+K VA+K++ VQ ++ + E+A+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR---VQTGEEGMPLSTIREVAVLRH 67
Query: 560 IGNIHHVNLVKLK----GFCAQGRQRL-LVYEYMNH---GSLDRILFGNGPVLEWQERFD 611
+ H N+V+L +L LV+E+++ LD++ P + + D
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKD 124
Query: 612 IALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTM 671
+ RGL +LHS +++H D+KP+NIL+ Q K++DFGL+++ + + + T++
Sbjct: 125 MMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSV 179
Query: 672 RGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGR 708
T Y APE L S+ + D++S G + E+ +
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-19
Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 24/203 (11%)
Query: 518 IGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCT----EIAIIGNIHHVNLVKLK 572
+GSG +GAV + VA+KK+ + F E+ ++ ++ H N++ L
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 573 G-FCAQGRQRL-----LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSG 626
F LV +M L +++ + + E + +F + +GL Y+H+
Sbjct: 91 DVFTPDETLDDFTDFYLVMPFMGT-DLGKLM-KHEKLGEDRIQF-LVYQMLKGLRYIHAA 147
Query: 627 CEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNS 686
IIH D+KP N+ ++ + KI DFGL++ E T TR Y APE + N
Sbjct: 148 ---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNW 200
Query: 687 AI-SEKTDVYSFGMVLLELVSGR 708
++ D++S G ++ E+++G+
Sbjct: 201 MRYTQTVDIWSVGCIMAEMITGK 223
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 26/207 (12%)
Query: 513 NFKNLIGSGGFGAVY----KGILNDKTIVAVKKITNVGVQGKKDF---CTEIAIIGNIHH 565
+ +G+G FG V K A+K + V K E I+ ++
Sbjct: 44 DRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 566 VNLVKLKGFCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERF---DIALGTARGLA 621
LVKL+ F + L +V EY+ G + L G E RF I L
Sbjct: 101 PFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FE 155
Query: 622 YLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPE 681
YLHS +I+ D+KPEN+L+ +++DFG +K T+ GT LAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPE 208
Query: 682 WLTNSAISEKTDVYSFGMVLLELVSGR 708
+ + ++ D ++ G+++ E+ +G
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 3e-19
Identities = 55/217 (25%), Positives = 89/217 (41%), Gaps = 27/217 (12%)
Query: 512 DNFKNL--IGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKD-F-CT---EIAIIGNI 563
++ L IG G FG V+K VA+KK+ ++ +K+ F T EI I+ +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKILQLL 73
Query: 564 HHVNLVKLKGFCAQGRQRL--------LVYEYMNHGSLDRILFGNGPVLEWQERFDIALG 615
H N+V L C LV+++ H L +L E +
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQM 132
Query: 616 TARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLL---TPEQSSLFTTMR 672
GL Y+H KI+H D+K N+L+ K++DFGL++ Q + +T
Sbjct: 133 LLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 189
Query: 673 GTRGYLAPEWLTNSAI-SEKTDVYSFGMVLLELVSGR 708
T Y PE L D++ G ++ E+ +
Sbjct: 190 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 3e-19
Identities = 53/248 (21%), Positives = 95/248 (38%), Gaps = 56/248 (22%)
Query: 507 LEVATDNFKNL--IGSGGFGAVYKGILND-KTIVAVKKITNVGVQGKKDFCT-EIAIIGN 562
LE ++ + +G+G FG V + + A+KK+ + E+ I+
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKV 56
Query: 563 IHHVNLVKLK-GFCAQGRQRLLVYEYMNHGSLDRILFGNGP------------------V 603
+ HVN++KL F G + + + + +
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 604 LEWQE-------RFDIALGTA--------------RGLAYLHSGCEQKIIHCDIKPENIL 642
+E+ + I G + R + ++HS I H DIKP+N+L
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLL 173
Query: 643 LHYH-FQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAI-SEKTDVYSFGMV 700
++ K+ DFG +K L P + S +R Y APE + + + D++S G V
Sbjct: 174 VNSKDNTLKLCDFGSAKKLIPSEPS--VAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231
Query: 701 LLELVSGR 708
EL+ G+
Sbjct: 232 FGELILGK 239
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 56/219 (25%), Positives = 87/219 (39%), Gaps = 45/219 (20%)
Query: 518 IGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCT----EIAIIGNIHHVNLVKLK 572
+G G +G V IVA+KKI K F EI I+ + H N++ +
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFD---KPLFALRTLREIKILKHFKHENIITIF 75
Query: 573 G-FCAQGRQRL----LVYEYMNHGSLDRILFGNGPVLE--------WQERFDIALGTARG 619
+ ++ E M L R++ +L +Q T R
Sbjct: 76 NIQRPDSFENFNEVYIIQELM-QTDLHRVISTQ--MLSDDHIQYFIYQ--------TLRA 124
Query: 620 LAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRG------ 673
+ LH +IH D+KP N+L++ + K+ DFGL++++ +
Sbjct: 125 VKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 674 ---TRGYLAPEWLTNSAI-SEKTDVYSFGMVLLELVSGR 708
TR Y APE + SA S DV+S G +L EL R
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 4e-19
Identities = 52/212 (24%), Positives = 101/212 (47%), Gaps = 36/212 (16%)
Query: 513 NFKNLIGSGGFGAVY----KG--------ILNDKTIVAVKKITNVGVQGKKDFCTEIAII 560
+G+G FG V+ + +L + +V +K++ + E ++
Sbjct: 9 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT--------NDERLML 60
Query: 561 GNIHHVNLVKLKGFCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERF---DIALGT 616
+ H ++++ Q Q++ ++ +Y+ G L +L + +F ++ L
Sbjct: 61 SIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA- 118
Query: 617 ARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRG 676
L YLHS + II+ D+KPENILL + KI+DFG +K + T+ GT
Sbjct: 119 ---LEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK----YVPDVTYTLCGTPD 168
Query: 677 YLAPEWLTNSAISEKTDVYSFGMVLLELVSGR 708
Y+APE ++ ++ D +SFG+++ E+++G
Sbjct: 169 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 9e-19
Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 24/203 (11%)
Query: 518 IGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCT----EIAIIGNIHHVNLVKLK 572
+GSG +G+V VAVKK++ E+ ++ ++ H N++ L
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 573 G-FCAQGRQRL-----LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSG 626
F LV M L+ I+ + + +F + RGL Y+HS
Sbjct: 95 DVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQ-KLTDDHVQF-LIYQILRGLKYIHSA 151
Query: 627 CEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNS 686
IIH D+KP N+ ++ + KI DFGL++ E T TR Y APE + N
Sbjct: 152 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYVATRWYRAPEIMLNW 204
Query: 687 AI-SEKTDVYSFGMVLLELVSGR 708
++ D++S G ++ EL++GR
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGR 227
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 33/214 (15%)
Query: 518 IGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCT----EIAIIGNIHHVNLVKLK 572
+G GG G V+ + + VA+KKI EI II + H N+VK+
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVL----TDPQSVKHALREIKIIRRLDHDNIVKVF 74
Query: 573 G-FCAQGRQRL-------------LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTAR 618
G Q +V EYM L +L GP+LE R R
Sbjct: 75 EILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVL-EQGPLLEEHARL-FMYQLLR 131
Query: 619 GLAYLHSGCEQKIIHCDIKPENILLHYHF-QAKISDFGLSKLLTPEQSS--LFTTMRGTR 675
GL Y+HS ++H D+KP N+ ++ KI DFGL++++ P S + T+
Sbjct: 132 GLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 676 GYLAPEWLTNSAI-SEKTDVYSFGMVLLELVSGR 708
Y +P L + ++ D+++ G + E+++G+
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 61/235 (25%), Positives = 100/235 (42%), Gaps = 42/235 (17%)
Query: 496 PGLPQRFDYEELEVATDNFKNL--IGSGGFGAV----YKGILNDKTIVAVKKITNVGVQG 549
P L + ++++ ++F +G G FG V +K A+K +
Sbjct: 1 PELNKERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKAL------- 50
Query: 550 KKDFC----------TEIAIIG-NIHHVNLVKLKGFCAQGRQRL-LVYEYMNHGSLDRIL 597
KKD E ++ H L + Q ++ L V EY+N G L +
Sbjct: 51 KKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHI 109
Query: 598 FGNGPVLEWQERF---DIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDF 654
+ F +I LG L +LHS + I++ D+K +NILL KI+DF
Sbjct: 110 QSCHKFDLSRATFYAAEIILG----LQFLHS---KGIVYRDLKLDNILLDKDGHIKIADF 162
Query: 655 GLSKL-LTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGR 708
G+ K + + + T GT Y+APE L + D +SFG++L E++ G+
Sbjct: 163 GMCKENMLGDAKT--NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 51/234 (21%), Positives = 89/234 (38%), Gaps = 39/234 (16%)
Query: 515 KNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCT----EIAIIGNIHHVNLV 569
K+LIG G +G VY N + VA+KK+ + C EI I+ + ++
Sbjct: 31 KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF--EDLIDCKRILREITILNRLKSDYII 88
Query: 570 KLKG-FCAQGRQRL----LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLH 624
+L + +V E + L ++ + E + I G ++H
Sbjct: 89 RLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKT-ILYNLLLGENFIH 146
Query: 625 SGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRG----------- 673
IIH D+KP N LL+ K+ DFGL++ + E+ +
Sbjct: 147 ES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKN 203
Query: 674 ----------TRGYLAPEWLTNSAI-SEKTDVYSFGMVLLELVSGRRNCSPRSQ 716
TR Y APE + ++ D++S G + EL++ ++
Sbjct: 204 LKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 68/209 (32%), Positives = 95/209 (45%), Gaps = 26/209 (12%)
Query: 513 NFKNLIGSGGFGAVY----KGILNDKTIVAVKKITNVGVQGKKDF-CT--EIAIIG-NIH 564
+F +IG G FG V K ++ AVK + + KK+ E ++ N+
Sbjct: 41 HFLKVIGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 565 HVNLVKLKGFCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERF---DIALGTARGL 620
H LV L F Q +L V +Y+N G L L LE + RF +IA L
Sbjct: 98 HPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASA----L 152
Query: 621 AYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKL-LTPEQSSLFTTMRGTRGYLA 679
YLHS I++ D+KPENILL ++DFGL K + ++ +T GT YLA
Sbjct: 153 GYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT--STFCGTPEYLA 207
Query: 680 PEWLTNSAISEKTDVYSFGMVLLELVSGR 708
PE L D + G VL E++ G
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 88.9 bits (220), Expect = 2e-18
Identities = 68/264 (25%), Positives = 108/264 (40%), Gaps = 45/264 (17%)
Query: 465 WWRRWKLHKSTDSKSGNPNTLSSGDLEAFYIPGLPQRFDYEELEVATDNFKNLIGSGGFG 524
R+ + P ++ + F G R + F ++G G FG
Sbjct: 301 ELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFN-----FLMVLGKGSFG 355
Query: 525 AV----YKGILNDKTIVAVKKITNVGVQGKKDF--------CT--EIAIIGNI-HHVNLV 569
V KG + AVK + KKD CT E ++ L
Sbjct: 356 KVMLSERKG---TDELYAVKIL-------KKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405
Query: 570 KLKGFCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERF---DIALGTARGLAYLHS 625
+L C Q RL V EY+N G L + G E F +IA+G L +L S
Sbjct: 406 QLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG----LFFLQS 460
Query: 626 GCEQKIIHCDIKPENILLHYHFQAKISDFGLSKL-LTPEQSSLFTTMRGTRGYLAPEWLT 684
+ II+ D+K +N++L KI+DFG+ K + ++ T GT Y+APE +
Sbjct: 461 ---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT--KTFCGTPDYIAPEIIA 515
Query: 685 NSAISEKTDVYSFGMVLLELVSGR 708
+ D ++FG++L E+++G+
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 40/216 (18%)
Query: 513 NFKNLIGSGGFGAV----YKGILNDKTIVAVKKITNVGVQGKKDFC----------TEIA 558
NF ++G G FG V KG + AVK + KKD E
Sbjct: 23 NFLMVLGKGSFGKVMLSERKG---TDELYAVKIL-------KKDVVIQDDDVECTMVEKR 72
Query: 559 IIGNI-HHVNLVKLKGFCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERF---DIA 613
++ L +L C Q RL V EY+N G L + G E F +IA
Sbjct: 73 VLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIA 131
Query: 614 LGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKL-LTPEQSSLFTTMR 672
+G L +L S + II+ D+K +N++L KI+DFG+ K + ++ T
Sbjct: 132 IG----LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT--KTFC 182
Query: 673 GTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGR 708
GT Y+APE + + D ++FG++L E+++G+
Sbjct: 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 40/216 (18%)
Query: 513 NFKNLIGSGGFGAVY----KGILNDKTIVAVKKITNVGVQGKKDFC----------TEIA 558
+ +IG G + V K I A+K + KK+ TE
Sbjct: 12 DLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVV-------KKELVNDDEDIDWVQTEKH 61
Query: 559 IIGNI-HHVNLVKLKGFCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERF---DIA 613
+ +H LV L C Q RL V EY+N G L + + E RF +I+
Sbjct: 62 VFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 120
Query: 614 LGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKL-LTPEQSSLFTTMR 672
L L YLH + II+ D+K +N+LL K++D+G+ K L P ++ +T
Sbjct: 121 LA----LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--STFC 171
Query: 673 GTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGR 708
GT Y+APE L D ++ G+++ E+++GR
Sbjct: 172 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 4e-18
Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 40/216 (18%)
Query: 513 NFKNLIGSGGFGAVY----KGILNDKTIVAVKKITNVGVQGKKDFC----------TEIA 558
F ++G G FG V K + AVK + KKD TE
Sbjct: 26 EFIRVLGKGSFGKVMLARVKE---TGDLYAVKVL-------KKDVILQDDDVECTMTEKR 75
Query: 559 IIGNI-HHVNLVKLKGFCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERF---DIA 613
I+ +H L +L C Q RL V E++N G L + + E + RF +I
Sbjct: 76 ILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEII 134
Query: 614 LGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKL-LTPEQSSLFTTMR 672
L +LH + II+ D+K +N+LL + K++DFG+ K + ++ T
Sbjct: 135 SA----LMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT--ATFC 185
Query: 673 GTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGR 708
GT Y+APE L D ++ G++L E++ G
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 7e-18
Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 40/216 (18%)
Query: 513 NFKNLIGSGGFGAVY----KGILNDKTIVAVKKITNVGVQGKKDFC----------TEIA 558
+ +IG G + V K I A++ + KK+ TE
Sbjct: 55 DLLRVIGRGSYAKVLLVRLKK---TDRIYAMRVV-------KKELVNDDEDIDWVQTEKH 104
Query: 559 IIGNI-HHVNLVKLKGFCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLEWQERF---DIA 613
+ +H LV L C Q RL V EY+N G L + + E RF +I+
Sbjct: 105 VFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 163
Query: 614 LGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKL-LTPEQSSLFTTMR 672
L L YLH E+ II+ D+K +N+LL K++D+G+ K L P ++ +T
Sbjct: 164 LA----LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--STFC 214
Query: 673 GTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGR 708
GT Y+APE L D ++ G+++ E+++GR
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 2e-17
Identities = 53/240 (22%), Positives = 96/240 (40%), Gaps = 44/240 (18%)
Query: 515 KNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCT----EIAIIGNIHHVNLV 569
++LIG+G +G V + +K +VA+KKI V C EIAI+ ++H ++V
Sbjct: 58 RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV--FEDLIDCKRILREIAILNRLNHDHVV 115
Query: 570 KLKG-FCAQGRQRL----LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLH 624
K+ + ++ +V E + ++ + E + + G+ Y+H
Sbjct: 116 KVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT-LLYNLLVGVKYVH 173
Query: 625 SGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRG----------- 673
S I+H D+KP N L++ K+ DFGL++ + ++
Sbjct: 174 SA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230
Query: 674 ---------------TRGYLAPEWLTNSAI-SEKTDVYSFGMVLLELVSGRRNCSPRSQS 717
TR Y APE + +E DV+S G + EL++ +
Sbjct: 231 PHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 6e-17
Identities = 24/199 (12%), Positives = 50/199 (25%), Gaps = 42/199 (21%)
Query: 517 LIGSGGFGAVYKGILNDKTI---VAVKKITNVGV---QGKKDFCTEIAIIGNIHHVNLVK 570
G ++ + D + VA+ + GV ++ + + I + +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 571 LKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQK 630
+ L+V E++ GSL + + A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAG 149
Query: 631 IIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISE 690
+ P + +S G L + +
Sbjct: 150 VALSIDHPSRVR--------VSIDGDVVL-------------AYPATMPDA-------NP 181
Query: 691 KTDVYSFGMVLLELVSGRR 709
+ D+ G L L+ R
Sbjct: 182 QDDIRGIGASLYALLVNRW 200
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 8e-17
Identities = 49/223 (21%), Positives = 89/223 (39%), Gaps = 47/223 (21%)
Query: 517 LIGSGGFGAVYKGI-LNDKTIVAVKKITNVGV---QGKKDFCTEIAIIGNIHHV------ 566
+G G F V+ + + T VA+K + V + EI ++ ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED----EIKLLQRVNDADNTKED 81
Query: 567 -----NLVKLKG-FCAQGRQRL---LVYEYMNHGSLDRILFGNGPVLEWQERFDIAL--G 615
+++KL F +G + +V+E + +L ++ +
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYE-----HRGIPLIYVKQ 135
Query: 616 TAR----GLAYLHSGCEQKIIHCDIKPENILL------HYHFQAKISDFGLSKLLTPEQS 665
++ GL Y+H C IIH DIKPEN+L+ Q KI+D G + +
Sbjct: 136 ISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 193
Query: 666 SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGR 708
+ TR Y +PE L + D++S ++ EL++G
Sbjct: 194 NSIQ----TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 62/237 (26%), Positives = 99/237 (41%), Gaps = 55/237 (23%)
Query: 511 TDNFKNL--IGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCT----EIAIIGNI 563
++ + +G G +G V+K I +VAVKKI + EI I+ +
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF--QNSTDAQRTFREIMILTEL 65
Query: 564 H-HVNLVKLKG-FCAQGRQRL-LVYEYMNHGSLDRILFGNGPVLE--------WQERFDI 612
H N+V L A + + LV++YM L ++ N +LE +Q
Sbjct: 66 SGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN--ILEPVHKQYVVYQ----- 117
Query: 613 ALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMR 672
+ + YLHSG ++H D+KP NILL+ K++DFGLS+ +
Sbjct: 118 ---LIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171
Query: 673 G--------------------TRGYLAPEWLTNSAI-SEKTDVYSFGMVLLELVSGR 708
TR Y APE L S ++ D++S G +L E++ G+
Sbjct: 172 SINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 36/161 (22%), Positives = 61/161 (37%), Gaps = 30/161 (18%)
Query: 514 FKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNI-HHVNLVKL 571
++G G G V + + A+K + + E+ + ++V++
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRI 76
Query: 572 KGFC---AQGRQRL-LVYEYMNHGSL-DRILFGNGPVLEWQERF------DIALGTARGL 620
GR+ L +V E ++ G L RI + F +I +
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGELFSRI------QDRGDQAFTEREASEIMKSIGEAI 130
Query: 621 AYLHSGCEQKIIHCDIKPENILLHYHFQA---KISDFGLSK 658
YLHS I H D+KPEN+L K++DFG +K
Sbjct: 131 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 7e-15
Identities = 57/215 (26%), Positives = 88/215 (40%), Gaps = 45/215 (20%)
Query: 517 LIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFC----TEIAII--------GNI 563
+IG G FG V K VA+K + N +K F EI I+ N
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRN-----EKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 564 HHVNLVKLKGF-------CAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERFDIALG 615
+V + + C + +E + +L + I A
Sbjct: 159 MNV--IHMLENFTFRNHIC-------MTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHS 208
Query: 616 TARGLAYLHSGCEQKIIHCDIKPENILLHYHFQA--KISDFGLSKLLTPEQSSLFTTMRG 673
+ L LH +IIHCD+KPENILL ++ K+ DFG S E ++T ++
Sbjct: 209 ILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYTYIQ- 261
Query: 674 TRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGR 708
+R Y APE + + D++S G +L EL++G
Sbjct: 262 SRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 61/217 (28%), Positives = 92/217 (42%), Gaps = 45/217 (20%)
Query: 516 NLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFC----TEIAII--------GN 562
+LIG G FG V K ++ VA+K I N KK F E+ ++
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-----KKAFLNQAQIEVRLLELMNKHDTEM 114
Query: 563 IHHVNLVKLKGF-------CAQGRQRLLVYEYMNHGSLDRIL--FGNGPVLEWQERFDIA 613
+++ V LK C LV+E + +L +L V R A
Sbjct: 115 KYYI--VHLKRHFMFRNHLC-------LVFEML-SYNLYDLLRNTNFRGVSLNLTR-KFA 163
Query: 614 LGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQA--KISDFGLSKLLTPEQSSLFTTM 671
L +L + E IIHCD+KPENILL ++ KI DFG S ++ +
Sbjct: 164 QQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS---CQLGQRIYQYI 219
Query: 672 RGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGR 708
+ +R Y +PE L D++S G +L+E+ +G
Sbjct: 220 Q-SRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 72.6 bits (177), Expect = 6e-14
Identities = 41/223 (18%), Positives = 61/223 (27%), Gaps = 57/223 (25%)
Query: 499 PQRFDYEELEVATDNFKNL--IGSGGFGAVYKGILNDKTIVAVKKI---TNVGVQGKK-- 551
P F + + T+ + IG G FG V++ I D T VA+K I V G
Sbjct: 10 PVPFSHC---LPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQK 65
Query: 552 ---DFCTEIAI---------IGNIHHVNLVKLKG-FCAQGR------------------- 579
+ EI I + L C QG
Sbjct: 66 TFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSA 125
Query: 580 ----------QRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQ 629
Q +V E+ G + + I LA +
Sbjct: 126 NDRPDFFKDDQLFIVLEFEFGGID--LEQMRTKLSSLATAKSILHQLTASLAVAEASL-- 181
Query: 630 KIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMR 672
+ H D+ N+LL K+ K T L ++
Sbjct: 182 RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 32/111 (28%), Positives = 53/111 (47%), Gaps = 12/111 (10%)
Query: 601 GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLL 660
L + + A+G+ +L S +K IH D+ NILL KI DFGL++ +
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDI 243
Query: 661 TPEQSSLFTTMRGTRGYL-----APEWLTNSAISEKTDVYSFGMVLLELVS 706
+ +R L APE + + + ++DV+SFG++L E+ S
Sbjct: 244 YKDP----DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 8e-11
Identities = 48/232 (20%), Positives = 80/232 (34%), Gaps = 31/232 (13%)
Query: 494 YIPGLPQRFDYEELEVATDN--FKNLIGSGGFGAVYKGILND------KTIVAVKKIT-N 544
+ LP +D + E D +G G FG V + VAVK +
Sbjct: 6 HCERLP--YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG 63
Query: 545 VGVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQ-GRQRLLVYEYMNHGSLDRILFGNGP 602
+ +E+ I+ +I HH+N+V L G C + G +++ E+ G+L L
Sbjct: 64 ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----- 118
Query: 603 VLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP 662
+R + +G + I D+K + + S F K L+
Sbjct: 119 ---RSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175
Query: 663 EQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPR 714
+ + +L E L + V + GM L R C R
Sbjct: 176 VEEEEAPEDLY-KDFLTLEHLICYSF----QV-AKGMEFLA----SRKCIHR 217
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 51/234 (21%), Positives = 80/234 (34%), Gaps = 67/234 (28%)
Query: 517 LIGSGGFGAVYKGI--LNDKTIVAVKKITNVGVQGKKDFC----TEIAII--------GN 562
+G G FG V + + K+ VA+K I N + EI ++ N
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRN-----VGKYREAARLEINVLKKIKEKDKEN 80
Query: 563 IHHVNLVKLKGF-------CAQGRQRLLVYEYMNHGSLDRILFGNGPV---LEWQERFDI 612
V + + C + +E + + L N L
Sbjct: 81 KFLC--VLMSDWFNFHGHMC-------IAFELL-GKNTFEFLKENNFQPYPLPHVRHMAY 130
Query: 613 ALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQA-------------------KISD 653
L A L +LH E ++ H D+KPENIL +++D
Sbjct: 131 QLCHA--LRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD 185
Query: 654 FGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSG 707
FG + T + T + TR Y PE + ++ DV+S G +L E G
Sbjct: 186 FGSA---TFDHEHHTTIVA-TRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 54/281 (19%), Positives = 86/281 (30%), Gaps = 99/281 (35%)
Query: 518 IGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEIAII-----GNIHHVNLVKL 571
+G G F V+ + K VA+K + + EI ++ + + N
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPN---- 99
Query: 572 KGFCAQ-----------GRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFD--------- 611
+ Q G +V+E + H +L+W + +
Sbjct: 100 REMVVQLLDDFKISGVNGTHICMVFEVLGH-----------HLLKWIIKSNYQGLPLPCV 148
Query: 612 --IALGTARGLAYLHSGCEQKIIHCDIKPENILLHY------------------------ 645
I +GL YLH+ C +IIH DIKPENILL
Sbjct: 149 KKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206
Query: 646 -------------------------HFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAP 680
+ KI+D G + + + TR Y +
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSL 262
Query: 681 EWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSMD 721
E L S + D++S + EL +G P S
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTR 303
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 25/191 (13%), Positives = 55/191 (28%), Gaps = 55/191 (28%)
Query: 508 EVATDNFKN------LIGSGGFGAVYKGI---------LNDKTIVAVK----------KI 542
V TD G +Y+ K ++K +
Sbjct: 34 TVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQ 93
Query: 543 TNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGF-CAQGRQRLLVYEYMNHGSLDRILFGNG 601
K + + + + + GF Q + R LV + G
Sbjct: 94 NFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL------------G 141
Query: 602 PVLE----WQERFDIALGTARGLA--------YLHSGCEQKIIHCDIKPENILLHYHFQA 649
L+ + ++ + +A +LH + +H ++ ENI + Q+
Sbjct: 142 RSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQS 198
Query: 650 KI--SDFGLSK 658
++ + +G +
Sbjct: 199 QVTLAGYGFAF 209
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 57/238 (23%), Positives = 90/238 (37%), Gaps = 71/238 (29%)
Query: 517 LIGSGGFGAVYKGI-LNDKTIVAVKKITNVGV---QGKKDFCTEIAIIGNI-------HH 565
+G G FG V +++K AVK + N+ K E I+ I ++
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI----EADILKKIQNDDINNNN 97
Query: 566 VNLVKLKGF-------CAQGRQRLLVYEYMNHGSLDRILFGNG----PVLEWQERFDIAL 614
+ VK G C L++E + SL I+ N + + + +
Sbjct: 98 I--VKYHGKFMYYDHMC-------LIFEPLGP-SLYEIITRNNYNGFHIEDIKL---YCI 144
Query: 615 GTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQA------------------------- 649
+ L YL + + H D+KPENILL +
Sbjct: 145 EILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201
Query: 650 KISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSG 707
K+ DFG + T + + + TR Y APE + N +D++SFG VL EL +G
Sbjct: 202 KLIDFGCA---TFKSDYHGSIIN-TRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 54/232 (23%), Positives = 82/232 (35%), Gaps = 63/232 (27%)
Query: 517 LIGSGGFGAVYKGI--LNDKTIVAVKKITNVGV---QGKKDFCTEIAIIGNIHHVNLVKL 571
+G G FG V + I VAVK + NV + EI + L L
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS----EIQV--------LEHL 68
Query: 572 KGFCAQGRQ---RLLVY-EYMNH---------GSLDRILFGNG----PVLEWQERFDIAL 614
++L + E+ H S + NG + ++ +A
Sbjct: 69 NTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRK---MAY 125
Query: 615 GTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQA-------------------KISDFG 655
+ + +LH K+ H D+KPENIL K+ DFG
Sbjct: 126 QICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
Query: 656 LSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSG 707
+ T + T + TR Y APE + S+ DV+S G +L+E G
Sbjct: 183 SA---TYDDEHHSTLVS-TRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 38/161 (23%), Positives = 59/161 (36%), Gaps = 39/161 (24%)
Query: 518 IGSGGFGAVYKGI-LNDKTIVAVK--KITNVGVQGKKDFCTEIAIIGNIHH-VNLVKLKG 573
IG G FG + G L VA+K + + Q E + + ++
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQ----LHLEYRFYKQLGSGDGIPQVYY 72
Query: 574 FCAQGRQRLLVYEYMNHGSLDRILFGNGPVLE----WQER-------FDIALGTARGLAY 622
F G+ +V E + GP LE +R IA+ + Y
Sbjct: 73 FGPCGKYNAMVLELL------------GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEY 120
Query: 623 LHSGCEQKIIHCDIKPENILLHYHFQAK-----ISDFGLSK 658
+HS + +I+ D+KPEN L+ I DF L+K
Sbjct: 121 VHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 8e-09
Identities = 32/159 (20%), Positives = 56/159 (35%), Gaps = 35/159 (22%)
Query: 518 IGSGGFGAVYKGI-LNDKTIVAVKK-ITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFC 575
IG G FG +++G L + VA+K +D ++ + + F
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGI--PNVYYFG 75
Query: 576 AQGRQRLLVYEYMNHGSLDRILFGNGPVLE----WQER-------FDIALGTARGLAYLH 624
+G +LV + + GP LE R A + +H
Sbjct: 76 QEGLHNVLVIDLL------------GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 123
Query: 625 SGCEQKIIHCDIKPENILLHYHFQAK-----ISDFGLSK 658
+ +++ DIKP+N L+ + DFG+ K
Sbjct: 124 E---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 38/169 (22%), Positives = 58/169 (34%), Gaps = 38/169 (22%)
Query: 517 LIGSGGFGAVYKGI-LNDKTIVAVK--KITNVGVQ------------GKKDFCTEIAIIG 561
IGSGGFG +Y N A K+ KKD +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 562 NIHHVNLVKLKGF----CAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFD------ 611
+ ++ + G R +V E + L +I NG F
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNG-------TFKKSTVLQ 155
Query: 612 IALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKI--SDFGLSK 658
+ + L Y+H + +H DIK N+LL Y ++ +D+GLS
Sbjct: 156 LGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 38/188 (20%), Positives = 64/188 (34%), Gaps = 49/188 (26%)
Query: 508 EVATDNFKN------LIGSGGFGAVYKGILNDKTIVAVKKITNVGVQ------------- 548
E+ TD IG GGFG +Y +N V V V+
Sbjct: 27 EIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKF 86
Query: 549 ----GKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQ----RLLVYEYMNHGSLDRILFGN 600
K + + + ++ + K G + R ++ + L +I N
Sbjct: 87 YQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEAN 145
Query: 601 GPVLEWQERFDIALGTARGLA--------YLHSGCEQKIIHCDIKPENILLHYHFQAKI- 651
+RF T L+ Y+H + +H DIK N+LL+Y ++
Sbjct: 146 A------KRFS--RKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVY 194
Query: 652 -SDFGLSK 658
D+GL+
Sbjct: 195 LVDYGLAY 202
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 3e-08
Identities = 78/574 (13%), Positives = 160/574 (27%), Gaps = 182/574 (31%)
Query: 201 SMDTKAYVDSRYIVDYMAINRTGVYLFGNNGSAVVIRVVLPPSNFRIAKLDASGQFTVLR 260
SM T+ Y++ R +R L+ +N V N + + LR
Sbjct: 106 SMMTRMYIEQR--------DR----LYNDN-------QVFAKYNVSRLQ-----PYLKLR 141
Query: 261 LSGSDLEQEYMGPDDGCQIPFICGRMG----------MCADDA------------TSGSP 298
+ L + + P I G + +C +
Sbjct: 142 QA---LLE--LRPAKNV---LIDG-VLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKN- 191
Query: 299 SCSCPAG--------FHLASQNTSGCVPSDASHSLPVACNSTRKESLLNASVVSYLRLGY 350
C+ P + N SD S ++ + +S + E LR
Sbjct: 192 -CNSPETVLEMLQKLLYQIDPN--WTSRSDHSSNIKLRIHSIQAE----------LR--- 235
Query: 351 GMDYFANHFFQPSTY--------DVNLSFCQELCSDDCSCLGIFFKNSSGSCYMLGNVLG 402
+ Y +V + F + SC +L
Sbjct: 236 -------RLLKSKPYENCLLVLLNVQ----------NAKAWNAF----NLSCKIL----- 269
Query: 403 SIMSSNTVDSDLVG---YIKVLVGPTQADLNPNNSSS-------NQNQDFPLVALVLLPF 452
+ + +D + + + L P+ S + QD P L P
Sbjct: 270 -LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPR 328
Query: 453 TGFFLFSAL---GFLWWRRWKLHKSTDSKSGNPNTLSSGDLEAFYIPGLPQRFDYEELEV 509
+ + G W WK H + D T+ L P ++ ++ L V
Sbjct: 329 R-LSIIAESIRDGLATWDNWK-HVNCDKL----TTIIESSLNVLE-PAEYRKM-FDRLSV 380
Query: 510 ATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGV---QGKKDFCTEIAIIGNIHHV 566
+ I + ++ ++ +V V K+ + Q K+ + I +
Sbjct: 381 FPPSAH--IPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTIS-------IPSI 431
Query: 567 NLVKLKGFCAQGRQ--RLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLH 624
L +LK R +V Y ++ + + + + +++ + + H
Sbjct: 432 YL-ELKVKLENEYALHRSIVDHY----NIPKTFDSDDLIPPYLDQY-----FYSHIGH-H 480
Query: 625 -SGCEQKIIHCDIKPENILLHYHF-QAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAP-- 680
E + L + F + KI + + + ++ + Y+
Sbjct: 481 LKNIEH--PERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDND 538
Query: 681 -----------EWL----TNSAISEKTDVYSFGM 699
++L N S+ TD+ +
Sbjct: 539 PKYERLVNAILDFLPKIEENLICSKYTDLLRIAL 572
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 40/161 (24%), Positives = 62/161 (38%), Gaps = 41/161 (25%)
Query: 518 IGSGGFGAVYKGI-LNDKTIVAVK--KITNVGVQGKKDFCTEIAI---IGNIHHVNLVKL 571
IGSG FG +Y G + VA+K + Q E I + + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI----ESKIYKMMQGGVGI--PTI 70
Query: 572 KGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLE----WQER-------FDIALGTARGL 620
+ A+G ++V E + GP LE + R +A +
Sbjct: 71 RWCGAEGDYNVMVMELL------------GPSLEDLFNFCSRKFSLKTVLLLADQMISRI 118
Query: 621 AYLHSGCEQKIIHCDIKPENILLHYHFQAK---ISDFGLSK 658
Y+HS + IH D+KP+N L+ + I DFGL+K
Sbjct: 119 EYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 40/161 (24%), Positives = 63/161 (39%), Gaps = 41/161 (25%)
Query: 518 IGSGGFGAVYKGI-LNDKTIVAVK--KITNVGVQGKKDFCTEIAI---IGNIHHVNLVKL 571
IGSG FG +Y G + VA+K + Q E I + + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY----ESKIYRILQGGTGI--PNV 68
Query: 572 KGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLE----WQER-------FDIALGTARGL 620
+ F +G +LV + + GP LE + R +A +
Sbjct: 69 RWFGVEGDYNVLVMDLL------------GPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
Query: 621 AYLHSGCEQKIIHCDIKPENILLHYHFQAK---ISDFGLSK 658
++HS + +H DIKP+N L+ +A I DFGL+K
Sbjct: 117 EFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 8e-05
Identities = 16/74 (21%), Positives = 30/74 (40%), Gaps = 5/74 (6%)
Query: 75 SNTIIWSANRDTPISGSGKMNLTPKG-IIISDENGNLKWSTP-PLKSSVSALRLTEMGNL 132
+T +W++N K L G ++ D G W++ + L L E GN+
Sbjct: 36 HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNV 95
Query: 133 VLLDGFNGSLWESF 146
V+ + +W +
Sbjct: 96 VI---YGSDIWSTG 106
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 38.8 bits (90), Expect = 9e-04
Identities = 21/107 (19%), Positives = 41/107 (38%), Gaps = 12/107 (11%)
Query: 40 YGGSFLTSHNGTFKAAIVNTRSQQNSFYLCIIHVLSNTIIWSANRDTPISGSGKMNLTPK 99
G L G + I QN L + +N +W++ + SG + +
Sbjct: 11 DTGGSLA--EGGYLFII------QNDCNLVLYD--NNRAVWASGTNGKASGC-VLKMQND 59
Query: 100 G-IIISDENGNLKWSTPPLKSSVSALRLTEMGNLVLLDGFNGSLWES 145
G ++I + + S ++ L L N+V+ D N ++W +
Sbjct: 60 GNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWAT 106
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 724 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.98 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.98 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.98 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.98 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.98 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.98 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.98 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.98 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.98 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.98 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.98 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.98 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.98 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.98 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.98 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.98 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.98 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.98 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.98 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.98 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.98 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.98 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.98 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.98 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.98 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.98 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.98 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.98 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.98 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.98 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.98 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.98 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.98 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.98 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.98 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.98 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.98 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.97 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.97 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.97 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.97 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.97 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.97 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.97 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.97 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.97 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.97 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.97 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.97 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.97 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.97 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.97 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.97 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.97 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.97 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.97 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.97 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.97 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 99.97 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.97 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.96 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.96 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.74 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.73 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.72 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.71 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.69 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.64 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.61 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.58 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.51 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.45 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.44 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.43 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.43 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.38 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.33 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.15 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.13 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.08 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.01 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.0 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 98.98 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.88 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 98.82 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.75 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.72 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.68 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.64 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.61 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.4 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.36 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.25 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.23 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.12 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.05 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.81 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.76 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.62 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.57 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.29 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.94 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.92 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.9 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.89 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.85 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.78 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.66 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.4 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.32 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.64 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.47 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 93.71 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.96 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 90.66 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 90.56 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 89.9 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.66 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 84.23 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 82.0 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=389.95 Aligned_cols=204 Identities=30% Similarity=0.514 Sum_probs=178.2
Q ss_pred hccccccccccccEEEEEEEEC------CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN------DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLV 584 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 584 (724)
.+.+.+.||+|+||+||+|++. ++..||||+++.......++|.+|+++|++++|||||+++|+|.+++..+||
T Consensus 14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV 93 (299)
T 4asz_A 14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV 93 (299)
T ss_dssp GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 3456789999999999999974 4678999999877666778899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEE
Q 043185 585 YEYMNHGSLDRILFGN------------GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKIS 652 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 652 (724)
||||++|+|.++|... ...+++.++++|+.||+.||+|||+ ++||||||||+||||+.++.+||+
T Consensus 94 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki~ 170 (299)
T 4asz_A 94 FEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIG 170 (299)
T ss_dssp EECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEEC
Confidence 9999999999999754 2468999999999999999999997 899999999999999999999999
Q ss_pred eecCccccCCCCcc-ceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 043185 653 DFGLSKLLTPEQSS-LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQS 717 (724)
Q Consensus 653 DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~~ 717 (724)
|||+|+........ ......||+.|||||++.+..|+.++|||||||+||||+| |+.||...+..
T Consensus 171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~ 237 (299)
T 4asz_A 171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN 237 (299)
T ss_dssp CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred CcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999876543322 1223468999999999999999999999999999999999 89999876543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=388.43 Aligned_cols=213 Identities=26% Similarity=0.436 Sum_probs=182.7
Q ss_pred CChHHHHHhhccccccccccccEEEEEEEEC------CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceece
Q 043185 502 FDYEELEVATDNFKNLIGSGGFGAVYKGILN------DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGF 574 (724)
Q Consensus 502 ~~~~~l~~a~~~~~~~lG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~ 574 (724)
..+.++..++.+|.+.||+|+||+||+|++. +++.||||+++... ....++|.+|+.++++++|||||+++|+
T Consensus 18 ~~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~ 97 (308)
T 4gt4_A 18 AKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGV 97 (308)
T ss_dssp -CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceE
Confidence 3444556667788899999999999999973 45789999997532 3456789999999999999999999999
Q ss_pred eecCCeEEEEEEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCC
Q 043185 575 CAQGRQRLLVYEYMNHGSLDRILFGNG---------------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPE 639 (724)
Q Consensus 575 ~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~ 639 (724)
|.++...+||||||++|+|.++|.... ..+++..+++|+.|||.||+|||+ ++||||||||+
T Consensus 98 ~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~ 174 (308)
T 4gt4_A 98 VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATR 174 (308)
T ss_dssp ECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCcccc
Confidence 999999999999999999999996432 358999999999999999999997 89999999999
Q ss_pred CeEEeCCCcEEEEeecCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 043185 640 NILLHYHFQAKISDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQS 717 (724)
Q Consensus 640 NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~~ 717 (724)
||||++++.+||+|||+++....... .......||+.|||||++.+..|+.++|||||||+||||+| |++||.+....
T Consensus 175 NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~ 254 (308)
T 4gt4_A 175 NVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 254 (308)
T ss_dssp GEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH
T ss_pred ceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987644322 22345679999999999999999999999999999999999 89999876543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=388.87 Aligned_cols=203 Identities=30% Similarity=0.516 Sum_probs=172.0
Q ss_pred ccccccccccccEEEEEEEEC------CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN------DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVY 585 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 585 (724)
..+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.++...+|||
T Consensus 43 ~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~ 122 (329)
T 4aoj_A 43 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVF 122 (329)
T ss_dssp EEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 345688999999999999974 46789999998776667788999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEE
Q 043185 586 EYMNHGSLDRILFGNG--------------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKI 651 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 651 (724)
|||++|+|.+++.... ..+++.+++.|+.||+.||+|||+ ++||||||||+||||++++.+||
T Consensus 123 Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~Ki 199 (329)
T 4aoj_A 123 EYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKI 199 (329)
T ss_dssp ECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEE
T ss_pred EcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcEEE
Confidence 9999999999997542 358999999999999999999997 89999999999999999999999
Q ss_pred EeecCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 043185 652 SDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQS 717 (724)
Q Consensus 652 ~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~~ 717 (724)
+|||+++....... .......||+.|||||++.+..|+.++|||||||+||||+| |+.||......
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~ 267 (329)
T 4aoj_A 200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT 267 (329)
T ss_dssp CCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH
T ss_pred cccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH
Confidence 99999987654332 22345679999999999999999999999999999999999 89999775543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=381.44 Aligned_cols=199 Identities=26% Similarity=0.404 Sum_probs=180.2
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
+.+.+.||+|+||+||+|+.. +++.||||++........+.+.+|+++|++++|||||++++++.+++..||||||+++
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 155 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 155 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 455678999999999999985 6889999999765556667789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
|+|.+++.+. .+++..+..++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+.+..... ....
T Consensus 156 g~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~ 229 (346)
T 4fih_A 156 GALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS 229 (346)
T ss_dssp EEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCC
T ss_pred CcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-cccc
Confidence 9999999764 58999999999999999999997 9999999999999999999999999999987754432 2356
Q ss_pred ccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.+||+.|||||++.+..|+.++|||||||+||||++|++||.+...
T Consensus 230 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~ 275 (346)
T 4fih_A 230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 275 (346)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence 7899999999999999999999999999999999999999987654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=378.72 Aligned_cols=201 Identities=33% Similarity=0.506 Sum_probs=169.9
Q ss_pred HhhccccccccccccEEEEEEEECCccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEE
Q 043185 509 VATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 509 ~a~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
.....+.+.||+|+||+||+|++.+ .||||+++... .+..++|.+|++++++++|||||+++|++.+ +..+||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 3344567899999999999998764 49999986432 3445789999999999999999999999865 56899999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC-c
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ-S 665 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~-~ 665 (724)
||++|+|.++|......+++..++.|+.||+.||+|||+ ++||||||||+||||++++.+||+|||+|+...... .
T Consensus 112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 999999999998777789999999999999999999997 899999999999999999999999999998765432 2
Q ss_pred cceecccccccccccccccC---CcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 666 SLFTTMRGTRGYLAPEWLTN---SAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 666 ~~~~~~~gt~~y~aPE~l~~---~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.......||+.|||||++.+ .+|+.++|||||||+||||+||+.||....
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~ 241 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN 241 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC
Confidence 23345689999999999964 368999999999999999999999997654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=373.43 Aligned_cols=202 Identities=25% Similarity=0.388 Sum_probs=181.2
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV---GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
|.+.+.||+|+||+||+|+.. +++.||||++.+. .....+.+.+|+++|++++|||||++++++.+++..||||||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy 113 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 113 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 667799999999999999975 6889999999753 234567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc-c
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS-S 666 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~-~ 666 (724)
+++|+|.+++...+ .+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+.+..... .
T Consensus 114 ~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 114 AKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp CTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence 99999999997653 58999999999999999999997 9999999999999999999999999999998754332 2
Q ss_pred ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
.....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..
T Consensus 190 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~ 240 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG 240 (311)
T ss_dssp CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 345678999999999999999999999999999999999999999876543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=380.34 Aligned_cols=203 Identities=25% Similarity=0.387 Sum_probs=173.5
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
.|.+.+.||+|+||+||+|+.. +++.||||++.... ....+++.+|+++|++++|||||++++++.+++..||||||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy 104 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 4666789999999999999975 68899999997542 33456799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 588 MNHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 588 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
+++|+|.+++... ...+++..+..|+.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+.+.... .
T Consensus 105 ~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~ 180 (350)
T 4b9d_A 105 CEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-E 180 (350)
T ss_dssp CTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-H
T ss_pred CCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-c
Confidence 9999999999754 4457889999999999999999997 999999999999999999999999999998764322 1
Q ss_pred ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
.....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..
T Consensus 181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~ 231 (350)
T 4b9d_A 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK 231 (350)
T ss_dssp HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH
Confidence 224567999999999999999999999999999999999999999876543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=382.86 Aligned_cols=199 Identities=26% Similarity=0.404 Sum_probs=180.6
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
|.+.+.||+|+||.||+|+.. +++.||||++........+.+.+|+.+|++++|||||++++++.+++.+|||||||++
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence 556688999999999999975 6889999999876566667899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
|+|.+++... .+++..+..++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+.+..... ....
T Consensus 233 G~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~ 306 (423)
T 4fie_A 233 GALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS 306 (423)
T ss_dssp EEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-CBCC
T ss_pred CcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-cccc
Confidence 9999999754 58999999999999999999997 9999999999999999999999999999987754432 2356
Q ss_pred ccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.+||+.|||||++.+..|+.++|||||||++|||++|++||.+...
T Consensus 307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~ 352 (423)
T 4fie_A 307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 352 (423)
T ss_dssp CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence 7899999999999999999999999999999999999999977654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=363.80 Aligned_cols=195 Identities=29% Similarity=0.430 Sum_probs=169.2
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeceeec----CCeEEEEE
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ----GRQRLLVY 585 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lV~ 585 (724)
.|.++||+|+||+||+|... ++..||+|++... .....++|.+|++++++++|||||++++++.. +...+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45678999999999999975 5788999999653 23345679999999999999999999999864 34689999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEecCCCCCCeEEeC-CCcEEEEeecCccccCC
Q 043185 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQK--IIHCDIKPENILLHY-HFQAKISDFGLSKLLTP 662 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiH~Dlkp~NILl~~-~~~~kl~DFGla~~~~~ 662 (724)
|||++|+|.+++... ..+++..+..++.||+.||+|||+ ++ ||||||||+||||+. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 999999999999765 468999999999999999999997 55 999999999999974 79999999999986543
Q ss_pred CCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 663 EQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 663 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.. .....||+.|||||++.+ .|+.++|||||||+||||++|+.||....
T Consensus 185 ~~---~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~ 233 (290)
T 3fpq_A 185 SF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 233 (290)
T ss_dssp TS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred Cc---cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 32 356789999999999875 69999999999999999999999997544
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=371.45 Aligned_cols=199 Identities=24% Similarity=0.328 Sum_probs=172.1
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
+.+.++||+|+||.||+|+.. +++.||||+++.... ..+|+.++++++|||||++++++.+++..+|||||+++
T Consensus 60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 134 (336)
T 4g3f_A 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCC
Confidence 445678999999999999975 688999999975322 24799999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCC-cEEEEeecCccccCCCCcc---
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHF-QAKISDFGLSKLLTPEQSS--- 666 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFGla~~~~~~~~~--- 666 (724)
|+|.+++...+ .+++..+..++.||+.||+|||+ ++||||||||+||||+.++ .+||+|||+|+.+......
T Consensus 135 g~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~ 210 (336)
T 4g3f_A 135 GSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 210 (336)
T ss_dssp CBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---------
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccce
Confidence 99999997654 58999999999999999999997 8999999999999999998 6999999999977543221
Q ss_pred -ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCCCC
Q 043185 667 -LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHS 719 (724)
Q Consensus 667 -~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~~ 719 (724)
.....+||+.|||||++.+..|+.++|||||||+||||++|++||......+.
T Consensus 211 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~ 264 (336)
T 4g3f_A 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL 264 (336)
T ss_dssp ---CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC
T ss_pred ecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH
Confidence 12335799999999999999999999999999999999999999987765543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=367.90 Aligned_cols=202 Identities=26% Similarity=0.347 Sum_probs=170.7
Q ss_pred hccccccccccccEEEEEEEEC----CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN----DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLV 584 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~----~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 584 (724)
.|.+.+.||+|+||+||+|+.. .++.||||++++.. .....++.+|+++|++++|||||++++++.+++..+||
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 104 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI 104 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 3667789999999999999862 46789999996532 23345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC
Q 043185 585 YEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (724)
|||+++|+|.+++...+ .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 105 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 105 LDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp ECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 99999999999997654 68999999999999999999997 999999999999999999999999999998654332
Q ss_pred ccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 665 SSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 665 ~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
. ......||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..
T Consensus 181 ~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~ 232 (304)
T 3ubd_A 181 K-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK 232 (304)
T ss_dssp C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred c-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH
Confidence 2 234568999999999999999999999999999999999999999876543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=354.99 Aligned_cols=199 Identities=27% Similarity=0.393 Sum_probs=163.1
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
.|.+.+.||+|+||+||+|+.. +++.||||++.+.. ....+.+.+|++++++++|||||++++++.+++..+||||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 4677789999999999999964 68899999997532 2345679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
|+ +|+|.+++...+ .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 94 y~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~- 167 (275)
T 3hyh_A 94 YA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF- 167 (275)
T ss_dssp CC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred CC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCCCc-
Confidence 99 679999987664 58999999999999999999997 9999999999999999999999999999987654322
Q ss_pred ceecccccccccccccccCCcC-CCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAI-SEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~-~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.....||+.|||||++.+..+ +.++|||||||++|||++|+.||...+.
T Consensus 168 -~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~ 217 (275)
T 3hyh_A 168 -LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI 217 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred -cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH
Confidence 345689999999999998876 5799999999999999999999987653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=371.62 Aligned_cols=209 Identities=26% Similarity=0.401 Sum_probs=178.2
Q ss_pred HHHHhhccccccccccccEEEEEEEECC------ccEEEEEEeecCCc-ccHHHHHHHHHHHhcCC-CCCccceeceeec
Q 043185 506 ELEVATDNFKNLIGSGGFGAVYKGILND------KTIVAVKKITNVGV-QGKKDFCTEIAIIGNIH-HVNLVKLKGFCAQ 577 (724)
Q Consensus 506 ~l~~a~~~~~~~lG~G~fG~Vy~~~~~~------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~ 577 (724)
|+....+.+.+.||+|+||+||+|++.+ ++.||||++..... ...++|.+|+++|.+++ |||||+++|+|.+
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 3445566778999999999999999643 35799999976433 34567999999999995 5999999999876
Q ss_pred C-CeEEEEEEecCCCCHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCe
Q 043185 578 G-RQRLLVYEYMNHGSLDRILFGN---------------GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENI 641 (724)
Q Consensus 578 ~-~~~~lV~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NI 641 (724)
. ...+||||||++|+|.++|+.. ...+++..++.++.|||.||+|||+ ++||||||||+||
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NI 216 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNI 216 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccce
Confidence 4 5789999999999999999753 2358899999999999999999997 8999999999999
Q ss_pred EEeCCCcEEEEeecCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 043185 642 LLHYHFQAKISDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQS 717 (724)
Q Consensus 642 Ll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~~ 717 (724)
||++++.+||+|||+|+.+..... .......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+....
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999997755433 22335678999999999999999999999999999999998 99999876543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=361.88 Aligned_cols=197 Identities=29% Similarity=0.385 Sum_probs=161.8
Q ss_pred ccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHH--HHHHHHHhcCCCCCccceeceeecCC----eEEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDF--CTEIAIIGNIHHVNLVKLKGFCAQGR----QRLLVY 585 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~--~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~lV~ 585 (724)
+.+.+.||+|+||+||+|+++ ++.||||+++.. ..+++ .+|+..+.+++|||||+++|++.+++ .++|||
T Consensus 5 i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 5 IVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 456789999999999999985 677999999753 23333 34566667889999999999998654 679999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcC-----CCCCeEecCCCCCCeEEeCCCcEEEEeecCcccc
Q 043185 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSG-----CEQKIIHCDIKPENILLHYHFQAKISDFGLSKLL 660 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 660 (724)
|||++|+|.++|... .+++..+.+++.|++.||+|||+. +..+||||||||+||||+.++++||+|||+|+..
T Consensus 81 Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred cCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 999999999999765 589999999999999999999973 1348999999999999999999999999999876
Q ss_pred CCCCcc---ceecccccccccccccccCC------cCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 661 TPEQSS---LFTTMRGTRGYLAPEWLTNS------AISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 661 ~~~~~~---~~~~~~gt~~y~aPE~l~~~------~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
...... ......||+.|||||++.+. .++.++|||||||+||||+||++||...
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~ 221 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcc
Confidence 543321 12345799999999999764 4788999999999999999998877543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=349.29 Aligned_cols=196 Identities=24% Similarity=0.406 Sum_probs=158.6
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCCc-ccHHHHHHHHHHHhcCCCCCccceeceeecCC----------
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV-QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR---------- 579 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~---------- 579 (724)
+++.+.||+|+||+||+|+.. +++.||||+++.... ...+++.+|+++|++++|||||++++++.+.+
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~ 86 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP 86 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence 556689999999999999975 688999999975433 34467899999999999999999999986543
Q ss_pred --eEEEEEEecCCCCHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeec
Q 043185 580 --QRLLVYEYMNHGSLDRILFGNGP--VLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFG 655 (724)
Q Consensus 580 --~~~lV~e~~~~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFG 655 (724)
..+|||||+++|+|.+++..... ..++..+..++.||+.||+|||+ ++||||||||+||||+.++.+||+|||
T Consensus 87 ~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 87 KVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred CcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEccCc
Confidence 36899999999999999976532 35567788999999999999997 899999999999999999999999999
Q ss_pred CccccCCCCcc-----------ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCC
Q 043185 656 LSKLLTPEQSS-----------LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSP 713 (724)
Q Consensus 656 la~~~~~~~~~-----------~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~ 713 (724)
+|+.+...... .....+||+.|||||++.+..|+.++|||||||++|||++ ||..
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 99877543221 1234579999999999999999999999999999999996 7754
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=334.46 Aligned_cols=211 Identities=22% Similarity=0.266 Sum_probs=166.9
Q ss_pred cccccccCCcccceeeeecCCCeEEeCCCeEEEEEEecCCCCceEEEEEEeccCCeEEEecCCCCCCCC-----CceEEE
Q 043185 22 FSEFIHPNFTASHVKFIDYGGSFLTSHNGTFKAAIVNTRSQQNSFYLCIIHVLSNTIIWSANRDTPISG-----SGKMNL 96 (724)
Q Consensus 22 ~~~~~~~~~t~~~~~~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~i~~~~~~~~tvVW~Anr~~pv~~-----~~~l~~ 96 (724)
..++|.+|.+++ .+++|+|++|+|+||||.++ + +|+ |. +.+ |||+||||+|+++ +++|+|
T Consensus 13 ~~~~l~~g~~l~-------~~~~l~S~~g~F~lgf~~~~--~--~~l-y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l 77 (276)
T 3m7h_A 13 GTSVLPAYQTLS-------AGQYLLSPNQRFKLLLQGDG--N--LVI-QD--NGA-TVWVANEQQPFSSTIPLRNKKAPL 77 (276)
T ss_dssp TSSEECTTEEBC-------TTCEEECTTSSEEEEECTTS--C--EEE-EE--TTE-EEEECSTTSTTEEEEECCCTTCCS
T ss_pred cCCEecCCCEec-------CCCEEEcCCCcEEEEEECCC--C--eEE-EC--CCC-eEEECCCCCCcCCcccccceEEEE
Confidence 457788887775 47899999999999999432 2 344 43 777 9999999999987 579999
Q ss_pred ccCc-cEE--EcCCCCeEEecCCCC------CceeEEEEecCCcEEEecCCCccceecccCCCcccccCCc----cCCCc
Q 043185 97 TPKG-III--SDENGNLKWSTPPLK------SSVSALRLTEMGNLVLLDGFNGSLWESFHHPRDTIVIGQH----LPAGA 163 (724)
Q Consensus 97 ~~~g-~~l--~~~~g~~vWst~~~~------~~~~~~~L~dsGNlVl~~~~~~~lWQSFd~PtDtlLpgq~----l~~~~ 163 (724)
+.+| |+| .|++|++||+|+++. ..+++|+|+|+|||||+| +.+|||| |||||+||||| |..|+
T Consensus 78 ~~~G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--~~~lWqS--~ptdtlLpg~~~~~~l~~g~ 153 (276)
T 3m7h_A 78 AFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--SLALWNG--TPAIPLVPGAIDSLLLAPGS 153 (276)
T ss_dssp EEEESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--EEEEEES--CTTSCCCCSCTTCEEECSSE
T ss_pred eCCCcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC--CceeeCc--ccccccccccccccccccCc
Confidence 9998 577 788899999999764 346789999999999998 7899999 99999999999 77888
Q ss_pred eEEecCCCCCCCCcceEEEeCCCccc-ccccc-ccceeecCCcccccccceeEeeEEecccceEEecCCCceEEEEeecC
Q 043185 164 SLSSAVSDYNLSTGDYSLTVGASDAE-LQWQG-QMYWKLSMDTKAYVDSRYIVDYMAINRTGVYLFGNNGSAVVIRVVLP 241 (724)
Q Consensus 164 ~L~S~~s~~dps~G~~~~~~~~~~~~-~~~~~-~~yw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (724)
+| ++.+||++|.|+++++++|.. +++++ ..||+++.+.... ....++.+|.+.+.++....+......
T Consensus 154 ~L---~S~~dps~G~fsl~l~~dGnlvLy~~~~~~yW~Sgt~~~~~-------~~l~l~~dGnLvl~d~~~~~vWsS~t~ 223 (276)
T 3m7h_A 154 EL---VQGVVYGAGASKLVFQGDGNLVAYGPNGAATWNAGTQGKGA-------VRAVFQGDGNLVVYGAGNAVLWHSHTG 223 (276)
T ss_dssp EE---CTTCEEEETTEEEEECTTSCEEEECTTSSEEEECCCTTTTC-------CEEEECTTSCEEEECTTSCEEEECSCT
T ss_pred cc---ccCCCCCCceEEEeecCCceEEEEeCCCeEEEECCCCCCcc-------EEEEEcCCCeEEEEeCCCcEEEEecCC
Confidence 88 557899999999999999876 44443 6899987654321 235678889888877544333333222
Q ss_pred CCceEEEEEcCCCcEEEEEE
Q 043185 242 PSNFRIAKLDASGQFTVLRL 261 (724)
Q Consensus 242 ~~~~~~~~l~~~G~l~~~~~ 261 (724)
....+|++|+.||++++|.|
T Consensus 224 ~~~~~rl~Ld~dGnLvly~~ 243 (276)
T 3m7h_A 224 GHASAVLRLQANGSIAILDE 243 (276)
T ss_dssp TCTTCEEEECTTSCEEEEEE
T ss_pred CCCCEEEEEcCCccEEEEcC
Confidence 22348999999999999998
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=349.83 Aligned_cols=201 Identities=27% Similarity=0.422 Sum_probs=171.6
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeec------CCeE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ------GRQR 581 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~------~~~~ 581 (724)
.|.+.+.||+|+||+||+|+.. +++.||||++++.. ....+.+.+|+++|++++|||||++++++.. ....
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~ 134 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV 134 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence 3566789999999999999975 78899999997542 2334678899999999999999999998753 4678
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccC
Q 043185 582 LLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 661 (724)
|||||||+ |+|.+++... ..+++..+..++.||+.||.|||+ ++||||||||+|||++.++.+||+|||+|+.+.
T Consensus 135 ~ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 135 YVVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp EEEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 99999996 6799988765 468999999999999999999997 999999999999999999999999999998764
Q ss_pred CCC---ccceecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 662 PEQ---SSLFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 662 ~~~---~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
... .......+||+.|||||++.+. .++.++||||+||++|||++|++||.+.+.
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~ 268 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY 268 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH
Confidence 321 2233467899999999998875 569999999999999999999999987654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=342.58 Aligned_cols=196 Identities=26% Similarity=0.376 Sum_probs=168.4
Q ss_pred hccccccccccccEEEEEEEEC----CccEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN----DKTIVAVKKITNVGVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVY 585 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 585 (724)
.|.+.+.||+|+||+||+|+.+ .++.||+|++.+. ....++.+|+++|..+ +|||||++++++.+.++.+|||
T Consensus 22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm 99 (361)
T 4f9c_A 22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM 99 (361)
T ss_dssp TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence 3667789999999999999853 4678999998753 3456788999999998 6999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCC-CcEEEEeecCccccCCCC
Q 043185 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYH-FQAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFGla~~~~~~~ 664 (724)
||+++|+|.+++. .+++.++..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+|+......
T Consensus 100 E~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 100 PYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp ECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred eCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 9999999999983 48899999999999999999997 999999999999999987 799999999998654321
Q ss_pred c---------------------------cceecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 665 S---------------------------SLFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 665 ~---------------------------~~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
. ......+||+.|||||++.+. .|+.++||||+||++|||++|+.||.+..
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 1 112345799999999999876 58999999999999999999999996544
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=360.30 Aligned_cols=197 Identities=26% Similarity=0.361 Sum_probs=170.6
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHH---HHHHHHhcCCCCCccceeceeecCCeEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFC---TEIAIIGNIHHVNLVKLKGFCAQGRQRLLV 584 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~---~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 584 (724)
+.+.++||+|+||+||+|+.. +++.||||++.+.. ........ .++.++..++|||||++++++.+.+.+|||
T Consensus 191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylV 270 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 270 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEE
Confidence 455689999999999999975 68899999996421 12223333 446777888999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC
Q 043185 585 YEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (724)
|||++||+|..+|...+ .+++..+..++.||+.||+|||+ ++||||||||+||||+.+|++||+|||+|+.+....
T Consensus 271 mEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~ 346 (689)
T 3v5w_A 271 LDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 346 (689)
T ss_dssp ECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC
T ss_pred EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecCCCC
Confidence 99999999999997653 58899999999999999999997 999999999999999999999999999998775443
Q ss_pred ccceecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 665 SSLFTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 665 ~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
....+||+.|||||++.+ ..|+.++|+|||||+||||++|++||.+..
T Consensus 347 ---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~ 395 (689)
T 3v5w_A 347 ---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 395 (689)
T ss_dssp ---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGG
T ss_pred ---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 245689999999999964 579999999999999999999999997654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=362.80 Aligned_cols=202 Identities=25% Similarity=0.397 Sum_probs=182.5
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
.|.+.+.||+|+||.||+|+.. +++.||+|++........+.+.+|+++|++++|||||++++++.++...+||||||+
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~ 237 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 4667789999999999999975 688999999987655666788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCC--CcEEEEeecCccccCCCCccc
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYH--FQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~--~~~kl~DFGla~~~~~~~~~~ 667 (724)
+|+|.+++......+++..+..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+|+.+.....
T Consensus 238 gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~-- 312 (573)
T 3uto_A 238 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-- 312 (573)
T ss_dssp CCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE--
T ss_pred CCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc--
Confidence 999999997766679999999999999999999997 999999999999999854 8999999999998765433
Q ss_pred eecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
.....||+.|||||++.+..|+.++|||||||+||||++|++||.+....
T Consensus 313 ~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~ 362 (573)
T 3uto_A 313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD 362 (573)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH
Confidence 34568999999999999999999999999999999999999999876543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=332.85 Aligned_cols=202 Identities=22% Similarity=0.276 Sum_probs=177.1
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
+.+.++||+|+||+||+|+.. +++.||+|++.+.. ....+.+.+|+.++..++||||+++++++.+....+|||||
T Consensus 76 y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey 155 (437)
T 4aw2_A 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDY 155 (437)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEec
Confidence 344589999999999999986 46789999997521 12233488999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
+++|+|.+++......+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++.........
T Consensus 156 ~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 232 (437)
T 4aw2_A 156 YVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 232 (437)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEE
T ss_pred CCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcc
Confidence 99999999998766679999999999999999999997 899999999999999999999999999998776554433
Q ss_pred eeccccccccccccccc-----CCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLT-----NSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~-----~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.....||+.|+|||++. ...++.++|||||||++|||++|++||.+.+.
T Consensus 233 ~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~ 286 (437)
T 4aw2_A 233 SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 286 (437)
T ss_dssp CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh
Confidence 34568999999999997 56789999999999999999999999987653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=313.33 Aligned_cols=210 Identities=26% Similarity=0.385 Sum_probs=185.7
Q ss_pred CCCChHHHHHhhcc------------ccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCC
Q 043185 500 QRFDYEELEVATDN------------FKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHV 566 (724)
Q Consensus 500 ~~~~~~~l~~a~~~------------~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~ 566 (724)
..++++++..++.. +.+.||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45788888877643 3468999999999999986 7889999999876666778899999999999999
Q ss_pred CccceeceeecCCeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCC
Q 043185 567 NLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYH 646 (724)
Q Consensus 567 nIv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~ 646 (724)
||+++++++......++||||+++++|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLD 177 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCC
Confidence 9999999999999999999999999999998643 68999999999999999999997 899999999999999999
Q ss_pred CcEEEEeecCccccCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 647 FQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 647 ~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
+.+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~ 245 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS 245 (321)
T ss_dssp CCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999876543322 245679999999999999999999999999999999999999997654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=311.79 Aligned_cols=202 Identities=27% Similarity=0.473 Sum_probs=178.9
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
.+.+.+.||+|+||.||+++.. +++.||+|++........+.+.+|++++++++||||+++++++.++...++||||++
T Consensus 11 ~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 90 (310)
T 3s95_A 11 DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIK 90 (310)
T ss_dssp GEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecC
Confidence 4556789999999999999985 678899999977666677889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc--
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL-- 667 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-- 667 (724)
+++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.........
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 167 (310)
T 3s95_A 91 GGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG 167 (310)
T ss_dssp TCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecccccccccc
Confidence 999999998877789999999999999999999997 899999999999999999999999999998764432211
Q ss_pred -----------eecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 668 -----------FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 668 -----------~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.....||+.|+|||.+.+..++.++||||||+++|||++|..|+....
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~ 226 (310)
T 3s95_A 168 LRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYL 226 (310)
T ss_dssp ------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTS
T ss_pred cccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchh
Confidence 114569999999999999999999999999999999999999986544
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=310.61 Aligned_cols=199 Identities=29% Similarity=0.431 Sum_probs=179.0
Q ss_pred hccccccccccccEEEEEEEE-CCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 511 TDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
.+.+.+.||+|+||.||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++..++..++||||++
T Consensus 21 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 100 (297)
T 3fxz_A 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (297)
T ss_dssp TBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCC
Confidence 455668999999999999996 5788999999976656667889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
+++|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++......... ..
T Consensus 101 ~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~ 174 (297)
T 3fxz_A 101 GGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RS 174 (297)
T ss_dssp TCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-BC
T ss_pred CCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc-cC
Confidence 99999999765 58899999999999999999997 89999999999999999999999999999876544332 34
Q ss_pred cccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 220 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (297)
T ss_dssp CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 5679999999999999999999999999999999999999997654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=317.16 Aligned_cols=215 Identities=44% Similarity=0.759 Sum_probs=184.0
Q ss_pred CCChHHHHHhhccc--cccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecC
Q 043185 501 RFDYEELEVATDNF--KNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG 578 (724)
Q Consensus 501 ~~~~~~l~~a~~~~--~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 578 (724)
++.+.++...+.+| .+.||+|+||.||+|+..+++.||||++........+++.+|++++++++||||+++++++.+.
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 34444444444444 5789999999999999888899999999876666678899999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeec
Q 043185 579 RQRLLVYEYMNHGSLDRILFGNG---PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFG 655 (724)
Q Consensus 579 ~~~~lV~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFG 655 (724)
+..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeecc
Confidence 99999999999999999986543 358999999999999999999997 899999999999999999999999999
Q ss_pred CccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 043185 656 LSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSH 718 (724)
Q Consensus 656 la~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~ 718 (724)
+++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~ 248 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE 248 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHH
Confidence 9986543222 22234568999999999999899999999999999999999999997655443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=314.40 Aligned_cols=201 Identities=28% Similarity=0.343 Sum_probs=176.9
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV---GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
.+.+.+.||+|+||.||+++.. +++.||+|++++. .....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 6 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E 85 (337)
T 1o6l_A 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEe
Confidence 3556789999999999999975 6889999999753 23455778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
|+++|+|..++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~- 160 (337)
T 1o6l_A 86 YANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA- 160 (337)
T ss_dssp CCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC-
Confidence 99999999998754 358899999999999999999997 8999999999999999999999999999986433222
Q ss_pred ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
......||+.|+|||++.+..++.++|+||||+++|||++|+.||.....
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 210 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH
Confidence 23456799999999999999999999999999999999999999976543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=327.11 Aligned_cols=202 Identities=22% Similarity=0.251 Sum_probs=176.9
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
+.+.+.||+|+||.||+++.. +++.||+|++.+.. ....+.+.+|..++.+++||||+++++++.+.+..+|||||
T Consensus 63 f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~ 142 (412)
T 2vd5_A 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEY 142 (412)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcC
Confidence 344588999999999999985 68899999997521 12334578999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
+++|+|.+++...+..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+++.........
T Consensus 143 ~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~ 219 (412)
T 2vd5_A 143 YVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR 219 (412)
T ss_dssp CCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEE
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhheeccCCCccc
Confidence 99999999998766679999999999999999999997 899999999999999999999999999998776544332
Q ss_pred eeccccccccccccccc-------CCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLT-------NSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~-------~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||...+.
T Consensus 220 ~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 275 (412)
T 2vd5_A 220 SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST 275 (412)
T ss_dssp CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH
Confidence 33467999999999997 45789999999999999999999999987654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=326.78 Aligned_cols=200 Identities=25% Similarity=0.304 Sum_probs=175.1
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
+.+.++||+|+||.||+++.. +++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+....+|||||
T Consensus 71 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~ 150 (410)
T 3v8s_A 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEY 150 (410)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 445689999999999999986 57889999996521 22334588999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
+++|+|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.........
T Consensus 151 ~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~ 225 (410)
T 3v8s_A 151 MPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225 (410)
T ss_dssp CTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEE
T ss_pred CCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCccc
Confidence 9999999999764 58889999999999999999997 899999999999999999999999999998776554333
Q ss_pred eecccccccccccccccCCc----CCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNSA----ISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~~----~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+.
T Consensus 226 ~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 278 (410)
T 3v8s_A 226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 278 (410)
T ss_dssp CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh
Confidence 34668999999999998765 88999999999999999999999987653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=318.48 Aligned_cols=206 Identities=24% Similarity=0.316 Sum_probs=174.0
Q ss_pred HHHhhccccccccccccEEEEEEEEC-CccEEEEEEeecC---CcccHHHHHHHHHHHhcC-CCCCccceeceeecCCeE
Q 043185 507 LEVATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV---GVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQR 581 (724)
Q Consensus 507 l~~a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~ 581 (724)
+....+.+.+.||+|+||.||+++.. +++.||||++++. .....+.+.+|.+++..+ +||||+++++++.+....
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 33445667789999999999999975 5789999999753 233456788999999988 799999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccC
Q 043185 582 LLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 661 (724)
+|||||+++|+|..++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 100 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 9999999999999998765 458899999999999999999997 899999999999999999999999999998643
Q ss_pred CCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 662 PEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 662 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 176 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~ 230 (353)
T 3txo_A 176 CNGV-TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED 230 (353)
T ss_dssp C----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cCCc-cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH
Confidence 3222 234567999999999999999999999999999999999999999876543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=313.51 Aligned_cols=199 Identities=27% Similarity=0.390 Sum_probs=176.2
Q ss_pred hccccccccccccEEEEEEEE-CCccEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 511 TDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
.+.+.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|++++++++||||+++++++......++||||
T Consensus 16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 95 (328)
T 3fe3_A 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY 95 (328)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEEC
Confidence 456678999999999999998 57889999999754 233456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 96 ~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-- 169 (328)
T 3fe3_A 96 ASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-- 169 (328)
T ss_dssp CTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG--
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc--
Confidence 9999999998765 358899999999999999999997 8999999999999999999999999999987654322
Q ss_pred eecccccccccccccccCCcCC-CccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNSAIS-EKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~~~~-~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.....||+.|+|||++.+..+. +++||||||+++|||++|+.||++..
T Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 218 (328)
T 3fe3_A 170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218 (328)
T ss_dssp GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence 3456799999999999988765 79999999999999999999998765
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=314.95 Aligned_cols=208 Identities=30% Similarity=0.517 Sum_probs=177.2
Q ss_pred HHHHhhccccccccccccEEEEEEEEC----CccEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeceeecCCe
Q 043185 506 ELEVATDNFKNLIGSGGFGAVYKGILN----DKTIVAVKKITNV-GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQ 580 (724)
Q Consensus 506 ~l~~a~~~~~~~lG~G~fG~Vy~~~~~----~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 580 (724)
++....+.+.+.||+|+||.||+|+.. .+..||||+++.. .....+++.+|+.++++++||||+++++++.++..
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL 124 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence 344456667789999999999999984 3456999999754 23445679999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCcccc
Q 043185 581 RLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLL 660 (724)
Q Consensus 581 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 660 (724)
.++||||+++++|.+++......+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 999999999999999998776779999999999999999999997 89999999999999999999999999999877
Q ss_pred CCCCcc--ceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 043185 661 TPEQSS--LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQ 716 (724)
Q Consensus 661 ~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~ 716 (724)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 260 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN 260 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH
Confidence 544322 1223346778999999999999999999999999999999 9999966543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=307.18 Aligned_cols=203 Identities=28% Similarity=0.394 Sum_probs=172.1
Q ss_pred hhccccccccccccEEEEEEEEC-CccEEEEEEeecCCc---ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV---QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVY 585 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 585 (724)
..+.+.+.||+|+||.||+++.. +++.||+|++..... ...+.+.+|+.++.+++||||+++++++.+++..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 34566789999999999999975 678899999864322 33467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc
Q 043185 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 665 (724)
||+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 91 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp ECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 9999999999997653 58999999999999999999997 8999999999999999999999999999987654433
Q ss_pred cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 666 SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 666 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~ 217 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA 217 (294)
T ss_dssp --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH
T ss_pred cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 333456799999999999999999999999999999999999999977653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=319.01 Aligned_cols=200 Identities=24% Similarity=0.305 Sum_probs=173.6
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVY 585 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 585 (724)
.+.+.++||+|+||.||+++.. +++.+|+|++++.. ....+.+.+|..++.++ +||||+++++++.+....+|||
T Consensus 53 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~ 132 (396)
T 4dc2_A 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 132 (396)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEE
Confidence 4556789999999999999986 56789999997542 22334578899999877 8999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc
Q 043185 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 665 (724)
||+++|+|..++... ..+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++......
T Consensus 133 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~- 207 (396)
T 4dc2_A 133 EYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG- 207 (396)
T ss_dssp ECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred EcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecccCC-
Confidence 999999999998765 358899999999999999999997 899999999999999999999999999998643222
Q ss_pred cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 666 SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 666 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~ 257 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 257 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTT
T ss_pred CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 22345689999999999999999999999999999999999999997543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=314.77 Aligned_cols=214 Identities=50% Similarity=0.861 Sum_probs=186.3
Q ss_pred CCCCChHHHHHhhccc--cccccccccEEEEEEEECCccEEEEEEeecCCc-ccHHHHHHHHHHHhcCCCCCccceecee
Q 043185 499 PQRFDYEELEVATDNF--KNLIGSGGFGAVYKGILNDKTIVAVKKITNVGV-QGKKDFCTEIAIIGNIHHVNLVKLKGFC 575 (724)
Q Consensus 499 ~~~~~~~~l~~a~~~~--~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~ 575 (724)
...+++.++.....+| .+.||+|+||.||+|+..+++.||||++..... .....+.+|++++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 3467888888887766 478999999999999988888999999975422 2334789999999999999999999999
Q ss_pred ecCCeEEEEEEecCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEE
Q 043185 576 AQGRQRLLVYEYMNHGSLDRILFGN---GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKIS 652 (724)
Q Consensus 576 ~~~~~~~lV~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 652 (724)
......++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+..+|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 9999999999999999999999764 2358999999999999999999998333399999999999999999999999
Q ss_pred eecCccccCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCC
Q 043185 653 DFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCS 712 (724)
Q Consensus 653 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~ 712 (724)
|||+++..............||+.|+|||.+.+..++.++||||||+++|||++|+.||+
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 999998776554444455669999999999999899999999999999999999999995
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=304.14 Aligned_cols=203 Identities=31% Similarity=0.486 Sum_probs=180.5
Q ss_pred hhccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
..+.+.+.||+|+||.||+++..+++.||+|++... ....+++.+|++++++++||||+++++++.+....++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 345667899999999999999988888999999764 3445789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
+++|.+++......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++...........
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (269)
T 4hcu_A 89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 165 (269)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccccccccc
Confidence 999999998777779999999999999999999997 89999999999999999999999999999876544332233
Q ss_pred cccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQ 716 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~ 716 (724)
...+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~ 213 (269)
T 4hcu_A 166 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 213 (269)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred CcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH
Confidence 4457788999999999999999999999999999999 9999976543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=303.85 Aligned_cols=203 Identities=28% Similarity=0.426 Sum_probs=180.8
Q ss_pred HhhccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 509 VATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 509 ~a~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
...+.+.+.||+|+||.||++...++..||+|+++.. ....+++.+|++++.+++||||+++++++.+....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT-TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccC-CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 3456677899999999999999998888999999764 334577999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
++++|.+++......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++...........
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 162 (268)
T 3sxs_A 86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS 162 (268)
T ss_dssp TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEEC
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcc
Confidence 9999999998766679999999999999999999997 8999999999999999999999999999987765543333
Q ss_pred ecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||+...
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (268)
T 3sxs_A 163 VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT 210 (268)
T ss_dssp CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC
Confidence 44556778999999999899999999999999999999 999997654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=307.71 Aligned_cols=203 Identities=27% Similarity=0.385 Sum_probs=175.1
Q ss_pred hccccccccccccEEEEEEEECCccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 511 TDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
.+.+.+.||+|+||.||+|+..+++.||+|++.... ....+.+.+|++++++++||||+++++++.++...++||||+
T Consensus 22 ~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 101 (311)
T 3niz_A 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFM 101 (311)
T ss_dssp EEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECC
T ss_pred hhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCC
Confidence 455678999999999999999889999999996432 223467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
++ +|.+++......+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 102 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~~ 176 (311)
T 3niz_A 102 EK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-SY 176 (311)
T ss_dssp SE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---
T ss_pred CC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-cc
Confidence 85 8888887776779999999999999999999997 8999999999999999999999999999987653322 22
Q ss_pred ecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRSQSH 718 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~ 718 (724)
....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||.+....+
T Consensus 177 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 227 (311)
T 3niz_A 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD 227 (311)
T ss_dssp -CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT
T ss_pred cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 44578999999999876 568999999999999999999999998766544
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=307.68 Aligned_cols=197 Identities=25% Similarity=0.370 Sum_probs=175.7
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
.+.+.+.||+|+||.||+++.. +++.||+|++++.. ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e 86 (318)
T 1fot_A 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 86 (318)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEe
Confidence 3556789999999999999985 68899999997531 2345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
|+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 ~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--- 159 (318)
T 1fot_A 87 YIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 159 (318)
T ss_dssp CCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence 99999999999765 358889999999999999999996 89999999999999999999999999999876432
Q ss_pred ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.....||+.|+|||++.+..++.++|+||||+++|||++|+.||....
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 207 (318)
T 1fot_A 160 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 207 (318)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred -cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 234579999999999999999999999999999999999999997654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=316.25 Aligned_cols=199 Identities=20% Similarity=0.241 Sum_probs=171.6
Q ss_pred hhccccccccccccEEEEEEE------ECCccEEEEEEeecCCcccHHHHHHHHHHHhcCC---CCCccceeceeecCCe
Q 043185 510 ATDNFKNLIGSGGFGAVYKGI------LNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIH---HVNLVKLKGFCAQGRQ 580 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~------~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~ 580 (724)
..+.+.+.||+|+||.||+|+ ...++.||||++... ...++.+|++++.+++ |+||+++++++...+.
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~ 141 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG 141 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence 345567899999999999994 446788999999753 4567788888888886 9999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC-----------
Q 043185 581 RLLVYEYMNHGSLDRILFG----NGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY----------- 645 (724)
Q Consensus 581 ~~lV~e~~~~gsL~~~l~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~----------- 645 (724)
.+|||||+++|+|.+++.. ....+++..+..|+.||+.||+|||+ .+|+||||||+||||+.
T Consensus 142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC------
T ss_pred cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCccccccc
Confidence 9999999999999999974 34569999999999999999999996 89999999999999998
Q ss_pred CCcEEEEeecCccccCCC-CccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 646 HFQAKISDFGLSKLLTPE-QSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 646 ~~~~kl~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
++.+||+|||+++.+... .........||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence 899999999999765322 222345567999999999999999999999999999999999999998544
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-35 Score=308.78 Aligned_cols=200 Identities=24% Similarity=0.339 Sum_probs=178.3
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
.+.+.+.||+|+||.||+++.. +++.+|+|.+... ......+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 84 (321)
T 1tki_A 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence 4566789999999999999976 5778999998753 3445678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC--CCcEEEEeecCccccCCCCccc
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY--HFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~--~~~~kl~DFGla~~~~~~~~~~ 667 (724)
+++|.+++......+++..+..++.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 85 g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~-- 159 (321)
T 1tki_A 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-- 159 (321)
T ss_dssp CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE--
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc--
Confidence 999999998766679999999999999999999997 89999999999999987 78999999999987754432
Q ss_pred eecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 208 (321)
T 1tki_A 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN 208 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH
Confidence 3456789999999999999899999999999999999999999977654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=310.89 Aligned_cols=200 Identities=26% Similarity=0.390 Sum_probs=177.3
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCcc------cHHHHHHHHHHHhcCCCCCccceeceeecCCeEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQ------GKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLL 583 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 583 (724)
.+.+.+.||+|+||.||+++.. +++.||+|.+...... ..+.+.+|+.++.+++||||+++++++.+....++
T Consensus 13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 92 (361)
T 2yab_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL 92 (361)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEE
Confidence 4566789999999999999986 6788999999754321 35789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCC----cEEEEeecCccc
Q 043185 584 VYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHF----QAKISDFGLSKL 659 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DFGla~~ 659 (724)
||||+++|+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|||+++.
T Consensus 93 v~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 93 ILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 99999999999999654 468999999999999999999997 8999999999999998877 799999999987
Q ss_pred cCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 660 LTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 660 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.+...
T Consensus 169 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~ 223 (361)
T 2yab_A 169 IEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 223 (361)
T ss_dssp CCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred cCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH
Confidence 654322 3456799999999999999999999999999999999999999977654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=315.94 Aligned_cols=205 Identities=27% Similarity=0.424 Sum_probs=176.3
Q ss_pred hhccccccccccccEEEEEEEEC--------CccEEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeceeecCC
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN--------DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGR 579 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~--------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~ 579 (724)
..+.+.+.||+|+||.||+|+.. ++..||||+++... ....+++.+|+++++++ +||||+++++++.+.+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 44566789999999999999862 45679999997542 23456799999999999 8999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEe
Q 043185 580 QRLLVYEYMNHGSLDRILFGNG---------------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLH 644 (724)
Q Consensus 580 ~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~ 644 (724)
..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEEC
Confidence 9999999999999999997643 347899999999999999999997 8999999999999999
Q ss_pred CCCcEEEEeecCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 043185 645 YHFQAKISDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQS 717 (724)
Q Consensus 645 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~~ 717 (724)
.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 999999999999987654322 22233457889999999999999999999999999999999 99999765543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=312.19 Aligned_cols=202 Identities=25% Similarity=0.342 Sum_probs=176.5
Q ss_pred hhccccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLV 584 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV 584 (724)
..+.+.+.||+|+||.||+|+.. +++.||+|++++.. ....+.+..|..++..+ +||||+++++++.+....++|
T Consensus 17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv 96 (345)
T 1xjd_A 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 96 (345)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence 44566789999999999999985 67889999997531 23456788899999877 999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC
Q 043185 585 YEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (724)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 97 ~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 97 MEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172 (345)
T ss_dssp EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence 9999999999999764 358899999999999999999997 899999999999999999999999999998643322
Q ss_pred ccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 665 SSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 665 ~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
. ......||+.|+|||++.+..++.++|+||||+++|||++|+.||.....
T Consensus 173 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (345)
T 1xjd_A 173 A-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 223 (345)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred C-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH
Confidence 2 23456799999999999999999999999999999999999999987654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-35 Score=312.02 Aligned_cols=203 Identities=25% Similarity=0.324 Sum_probs=177.4
Q ss_pred HhhccccccccccccEEEEEEEEC-CccEEEEEEeecC---CcccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEE
Q 043185 509 VATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV---GVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLL 583 (724)
Q Consensus 509 ~a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l 583 (724)
...+.+.+.||+|+||.||+++.. +++.||+|++++. .....+.+.+|..++..+ +||||+++++++.+.+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 345666789999999999999986 4788999999753 234456788999999988 89999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCC
Q 043185 584 VYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE 663 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (724)
||||+++|+|.+++...+ .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 99 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 999999999999997643 58899999999999999999997 89999999999999999999999999999864332
Q ss_pred CccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 664 QSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 664 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.. ......||+.|+|||++.+..++.++|+||||+++|||++|+.||.....
T Consensus 175 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~ 226 (353)
T 2i0e_A 175 GV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 226 (353)
T ss_dssp TC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred Cc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH
Confidence 22 23456799999999999999999999999999999999999999987654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=309.56 Aligned_cols=199 Identities=25% Similarity=0.307 Sum_probs=174.3
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVY 585 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 585 (724)
.+.+.+.||+|+||.||+++.. +++.||+|++.+.. ....+.+.+|..++.++ +||||+++++++.+....++||
T Consensus 10 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 89 (345)
T 3a8x_A 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 89 (345)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEE
Confidence 3556689999999999999986 57889999997542 22345678999999988 8999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc
Q 043185 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 665 (724)
||+++|+|..++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 90 e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~ 165 (345)
T 3a8x_A 90 EYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165 (345)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred eCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence 999999999998764 358899999999999999999997 8999999999999999999999999999986433222
Q ss_pred cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 666 SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 666 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
......||+.|+|||++.+..++.++|+||||+++|||++|+.||...
T Consensus 166 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 213 (345)
T 3a8x_A 166 -TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 213 (345)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTT
T ss_pred -cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCc
Confidence 234567999999999999999999999999999999999999999653
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=312.47 Aligned_cols=201 Identities=30% Similarity=0.411 Sum_probs=176.4
Q ss_pred hhccccccccccccEEEEEEEEC-CccEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV---GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVY 585 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 585 (724)
..+.+.+.||+|+||.||++... +++.||+|++.+. .....+.+.+|++++++++||||+++++++.+....++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 44566789999999999999975 5788999998643 2344577899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc
Q 043185 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 665 (724)
||+++|+|..++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 95 e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 170 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170 (384)
T ss_dssp CCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred ecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCCCc
Confidence 999999999999764 468999999999999999999997 8999999999999999999999999999987654322
Q ss_pred cceecccccccccccccccC---CcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 666 SLFTTMRGTRGYLAPEWLTN---SAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 666 ~~~~~~~gt~~y~aPE~l~~---~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.....||+.|+|||++.. ..++.++||||||+++|||++|+.||.....
T Consensus 171 --~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~ 222 (384)
T 4fr4_A 171 --ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS 222 (384)
T ss_dssp --BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT
T ss_pred --eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC
Confidence 345679999999999974 4589999999999999999999999976543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-35 Score=306.60 Aligned_cols=202 Identities=33% Similarity=0.547 Sum_probs=166.7
Q ss_pred hhccccccccccccEEEEEEEECCccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
..+.+.+.||+|+||.||+|+.. ++.||||++.... ....+++.+|++++++++||||+++++++.+....++||||
T Consensus 37 ~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 3p86_A 37 CDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY 115 (309)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEEC
T ss_pred hHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEec
Confidence 44566789999999999999874 5679999987543 23346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEecCCCCCCeEEeCCCcEEEEeecCccccCCC
Q 043185 588 MNHGSLDRILFGNGP--VLEWQERFDIALGTARGLAYLHSGCEQK--IIHCDIKPENILLHYHFQAKISDFGLSKLLTPE 663 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (724)
+++++|.+++..... .+++..++.++.|++.||+|||+ .+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 116 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp CTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred CCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 999999999976532 38899999999999999999997 77 999999999999999999999999999765433
Q ss_pred CccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 664 QSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 664 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 193 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~ 244 (309)
T 3p86_A 193 FL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP 244 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH
T ss_pred cc-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 21 12345799999999999999999999999999999999999999976543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=312.98 Aligned_cols=200 Identities=26% Similarity=0.385 Sum_probs=178.8
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
.+.+.+.||+|+||.||+|... +++.+|+|++..........+.+|++++.+++||||+++++++.+....++||||++
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 131 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence 4666789999999999999975 678899999976555556788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC--CCcEEEEeecCccccCCCCccc
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY--HFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~--~~~~kl~DFGla~~~~~~~~~~ 667 (724)
+++|.+++......+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 132 gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~-- 206 (387)
T 1kob_A 132 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI-- 206 (387)
T ss_dssp CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC--
T ss_pred CCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCcc--
Confidence 999999998766678999999999999999999997 89999999999999974 47799999999987755432
Q ss_pred eecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 254 (387)
T 1kob_A 207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 254 (387)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC
Confidence 234579999999999999999999999999999999999999997654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=313.65 Aligned_cols=197 Identities=29% Similarity=0.424 Sum_probs=171.6
Q ss_pred cccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCCH
Q 043185 515 KNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSL 593 (724)
Q Consensus 515 ~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gsL 593 (724)
.+.||+|+||.||+|+.. +++.||+|+++.......+++.+|++++++++||||+++++++.+.+..+|||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 467999999999999974 6889999999876556677899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEE--eCCCcEEEEeecCccccCCCCccceecc
Q 043185 594 DRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILL--HYHFQAKISDFGLSKLLTPEQSSLFTTM 671 (724)
Q Consensus 594 ~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl--~~~~~~kl~DFGla~~~~~~~~~~~~~~ 671 (724)
.+++......+++..+..++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++....... ....
T Consensus 174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~~ 248 (373)
T 2x4f_A 174 FDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKVN 248 (373)
T ss_dssp HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CCCC
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--cccc
Confidence 99987766678999999999999999999997 899999999999999 5677899999999987754432 2345
Q ss_pred cccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 672 RGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 672 ~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.||+.|+|||++.+..++.++||||||+++|||++|+.||.+...
T Consensus 249 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 293 (373)
T 2x4f_A 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND 293 (373)
T ss_dssp CSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred cCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 699999999999999999999999999999999999999977653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-35 Score=308.92 Aligned_cols=201 Identities=32% Similarity=0.445 Sum_probs=171.0
Q ss_pred hhccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCC----eEEEEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR----QRLLVY 585 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~lV~ 585 (724)
..+.+.++||+|+||.||+|+.. ++.||||++... ......+.+|+.++.+++||||+++++++.+.. ..++||
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 34566789999999999999987 577999999654 233445667899999999999999999998744 479999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC----------CeEecCCCCCCeEEeCCCcEEEEeec
Q 043185 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQ----------KIIHCDIKPENILLHYHFQAKISDFG 655 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~----------~iiH~Dlkp~NILl~~~~~~kl~DFG 655 (724)
||+++|+|.+++... .+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||
T Consensus 102 e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 102 AFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred ecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 999999999999765 48999999999999999999997 6 99999999999999999999999999
Q ss_pred CccccCCCCc-cceecccccccccccccccC-----CcCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 656 LSKLLTPEQS-SLFTTMRGTRGYLAPEWLTN-----SAISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 656 la~~~~~~~~-~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
+++....... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.+....
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~ 244 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCC
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcch
Confidence 9987654332 12234579999999999987 45677899999999999999999999876543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=302.20 Aligned_cols=203 Identities=27% Similarity=0.424 Sum_probs=176.8
Q ss_pred HhhccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 509 VATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 509 ~a~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
...+.+.+.||+|+||.||++...++..||+|++... ....+++.+|++++.+++||||+++++++.+....++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC-CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 3455667899999999999999998888999999764 334578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
++++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..........
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (283)
T 3gen_A 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 178 (283)
T ss_dssp TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHST
T ss_pred CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccccccccc
Confidence 9999999998755679999999999999999999997 8999999999999999999999999999987654332222
Q ss_pred ecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~ 226 (283)
T 3gen_A 179 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 226 (283)
T ss_dssp TSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC
Confidence 34456788999999998899999999999999999998 999997654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=309.07 Aligned_cols=202 Identities=26% Similarity=0.370 Sum_probs=167.1
Q ss_pred hhccccccccccccEEEEEEEE----CCccEEEEEEeecCC----cccHHHHHHHHHHHhcCCCCCccceeceeecCCeE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGIL----NDKTIVAVKKITNVG----VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQR 581 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 581 (724)
..+.+.+.||+|+||.||+++. .+++.||+|++++.. ......+.+|+.++++++||||+++++++..++..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 4566778999999999999997 478899999997542 23345678999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccC
Q 043185 582 LLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 661 (724)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 97 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 97 YLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp EEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred EEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 9999999999999998764 357889999999999999999997 899999999999999999999999999997543
Q ss_pred CCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 662 PEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 662 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 173 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 226 (327)
T 3a62_A 173 HDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR 226 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH
Confidence 3221 22345799999999999999999999999999999999999999976543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=309.21 Aligned_cols=198 Identities=23% Similarity=0.290 Sum_probs=176.4
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
.+.+.+.||+|+||.||+++.. +++.||+|++.+.. ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 121 (350)
T 1rdq_E 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence 3556689999999999999985 68899999996531 2445778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
|+++|+|.+++...+ .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 122 ~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~-- 195 (350)
T 1rdq_E 122 YVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-- 195 (350)
T ss_dssp CCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB--
T ss_pred CCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCCc--
Confidence 999999999997653 58899999999999999999997 999999999999999999999999999998765432
Q ss_pred ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
....||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 196 --~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 243 (350)
T 1rdq_E 196 --WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243 (350)
T ss_dssp --CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred --ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH
Confidence 345799999999999999999999999999999999999999976543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=303.33 Aligned_cols=201 Identities=27% Similarity=0.388 Sum_probs=177.7
Q ss_pred hhccccccccccccEEEEEEEEC-CccEEEEEEeecCCc------ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV------QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRL 582 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 582 (724)
..+.+.+.||+|+||.||+++.. +++.||+|++..... ...+++.+|+.++++++||||+++++++.+....+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45677889999999999999985 678899999975322 24678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCC----cEEEEeecCcc
Q 043185 583 LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHF----QAKISDFGLSK 658 (724)
Q Consensus 583 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DFGla~ 658 (724)
+||||+++++|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|||+++
T Consensus 91 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 999999999999999654 468999999999999999999997 8999999999999999887 89999999998
Q ss_pred ccCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 659 LLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 659 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.+...
T Consensus 167 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 222 (326)
T 2y0a_A 167 KIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 222 (326)
T ss_dssp ECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred ECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH
Confidence 7654322 2445799999999999999999999999999999999999999976543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=317.18 Aligned_cols=205 Identities=28% Similarity=0.505 Sum_probs=166.0
Q ss_pred HHhhccccccccccccEEEEEEEEC----CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEE
Q 043185 508 EVATDNFKNLIGSGGFGAVYKGILN----DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRL 582 (724)
Q Consensus 508 ~~a~~~~~~~lG~G~fG~Vy~~~~~----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 582 (724)
....+.+.+.||+|+||.||+|+.. ++..||||+++... ....++|.+|+.++++++||||+++++++.+....+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 3345666789999999999999864 56779999997542 334567999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCC
Q 043185 583 LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP 662 (724)
Q Consensus 583 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (724)
+||||+++++|.+++......+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 123 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 9999999999999998877789999999999999999999997 8999999999999999999999999999987654
Q ss_pred CCccc--eecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 663 EQSSL--FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 663 ~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
..... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~ 255 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 33211 112235778999999999999999999999999999998 999996554
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=309.68 Aligned_cols=202 Identities=24% Similarity=0.303 Sum_probs=175.8
Q ss_pred HhhccccccccccccEEEEEEEEC-CccEEEEEEeecC-----CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEE
Q 043185 509 VATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV-----GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRL 582 (724)
Q Consensus 509 ~a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 582 (724)
...|.+.+.||+|+||.||+++.. +++.||||++... .....+.+.+|+.++++++||||+++++++.++...+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 345777899999999999999975 6789999998632 1224678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCc---EEEEeecC
Q 043185 583 LVYEYMNHGSLDRILFGN---GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQ---AKISDFGL 656 (724)
Q Consensus 583 lV~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DFGl 656 (724)
+||||+++++|.+.+... ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998877542 3458999999999999999999997 89999999999999987655 99999999
Q ss_pred ccccCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 657 SKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 657 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence 987755432 123457999999999999999999999999999999999999999764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=300.82 Aligned_cols=199 Identities=30% Similarity=0.388 Sum_probs=171.1
Q ss_pred ccccccccccccEEEEEEEECCccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 512 DNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
+.+.+.||+|+||.||+|+..+++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred chhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC
Confidence 55678999999999999999888999999996532 2234778899999999999999999999999999999999998
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
+ +|.+++......+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 158 (288)
T 1ob3_A 84 Q-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYT 158 (288)
T ss_dssp E-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred C-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-ccc
Confidence 6 9999988766678999999999999999999997 8999999999999999999999999999987653322 123
Q ss_pred cccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
...+|+.|+|||.+.+. .++.++||||||+++|||++|+.||....
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 205 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 45689999999999764 58999999999999999999999997654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-35 Score=324.85 Aligned_cols=205 Identities=27% Similarity=0.458 Sum_probs=177.6
Q ss_pred HHHhhccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEE
Q 043185 507 LEVATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 507 l~~a~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
+....+.+.+.||+|+||.||+|+..++..||||+++.. ....++|.+|++++++++||||+++++++. ....++|||
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC-CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 344556677899999999999999988888999999764 345788999999999999999999999987 567899999
Q ss_pred ecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc
Q 043185 587 YMNHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 587 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 665 (724)
|+++|+|.+++... ...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 99999999999754 2357889999999999999999997 8999999999999999999999999999987654322
Q ss_pred cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 043185 666 SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQ 716 (724)
Q Consensus 666 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~ 716 (724)
.......++..|+|||.+....++.++||||||++||||++ |+.||.....
T Consensus 340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~ 391 (454)
T 1qcf_A 340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 391 (454)
T ss_dssp HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH
Confidence 22233456788999999998899999999999999999999 9999976543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=308.13 Aligned_cols=201 Identities=24% Similarity=0.385 Sum_probs=176.4
Q ss_pred HhhccccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEE
Q 043185 509 VATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVY 585 (724)
Q Consensus 509 ~a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 585 (724)
...+.+.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 345677889999999999999975 67889999997543 234467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCC---cEEEEeecCccccCC
Q 043185 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHF---QAKISDFGLSKLLTP 662 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~DFGla~~~~~ 662 (724)
||+++|+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|||++.....
T Consensus 108 e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 108 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp CCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 999999999988655 468899999999999999999997 8999999999999998654 599999999987654
Q ss_pred CCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 663 EQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 663 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
... .....||+.|+|||++.+..++.++||||||+++|||++|++||....
T Consensus 184 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~ 234 (362)
T 2bdw_A 184 SEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 234 (362)
T ss_dssp CCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Ccc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 322 245679999999999999999999999999999999999999997654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=305.09 Aligned_cols=203 Identities=32% Similarity=0.487 Sum_probs=172.4
Q ss_pred HHhhccccccccccccEEEEEEEEC-----CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecC--Ce
Q 043185 508 EVATDNFKNLIGSGGFGAVYKGILN-----DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG--RQ 580 (724)
Q Consensus 508 ~~a~~~~~~~lG~G~fG~Vy~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~ 580 (724)
....+.+.+.||+|+||.||++++. +++.||||++........+++.+|++++++++||||+++++++... ..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 3455667789999999999999852 5788999999876566667899999999999999999999998543 56
Q ss_pred EEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCcccc
Q 043185 581 RLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLL 660 (724)
Q Consensus 581 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 660 (724)
.++||||+++++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred eEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 899999999999999998876679999999999999999999997 89999999999999999999999999999876
Q ss_pred CCCCc--cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCC
Q 043185 661 TPEQS--SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSP 713 (724)
Q Consensus 661 ~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~ 713 (724)
..... .......++..|+|||.+.+..++.++||||||+++|||++|..|+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence 54322 112234577789999999999999999999999999999999998854
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=305.80 Aligned_cols=203 Identities=27% Similarity=0.383 Sum_probs=175.8
Q ss_pred hccccccccccccEEEEEEEE-CCccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
.|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++......++|||
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 89 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE 89 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence 456678999999999999997 577899999986421 2234678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
|+ +|+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 90 ~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~- 163 (336)
T 3h4j_B 90 YA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF- 163 (336)
T ss_dssp CC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT-
T ss_pred CC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc-
Confidence 99 67888888654 358899999999999999999997 8999999999999999999999999999987654332
Q ss_pred ceecccccccccccccccCCcC-CCccchhhHHHHHHHHHhCCCCCCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAI-SEKTDVYSFGMVLLELVSGRRNCSPRSQSHSM 720 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~-~~~sDv~SlGv~l~elltG~~p~~~~~~~~~~ 720 (724)
.....||+.|+|||++.+..+ ++++||||||+++|||++|+.||+.....+..
T Consensus 164 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~ 217 (336)
T 3h4j_B 164 -LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF 217 (336)
T ss_dssp -TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB
T ss_pred -cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH
Confidence 245579999999999998876 78999999999999999999999876555443
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-35 Score=327.22 Aligned_cols=208 Identities=28% Similarity=0.440 Sum_probs=181.5
Q ss_pred HHHHhhccccccccccccEEEEEEEECC-ccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEE
Q 043185 506 ELEVATDNFKNLIGSGGFGAVYKGILND-KTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLV 584 (724)
Q Consensus 506 ~l~~a~~~~~~~lG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 584 (724)
++....+.+.+.||+|+||.||+|+... +..||||+++.. ....++|.+|+.++++++||||+++++++.+....+||
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 3444556677899999999999999874 678999999754 34568899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCC
Q 043185 585 YEYMNHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE 663 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (724)
|||+++|+|.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 9999999999999764 4568999999999999999999997 89999999999999999999999999999877554
Q ss_pred CccceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 043185 664 QSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQS 717 (724)
Q Consensus 664 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~~ 717 (724)
.........++..|+|||.+.+..++.++||||||++||||++ |+.||......
T Consensus 372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~ 426 (495)
T 1opk_A 372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 426 (495)
T ss_dssp CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence 3332334456789999999999999999999999999999999 99999765543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=306.81 Aligned_cols=201 Identities=20% Similarity=0.261 Sum_probs=175.6
Q ss_pred hccccccccccccEEEEEEEE-CCccEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEEEEEec
Q 043185 511 TDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
.+.+.+.||+|+||.||+|+. .+++.||||++.... ..+++.+|+++++++ +||||+++++++..+...++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred CeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 355678999999999999997 577889999987542 234688999999999 9999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCc-----EEEEeecCccccCCC
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQ-----AKISDFGLSKLLTPE 663 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~-----~kl~DFGla~~~~~~ 663 (724)
+++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++.+...
T Consensus 88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 88 -GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence 999999998766789999999999999999999997 89999999999999999887 999999999876443
Q ss_pred Ccc------ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 664 QSS------LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 664 ~~~------~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~ 223 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD 223 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS
T ss_pred CCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc
Confidence 221 123567999999999999999999999999999999999999999876543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=322.48 Aligned_cols=200 Identities=28% Similarity=0.385 Sum_probs=177.3
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV---GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
+.+.+.||+|+||.||+++.. +++.||+|++.+. .......+.+|++++++++||||+++++++.+....+|||||
T Consensus 186 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy 265 (576)
T 2acx_A 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 265 (576)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEc
Confidence 445688999999999999985 6889999999653 123456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 588 MNHGSLDRILFGNG-PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 588 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
+++|+|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++.......
T Consensus 266 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~- 341 (576)
T 2acx_A 266 MNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 341 (576)
T ss_dssp CCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC-
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccCcc-
Confidence 99999999987653 358999999999999999999997 8999999999999999999999999999987654332
Q ss_pred ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 342 -~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~ 390 (576)
T 2acx_A 342 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK 390 (576)
T ss_dssp -EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSS
T ss_pred -ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccccc
Confidence 3456899999999999999999999999999999999999999987643
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=317.36 Aligned_cols=203 Identities=31% Similarity=0.414 Sum_probs=175.5
Q ss_pred hhccccccccccccEEEEEEEEC-CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
..+.+.+.||+|+||.||+|+.. +++.||||+++... ....++|.+|++++++++||||+++++++.+....++||||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 193 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 193 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence 44556789999999999999986 78899999987542 23345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
+++|+|.+++...+..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.........
T Consensus 194 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~ 270 (377)
T 3cbl_A 194 VQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270 (377)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence 99999999998766678999999999999999999997 899999999999999999999999999998654332111
Q ss_pred e-ecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 668 F-TTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 668 ~-~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
. ....++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 271 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~ 320 (377)
T 3cbl_A 271 SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320 (377)
T ss_dssp CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 1 11235778999999998899999999999999999998 999997654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=310.88 Aligned_cols=202 Identities=30% Similarity=0.395 Sum_probs=167.2
Q ss_pred hhccccccccccccEEEEEEEEC-CccEEEEEEeecCCc---ccHHHHHHHHHH-HhcCCCCCccceeceeecCCeEEEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV---QGKKDFCTEIAI-IGNIHHVNLVKLKGFCAQGRQRLLV 584 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~-l~~l~H~nIv~l~g~~~~~~~~~lV 584 (724)
..+.+.+.||+|+||.||+++.. +++.+|+|++.+... ...+.+.+|..+ ++.++||||+++++++.+.+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 34566789999999999999986 578899999975432 233456677776 5778999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC
Q 043185 585 YEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (724)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 118 ~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 118 LDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 9999999999998764 357888899999999999999997 899999999999999999999999999998643322
Q ss_pred ccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 665 SSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 665 ~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
. ......||+.|+|||++.+..++.++|+||||+++|||++|+.||.....
T Consensus 194 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~ 244 (373)
T 2r5t_A 194 S-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT 244 (373)
T ss_dssp C-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH
T ss_pred C-ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH
Confidence 1 23456799999999999999999999999999999999999999977653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=305.41 Aligned_cols=202 Identities=30% Similarity=0.424 Sum_probs=173.0
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCc-ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV-QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
.+.+.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.++...++||||+
T Consensus 8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 87 (323)
T 3tki_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87 (323)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcC
Confidence 3556789999999999999976 778899999864322 33466889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc-cc
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS-SL 667 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~-~~ 667 (724)
++++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+..... ..
T Consensus 88 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 163 (323)
T 3tki_A 88 SGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (323)
T ss_dssp TTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred CCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence 999999998654 458999999999999999999997 8999999999999999999999999999986643221 22
Q ss_pred eecccccccccccccccCCcC-CCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNSAI-SEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~~~-~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 213 (323)
T 3tki_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (323)
T ss_dssp BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence 345679999999999988765 7899999999999999999999976554
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=302.19 Aligned_cols=200 Identities=23% Similarity=0.387 Sum_probs=173.3
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCC--eEEEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR--QRLLVYE 586 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--~~~lV~e 586 (724)
.+.+.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (319)
T 4euu_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (319)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEe
Confidence 4566789999999999999986 47889999997533 344677889999999999999999999987655 7899999
Q ss_pred ecCCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEE----eCCCcEEEEeecCcccc
Q 043185 587 YMNHGSLDRILFGNG--PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILL----HYHFQAKISDFGLSKLL 660 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DFGla~~~ 660 (724)
|+++++|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++..
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp CCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred CCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 999999999997643 338999999999999999999997 899999999999999 77888999999999877
Q ss_pred CCCCccceeccccccccccccccc--------CCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 661 TPEQSSLFTTMRGTRGYLAPEWLT--------NSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 661 ~~~~~~~~~~~~gt~~y~aPE~l~--------~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
..... .....||+.|+|||++. +..++.++||||||+++|||++|+.||.+..
T Consensus 167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 227 (319)
T 4euu_A 167 EDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (319)
T ss_dssp CTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred CCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 55432 23457999999999986 5688999999999999999999999997544
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-34 Score=313.66 Aligned_cols=202 Identities=22% Similarity=0.330 Sum_probs=175.3
Q ss_pred hhccccccccccccEEEEEEEEC-CccEEEEEEeecCCc--ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV--QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
..|.+.+.||+|+||.||++... +++.+|+|++..... ...+.+.+|++++++++||||+++++++.++...++|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 45677889999999999999974 678899999975432 334678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEe---CCCcEEEEeecCccccCCC
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLH---YHFQAKISDFGLSKLLTPE 663 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kl~DFGla~~~~~~ 663 (724)
|+++|+|.+.+... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||+++.....
T Consensus 91 ~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 91 LVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp CCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred eCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 99999999998765 458999999999999999999997 8999999999999998 4678999999999876544
Q ss_pred CccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 664 QSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 664 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.. ......||+.|+|||++.+..++.++||||||+++|||++|++||.....
T Consensus 167 ~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~ 218 (444)
T 3soa_A 167 QQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ 218 (444)
T ss_dssp CC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred Cc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH
Confidence 32 22456799999999999999999999999999999999999999976543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=295.18 Aligned_cols=201 Identities=31% Similarity=0.476 Sum_probs=178.6
Q ss_pred hccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 511 TDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
.+.+.+.||+|+||.||+++..+++.||+|++... ....+++.+|++++.+++||||+++++++.+....++||||+++
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (267)
T 3t9t_A 9 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH 87 (267)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-TBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred heeeeeEecCCCceeEEEEEecCCCeEEEEEcccc-CCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence 45567899999999999999988888999999764 33457899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
++|.+++......+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.............
T Consensus 88 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 164 (267)
T 3t9t_A 88 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 164 (267)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred CcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccccccccccc
Confidence 99999998776778999999999999999999997 899999999999999999999999999998765432222233
Q ss_pred ccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (267)
T 3t9t_A 165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 210 (267)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC
Confidence 457788999999998899999999999999999999 899997654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=300.75 Aligned_cols=205 Identities=24% Similarity=0.351 Sum_probs=164.8
Q ss_pred HhhccccccccccccEEEEEEEECC----ccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEE
Q 043185 509 VATDNFKNLIGSGGFGAVYKGILND----KTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLL 583 (724)
Q Consensus 509 ~a~~~~~~~lG~G~fG~Vy~~~~~~----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 583 (724)
...+.+.+.||+|+||.||+|.... +..||+|++.... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 3456677899999999999999743 4569999987532 334567899999999999999999999985 467899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCC
Q 043185 584 VYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE 663 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (724)
||||+++++|.+++......+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 999999999999998776679999999999999999999997 89999999999999999999999999999876544
Q ss_pred CccceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 043185 664 QSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQS 717 (724)
Q Consensus 664 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~~ 717 (724)
.........+++.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~ 224 (281)
T 1mp8_A 170 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 224 (281)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH
Confidence 3322334457789999999998899999999999999999997 99999776543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=298.40 Aligned_cols=202 Identities=26% Similarity=0.310 Sum_probs=169.1
Q ss_pred HHHHHhhccccccccccccEEEEEEEEC-CccEEEEEEeecCCc--ccHHHHHHHHHHHhcC-CCCCccceeceeecCCe
Q 043185 505 EELEVATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV--QGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQ 580 (724)
Q Consensus 505 ~~l~~a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~ 580 (724)
.++....+.+.++||+|+||+||+|+.. +++.||||++..... ....++..|+..+.++ +||||+++++++.++..
T Consensus 52 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~ 131 (311)
T 3p1a_A 52 ESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI 131 (311)
T ss_dssp SCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE
Confidence 3445566777889999999999999986 788999999865322 2334455666666555 89999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCcccc
Q 043185 581 RLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLL 660 (724)
Q Consensus 581 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 660 (724)
.++||||+ +++|.+++......+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred EEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 99999999 669999887776779999999999999999999997 89999999999999999999999999999876
Q ss_pred CCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCC
Q 043185 661 TPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSP 713 (724)
Q Consensus 661 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~ 713 (724)
..... .....||+.|+|||++.+ .++.++||||||+++|||++|..|+..
T Consensus 208 ~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 208 GTAGA--GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp C--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred ccCCC--CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 54332 234569999999999886 789999999999999999999776644
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=300.89 Aligned_cols=193 Identities=27% Similarity=0.390 Sum_probs=152.2
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCC-CCCccceeceeecCCeEEEEEEecCCCCH
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIH-HVNLVKLKGFCAQGRQRLLVYEYMNHGSL 593 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~e~~~~gsL 593 (724)
+.||+|+||.||+++.. +++.||||++.+ .....+.+|+.++.++. ||||+++++++.++...++||||+++++|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 68999999999999985 678899999974 34567889999999997 99999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCC---cEEEEeecCccccCCCCccceec
Q 043185 594 DRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHF---QAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 594 ~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||+++....... ....
T Consensus 94 ~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~ 168 (325)
T 3kn6_A 94 FERIKKK-KHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLKT 168 (325)
T ss_dssp HHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-cccc
Confidence 9999775 468999999999999999999997 8999999999999998766 899999999986654332 2345
Q ss_pred ccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
..||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 169 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 214 (325)
T 3kn6_A 169 PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDR 214 (325)
T ss_dssp ---------------CCCCHHHHHHHHHHHHHHHHHSSCTTC----
T ss_pred cCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcc
Confidence 5689999999999999999999999999999999999999976553
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-34 Score=319.21 Aligned_cols=201 Identities=27% Similarity=0.396 Sum_probs=176.9
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
+.+.+.||+|+||.||+++.. +++.||+|++.+.. ....+.+.+|+.++++++||||+++++++......++||||
T Consensus 187 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~ 266 (543)
T 3c4z_A 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTI 266 (543)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEe
Confidence 334578999999999999985 68899999996532 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC
Q 043185 588 MNHGSLDRILFGN---GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 588 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (724)
+++|+|..++... ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 267 ~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~ 343 (543)
T 3c4z_A 267 MNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343 (543)
T ss_dssp CTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred ccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC
Confidence 9999999998754 3468999999999999999999997 899999999999999999999999999998765443
Q ss_pred ccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 665 SSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 665 ~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 344 ~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~ 394 (543)
T 3c4z_A 344 TK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394 (543)
T ss_dssp CC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTC
T ss_pred cc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCcc
Confidence 22 2345799999999999999999999999999999999999999987643
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=296.80 Aligned_cols=214 Identities=43% Similarity=0.693 Sum_probs=184.7
Q ss_pred CCCChHHHHHhhcccc--------ccccccccEEEEEEEECCccEEEEEEeecCC----cccHHHHHHHHHHHhcCCCCC
Q 043185 500 QRFDYEELEVATDNFK--------NLIGSGGFGAVYKGILNDKTIVAVKKITNVG----VQGKKDFCTEIAIIGNIHHVN 567 (724)
Q Consensus 500 ~~~~~~~l~~a~~~~~--------~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~H~n 567 (724)
..|+++++..++.+|. +.||+|+||.||+|+. +++.||||++.... ....+.+.+|+.++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 4589999999998885 5699999999999987 56789999986432 234577899999999999999
Q ss_pred ccceeceeecCCeEEEEEEecCCCCHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC
Q 043185 568 LVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGN--GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY 645 (724)
Q Consensus 568 Iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~ 645 (724)
|+++++++.+....++||||+++++|.+++... ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEcC
Confidence 999999999999999999999999999998642 3568999999999999999999997 89999999999999999
Q ss_pred CCcEEEEeecCccccCCCCcc-ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 043185 646 HFQAKISDFGLSKLLTPEQSS-LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSH 718 (724)
Q Consensus 646 ~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~ 718 (724)
++.+||+|||+++........ ......||+.|+|||.+.+ .++.++||||||+++|||++|++||......+
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 241 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH
Confidence 999999999999876543221 2234568999999999876 57999999999999999999999998765543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=293.48 Aligned_cols=204 Identities=27% Similarity=0.414 Sum_probs=158.1
Q ss_pred hccccccccccccEEEEEEEE-CCccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
.+.+.+.||+|+||.||+|+. .+++.||+|++.... ....+++.+|+.++.+++||||+++++++.+....++|||
T Consensus 12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (278)
T 3cok_A 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLE 91 (278)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEe
Confidence 355668999999999999997 478889999996431 2334778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
|+++++|.+++......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 168 (278)
T 3cok_A 92 MCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK 168 (278)
T ss_dssp CCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred cCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc
Confidence 999999999998776779999999999999999999997 89999999999999999999999999999876543221
Q ss_pred ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSH 718 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~ 718 (724)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+
T Consensus 169 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 219 (278)
T 3cok_A 169 -HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN 219 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-
T ss_pred -ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH
Confidence 234568999999999999999999999999999999999999998765443
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-34 Score=300.24 Aligned_cols=200 Identities=27% Similarity=0.410 Sum_probs=162.6
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
+.+.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 86 (317)
T 2pmi_A 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD 86 (317)
T ss_dssp ------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC
T ss_pred eeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC
Confidence 445678999999999999965 67889999997543 3344778899999999999999999999999999999999998
Q ss_pred CCCHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC
Q 043185 590 HGSLDRILFGN-----GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 590 ~gsL~~~l~~~-----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (724)
++|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 87 -~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 162 (317)
T 2pmi_A 87 -NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162 (317)
T ss_dssp -CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred -CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence 5998888643 2458899999999999999999997 899999999999999999999999999998765332
Q ss_pred ccceecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 665 SSLFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 665 ~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
. ......+|+.|+|||++.+. .++.++||||||+++|||++|+.||.+...
T Consensus 163 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 214 (317)
T 2pmi_A 163 N-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND 214 (317)
T ss_dssp C-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred c-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 2 22345789999999999764 689999999999999999999999976543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=319.83 Aligned_cols=202 Identities=28% Similarity=0.334 Sum_probs=166.5
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV---GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
.+.+.+.||+|+||.||+++.. +++.||||++... .......+.+|++++++++||||+++++++.+.+..+||||
T Consensus 149 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 228 (446)
T 4ejn_A 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME 228 (446)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEEC
T ss_pred HcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEe
Confidence 4556789999999999999975 6789999999752 23344677899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
|+++|+|.+++... ..+++..+..++.||+.||+|||+ ..+|+||||||+||||+.++.+||+|||+++.......
T Consensus 229 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 304 (446)
T 4ejn_A 229 YANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA- 304 (446)
T ss_dssp CCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----
T ss_pred eCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc-
Confidence 99999999998765 368899999999999999999995 37899999999999999999999999999986433322
Q ss_pred ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 305 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 354 (446)
T 4ejn_A 305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 354 (446)
T ss_dssp --CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH
Confidence 23456799999999999999999999999999999999999999976543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=305.65 Aligned_cols=204 Identities=24% Similarity=0.424 Sum_probs=169.8
Q ss_pred HhhccccccccccccEEEEEEEEC-Ccc----EEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEE
Q 043185 509 VATDNFKNLIGSGGFGAVYKGILN-DKT----IVAVKKITNV-GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRL 582 (724)
Q Consensus 509 ~a~~~~~~~lG~G~fG~Vy~~~~~-~~~----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 582 (724)
...+.+.+.||+|+||.||+|+.. +++ .||+|++... .....+++.+|+.++++++||||+++++++.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 345666789999999999999964 333 3688887543 2345678999999999999999999999998764 78
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCC
Q 043185 583 LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP 662 (724)
Q Consensus 583 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (724)
+|+||+++|+|.+++......+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 9999999999999998877789999999999999999999997 8999999999999999999999999999987754
Q ss_pred CCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 043185 663 EQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQ 716 (724)
Q Consensus 663 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~ 716 (724)
... .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||+....
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 225 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH
Confidence 432 12233456889999999999999999999999999999999 9999987654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=295.05 Aligned_cols=195 Identities=24% Similarity=0.380 Sum_probs=169.3
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
+.+.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.++...++||||+
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (292)
T 3o0g_A 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecC
Confidence 556789999999999999985 67889999997533 233477889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
++ +|.+.+......+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 84 ~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 158 (292)
T 3o0g_A 84 DQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CY 158 (292)
T ss_dssp SE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-CC
T ss_pred CC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-cc
Confidence 86 6666666655679999999999999999999997 8999999999999999999999999999987654322 23
Q ss_pred ecccccccccccccccCCc-CCCccchhhHHHHHHHHHhCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTNSA-ISEKTDVYSFGMVLLELVSGRRNC 711 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~~~-~~~~sDv~SlGv~l~elltG~~p~ 711 (724)
....||+.|+|||.+.+.. ++.++||||||+++|||++|..||
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~ 202 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCC
Confidence 4457899999999998765 899999999999999999988775
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-34 Score=298.11 Aligned_cols=198 Identities=29% Similarity=0.423 Sum_probs=166.6
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCc--------------------------ccHHHHHHHHHHHhcC
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV--------------------------QGKKDFCTEIAIIGNI 563 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~--------------------------~~~~~~~~E~~~l~~l 563 (724)
.+.+.+.||+|+||.||+|+.. +++.||||++..... ...+++.+|+++++++
T Consensus 14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 93 (298)
T 2zv2_A 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL 93 (298)
T ss_dssp TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence 4566789999999999999975 678899999865321 1135688999999999
Q ss_pred CCCCccceeceeec--CCeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCe
Q 043185 564 HHVNLVKLKGFCAQ--GRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENI 641 (724)
Q Consensus 564 ~H~nIv~l~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NI 641 (724)
+||||+++++++.+ ....++||||+++++|.+++. ...+++..+..++.||+.||+|||+ .+|+||||||+||
T Consensus 94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNL 168 (298)
T ss_dssp CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGE
T ss_pred CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHE
Confidence 99999999999986 568899999999999988653 3468999999999999999999997 8999999999999
Q ss_pred EEeCCCcEEEEeecCccccCCCCccceecccccccccccccccCCc---CCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 642 LLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSA---ISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 642 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
|++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||...
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 999999999999999987654332 234567999999999998765 478899999999999999999999754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=300.93 Aligned_cols=198 Identities=23% Similarity=0.373 Sum_probs=167.7
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCC---------
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR--------- 579 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--------- 579 (724)
.+.+.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.+..
T Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 86 (332)
T 3qd2_B 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMD 86 (332)
T ss_dssp HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHH
T ss_pred cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhh
Confidence 4566789999999999999986 78899999997533 334578999999999999999999999886543
Q ss_pred ------------------------------------------------eEEEEEEecCCCCHHHHHhcCC--CCCCHHHH
Q 043185 580 ------------------------------------------------QRLLVYEYMNHGSLDRILFGNG--PVLEWQER 609 (724)
Q Consensus 580 ------------------------------------------------~~~lV~e~~~~gsL~~~l~~~~--~~l~~~~~ 609 (724)
..++||||+++++|.+++.... ...++..+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 166 (332)
T 3qd2_B 87 EIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166 (332)
T ss_dssp C--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHH
T ss_pred hhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHH
Confidence 3799999999999999997653 33566778
Q ss_pred HHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc-----------cceeccccccccc
Q 043185 610 FDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS-----------SLFTTMRGTRGYL 678 (724)
Q Consensus 610 ~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~-----------~~~~~~~gt~~y~ 678 (724)
..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... .......||+.|+
T Consensus 167 ~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 167 LHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 9999999999999997 8999999999999999999999999999987755421 1123456999999
Q ss_pred ccccccCCcCCCccchhhHHHHHHHHHhCCCCC
Q 043185 679 APEWLTNSAISEKTDVYSFGMVLLELVSGRRNC 711 (724)
Q Consensus 679 aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~ 711 (724)
|||.+.+..++.++||||||+++|||++|..|+
T Consensus 244 aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~ 276 (332)
T 3qd2_B 244 SPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276 (332)
T ss_dssp CHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred ChHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh
Confidence 999999999999999999999999999998775
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=307.35 Aligned_cols=205 Identities=18% Similarity=0.230 Sum_probs=176.4
Q ss_pred hcccccccccc--ccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEE
Q 043185 511 TDNFKNLIGSG--GFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVY 585 (724)
Q Consensus 511 ~~~~~~~lG~G--~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 585 (724)
.|.+.+.||+| +||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 26 ~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 105 (389)
T 3gni_B 26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 105 (389)
T ss_dssp GEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEE
Confidence 46667899999 99999999986 68899999997542 233467888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC
Q 043185 586 EYMNHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 586 e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (724)
||+++++|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 106 SFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp ECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred EccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 999999999999764 3568999999999999999999997 899999999999999999999999999886542211
Q ss_pred c------cceecccccccccccccccC--CcCCCccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 043185 665 S------SLFTTMRGTRGYLAPEWLTN--SAISEKTDVYSFGMVLLELVSGRRNCSPRSQSH 718 (724)
Q Consensus 665 ~------~~~~~~~gt~~y~aPE~l~~--~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~ 718 (724)
. .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 244 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ 244 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT
T ss_pred ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 1 11123468999999999987 679999999999999999999999998765544
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=290.21 Aligned_cols=200 Identities=27% Similarity=0.378 Sum_probs=177.2
Q ss_pred hhccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
..+.+.+.||+|+||.||+|+.. ++..+|+|++........+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 34667789999999999999986 46689999998765667788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEE---eCCCcEEEEeecCccccCCCCc
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILL---HYHFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DFGla~~~~~~~~ 665 (724)
++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||++........
T Consensus 89 ~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~ 164 (277)
T 3f3z_A 89 TGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164 (277)
T ss_dssp CSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence 999999988765 358899999999999999999997 899999999999999 7889999999999987654432
Q ss_pred cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 666 SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 666 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.....||+.|+|||.+.+. ++.++||||||+++|||++|+.||.....
T Consensus 165 --~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 212 (277)
T 3f3z_A 165 --MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD 212 (277)
T ss_dssp --BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred --hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH
Confidence 2445799999999998765 89999999999999999999999976543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=316.31 Aligned_cols=199 Identities=33% Similarity=0.459 Sum_probs=171.7
Q ss_pred hhccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCC-eEEEEEEec
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR-QRLLVYEYM 588 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-~~~lV~e~~ 588 (724)
..+.+.+.||+|+||.||+|... ++.||||+++.. ...++|.+|++++++++||||+++++++.+.. ..++||||+
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSC--TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred HHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCc--hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 34456689999999999999987 457999999764 35578999999999999999999999987665 789999999
Q ss_pred CCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 589 NHGSLDRILFGNGP-VLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 589 ~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
++|+|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 270 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 343 (450)
T 1k9a_A 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 343 (450)
T ss_dssp TTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc---
Confidence 99999999986543 47899999999999999999997 899999999999999999999999999998654322
Q ss_pred eecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQSH 718 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~~~ 718 (724)
....++..|+|||.+.+..++.++||||||++||||++ |+.||......+
T Consensus 344 -~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~ 394 (450)
T 1k9a_A 344 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 394 (450)
T ss_dssp ----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT
T ss_pred -cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 22357889999999999999999999999999999999 999997765443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=303.96 Aligned_cols=202 Identities=24% Similarity=0.378 Sum_probs=166.5
Q ss_pred hccccccccccccEEEEEEEE-CCccEEEEEEeecCCc---ccHHHHHHHHHHHhcCCCCCccceeceeecCC----eEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGV---QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR----QRL 582 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~ 582 (724)
.+.+.+.||+|+||.||+++. .+++.||||++..... ...+.+.+|+.++.+++||||+++++++.... ..+
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 92 (311)
T 3ork_A 13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 92 (311)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence 456678999999999999997 5778899999976432 23457889999999999999999999987654 349
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCC
Q 043185 583 LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP 662 (724)
Q Consensus 583 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (724)
+||||+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 93 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 93 IVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred EEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 9999999999999997653 58899999999999999999997 8999999999999999999999999999987654
Q ss_pred CCc--cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 663 EQS--SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 663 ~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~ 224 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224 (311)
T ss_dssp -------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 322 122345689999999999999999999999999999999999999976653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=320.26 Aligned_cols=203 Identities=29% Similarity=0.457 Sum_probs=170.9
Q ss_pred HHhhccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 508 EVATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 508 ~~a~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
....+.+.+.||+|+||.||+|+..++..||||+++... ...++|.+|++++++++||||+++++++.+ ...++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 344556678999999999999999888889999997643 446789999999999999999999999876 678999999
Q ss_pred cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 588 MNHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 588 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
+++|+|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 9999999999753 3468999999999999999999997 89999999999999999999999999999876543332
Q ss_pred ceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||.+..
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~ 386 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 386 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC
Confidence 2234457789999999999899999999999999999999 999997654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=298.85 Aligned_cols=197 Identities=27% Similarity=0.444 Sum_probs=172.4
Q ss_pred HhhccccccccccccEEEEEEEECC-c-------cEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCe
Q 043185 509 VATDNFKNLIGSGGFGAVYKGILND-K-------TIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQ 580 (724)
Q Consensus 509 ~a~~~~~~~lG~G~fG~Vy~~~~~~-~-------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 580 (724)
...+.+.+.||+|+||.||+|+... + ..||+|++........+.+.+|++++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3456677899999999999998653 2 4699999977666667889999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCc--------EEEE
Q 043185 581 RLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQ--------AKIS 652 (724)
Q Consensus 581 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~--------~kl~ 652 (724)
.++||||+++++|.+++......+++..+..++.||+.||.|||+ .+|+||||||+|||++.++. +||+
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeeec
Confidence 999999999999999998876669999999999999999999997 89999999999999999887 9999
Q ss_pred eecCccccCCCCccceecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCC-CCCCC
Q 043185 653 DFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGR-RNCSP 713 (724)
Q Consensus 653 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~-~p~~~ 713 (724)
|||++...... ....+++.|+|||.+.+ ..++.++||||||+++|||++|. +||..
T Consensus 164 Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~ 221 (289)
T 4fvq_A 164 DPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221 (289)
T ss_dssp CCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred cCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc
Confidence 99998754332 23457899999999987 67899999999999999999965 44443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=303.77 Aligned_cols=198 Identities=29% Similarity=0.408 Sum_probs=159.1
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
.+.+.+.||+|+||.||+|+.. +++.||||+++.. ...+.+.+|++++.+++||||+++++++.+....++||||++
T Consensus 54 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 131 (349)
T 2w4o_A 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT 131 (349)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc--hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence 3556789999999999999986 5778999999754 234678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC---CCcEEEEeecCccccCCCCcc
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY---HFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DFGla~~~~~~~~~ 666 (724)
+++|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 132 ~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-- 205 (349)
T 2w4o_A 132 GGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV-- 205 (349)
T ss_dssp SCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc--
Confidence 99999998765 458899999999999999999997 89999999999999975 8899999999998664332
Q ss_pred ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 255 (349)
T 2w4o_A 206 LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG 255 (349)
T ss_dssp -------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC
T ss_pred ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc
Confidence 12345789999999999999999999999999999999999999966543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=330.00 Aligned_cols=206 Identities=25% Similarity=0.326 Sum_probs=178.6
Q ss_pred HHHhhccccccccccccEEEEEEEEC-CccEEEEEEeecC---CcccHHHHHHHHHHHhcC-CCCCccceeceeecCCeE
Q 043185 507 LEVATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV---GVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQR 581 (724)
Q Consensus 507 l~~a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~ 581 (724)
+....+.+.++||+|+||.||+|+.. +++.||||++++. .....+.+..|..++..+ +||+|+++++++.+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 33445666789999999999999975 5778999999752 234456788999999988 799999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccC
Q 043185 582 LLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 661 (724)
+|||||+++|+|..++...+ .+++..+..++.||+.||+|||+ .+||||||||+||||+.++.+||+|||+++...
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 99999999999999997653 58899999999999999999997 899999999999999999999999999998643
Q ss_pred CCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 662 PEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 662 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
.... ......||+.|+|||++.+..++.++||||||++||||++|+.||.+.+..
T Consensus 494 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~ 548 (674)
T 3pfq_A 494 WDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 548 (674)
T ss_dssp CTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH
Confidence 3322 234568999999999999999999999999999999999999999876543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=302.25 Aligned_cols=195 Identities=31% Similarity=0.459 Sum_probs=171.0
Q ss_pred ccccccccccccEEEEEEEE-CCccEEEEEEeecCCc---ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 512 DNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGV---QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
+...+.||+|+||.||+|+. .+++.||||++..... ...+++.+|++++++++||||+++++++..+...++||||
T Consensus 56 y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 135 (348)
T 1u5q_A 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 135 (348)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEec
Confidence 55567899999999999997 5788899999975422 2335789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
++ |+|.+++......+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 136 ~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---- 207 (348)
T 1u5q_A 136 CL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 207 (348)
T ss_dssp CS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----
T ss_pred CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC----
Confidence 98 58888886655679999999999999999999997 89999999999999999999999999999866432
Q ss_pred eeccccccccccccccc---CCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLT---NSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~---~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
....||+.|+|||++. +..++.++||||||+++|||++|+.||....
T Consensus 208 -~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 257 (348)
T 1u5q_A 208 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 257 (348)
T ss_dssp -CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred -CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 3457899999999984 5678999999999999999999999996644
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=308.37 Aligned_cols=203 Identities=21% Similarity=0.270 Sum_probs=168.9
Q ss_pred HhhccccccccccccEEEEEEEECC------ccEEEEEEeecCCccc-----------HHHHHHHHHHHhcCCCCCccce
Q 043185 509 VATDNFKNLIGSGGFGAVYKGILND------KTIVAVKKITNVGVQG-----------KKDFCTEIAIIGNIHHVNLVKL 571 (724)
Q Consensus 509 ~a~~~~~~~lG~G~fG~Vy~~~~~~------~~~vAvK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~nIv~l 571 (724)
...+.+.+.||+|+||.||+|.... ++.||||++....... ...+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 3456677899999999999999864 3679999987543211 1224456667788899999999
Q ss_pred eceeecC----CeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEe--C
Q 043185 572 KGFCAQG----RQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLH--Y 645 (724)
Q Consensus 572 ~g~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~--~ 645 (724)
++++... ...+|||||+ +++|.+++......+++..++.++.||+.||+|||+ .+|+||||||+|||++ .
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESSC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecCC
Confidence 9998764 4589999999 999999998876789999999999999999999997 8999999999999999 8
Q ss_pred CCcEEEEeecCccccCCCCcc------ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 646 HFQAKISDFGLSKLLTPEQSS------LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 646 ~~~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
++.+||+|||+++.+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 899999999999876432211 1123459999999999999999999999999999999999999997543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=312.78 Aligned_cols=206 Identities=30% Similarity=0.415 Sum_probs=174.4
Q ss_pred HHhhccccccccccccEEEEEEEEC------CccEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeceeecCCe
Q 043185 508 EVATDNFKNLIGSGGFGAVYKGILN------DKTIVAVKKITNV-GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQ 580 (724)
Q Consensus 508 ~~a~~~~~~~lG~G~fG~Vy~~~~~------~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 580 (724)
....+.+.+.||+|+||.||+|+.. +++.||||+++.. ......++.+|+.++++++||||+++++++.+...
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 3455667789999999999999953 4567999999653 23445678999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCC---cEEE
Q 043185 581 RLLVYEYMNHGSLDRILFGNG------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHF---QAKI 651 (724)
Q Consensus 581 ~~lV~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl 651 (724)
.++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEE
Confidence 999999999999999997542 458899999999999999999997 8999999999999999655 4999
Q ss_pred EeecCccccCCCC-ccceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 043185 652 SDFGLSKLLTPEQ-SSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQ 716 (724)
Q Consensus 652 ~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~ 716 (724)
+|||+++...... ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~ 292 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 292 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999997543221 122234567899999999999999999999999999999998 9999976543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=307.60 Aligned_cols=206 Identities=29% Similarity=0.407 Sum_probs=177.5
Q ss_pred HHHhhccccccccccccEEEEEEEEC--------CccEEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeceee
Q 043185 507 LEVATDNFKNLIGSGGFGAVYKGILN--------DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCA 576 (724)
Q Consensus 507 l~~a~~~~~~~lG~G~fG~Vy~~~~~--------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~ 576 (724)
+....+.+.+.||+|+||.||+|+.. .+..||||+++... ....+++.+|+++++++ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 33456667789999999999999962 33579999997542 33447789999999999 9999999999999
Q ss_pred cCCeEEEEEEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCe
Q 043185 577 QGRQRLLVYEYMNHGSLDRILFGNG---------------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENI 641 (724)
Q Consensus 577 ~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NI 641 (724)
+++..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceE
Confidence 9999999999999999999997653 358999999999999999999997 8999999999999
Q ss_pred EEeCCCcEEEEeecCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 642 LLHYHFQAKISDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 642 Ll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
|++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999987654322 22234467889999999999999999999999999999999 999997654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=311.06 Aligned_cols=205 Identities=27% Similarity=0.412 Sum_probs=173.3
Q ss_pred HhhccccccccccccEEEEEEEE------CCccEEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeceeecCC-
Q 043185 509 VATDNFKNLIGSGGFGAVYKGIL------NDKTIVAVKKITNVG-VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGR- 579 (724)
Q Consensus 509 ~a~~~~~~~lG~G~fG~Vy~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~- 579 (724)
...+.+.+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|++++.++ +||||+++++++.+.+
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 100 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 100 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCC
Confidence 34455678999999999999984 245789999997643 23446799999999999 8999999999988755
Q ss_pred eEEEEEEecCCCCHHHHHhcCCC---------------------------------------------------------
Q 043185 580 QRLLVYEYMNHGSLDRILFGNGP--------------------------------------------------------- 602 (724)
Q Consensus 580 ~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 602 (724)
..++||||+++|+|.+++.....
T Consensus 101 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (359)
T 3vhe_A 101 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 180 (359)
T ss_dssp CCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------------
T ss_pred ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcc
Confidence 48999999999999999976432
Q ss_pred --------CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc-cceecccc
Q 043185 603 --------VLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS-SLFTTMRG 673 (724)
Q Consensus 603 --------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~g 673 (724)
.+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... .......|
T Consensus 181 ~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp ---CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred cccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence 18889999999999999999997 8999999999999999999999999999986644322 22334568
Q ss_pred cccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 043185 674 TRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQ 716 (724)
Q Consensus 674 t~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~ 716 (724)
|+.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 258 t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 301 (359)
T 3vhe_A 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 301 (359)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred CceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch
Confidence 899999999999999999999999999999998 9999977654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=306.07 Aligned_cols=207 Identities=26% Similarity=0.433 Sum_probs=175.1
Q ss_pred HHHhhccccccccccccEEEEEEEE------CCccEEEEEEeecC-CcccHHHHHHHHHHHhcC-CCCCccceeceeecC
Q 043185 507 LEVATDNFKNLIGSGGFGAVYKGIL------NDKTIVAVKKITNV-GVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQG 578 (724)
Q Consensus 507 l~~a~~~~~~~lG~G~fG~Vy~~~~------~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~ 578 (724)
+....+.+.+.||+|+||.||+|+. ..+..||||++... .....+.+.+|+.++.++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3345566778999999999999996 24567999999753 233457899999999999 899999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHhcCCC----------------------CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCC
Q 043185 579 RQRLLVYEYMNHGSLDRILFGNGP----------------------VLEWQERFDIALGTARGLAYLHSGCEQKIIHCDI 636 (724)
Q Consensus 579 ~~~~lV~e~~~~gsL~~~l~~~~~----------------------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dl 636 (724)
+..++||||+++|+|.+++..... .+++..+..++.||+.||+|||+ .+|+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCC
Confidence 999999999999999999976532 37889999999999999999997 89999999
Q ss_pred CCCCeEEeCCCcEEEEeecCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 043185 637 KPENILLHYHFQAKISDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPR 714 (724)
Q Consensus 637 kp~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~ 714 (724)
||+|||++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999986644332 12233457889999999999999999999999999999998 99999776
Q ss_pred CC
Q 043185 715 SQ 716 (724)
Q Consensus 715 ~~ 716 (724)
..
T Consensus 279 ~~ 280 (344)
T 1rjb_A 279 PV 280 (344)
T ss_dssp CC
T ss_pred Cc
Confidence 54
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-34 Score=297.11 Aligned_cols=208 Identities=28% Similarity=0.444 Sum_probs=181.8
Q ss_pred HHHHhhccccccccccccEEEEEEEECC-ccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEE
Q 043185 506 ELEVATDNFKNLIGSGGFGAVYKGILND-KTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLV 584 (724)
Q Consensus 506 ~l~~a~~~~~~~lG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 584 (724)
++....+.+.+.||+|+||.||+|.... +..||+|++... ....+++.+|++++++++||||+++++++.+....++|
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 3444556677899999999999999864 678999999754 44567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCC
Q 043185 585 YEYMNHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE 663 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (724)
|||+++++|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 9999999999999764 4568999999999999999999997 89999999999999999999999999999877655
Q ss_pred CccceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 043185 664 QSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQS 717 (724)
Q Consensus 664 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~~ 717 (724)
.........+++.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~ 219 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 219 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 4433344567889999999999999999999999999999999 99999765543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=293.50 Aligned_cols=199 Identities=19% Similarity=0.253 Sum_probs=174.9
Q ss_pred hccccccccccccEEEEEEEE-CCccEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEEEEEec
Q 043185 511 TDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
.+.+.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|++++.++ +|+|++++++++.++...++||||+
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 456678999999999999996 577889999986532 334678899999999 8999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCc-----EEEEeecCccccCCC
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQ-----AKISDFGLSKLLTPE 663 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~-----~kl~DFGla~~~~~~ 663 (724)
+++|.+++......+++..+..++.||+.||+|||+ .+|+||||||+|||++.++. +||+|||+++.....
T Consensus 89 -~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 89 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 999999998776779999999999999999999996 89999999999999988776 999999999876543
Q ss_pred Cc------cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 664 QS------SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 664 ~~------~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 222 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 222 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence 22 12244569999999999999999999999999999999999999998754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=306.44 Aligned_cols=203 Identities=30% Similarity=0.474 Sum_probs=163.4
Q ss_pred HHhhccccccccccccEEEEEEEEC-CccEEEEEEeecC--CcccHHHHHHHHHHHhcCC-CCCccceeceeecCC--eE
Q 043185 508 EVATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV--GVQGKKDFCTEIAIIGNIH-HVNLVKLKGFCAQGR--QR 581 (724)
Q Consensus 508 ~~a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~--~~ 581 (724)
....+.+.+.||+|+||.||+|... +++.||||++... .....+++.+|+.++.++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 3455677889999999999999974 6789999998643 2334567889999999997 999999999997544 78
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccC
Q 043185 582 LLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 661 (724)
++||||++ ++|..++... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 87 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred EEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 99999998 5899988764 68889999999999999999997 899999999999999999999999999998653
Q ss_pred CC--------------------CccceecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 662 PE--------------------QSSLFTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 662 ~~--------------------~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.. .........||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 21 1112344679999999999987 6789999999999999999999999987654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=297.13 Aligned_cols=204 Identities=30% Similarity=0.441 Sum_probs=174.5
Q ss_pred HHHHhhccccccccccccEEEEEEEE-----CCccEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeceeecC-
Q 043185 506 ELEVATDNFKNLIGSGGFGAVYKGIL-----NDKTIVAVKKITNV-GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG- 578 (724)
Q Consensus 506 ~l~~a~~~~~~~lG~G~fG~Vy~~~~-----~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~- 578 (724)
.+....+.+.+.||+|+||.||++++ .+++.||+|++... .....+++.+|++++++++||||+++++++.+.
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 33444566778999999999999995 36788999999743 234557899999999999999999999999876
Q ss_pred -CeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCc
Q 043185 579 -RQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLS 657 (724)
Q Consensus 579 -~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 657 (724)
...++||||+++++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECccccc
Confidence 66899999999999999997666679999999999999999999997 89999999999999999999999999999
Q ss_pred cccCCCCc--cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCC
Q 043185 658 KLLTPEQS--SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCS 712 (724)
Q Consensus 658 ~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~ 712 (724)
........ .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 87755432 22234568888999999999999999999999999999999998863
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=297.49 Aligned_cols=206 Identities=28% Similarity=0.453 Sum_probs=178.0
Q ss_pred HHhhccccccccccccEEEEEEEE------CCccEEEEEEeecCCc-ccHHHHHHHHHHHhcC-CCCCccceeceeecCC
Q 043185 508 EVATDNFKNLIGSGGFGAVYKGIL------NDKTIVAVKKITNVGV-QGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGR 579 (724)
Q Consensus 508 ~~a~~~~~~~lG~G~fG~Vy~~~~------~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~ 579 (724)
....+.+.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.++.++ +||||+++++++.+++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 344566778999999999999985 3567899999975432 3457789999999999 9999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcCCC-----------------CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeE
Q 043185 580 QRLLVYEYMNHGSLDRILFGNGP-----------------VLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENIL 642 (724)
Q Consensus 580 ~~~lV~e~~~~gsL~~~l~~~~~-----------------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NIL 642 (724)
..++||||+++|+|.+++..... .+++..+..++.||+.||.|||+ .+|+||||||+|||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEE
Confidence 99999999999999999976532 48999999999999999999997 89999999999999
Q ss_pred EeCCCcEEEEeecCccccCCCCcc-ceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 043185 643 LHYHFQAKISDFGLSKLLTPEQSS-LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQ 716 (724)
Q Consensus 643 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~ 716 (724)
++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 999999999999999876554322 1223457889999999999999999999999999999999 9999976654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=303.08 Aligned_cols=202 Identities=31% Similarity=0.480 Sum_probs=173.9
Q ss_pred hccccccccccccEEEEEEEEC------CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN------DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLL 583 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 583 (724)
.+.+.+.||+|+||.||+|+.. +++.||||+++... ....+++.+|+.++++++||||+++++++.++...++
T Consensus 48 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 127 (343)
T 1luf_A 48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL 127 (343)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEE
Confidence 4455689999999999999974 34789999997543 2345679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCC
Q 043185 584 VYEYMNHGSLDRILFGNG-----------------------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPEN 640 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~N 640 (724)
||||+++++|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~N 204 (343)
T 1luf_A 128 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRN 204 (343)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGG
T ss_pred EEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcce
Confidence 999999999999997642 568899999999999999999997 899999999999
Q ss_pred eEEeCCCcEEEEeecCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 641 ILLHYHFQAKISDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 641 ILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
||++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 205 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 205 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred EEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999986643321 12234567899999999999899999999999999999999 999997654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=296.49 Aligned_cols=200 Identities=28% Similarity=0.405 Sum_probs=164.7
Q ss_pred hhccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhc--CCCCCccceeceeec----CCeEEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGN--IHHVNLVKLKGFCAQ----GRQRLL 583 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~g~~~~----~~~~~l 583 (724)
..+.+.+.||+|+||.||+|+. +++.||||++.. ...+.+.+|.+++.. ++||||+++++++.. ....++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 3456678999999999999998 467799999864 344566677777666 799999999998654 346899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeEecCCCCCCeEEeCCCcEEEEeecCcc
Q 043185 584 VYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGC-----EQKIIHCDIKPENILLHYHFQAKISDFGLSK 658 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~ 658 (724)
||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.. ..+|+||||||+|||++.++.+||+|||+++
T Consensus 84 v~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 161 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV 161 (301)
T ss_dssp EECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCee
Confidence 9999999999999954 36899999999999999999999211 2899999999999999999999999999997
Q ss_pred ccCCCCccc---eecccccccccccccccCC------cCCCccchhhHHHHHHHHHhC----------CCCCCCCC
Q 043185 659 LLTPEQSSL---FTTMRGTRGYLAPEWLTNS------AISEKTDVYSFGMVLLELVSG----------RRNCSPRS 715 (724)
Q Consensus 659 ~~~~~~~~~---~~~~~gt~~y~aPE~l~~~------~~~~~sDv~SlGv~l~elltG----------~~p~~~~~ 715 (724)
......... .....||+.|+|||.+.+. .+++++||||||+++|||++| +.||....
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp EEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred ecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 664433211 2234799999999999876 566799999999999999999 88885543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=304.65 Aligned_cols=199 Identities=29% Similarity=0.342 Sum_probs=163.6
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
.|.+.+.||+|+||.||+++.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 99 (361)
T 3uc3_A 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS 99 (361)
T ss_dssp TEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence 4667789999999999999986 77889999997642 334678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCc--EEEEeecCccccCCCCccc
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQ--AKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~--~kl~DFGla~~~~~~~~~~ 667 (724)
+|+|.+++...+ .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++...... .
T Consensus 100 ~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~--~ 173 (361)
T 3uc3_A 100 GGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--Q 173 (361)
T ss_dssp SCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC--C
Confidence 999999986643 58999999999999999999997 89999999999999987765 9999999997543222 1
Q ss_pred eecccccccccccccccCCcCCCc-cchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNSAISEK-TDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~~~~~~-sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.....||+.|+|||++.+..+..+ +||||||+++|||++|+.||.....
T Consensus 174 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (361)
T 3uc3_A 174 PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 223 (361)
T ss_dssp -------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----
T ss_pred CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc
Confidence 234579999999999988877655 8999999999999999999977554
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-34 Score=294.18 Aligned_cols=201 Identities=30% Similarity=0.479 Sum_probs=175.3
Q ss_pred hhccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
..+.+.+.||+|+||.||+|+..++..||+|++... ....+.+.+|++++++++||||+++++++.+ +..++||||++
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 90 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCC
Confidence 456677899999999999999988888999999754 3456789999999999999999999999874 56899999999
Q ss_pred CCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce
Q 043185 590 HGSLDRILFGNG-PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 590 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
+++|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++...........
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 167 (279)
T 1qpc_A 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (279)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccc
Confidence 999999986532 358899999999999999999997 8999999999999999999999999999987765433323
Q ss_pred ecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
....++..|+|||.+.+..++.++||||||++++||++ |+.||....
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 215 (279)
T 1qpc_A 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215 (279)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC
Confidence 34457789999999998899999999999999999999 999997654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-33 Score=294.84 Aligned_cols=201 Identities=26% Similarity=0.389 Sum_probs=177.7
Q ss_pred hhccccccccccccEEEEEEEEC-CccEEEEEEeecCCcc------cHHHHHHHHHHHhcCCCCCccceeceeecCCeEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQ------GKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRL 582 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 582 (724)
..+.+.+.||+|+||.||+++.. +++.||+|++...... ..+++.+|+.++.+++||||+++++++.+....+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 45677899999999999999985 6788999999754221 3678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCC----cEEEEeecCcc
Q 043185 583 LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHF----QAKISDFGLSK 658 (724)
Q Consensus 583 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DFGla~ 658 (724)
+||||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||++.
T Consensus 92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 999999999999999764 468899999999999999999997 8999999999999999888 79999999998
Q ss_pred ccCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 659 LLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 659 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 168 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 223 (321)
T 2a2a_A 168 EIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 223 (321)
T ss_dssp ECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred ecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH
Confidence 7654322 2345689999999999999999999999999999999999999976543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=298.29 Aligned_cols=205 Identities=30% Similarity=0.430 Sum_probs=176.3
Q ss_pred hhccccccccccccEEEEEEEE------CCccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGIL------NDKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRL 582 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 582 (724)
..+.+.+.||+|+||.||+++. .+++.||||++.... ....+++.+|++++++++||||+++++++.+....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 102 (314)
T 2ivs_A 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLL 102 (314)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceE
Confidence 4456678999999999999986 245789999997542 344577899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCC
Q 043185 583 LVYEYMNHGSLDRILFGNG-----------------------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPE 639 (724)
Q Consensus 583 lV~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~ 639 (724)
+||||+++++|.+++.... ..+++..+..++.||+.||.|||+ .+|+||||||+
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp~ 179 (314)
T 2ivs_A 103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAAR 179 (314)
T ss_dssp EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGG
T ss_pred EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccchh
Confidence 9999999999999997643 237889999999999999999997 89999999999
Q ss_pred CeEEeCCCcEEEEeecCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 043185 640 NILLHYHFQAKISDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQS 717 (724)
Q Consensus 640 NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~~ 717 (724)
|||++.++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 180 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 259 (314)
T 2ivs_A 180 NILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259 (314)
T ss_dssp GEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987654332 12233457888999999999999999999999999999999 99999776543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-34 Score=306.08 Aligned_cols=203 Identities=25% Similarity=0.322 Sum_probs=173.7
Q ss_pred hhccccccccccccEEEEEEEE----CCccEEEEEEeecCC----cccHHHHHHHHHHHhcC-CCCCccceeceeecCCe
Q 043185 510 ATDNFKNLIGSGGFGAVYKGIL----NDKTIVAVKKITNVG----VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQ 580 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~ 580 (724)
..+.+.+.||+|+||.||+++. .+++.||||+++... ....+.+.+|++++.++ +||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 3466678999999999999997 367899999986432 23345677899999999 79999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCcccc
Q 043185 581 RLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLL 660 (724)
Q Consensus 581 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 660 (724)
.+|||||+++++|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred EEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 99999999999999999765 358899999999999999999997 89999999999999999999999999999876
Q ss_pred CCCCccceecccccccccccccccC--CcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 661 TPEQSSLFTTMRGTRGYLAPEWLTN--SAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 661 ~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
............||+.|+|||++.+ ..++.++||||||+++|||++|+.||.....
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~ 267 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 267 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS
T ss_pred ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCc
Confidence 5443333345679999999999986 3578999999999999999999999976543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=313.83 Aligned_cols=196 Identities=27% Similarity=0.345 Sum_probs=163.6
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeceeecC------CeE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG------RQR 581 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~ 581 (724)
.+.+.+.||+|+||.||+|... +++.||||++... .....+++.+|+.++++++||||+++++++... ...
T Consensus 63 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 142 (464)
T 3ttj_A 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 142 (464)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeE
Confidence 4556789999999999999975 6788999999753 233456788999999999999999999998654 467
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccC
Q 043185 582 LLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 661 (724)
+|||||++++ |...+.. .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 143 ~lv~E~~~~~-l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 143 YLVMELMDAN-LCQVIQM---ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp EEEEECCSEE-HHHHHTS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred EEEEeCCCCC-HHHHHhh---cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 9999999875 6555543 38899999999999999999997 899999999999999999999999999998765
Q ss_pred CCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 662 PEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 662 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.+.+
T Consensus 216 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~ 267 (464)
T 3ttj_A 216 TSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267 (464)
T ss_dssp -CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 432 2345679999999999999999999999999999999999999998765
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-33 Score=304.16 Aligned_cols=192 Identities=25% Similarity=0.344 Sum_probs=160.8
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHh-cCCCCCccceeceeec----CCeEEEEEEecC
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIG-NIHHVNLVKLKGFCAQ----GRQRLLVYEYMN 589 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~-~l~H~nIv~l~g~~~~----~~~~~lV~e~~~ 589 (724)
++||+|+||.||++... +++.||||++... ..+.+|+.++. ..+||||+++++++.. ....+|||||++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 68999999999999975 6788999998642 46778888874 4589999999998865 567899999999
Q ss_pred CCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC---CCcEEEEeecCccccCCCCc
Q 043185 590 HGSLDRILFGNG-PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY---HFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 590 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DFGla~~~~~~~~ 665 (724)
+|+|.+++.... ..+++..+..|+.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 143 gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~ 219 (400)
T 1nxk_A 143 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 219 (400)
T ss_dssp SEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC----
T ss_pred CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccccccCCCCc
Confidence 999999998653 468999999999999999999997 89999999999999998 78999999999987654322
Q ss_pred cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 666 SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 666 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 220 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 269 (400)
T 1nxk_A 220 --LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 269 (400)
T ss_dssp ---------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTC
T ss_pred --cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccc
Confidence 34567899999999999999999999999999999999999999776543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=296.39 Aligned_cols=195 Identities=34% Similarity=0.540 Sum_probs=163.1
Q ss_pred hccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 511 TDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
.+.+.+.||+|+||.||+++.. ++.||||++.. ....+.+.+|++++++++||||+++++++.+ ..++||||+++
T Consensus 9 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~ 83 (307)
T 2eva_A 9 EIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEG 83 (307)
T ss_dssp GEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTT
T ss_pred HeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCC
Confidence 4556789999999999999986 46699999864 3455789999999999999999999998874 47899999999
Q ss_pred CCHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCc-EEEEeecCccccCCCCccc
Q 043185 591 GSLDRILFGNGP--VLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQ-AKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 591 gsL~~~l~~~~~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~-~kl~DFGla~~~~~~~~~~ 667 (724)
++|.+++..... .+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||++.......
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~--- 160 (307)
T 2eva_A 84 GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM--- 160 (307)
T ss_dssp CBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred CCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc---
Confidence 999999976542 4788999999999999999999744478999999999999999887 7999999997654322
Q ss_pred eecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||+..
T Consensus 161 -~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 206 (307)
T 2eva_A 161 -TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206 (307)
T ss_dssp -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred -ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence 3346899999999999999999999999999999999999999754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=311.95 Aligned_cols=200 Identities=28% Similarity=0.417 Sum_probs=176.4
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
.+.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++......++|||
T Consensus 17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 96 (476)
T 2y94_A 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME 96 (476)
T ss_dssp TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 4566789999999999999986 78899999996532 2335678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
|+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 97 ~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~- 171 (476)
T 2y94_A 97 YVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF- 171 (476)
T ss_dssp CCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC-
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcccccc-
Confidence 99999999999754 458999999999999999999996 8999999999999999999999999999987654332
Q ss_pred ceecccccccccccccccCCcC-CCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAI-SEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~-~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.....||+.|+|||++.+..+ +.++||||||+++|||++|+.||+....
T Consensus 172 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~ 221 (476)
T 2y94_A 172 -LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV 221 (476)
T ss_dssp -BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS
T ss_pred -ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH
Confidence 245579999999999998765 7899999999999999999999976543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-33 Score=290.13 Aligned_cols=198 Identities=32% Similarity=0.570 Sum_probs=170.5
Q ss_pred hhccccccccccccEEEEEEEEC-CccEEEEEEeecCCccc-------HHHHHHHHHHHhcCCCCCccceeceeecCCeE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQG-------KKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQR 581 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~-------~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 581 (724)
..+.+.+.||+|+||.||+|+.. +++.||+|++....... .+++.+|++++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 34566789999999999999984 77889999986432221 167899999999999999999999987665
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEecCCCCCCeEEeCCCc-----EEEEee
Q 043185 582 LLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQK--IIHCDIKPENILLHYHFQ-----AKISDF 654 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiH~Dlkp~NILl~~~~~-----~kl~DF 654 (724)
++||||+++++|.+++......+++..+..++.|++.||+|||+ .+ |+||||||+|||++.++. +||+||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 69999999999999998877789999999999999999999997 77 999999999999988876 999999
Q ss_pred cCccccCCCCccceecccccccccccccc--cCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 655 GLSKLLTPEQSSLFTTMRGTRGYLAPEWL--TNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 655 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l--~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
|+++..... .....||+.|+|||.+ ....++.++||||||+++|||++|+.||.....
T Consensus 174 g~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 233 (287)
T 4f0f_A 174 GLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY 233 (287)
T ss_dssp TTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred Ccccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc
Confidence 999754332 3456799999999999 455678999999999999999999999976543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-34 Score=301.75 Aligned_cols=202 Identities=26% Similarity=0.451 Sum_probs=169.7
Q ss_pred hccccccccccccEEEEEEEEC-Ccc----EEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKT----IVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLV 584 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 584 (724)
.+.+.+.||+|+||.||+|+.. +++ .||+|.+.... ....+++.+|+.++++++||||+++++++. +...++|
T Consensus 14 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v 92 (325)
T 3kex_A 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLV 92 (325)
T ss_dssp TEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEE
T ss_pred HceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEE
Confidence 3455689999999999999974 333 37888875432 333456789999999999999999999986 4568899
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC
Q 043185 585 YEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (724)
+||+++|+|.+++......+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 169 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169 (325)
T ss_dssp EECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred EEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence 99999999999998766678889999999999999999997 899999999999999999999999999998775443
Q ss_pred c-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 043185 665 S-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQ 716 (724)
Q Consensus 665 ~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~ 716 (724)
. .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 223 (325)
T 3kex_A 170 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL 223 (325)
T ss_dssp TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT
T ss_pred ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH
Confidence 2 22344567889999999999999999999999999999999 9999977553
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=295.13 Aligned_cols=199 Identities=28% Similarity=0.357 Sum_probs=168.2
Q ss_pred cccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEEEEEecCCCC
Q 043185 515 KNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYEYMNHGS 592 (724)
Q Consensus 515 ~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~e~~~~gs 592 (724)
.+.||+|+||.||+++.. +++.||||++........+.+.+|++++.++ +||||+++++++.+++..++||||+++++
T Consensus 18 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 97 (316)
T 2ac3_A 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS 97 (316)
T ss_dssp CCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred CceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCc
Confidence 367999999999999964 6789999999876566678899999999885 79999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCc---EEEEeecCccccCCCCc----
Q 043185 593 LDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQ---AKISDFGLSKLLTPEQS---- 665 (724)
Q Consensus 593 L~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DFGla~~~~~~~~---- 665 (724)
|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++. +||+|||++........
T Consensus 98 L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 173 (316)
T 2ac3_A 98 ILSHIHKR-RHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPI 173 (316)
T ss_dssp HHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----------
T ss_pred HHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccc
Confidence 99999765 358899999999999999999997 89999999999999998776 99999999876542211
Q ss_pred --cceecccccccccccccccC-----CcCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 666 --SLFTTMRGTRGYLAPEWLTN-----SAISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 666 --~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
.......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 232 (316)
T 2ac3_A 174 STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGS 232 (316)
T ss_dssp --------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCS
T ss_pred cccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccc
Confidence 11223459999999999975 56899999999999999999999999876543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=323.87 Aligned_cols=204 Identities=29% Similarity=0.459 Sum_probs=176.8
Q ss_pred HHHhhccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEE
Q 043185 507 LEVATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 507 l~~a~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
+....+.+.+.||+|+||.||+|++.++..||||+++... ...++|.+|+++|++++|+||+++++++.+ ...+||||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 3344566778999999999999999888889999997643 446789999999999999999999999876 67899999
Q ss_pred ecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc
Q 043185 587 YMNHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 587 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 665 (724)
|+++|+|.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++.......
T Consensus 342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 99999999999753 3468899999999999999999997 8999999999999999999999999999987654322
Q ss_pred cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 666 SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 666 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
.......++..|+|||.+.+..++.++||||||++||||++ |+.||....
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~ 469 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 469 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC
T ss_pred ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 22233456789999999999899999999999999999999 999997654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-33 Score=298.87 Aligned_cols=199 Identities=28% Similarity=0.337 Sum_probs=174.0
Q ss_pred HHhhccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCC-----CCCccceeceeecCCeE
Q 043185 508 EVATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIH-----HVNLVKLKGFCAQGRQR 581 (724)
Q Consensus 508 ~~a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----H~nIv~l~g~~~~~~~~ 581 (724)
....+.+.++||+|+||.||+|+.. +++.||||+++.. ....+.+..|+.++.+++ ||||+++++++...+..
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~ 111 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHM 111 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEE
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCee
Confidence 3445666789999999999999984 6788999999753 344566788999999886 99999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC---------------
Q 043185 582 LLVYEYMNHGSLDRILFGNG-PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY--------------- 645 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~--------------- 645 (724)
++||||+ +++|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.
T Consensus 112 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~ 187 (360)
T 3llt_A 112 CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTD 187 (360)
T ss_dssp EEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEEEEEECTTT
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccccchhcccc
Confidence 9999999 899999997653 458999999999999999999997 89999999999999975
Q ss_pred ----------CCcEEEEeecCccccCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 646 ----------HFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 646 ----------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
++.+||+|||+++...... ....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 188 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 188 GKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp CCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence 7899999999998654332 34578999999999999999999999999999999999999997654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=299.78 Aligned_cols=200 Identities=26% Similarity=0.434 Sum_probs=166.3
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCcc-cHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQ-GKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
.|.+.+.||+|+||.||+|+.. +++.||+|++...... ....+.+|++++++++||||+++++++..+...++||||+
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 82 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccc
Confidence 3556689999999999999986 6788999998643221 1124567999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
+ ++|.+++......+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~~ 157 (324)
T 3mtl_A 83 D-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TY 157 (324)
T ss_dssp S-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred c-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-cc
Confidence 8 58999988877789999999999999999999997 8999999999999999999999999999986543322 22
Q ss_pred ecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 205 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST 205 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 34568999999999876 578999999999999999999999997755
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=299.28 Aligned_cols=204 Identities=25% Similarity=0.416 Sum_probs=160.8
Q ss_pred hccccccccccccEEEEEEEECCc----cEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeE---
Q 043185 511 TDNFKNLIGSGGFGAVYKGILNDK----TIVAVKKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQR--- 581 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~~~----~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~--- 581 (724)
.+.+.+.||+|+||.||+|+.... ..||||+++.. .....+++.+|++++++++||||+++++++......
T Consensus 24 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (323)
T 3qup_A 24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRL 103 (323)
T ss_dssp -CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC------
T ss_pred HeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCC
Confidence 456678999999999999996533 27999998753 234567899999999999999999999999877655
Q ss_pred ---EEEEEecCCCCHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEe
Q 043185 582 ---LLVYEYMNHGSLDRILFGN-----GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISD 653 (724)
Q Consensus 582 ---~lV~e~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 653 (724)
++|+||+++++|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|
T Consensus 104 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~kl~D 180 (323)
T 3qup_A 104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVAD 180 (323)
T ss_dssp -CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECC
T ss_pred CccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEEEee
Confidence 9999999999999998642 2258899999999999999999997 8999999999999999999999999
Q ss_pred ecCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 043185 654 FGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQS 717 (724)
Q Consensus 654 FGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~~ 717 (724)
||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~ 246 (323)
T 3qup_A 181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA 246 (323)
T ss_dssp CCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred ccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH
Confidence 999987644322 22233456789999999999999999999999999999999 99999876543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=293.66 Aligned_cols=203 Identities=29% Similarity=0.407 Sum_probs=170.0
Q ss_pred HHhhccccccccccccEEEEEEEE-CCccEEEEEEeecCC-----cccHHHHHHHHHHHhcC---CCCCccceeceeecC
Q 043185 508 EVATDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVG-----VQGKKDFCTEIAIIGNI---HHVNLVKLKGFCAQG 578 (724)
Q Consensus 508 ~~a~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~~ 578 (724)
....+.+.+.||+|+||.||+|+. .+++.||||++.... ......+.+|+.+++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 344567778999999999999996 467889999986422 12235667788777766 499999999999775
Q ss_pred C-----eEEEEEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEE
Q 043185 579 R-----QRLLVYEYMNHGSLDRILFGNG-PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKIS 652 (724)
Q Consensus 579 ~-----~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 652 (724)
. ..++||||++ ++|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEEe
Confidence 5 5789999997 59999987653 348999999999999999999997 899999999999999999999999
Q ss_pred eecCccccCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 653 DFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 653 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
|||+++....... .....||+.|+|||++.+..++.++||||||+++|||++|++||.....
T Consensus 163 Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 224 (308)
T 3g33_A 163 DFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 224 (308)
T ss_dssp SCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH
T ss_pred eCccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999987654322 2456789999999999999999999999999999999999999976554
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=291.35 Aligned_cols=203 Identities=27% Similarity=0.405 Sum_probs=170.6
Q ss_pred hhccccccccccccEEEEEEEECC----ccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILND----KTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLV 584 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~~----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 584 (724)
..+.+.+.||+|+||.||+|+..+ +..||+|++.... ....+++.+|+.++++++||||+++++++.+ ...++|
T Consensus 12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v 90 (281)
T 3cc6_A 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWII 90 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEE
T ss_pred cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEE
Confidence 345567899999999999998642 3469999987542 3445779999999999999999999999875 456899
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC
Q 043185 585 YEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (724)
|||+++++|.+++......+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 91 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 167 (281)
T 3cc6_A 91 MELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167 (281)
T ss_dssp EECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred EecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence 99999999999998776678999999999999999999997 899999999999999999999999999998765543
Q ss_pred ccceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 043185 665 SSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQ 716 (724)
Q Consensus 665 ~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~ 716 (724)
........+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~ 220 (281)
T 3cc6_A 168 YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 220 (281)
T ss_dssp -----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG
T ss_pred ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh
Confidence 333344567889999999998899999999999999999998 9999965443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=290.51 Aligned_cols=196 Identities=32% Similarity=0.516 Sum_probs=160.7
Q ss_pred hccccccccccccEEEEEEEECCccEEEEEEeecCC----cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVG----VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
.+.+.+.||+|+||.||+|+.. ++.||||+++... ....+.+.+|+++++.++||||+++++++.++...++|||
T Consensus 8 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (271)
T 3dtc_A 8 ELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME 86 (271)
T ss_dssp SEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred heeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence 4566789999999999999986 6679999986532 2334678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC---eEecCCCCCCeEEeC--------CCcEEEEeec
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQK---IIHCDIKPENILLHY--------HFQAKISDFG 655 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~---iiH~Dlkp~NILl~~--------~~~~kl~DFG 655 (724)
|+++++|.+++.. ..+++..+..++.|++.||+|||+ .+ ++||||||+|||++. ++.+||+|||
T Consensus 87 ~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 87 FARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp CCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred cCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999999854 468999999999999999999997 66 999999999999986 6789999999
Q ss_pred CccccCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 656 LSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 656 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
++........ ....|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 162 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 218 (271)
T 3dtc_A 162 LAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID 218 (271)
T ss_dssp C----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred cccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9986644322 24568999999999999999999999999999999999999997654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-33 Score=289.28 Aligned_cols=197 Identities=27% Similarity=0.461 Sum_probs=171.6
Q ss_pred ccccccccEEEEEEEEC---CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCC
Q 043185 516 NLIGSGGFGAVYKGILN---DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHG 591 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~---~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~g 591 (724)
+.||+|+||.||+|+.. ++..||||+++... ....+++.+|++++++++||||+++++++ +.+..++||||++++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 38999999999999864 56789999997642 34457799999999999999999999999 456789999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc--cee
Q 043185 592 SLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS--LFT 669 (724)
Q Consensus 592 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~--~~~ 669 (724)
+|.+++......+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++........ ...
T Consensus 95 ~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 171 (287)
T 1u59_A 95 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 171 (287)
T ss_dssp EHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCC
T ss_pred CHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccc
Confidence 9999998776779999999999999999999997 89999999999999999999999999999877544321 112
Q ss_pred cccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQ 716 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~ 716 (724)
...+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 172 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 219 (287)
T 1u59_A 172 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 219 (287)
T ss_dssp SSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred cccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 3346889999999998899999999999999999998 9999976543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=299.75 Aligned_cols=202 Identities=30% Similarity=0.455 Sum_probs=176.3
Q ss_pred hhccccccccccccEEEEEEEE-----CCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceee--cCCeEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGIL-----NDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCA--QGRQRL 582 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~--~~~~~~ 582 (724)
..+.+.+.||+|+||.||++++ .+++.||||++........+.+.+|++++++++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 4556678999999999999995 367889999998765666678999999999999999999999886 456789
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCC
Q 043185 583 LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP 662 (724)
Q Consensus 583 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (724)
+||||+++++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 9999999999999998755578999999999999999999997 8999999999999999999999999999987754
Q ss_pred CCcc--ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 663 EQSS--LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 663 ~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
.... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 233 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSP 233 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccc
Confidence 4321 222345788899999999999999999999999999999999998543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-34 Score=308.79 Aligned_cols=200 Identities=16% Similarity=0.158 Sum_probs=160.4
Q ss_pred ccccccccccccEEEEEEEE-CCccEEEEEEeecC---CcccHHHHHHHH---HHHhcCCCCCcccee-------ceeec
Q 043185 512 DNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNV---GVQGKKDFCTEI---AIIGNIHHVNLVKLK-------GFCAQ 577 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~---~~~~~~~~~~E~---~~l~~l~H~nIv~l~-------g~~~~ 577 (724)
+.+.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+ +++++++|||||+++ +++..
T Consensus 75 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~ 154 (377)
T 3byv_A 75 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 154 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEEC
T ss_pred EEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhc
Confidence 44568999999999999996 56889999999742 234557889999 556666899999998 44443
Q ss_pred CC-----------------eEEEEEEecCCCCHHHHHhcCCCC------CCHHHHHHHHHHHHHHHHHHHcCCCCCeEec
Q 043185 578 GR-----------------QRLLVYEYMNHGSLDRILFGNGPV------LEWQERFDIALGTARGLAYLHSGCEQKIIHC 634 (724)
Q Consensus 578 ~~-----------------~~~lV~e~~~~gsL~~~l~~~~~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~ 634 (724)
.+ ..+|||||+ +|+|.+++...... +++..++.|+.||+.||+|||+ .+|+||
T Consensus 155 ~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHr 230 (377)
T 3byv_A 155 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHT 230 (377)
T ss_dssp TTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTEECS
T ss_pred cCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence 32 278999999 57999999754222 2358888999999999999997 899999
Q ss_pred CCCCCCeEEeCCCcEEEEeecCccccCCCCccceecccccccccccccccCC-----------cCCCccchhhHHHHHHH
Q 043185 635 DIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNS-----------AISEKTDVYSFGMVLLE 703 (724)
Q Consensus 635 Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~~~~sDv~SlGv~l~e 703 (724)
||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||||||+++||
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 9999999999999999999999986433 2345567 999999999887 89999999999999999
Q ss_pred HHhCCCCCCCCCCCCCC
Q 043185 704 LVSGRRNCSPRSQSHSM 720 (724)
Q Consensus 704 lltG~~p~~~~~~~~~~ 720 (724)
|++|+.||......+.+
T Consensus 306 lltg~~Pf~~~~~~~~~ 322 (377)
T 3byv_A 306 IWCADLPITKDAALGGS 322 (377)
T ss_dssp HHHSSCCC------CCS
T ss_pred HHHCCCCCcccccccch
Confidence 99999999776654433
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=293.96 Aligned_cols=204 Identities=35% Similarity=0.526 Sum_probs=162.6
Q ss_pred HHHHhhccccccccccccEEEEEEEECCccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEE
Q 043185 506 ELEVATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLL 583 (724)
Q Consensus 506 ~l~~a~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 583 (724)
|+....+.+.+.||+|+||.||+|+..+ .+|+|+++... ....+.+.+|+.++++++||||+++++++ .....++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 4445566777899999999999998654 49999986532 33456789999999999999999999965 4557899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCC
Q 043185 584 VYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE 663 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (724)
||||+++++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccccc
Confidence 999999999999998777789999999999999999999997 89999999999999999999999999999765432
Q ss_pred C-ccceeccccccccccccccc---CCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 664 Q-SSLFTTMRGTRGYLAPEWLT---NSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 664 ~-~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
. ........||+.|+|||.+. +..++.++||||||+++|||++|+.||....
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 229 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc
Confidence 2 22234457899999999986 5678899999999999999999999997644
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=304.36 Aligned_cols=203 Identities=30% Similarity=0.502 Sum_probs=163.4
Q ss_pred ccccccccccccEEEEEEEEC--C--ccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeec-CCeEEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN--D--KTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ-GRQRLLVY 585 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~--~--~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~lV~ 585 (724)
+.+.+.||+|+||.||+|+.. + +..||||.++... ....+++.+|+.++++++||||+++++++.+ +...++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 445689999999999999963 2 2468999986532 3455789999999999999999999998754 45789999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc
Q 043185 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 665 (724)
||+++|+|.+++......+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 171 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred ECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 9999999999998877778999999999999999999997 8999999999999999999999999999986643321
Q ss_pred c---ceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 043185 666 S---LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQS 717 (724)
Q Consensus 666 ~---~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~~ 717 (724)
. ......+++.|+|||.+.+..++.++||||||+++|||++ |.+||......
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~ 303 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 303 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS
T ss_pred ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH
Confidence 1 1233457789999999999999999999999999999999 67888665543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-33 Score=292.78 Aligned_cols=202 Identities=25% Similarity=0.337 Sum_probs=165.3
Q ss_pred hhccccccccccccEEEEEEEEC-CccEEEEEEeecCCc---ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV---QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVY 585 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 585 (724)
..+.+.+.||+|+||.||+++.. +++.||+|++..... ...+.+.+|+.++.+++||||+++++++..++..++|+
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM 113 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence 44667789999999999999975 678899999975422 22467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc
Q 043185 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 665 (724)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 114 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 114 RLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp ECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 999999999999765 358899999999999999999997 8999999999999999999999999999987655433
Q ss_pred cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 666 SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 666 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.......|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 239 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ 239 (309)
T ss_dssp -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH
T ss_pred ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch
Confidence 33345578999999999999999999999999999999999999997643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=299.92 Aligned_cols=211 Identities=30% Similarity=0.344 Sum_probs=171.8
Q ss_pred CChHHHHHhhccccccccccccEEEEEEEEC-CccEEEEEEeecC-----CcccHHHHHHHHHHHhcCCCCCccceecee
Q 043185 502 FDYEELEVATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV-----GVQGKKDFCTEIAIIGNIHHVNLVKLKGFC 575 (724)
Q Consensus 502 ~~~~~l~~a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~ 575 (724)
-+..++. ..+.+.+.||+|+||.||+|+.. +++.||+|++... .....+++.+|++++++++||||+++++++
T Consensus 19 ~~~~~~~-~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 97 (345)
T 3hko_A 19 GSLLELQ-KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY 97 (345)
T ss_dssp BCHHHHH-HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred chhhhhh-hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh
Confidence 3444444 45777899999999999999974 6778999998643 234557899999999999999999999999
Q ss_pred ecCCeEEEEEEecCCCCHHHHHhcC---------------------------------------CCCCCHHHHHHHHHHH
Q 043185 576 AQGRQRLLVYEYMNHGSLDRILFGN---------------------------------------GPVLEWQERFDIALGT 616 (724)
Q Consensus 576 ~~~~~~~lV~e~~~~gsL~~~l~~~---------------------------------------~~~l~~~~~~~i~~~i 616 (724)
.+....++||||+++|+|.+++... ...+++..+..++.||
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 9999999999999999999988521 1123466788899999
Q ss_pred HHHHHHHHcCCCCCeEecCCCCCCeEEeCCC--cEEEEeecCccccCCCC---ccceecccccccccccccccC--CcCC
Q 043185 617 ARGLAYLHSGCEQKIIHCDIKPENILLHYHF--QAKISDFGLSKLLTPEQ---SSLFTTMRGTRGYLAPEWLTN--SAIS 689 (724)
Q Consensus 617 a~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~--~~kl~DFGla~~~~~~~---~~~~~~~~gt~~y~aPE~l~~--~~~~ 689 (724)
+.||+|||+ .+|+||||||+|||++.++ .+||+|||+++.+.... ........||+.|+|||.+.+ ..++
T Consensus 178 ~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 254 (345)
T 3hko_A 178 FSALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYG 254 (345)
T ss_dssp HHHHHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCC
T ss_pred HHHHHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCC
Confidence 999999997 8999999999999998776 89999999998653321 112345679999999999975 6789
Q ss_pred CccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 690 EKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 690 ~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.++||||||+++|||++|+.||.....
T Consensus 255 ~~~DiwslG~il~el~~g~~pf~~~~~ 281 (345)
T 3hko_A 255 PKCDAWSAGVLLHLLLMGAVPFPGVND 281 (345)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cHHHHHHHHHHHHHHHHCCCCCCCCCh
Confidence 999999999999999999999976543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-33 Score=292.08 Aligned_cols=201 Identities=31% Similarity=0.408 Sum_probs=168.9
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCc--ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV--QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
.+.+.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++.+....++||||
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY 83 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence 3556789999999999999985 578899999865432 2246688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
+++++|..++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........ .
T Consensus 84 ~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 158 (311)
T 4agu_A 84 CDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-Y 158 (311)
T ss_dssp CSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred CCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-c
Confidence 9999998887654 458899999999999999999997 8999999999999999999999999999987654322 1
Q ss_pred eecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 208 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD 208 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 234578999999999976 5789999999999999999999999977653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=298.48 Aligned_cols=199 Identities=29% Similarity=0.362 Sum_probs=173.1
Q ss_pred hhccccccccccccEEEEEEEEC-CccEEEEEEeecCCc--------ccHHHHHHHHHHHhcCCCCCccceeceeecCCe
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV--------QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQ 580 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 580 (724)
..+.+.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 34566789999999999999964 678899999975421 123457789999999999999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccc
Q 043185 581 RLLVYEYMNHG-SLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKL 659 (724)
Q Consensus 581 ~~lV~e~~~~g-sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 659 (724)
.++||||+..| +|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 99999999777 999988765 458999999999999999999997 8999999999999999999999999999987
Q ss_pred cCCCCccceecccccccccccccccCCcC-CCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 660 LTPEQSSLFTTMRGTRGYLAPEWLTNSAI-SEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 660 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||...
T Consensus 180 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 233 (335)
T 3dls_A 180 LERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233 (335)
T ss_dssp CCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred CCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence 754432 234579999999999988876 88999999999999999999999653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=285.94 Aligned_cols=201 Identities=26% Similarity=0.406 Sum_probs=173.8
Q ss_pred hhccccccccccccEEEEEEEEC-CccEEEEEEeecCCc------ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV------QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRL 582 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 582 (724)
..+.+.+.||+|+||.||+++.. +++.||+|.++.... ...+++.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 35667789999999999999986 678999999875321 23678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCC----cEEEEeecCcc
Q 043185 583 LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHF----QAKISDFGLSK 658 (724)
Q Consensus 583 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DFGla~ 658 (724)
+||||+++++|.+++... ..+++..+..++.||+.||+|||+ .+++||||||+||+++.++ .+||+|||++.
T Consensus 85 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 999999999999999654 458899999999999999999997 8999999999999998877 89999999998
Q ss_pred ccCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 659 LLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 659 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
....... .....+++.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 161 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 216 (283)
T 3bhy_A 161 KIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK 216 (283)
T ss_dssp ECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred eccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch
Confidence 7654322 2345689999999999999999999999999999999999999976543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-33 Score=310.17 Aligned_cols=200 Identities=28% Similarity=0.397 Sum_probs=155.6
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeec-----CCeEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ-----GRQRL 582 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-----~~~~~ 582 (724)
.+.+.+.||+|+||.||+|+.. +++.||||++.... ....+++.+|++++++++||||+++++++.. ....+
T Consensus 54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 133 (458)
T 3rp9_A 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY 133 (458)
T ss_dssp TEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence 4667789999999999999975 67899999996532 2345678999999999999999999999843 35789
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCC
Q 043185 583 LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP 662 (724)
Q Consensus 583 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (724)
+||||++ ++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++....
T Consensus 134 lv~e~~~-~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 134 VVLEIAD-SDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp EEECCCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred EEEeccc-cchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 9999985 6898888654 468999999999999999999997 8999999999999999999999999999987643
Q ss_pred CCc--------------------------cceecccccccccccccc-cCCcCCCccchhhHHHHHHHHHh---------
Q 043185 663 EQS--------------------------SLFTTMRGTRGYLAPEWL-TNSAISEKTDVYSFGMVLLELVS--------- 706 (724)
Q Consensus 663 ~~~--------------------------~~~~~~~gt~~y~aPE~l-~~~~~~~~sDv~SlGv~l~ellt--------- 706 (724)
... .......||+.|+|||++ ....++.++|||||||+||||++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~ 288 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence 211 123445789999999986 56679999999999999999999
Q ss_pred --CCCCCCCCC
Q 043185 707 --GRRNCSPRS 715 (724)
Q Consensus 707 --G~~p~~~~~ 715 (724)
|+++|.+.+
T Consensus 289 ~~~~p~f~g~~ 299 (458)
T 3rp9_A 289 ADRGPLFPGSS 299 (458)
T ss_dssp GGCCCSCC---
T ss_pred ccccccCCCCc
Confidence 667775544
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=299.73 Aligned_cols=205 Identities=27% Similarity=0.439 Sum_probs=174.5
Q ss_pred HhhccccccccccccEEEEEEEECC------ccEEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeceeecCCe
Q 043185 509 VATDNFKNLIGSGGFGAVYKGILND------KTIVAVKKITNVG-VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQ 580 (724)
Q Consensus 509 ~a~~~~~~~lG~G~fG~Vy~~~~~~------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~ 580 (724)
...+.+.+.||+|+||.||+|.... ...||+|++.... ....+.+.+|+.++.++ +||||+++++++.+...
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 3455667899999999999999743 2479999997543 23456789999999999 89999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCC
Q 043185 581 RLLVYEYMNHGSLDRILFGN-------------GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHF 647 (724)
Q Consensus 581 ~~lV~e~~~~gsL~~~l~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 647 (724)
.++||||+++|+|.+++... ...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCC
Confidence 99999999999999998643 2357899999999999999999997 8999999999999999999
Q ss_pred cEEEEeecCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 043185 648 QAKISDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQ 716 (724)
Q Consensus 648 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~ 716 (724)
.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 272 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 272 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch
Confidence 999999999986543322 11223457889999999999999999999999999999999 9999976543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=287.43 Aligned_cols=200 Identities=25% Similarity=0.365 Sum_probs=175.4
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
.+.+.+.||+|+||.||++... +++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 95 (294)
T 2rku_A 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 95 (294)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEe
Confidence 4556789999999999999986 56789999986532 2345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
|+++++|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 96 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 171 (294)
T 2rku_A 96 LCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 171 (294)
T ss_dssp CCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred cCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccCccc
Confidence 99999999988654 368899999999999999999997 89999999999999999999999999999876533221
Q ss_pred ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 219 (294)
T 2rku_A 172 -KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 219 (294)
T ss_dssp -BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred -cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 234568999999999999999999999999999999999999997654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=322.09 Aligned_cols=197 Identities=26% Similarity=0.456 Sum_probs=168.4
Q ss_pred cccccccEEEEEEEEC---CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCC
Q 043185 517 LIGSGGFGAVYKGILN---DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGS 592 (724)
Q Consensus 517 ~lG~G~fG~Vy~~~~~---~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gs 592 (724)
.||+|+||.||+|.+. ++..||||+++... ....+++.+|+++|++++|||||++++++.. +..+|||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999874 56679999997643 3456889999999999999999999999976 56899999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc--ceec
Q 043185 593 LDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS--LFTT 670 (724)
Q Consensus 593 L~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~--~~~~ 670 (724)
|.+++......+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++........ ....
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 498 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence 999998777779999999999999999999997 89999999999999999999999999999876543221 1122
Q ss_pred ccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQS 717 (724)
Q Consensus 671 ~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~~ 717 (724)
..+++.|+|||++.+..++.++||||||++||||++ |+.||......
T Consensus 499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~ 546 (613)
T 2ozo_A 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 546 (613)
T ss_dssp ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH
T ss_pred CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH
Confidence 345689999999999999999999999999999998 99999776543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-33 Score=290.61 Aligned_cols=202 Identities=30% Similarity=0.508 Sum_probs=169.2
Q ss_pred ccccccccccccEEEEEEEECCc----cEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceee-cCCeEEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILNDK----TIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCA-QGRQRLLVY 585 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~~~----~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~-~~~~~~lV~ 585 (724)
+.+.+.||+|+||.||+|+..+. ..+|+|++.... ....+.+.+|+.++++++||||+++++++. .+...++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 45668999999999999996432 358999987533 334577899999999999999999999864 556889999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc
Q 043185 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 665 (724)
||+++++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 107 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp ECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred eCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 9999999999998777778999999999999999999997 8999999999999999999999999999986644321
Q ss_pred ---cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 043185 666 ---SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQ 716 (724)
Q Consensus 666 ---~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~ 716 (724)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||.....
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~ 238 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 238 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT
T ss_pred hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH
Confidence 11234457889999999999999999999999999999999 5667665543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=293.90 Aligned_cols=201 Identities=25% Similarity=0.362 Sum_probs=176.1
Q ss_pred hhccccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVY 585 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 585 (724)
..+.+.+.||+|+||.||+++.. +++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 34556789999999999999986 56789999986532 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc
Q 043185 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 665 (724)
||+++++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 121 e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 121 ELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp CCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred ecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence 999999999988654 468899999999999999999997 8999999999999999999999999999987653322
Q ss_pred cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 666 SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 666 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
. .....|++.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 197 ~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 245 (335)
T 2owb_A 197 R-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 245 (335)
T ss_dssp C-BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred c-ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC
Confidence 1 234568999999999999999999999999999999999999997654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-33 Score=287.10 Aligned_cols=198 Identities=29% Similarity=0.447 Sum_probs=170.6
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
.+.+.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (279)
T 3fdn_A 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 89 (279)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEe
Confidence 3556689999999999999976 56789999986421 2334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
|+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 90 ~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~-- 163 (279)
T 3fdn_A 90 YAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 163 (279)
T ss_dssp CCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCccc--
Confidence 99999999998765 358899999999999999999996 899999999999999999999999999986543322
Q ss_pred ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 164 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 211 (279)
T 3fdn_A 164 -RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211 (279)
T ss_dssp -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred -ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc
Confidence 234578999999999999999999999999999999999999997654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-33 Score=295.01 Aligned_cols=204 Identities=25% Similarity=0.431 Sum_probs=167.5
Q ss_pred hhccccccccccccEEEEEEEEC-Ccc----EEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKT----IVAVKKITNV-GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLL 583 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 583 (724)
..+.+.+.||+|+||.||+|+.. +++ .||+|.+... .....+++.+|+.++++++||||+++++++..+. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 34556789999999999999974 333 3577777543 3456688999999999999999999999998765 789
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCC
Q 043185 584 VYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE 663 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (724)
|+||+++|+|.+++......+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 999999999999998877789999999999999999999997 89999999999999999999999999999876543
Q ss_pred Cc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 043185 664 QS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQS 717 (724)
Q Consensus 664 ~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~~ 717 (724)
.. .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~ 226 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 226 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH
Confidence 22 12233456789999999999999999999999999999999 99999876543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=298.32 Aligned_cols=203 Identities=30% Similarity=0.521 Sum_probs=168.4
Q ss_pred hhccccccccccccEEEEEEEECC-----ccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILND-----KTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLL 583 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~~-----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 583 (724)
..+.+.+.||+|+||.||+|.... +..||||+++... .....++.+|+.++++++||||+++++++.+....++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 344556889999999999998642 2469999997542 2344678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCC
Q 043185 584 VYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE 663 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (724)
||||+++++|.+++......+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 999999999999998776789999999999999999999997 89999999999999999999999999999876543
Q ss_pred Ccc--ceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 664 QSS--LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 664 ~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~ 255 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS 255 (333)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC
Confidence 221 1122346788999999999999999999999999999999 999996544
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=285.97 Aligned_cols=199 Identities=25% Similarity=0.394 Sum_probs=174.0
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
.+.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 86 (284)
T 3kk8_A 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 86 (284)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEec
Confidence 3556789999999999999975 57889999996532 33446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCc---EEEEeecCccccCCCC
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQ---AKISDFGLSKLLTPEQ 664 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DFGla~~~~~~~ 664 (724)
+++++|.+.+... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++. +||+|||++.......
T Consensus 87 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (284)
T 3kk8_A 87 VTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162 (284)
T ss_dssp CCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence 9999998888655 458899999999999999999997 89999999999999987665 9999999998765433
Q ss_pred ccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 665 SSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 665 ~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 163 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 211 (284)
T 3kk8_A 163 A--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 211 (284)
T ss_dssp B--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred c--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc
Confidence 2 234679999999999999999999999999999999999999996654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=296.17 Aligned_cols=203 Identities=25% Similarity=0.332 Sum_probs=172.7
Q ss_pred hhccccccccccccEEEEEEEE-CCccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeec--------C
Q 043185 510 ATDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ--------G 578 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--------~ 578 (724)
..+.+.+.||+|+||.||+|+. .+++.||||++.... ......+.+|++++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 4566778999999999999998 478899999986432 2334678899999999999999999999877 4
Q ss_pred CeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCcc
Q 043185 579 RQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSK 658 (724)
Q Consensus 579 ~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~ 658 (724)
...++||||+++ +|...+......+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 468999999985 7878777766679999999999999999999997 899999999999999999999999999998
Q ss_pred ccCCCC---ccceecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 659 LLTPEQ---SSLFTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 659 ~~~~~~---~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.+.... ........||+.|+|||++.+ ..++.++||||||+++|||++|++||.+...
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 234 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 234 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 765322 122344568999999999876 4689999999999999999999999987543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-33 Score=297.54 Aligned_cols=198 Identities=25% Similarity=0.385 Sum_probs=165.7
Q ss_pred hccccccccccccEEEEEEEECCccEEEEEEeecCC--cccHHHHHHHHHHHhcCCC--CCccceeceeecCCeEEEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHH--VNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~~~~lV~e 586 (724)
.|.+.+.||+|+||.||++...+++.||||++.... ....+.+.+|+.++.+++| +||+++++++..+...+||||
T Consensus 10 ~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e 89 (343)
T 3dbq_A 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 89 (343)
T ss_dssp EEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe
Confidence 355678999999999999999889999999987542 2344678999999999976 999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
+.+++|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++ ++.+||+|||+++........
T Consensus 90 -~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 90 -CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp -CCSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred -CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 5678999999775 468899999999999999999997 8999999999999997 678999999999876544321
Q ss_pred -ceecccccccccccccccC-----------CcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 667 -LFTTMRGTRGYLAPEWLTN-----------SAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 667 -~~~~~~gt~~y~aPE~l~~-----------~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 223 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence 2234579999999999865 67899999999999999999999999653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-33 Score=287.97 Aligned_cols=200 Identities=29% Similarity=0.390 Sum_probs=169.8
Q ss_pred hhccccccccccccEEEEEEEEC-CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
..+.+.+.||+|+||.||+++.. ++..+|+|++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 45677899999999999999975 67889999997543 34567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEE---eCCCcEEEEeecCccccC
Q 043185 588 MNHGSLDRILFGN---GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILL---HYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 588 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DFGla~~~~ 661 (724)
+++++|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999988542 4678999999999999999999997 899999999999999 456889999999998665
Q ss_pred CCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 662 PEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 662 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.... .....||+.|+|||.+. ..++.++||||||+++|||++|+.||....
T Consensus 179 ~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~ 229 (285)
T 3is5_A 179 SDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Cccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC
Confidence 4322 23456899999999986 468999999999999999999999997654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-33 Score=295.71 Aligned_cols=205 Identities=27% Similarity=0.426 Sum_probs=175.4
Q ss_pred HHhhccccccccccccEEEEEEEEC--------CccEEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeceeec
Q 043185 508 EVATDNFKNLIGSGGFGAVYKGILN--------DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQ 577 (724)
Q Consensus 508 ~~a~~~~~~~lG~G~fG~Vy~~~~~--------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~ 577 (724)
....+.+.+.||+|+||.||+|+.. ++..||||++.... ....+++.+|+++++++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3455667789999999999999973 45689999997542 23456789999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeE
Q 043185 578 GRQRLLVYEYMNHGSLDRILFGNG---------------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENIL 642 (724)
Q Consensus 578 ~~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NIL 642 (724)
.+..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEE
Confidence 999999999999999999997653 248899999999999999999997 89999999999999
Q ss_pred EeCCCcEEEEeecCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 643 LHYHFQAKISDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 643 l~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
++.++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 99999999999999987654332 12233457889999999999899999999999999999999 999997654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-33 Score=290.39 Aligned_cols=199 Identities=28% Similarity=0.411 Sum_probs=172.9
Q ss_pred hhccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
..+.+.+.||+|+||.||+++.. +++.||+|++........+.+.+|+.++.+++||||+++++++.+....++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 45667789999999999999975 67889999998654445567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEE---eCCCcEEEEeecCccccCCCCc
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILL---HYHFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DFGla~~~~~~~~ 665 (724)
++++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||++ +.++.+||+|||++.......
T Consensus 89 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~- 163 (304)
T 2jam_A 89 SGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI- 163 (304)
T ss_dssp CSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT-
T ss_pred CCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc-
Confidence 999999988654 358899999999999999999997 899999999999999 788999999999987544321
Q ss_pred cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 666 SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 666 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 164 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 211 (304)
T 2jam_A 164 --MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET 211 (304)
T ss_dssp --THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred --cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 234568999999999999999999999999999999999999997654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=290.31 Aligned_cols=200 Identities=30% Similarity=0.427 Sum_probs=173.1
Q ss_pred hhccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
..+.+.+.||+|+||.||+|... +++.||+|++... ...+++.+|+.++.+++||||+++++++......++||||+
T Consensus 29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (314)
T 3com_A 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106 (314)
T ss_dssp -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence 34556789999999999999986 5788999999763 34577899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
++++|.+++......+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++........ ..
T Consensus 107 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~ 182 (314)
T 3com_A 107 GAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-KR 182 (314)
T ss_dssp TTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-CB
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-cc
Confidence 9999999997656678999999999999999999997 8999999999999999999999999999987654322 12
Q ss_pred ecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
....|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 183 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 229 (314)
T 3com_A 183 NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH 229 (314)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 34568999999999999999999999999999999999999997543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-33 Score=284.84 Aligned_cols=196 Identities=23% Similarity=0.344 Sum_probs=169.4
Q ss_pred hhccccccccccccEEEEEEEECCccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecC--CeEEEEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG--RQRLLVY 585 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV~ 585 (724)
..+.+.+.||+|+||.||+|+.. ++.||||++.... ....+++.+|+.++++++||||+++++++.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 34556789999999999999986 6679999997542 33456799999999999999999999999877 7889999
Q ss_pred EecCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEecCCCCCCeEEeCCCcEEEEeecCccccCC
Q 043185 586 EYMNHGSLDRILFGNGP-VLEWQERFDIALGTARGLAYLHSGCEQK--IIHCDIKPENILLHYHFQAKISDFGLSKLLTP 662 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (724)
||+++++|.+++..... .+++..+..++.|++.||+|||+ .+ ++||||||+|||++.++.++|+|||++.....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 99999999999987543 58999999999999999999996 67 99999999999999999999999998764322
Q ss_pred CCccceecccccccccccccccCCcCCC---ccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 663 EQSSLFTTMRGTRGYLAPEWLTNSAISE---KTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 663 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~---~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
....+|+.|+|||.+.+..++. ++||||||+++|||++|+.||....
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 215 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS 215 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 2346899999999998766554 7999999999999999999997644
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-33 Score=301.67 Aligned_cols=198 Identities=25% Similarity=0.378 Sum_probs=167.0
Q ss_pred hccccccccccccEEEEEEEECCccEEEEEEeecCC--cccHHHHHHHHHHHhcCC--CCCccceeceeecCCeEEEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIH--HVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~~~~~lV~e 586 (724)
.|.+.+.||+|+||.||++...+++.||||++.... ....+.+.+|+.++.+++ ||||+++++++..+...+||||
T Consensus 57 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E 136 (390)
T 2zmd_A 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 136 (390)
T ss_dssp EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe
Confidence 366678999999999999998888999999996532 334577899999999996 5999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
+.+++|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++ ++.+||+|||+++.+......
T Consensus 137 -~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 137 -CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp -CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred -cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 56889999997764 67888999999999999999997 8999999999999995 689999999999876543321
Q ss_pred -ceecccccccccccccccC-----------CcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 667 -LFTTMRGTRGYLAPEWLTN-----------SAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 667 -~~~~~~gt~~y~aPE~l~~-----------~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 270 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh
Confidence 2234579999999999865 36889999999999999999999999754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=284.45 Aligned_cols=203 Identities=31% Similarity=0.427 Sum_probs=176.0
Q ss_pred hhccccccccccccEEEEEEEEC-CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
..+.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.++...++|+||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 34667789999999999999986 67889999997432 34457789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc-c
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS-S 666 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~-~ 666 (724)
+++++|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........ .
T Consensus 87 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 87 CSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp CTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 9999999988654 468899999999999999999997 8999999999999999999999999999986543221 2
Q ss_pred ceecccccccccccccccCCcC-CCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAI-SEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~-~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||.....
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 213 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence 2334568999999999988765 7899999999999999999999977654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-33 Score=295.55 Aligned_cols=196 Identities=28% Similarity=0.410 Sum_probs=169.2
Q ss_pred hhccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEEEEEe
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
..+.+.+.||+|+||.||+++.. +++.||||++.+... ...+|++++.++ +||||+++++++.++...++||||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 34667789999999999999986 678899999976432 235688888887 799999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCC----CcEEEEeecCccccCCC
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYH----FQAKISDFGLSKLLTPE 663 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~----~~~kl~DFGla~~~~~~ 663 (724)
+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||+..+ +.+||+|||+++.....
T Consensus 98 ~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 98 MKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp CCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 9999999998765 468999999999999999999997 899999999999998543 35999999999876543
Q ss_pred CccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 664 QSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 664 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 174 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 174 NG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG 223 (342)
T ss_dssp TC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred CC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence 32 234567899999999999888999999999999999999999999753
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-33 Score=298.96 Aligned_cols=196 Identities=26% Similarity=0.378 Sum_probs=164.7
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCC------eE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR------QR 581 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~ 581 (724)
.|.+.+.||+|+||.||+|+.. +++.||||++.... ....+++.+|++++++++||||+++++++.... ..
T Consensus 26 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 105 (367)
T 1cm8_A 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 105 (367)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred eEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence 3556688999999999999974 68899999996532 233467889999999999999999999987653 46
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccC
Q 043185 582 LLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 661 (724)
++||||+ +++|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 106 ~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 106 YLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp EEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 9999999 78999998763 58899999999999999999997 899999999999999999999999999998764
Q ss_pred CCCccceecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 662 PEQSSLFTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 662 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.. .....+|+.|+|||++.+ ..++.++||||||++++||++|++||.+.+.
T Consensus 180 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 231 (367)
T 1cm8_A 180 SE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 231 (367)
T ss_dssp SS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 32 244578999999999987 6899999999999999999999999987653
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=305.71 Aligned_cols=200 Identities=23% Similarity=0.386 Sum_probs=172.4
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCC--eEEEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR--QRLLVYE 586 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--~~~lV~e 586 (724)
.|.+.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.. ..++|||
T Consensus 10 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e 89 (396)
T 4eut_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (396)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEC
T ss_pred ceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEe
Confidence 4566789999999999999986 57899999997533 344577889999999999999999999988655 7899999
Q ss_pred ecCCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEE----eCCCcEEEEeecCcccc
Q 043185 587 YMNHGSLDRILFGNG--PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILL----HYHFQAKISDFGLSKLL 660 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DFGla~~~ 660 (724)
|+++++|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++..
T Consensus 90 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp CCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred cCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 999999999997542 238999999999999999999997 899999999999999 77788999999999876
Q ss_pred CCCCccceecccccccccccccccC--------CcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 661 TPEQSSLFTTMRGTRGYLAPEWLTN--------SAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 661 ~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.+..
T Consensus 167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~ 227 (396)
T 4eut_A 167 EDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (396)
T ss_dssp CCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred cCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 54332 234579999999999875 567889999999999999999999997544
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=304.13 Aligned_cols=196 Identities=26% Similarity=0.397 Sum_probs=163.7
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecC-----CeEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG-----RQRL 582 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~~ 582 (724)
.+.+.+.||+|+||.||+|+.. +++.||||++.... ....+++.+|++++++++||||+++++++... ...+
T Consensus 27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 106 (432)
T 3n9x_A 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY 106 (432)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence 4566789999999999999975 57789999997532 23456789999999999999999999998766 5789
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCC
Q 043185 583 LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP 662 (724)
Q Consensus 583 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (724)
+||||++ ++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 107 lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 107 IVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp EEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred EEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 9999987 5999998654 468999999999999999999997 8999999999999999999999999999987654
Q ss_pred CCc---------------------cceecccccccccccccc-cCCcCCCccchhhHHHHHHHHHhCCCCC
Q 043185 663 EQS---------------------SLFTTMRGTRGYLAPEWL-TNSAISEKTDVYSFGMVLLELVSGRRNC 711 (724)
Q Consensus 663 ~~~---------------------~~~~~~~gt~~y~aPE~l-~~~~~~~~sDv~SlGv~l~elltG~~p~ 711 (724)
... .......||+.|+|||++ ....++.++|||||||++|||++|..||
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 321 123556799999999986 5667999999999999999999854444
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-33 Score=305.17 Aligned_cols=203 Identities=31% Similarity=0.408 Sum_probs=163.4
Q ss_pred HHhhccccccccccccEEEEEEEEC-CccEEEEEEeecCC--------cccHHHHHHHHHHHhcCCCCCccceeceeecC
Q 043185 508 EVATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--------VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG 578 (724)
Q Consensus 508 ~~a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 578 (724)
....+.+.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 3456777899999999999999975 57889999986531 1112347899999999999999999999754
Q ss_pred CeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCC---cEEEEeec
Q 043185 579 RQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHF---QAKISDFG 655 (724)
Q Consensus 579 ~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~DFG 655 (724)
...++||||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred CceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEeecc
Confidence 5689999999999999988655 468999999999999999999997 8999999999999997544 59999999
Q ss_pred CccccCCCCccceecccccccccccccccC---CcCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 656 LSKLLTPEQSSLFTTMRGTRGYLAPEWLTN---SAISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 656 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
+++...... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......
T Consensus 288 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~ 350 (419)
T 3i6u_A 288 HSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 350 (419)
T ss_dssp TTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS
T ss_pred cceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch
Confidence 998765432 2345679999999999864 57889999999999999999999999765443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-33 Score=297.64 Aligned_cols=200 Identities=30% Similarity=0.393 Sum_probs=169.8
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCcc-----cHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQ-----GKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLV 584 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 584 (724)
.+.+.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|++++++++||||+++++++.+....++|
T Consensus 11 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 90 (346)
T 1ua2_A 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLV 90 (346)
T ss_dssp --CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEE
T ss_pred ccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEE
Confidence 4556789999999999999975 5789999998643221 124688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC
Q 043185 585 YEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (724)
|||+++ +|..++......+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 91 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 91 FDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp EECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred EEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 999986 8988887776678889999999999999999997 899999999999999999999999999998765432
Q ss_pred ccceecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 665 SSLFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 665 ~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
. ......+|+.|+|||.+.+. .++.++||||||+++|||++|.+||.+..
T Consensus 167 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~ 217 (346)
T 1ua2_A 167 R-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS 217 (346)
T ss_dssp C-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred c-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence 2 23445789999999999764 58999999999999999999999997654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-32 Score=285.02 Aligned_cols=199 Identities=29% Similarity=0.439 Sum_probs=174.8
Q ss_pred hhccccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVY 585 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 585 (724)
..+.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 34566789999999999999986 56789999986421 233567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc
Q 043185 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 665 (724)
||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 94 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 168 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR- 168 (284)
T ss_dssp CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC-
T ss_pred EeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCcccc-
Confidence 9999999999987653 58899999999999999999996 899999999999999999999999999987654322
Q ss_pred cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 666 SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 666 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 169 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 216 (284)
T 2vgo_A 169 --RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216 (284)
T ss_dssp --BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred --cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC
Confidence 234568999999999999999999999999999999999999997654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=300.95 Aligned_cols=205 Identities=23% Similarity=0.320 Sum_probs=167.6
Q ss_pred hHHHHHhhccccccccccccEEEEEEEEC----CccEEEEEEeecCCcc-----------cHHHHHHHHHHHhcCCCCCc
Q 043185 504 YEELEVATDNFKNLIGSGGFGAVYKGILN----DKTIVAVKKITNVGVQ-----------GKKDFCTEIAIIGNIHHVNL 568 (724)
Q Consensus 504 ~~~l~~a~~~~~~~lG~G~fG~Vy~~~~~----~~~~vAvK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~nI 568 (724)
..++....+.+.+.||+|+||.||+|+.. .+..+|+|++...... ..+.+.+|+..+..++||||
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni 110 (345)
T 2v62_A 31 LDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGI 110 (345)
T ss_dssp EECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCC
T ss_pred eccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCc
Confidence 34444456777899999999999999985 5678999998754321 12346788899999999999
Q ss_pred cceeceeec----CCeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEe
Q 043185 569 VKLKGFCAQ----GRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLH 644 (724)
Q Consensus 569 v~l~g~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~ 644 (724)
+++++++.. ....++||||+ +++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++
T Consensus 111 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~ 185 (345)
T 2v62_A 111 PLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLG 185 (345)
T ss_dssp CCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEE
T ss_pred ceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEc
Confidence 999999987 77899999999 999999987654 78999999999999999999997 8999999999999999
Q ss_pred CCC--cEEEEeecCccccCCCCc------cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCC
Q 043185 645 YHF--QAKISDFGLSKLLTPEQS------SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSP 713 (724)
Q Consensus 645 ~~~--~~kl~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~ 713 (724)
.++ .+||+|||+++.+..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 186 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 186 YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp SSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred cCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 887 999999999987643211 111345799999999999999999999999999999999999999965
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=288.03 Aligned_cols=199 Identities=27% Similarity=0.418 Sum_probs=168.8
Q ss_pred cccccccccccEEEEEEEEC-C---ccEEEEEEeecCCc-ccHHHHHHHHHHHhcCCCCCccceeceeecCCeE-EEEEE
Q 043185 513 NFKNLIGSGGFGAVYKGILN-D---KTIVAVKKITNVGV-QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQR-LLVYE 586 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~---~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~-~lV~e 586 (724)
...++||+|+||.||+|+.. + +..+|+|++..... ...+.+.+|+.++++++||||+++++++.+.+.. ++|+|
T Consensus 24 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e 103 (298)
T 3pls_A 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLP 103 (298)
T ss_dssp EEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEC
T ss_pred ccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEe
Confidence 34578999999999999863 2 23699999875432 3457789999999999999999999999876655 99999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc-
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS- 665 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~- 665 (724)
|+.+++|.+++......+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++.......
T Consensus 104 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 180 (298)
T 3pls_A 104 YMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180 (298)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred cccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence 999999999998877788999999999999999999997 8999999999999999999999999999986543221
Q ss_pred --cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCC-CCCC
Q 043185 666 --SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRN-CSPR 714 (724)
Q Consensus 666 --~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p-~~~~ 714 (724)
.......+++.|+|||.+.+..++.++||||||+++|||++|..| |...
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~ 232 (298)
T 3pls_A 181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI 232 (298)
T ss_dssp CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC
Confidence 122345678999999999999999999999999999999995544 4433
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-33 Score=294.76 Aligned_cols=201 Identities=25% Similarity=0.349 Sum_probs=163.9
Q ss_pred hhccccccccccccEEEEEEEEC-CccEEEEEEeecCCc--ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV--QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
..+.+.+.||+|+||.||+|+.. +++.||||+++.... ...+.+.+|++++++++||||+++++++.++...++|||
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 113 (329)
T 3gbz_A 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFE 113 (329)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEe
Confidence 34666789999999999999965 678899999965322 234567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEe-----CCCcEEEEeecCccccC
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLH-----YHFQAKISDFGLSKLLT 661 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-----~~~~~kl~DFGla~~~~ 661 (724)
|+++ +|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||+++...
T Consensus 114 ~~~~-~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 114 YAEN-DLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp CCSE-EHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred cCCC-CHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 9985 9999987653 58899999999999999999997 8999999999999994 45569999999998765
Q ss_pred CCCccceecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 662 PEQSSLFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 662 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.... ......+|+.|+|||++.+. .++.++||||||+++|||++|+.||.....
T Consensus 189 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 243 (329)
T 3gbz_A 189 IPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE 243 (329)
T ss_dssp ------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred Cccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH
Confidence 4322 22445689999999999875 589999999999999999999999976543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=286.84 Aligned_cols=202 Identities=23% Similarity=0.285 Sum_probs=170.6
Q ss_pred hhccccccccccccEEEEEEEE-CCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceecee-ecCCeEEEEEEe
Q 043185 510 ATDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFC-AQGRQRLLVYEY 587 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~-~~~~~~~lV~e~ 587 (724)
..+.+.+.||+|+||.||+|+. .+++.||||++.... ..+++.+|++++.+++|++++..+..+ .+....++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 3456678999999999999997 577889999876432 224578899999999988877777665 667788999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEE---eCCCcEEEEeecCccccCCCC
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILL---HYHFQAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DFGla~~~~~~~ 664 (724)
+ +++|.+++......+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++......
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp C-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 9 999999998766679999999999999999999997 899999999999999 789999999999998765432
Q ss_pred c------cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 665 S------SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 665 ~------~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 221 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 221 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS
T ss_pred cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchh
Confidence 2 1123457899999999999999999999999999999999999999775543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-33 Score=295.32 Aligned_cols=202 Identities=32% Similarity=0.474 Sum_probs=175.1
Q ss_pred HhhccccccccccccEEEEEEEE-----CCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCC--eE
Q 043185 509 VATDNFKNLIGSGGFGAVYKGIL-----NDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR--QR 581 (724)
Q Consensus 509 ~a~~~~~~~lG~G~fG~Vy~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--~~ 581 (724)
...+.+.+.||+|+||.||++++ .+++.||||++........+++.+|++++++++||||+++++++.... ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 34456678999999999999985 357889999998765666678999999999999999999999887654 78
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccC
Q 043185 582 LLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 661 (724)
++||||+++++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 99999999999999998876779999999999999999999997 899999999999999999999999999998775
Q ss_pred CCCcc--ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCC
Q 043185 662 PEQSS--LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSP 713 (724)
Q Consensus 662 ~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~ 713 (724)
..... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 44321 11234567789999999998999999999999999999999988853
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=292.07 Aligned_cols=201 Identities=30% Similarity=0.457 Sum_probs=169.0
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCcc--cHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQ--GKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
.+.+.+.||+|+||.||+++.. +++.||||++...... ..+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 105 (331)
T 4aaa_A 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF 105 (331)
T ss_dssp GEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEec
Confidence 4556789999999999999986 5788999998654322 345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
+++++|..++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 106 ~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 180 (331)
T 4aaa_A 106 VDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-V 180 (331)
T ss_dssp CSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred CCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-c
Confidence 9999998876544 458999999999999999999997 8999999999999999999999999999986644322 2
Q ss_pred eecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.....|++.|+|||.+.+. .++.++||||||+++|||++|+.||.....
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 230 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD 230 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 2345689999999999875 789999999999999999999999977653
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-32 Score=285.19 Aligned_cols=200 Identities=24% Similarity=0.287 Sum_probs=171.4
Q ss_pred hccccccccccccEEEEEEEE-CCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceecee-ecCCeEEEEEEec
Q 043185 511 TDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFC-AQGRQRLLVYEYM 588 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~-~~~~~~~lV~e~~ 588 (724)
.+.+.+.||+|+||.||+|+. .+++.||||++.... ..+++.+|+.++.+++|++++..+..+ .++...++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 355678999999999999997 578899999987542 235688999999999988877766655 5667889999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEE---eCCCcEEEEeecCccccCCCCc
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILL---HYHFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DFGla~~~~~~~~ 665 (724)
+++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred -CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 899999998666779999999999999999999997 899999999999999 4889999999999987654322
Q ss_pred c------ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 666 S------LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 666 ~------~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCc
Confidence 1 12345799999999999999999999999999999999999999987543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=289.12 Aligned_cols=202 Identities=23% Similarity=0.409 Sum_probs=163.4
Q ss_pred hhccccccccccccEEEEEEEE-CCccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVY 585 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 585 (724)
..+.+.+.||+|+||.||+|.. .+++.||+|++.... ....+++.+|+.++++++||||+++++++.+....++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 3566778999999999999997 478899999997532 234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCC
Q 043185 586 EYMNHGSLDRILFG---NGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP 662 (724)
Q Consensus 586 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (724)
||+++++|.+++.. ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999864 34568999999999999999999997 8999999999999999999999999999986654
Q ss_pred CCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 663 EQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 663 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 189 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 240 (310)
T 2wqm_A 189 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 240 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred CCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 322 1234568999999999999999999999999999999999999996543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.1e-32 Score=285.49 Aligned_cols=198 Identities=33% Similarity=0.443 Sum_probs=175.4
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
+...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 103 (303)
T 3a7i_A 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 103 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence 455688999999999999975 67889999997543 3456789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
+++|.+++.. ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++......... ..
T Consensus 104 ~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~ 177 (303)
T 3a7i_A 104 GGSALDLLEP--GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RN 177 (303)
T ss_dssp TEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC-BC
T ss_pred CCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccccc-cC
Confidence 9999999864 368999999999999999999997 89999999999999999999999999999876543321 23
Q ss_pred cccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 178 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 223 (303)
T 3a7i_A 178 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 223 (303)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC
Confidence 4578999999999999999999999999999999999999997543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=4.2e-33 Score=300.60 Aligned_cols=200 Identities=28% Similarity=0.409 Sum_probs=173.3
Q ss_pred hhccccccccccccEEEEEEEEC-CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
..+.+.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++.+++||||+++++++.+++..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 34556688999999999999986 67889999997542 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
+++++|.+++.... .+++..+..++.|++.||+|||+ ..+|+||||||+|||++.++.+||+|||++.......
T Consensus 113 ~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 186 (360)
T 3eqc_A 113 MDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 186 (360)
T ss_dssp CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC---
T ss_pred CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH--hCCEEcCCccHHHEEECCCCCEEEEECCCCccccccc---
Confidence 99999999997653 58899999999999999999996 2389999999999999999999999999987553221
Q ss_pred eecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 234 (360)
T 3eqc_A 187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234 (360)
T ss_dssp ----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 234578999999999999999999999999999999999999997654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=296.90 Aligned_cols=205 Identities=26% Similarity=0.367 Sum_probs=166.1
Q ss_pred HHHHHhh--ccccccccccccEEEEEEEECCccEEEEEEeecCCcc-----------cHHHHHHHHHHHhcCCCCCccce
Q 043185 505 EELEVAT--DNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQ-----------GKKDFCTEIAIIGNIHHVNLVKL 571 (724)
Q Consensus 505 ~~l~~a~--~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~nIv~l 571 (724)
.++.... +.+.+.||+|+||.||+|...+++.||||++...... ..+.+.+|++++++++||||+++
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 94 (362)
T 3pg1_A 15 AELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGL 94 (362)
T ss_dssp HHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred HHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccce
Confidence 3444433 4456899999999999999888999999998642211 13678999999999999999999
Q ss_pred eceeec-----CCeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCC
Q 043185 572 KGFCAQ-----GRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYH 646 (724)
Q Consensus 572 ~g~~~~-----~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~ 646 (724)
++++.. ....++||||++ |+|.+++......+++..+..++.||+.||.|||+ .+|+||||||+|||++.+
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~ 170 (362)
T 3pg1_A 95 RDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADN 170 (362)
T ss_dssp SEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTT
T ss_pred eeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEcCC
Confidence 999843 346899999998 58888887776789999999999999999999997 899999999999999999
Q ss_pred CcEEEEeecCccccCCCCccceecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 647 FQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 647 ~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
+.+||+|||+++....... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.+..
T Consensus 171 ~~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 238 (362)
T 3pg1_A 171 NDITICDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238 (362)
T ss_dssp CCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCEEEEecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9999999999975543322 234568999999999987 678999999999999999999999998754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=307.87 Aligned_cols=201 Identities=29% Similarity=0.401 Sum_probs=177.2
Q ss_pred HhhccccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEE
Q 043185 509 VATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLV 584 (724)
Q Consensus 509 ~a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 584 (724)
...|.+.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 346777899999999999999986 77899999996532 34567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEE---eCCCcEEEEeecCccccC
Q 043185 585 YEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILL---HYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DFGla~~~~ 661 (724)
|||+++++|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++...
T Consensus 105 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp ECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 9999999999988765 468999999999999999999997 899999999999999 567899999999998775
Q ss_pred CCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 662 PEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 662 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.... .....||+.|+|||++.+ .++.++||||||+++|||++|++||.....
T Consensus 181 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 232 (484)
T 3nyv_A 181 ASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE 232 (484)
T ss_dssp CCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH
Confidence 4432 244579999999999977 689999999999999999999999987654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3e-32 Score=290.00 Aligned_cols=209 Identities=24% Similarity=0.362 Sum_probs=175.0
Q ss_pred CChHHHHHhhcccc-ccccccccEEEEEEEEC-CccEEEEEEeecC--CcccHHHHHHHHHHHhcC-CCCCccceeceee
Q 043185 502 FDYEELEVATDNFK-NLIGSGGFGAVYKGILN-DKTIVAVKKITNV--GVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCA 576 (724)
Q Consensus 502 ~~~~~l~~a~~~~~-~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~ 576 (724)
|...+.....+.+. +.||+|+||.||+|+.. +++.||+|++... ......++.+|+.++.++ +||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 33333344445554 88999999999999976 6789999998753 234467899999999999 5799999999999
Q ss_pred cCCeEEEEEEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC---CCcEEEE
Q 043185 577 QGRQRLLVYEYMNHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY---HFQAKIS 652 (724)
Q Consensus 577 ~~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~ 652 (724)
+....++||||+++++|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEe
Confidence 999999999999999999998653 4578999999999999999999997 89999999999999988 7899999
Q ss_pred eecCccccCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 653 DFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 653 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
|||+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 177 Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 237 (327)
T 3lm5_A 177 DFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED 237 (327)
T ss_dssp CGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999987654322 234579999999999999999999999999999999999999997654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.98 E-value=4.9e-32 Score=282.98 Aligned_cols=196 Identities=29% Similarity=0.422 Sum_probs=168.4
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeceeec----CCeEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ----GRQRLLV 584 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lV 584 (724)
+.+.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 455678999999999999975 6778999998753 23345678999999999999999999998765 4568999
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEecCCCCCCeEEe-CCCcEEEEeecCccccC
Q 043185 585 YEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQK--IIHCDIKPENILLH-YHFQAKISDFGLSKLLT 661 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiH~Dlkp~NILl~-~~~~~kl~DFGla~~~~ 661 (724)
|||+++++|.+++... ..+++..+..++.||+.||.|||+ .+ |+||||||+|||++ .++.+||+|||++....
T Consensus 108 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 9999999999999764 458899999999999999999997 66 99999999999997 78999999999997654
Q ss_pred CCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 662 PEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 662 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
... .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||....
T Consensus 184 ~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 233 (290)
T 1t4h_A 184 ASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 233 (290)
T ss_dssp TTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred ccc---cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcC
Confidence 432 234569999999998875 58999999999999999999999997643
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=290.10 Aligned_cols=201 Identities=27% Similarity=0.371 Sum_probs=170.0
Q ss_pred hhccccccccccccEEEEEEEE-CCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceee----cCCeEEEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCA----QGRQRLLV 584 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~----~~~~~~lV 584 (724)
..+.+.+.||+|+||.||+++. .+++.||||++........+.+.+|++++++++||||+++++++. .....++|
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 108 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL 108 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence 4566778999999999999997 578899999997665666778999999999999999999999986 33478999
Q ss_pred EEecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccC
Q 043185 585 YEYMNHGSLDRILFG---NGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 661 (724)
+||+++++|.+++.. ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 999999999999875 35678999999999999999999997 899999999999999999999999999987654
Q ss_pred CCCcc--------ceecccccccccccccccCCc---CCCccchhhHHHHHHHHHhCCCCCCC
Q 043185 662 PEQSS--------LFTTMRGTRGYLAPEWLTNSA---ISEKTDVYSFGMVLLELVSGRRNCSP 713 (724)
Q Consensus 662 ~~~~~--------~~~~~~gt~~y~aPE~l~~~~---~~~~sDv~SlGv~l~elltG~~p~~~ 713 (724)
..... ......||+.|+|||.+.+.. +++++||||||+++|||++|+.||..
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 22110 012235799999999997653 78999999999999999999999953
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=6.1e-32 Score=288.38 Aligned_cols=196 Identities=28% Similarity=0.417 Sum_probs=161.3
Q ss_pred HHHHhhccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcC--CCCCccceeceeecC----C
Q 043185 506 ELEVATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNI--HHVNLVKLKGFCAQG----R 579 (724)
Q Consensus 506 ~l~~a~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l--~H~nIv~l~g~~~~~----~ 579 (724)
+.....+.+.+.||+|+||.||+|+.. ++.||||++... ....+.+|.+++..+ +||||+++++++... .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 334456777899999999999999987 677999998643 334556666666655 899999999999877 7
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeEecCCCCCCeEEeCCCcEEEEee
Q 043185 580 QRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGC-----EQKIIHCDIKPENILLHYHFQAKISDF 654 (724)
Q Consensus 580 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~iiH~Dlkp~NILl~~~~~~kl~DF 654 (724)
..++||||+++|+|.+++... .+++..+..++.|++.||+|||+.. ..+|+||||||+|||++.++.+||+||
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred ceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 899999999999999999765 5889999999999999999999710 129999999999999999999999999
Q ss_pred cCccccCCCCcc---ceecccccccccccccccCCcCCCc------cchhhHHHHHHHHHhC
Q 043185 655 GLSKLLTPEQSS---LFTTMRGTRGYLAPEWLTNSAISEK------TDVYSFGMVLLELVSG 707 (724)
Q Consensus 655 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~------sDv~SlGv~l~elltG 707 (724)
|+++........ ......||+.|+|||++.+.....+ +||||||+++|||++|
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg 248 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence 999776543321 1124579999999999988766665 9999999999999999
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=6.9e-33 Score=293.96 Aligned_cols=204 Identities=25% Similarity=0.439 Sum_probs=173.9
Q ss_pred HhhccccccccccccEEEEEEEEC------CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeE
Q 043185 509 VATDNFKNLIGSGGFGAVYKGILN------DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQR 581 (724)
Q Consensus 509 ~a~~~~~~~lG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 581 (724)
...+.+.+.||+|+||.||+|+.. .++.||+|++.... .....++.+|+.++++++||||+++++++.+....
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 103 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 103 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCcc
Confidence 345666789999999999999864 36789999997543 23445789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEE
Q 043185 582 LLVYEYMNHGSLDRILFGNG---------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKIS 652 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 652 (724)
++||||+++++|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+
T Consensus 104 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~kl~ 180 (322)
T 1p4o_A 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIG 180 (322)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeEEEC
Confidence 99999999999999986421 456899999999999999999997 899999999999999999999999
Q ss_pred eecCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 653 DFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 653 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 245 (322)
T 1p4o_A 181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245 (322)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred cCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC
Confidence 9999976543221 11123356889999999999999999999999999999999 899997654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.3e-33 Score=291.39 Aligned_cols=201 Identities=25% Similarity=0.375 Sum_probs=170.4
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
.+.+.+.||+|+||.||+|+.. +++.||+|++........+++.+|++++.+++||||+++++++......++||||++
T Consensus 20 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 99 (302)
T 2j7t_A 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCP 99 (302)
T ss_dssp TEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCT
T ss_pred ceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCC
Confidence 4566788999999999999986 578899999977666677889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
+++|.+++......+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++....... ....
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 175 (302)
T 2j7t_A 100 GGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-QKRD 175 (302)
T ss_dssp TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-HC--
T ss_pred CCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-cccc
Confidence 999999987766679999999999999999999997 899999999999999999999999999875432111 1113
Q ss_pred cccccccccccccc-----cCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWL-----TNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 670 ~~~gt~~y~aPE~l-----~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
...|++.|+|||++ .+..++.++||||||+++|||++|+.||....
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 226 (302)
T 2j7t_A 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226 (302)
T ss_dssp ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 34689999999998 46678999999999999999999999997644
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.6e-32 Score=292.72 Aligned_cols=206 Identities=24% Similarity=0.327 Sum_probs=156.3
Q ss_pred hhccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCC-CCCccceeceee--------cCC
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIH-HVNLVKLKGFCA--------QGR 579 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~--------~~~ 579 (724)
..+.+.++||+|+||.||+++.. +++.||||++........+.+.+|+.++.++. ||||+++++++. ...
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 35667789999999999999974 67889999997665566678999999999996 999999999983 344
Q ss_pred eEEEEEEecCCCCHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEecCCCCCCeEEeCCCcEEEEeec
Q 043185 580 QRLLVYEYMNHGSLDRILFG--NGPVLEWQERFDIALGTARGLAYLHSGCEQK--IIHCDIKPENILLHYHFQAKISDFG 655 (724)
Q Consensus 580 ~~~lV~e~~~~gsL~~~l~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiH~Dlkp~NILl~~~~~~kl~DFG 655 (724)
..++|+||++ |+|.+++.. ....+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEecCc
Confidence 6789999996 689888864 34568999999999999999999997 77 9999999999999999999999999
Q ss_pred CccccCCCCcc-----------ceecccccccccccccc---cCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCCCC
Q 043185 656 LSKLLTPEQSS-----------LFTTMRGTRGYLAPEWL---TNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHS 719 (724)
Q Consensus 656 la~~~~~~~~~-----------~~~~~~gt~~y~aPE~l---~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~~ 719 (724)
+++........ ......||+.|+|||++ .+..++.++||||||+++|||++|+.||......++
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 261 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI 261 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence 99876543221 11134589999999998 566789999999999999999999999976554433
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.98 E-value=3.3e-32 Score=294.09 Aligned_cols=200 Identities=28% Similarity=0.430 Sum_probs=173.5
Q ss_pred hhccccccccccccEEEEEEEEC-CccEEEEEEeecCCcc--------cHHHHHHHHHHHhcC-CCCCccceeceeecCC
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQ--------GKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGR 579 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~--------~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~ 579 (724)
..+.+.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+.++.++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 34556689999999999999985 6889999998754211 135678999999999 7999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccc
Q 043185 580 QRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKL 659 (724)
Q Consensus 580 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 659 (724)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++..
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~ 249 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCH 249 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecCcccc
Confidence 999999999999999998754 458899999999999999999997 8999999999999999999999999999987
Q ss_pred cCCCCccceecccccccccccccccC------CcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 660 LTPEQSSLFTTMRGTRGYLAPEWLTN------SAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 660 ~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
+..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 250 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 309 (365)
T 2y7j_A 250 LEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309 (365)
T ss_dssp CCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC
Confidence 654332 245679999999999863 358899999999999999999999997654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.7e-32 Score=285.43 Aligned_cols=195 Identities=28% Similarity=0.392 Sum_probs=167.9
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCCHH
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLD 594 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gsL~ 594 (724)
.+||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++||||+++++++.+....++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 48999999999999974 67889999998765666688999999999999999999999999999999999999999999
Q ss_pred HHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC-CCcEEEEeecCccccCCCCccceecc
Q 043185 595 RILFGNG--PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY-HFQAKISDFGLSKLLTPEQSSLFTTM 671 (724)
Q Consensus 595 ~~l~~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~ 671 (724)
+++.... ..+++..+..++.|++.||+|||+ .+++|+||||+||+++. ++.+||+|||++........ .....
T Consensus 108 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 183 (295)
T 2clq_A 108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CTETF 183 (295)
T ss_dssp HHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CCC
T ss_pred HHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-ccccc
Confidence 9997653 345688889999999999999997 89999999999999998 89999999999987654322 12345
Q ss_pred cccccccccccccCCc--CCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 672 RGTRGYLAPEWLTNSA--ISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 672 ~gt~~y~aPE~l~~~~--~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
.|++.|+|||.+.+.. ++.++||||||+++|||++|+.||...
T Consensus 184 ~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (295)
T 2clq_A 184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228 (295)
T ss_dssp CCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGG
T ss_pred CCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCC
Confidence 6899999999997653 789999999999999999999999643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.3e-32 Score=306.28 Aligned_cols=200 Identities=29% Similarity=0.423 Sum_probs=170.4
Q ss_pred hhccccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
..|.+.+.||+|+||.||+|+.. ++..+|+|++.... ......+.+|+.++++++||||+++++++.+....++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 45677889999999999999985 67889999997542 3345788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC---CCcEEEEeecCccccCCC
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY---HFQAKISDFGLSKLLTPE 663 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DFGla~~~~~~ 663 (724)
|+++|+|.+.+... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||+++.....
T Consensus 117 ~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 117 CYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 99999999888655 358899999999999999999997 89999999999999976 455999999999876543
Q ss_pred CccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 664 QSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 664 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.. .....||+.|+|||++.+ .++.++||||||+++|||++|++||.+...
T Consensus 193 ~~--~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 242 (494)
T 3lij_A 193 KK--MKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTD 242 (494)
T ss_dssp BC--BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cc--ccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 32 345679999999999874 689999999999999999999999987654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.7e-32 Score=306.46 Aligned_cols=201 Identities=29% Similarity=0.417 Sum_probs=174.6
Q ss_pred HhhccccccccccccEEEEEEEEC-CccEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEE
Q 043185 509 VATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVY 585 (724)
Q Consensus 509 ~a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 585 (724)
...|.+.+.||+|+||.||+++.. +++.||||++... .....+.+.+|++++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 356778899999999999999985 6789999998642 2345678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEe---CCCcEEEEeecCccccCC
Q 043185 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLH---YHFQAKISDFGLSKLLTP 662 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kl~DFGla~~~~~ 662 (724)
||+++++|.+.+... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++ .++.+||+|||+++....
T Consensus 101 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 999999999888665 358899999999999999999997 8999999999999995 456799999999987654
Q ss_pred CCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 663 EQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 663 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
... .....||+.|+|||++.+ .++.++||||||+++|||++|++||.+...
T Consensus 177 ~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 227 (486)
T 3mwu_A 177 NTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE 227 (486)
T ss_dssp C------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCc--cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 322 345579999999999986 589999999999999999999999977654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=290.84 Aligned_cols=207 Identities=23% Similarity=0.401 Sum_probs=163.8
Q ss_pred HHhhccccccccccccEEEEEEEEC----CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCC--
Q 043185 508 EVATDNFKNLIGSGGFGAVYKGILN----DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR-- 579 (724)
Q Consensus 508 ~~a~~~~~~~lG~G~fG~Vy~~~~~----~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-- 579 (724)
....+.+.+.||+|+||.||+|+.. .+..||+|++.... ....+++.+|+.++.+++||||+++++++.+..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 3345566789999999999999864 34579999986532 334467899999999999999999999998765
Q ss_pred ---eEEEEEEecCCCCHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEE
Q 043185 580 ---QRLLVYEYMNHGSLDRILFG-----NGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKI 651 (724)
Q Consensus 580 ---~~~lV~e~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 651 (724)
..++|+||+++++|.+++.. ....+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEE
Confidence 34999999999999999853 23568999999999999999999996 89999999999999999999999
Q ss_pred EeecCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 043185 652 SDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQS 717 (724)
Q Consensus 652 ~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~~ 717 (724)
+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 256 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH 256 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH
Confidence 99999986644322 12233457889999999999999999999999999999999 89999766543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=8.3e-33 Score=292.32 Aligned_cols=204 Identities=27% Similarity=0.417 Sum_probs=173.6
Q ss_pred hhccccccccccccEEEEEEEE------CCccEEEEEEeecCCc-ccHHHHHHHHHHHhcC-CCCCccceeceeecCC-e
Q 043185 510 ATDNFKNLIGSGGFGAVYKGIL------NDKTIVAVKKITNVGV-QGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGR-Q 580 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~------~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~-~ 580 (724)
..+.+.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.++.++ +||||+++++++...+ .
T Consensus 27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 106 (316)
T 2xir_A 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 106 (316)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCc
Confidence 4556678999999999999985 3567899999976432 3446789999999999 7999999999987654 5
Q ss_pred EEEEEEecCCCCHHHHHhcCCCC---------------CCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC
Q 043185 581 RLLVYEYMNHGSLDRILFGNGPV---------------LEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY 645 (724)
Q Consensus 581 ~~lV~e~~~~gsL~~~l~~~~~~---------------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~ 645 (724)
.++||||+++++|.+++...... +++..+..++.|++.||.|||+ .+|+||||||+||+++.
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSE 183 (316)
T ss_dssp CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECG
T ss_pred eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECC
Confidence 89999999999999999765432 7889999999999999999997 89999999999999999
Q ss_pred CCcEEEEeecCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 043185 646 HFQAKISDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQ 716 (724)
Q Consensus 646 ~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~ 716 (724)
++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred CCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 99999999999987654332 22234457889999999999999999999999999999998 9999976553
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=318.05 Aligned_cols=196 Identities=30% Similarity=0.466 Sum_probs=166.1
Q ss_pred ccccccccEEEEEEEEC---CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 516 NLIGSGGFGAVYKGILN---DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~---~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
+.||+|+||.||+|.+. .++.||||+++... ....+++.+|++++.+++|||||++++++.. +..+|||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999763 46789999997532 2345789999999999999999999999965 568899999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc--cce
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS--SLF 668 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~--~~~ 668 (724)
|+|.+++... ..+++..+..|+.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++.+..... ...
T Consensus 454 g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 454 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 9999999765 468899999999999999999997 8999999999999999999999999999987754332 122
Q ss_pred ecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQ 716 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~ 716 (724)
....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+...
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~ 578 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 578 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 33456789999999999999999999999999999998 9999977653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=292.50 Aligned_cols=196 Identities=33% Similarity=0.502 Sum_probs=158.6
Q ss_pred hccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHH--HhcCCCCCccceeceee-----cCCeEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAI--IGNIHHVNLVKLKGFCA-----QGRQRLL 583 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~--l~~l~H~nIv~l~g~~~-----~~~~~~l 583 (724)
.+.+.+.||+|+||.||+|+. +++.||||++... ....+..|.++ +..++||||+++++.+. .....++
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l 89 (336)
T 3g2f_A 14 NLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL 89 (336)
T ss_dssp SEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred HhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence 455678999999999999987 4677999999743 33445555555 44589999999998543 2336789
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC---------CeEecCCCCCCeEEeCCCcEEEEee
Q 043185 584 VYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQ---------KIIHCDIKPENILLHYHFQAKISDF 654 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~---------~iiH~Dlkp~NILl~~~~~~kl~DF 654 (724)
||||+++|+|.+++... ..++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+||
T Consensus 90 v~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 90 VMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred EEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 99999999999999765 34888999999999999999997 6 9999999999999999999999999
Q ss_pred cCccccCCCC-------ccceecccccccccccccccC-------CcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 655 GLSKLLTPEQ-------SSLFTTMRGTRGYLAPEWLTN-------SAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 655 Gla~~~~~~~-------~~~~~~~~gt~~y~aPE~l~~-------~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
|+++.+.... ........||+.|+|||++.+ ..++.++||||||+++|||++|..||.+..
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 9998764321 111224569999999999987 467789999999999999999977764443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.7e-33 Score=300.34 Aligned_cols=195 Identities=12% Similarity=0.062 Sum_probs=151.8
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCCc---ccHHHHHHHH---HHHhcCCCCCcccee-------ceeec
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV---QGKKDFCTEI---AIIGNIHHVNLVKLK-------GFCAQ 577 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~---~~l~~l~H~nIv~l~-------g~~~~ 577 (724)
+.+.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+ .+|++ +||||++++ +++..
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEE
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheec
Confidence 456689999999999999975 778999999986432 2345677785 45555 799988755 33322
Q ss_pred C-----------------CeEEEEEEecCCCCHHHHHhcCCCCCCHHHH------HHHHHHHHHHHHHHHcCCCCCeEec
Q 043185 578 G-----------------RQRLLVYEYMNHGSLDRILFGNGPVLEWQER------FDIALGTARGLAYLHSGCEQKIIHC 634 (724)
Q Consensus 578 ~-----------------~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~------~~i~~~ia~~L~yLH~~~~~~iiH~ 634 (724)
. ...+|||||++ ++|.+++...+..+.+..+ ..++.||+.||+|||+ .+|+||
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~ivHr 218 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHG 218 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEEET
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCccC
Confidence 2 34799999999 8999999865444555566 7888999999999997 899999
Q ss_pred CCCCCCeEEeCCCcEEEEeecCccccCCCCccceecccccccccccccccC--CcCCCccchhhHHHHHHHHHhCCCCCC
Q 043185 635 DIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTN--SAISEKTDVYSFGMVLLELVSGRRNCS 712 (724)
Q Consensus 635 Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDv~SlGv~l~elltG~~p~~ 712 (724)
||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||.
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999998664321 24457799999999987 789999999999999999999999997
Q ss_pred CCC
Q 043185 713 PRS 715 (724)
Q Consensus 713 ~~~ 715 (724)
...
T Consensus 295 ~~~ 297 (371)
T 3q60_A 295 LVT 297 (371)
T ss_dssp BCC
T ss_pred CcC
Confidence 763
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=289.42 Aligned_cols=196 Identities=30% Similarity=0.422 Sum_probs=170.1
Q ss_pred cccccccccccEEEEEEEEC-----CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeec--CCeEEEE
Q 043185 513 NFKNLIGSGGFGAVYKGILN-----DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ--GRQRLLV 584 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV 584 (724)
.+.+.||+|+||.||++.+. +++.||||++.... ....+.+.+|++++++++||||+++++++.+ ....++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 56689999999999998753 56789999997643 2345678999999999999999999999987 4678999
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC
Q 043185 585 YEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (724)
|||+++++|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 114 ~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 188 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188 (318)
T ss_dssp ECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred EecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence 9999999999999765 48899999999999999999997 899999999999999999999999999998775543
Q ss_pred c--cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCC
Q 043185 665 S--SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSP 713 (724)
Q Consensus 665 ~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~ 713 (724)
. .......++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 189 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 239 (318)
T 3lxp_A 189 EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239 (318)
T ss_dssp SEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence 2 122344578889999999999999999999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=300.71 Aligned_cols=207 Identities=28% Similarity=0.352 Sum_probs=172.8
Q ss_pred ChHHHHHhhccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCC--------CCCccceec
Q 043185 503 DYEELEVATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIH--------HVNLVKLKG 573 (724)
Q Consensus 503 ~~~~l~~a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~--------H~nIv~l~g 573 (724)
...++....+.+.++||+|+||.||+|+.. +++.||||++... ....+.+.+|++++++++ |+||+++++
T Consensus 30 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~ 108 (397)
T 1wak_A 30 KIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD 108 (397)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred ehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence 333444456777889999999999999964 6788999999753 344567889999999885 788999999
Q ss_pred eee----cCCeEEEEEEecCCCCHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC-CeEecCCCCCCeEEeCCC
Q 043185 574 FCA----QGRQRLLVYEYMNHGSLDRILF-GNGPVLEWQERFDIALGTARGLAYLHSGCEQ-KIIHCDIKPENILLHYHF 647 (724)
Q Consensus 574 ~~~----~~~~~~lV~e~~~~gsL~~~l~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~iiH~Dlkp~NILl~~~~ 647 (724)
++. .....+|||||+.+ +|.+.+. .....+++..+..++.||+.||+|||+ + +|+||||||+|||++.++
T Consensus 109 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 109 DFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNE 184 (397)
T ss_dssp EEEEEETTEEEEEEEECCCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCH
T ss_pred ceeecCCCCceEEEEEeccCc-cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccc
Confidence 987 55688999999955 5555544 444679999999999999999999997 6 999999999999999775
Q ss_pred -------------------------------------------------cEEEEeecCccccCCCCccceeccccccccc
Q 043185 648 -------------------------------------------------QAKISDFGLSKLLTPEQSSLFTTMRGTRGYL 678 (724)
Q Consensus 648 -------------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~ 678 (724)
.+||+|||++...... .....||+.|+
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~ 260 (397)
T 1wak_A 185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYR 260 (397)
T ss_dssp HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGC
T ss_pred hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCccc
Confidence 7999999999876543 23457899999
Q ss_pred ccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 043185 679 APEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSH 718 (724)
Q Consensus 679 aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~ 718 (724)
|||++.+..++.++||||||+++|||++|+.||.+....+
T Consensus 261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 300 (397)
T 1wak_A 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEE 300 (397)
T ss_dssp CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSS
T ss_pred CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccc
Confidence 9999999999999999999999999999999998766443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.2e-32 Score=295.37 Aligned_cols=196 Identities=26% Similarity=0.384 Sum_probs=164.8
Q ss_pred hccccccccccccEEEEEEEE-CCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeec------------
Q 043185 511 TDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ------------ 577 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~------------ 577 (724)
.+.+.+.||+|+||.||+|+. .+++.||||++..... ...+|+++++.++||||+++++++..
T Consensus 8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~ 83 (383)
T 3eb0_A 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP 83 (383)
T ss_dssp TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence 456678999999999999997 4788999999865422 23479999999999999999999843
Q ss_pred --------------------------CCeEEEEEEecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCC
Q 043185 578 --------------------------GRQRLLVYEYMNHGSLDRILFG---NGPVLEWQERFDIALGTARGLAYLHSGCE 628 (724)
Q Consensus 578 --------------------------~~~~~lV~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ 628 (724)
....++||||+++ +|.+.+.. ....+++..+..++.||+.||+|||+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--- 159 (383)
T 3eb0_A 84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS--- 159 (383)
T ss_dssp --------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---
T ss_pred cccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---
Confidence 3348899999984 87777653 45678999999999999999999996
Q ss_pred CCeEecCCCCCCeEEe-CCCcEEEEeecCccccCCCCccceecccccccccccccccCC-cCCCccchhhHHHHHHHHHh
Q 043185 629 QKIIHCDIKPENILLH-YHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVS 706 (724)
Q Consensus 629 ~~iiH~Dlkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~ellt 706 (724)
.+|+||||||+|||++ .++.+||+|||+++....... .....+|+.|+|||.+.+. .++.++||||||+++|||++
T Consensus 160 ~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 160 LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 8999999999999998 689999999999987654432 2345789999999998875 58999999999999999999
Q ss_pred CCCCCCCCCC
Q 043185 707 GRRNCSPRSQ 716 (724)
Q Consensus 707 G~~p~~~~~~ 716 (724)
|+.||.+...
T Consensus 238 g~~pf~~~~~ 247 (383)
T 3eb0_A 238 GKPLFSGETS 247 (383)
T ss_dssp SSCSSCCSSH
T ss_pred CCCCCCCCCh
Confidence 9999987653
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=3e-32 Score=295.20 Aligned_cols=197 Identities=26% Similarity=0.335 Sum_probs=161.0
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCC------eE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR------QR 581 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~ 581 (724)
.+.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.... ..
T Consensus 26 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 105 (371)
T 2xrw_A 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 105 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEE
T ss_pred heeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccce
Confidence 4556789999999999999975 67889999997532 234467889999999999999999999987654 78
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccC
Q 043185 582 LLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 661 (724)
++||||+++ +|.+++.. .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 106 ~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 106 YIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp EEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred EEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 999999985 78777753 48889999999999999999997 899999999999999999999999999998664
Q ss_pred CCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 662 PEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 662 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.+.+.
T Consensus 179 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 231 (371)
T 2xrw_A 179 TSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH 231 (371)
T ss_dssp -------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 332 12345789999999999999999999999999999999999999977653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=301.93 Aligned_cols=195 Identities=31% Similarity=0.393 Sum_probs=162.6
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecC------CeEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG------RQRLL 583 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~~l 583 (724)
.+.+.+.||+|+||.||+|+.. +++.||||++.... +.+.+|++++++++||||+++++++... ...++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 3556689999999999999985 58899999986532 2234799999999999999999988532 24679
Q ss_pred EEEecCCCCHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCC-CcEEEEeecCccc
Q 043185 584 VYEYMNHGSLDRILF---GNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYH-FQAKISDFGLSKL 659 (724)
Q Consensus 584 V~e~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFGla~~ 659 (724)
||||+++ +|.+++. .....+++..+..++.||+.||+|||+ .+|+||||||+||||+.+ +.+||+|||+++.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999986 5655553 345678999999999999999999996 899999999999999965 5689999999987
Q ss_pred cCCCCccceecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 660 LTPEQSSLFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 660 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
+..... .....+|+.|+|||++.+. .++.++|||||||++|||++|++||.+..
T Consensus 207 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~ 261 (420)
T 1j1b_A 207 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 261 (420)
T ss_dssp CCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 654332 2345789999999999765 79999999999999999999999998765
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.2e-32 Score=282.53 Aligned_cols=196 Identities=27% Similarity=0.372 Sum_probs=169.2
Q ss_pred hhccccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEEEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVY 585 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 585 (724)
..+.+.+.||+|+||.||+|+.. +++.||+|++.... .....++.+|+..+.++ +||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 44666789999999999999986 78899999997532 33456788999999999 9999999999999999999999
Q ss_pred EecCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCC----------------
Q 043185 586 EYMNHGSLDRILFGN---GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYH---------------- 646 (724)
Q Consensus 586 e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~---------------- 646 (724)
||+++++|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC------------------
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 999999999999754 2568999999999999999999997 899999999999999844
Q ss_pred ---CcEEEEeecCccccCCCCccceecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCC
Q 043185 647 ---FQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSP 713 (724)
Q Consensus 647 ---~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~ 713 (724)
..+||+|||++....... ...||+.|+|||.+.+. .+++++||||||++++||++|++|+..
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 233 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN 233 (289)
T ss_dssp --CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred CCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 479999999998765432 23589999999999876 667899999999999999999987643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.6e-32 Score=283.79 Aligned_cols=198 Identities=28% Similarity=0.460 Sum_probs=172.3
Q ss_pred HHHHhhccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeec-------
Q 043185 506 ELEVATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ------- 577 (724)
Q Consensus 506 ~l~~a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~------- 577 (724)
......+.+.+.||+|+||.||+|+.. +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 344456677789999999999999986 78899999997542 356789999999999999999998754
Q ss_pred ---------CCeEEEEEEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCC
Q 043185 578 ---------GRQRLLVYEYMNHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHF 647 (724)
Q Consensus 578 ---------~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 647 (724)
....++||||+++++|.+++... ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETT
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCC
Confidence 44579999999999999999754 3568999999999999999999997 8999999999999999999
Q ss_pred cEEEEeecCccccCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCC
Q 043185 648 QAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCS 712 (724)
Q Consensus 648 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~ 712 (724)
.+||+|||++........ .....+++.|+|||.+.+..++.++||||||+++|||++|..|+.
T Consensus 160 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp EEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred CEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 999999999987654432 234568999999999999999999999999999999999998873
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=292.61 Aligned_cols=201 Identities=32% Similarity=0.498 Sum_probs=169.0
Q ss_pred hhccccccccccccEEEEEEEEC-CccE--EEEEEeecC-CcccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTI--VAVKKITNV-GVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLV 584 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~--vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV 584 (724)
..+.+.+.||+|+||.||+|+.. ++.. +|+|+++.. .....+++.+|++++.++ +||||+++++++.+....++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 45566789999999999999964 4443 589988753 233456789999999999 899999999999999999999
Q ss_pred EEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcE
Q 043185 585 YEYMNHGSLDRILFGNG---------------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQA 649 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 649 (724)
|||+++++|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence 99999999999997653 468999999999999999999997 899999999999999999999
Q ss_pred EEEeecCccccCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 650 KISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 650 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
||+|||+++...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~ 246 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246 (327)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc
Confidence 999999997443211 1123457889999999998899999999999999999998 999997654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.4e-32 Score=297.06 Aligned_cols=197 Identities=29% Similarity=0.346 Sum_probs=164.1
Q ss_pred hccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCC------eEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR------QRLLV 584 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~~lV 584 (724)
.|.+.+.||+|+||.||+|+...+..+|+|++..... ...+|+++++.++||||+++++++.... ..++|
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 4666789999999999999997766799999865322 2236999999999999999999985433 37899
Q ss_pred EEecCCCCHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEe-CCCcEEEEeecCccccC
Q 043185 585 YEYMNHGSLDRILF--GNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLH-YHFQAKISDFGLSKLLT 661 (724)
Q Consensus 585 ~e~~~~gsL~~~l~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DFGla~~~~ 661 (724)
|||++++.+..... .....+++..+..++.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||+++...
T Consensus 117 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp EECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 99998765443332 234578999999999999999999997 8999999999999999 79999999999998765
Q ss_pred CCCccceecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 662 PEQSSLFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 662 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.... .....+|+.|+|||++.+. .++.++||||||+++|||++|++||.+.+.
T Consensus 194 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 247 (394)
T 4e7w_A 194 AGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG 247 (394)
T ss_dssp TTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 4332 2345789999999999765 589999999999999999999999987653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=8.2e-32 Score=286.71 Aligned_cols=193 Identities=23% Similarity=0.391 Sum_probs=168.8
Q ss_pred hhccccccccccccEEEEEEEE-CCccEEEEEEeecCCcccHHHHHHHHHHHhcCC-CCCccceeceeec--CCeEEEEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIH-HVNLVKLKGFCAQ--GRQRLLVY 585 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~--~~~~~lV~ 585 (724)
..+.+.+.||+|+||.||+|+. .+++.||||+++. ...+.+.+|++++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 3455678999999999999997 4778999999874 34578899999999997 9999999999987 66789999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCC-cEEEEeecCccccCCCC
Q 043185 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHF-QAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFGla~~~~~~~ 664 (724)
||+++++|..++. .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||+++......
T Consensus 113 e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp ECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred eccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 9999999999884 37889999999999999999997 8999999999999999777 89999999998765433
Q ss_pred ccceecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 665 SSLFTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 665 ~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
. .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 186 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~ 234 (330)
T 3nsz_A 186 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234 (330)
T ss_dssp C--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred c--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 2 234578999999999987 67899999999999999999999999543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.9e-32 Score=300.33 Aligned_cols=196 Identities=26% Similarity=0.410 Sum_probs=153.0
Q ss_pred cccccccccEEEEEEEEC---CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceee--cCCeEEEEEEecC
Q 043185 515 KNLIGSGGFGAVYKGILN---DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCA--QGRQRLLVYEYMN 589 (724)
Q Consensus 515 ~~~lG~G~fG~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~--~~~~~~lV~e~~~ 589 (724)
.++||+|+||.||+|+.. +++.||||++... ...+.+.+|+.++++++||||+++++++. .....+|||||++
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 458999999999999975 4678999999753 23357889999999999999999999994 4678999999997
Q ss_pred CCCHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEE----eCCCcEEEEeecCc
Q 043185 590 HGSLDRILFGN--------GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILL----HYHFQAKISDFGLS 657 (724)
Q Consensus 590 ~gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DFGla 657 (724)
+ +|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+|||| +.++.+||+|||++
T Consensus 104 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 104 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp E-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred C-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 5 777776421 2248899999999999999999997 899999999999999 67889999999999
Q ss_pred cccCCCCc--cceecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 658 KLLTPEQS--SLFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 658 ~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
+....... .......||+.|+|||++.+. .++.++|||||||++|||++|++||.....
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 87654321 223446789999999999874 589999999999999999999999976654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.1e-32 Score=289.69 Aligned_cols=207 Identities=28% Similarity=0.382 Sum_probs=173.1
Q ss_pred ChHHHHHhhccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhc--CCCCCccceeceeecCC-
Q 043185 503 DYEELEVATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGN--IHHVNLVKLKGFCAQGR- 579 (724)
Q Consensus 503 ~~~~l~~a~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~g~~~~~~- 579 (724)
...+.....+.+.+.||+|+||.||+|+.. ++.||||++.. ...+.+.+|++++.. ++||||+++++++....
T Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 35 LVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred eecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 344555667788899999999999999985 67899999964 345677889988877 78999999999998776
Q ss_pred ---eEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeEecCCCCCCeEEeCCCcEEE
Q 043185 580 ---QRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGC-----EQKIIHCDIKPENILLHYHFQAKI 651 (724)
Q Consensus 580 ---~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~iiH~Dlkp~NILl~~~~~~kl 651 (724)
..++||||+++|+|.+++... .+++..+..++.|++.||+|||... ..+|+||||||+|||++.++.+||
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL 188 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 188 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEE
T ss_pred ccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEE
Confidence 789999999999999999764 5889999999999999999999210 289999999999999999999999
Q ss_pred EeecCccccCCCCcc---ceecccccccccccccccCC------cCCCccchhhHHHHHHHHHhC----------CCCCC
Q 043185 652 SDFGLSKLLTPEQSS---LFTTMRGTRGYLAPEWLTNS------AISEKTDVYSFGMVLLELVSG----------RRNCS 712 (724)
Q Consensus 652 ~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~------~~~~~sDv~SlGv~l~elltG----------~~p~~ 712 (724)
+|||++......... ......||+.|+|||.+.+. .++.++||||||+++|||++| +.||.
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~ 268 (342)
T 1b6c_B 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268 (342)
T ss_dssp CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence 999999876543321 12345699999999999876 344789999999999999999 77886
Q ss_pred CCC
Q 043185 713 PRS 715 (724)
Q Consensus 713 ~~~ 715 (724)
...
T Consensus 269 ~~~ 271 (342)
T 1b6c_B 269 DLV 271 (342)
T ss_dssp TTS
T ss_pred ccC
Confidence 543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.98 E-value=6.6e-32 Score=304.58 Aligned_cols=201 Identities=28% Similarity=0.428 Sum_probs=172.3
Q ss_pred hhccccccccccccEEEEEEEEC-CccEEEEEEeecCCc-------------ccHHHHHHHHHHHhcCCCCCccceecee
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV-------------QGKKDFCTEIAIIGNIHHVNLVKLKGFC 575 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~nIv~l~g~~ 575 (724)
..|.+.+.||+|+||.||+|+.. +++.||+|++..... ...+++.+|+.++++++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34666789999999999999975 578899999975321 2356789999999999999999999999
Q ss_pred ecCCeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCC---cEEEE
Q 043185 576 AQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHF---QAKIS 652 (724)
Q Consensus 576 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~ 652 (724)
.+....++||||+++|+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 9999999999999999999988665 358999999999999999999997 8999999999999998876 69999
Q ss_pred eecCccccCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 653 DFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 653 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
|||+++....... .....||+.|+|||++.+ .++.++||||||+++|||++|++||.+....
T Consensus 192 Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 253 (504)
T 3q5i_A 192 DFGLSSFFSKDYK--LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ 253 (504)
T ss_dssp CCTTCEECCTTSC--BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ECCCCEEcCCCCc--cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999987755432 345579999999999875 6899999999999999999999999876543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.6e-32 Score=296.50 Aligned_cols=196 Identities=29% Similarity=0.402 Sum_probs=152.5
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecC------CeE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG------RQR 581 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~ 581 (724)
.+.+.+.||+|+||.||+|... +++.||||++.... ....+++.+|++++++++||||+++++++... ...
T Consensus 30 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 109 (367)
T 2fst_X 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 109 (367)
T ss_dssp TEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred ceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeE
Confidence 4556689999999999999964 67889999996532 23456788999999999999999999998654 567
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccC
Q 043185 582 LLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 661 (724)
++|+|++ +++|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 110 ~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 110 YLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp EEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred EEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 9999999 6799888865 468999999999999999999997 899999999999999999999999999998654
Q ss_pred CCCccceecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 662 PEQSSLFTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 662 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.. .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.+...
T Consensus 184 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 235 (367)
T 2fst_X 184 DE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 235 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 32 244578999999999987 6789999999999999999999999977653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.2e-32 Score=281.23 Aligned_cols=199 Identities=27% Similarity=0.415 Sum_probs=166.6
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
.+.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence 4566789999999999999986 68899999986431 2345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
|+++++|.+++.... .+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 92 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 166 (276)
T 2h6d_A 92 YVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF- 166 (276)
T ss_dssp CCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred ccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCCcc-
Confidence 999999999997653 58899999999999999999997 8999999999999999999999999999987654322
Q ss_pred ceecccccccccccccccCCcC-CCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAI-SEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~-~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.....+++.|+|||.+.+..+ +.++||||||+++|||++|+.||....
T Consensus 167 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 215 (276)
T 2h6d_A 167 -LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH 215 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 234568999999999988765 689999999999999999999997653
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5e-32 Score=283.18 Aligned_cols=200 Identities=29% Similarity=0.458 Sum_probs=168.5
Q ss_pred hccccc-cccccccEEEEEEEEC---CccEEEEEEeecCCc--ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEE
Q 043185 511 TDNFKN-LIGSGGFGAVYKGILN---DKTIVAVKKITNVGV--QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLV 584 (724)
Q Consensus 511 ~~~~~~-~lG~G~fG~Vy~~~~~---~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 584 (724)
.+.+.+ .||+|+||.||+|... .++.||||++..... ...+++.+|++++++++||||+++++++ +....++|
T Consensus 17 ~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv 95 (291)
T 1xbb_A 17 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLV 95 (291)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEE
T ss_pred hhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEE
Confidence 445555 8999999999999652 467899999975422 2357799999999999999999999999 56778999
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC
Q 043185 585 YEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (724)
|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 96 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (291)
T 1xbb_A 96 MEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171 (291)
T ss_dssp EECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred EEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence 9999999999999765 458899999999999999999997 899999999999999999999999999998775543
Q ss_pred cc--ceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 665 SS--LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 665 ~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
.. ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 172 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 225 (291)
T 1xbb_A 172 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225 (291)
T ss_dssp SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred CcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 21 1122346788999999998889999999999999999999 999997654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.2e-32 Score=299.57 Aligned_cols=197 Identities=26% Similarity=0.354 Sum_probs=170.8
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcC------CCCCccceeceeecCCeEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNI------HHVNLVKLKGFCAQGRQRLL 583 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l------~H~nIv~l~g~~~~~~~~~l 583 (724)
.+.+.+.||+|+||.||+|... +++.||||++... ....+++.+|++++..+ +|+||+++++++......++
T Consensus 98 ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 176 (429)
T 3kvw_A 98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM 176 (429)
T ss_dssp TEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred cEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence 4666789999999999999975 5788999999753 33345677888887776 57799999999999999999
Q ss_pred EEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCc--EEEEeecCcccc
Q 043185 584 VYEYMNHGSLDRILFGNG-PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQ--AKISDFGLSKLL 660 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~--~kl~DFGla~~~ 660 (724)
||||++ ++|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++. +||+|||++...
T Consensus 177 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~ 252 (429)
T 3kvw_A 177 TFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252 (429)
T ss_dssp EECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence 999996 58988887653 458999999999999999999997 89999999999999999987 999999999765
Q ss_pred CCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 661 TPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 661 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
... .....||+.|+|||++.+..++.++|||||||++|||++|++||.+...
T Consensus 253 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 253 HQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp TCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 433 2345789999999999999999999999999999999999999987654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-32 Score=292.96 Aligned_cols=202 Identities=28% Similarity=0.433 Sum_probs=171.3
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCc-ccHHHHHHHHHHHhcCCCCCccceeceeecC-----CeEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV-QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG-----RQRLL 583 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~~l 583 (724)
.+.+.+.||+|+||.||+++.. +++.||||++..... ...+.+.+|++++.+++||||+++++++... ...++
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i 107 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence 4566789999999999999975 677899999975432 3346789999999999999999999998654 36899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCC
Q 043185 584 VYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE 663 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (724)
|+||+++ +|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 108 v~e~~~~-~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 108 VQDLMET-DLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp EEECCSE-EHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEcccCc-CHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 9999984 899988664 58899999999999999999997 89999999999999999999999999999876543
Q ss_pred Cc--cceecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 043185 664 QS--SLFTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRSQSH 718 (724)
Q Consensus 664 ~~--~~~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~ 718 (724)
.. .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.+....+
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 239 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 239 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG
T ss_pred CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH
Confidence 22 11234579999999998754 458999999999999999999999998766443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.6e-33 Score=293.70 Aligned_cols=206 Identities=30% Similarity=0.419 Sum_probs=170.7
Q ss_pred HHHhhccccccccccccEEEEEEEE------CCccEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeceeecCC
Q 043185 507 LEVATDNFKNLIGSGGFGAVYKGIL------NDKTIVAVKKITNV-GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR 579 (724)
Q Consensus 507 l~~a~~~~~~~lG~G~fG~Vy~~~~------~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 579 (724)
+....+.+.+.||+|+||.||+|+. .++..||||++... ......++.+|+.++++++||||+++++++.+..
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 3445667778999999999999984 24668999999653 2344567899999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC---CCcEE
Q 043185 580 QRLLVYEYMNHGSLDRILFGNG------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY---HFQAK 650 (724)
Q Consensus 580 ~~~lV~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~k 650 (724)
..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999998653 358899999999999999999997 89999999999999984 44699
Q ss_pred EEeecCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 651 ISDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 651 l~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
|+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 250 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC
Confidence 999999975533221 12234467889999999998899999999999999999998 999997654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=285.76 Aligned_cols=201 Identities=24% Similarity=0.383 Sum_probs=170.3
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceee--cCCeEEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCA--QGRQRLLVY 585 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~--~~~~~~lV~ 585 (724)
.+.+.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++. .....++||
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 86 (279)
T 2w5a_A 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 86 (279)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEE
T ss_pred heeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEE
Confidence 4556789999999999999985 67889999997542 334567899999999999999999999874 456899999
Q ss_pred EecCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-----eEecCCCCCCeEEeCCCcEEEEeecCc
Q 043185 586 EYMNHGSLDRILFGN---GPVLEWQERFDIALGTARGLAYLHSGCEQK-----IIHCDIKPENILLHYHFQAKISDFGLS 657 (724)
Q Consensus 586 e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-----iiH~Dlkp~NILl~~~~~~kl~DFGla 657 (724)
||+++++|.+++... ...+++..+..++.|++.||+|||+ .+ |+||||||+||+++.++.+||+|||++
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp ECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred eCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 999999999998653 3458999999999999999999997 66 999999999999999999999999999
Q ss_pred cccCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 658 KLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 658 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
+....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 164 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 220 (279)
T 2w5a_A 164 RILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220 (279)
T ss_dssp HHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC
Confidence 87654322 1234568999999999999999999999999999999999999997654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-32 Score=287.54 Aligned_cols=202 Identities=31% Similarity=0.416 Sum_probs=168.8
Q ss_pred HhhccccccccccccEEEEEEEEC-CccEEEEEEeecCCc--------ccHHHHHHHHHHHhcCCCCCccceeceeecCC
Q 043185 509 VATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV--------QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR 579 (724)
Q Consensus 509 ~a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 579 (724)
...+.+.+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++..+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 456777899999999999999975 578899999864321 22345889999999999999999999987655
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCc---EEEEeecC
Q 043185 580 QRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQ---AKISDFGL 656 (724)
Q Consensus 580 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DFGl 656 (724)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++. +||+|||+
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred -eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 89999999999999988654 468899999999999999999997 89999999999999987665 99999999
Q ss_pred ccccCCCCccceeccccccccccccccc---CCcCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 657 SKLLTPEQSSLFTTMRGTRGYLAPEWLT---NSAISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 657 a~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
++...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||......
T Consensus 164 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 225 (322)
T 2ycf_A 164 SKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 225 (322)
T ss_dssp CEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS
T ss_pred ceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH
Confidence 98765432 123456899999999974 567899999999999999999999999765543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-32 Score=289.64 Aligned_cols=203 Identities=28% Similarity=0.381 Sum_probs=155.8
Q ss_pred hhccccccccccccEEEEEEEE-CCccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 510 ATDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
..+.+.+.||+|+||.||++.. .+++.||||++.... ....+++.+|+.++.+++||||+++++++...+..++||||
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 94 (303)
T 2vwi_A 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL 94 (303)
T ss_dssp CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence 3455678999999999999985 467889999986432 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCcccc
Q 043185 588 MNHGSLDRILFG-------NGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLL 660 (724)
Q Consensus 588 ~~~gsL~~~l~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 660 (724)
+++++|.+++.. ....+++..+..++.||+.||.|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 171 (303)
T 2vwi_A 95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFL 171 (303)
T ss_dssp CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence 999999999864 24568999999999999999999997 89999999999999999999999999999766
Q ss_pred CCCCc----cceecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 661 TPEQS----SLFTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 661 ~~~~~----~~~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
..... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 231 (303)
T 2vwi_A 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP 231 (303)
T ss_dssp C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCc
Confidence 43211 11234568999999999976 568999999999999999999999997644
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=292.11 Aligned_cols=200 Identities=26% Similarity=0.390 Sum_probs=174.5
Q ss_pred hccccccccccccEEEEEEEECCccEEEEEEeecCCccc-----------------HHHHHHHHHHHhcCCCCCccceec
Q 043185 511 TDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQG-----------------KKDFCTEIAIIGNIHHVNLVKLKG 573 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~-----------------~~~~~~E~~~l~~l~H~nIv~l~g 573 (724)
.+.+.+.||+|+||.||+|+. +++.||+|++....... .+.+.+|+.++.+++||||+++++
T Consensus 32 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 110 (348)
T 2pml_X 32 DYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG 110 (348)
T ss_dssp TEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSE
T ss_pred ceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 456678999999999999999 88899999996432111 178999999999999999999999
Q ss_pred eeecCCeEEEEEEecCCCCHHHH------HhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCC
Q 043185 574 FCAQGRQRLLVYEYMNHGSLDRI------LFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYH 646 (724)
Q Consensus 574 ~~~~~~~~~lV~e~~~~gsL~~~------l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~ 646 (724)
++.+.+..++||||+++++|.++ +... ...+++..+..++.|++.||.|||+ ..+|+||||||+||+++.+
T Consensus 111 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~~~ 188 (348)
T 2pml_X 111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKN 188 (348)
T ss_dssp EEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEECTT
T ss_pred EEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEcCC
Confidence 99999999999999999999998 5442 4678999999999999999999995 4899999999999999999
Q ss_pred CcEEEEeecCccccCCCCccceecccccccccccccccCC-cCCC-ccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 647 FQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNS-AISE-KTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 647 ~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~-~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
+.+||+|||++...... ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.||.....
T Consensus 189 ~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 189 GRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp SCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred CcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 99999999999876443 23456789999999999887 6666 99999999999999999999977654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=296.14 Aligned_cols=197 Identities=18% Similarity=0.234 Sum_probs=168.3
Q ss_pred hhccccccccccccEEEEEEEECC---------ccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccc----------
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILND---------KTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVK---------- 570 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~~---------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~---------- 570 (724)
..+.+.+.||+|+||.||+|+... ++.||+|++... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 356667899999999999999764 678999998753 46789999999999999988
Q ss_pred -----eeceeec-CCeEEEEEEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEE
Q 043185 571 -----LKGFCAQ-GRQRLLVYEYMNHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILL 643 (724)
Q Consensus 571 -----l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 643 (724)
+++++.. +...++||||+ +++|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+|||+
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEE
Confidence 5566655 67889999999 99999999865 3579999999999999999999997 899999999999999
Q ss_pred eCCC--cEEEEeecCccccCCCCc------cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 644 HYHF--QAKISDFGLSKLLTPEQS------SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 644 ~~~~--~~kl~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
+.++ .+||+|||+++.+..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 899999999987643221 11133479999999999999999999999999999999999999997654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-32 Score=285.47 Aligned_cols=200 Identities=28% Similarity=0.402 Sum_probs=163.7
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceee-------------
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCA------------- 576 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~------------- 576 (724)
.+.+.+.||+|+||.||+|+.. +++.||+|++........+++.+|++++++++||||+++++++.
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 91 (320)
T 2i6l_A 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSL 91 (320)
T ss_dssp TEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----C
T ss_pred ceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccc
Confidence 3556689999999999999986 47889999998765566788999999999999999999998873
Q ss_pred -cCCeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEe-CCCcEEEEee
Q 043185 577 -QGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLH-YHFQAKISDF 654 (724)
Q Consensus 577 -~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DF 654 (724)
+....++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++ .++.+||+||
T Consensus 92 ~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 92 TELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp CSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred cccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEEccC
Confidence 4468899999998 599999854 358899999999999999999997 8999999999999997 5679999999
Q ss_pred cCccccCCCCc--cceecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 655 GLSKLLTPEQS--SLFTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 655 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
|+++....... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.....
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 230 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE 230 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH
Confidence 99987643221 12234457899999998865 6789999999999999999999999987653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=280.99 Aligned_cols=199 Identities=29% Similarity=0.418 Sum_probs=172.5
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCc---------ccHHHHHHHHHHHhcCC-CCCccceeceeecCC
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV---------QGKKDFCTEIAIIGNIH-HVNLVKLKGFCAQGR 579 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~---------~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~ 579 (724)
.+.+.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++.++. ||||+++++++....
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (298)
T 1phk_A 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 97 (298)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred ccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCC
Confidence 4556689999999999999985 678899999975421 12356789999999995 999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccc
Q 043185 580 QRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKL 659 (724)
Q Consensus 580 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 659 (724)
..++||||+++++|.+++... ..+++..+..++.||+.||+|||+ .+++|+||||+||+++.++.+||+|||++..
T Consensus 98 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 98 FFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 999999999999999999764 468899999999999999999997 8999999999999999999999999999987
Q ss_pred cCCCCccceeccccccccccccccc------CCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 660 LTPEQSSLFTTMRGTRGYLAPEWLT------NSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 660 ~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
...... .....+++.|+|||++. ...++.++||||||+++|||++|+.||....
T Consensus 174 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 233 (298)
T 1phk_A 174 LDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233 (298)
T ss_dssp CCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc
Confidence 654332 23456899999999985 4568899999999999999999999997654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.6e-32 Score=286.43 Aligned_cols=199 Identities=29% Similarity=0.433 Sum_probs=164.8
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeceeec------CCeEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQ------GRQRLL 583 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~------~~~~~l 583 (724)
+.+.+.||+|+||.||+|+.. +++.||||++... ....+++.+|+.++.++ +||||+++++++.. ....++
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~l 104 (326)
T 2x7f_A 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL 104 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEE
T ss_pred EEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEE
Confidence 455689999999999999984 6788999999754 34457889999999999 89999999999976 468899
Q ss_pred EEEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCC
Q 043185 584 VYEYMNHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP 662 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (724)
||||+++++|.+++... ...+++..+..++.||+.||.|||+ .+|+|+||||+|||++.++.+||+|||++.....
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 181 (326)
T 2x7f_A 105 VMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181 (326)
T ss_dssp EEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCTTTC----
T ss_pred EEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEeeCcCceecCc
Confidence 99999999999999764 3568899999999999999999997 8999999999999999999999999999986643
Q ss_pred CCccceeccccccccccccccc-----CCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 663 EQSSLFTTMRGTRGYLAPEWLT-----NSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 663 ~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
... ......|++.|+|||++. +..++.++||||||+++|||++|+.||....
T Consensus 182 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 238 (326)
T 2x7f_A 182 TVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238 (326)
T ss_dssp ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred Ccc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 321 123456899999999997 5678999999999999999999999996543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-32 Score=284.37 Aligned_cols=197 Identities=33% Similarity=0.459 Sum_probs=163.4
Q ss_pred hhccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecC-CeEEEEEEec
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG-RQRLLVYEYM 588 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~lV~e~~ 588 (724)
..+.+.+.||+|+||.||+++.. ++.||||+++.. ...+.+.+|++++++++||||+++++++.+. ...++||||+
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 45566789999999999999986 567999999753 3557899999999999999999999987554 4789999999
Q ss_pred CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 589 NHGSLDRILFGNG-PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 589 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
++++|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--- 171 (278)
T 1byg_A 98 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 171 (278)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc---
Confidence 9999999997543 237889999999999999999997 899999999999999999999999999987654332
Q ss_pred eecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQ 716 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~ 716 (724)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 172 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 220 (278)
T 1byg_A 172 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 220 (278)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG
T ss_pred -cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 23357889999999999999999999999999999998 9999976543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-32 Score=283.60 Aligned_cols=198 Identities=26% Similarity=0.338 Sum_probs=155.5
Q ss_pred hhccccccccccccEEEEEEEE-CCccEEEEEEeecCCc-ccH-HHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGV-QGK-KDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~-~~~-~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
..+.+.+.||+|+||.||+++. .+++.||+|++..... ... +.+.++...++.++||||+++++++.+++..++|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e 86 (290)
T 3fme_A 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME 86 (290)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence 3456678999999999999997 4778899999975422 222 334455556888899999999999999999999999
Q ss_pred ecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCC-CeEecCCCCCCeEEeCCCcEEEEeecCccccCC
Q 043185 587 YMNHGSLDRILFG---NGPVLEWQERFDIALGTARGLAYLHSGCEQ-KIIHCDIKPENILLHYHFQAKISDFGLSKLLTP 662 (724)
Q Consensus 587 ~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (724)
|+++ +|.+++.. ....+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 87 LMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred hhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9985 88777653 45679999999999999999999997 6 999999999999999999999999999987654
Q ss_pred CCccceecccccccccccccc----cCCcCCCccchhhHHHHHHHHHhCCCCCCC
Q 043185 663 EQSSLFTTMRGTRGYLAPEWL----TNSAISEKTDVYSFGMVLLELVSGRRNCSP 713 (724)
Q Consensus 663 ~~~~~~~~~~gt~~y~aPE~l----~~~~~~~~sDv~SlGv~l~elltG~~p~~~ 713 (724)
... .....||+.|+|||.+ .+..++.++||||||+++|||++|+.||+.
T Consensus 163 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 163 DVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred ccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 332 2334689999999996 566789999999999999999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-32 Score=284.51 Aligned_cols=202 Identities=27% Similarity=0.372 Sum_probs=164.0
Q ss_pred hhccccccccccccEEEEEEEEC--Cc--cEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN--DK--TIVAVKKITNV---GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRL 582 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~--~~--~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 582 (724)
..+.+.+.||+|+||.||+|++. ++ ..||||+++.. .....+++.+|++++.+++||||+++++++.... .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 45666789999999999999863 22 36899988653 2334578899999999999999999999998765 88
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCC
Q 043185 583 LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP 662 (724)
Q Consensus 583 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (724)
+|+||+++++|.+++......+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 9999999999999998765678999999999999999999997 8999999999999999999999999999987754
Q ss_pred CCcc--ceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 663 EQSS--LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 663 ~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
.... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 229 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC
Confidence 4321 1223457788999999999889999999999999999999 999997654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-32 Score=315.06 Aligned_cols=203 Identities=25% Similarity=0.356 Sum_probs=171.3
Q ss_pred HhhccccccccccccEEEEEEEECC----ccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEE
Q 043185 509 VATDNFKNLIGSGGFGAVYKGILND----KTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLL 583 (724)
Q Consensus 509 ~a~~~~~~~lG~G~fG~Vy~~~~~~----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 583 (724)
...+.+.+.||+|+||.||+|+... +..||+|+++... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEE
Confidence 4456677899999999999999742 4579999987532 2334679999999999999999999999854 56899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCC
Q 043185 584 VYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE 663 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (724)
||||+++|+|.+++......+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 999999999999998776679999999999999999999997 89999999999999999999999999999877554
Q ss_pred CccceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 664 QSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 664 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
.........+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 545 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 597 (656)
T 2j0j_A 545 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 597 (656)
T ss_dssp ---------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 3333334457789999999998899999999999999999997 999997654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=298.20 Aligned_cols=200 Identities=24% Similarity=0.308 Sum_probs=171.6
Q ss_pred hccccccccccccEEEEEEEE-CCccEEEEEEeecCCcccHHHHHHHHHHHhcCCC-CCccceeceeecCCeEEEEEEec
Q 043185 511 TDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHH-VNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
.+.+.++||+|+||.||+|+. .+++.||||++..... .+++.+|++++..++| ++|..+..++.+....+|||||+
T Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 456678999999999999997 4688999998865322 3457899999999976 56666666777888999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEE---eCCCcEEEEeecCccccCCCCc
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILL---HYHFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DFGla~~~~~~~~ 665 (724)
+++|.+++......+++..++.|+.||+.||+|||+ .+|+||||||+|||| +.++.+||+|||+++.+.....
T Consensus 86 -g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (483)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred -CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence 999999998766789999999999999999999997 899999999999999 6889999999999987654322
Q ss_pred c------ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 666 S------LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 666 ~------~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
. ......||+.|+|||.+.+..++.++||||||++||||++|+.||.....
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 1 12256799999999999999999999999999999999999999977544
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=285.51 Aligned_cols=198 Identities=27% Similarity=0.375 Sum_probs=171.7
Q ss_pred hhccccccccccccEEEEEEEE--CCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCC------ccceeceeecCCeE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGIL--NDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVN------LVKLKGFCAQGRQR 581 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~--~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~g~~~~~~~~ 581 (724)
..+.+.+.||+|+||.||++.. .+++.||||+++.. ....+.+.+|++++++++|++ ++++++++.+....
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 4566778999999999999987 36788999999754 344567889999998887664 99999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC---------------
Q 043185 582 LLVYEYMNHGSLDRILFGNG-PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY--------------- 645 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~--------------- 645 (724)
++||||+ +++|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 9999999 889999987654 468899999999999999999997 89999999999999987
Q ss_pred ----CCcEEEEeecCccccCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 646 ----HFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 646 ----~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
++.+||+|||+++...... ....||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp EEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred ccccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 6689999999998654332 345789999999999999999999999999999999999999976543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=290.56 Aligned_cols=194 Identities=26% Similarity=0.390 Sum_probs=164.5
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeE------
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQR------ 581 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~------ 581 (724)
.+.+.+.||+|+||.||+|... +++.||||++.... ....+++.+|+.++++++||||+++++++......
T Consensus 43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 122 (371)
T 4exu_A 43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 122 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence 3455688999999999999975 67889999997542 22346788999999999999999999999877655
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccC
Q 043185 582 LLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 661 (724)
++||||++ ++|.+++. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 123 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 123 YLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp EEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred EEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99999998 58877763 348999999999999999999997 899999999999999999999999999998654
Q ss_pred CCCccceecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 662 PEQSSLFTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 662 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.. .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.+..
T Consensus 196 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 246 (371)
T 4exu_A 196 AE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 246 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 33 234578999999999987 688999999999999999999999998754
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=288.26 Aligned_cols=205 Identities=23% Similarity=0.291 Sum_probs=157.7
Q ss_pred HHHhhccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCC------
Q 043185 507 LEVATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR------ 579 (724)
Q Consensus 507 l~~a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------ 579 (724)
.....+.+.+.||+|+||.||+|+.. +++.||||++... ......+.+|++.+..++||||+++++++....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 33445666789999999999999985 6788999998654 233356678888899999999999999986533
Q ss_pred -eEEEEEEecCCCCHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC-CCcEEEEee
Q 043185 580 -QRLLVYEYMNHGSLDRILF---GNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY-HFQAKISDF 654 (724)
Q Consensus 580 -~~~lV~e~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DF 654 (724)
..++||||+++ +|...+. .....+++..+..++.|++.||.|||. +..+|+||||||+|||++. ++.+||+||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~~~~~~kl~Df 176 (360)
T 3e3p_A 99 IYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLKLCDF 176 (360)
T ss_dssp EEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEETTTTEEEECCC
T ss_pred eeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeCCCCcEEEeeC
Confidence 37899999987 4444333 245578889999999999999999992 1289999999999999997 899999999
Q ss_pred cCccccCCCCccceecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 655 GLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 655 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
|+++....... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||.....
T Consensus 177 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 237 (360)
T 3e3p_A 177 GSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS 237 (360)
T ss_dssp TTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh
Confidence 99987654432 2345689999999998765 489999999999999999999999987653
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=280.71 Aligned_cols=201 Identities=25% Similarity=0.362 Sum_probs=168.0
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCC----cccHHHHHHHHHHHhcCCCCCccceeceee--cCCeEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG----VQGKKDFCTEIAIIGNIHHVNLVKLKGFCA--QGRQRLL 583 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~--~~~~~~l 583 (724)
.|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++++. +....++
T Consensus 6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (305)
T 2wtk_C 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM 85 (305)
T ss_dssp CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence 4667789999999999999974 67889999996532 234577999999999999999999999984 4568899
Q ss_pred EEEecCCCCHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCC
Q 043185 584 VYEYMNHGSLDRILFG-NGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP 662 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (724)
||||++++ |.+++.. ....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 86 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 86 VMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 99999987 6666654 34568999999999999999999997 8999999999999999999999999999987654
Q ss_pred CCc-cceecccccccccccccccCCc--CCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 663 EQS-SLFTTMRGTRGYLAPEWLTNSA--ISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 663 ~~~-~~~~~~~gt~~y~aPE~l~~~~--~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
... .......|++.|+|||.+.+.. ++.++||||||+++|||++|+.||....
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 217 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch
Confidence 322 2223456899999999997643 4789999999999999999999997654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=284.30 Aligned_cols=199 Identities=28% Similarity=0.420 Sum_probs=167.8
Q ss_pred hccccccccccccEEEEEEEE--CCccEEEEEEeecCC--cccHHHHHHHHHHHhcC---CCCCccceeceee-----cC
Q 043185 511 TDNFKNLIGSGGFGAVYKGIL--NDKTIVAVKKITNVG--VQGKKDFCTEIAIIGNI---HHVNLVKLKGFCA-----QG 578 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~--~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~-----~~ 578 (724)
.+.+.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+.+++++ +||||+++++++. ..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 91 (326)
T 1blx_A 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 91 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred ceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCC
Confidence 355678999999999999998 467889999986432 22234566777776665 8999999999987 55
Q ss_pred CeEEEEEEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCc
Q 043185 579 RQRLLVYEYMNHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLS 657 (724)
Q Consensus 579 ~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla 657 (724)
...++||||++ ++|.+++... ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 92 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 92 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp EEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred ceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 67899999998 5999998765 3458999999999999999999997 89999999999999999999999999999
Q ss_pred cccCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 658 KLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 658 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
+...... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 168 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (326)
T 1blx_A 168 RIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 223 (326)
T ss_dssp CCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 8654322 2244578999999999999999999999999999999999999997654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=286.83 Aligned_cols=199 Identities=27% Similarity=0.406 Sum_probs=167.9
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecC-----CeEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG-----RQRLL 583 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~~l 583 (724)
.+.+.+.||+|+||.||+|+.. +++.||||++.... .....++.+|++++++++||||+++++++... ...++
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 91 (353)
T 2b9h_A 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI 91 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEE
T ss_pred ceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEE
Confidence 3556789999999999999986 67889999996532 23346788999999999999999999987654 67899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCC
Q 043185 584 VYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE 663 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (724)
|+||++ ++|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 92 v~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 92 IQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp EECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 999997 5899988764 68999999999999999999997 89999999999999999999999999999876532
Q ss_pred Ccc---------ceecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 664 QSS---------LFTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 664 ~~~---------~~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
... ......||+.|+|||++.+ ..++.++||||||+++|||++|++||.+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 211 1223468999999998764 678999999999999999999999997654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=279.49 Aligned_cols=192 Identities=28% Similarity=0.442 Sum_probs=161.0
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeec------------
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ------------ 577 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~------------ 577 (724)
.+.+.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 4566789999999999999975 7889999999653 3445778999999999999999999998754
Q ss_pred -CCeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecC
Q 043185 578 -GRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGL 656 (724)
Q Consensus 578 -~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGl 656 (724)
....++||||+++++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred cCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 357799999999999999998776678889999999999999999997 8999999999999999999999999999
Q ss_pred ccccCCCC-------------ccceecccccccccccccccCC-cCCCccchhhHHHHHHHHHh
Q 043185 657 SKLLTPEQ-------------SSLFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVS 706 (724)
Q Consensus 657 a~~~~~~~-------------~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~ellt 706 (724)
+....... ........|++.|+|||.+.+. .++.++||||||+++|||++
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 98664321 1112345689999999999865 78999999999999999998
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=288.93 Aligned_cols=200 Identities=29% Similarity=0.368 Sum_probs=170.2
Q ss_pred hhccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCC-CC-----CccceeceeecCCeEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIH-HV-----NLVKLKGFCAQGRQRL 582 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----nIv~l~g~~~~~~~~~ 582 (724)
..+.+.+.||+|+||.||+|+.. +++.||||+++.. ....+++..|++++..++ |+ +|+++++++......+
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 132 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence 34566789999999999999975 6778999999753 333466778888888774 44 4999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEe--CCCcEEEEeecCccc
Q 043185 583 LVYEYMNHGSLDRILFGNG-PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLH--YHFQAKISDFGLSKL 659 (724)
Q Consensus 583 lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~--~~~~~kl~DFGla~~ 659 (724)
|||||+++ +|.+++.... ..+++..+..++.|++.||.|||+ ++.+|+||||||+|||++ .++.+||+|||+++.
T Consensus 133 lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~ 210 (382)
T 2vx3_A 133 LVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 210 (382)
T ss_dssp EEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence 99999965 9999987653 568999999999999999999995 247899999999999995 477899999999987
Q ss_pred cCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 660 LTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 660 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.... .....||+.|+|||++.+..++.++||||||+++|||++|++||.+...
T Consensus 211 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 211 LGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp TTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 6543 2345789999999999999999999999999999999999999987654
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=267.54 Aligned_cols=208 Identities=14% Similarity=0.185 Sum_probs=151.6
Q ss_pred cccccccCCcccceeeeecCCCeEEeCCCeEEEEEEecCCCCceEEEEEEeccCCeEEEecCCCCCCCCCceEEEccCc-
Q 043185 22 FSEFIHPNFTASHVKFIDYGGSFLTSHNGTFKAAIVNTRSQQNSFYLCIIHVLSNTIIWSANRDTPISGSGKMNLTPKG- 100 (724)
Q Consensus 22 ~~~~~~~~~t~~~~~~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~i~~~~~~~~tvVW~Anr~~pv~~~~~l~~~~~g- 100 (724)
..++|.++++|+ .+++| ++|.|+|||+.+++ +.+ +. .+|+||+|||+.| ..+.|+|+.||
T Consensus 7 ~~~~i~~g~~L~-------~g~~l--~~g~f~l~f~~~gn----l~l-y~---~~~~vW~an~~~~--~~~~l~l~~dGn 67 (236)
T 1dlp_A 7 LSHEGSHPQTLH-------AAQSL--ELSSFRFTMQSDCN----LVL-FD---SDVRVWASNTAGA--TGCRAVLQSDGL 67 (236)
T ss_dssp SSSSSCSCSCCC-------TTCEE--CSTTEEEEECTTSC----EEE-EE---SSSEEECCCCCSC--SCCBCCBCSSSC
T ss_pred ccceeCCCCEEC-------CCCEE--EcCCEEEEECCCCc----EEE-EE---CCEEEEECCCCCC--CCeEEEEcCCCc
Confidence 347788888875 46778 49999999985542 222 22 2799999999999 55799999999
Q ss_pred cEEEcCCCCeEEecCCCCC-ceeEEEEecCCcEEEecCCCccceecccCCCccc----------ccCCccCCC-ceEEec
Q 043185 101 IIISDENGNLKWSTPPLKS-SVSALRLTEMGNLVLLDGFNGSLWESFHHPRDTI----------VIGQHLPAG-ASLSSA 168 (724)
Q Consensus 101 ~~l~~~~g~~vWst~~~~~-~~~~~~L~dsGNlVl~~~~~~~lWQSFd~PtDtl----------Lpgq~l~~~-~~L~S~ 168 (724)
+||+|++|++||+|++... ...+|+|+|+|||||+++ ++||||||||||+ +|||+++.+ ++|+|
T Consensus 68 Lvl~d~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~---~~W~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~~~L~s- 143 (236)
T 1dlp_A 68 LVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGP---GLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHA- 143 (236)
T ss_dssp BCCBCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEECS---EEEECSCCCSSCCCCSSCCCEECCCC--CCCCCCEECS-
T ss_pred EEEEcCCCcEEEeCCccccCCcEEEEEeCCCCEEEecC---CEEECCCCCCcccccCCccceEEecCCcCCCccceEEc-
Confidence 5889999999999998643 345799999999999964 8999999998655 777777653 46775
Q ss_pred CCCCCCCCcceEEEeCCCccccccc-cccceeecCCcccccccceeEeeEEecccceEEecC-CCceEEEEeecCCCceE
Q 043185 169 VSDYNLSTGDYSLTVGASDAELQWQ-GQMYWKLSMDTKAYVDSRYIVDYMAINRTGVYLFGN-NGSAVVIRVVLPPSNFR 246 (724)
Q Consensus 169 ~s~~dps~G~~~~~~~~~~~~~~~~-~~~yw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 246 (724)
.+||++|.|+++++++|..+.|+ +..||+++.+... .. ....++.+|.+.+.+ ++..+..++.......+
T Consensus 144 --~~d~s~G~~~l~l~~dG~LvL~~~~~~~W~s~~~~~~-~~-----~~~~L~~~Gnl~ly~~~~~~vw~s~~~~~~~~~ 215 (236)
T 1dlp_A 144 --TQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKG-TG-----CRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRY 215 (236)
T ss_dssp --SCCCBCSSCEEEEETTTEEEEEBTTBCCSCCCCCSSC-SS-----CEEEEETTTEEEEEETTTEEEEECCCCCSSSCC
T ss_pred --CcEeecCcEEEEECCCCcEEEEcCCEeEEeCCCcCCC-Cc-----eEEEECCCCcEEEEeCCCcEEEEeCCCCCCCCE
Confidence 68999999999999999665454 4589998766432 11 124466777654333 44344333332233468
Q ss_pred EEEEcCCCcEEEEE
Q 043185 247 IAKLDASGQFTVLR 260 (724)
Q Consensus 247 ~~~l~~~G~l~~~~ 260 (724)
|++|+.||++++|.
T Consensus 216 rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 216 VFVLQPDRNLAIYG 229 (236)
T ss_dssp EEEECSSSCEEEEC
T ss_pred EEEEcCCCcEEEeC
Confidence 99999999999984
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-31 Score=284.49 Aligned_cols=198 Identities=24% Similarity=0.340 Sum_probs=169.0
Q ss_pred hhccccccccccccEEEEEEEEC-C-ccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCC------ccceeceeecCCeE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-D-KTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVN------LVKLKGFCAQGRQR 581 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~g~~~~~~~~ 581 (724)
..+.+.+.||+|+||.||++... + ++.||+|+++.. ....+.+.+|+.++++++|++ ++.+++++......
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 45667789999999999999974 3 368999999753 344567888999999987766 89999999999999
Q ss_pred EEEEEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEE-----------------
Q 043185 582 LLVYEYMNHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILL----------------- 643 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl----------------- 643 (724)
++||||+ +++|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccccccccc
Confidence 9999999 55666666544 3568999999999999999999996 899999999999999
Q ss_pred --eCCCcEEEEeecCccccCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 644 --HYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 644 --~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 678899999999998654332 345789999999999999999999999999999999999999976543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-31 Score=275.01 Aligned_cols=203 Identities=29% Similarity=0.404 Sum_probs=174.9
Q ss_pred HHHHhhccccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEE
Q 043185 506 ELEVATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRL 582 (724)
Q Consensus 506 ~l~~a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 582 (724)
......+.+.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 344456778899999999999999986 67889999986532 345678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCC---CcEEEEeecCccc
Q 043185 583 LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYH---FQAKISDFGLSKL 659 (724)
Q Consensus 583 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DFGla~~ 659 (724)
+|+||+++++|.+++.... .+++..+..++.||+.||.|||+ .+++||||||+||+++.+ +.+||+|||++..
T Consensus 98 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp EEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 9999999999998886543 58899999999999999999997 899999999999999764 4699999999987
Q ss_pred cCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 660 LTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 660 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
...... .....+++.|+|||.+.+. ++.++||||||+++|||++|+.||....
T Consensus 174 ~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (287)
T 2wei_A 174 FQQNTK--MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKN 226 (287)
T ss_dssp BCCCSS--CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecCCCc--cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCC
Confidence 654322 2334589999999998764 8999999999999999999999997654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=286.30 Aligned_cols=194 Identities=26% Similarity=0.385 Sum_probs=163.8
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCe------E
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQ------R 581 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~------~ 581 (724)
.+.+.+.||+|+||.||+|+.. +++.||||++.... ....+++.+|+.++++++||||+++++++..... .
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 104 (353)
T 3coi_A 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 104 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence 3555688999999999999975 67889999996532 2234678899999999999999999999987654 4
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccC
Q 043185 582 LLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 661 (724)
++||||++ ++|.+++.. .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 105 YLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp EEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred EEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 99999998 588777643 48899999999999999999997 899999999999999999999999999998654
Q ss_pred CCCccceecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 662 PEQSSLFTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 662 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.. .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.+..
T Consensus 178 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 178 AE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred CC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 32 234578999999999987 678999999999999999999999997654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-31 Score=279.63 Aligned_cols=198 Identities=29% Similarity=0.395 Sum_probs=148.8
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCC-cccHHHHHHHHH-HHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG-VQGKKDFCTEIA-IIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
.+.+.+.||+|+||.||+|... +++.||||++.... .....++..|+. +++.++||||+++++++.+.+..++||||
T Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~ 102 (327)
T 3aln_A 23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMEL 102 (327)
T ss_dssp SEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred HhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEee
Confidence 3445688999999999999985 67889999997542 233445666666 67788999999999999999999999999
Q ss_pred cCCCCHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCC-CeEecCCCCCCeEEeCCCcEEEEeecCccccCC
Q 043185 588 MNHGSLDRILFG----NGPVLEWQERFDIALGTARGLAYLHSGCEQ-KIIHCDIKPENILLHYHFQAKISDFGLSKLLTP 662 (724)
Q Consensus 588 ~~~gsL~~~l~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (724)
+++ +|.+++.. ....+++..+..++.|++.||.|||+ . +|+||||||+|||++.++.+||+|||+++....
T Consensus 103 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 103 MST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred cCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 986 77777652 24578999999999999999999997 6 999999999999999999999999999986644
Q ss_pred CCccceecccccccccccccc----cCCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 663 EQSSLFTTMRGTRGYLAPEWL----TNSAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 663 ~~~~~~~~~~gt~~y~aPE~l----~~~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
... .....||+.|+|||.+ .+..++.++||||||+++|||++|+.||...
T Consensus 179 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (327)
T 3aln_A 179 SIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred ccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 322 2334689999999999 4567899999999999999999999999764
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-31 Score=292.13 Aligned_cols=193 Identities=29% Similarity=0.362 Sum_probs=155.4
Q ss_pred cccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEEEEEecCCCCH
Q 043185 515 KNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYEYMNHGSL 593 (724)
Q Consensus 515 ~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~e~~~~gsL 593 (724)
.++||+|+||+||.+...+++.||||++... ..+.+.+|++++.++ +||||+++++++.++...+|||||++ |+|
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL 95 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL 95 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence 4789999999998777778899999998642 345678999999876 89999999999999999999999996 699
Q ss_pred HHHHhcCCCCC------CHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCC-------------CcEEEEee
Q 043185 594 DRILFGNGPVL------EWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYH-------------FQAKISDF 654 (724)
Q Consensus 594 ~~~l~~~~~~l------~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-------------~~~kl~DF 654 (724)
.+++....... .+..+..++.||+.||+|||+ .+|+||||||+|||++.+ +.+||+||
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF 172 (434)
T 2rio_A 96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172 (434)
T ss_dssp HHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence 99997653211 223456799999999999997 899999999999999764 48999999
Q ss_pred cCccccCCCCcc---ceecccccccccccccccC-------CcCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 043185 655 GLSKLLTPEQSS---LFTTMRGTRGYLAPEWLTN-------SAISEKTDVYSFGMVLLELVS-GRRNCSPR 714 (724)
Q Consensus 655 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~l~~-------~~~~~~sDv~SlGv~l~ellt-G~~p~~~~ 714 (724)
|+++........ ......||+.|+|||++.+ ..++.++||||||+++|||++ |+.||...
T Consensus 173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 999877654321 1234579999999999976 578999999999999999999 99999654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-31 Score=281.49 Aligned_cols=196 Identities=24% Similarity=0.297 Sum_probs=143.5
Q ss_pred ccc-cccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeec----CCeEEEEE
Q 043185 512 DNF-KNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ----GRQRLLVY 585 (724)
Q Consensus 512 ~~~-~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lV~ 585 (724)
+.+ .++||+|+||.||+|+.. +++.||||++... .+...+....+..++||||+++++++.. +...++||
T Consensus 30 y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 105 (336)
T 3fhr_A 30 YQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM 105 (336)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred eEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEE
Confidence 444 357999999999999986 6889999999653 1222223334567799999999999876 45689999
Q ss_pred EecCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC---CCcEEEEeecCccccC
Q 043185 586 EYMNHGSLDRILFGNG-PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY---HFQAKISDFGLSKLLT 661 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DFGla~~~~ 661 (724)
||+++|+|.+++.... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||+++...
T Consensus 106 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~ 182 (336)
T 3fhr_A 106 ECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182 (336)
T ss_dssp ECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence 9999999999998653 468999999999999999999997 89999999999999976 4559999999998665
Q ss_pred CCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 662 PEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 662 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
... .....+|+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 235 (336)
T 3fhr_A 183 QNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ 235 (336)
T ss_dssp ------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccch
Confidence 332 23456899999999999999999999999999999999999999665543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=288.36 Aligned_cols=199 Identities=25% Similarity=0.318 Sum_probs=167.7
Q ss_pred HHhhccccccccccccEEEEEEEE-CCccEEEEEEeecCCcccHHHHHHHHHHHhcCC-----------CCCccceecee
Q 043185 508 EVATDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIH-----------HVNLVKLKGFC 575 (724)
Q Consensus 508 ~~a~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~g~~ 575 (724)
....+.+.+.||+|+||.||+|+. .+++.||||++... ....+.+.+|+.++++++ |+||+++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 345677789999999999999997 46788999999743 334567889999998886 89999999998
Q ss_pred ecCC----eEEEEEEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCC-CeEecCCCCCCeEEeC----
Q 043185 576 AQGR----QRLLVYEYMNHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQ-KIIHCDIKPENILLHY---- 645 (724)
Q Consensus 576 ~~~~----~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~iiH~Dlkp~NILl~~---- 645 (724)
.... ..++||||+ +++|.+++... ...+++..+..++.||+.||+|||+ . +|+||||||+|||++.
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETT
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCC
Confidence 7654 789999999 88999998764 3458999999999999999999997 6 9999999999999954
Q ss_pred --CCcEEEEeecCccccCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 646 --HFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 646 --~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.+.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.+..
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 347999999999876543 234578999999999999999999999999999999999999998665
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-31 Score=277.48 Aligned_cols=199 Identities=25% Similarity=0.380 Sum_probs=165.0
Q ss_pred hhccccccccccccEEEEEEEECCccEEEEEEeecCC--cccHHHHHHHHHHHhcCC--CCCccceeceeecCCeEEEEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIH--HVNLVKLKGFCAQGRQRLLVY 585 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~~~~~lV~ 585 (724)
..+.+.+.||+|+||.||+++..+++.||||++.... ....+.+.+|++++.+++ |+||+++++++......++||
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 107 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 107 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEE
T ss_pred ceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEE
Confidence 3456678999999999999998888999999996532 334577899999999997 599999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc
Q 043185 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 665 (724)
| +.+++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++ ++.+||+|||+++.......
T Consensus 108 e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~ 181 (313)
T 3cek_A 108 E-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 181 (313)
T ss_dssp C-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCC------
T ss_pred e-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEE-CCeEEEeeccccccccCccc
Confidence 9 5688999999765 368889999999999999999997 8999999999999996 48999999999987654322
Q ss_pred c-ceecccccccccccccccC-----------CcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 666 S-LFTTMRGTRGYLAPEWLTN-----------SAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 666 ~-~~~~~~gt~~y~aPE~l~~-----------~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
. ......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence 1 1234568999999999875 46888999999999999999999999654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-32 Score=288.85 Aligned_cols=192 Identities=21% Similarity=0.184 Sum_probs=158.2
Q ss_pred HhhccccccccccccEEEEEEEECCccEEEEEEeecCC--------cccHHHHHHHHHHHhcCC---------CCCccce
Q 043185 509 VATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVG--------VQGKKDFCTEIAIIGNIH---------HVNLVKL 571 (724)
Q Consensus 509 ~a~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~---------H~nIv~l 571 (724)
...+.+.+.||+|+||.||+|+. +++.||||++.... ....+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 34566678999999999999998 56889999997542 223478889999988886 5555555
Q ss_pred e-----------------ceeec-------------CCeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHH
Q 043185 572 K-----------------GFCAQ-------------GRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLA 621 (724)
Q Consensus 572 ~-----------------g~~~~-------------~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~ 621 (724)
. +++.+ ....+|||||+++|++.+.+.+ ..+++..+..++.||+.||+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence 4 44443 6789999999999976666643 46889999999999999999
Q ss_pred HHH-cCCCCCeEecCCCCCCeEEeCCC--------------------cEEEEeecCccccCCCCccceeccccccccccc
Q 043185 622 YLH-SGCEQKIIHCDIKPENILLHYHF--------------------QAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAP 680 (724)
Q Consensus 622 yLH-~~~~~~iiH~Dlkp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aP 680 (724)
||| + .+|+||||||+|||++.++ .+||+|||+++..... ...||+.|+||
T Consensus 176 ~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aP 246 (336)
T 2vuw_A 176 VAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDE 246 (336)
T ss_dssp HHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCS
T ss_pred HHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccCh
Confidence 999 7 8999999999999999987 8999999999876432 34699999999
Q ss_pred ccccCCcCCCccchhhHHHH-HHHHHhCCCCCCC
Q 043185 681 EWLTNSAISEKTDVYSFGMV-LLELVSGRRNCSP 713 (724)
Q Consensus 681 E~l~~~~~~~~sDv~SlGv~-l~elltG~~p~~~ 713 (724)
|++.+.. +.++|||||+++ .+++++|..||..
T Consensus 247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred hhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 9998876 889999998777 7889999999853
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=293.06 Aligned_cols=196 Identities=28% Similarity=0.348 Sum_probs=157.7
Q ss_pred ccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEEEEEecCC
Q 043185 512 DNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
+...++||+|+||+|+.....+++.||||++..... ..+.+|+++++++ +|||||++++++.+....+|||||++
T Consensus 26 y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~- 101 (432)
T 3p23_A 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA- 101 (432)
T ss_dssp EEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred EecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence 445689999999997665566788899999975322 2356899999999 79999999999999999999999997
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC-----CCcEEEEeecCccccCCCCc
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY-----HFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-----~~~~kl~DFGla~~~~~~~~ 665 (724)
|+|.+++...........+..++.||+.||+|||+ .+|+||||||+|||++. ...+||+|||+++.......
T Consensus 102 g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~ 178 (432)
T 3p23_A 102 ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178 (432)
T ss_dssp EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence 59999998765555555677899999999999997 89999999999999953 23588999999987654321
Q ss_pred --cceeccccccccccccccc---CCcCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 043185 666 --SLFTTMRGTRGYLAPEWLT---NSAISEKTDVYSFGMVLLELVS-GRRNCSPR 714 (724)
Q Consensus 666 --~~~~~~~gt~~y~aPE~l~---~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~ 714 (724)
.......||+.|+|||++. ...++.++||||||+++|||++ |+.||...
T Consensus 179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~ 233 (432)
T 3p23_A 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS 233 (432)
T ss_dssp -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST
T ss_pred ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh
Confidence 2234567999999999997 4567889999999999999999 99999543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=283.39 Aligned_cols=200 Identities=26% Similarity=0.378 Sum_probs=166.5
Q ss_pred hhccccccccccccEEEEEEEECCccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
..+.+.+.||+|+||.||+|+..+ .+|+|++.... ....+.+.+|+.++++++||||+++++++.+....++|+||
T Consensus 33 ~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~ 110 (319)
T 2y4i_B 33 EQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSL 110 (319)
T ss_dssp SCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBC
T ss_pred HHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeec
Confidence 345567899999999999999865 38999986432 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC---
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ--- 664 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~--- 664 (724)
+++++|.+++......+++..+..++.||+.||+|||+ .+++||||||+|||++ ++.+||+|||+++......
T Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~ 186 (319)
T 2y4i_B 111 CKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR 186 (319)
T ss_dssp CCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC---------
T ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCccccccccccc
Confidence 99999999998776678999999999999999999997 8999999999999998 6799999999987653211
Q ss_pred -ccceecccccccccccccccC---------CcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 665 -SSLFTTMRGTRGYLAPEWLTN---------SAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 665 -~~~~~~~~gt~~y~aPE~l~~---------~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
........|++.|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 187 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 247 (319)
T 2y4i_B 187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247 (319)
T ss_dssp -CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC
T ss_pred cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 112233458999999999874 457889999999999999999999997654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-31 Score=280.38 Aligned_cols=198 Identities=25% Similarity=0.412 Sum_probs=169.7
Q ss_pred hhccccccccccccEEEEEEEEC-CccEEEEEEeecCCcc------cHHHHHHHHHHHhcCC--CCCccceeceeecCCe
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQ------GKKDFCTEIAIIGNIH--HVNLVKLKGFCAQGRQ 580 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~~~ 580 (724)
..+.+.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+.++++++ |+||+++++++...+.
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~ 122 (320)
T 3a99_A 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122 (320)
T ss_dssp TTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCc
Confidence 34666789999999999999964 6788999999753221 2245678999999996 5999999999999999
Q ss_pred EEEEEEecCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEe-CCCcEEEEeecCcc
Q 043185 581 RLLVYEYMNH-GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLH-YHFQAKISDFGLSK 658 (724)
Q Consensus 581 ~~lV~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DFGla~ 658 (724)
.++|+|++.+ ++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||+++
T Consensus 123 ~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 123 FVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp EEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 9999999986 8999998764 458899999999999999999997 8999999999999999 78999999999998
Q ss_pred ccCCCCccceecccccccccccccccCCcC-CCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 659 LLTPEQSSLFTTMRGTRGYLAPEWLTNSAI-SEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 659 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||...
T Consensus 199 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 252 (320)
T 3a99_A 199 LLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252 (320)
T ss_dssp ECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred cccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence 765432 234568999999999987665 78899999999999999999999653
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=280.30 Aligned_cols=199 Identities=29% Similarity=0.410 Sum_probs=163.4
Q ss_pred HHhhccccccccccccEEEEEEEE-CCccEEEEEEeecCCcc------cHHHHHHHHHHHhcC----CCCCccceeceee
Q 043185 508 EVATDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQ------GKKDFCTEIAIIGNI----HHVNLVKLKGFCA 576 (724)
Q Consensus 508 ~~a~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l----~H~nIv~l~g~~~ 576 (724)
....+.+.+.||+|+||.||+|+. .+++.||||++...... ....+.+|+.++.++ +|+||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 345577789999999999999986 46788999999654321 223456788888888 8999999999999
Q ss_pred cCCeEEEEEEe-cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEe-CCCcEEEEee
Q 043185 577 QGRQRLLVYEY-MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLH-YHFQAKISDF 654 (724)
Q Consensus 577 ~~~~~~lV~e~-~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DF 654 (724)
..+..++|+|+ +++++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++ .++.+||+||
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~df 184 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDF 184 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred cCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEEEEc
Confidence 99999999999 78999999997653 58999999999999999999997 8999999999999999 8899999999
Q ss_pred cCccccCCCCccceecccccccccccccccCCcC-CCccchhhHHHHHHHHHhCCCCCCC
Q 043185 655 GLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAI-SEKTDVYSFGMVLLELVSGRRNCSP 713 (724)
Q Consensus 655 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDv~SlGv~l~elltG~~p~~~ 713 (724)
|+++...... .....|+..|+|||++.+..+ +.++||||||+++|||++|+.||..
T Consensus 185 g~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 185 GSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp SSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred chhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 9998765433 234568999999999987666 4589999999999999999999964
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=275.13 Aligned_cols=199 Identities=23% Similarity=0.336 Sum_probs=150.3
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCcc-cH-HHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQ-GK-KDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~-~~-~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
.+.+.+.||+|+||.||+|+.. +++.||||++...... .. +.+.++..+++.++||||+++++++.++...++||||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 105 (318)
T 2dyl_A 26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL 105 (318)
T ss_dssp GEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred cccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Confidence 3455688999999999999985 6789999999764322 22 3344555678888999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
+ ++.+..+.......+++..+..++.|++.||.|||+ ..+++||||||+|||++.++.+||+|||++........
T Consensus 106 ~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-- 180 (318)
T 2dyl_A 106 M-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA-- 180 (318)
T ss_dssp C-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH--HHCCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred c-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh--hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc--
Confidence 9 556666665545678999999999999999999996 13899999999999999999999999999976644322
Q ss_pred eeccccccccccccccc-----CCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLT-----NSAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~-----~~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
.....+++.|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 181 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (318)
T 2dyl_A 181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC 232 (318)
T ss_dssp ------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCC
Confidence 23456899999999994 457889999999999999999999999763
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-31 Score=299.51 Aligned_cols=200 Identities=32% Similarity=0.459 Sum_probs=172.1
Q ss_pred hhccccccccccccEEEEEEEEC-CccEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeceeec------CCeE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV-GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ------GRQR 581 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~------~~~~ 581 (724)
..+.+.+.||+|+||.||+|... +++.||||++... .....+++.+|++++.+++||||+++++++.. +...
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 45667899999999999999974 6788999998753 23445678999999999999999999998765 6778
Q ss_pred EEEEEecCCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCc---EEEEeecC
Q 043185 582 LLVYEYMNHGSLDRILFGNG--PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQ---AKISDFGL 656 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DFGl 656 (724)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999997643 358888999999999999999997 89999999999999997765 99999999
Q ss_pred ccccCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 657 SKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 657 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
+........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.+.
T Consensus 171 a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~ 226 (676)
T 3qa8_A 171 AKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226 (676)
T ss_dssp CCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcc
Confidence 987654332 24467999999999999999999999999999999999999999653
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.3e-31 Score=305.73 Aligned_cols=193 Identities=26% Similarity=0.384 Sum_probs=165.0
Q ss_pred hhccccccccccccEEEEEEEEC--CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCe-----E
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN--DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQ-----R 581 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~--~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~-----~ 581 (724)
..+.+.+.||+|+||.||++... +++.||||++.... ....+.+.+|++++.+++||||+++++++.+... .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 45677789999999999999985 57889999986532 2344678999999999999999999999987655 7
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccC
Q 043185 582 LLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 661 (724)
+|||||+++++|.+++.. .+++..++.++.||+.||.|||+ .+|+||||||+|||++.+ .+||+|||+++...
T Consensus 160 ~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp EEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred EEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 999999999999887754 68999999999999999999997 899999999999999986 89999999998765
Q ss_pred CCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 662 PEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 662 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.. ....||+.|+|||++.+.. +.++||||||++++||++|.+||.+..
T Consensus 233 ~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~ 280 (681)
T 2pzi_A 233 SF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRY 280 (681)
T ss_dssp CC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEE
T ss_pred cC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccc
Confidence 43 3456999999999997654 889999999999999999999987543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=263.57 Aligned_cols=176 Identities=11% Similarity=0.070 Sum_probs=152.3
Q ss_pred HhhccccccccccccEEEEEEEEC-CccEEEEEEeecCCc---ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEE
Q 043185 509 VATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV---QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLV 584 (724)
Q Consensus 509 ~a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 584 (724)
...|.+.+.||+|+||.||+|+.. +++.||||++..... ...+++.+|+.++.+++||||+++++++.+++..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 345677789999999999999986 478899999976432 2236789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC
Q 043185 585 YEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (724)
|||+++++|.+++... ....+..+++.|++.||+|||+ .+|+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 9999999999999543 3556788999999999999997 899999999999999999999997443
Q ss_pred ccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 043185 665 SSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSH 718 (724)
Q Consensus 665 ~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~ 718 (724)
|++ +++.++||||||+++|||++|+.||......+
T Consensus 175 ------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~ 209 (286)
T 3uqc_A 175 ------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRS 209 (286)
T ss_dssp ------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCC
T ss_pred ------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcch
Confidence 333 36899999999999999999999998876544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-30 Score=283.35 Aligned_cols=198 Identities=16% Similarity=0.144 Sum_probs=153.7
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHHHHHHHHhcCCC-CCccceec---------e----
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIHH-VNLVKLKG---------F---- 574 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H-~nIv~l~g---------~---- 574 (724)
...++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++| +|...... .
T Consensus 81 ~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (413)
T 3dzo_A 81 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 160 (413)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECC
T ss_pred EEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccC
Confidence 34578999999999999964 68899999987332 2335789999999999977 32211111 1
Q ss_pred --------eec-----CCeEEEEEEecCCCCHHHHHh------cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecC
Q 043185 575 --------CAQ-----GRQRLLVYEYMNHGSLDRILF------GNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCD 635 (724)
Q Consensus 575 --------~~~-----~~~~~lV~e~~~~gsL~~~l~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~D 635 (724)
... ....+++|+++ +++|.+++. .....+++..++.++.||+.||+|||+ .+|+|||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iiHrD 236 (413)
T 3dzo_A 161 QKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTY 236 (413)
T ss_dssp C---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEECSC
T ss_pred CCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCC
Confidence 111 12345666654 679998884 224457788899999999999999997 8999999
Q ss_pred CCCCCeEEeCCCcEEEEeecCccccCCCCccceecccccccccccccc----------cCCcCCCccchhhHHHHHHHHH
Q 043185 636 IKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL----------TNSAISEKTDVYSFGMVLLELV 705 (724)
Q Consensus 636 lkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l----------~~~~~~~~sDv~SlGv~l~ell 705 (724)
|||+||||+.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|||+
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred cccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 9999999999999999999998865432 344567 999999999 6667899999999999999999
Q ss_pred hCCCCCCCCCCCCC
Q 043185 706 SGRRNCSPRSQSHS 719 (724)
Q Consensus 706 tG~~p~~~~~~~~~ 719 (724)
+|+.||......+.
T Consensus 312 tg~~Pf~~~~~~~~ 325 (413)
T 3dzo_A 312 CADLPNTDDAALGG 325 (413)
T ss_dssp HSSCCCCTTGGGSC
T ss_pred HCCCCCCCcchhhh
Confidence 99999987665443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-28 Score=257.06 Aligned_cols=170 Identities=23% Similarity=0.355 Sum_probs=147.5
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHH-hcCCCCCccceeceeec----CCeEEEEEEecC
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAII-GNIHHVNLVKLKGFCAQ----GRQRLLVYEYMN 589 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l-~~l~H~nIv~l~g~~~~----~~~~~lV~e~~~ 589 (724)
+.||+|+||.||++... +++.||+|+++.. ..+.+|+.++ +.++||||+++++++.. ....++||||++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 98 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 98 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence 67999999999999974 6789999998642 5677888887 56699999999999876 678899999999
Q ss_pred CCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC---CCcEEEEeecCccccCCCCc
Q 043185 590 HGSLDRILFGNG-PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY---HFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 590 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DFGla~~~~~~~~ 665 (724)
+++|.+++.... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++. ++.+||+|||++....
T Consensus 99 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~---- 171 (299)
T 3m2w_A 99 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---- 171 (299)
T ss_dssp SCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT----
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccccccc----
Confidence 999999998753 468999999999999999999997 89999999999999998 7889999999986432
Q ss_pred cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 666 SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 666 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
+..++.++||||||+++|||++|+.||.....
T Consensus 172 -------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 203 (299)
T 3m2w_A 172 -------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 203 (299)
T ss_dssp -------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---
T ss_pred -------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 24578899999999999999999999976543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-28 Score=277.42 Aligned_cols=185 Identities=17% Similarity=0.069 Sum_probs=129.3
Q ss_pred ccccccccEEEEEEE-ECCccEEEEEEeecCC----------cccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEE
Q 043185 516 NLIGSGGFGAVYKGI-LNDKTIVAVKKITNVG----------VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLL 583 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~-~~~~~~vAvK~~~~~~----------~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l 583 (724)
..++.|+.|.+.+++ +--++.+|+|.+.+.. ....++|.+|+++|+++ .|+||+++++++.++...||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 346677777766655 2345669999996531 12235799999999999 79999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCC
Q 043185 584 VYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE 663 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (724)
||||++|++|.++|...+ .++.. +|+.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+.....
T Consensus 320 VMEyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EEECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EEecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 999999999999998764 45543 488999999999997 99999999999999999999999999999876544
Q ss_pred CccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCC
Q 043185 664 QSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRR 709 (724)
Q Consensus 664 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~ 709 (724)
.. ......||+.|||||++.+. +..++|+||+|++++++.++..
T Consensus 393 ~~-~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 393 CS-WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp -C-CSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred Cc-cccCceechhhccHHHhCCC-CCCcccccccccchhhhccccc
Confidence 32 23456799999999999874 5678999999998887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.8e-25 Score=251.26 Aligned_cols=183 Identities=18% Similarity=0.221 Sum_probs=147.4
Q ss_pred cccccccccEEEEEEEECCccEEEEEEeecCCcc--------cHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEE
Q 043185 515 KNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQ--------GKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 515 ~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~--------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
.++||+|+||.||++... ++.+++|+....... ..+++.+|++++++++||||+++..++...+..+||||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 468999999999999554 466888886432211 13458999999999999999977777777788899999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
|+++++|.+++.. +..++.|+++||+|||+ ++|+||||||+|||++. .+||+|||+++........
T Consensus 420 ~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 420 YINGKLAKDVIED---------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp CCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred CCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence 9999999999865 56799999999999997 89999999999999998 9999999999987553221
Q ss_pred c------eecccccccccccccccC--CcCCCccchhhHHHHHHHHHhCCCCCC
Q 043185 667 L------FTTMRGTRGYLAPEWLTN--SAISEKTDVYSFGMVLLELVSGRRNCS 712 (724)
Q Consensus 667 ~------~~~~~gt~~y~aPE~l~~--~~~~~~sDv~SlGv~l~elltG~~p~~ 712 (724)
. .....||+.|||||++.. ..|+...|+|+..+-.++.+.++.+|.
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 1 135679999999999987 678889999999999999999888774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=9.8e-22 Score=203.77 Aligned_cols=154 Identities=17% Similarity=0.110 Sum_probs=122.6
Q ss_pred ccccccccccEEEEEEEECCccEEEEEEeecCCc------------------ccHHHHHHHHHHHhcCCCCCccceecee
Q 043185 514 FKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGV------------------QGKKDFCTEIAIIGNIHHVNLVKLKGFC 575 (724)
Q Consensus 514 ~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~nIv~l~g~~ 575 (724)
+.+.||+|+||.||+|...+++.||+|.++.... .....+.+|++++++++ | +++.+++
T Consensus 94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~ 170 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY 170 (282)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence 4588999999999999997788999999964211 12456899999999998 4 6666655
Q ss_pred ecCCeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeec
Q 043185 576 AQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFG 655 (724)
Q Consensus 576 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFG 655 (724)
.. +..++||||+++++|.+ +.. .....++.|++.||.|||+ .+|+||||||+|||++ ++.+||+|||
T Consensus 171 ~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~vkl~DFG 237 (282)
T 1zar_A 171 AW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWIIDFP 237 (282)
T ss_dssp EE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred ec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCcEEEEECC
Confidence 43 55699999999999988 421 2244699999999999997 9999999999999999 9999999999
Q ss_pred CccccCCCCccceecccccccccccccccC----------CcCCCccchhhH
Q 043185 656 LSKLLTPEQSSLFTTMRGTRGYLAPEWLTN----------SAISEKTDVYSF 697 (724)
Q Consensus 656 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~----------~~~~~~sDv~Sl 697 (724)
+++. +..++|||++.. ..+..++|+|.+
T Consensus 238 ~a~~--------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 238 QSVE--------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp TCEE--------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred CCeE--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 9863 345788998854 455666777653
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.74 E-value=1.3e-17 Score=144.50 Aligned_cols=102 Identities=17% Similarity=0.336 Sum_probs=82.5
Q ss_pred cccccCCcccceeeeecCCCeEEeCCCeEEEEEEecCCCCceEEEEEEeccCCeEEEecCCCCCCCCCceEEEccCcc-E
Q 043185 24 EFIHPNFTASHVKFIDYGGSFLTSHNGTFKAAIVNTRSQQNSFYLCIIHVLSNTIIWSANRDTPISGSGKMNLTPKGI-I 102 (724)
Q Consensus 24 ~~~~~~~t~~~~~~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~i~~~~~~~~tvVW~Anr~~pv~~~~~l~~~~~g~-~ 102 (724)
+.|.+|+++. .+++|+| |.|.|.|...++ +.+. ...++||+|||+.|....+.|.|+.||+ |
T Consensus 2 n~L~~g~~L~-------~g~~L~s--g~y~l~~q~DgN----Lvly----~~~~~vW~ant~~~~~~~~~L~l~~dGnLv 64 (105)
T 4h3o_A 2 NILDNNEGLY-------AGQSLDV--EPYHFIMQDDCN----LVLY----DHSTSTWASNTEIGGKSGCSAVLQSDGNFV 64 (105)
T ss_dssp CEECTTEEEC-------TTCEEEE--TTEEEEECTTSC----EEEE----ETTEEEEECCCCCTTCCSCEEEECTTSCEE
T ss_pred CCcCCCCEEc-------CCCEEEE--CCEEEEECCCCe----EEEE----ECCEEEEEecCCCCCCccEEEEEeCCccEE
Confidence 5677777775 3678887 889999975542 3332 1578999999999998888999999995 8
Q ss_pred EEcCCCCeEEecCCCCC-ceeEEEEecCCcEEEecCCCccceec
Q 043185 103 ISDENGNLKWSTPPLKS-SVSALRLTEMGNLVLLDGFNGSLWES 145 (724)
Q Consensus 103 l~~~~g~~vWst~~~~~-~~~~~~L~dsGNlVl~~~~~~~lWQS 145 (724)
|+|++|++||+|+++.. ...+|+|+|+|||||+++ .+|||
T Consensus 65 L~d~~~~~vWss~t~~~~~~~~l~L~ddGNlVly~~---~~W~S 105 (105)
T 4h3o_A 65 VYDSSGRSLWASHSTRGSGNYILILQDDGNVIIYGS---DIWST 105 (105)
T ss_dssp EECTTCCEEEECCCCCCSSCEEEEECTTSCEEEEES---EEEEC
T ss_pred EECCCcEEEEEecCCCCCCCEEEEEeCCCeEEEECC---cEecC
Confidence 99999999999998643 446799999999999964 69998
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.7e-18 Score=177.16 Aligned_cols=136 Identities=15% Similarity=0.111 Sum_probs=104.6
Q ss_pred cccccccccccEEEEEEEE-CCccE--EEEEEeecCCcc------------------------cHHHHHHHHHHHhcCCC
Q 043185 513 NFKNLIGSGGFGAVYKGIL-NDKTI--VAVKKITNVGVQ------------------------GKKDFCTEIAIIGNIHH 565 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~-~~~~~--vAvK~~~~~~~~------------------------~~~~~~~E~~~l~~l~H 565 (724)
.+.+.||+|+||.||+|.. .+++. ||||+++..... ....+.+|++++.+++|
T Consensus 50 ~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 129 (258)
T 1zth_A 50 AMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE 129 (258)
T ss_dssp EEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred hhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence 3567899999999999998 67888 999987542111 01367899999999988
Q ss_pred CCc--cceeceeecCCeEEEEEEecCC-C----CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCeEecCCC
Q 043185 566 VNL--VKLKGFCAQGRQRLLVYEYMNH-G----SLDRILFGNGPVLEWQERFDIALGTARGLAYLH-SGCEQKIIHCDIK 637 (724)
Q Consensus 566 ~nI--v~l~g~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~iiH~Dlk 637 (724)
+++ +.++.. ...+|||||+.+ | +|.++... .++.....++.|++.+|.||| + .+|+|||||
T Consensus 130 ~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~---~givHrDlk 198 (258)
T 1zth_A 130 AGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQE---AELVHADLS 198 (258)
T ss_dssp TTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHT---SCEECSSCS
T ss_pred CCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHH---CCEEeCCCC
Confidence 864 333332 356899999942 4 67665432 123456789999999999999 6 899999999
Q ss_pred CCCeEEeCCCcEEEEeecCccccC
Q 043185 638 PENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 638 p~NILl~~~~~~kl~DFGla~~~~ 661 (724)
|.|||++. .++|+|||+|....
T Consensus 199 p~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEETT
T ss_pred HHHEEEcC--cEEEEECcccccCC
Confidence 99999988 99999999997653
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=4.7e-17 Score=142.45 Aligned_cols=107 Identities=17% Similarity=0.277 Sum_probs=85.2
Q ss_pred cccccCCcccceeeeecCCCeEEeCCCeEEEEEEecCCCCceEEEEEEeccCCeEEEecCCCCCCCCCceEEEccCcc-E
Q 043185 24 EFIHPNFTASHVKFIDYGGSFLTSHNGTFKAAIVNTRSQQNSFYLCIIHVLSNTIIWSANRDTPISGSGKMNLTPKGI-I 102 (724)
Q Consensus 24 ~~~~~~~t~~~~~~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~i~~~~~~~~tvVW~Anr~~pv~~~~~l~~~~~g~-~ 102 (724)
|.|.+|+++. .+++|+ ++|.|+|+|+..++ + +++. ..++||.||++.|- .++.+.|.++|+ |
T Consensus 2 d~l~~g~~L~-------~g~~l~-~~~~~~l~~~~dGn----l-vl~~---~~~~vW~sn~~~~~-~~~~l~l~~dGNLV 64 (110)
T 3a0c_A 2 NSLSSPNSLF-------TGHSLE-VGPSYRLIMQGDCN----F-VLYD---SGKPVWASNTGGLG-SGCRLTLHNNGNLV 64 (110)
T ss_dssp CEEETTCEEC-------TTCEEE-ETTTEEEEECTTSC----E-EEEE---TTEEEEECCCTTSC-SSCEEEECTTSCEE
T ss_pred CEeCCCCEEC-------CCCEEE-ECCCEEEEEcCCCc----E-EEEE---CCEEEEECCCCCCC-CcEEEEEeCCCCEE
Confidence 5677777764 478999 99999999986653 2 3343 47999999998773 346899999995 8
Q ss_pred EEcCCCCeEEecCCCCC-ceeEEEEecCCcEEEecCCCccceecccCCC
Q 043185 103 ISDENGNLKWSTPPLKS-SVSALRLTEMGNLVLLDGFNGSLWESFHHPR 150 (724)
Q Consensus 103 l~~~~g~~vWst~~~~~-~~~~~~L~dsGNlVl~~~~~~~lWQSFd~Pt 150 (724)
|.|.+|+++|+|++..+ +..+++|+|+|||||++. .+||||+||.
T Consensus 65 l~~~~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~ 110 (110)
T 3a0c_A 65 IYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP---VVWATGSGPA 110 (110)
T ss_dssp EECTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEEECSCCC-
T ss_pred EECCCCcEEEecCCCCCCCCEEEEEeCCccEEEECC---CEecCCCcCC
Confidence 88999999999997644 345799999999999975 7999999983
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.71 E-value=5.9e-17 Score=143.67 Aligned_cols=105 Identities=15% Similarity=0.247 Sum_probs=83.6
Q ss_pred ccccccCCcccceeeeecCCCeEE--eCCCeEEEEEEecCCCCceEEEEEEeccCCeEEEecCCCCCCCCCceEEEccCc
Q 043185 23 SEFIHPNFTASHVKFIDYGGSFLT--SHNGTFKAAIVNTRSQQNSFYLCIIHVLSNTIIWSANRDTPISGSGKMNLTPKG 100 (724)
Q Consensus 23 ~~~~~~~~t~~~~~~~~~~~~~lv--S~~g~F~lGF~~~~~~~~~~~i~~~~~~~~tvVW~Anr~~pv~~~~~l~~~~~g 100 (724)
.+.|.++++|. .+++|+ |++|.|+|+|+.++. + +++.+ .++||+||++.| ..++.|.|.++|
T Consensus 8 ~~~l~~g~~L~-------~g~~l~~~S~~g~~~L~~~~dgn----l-vly~~---~~~vW~sn~~~~-~~~~~l~l~~dG 71 (119)
T 1b2p_A 8 QPDDNHPQILH-------ATESLEILFGTHVYRFIMQTDCN----L-VLYDN---NNPIWATNTGGL-GNGCRAVLQPDG 71 (119)
T ss_dssp CSSSCCCCEEE-------TTCEEEEEETTEEEEEEECTTSC----E-EEEET---TEEEEECCCTTS-CSSCEEEECTTS
T ss_pred CcccCCCCEEc-------CCCEEEEeCCCCCEEEEEecCCC----E-EEEEC---CEEEEeCCCccC-CCceEEEEccCC
Confidence 46667777664 478999 999999999997653 2 34543 799999999977 334789999999
Q ss_pred c-EEEcCCCCeEEecCCCCC-ceeEEEEecCCcEEEecCCCccceecc
Q 043185 101 I-IISDENGNLKWSTPPLKS-SVSALRLTEMGNLVLLDGFNGSLWESF 146 (724)
Q Consensus 101 ~-~l~~~~g~~vWst~~~~~-~~~~~~L~dsGNlVl~~~~~~~lWQSF 146 (724)
+ ||+|.+|+++|+|++..+ +..+++|+|+|||||++ ..+|||=
T Consensus 72 NLVl~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~---~~~W~Sg 116 (119)
T 1b2p_A 72 VLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWATQ 116 (119)
T ss_dssp CEEEECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEECC
T ss_pred EEEEEeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC---ccEeCCC
Confidence 5 888999999999987543 35678999999999997 3899983
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=1.3e-16 Score=141.09 Aligned_cols=107 Identities=21% Similarity=0.307 Sum_probs=84.5
Q ss_pred cccccCCcccceeeeecCCCeEEeCCCeEEEEEEecCCCCceEEEEEEeccCCeEEEecCCCCCCCCCceEEEccCcc-E
Q 043185 24 EFIHPNFTASHVKFIDYGGSFLTSHNGTFKAAIVNTRSQQNSFYLCIIHVLSNTIIWSANRDTPISGSGKMNLTPKGI-I 102 (724)
Q Consensus 24 ~~~~~~~t~~~~~~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~i~~~~~~~~tvVW~Anr~~pv~~~~~l~~~~~g~-~ 102 (724)
|+|.+++++. .+++|+ +|.|+|+|+.++. +.+ +. ..++||+||++.|. .++.|.|.++|+ |
T Consensus 3 dtl~~gq~L~-------~g~~L~--~g~~~L~~~~dgn----lvl-y~---~~~~vW~sn~~~~~-~~~~l~l~~~GnLv 64 (115)
T 2dpf_A 3 NVLLSGQTLH-------ADHSLQ--AGAYTLTIQNKCN----LVK-YQ---NGRQIWASNTDRRG-SGCRLTLLSDGNLV 64 (115)
T ss_dssp CEEETTCEEE-------TTEEEE--ETTEEEEECTTSC----EEE-EE---TTEEEEECSCTTSC-SSCEEEECTTSCEE
T ss_pred CEeCCCCEEC-------CCCEEE--CCCEEEEEcCCCc----EEE-Ee---CCEEEEeCCCCCCC-CceEEEECCCCcEE
Confidence 5677777764 467887 8999999986552 222 32 48999999999883 347899999995 8
Q ss_pred EEcCCCCeEEecCCCC-CceeEEEEecCCcEEEecCCCccceecccCCCc
Q 043185 103 ISDENGNLKWSTPPLK-SSVSALRLTEMGNLVLLDGFNGSLWESFHHPRD 151 (724)
Q Consensus 103 l~~~~g~~vWst~~~~-~~~~~~~L~dsGNlVl~~~~~~~lWQSFd~PtD 151 (724)
|.|.+|+++|+|++.. ....+++|+|+|||||++. .+||||.++..
T Consensus 65 l~d~~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~~ 111 (115)
T 2dpf_A 65 IYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGP---VLWSLGPNGCR 111 (115)
T ss_dssp EECTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEECSSTTCBC
T ss_pred EECCCceEEEEcCCCCCCCCEEEEEeCCCeEEEECC---CEEECCCCCCc
Confidence 8898899999999753 3346799999999999964 89999998765
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.64 E-value=8e-16 Score=135.32 Aligned_cols=107 Identities=16% Similarity=0.324 Sum_probs=83.2
Q ss_pred cccccCCcccceeeeecCCCeEEeCCCeEEEEEEecCCCCceEEEEEEeccCCeEEEecCCCCCCCCCceEEEccCcc-E
Q 043185 24 EFIHPNFTASHVKFIDYGGSFLTSHNGTFKAAIVNTRSQQNSFYLCIIHVLSNTIIWSANRDTPISGSGKMNLTPKGI-I 102 (724)
Q Consensus 24 ~~~~~~~t~~~~~~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~i~~~~~~~~tvVW~Anr~~pv~~~~~l~~~~~g~-~ 102 (724)
|+|.+++++. .+++| ++|.|+|+|+.++. + +++.. .++||+||++.+ ..++.|.|..+|+ |
T Consensus 2 dtl~~gq~L~-------~g~~L--~~~~~~L~~~~dgn----l-vl~~~---~~~vW~sn~~~~-~~~~~l~l~~~GNLv 63 (112)
T 1xd5_A 2 DRLNSGHQLD-------TGGSL--AEGGYLFIIQNDCN----L-VLYDN---NRAVWASGTNGK-ASGCVLKMQNDGNLV 63 (112)
T ss_dssp CEEETTEEEC-------TTCEE--EETTEEEEECTTSC----E-EEEET---TEEEEECCCTTS-CSSEEEEECTTSCEE
T ss_pred CCCCCCCEEC-------CCCEE--eCCCEEEEEcCCCc----E-EEEEC---CEEEEeCCCcCC-CCCEEEEEeCCCCEE
Confidence 5677777765 46777 58999999987763 2 23332 689999999863 2236899999995 8
Q ss_pred EEcCCCCeEEecCCCCC-ceeEEEEecCCcEEEecCCCccceecccCC
Q 043185 103 ISDENGNLKWSTPPLKS-SVSALRLTEMGNLVLLDGFNGSLWESFHHP 149 (724)
Q Consensus 103 l~~~~g~~vWst~~~~~-~~~~~~L~dsGNlVl~~~~~~~lWQSFd~P 149 (724)
|.| ++.++|+|++..+ +..+++|+++|||||++..+..+||||++.
T Consensus 64 l~d-~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~~~~~W~S~~~~ 110 (112)
T 1xd5_A 64 IYS-GSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNV 110 (112)
T ss_dssp EEE-TTEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCC
T ss_pred EEc-CCEEEEECCccCCCCCEEEEEeCCCcEEEECCCCceEEECCCcc
Confidence 888 8889999987543 346799999999999987778999999985
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=3.8e-15 Score=130.17 Aligned_cols=103 Identities=17% Similarity=0.285 Sum_probs=79.8
Q ss_pred cccccCCcccceeeeecCCCeEEeCCCeEEEEEEecCCCCceEEEEEEeccCCeEEEecCCCCCCCCCceEEEccCcc-E
Q 043185 24 EFIHPNFTASHVKFIDYGGSFLTSHNGTFKAAIVNTRSQQNSFYLCIIHVLSNTIIWSANRDTPISGSGKMNLTPKGI-I 102 (724)
Q Consensus 24 ~~~~~~~t~~~~~~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~i~~~~~~~~tvVW~Anr~~pv~~~~~l~~~~~g~-~ 102 (724)
++|.||+++. .+++|+ +|.|+|.|+..++ +.+ +.. .++||+||++.+ ..++.|.|..+|+ |
T Consensus 2 ntL~~gq~L~-------~g~~L~--~g~~~L~~q~dGn----Lvl-y~~---~~~vW~snt~~~-~~~~~l~l~~dGNLv 63 (109)
T 3dzw_A 2 NILYSGETLS-------PGEFLN--NGRYVFIMQEDCN----LVL-YDV---DKPIWATNTGGL-DRRCHLSMQSDGNLV 63 (109)
T ss_dssp CEEETTEEEC-------TTCEEE--ETTEEEEECTTSC----EEE-EET---TEEEEECCCTTS-SSSCEEEECTTSCEE
T ss_pred CCcCCCCEeC-------CCCEEE--CCCEEEEEcCCCc----EEE-EeC---CEEEEECCcccC-CCCEEEEEeCCCCEE
Confidence 5677777764 467886 7999999986653 333 332 689999999876 2346899999995 8
Q ss_pred EEcCCCCeEEecCCCCCc-eeEEEEecCCcEEEecCCCccceeccc
Q 043185 103 ISDENGNLKWSTPPLKSS-VSALRLTEMGNLVLLDGFNGSLWESFH 147 (724)
Q Consensus 103 l~~~~g~~vWst~~~~~~-~~~~~L~dsGNlVl~~~~~~~lWQSFd 147 (724)
|.|.+|+++|+|++.... ..+|+|+|+|||||+++ .+|||=-
T Consensus 64 l~~~~~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~---~~W~s~t 106 (109)
T 3dzw_A 64 VYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGT---ARWATGT 106 (109)
T ss_dssp EECTTSCEEEECCCCCSSSCEEEEECTTSCEEEEES---CCCCCCC
T ss_pred EECCCCCEEEECCCCCCCCCEEEEEeCCCEEEEECC---CEEeCCC
Confidence 889899999999986443 36799999999999974 8999843
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.58 E-value=1.1e-15 Score=162.65 Aligned_cols=138 Identities=12% Similarity=0.069 Sum_probs=96.4
Q ss_pred ccccccccccccEEEEEEEECCccEEEEEEeecCCc--------------ccHHHH--------HHHHHHHhcCCCCCcc
Q 043185 512 DNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGV--------------QGKKDF--------CTEIAIIGNIHHVNLV 569 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~--------------~~~~~~--------~~E~~~l~~l~H~nIv 569 (724)
+.+.+.||+|++|.||+|...+|+.||||+++.... ...... .+|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 445678999999999999998999999998753110 011122 2345555555443332
Q ss_pred ceeceeecCCeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCC--
Q 043185 570 KLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHF-- 647 (724)
Q Consensus 570 ~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-- 647 (724)
...-+.. ...+|||||+++++|..+... .....++.|++.+|.|||+ .+||||||||.|||+++++
T Consensus 177 vp~p~~~--~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 177 VPEPIAQ--SRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CCCEEEE--ETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEECS
T ss_pred CCeeeec--cCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCCCc
Confidence 2111111 123699999999888654321 1234678999999999997 8999999999999999877
Q ss_pred --------cEEEEeecCccccC
Q 043185 648 --------QAKISDFGLSKLLT 661 (724)
Q Consensus 648 --------~~kl~DFGla~~~~ 661 (724)
.+.|+||+-+....
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEETT
T ss_pred ccccccccceEEEEeCCcccCC
Confidence 38999999876543
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=2.5e-14 Score=125.12 Aligned_cols=97 Identities=19% Similarity=0.311 Sum_probs=75.2
Q ss_pred EEEecCCCCCCCCCceEEEccCcc-EEEcCCCCeEEecCCCCC-ceeEEEEecCCcEEEecCCCccceecccCCCccccc
Q 043185 78 IIWSANRDTPISGSGKMNLTPKGI-IISDENGNLKWSTPPLKS-SVSALRLTEMGNLVLLDGFNGSLWESFHHPRDTIVI 155 (724)
Q Consensus 78 vVW~Anr~~pv~~~~~l~~~~~g~-~l~~~~g~~vWst~~~~~-~~~~~~L~dsGNlVl~~~~~~~lWQSFd~PtDtlLp 155 (724)
.+|..+.-. .+...+|.+..||+ +|++ .+++||++++... ...+++|+|+|||||++.++.++||||
T Consensus 9 ~L~~g~~l~-~~~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~~~~~W~S~--------- 77 (110)
T 3a0c_A 9 SLFTGHSLE-VGPSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIWQTK--------- 77 (110)
T ss_dssp EECTTCEEE-ETTTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECC---------
T ss_pred EECCCCEEE-ECCCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCCCcEEEecC---------
Confidence 444444433 23447899999995 7777 5889999998543 346899999999999999889999999
Q ss_pred CCccCCCceEEecCCCCCCCCcceEEEeCCCccccccccccceeecC
Q 043185 156 GQHLPAGASLSSAVSDYNLSTGDYSLTVGASDAELQWQGQMYWKLSM 202 (724)
Q Consensus 156 gq~l~~~~~L~S~~s~~dps~G~~~~~~~~~~~~~~~~~~~yw~~~~ 202 (724)
+++++|.|+++++++|..+.+++ .||.+..
T Consensus 78 ----------------t~~~~g~~~l~l~~dGnlvl~~~-~~W~S~~ 107 (110)
T 3a0c_A 78 ----------------TNGKEDHYVLVLQQDRNVVIYGP-VVWATGS 107 (110)
T ss_dssp ----------------CCCSSSCCEEEECTTSCEEEECS-EEEECSC
T ss_pred ----------------CCCCCCCEEEEEeCCccEEEECC-CEecCCC
Confidence 35677999999999998755655 7998753
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.45 E-value=8.1e-13 Score=115.96 Aligned_cols=105 Identities=14% Similarity=0.207 Sum_probs=79.2
Q ss_pred cccccccCCcccceeeeecCCCeEEeCCCeEEEEEEecCCCCceEEEEEEeccCCeEEEecCCCCCCCCCceEEEccCcc
Q 043185 22 FSEFIHPNFTASHVKFIDYGGSFLTSHNGTFKAAIVNTRSQQNSFYLCIIHVLSNTIIWSANRDTPISGSGKMNLTPKGI 101 (724)
Q Consensus 22 ~~~~~~~~~t~~~~~~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~i~~~~~~~~tvVW~Anr~~pv~~~~~l~~~~~g~ 101 (724)
..++|.+|+++. .++.|. +|.|.|-|...+ .+.+. .....++||.+|+..+- ....|.|.++|+
T Consensus 5 ~~~tL~~gq~L~-------~g~~L~--~g~~~L~~q~dG----NLvL~--~~~~~~~vWssnt~~~~-~~~~l~l~~dGN 68 (113)
T 3mez_B 5 VRNVLFSSQVMY-------DNAQLA--TRDYSLVMRDDC----NLVLT--KGSKTNIVWESGTSGRG-QHCFMRLGHSGE 68 (113)
T ss_dssp CSSEEETTCEEE-------TTCEEE--ETTEEEEECTTS----CEEEE--ETTTTEEEEECCCTTSC-SSCEEEECTTSC
T ss_pred cCCEeCCCCEEC-------CCCEeE--cCCEEEEEcCCC----EEEEE--ECCCCEEEEECCcccCC-cCEEEEEeCCCc
Confidence 357888888875 356675 488999986444 23332 22247899999998762 236899999995
Q ss_pred -EEEcCCCCeEEecCCCCC-ceeEEEEecCCcEEEecCCCccceec
Q 043185 102 -IISDENGNLKWSTPPLKS-SVSALRLTEMGNLVLLDGFNGSLWES 145 (724)
Q Consensus 102 -~l~~~~g~~vWst~~~~~-~~~~~~L~dsGNlVl~~~~~~~lWQS 145 (724)
||.|.+|+++|+|++... ...+|+|+|+|||||++ ..+|+|
T Consensus 69 LVl~d~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~---~~~W~s 111 (113)
T 3mez_B 69 LDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYG---PAVWST 111 (113)
T ss_dssp EEEECTTSCEEEECSCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred EEEECCCCCEEEECCCcCCCCCEEEEEcCCceEEEec---CCEecC
Confidence 888999999999998543 34689999999999997 589997
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.44 E-value=1.9e-13 Score=120.11 Aligned_cols=86 Identities=17% Similarity=0.332 Sum_probs=69.5
Q ss_pred ceEEEccCcc-EEEcCCCCeEEecCCCCC-ceeEEEEecCCcEEEecCCCccceecccCCCcccccCCccCCCceEEecC
Q 043185 92 GKMNLTPKGI-IISDENGNLKWSTPPLKS-SVSALRLTEMGNLVLLDGFNGSLWESFHHPRDTIVIGQHLPAGASLSSAV 169 (724)
Q Consensus 92 ~~l~~~~~g~-~l~~~~g~~vWst~~~~~-~~~~~~L~dsGNlVl~~~~~~~lWQSFd~PtDtlLpgq~l~~~~~L~S~~ 169 (724)
.+|.+..+|+ +|++. +++||++++... ...+|+|+++|||||+| .+.++||||+
T Consensus 21 ~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~~~~~W~S~~---------------------- 76 (112)
T 1xd5_A 21 YLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-GSRAIWASNT---------------------- 76 (112)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-TTEEEEECCC----------------------
T ss_pred EEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-CCEEEEECCc----------------------
Confidence 6899999985 77776 889999998643 34689999999999999 7789999994
Q ss_pred CCCCCCCcceEEEeCCCccccccc--cccceeecCCc
Q 043185 170 SDYNLSTGDYSLTVGASDAELQWQ--GQMYWKLSMDT 204 (724)
Q Consensus 170 s~~dps~G~~~~~~~~~~~~~~~~--~~~yw~~~~~~ 204 (724)
+|++|.|++.++++|..+.+. +..||++..+.
T Consensus 77 ---~~~~g~~~l~l~~dGnlvl~~~~~~~~W~S~~~~ 110 (112)
T 1xd5_A 77 ---NRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNV 110 (112)
T ss_dssp ---CCSCCCCEEEECTTSCEEEECTTSCEEEECCCCC
T ss_pred ---cCCCCCEEEEEeCCCcEEEECCCCceEEECCCcc
Confidence 456789999999999774443 45899887654
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.43 E-value=3.2e-13 Score=119.60 Aligned_cols=84 Identities=18% Similarity=0.269 Sum_probs=68.7
Q ss_pred ceEEEccCcc-EEEcCCCCeEEecCCCCC-ceeEEEEecCCcEEEecCCCccceecccCCCcccccCCccCCCceEEecC
Q 043185 92 GKMNLTPKGI-IISDENGNLKWSTPPLKS-SVSALRLTEMGNLVLLDGFNGSLWESFHHPRDTIVIGQHLPAGASLSSAV 169 (724)
Q Consensus 92 ~~l~~~~~g~-~l~~~~g~~vWst~~~~~-~~~~~~L~dsGNlVl~~~~~~~lWQSFd~PtDtlLpgq~l~~~~~L~S~~ 169 (724)
.+|.+..||+ +|++. +++||++++... ....|+|+|+|||||+|.++.++||||
T Consensus 32 ~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~~~~lW~S~----------------------- 87 (119)
T 1b2p_A 32 YRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSP----------------------- 87 (119)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECS-----------------------
T ss_pred EEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCCCcEEEcCC-----------------------
Confidence 3788888885 77776 889999998543 346899999999999999899999999
Q ss_pred CCCCCCCcceEEEeCCCccccccccccceeecC
Q 043185 170 SDYNLSTGDYSLTVGASDAELQWQGQMYWKLSM 202 (724)
Q Consensus 170 s~~dps~G~~~~~~~~~~~~~~~~~~~yw~~~~ 202 (724)
+||++|.|++.++++|..+.+. ..||++++
T Consensus 88 --~~~~~g~~~l~l~~~Gnlvl~~-~~~W~Sg~ 117 (119)
T 1b2p_A 88 --VAGKAGHYVLVLQPDRNVVIYG-DALWATQT 117 (119)
T ss_dssp --CCCCSSCEEEEECTTSCEEEEE-SEEEECCC
T ss_pred --CCCCCCCEEEEEECCCcEEEEC-ccEeCCCC
Confidence 4567899999999999765554 47998754
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.43 E-value=4.9e-13 Score=116.67 Aligned_cols=102 Identities=19% Similarity=0.240 Sum_probs=75.8
Q ss_pred cccccccCCcccceeeeecCCCeEEeCCCeEEEEEEecCCCCceEEEEEEeccCCeEEEecCCCCCCCCCceEEEccCcc
Q 043185 22 FSEFIHPNFTASHVKFIDYGGSFLTSHNGTFKAAIVNTRSQQNSFYLCIIHVLSNTIIWSANRDTPISGSGKMNLTPKGI 101 (724)
Q Consensus 22 ~~~~~~~~~t~~~~~~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~i~~~~~~~~tvVW~Anr~~pv~~~~~l~~~~~g~ 101 (724)
..|+|.||+++. .+++|+| |.|+|-|...+ .+.+ +.. ++||.+|++.. ..+..|.|.++|+
T Consensus 5 ~~dtL~~gq~L~-------~g~~L~s--g~~~L~~q~dG----nLvl-~~~----~~vW~snt~~~-~~~~~l~l~~dGN 65 (110)
T 3r0e_B 5 TNNLLFSGQVLY-------GDGRLTA--KNHQLVMQGDC----NLVL-YGG----KYGWQSNTHGN-GEHCFLRLNHKGE 65 (110)
T ss_dssp BTTEEETTCEEE-------TTEEEEC--SSCEEEECTTS----CEEE-ECS----SSCEECCCTTS-SSSCEEEECTTSC
T ss_pred ccCEECCCCEec-------CCCEEEe--CCEEEEEcCCC----eEEE-ECC----eEEEECCCcCC-CcCEEEEEeCCCc
Confidence 357888888874 4778887 45888664333 1333 322 58999999862 2236899999995
Q ss_pred -EEEcCCCCeEEecCCCCC-ceeEEEEecCCcEEEecCCCccceec
Q 043185 102 -IISDENGNLKWSTPPLKS-SVSALRLTEMGNLVLLDGFNGSLWES 145 (724)
Q Consensus 102 -~l~~~~g~~vWst~~~~~-~~~~~~L~dsGNlVl~~~~~~~lWQS 145 (724)
||.|.+|.++|+|++... ...+|+|+|+|||||++ ..+|+|
T Consensus 66 Lvl~d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~---~~~W~t 108 (110)
T 3r0e_B 66 LIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG---PAIFET 108 (110)
T ss_dssp EEEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred EEEEeCCCCEEEEcCCcCCCCCEEEEEcCCccEEEec---CCEecC
Confidence 888999999999998543 33689999999999998 479997
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=1.2e-12 Score=115.53 Aligned_cols=89 Identities=24% Similarity=0.377 Sum_probs=72.3
Q ss_pred CCceEEEccCcc-EEEcCCCCeEEecCCCCC-ceeEEEEecCCcEEEecCCCccceecccCCCcccccCCccCCCceEEe
Q 043185 90 GSGKMNLTPKGI-IISDENGNLKWSTPPLKS-SVSALRLTEMGNLVLLDGFNGSLWESFHHPRDTIVIGQHLPAGASLSS 167 (724)
Q Consensus 90 ~~~~l~~~~~g~-~l~~~~g~~vWst~~~~~-~~~~~~L~dsGNlVl~~~~~~~lWQSFd~PtDtlLpgq~l~~~~~L~S 167 (724)
+..+|.+..+|+ +|++ .++++|++++... ....++|+++|||||+|.++.++|||||+
T Consensus 20 g~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~~~~vW~S~~~------------------- 79 (115)
T 2dpf_A 20 GAYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNNDVWGSACW------------------- 79 (115)
T ss_dssp TTEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTTCCEEEECCCC-------------------
T ss_pred CCEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCCceEEEEcCCC-------------------
Confidence 345788888884 7777 5889999997543 34689999999999999888899999997
Q ss_pred cCCCCCCCCcceEEEeCCCccccccccccceeecCCcc
Q 043185 168 AVSDYNLSTGDYSLTVGASDAELQWQGQMYWKLSMDTK 205 (724)
Q Consensus 168 ~~s~~dps~G~~~~~~~~~~~~~~~~~~~yw~~~~~~~ 205 (724)
+++|.|++.++++|..+.+++ .||++.+|..
T Consensus 80 ------~~~g~~~l~l~~dGnlvl~~~-~~W~S~~~~~ 110 (115)
T 2dpf_A 80 ------GDNGKYALVLQKDGRFVIYGP-VLWSLGPNGC 110 (115)
T ss_dssp ------CSSSCCEEEECTTSCEEEECS-EEECSSTTCB
T ss_pred ------CCCCCEEEEEeCCCeEEEECC-CEEECCCCCC
Confidence 356789999999998766655 7999887654
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.33 E-value=4.3e-12 Score=110.46 Aligned_cols=99 Identities=20% Similarity=0.335 Sum_probs=75.5
Q ss_pred ccccccCCcccceeeeecCCCeEEeCCCeEEEEEEecCCCCceEEEEEEeccCCeEEEecCCCCCCCCCceEEEccCcc-
Q 043185 23 SEFIHPNFTASHVKFIDYGGSFLTSHNGTFKAAIVNTRSQQNSFYLCIIHVLSNTIIWSANRDTPISGSGKMNLTPKGI- 101 (724)
Q Consensus 23 ~~~~~~~~t~~~~~~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~i~~~~~~~~tvVW~Anr~~pv~~~~~l~~~~~g~- 101 (724)
+|+|.||+++. .++.| .+|.|.|.|...++ +.+ +. .+|.+|+..+ ..+..|.|..+|+
T Consensus 3 ~dtL~~gq~L~-------~g~~L--~~g~~~L~~q~dGN----Lvl-~~------~~Wssnt~~~-~~~~~l~l~~dGnL 61 (109)
T 3r0e_A 3 TNYLLSGQTLD-------TEGHL--KNGDFDLVMQDDCN----LVL-YN------GNWQSNTANN-GRDCKLTLTDYGEL 61 (109)
T ss_dssp CSEEETTCEEC-------TTCEE--EETTEEEEECTTSC----EEE-ET------TTEECCCTTS-CSSCEEEECTTSCE
T ss_pred cCCcCCCCCcC-------CCCEe--ECCCEEEEEecCCe----EEE-Ee------CeEEcCCCCC-CCcEEEEEcCCCeE
Confidence 57888888875 36667 57999999865442 211 11 1699999865 2347999999995
Q ss_pred EEEcCCCCeEEecCCCCC-ceeEEEEecCCcEEEecCCCccceec
Q 043185 102 IISDENGNLKWSTPPLKS-SVSALRLTEMGNLVLLDGFNGSLWES 145 (724)
Q Consensus 102 ~l~~~~g~~vWst~~~~~-~~~~~~L~dsGNlVl~~~~~~~lWQS 145 (724)
||.|.++.++|+|++... ...+|+|+|+|||||++ ..+|+|
T Consensus 62 vl~d~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~---~~~W~s 103 (109)
T 3r0e_A 62 VIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG---PSVFKI 103 (109)
T ss_dssp EEECTTSCEEEECCCCCSSSCCEEEEETTTEEEEEC---SEEEEE
T ss_pred EEEeCCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe---cCEECC
Confidence 888999999999998643 34689999999999997 679998
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.15 E-value=9e-11 Score=119.72 Aligned_cols=140 Identities=16% Similarity=-0.002 Sum_probs=108.3
Q ss_pred ccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCC-CCCccceeceeecCCeEEEEEEecCC
Q 043185 512 DNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIH-HVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
+.+...++.|+.+.||+.... ++.+++|+..........++.+|+++++.+. |..+.++++++...+..++||||++|
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 94 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADG 94 (263)
T ss_dssp SEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSS
T ss_pred ceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCC
Confidence 345567888888999999765 5679999986532233346889999999884 77888999999988899999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC-------------------------------------------
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGC------------------------------------------- 627 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------------- 627 (724)
.+|.+.+. +......++.+++++|..||+..
T Consensus 95 ~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (263)
T 3tm0_A 95 VLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR 168 (263)
T ss_dssp EEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHH
T ss_pred eehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHH
Confidence 99877631 11223467889999999999710
Q ss_pred -------------CCCeEecCCCCCCeEEeCCCcEEEEeecCcc
Q 043185 628 -------------EQKIIHCDIKPENILLHYHFQAKISDFGLSK 658 (724)
Q Consensus 628 -------------~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~ 658 (724)
...++|+|++|.|||++.+..+.|+||+.+.
T Consensus 169 ~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1459999999999999876566799999775
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.13 E-value=2e-10 Score=100.21 Aligned_cols=101 Identities=13% Similarity=0.141 Sum_probs=73.8
Q ss_pred ccccccCCcccceeeeecCCCeEEeCCCeEEEEEEecCCCCceEEEEEEeccCCeEEEecCCCCCCCCCceEEEccCcc-
Q 043185 23 SEFIHPNFTASHVKFIDYGGSFLTSHNGTFKAAIVNTRSQQNSFYLCIIHVLSNTIIWSANRDTPISGSGKMNLTPKGI- 101 (724)
Q Consensus 23 ~~~~~~~~t~~~~~~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~i~~~~~~~~tvVW~Anr~~pv~~~~~l~~~~~g~- 101 (724)
+++|.+|+++. .++.| .+|.|.|-|...++ +.+ +. . .. ||.+|+..+ .....|.|..+|+
T Consensus 2 ~~~l~~gq~L~-------~g~~L--~~g~~~L~~q~dGn----Lvl-~~--~-~~-vW~snt~~~-~~~~~l~l~~dGNL 62 (111)
T 3mez_A 2 NNVLLTGDVIH-------TDNQL--SYESAAFVMQGDCN----LVL-YN--E-AG-GFQSNTHGR-GVDCTLRLNNRGQL 62 (111)
T ss_dssp TTEEETTCEEC-------TTCEE--EETTEEEEECTTSC----EEE-EC--S-SC-CEECCCTTS-CSSCEEEECTTSCE
T ss_pred cCEeCCCCEeC-------CCCEE--ecCCEEEEEccCCe----EEE-EC--C-CC-EEECCcccC-CcCEEEEEcCCCcE
Confidence 46778888875 36667 47899999964442 322 22 1 23 999999876 2246899999995
Q ss_pred EEEcCCCC-eEEecCCC---CCceeEEEEecCCcEEEecCCCccceec
Q 043185 102 IISDENGN-LKWSTPPL---KSSVSALRLTEMGNLVLLDGFNGSLWES 145 (724)
Q Consensus 102 ~l~~~~g~-~vWst~~~---~~~~~~~~L~dsGNlVl~~~~~~~lWQS 145 (724)
||.|.++. ++|+|++. .....+++|+++|||||++ ..+|+|
T Consensus 63 Vl~~~~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~---~~~W~s 107 (111)
T 3mez_A 63 EIHSANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG---PAIWST 107 (111)
T ss_dssp EEECSSCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC---SEEEEC
T ss_pred EEEeCCCCEEEEEeccccCCCCcCEEEEECCCCeEEEec---cCEEcc
Confidence 88888876 59999963 2234678999999999997 679997
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.08 E-value=2.8e-10 Score=116.12 Aligned_cols=116 Identities=16% Similarity=0.243 Sum_probs=80.9
Q ss_pred cccccccCCcccceeeeecCCCeEEeCCCeEEEEEEecC-CCCceEEEEEEeccCCeEEEecCCCCCCCCCceEEEccCc
Q 043185 22 FSEFIHPNFTASHVKFIDYGGSFLTSHNGTFKAAIVNTR-SQQNSFYLCIIHVLSNTIIWSANRDTPISGSGKMNLTPKG 100 (724)
Q Consensus 22 ~~~~~~~~~t~~~~~~~~~~~~~lvS~~g~F~lGF~~~~-~~~~~~~i~~~~~~~~tvVW~Anr~~pv~~~~~l~~~~~g 100 (724)
|+|++.|++.+... +. .+++|.| ...++.|+|+.. .....+.+ ++ ...+++|.+++..+- ...|.+..+|
T Consensus 135 ptdtlLpg~~~~~~--l~-~g~~L~S-~~dps~G~fsl~l~~dGnlvL-y~--~~~~~yW~Sgt~~~~--~~~l~l~~dG 205 (276)
T 3m7h_A 135 PAIPLVPGAIDSLL--LA-PGSELVQ-GVVYGAGASKLVFQGDGNLVA-YG--PNGAATWNAGTQGKG--AVRAVFQGDG 205 (276)
T ss_dssp TTSCCCCSCTTCEE--EC-SSEEECT-TCEEEETTEEEEECTTSCEEE-EC--TTSSEEEECCCTTTT--CCEEEECTTS
T ss_pred cccccccccccccc--cc-cCccccc-CCCCCCceEEEeecCCceEEE-Ee--CCCeEEEECCCCCCc--cEEEEEcCCC
Confidence 56777776663221 11 3455654 346666666543 11113444 22 236899999998763 2689999999
Q ss_pred c-EEEcCCCCeEEecCCCCCceeEEEEecCCcEEEecCCCccceecccC
Q 043185 101 I-IISDENGNLKWSTPPLKSSVSALRLTEMGNLVLLDGFNGSLWESFHH 148 (724)
Q Consensus 101 ~-~l~~~~g~~vWst~~~~~~~~~~~L~dsGNlVl~~~~~~~lWQSFd~ 148 (724)
+ ++.|.++.++|++++......+|+|+++|||||++. ..+||||||
T Consensus 206 nLvl~d~~~~~vWsS~t~~~~~~rl~Ld~dGnLvly~~--~~~Wqsf~~ 252 (276)
T 3m7h_A 206 NLVVYGAGNAVLWHSHTGGHASAVLRLQANGSIAILDE--KPVWARFGF 252 (276)
T ss_dssp CEEEECTTSCEEEECSCTTCTTCEEEECTTSCEEEEEE--EEEEESSSC
T ss_pred eEEEEeCCCcEEEEecCCCCCCEEEEEcCCccEEEEcC--CCeEEccCc
Confidence 5 888988899999998655557899999999999986 689999997
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.01 E-value=6.3e-10 Score=97.42 Aligned_cols=91 Identities=15% Similarity=0.306 Sum_probs=68.5
Q ss_pred CCCCCCC-ceEEEccCcc-EEEcC-CCCeEEecCCCCC-ceeEEEEecCCcEEEecCCCccceecccCCCcccccCCccC
Q 043185 85 DTPISGS-GKMNLTPKGI-IISDE-NGNLKWSTPPLKS-SVSALRLTEMGNLVLLDGFNGSLWESFHHPRDTIVIGQHLP 160 (724)
Q Consensus 85 ~~pv~~~-~~l~~~~~g~-~l~~~-~g~~vWst~~~~~-~~~~~~L~dsGNlVl~~~~~~~lWQSFd~PtDtlLpgq~l~ 160 (724)
+.|+.+. .+|.+..||+ ||++. .++++|++++... ....++|+++|||||+|.++.++|||=.+ +
T Consensus 18 g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~~~~iW~S~t~-------~---- 86 (113)
T 3mez_B 18 NAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNTVFVSNTV-------G---- 86 (113)
T ss_dssp TCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECSCC-------C----
T ss_pred CCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCCCCEEEECCCc-------C----
Confidence 3444444 6899999995 78887 4889999998643 34689999999999999888899998431 0
Q ss_pred CCceEEecCCCCCCCCcceEEEeCCCccccccccccceeec
Q 043185 161 AGASLSSAVSDYNLSTGDYSLTVGASDAELQWQGQMYWKLS 201 (724)
Q Consensus 161 ~~~~L~S~~s~~dps~G~~~~~~~~~~~~~~~~~~~yw~~~ 201 (724)
..|.|.+.++.+|....+. ...|.++
T Consensus 87 --------------~~~~~~~~L~~dGnlvly~-~~~W~s~ 112 (113)
T 3mez_B 87 --------------QEGDYVLILQINGQAVVYG-PAVWSTA 112 (113)
T ss_dssp --------------SSSCCEEEECTTSCEEEEC-SEEEESC
T ss_pred --------------CCCCEEEEEcCCceEEEec-CCEecCC
Confidence 1245889999999886665 5677653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.00 E-value=7e-10 Score=112.60 Aligned_cols=129 Identities=14% Similarity=0.066 Sum_probs=96.9
Q ss_pred cccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCC--ccceeceeecCCeEEEEEEecCCCCHHHH
Q 043185 519 GSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVN--LVKLKGFCAQGRQRLLVYEYMNHGSLDRI 596 (724)
Q Consensus 519 G~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 596 (724)
+.|..+.||++...++..+++|..... ....+.+|+++++.+.+.+ +.+++++...++..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 456669999998777777999987643 2345778999998885444 566888888777889999999998884
Q ss_pred HhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC-------------------------------------------------
Q 043185 597 LFGNGPVLEWQERFDIALGTARGLAYLHSGC------------------------------------------------- 627 (724)
Q Consensus 597 l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------------------- 627 (724)
. .. .+ ...++.+++..|..||+..
T Consensus 104 ~-~~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 176 (264)
T 1nd4_A 104 S-SH---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKA 176 (264)
T ss_dssp T-SC---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHH
T ss_pred c-Cc---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHH
Confidence 2 11 12 2356778888888888622
Q ss_pred ------CCCeEecCCCCCCeEEeCCCcEEEEeecCccc
Q 043185 628 ------EQKIIHCDIKPENILLHYHFQAKISDFGLSKL 659 (724)
Q Consensus 628 ------~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 659 (724)
...++|+|++|.|||++.+..+.|+||+.+..
T Consensus 177 ~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 177 RMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998776677999998754
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.98 E-value=1.2e-09 Score=95.29 Aligned_cols=84 Identities=17% Similarity=0.319 Sum_probs=65.0
Q ss_pred ceEEEccCcc-EEEcCCCCeEEecCCCCC-ceeEEEEecCCcEEEecCCCcc-ceecccCCCcccccCCccCCCceEEec
Q 043185 92 GKMNLTPKGI-IISDENGNLKWSTPPLKS-SVSALRLTEMGNLVLLDGFNGS-LWESFHHPRDTIVIGQHLPAGASLSSA 168 (724)
Q Consensus 92 ~~l~~~~~g~-~l~~~~g~~vWst~~~~~-~~~~~~L~dsGNlVl~~~~~~~-lWQSFd~PtDtlLpgq~l~~~~~L~S~ 168 (724)
.+|.+..||+ ||++.++ +|++++... ....++|+++|||||++.++.. +|||..+
T Consensus 22 ~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~~~~vW~S~t~-------------------- 79 (111)
T 3mez_A 22 AAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVWVYPRS-------------------- 79 (111)
T ss_dssp EEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSCSSCSEEESSS--------------------
T ss_pred EEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCCCEEEEEeccc--------------------
Confidence 5899999995 7877776 999998643 3468999999999999987764 9999831
Q ss_pred CCCCCCCCcceEEEeCCCccccccccccceeec
Q 043185 169 VSDYNLSTGDYSLTVGASDAELQWQGQMYWKLS 201 (724)
Q Consensus 169 ~s~~dps~G~~~~~~~~~~~~~~~~~~~yw~~~ 201 (724)
.....|.|.+.++.+|....+. ..+|.+.
T Consensus 80 ---~~~~~~~~~l~Lq~dGNlvly~-~~~W~s~ 108 (111)
T 3mez_A 80 ---VNTVRGNYAATLGPDQHVTIYG-PAIWSTP 108 (111)
T ss_dssp ---CCCCSSCCEEEECTTSCEEEEC-SEEEECC
T ss_pred ---cCCCCcCEEEEECCCCeEEEec-cCEEccC
Confidence 0113478999999999886665 5688764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.88 E-value=3.3e-09 Score=113.46 Aligned_cols=140 Identities=17% Similarity=0.232 Sum_probs=104.9
Q ss_pred ccccccccEEEEEEEECCccEEEEEEee--cCC-cccHHHHHHHHHHHhcCC--CCCccceeceeecC---CeEEEEEEe
Q 043185 516 NLIGSGGFGAVYKGILNDKTIVAVKKIT--NVG-VQGKKDFCTEIAIIGNIH--HVNLVKLKGFCAQG---RQRLLVYEY 587 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~~vAvK~~~--~~~-~~~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~---~~~~lV~e~ 587 (724)
+.|+.|.++.||+....+ ..+++|+.. ... .....++.+|+++++.+. +..+.+++.++.+. ...++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 468899999999998765 457888775 321 123456788999999886 55688899888776 458999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC----------------------------------------
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGC---------------------------------------- 627 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~---------------------------------------- 627 (724)
+++..+.+.. ...++...+..++.+++..|+.||+..
T Consensus 123 v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (359)
T 3dxp_A 123 VSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDS 199 (359)
T ss_dssp CCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHH
T ss_pred cCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHH
Confidence 9998774321 124677888889999999999999721
Q ss_pred ---------------CCCeEecCCCCCCeEEeCCCc--EEEEeecCccc
Q 043185 628 ---------------EQKIIHCDIKPENILLHYHFQ--AKISDFGLSKL 659 (724)
Q Consensus 628 ---------------~~~iiH~Dlkp~NILl~~~~~--~kl~DFGla~~ 659 (724)
...++|+|+++.|||++.++. +.|+||+.+..
T Consensus 200 ~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 200 LMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999998753 68999998864
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=98.82 E-value=1.2e-08 Score=88.60 Aligned_cols=84 Identities=17% Similarity=0.251 Sum_probs=64.2
Q ss_pred CceEEEccCcc-EEEcCCCCeEEecCCCCC-ceeEEEEecCCcEEEecCCCccceecccCCCcccccCCccCCCceEEec
Q 043185 91 SGKMNLTPKGI-IISDENGNLKWSTPPLKS-SVSALRLTEMGNLVLLDGFNGSLWESFHHPRDTIVIGQHLPAGASLSSA 168 (724)
Q Consensus 91 ~~~l~~~~~g~-~l~~~~g~~vWst~~~~~-~~~~~~L~dsGNlVl~~~~~~~lWQSFd~PtDtlLpgq~l~~~~~L~S~ 168 (724)
..+|.+..||+ +|++. ++++|++++... ....++|+++|||||+|.++.++|||....
T Consensus 20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~~~~~W~S~t~~------------------- 79 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIWASNTGG------------------- 79 (109)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTTSCEEEECCCCC-------------------
T ss_pred CEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCCCCEEEECCCCC-------------------
Confidence 35889999995 77766 789999998543 346899999999999998888999986421
Q ss_pred CCCCCCCCcceEEEeCCCccccccccccceeec
Q 043185 169 VSDYNLSTGDYSLTVGASDAELQWQGQMYWKLS 201 (724)
Q Consensus 169 ~s~~dps~G~~~~~~~~~~~~~~~~~~~yw~~~ 201 (724)
..+.|.+.++.+|....+.. ..|.++
T Consensus 80 ------~~~~~~~~L~ddGNlvly~~-~~W~s~ 105 (109)
T 3dzw_A 80 ------ENGNYVCVLQKDRNVVIYGT-ARWATG 105 (109)
T ss_dssp ------SSSCEEEEECTTSCEEEEES-CCCCCC
T ss_pred ------CCCCEEEEEeCCCEEEEECC-CEEeCC
Confidence 12468899999998866553 567653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.75 E-value=3.5e-09 Score=110.41 Aligned_cols=182 Identities=19% Similarity=0.210 Sum_probs=120.2
Q ss_pred ccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCC--ccceeceeecCC---eEEEEEEecC
Q 043185 516 NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNI-HHVN--LVKLKGFCAQGR---QRLLVYEYMN 589 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~n--Iv~l~g~~~~~~---~~~lV~e~~~ 589 (724)
+.++.|....||+.. ..+++|+... ......+.+|+++++.+ .+.. +.+++....... ..|+|||+++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 458899999999863 3488887643 23456788999999887 3433 445555443333 3489999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcC-------------------------------------------
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSG------------------------------------------- 626 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------------------- 626 (724)
|.+|...... .++..++..++.+++..|+.||+.
T Consensus 100 G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 100 GVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred CeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 9888654332 356677778888888888888851
Q ss_pred ------------CCCCeEecCCCCCCeEEeC--CCcEEEEeecCccccCCCCccceecccccccc---cccccccC----
Q 043185 627 ------------CEQKIIHCDIKPENILLHY--HFQAKISDFGLSKLLTPEQSSLFTTMRGTRGY---LAPEWLTN---- 685 (724)
Q Consensus 627 ------------~~~~iiH~Dlkp~NILl~~--~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y---~aPE~l~~---- 685 (724)
....++|+|++|.||+++. ...+.|+||+.+....+... ....... ..|+....
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-----l~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-----FISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH-----HHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH-----HHHHHhhccccCHHHHHHHHHH
Confidence 1135899999999999998 45678999998865432110 0000011 12221110
Q ss_pred ----------CcCCCccchhhHHHHHHHHHhCCCCC
Q 043185 686 ----------SAISEKTDVYSFGMVLLELVSGRRNC 711 (724)
Q Consensus 686 ----------~~~~~~sDv~SlGv~l~elltG~~p~ 711 (724)
.......+.|+++.+++++.+|+.+|
T Consensus 252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00112358999999999999999876
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.72 E-value=2.5e-08 Score=99.67 Aligned_cols=83 Identities=18% Similarity=0.261 Sum_probs=61.2
Q ss_pred ceEEEccCcc-EEEcCCCCeEEecCCCCCceeEEEEecCCcEEEecCCCccceecccCCCcccccCCccCCCceEEecCC
Q 043185 92 GKMNLTPKGI-IISDENGNLKWSTPPLKSSVSALRLTEMGNLVLLDGFNGSLWESFHHPRDTIVIGQHLPAGASLSSAVS 170 (724)
Q Consensus 92 ~~l~~~~~g~-~l~~~~g~~vWst~~~~~~~~~~~L~dsGNlVl~~~~~~~lWQSFd~PtDtlLpgq~l~~~~~L~S~~s 170 (724)
-+|.|..+|+ ++.+. +++||.+|+.......++|+++|||||+|+++.++|+|+++.
T Consensus 28 f~l~f~~~gnl~ly~~-~~~vW~an~~~~~~~~l~l~~dGnLvl~d~~~~~vW~s~~~~--------------------- 85 (236)
T 1dlp_A 28 FRFTMQSDCNLVLFDS-DVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSGTKG--------------------- 85 (236)
T ss_dssp EEEEECTTSCEEEEES-SSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCCCCCC---------------------
T ss_pred EEEEECCCCcEEEEEC-CEEEEECCCCCCCCeEEEEcCCCcEEEEcCCCcEEEeCCccc---------------------
Confidence 3666766774 66665 789999998655556789999999999999999999999751
Q ss_pred CCCCCCcceEEEeCCCccccccccccceeec
Q 043185 171 DYNLSTGDYSLTVGASDAELQWQGQMYWKLS 201 (724)
Q Consensus 171 ~~dps~G~~~~~~~~~~~~~~~~~~~yw~~~ 201 (724)
+.|.|.+.++.+|....+.. .+|.+.
T Consensus 86 ----~~~~~~~~l~d~Gnlvl~~~-~~W~S~ 111 (236)
T 1dlp_A 86 ----SIGNYVLVLQPDRTVTIYGP-GLWDSG 111 (236)
T ss_dssp ----CSSCCEEEECSSSCEEEECS-EEEECS
T ss_pred ----cCCcEEEEEeCCCCEEEecC-CEEECC
Confidence 13456777777776644432 677654
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.68 E-value=5.3e-08 Score=84.62 Aligned_cols=81 Identities=15% Similarity=0.304 Sum_probs=61.8
Q ss_pred ceEEEccCcc-EEEcCCCCeEEecCCCCCc-eeEEEEecCCcEEEecCCCccceecccCCCcccccCCccCCCceEEecC
Q 043185 92 GKMNLTPKGI-IISDENGNLKWSTPPLKSS-VSALRLTEMGNLVLLDGFNGSLWESFHHPRDTIVIGQHLPAGASLSSAV 169 (724)
Q Consensus 92 ~~l~~~~~g~-~l~~~~g~~vWst~~~~~~-~~~~~L~dsGNlVl~~~~~~~lWQSFd~PtDtlLpgq~l~~~~~L~S~~ 169 (724)
.+|.+..||+ +|++. +++|++++.... ...++|+++|||||+|.++.++|||-.+-
T Consensus 26 ~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~~~~iW~S~t~~-------------------- 83 (110)
T 3r0e_B 26 HQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKTIWSSRSSS-------------------- 83 (110)
T ss_dssp CEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTTCCEEEECCCCC--------------------
T ss_pred EEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCCCCEEEEcCCcC--------------------
Confidence 5788999995 67665 689999986433 36899999999999999889999986321
Q ss_pred CCCCCCCcceEEEeCCCccccccccccceee
Q 043185 170 SDYNLSTGDYSLTVGASDAELQWQGQMYWKL 200 (724)
Q Consensus 170 s~~dps~G~~~~~~~~~~~~~~~~~~~yw~~ 200 (724)
..|.|.+.++.+|....+. ...|.+
T Consensus 84 -----~~~~~~~~L~~dGNlvly~-~~~W~t 108 (110)
T 3r0e_B 84 -----KQGEYVLILQDDGFGVIYG-PAIFET 108 (110)
T ss_dssp -----SSSCCEEEECTTSCEEEEC-SEEEES
T ss_pred -----CCCCEEEEEcCCccEEEec-CCEecC
Confidence 1245889999999886665 356754
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.64 E-value=5.8e-08 Score=84.22 Aligned_cols=89 Identities=16% Similarity=0.307 Sum_probs=65.2
Q ss_pred CCCCCCC-ceEEEccCcc-EEEcCCCCeEEecCCCCC-ceeEEEEecCCcEEEecCCCccceecccCCCcccccCCccCC
Q 043185 85 DTPISGS-GKMNLTPKGI-IISDENGNLKWSTPPLKS-SVSALRLTEMGNLVLLDGFNGSLWESFHHPRDTIVIGQHLPA 161 (724)
Q Consensus 85 ~~pv~~~-~~l~~~~~g~-~l~~~~g~~vWst~~~~~-~~~~~~L~dsGNlVl~~~~~~~lWQSFd~PtDtlLpgq~l~~ 161 (724)
+.|++.. ..|.+..||+ ||+++ +|+|++... ....++|+++|||||+|.++.++|+|-..
T Consensus 15 g~~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~~~~vWss~t~------------- 77 (109)
T 3r0e_A 15 EGHLKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGDGSTVWKSGAQ------------- 77 (109)
T ss_dssp TCEEEETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECCCC-------------
T ss_pred CCEeECCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCCCCEEEcCCCc-------------
Confidence 3444433 5899999995 77764 799998653 34688999999999999888899976310
Q ss_pred CceEEecCCCCCCCCcceEEEeCCCccccccccccceeecCC
Q 043185 162 GASLSSAVSDYNLSTGDYSLTVGASDAELQWQGQMYWKLSMD 203 (724)
Q Consensus 162 ~~~L~S~~s~~dps~G~~~~~~~~~~~~~~~~~~~yw~~~~~ 203 (724)
-..+.|.+.++++|....+. ...|.++.+
T Consensus 78 ------------~~~~~~~~~L~~dGNlvly~-~~~W~s~t~ 106 (109)
T 3r0e_A 78 ------------SVKGNYAAVVHPDGRLVVFG-PSVFKIDPW 106 (109)
T ss_dssp ------------CSSSCCEEEEETTTEEEEEC-SEEEEECTT
T ss_pred ------------CCCcCEEEEEcCCCeEEEEe-cCEECCCCc
Confidence 02356889999999886665 568877654
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.61 E-value=1.4e-07 Score=81.23 Aligned_cols=81 Identities=20% Similarity=0.352 Sum_probs=60.3
Q ss_pred ceEEEccCcc-EEEcCCCCeEEecCCCC--CceeEEEEecCCcEEEecCCCccceecccCCCcccccCCccCCCceEEec
Q 043185 92 GKMNLTPKGI-IISDENGNLKWSTPPLK--SSVSALRLTEMGNLVLLDGFNGSLWESFHHPRDTIVIGQHLPAGASLSSA 168 (724)
Q Consensus 92 ~~l~~~~~g~-~l~~~~g~~vWst~~~~--~~~~~~~L~dsGNlVl~~~~~~~lWQSFd~PtDtlLpgq~l~~~~~L~S~ 168 (724)
-+|.+..||+ ||.+ .+++||++++.. .....++|+++|||||.|.++..+|+|-.
T Consensus 21 y~l~~q~DgNLvly~-~~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~~~~vWss~t--------------------- 78 (105)
T 4h3o_A 21 YHFIMQDDCNLVLYD-HSTSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSGRSLWASHS--------------------- 78 (105)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCCCTTCCSCEEEECTTSCEEEECTTCCEEEECCC---------------------
T ss_pred EEEEECCCCeEEEEE-CCEEEEEecCCCCCCccEEEEEeCCccEEEECCCcEEEEEecC---------------------
Confidence 3688889996 5555 568999999753 34468999999999999999999998721
Q ss_pred CCCCCCCCcceEEEeCCCcccccccccccee
Q 043185 169 VSDYNLSTGDYSLTVGASDAELQWQGQMYWK 199 (724)
Q Consensus 169 ~s~~dps~G~~~~~~~~~~~~~~~~~~~yw~ 199 (724)
....+.|.+.++.+|..+.++. ..|.
T Consensus 79 ----~~~~~~~~l~L~ddGNlVly~~-~~W~ 104 (105)
T 4h3o_A 79 ----TRGSGNYILILQDDGNVIIYGS-DIWS 104 (105)
T ss_dssp ----CCCSSCEEEEECTTSCEEEEES-EEEE
T ss_pred ----CCCCCCEEEEEeCCCeEEEECC-cEec
Confidence 1124678899999998765532 3553
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=4.8e-06 Score=86.59 Aligned_cols=136 Identities=18% Similarity=0.168 Sum_probs=93.4
Q ss_pred ccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCC---Cccceeceee-cCCeEEEEEEecCCC
Q 043185 516 NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHV---NLVKLKGFCA-QGRQRLLVYEYMNHG 591 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~---nIv~l~g~~~-~~~~~~lV~e~~~~g 591 (724)
+.++.|....||+. +..+++|+... ......+.+|+++|+.+.+. .+.+.+.+.. ..+..++|||+++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 45788888899987 34578887532 23456788999999998642 3566776664 445678999999998
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcC---------------------------------------------
Q 043185 592 SLDRILFGNGPVLEWQERFDIALGTARGLAYLHSG--------------------------------------------- 626 (724)
Q Consensus 592 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~--------------------------------------------- 626 (724)
.+...... .++...+..++.+++..|+.||+.
T Consensus 99 ~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 99 ILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp ECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred ECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 88663221 233444455555555555555541
Q ss_pred ------------CCCCeEecCCCCCCeEEeC---CCc-EEEEeecCcccc
Q 043185 627 ------------CEQKIIHCDIKPENILLHY---HFQ-AKISDFGLSKLL 660 (724)
Q Consensus 627 ------------~~~~iiH~Dlkp~NILl~~---~~~-~kl~DFGla~~~ 660 (724)
....++|+|+++.|||++. ++. +.|+||+.+..-
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 1235799999999999987 455 489999987654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=3.8e-06 Score=85.54 Aligned_cols=135 Identities=16% Similarity=0.105 Sum_probs=95.4
Q ss_pred cccccccE-EEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCC-CCCccceeceeecCCeEEEEEEecCCCCH
Q 043185 517 LIGSGGFG-AVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIH-HVNLVKLKGFCAQGRQRLLVYEYMNHGSL 593 (724)
Q Consensus 517 ~lG~G~fG-~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~e~~~~gsL 593 (724)
.+..|..| .||+.... ++..+++|+... ....++.+|...|+.+. +--+.++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34445444 68987754 456688888653 33567888999988774 44577889999998999999999999887
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC----------------------------------------------
Q 043185 594 DRILFGNGPVLEWQERFDIALGTARGLAYLHSGC---------------------------------------------- 627 (724)
Q Consensus 594 ~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~---------------------------------------------- 627 (724)
.+..... ......+..+++..|.-||...
T Consensus 108 ~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 108 FQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred cccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 7654321 1222345555666666666410
Q ss_pred ---------CCCeEecCCCCCCeEEeCCCcEEEEeecCccc
Q 043185 628 ---------EQKIIHCDIKPENILLHYHFQAKISDFGLSKL 659 (724)
Q Consensus 628 ---------~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 659 (724)
...++|+|+++.|||++.++.+-|+||+.+..
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11389999999999999887778999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.12 E-value=3.2e-06 Score=89.89 Aligned_cols=79 Identities=8% Similarity=0.046 Sum_probs=54.6
Q ss_pred ccc-cccccEEEEEEEEC-------CccEEEEEEeecCC---cccHHHHHHHHHHHhcCC-C--CCccceeceeecC---
Q 043185 516 NLI-GSGGFGAVYKGILN-------DKTIVAVKKITNVG---VQGKKDFCTEIAIIGNIH-H--VNLVKLKGFCAQG--- 578 (724)
Q Consensus 516 ~~l-G~G~fG~Vy~~~~~-------~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~-H--~nIv~l~g~~~~~--- 578 (724)
+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.+. + ..+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 78888999998765 25668888765321 111245778888888874 3 3577788877655
Q ss_pred CeEEEEEEecCCCCHH
Q 043185 579 RQRLLVYEYMNHGSLD 594 (724)
Q Consensus 579 ~~~~lV~e~~~~gsL~ 594 (724)
...++||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.81 E-value=0.00011 Score=77.32 Aligned_cols=138 Identities=17% Similarity=0.222 Sum_probs=80.1
Q ss_pred cccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCC--CCccceec------eeecCCeEEEEEEec
Q 043185 517 LIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHH--VNLVKLKG------FCAQGRQRLLVYEYM 588 (724)
Q Consensus 517 ~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~g------~~~~~~~~~lV~e~~ 588 (724)
.|+.|..+.||+....++. +++|+.... ..+...|+.++..+.. -.+.+++. +....+..++++||+
T Consensus 39 ~l~gG~~n~~~~v~~~~~~-~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSGA-VCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp ECC----CEEEEEEETTEE-EEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eccccccCcEEEEEeCCCC-EEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 4666778899999887765 888888642 2344455555555531 12344443 123456789999999
Q ss_pred CCCCHH-----------HH---Hhc--C-C--C--------CCCHHHHH-------------------------------
Q 043185 589 NHGSLD-----------RI---LFG--N-G--P--------VLEWQERF------------------------------- 610 (724)
Q Consensus 589 ~~gsL~-----------~~---l~~--~-~--~--------~l~~~~~~------------------------------- 610 (724)
+|..+. .. ++. . . + ...|....
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986542 11 110 0 0 0 11232110
Q ss_pred HHHHHHHHHHHHHHc----------CCCCCeEecCCCCCCeEEeCCCcEEEEeecCccc
Q 043185 611 DIALGTARGLAYLHS----------GCEQKIIHCDIKPENILLHYHFQAKISDFGLSKL 659 (724)
Q Consensus 611 ~i~~~ia~~L~yLH~----------~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 659 (724)
.+...+..++.+|+. .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 011123345666652 0247899999999999998888999999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.76 E-value=9.5e-05 Score=79.73 Aligned_cols=74 Identities=12% Similarity=0.037 Sum_probs=48.2
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecCCc-------ccHHHHHHHHHHHhcCCC--C-CccceeceeecCCeEEEE
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV-------QGKKDFCTEIAIIGNIHH--V-NLVKLKGFCAQGRQRLLV 584 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~-nIv~l~g~~~~~~~~~lV 584 (724)
+.||.|..+.||++... +++.++||....... ....++..|.++++.+.+ + .+.+++.+ +....++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 56899999999999754 457799998653211 123456788888887732 3 34455544 33456899
Q ss_pred EEecCCC
Q 043185 585 YEYMNHG 591 (724)
Q Consensus 585 ~e~~~~g 591 (724)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00028 Score=72.36 Aligned_cols=74 Identities=18% Similarity=0.142 Sum_probs=54.6
Q ss_pred ccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCC-C--CCccceeceeecCCeEEEEEEecCCCC
Q 043185 516 NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIH-H--VNLVKLKGFCAQGRQRLLVYEYMNHGS 592 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H--~nIv~l~g~~~~~~~~~lV~e~~~~gs 592 (724)
+.+|.|..+.||+.++.+|+.+++|+...........|.+|++.|+.+. . --+.+++++. ..++||||++++.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccC
Confidence 5689999999999999999999999876544444456888999888774 2 2344555432 2378999998765
Q ss_pred H
Q 043185 593 L 593 (724)
Q Consensus 593 L 593 (724)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00025 Score=73.49 Aligned_cols=135 Identities=16% Similarity=0.113 Sum_probs=90.7
Q ss_pred ccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCC---CCCccceeceeecCCeEEEEEEecCCCC
Q 043185 516 NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIH---HVNLVKLKGFCAQGRQRLLVYEYMNHGS 592 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lV~e~~~~gs 592 (724)
+.|+.|....+|+.... +..+++|+.... ....+..|.+.|+.+. ...+.+++.+....+..++||||+++..
T Consensus 42 ~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred EEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 45889999999998764 556888887642 3567889999888873 3678889988887888999999999876
Q ss_pred HH--------HH---HhcCCC---------------------CCCHHHHH---HHHH----------------HHHH-HH
Q 043185 593 LD--------RI---LFGNGP---------------------VLEWQERF---DIAL----------------GTAR-GL 620 (724)
Q Consensus 593 L~--------~~---l~~~~~---------------------~l~~~~~~---~i~~----------------~ia~-~L 620 (724)
+. .. |+.... .-+|.... ++.. .+.. ..
T Consensus 118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~ 197 (312)
T 3jr1_A 118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA 197 (312)
T ss_dssp CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence 41 11 111110 12454321 1111 1111 12
Q ss_pred HHHHc-CCCCCeEecCCCCCCeEEeCCCcEEEEeec
Q 043185 621 AYLHS-GCEQKIIHCDIKPENILLHYHFQAKISDFG 655 (724)
Q Consensus 621 ~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DFG 655 (724)
..|.. .....++|+|+.+.||+++.++ +.|.|+.
T Consensus 198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23421 2346799999999999999887 8999984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00076 Score=73.19 Aligned_cols=77 Identities=12% Similarity=0.019 Sum_probs=45.7
Q ss_pred CCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceeccc--ccccccccccccCC---cCCCccchhhHHHHHH
Q 043185 628 EQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMR--GTRGYLAPEWLTNS---AISEKTDVYSFGMVLL 702 (724)
Q Consensus 628 ~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~--gt~~y~aPE~l~~~---~~~~~sDv~SlGv~l~ 702 (724)
...++|+|+++.|||++.++ ++|+||+.+..-.+...- .... -...|.+|+..... .-....++......+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl--a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI--GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH--HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH--HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 47899999999999998876 999999988643221100 0000 01345555544311 1112344556677777
Q ss_pred HHHhC
Q 043185 703 ELVSG 707 (724)
Q Consensus 703 elltG 707 (724)
+.+.+
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 66654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0012 Score=71.65 Aligned_cols=71 Identities=18% Similarity=0.193 Sum_probs=48.6
Q ss_pred ccccccccEEEEEEEECC--------ccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCc-cceeceeecCCeEEEEEE
Q 043185 516 NLIGSGGFGAVYKGILND--------KTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNL-VKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~e 586 (724)
+.|+.|....||+....+ ++.+++|+.... .....+.+|..++..+...++ .++++.+.. .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 457788889999998763 467888887432 122556689998888843333 567766543 28999
Q ss_pred ecCCCC
Q 043185 587 YMNHGS 592 (724)
Q Consensus 587 ~~~~gs 592 (724)
|+++.+
T Consensus 153 ~l~G~~ 158 (429)
T 1nw1_A 153 YIPSRP 158 (429)
T ss_dssp CCCEEE
T ss_pred EeCCcc
Confidence 998643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.92 E-value=0.002 Score=66.85 Aligned_cols=140 Identities=11% Similarity=0.109 Sum_probs=78.9
Q ss_pred ccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCC--ccceece------eecCCeEEEEEEe
Q 043185 516 NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVN--LVKLKGF------CAQGRQRLLVYEY 587 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~------~~~~~~~~lV~e~ 587 (724)
+.|+.|....+|+....+++ +++|..... ...+++..|+.++..+.... +.+++.. ....+..+++++|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g~-~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKDP-LILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCcc-EEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 34667888899999887764 778887652 12234556777777663222 3334322 1223567899999
Q ss_pred cCCCCHHH-----------H---Hhc---C-C-CC---C---CHHHHHH------------HHHHHHHHHHHHHc----C
Q 043185 588 MNHGSLDR-----------I---LFG---N-G-PV---L---EWQERFD------------IALGTARGLAYLHS----G 626 (724)
Q Consensus 588 ~~~gsL~~-----------~---l~~---~-~-~~---l---~~~~~~~------------i~~~ia~~L~yLH~----~ 626 (724)
++|..+.. . ++. . . .. . .|..... +...+...++.++. .
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 99865311 0 111 0 0 00 1 1222110 01123445555553 1
Q ss_pred CCCCeEecCCCCCCeEEeCCCcEEEEeecCcc
Q 043185 627 CEQKIIHCDIKPENILLHYHFQAKISDFGLSK 658 (724)
Q Consensus 627 ~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~ 658 (724)
....++|+|+++.|||++.+..+.|+||+.+.
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 23579999999999999987666899998765
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0014 Score=67.47 Aligned_cols=135 Identities=15% Similarity=0.085 Sum_probs=72.7
Q ss_pred ccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCc-cceeceeecCCeEEEEEEec-CCCCH
Q 043185 516 NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNL-VKLKGFCAQGRQRLLVYEYM-NHGSL 593 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~e~~-~~gsL 593 (724)
+.|+.|....+|+. ..+++|+...... ...+..+|+.+++.+....+ .++++.. .+.-++|+||+ ++.++
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence 56888999999998 3478887754211 11123467777776643333 4555543 33346899999 65444
Q ss_pred HHH---------------H---hcCCCC----CCH-HHHHHH------------------HHHHHHHHHHHHc-CCCCCe
Q 043185 594 DRI---------------L---FGNGPV----LEW-QERFDI------------------ALGTARGLAYLHS-GCEQKI 631 (724)
Q Consensus 594 ~~~---------------l---~~~~~~----l~~-~~~~~i------------------~~~ia~~L~yLH~-~~~~~i 631 (724)
... + +..... ... .....+ ...+....+.|.. .....+
T Consensus 96 ~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l 175 (301)
T 3dxq_A 96 SPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAA 175 (301)
T ss_dssp CHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEE
T ss_pred CHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCcee
Confidence 210 0 111110 011 111000 0011111111211 123458
Q ss_pred EecCCCCCCeEEeCCCcEEEEeecCccc
Q 043185 632 IHCDIKPENILLHYHFQAKISDFGLSKL 659 (724)
Q Consensus 632 iH~Dlkp~NILl~~~~~~kl~DFGla~~ 659 (724)
+|+|+.+.||+ ..++.+.|+||..+..
T Consensus 176 ~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 176 CHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp ECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eccCCCcCCEE-ECCCCEEEEecccccC
Confidence 99999999999 6677889999988764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0041 Score=64.90 Aligned_cols=139 Identities=10% Similarity=0.026 Sum_probs=71.4
Q ss_pred cccccccEE-EEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCC--CCccceeceeecCCeEEEEEEecCCCCH
Q 043185 517 LIGSGGFGA-VYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHH--VNLVKLKGFCAQGRQRLLVYEYMNHGSL 593 (724)
Q Consensus 517 ~lG~G~fG~-Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~~~~lV~e~~~~gsL 593 (724)
.|+.|+... +|+....++..+++|....... .++..|+.++..+.. -.+.+++.+..+.. +++||++.+..+
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l 99 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALF 99 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcch
Confidence 455554444 6676654355676766543211 233456666666532 23556666544333 789999977666
Q ss_pred HHHHhcC-------------------------CCCCCHHHHH-------H-------------HHHHHHHHHHHHH---c
Q 043185 594 DRILFGN-------------------------GPVLEWQERF-------D-------------IALGTARGLAYLH---S 625 (724)
Q Consensus 594 ~~~l~~~-------------------------~~~l~~~~~~-------~-------------i~~~ia~~L~yLH---~ 625 (724)
.+.+... .+..+..... . ....+...++.|. .
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~ 179 (333)
T 3csv_A 100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL 179 (333)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence 4333211 0111111100 0 0011112222231 1
Q ss_pred CCCCCeEecCCCCCCeEEeCC----CcEEEEeecCcccc
Q 043185 626 GCEQKIIHCDIKPENILLHYH----FQAKISDFGLSKLL 660 (724)
Q Consensus 626 ~~~~~iiH~Dlkp~NILl~~~----~~~kl~DFGla~~~ 660 (724)
.....++|+|+++.|||++.+ ..+.|+||+.+..-
T Consensus 180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 124679999999999999875 68999999987654
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0022 Score=68.30 Aligned_cols=139 Identities=18% Similarity=0.185 Sum_probs=81.2
Q ss_pred ccccccccEEEEEEEECC--------ccEEEEEEeecCCcccHHHHHHHHHHHhcCC-CCCccceeceeecCCeEEEEEE
Q 043185 516 NLIGSGGFGAVYKGILND--------KTIVAVKKITNVGVQGKKDFCTEIAIIGNIH-HVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~e 586 (724)
+.|..|-...+|+....+ ++.+++|+.-.. ........+|.++++.+. +.-..++++.+.++ +|+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEE
Confidence 346667778889988742 467888876332 234566778999988874 33335667666542 8999
Q ss_pred ecCCCCHHH--------------HH---hcC----CCCCC--HHHHHHHHHHHH-------------------HHHHHH-
Q 043185 587 YMNHGSLDR--------------IL---FGN----GPVLE--WQERFDIALGTA-------------------RGLAYL- 623 (724)
Q Consensus 587 ~~~~gsL~~--------------~l---~~~----~~~l~--~~~~~~i~~~ia-------------------~~L~yL- 623 (724)
|++|..|.. .| +.. ..... +.+..++..++. ..+..|
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 999855421 11 111 11122 334444433321 122333
Q ss_pred ---Hc-CCCCCeEecCCCCCCeEEeCC----CcEEEEeecCccc
Q 043185 624 ---HS-GCEQKIIHCDIKPENILLHYH----FQAKISDFGLSKL 659 (724)
Q Consensus 624 ---H~-~~~~~iiH~Dlkp~NILl~~~----~~~kl~DFGla~~ 659 (724)
.. .....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 123569999999999999887 7899999998763
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.78 E-value=0.008 Score=62.44 Aligned_cols=139 Identities=14% Similarity=0.083 Sum_probs=80.8
Q ss_pred cccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCC--Cccceece-----eecCCeEEEEEEecC
Q 043185 517 LIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHV--NLVKLKGF-----CAQGRQRLLVYEYMN 589 (724)
Q Consensus 517 ~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~g~-----~~~~~~~~lV~e~~~ 589 (724)
.|+ |....||+....+++.+++|..... .....++..|..++..+... .+++++.. ...++..++++|+++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 355 7778899887777767899988632 22445677788888777422 24445443 122446688999998
Q ss_pred CCCHH-----H------HH---hc---C-----CCCCCHHHH----HHH---------------HHHHHHHHHHHHc---
Q 043185 590 HGSLD-----R------IL---FG---N-----GPVLEWQER----FDI---------------ALGTARGLAYLHS--- 625 (724)
Q Consensus 590 ~gsL~-----~------~l---~~---~-----~~~l~~~~~----~~i---------------~~~ia~~L~yLH~--- 625 (724)
|..+. . .+ +. . ....++... ..+ ...+...++.+..
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 75431 1 11 10 0 011222111 000 1111122333322
Q ss_pred -CCCCCeEecCCCCCCeEEeCCCcEEEEeecCccc
Q 043185 626 -GCEQKIIHCDIKPENILLHYHFQAKISDFGLSKL 659 (724)
Q Consensus 626 -~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 659 (724)
.....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1245689999999999998 5 899999987754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.66 E-value=0.0044 Score=67.68 Aligned_cols=73 Identities=15% Similarity=0.041 Sum_probs=45.9
Q ss_pred ccccccccEEEEEEEECC-ccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCc-cceeceeecCCeEEEEEEecCCCCH
Q 043185 516 NLIGSGGFGAVYKGILND-KTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNL-VKLKGFCAQGRQRLLVYEYMNHGSL 593 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~e~~~~gsL 593 (724)
+.|+.|-...+|+....+ +..+++|+..... ...-+..+|..++..+...++ .++++.+. + .+|+||+++..|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 467888889999999876 4567788764321 111122578888888854444 56777663 2 259999987443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.40 E-value=0.0041 Score=66.05 Aligned_cols=73 Identities=15% Similarity=0.103 Sum_probs=42.9
Q ss_pred ccccccccEEEEEEEECCc---------cEEEEEEeecCCcccHHHHHHHHHHHhcCCCCC-ccceeceeecCCeEEEEE
Q 043185 516 NLIGSGGFGAVYKGILNDK---------TIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVN-LVKLKGFCAQGRQRLLVY 585 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~---------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~ 585 (724)
+.|+.|....+|+....++ ..+++|+.... .....+...|.++++.+...+ ..++++.. . -++|+
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH-VDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT-GGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC-ccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 4577788889999987642 56777776532 111112357888887774333 44666544 2 26899
Q ss_pred EecCCCCH
Q 043185 586 EYMNHGSL 593 (724)
Q Consensus 586 e~~~~gsL 593 (724)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.32 E-value=0.022 Score=59.56 Aligned_cols=32 Identities=25% Similarity=0.278 Sum_probs=28.1
Q ss_pred CCeEecCCCCCCeEEeCCCcEEEEeecCcccc
Q 043185 629 QKIIHCDIKPENILLHYHFQAKISDFGLSKLL 660 (724)
Q Consensus 629 ~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~ 660 (724)
..++|+|+.+.||+++.++.+.|+||+.+..-
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 57999999999999998888999999877543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.47 E-value=0.077 Score=50.95 Aligned_cols=100 Identities=13% Similarity=0.085 Sum_probs=67.8
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
.-+|.++|...+.++++++++.++.|.+..|.-+-. +..-..+=+.|..|++..+|.+.+.+ ..+.
T Consensus 32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc-----------
Confidence 348999999888999999999999999999877621 01111233457899999999988764 1110
Q ss_pred cccccccccccccccCCcCCCccchhhHHHHHHHHHh
Q 043185 670 TMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS 706 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt 706 (724)
.....+.|||... ...+.+.=|||||+++|..+-
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1123566888764 345678899999999999887
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=93.71 E-value=0.07 Score=42.46 Aligned_cols=36 Identities=25% Similarity=0.468 Sum_probs=32.2
Q ss_pred ccCCHHHHHHHcccCCCeeEEEeeCCCCceEeeccc
Q 043185 365 YDVNLSFCQELCSDDCSCLGIFFKNSSGSCYMLGNV 400 (724)
Q Consensus 365 ~~~~~~~C~~~Cl~nCsC~a~~y~~~~~~C~~~~~l 400 (724)
..+++++|++.|+.+=.|.||.|......|+++...
T Consensus 28 ~~~sl~~Cq~aC~a~~~C~aFTyN~~s~~CflKs~~ 63 (82)
T 2ll3_A 28 RASSLSECRARCQAEKECSHYTYNVKSGLCYPKRGK 63 (82)
T ss_dssp ECSSHHHHHHHHHHCTTEEEEEEETTTTEEEEEESS
T ss_pred cCCCHHHHHHHhhccCCCCeEEeccCCCceEcccCC
Confidence 357999999999999999999999999999987654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.96 E-value=0.17 Score=54.34 Aligned_cols=73 Identities=11% Similarity=0.017 Sum_probs=45.6
Q ss_pred ccccccccEEEEEEEECC--------ccEEEEEEeecCCcccHHHHHHHHHHHhcCC-CCCccceeceeecCCeEEEEEE
Q 043185 516 NLIGSGGFGAVYKGILND--------KTIVAVKKITNVGVQGKKDFCTEIAIIGNIH-HVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~e 586 (724)
+.|..|-...+|+....+ ++.+++++.... ....-+..+|.++++.+. +.-..++++.+. -++|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~-t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH-VGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC-C-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC-cchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 456677788899998763 466888876432 122222357888877774 322455555332 278999
Q ss_pred ecCCCCH
Q 043185 587 YMNHGSL 593 (724)
Q Consensus 587 ~~~~gsL 593 (724)
|+++..|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998653
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.66 E-value=0.35 Score=33.27 Aligned_cols=21 Identities=10% Similarity=0.056 Sum_probs=9.7
Q ss_pred HHHHHHHHHHHHHhhhhhccc
Q 043185 452 FTGFFLFSALGFLWWRRWKLH 472 (724)
Q Consensus 452 ~~~~~l~~~l~~~~~rr~~~~ 472 (724)
+++++++++++++++||++++
T Consensus 20 v~~v~ii~~~~~~~~RRRr~~ 40 (44)
T 2l2t_A 20 LFILVIVGLTFAVYVRRKSIK 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHTTCSS
T ss_pred HHHHHHHHHHHHHHhhhhhhh
Confidence 333444444455555554443
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.56 E-value=0.37 Score=33.27 Aligned_cols=25 Identities=12% Similarity=0.012 Sum_probs=10.9
Q ss_pred hhhhHHHHHHHHHHHHHHhhhhhcc
Q 043185 447 LVLLPFTGFFLFSALGFLWWRRWKL 471 (724)
Q Consensus 447 ~i~~~~~~~~l~~~l~~~~~rr~~~ 471 (724)
.++..+++++++++++++++||+++
T Consensus 16 gVVgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 16 GMVGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred ehhHHHHHHHHHHHHHHHHhhhhHh
Confidence 3333333344444444555554443
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=89.90 E-value=0.42 Score=32.82 Aligned_cols=17 Identities=6% Similarity=0.040 Sum_probs=7.1
Q ss_pred HHHHHHHHHHhhhhhcc
Q 043185 455 FFLFSALGFLWWRRWKL 471 (724)
Q Consensus 455 ~~l~~~l~~~~~rr~~~ 471 (724)
++++++++++++||++.
T Consensus 24 ~vi~~l~~~~~~RRR~~ 40 (44)
T 2jwa_A 24 VVVLGVVFGILIKRRQQ 40 (44)
T ss_dssp HHHHHHHHHHHHHHHCS
T ss_pred HHHHHHHHHhheehhhh
Confidence 33333334444444443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.66 E-value=0.58 Score=49.87 Aligned_cols=30 Identities=30% Similarity=0.337 Sum_probs=25.0
Q ss_pred CeEecCCCCCCeEE------eCCCcEEEEeecCccc
Q 043185 630 KIIHCDIKPENILL------HYHFQAKISDFGLSKL 659 (724)
Q Consensus 630 ~iiH~Dlkp~NILl------~~~~~~kl~DFGla~~ 659 (724)
.++|+|+.+.|||+ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 3466799999988763
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=84.23 E-value=1.1 Score=29.83 Aligned_cols=18 Identities=22% Similarity=0.183 Sum_probs=8.7
Q ss_pred HHHHHHHHHHHHHHhhhh
Q 043185 451 PFTGFFLFSALGFLWWRR 468 (724)
Q Consensus 451 ~~~~~~l~~~l~~~~~rr 468 (724)
++++++++++++++++||
T Consensus 20 ~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 20 LLLGAALLLGILVFRSRR 37 (38)
T ss_dssp HHHHHHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHeec
Confidence 333444455555555544
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=82.00 E-value=0.16 Score=55.33 Aligned_cols=59 Identities=8% Similarity=0.071 Sum_probs=17.1
Q ss_pred ccccccccccEEEEEEEECC-ccEEEE------EEeecC--CcccHHHHHHHHHHHhcCCCCCccceecee
Q 043185 514 FKNLIGSGGFGAVYKGILND-KTIVAV------KKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLKGFC 575 (724)
Q Consensus 514 ~~~~lG~G~fG~Vy~~~~~~-~~~vAv------K~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~ 575 (724)
+.+.|| ||.||+|.+.. ..+||| |..+.. ..+....|.+|..++..++|||+++.+++.
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence 446677 99999999865 356888 666432 233345788999999999999999998874
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 724 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-64 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-63 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-61 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-58 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-57 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-56 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-55 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-55 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-55 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-55 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-54 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-53 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-53 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-53 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-52 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-51 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-51 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-51 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-51 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-50 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-50 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-49 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-48 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-48 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-47 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-43 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-43 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-43 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-38 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-37 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-20 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 2e-10 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 2e-07 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 5e-06 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 7e-06 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 5e-04 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 7e-04 | |
| d1dx5i3 | 40 | g.3.11.1 (I:423-462) Thrombomodulin, different EGF | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 7e-64
Identities = 67/211 (31%), Positives = 104/211 (49%), Gaps = 10/211 (4%)
Query: 505 EELEVATDNFK--NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGN 562
++ E+ IGSG FG VYKG + V + +T Q + F E+ ++
Sbjct: 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK 60
Query: 563 IHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAY 622
HVN++ G+ Q +V ++ SL L E + DIA TA+G+ Y
Sbjct: 61 TRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 119
Query: 623 LHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP-EQSSLFTTMRGTRGYLAPE 681
LH + IIH D+K NI LH KI DFGL+ + + S F + G+ ++APE
Sbjct: 120 LH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176
Query: 682 WLT---NSAISEKTDVYSFGMVLLELVSGRR 709
+ + S ++DVY+FG+VL EL++G+
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQL 207
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 2e-63
Identities = 57/207 (27%), Positives = 104/207 (50%), Gaps = 10/207 (4%)
Query: 507 LEVATDNFK--NLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQG-KKDFCTEIAIIGN 562
+E+ D+F+ + +G+G G V+K ++A K I + E+ ++
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 563 IHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAY 622
+ +V G + + E+M+ GSLD++L G + Q +++ +GL Y
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTY 119
Query: 623 LHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEW 682
L + KI+H D+KP NIL++ + K+ DFG+S L + + GTR Y++PE
Sbjct: 120 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPER 174
Query: 683 LTNSAISEKTDVYSFGMVLLELVSGRR 709
L + S ++D++S G+ L+E+ GR
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRY 201
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 1e-61
Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 8/212 (3%)
Query: 505 EELEVATDNFK--NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGN 562
+E EV + K +G+G FG V+ G N T VAVK + G F E ++
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQ 64
Query: 563 IHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPV-LEWQERFDIALGTARGLA 621
+ H LV+L Q ++ EYM +GSL L + L + D+A A G+A
Sbjct: 65 LQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 622 YLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPE 681
++ + IH D++ NIL+ KI+DFGL++L+ + + + + APE
Sbjct: 124 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180
Query: 682 WLTNSAISEKTDVYSFGMVLLELVSGRRNCSP 713
+ + K+DV+SFG++L E+V+ R P
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 212
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 2e-58
Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 4/197 (2%)
Query: 513 NFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLK 572
F +G+G FG V G + VA+K I G + +F E ++ N+ H LV+L
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLY 65
Query: 573 GFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKII 632
G C + R ++ EYM +G L L + Q+ ++ + YL ++ +
Sbjct: 66 GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFL 122
Query: 633 HCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKT 692
H D+ N L++ K+SDFGLS+ + ++ + + + PE L S S K+
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182
Query: 693 DVYSFGMVLLELVSGRR 709
D+++FG+++ E+ S +
Sbjct: 183 DIWAFGVLMWEIYSLGK 199
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 2e-58
Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 9/207 (4%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGN 562
D EL F IGSG FG V+ G +K VA+K I G ++DF E ++
Sbjct: 3 DPSELT-----FVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMK 56
Query: 563 IHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAY 622
+ H LV+L G C + LV+E+M HG L L + + + L G+AY
Sbjct: 57 LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 116
Query: 623 LHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEW 682
L E +IH D+ N L+ + K+SDFG+++ + +Q + T + + +PE
Sbjct: 117 L---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 173
Query: 683 LTNSAISEKTDVYSFGMVLLELVSGRR 709
+ S S K+DV+SFG+++ E+ S +
Sbjct: 174 FSFSRYSSKSDVWSFGVLMWEVFSEGK 200
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-57
Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 8/213 (3%)
Query: 504 YEELEVATDNFK--NLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIG 561
+ E+ ++ + +G G FG V+ G N T VA+K + G + F E ++
Sbjct: 9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMK 67
Query: 562 NIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFG-NGPVLEWQERFDIALGTARGL 620
+ H LV+L ++ +V EYM+ GSL L G G L + D+A A G+
Sbjct: 68 KLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 126
Query: 621 AYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAP 680
AY+ +H D++ NIL+ + K++DFGL++L+ + + + + AP
Sbjct: 127 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 183
Query: 681 EWLTNSAISEKTDVYSFGMVLLELVSGRRNCSP 713
E + K+DV+SFG++L EL + R P
Sbjct: 184 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 216
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (486), Expect = 5e-56
Identities = 62/228 (27%), Positives = 109/228 (47%), Gaps = 23/228 (10%)
Query: 502 FDYEELEVATDNF-----------KNLIGSGGFGAVYKGIL----NDKTIVAVKKI-TNV 545
F +E+ A F + +IG+G FG V G L + VA+K + +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 546 GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLE 605
+ ++DF +E +I+G H N++ L+G + +++ E+M +GSLD L N
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 606 WQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS 665
+ + G A G+ YL + +H D+ NIL++ + K+SDFGLS+ L + S
Sbjct: 127 VIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 666 SLFTT----MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
T + + APE + + +DV+S+G+V+ E++S
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 2e-55
Identities = 56/207 (27%), Positives = 88/207 (42%), Gaps = 12/207 (5%)
Query: 511 TDNFK--NLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVN 567
D ++ +G G FG VYK + A K I + +D+ EI I+ + H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 568 LVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGC 627
+VKL ++ E+ G++D ++ L + + T L YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD-- 128
Query: 628 EQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL---- 683
KIIH D+K NIL K++DFG+S T + GT ++APE +
Sbjct: 129 -NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR-DSFIGTPYWMAPEVVMCET 186
Query: 684 -TNSAISEKTDVYSFGMVLLELVSGRR 709
+ K DV+S G+ L+E+
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEP 213
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (483), Expect = 2e-55
Identities = 65/223 (29%), Positives = 103/223 (46%), Gaps = 21/223 (9%)
Query: 496 PGLPQRFDYEELEVATDNFKNL--IGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGK-- 550
P + + F ++ E F +L IG G FGAVY + + +VA+KK++ G Q
Sbjct: 2 PDVAELFFKDDPE---KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK 58
Query: 551 -KDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQER 609
+D E+ + + H N ++ +G + LV EY + D + P L+ E
Sbjct: 59 WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEI 117
Query: 610 FDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669
+ G +GLAYLHS +IH D+K NILL K+ DFG + ++ P
Sbjct: 118 AAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----N 169
Query: 670 TMRGTRGYLAPEWL---TNSAISEKTDVYSFGMVLLELVSGRR 709
+ GT ++APE + K DV+S G+ +EL +
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 188 bits (478), Expect = 4e-55
Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 8/215 (3%)
Query: 499 PQRFDYEELEVATDNFK--NLIGSGGFGAVYKGILND-KTIVAVKKITNVGVQGKKDFCT 555
P +Y++ E+ + + +G G +G VY+G+ VAVK + ++F
Sbjct: 4 PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLK 62
Query: 556 EIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILF-GNGPVLEWQERFDIAL 614
E A++ I H NLV+L G C + ++ E+M +G+L L N + +A
Sbjct: 63 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 122
Query: 615 GTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGT 674
+ + YL + IH D+ N L+ + K++DFGLS+L+T + + +
Sbjct: 123 QISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 179
Query: 675 RGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
+ APE L + S K+DV++FG++L E+ +
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 214
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 8e-55
Identities = 57/214 (26%), Positives = 100/214 (46%), Gaps = 13/214 (6%)
Query: 505 EELEVATDNFKNL---IGSGGFGAVYKGIL---NDKTIVAVKKITNVGVQG-KKDFCTEI 557
++L + DN +G G FG+V +G+ + VA+K + + ++ E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 558 AIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTA 617
I+ + + +V+L G C Q +LV E G L + L G + ++ +
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119
Query: 618 RGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS--SLFTTMRGTR 675
G+ YL E+ +H D+ N+LL AKISDFGLSK L + S + + +
Sbjct: 120 MGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 676 GYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
+ APE + S ++DV+S+G+ + E +S +
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 210
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (472), Expect = 2e-54
Identities = 67/210 (31%), Positives = 95/210 (45%), Gaps = 17/210 (8%)
Query: 502 FDYEELEVATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIG 561
+ +EL+ IG G FG V G VAVK I N + F E +++
Sbjct: 4 LNMKELK-----LLQTIGKGEFGDVMLGDYRG-NKVAVKCIKNDATA--QAFLAEASVMT 55
Query: 562 NIHHVNLVKLKGFCAQGRQRL-LVYEYMNHGSLDRILFGNG-PVLEWQERFDIALGTARG 619
+ H NLV+L G + + L +V EYM GSL L G VL +L
Sbjct: 56 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 115
Query: 620 LAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLA 679
+ YL +H D+ N+L+ AK+SDFGL+K + Q T + + A
Sbjct: 116 MEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTA 168
Query: 680 PEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
PE L S K+DV+SFG++L E+ S R
Sbjct: 169 PEALREKKFSTKSDVWSFGILLWEIYSFGR 198
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 7e-54
Identities = 62/222 (27%), Positives = 103/222 (46%), Gaps = 16/222 (7%)
Query: 489 DLEAFYIPGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGV 547
L + G P++ Y E IG G G VY + + VA++++
Sbjct: 8 KLRSIVSVGDPKK-KYTRFEK--------IGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 58
Query: 548 QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQ 607
K+ EI ++ + N+V G + +V EY+ GSL ++ +
Sbjct: 59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEG 116
Query: 608 ERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667
+ + + L +LHS ++IH DIK +NILL K++DFG +TPEQS
Sbjct: 117 QIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173
Query: 668 FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
+TM GT ++APE +T A K D++S G++ +E++ G
Sbjct: 174 -STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 1e-53
Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 16/222 (7%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKI-TNVGVQGKKDFCTEIAII 560
D++ ++ +G G +G V + + VAVK + V ++ EI I
Sbjct: 6 DWDLVQT--------LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN 57
Query: 561 GNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGL 620
++H N+VK G +G + L EY + G L + + + + G+
Sbjct: 58 KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGV 116
Query: 621 AYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP-EQSSLFTTMRGTRGYLA 679
YLH I H DIKPEN+LL KISDFGL+ + + L M GT Y+A
Sbjct: 117 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 173
Query: 680 PEWLTNSAI-SEKTDVYSFGMVLLELVSGRRNCSPRSQSHSM 720
PE L +E DV+S G+VL +++G S S
Sbjct: 174 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 215
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 2e-53
Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 13/204 (6%)
Query: 512 DNFK--NLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQGK---KDFCTEIAIIGNIHH 565
++F+ +G G FG VY K I+A+K + ++ E+ I ++ H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 566 VNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHS 625
N+++L G+ + L+ EY G++ R L + Q A L+Y HS
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHS 124
Query: 626 GCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTN 685
+++IH DIKPEN+LL + KI+DFG S SS TT+ GT YL PE +
Sbjct: 125 ---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTTLCGTLDYLPPEMIEG 178
Query: 686 SAISEKTDVYSFGMVLLELVSGRR 709
EK D++S G++ E + G+
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKP 202
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 2e-53
Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 19/217 (8%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKI--TNVGVQGKKDFCTEIAI 559
DYE L IG+G +G K +D I+ K++ ++ K+ +E+ +
Sbjct: 5 DYEVLYT--------IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNL 56
Query: 560 IGNIHHVNLVKLKGFC--AQGRQRLLVYEYMNHGSLDRILFGNG---PVLEWQERFDIAL 614
+ + H N+V+ +V EY G L ++ L+ + +
Sbjct: 57 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 116
Query: 615 GTARGLAYLH--SGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMR 672
L H S ++H D+KP N+ L K+ DFGL+++L + S
Sbjct: 117 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA-KAFV 175
Query: 673 GTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
GT Y++PE + + +EK+D++S G +L EL +
Sbjct: 176 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 212
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 8e-53
Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 14/204 (6%)
Query: 514 FKNLIGSGGFGAVYKGILND-KTIVAVKKI--TNVGVQGKKDFCTEIAIIGNIHHVNLVK 570
F IG G F VYKG+ + VA ++ + ++ F E ++ + H N+V+
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 571 LKGFCA----QGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSG 626
+ +LV E M G+L L ++ + +GL +LH+
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLHTR 131
Query: 627 CEQKIIHCDIKPENILL-HYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTN 685
IIH D+K +NI + KI D GL+ L + + GT ++APE
Sbjct: 132 T-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEMYEE 187
Query: 686 SAISEKTDVYSFGMVLLELVSGRR 709
E DVY+FGM +LE+ +
Sbjct: 188 K-YDESVDVYAFGMCMLEMATSEY 210
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 2e-52
Identities = 62/225 (27%), Positives = 101/225 (44%), Gaps = 14/225 (6%)
Query: 496 PGLPQRFDYEEL--EVATDNFKNLIGSGGFGAVYKGILND----KTIVAVKKITNVGVQG 549
P L Q + + +F +IG G FG VY G L D K AVK + + G
Sbjct: 11 PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG 70
Query: 550 K-KDFCTEIAIIGNIHHVNLVKLKGFCAQGRQR-LLVYEYMNHGSLDRILFGNGPVLEWQ 607
+ F TE I+ + H N++ L G C + L+V YM HG L + +
Sbjct: 71 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 130
Query: 608 ERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ--- 664
+ L A+G+ +K +H D+ N +L F K++DFGL++ + ++
Sbjct: 131 DLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187
Query: 665 SSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
T + ++A E L + K+DV+SFG++L EL++
Sbjct: 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 232
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 180 bits (458), Expect = 4e-52
Identities = 64/240 (26%), Positives = 103/240 (42%), Gaps = 36/240 (15%)
Query: 503 DYEELEVATDNFK--NLIGSGGFGAVYKGIL------NDKTIVAVKKIT-NVGVQGKKDF 553
LE +N + IG G FG V++ T+VAVK + + DF
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 554 CTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNG------------ 601
E A++ + N+VKL G CA G+ L++EYM +G L+ L
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 602 -----------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAK 650
P L E+ IA A G+AYL +K +H D+ N L+ + K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVK 180
Query: 651 ISDFGLSKLLTP-EQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
I+DFGLS+ + + ++ PE + + + ++DV+++G+VL E+ S
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 180 bits (457), Expect = 3e-51
Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 11/217 (5%)
Query: 498 LPQRFDYEELEVATDNFK--NLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFC 554
PQ + + V D++ +G+G FG V++ A K + K+
Sbjct: 13 YPQPVEIKHDHVL-DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR 71
Query: 555 TEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIAL 614
EI + + H LV L + +++YE+M+ G L + + E +
Sbjct: 72 KEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR 131
Query: 615 GTARGLAYLHSGCEQKIIHCDIKPENILL--HYHFQAKISDFGLSKLLTPEQSSLFTTMR 672
+GL ++H E +H D+KPENI+ + K+ DFGL+ L P+QS
Sbjct: 132 QVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKVTT 186
Query: 673 GTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
GT + APE + TD++S G++ L+SG
Sbjct: 187 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLS 223
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 3e-51
Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 12/201 (5%)
Query: 516 NLIGSGGFGAVYKGILNDK---TIVAVKKITNVGVQG--KKDFCTEIAIIGNIHHVNLVK 570
+GSG FG V KG K VAVK + N K + E ++ + + +V+
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 571 LKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQK 630
+ G C + +LV E G L++ L N ++ + ++ + G+ YL E
Sbjct: 73 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLE---ESN 127
Query: 631 IIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT--MRGTRGYLAPEWLTNSAI 688
+H D+ N+LL AKISDFGLSK L +++ + + APE +
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187
Query: 689 SEKTDVYSFGMVLLELVSGRR 709
S K+DV+SFG+++ E S +
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQ 208
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 4e-51
Identities = 64/234 (27%), Positives = 105/234 (44%), Gaps = 30/234 (12%)
Query: 496 PGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGILND---KTIVAVKKITNVGV-QGKK 551
P + D+ +++ F+++IG G FG V K + + A+K++ +
Sbjct: 1 PTIYPVLDWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR 55
Query: 552 DFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGN---------- 600
DF E+ ++ + HH N++ L G C L EY HG+L L +
Sbjct: 56 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 115
Query: 601 -----GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFG 655
L Q+ A ARG+ YL ++ IH D+ NIL+ ++ AKI+DFG
Sbjct: 116 IANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 172
Query: 656 LSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
LS+ T R ++A E L S + +DV+S+G++L E+VS
Sbjct: 173 LSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 5e-51
Identities = 61/223 (27%), Positives = 113/223 (50%), Gaps = 13/223 (5%)
Query: 508 EVATDNFK--NLIGSGGFGAVYKGILND-----KTIVAVKKITNVGVQG-KKDFCTEIAI 559
E+ +IG+G FG VYKG+L + VA+K + + + DF E I
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 560 IGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARG 619
+G H N+++L+G ++ + +++ EYM +G+LD+ L + + G A G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 122
Query: 620 LAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT--MRGTRGY 677
+ YL + +H D+ NIL++ + K+SDFGLS++L + + +TT + +
Sbjct: 123 MKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 678 LAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSM 720
APE ++ + +DV+SFG+V+ E+++ +H +
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV 222
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 6e-50
Identities = 60/245 (24%), Positives = 104/245 (42%), Gaps = 34/245 (13%)
Query: 502 FDYEELEVATDNFKNLIGSGGFGAVYKGIL------NDKTIVAVKKITNVGVQG-KKDFC 554
F L F +G+G FG V + + VAVK + ++
Sbjct: 20 FPRNRLS-----FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM 74
Query: 555 TEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGP----------- 602
+E+ ++ + +H+N+V L G C G L++ EY +G L L
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 603 ------VLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGL 656
L+ ++ + A+G+A+L S + IH D+ NILL + KI DFGL
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGL 191
Query: 657 SKLLTPEQSSLFTTM-RGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715
++ + + + + R ++APE + N + ++DV+S+G+ L EL S + P
Sbjct: 192 ARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251
Query: 716 QSHSM 720
S
Sbjct: 252 PVDSK 256
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 7e-50
Identities = 60/260 (23%), Positives = 108/260 (41%), Gaps = 39/260 (15%)
Query: 484 TLSSGDLEAFYIPGLPQRFDYEEL-EVATDNFK--NLIGSGGFGAVYKGILND------K 534
S D E FY+ + ++Y+ E +N + ++GSG FG V
Sbjct: 10 VTGSSDNEYFYVD--FREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVS 67
Query: 535 TIVAVKKITNVGVQG-KKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYEYMNHGS 592
VAVK + ++ +E+ ++ + H N+V L G C L++EY +G
Sbjct: 68 IQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGD 127
Query: 593 LDRILFGNGP----------------------VLEWQERFDIALGTARGLAYLHSGCEQK 630
L L VL +++ A A+G+ +L +
Sbjct: 128 LLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KS 184
Query: 631 IIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAIS 689
+H D+ N+L+ + KI DFGL++ + + + + R ++APE L +
Sbjct: 185 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT 244
Query: 690 EKTDVYSFGMVLLELVSGRR 709
K+DV+S+G++L E+ S
Sbjct: 245 IKSDVWSYGILLWEIFSLGV 264
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 1e-49
Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 22/214 (10%)
Query: 514 FKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKG 573
+ IG G FG V++G + VAVK ++ + EI + H N++
Sbjct: 7 LQESIGKGRFGEVWRGKWRGE-EVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIA 64
Query: 574 FCAQGR----QRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGC-- 627
+ Q LV +Y HGSL L + + +AL TA GLA+LH
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 628 ---EQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF---TTMRGTRGYLAPE 681
+ I H D+K +NIL+ + I+D GL+ ++ GT+ Y+APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 682 WLTNSA------ISEKTDVYSFGMVLLELVSGRR 709
L +S ++ D+Y+ G+V E+
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 216
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 2e-49
Identities = 52/223 (23%), Positives = 91/223 (40%), Gaps = 13/223 (5%)
Query: 506 ELEVATDNFK--NLIGSGGFGAVYKGIL----NDKTIVAVKKITNVGVQG-KKDFCTEIA 558
+ E+ + + IG G FG V++GI N VA+K N ++ F E
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 559 IIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTAR 618
+ H ++VKL G + ++ E G L L L+ A +
Sbjct: 61 TMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119
Query: 619 GLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYL 678
LAYL ++ +H DI N+L+ + K+ DFGLS+ + + + ++
Sbjct: 120 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 176
Query: 679 APEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSMD 721
APE + + +DV+ FG+ + E++ P + D
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGV--KPFQGVKNND 217
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 2e-49
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 11/205 (5%)
Query: 512 DNFK--NLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKD---FCTEIAIIGNIHH 565
++FK ++G G F V L A+K + + + E ++ + H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 566 VNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHS 625
VKL + Y +G L + + G E RF A ++ L
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA----EIVSALEY 123
Query: 626 GCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLT 684
+ IIH D+KPENILL+ +I+DFG +K+L+PE + + GT Y++PE LT
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 685 NSAISEKTDVYSFGMVLLELVSGRR 709
+ + +D+++ G ++ +LV+G
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLP 208
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 171 bits (435), Expect = 3e-48
Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEIAIIG 561
Y+ LE +GSG FG V++ + + K I K EI+I+
Sbjct: 30 YYDILEE--------LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMN 81
Query: 562 NIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLA 621
+HH L+ L + +L+ E+++ G L + + E + GL
Sbjct: 82 QLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 141
Query: 622 YLHSGCEQKIIHCDIKPENILLHYHF--QAKISDFGLSKLLTPEQSSLFTTMRGTRGYLA 679
++H I+H DIKPENI+ KI DFGL+ L P++ TT T + A
Sbjct: 142 HMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAA 196
Query: 680 PEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
PE + + TD+++ G++ L+SG
Sbjct: 197 PEIVDREPVGFYTDMWAIGVLGYVLLSGLS 226
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 5e-48
Identities = 56/216 (25%), Positives = 88/216 (40%), Gaps = 21/216 (9%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGILNDKT----IVAVKKITNVGV---QGKKDFCT 555
D LE +G G FG V +G + + VAVK + + + DF
Sbjct: 9 DLRLLEK--------LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 60
Query: 556 EIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALG 615
E+ + ++ H NL++L G ++ V E GSL L + A+
Sbjct: 61 EVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 616 TARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS--LFTTMRG 673
A G+ YL S ++ IH D+ N+LL KI DFGL + L + +
Sbjct: 120 VAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
Query: 674 TRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
+ APE L S +D + FG+ L E+ + +
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ 212
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-47
Identities = 50/214 (23%), Positives = 106/214 (49%), Gaps = 19/214 (8%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGILND-----KTIVAVKKIT-NVGVQGKKDFCTE 556
++++++V +GSG FG VYKG+ K VA+K++ + K+ E
Sbjct: 10 EFKKIKV--------LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61
Query: 557 IAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGT 616
++ ++ + ++ +L G C +L + + M G L + + + Q + +
Sbjct: 62 AYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120
Query: 617 ARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT-MRGTR 675
A+G+ YL +++++H D+ N+L+ KI+DFGL+KLL E+ +
Sbjct: 121 AKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 676 GYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
++A E + + + ++DV+S+G+ + EL++
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 211
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 2e-45
Identities = 58/236 (24%), Positives = 105/236 (44%), Gaps = 28/236 (11%)
Query: 499 PQRF------DYEELEVATDNFK--NLIGSGGFGAVYKGILN------DKTIVAVKKIT- 543
P+ F +E EVA + +G G FG VY+G+ +T VA+K +
Sbjct: 1 PEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 60
Query: 544 NVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPV 603
++ + +F E +++ + ++V+L G +QG+ L++ E M G L L P
Sbjct: 61 AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPA 120
Query: 604 ---------LEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDF 654
+ +A A G+AYL++ K +H D+ N ++ F KI DF
Sbjct: 121 MANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDF 177
Query: 655 GLSKLLTPEQSSLFTT-MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
G+++ + +++PE L + + +DV+SFG+VL E+ +
Sbjct: 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 233
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 4e-45
Identities = 48/196 (24%), Positives = 86/196 (43%), Gaps = 9/196 (4%)
Query: 517 LIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFC 575
+G G FG V++ + + K K + G + EI+I+ H N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 576 AQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCD 635
+ ++++E+++ + + + L +E L +LHS I H D
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFD 127
Query: 636 IKPENILLHYH--FQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTD 693
I+PENI+ KI +FG ++ L P + F + Y APE + +S TD
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQHDVVSTATD 185
Query: 694 VYSFGMVLLELVSGRR 709
++S G ++ L+SG
Sbjct: 186 MWSLGTLVYVLLSGIN 201
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (408), Expect = 5e-45
Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 13/213 (6%)
Query: 504 YEELEVATDNFK--NLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKD-FCTEIAI 559
+++ E D + +++G+G F V + +VA+K I ++GK+ EIA+
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 560 IGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARG 619
+ I H N+V L G L+ + ++ G L + G ++ +
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDA 119
Query: 620 LAYLHSGCEQKIIHCDIKPENILLHYH---FQAKISDFGLSKLLTPEQSSLFTTMRGTRG 676
+ YLH I+H D+KPEN+L + + ISDFGLSK+ P S+ +T GT G
Sbjct: 120 VKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGTPG 174
Query: 677 YLAPEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
Y+APE L S+ D +S G++ L+ G
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP 207
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 161 bits (408), Expect = 2e-44
Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 17/207 (8%)
Query: 512 DNFK--NLIGSGGFGAVYKGILND-KTIVAVKKITNVGVQGKKD------FCTEIAIIGN 562
++F +IG GGFG VY D + A+K + ++ K+ ++++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 563 IHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAY 622
+V + + + + MN G L L +G E RF A GL +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIILGLEH 122
Query: 623 LHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEW 682
+H+ + +++ D+KP NILL H +ISD GL+ + ++ GT GY+APE
Sbjct: 123 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEV 176
Query: 683 L-TNSAISEKTDVYSFGMVLLELVSGR 708
L A D +S G +L +L+ G
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 157 bits (398), Expect = 5e-44
Identities = 58/223 (26%), Positives = 92/223 (41%), Gaps = 31/223 (13%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGV---------QGKKD 552
+YE E+ +G G V + I AVK I G + ++
Sbjct: 4 NYEPKEI--------LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 55
Query: 553 FCTEIAIIGNIH-HVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFD 611
E+ I+ + H N+++LK LV++ M G L L L +E
Sbjct: 56 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRK 114
Query: 612 IALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTM 671
I + LH I+H D+KPENILL K++DFG S L P + +
Sbjct: 115 IMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REV 169
Query: 672 RGTRGYLAPEWLT------NSAISEKTDVYSFGMVLLELVSGR 708
GT YLAPE + + ++ D++S G+++ L++G
Sbjct: 170 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 156 bits (394), Expect = 2e-43
Identities = 52/211 (24%), Positives = 94/211 (44%), Gaps = 16/211 (7%)
Query: 511 TDNFK--NLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGK---KDFCTEIAIIGNIH 564
+D ++ ++G GG V+ L VAVK + + F E ++
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 565 HVNLVKLKGFC----AQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGL 620
H +V + G +V EY++ +L I+ GP + + ++ + L
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 124
Query: 621 AYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL--FTTMRGTRGYL 678
+ H IIH D+KP NI++ K+ DFG+++ + +S+ + GT YL
Sbjct: 125 NFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 679 APEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
+PE ++ ++DVYS G VL E+++G
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEP 212
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 3e-43
Identities = 63/240 (26%), Positives = 102/240 (42%), Gaps = 34/240 (14%)
Query: 498 LPQRFDYEELEVATDNFK--NLIGSGGFGAVYKGIL--------NDKTIVAVKKI-TNVG 546
LP+ E+ D +G G FG V N T VAVK + ++
Sbjct: 2 LPED---PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 58
Query: 547 VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGP--- 602
+ D +E+ ++ I H N++ L G C Q ++ EY + G+L L P
Sbjct: 59 EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 118
Query: 603 ------------VLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAK 650
L ++ A ARG+ YL S +K IH D+ N+L+ K
Sbjct: 119 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMK 175
Query: 651 ISDFGLSKLLTPEQSSLFT-TMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
I+DFGL++ + T R ++APE L + + ++DV+SFG++L E+ +
Sbjct: 176 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 235
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 8e-43
Identities = 62/243 (25%), Positives = 104/243 (42%), Gaps = 32/243 (13%)
Query: 498 LPQRFDYEELEVATDNFK--NLIGSGGFGAVYKGILN------DKTIVAVKKITNVGVQG 549
LP +D + E D K +G G FG V + VAVK +
Sbjct: 1 LP--YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 58
Query: 550 -KKDFCTEIAIIGNI-HHVNLVKLKGFCAQ-GRQRLLVYEYMNHGSLDRILFGNGP---- 602
+ +E+ I+ +I HH+N+V L G C + G +++ E+ G+L L
Sbjct: 59 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 118
Query: 603 -----------VLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKI 651
L + + A+G+ +L S +K IH D+ NILL KI
Sbjct: 119 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKI 175
Query: 652 SDFGLSKLLTPEQSSLFTT-MRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRN 710
DFGL++ + + + R ++APE + + + ++DV+SFG++L E+ S +
Sbjct: 176 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 235
Query: 711 CSP 713
P
Sbjct: 236 PYP 238
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 9e-43
Identities = 51/205 (24%), Positives = 81/205 (39%), Gaps = 12/205 (5%)
Query: 512 DNFK--NLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKD---FCTEIAIIG-NIH 564
++F ++G G FG V+ A+K + V D E ++
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 565 HVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLH 624
H L + V EY+N G L + + A GL +L
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFL- 119
Query: 625 SGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLT 684
+ I++ D+K +NILL KI+DFG+ K + T GT Y+APE L
Sbjct: 120 --HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNTFCGTPDYIAPEILL 176
Query: 685 NSAISEKTDVYSFGMVLLELVSGRR 709
+ D +SFG++L E++ G+
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQS 201
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 4e-42
Identities = 55/214 (25%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 510 ATDNFK--NLIGSGGFGAVYKG--ILNDKTIVAVKKITNVGVQGK--KDFCTEIAI---I 560
A ++ IG G +G V+K + N VA+K++ + E+A+ +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 561 GNIHHVNLVKLKGFCAQGRQR-----LLVYEYMNHGSLDRILFGNGPVLEWQERFDIALG 615
H N+V+L C R LV+E+++ + P + + D+
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 616 TARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTR 675
RGL +LHS +++H D+KP+NIL+ Q K++DFGL+++ + + + T++ T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVTL 179
Query: 676 GYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
Y APE L S+ + D++S G + E+ +
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 213
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 152 bits (386), Expect = 7e-42
Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKD---FCTEIA 558
D++ L +G+G FG V+ ++ A+K + V K E
Sbjct: 5 DFQILRT--------LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERL 56
Query: 559 IIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTAR 618
++ + H ++++ G +Q ++ +Y+ G L +L + +F A
Sbjct: 57 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCL 115
Query: 619 GLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYL 678
L YLH + II+ D+KPENILL + KI+DFG +K + + T+ GT Y+
Sbjct: 116 ALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYI 168
Query: 679 APEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
APE ++ ++ D +SFG+++ E+++G
Sbjct: 169 APEVVSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 8e-42
Identities = 62/200 (31%), Positives = 90/200 (45%), Gaps = 12/200 (6%)
Query: 516 NLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKD-----FCTEIAIIGNIHHVNLV 569
+ +G G F VYK N IVA+KKI KD EI ++ + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 570 KLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQ 629
L LV+++M L+ I+ N VL L T +GL YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---H 119
Query: 630 KIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL-TNSAI 688
I+H D+KP N+LL + K++DFGL+K + +T TR Y APE L
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-YTHQVVTRWYRAPELLFGARMY 178
Query: 689 SEKTDVYSFGMVLLELVSGR 708
D+++ G +L EL+
Sbjct: 179 GVGVDMWAVGCILAELLLRV 198
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 1e-41
Identities = 65/225 (28%), Positives = 99/225 (44%), Gaps = 28/225 (12%)
Query: 496 PGLPQRFDYEELEVATDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQGKKDFC 554
P PQ Y + +V IG+G FG VY+ L + +VA+KK+ Q K+
Sbjct: 14 PDRPQEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKN 61
Query: 555 TEIAIIGNIHHVNLVKLKGFCAQGRQR------LLVYEYMNHGSLDRILFGN--GPVLEW 606
E+ I+ + H N+V+L+ F ++ LV +Y+ + L
Sbjct: 62 RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121
Query: 607 QERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYH-FQAKISDFGLSKLLTPEQS 665
R LAY+HS I H DIKP+N+LL K+ DFG +K L +
Sbjct: 122 IYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RG 176
Query: 666 SLFTTMRGTRGYLAPEWLTNSA-ISEKTDVYSFGMVLLELVSGRR 709
+ +R Y APE + + + DV+S G VL EL+ G+
Sbjct: 177 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 149 bits (377), Expect = 4e-41
Identities = 51/201 (25%), Positives = 89/201 (44%), Gaps = 8/201 (3%)
Query: 512 DNFKNL--IGSGGFGAVYKGILNDKTIVAVKKI--TNVGVQGKKDFCTEIAIIGNIHHVN 567
+ + L IG G +G VYK N A+KKI EI+I+ + H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 568 LVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGC 627
+VKL ++ +LV+E+++ + G LE L G+AY H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHD-- 118
Query: 628 EQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSA 687
++++H D+KP+N+L++ + KI+DFGL++ + + +
Sbjct: 119 -RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 688 ISEKTDVYSFGMVLLELVSGR 708
S D++S G + E+V+G
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGT 198
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 6e-41
Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 26/222 (11%)
Query: 500 QRFD----YEELEVATDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQG-KKDF 553
Q FD Y L IG G +G V +K VA+KKI+ Q +
Sbjct: 2 QVFDVGPRYTNLSY--------IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT 53
Query: 554 CTEIAIIGNIHHVNLVKLKGFCA----QGRQRLLVYEYMNHGSLDRILFGNGPVLEWQER 609
EI I+ H N++ + + + + + ++ L ++L L
Sbjct: 54 LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHI 111
Query: 610 FDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS--L 667
RGL Y+HS ++H D+KP N+LL+ KI DFGL+++ P+
Sbjct: 112 CYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 168
Query: 668 FTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGR 708
T TR Y APE + NS ++ D++S G +L E++S R
Sbjct: 169 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 8e-41
Identities = 48/204 (23%), Positives = 84/204 (41%), Gaps = 17/204 (8%)
Query: 517 LIGSGGFGAVYKGI-LNDKTIVAVKKI------TNVGVQGKKDFCTEIAIIGNIH--HVN 567
L+GSGGFG+VY GI ++D VA+K + + E+ ++ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 568 LVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGC 627
+++L + + +L+ E L+ + + +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC---H 127
Query: 628 EQKIIHCDIKPENILLHYH-FQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWL-TN 685
++H DIK ENIL+ + + K+ DFG LL +T GTR Y PEW+ +
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYH 184
Query: 686 SAISEKTDVYSFGMVLLELVSGRR 709
V+S G++L ++V G
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDI 208
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 1e-40
Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 10/204 (4%)
Query: 512 DNFK--NLIGSGGFGAVYKGI-LNDKTIVAVKKI--TNVGVQGKKDFCTEIAIIGNIHHV 566
+NF+ IG G +G VYK +VA+KKI EI+++ ++H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 567 NLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSG 626
N+VKL + LV+E+++ + + +GLA+ HS
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 120
Query: 627 CEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNS 686
+++H D+KP+N+L++ K++DFGL++ + +T T Y APE L
Sbjct: 121 --HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGC 177
Query: 687 -AISEKTDVYSFGMVLLELVSGRR 709
S D++S G + E+V+ R
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRA 201
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 3e-40
Identities = 52/217 (23%), Positives = 86/217 (39%), Gaps = 27/217 (12%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEIAIIG 561
DY+ ++G G G V + + A+K + Q E+ +
Sbjct: 12 DYKVTS-------QVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHW 59
Query: 562 NI-HHVNLVKLKGFC----AQGRQRLLVYEYMNHGSLDRILFGNGP-VLEWQERFDIALG 615
++V++ A + L+V E ++ G L + G +E +I
Sbjct: 60 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 119
Query: 616 TARGLAYLHSGCEQKIIHCDIKPENILLHYHFQ---AKISDFGLSKLLTPEQSSLFTTMR 672
+ YLHS I H D+KPEN+L K++DFG +K T S TT
Sbjct: 120 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPC 174
Query: 673 GTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
T Y+APE L + D++S G+++ L+ G
Sbjct: 175 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 211
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 144 bits (365), Expect = 2e-39
Identities = 38/218 (17%), Positives = 73/218 (33%), Gaps = 19/218 (8%)
Query: 517 LIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNI-HHVNLVKLKGF 574
IG G FG +++G L + VA+K E + + + F
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 575 CAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHC 634
+G +LV + + D +L G + A + +H + +++
Sbjct: 70 GQEGLHNVLVIDLLGPSLED-LLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYR 125
Query: 635 DIKPENILL-----HYHFQAKISDFGLSKLLTPEQSS------LFTTMRGTRGYLAPEWL 683
DIKP+N L+ + DFG+ K + + GT Y++
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 684 TNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSMD 721
S + D+ + G V + + G + +
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ 223
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 2e-38
Identities = 55/211 (26%), Positives = 88/211 (41%), Gaps = 17/211 (8%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKD---FCTEIA 558
D++ L++ +G G FG V A+K + + K + TE
Sbjct: 6 DFDYLKL--------LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 559 IIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTAR 618
++ N H L LK + V EY N G L L E + A
Sbjct: 58 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER----ARFYGAE 113
Query: 619 GLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYL 678
++ L + +++ DIK EN++L KI+DFGL K + +++ T GT YL
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYL 172
Query: 679 APEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
APE L ++ D + G+V+ E++ GR
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-38
Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 17/206 (8%)
Query: 514 FKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQG------KKDFCTEIAIIGNIHHV 566
+GSG F V K + A K I + ++D E++I+ I H
Sbjct: 14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 567 NLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSG 626
N++ L +L+ E + G L L + E + + + L ++
Sbjct: 74 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL----KQILNGVYYL 129
Query: 627 CEQKIIHCDIKPENILLHYH----FQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEW 682
+I H D+KPENI+L + KI DFGL+ + + F + GT ++APE
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--GNEFKNIFGTPEFVAPEI 187
Query: 683 LTNSAISEKTDVYSFGMVLLELVSGR 708
+ + + D++S G++ L+SG
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGA 213
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (356), Expect = 1e-37
Identities = 48/211 (22%), Positives = 84/211 (39%), Gaps = 20/211 (9%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKD---FCTEIA 558
++ ++ +G+G FG V A+K + V K E
Sbjct: 42 QFDRIKT--------LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 559 IIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTAR 618
I+ ++ LVKL+ +V EY+ G + L G A
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVL 152
Query: 619 GLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYL 678
YLHS +I+ D+KPEN+L+ +++DFG +K T+ GT L
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEAL 205
Query: 679 APEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
APE + + ++ D ++ G+++ E+ +G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 236
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (352), Expect = 1e-37
Identities = 47/219 (21%), Positives = 75/219 (34%), Gaps = 17/219 (7%)
Query: 514 FKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLK 572
IGSG FG +Y G + VA+K E I + +
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTI 68
Query: 573 GFC-AQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKI 631
+C A+G ++V E + D F + + +A + Y+HS +
Sbjct: 69 RWCGAEGDYNVMVMELLGPSLEDLFNFCSRK-FSLKTVLLLADQMISRIEYIHS---KNF 124
Query: 632 IHCDIKPENILLH---YHFQAKISDFGLSKLLTPEQSSLF------TTMRGTRGYLAPEW 682
IH D+KP+N L+ I DFGL+K ++ + GT Y +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 683 LTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSMD 721
S + D+ S G VL+ G +
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ 223
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 4e-36
Identities = 53/234 (22%), Positives = 87/234 (37%), Gaps = 27/234 (11%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKI--TNVGVQGKKDFCTEIAI 559
YE+L IG G FG V+K VA+KK+ N EI I
Sbjct: 11 KYEKLAK--------IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKI 62
Query: 560 IGNIHHVNLVKLKGFCAQGRQR--------LLVYEYMNHGSLDRILFGNGPVLEWQERFD 611
+ + H N+V L C LV+++ H + E
Sbjct: 63 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKR 121
Query: 612 IALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS---LF 668
+ GL Y+ KI+H D+K N+L+ K++DFGL++ + ++S +
Sbjct: 122 VMQMLLNGLYYI---HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 178
Query: 669 TTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSMD 721
T T Y PE L D++ G ++ E+ + ++ H +
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA 232
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 4e-35
Identities = 44/210 (20%), Positives = 84/210 (40%), Gaps = 15/210 (7%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKI--TNVGVQGKKDFCTEIAI 559
YE+LE IG G +G V+K IVA+K++ + EI +
Sbjct: 3 KYEKLEK--------IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICL 54
Query: 560 IGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARG 619
+ + H N+V+L ++ LV+E+ + NG + + +
Sbjct: 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKS----FLFQL 110
Query: 620 LAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLA 679
L L + ++H D+KP+N+L++ + + K+++FGL++ +
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPP 170
Query: 680 PEWLTNSAISEKTDVYSFGMVLLELVSGRR 709
S D++S G + EL + R
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 131 bits (330), Expect = 2e-34
Identities = 52/222 (23%), Positives = 99/222 (44%), Gaps = 23/222 (10%)
Query: 499 PQRFDYEELEVAT---DNFK--NLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKD 552
+ +DYE V D+++ +G G + V++ I + + V VK + V KK
Sbjct: 19 REYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKK 75
Query: 553 FCTEIAIIGNI-HHVNLVKLKGFCAQGRQRL--LVYEYMNHGSLDRILFGNGPVLEWQER 609
EI I+ N+ N++ L R LV+E++N+ ++ + ++ R
Sbjct: 76 IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIR 132
Query: 610 FDIALGTARGLAYLHSGCEQKIIHCDIKPENILL-HYHFQAKISDFGLSKLLTPEQSSLF 668
F + L Y HS I+H D+KP N+++ H H + ++ D+GL++ P Q +
Sbjct: 133 F-YMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--Y 186
Query: 669 TTMRGTRGYLAPE-WLTNSAISEKTDVYSFGMVLLELVSGRR 709
+R + PE + D++S G +L ++ +
Sbjct: 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 9e-34
Identities = 52/215 (24%), Positives = 91/215 (42%), Gaps = 28/215 (13%)
Query: 504 YEELEVATDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKI--TNVGVQGKKDFCTEIAII 560
Y +L+ +GSG +GAV + VA+KK+ K E+ ++
Sbjct: 20 YRDLQP--------VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 71
Query: 561 GNIHHVNLVKLKGFCAQGRQR------LLVYEYMNHGSLDRILFGNGPVLEWQERFDIAL 614
++ H N++ L LV +M + L +
Sbjct: 72 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK---LGEDRIQFLVY 128
Query: 615 GTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGT 674
+GL Y+H+ IIH D+KP N+ ++ + KI DFGL++ + S T T
Sbjct: 129 QMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR----QADSEMTGYVVT 181
Query: 675 RGYLAPEWLTNSA-ISEKTDVYSFGMVLLELVSGR 708
R Y APE + N ++ D++S G ++ E+++G+
Sbjct: 182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 1e-33
Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 17/214 (7%)
Query: 509 VATDNFK--NLIGSGGFGAVYKGIL----NDKTIVAVKKITNVGV----QGKKDFCTEIA 558
V +NF+ ++G+G +G V+ + + A+K + + + + TE
Sbjct: 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80
Query: 559 IIGNI-HHVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTA 617
++ +I LV L + L+ +Y+N G L L E + + +
Sbjct: 81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG---- 136
Query: 618 RGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGY 677
+ L + II+ DIK ENILL + ++DFGLSK +++ GT Y
Sbjct: 137 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196
Query: 678 LAPEWL--TNSAISEKTDVYSFGMVLLELVSGRR 709
+AP+ + +S + D +S G+++ EL++G
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (313), Expect = 9e-32
Identities = 55/215 (25%), Positives = 88/215 (40%), Gaps = 26/215 (12%)
Query: 503 DYEELEVATDNFKNLIGSGGFGAVYKGI-LNDKTIVAVKKITNVGV--QGKKDFCTEIAI 559
Y+ L+ IGSG G V VA+KK++ K E+ +
Sbjct: 18 RYQNLKP--------IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 69
Query: 560 IGNIHHVNLVKLKGFCA------QGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIA 613
+ ++H N++ L + + LV E M+ I + + +
Sbjct: 70 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLL 125
Query: 614 LGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRG 673
G+ +LHS IIH D+KP NI++ KI DFGL++ T S + T
Sbjct: 126 YQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVV 180
Query: 674 TRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGR 708
TR Y APE + E D++S G ++ E+V +
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 4e-31
Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 20/222 (9%)
Query: 511 TDNFKNL--IGSGGFGAVYKGI-LNDKTIVAVKKI--TNVGVQGKKDFCTEIAIIGNIHH 565
+ ++NL +GSG +G+V VAVKK+ + K E+ ++ ++ H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 566 VNLVKLKGFCAQGR-----QRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGL 620
N++ L R + + ++ L+ I+ L + RGL
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGL 134
Query: 621 AYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMRGTRGYLAP 680
Y+HS IIH D+KP N+ ++ + KI DFGL++ E T TR Y AP
Sbjct: 135 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAP 187
Query: 681 EWLTNSA-ISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSMD 721
E + N ++ D++S G ++ EL++GR +
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 229
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 116 bits (290), Expect = 1e-28
Identities = 52/241 (21%), Positives = 87/241 (36%), Gaps = 36/241 (14%)
Query: 512 DNFKN-------LIGSGGFGAVYKGI-LNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNI 563
+ +K+ +G G F V+ + + T VA+K + V + EI ++ +
Sbjct: 8 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRV 66
Query: 564 HHVNLVKLKGFCAQGRQRLLVY---------------EYMNHGSLDRILFGNGPVLEWQE 608
+ + K A +LL + E + L I +
Sbjct: 67 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 126
Query: 609 RFDIALGTARGLAYLHSGCEQKIIHCDIKPENILL------HYHFQAKISDFGLSKLLTP 662
I+ GL Y+H IIH DIKPEN+L+ Q KI+D G +
Sbjct: 127 VKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 184
Query: 663 EQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSHSMDS 722
+T TR Y +PE L + D++S ++ EL++G P
Sbjct: 185 H----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240
Query: 723 N 723
+
Sbjct: 241 D 241
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.9 bits (217), Expect = 2e-20
Identities = 29/165 (17%), Positives = 47/165 (28%), Gaps = 20/165 (12%)
Query: 512 DNFKNLIGSGGFGAVYKGILNDKTIVAVK----------KITNVGVQGKKDFCTEIAIIG 561
D L+G G AV+ VK K+ G F
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61
Query: 562 NIHHVNLVKLKGFCAQGRQRLLVYEYMNHGSL-DRILFGNGPVLEWQERFDIALGTARGL 620
L KL+G Y + + L + I + + ++ +
Sbjct: 62 RNEFRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEV 116
Query: 621 AYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS 665
A + I+H D+ N+L+ I DF S + E
Sbjct: 117 AKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGW 157
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 56.5 bits (136), Expect = 2e-10
Identities = 22/111 (19%), Positives = 38/111 (34%), Gaps = 15/111 (13%)
Query: 40 YGGSFLTSHNGTFKAAIVNTRSQQNSFYLCIIHVLSNTIIWSANRDTPISGSGKMNLTPK 99
Y G L F Q L + +T +W++N K L
Sbjct: 11 YAGQSLDVEPYHF--------IMQEDCNLVLYD--HSTSVWASNTGILGKKGCKAVLQSD 60
Query: 100 G-IIISDENGNLKWSTP-PLKSSVSALRLTEMGNLVLLDGFNGSLWESFHH 148
G ++ D G W++ + L L E GN+V+ + +W + +
Sbjct: 61 GNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVI---YGSDIWSTGTY 108
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 47.5 bits (112), Expect = 2e-07
Identities = 14/78 (17%), Positives = 34/78 (43%), Gaps = 2/78 (2%)
Query: 75 SNTIIWSANRDTPISGSGKMNLTPKG-IIISDENGNLKWSTPPLKSSVSALRLTEMGNLV 133
+N +W++ + SG + + G ++I + + S ++ L L N+V
Sbjct: 36 NNRAVWASGTNGKASGC-VLKMQNDGNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVV 94
Query: 134 LLDGFNGSLWESFHHPRD 151
+ D N ++W + + +
Sbjct: 95 IYDNSNNAIWATHTNVGN 112
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 43.8 bits (103), Expect = 5e-06
Identities = 13/86 (15%), Positives = 30/86 (34%), Gaps = 3/86 (3%)
Query: 64 NSFYLCIIHVLSNTIIWSANRDTPIS-GSGKMNLTPKGIIISDENGNLKWSTPPLKSSVS 122
N+ + H S+ + + + S + + ++ ++ W++ ++
Sbjct: 1 NNILFGLSHEGSHP--QTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRVWASNTAGATGC 58
Query: 123 ALRLTEMGNLVLLDGFNGSLWESFHH 148
L G LV+L N W S
Sbjct: 59 RAVLQSDGLLVILTAQNTIRWSSGTK 84
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 43.4 bits (102), Expect = 7e-06
Identities = 8/74 (10%), Positives = 28/74 (37%), Gaps = 2/74 (2%)
Query: 75 SNTIIWSANRDTPIS-GSGKMNLTPKG-IIISDENGNLKWSTPPLKSSVSALRLTEMGNL 132
++ + + + ++++ +++ D + + + K + L G +
Sbjct: 19 NDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAVLQPNGRM 78
Query: 133 VLLDGFNGSLWESF 146
+L N ++W S
Sbjct: 79 DVLTNQNIAVWTSG 92
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 38.1 bits (88), Expect = 5e-04
Identities = 10/75 (13%), Positives = 26/75 (34%), Gaps = 4/75 (5%)
Query: 75 SNTIIWSANRDTPISGSGKMNLTPKGIIISDENGNLKWSTPPLKSSVS-ALRLTEMGNLV 133
+ IW+ N T +++ + + W++ + + L + N+V
Sbjct: 36 VDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVV 95
Query: 134 LLDGFNGSLWESFHH 148
+ + W + H
Sbjct: 96 I---YGTDRWATGTH 107
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 37.7 bits (87), Expect = 7e-04
Identities = 17/72 (23%), Positives = 30/72 (41%), Gaps = 6/72 (8%)
Query: 76 NTIIWSANRDTPISGSGKMNLTPKG-IIISDENGNLKWSTP-PLKSSVSALRLTEMGNLV 133
N IW+ N +G + L P G +++ W +P K+ L L N+V
Sbjct: 48 NNPIWATNTGGLGNGC-RAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVV 106
Query: 134 LLDGFNGSLWES 145
+ + +LW +
Sbjct: 107 I---YGDALWAT 115
|
| >d1dx5i3 g.3.11.1 (I:423-462) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} Length = 40 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Thrombomodulin, different EGF-like domains species: Human (Homo sapiens) [TaxId: 9606]
Score = 34.0 bits (78), Expect = 0.003
Identities = 12/42 (28%), Positives = 17/42 (40%), Gaps = 4/42 (9%)
Query: 275 DGCQIPFICGRMGMCADDATSGSPSCSCPAGFHLASQNTSGC 316
D C+ C G+C + G+ C C LA Q + C
Sbjct: 3 DECENGGFCS--GVCHN--LPGTFECICGPDSALAGQIGTDC 40
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 724 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.96 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.84 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.73 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.72 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.68 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.58 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.47 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.43 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 98.97 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.81 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.81 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.64 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.63 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.6 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.19 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.67 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.31 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.79 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.04 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.09 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 92.82 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 87.68 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 86.61 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 85.39 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 84.38 | |
| d1i0ua2 | 41 | Low density lipoprotein (LDL) receptor, different | 83.3 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 80.56 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-43 Score=358.02 Aligned_cols=200 Identities=31% Similarity=0.478 Sum_probs=168.3
Q ss_pred ccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCC
Q 043185 512 DNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHG 591 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~g 591 (724)
+.+.+.||+|+||+||+|++.+++.||||+++.. ....++|.+|++++++++|||||+++|++.+++..++||||+++|
T Consensus 7 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g 85 (263)
T d1sm2a_ 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG 85 (263)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred cEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCC
Confidence 4566899999999999999988888999999764 455678999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceecc
Q 043185 592 SLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTM 671 (724)
Q Consensus 592 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 671 (724)
+|.+++......+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.............
T Consensus 86 ~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~ 162 (263)
T d1sm2a_ 86 CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 162 (263)
T ss_dssp BHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC----------------
T ss_pred cHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCceeecce
Confidence 9999998877789999999999999999999997 8999999999999999999999999999987765444333456
Q ss_pred cccccccccccccCCcCCCccchhhHHHHHHHHHhC-CCCCCCCC
Q 043185 672 RGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSG-RRNCSPRS 715 (724)
Q Consensus 672 ~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG-~~p~~~~~ 715 (724)
.||+.|+|||++.+..++.++|||||||++|||+++ ++||....
T Consensus 163 ~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~ 207 (263)
T d1sm2a_ 163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 207 (263)
T ss_dssp --CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC
T ss_pred ecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC
Confidence 789999999999999999999999999999999995 66665544
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-42 Score=358.01 Aligned_cols=200 Identities=29% Similarity=0.429 Sum_probs=179.8
Q ss_pred hccccccccccccEEEEEEEE-CCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 511 TDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
.|.+.+.||+|+||+||+|+. .+++.||||++........+.+.+|++++++++|||||++++++.+++..+|||||++
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 100 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence 356668899999999999996 4688999999986655667889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
+|+|.+++.+. .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.+...... ..
T Consensus 101 gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~-~~ 174 (293)
T d1yhwa1 101 GGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RS 174 (293)
T ss_dssp TCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-BC
T ss_pred CCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecccccc-cc
Confidence 99999988664 58999999999999999999997 89999999999999999999999999999877544322 34
Q ss_pred cccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.+...
T Consensus 175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 221 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221 (293)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH
Confidence 56799999999999999999999999999999999999999976553
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-42 Score=351.43 Aligned_cols=198 Identities=30% Similarity=0.448 Sum_probs=177.4
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV---GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
+.+.+.||+|+||+||+|+.. +++.||+|++.+. .....+.+.+|++++++++|||||++++++.+++..+|||||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence 566789999999999999985 6789999998642 234457789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
+++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 88 ~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~--- 160 (263)
T d2j4za1 88 APLGTVYRELQKL-SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--- 160 (263)
T ss_dssp CTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC---
T ss_pred cCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCCc---
Confidence 9999999999765 358999999999999999999997 899999999999999999999999999998665432
Q ss_pred eecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.....||+.|||||++.+..++.++|||||||+||||++|+.||...+.
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 209 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 209 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH
Confidence 2456799999999999999999999999999999999999999987654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-43 Score=358.53 Aligned_cols=200 Identities=34% Similarity=0.510 Sum_probs=169.1
Q ss_pred hccccccccccccEEEEEEEECCccEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 511 TDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
.+.+.+.||+|+||+||+|++++ .||||+++.. .....++|.+|++++++++|||||++++++.+ ...+|||||+
T Consensus 9 ~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~ 85 (276)
T d1uwha_ 9 QITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWC 85 (276)
T ss_dssp CCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred cEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecC
Confidence 34567899999999999998754 4999998643 34456789999999999999999999998765 5689999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc-cc
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS-SL 667 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~-~~ 667 (724)
++|+|.+++......+++..+..++.||++||+|||+ ++||||||||+||||+.++.+||+|||+|+....... ..
T Consensus 86 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~ 162 (276)
T d1uwha_ 86 EGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 162 (276)
T ss_dssp CEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC---------
T ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCCccc
Confidence 9999999998777779999999999999999999997 8999999999999999999999999999987654322 23
Q ss_pred eecccccccccccccccCC---cCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNS---AISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~---~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.....||+.|||||++.+. .|+.++|||||||+||||++|+.||.....
T Consensus 163 ~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~ 214 (276)
T d1uwha_ 163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214 (276)
T ss_dssp ---CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred ccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh
Confidence 3456799999999999643 589999999999999999999999976543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-43 Score=361.45 Aligned_cols=203 Identities=27% Similarity=0.372 Sum_probs=179.7
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
|.+.+.||+|+||+||+|+.. +++.||||+++.......+.+.+|++++++++|||||++++++.+++..+|||||+++
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence 456688999999999999975 6788999999876666778899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceec
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTT 670 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 670 (724)
|+|.+++.+....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+...... .....
T Consensus 94 g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~~~ 169 (288)
T d2jfla1 94 GAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDS 169 (288)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHHTC
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCc-ccccc
Confidence 99999987766679999999999999999999997 899999999999999999999999999997653321 11234
Q ss_pred cccccccccccccc-----CCcCCCccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 043185 671 MRGTRGYLAPEWLT-----NSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSH 718 (724)
Q Consensus 671 ~~gt~~y~aPE~l~-----~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~ 718 (724)
..||+.|+|||++. +..|+.++|||||||++|||++|+.||......+
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~ 222 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR 222 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG
T ss_pred cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH
Confidence 67999999999984 4568999999999999999999999998766544
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-42 Score=354.95 Aligned_cols=202 Identities=31% Similarity=0.433 Sum_probs=174.5
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
+.+.+.||+|+||+||+|+.. +++.||||++.... ....+++.+|++++++++|||||++++++.+++..+|||||++
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 86 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 86 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccC
Confidence 556689999999999999985 68899999997543 2344678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc-cce
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS-SLF 668 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~-~~~ 668 (724)
+|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+....... ...
T Consensus 87 gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~ 162 (271)
T d1nvra_ 87 GGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 162 (271)
T ss_dssp TEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred CCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence 99999998654 468999999999999999999997 8999999999999999999999999999987654332 223
Q ss_pred ecccccccccccccccCCcC-CCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTNSAI-SEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~~~~-~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
....||+.|||||++.+..+ +.++|||||||++|||++|++||......
T Consensus 163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~ 212 (271)
T d1nvra_ 163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 212 (271)
T ss_dssp CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT
T ss_pred cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH
Confidence 45679999999999988876 67899999999999999999999765543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-42 Score=358.28 Aligned_cols=204 Identities=28% Similarity=0.441 Sum_probs=180.0
Q ss_pred HHHHhhccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEE
Q 043185 506 ELEVATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLV 584 (724)
Q Consensus 506 ~l~~a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 584 (724)
|+....+.+.+.||+|+||+||+|++. +++.||||+++.. ....++|.+|+++|++++|||||++++++.+++..+||
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence 344455667789999999999999986 5778999998754 44567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCC
Q 043185 585 YEYMNHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE 663 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (724)
|||+++|+|.+++... ...+++..+..|+.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++.....
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 9999999999998753 5678999999999999999999997 89999999999999999999999999999987665
Q ss_pred CccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCC
Q 043185 664 QSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSP 713 (724)
Q Consensus 664 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~ 713 (724)
.........|++.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~ 218 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 218 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence 54444455689999999999999999999999999999999997666543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-42 Score=355.63 Aligned_cols=201 Identities=30% Similarity=0.470 Sum_probs=175.2
Q ss_pred HhhccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 509 VATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 509 ~a~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
...+.+.+.||+|+||.||+|++++++.||||+++.. ....++|.+|++++++++|||||+++|++.+ +..+|||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 3456677899999999999999998889999999764 4456789999999999999999999998865 5678999999
Q ss_pred CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 589 NHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 589 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
++|+|.+++... ...+++..+++|+.||++||.|||+ ++|+||||||+||||++++.+||+|||+|+.+.......
T Consensus 90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 999999887543 3358999999999999999999997 899999999999999999999999999999876554444
Q ss_pred eecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCC-CCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRN-CSPR 714 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p-~~~~ 714 (724)
.....||+.|||||++.+..++.++|||||||++|||+||..| +...
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~ 214 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence 4556789999999999999999999999999999999996554 4443
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-42 Score=360.08 Aligned_cols=201 Identities=29% Similarity=0.512 Sum_probs=164.7
Q ss_pred ccccccccccEEEEEEEECC-c---cEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 514 FKNLIGSGGFGAVYKGILND-K---TIVAVKKITNV-GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 514 ~~~~lG~G~fG~Vy~~~~~~-~---~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
+.++||+|+||+||+|++.. + ..||||++... .....++|.+|+++|++++|||||+++|++.+++..++||||+
T Consensus 30 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~ 109 (299)
T d1jpaa_ 30 IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFM 109 (299)
T ss_dssp EEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred EeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEec
Confidence 34689999999999999752 2 35889988653 3344578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc--
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS-- 666 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-- 666 (724)
++|+|.+++......+++.+++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++.+......
T Consensus 110 ~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~ 186 (299)
T d1jpaa_ 110 ENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 186 (299)
T ss_dssp TTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC--------------
T ss_pred CCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccCCCCcce
Confidence 9999999998877789999999999999999999997 89999999999999999999999999999877543221
Q ss_pred --ceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 043185 667 --LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQS 717 (724)
Q Consensus 667 --~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~~ 717 (724)
......||+.|||||.+.+..++.++|||||||+||||+| |++||......
T Consensus 187 ~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~ 240 (299)
T d1jpaa_ 187 YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240 (299)
T ss_dssp ---------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred eeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH
Confidence 1123457899999999999999999999999999999998 89999766543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-42 Score=348.18 Aligned_cols=201 Identities=27% Similarity=0.443 Sum_probs=182.1
Q ss_pred cccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCCCC
Q 043185 513 NFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNHGS 592 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~gs 592 (724)
.|.++||+|+||+||+|++++++.||||+++.. ....++|.+|+.++++++||||++++|++.+++..++||||+++|+
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~ 85 (258)
T d1k2pa_ 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 85 (258)
T ss_dssp CCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEE
T ss_pred EEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCc
Confidence 466899999999999999998889999999865 3456789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccceeccc
Q 043185 593 LDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFTTMR 672 (724)
Q Consensus 593 L~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 672 (724)
|..++......+++..+.+++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++..............
T Consensus 86 l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 162 (258)
T d1k2pa_ 86 LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK 162 (258)
T ss_dssp HHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSC
T ss_pred HHHhhhccccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCceeecccC
Confidence 999988777788999999999999999999997 89999999999999999999999999999877655444444567
Q ss_pred ccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 043185 673 GTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQS 717 (724)
Q Consensus 673 gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~~ 717 (724)
+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......
T Consensus 163 ~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~ 208 (258)
T d1k2pa_ 163 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 208 (258)
T ss_dssp CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH
T ss_pred CCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH
Confidence 8999999999999999999999999999999998 89999876543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=365.14 Aligned_cols=200 Identities=28% Similarity=0.409 Sum_probs=175.5
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
.+.+.+.||+|+||+||+|+.. +++.||+|+++... ....+++.+|+.+|++++|||||++++++.+....+|||||+
T Consensus 7 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~ 86 (322)
T d1s9ja_ 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 86 (322)
T ss_dssp GEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 3455689999999999999975 67899999997542 334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
++|+|.+++.+.+ .+++..+..++.|++.||.|||+ .++|+||||||+||||+.++.+||+|||+|+...... .
T Consensus 87 ~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---~ 160 (322)
T d1s9ja_ 87 DGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---A 160 (322)
T ss_dssp TTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT---C
T ss_pred CCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc---c
Confidence 9999999997653 58999999999999999999996 2489999999999999999999999999998664322 2
Q ss_pred ecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
....||+.|+|||++.+..|+.++|||||||++|||++|+.||.+...
T Consensus 161 ~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 161 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp ---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 456899999999999999999999999999999999999999987653
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-42 Score=349.87 Aligned_cols=204 Identities=24% Similarity=0.377 Sum_probs=163.5
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeec--CCeEEEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ--GRQRLLVYE 586 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV~e 586 (724)
+++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++|||||++++++.+ +...+||||
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE 85 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 85 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence 556789999999999999975 68899999997543 2344678999999999999999999998865 456899999
Q ss_pred ecCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeEecCCCCCCeEEeCCCcEEEEeecCccccC
Q 043185 587 YMNHGSLDRILFG---NGPVLEWQERFDIALGTARGLAYLHSGC--EQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 587 ~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 661 (724)
|+++|+|.+++.. ....+++..+..++.||+.||.|||+.. ..+||||||||+||||+.++.+||+|||+++.+.
T Consensus 86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 165 (269)
T d2java1 86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 165 (269)
T ss_dssp CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-
T ss_pred cCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecc
Confidence 9999999999864 2467999999999999999999999721 1359999999999999999999999999998875
Q ss_pred CCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 662 PEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 662 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
.... ......||+.|||||++.+..++.++|||||||++|||++|++||...+.
T Consensus 166 ~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~ 219 (269)
T d2java1 166 HDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ 219 (269)
T ss_dssp -----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH
Confidence 4332 23456799999999999999999999999999999999999999987654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=351.33 Aligned_cols=201 Identities=25% Similarity=0.376 Sum_probs=175.6
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV---GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
+.+.+.||+|+||+||+|+.. +++.||||++.+. .....+.+.+|++++++++||||+++++++.+++..+|||||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence 567789999999999999985 6889999999642 234457799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc-c
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS-S 666 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~-~ 666 (724)
+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+|+.+..... .
T Consensus 90 ~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 90 AKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp CTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred cCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence 9999999988765 358899999999999999999997 9999999999999999999999999999987754332 2
Q ss_pred ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
......||+.|+|||++.+..++.++|||||||+||||++|+.||...+.
T Consensus 166 ~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~ 215 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 215 (288)
T ss_dssp ----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH
Confidence 23456799999999999999999999999999999999999999987654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-41 Score=344.16 Aligned_cols=195 Identities=29% Similarity=0.431 Sum_probs=168.8
Q ss_pred cccccccccccEEEEEEEEC-CccEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeceeec----CCeEEEEE
Q 043185 513 NFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ----GRQRLLVY 585 (724)
Q Consensus 513 ~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lV~ 585 (724)
.|.++||+|+||+||+|+.. +++.||+|++... .....+++.+|+++|++++|||||++++++.+ ....+|||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 46678999999999999975 5778999998653 23345678999999999999999999999864 35679999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEecCCCCCCeEEe-CCCcEEEEeecCccccCC
Q 043185 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQK--IIHCDIKPENILLH-YHFQAKISDFGLSKLLTP 662 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiH~Dlkp~NILl~-~~~~~kl~DFGla~~~~~ 662 (724)
||+++|+|.+++.+. ..+++..+..++.||+.||+|||+ ++ |+||||||+|||++ +++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 999999999999765 468899999999999999999996 56 99999999999996 578999999999986544
Q ss_pred CCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 663 EQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 663 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.. .....||+.|||||++.+ .++.++|||||||++|||++|+.||....
T Consensus 168 ~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~ 216 (270)
T d1t4ha_ 168 SF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 216 (270)
T ss_dssp TS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred Cc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc
Confidence 32 245689999999999876 59999999999999999999999997544
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=351.61 Aligned_cols=200 Identities=27% Similarity=0.464 Sum_probs=173.8
Q ss_pred ccc-cccccccEEEEEEEEC---CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 514 FKN-LIGSGGFGAVYKGILN---DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 514 ~~~-~lG~G~fG~Vy~~~~~---~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
+.+ +||+|+||+||+|.+. ++..||||+++... ....++|.+|+++|++++|||||+++|++.. +..+|||||+
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~ 90 (285)
T d1u59a_ 12 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMA 90 (285)
T ss_dssp EEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred ECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeC
Confidence 345 4999999999999864 34579999997543 3445789999999999999999999999865 4689999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc--c
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS--S 666 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~--~ 666 (724)
++|+|.+++......+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++.+..... .
T Consensus 91 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (285)
T d1u59a_ 91 GGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 167 (285)
T ss_dssp TTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEEC
T ss_pred CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccccccccc
Confidence 9999999987777789999999999999999999997 8999999999999999999999999999998765432 2
Q ss_pred ceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQS 717 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~~ 717 (724)
......||+.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~ 219 (285)
T d1u59a_ 168 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 219 (285)
T ss_dssp CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH
T ss_pred cccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH
Confidence 2234568999999999999999999999999999999998 99999776543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.3e-41 Score=359.29 Aligned_cols=202 Identities=25% Similarity=0.396 Sum_probs=182.0
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
.|.+.+.||+|+||.||+|+.. +++.||||++........+.+.+|+.+|++++|||||++++++.+++..+|||||++
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 4677899999999999999975 688999999987655666789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC--CCcEEEEeecCccccCCCCccc
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY--HFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~--~~~~kl~DFGla~~~~~~~~~~ 667 (724)
+|+|.+++......+++..+..++.||+.||+|||+ ++||||||||+|||++. ++.+||+|||+++.+.....
T Consensus 107 gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~-- 181 (350)
T d1koaa2 107 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-- 181 (350)
T ss_dssp SCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC--
T ss_pred CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheecccccc--
Confidence 999999997666679999999999999999999997 99999999999999964 57899999999987765433
Q ss_pred eecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
.....||+.|||||++.+..++.++|||||||++|||++|+.||.+.+..
T Consensus 182 ~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~ 231 (350)
T d1koaa2 182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD 231 (350)
T ss_dssp EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH
Confidence 34567999999999999999999999999999999999999999876543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-40 Score=354.29 Aligned_cols=202 Identities=25% Similarity=0.379 Sum_probs=182.1
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
.|.+.+.||+|+||.||+|+.. +++.||||++........+.+.+|+++|++++|||||++++++.++...+|||||++
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 109 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 4667789999999999999974 688999999987655566778899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEe--CCCcEEEEeecCccccCCCCccc
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLH--YHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~--~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
+|+|.+++......+++.++..|+.||+.||.|||+ .+|+||||||+||||+ .++.+||+|||+|+.+.....
T Consensus 110 gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~-- 184 (352)
T d1koba_ 110 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI-- 184 (352)
T ss_dssp CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC--
T ss_pred CChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCCc--
Confidence 999999887776779999999999999999999997 9999999999999998 578999999999998765433
Q ss_pred eecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~ 234 (352)
T d1koba_ 185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL 234 (352)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 34567999999999999999999999999999999999999999776543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=351.28 Aligned_cols=201 Identities=28% Similarity=0.343 Sum_probs=179.1
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV---GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
+.+.+.||+|+||.||+|+.. +++.||||++++. .....+.+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence 556789999999999999974 7889999999753 234567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
+++|+|..++...+ .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+....... .
T Consensus 87 ~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~-~ 161 (337)
T d1o6la_ 87 ANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-T 161 (337)
T ss_dssp CTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-C
T ss_pred cCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCCc-c
Confidence 99999999987654 57888999999999999999997 9999999999999999999999999999987654332 2
Q ss_pred eecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
.....||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..
T Consensus 162 ~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~ 211 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH
Confidence 34568999999999999999999999999999999999999999877643
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-40 Score=347.85 Aligned_cols=198 Identities=25% Similarity=0.374 Sum_probs=176.8
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV---GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
+.+.+.||+|+||+||+|+.. +++.||||++++. .....+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence 556789999999999999974 6889999999642 234567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
+++|+|..++.... .+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+......
T Consensus 86 ~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~--- 158 (316)
T d1fota_ 86 IEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT--- 158 (316)
T ss_dssp CCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB---
T ss_pred cCCccccccccccc-cccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEecccc---
Confidence 99999999887654 57788888999999999999996 899999999999999999999999999998765432
Q ss_pred eecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
....||+.|||||++.+..++.++|||||||++|||++|+.||.+.+..
T Consensus 159 -~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~ 207 (316)
T d1fota_ 159 -YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM 207 (316)
T ss_dssp -CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred -ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH
Confidence 3567999999999999999999999999999999999999999876543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-41 Score=343.58 Aligned_cols=196 Identities=30% Similarity=0.463 Sum_probs=167.6
Q ss_pred ccccccccEEEEEEEEC---CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecCC
Q 043185 516 NLIGSGGFGAVYKGILN---DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMNH 590 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~---~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 590 (724)
++||+|+||+||+|.+. .++.||||+++... ....++|.+|++++++++|||||+++|+|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 47999999999999864 34679999996532 2335679999999999999999999999865 467899999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc--ce
Q 043185 591 GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS--LF 668 (724)
Q Consensus 591 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~--~~ 668 (724)
|+|.+++... ..+++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++.+...... ..
T Consensus 92 g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 9999998765 468999999999999999999997 89999999999999999999999999999877554332 22
Q ss_pred ecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQ 716 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~ 716 (724)
....||+.|||||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~ 216 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 216 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH
Confidence 34568999999999999999999999999999999998 8999976553
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.8e-41 Score=349.06 Aligned_cols=201 Identities=28% Similarity=0.453 Sum_probs=161.4
Q ss_pred hhccccccccccccEEEEEEEEC-CccEEEEEEeecCCc-ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV-QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
..|.+.+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|++++++++|||||++++++.+++..+|||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 34677899999999999999975 678899999975432 3345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEe---CCCcEEEEeecCccccCCCC
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLH---YHFQAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kl~DFGla~~~~~~~ 664 (724)
+++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||+. +++.+||+|||+++......
T Consensus 89 ~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 89 VSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp CCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred cCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 9999999999765 468999999999999999999997 9999999999999995 57899999999998665432
Q ss_pred ccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 665 SSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 665 ~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
. .....||+.|||||++.+..+++++|||||||++|||++|+.||.....
T Consensus 165 ~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~ 214 (307)
T d1a06a_ 165 V--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND 214 (307)
T ss_dssp ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred e--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH
Confidence 2 3456799999999999999999999999999999999999999976543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-41 Score=345.63 Aligned_cols=198 Identities=29% Similarity=0.500 Sum_probs=165.3
Q ss_pred ccccccccccccEEEEEEEECCc-----cEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILNDK-----TIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVY 585 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~~~-----~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 585 (724)
+.+.++||+|+||+||+|++.+. ..||||++.... .....+|.+|++++++++|||||+++|++.+....++||
T Consensus 9 ~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~ 88 (283)
T d1mqba_ 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT 88 (283)
T ss_dssp EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEE
Confidence 44568999999999999997532 469999996532 334467999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc
Q 043185 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 665 (724)
||++++++.+++......+++..++.++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++.+.....
T Consensus 89 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 165 (283)
T d1mqba_ 89 EYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 165 (283)
T ss_dssp ECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred EecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence 9999999999988887789999999999999999999997 8999999999999999999999999999987654322
Q ss_pred --cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCC
Q 043185 666 --SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCS 712 (724)
Q Consensus 666 --~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~ 712 (724)
.......||+.|||||++.+..++.++|||||||++|||++|..|+.
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~ 214 (283)
T d1mqba_ 166 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 214 (283)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcc
Confidence 12234568999999999999999999999999999999999655543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-41 Score=353.84 Aligned_cols=207 Identities=26% Similarity=0.430 Sum_probs=174.5
Q ss_pred HHhhccccccccccccEEEEEEEECC------ccEEEEEEeecC-CcccHHHHHHHHHHHhcC-CCCCccceeceeecCC
Q 043185 508 EVATDNFKNLIGSGGFGAVYKGILND------KTIVAVKKITNV-GVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGR 579 (724)
Q Consensus 508 ~~a~~~~~~~lG~G~fG~Vy~~~~~~------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~ 579 (724)
....+.+.++||+|+||+||+|+... ...||||++... .......+.+|+.++.++ +|||||++++++.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 33456677999999999999999642 236999998643 334456789999999998 8999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCC
Q 043185 580 QRLLVYEYMNHGSLDRILFGNG----------------------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIK 637 (724)
Q Consensus 580 ~~~lV~e~~~~gsL~~~l~~~~----------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk 637 (724)
..+|||||+++|+|.+++.... ..+++..++.++.||++||+|||+ ++|||||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCc
Confidence 9999999999999999997543 247889999999999999999997 899999999
Q ss_pred CCCeEEeCCCcEEEEeecCccccCCCCcc-ceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 043185 638 PENILLHYHFQAKISDFGLSKLLTPEQSS-LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRS 715 (724)
Q Consensus 638 p~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~ 715 (724)
|+|||++.++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||+||||++ |++||.+..
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876544322 2234568999999999999999999999999999999998 899998765
Q ss_pred CC
Q 043185 716 QS 717 (724)
Q Consensus 716 ~~ 717 (724)
..
T Consensus 272 ~~ 273 (325)
T d1rjba_ 272 VD 273 (325)
T ss_dssp CS
T ss_pred HH
Confidence 44
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-40 Score=344.96 Aligned_cols=196 Identities=30% Similarity=0.437 Sum_probs=172.0
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCCc---ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEe
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV---QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEY 587 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 587 (724)
+...+.||+|+||+||+|+.. +++.||||++..... ...+++.+|+++|++++|||||++++++.+++..+|||||
T Consensus 17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 96 (309)
T d1u5ra_ 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEe
Confidence 555688999999999999974 678899999975432 2335789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccc
Q 043185 588 MNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 588 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 667 (724)
+++|+|..++... ..+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.....
T Consensus 97 ~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---- 168 (309)
T d1u5ra_ 97 CLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (309)
T ss_dssp CSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----
T ss_pred cCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC----
Confidence 9999997766554 468999999999999999999997 89999999999999999999999999999865432
Q ss_pred eecccccccccccccccC---CcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTN---SAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~---~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
....||+.|||||++.+ ..|+.++|||||||++|||++|+.||.....
T Consensus 169 -~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~ 219 (309)
T d1u5ra_ 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (309)
T ss_dssp -CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred -CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH
Confidence 34579999999999864 4689999999999999999999999976543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-41 Score=345.72 Aligned_cols=198 Identities=29% Similarity=0.460 Sum_probs=167.0
Q ss_pred hhccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
..+.+.+.||+|+||+||+|+.++++.||||+++.. ....++|.+|+.++++++|||||+++|++.+ +..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 456678899999999999999988888999999754 4556789999999999999999999999865 56789999999
Q ss_pred CCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce
Q 043185 590 HGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 590 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
+|+|..++... ...+++..++.++.||+.||+|||+ ++|+||||||+||||+.++++||+|||+++..........
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 171 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence 99999888653 3568999999999999999999997 8999999999999999999999999999987755444434
Q ss_pred ecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCS 712 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~ 712 (724)
....||+.|+|||++.+..++.++||||||+++|||++|..|+.
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~ 215 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 215 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCC
Confidence 45679999999999999999999999999999999999655553
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-40 Score=339.97 Aligned_cols=201 Identities=27% Similarity=0.383 Sum_probs=177.8
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCC------cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG------VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLL 583 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 583 (724)
.|.+.+.||+|+||+||+|+.. +++.||||++++.. ....+.+.+|+++|++++|||||++++++.+....+|
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4667789999999999999984 68899999996432 1235789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCC----cEEEEeecCccc
Q 043185 584 VYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHF----QAKISDFGLSKL 659 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DFGla~~ 659 (724)
||||+++|+|.+++...+ .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||+++.
T Consensus 91 v~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 91 ILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 999999999999997653 68999999999999999999997 9999999999999998876 499999999987
Q ss_pred cCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 660 LTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 660 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....
T Consensus 167 ~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~ 222 (293)
T d1jksa_ 167 IDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 222 (293)
T ss_dssp CTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH
Confidence 754432 24557899999999999999999999999999999999999999876543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-40 Score=339.62 Aligned_cols=205 Identities=24% Similarity=0.359 Sum_probs=166.3
Q ss_pred hhccccccccccccEEEEEEEECC----ccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILND----KTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLV 584 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~~----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 584 (724)
..+.+.+.||+|+||.||+|++.. +..||||+++... ....+.|.+|++++++++|||||+++|++.+ +..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEE
Confidence 456677999999999999999743 3468899886543 3345679999999999999999999999864 678999
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC
Q 043185 585 YEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (724)
|||+++|+|.+++......+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++.+....
T Consensus 86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 99999999999988777789999999999999999999997 999999999999999999999999999998776544
Q ss_pred ccceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCCCC
Q 043185 665 SSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQSH 718 (724)
Q Consensus 665 ~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~~~ 718 (724)
........||+.|+|||++.+..++.++|||||||++|||++ |++||......+
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~ 217 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 217 (273)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH
Confidence 434455678999999999999999999999999999999998 899998776554
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-39 Score=345.14 Aligned_cols=198 Identities=23% Similarity=0.290 Sum_probs=177.4
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV---GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
.+.+.+.||+|+||.||+|+.. +++.||||++.+. .....+.+.+|+++|++++|||||++++++.+....++|||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 3556689999999999999985 6889999998642 23445778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
|+.+|+|..++...+ .+++..+..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+......
T Consensus 122 ~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~-- 195 (350)
T d1rdqe_ 122 YVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-- 195 (350)
T ss_dssp CCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB--
T ss_pred cccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc--
Confidence 999999999987654 58999999999999999999997 899999999999999999999999999998775432
Q ss_pred ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
....||+.|||||++.+..++.++|||||||++|||++|+.||.+...
T Consensus 196 --~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 243 (350)
T d1rdqe_ 196 --WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243 (350)
T ss_dssp --CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred --ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH
Confidence 346799999999999999999999999999999999999999987653
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-39 Score=338.23 Aligned_cols=201 Identities=25% Similarity=0.346 Sum_probs=175.7
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecC---CcccHHHHHHHHHHHh-cCCCCCccceeceeecCCeEEEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV---GVQGKKDFCTEIAIIG-NIHHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~-~l~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
+.+.+.||+|+||+||+|+.. +++.||||++++. .....+.+..|..++. .++|||||++++++.+++..+||||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence 566789999999999999985 6888999999742 1344566777777765 6899999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcc
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSS 666 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 666 (724)
|+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 y~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~- 158 (320)
T d1xjda_ 84 YLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA- 158 (320)
T ss_dssp CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC-
T ss_pred ecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcccccc-
Confidence 999999999997653 57889999999999999999997 8999999999999999999999999999986654332
Q ss_pred ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 667 LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 667 ~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~ 209 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE 209 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH
Confidence 234567999999999999999999999999999999999999999876543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-39 Score=340.21 Aligned_cols=203 Identities=25% Similarity=0.436 Sum_probs=171.3
Q ss_pred ccccccccccccEEEEEEEEC-Ccc----EEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKT----IVAVKKITNV-GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVY 585 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 585 (724)
+.+.++||+|+||+||+|++. +++ .||+|+++.. ..+..++|.+|++++++++|||||+++|+|.++ ..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 455689999999999999975 333 5899988643 345568899999999999999999999999875 567889
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc
Q 043185 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 665 (724)
||+.+|+|.+++......+++..+++++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++.......
T Consensus 90 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 90 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp ECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred EeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence 9999999999998888889999999999999999999997 8999999999999999999999999999998765433
Q ss_pred c-ceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCCCC
Q 043185 666 S-LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQSH 718 (724)
Q Consensus 666 ~-~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~~~ 718 (724)
. ......||+.|+|||++.+..++.++|||||||++|||+| |++||+.....+
T Consensus 167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~ 221 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 221 (317)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG
T ss_pred cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH
Confidence 2 2234568999999999999999999999999999999998 899998765443
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-39 Score=337.28 Aligned_cols=201 Identities=23% Similarity=0.339 Sum_probs=178.3
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
+|.+.+.||+|+||+||+|+.. +++.||||+++.. ......+.+|+++|++++|||||++++++.+++..+|||||++
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~ 84 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence 3567789999999999999975 6788999999764 3334568899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCC--CcEEEEeecCccccCCCCccc
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYH--FQAKISDFGLSKLLTPEQSSL 667 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~--~~~kl~DFGla~~~~~~~~~~ 667 (724)
+|+|.+++...+..+++.++..++.||+.||+|||+ .+|+||||||+|||++.+ ..+||+|||+++.......
T Consensus 85 gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~-- 159 (321)
T d1tkia_ 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-- 159 (321)
T ss_dssp CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE--
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCCc--
Confidence 999999998776679999999999999999999997 999999999999999854 5799999999987654332
Q ss_pred eecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 668 FTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 668 ~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
.....+|+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~ 209 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ 209 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH
Confidence 34567899999999999999999999999999999999999999876543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-39 Score=336.18 Aligned_cols=201 Identities=30% Similarity=0.502 Sum_probs=172.9
Q ss_pred ccccccccccccEEEEEEEECCc----cEEEEEEeecC-CcccHHHHHHHHHHHhcCCCCCccceeceeec-CCeEEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILNDK----TIVAVKKITNV-GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ-GRQRLLVY 585 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~~~----~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~lV~ 585 (724)
.+|.++||+|+||+||+|++.+. ..||||+++.. .....++|.+|++++++++|||||+++|++.+ +...++||
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 35578999999999999997532 35899999753 34455789999999999999999999999875 46889999
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc
Q 043185 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 665 (724)
||+++|+|.+++........+..+++++.|+++||.|||+ .+|+||||||+||||++++.+||+|||+++.......
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 9999999999998887788899999999999999999997 8999999999999999999999999999987654332
Q ss_pred c---ceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 666 S---LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 666 ~---~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~ 238 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC
Confidence 1 2223568999999999999999999999999999999999887775543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.3e-39 Score=342.42 Aligned_cols=199 Identities=26% Similarity=0.344 Sum_probs=171.0
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC---cccHHHHH---HHHHHHhcCCCCCccceeceeecCCeEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG---VQGKKDFC---TEIAIIGNIHHVNLVKLKGFCAQGRQRLLV 584 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~---~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 584 (724)
+.+.++||+|+||.||+|+.. +++.||||++.+.. ......+. +|+++++.++|||||++++++.+.+..+||
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv 85 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 85 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence 456789999999999999975 68899999986421 12223333 447778888999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC
Q 043185 585 YEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (724)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+ ++||||||||+|||++.++.+||+|||+|+.+....
T Consensus 86 mE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~ 161 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 161 (364)
T ss_dssp ECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC
T ss_pred EEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecCCCc
Confidence 9999999999999765 457889999999999999999997 999999999999999999999999999998775543
Q ss_pred ccceecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 665 SSLFTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 665 ~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
.....||+.|+|||++.. ..++.++|||||||+||||++|+.||......
T Consensus 162 ---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~ 212 (364)
T d1omwa3 162 ---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 212 (364)
T ss_dssp ---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS
T ss_pred ---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH
Confidence 245679999999999964 57899999999999999999999999775543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8.4e-39 Score=329.63 Aligned_cols=202 Identities=24% Similarity=0.359 Sum_probs=167.6
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCc---ccHHHHHHHHHHHhcCCCCCccceeceeecCC----eEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGV---QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR----QRL 582 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~ 582 (724)
.|.+.+.||+|+||+||+|+.. +++.||||+++.... ...+++.+|++++++++|||||++++++.... ..+
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 3567789999999999999974 788999999975432 23457899999999999999999999987643 478
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCC
Q 043185 583 LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP 662 (724)
Q Consensus 583 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (724)
|||||+++++|..++...+ .+++.++..++.||+.||+|||+ .+|+||||||+|||++.++..+|+|||.+.....
T Consensus 88 lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 9999999999999886653 58899999999999999999997 9999999999999999999999999999876543
Q ss_pred CCc--cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 663 EQS--SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 663 ~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
... .......||+.|+|||++.+..+++++|||||||++|||++|+.||.....
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 219 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 219 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH
Confidence 322 223456799999999999999999999999999999999999999987654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.5e-38 Score=326.60 Aligned_cols=201 Identities=29% Similarity=0.402 Sum_probs=175.3
Q ss_pred hccccccccccccEEEEEEEE-CCccEEEEEEeecCCcc---------cHHHHHHHHHHHhcCC-CCCccceeceeecCC
Q 043185 511 TDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQ---------GKKDFCTEIAIIGNIH-HVNLVKLKGFCAQGR 579 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~---------~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~ 579 (724)
.+.+.+.||+|+||+||+|+. .+++.+|||++...... ..+.+.+|+.++++++ ||||+++++++.+++
T Consensus 4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 83 (277)
T d1phka_ 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 83 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence 355678999999999999997 47889999999753221 1245889999999996 999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccc
Q 043185 580 QRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKL 659 (724)
Q Consensus 580 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 659 (724)
..+|||||+++|+|.+++...+ .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 84 FFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchheeE
Confidence 9999999999999999997654 68999999999999999999997 8999999999999999999999999999988
Q ss_pred cCCCCccceecccccccccccccccC------CcCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 660 LTPEQSSLFTTMRGTRGYLAPEWLTN------SAISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 660 ~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
...... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....
T Consensus 160 ~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~ 221 (277)
T d1phka_ 160 LDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 221 (277)
T ss_dssp CCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH
Confidence 765432 245679999999999863 35688999999999999999999999877643
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=332.02 Aligned_cols=197 Identities=32% Similarity=0.448 Sum_probs=164.0
Q ss_pred ccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecC-CeEEEEEEecCC
Q 043185 512 DNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG-RQRLLVYEYMNH 590 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~lV~e~~~~ 590 (724)
+.+.+.||+|+||.||+|+++ +..||||++++. ...++|.+|++++++++||||++++|++.+. +..+|||||+++
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~ 85 (262)
T d1byga_ 9 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 85 (262)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred eEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCC
Confidence 456788999999999999996 457999999753 4457899999999999999999999998654 568999999999
Q ss_pred CCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 591 GSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 591 gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
|+|.+++... ...+++..+++|+.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 86 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~----~ 158 (262)
T d1byga_ 86 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----D 158 (262)
T ss_dssp EEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCC----c
Confidence 9999999654 2458999999999999999999997 899999999999999999999999999998654332 3
Q ss_pred cccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQSH 718 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~~~ 718 (724)
...++..|+|||++.+..+++++||||||+++|||++ |++||......+
T Consensus 159 ~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~ 208 (262)
T d1byga_ 159 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 208 (262)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG
T ss_pred cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH
Confidence 3468899999999999999999999999999999998 788887665443
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-38 Score=337.07 Aligned_cols=196 Identities=24% Similarity=0.325 Sum_probs=169.5
Q ss_pred cccc-ccccccccEEEEEEEE-CCccEEEEEEeecCCcccHHHHHHHHHHHhcC-CCCCccceeceeec----CCeEEEE
Q 043185 512 DNFK-NLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQ----GRQRLLV 584 (724)
Q Consensus 512 ~~~~-~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~----~~~~~lV 584 (724)
|.+. ++||+|+||+||+|+. .+++.||||++++. +.+.+|++++.++ +|||||++++++.+ +...+||
T Consensus 13 y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~iv 87 (335)
T d2ozaa1 13 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 87 (335)
T ss_dssp EEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEE
Confidence 4443 5799999999999997 46889999998643 5677899987654 89999999999865 4578999
Q ss_pred EEecCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC---CCcEEEEeecCcccc
Q 043185 585 YEYMNHGSLDRILFGN-GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY---HFQAKISDFGLSKLL 660 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DFGla~~~ 660 (724)
|||+++|+|.+++... ...+++.++..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+|+..
T Consensus 88 mEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~ 164 (335)
T d2ozaa1 88 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164 (335)
T ss_dssp EECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceeeec
Confidence 9999999999999765 3568999999999999999999997 99999999999999985 567999999999877
Q ss_pred CCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 661 TPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 661 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
..... .....||+.|||||++.+..|+.++|||||||+||||++|+.||.+....
T Consensus 165 ~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~ 219 (335)
T d2ozaa1 165 TSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 219 (335)
T ss_dssp CCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC
T ss_pred cCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHH
Confidence 65433 34567999999999999999999999999999999999999999766543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-39 Score=337.08 Aligned_cols=203 Identities=30% Similarity=0.462 Sum_probs=173.4
Q ss_pred ccccccccccccEEEEEEEEC------CccEEEEEEeecCCc-ccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN------DKTIVAVKKITNVGV-QGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLV 584 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 584 (724)
+.+.+.||+|+||+||+|+.. +++.||||+++.... ...++|.+|++++++++||||+++++++.+....++|
T Consensus 15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v 94 (301)
T d1lufa_ 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 94 (301)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEE
Confidence 455689999999999999964 357899999975433 3456799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCe
Q 043185 585 YEYMNHGSLDRILFGNG-----------------------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENI 641 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NI 641 (724)
|||+++|+|.+++.... ..+++..++.|+.|++.||+|||+ ++||||||||+||
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlKp~NI 171 (301)
T d1lufa_ 95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNC 171 (301)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred EEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEcccce
Confidence 99999999999986432 347889999999999999999997 9999999999999
Q ss_pred EEeCCCcEEEEeecCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCC-CCCCCCCCC
Q 043185 642 LLHYHFQAKISDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGR-RNCSPRSQS 717 (724)
Q Consensus 642 Ll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~-~p~~~~~~~ 717 (724)
||+.++.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++|. +||......
T Consensus 172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~ 249 (301)
T d1lufa_ 172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249 (301)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred EECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHH
Confidence 999999999999999986644322 2223456889999999999999999999999999999999985 677665543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-39 Score=329.90 Aligned_cols=202 Identities=27% Similarity=0.378 Sum_probs=164.6
Q ss_pred ccccccccccccEEEEEEEECC----ccEEEEEEeecC---CcccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILND----KTIVAVKKITNV---GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLV 584 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~~----~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 584 (724)
+.+.+.||+|+||.||+|++.. ...||||++++. ..+..++|.+|++++++++|||||+++|++.+ ...++|
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv 88 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV 88 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhee
Confidence 4566889999999999998642 236899998653 23345789999999999999999999999976 467899
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCC
Q 043185 585 YEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQ 664 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~ 664 (724)
|||+++|+|.+++......+++..+++++.||++||.|||+ ++|+||||||+||||+.++.+||+|||+++......
T Consensus 89 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 89 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred eeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 99999999999887766679999999999999999999997 899999999999999999999999999999875543
Q ss_pred cc--ceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 043185 665 SS--LFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQS 717 (724)
Q Consensus 665 ~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~~ 717 (724)
.. ......|+..|+|||.+.+..++.++||||||+++|||++ |+.||...+..
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~ 221 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS 221 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH
Confidence 32 2233457889999999999999999999999999999998 89999766543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-39 Score=333.68 Aligned_cols=196 Identities=30% Similarity=0.391 Sum_probs=166.3
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecCCcc-----cHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQ-----GKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
++||+|+||+||+|+.. +++.||||+++..... ..+.+.+|+.++++++|||||++++++.+++..+|||||++
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 67999999999999974 6889999998643221 12468899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
++++..+. .....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........ ..
T Consensus 84 ~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~-~~ 158 (299)
T d1ua2a_ 84 TDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-YT 158 (299)
T ss_dssp EEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-CC
T ss_pred chHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCccc-cc
Confidence 88776555 444568888999999999999999997 99999999999999999999999999999876544322 23
Q ss_pred cccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
...||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+.
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~ 206 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD 206 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH
Confidence 45799999999998654 679999999999999999999999977653
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-38 Score=329.10 Aligned_cols=199 Identities=29% Similarity=0.382 Sum_probs=162.9
Q ss_pred hccccccccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHH--HHHHhcCCCCCccceeceeecCC----eEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTE--IAIIGNIHHVNLVKLKGFCAQGR----QRLLV 584 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E--~~~l~~l~H~nIv~l~g~~~~~~----~~~lV 584 (724)
++.+.+.||+|+||.||+|+++ ++.||||+++.. ..+++.+| +..+.+++|||||++++++.+.. ..+||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 3456789999999999999985 567999998643 33444444 44556789999999999997654 67999
Q ss_pred EEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcC-----CCCCeEecCCCCCCeEEeCCCcEEEEeecCccc
Q 043185 585 YEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSG-----CEQKIIHCDIKPENILLHYHFQAKISDFGLSKL 659 (724)
Q Consensus 585 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 659 (724)
|||+++|+|.+++... .+++..+++++.|++.||+|||+. .+++||||||||+||||+.++.+||+|||+++.
T Consensus 80 ~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 9999999999999765 589999999999999999999962 246999999999999999999999999999987
Q ss_pred cCCCCc---cceecccccccccccccccCC------cCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 660 LTPEQS---SLFTTMRGTRGYLAPEWLTNS------AISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 660 ~~~~~~---~~~~~~~gt~~y~aPE~l~~~------~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
...... .......||+.|+|||++.+. .++.++|||||||+||||++|..||....
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~ 222 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccc
Confidence 754332 122346799999999998764 36789999999999999999998885443
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-38 Score=326.66 Aligned_cols=200 Identities=27% Similarity=0.354 Sum_probs=170.9
Q ss_pred ccccccccccccEEEEEEEE-CCccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 512 DNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
|.+.+.||+|+||+||+|+. .+++.||||+++... ....+++.+|++++++++|||||++++++.++...++||||+
T Consensus 4 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~ 83 (298)
T d1gz8a_ 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 83 (298)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeec
Confidence 44568999999999999997 468899999996432 233578899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
.++.+..........+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+........ .
T Consensus 84 ~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~-~ 159 (298)
T d1gz8a_ 84 HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-Y 159 (298)
T ss_dssp SEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC-T
T ss_pred CCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCccc-c
Confidence 8765555545556679999999999999999999997 99999999999999999999999999999877544322 3
Q ss_pred ecccccccccccccccCCc-CCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTNSA-ISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~~~-~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
....||+.|+|||.+.... ++.++|+|||||++|||++|+.||.+.+
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~ 207 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC
Confidence 4457999999999987765 5789999999999999999999997654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-38 Score=330.23 Aligned_cols=208 Identities=27% Similarity=0.458 Sum_probs=178.1
Q ss_pred HHHhhccccccccccccEEEEEEEE------CCccEEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeceeecC
Q 043185 507 LEVATDNFKNLIGSGGFGAVYKGIL------NDKTIVAVKKITNVG-VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQG 578 (724)
Q Consensus 507 l~~a~~~~~~~lG~G~fG~Vy~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~ 578 (724)
+....+.+.+.||+|+||.||+|++ ..++.||||+++... .....+|.+|+.++.++ +|||||+++|++.+.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 3445666788999999999999986 245689999997543 33456789999999999 799999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHhcCC-----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCe
Q 043185 579 RQRLLVYEYMNHGSLDRILFGNG-----------------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENI 641 (724)
Q Consensus 579 ~~~~lV~e~~~~gsL~~~l~~~~-----------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NI 641 (724)
...+|||||+++|+|.+++.... ..+++..+..++.||+.||+|||+ ++++||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccc
Confidence 99999999999999999987542 258899999999999999999997 8999999999999
Q ss_pred EEeCCCcEEEEeecCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCCC
Q 043185 642 LLHYHFQAKISDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQS 717 (724)
Q Consensus 642 Ll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~~ 717 (724)
|++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++ |++||......
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999987754432 22334678999999999999999999999999999999999 66667665544
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-38 Score=330.19 Aligned_cols=206 Identities=26% Similarity=0.389 Sum_probs=164.2
Q ss_pred HhhccccccccccccEEEEEEEEC------CccEEEEEEeecCC-cccHHHHHHHHHHHhcC-CCCCccceeceeecC-C
Q 043185 509 VATDNFKNLIGSGGFGAVYKGILN------DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQG-R 579 (724)
Q Consensus 509 ~a~~~~~~~lG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~-~ 579 (724)
...+.+.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|..++.++ +|+||+.+++++.+. .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 345677899999999999999963 34689999997532 33456788888888777 799999999988654 4
Q ss_pred eEEEEEEecCCCCHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEe
Q 043185 580 QRLLVYEYMNHGSLDRILFGN---------------GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLH 644 (724)
Q Consensus 580 ~~~lV~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~ 644 (724)
..++||||+++|+|.+++... ...+++..+..++.||+.||.|||+ ++||||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeEC
Confidence 689999999999999999753 2358899999999999999999997 8999999999999999
Q ss_pred CCCcEEEEeecCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhC-CCCCCCCCCC
Q 043185 645 YHFQAKISDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSG-RRNCSPRSQS 717 (724)
Q Consensus 645 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG-~~p~~~~~~~ 717 (724)
.++.+||+|||+|+....... .......||+.|+|||.+.+..++.++|||||||++|||++| ++||......
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999987654432 223356799999999999999999999999999999999997 5678665543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-37 Score=326.29 Aligned_cols=200 Identities=31% Similarity=0.476 Sum_probs=167.8
Q ss_pred ccccccccccccEEEEEEEECC-cc--EEEEEEeecC-CcccHHHHHHHHHHHhcC-CCCCccceeceeecCCeEEEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILND-KT--IVAVKKITNV-GVQGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~~-~~--~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~e 586 (724)
+.+.++||+|+||.||+|++.+ +. .||||+++.. .....++|.+|+++|.++ +|||||+++|++.+++..++|||
T Consensus 12 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~e 91 (309)
T d1fvra_ 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 91 (309)
T ss_dssp CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEE
Confidence 3456899999999999999753 33 5788888643 234556899999999999 79999999999999999999999
Q ss_pred ecCCCCHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEE
Q 043185 587 YMNHGSLDRILFGN---------------GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKI 651 (724)
Q Consensus 587 ~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 651 (724)
|+++|+|.+++... ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||
T Consensus 92 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~kl 168 (309)
T d1fvra_ 92 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKI 168 (309)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEE
T ss_pred ecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCceEE
Confidence 99999999998643 3578999999999999999999997 89999999999999999999999
Q ss_pred EeecCccccCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCC-CCCCCCCC
Q 043185 652 SDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGR-RNCSPRSQ 716 (724)
Q Consensus 652 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~-~p~~~~~~ 716 (724)
+|||+++....... .....||..|+|||.+.+..++.++||||||+++|||++|. +||.....
T Consensus 169 ~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~ 232 (309)
T d1fvra_ 169 ADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 232 (309)
T ss_dssp CCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred cccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH
Confidence 99999986543322 23456899999999999999999999999999999999975 56765543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-38 Score=326.09 Aligned_cols=205 Identities=28% Similarity=0.405 Sum_probs=170.9
Q ss_pred HhhccccccccccccEEEEEEEECC--------ccEEEEEEeecCCc-ccHHHHHHHHHHHhcC-CCCCccceeceeecC
Q 043185 509 VATDNFKNLIGSGGFGAVYKGILND--------KTIVAVKKITNVGV-QGKKDFCTEIAIIGNI-HHVNLVKLKGFCAQG 578 (724)
Q Consensus 509 ~a~~~~~~~lG~G~fG~Vy~~~~~~--------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~ 578 (724)
...+.+.+.||+|+||.||+|+..+ +..||||+++.... ....++.+|+..+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3456677899999999999998632 34799999976433 3457788999999888 899999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEE
Q 043185 579 RQRLLVYEYMNHGSLDRILFGNG---------------PVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILL 643 (724)
Q Consensus 579 ~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 643 (724)
...++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ .+||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceee
Confidence 99999999999999999997543 358999999999999999999997 999999999999999
Q ss_pred eCCCcEEEEeecCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 043185 644 HYHFQAKISDFGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVS-GRRNCSPRSQ 716 (724)
Q Consensus 644 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~ellt-G~~p~~~~~~ 716 (724)
+.++.+||+|||+++....... .......+++.|+|||.+.+..|++++||||||+++|||++ |++||.....
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 9999999999999987754432 22344578999999999999999999999999999999998 7888865543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-38 Score=329.84 Aligned_cols=204 Identities=25% Similarity=0.430 Sum_probs=174.1
Q ss_pred hhccccccccccccEEEEEEEEC------CccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEE
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN------DKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRL 582 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 582 (724)
..+.+.+.||+|+||+||+|.+. +++.||||+++... ......|.+|+.++++++|||||+++|++..+...+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 44456789999999999999864 25689999997542 334456899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEe
Q 043185 583 LVYEYMNHGSLDRILFGN---------GPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISD 653 (724)
Q Consensus 583 lV~e~~~~gsL~~~l~~~---------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 653 (724)
+||||+++|+|.+++... ...+++..+..++.|+++||.|||+ ++|+||||||+|||++.++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEee
Confidence 999999999999988632 2357899999999999999999997 8999999999999999999999999
Q ss_pred ecCccccCCCCc-cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhC-CCCCCCCCC
Q 043185 654 FGLSKLLTPEQS-SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSG-RRNCSPRSQ 716 (724)
Q Consensus 654 FGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG-~~p~~~~~~ 716 (724)
||+++.+..... .......+|+.|+|||.+.+..++.++||||||+++|||++| ++||.....
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~ 241 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 241 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH
Confidence 999987654332 222334689999999999999999999999999999999998 577766543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-38 Score=321.26 Aligned_cols=197 Identities=25% Similarity=0.415 Sum_probs=168.0
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCcc------cHHHHHHHHHHHhcCC--CCCccceeceeecCCeE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQ------GKKDFCTEIAIIGNIH--HVNLVKLKGFCAQGRQR 581 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~~~~ 581 (724)
.|.+.++||+|+||+||+|+.. +++.||||++.+.... ...++.+|+.++++++ |||||++++++.+.+..
T Consensus 5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~ 84 (273)
T d1xwsa_ 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 84 (273)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence 4667789999999999999975 6889999998653211 1234678999999986 99999999999999999
Q ss_pred EEEEEecCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCC-CcEEEEeecCccc
Q 043185 582 LLVYEYMNH-GSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYH-FQAKISDFGLSKL 659 (724)
Q Consensus 582 ~lV~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DFGla~~ 659 (724)
++||||+++ +++.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+++.
T Consensus 85 ~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 85 VLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECcccccee
Confidence 999999976 5777777654 468999999999999999999997 999999999999999965 7999999999987
Q ss_pred cCCCCccceecccccccccccccccCCcC-CCccchhhHHHHHHHHHhCCCCCCCC
Q 043185 660 LTPEQSSLFTTMRGTRGYLAPEWLTNSAI-SEKTDVYSFGMVLLELVSGRRNCSPR 714 (724)
Q Consensus 660 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDv~SlGv~l~elltG~~p~~~~ 714 (724)
..... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||...
T Consensus 161 ~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 161 LKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp CCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred ccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 54432 345679999999999987765 67799999999999999999999753
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-37 Score=322.48 Aligned_cols=201 Identities=26% Similarity=0.382 Sum_probs=168.8
Q ss_pred hccccccccccccEEEEEEEEC--CccEEEEEEeecCC--cccHHHHHHHHHHHhcC---CCCCccceeceeec-----C
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN--DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNI---HHVNLVKLKGFCAQ-----G 578 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~--~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~-----~ 578 (724)
.|++.+.||+|+||+||+|+.. +++.||||+++... ......+.+|+.+++.+ +||||+++++++.. .
T Consensus 8 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~ 87 (305)
T d1blxa_ 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 87 (305)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred CEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccC
Confidence 4566789999999999999974 35679999986422 22234566777776655 89999999999853 3
Q ss_pred CeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCcc
Q 043185 579 RQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSK 658 (724)
Q Consensus 579 ~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~ 658 (724)
...++++||++++.+..........+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 88 ~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 88 TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 47889999999988877766667789999999999999999999997 999999999999999999999999999987
Q ss_pred ccCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 659 LLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 659 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
...... ......||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+.
T Consensus 165 ~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~ 220 (305)
T d1blxa_ 165 IYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 220 (305)
T ss_dssp CCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred hhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH
Confidence 654332 23456799999999999999999999999999999999999999987653
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.3e-37 Score=317.72 Aligned_cols=199 Identities=29% Similarity=0.369 Sum_probs=169.6
Q ss_pred ccccccccccccEEEEEEEECCccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEecC
Q 043185 512 DNFKNLIGSGGFGAVYKGILNDKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYMN 589 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~ 589 (724)
|.+.+.||+|+||+||+|+.++++.||||++.... ....+++.+|+.+|++++|||||++++++..++..++++||+.
T Consensus 4 Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~ 83 (286)
T d1ob3a_ 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (286)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred ceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeeh
Confidence 45568899999999999999999999999996532 2335789999999999999999999999999999999999998
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCcccee
Q 043185 590 HGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLFT 669 (724)
Q Consensus 590 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 669 (724)
++.+..+.. ....+++..+..++.||+.||+|||+ .+||||||||+|||++.++.+||+|||++......... ..
T Consensus 84 ~~~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~ 158 (286)
T d1ob3a_ 84 QDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-YT 158 (286)
T ss_dssp EEHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred hhhHHHHHh-hcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCccc-cc
Confidence 876666554 44679999999999999999999997 89999999999999999999999999999876544322 23
Q ss_pred cccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 670 TMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 670 ~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
...+++.|+|||.+.+. .++.++|||||||++|||++|+.||....
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~ 205 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC
Confidence 44689999999999764 57999999999999999999999997654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.3e-36 Score=312.46 Aligned_cols=201 Identities=19% Similarity=0.252 Sum_probs=173.3
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCC-CCccceeceeecCCeEEEEEEec
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHH-VNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
.|.+.+.||+|+||+||+|+.. +++.||||++.... ..+++.+|++.+..++| +|++.+++++.++...++||||+
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 4667889999999999999975 67889999886532 23456788889988864 89999999999999999999998
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC-----CCcEEEEeecCccccCCC
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY-----HFQAKISDFGLSKLLTPE 663 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-----~~~~kl~DFGla~~~~~~ 663 (724)
+++|.+++......++...+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+|+.+...
T Consensus 84 -~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 84 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 689999998877789999999999999999999996 99999999999999974 578999999999876433
Q ss_pred Cc------cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCC
Q 043185 664 QS------SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQS 717 (724)
Q Consensus 664 ~~------~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~ 717 (724)
.. .......||+.|||||.+.+..+++++||||||+++|||++|+.||.+....
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~ 219 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 219 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC
T ss_pred ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch
Confidence 21 1223467999999999999999999999999999999999999999866543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-35 Score=316.13 Aligned_cols=197 Identities=30% Similarity=0.361 Sum_probs=164.2
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccceeceeecC------CeEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG------RQRLL 583 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~~l 583 (724)
+|...++||+|+||+||+|+.. +++.||||++..... .+.+|+++|++++||||+++++++... .+.+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 4455678999999999999985 688999999975432 234799999999999999999998532 35789
Q ss_pred EEEecCCCCHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCC-cEEEEeecCcccc
Q 043185 584 VYEYMNHGSLDRILF--GNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHF-QAKISDFGLSKLL 660 (724)
Q Consensus 584 V~e~~~~gsL~~~l~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFGla~~~ 660 (724)
||||++++.+..+.. .....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 999998765444432 345578999999999999999999997 9999999999999999875 8999999999877
Q ss_pred CCCCccceecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 661 TPEQSSLFTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 661 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|++||...+.
T Consensus 174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~ 228 (350)
T d1q5ka_ 174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228 (350)
T ss_dssp CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH
T ss_pred cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH
Confidence 55432 244679999999998865 5789999999999999999999999976653
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-36 Score=315.40 Aligned_cols=204 Identities=24% Similarity=0.312 Sum_probs=174.7
Q ss_pred hccccccccccccEEEEEEEEC----CccEEEEEEeecCC----cccHHHHHHHHHHHhcCCC-CCccceeceeecCCeE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN----DKTIVAVKKITNVG----VQGKKDFCTEIAIIGNIHH-VNLVKLKGFCAQGRQR 581 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~----~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~~ 581 (724)
.+++.+.||+|+||+||+|+.. +++.||||++++.. ....+.+.+|++++++++| |||+++++++.+....
T Consensus 25 ~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~ 104 (322)
T d1vzoa_ 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 104 (322)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred ceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCce
Confidence 3677799999999999999862 46889999985421 2334678899999999965 8999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccC
Q 043185 582 LLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 661 (724)
++|+||+++|+|.+++.... .+.+.....++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 105 ~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 105 HLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred eeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 99999999999999987664 45678888899999999999997 899999999999999999999999999998776
Q ss_pred CCCccceecccccccccccccccCC--cCCCccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 043185 662 PEQSSLFTTMRGTRGYLAPEWLTNS--AISEKTDVYSFGMVLLELVSGRRNCSPRSQSH 718 (724)
Q Consensus 662 ~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~ 718 (724)
...........|++.|+|||.+.+. .++.++|||||||+||||++|+.||......+
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~ 239 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 5544444566799999999999764 46889999999999999999999998776554
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-35 Score=314.28 Aligned_cols=199 Identities=27% Similarity=0.415 Sum_probs=165.6
Q ss_pred ccccccccccccEEEEEEEE-CCccEEEEEEeecCC-cccHHHHHHHHHHHhcCCCCCccceeceeecCC----eEEEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVG-VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR----QRLLVY 585 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~lV~ 585 (724)
|.+.+.||+|+||+||+|+. .+++.||||++.+.. ....+++.+|+++|++++||||+++++++.... ..++++
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~ 89 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence 55668999999999999997 478899999997543 234567899999999999999999999986543 334555
Q ss_pred EecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCc
Q 043185 586 EYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 586 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 665 (724)
+|+.+|+|.+++... .+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+++.......
T Consensus 90 ~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 90 THLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 677799999999764 58999999999999999999997 8999999999999999999999999999987644322
Q ss_pred --cceecccccccccccccccC-CcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 666 --SLFTTMRGTRGYLAPEWLTN-SAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 666 --~~~~~~~gt~~y~aPE~l~~-~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.......||+.|+|||.+.. ..++.++||||+||++|||++|+.||....
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~ 217 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 217 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence 12344579999999999855 467899999999999999999999997765
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-35 Score=307.90 Aligned_cols=202 Identities=23% Similarity=0.258 Sum_probs=166.5
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCccce-eceeecCCeEEEEEEec
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNLVKL-KGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l-~g~~~~~~~~~lV~e~~ 588 (724)
+|.+.+.||+|+||.||+|+.. +++.||||++.... ..+++.+|++++++++|+|++.. .++..++...++||||+
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 4667789999999999999974 67889999887532 23457889999999987765554 55567788899999998
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeC---CCcEEEEeecCccccCCCCc
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHY---HFQAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DFGla~~~~~~~~ 665 (724)
. ++|...+......+++..+..++.|++.||+|||+ ++|+||||||+|||++. +..+||+|||+|+.+.....
T Consensus 86 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 86 G-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp C-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred C-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 4 56777776666789999999999999999999997 99999999999999864 55799999999997754322
Q ss_pred ------cceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCCCC
Q 043185 666 ------SLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQSH 718 (724)
Q Consensus 666 ------~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~~~ 718 (724)
.......||+.|||||.+.+..++.++||||||+++|||++|+.||.......
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~ 220 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 220 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC---
T ss_pred ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHH
Confidence 12234579999999999999999999999999999999999999997765443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-35 Score=310.05 Aligned_cols=202 Identities=24% Similarity=0.308 Sum_probs=167.1
Q ss_pred hhccccccccccccEEEEEEEEC-CccEEEEEEeecC--CcccHHHHHHHHHHHhcCCCCCccceeceeec--------C
Q 043185 510 ATDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNV--GVQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ--------G 578 (724)
Q Consensus 510 a~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--------~ 578 (724)
.+|.+.+.||+|+||+||+|+.. +++.||||++... .....+++.+|+++|++++||||+++++++.. +
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 45667789999999999999974 7889999998543 23445778999999999999999999998855 3
Q ss_pred CeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCcc
Q 043185 579 RQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSK 658 (724)
Q Consensus 579 ~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~ 658 (724)
...++||||++++.+..+ ......+....+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~~~iv~e~~~~~~~~~~-~~~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp -CEEEEEECCCEEHHHHH-TCTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEeccCCCccchh-hhcccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecceee
Confidence 467899999988766544 3445678889999999999999999997 999999999999999999999999999998
Q ss_pred ccCCCCc---cceecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 659 LLTPEQS---SLFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 659 ~~~~~~~---~~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
....... .......||+.|+|||.+.+. .+++++|||||||++|||++|+.||++..
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~ 226 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 226 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC
Confidence 7654322 122335699999999998765 68999999999999999999999997654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-35 Score=313.91 Aligned_cols=195 Identities=26% Similarity=0.375 Sum_probs=162.5
Q ss_pred hccccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCC------eE
Q 043185 511 TDNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGR------QR 581 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~ 581 (724)
.|.+.+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|+++|++++|||||++++++...+ ..
T Consensus 19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 98 (346)
T d1cm8a_ 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98 (346)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence 3555688999999999999975 68899999997532 233467889999999999999999999987654 56
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccC
Q 043185 582 LLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLT 661 (724)
Q Consensus 582 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~ 661 (724)
+|||||+ +.+|..+.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 99 ~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 99 YLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp EEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccceeccC
Confidence 9999999 55777777543 68999999999999999999997 999999999999999999999999999998765
Q ss_pred CCCccceecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 662 PEQSSLFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 662 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.. .....||+.|+|||.+.+. .++.++|||||||++|||++|++||.+.+
T Consensus 173 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~ 223 (346)
T d1cm8a_ 173 SE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 223 (346)
T ss_dssp SS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Cc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC
Confidence 43 2456799999999998764 57899999999999999999999997764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.2e-34 Score=305.90 Aligned_cols=193 Identities=23% Similarity=0.392 Sum_probs=166.7
Q ss_pred hccccccccccccEEEEEEEE-CCccEEEEEEeecCCcccHHHHHHHHHHHhcCC-CCCccceeceeec--CCeEEEEEE
Q 043185 511 TDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIH-HVNLVKLKGFCAQ--GRQRLLVYE 586 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~--~~~~~lV~e 586 (724)
.+.+.++||+|+||+||+|+. .+++.||||+++. ...+++.+|+++|.+++ ||||+++++++.. ....++|||
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH---HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 456678999999999999997 4688899999974 34577899999999995 9999999999874 456899999
Q ss_pred ecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCC-cEEEEeecCccccCCCCc
Q 043185 587 YMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHF-QAKISDFGLSKLLTPEQS 665 (724)
Q Consensus 587 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DFGla~~~~~~~~ 665 (724)
|+++++|..+. ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++.......
T Consensus 113 ~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~ 185 (328)
T d3bqca1 113 HVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185 (328)
T ss_dssp CCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC
T ss_pred ecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCCCc
Confidence 99999987654 358899999999999999999997 9999999999999999765 689999999987765432
Q ss_pred cceecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 666 SLFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 666 ~~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.....+|+.|+|||.+.+. .++.++||||||++++||++|+.||....
T Consensus 186 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 186 --YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp --CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred --ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 2456789999999998765 57999999999999999999999997654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-34 Score=298.15 Aligned_cols=196 Identities=23% Similarity=0.354 Sum_probs=170.2
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecCCeEEEEEEec
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQGRQRLLVYEYM 588 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 588 (724)
|++.+.||+|+||+||+|+.. +++.||||+++... ....+++.+|+.++++++||||+++++++.+....++|+|++
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~ 83 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeec
Confidence 556689999999999999974 77889999996432 234578899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCCCccce
Q 043185 589 NHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPEQSSLF 668 (724)
Q Consensus 589 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 668 (724)
.+++|..++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||.++........ .
T Consensus 84 ~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~-~ 158 (292)
T d1unla_ 84 DQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-Y 158 (292)
T ss_dssp SEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC-C
T ss_pred cccccccccccc-cccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCcc-c
Confidence 999888777544 567889999999999999999997 89999999999999999999999999999877544322 2
Q ss_pred ecccccccccccccccCCc-CCCccchhhHHHHHHHHHhCCCCCC
Q 043185 669 TTMRGTRGYLAPEWLTNSA-ISEKTDVYSFGMVLLELVSGRRNCS 712 (724)
Q Consensus 669 ~~~~gt~~y~aPE~l~~~~-~~~~sDv~SlGv~l~elltG~~p~~ 712 (724)
....+++.|+|||.+.... ++.++|||||||++|||++|+.||.
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 203 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC
Confidence 3445788899999987665 6899999999999999999999874
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-34 Score=304.55 Aligned_cols=195 Identities=27% Similarity=0.316 Sum_probs=157.3
Q ss_pred ccccccccccccEEEEEEEEC-CccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeec------CCeEE
Q 043185 512 DNFKNLIGSGGFGAVYKGILN-DKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQ------GRQRL 582 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~------~~~~~ 582 (724)
|++.++||+|+||+||+|+.. +++.||||++.... .....++.+|+.++++++|||||++++++.. ....+
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~ 98 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98 (355)
T ss_dssp EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence 455679999999999999975 68899999997542 2334578899999999999999999999853 36889
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCC
Q 043185 583 LVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTP 662 (724)
Q Consensus 583 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~ 662 (724)
+||||+.++.+. .+. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+|++|||+++....
T Consensus 99 iv~Ey~~~~l~~-~~~---~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 99 LVMELMDANLCQ-VIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp EEEECCSEEHHH-HHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEeccchHHHH-hhh---cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhcccc
Confidence 999999776554 442 357889999999999999999997 8999999999999999999999999999886654
Q ss_pred CCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 663 EQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 663 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
... .....+|+.|+|||++.+..+++++||||+||+++||++|+.||.+.+
T Consensus 172 ~~~--~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~ 222 (355)
T d2b1pa1 172 SFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_dssp -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccc--cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC
Confidence 332 345578999999999999999999999999999999999999997664
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-34 Score=304.72 Aligned_cols=195 Identities=27% Similarity=0.381 Sum_probs=163.6
Q ss_pred ccccccccccccEEEEEEEE-CCccEEEEEEeecCC--cccHHHHHHHHHHHhcCCCCCccceeceeecC-----CeEEE
Q 043185 512 DNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVG--VQGKKDFCTEIAIIGNIHHVNLVKLKGFCAQG-----RQRLL 583 (724)
Q Consensus 512 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~~l 583 (724)
|...+.||+|+||+||+|+. .+++.||||++++.. ....+++.+|+++|++++|||||++++++... ...++
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 99 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 99 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEE
Confidence 55568999999999999996 478899999997542 23446788999999999999999999998633 34567
Q ss_pred EEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeecCccccCCC
Q 043185 584 VYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFGLSKLLTPE 663 (724)
Q Consensus 584 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~~~~~ 663 (724)
+++|+.+|+|.+++... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||++......
T Consensus 100 i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~ 174 (348)
T d2gfsa1 100 LVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174 (348)
T ss_dssp EEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CCTGG
T ss_pred EEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcccCcc
Confidence 77888999999998543 68999999999999999999997 89999999999999999999999999999755332
Q ss_pred CccceecccccccccccccccCC-cCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 043185 664 QSSLFTTMRGTRGYLAPEWLTNS-AISEKTDVYSFGMVLLELVSGRRNCSPRS 715 (724)
Q Consensus 664 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDv~SlGv~l~elltG~~p~~~~~ 715 (724)
.....|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+
T Consensus 175 ----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~ 223 (348)
T d2gfsa1 175 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223 (348)
T ss_dssp ----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC
Confidence 2446789999999987765 46899999999999999999999997765
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=3.5e-30 Score=275.38 Aligned_cols=199 Identities=24% Similarity=0.245 Sum_probs=158.4
Q ss_pred hccccccccccccEEEEEEEE-CCccEEEEEEeecCCcccHHHHHHHHHHHhcCC-----------CCCccceeceeecC
Q 043185 511 TDNFKNLIGSGGFGAVYKGIL-NDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIH-----------HVNLVKLKGFCAQG 578 (724)
Q Consensus 511 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~g~~~~~ 578 (724)
+|.+.++||+|+||+||+|+. .+++.||||++++. ....+.+.+|+.++++++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 467789999999999999997 47889999999754 233466788998888775 57899999887543
Q ss_pred --CeEEEEEEecCCCCHHH--HHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCc------
Q 043185 579 --RQRLLVYEYMNHGSLDR--ILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQ------ 648 (724)
Q Consensus 579 --~~~~lV~e~~~~gsL~~--~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~------ 648 (724)
...+++++++..+.... ........+.+..+..++.||+.||+|||+ ..+|+||||||+||||+.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccce
Confidence 45667777665544322 223345678889999999999999999996 588999999999999987654
Q ss_pred EEEEeecCccccCCCCccceecccccccccccccccCCcCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 043185 649 AKISDFGLSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVLLELVSGRRNCSPRSQ 716 (724)
Q Consensus 649 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l~elltG~~p~~~~~~ 716 (724)
++++|||.+....... ....||+.|+|||++.+..++.++|+||+||+++||++|+.||.+...
T Consensus 171 ~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~ 234 (362)
T d1q8ya_ 171 IKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 234 (362)
T ss_dssp EEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred eeEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcc
Confidence 9999999998654332 345799999999999999999999999999999999999999987654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.84 E-value=1.3e-21 Score=188.56 Aligned_cols=168 Identities=15% Similarity=0.117 Sum_probs=119.2
Q ss_pred ccccccccccEEEEEEEECCccEEEEEEeecCCc-----c-------------cHHHHHHHHHHHhcCCCCCccceecee
Q 043185 514 FKNLIGSGGFGAVYKGILNDKTIVAVKKITNVGV-----Q-------------GKKDFCTEIAIIGNIHHVNLVKLKGFC 575 (724)
Q Consensus 514 ~~~~lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~-----~-------------~~~~~~~E~~~l~~l~H~nIv~l~g~~ 575 (724)
+.++||+|+||+||+|+..+++.||||+++.... . ......+|...+.++.|++++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 4688999999999999998889999998753110 0 012345688899999999999887653
Q ss_pred ecCCeEEEEEEecCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeEEeCCCcEEEEeec
Q 043185 576 AQGRQRLLVYEYMNHGSLDRILFGNGPVLEWQERFDIALGTARGLAYLHSGCEQKIIHCDIKPENILLHYHFQAKISDFG 655 (724)
Q Consensus 576 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DFG 655 (724)
. .+++|||+++..+.. +......+++.|++.+|+|||+ .+|+||||||+|||++++ .++|+|||
T Consensus 84 ~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~liDFG 147 (191)
T d1zara2 84 G----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIIDFP 147 (191)
T ss_dssp T----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEECCCT
T ss_pred C----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEEECC
Confidence 2 379999999866533 2334456789999999999997 899999999999999965 58999999
Q ss_pred CccccCCCCccceecccccccccccccccCCcCCCccchhhHHHHH
Q 043185 656 LSKLLTPEQSSLFTTMRGTRGYLAPEWLTNSAISEKTDVYSFGMVL 701 (724)
Q Consensus 656 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDv~SlGv~l 701 (724)
+|+........... ...... ..|.+ .+.|..++|+||..--+
T Consensus 148 ~a~~~~~~~~~~~l--~rd~~~-~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 148 QSVEVGEEGWREIL--ERDVRN-IITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TCEETTSTTHHHHH--HHHHHH-HHHHH-HHHHCCCCCHHHHHHHH
T ss_pred CcccCCCCCcHHHH--HHHHHH-HHHHH-cCCCCCcccHHHHHHHH
Confidence 99766433211000 000000 01111 35678899999965433
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.73 E-value=9.1e-18 Score=145.52 Aligned_cols=110 Identities=19% Similarity=0.352 Sum_probs=86.5
Q ss_pred ccccccCCcccceeeeecCCCeEEeCCCeEEEEEEecCCCCceEEEEEEeccCCeEEEecCCCCCCCCCceEEEccCcc-
Q 043185 23 SEFIHPNFTASHVKFIDYGGSFLTSHNGTFKAAIVNTRSQQNSFYLCIIHVLSNTIIWSANRDTPISGSGKMNLTPKGI- 101 (724)
Q Consensus 23 ~~~~~~~~t~~~~~~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~i~~~~~~~~tvVW~Anr~~pv~~~~~l~~~~~g~- 101 (724)
+|+|.||++|. .+++|+ +|.|+|.|+..++ +.++. ..++||.||++.|... ..|.|+.+|+
T Consensus 1 tDtL~~gq~L~-------~g~~l~--~g~~~l~~q~DGN----Lvly~----~~~~vW~s~~~~~~~~-~~l~l~~dGnL 62 (112)
T d1xd5a_ 1 SDRLNSGHQLD-------TGGSLA--EGGYLFIIQNDCN----LVLYD----NNRAVWASGTNGKASG-CVLKMQNDGNL 62 (112)
T ss_dssp CCEEETTEEEC-------TTCEEE--ETTEEEEECTTSC----EEEEE----TTEEEEECCCTTSCSS-EEEEECTTSCE
T ss_pred CCEecCCCEec-------CCCEEE--ECCEEEEEcCCCC----EEEEc----CCcEEEEccCccCCCC-cEEEEeccccE
Confidence 37788888875 477887 4999999986653 33332 5789999999988433 5899999995
Q ss_pred EEEcCCCCeEEecCCCCC-ceeEEEEecCCcEEEecCCCccceecccCCCc
Q 043185 102 IISDENGNLKWSTPPLKS-SVSALRLTEMGNLVLLDGFNGSLWESFHHPRD 151 (724)
Q Consensus 102 ~l~~~~g~~vWst~~~~~-~~~~~~L~dsGNlVl~~~~~~~lWQSFd~PtD 151 (724)
+|.|. +..+|++++... +..+|+|+|+|||||++.++.++|||+.+|++
T Consensus 63 vl~~~-~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 63 VIYSG-SRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112 (112)
T ss_dssp EEEET-TEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCCCC
T ss_pred EEEec-CCeEEEEeeccCCCceEEEEcCCCCEEEECCCCcEEecCCCccCC
Confidence 67775 567777776543 45689999999999999999999999999986
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.72 E-value=2.5e-17 Score=141.32 Aligned_cols=105 Identities=18% Similarity=0.322 Sum_probs=84.1
Q ss_pred cccccCCcccceeeeecCCCeEEeCCCeEEEEEEecCCCCceEEEEEEeccCCeEEEecCCCCCCCCCceEEEccCc-cE
Q 043185 24 EFIHPNFTASHVKFIDYGGSFLTSHNGTFKAAIVNTRSQQNSFYLCIIHVLSNTIIWSANRDTPISGSGKMNLTPKG-II 102 (724)
Q Consensus 24 ~~~~~~~t~~~~~~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~i~~~~~~~~tvVW~Anr~~pv~~~~~l~~~~~g-~~ 102 (724)
|.|.||+++. .++.|. +|.|.|+|...++ +.++ ...++||+||++.|....+.|.|+.+| ++
T Consensus 2 ~~L~~g~~L~-------~g~~l~--~g~~~l~~q~dgn----Lvl~----~~~~~vW~ant~~~~~~~~~l~l~~dGnLv 64 (109)
T d1kj1a_ 2 NLLTNGEGLY-------AGQSLD--VEPYHFIMQEDCN----LVLY----DHSTSVWASNTGILGKKGCKAVLQSDGNFV 64 (109)
T ss_dssp CEEETTCEEE-------TTCEEE--ETTEEEEECTTSC----EEEE----ETTEEEEECCCCCTTCCCCEEEECTTSCEE
T ss_pred CCccCCCEEe-------CCCEEE--eCCEEEEecCCCe----EEEE----eCCEEEEEeCCCCCCceeEEEEEcCCceEE
Confidence 5677788875 367776 4889999975542 3332 256899999999999888899999999 58
Q ss_pred EEcCCCCeEEecCCCC-CceeEEEEecCCcEEEecCCCccceecccC
Q 043185 103 ISDENGNLKWSTPPLK-SSVSALRLTEMGNLVLLDGFNGSLWESFHH 148 (724)
Q Consensus 103 l~~~~g~~vWst~~~~-~~~~~~~L~dsGNlVl~~~~~~~lWQSFd~ 148 (724)
|.|++|++||+|+++. .+..+|+|+|+|||||+++ .+|||+-|
T Consensus 65 l~~~~g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~---~~W~S~t~ 108 (109)
T d1kj1a_ 65 VYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGS---DIWSTGTY 108 (109)
T ss_dssp EECSSSCEEEECCCCCCSSCCEEEECTTSCEEEECC---EEEECCCC
T ss_pred EEeCCCcEEEEEeeECCCCCEEEEEeCCCcEEEECC---CEecCCCc
Confidence 8899999999999864 4456799999999999964 59999875
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.68 E-value=1.3e-16 Score=136.86 Aligned_cols=104 Identities=18% Similarity=0.286 Sum_probs=81.5
Q ss_pred cccccCCcccceeeeecCCCeEEeCCCeEEEEEEecCCCCceEEEEEEeccCCeEEEecCCCCCCCCCceEEEccCcc-E
Q 043185 24 EFIHPNFTASHVKFIDYGGSFLTSHNGTFKAAIVNTRSQQNSFYLCIIHVLSNTIIWSANRDTPISGSGKMNLTPKGI-I 102 (724)
Q Consensus 24 ~~~~~~~t~~~~~~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~i~~~~~~~~tvVW~Anr~~pv~~~~~l~~~~~g~-~ 102 (724)
|.|.+|+++. .++.|. +|.|+|.|+..++ +.|+. ..++||.||++.|-. ...|.++.+|+ +
T Consensus 2 ~~L~~g~~L~-------~G~~l~--ng~~~l~~q~DGN----Lvly~----~~~~vW~s~~~~~~~-~~~l~l~~~Gnlv 63 (108)
T d1jpca_ 2 NILYSGETLS-------TGEFLN--YGSFVFIMQEDCN----LVLYD----VDKPIWATNTGGLSR-SCFLSMQTDGNLV 63 (108)
T ss_dssp CEEETTEEEC-------TTCEEE--ETTEEEEECTTSC----EEEEE----TTEEEEECCCTTSCS-SCEEEECTTSCEE
T ss_pred CCccCCCEec-------CCCEEE--cCCEEEEECCCCe----EEEEe----CCceeeEeCCCCCCC-ccEEEEeccceEE
Confidence 5677777765 467774 6999999987763 44432 468999999998832 35799999995 8
Q ss_pred EEcCCCCeEEecCCCCCc-eeEEEEecCCcEEEecCCCccceecccC
Q 043185 103 ISDENGNLKWSTPPLKSS-VSALRLTEMGNLVLLDGFNGSLWESFHH 148 (724)
Q Consensus 103 l~~~~g~~vWst~~~~~~-~~~~~L~dsGNlVl~~~~~~~lWQSFd~ 148 (724)
|.|++|.+||+|++.... ..+|+|+|+|||||++. .+||||+|
T Consensus 64 l~~~~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~---~~W~S~t~ 107 (108)
T d1jpca_ 64 VYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGT---DRWATGTH 107 (108)
T ss_dssp EECTTCCEEEECCCCCSCSCEEEEECTTSCEEEEEC---CCCCCCCC
T ss_pred EECCCccceEEccccCCCCcEEEEEcCCCCEEEeCC---CcccCCCC
Confidence 889999999999976543 35689999999999954 59999987
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.58 E-value=8.3e-16 Score=133.92 Aligned_cols=106 Identities=14% Similarity=0.192 Sum_probs=85.6
Q ss_pred EEEEEeccCCeEEEecCCCCCCCCC-ceEEEccCcc-EEEcCCCCeEEecCCCCC-ceeEEEEecCCcEEEecCCCccce
Q 043185 67 YLCIIHVLSNTIIWSANRDTPISGS-GKMNLTPKGI-IISDENGNLKWSTPPLKS-SVSALRLTEMGNLVLLDGFNGSLW 143 (724)
Q Consensus 67 ~i~~~~~~~~tvVW~Anr~~pv~~~-~~l~~~~~g~-~l~~~~g~~vWst~~~~~-~~~~~~L~dsGNlVl~~~~~~~lW 143 (724)
.|||..+++++.+|++|++.|+... -+|.+..||+ +|.+ .+.++|++++... ...+|+|+++|||||+|.++.++|
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~-~~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~~~lW 89 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFD-RDDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVW 89 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEB-TTBCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEEE
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEec-CCcEEEEEccccCCCcEEEEEeCCeeEEEEcCCCCEEE
Confidence 4677778889999999999999877 5999999996 5555 5778999998654 457899999999999999999999
Q ss_pred ecccCCCcccccCCccCCCceEEecCCCCCCCCcceEEEeCCCcccccccccccee
Q 043185 144 ESFHHPRDTIVIGQHLPAGASLSSAVSDYNLSTGDYSLTVGASDAELQWQGQMYWK 199 (724)
Q Consensus 144 QSFd~PtDtlLpgq~l~~~~~L~S~~s~~dps~G~~~~~~~~~~~~~~~~~~~yw~ 199 (724)
||++ +.++|.|.+.++++|....|. .++|.
T Consensus 90 ~S~t-------------------------~~~~~~~~l~Lq~DGnlvlY~-~~~W~ 119 (120)
T d1dlpa2 90 TSGN-------------------------SRSAGRYVFVLQPDRNLAIYG-GALWT 119 (120)
T ss_dssp ECCC-------------------------CCSSSCCEEEECSSSCEEEEC-CCCCB
T ss_pred EeCC-------------------------CCCCCcEEEEECCCCcEEEeC-CCccc
Confidence 9983 345788999999999886553 35664
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.47 E-value=8.3e-15 Score=126.12 Aligned_cols=108 Identities=16% Similarity=0.188 Sum_probs=87.8
Q ss_pred EEEEeccCCeEEEecCCCCCCCCC-ceEEEccCcc-EEEcCCCCeEEecCCCCCceeEEEEecCCcEEEecCCCccceec
Q 043185 68 LCIIHVLSNTIIWSANRDTPISGS-GKMNLTPKGI-IISDENGNLKWSTPPLKSSVSALRLTEMGNLVLLDGFNGSLWES 145 (724)
Q Consensus 68 i~~~~~~~~tvVW~Anr~~pv~~~-~~l~~~~~g~-~l~~~~g~~vWst~~~~~~~~~~~L~dsGNlVl~~~~~~~lWQS 145 (724)
|||--.+..+..|+.+.+.++... .+|.+..||+ ||.+ ++.++|++++.+..+..+.|+++|||||+|.++.++|||
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~~~~~~~l~l~~dGNLvl~d~~~~~vWsS 81 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSS 81 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEE-SSSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCC
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEc-CCeeEEEcccCCCCceEEEEeccCCEEEEccCCCEEEEc
Confidence 344444556778999999999877 5999999996 5555 678999999877777889999999999999999999998
Q ss_pred ccCCCcccccCCccCCCceEEecCCCCCCCCcceEEEeCCCccccccccccceeecC
Q 043185 146 FHHPRDTIVIGQHLPAGASLSSAVSDYNLSTGDYSLTVGASDAELQWQGQMYWKLSM 202 (724)
Q Consensus 146 Fd~PtDtlLpgq~l~~~~~L~S~~s~~dps~G~~~~~~~~~~~~~~~~~~~yw~~~~ 202 (724)
+. +.+.|.|.+.++++|....+ +..+|.++.
T Consensus 82 ~t-------------------------~~~~g~y~l~Lq~DGNlvlY-~~~~Wssgt 112 (115)
T d1dlpa1 82 GT-------------------------KGSIGNYVLVLQPDRTVTIY-GPGLWDSGT 112 (115)
T ss_dssp CC-------------------------CCCSSCCEEEECSSSCEEEE-CSEEEECSC
T ss_pred CC-------------------------CCCCCCEEEEECCCCcEEEe-CCCeecCCC
Confidence 73 34679999999999988655 346887653
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.43 E-value=5.5e-13 Score=115.36 Aligned_cols=91 Identities=18% Similarity=0.329 Sum_probs=72.3
Q ss_pred EEeCCCeEEEEEEecCCCCceEEEEEEeccCCeEEEecCCCCCCCCCceEEEccCc-cEEEcCCCCeEEecCCCCC-cee
Q 043185 45 LTSHNGTFKAAIVNTRSQQNSFYLCIIHVLSNTIIWSANRDTPISGSGKMNLTPKG-IIISDENGNLKWSTPPLKS-SVS 122 (724)
Q Consensus 45 lvS~~g~F~lGF~~~~~~~~~~~i~~~~~~~~tvVW~Anr~~pv~~~~~l~~~~~g-~~l~~~~g~~vWst~~~~~-~~~ 122 (724)
+++..|.|.|.|...++ +.+ + ...++||.||+..|.. ...|.|..+| ++|.|.+|.+||++++... ...
T Consensus 25 ~~~~~~~y~l~mQ~DGN----LVL-y---~~~~~vWssnt~~~~~-~~~l~l~~dGnLvL~d~~g~~vWsS~t~~~~~~~ 95 (119)
T d1b2pa_ 25 ILFGTHVYRFIMQTDCN----LVL-Y---DNNNPIWATNTGGLGN-GCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHY 95 (119)
T ss_dssp EEETTEEEEEEECTTSC----EEE-E---ETTEEEEECCCTTSCS-SCEEEECTTSCEEEECTTCCEEEECSCCCCSSCE
T ss_pred EecCCceEEEEECCCCc----EEE-E---ECCeEEEEecCCCCCc-ceEEEEEeCCCEEEECCCCcEEEECCCcCCCCce
Confidence 57789999999986663 333 2 2468999999987743 2689999999 5899999999999998654 345
Q ss_pred EEEEecCCcEEEecCCCccceeccc
Q 043185 123 ALRLTEMGNLVLLDGFNGSLWESFH 147 (724)
Q Consensus 123 ~~~L~dsGNlVl~~~~~~~lWQSFd 147 (724)
+|+|+|+|||||++ ..+|||-.
T Consensus 96 ~l~Lq~DGNlvlYg---~~~W~S~T 117 (119)
T d1b2pa_ 96 VLVLQPDRNVVIYG---DALWATQT 117 (119)
T ss_dssp EEEECTTSCEEEEE---SEEEECCC
T ss_pred EEEEcCCCCEEEEC---CCEeccCC
Confidence 78999999999985 47999965
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.97 E-value=6.3e-10 Score=95.07 Aligned_cols=91 Identities=19% Similarity=0.358 Sum_probs=68.1
Q ss_pred CCeEEeCCCeEEEEEEecCCCCceEEEEEEeccCCeEEEecCCCCCCCCCceEEEccCcc-EEEcCCCCeEEecCCCCC-
Q 043185 42 GSFLTSHNGTFKAAIVNTRSQQNSFYLCIIHVLSNTIIWSANRDTPISGSGKMNLTPKGI-IISDENGNLKWSTPPLKS- 119 (724)
Q Consensus 42 ~~~lvS~~g~F~lGF~~~~~~~~~~~i~~~~~~~~tvVW~Anr~~pv~~~~~l~~~~~g~-~l~~~~g~~vWst~~~~~- 119 (724)
++.| .+|.|.|.|...++ +.|. . ..++||.+|... .....+.|..+|+ ||.|.++++||++++...
T Consensus 20 ~~~l--~~g~~~l~~q~DGN----LvL~--~--~~~~vW~s~t~~--~~~~~l~l~~dGNLvl~d~~~~~vWsS~t~~~~ 87 (115)
T d1dlpa1 20 AQSL--ELSSFRFTMQSDCN----LVLF--D--SDVRVWASNTAG--ATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSI 87 (115)
T ss_dssp TCEE--CSTTEEEEECTTSC----EEEE--E--SSSEEECCCCCS--CSCCBCCBCSSSCBCCBCTTTCCSCCCCCCCCS
T ss_pred CCcE--EcCCEEEEECCCCe----EEEE--c--CCeeEEEcccCC--CCceEEEEeccCCEEEEccCCCEEEEcCCCCCC
Confidence 4445 46889999986653 4332 2 467899998754 2346899999995 888999999999998643
Q ss_pred ceeEEEEecCCcEEEecCCCccceeccc
Q 043185 120 SVSALRLTEMGNLVLLDGFNGSLWESFH 147 (724)
Q Consensus 120 ~~~~~~L~dsGNlVl~~~~~~~lWQSFd 147 (724)
+.-+++|+++|||||++ ..+|+|-.
T Consensus 88 g~y~l~Lq~DGNlvlY~---~~~Wssgt 112 (115)
T d1dlpa1 88 GNYVLVLQPDRTVTIYG---PGLWDSGT 112 (115)
T ss_dssp SCCEEEECSSSCEEEEC---SEEEECSC
T ss_pred CCEEEEECCCCcEEEeC---CCeecCCC
Confidence 34578999999999984 47999854
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.81 E-value=1.1e-08 Score=87.27 Aligned_cols=110 Identities=14% Similarity=0.146 Sum_probs=77.0
Q ss_pred CcccccCCccCCCceEEecCCCCCCCCcceEEEeCCCccc-cccccccceeecCCcccccccceeEeeEEecccceEEec
Q 043185 150 RDTIVIGQHLPAGASLSSAVSDYNLSTGDYSLTVGASDAE-LQWQGQMYWKLSMDTKAYVDSRYIVDYMAINRTGVYLFG 228 (724)
Q Consensus 150 tDtlLpgq~l~~~~~L~S~~s~~dps~G~~~~~~~~~~~~-~~~~~~~yw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (724)
||||+|||.|..|..|++ |+|+|.++.+|.. +++++..+|........ ......+..+|.+.+.
T Consensus 1 tDtL~~gq~L~~g~~l~~---------g~~~l~~q~DGNLvly~~~~~vW~s~~~~~~------~~~~l~l~~dGnLvl~ 65 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVLYDNNRAVWASGTNGKA------SGCVLKMQNDGNLVIY 65 (112)
T ss_dssp CCEEETTEEECTTCEEEE---------TTEEEEECTTSCEEEEETTEEEEECCCTTSC------SSEEEEECTTSCEEEE
T ss_pred CCEecCCCEecCCCEEEE---------CCEEEEEcCCCCEEEEcCCcEEEEccCccCC------CCcEEEEeccccEEEE
Confidence 899999999999999976 8999999999988 55566789976533211 1123567888988877
Q ss_pred CCCceEEEEeecCCCceEEEEEcCCCcEEEEEEeCCCcceeeeccCCCC
Q 043185 229 NNGSAVVIRVVLPPSNFRIAKLDASGQFTVLRLSGSDLEQEYMGPDDGC 277 (724)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~l~~~G~l~~~~~~~~~~~~~~~~p~~~C 277 (724)
+.+..+..+........++++|+.||++++|. ......|....+.|
T Consensus 66 ~~~~~~w~s~t~~~~~~~~l~L~ddGNlvly~---~~~~~~W~S~t~~~ 111 (112)
T d1xd5a_ 66 SGSRAIWASNTNRQNGNYYLILQRDRNVVIYD---NSNNAIWATHTNVG 111 (112)
T ss_dssp ETTEEEEECCCCCSCCCCEEEECTTSCEEEEC---TTSCEEEECCCCCC
T ss_pred ecCCeEEEEeeccCCCceEEEEcCCCCEEEEC---CCCcEEecCCCccC
Confidence 66554444433333345789999999999983 23334455555444
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.81 E-value=4.1e-09 Score=90.87 Aligned_cols=109 Identities=15% Similarity=0.130 Sum_probs=73.4
Q ss_pred CcEEEecCCCccce--ecccCCCcccccCCccCCCceEEecCCCCCCCCcceEEEeCCCccc-cccccccceeecCCccc
Q 043185 130 GNLVLLDGFNGSLW--ESFHHPRDTIVIGQHLPAGASLSSAVSDYNLSTGDYSLTVGASDAE-LQWQGQMYWKLSMDTKA 206 (724)
Q Consensus 130 GNlVl~~~~~~~lW--QSFd~PtDtlLpgq~l~~~~~L~S~~s~~dps~G~~~~~~~~~~~~-~~~~~~~yw~~~~~~~~ 206 (724)
||+|+++..+.++| +|.|.|+++|.++|.|. .|.|+|.++.+|.. ++..+..+|.+......
T Consensus 1 g~~v~~~~~n~il~~~~~~~~~~~~l~~~q~l~---------------~g~y~L~~q~DGNLvL~~~~~~vW~s~t~~~~ 65 (120)
T d1dlpa2 1 GSVVVANNGNSILYSTQGNDNHPQTLHATQSLQ---------------LSPYRLSMETDCNLVLFDRDDRVWSTNTAGKG 65 (120)
T ss_dssp SCCCCSSCCCEECCCC--CCCCCCEECSSCCCB---------------CSSCEEEEETTTEEEEEBTTBCCSCCCCCSSC
T ss_pred CcEEEEeCCCeEEEcCCCCCCcccEEcCCCeeE---------------cCCEEEEEcCCCcEEEecCCcEEEEEccccCC
Confidence 45555555555556 67899999999999984 47799999999988 45556688876422111
Q ss_pred ccccceeEeeEEecccceEEecCCCceEEEEeecC-CCceEEEEEcCCCcEEEE
Q 043185 207 YVDSRYIVDYMAINRTGVYLFGNNGSAVVIRVVLP-PSNFRIAKLDASGQFTVL 259 (724)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~G~l~~~ 259 (724)
....+.+..+|.+.+.+............ ....++++|+.||++++|
T Consensus 66 ------~~~~~~l~~~GnLvl~d~~~~~lW~S~t~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 66 ------TGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp ------SSCEEEEETTTEEEEEETTTEEEEECCCCCSSSCCEEEECSSSCEEEE
T ss_pred ------CcEEEEEeCCeeEEEEcCCCCEEEEeCCCCCCCcEEEEECCCCcEEEe
Confidence 11235677889888776655555443332 233468999999999998
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.64 E-value=5e-08 Score=82.43 Aligned_cols=83 Identities=17% Similarity=0.268 Sum_probs=62.7
Q ss_pred ceEEEccCccEEEcCCCCeEEecCCCC--CceeEEEEecCCcEEEecCCCccceecccCCCcccccCCccCCCceEEecC
Q 043185 92 GKMNLTPKGIIISDENGNLKWSTPPLK--SSVSALRLTEMGNLVLLDGFNGSLWESFHHPRDTIVIGQHLPAGASLSSAV 169 (724)
Q Consensus 92 ~~l~~~~~g~~l~~~~g~~vWst~~~~--~~~~~~~L~dsGNlVl~~~~~~~lWQSFd~PtDtlLpgq~l~~~~~L~S~~ 169 (724)
-.|.+..||++++...+.+||++++.. .....+.|+++|||||+++++.++|+|=
T Consensus 21 ~~l~~q~dgnLvl~~~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~s~----------------------- 77 (109)
T d1kj1a_ 21 YHFIMQEDCNLVLYDHSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWASH----------------------- 77 (109)
T ss_dssp EEEEECTTSCEEEEETTEEEEECCCCCTTCCCCEEEECTTSCEEEECSSSCEEEECC-----------------------
T ss_pred EEEEecCCCeEEEEeCCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCCCcEEEEEe-----------------------
Confidence 367788899755555778999999753 3456789999999999999999999871
Q ss_pred CCCCCCCcceEEEeCCCccccccccccceee
Q 043185 170 SDYNLSTGDYSLTVGASDAELQWQGQMYWKL 200 (724)
Q Consensus 170 s~~dps~G~~~~~~~~~~~~~~~~~~~yw~~ 200 (724)
+.-+.|.|.+.++++|..+.+. ...|.+
T Consensus 78 --t~~~~~~~~l~L~ddGNlvly~-~~~W~S 105 (109)
T d1kj1a_ 78 --SVRGNGNYVLVLQEDGNVVIYG-SDIWST 105 (109)
T ss_dssp --CCCCSSCCEEEECTTSCEEEEC-CEEEEC
T ss_pred --eECCCCCEEEEEeCCCcEEEEC-CCEecC
Confidence 1113467899999999886554 357754
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.63 E-value=5.1e-08 Score=83.56 Aligned_cols=83 Identities=19% Similarity=0.309 Sum_probs=62.7
Q ss_pred eEEEccCccEEEcCCCCeEEecCCCCC-ceeEEEEecCCcEEEecCCCccceecccCCCcccccCCccCCCceEEecCCC
Q 043185 93 KMNLTPKGIIISDENGNLKWSTPPLKS-SVSALRLTEMGNLVLLDGFNGSLWESFHHPRDTIVIGQHLPAGASLSSAVSD 171 (724)
Q Consensus 93 ~l~~~~~g~~l~~~~g~~vWst~~~~~-~~~~~~L~dsGNlVl~~~~~~~lWQSFd~PtDtlLpgq~l~~~~~L~S~~s~ 171 (724)
.|.+..||++++-..+.++|++++.+. ....++|+++|||||.|..+..+|+|.-
T Consensus 33 ~l~mQ~DGNLVLy~~~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~g~~vWsS~t------------------------ 88 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDNNNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPV------------------------ 88 (119)
T ss_dssp EEEECTTSCEEEEETTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECSC------------------------
T ss_pred EEEECCCCcEEEEECCeEEEEecCCCCCcceEEEEEeCCCEEEECCCCcEEEECCC------------------------
Confidence 577889996444345678999998654 3578999999999999999999998641
Q ss_pred CCCCCcceEEEeCCCccccccccccceeec
Q 043185 172 YNLSTGDYSLTVGASDAELQWQGQMYWKLS 201 (724)
Q Consensus 172 ~dps~G~~~~~~~~~~~~~~~~~~~yw~~~ 201 (724)
.-+.|.|.+.++++|....+ +.+.|.+.
T Consensus 89 -~~~~~~~~l~Lq~DGNlvlY-g~~~W~S~ 116 (119)
T d1b2pa_ 89 -AGKAGHYVLVLQPDRNVVIY-GDALWATQ 116 (119)
T ss_dssp -CCCSSCEEEEECTTSCEEEE-ESEEEECC
T ss_pred -cCCCCceEEEEcCCCCEEEE-CCCEeccC
Confidence 11346789999999988655 44677653
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.60 E-value=6.3e-08 Score=81.73 Aligned_cols=82 Identities=17% Similarity=0.252 Sum_probs=61.9
Q ss_pred ceEEEccCcc-EEEcCCCCeEEecCCCCC-ceeEEEEecCCcEEEecCCCccceecccCCCcccccCCccCCCceEEecC
Q 043185 92 GKMNLTPKGI-IISDENGNLKWSTPPLKS-SVSALRLTEMGNLVLLDGFNGSLWESFHHPRDTIVIGQHLPAGASLSSAV 169 (724)
Q Consensus 92 ~~l~~~~~g~-~l~~~~g~~vWst~~~~~-~~~~~~L~dsGNlVl~~~~~~~lWQSFd~PtDtlLpgq~l~~~~~L~S~~ 169 (724)
-+|.+..||+ ||.+ .+.+||++++... ....++|+++|||||+++++..+|+|
T Consensus 21 ~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~g~~vWsS------------------------ 75 (108)
T d1jpca_ 21 FVFIMQEDCNLVLYD-VDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWAS------------------------ 75 (108)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEEC------------------------
T ss_pred EEEEECCCCeEEEEe-CCceeeEeCCCCCCCccEEEEeccceEEEECCCccceEEc------------------------
Confidence 3678889996 5554 6789999998654 34679999999999999999999986
Q ss_pred CCCCCCCcceEEEeCCCccccccccccceee
Q 043185 170 SDYNLSTGDYSLTVGASDAELQWQGQMYWKL 200 (724)
Q Consensus 170 s~~dps~G~~~~~~~~~~~~~~~~~~~yw~~ 200 (724)
.+....+.|.+.++++|..+.+. .+.|.+
T Consensus 76 -~t~~~~~~~~l~L~ddGNlVly~-~~~W~S 104 (108)
T d1jpca_ 76 -NTGGQNGNYVCILQKDRNVVIYG-TDRWAT 104 (108)
T ss_dssp -CCCCSCSCEEEEECTTSCEEEEE-CCCCCC
T ss_pred -cccCCCCcEEEEEcCCCCEEEeC-CCcccC
Confidence 11123567889999999886553 346654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.19 E-value=2.4e-06 Score=84.05 Aligned_cols=132 Identities=17% Similarity=0.022 Sum_probs=90.1
Q ss_pred cccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCC-CCCccceeceeecCCeEEEEEEecCCCCHHHHHhc
Q 043185 521 GGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIH-HVNLVKLKGFCAQGRQRLLVYEYMNHGSLDRILFG 599 (724)
Q Consensus 521 G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~ 599 (724)
++...||+.... ++.+++|+..........++.+|...+..+. +--+.+++.+...++..++||+++++.++......
T Consensus 25 ~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~ 103 (263)
T d1j7la_ 25 MSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED 103 (263)
T ss_dssp CSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred CCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc
Confidence 344689988654 4457888886544444456778888887763 44567888888888899999999999887554321
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHcCC----------------------------------------------------
Q 043185 600 NGPVLEWQERFDIALGTARGLAYLHSGC---------------------------------------------------- 627 (724)
Q Consensus 600 ~~~~l~~~~~~~i~~~ia~~L~yLH~~~---------------------------------------------------- 627 (724)
. .....++.++++.++.||+..
T Consensus 104 ~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 177 (263)
T d1j7la_ 104 E------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTE 177 (263)
T ss_dssp C------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHS
T ss_pred c------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhc
Confidence 1 112223445555555555310
Q ss_pred ----CCCeEecCCCCCCeEEeCCCcEEEEeecCccc
Q 043185 628 ----EQKIIHCDIKPENILLHYHFQAKISDFGLSKL 659 (724)
Q Consensus 628 ----~~~iiH~Dlkp~NILl~~~~~~kl~DFGla~~ 659 (724)
...++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 178 ~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 178 KPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12389999999999999876677999987753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.67 E-value=6.6e-05 Score=72.95 Aligned_cols=73 Identities=14% Similarity=0.093 Sum_probs=52.2
Q ss_pred ccccc-cEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCC--CCCccceeceeecCCeEEEEEEecCCCCH
Q 043185 518 IGSGG-FGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIH--HVNLVKLKGFCAQGRQRLLVYEYMNHGSL 593 (724)
Q Consensus 518 lG~G~-fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~~~~~lV~e~~~~gsL 593 (724)
+..|. -..||+...+++..+++|...... ..++..|+..++.+. .-.+.+++.+..+++..++|||++++.++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 34444 367999998888878888765432 234567777776663 34467788888888889999999988655
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.31 E-value=0.00034 Score=72.61 Aligned_cols=75 Identities=15% Similarity=0.095 Sum_probs=47.1
Q ss_pred ccccccccEEEEEEEEC-CccEEEEEEeecC----C---cccHHHHHHHHHHHhcC-CC--CCccceeceeecCCeEEEE
Q 043185 516 NLIGSGGFGAVYKGILN-DKTIVAVKKITNV----G---VQGKKDFCTEIAIIGNI-HH--VNLVKLKGFCAQGRQRLLV 584 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~-~~~~vAvK~~~~~----~---~~~~~~~~~E~~~l~~l-~H--~nIv~l~g~~~~~~~~~lV 584 (724)
+.||.|....||+.... +++.++||..... . .....+...|.+.|+.+ .+ ..+.+++.+ +....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 46899999999999865 4567888876431 0 11233455688777665 22 345555544 44456799
Q ss_pred EEecCCCC
Q 043185 585 YEYMNHGS 592 (724)
Q Consensus 585 ~e~~~~gs 592 (724)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99998754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.79 E-value=0.0008 Score=67.74 Aligned_cols=133 Identities=11% Similarity=0.065 Sum_probs=77.7
Q ss_pred EEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCc--cceec-----eeecCCeEEEEEEecCCCCHH--
Q 043185 524 GAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNL--VKLKG-----FCAQGRQRLLVYEYMNHGSLD-- 594 (724)
Q Consensus 524 G~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nI--v~l~g-----~~~~~~~~~lV~e~~~~gsL~-- 594 (724)
-.||+++.++|+.+++|..+.. ....+++..|...+..|....+ +..+. ....+...+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 5799999999998999987653 4456778889888887743322 22221 223455778899998864321
Q ss_pred ---HH------H---h----c----CCCCCCHH----------------------HHHHHHHHHHHHHHHH-HcCCCCCe
Q 043185 595 ---RI------L---F----G----NGPVLEWQ----------------------ERFDIALGTARGLAYL-HSGCEQKI 631 (724)
Q Consensus 595 ---~~------l---~----~----~~~~l~~~----------------------~~~~i~~~ia~~L~yL-H~~~~~~i 631 (724)
.+ + + . .....+.. .....+.++...+.-+ ......++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 11 1 0 0 00111111 1112222222222222 12234579
Q ss_pred EecCCCCCCeEEeCCCcEEEEeecCccc
Q 043185 632 IHCDIKPENILLHYHFQAKISDFGLSKL 659 (724)
Q Consensus 632 iH~Dlkp~NILl~~~~~~kl~DFGla~~ 659 (724)
||+|+++.|||++.+ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999743 45899987753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.04 E-value=0.0047 Score=63.69 Aligned_cols=72 Identities=17% Similarity=0.119 Sum_probs=47.7
Q ss_pred ccccccccEEEEEEEECCc--------cEEEEEEeecCCcccHHHHHHHHHHHhcCC-CCCccceeceeecCCeEEEEEE
Q 043185 516 NLIGSGGFGAVYKGILNDK--------TIVAVKKITNVGVQGKKDFCTEIAIIGNIH-HVNLVKLKGFCAQGRQRLLVYE 586 (724)
Q Consensus 516 ~~lG~G~fG~Vy~~~~~~~--------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~e 586 (724)
+.|+.|-.-.+|+....++ +.|.+++.- . .....+..+|..+++.+. +.-..++++++.. .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 4677888889999987643 345555443 2 333445668888888884 4334577777654 58899
Q ss_pred ecCCCCH
Q 043185 587 YMNHGSL 593 (724)
Q Consensus 587 ~~~~gsL 593 (724)
|+++..|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.09 E-value=0.018 Score=56.94 Aligned_cols=138 Identities=12% Similarity=0.045 Sum_probs=71.5
Q ss_pred ccccccEEEEEEEECCccEEEEEEeecCCcccHHHHHHHHHHHhcCCCCCc--cceec------eeecCCeEEEEEEecC
Q 043185 518 IGSGGFGAVYKGILNDKTIVAVKKITNVGVQGKKDFCTEIAIIGNIHHVNL--VKLKG------FCAQGRQRLLVYEYMN 589 (724)
Q Consensus 518 lG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nI--v~l~g------~~~~~~~~~lV~e~~~ 589 (724)
|..|---+.|+.+.++++ .++|+.... ...++...|++++..+.+.++ ...+- +.........++.+..
T Consensus 26 i~~G~~N~ny~v~t~~g~-yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~ 102 (316)
T d2ppqa1 26 IAEGVENSNFLLHTTKDP-LILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE 102 (316)
T ss_dssp ECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred CCCCcccCeEEEEECCCc-EEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeecc
Confidence 456666788999988776 788887642 122344556667666642222 22221 1122345566777766
Q ss_pred CCCHHH-----------HH---h---cC--C---CCCCH------------------HHHHHHHHHHHHHHHHHHc-CCC
Q 043185 590 HGSLDR-----------IL---F---GN--G---PVLEW------------------QERFDIALGTARGLAYLHS-GCE 628 (724)
Q Consensus 590 ~gsL~~-----------~l---~---~~--~---~~l~~------------------~~~~~i~~~ia~~L~yLH~-~~~ 628 (724)
+..... .+ + .. . ..... ......+..+...+.-.+. ...
T Consensus 103 g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~ 182 (316)
T d2ppqa1 103 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP 182 (316)
T ss_dssp CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred cccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCccccc
Confidence 543210 00 0 00 0 00000 0111122222222222221 234
Q ss_pred CCeEecCCCCCCeEEeCCCcEEEEeecCcc
Q 043185 629 QKIIHCDIKPENILLHYHFQAKISDFGLSK 658 (724)
Q Consensus 629 ~~iiH~Dlkp~NILl~~~~~~kl~DFGla~ 658 (724)
.++||+|+.+.||+++.+...-|.||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 679999999999999988777899999875
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.82 E-value=0.014 Score=35.80 Aligned_cols=34 Identities=32% Similarity=0.803 Sum_probs=27.1
Q ss_pred CCCCCCCCCCCCCccccCCCCCCCCCCCCCccccccC
Q 043185 274 DDGCQIPFICGRMGMCADDATSGSPSCSCPAGFHLAS 310 (724)
Q Consensus 274 ~~~C~~~~~CG~~g~C~~~~~~~~~~C~C~~GF~~~~ 310 (724)
.|.|.+-..|| +|-|++- .+...|.|-+||+|..
T Consensus 1 tdECsignpCG-nGTCtNv--iGgFec~C~~GFepgp 34 (39)
T d1emoa2 1 TDECSVGNPCG-NGTCKNV--IGGFECTCEEGFEPGP 34 (39)
T ss_dssp CCGGGTTCSSS-SSCEEEC--SSSEEECCSSSSCCCS
T ss_pred CCccccCCccC-Cceeeec--ccceEEeecCCcCCCc
Confidence 37899999998 7889753 2467899999999864
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.68 E-value=0.077 Score=34.86 Aligned_cols=31 Identities=32% Similarity=0.836 Sum_probs=25.0
Q ss_pred CCCCC-CCCCCCCccccCCCCCCCCCCCCCcccc
Q 043185 275 DGCQI-PFICGRMGMCADDATSGSPSCSCPAGFH 307 (724)
Q Consensus 275 ~~C~~-~~~CG~~g~C~~~~~~~~~~C~C~~GF~ 307 (724)
|+|.. ...|...|.|.... ++-.|.|++||+
T Consensus 4 deC~~~~~pC~n~g~C~n~~--g~y~C~C~~G~~ 35 (42)
T d2vj3a1 4 DECSLGANPCEHAGKCINTL--GSFECQCLQGYT 35 (42)
T ss_dssp CTTTSSSCSSSTTCEEEECS--SSEEEECCTTEE
T ss_pred ccccCCCCCCCCCcEeECCC--CCEEeECCCCCc
Confidence 67875 57899999997653 467899999996
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.61 E-value=0.098 Score=34.65 Aligned_cols=34 Identities=29% Similarity=0.791 Sum_probs=24.6
Q ss_pred CCCCCC-CCCCCCccccCCCCCCCCCCCCCccccccCC
Q 043185 275 DGCQIP-FICGRMGMCADDATSGSPSCSCPAGFHLASQ 311 (724)
Q Consensus 275 ~~C~~~-~~CG~~g~C~~~~~~~~~~C~C~~GF~~~~~ 311 (724)
|+|... ..| .++.|.+.. ++-.|.|++||+...+
T Consensus 4 dEC~~~~~~C-~~~~C~Nt~--Gsy~C~C~~Gy~~~~~ 38 (44)
T d1lmja1 4 DECRISPDLC-GRGQCVNTP--GDFECKCDEGYESGFM 38 (44)
T ss_dssp CTTTTCSSTT-TTSCEEEET--TEEEECCCSSEEECTT
T ss_pred cccCCCCCCC-CCCEeEcCC--CCeEEeCCCCCccCCC
Confidence 678764 456 478997553 5788999999986543
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.39 E-value=0.22 Score=31.90 Aligned_cols=30 Identities=37% Similarity=0.918 Sum_probs=23.6
Q ss_pred CCCCCCCCCCCCccccCCCCCCCCCCCCCcccc
Q 043185 275 DGCQIPFICGRMGMCADDATSGSPSCSCPAGFH 307 (724)
Q Consensus 275 ~~C~~~~~CG~~g~C~~~~~~~~~~C~C~~GF~ 307 (724)
|+|. ...|...|.|.... ..-.|.|++||+
T Consensus 1 D~C~-~~PC~ngg~C~~~~--~~y~C~C~~G~~ 30 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKDGL--GEYTCTCLEGFE 30 (39)
T ss_dssp CTTT-TCCCCSSCEECCCS--SSCCEECCTTEE
T ss_pred CcCC-CCCCCCCcEEECCC--CCEEEECCCCCC
Confidence 4565 57899999997553 468899999996
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.38 E-value=0.38 Score=31.54 Aligned_cols=32 Identities=38% Similarity=0.827 Sum_probs=24.6
Q ss_pred CCCCCCCCCCCCCccccCCCCCCCCCCCCCccccc
Q 043185 274 DDGCQIPFICGRMGMCADDATSGSPSCSCPAGFHL 308 (724)
Q Consensus 274 ~~~C~~~~~CG~~g~C~~~~~~~~~~C~C~~GF~~ 308 (724)
-|+|..+. |+..+.|.+.. ++-.|.|++||+.
T Consensus 5 idEC~~~~-~~~~~~C~Nt~--Gsy~C~C~~Gy~~ 36 (43)
T d1emoa1 5 MDECKEPD-VCKHGQCINTD--GSYRCECPFGYIL 36 (43)
T ss_dssp CCSSSSTT-SCSSSCCCCCS--SCCCCCCCTTEEE
T ss_pred eeccCCcC-CCCCCEeECCC--CCeEeECCCCccc
Confidence 47897654 55789997553 5789999999986
|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.30 E-value=0.33 Score=31.46 Aligned_cols=32 Identities=38% Similarity=0.876 Sum_probs=24.3
Q ss_pred CCCCCCCCCCCCccccCCCCCCCCCCCCCccccccC
Q 043185 275 DGCQIPFICGRMGMCADDATSGSPSCSCPAGFHLAS 310 (724)
Q Consensus 275 ~~C~~~~~CG~~g~C~~~~~~~~~~C~C~~GF~~~~ 310 (724)
|+|...+.| ..+|.+.. ++-.|.|++||+...
T Consensus 2 dEC~~~~~C--~~~C~n~~--Gsy~C~C~~Gy~L~~ 33 (41)
T d1i0ua2 2 DECQDPDTC--SQLCVNLE--GGYKCQCEEGFQLDP 33 (41)
T ss_dssp CTTTTTTSC--SSCEECSS--SCCEECCCTTEEECT
T ss_pred ccCCCCCCC--CCEeECCC--CCEEeECCCCCeECC
Confidence 678877777 46897543 578899999999754
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.56 E-value=0.25 Score=31.69 Aligned_cols=30 Identities=27% Similarity=0.703 Sum_probs=23.4
Q ss_pred CCCCCCCCCCCCccccCCCCCCCCCCCCCcccc
Q 043185 275 DGCQIPFICGRMGMCADDATSGSPSCSCPAGFH 307 (724)
Q Consensus 275 ~~C~~~~~CG~~g~C~~~~~~~~~~C~C~~GF~ 307 (724)
|+|. ...|...|.|.... .+-.|.|++||.
T Consensus 2 d~C~-~~PC~n~g~C~~~~--~~y~C~C~~G~~ 31 (39)
T d2vj3a2 2 NECV-SNPCQNDATCLDQI--GEFQCICMPGYE 31 (39)
T ss_dssp CTTT-TCCCCSSCEEEECS--SCEEEECCTTEE
T ss_pred cCCc-CCCCCCCCEEECCC--CCEEEeCCCCCc
Confidence 5564 46799999998653 468899999996
|